-- MySQL Script generated by MySQL Workbench
-- seg 16 mar 2020 14:28:58 -03
-- Model: New Model    Version: 1.0
-- MySQL Workbench Forward Engineering

SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0;
SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0;
SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='TRADITIONAL,ALLOW_INVALID_DATES';

-- -----------------------------------------------------
-- Schema kegg-pathway-bottleneck
-- -----------------------------------------------------
DROP SCHEMA IF EXISTS `kegg-pathway-bottleneck` ;

-- -----------------------------------------------------
-- Schema kegg-pathway-bottleneck
-- -----------------------------------------------------
CREATE SCHEMA IF NOT EXISTS `kegg-pathway-bottleneck` DEFAULT CHARACTER SET utf8 ;
USE `kegg-pathway-bottleneck` ;

-- -----------------------------------------------------
-- Table `kegg-pathway-bottleneck`.`pathway_data`
-- -----------------------------------------------------
DROP TABLE IF EXISTS `kegg-pathway-bottleneck`.`pathway_data` ;

CREATE TABLE IF NOT EXISTS `kegg-pathway-bottleneck`.`pathway_data` (
  `id` INT NOT NULL AUTO_INCREMENT,
  `code` VARCHAR(10) NOT NULL,
  `name` VARCHAR(150) NULL,
  `description` MEDIUMTEXT NULL,
  `class` MEDIUMTEXT NULL,
  `pathway_map` MEDIUMTEXT NULL,
  `module` MEDIUMTEXT NULL,
  `disease` MEDIUMTEXT NULL,
  `dblinks` MEDIUMTEXT NULL,
  `ko_pathway` MEDIUMTEXT NULL,
  `reference` MEDIUMTEXT NULL,
  `eukaryotes_count` INT NULL,
  `prokaryotes_count` INT NULL,
  `animals_count` INT NULL,
  `plants_count` INT NULL,
  `fungi_count` INT NULL,
  `protists_count` INT NULL,
  `bacteria_count` INT NULL,
  `archaea_count` INT NULL,
  PRIMARY KEY (`id`),
  UNIQUE INDEX `pathway_code_UNIQUE` (`code` ASC))
ENGINE = InnoDB;


SET SQL_MODE=@OLD_SQL_MODE;
SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS;
SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS;

-- -----------------------------------------------------
-- Data for table `kegg-pathway-bottleneck`.`pathway_data`
-- -----------------------------------------------------
START TRANSACTION;
USE `kegg-pathway-bottleneck`;
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (1, '00010', 'Glycolysis / Gluconeogenesis', 'Glycolysis is the process of converting glucose into pyruvate and generating small amounts of ATP (energy) and NADH (reducing power). It is a central pathway that produces important precursor metabolites: six-carbon compounds of glucose-6P and fructose-6P and three-carbon compounds of glycerone-P, glyceraldehyde-3P, glycerate-3P, phosphoenolpyruvate, and pyruvate [MD:M00001]. Acetyl-CoA, another important precursor metabolite, is produced by oxidative decarboxylation of pyruvate [MD:M00307]. When the enzyme genes of this pathway are examined in completely sequenced genomes, the reaction steps of three-carbon compounds from glycerone-P to pyruvate form a conserved core module [MD:M00002], which is found in almost all organisms and which sometimes contains operon structures in bacterial genomes. Gluconeogenesis is a synthesis pathway of glucose from noncarbohydrate precursors. It is essentially a reversal of glycolysis with minor variations of alternative paths [MD:M00003].', 'Metabolism; Carbohydrate metabolism', 'Glycolysis / Gluconeogenesis', 'Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate [PATH:map00010], Glycolysis, core module involving three-carbon compounds [PATH:map00010], Gluconeogenesis, oxaloacetate => fructose-6P [PATH:map00010], Ascorbate biosynthesis, plants, glucose-6P => ascorbate [PATH:map00010], Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map00010]', 'Glycogen storage disease, Hereditary fructose intolerance, Pyruvate dehydrogenase complex deficiency, Fructose-1,6-bisphosphatase deficiency, Anemia due to disorders of glycolytic enzymes, Acute alcohol sensitivity, Pyruvate kinase deficiency, Familial hyperinsulinemic hypoglycemia, Hepatic glycogen storage disease, Muscle glycogen storage disease, Glycogen storage disease type I, Glycogen storage disease type VII, Glycogen storage disease type XI, Glycogen storage disease type X, Glycogen storage disease type XII, Glycogen storage disease type XIII, Glycogen storage disease type XIV, Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-beta deficiency, Pyruvate dehydrogenase E2 deficiency, Dihydrolipoamide dehydrogenase deficiency', 'GO: 0006096 0006094', 'ko00010', 'list(REFERENCE = \"(map 1)\", AUTHORS = \"Nishizuka Y (ed).\", TITLE = \"[Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1980)\"), list(REFERENCE = \"(map 1)\", AUTHORS = \"Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\", TITLE = \"[Cellular Functions and Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1997)\"), list(REFERENCE = \"\", AUTHORS = \"Michal G.\", TITLE = \"Biochemical Pathways\", JOURNAL = \"Wiley (1999)\")', 531, 5553, 248, 105, 128, 50, 5256, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (2, '00020', 'Citrate cycle (TCA cycle)', 'The citrate cycle (TCA cycle, Krebs cycle) is an important aerobic pathway for the final steps of the oxidation of carbohydrates and fatty acids. The cycle starts with acetyl-CoA, the activated form of acetate, derived from glycolysis and pyruvate oxidation for carbohydrates and from beta oxidation of fatty acids. The two-carbon acetyl group in acetyl-CoA is transferred to the four-carbon compound of oxaloacetate to form the six-carbon compound of citrate. In a series of reactions two carbons in citrate are oxidized to CO2 and the reaction pathway supplies NADH for use in the oxidative phosphorylation and other metabolic processes. The pathway also supplies important precursor metabolites including 2-oxoglutarate. At the end of the cycle the remaining four-carbon part is transformed back to oxaloacetate. According to the genome sequence data, many organisms seem to lack genes for the full cycle [MD:M00009], but contain genes for specific segments [MD:M00010 M00011].', 'Metabolism; Carbohydrate metabolism', 'Citrate cycle (TCA cycle)', 'Gluconeogenesis, oxaloacetate => fructose-6P [PATH:map00020], Citrate cycle (TCA cycle, Krebs cycle) [PATH:map00020], Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map00020], Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:map00020], Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map00020], Methylaspartate cycle [PATH:map00020]', 'Pyruvate carboxylase deficiency, Mitochondrial DNA depletion syndrome, Multiple cutaneous and uterine leiomyomata, Diseases of the tricarboxylic acid cycle, D-2-hydroxyglutaric aciduria, Dihydrolipoamide dehydrogenase deficiency, Fumarase deficiency, Mitochondrial complex II deficiency, Alpha-ketoglutarate dehydrogenase complex deficiency, Infantile cerebellar-retinal degeneration', 'GO: 0006099', 'ko00020', 'list(REFERENCE = \"(map 2)\", AUTHORS = \"Nishizuka Y (ed).\", TITLE = \"[Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1980)\"), list(REFERENCE = \"(map 3)\", AUTHORS = \"Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\", TITLE = \"[Cellular Functions and Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1997)\"), list(REFERENCE = \"\", AUTHORS = \"Michal G.\", TITLE = \"Biochemical Pathways\", JOURNAL = \"Wiley (1999)\")', 526, 5480, 248, 105, 128, 45, 5183, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (3, '00030', 'Pentose phosphate pathway', 'The pentose phosphate pathway is a process of glucose turnover that produces NADPH as reducing equivalents and pentoses as essential parts of nucleotides. There are two different phases in the pathway. One is irreversible oxidative phase in which glucose-6P is converted to ribulose-5P by oxidative decarboxylation, and NADPH is generated [MD:M00006]. The other is reversible non-oxidative phase in which phosphorylated sugars are interconverted to generate xylulose-5P, ribulose-5P, and ribose-5P [MD:M00007]. Phosphoribosyl pyrophosphate (PRPP) formed from ribose-5P [MD:M00005] is an activated compound used in the biosynthesis of histidine and purine/pyrimidine nucleotides. This pathway map also shows the Entner-Doudoroff pathway where 6-P-gluconate is dehydrated and then cleaved into pyruvate and glyceraldehyde-3P [MD:M00008].', 'Metabolism; Carbohydrate metabolism', 'Pentose phosphate pathway', 'Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map00030], PRPP biosynthesis, ribose 5P => PRPP [PATH:map00030], Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map00030], Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map00030], Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map00030], D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P [PATH:map00030], Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map00030], Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map00030], Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map00030], Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map00030], D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P [PATH:map00030], Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map00030]', 'Phosphoribosylpyrophosphate synthetase superactivity, Anemia due to disorders of glutathione metabolism, Arts syndrome, Cortisone reductase deficiency, Ribose 5-phosphate isomerase deficiency, Transaldolase deficiency, Glucose 6-phosphate dehydrogenase deficiency, Glycogen storage disease type XII', 'GO: 0006098', 'ko00030', 'list(REFERENCE = \"(map 3)\", AUTHORS = \"Nishizuka Y (ed).\", TITLE = \"[Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1980)\"), list(REFERENCE = \"(map 4)\", AUTHORS = \"Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\", TITLE = \"[Cellular Functions and Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1997)\"), list(REFERENCE = \"\", AUTHORS = \"Michal G.\", TITLE = \"Biochemical Pathways\", JOURNAL = \"Wiley (1999)\"), list(REFERENCE = \"PMID:12700258\", AUTHORS = \"Hove-Jensen B, Rosenkrantz TJ, Haldimann A, Wanner BL.\", TITLE = \"Escherichia coli phnN, encoding ribose 1,5-bisphosphokinase activity (phosphoribosyl diphosphate forming): dual role in phosphonate degradation and NAD biosynthesis pathways.\", JOURNAL = c(\"J Bacteriol 185:2793-801 (2003)\", \"DOI:10.1128/JB.185.9.2793-2801.2003\")), list(REFERENCE = \"PMID:16788179\", AUTHORS = \"Orita I, Sato T, Yurimoto H, Kato N, Atomi H, Imanaka T, Sakai Y\", TITLE = \"The ribulose monophosphate pathway substitutes for the missing pentose phosphate pathway in the archaeon Thermococcus kodakaraensis.\", JOURNAL = c(\"J Bacteriol 188:4698-704 (2006)\", \"DOI:10.1128/JB.00492-06\")), list(REFERENCE = \"PMID:16428816\", AUTHORS = \"Kato N, Yurimoto H, Thauer RK\", TITLE = \"The physiological role of the ribulose monophosphate pathway in bacteria and archaea.\", JOURNAL = c(\"Biosci Biotechnol Biochem 70:10-21 (2006)\", \"DOI:10.1271/bbb.70.10\")), list(REFERENCE = \"PMID:23279921\", AUTHORS = \"Kouril T, Wieloch P, Reimann J, Wagner M, Zaparty M, Albers SV, Schomburg D, Ruoff P, Siebers B\", TITLE = \"Unraveling the function of the two Entner-Doudoroff branches in the thermoacidophilic Crenarchaeon Sulfolobus solfataricus P2.\", JOURNAL = c(\"FEBS J 280:1126-38 (2013)\", \"DOI:10.1111/febs.12106\")), list(REFERENCE = \"PMID:16458304\", AUTHORS = \"Reher M, Schonheit P\", TITLE = \"Glyceraldehyde dehydrogenases from the thermoacidophilic euryarchaeota Picrophilus torridus and Thermoplasma acidophilum, key enzymes of the non-phosphorylative Entner-Doudoroff pathway, constitute a novel enzyme family within the aldehyde dehydrogenase superfamily.\", JOURNAL = c(\"FEBS Lett 580:1198-204 (2006)\", \"DOI:10.1016/j.febslet.2006.01.029\")), list(REFERENCE = \"PMID:20023024\", AUTHORS = \"Reher M, Fuhrer T, Bott M, Schonheit P\", TITLE = \"The nonphosphorylative Entner-Doudoroff pathway in the thermoacidophilic euryarchaeon Picrophilus torridus involves a novel 2-keto-3-deoxygluconate- specific aldolase.\", JOURNAL = c(\"J Bacteriol 192:964-74 (2010)\", \"DOI:10.1128/JB.01281-09\"))', 531, 5524, 248, 105, 128, 50, 5227, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (4, '00040', 'Pentose and glucuronate interconversions', 'Metabolism; Carbohydrate metabolism', 'Pentose and glucuronate interconversions', 'Glucuronate pathway (uronate pathway) [PATH:map00040], D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P [PATH:map00040], Pectin degradation [PATH:map00040], Ascorbate biosynthesis, animals, glucose-1P => ascorbate [PATH:map00040], D-Galacturonate degradation (fungi), D-galacturonate => glycerol [PATH:map00040], D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P [PATH:map00040]', 'Pentosuria, Familial tumoral calcinosis', 'ko00040', 'list(REFERENCE = \"PMID:11741871\", AUTHORS = \"Yew WS, Gerlt JA.\", TITLE = \"Utilization of L-ascorbate by Escherichia coli K-12: assignments of functions to products of the yjf-sga and yia-sgb operons.\", JOURNAL = c(\"J Bacteriol 184:302-6 (2002)\", \"DOI:10.1128/JB.184.1.302-306.2002\")), list(REFERENCE = \"PMID:15697206\", AUTHORS = \"Yew WS, Akana J, Wise EL, Rayment I, Gerlt JA\", TITLE = \"Evolution of enzymatic activities in the orotidine 5\'-monophosphate decarboxylase suprafamily: enhancing the promiscuous D-arabino-hex-3-ulose 6-phosphate synthase reaction catalyzed by 3-keto-L-gulonate 6-phosphate decarboxylase.\", JOURNAL = c(\"Biochemistry 44:1807-15 (2005)\", \"DOI:10.1021/bi047815v\")), list(REFERENCE = \"PMID:10572115\", AUTHORS = \"Yasueda H, Kawahara Y, Sugimoto S.\", TITLE = \"Bacillus subtilis yckG and yckF encode two key enzymes of the ribulose monophosphate pathway used by methylotrophs, and yckH is required for their expression.\", JOURNAL = \"J Bacteriol 181:7154-60 (1999)\"), list(REFERENCE = \"PMID:10913097\", AUTHORS = \"Ibanez E, Gimenez R, Pedraza T, Baldoma L, Aguilar J, Badia J\", TITLE = \"Role of the yiaR and yiaS genes of Escherichia coli in metabolism of endogenously formed L-xylulose.\", JOURNAL = c(\"J Bacteriol 182:4625-7 (2000)\", \"DOI:10.1128/JB.182.16.4625-4627.2000\")), list(REFERENCE = \"PMID:15901685\", AUTHORS = \"Orita I, Yurimoto H, Hirai R, Kawarabayasi Y, Sakai Y, Kato N\", TITLE = \"The archaeon Pyrococcus horikoshii possesses a bifunctional enzyme for formaldehyde fixation via the ribulose monophosphate pathway.\", JOURNAL = c(\"J Bacteriol 187:3636-42 (2005)\", \"DOI:10.1128/JB.187.11.3636-3642.2005\"))', 'map00040', 'Pentose and glucuronate interconversions', 525, 5002, 248, 105, 128, 44, 4812, 190);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (5, '00051', 'Fructose and mannose metabolism', 'Metabolism; Carbohydrate metabolism', 'Fructose and mannose metabolism', 'Ascorbate biosynthesis, plants, glucose-6P => ascorbate [PATH:map00051]', 'Congenital disorders of glycosylation type I, Glycogen storage disease type XII', 'GO: 0006000 0006013', 'ko00051', 'map00051', 'Fructose and mannose metabolism', 531, 5526, 248, 105, 128, 50, 5230, 296);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (6, '00052', 'Galactose metabolism', 'Metabolism; Carbohydrate metabolism', 'Galactose metabolism', 'Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map00052], D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P [PATH:map00052], Nucleotide sugar biosynthesis, galactose => UDP-galactose [PATH:map00052], Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P [PATH:map00052], Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map00052]', 'Galactosemia, Congenital lactase deficiency, Glycogen storage disease type II, Galactose-1P uridylyltransferase deficiency, Galactokinase deficiency, Galactose epimerase deficiency', 'GO: 0006012', 'ko00052', 'map00052', 'Galactose metabolism', 526, 5200, 248, 105, 128, 45, 4907, 293);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (7, '00053', 'Ascorbate and aldarate metabolism', 'Metabolism; Carbohydrate metabolism', 'Ascorbate and aldarate metabolism', 'Ascorbate biosynthesis, plants, glucose-6P => ascorbate [PATH:map00053], Ascorbate biosynthesis, animals, glucose-1P => ascorbate [PATH:map00053], Ascorbate degradation, ascorbate => D-xylulose-5P [PATH:map00053]', 'GO: 0019852 0019572', 'ko00053', 'list(REFERENCE = \"PMID:17222174\", AUTHORS = \"Linster CL, Van Schaftingen E\", TITLE = \"Vitamin C. Biosynthesis, recycling and degradation in mammals.\", JOURNAL = c(\"FEBS J 274:1-22 (2007)\", \"DOI:10.1111/j.1742-4658.2006.05607.x\")), list(REFERENCE = \"PMID:15564123\", AUTHORS = \"Valpuesta V, Botella MA.\", TITLE = \"Biosynthesis of L-ascorbic acid in plants: new pathways for an old antioxidant.\", JOURNAL = c(\"Trends Plant Sci 9:573-7 (2004)\", \"DOI:10.1016/j.tplants.2004.10.002\")), list(REFERENCE = \"PMID:10517845\", AUTHORS = \"Davey MW, Gilot C, Persiau G, Ostergaard J, Han Y, Bauw GC, Van Montagu MC.\", TITLE = \"Ascorbate biosynthesis in Arabidopsis cell suspension culture.\", JOURNAL = c(\"Plant Physiol 121:535-43 (1999)\", \"DOI:10.1104/pp.121.2.535\")), list(REFERENCE = \"PMID:16595667\", AUTHORS = \"Conklin PL, Gatzek S, Wheeler GL, Dowdle J, Raymond MJ, Rolinski S, Isupov M, Littlechild JA, Smirnoff N.\", TITLE = \"Arabidopsis thaliana VTC4 encodes L-galactose-1-P phosphatase, a plant ascorbic acid biosynthetic enzyme.\", JOURNAL = c(\"J Biol Chem 281:15662-70 (2006)\", \"DOI:10.1074/jbc.M601409200\")), list(REFERENCE = \"PMID:17462988\", AUTHORS = \"Linster CL, Gomez TA, Christensen KC, Adler LN, Young BD, Brenner C, Clarke SG.\", TITLE = \"Arabidopsis VTC2 Encodes a GDP-L-Galactose Phosphorylase, the Last Unknown Enzyme in the Smirnoff-Wheeler Pathway to Ascorbic Acid in Plants.\", JOURNAL = c(\"J Biol Chem 282:18879-85 (2007)\", \"DOI:10.1074/jbc.M702094200\")), list(REFERENCE = \"PMID:14996803\", AUTHORS = \"Campos E, Baldoma L, Aguilar J, Badia J.\", TITLE = \"Regulation of expression of the divergent ulaG and ulaABCDEF operons involved in LaAscorbate dissimilation in Escherichia coli.\", JOURNAL = c(\"J Bacteriol 186:1720-8 (2004)\", \"DOI:10.1128/JB.186.6.1720-1728.2004\")), list(REFERENCE = \"PMID:12644495\", AUTHORS = \"Zhang Z, Aboulwafa M, Smith MH, Saier MH Jr.\", TITLE = \"The ascorbate transporter of Escherichia coli.\", JOURNAL = c(\"J Bacteriol 185:2243-50 (2003)\", \"DOI:10.1128/JB.185.7.2243-2250.2003\"))', 'map00053', 'Ascorbate and aldarate metabolism', 493, 3790, 248, 105, 111, 29, 3700, 90);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (8, '00061', 'Fatty acid biosynthesis', 'Metabolism; Lipid metabolism', 'Fatty acid biosynthesis', 'Fatty acid biosynthesis, initiation [PATH:map00061], Fatty acid biosynthesis, elongation [PATH:map00061], beta-Oxidation, acyl-CoA synthesis [PATH:map00061], Fatty acid biosynthesis in mitochondria, animals [PATH:map00061], Fatty acid biosynthesis in mitochondria, fungi [PATH:map00061]', 'Combined malonic and methylmalonic aciduria', 'ko00061', 'list(REFERENCE = \"PMID:12061798\", AUTHORS = \"Salas JJ, Ohlrogge JB.\", TITLE = \"Characterization of substrate specificity of plant FatA and FatB acyl-ACP thioesterases.\", JOURNAL = c(\"Arch Biochem Biophys 403:25-34 (2002)\", \"DOI:10.1016/S0003-9861(02)00017-6\")), list(REFERENCE = \"PMID:12518017\", AUTHORS = \"Zhang YM, Marrakchi H, White SW, Rock CO.\", TITLE = \"The application of computational methods to explore the diversity and structure of bacterial fatty acid synthase.\", JOURNAL = c(\"J Lipid Res 44:1-10 (2003)\", \"DOI:10.1194/jlr.R200016-JLR200\")), list(REFERENCE = \"PMID:11337402\", AUTHORS = \"Voelker T, Kinney AJ.\", TITLE = \"VARIATIONS IN THE BIOSYNTHESIS OF SEED-STORAGE LIPIDS.\", JOURNAL = c(\"Annu Rev Plant Physiol Plant Mol Biol 52:335-361 (2001)\", \"DOI:10.1146/annurev.arplant.52.1.335\")), list(REFERENCE = \"PMID:17573542\", AUTHORS = \"Barker GC, Larson TR, Graham IA, Lynn JR, King GJ.\", TITLE = \"Novel insights into seed fatty acid synthesis and modification pathways from genetic diversity and quantitative trait Loci analysis of the Brassica C genome.\", JOURNAL = c(\"Plant Physiol 144:1827-42 (2007)\", \"DOI:10.1104/pp.107.096172\")), list(REFERENCE = \"PMID:30201289\", AUTHORS = \"Bowman CE, Wolfgang MJ\", TITLE = \"Role of the malonyl-CoA synthetase ACSF3 in mitochondrial metabolism.\", JOURNAL = c(\"Adv Biol Regul 71:34-40 (2019)\", \"DOI:10.1016/j.jbior.2018.09.002\")), list(REFERENCE = \"PMID:25203508\", AUTHORS = \"Venkatesan R, Sah-Teli SK, Awoniyi LO, Jiang G, Prus P, Kastaniotis AJ, Hiltunen JK, Wierenga RK, Chen Z\", TITLE = \"Insights into mitochondrial fatty acid synthesis from the structure of heterotetrameric 3-ketoacyl-ACP reductase/3R-hydroxyacyl-CoA dehydrogenase.\", JOURNAL = c(\"Nat Commun 5:4805 (2014)\", \"DOI:10.1038/ncomms5805\")), list(REFERENCE = \"PMID:19686777\", AUTHORS = \"Hiltunen JK, Chen Z, Haapalainen AM, Wierenga RK, Kastaniotis AJ\", TITLE = \"Mitochondrial fatty acid synthesis--an adopted set of enzymes making a pathway of major importance for the cellular metabolism.\", JOURNAL = c(\"Prog Lipid Res 49:27-45 (2010)\", \"DOI:10.1016/j.plipres.2009.08.001\")), list(REFERENCE = \"PMID:27553474\", AUTHORS = \"Kastaniotis AJ, Autio KJ, Keratar JM, Monteuuis G, Makela AM, Nair RR, Pietikainen LP, Shvetsova A, Chen Z, Hiltunen JK\", TITLE = \"Mitochondrial fatty acid synthesis, fatty acids and mitochondrial physiology.\", JOURNAL = c(\"Biochim Biophys Acta Mol Cell Biol Lipids 1862:39-48 (2017)\", \"DOI:10.1016/j.bbalip.2016.08.011\"))', 'map00061', 'Fatty acid biosynthesis', 531, 5334, 248, 105, 128, 50, 5085, 249);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (9, '00062', 'Fatty acid elongation', 'Metabolism; Lipid metabolism', 'Fatty acid elongation', 'Fatty acid elongation in mitochondria [PATH:map00062], Fatty acid elongation in endoplasmic reticulum [PATH:map00062]', 'Neuronal ceroid lipofuscinosis, Stargardt disease, 3-Hydroxyacyl-CoA dehydrogenase deficiency, Santavuori-Haltia disease', 'ko00062', 'list(REFERENCE = \"PMID:4387390\", AUTHORS = \"Seubert W, Lamberts I, Kramer R, Ohly B\", TITLE = \"On the mechanism of malonyl-CoA-independent fatty acid synthesis. I. The mechanism of elongation of long-chain fatty acids by acetyl-CoA.\", JOURNAL = c(\"Biochim Biophys Acta 164:498-517 (1968)\", \"DOI:10.1016/0005-2760(68)90180-X\")), list(REFERENCE = \"PMID:7150615\", AUTHORS = \"El-Fakhri M, Middleton B\", TITLE = \"The existence of an inner-membrane-bound, long acyl-chain-specific 3-hydroxyacyl-CoA dehydrogenase in mammalian mitochondria.\", JOURNAL = c(\"Biochim Biophys Acta 713:270-9 (1982)\", \"DOI:10.1016/0005-2760(82)90244-2\")), list(REFERENCE = \"PMID:8190743\", AUTHORS = \"Cassagne C, Lessire R, Bessoule JJ, Moreau P, Creach A, Schneider F, Sturbois B\", TITLE = \"Biosynthesis of very long chain fatty acids in higher plants.\", JOURNAL = c(\"Prog Lipid Res 33:55-69 (1994)\", \"DOI:10.1016/0163-7827(94)90009-4\")), list(REFERENCE = \"PMID:16564093\", AUTHORS = \"Jakobsson A, Westerberg R, Jacobsson A.\", TITLE = \"Fatty acid elongases in mammals: their regulation and roles in metabolism.\", JOURNAL = c(\"Prog Lipid Res 45:237-49 (2006)\", \"DOI:10.1016/j.plipres.2006.01.004\")), list(REFERENCE = \"PMID:16765910\", AUTHORS = \"Blacklock BJ, Jaworski JG\", TITLE = \"Substrate specificity of Arabidopsis 3-ketoacyl-CoA synthases.\", JOURNAL = c(\"Biochem Biophys Res Commun 346:583-90 (2006)\", \"DOI:10.1016/j.bbrc.2006.05.162\")), list(REFERENCE = \"PMID:16866954\", AUTHORS = \"Shepherd T, Wynne Griffiths D\", TITLE = \"The effects of stress on plant cuticular waxes.\", JOURNAL = c(\"New Phytol 171:469-99 (2006)\", \"DOI:10.1111/j.1469-8137.2006.01826.x\")), list(REFERENCE = \"PMID:17719534\", AUTHORS = \"Riezman H\", TITLE = \"The long and short of fatty acid synthesis.\", JOURNAL = c(\"Cell 130:587-8 (2007)\", \"DOI:10.1016/j.cell.2007.08.008\")), list(REFERENCE = \"PMID:19649180\", AUTHORS = \"Raffaele S, Leger A, Roby D\", TITLE = \"Very long chain fatty acid and lipid signaling in the response of plants to pathogens.\", JOURNAL = c(\"Plant Signal Behav 4:94-9 (2009)\", \"DOI:10.4161/psb.4.2.7580\"))', 'map00062', 'Fatty acid elongation', 524, 28, 248, 105, 126, 45, 28, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (10, '00071', 'Fatty acid degradation', 'Metabolism; Lipid metabolism', 'Fatty acid degradation', 'beta-Oxidation, acyl-CoA synthesis [PATH:map00071], beta-Oxidation [PATH:map00071]', 'Sjogren-Larsson syndrome, Glutaric acidemia, SBCAD deficiency, VLCAD deficiency, MCAD deficiency, Disorders of mitochondrial fatty-acid oxidation, Familial hyperinsulinemic hypoglycemia, Mitochondrial trifunctional protein deficiency, 3-Hydroxyacyl-CoA dehydrogenase deficiency, Secondary hyperammonemia, SCAD deficiency, Carnitine palmitoyltransferase I deficiency, Carnitine palmitoyltransferase II deficiency, Peroxisomal acyl-CoA oxidase deficiency', 'ko00071', 'list(REFERENCE = \"PMID:869535\", AUTHORS = \"Parekh VR, Traxler RW, Sobek JM\", TITLE = \"N-Alkane oxidation enzymes of a pseudomonad.\", JOURNAL = \"Appl Environ Microbiol 33:881-4 (1977)\")', 'map00071', 'Fatty acid degradation', 529, 4641, 248, 105, 128, 48, 4346, 295);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (11, '00072', 'Synthesis and degradation of ketone bodies', 'Metabolism; Lipid metabolism', 'Synthesis and degradation of ketone bodies', 'Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone [PATH:map00072]', 'Alpha-methylacetoacetic aciduria, Succinyl CoA:3-oxoacid CoA transferase (SCOT) deficiency, HMG-CoA synthase deficiency', 'ko00072', 'map00072', 'Synthesis and degradation of ketone bodies', 'Metabolism; Lipid metabolism', 492, 3305, 247, 100, 122, 23, 3015, 290);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (12, '00073', 'Cutin, suberine and wax biosynthesis', 'Metabolism; Lipid metabolism', 'Cutin, suberine and wax biosynthesis', 'GO: 0010143 0010345 0010025', 'ko00073', 'list(REFERENCE = \"PMID:18621978\", AUTHORS = \"Li F, Wu X, Lam P, Bird D, Zheng H, Samuels L, Jetter R, Kunst L\", TITLE = \"Identification of the wax ester synthase/acyl-coenzyme A: diacylglycerol acyltransferase WSD1 required for stem wax ester biosynthesis in Arabidopsis.\", JOURNAL = c(\"Plant Physiol 148:97-107 (2008)\", \"DOI:10.1104/pp.108.123471\")), list(REFERENCE = \"PMID:16866954\", AUTHORS = \"Shepherd T, Wynne Griffiths D\", TITLE = \"The effects of stress on plant cuticular waxes.\", JOURNAL = c(\"New Phytol 171:469-99 (2006)\", \"DOI:10.1111/j.1469-8137.2006.01826.x\")), list(REFERENCE = \"PMID:19649180\", AUTHORS = \"Raffaele S, Leger A, Roby D\", TITLE = \"Very long chain fatty acid and lipid signaling in the response of plants to pathogens.\", JOURNAL = c(\"Plant Signal Behav 4:94-9 (2009)\", \"DOI:10.4161/psb.4.2.7580\")), list(REFERENCE = \"PMID:16404574\", AUTHORS = \"Kurdyukov S, Faust A, Trenkamp S, Bar S, Franke R, Efremova N, Tietjen K, Schreiber L, Saedler H, Yephremov A\", TITLE = \"Genetic and biochemical evidence for involvement of HOTHEAD in the biosynthesis of long-chain alpha-,omega-dicarboxylic fatty acids and formation of extracellular matrix.\", JOURNAL = c(\"Planta 224:315-29 (2006)\", \"DOI:10.1007/s00425-005-0215-7\")), list(REFERENCE = \"PMID:17323080\", AUTHORS = \"King A, Nam JW, Han J, Hilliard J, Jaworski JG\", TITLE = \"Cuticular wax biosynthesis in petunia petals: cloning and characterization of an alcohol-acyltransferase that synthesizes wax-esters.\", JOURNAL = c(\"Planta 226:381-94 (2007)\", \"DOI:10.1007/s00425-007-0489-z\")), list(REFERENCE = \"PMID:18440267\", AUTHORS = \"Pollard M, Beisson F, Li Y, Ohlrogge JB\", TITLE = \"Building lipid barriers: biosynthesis of cutin and suberin.\", JOURNAL = c(\"Trends Plant Sci 13:236-46 (2008)\", \"DOI:10.1016/j.tplants.2008.03.003\")), list(REFERENCE = \"PMID:19344744\", AUTHORS = \"Li Y, Beisson F\", TITLE = \"The biosynthesis of cutin and suberin as an alternative source of enzymes for the production of bio-based chemicals and materials.\", JOURNAL = c(\"Biochimie 91:685-91 (2009)\", \"DOI:10.1016/j.biochi.2009.03.016\"))', 'map00073', 'Cutin, suberine and wax biosynthesis', 'Metabolism; Lipid metabolism', 100, 1, 0, 96, 1, 3, 1, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (13, '00100', 'Steroid biosynthesis', 'Metabolism; Lipid metabolism', 'Steroid biosynthesis', 'Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol [PATH:map00100], Ergocalciferol biosynthesis [PATH:map00100], Cholecalciferol biosynthesis [PATH:map00100]', 'Lysosomal acid lipase deficiency, Smith-Lemli-Opitz syndrome, Congenital hemidysplasia with ichthyosiform nevus and limb defects (CHILD), Desmosterolosis, Vitamin D-dependent rickets, X-linked chondrodysplasia punctata, Lathosterolosis, Hypercalcemia infantile, CK syndrome, MEND syndrome', 'GO: 0016126', 'ko00100', 'list(REFERENCE = \"\", AUTHORS = \"Koshiba K, Kamiya Y.\", TITLE = \"[Atarasii Syokubutuhorumon no Kagaku] (In Japanese)\", JOURNAL = \"Koudansya saientific:199-138 (2002)\"), list(REFERENCE = \"PMID:16531502\", AUTHORS = \"Morikawa T, Mizutani M, Aoki N, Watanabe B, Saga H, Saito S, Oikawa A, Suzuki H, Sakurai N, Shibata D, Wadano A, Sakata K, Ohta D.\", TITLE = \"Cytochrome P450 CYP710A encodes the sterol C-22 desaturase in Arabidopsis and tomato.\", JOURNAL = c(\"Plant Cell 18:1008-22 (2006)\", \"DOI:10.1105/tpc.105.036012\")), list(REFERENCE = \"PMID:12777052\", AUTHORS = \"Lange BM, Ghassemian M.\", TITLE = \"Genome organization in Arabidopsis thaliana: a survey for genes involved in isoprenoid and chlorophyll metabolism.\", JOURNAL = c(\"Plant Mol Biol 51:925-48 (2003)\", \"DOI:10.1023/A:1023005504702\"))', 'map00100', 501, 582, 246, 105, 123, 27, 524, 58);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (14, '00120', 'Primary bile acid biosynthesis', 'Bile acids are steroid carboxylic acids derived from cholesterol in vertebrates. The primary bile acids, cholic acid and chenodeoxycholic acid, are synthesized in the liver and conjugated with taurine or glycine before secretion via bile into the intestine. The conversion from cholesterol to cholic and chenodeoxycholic acids involves four steps: 1) the initiation of synthesis by 7alpha-hydroxylation of sterol precursors, 2) further modifications to the ring structures, 3) side-chain oxidation and shortening (cleavage) by three carbons, and 4) conjugation of the bile acid with taurine or glycine.', 'Metabolism; Lipid metabolism', 'Primary bile acid biosynthesis', 'Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate [PATH:map00120], Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate [PATH:map00120], beta-Oxidation, peroxisome, tri/dihydroxycholestanoyl-CoA => choloyl/chenodeoxycholoyl-CoA [PATH:map00120]', 'Cerebrotendinous xanthomatosis, Peroxisomal beta-oxidation enzyme deficiency, Congenital bile acid synthesis defect, Leukoencephalopathy with dystonia and motor neuropathy, Perrault syndrome, D-bifunctional protein deficiency, Alpha-methylacyl-CoA racemase deficiency', 'ko00120', 'list(REFERENCE = \"PMID:12543708\", AUTHORS = \"Russell DW\", TITLE = \"The enzymes, regulation, and genetics of bile acid synthesis.\", JOURNAL = c(\"Annu Rev Biochem 72:137-74 (2003)\", \"DOI:10.1146/annurev.biochem.72.121801.161712\")), list(REFERENCE = \"PMID:17346171\", AUTHORS = \"Norlin M, Wikvall K\", TITLE = \"Enzymes in the conversion of cholesterol into bile acids.\", JOURNAL = c(\"Curr Mol Med 7:199-218 (2007)\", \"DOI:10.2174/156652407780059168\")), list(REFERENCE = \"PMID:10198776\", AUTHORS = \"Vlahcevic ZR, Pandak WM, Stravitz RT\", TITLE = \"Regulation of bile acid biosynthesis.\", JOURNAL = c(\"Gastroenterol Clin North Am 28:1-25, v (1999)\", \"DOI:10.1016/S0889-8553(05)70041-8\")), list(REFERENCE = \"PMID:18081658\", AUTHORS = \"Pellicoro A, Faber KN\", TITLE = \"Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport.\", JOURNAL = c(\"Aliment Pharmacol Ther 26 Suppl 2:149-60 (2007)\", \"DOI:10.1111/j.1365-2036.2007.03522.x\")), list(REFERENCE = \"PMID:18488143\", AUTHORS = \"Hofmann AF, Hagey LR\", TITLE = \"Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.\", JOURNAL = c(\"Cell Mol Life Sci 65:2461-83 (2008)\", \"DOI:10.1007/s00018-008-7568-6\")), list(REFERENCE = \"PMID:11067870\", AUTHORS = \"Schwarz M, Wright AC, Davis DL, Nazer H, Bjorkhem I, Russell DW\", TITLE = \"The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis.\", JOURNAL = c(\"J Clin Invest 106:1175-84 (2000)\", \"DOI:10.1172/JCI10902\")), list(REFERENCE = \"PMID:16299351\", AUTHORS = \"Ridlon JM, Kang DJ, Hylemon PB\", TITLE = \"Bile salt biotransformations by human intestinal bacteria.\", JOURNAL = c(\"J Lipid Res 47:241-59 (2006)\", \"DOI:10.1194/jlr.R500013-JLR200\")), list(REFERENCE = \"PMID:9292932\", AUTHORS = \"Bortolini O, Medici A, Poli S\", TITLE = \"Biotransformations on steroid nucleus of bile acids.\", JOURNAL = c(\"Steroids 62:564-77 (1997)\", \"DOI:10.1016/S0039-128X(97)00043-3\"))', 'map00120', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (15, '00121', 'Secondary bile acid biosynthesis', 'The secondary bile acids are derived from the primary bile acids by the enzymatic action of intestinal bacteria through the process of deconjugation and dehydroxylation. The secondary bile acids in humans include deoxycholic acid and lithocholic acid, formed from the 7alpha-dehydroxylation of cholic acid and chenodeoxycholic acid, respectively.', 'Metabolism; Lipid metabolism', 'Secondary bile acid biosynthesis', 'ko00121', 'list(REFERENCE = \"PMID:18488143\", AUTHORS = \"Hofmann AF, Hagey LR\", TITLE = \"Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics.\", JOURNAL = c(\"Cell Mol Life Sci 65:2461-83 (2008)\", \"DOI:10.1007/s00018-008-7568-6\")), list(REFERENCE = \"PMID:16299351\", AUTHORS = \"Ridlon JM, Kang DJ, Hylemon PB\", TITLE = \"Bile salt biotransformations by human intestinal bacteria.\", JOURNAL = c(\"J Lipid Res 47:241-59 (2006)\", \"DOI:10.1194/jlr.R500013-JLR200\")), list(REFERENCE = \"PMID:19464381\", AUTHORS = \"Ridlon JM, Kang DJ, Hylemon PB\", TITLE = \"Isolation and characterization of a bile acid inducible 7alpha-dehydroxylating operon in Clostridium hylemonae TN271.\", JOURNAL = c(\"Anaerobe 16:137-46 (2010)\", \"DOI:10.1016/j.anaerobe.2009.05.004\")), list(REFERENCE = \"PMID:18047844\", AUTHORS = \"Kang DJ, Ridlon JM, Moore DR 2nd, Barnes S, Hylemon PB\", TITLE = \"Clostridium scindens baiCD and baiH genes encode stereo-specific 7alpha/7beta-hydroxy-3-oxo-delta4-cholenoic acid oxidoreductases.\", JOURNAL = c(\"Biochim Biophys Acta 1781:16-25 (2008)\", \"DOI:10.1016/j.bbalip.2007.10.008\")), list(REFERENCE = \"PMID:16061950\", AUTHORS = \"Moschetta A, Xu F, Hagey LR, van Berge-Henegouwen GP, van Erpecum KJ, Brouwers JF, Cohen JC, Bierman M, Hobbs HH, Steinbach JH, Hofmann AF\", TITLE = \"A phylogenetic survey of biliary lipids in vertebrates.\", JOURNAL = c(\"J Lipid Res 46:2221-32 (2005)\", \"DOI:10.1194/jlr.M500178-JLR200\"))', 'map00121', 'Secondary bile acid biosynthesis', 'The secondary bile acids are derived from the primary bile acids by the enzymatic action of intestinal bacteria through the process of deconjugation and dehydroxylation. The secondary bile acids in humans include deoxycholic acid and lithocholic acid, formed from the 7alpha-dehydroxylation of cholic acid and chenodeoxycholic acid, respectively.', 0, 1677, 0, 0, 0, 0, 1650, 27);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (16, '00130', 'Ubiquinone and other terpenoid-quinone biosynthesis', 'Ubiquinone (UQ), also called coenzyme Q, and plastoquinone (PQ) are electron carriers in oxidative phosphorylation and photosynthesis, respectively. The quinoid nucleus of ubiquinone is derived from the shikimate pathway; 4-hydroxybenzoate is directly formed from chorismate in bacteria, while it can be formed from either chorismate or tyrosine in yeast. The following biosynthesis of terpenoid moiety involves reactions of prenylation, decarboxylation, and three hydroxylations alternating with three methylations. The order of these reactions are somewhat different between bacteria and yeast. Phylloquinone (vitamin K1), menaquinone (vitamin K2), and tocopherol (vitamin E) are fat-soluble vitamins. Phylloquinone is a compound present in all photosynthetic plants serving as a cofactor for photosystem I-mediated electron transport. Menaquinone is an obligatory component of the electron-transfer pathway in bacteria.', 'Metabolism; Metabolism of cofactors and vitamins', 'Ubiquinone and other terpenoid-quinone biosynthesis', 'Tocopherol/tocotorienol biosynthesis [PATH:map00130], Menaquinone biosynthesis, chorismate => menaquinol [PATH:map00130], Ubiquinone biosynthesis, prokaryotes, chorismate => ubiquinone [PATH:map00130], Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate => ubiquinone [PATH:map00130]', 'Combined deficiency of vitamin K-dependent clotting factors, Coenzyme Q10 deficiency, Multiple system atrophy', 'GO: 0006744 0009234 0042372', 'ko00130', 'list(REFERENCE = \"PMID:12908086\", AUTHORS = \"Ward MJ, Fu QS, Rhoads KR, Yeung CH, Spormann AM, Criddle CS.\", TITLE = \"A derivative of the menaquinone precursor 1,4-dihydroxy-2-naphthoate is involved in the reductive transformation of carbon tetrachloride by aerobically grown Shewanella oneidensis MR-1.\", JOURNAL = c(\"Appl Microbiol Biotechnol 63:571-7 (2004)\", \"DOI:10.1007/s00253-003-1407-3\")), list(REFERENCE = \"PMID:14499605\", AUTHORS = \"Monzingo AF, Gao J, Qiu J, Georgiou G, Robertus JD.\", TITLE = \"The X-ray structure of Escherichia coli RraA (MenG), A protein inhibitor of RNA processing.\", JOURNAL = c(\"J Mol Biol 332:1015-24 (2003)\", \"DOI:10.1016/S0022-2836(03)00970-7\")), list(REFERENCE = \"PMID:11470786\", AUTHORS = \"Johnson TW, Zybailov B, Jones AD, Bittl R, Zech S, Stehlik D, Golbeck JH, Chitnis PR.\", TITLE = \"Recruitment of a foreign quinone into the A1 site of photosystem I. In vivo replacement of plastoquinone-9 by media-supplemented naphthoquinones in phylloquinone biosynthetic pathway mutants of Synechocystis sp. PCC 6803.\", JOURNAL = c(\"J Biol Chem 276:39512-21 (2001)\", \"DOI:10.1074/jbc.M104040200\")), list(REFERENCE = \"PMID:12615349\", AUTHORS = \"Wade Johnson T, Naithani S, Stewart C Jr, Zybailov B, Daniel Jones A, Golbeck JH, Chitnis PR.\", TITLE = \"The menD and menE homologs code for 2-succinyl-6-hydroxyl-2,4-cyclohexadiene-1-carboxylate synthase and O-succinylbenzoic acid-CoA synthase in the phylloquinone biosynthetic pathway of Synechocystis sp. PCC 6803.\", JOURNAL = c(\"Biochim Biophys Acta 1557:67-76 (2003)\", \"DOI:10.1016/S0005-2728(02)00396-1\")), list(REFERENCE = \"PMID:12721307\", AUTHORS = \"Gin P, Hsu AY, Rothman SC, Jonassen T, Lee PT, Tzagoloff A, Clarke CF.\", TITLE = \"The Saccharomyces cerevisiae COQ6 gene encodes a mitochondrial flavin-dependent monooxygenase required for coenzyme Q biosynthesis.\", JOURNAL = c(\"J Biol Chem 278:25308-16 (2003)\", \"DOI:10.1074/jbc.M303234200\")), list(REFERENCE = \"PMID:18284213\", AUTHORS = \"Jiang M, Chen X, Guo ZF, Cao Y, Chen M, Guo Z.\", TITLE = \"Identification and Characterization of (1R,6R)-2-Succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate Synthase in the Menaquinone Biosynthesis of Escherichia coli.\", JOURNAL = c(\"Biochemistry 47:3426-34 (2008)\", \"DOI:10.1021/bi7023755\")), list(REFERENCE = \"PMID:17760421\", AUTHORS = \"Jiang M, Cao Y, Guo ZF, Chen M, Chen X, Guo Z.\", TITLE = \"Menaquinone biosynthesis in Escherichia coli: identification of 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate as a novel intermediate and re-evaluation of MenD activity.\", JOURNAL = c(\"Biochemistry 46:10979-89 (2007)\", \"DOI:10.1021/bi700810x\")), list(REFERENCE = \"PMID:17956107\", AUTHORS = \"Jiang M, Chen M, Cao Y, Yang Y, Sze KH, Chen X, Guo Z.\", TITLE = \"Determination of the stereochemistry of 2-succinyl-5-enolpyruvyl-6-hydroxy-3- cyclohexene-1-carboxylate, a key intermediate in menaquinone biosynthesis.\", JOURNAL = c(\"Org Lett 9:4765-7 (2007)\", \"DOI:10.1021/ol702126m\")), list(REFERENCE = \"PMID:18801996\", AUTHORS = \"Hiratsuka T, Furihata K, Ishikawa J, Yamashita H, Itoh N, Seto H, Dairi T\", TITLE = \"An alternative menaquinone biosynthetic pathway operating in microorganisms.\", JOURNAL = c(\"Science 321:1670-3 (2008)\", \"DOI:10.1126/science.1160446\")), list(REFERENCE = \"PMID:12232327\", AUTHORS = \"Loscher R, Heide L\", TITLE = \"Biosynthesis of p-Hydroxybenzoate from p-Coumarate and p-Coumaroyl-Coenzyme A in Cell-Free Extracts of Lithospermum erythrorhizon Cell Cultures.\", JOURNAL = c(\"Plant Physiol 106:271-279 (1994)\", \"DOI:10.1104/pp.106.1.271\")), list(REFERENCE = \"PMID:11583838\", AUTHORS = \"Meganathan R\", TITLE = \"Ubiquinone biosynthesis in microorganisms.\", JOURNAL = c(\"FEMS Microbiol Lett 203:131-9 (2001)\", \"DOI:10.1111/j.1574-6968.2001.tb10831.x\")), list(REFERENCE = \"PMID:14508009\", AUTHORS = \"Cheng Z, Sattler S, Maeda H, Sakuragi Y, Bryant DA, DellaPenna D\", TITLE = \"Highly divergent methyltransferases catalyze a conserved reaction in tocopherol and plastoquinone synthesis in cyanobacteria and photosynthetic eukaryotes.\", JOURNAL = c(\"Plant Cell 15:2343-56 (2003)\", \"DOI:10.1105/tpc.013656\")), list(REFERENCE = \"PMID:16989822\", AUTHORS = \"Sadre R, Gruber J, Frentzen M\", TITLE = \"Characterization of homogentisate prenyltransferases involved in plastoquinone-9 and tocochromanol biosynthesis.\", JOURNAL = c(\"FEBS Lett 580:5357-62 (2006)\", \"DOI:10.1016/j.febslet.2006.09.002\")), list(REFERENCE = \"PMID:12523993\", AUTHORS = \"Hofius D, Sonnewald U.\", TITLE = \"Vitamin E biosynthesis: biochemistry meets cell biology.\", JOURNAL = c(\"Trends Plant Sci 8:6-8 (2003)\", \"DOI:10.1016/S1360-1385(02)00002-X\")), list(REFERENCE = \"PMID:16233343\", AUTHORS = \"Kawamukai M\", TITLE = \"Biosynthesis, bioproduction and novel roles of ubiquinone.\", JOURNAL = c(\"J Biosci Bioeng 94:511-7 (2002)\", \"DOI:10.1016/S1389-1723(02)80188-8\")), list(REFERENCE = \"PMID:21239697\", AUTHORS = \"Tie JK, Jin DY, Straight DL, Stafford DW\", TITLE = \"Functional study of the vitamin K cycle in mammalian cells.\", JOURNAL = c(\"Blood 117:2967-74 (2011)\", \"DOI:10.1182/blood-2010-08-304303\")), list(REFERENCE = \"PMID:23113660\", AUTHORS = \"Zhou L, Wang JY, Wu J, Wang J, Poplawsky A, Lin S, Zhu B, Chang C, Zhou T, Zhang LH, He YW\", TITLE = \"The diffusible factor synthase XanB2 is a bifunctional chorismatase that links the shikimate pathway to ubiquinone and xanthomonadins biosynthetic pathways.\", JOURNAL = c(\"Mol Microbiol 87:80-93 (2013)\", \"DOI:10.1111/mmi.12084\"))', 519, 4865, 248, 105, 122, 44, 4636, 229);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (17, '00140', 'Steroid hormone biosynthesis', 'Steroid hormones derived from cholesterol are a class of biologically active compounds in vertebrates. The cholesterol side-chain cleavage enzyme CYP11A1 catalyzes conversion of cholesterol, a C27 compound, to the first C21 steroid, pregnenolone, which is converted by a bifunctional enzyme complex to the gestagen hormone, progesterone [MD:M00107]. Pregnenolone and progesterone are the starting materials for the three groups of steroids: C21 steroids of glucocorticoids and mineralocorticoids, C19 steroids of androgens, and C18 steroids of estrogens. (i) Progesterone is converted by hydroxylations at carbons 21 and 11 to corticosterone, which is further modified by hydroxylation and oxydoreduction at carbon 18 to yield aldosterone, a mineralcorticoid [MD:M00108]. Cortisol, the main glucocorticoid, is formed from 17alpha-hydroxyprogesterone with 11-deoxycortisol as an intermediate [MD:M00109]. (ii) Male hormone testosterone is formed from pregnenolone by two pathways, delta5 pathway via dehydroepiandrosterone and delta4 pathway via androstenedione [MD:M00110]. The enzyme CYP17A1 is responsible for the 17,20 lyase and 17alpha-hydroxylase activities in respective pathways. (iii) Female hormones estrone and estradiol are formed from testosterone and 4-androstene-3,17-dione by oxidative removal of the C19 methyl group and subsequent aromatization of ring A [MD:M00111]. In addition to these three groups, recent studies show that there is another group, termed neurosteroids, synthesized in the brain rather than the peripheral endocrine gland.', 'Metabolism; Lipid metabolism', 'Steroid hormone biosynthesis', 'Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone [PATH:map00140], C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone [PATH:map00140], C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone [PATH:map00140], C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone [PATH:map00140]', 'X-linked ichthyosis, Congenital adrenal hyperplasia, Aldosterone synthase deficiency, Apparent mineralocorticoid excess syndrome, Glucocorticoid-remediable aldosteronism (GRA), 46,XY disorder of sex development due to testosterone secretion defect, Congenital bile acid synthesis defect, Aromatase excess syndrome, Cortisone reductase deficiency, Primary congenital glaucoma, Glucocorticoid-induced osteonecrosis, Aromatase deficiency, Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete', 'GO: 0034754', 'ko00140', 'list(REFERENCE = \"PMID:10998348\", AUTHORS = \"Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K\", TITLE = \"Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones.\", JOURNAL = c(\"Biochem J 351:67-77 (2000)\", \"DOI:10.1042/bj3510067\")), list(REFERENCE = \"PMID:11469811\", AUTHORS = \"Tomlinson JW, Stewart PM\", TITLE = \"Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.\", JOURNAL = c(\"Best Pract Res Clin Endocrinol Metab 15:61-78 (2001)\", \"DOI:10.1053/beem.2000.0119\")), list(REFERENCE = \"PMID:12604236\", AUTHORS = \"Higaki Y, Usami N, Shintani S, Ishikura S, El-Kabbani O, Hara A\", TITLE = \"Selective and potent inhibitors of human 20alpha-hydroxysteroid dehydrogenase (AKR1C1) that metabolizes neurosteroids derived from progesterone.\", JOURNAL = c(\"Chem Biol Interact 143-144:503-13 (2003)\", \"DOI:10.1016/S0009-2797(02)00206-5\")), list(REFERENCE = \"PMID:12832414\", AUTHORS = \"Thomas JL, Duax WL, Addlagatta A, Brandt S, Fuller RR, Norris W\", TITLE = \"Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1 3 beta-hydroxysteroid dehydrogenase/isomerase.\", JOURNAL = c(\"J Biol Chem 278:35483-90 (2003)\", \"DOI:10.1074/jbc.M304752200\")), list(REFERENCE = \"PMID:15642792\", AUTHORS = \"Cavigelli SA, Monfort SL, Whitney TK, Mechref YS, Novotny M, McClintock MK\", TITLE = \"Frequent serial fecal corticoid measures from rats reflect circadian and ovarian corticosterone rhythms.\", JOURNAL = c(\"J Endocrinol 184:153-63 (2005)\", \"DOI:10.1677/joe.1.05935\")), list(REFERENCE = \"PMID:16413106\", AUTHORS = \"Holmes MC, Seckl JR\", TITLE = \"The role of 11beta-hydroxysteroid dehydrogenases in the brain.\", JOURNAL = c(\"Mol Cell Endocrinol 248:9-14 (2006)\", \"DOI:10.1016/j.mce.2005.12.002\")), list(REFERENCE = \"PMID:16547389\", AUTHORS = \"Matsunaga T, Shintani S, Hara A\", TITLE = \"Multiplicity of mammalian reductases for xenobiotic carbonyl compounds.\", JOURNAL = c(\"Drug Metab Pharmacokinet 21:1-18 (2006)\", \"DOI:10.2133/dmpk.21.1\")), list(REFERENCE = \"PMID:17459698\", AUTHORS = \"Morris DJ, Latif SA, Hardy MP, Brem AS\", TITLE = \"Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.\", JOURNAL = c(\"J Steroid Biochem Mol Biol 104:161-8 (2007)\", \"DOI:10.1016/j.jsbmb.2007.03.020\")), list(REFERENCE = \"PMID:17475203\", AUTHORS = \"Sanai M, Endo S, Matsunaga T, Ishikura S, Tajima K, El-Kabbani O, Hara A\", TITLE = \"Rat NAD+-dependent 3alpha-hydroxysteroid dehydrogenase (AKR1C17): a member of the aldo-keto reductase family highly expressed in kidney cytosol.\", JOURNAL = c(\"Arch Biochem Biophys 464:122-9 (2007)\", \"DOI:10.1016/j.abb.2007.04.003\")), list(REFERENCE = \"PMID:17926129\", AUTHORS = \"Ghayee HK, Auchus RJ\", TITLE = \"Basic concepts and recent developments in human steroid hormone biosynthesis.\", JOURNAL = c(\"Rev Endocr Metab Disord 8:289-300 (2007)\", \"DOI:10.1007/s11154-007-9052-2\"))', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (18, '00190', 'Oxidative phosphorylation', 'Metabolism; Energy metabolism', 'Oxidative phosphorylation', 'NADH:ubiquinone oxidoreductase, mitochondria [PATH:map00190], NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria [PATH:map00190], NADH:quinone oxidoreductase, prokaryotes [PATH:map00190], NAD(P)H:quinone oxidoreductase, chloroplasts and cyanobacteria [PATH:map00190], NADH dehydrogenase (ubiquinone) 1 alpha subcomplex [PATH:map00190], NADH dehydrogenase (ubiquinone) 1 beta subcomplex [PATH:map00190], Succinate dehydrogenase (ubiquinone) [PATH:map00190], Succinate dehydrogenase, prokaryotes [PATH:map00190], Fumarate reductase, prokaryotes [PATH:map00190], Cytochrome bc1 complex respiratory unit [PATH:map00190], Cytochrome bc1 complex [PATH:map00190], Cytochrome bd ubiquinol oxidase [PATH:map00190], Cytochrome c oxidase [PATH:map00190], Cytochrome c oxidase, prokaryotes [PATH:map00190], Cytochrome c oxidase, cbb3-type [PATH:map00190], F-type ATPase, prokaryotes and chloroplasts [PATH:map00190], F-type ATPase, eukaryotes [PATH:map00190], V/A-type ATPase, prokaryotes [PATH:map00190], V-type ATPase, eukaryotes [PATH:map00190], Cytochrome aa3-600 menaquinol oxidase [PATH:map00190], Cytochrome o ubiquinol oxidase [PATH:map00190]', 'Leber hereditary optic atrophy, Mitochondrial complex I deficiency, Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, Infantile bilateral striatal necrosis, Fatal infantile cardioencephalomyopathy, MELAS Syndrome, Leigh syndrome, Kearns-Sayre syndrome, Myoclonic Epilepsy and Ragged-Red Fiber Disease, NARP syndrome, Leber hereditary optic neuropathy and dystonia, Cytochrome c oxidase (COX) deficiency, ATP synthase deficiency, Microphthalmia with linear skin defects syndrome, Mitochondrial complex II deficiency, Mitochondrial complex III deficiency', 'ko00190', 'list(REFERENCE = \"PMID:16469879\", AUTHORS = \"Sazanov LA, Hinchliffe P.\", TITLE = \"Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus.\", JOURNAL = c(\"Science 311:1430-6 (2006)\", \"DOI:10.1126/science.1123809\")), list(REFERENCE = \"PMID:16584177\", AUTHORS = \"Hinchliffe P, Carroll J, Sazanov LA.\", TITLE = \"Identification of a novel subunit of respiratory complex I from Thermus thermophilus.\", JOURNAL = c(\"Biochemistry 45:4413-20 (2006)\", \"DOI:10.1021/bi0600998\"))', 'map00190', 'Oxidative phosphorylation', 531, 5555, 248, 105, 128, 50, 5258, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (19, '00195', 'Photosynthesis', 'Photosynthesis in green plants and specialized bacteria is the process of utilizing light energy to synthesize organic compounds from carbon dioxide and water. It consists of the light dependent part (light reaction) and the light independent part (dark reaction, carbon fixation). The light reaction takes place in thylakoid, a membrane-bound compartment inside chloroplasts and cyanobacteria. The light energy is used by photosystems I and II to generate proton motive force and reducing power (NADPH or NADH). The proton motive force is used by ATP synthase to generate ATP, essentially in the same way as the mitochondrial respiratory chain. The supplies of ATP and NAD(P)H are then used to fix carbon dioxide.', 'Metabolism; Energy metabolism', 'Photosynthesis', 'F-type ATPase, prokaryotes and chloroplasts [PATH:map00195], Photosystem II [PATH:map00195], Cytochrome b6f complex [PATH:map00195], Photosystem I [PATH:map00195]', 'ko00195', 'list(REFERENCE = \"PMID:14764885\", AUTHORS = \"Ferreira KN, Iverson TM, Maghlaoui K, Barber J, Iwata S.\", TITLE = \"Architecture of the photosynthetic oxygen-evolving center.\", JOURNAL = c(\"Science 303:1831-8 (2004)\", \"DOI:10.1126/science.1093087\")), list(REFERENCE = \"PMID:12518057\", AUTHORS = \"Kamiya N, Shen JR.\", TITLE = \"Crystal structure of oxygen-evolving photosystem II from Thermosynechococcus vulcanus at 3.7-A resolution.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 100:98-103 (2003)\", \"DOI:10.1073/pnas.0135651100\")), list(REFERENCE = \"PMID:11217865\", AUTHORS = \"Zouni A, Witt HT, Kern J, Fromme P, Krauss N, Saenger W, Orth P.\", TITLE = \"Crystal structure of photosystem II from Synechococcus elongatus at 3.8 A resolution.\", JOURNAL = c(\"Nature 409:739-743 (2001)\", \"DOI:10.1038/35055589\")), list(REFERENCE = \"PMID:11418848\", AUTHORS = \"Jordan P, Fromme P, Witt HT, Klukas O, Saenger W, Krauss N.\", TITLE = \"Three-dimensional structure of cyanobacterial photosystem I at 2.5 A resolution.\", JOURNAL = c(\"Nature 411:909-917 (2001)\", \"DOI:10.1038/35082000\")), list(REFERENCE = \"PMID:11369223\", AUTHORS = \"Jones MR, Fyfe PK.\", TITLE = \"Photosynthesis: new light on biological oxygen production.\", JOURNAL = c(\"Curr Biol 17:R318-R321 (2001)\", \"DOI:10.1016/S0960-9822(01)00174-9\")), list(REFERENCE = \"PMID:11914373\", AUTHORS = \"Shen G, Zhao J, Reimer SK, Antonkine ML, Cai Q, Weiland SM, Golbeck JH, Bryant DA.\", TITLE = \"Assembly of photosystem I. I. Inactivation of the rubA gene encoding a membrane-associated rubredoxin in the cyanobacterium Synechococcus sp. PCC 7002 causes a loss of photosystem I activity.\", JOURNAL = c(\"J Biol Chem 277:20343-54 (2002)\", \"DOI:10.1074/jbc.M201103200\"))', 'map00195', 'Photosynthesis', 108, 117, 0, 105, 0, 3, 117, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (20, '00196', 'Photosynthesis - antenna proteins', 'The chlorophyll-binding subunits of photosystems I and II are internal antenna light-harvesting proteins of oxygenic photosynthesis. The antenna proteins that exist in phycobilisomes in cyanobacteria and light-harvesting chlorophyll protein complexes in green plants act as peripheral antenna systems, enabling more efficient absorption of light energy.', 'Metabolism; Energy metabolism', 'Photosynthesis - antenna proteins', 'ko00196', 'list(REFERENCE = \"PMID:10625426\", AUTHORS = \"Nield J, Orlova EV, Morris EP, Gowen B, van Heel M, Barber J.\", TITLE = \"3D map of the plant photosystem II supercomplex obtained by cryoelectron microscopy and single particle analysis.\", JOURNAL = c(\"Nat Struct Biol 7:44-7 (2000)\", \"DOI:10.1038/71242\")), list(REFERENCE = \"PMID:15994896\", AUTHORS = \"Sener MK, Jolley C, Ben-Shem A, Fromme P, Nelson N, Croce R, Schulten K.\", TITLE = \"Comparison of the light-harvesting networks of plant and cyanobacterial photosystem I.\", JOURNAL = c(\"Biophys J 89:1630-42 (2005)\", \"DOI:10.1529/biophysj.105.066464\")), list(REFERENCE = \"PMID:14668855\", AUTHORS = \"Ben-Shem A, Frolow F, Nelson N.\", TITLE = \"Crystal structure of plant photosystem I.\", JOURNAL = c(\"Nature 426:630-5 (2003)\", \"DOI:10.1038/nature02200\")), list(REFERENCE = \"PMID:15955818\", AUTHORS = \"Jolley C, Ben-Shem A, Nelson N, Fromme P.\", TITLE = \"Structure of plant photosystem I revealed by theoretical modeling.\", JOURNAL = c(\"J Biol Chem 280:33627-36 (2005)\", \"DOI:10.1074/jbc.M500937200\")), list(REFERENCE = \"PMID:16098971\", AUTHORS = \"Ihalainen JA, Klimmek F, Ganeteg U, van Stokkum IH, van Grondelle R, Jansson S, Dekker JP.\", TITLE = \"Excitation energy trapping in photosystem I complexes depleted in Lhca1 and Lhca4.\", JOURNAL = c(\"FEBS Lett 579:4787-91 (2005)\", \"DOI:10.1016/j.febslet.2005.06.091\")), list(REFERENCE = \"PMID:16401064\", AUTHORS = \"Melkozernov AN, Barber J, Blankenship RE.\", TITLE = \"Light harvesting in photosystem I supercomplexes.\", JOURNAL = c(\"Biochemistry 45:331-45 (2006)\", \"DOI:10.1021/bi051932o\"))', 'map00196', 'Photosynthesis - antenna proteins', 'The chlorophyll-binding subunits of photosystems I and II are internal antenna light-harvesting proteins of oxygenic photosynthesis. The antenna proteins that exist in phycobilisomes in cyanobacteria and light-harvesting chlorophyll protein complexes in green plants act as peripheral antenna systems, enabling more efficient absorption of light energy.', 105, 114, 0, 105, 0, 0, 114, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (21, '00220', 'Arginine biosynthesis', 'Metabolism; Amino acid metabolism', 'Arginine biosynthesis', 'Ornithine biosynthesis, glutamate => ornithine [PATH:map00220], Urea cycle [PATH:map00220], Ornithine biosynthesis, mediated by LysW, glutamate => ornithine [PATH:map00220], Arginine biosynthesis, ornithine => arginine [PATH:map00220], Arginine biosynthesis, glutamate => acetylcitrulline => arginine [PATH:map00220]', 'Carbamoyl phosphate synthetase I deficiency, Citrullinemia, Hyperargininemia, Ornithine transcarbamylase deficiency, Congenital systemic glutamine deficiency, Argininosuccinic aciduria, N-acetylglutamate synthase deficiency, Aminoacylase 1 deficiency, Primary hyperammonemic disorders (Urea cycle disorders)', 'GO: 0006525', 'ko00220', 'map00220', 'Arginine biosynthesis', 524, 5295, 248, 105, 123, 48, 4999, 296);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (22, '00230', 'Purine metabolism', 'Metabolism; Nucleotide metabolism', 'Purine metabolism', 'PRPP biosynthesis, ribose 5P => PRPP [PATH:map00230], Inosine monophosphate biosynthesis, PRPP + glutamine => IMP [PATH:map00230], Adenine ribonucleotide biosynthesis, IMP => ADP,ATP [PATH:map00230], Guanine ribonucleotide biosynthesis IMP => GDP,GTP [PATH:map00230], Purine degradation, xanthine => urea [PATH:map00230]', 'Hypermethioninemia, Xanthinuria, Lesch-Nyhan syndrome, Adenine phosphoribosyltransferase deficiency, Phosphoribosylpyrophosphate synthetase superactivity, Adenylosuccinate lyase deficiency, Mitochondrial DNA depletion syndrome, Cone-rod dystrophy and cone dystrophy, Desbuquois syndrome, Anemia due to disorders of nucleotide metabolism, SEMD, Pakistani type, Calcification of joints and arteries, Leber congenital amaurosis, Arts syndrome, AICA-ribosiduria, Generalized arterial calcification of infancy, Pyruvate kinase deficiency, Reticular dysgenesis, Cole disease, Gout, Autosomal dominant striatal degeneration, AMP deaminase deficiency, Adenosine deaminase deficiency', 'GO: 0042278', 'ko00230', 'list(REFERENCE = \"PMID:10601204\", AUTHORS = \"Cusa E, Obradors N, Baldoma L, Badia J, Aguilar J.\", TITLE = \"Genetic analysis of a chromosomal region containing genes required for assimilation of allantoin nitrogen and linked glyoxylate metabolism in Escherichia coli.\", JOURNAL = \"J Bacteriol 181:7479-84 (1999)\"), list(REFERENCE = \"PMID:10986234\", AUTHORS = \"Xi H, Schneider BL, Reitzer L.\", TITLE = \"Purine catabolism in Escherichia coli and function of xanthine dehydrogenase in purine salvage.\", JOURNAL = c(\"J Bacteriol 182:5332-41 (2000)\", \"DOI:10.1128/JB.182.19.5332-5341.2000\"))', 'map00230', 531, 5544, 248, 105, 128, 50, 5245, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (23, '00231', 'Puromycin biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Puromycin biosynthesis', 'D05653, Puromycin (USAN)', 'GO: 0043638', 'ko00231', 'list(REFERENCE = \"PMID:8576156\", AUTHORS = \"Tercero JA, Espinosa JC, Lacalle RA, Jimenez A.\", TITLE = \"The biosynthetic pathway of the aminonucleoside antibiotic puromycin, as deduced from the molecular analysis of the pur cluster of Streptomyces alboniger.\", JOURNAL = c(\"J Biol Chem 271:1579-90 (1996)\", \"DOI:10.1074/jbc.271.3.1579\"))', 'map00231', 'Puromycin biosynthesis', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (24, '00232', 'Caffeine metabolism', 'Metabolism; Biosynthesis of other secondary metabolites', 'Caffeine metabolism', 'UMBBD: caf caf2', 'ko00232', 'list(REFERENCE = \"PMID:9705852\", AUTHORS = \"Madyastha KM, Sridhar GR.\", TITLE = \"A novel pathway for the metabolism of caffeine by a mixed culture consortium.\", JOURNAL = c(\"Biochem Biophys Res Commun 249:178-81 (1998)\", \"DOI:10.1006/bbrc.1998.9102\")), list(REFERENCE = \"PMID:14977550\", AUTHORS = \"Mazzafera P.\", TITLE = \"Catabolism of caffeine in plants and microorganisms.\", JOURNAL = c(\"Front Biosci 9:1348-59 (2004)\", \"DOI:10.2741/1339\")), list(REFERENCE = \"PMID:11393735\", AUTHORS = \"Nyeki A, Biollaz J, Kesselring UW, Decosterd LA.\", TITLE = \"Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment.\", JOURNAL = c(\"J Chromatogr B Biomed Sci Appl 755:73-84 (2001)\", \"DOI:10.1016/S0378-4347(00)00616-2\")), list(REFERENCE = \"PMID:11544129\", AUTHORS = \"Ashihara H, Crozier A.\", TITLE = \"Caffeine: a well known but little mentioned compound in plant science.\", JOURNAL = c(\"Trends Plant Sci 6:407-13 (2001)\", \"DOI:10.1016/S1360-1385(01)02055-6\")), list(REFERENCE = \"PMID:16333668\", AUTHORS = \"Yoneyama N, Morimoto H, Ye CX, Ashihara H, Mizuno K, Kato M.\", TITLE = \"Substrate specificity of N-methyltransferase involved in purine alkaloids synthesis is dependent upon one amino acid residue of the enzyme.\", JOURNAL = c(\"Mol Genet Genomics 275:125-35 (2006)\", \"DOI:10.1007/s00438-005-0070-z\"))', 'map00232', 'Caffeine metabolism', 'Metabolism; Biosynthesis of other secondary metabolites', 415, 18, 234, 100, 63, 18, 18, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (25, '00240', 'Pyrimidine metabolism', 'Metabolism; Nucleotide metabolism', 'Pyrimidine metabolism', 'Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate [PATH:map00240], Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP [PATH:map00240], Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP [PATH:map00240], Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP [PATH:map00240]', 'Dihydropyrimidine dehydrogenase deficiency, Orotic aciduria, Dihydropyrimidinase deficiency, Beta-ureidopropionase deficiency, Mitochondrial DNA depletion syndrome, Desbuquois syndrome, Anemia due to disorders of nucleotide metabolism, Calcification of joints and arteries, Acrofacial dysostosis, Mitochondrial neurogastrointestinal encephalomyopathy', 'GO: 0006220', 'ko00240', 'map00240', 'Pyrimidine metabolism', 531, 5544, 248, 105, 128, 50, 5245, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (26, '00250', 'Alanine, aspartate and glutamate metabolism', 'Metabolism; Amino acid metabolism', 'Alanine, aspartate and glutamate metabolism', 'GABA (gamma-Aminobutyrate) shunt [PATH:map00250], Methylaspartate cycle [PATH:map00250]', 'Canavan disease, Carbamoyl phosphate synthetase I deficiency, Citrullinemia, Adenylosuccinate lyase deficiency, Succinic semialdehyde dehydrogenase deficiency, Congenital systemic glutamine deficiency, Argininosuccinic aciduria, GABA-transaminase deficiency, Asparagine synthetase deficiency', 'GO: 0006522 0006531 0006536', 'ko00250', 'list(REFERENCE = \"\", AUTHORS = \"Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\", TITLE = \"[Cellular Functions and Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1997)\"), list(REFERENCE = \"PMID:9687539\", AUTHORS = \"Wu G\", TITLE = \"Intestinal mucosal amino acid catabolism.\", JOURNAL = c(\"J Nutr 128:1249-52 (1998)\", \"DOI:10.1093/jn/128.8.1249\"))', 'map00250', 526, 5444, 248, 105, 123, 50, 5149, 295);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (27, '00253', 'Tetracycline biosynthesis', 'Tetracyclines are aromatic polyketide antibiotics produced by Streptomyces species via type II polyketide synthases (PKSs). Tetracyclines contain a linear tetracyclic skeleton, which is formed from a malonamate starter unit and malonyl-CoA extender units through a common polyketide pathway [MD:M00778]. This diagram shows biosynthesis of naturally occurring tetracyclines (tetracycline, oxytetracycline and chlortetracycline) via a common intermediate anhydrotetracycline [MD:M00780 M00823].', 'Metabolism; Metabolism of terpenoids and polyketides', 'Tetracycline biosynthesis', 'Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide [PATH:map00253], Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline [PATH:map00253], Chlortetracycline biosynthesis, pretetramide => chlortetracycline [PATH:map00253]', 'D00201, Tetracycline (JAN/USP/INN), D07689, Chlortetracycline (INN)', 'GO: 0043644', 'ko00253', 'list(REFERENCE = \"PMID:16959966\", AUTHORS = \"Petkovic H, Cullum J, Hranueli D, Hunter IS, Peric-Concha N, Pigac J, Thamchaipenet A, Vujaklija D, Long PF\", TITLE = \"Genetics of Streptomyces rimosus, the oxytetracycline producer.\", JOURNAL = c(\"Microbiol Mol Biol Rev 70:704-28 (2006)\", \"DOI:10.1128/MMBR.00004-06\")), list(REFERENCE = \"PMID:20522541\", AUTHORS = \"Pickens LB, Tang Y\", TITLE = \"Oxytetracycline biosynthesis.\", JOURNAL = c(\"J Biol Chem 285:27509-15 (2010)\", \"DOI:10.1074/jbc.R110.130419\")), list(REFERENCE = \"PMID:16597959\", AUTHORS = \"Zhang W, Ames BD, Tsai SC, Tang Y\", TITLE = \"Engineered biosynthesis of a novel amidated polyketide, using the malonamyl-specific initiation module from the oxytetracycline polyketide synthase.\", JOURNAL = c(\"Appl Environ Microbiol 72:2573-80 (2006)\", \"DOI:10.1128/AEM.72.4.2573-2580.2006\")), list(REFERENCE = \"\", AUTHORS = \"Dewick PM.\", TITLE = \"Medicinal Natural Products: A Biosynthetic Approach, Second Edition\", JOURNAL = \"John Wiley and Sons (2001)\"), list(REFERENCE = \"PMID:1134373\", AUTHORS = \"Miller PA, Hash JH\", TITLE = \"S-adenosylmethionine:dedimethylamino-4-aminoanhydrotetracycline N-methyltransferase.\", JOURNAL = c(\"Methods Enzymol 43:603-6 (1975)\", \"DOI:10.1016/0076-6879(75)43122-6\")), list(REFERENCE = \"PMID:1134374\", AUTHORS = \"Miller PA, Hash JH\", TITLE = \"ADP; tetracyclin 5a(11a)dehydrogenase.\", JOURNAL = c(\"Methods Enzymol 43:606-7 (1975)\", \"DOI:10.1016/0076-6879(75)43123-8\")), list(REFERENCE = \"PMID:19472250\", AUTHORS = \"Wang P, Zhang W, Zhan J, Tang Y\", TITLE = \"Identification of OxyE as an ancillary oxygenase during tetracycline biosynthesis.\", JOURNAL = c(\"Chembiochem 10:1544-50 (2009)\", \"DOI:10.1002/cbic.200900122\")), list(REFERENCE = \"PMID:18422316\", AUTHORS = \"Zhang W, Watanabe K, Cai X, Jung ME, Tang Y, Zhan J\", TITLE = \"Identifying the minimal enzymes required for anhydrotetracycline biosynthesis.\", JOURNAL = c(\"J Am Chem Soc 130:6068-9 (2008)\", \"DOI:10.1021/ja800951e\")), list(REFERENCE = \"PMID:10551844\", AUTHORS = \"Petkovic H, Thamchaipenet A, Zhou LH, Hranueli D, Raspor P, Waterman PG, Hunter IS\", TITLE = \"Disruption of an aromatase/cyclase from the oxytetracycline gene cluster of Streptomyces rimosus results in production of novel polyketides with shorter chain lengths.\", JOURNAL = \"J Biol Chem 274:32829-34 (1999)\"), list(REFERENCE = \"PMID:16148009\", AUTHORS = \"Peric-Concha N, Borovicka B, Long PF, Hranueli D, Waterman PG, Hunter IS\", TITLE = \"Ablation of the otcC gene encoding a post-polyketide hydroxylase from the oxytetracyline biosynthetic pathway in Streptomyces rimosus results in novel polyketides with altered chain length.\", JOURNAL = c(\"J Biol Chem 280:37455-60 (2005)\", \"DOI:10.1074/jbc.M503191200\")), list(REFERENCE = \"PMID:17631493\", AUTHORS = \"Zhang W, Watanabe K, Wang CC, Tang Y\", TITLE = \"Investigation of early tailoring reactions in the oxytetracycline biosynthetic pathway.\", JOURNAL = c(\"J Biol Chem 282:25717-25 (2007)\", \"DOI:10.1074/jbc.M703437200\")), list(REFERENCE = \"PMID:8163168\", AUTHORS = \"Kim ES, Bibb MJ, Butler MJ, Hopwood DA, Sherman DH.\", TITLE = \"Sequences of the oxytetracycline polyketide synthase-encoding otc genes from Streptomyces rimosus.\", JOURNAL = c(\"Gene 141:141-2 (1994)\", \"DOI:10.1016/0378-1119(94)90144-9\")), list(REFERENCE = \"PMID:7612997\", AUTHORS = \"Dairi T, Nakano T, Aisaka K, Katsumata R, Hasegawa M.\", TITLE = \"Cloning and nucleotide sequence of the gene responsible for chlorination of tetracycline.\", JOURNAL = c(\"Biosci Biotechnol Biochem 59:1099-106 (1995)\", \"DOI:10.1271/bbb.59.1099\")), list(REFERENCE = \"PMID:23621493\", AUTHORS = \"Wang P, Bashiri G, Gao X, Sawaya MR, Tang Y\", TITLE = \"Uncovering the enzymes that catalyze the final steps in oxytetracycline biosynthesis.\", JOURNAL = c(\"J Am Chem Soc 135:7138-41 (2013)\", \"DOI:10.1021/ja403516u\")), list(REFERENCE = \"PMID:23800859\", AUTHORS = \"Zhu T, Cheng X, Liu Y, Deng Z, You D\", TITLE = \"Deciphering and engineering of the final step halogenase for improved chlortetracycline biosynthesis in industrial Streptomyces aureofaciens.\", JOURNAL = c(\"Metab Eng 19:69-78 (2013)\", \"DOI:10.1016/j.ymben.2013.06.003\")), list(REFERENCE = \"PMID:15452119\", AUTHORS = \"Yang W, Moore IF, Koteva KP, Bareich DC, Hughes DW, Wright GD\", TITLE = \"TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics.\", JOURNAL = c(\"J Biol Chem 279:52346-52 (2004)\", \"DOI:10.1074/jbc.M409573200\"))', 0, 82, 0, 0, 0, 0, 82, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (28, '00254', 'Aflatoxin biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Aflatoxin biosynthesis', 'GO: 0045122', 'ko00254', 'list(REFERENCE = \"PMID:23202305\", AUTHORS = \"Yu J\", TITLE = \"Current understanding on aflatoxin biosynthesis and future perspective in reducing aflatoxin contamination.\", JOURNAL = c(\"Toxins (Basel) 4:1024-57 (2012)\", \"DOI:10.3390/toxins4111024\")), list(REFERENCE = \"PMID:15022028\", AUTHORS = \"Yabe K, Nakajima H\", TITLE = \"Enzyme reactions and genes in aflatoxin biosynthesis.\", JOURNAL = c(\"Appl Microbiol Biotechnol 64:745-55 (2004)\", \"DOI:10.1007/s00253-004-1566-x\")), list(REFERENCE = \"PMID:22069531\", AUTHORS = \"Ehrlich KC\", TITLE = \"Predicted roles of the uncharacterized clustered genes in aflatoxin biosynthesis.\", JOURNAL = c(\"Toxins (Basel) 1:37-58 (2009)\", \"DOI:10.3390/toxins1010037\")), list(REFERENCE = \"PMID:20332208\", AUTHORS = \"Korman TP, Crawford JM, Labonte JW, Newman AG, Wong J, Townsend CA, Tsai SC\", TITLE = \"Structure and function of an iterative polyketide synthase thioesterase domain catalyzing Claisen cyclization in aflatoxin biosynthesis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 107:6246-51 (2010)\", \"DOI:10.1073/pnas.0913531107\")), list(REFERENCE = \"PMID:15932995\", AUTHORS = \"Sakuno E, Wen Y, Hatabayashi H, Arai H, Aoki C, Yabe K, Nakajima H\", TITLE = \"Aspergillus parasiticus cyclase catalyzes two dehydration steps in aflatoxin biosynthesis.\", JOURNAL = c(\"Appl Environ Microbiol 71:2999-3006 (2005)\", \"DOI:10.1128/AEM.71.6.2999-3006.2005\")), list(REFERENCE = \"PMID:19211038\", AUTHORS = \"Shima Y, Shiina M, Shinozawa T, Ito Y, Nakajima H, Adachi Y, Yabe K\", TITLE = \"Participation in aflatoxin biosynthesis by a reductase enzyme encoded by vrdA gene outside the aflatoxin gene cluster.\", JOURNAL = c(\"Fungal Genet Biol 46:221-31 (2009)\", \"DOI:10.1016/j.fgb.2008.12.005\"))', 'map00254', 'Aflatoxin biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 50, 0, 0, 1, 49, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (29, '00260', 'Glycine, serine and threonine metabolism', 'Serine is derived from 3-phospho-D-glycerate, an intermediate of glycolysis [MD:M00020], and glycine is derived from serine. Threonine is an essential amino acid, which animals cannot synthesize. In bacteria and plants, threonine is derived from aspartate [MD:M00018].', 'Metabolism; Amino acid metabolism', 'Glycine, serine and threonine metabolism', 'Threonine biosynthesis, aspartate => homoserine => threonine [PATH:map00260], Serine biosynthesis, glycerate-3P => serine [PATH:map00260], Ectoine biosynthesis, aspartate => ectoine [PATH:map00260], Cysteine biosynthesis, homocysteine + serine => cysteine [PATH:map00260], Betaine biosynthesis, choline => betaine [PATH:map00260]', 'Primary hyperoxaluria, Cystathioninuria, Homocystinuria, Hypermethioninemia, Nonketotic hyperglycinemia, Guanidinoacetate methyltransferase deficiency, Cerebral creatine deficiency syndrome, Dimethylglycine dehydrogenase deficiency, 3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency, Phosphoserine aminotransferase deficiency, Glycogen storage disease type X, Phosphoserine phosphatase deficiency, Neu-Laxova syndrome', 'GO: 0006544 0006563 0070178 0006566', 'ko00260', 'list(REFERENCE = \"\", AUTHORS = \"Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\", TITLE = \"[Cellular Functions and Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1997)\"), list(REFERENCE = \"PMID:11823218\", AUTHORS = \"Kuhlmann AU, Bremer E.\", TITLE = \"Osmotically regulated synthesis of the compatible solute ectoine in Bacillus pasteurii and related Bacillus spp.\", JOURNAL = c(\"Appl Environ Microbiol 68:772-83 (2002)\", \"DOI:10.1128/AEM.68.2.772-783.2002\")), list(REFERENCE = \"PMID:10473374\", AUTHORS = \"Canovas D, Borges N, Vargas C, Ventosa A, Nieto JJ, Santos H.\", TITLE = \"Role of Ngamma-acetyldiaminobutyrate as an enzyme stabilizer and an intermediate in the biosynthesis of hydroxyectoine.\", JOURNAL = \"Appl Environ Microbiol 65:3774-9 (1999)\"), list(REFERENCE = \"PMID:17636255\", AUTHORS = \"Bursy J, Pierik AJ, Pica N, Bremer E.\", TITLE = \"Osmotically induced synthesis of the compatible solute hydroxyectoine is mediated by an evolutionarily conserved ectoine hydroxylase.\", JOURNAL = c(\"J Biol Chem 282:31147-55 (2007)\", \"DOI:10.1074/jbc.M704023200\")), list(REFERENCE = \"PMID:16707670\", AUTHORS = \"Garcia-Estepa R, Argandona M, Reina-Bueno M, Capote N, Iglesias-Guerra F, Nieto JJ, Vargas C.\", TITLE = \"The ectD gene, which is involved in the synthesis of the compatible solute hydroxyectoine, is essential for thermoprotection of the halophilic bacterium Chromohalobacter salexigens.\", JOURNAL = c(\"J Bacteriol 188:3774-84 (2006)\", \"DOI:10.1128/JB.00136-06\")), list(REFERENCE = \"PMID:15470257\", AUTHORS = \"Arevalo-Rodriguez M, Pan X, Boeke JD, Heitman J\", TITLE = \"FKBP12 controls aspartate pathway flux in Saccharomyces cerevisiae to prevent toxic intermediate accumulation.\", JOURNAL = c(\"Eukaryot Cell 3:1287-96 (2004)\", \"DOI:10.1128/EC.3.5.1287-1296.2004\")), list(REFERENCE = \"PMID:7639721\", AUTHORS = \"Rees WD, Hay SM\", TITLE = \"The biosynthesis of threonine by mammalian cells: expression of a complete bacterial biosynthetic pathway in an animal cell.\", JOURNAL = c(\"Biochem J 309 ( Pt 3):999-1007 (1995)\", \"DOI:10.1042/bj3090999\")), list(REFERENCE = \"PMID:11341914\", AUTHORS = \"Jacques SL, Nieman C, Bareich D, Broadhead G, Kinach R, Honek JF, Wright GD\", TITLE = \"Characterization of yeast homoserine dehydrogenase, an antifungal target: the invariant histidine 309 is important for enzyme integrity.\", JOURNAL = c(\"Biochim Biophys Acta 1544:28-41 (2001)\", \"DOI:10.1016/S0167-4838(00)00203-X\")), list(REFERENCE = \"PMID:15520012\", AUTHORS = \"Chen X, Jhee KH, Kruger WD\", TITLE = \"Production of the neuromodulator H2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine.\", JOURNAL = c(\"J Biol Chem 279:52082-6 (2004)\", \"DOI:10.1074/jbc.C400481200\"))', 530, 5547, 248, 105, 127, 50, 5250, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (30, '00261', 'Monobactam biosynthesis', 'Monobactams are beta-lactam antibiotics containing a monocyclic beta-lactam nucleus, which is structurally different from penicillin and cephalosporin core structures with another fused ring. This diagram shows biosynthesis of nocardicin A, a naturally occurring monobactam, via the pentapeptide formed by condensation of L-4-hydroxyphenylglycine (L-pHPG), L-arginine and L-serine [MD:M00736]. Other naturally occurring monobactams are also shown but the biosynthetic pathway is not yet fully characterized. Sulfazecin and other 3-aminomonobactamic acid derivatives are derived from serine or threonine, and tabtoxinine-beta-lactam is a phytotoxin. Aztreonam, a synthetic monobactam originally isolated as SQ 26,180 from Chromobacterium violaceum, is the first clinically used monobactam.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Monobactam biosynthesis', 'Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A [PATH:map00261]', 'ko00261', 'list(REFERENCE = \"PMID:23135477\", AUTHORS = \"Hamed RB, Gomez-Castellanos JR, Henry L, Ducho C, McDonough MA, Schofield CJ\", TITLE = \"The enzymes of beta-lactam biosynthesis.\", JOURNAL = c(\"Nat Prod Rep 30:21-107 (2013)\", \"DOI:10.1039/c2np20065a\")), list(REFERENCE = \"PMID:15271351\", AUTHORS = \"Gunsior M, Breazeale SD, Lind AJ, Ravel J, Janc JW, Townsend CA\", TITLE = \"The biosynthetic gene cluster for a monocyclic beta-lactam antibiotic, nocardicin A.\", JOURNAL = c(\"Chem Biol 11:927-38 (2004)\", \"DOI:10.1016/j.chembiol.2004.04.012\")), list(REFERENCE = \"PMID:15252031\", AUTHORS = \"Kelly WL, Townsend CA\", TITLE = \"Mutational analysis and characterization of nocardicin C-9\' epimerase.\", JOURNAL = c(\"J Biol Chem 279:38220-7 (2004)\", \"DOI:10.1074/jbc.M405450200\")), list(REFERENCE = \"PMID:15629944\", AUTHORS = \"Kelly WL, Townsend CA\", TITLE = \"Mutational analysis of nocK and nocL in the nocardicin a producer Nocardia uniformis.\", JOURNAL = c(\"J Bacteriol 187:739-46 (2005)\", \"DOI:10.1128/JB.187.2.739-746.2005\")), list(REFERENCE = \"PMID:9804844\", AUTHORS = \"Reeve AM, Breazeale SD, Townsend CA\", TITLE = \"Purification, characterization, and cloning of an S-adenosylmethionine-dependent 3-amino-3-carboxypropyltransferase in nocardicin biosynthesis.\", JOURNAL = c(\"J Biol Chem 273:30695-703 (1998)\", \"DOI:10.1074/jbc.273.46.30695\")), list(REFERENCE = \"PMID:12105888\", AUTHORS = \"Kelly WL, Townsend CA\", TITLE = \"Role of the cytochrome P450 NocL in nocardicin A biosynthesis.\", JOURNAL = c(\"J Am Chem Soc 124:8186-7 (2002)\", \"DOI:10.1021/ja025926g\")), list(REFERENCE = \"PMID:11137816\", AUTHORS = \"Hubbard BK, Thomas MG, Walsh CT\", TITLE = \"Biosynthesis of L-p-hydroxyphenylglycine, a non-proteinogenic amino acid constituent of peptide antibiotics.\", JOURNAL = c(\"Chem Biol 7:931-42 (2000)\", \"DOI:10.1016/S1074-5521(00)00043-0\")), list(REFERENCE = \"PMID:25624104\", AUTHORS = \"Gaudelli NM, Long DH, Townsend CA\", TITLE = \"beta-Lactam formation by a non-ribosomal peptide synthetase during antibiotic biosynthesis.\", JOURNAL = c(\"Nature 520:383-7 (2015)\", \"DOI:10.1038/nature14100\")), list(REFERENCE = \"PMID:24531841\", AUTHORS = \"Gaudelli NM, Townsend CA\", TITLE = \"Epimerization and substrate gating by a TE domain in beta-lactam antibiotic biosynthesis.\", JOURNAL = c(\"Nat Chem Biol 10:251-8 (2014)\", \"DOI:10.1038/nchembio.1456\")), list(REFERENCE = \"PMID:22365611\", AUTHORS = \"Davidsen JM, Townsend CA\", TITLE = \"In vivo characterization of nonribosomal peptide synthetases NocA and NocB in the biosynthesis of nocardicin A.\", JOURNAL = c(\"Chem Biol 19:297-306 (2012)\", \"DOI:10.1016/j.chembiol.2011.10.020\")), list(REFERENCE = \"PMID:23330869\", AUTHORS = \"Davidsen JM, Bartley DM, Townsend CA\", TITLE = \"Non-ribosomal propeptide precursor in nocardicin A biosynthesis predicted from adenylation domain specificity dependent on the MbtH family protein NocI.\", JOURNAL = c(\"J Am Chem Soc 135:1749-59 (2013)\", \"DOI:10.1021/ja307710d\")), list(REFERENCE = \"PMID:6805424\", AUTHORS = \"O\'Sullivan J, Gillum AM, Aklonis CA, Souser ML, Sykes RB\", TITLE = \"Biosynthesis of monobactam compounds: origin of the carbon atoms in the beta-lactam ring.\", JOURNAL = c(\"Antimicrob Agents Chemother 21:558-64 (1982)\", \"DOI:10.1128/AAC.21.4.558\")), list(REFERENCE = \"PMID:6859838\", AUTHORS = \"O\'Sullivan J, Souser ML, Kao CC, Aklonis CA\", TITLE = \"Sulfur metabolism in the biosynthesis of monobactams.\", JOURNAL = c(\"Antimicrob Agents Chemother 23:598-602 (1983)\", \"DOI:10.1128/AAC.23.4.598\")), list(REFERENCE = \"PMID:16506699\", AUTHORS = \"Kinscherf TG, Willis DK\", TITLE = \"The biosynthetic gene cluster for the beta-lactam antibiotic tabtoxin in Pseudomonas syringae.\", JOURNAL = c(\"J Antibiot (Tokyo) 58:817-21 (2005)\", \"DOI:10.1038/ja.2005.109\")), list(REFERENCE = \"PMID:22994681\", AUTHORS = \"Wencewicz TA, Walsh CT\", TITLE = \"Pseudomonas syringae self-protection from tabtoxinine-beta-lactam by ligase TblF and acetylase Ttr.\", JOURNAL = c(\"Biochemistry 51:7712-25 (2012)\", \"DOI:10.1021/bi3011384\")), list(REFERENCE = \"PMID:23770908\", AUTHORS = \"Arai T, Arimura Y, Ishikura S, Kino K\", TITLE = \"L-amino acid ligase from Pseudomonas syringae producing tabtoxin can be used for enzymatic synthesis of various functional peptides.\", JOURNAL = c(\"Appl Environ Microbiol 79:5023-9 (2013)\", \"DOI:10.1128/AEM.01003-13\")), list(REFERENCE = \"PMID:1515668\", AUTHORS = \"Engst K, Shaw PD\", TITLE = \"Identification of a lysA-like gene required for tabtoxin biosynthesis and pathogenicity in Pseudomonas syringae pv. tabaci strain PTBR2.024.\", JOURNAL = \"Mol Plant Microbe Interact 5:322-9 (1992)\"), list(REFERENCE = \"PMID:8990304\", AUTHORS = \"Liu L, Shaw PD\", TITLE = \"Characterization of dapB, a gene required by Pseudomonas syringae pv. tabaci BR2.024 for lysine and tabtoxinine-beta-lactam biosynthesis.\", JOURNAL = c(\"J Bacteriol 179:507-13 (1997)\", \"DOI:10.1128/JB.179.2.507-513.1997\")), list(REFERENCE = \"PMID:9294453\", AUTHORS = \"Liu L, Shaw PD\", TITLE = \"A possible role for acetylated intermediates in diaminopimelate and tabtoxinine-beta-lactam biosynthesis in Pseudomonas syringae pv. tabaci BR2.024.\", JOURNAL = c(\"J Bacteriol 179:5922-7 (1997)\", \"DOI:10.1128/JB.179.18.5922-5927.1997\")), list(REFERENCE = \"PMID:2881927\", AUTHORS = \"Unkefer CJ, London RE, Durbin RD, Uchytil TF, Langston-Unkefer PJ\", TITLE = \"The biosynthesis of tabtoxinine-beta-lactam. Use of specifically 13C-labeled glucose and 13C NMR spectroscopy to identify its biosynthetic precursors.\", JOURNAL = \"J Biol Chem 262:4994-9 (1987)\")', 'map00261', 'Monobactam biosynthesis', 244, 5236, 3, 105, 122, 14, 4967, 269);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (31, '00270', 'Cysteine and methionine metabolism', 'Cysteine and methionine are sulfur-containing amino acids. Cysteine is synthesized from serine through different pathways in different organism groups. In bacteria and plants, cysteine is converted from serine (via acetylserine) by transfer of hydrogen sulfide [MD:M00021]. In animals, methionine-derived homocysteine is used as sulfur source and its condensation product with serine (cystathionine) is converted to cysteine [MD:M00338]. Cysteine is metabolized to pyruvate in multiple routes. Methionine is an essential amino acid, which animals cannot synthesize. In bacteria and plants, methionine is synthesized from aspartate [MD:M00017]. S-Adenosylmethionine (SAM), synthesized from methionine and ATP, is a methyl group donor in many important transfer reactions including DNA methylation for regulation of gene expression. SAM may also be used to regenerate methionine in the methionine salvage pathway [MD:M00034].', 'Metabolism; Amino acid metabolism', 'Cysteine and methionine metabolism', 'Methionine biosynthesis, apartate => homoserine => methionine [PATH:map00270], Cysteine biosynthesis, serine => cysteine [PATH:map00270], Methionine salvage pathway [PATH:map00270], Methionine degradation [PATH:map00270], Cysteine biosynthesis, homocysteine + serine => cysteine [PATH:map00270], Ethylene biosynthesis, methionine => ethylene [PATH:map00270], Cysteine biosynthesis, methionine => cysteine [PATH:map00270]', 'Cystathioninuria, Homocystinuria, Hypermethioninemia, Snyder-Robinson syndrome, Methylcobalamin deficiency type G, Tatton-Brown-Rahman syndrome', 'GO: 0006534 0006555', 'ko00270', 'list(REFERENCE = \"PMID:15102328\", AUTHORS = \"Sekowska A, Denervaud V, Ashida H, Michoud K, Haas D, Yokota A, Danchin A\", TITLE = \"Bacterial variations on the methionine salvage pathway.\", JOURNAL = c(\"BMC Microbiol 4:9 (2004)\", \"DOI:10.1186/1471-2180-4-9\")), list(REFERENCE = \"PMID:14551435\", AUTHORS = \"Ashida H, Saito Y, Kojima C, Kobayashi K, Ogasawara N, Yokota A.\", TITLE = \"A functional link between RuBisCO-like protein of Bacillus and photosynthetic RuBisCO.\", JOURNAL = c(\"Science 302:286-90 (2003)\", \"DOI:10.1126/science.1086997\")), list(REFERENCE = \"PMID:12022921\", AUTHORS = \"Sekowska A, Danchin A.\", TITLE = \"The methionine salvage pathway in Bacillus subtilis.\", JOURNAL = c(\"BMC Microbiol 2:8 (2002)\", \"DOI:10.1186/1471-2180-2-8\")), list(REFERENCE = \"PMID:12670965\", AUTHORS = \"Berger BJ, English S, Chan G, Knodel MH.\", TITLE = \"Methionine regeneration and aminotransferases in Bacillus subtilis, Bacillus cereus, and Bacillus anthracis.\", JOURNAL = c(\"J Bacteriol 185:2418-31 (2003)\", \"DOI:10.1128/JB.185.8.2418-2431.2003\")), list(REFERENCE = \"PMID:17169919\", AUTHORS = \"Goyer A, Collakova E, Shachar-Hill Y, Hanson AD\", TITLE = \"Functional characterization of a methionine gamma-lyase in Arabidopsis and its implication in an alternative to the reverse trans-sulfuration pathway.\", JOURNAL = c(\"Plant Cell Physiol 48:232-42 (2007)\", \"DOI:10.1093/pcp/pcl055\")), list(REFERENCE = \"PMID:17030798\", AUTHORS = \"Rebeille F, Jabrin S, Bligny R, Loizeau K, Gambonnet B, Van Wilder V, Douce R, Ravanel S\", TITLE = \"Methionine catabolism in Arabidopsis cells is initiated by a gamma-cleavage process and leads to S-methylcysteine and isoleucine syntheses.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 103:15687-92 (2006)\", \"DOI:10.1073/pnas.0606195103\")), list(REFERENCE = \"PMID:18625006\", AUTHORS = \"Pirkov I, Norbeck J, Gustafsson L, Albers E\", TITLE = \"A complete inventory of all enzymes in the eukaryotic methionine salvage pathway.\", JOURNAL = c(\"FEBS J 275:4111-20 (2008)\", \"DOI:10.1111/j.1742-4658.2008.06552.x\")), list(REFERENCE = \"PMID:18391471\", AUTHORS = \"Ashida H, Saito Y, Kojima C, Yokota A\", TITLE = \"Enzymatic characterization of 5-methylthioribulose-1-phosphate dehydratase of the methionine salvage pathway in Bacillus subtilis.\", JOURNAL = c(\"Biosci Biotechnol Biochem 72:959-67 (2008)\", \"DOI:10.1271/bbb.70651\")), list(REFERENCE = \"PMID:10613873\", AUTHORS = \"Kitabatake M, So MW, Tumbula DL, Soll D\", TITLE = \"Cysteine biosynthesis pathway in the archaeon Methanosarcina barkeri encoded by acquired bacterial genes?\", JOURNAL = c(\"J Bacteriol 182:143-5 (2000)\", \"DOI:10.1128/JB.182.1.143-145.2000\")), list(REFERENCE = \"PMID:12644499\", AUTHORS = \"Mino K, Ishikawa K\", TITLE = \"Characterization of a novel thermostable O-acetylserine sulfhydrylase from Aeropyrum pernix K1.\", JOURNAL = c(\"J Bacteriol 185:2277-84 (2003)\", \"DOI:10.1128/JB.185.7.2277-2284.2003\")), list(REFERENCE = \"PMID:18520135\", AUTHORS = \"Tanabe S\", TITLE = \"Development of assay methods for endogenous inorganic sulfur compounds and sulfurtransferases and evaluation of the physiological functions of bound sulfur.\", JOURNAL = c(\"Yakugaku Zasshi 128:881-900 (2008)\", \"DOI:10.1248/yakushi.128.881\")), list(REFERENCE = \"\", AUTHORS = \"Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\", TITLE = \"[Cellular Functions and Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1997)\"), list(REFERENCE = \"PMID:19270684\", AUTHORS = \"Gutierrez JA, Crowder T, Rinaldo-Matthis A, Ho MC, Almo SC, Schramm VL\", TITLE = \"Transition state analogs of 5\'-methylthioadenosine nucleosidase disrupt quorum sensing.\", JOURNAL = c(\"Nat Chem Biol 5:251-7 (2009)\", \"DOI:10.1038/nchembio.153\"))', 527, 5548, 248, 105, 124, 50, 5252, 296);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (32, '00280', 'Valine, leucine and isoleucine degradation', 'Metabolism; Amino acid metabolism', 'Valine, leucine and isoleucine degradation', 'Leucine degradation, leucine => acetoacetate + acetyl-CoA [PATH:map00280], Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA [PATH:map00280]', 'Maple syrup urine disease, Isovaleric acidemia, Methylmalonic aciduria, Propionic acidemia, 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency, 3-Methylcrotonylglycinuria, SBCAD deficiency, 3-Methylglutaconic aciduria, 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency, Alpha-methylacetoacetic aciduria, Succinyl CoA:3-oxoacid CoA transferase (SCOT) deficiency, HMG-CoA synthase deficiency, Isobutyryl-CoA dehydrogenase deficiency, Methacrylic aciduria, 3-Hydroxyacyl-CoA dehydrogenase deficiency, Secondary hyperammonemia, Dihydrolipoamide dehydrogenase deficiency, Combined malonic and methylmalonic aciduria, Methylmalonate semialdehyde dehydrogenase deficiency', 'GO: 0006550 0006552 0006574', 'ko00280', 'map00280', 'Valine, leucine and isoleucine degradation', 530, 5501, 248, 105, 128, 49, 5204, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (33, '00281', 'Geraniol degradation', 'Metabolism; Metabolism of terpenoids and polyketides', 'Geraniol degradation', 'UMBBD: ger cit', 'ko00281', 'list(REFERENCE = \"PMID:11778886\", AUTHORS = \"Wolken WA, van der Werf MJ.\", TITLE = \"Geraniol biotransformation-pathway in spores of Penicillium digitatum.\", JOURNAL = c(\"Appl Microbiol Biotechnol 57:731-7 (2001)\", \"DOI:10.1007/s002530100821\")), list(REFERENCE = \"PMID:16272386\", AUTHORS = \"Hoschle B, Gnau V, Jendrossek D.\", TITLE = \"Methylcrotonyl-CoA and geranyl-CoA carboxylases are involved in leucine/isovalerate utilization (Liu) and acyclic terpene utilization (Atu), and are encoded by liuB/liuD and atuC/atuF, in Pseudomonas aeruginosa.\", JOURNAL = c(\"Microbiology 151:3649-56 (2005)\", \"DOI:10.1099/mic.0.28260-0\")), list(REFERENCE = \"PMID:16820476\", AUTHORS = \"Forster-Fromme K, Hoschle B, Mack C, Bott M, Armbruster W, Jendrossek D\", TITLE = \"Identification of genes and proteins necessary for catabolism of acyclic terpenes and leucine/isovalerate in Pseudomonas aeruginosa.\", JOURNAL = c(\"Appl Environ Microbiol 72:4819-28 (2006)\", \"DOI:10.1128/AEM.00853-06\")), list(REFERENCE = \"PMID:16000717\", AUTHORS = \"Hoschle B, Jendrossek D.\", TITLE = \"Utilization of geraniol is dependent on molybdenum in Pseudomonas aeruginosa: evidence for different metabolic routes for oxidation of geraniol and citronellol.\", JOURNAL = c(\"Microbiology 151:2277-83 (2005)\", \"DOI:10.1099/mic.0.27957-0\")), list(REFERENCE = \"PMID:681275\", AUTHORS = \"Cantwell SG, Lau EP, Watt DS, Fall RR.\", TITLE = \"Biodegradation of acyclic isoprenoids by Pseudomonas species.\", JOURNAL = \"J Bacteriol 135:324-33 (1978)\"), list(REFERENCE = \"PMID:19597963\", AUTHORS = \"Chavez-Aviles M, Diaz-Perez AL, Campos-Garcia J\", TITLE = \"The bifunctional role of LiuE from Pseudomonas aeruginosa, displays additionally HIHG-CoA lyase enzymatic activity.\", JOURNAL = c(\"Mol Biol Rep 37:1787-91 (2010)\", \"DOI:10.1007/s11033-009-9611-6\"))', 'map00281', 'Geraniol degradation', 'Metabolism; Metabolism of terpenoids and polyketides', 0, 3092, 0, 0, 0, 0, 3026, 66);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (34, '00290', 'Valine, leucine and isoleucine biosynthesis', 'Metabolism; Amino acid metabolism', 'Valine, leucine and isoleucine biosynthesis', 'Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map00290], Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map00290], Isoleucine biosynthesis, pyruvate => 2-oxobutanoate [PATH:map00290], Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine [PATH:map00290]', 'GO: 0009097 0009098 0009099', 'ko00290', 'list(REFERENCE = \"PMID:15292141\", AUTHORS = \"Xu H, Zhang Y, Guo X, Ren S, Staempfli AA, Chiao J, Jiang W, Zhao G.\", TITLE = \"Isoleucine biosynthesis in Leptospira interrogans serotype lai strain 56601 proceeds via a threonine-independent pathway.\", JOURNAL = c(\"J Bacteriol 186:5400-9 (2004)\", \"DOI:10.1128/JB.186.16.5400-5409.2004\"))', 'map00290', 'Valine, leucine and isoleucine biosynthesis', 504, 5215, 244, 105, 123, 32, 4957, 258);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (35, '00300', 'Lysine biosynthesis', 'Metabolism; Amino acid metabolism', 'Lysine biosynthesis', 'Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine [PATH:map00300], Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine [PATH:map00300], Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine [PATH:map00300], Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate [PATH:map00300], Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine [PATH:map00300], Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine [PATH:map00300], Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine [PATH:map00300], 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map00300]', 'Hyperlysinemia', 'GO: 0009085', 'ko00300', 'list(REFERENCE = \"PMID:10074354\", AUTHORS = \"Ledwidge R, Blanchard JS.\", TITLE = \"The dual biosynthetic capability of N-acetylornithine aminotransferase in arginine and lysine biosynthesis.\", JOURNAL = c(\"Biochemistry 38:3019-3024 (1999)\", \"DOI:10.1021/bi982574a\")), list(REFERENCE = \"PMID:10850974\", AUTHORS = \"Fuchs TM, Schneider B, Krumbach K, Eggeling L, Gross R.\", TITLE = \"Characterization of a bordetella pertussis diaminopimelate (DAP) biosynthesis locus identifies dapC, a novel gene coding for an N-succinyl-L,L-DAP aminotransferase.\", JOURNAL = c(\"J Bacteriol 182:3626-3631 (2000)\", \"DOI:10.1128/JB.182.13.3626-3631.2000\")), list(REFERENCE = \"PMID:10714900\", AUTHORS = \"Zabriskie TM, Jackson MD.\", TITLE = \"Lysine biosynthesis and metabolism in fungi.\", JOURNAL = c(\"Nat Prod Rep 17:85-97 (2000)\", \"DOI:10.1039/A801345D\")), list(REFERENCE = \"PMID:14627808\", AUTHORS = \"Rodionov DA, Vitreschak AG, Mironov AA, Gelfand MS.\", TITLE = \"Regulation of lysine biosynthesis and transport genes in bacteria: yet another RNA riboswitch?\", JOURNAL = c(\"Nucleic Acids Res 31:6748-57 (2003)\", \"DOI:10.1093/nar/gkg900\")), list(REFERENCE = \"PMID:12355264\", AUTHORS = \"Velasco AM, Leguina JI, Lazcano A.\", TITLE = \"Molecular evolution of the lysine biosynthetic pathways.\", JOURNAL = c(\"J Mol Evol 55:445-59 (2002)\", \"DOI:10.1007/s00239-002-2340-2\")), list(REFERENCE = \"PMID:15256574\", AUTHORS = \"Miyazaki T, Miyazaki J, Yamane H, Nishiyama M.\", TITLE = \"alpha-Aminoadipate aminotransferase from an extremely thermophilic bacterium, Thermus thermophilus.\", JOURNAL = c(\"Microbiology 150:2327-34 (2004)\", \"DOI:10.1099/mic.0.27037-0\")), list(REFERENCE = \"PMID:12126930\", AUTHORS = \"Goh DL, Patel A, Thomas GH, Salomons GS, Schor DS, Jakobs C, Geraghty MT.\", TITLE = \"Characterization of the human gene encoding alpha-aminoadipate aminotransferase (AADAT).\", JOURNAL = c(\"Mol Genet Metab 76:172-80 (2002)\", \"DOI:10.1016/S1096-7192(02)00037-9\")), list(REFERENCE = \"PMID:15160885\", AUTHORS = \"Nishiyama M.\", TITLE = \"[Novel lysine biosynthesis: a key to elucidate evolution of metabolic and biosynthetic pathways]\", JOURNAL = \"Tanpakushitsu Kakusan Koso 49:758-63 (2004)\"), list(REFERENCE = \"PMID:10613839\", AUTHORS = \"Nishida H, Nishiyama M, Kobashi N, Kosuge T, Hoshino T, Yamane H.\", TITLE = \"A prokaryotic gene cluster involved in synthesis of lysine through the amino adipate pathway: a key to the evolution of amino acid biosynthesis.\", JOURNAL = c(\"Genome Res 9:1175-83 (1999)\", \"DOI:10.1101/gr.9.12.1175\")), list(REFERENCE = \"PMID:12963379\", AUTHORS = \"Sakai H, Vassylyeva MN, Matsuura T, Sekine S, Gotoh K, Nishiyama M, Terada T, Shirouzu M, Kuramitsu S, Vassylyev DG, Yokoyama S.\", TITLE = \"Crystal structure of a lysine biosynthesis enzyme, LysX, from Thermus thermophilus HB8.\", JOURNAL = c(\"J Mol Biol 332:729-40 (2003)\", \"DOI:10.1016/S0022-2836(03)00946-X\")), list(REFERENCE = \"PMID:16361515\", AUTHORS = \"Hudson AO, Singh BK, Leustek T, Gilvarg C.\", TITLE = \"An LL-diaminopimelate aminotransferase defines a novel variant of the lysine biosynthesis pathway in plants.\", JOURNAL = c(\"Plant Physiol 140:292-301 (2006)\", \"DOI:10.1104/pp.105.072629\")), list(REFERENCE = \"PMID:19620981\", AUTHORS = \"Horie A, Tomita T, Saiki A, Kono H, Taka H, Mineki R, Fujimura T, Nishiyama C, Kuzuyama T, Nishiyama M\", TITLE = \"Discovery of proteinaceous N-modification in lysine biosynthesis of Thermus thermophilus.\", JOURNAL = c(\"Nat Chem Biol 5:673-9 (2009)\", \"DOI:10.1038/nchembio.198\")), list(REFERENCE = \"PMID:21547300\", AUTHORS = \"Dairi T, Kuzuyama T, Nishiyama M, Fujii I\", TITLE = \"Convergent strategies in biosynthesis.\", JOURNAL = c(\"Nat Prod Rep 28:1054-86 (2011)\", \"DOI:10.1039/c0np00047g\")), list(REFERENCE = \"PMID:21550296\", AUTHORS = \"Gaston MA, Jiang R, Krzycki JA\", TITLE = \"Functional context, biosynthesis, and genetic encoding of pyrrolysine.\", JOURNAL = c(\"Curr Opin Microbiol 14:342-9 (2011)\", \"DOI:10.1016/j.mib.2011.04.001\"))', 'map00300', 259, 5390, 12, 105, 123, 19, 5096, 294);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (36, '00310', 'Lysine degradation', 'Metabolism; Amino acid metabolism', 'Lysine degradation', 'Lysine degradation, lysine => saccharopine => acetoacetyl-CoA [PATH:map00310]', 'Glutaric acidemia, Hyperlysinemia, Kabuki syndrome, Sotos syndrome, Kleefstra syndrome, Nevo syndrome, Lysyl hydroxylase 3 deficiency, Saccharopinuria, Pyridoxine-dependent epilepsy, 3-Hydroxyacyl-CoA dehydrogenase deficiency, Weaver syndrome', 'ko00310', 'list(REFERENCE = \"PMID:11802770\", AUTHORS = \"Vaz FM, Wanders RJ.\", TITLE = \"Carnitine biosynthesis in mammals.\", JOURNAL = c(\"Biochem J 361:417-29 (2002)\", \"DOI:10.1042/bj3610417\")), list(REFERENCE = \"PMID:1682209\", AUTHORS = \"Large PJ, Robertson A.\", TITLE = \"The route of lysine breakdown in Candida tropicalis.\", JOURNAL = c(\"FEMS Microbiol Lett 66:209-13 (1991)\", \"DOI:10.1111/j.1574-6968.1990.tb03998.x\"))', 'map00310', 'Lysine degradation', 528, 4837, 248, 105, 125, 50, 4579, 258);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (37, '00311', 'Penicillin and cephalosporin biosynthesis', 'Penicillins (Penams) and cephalosporins (cephems) are beta-lactam antibiotics containing 6-aminopenicillanate (6-APA) and 7-aminocephalosporanate (7-ACA) nuclei, respectively. 6-APA and 7-ACA are key intermediates for a variety of semisynthetic penicillin and cephalosporin derivatives. Penicillins are produced only by fungi, while cephalosporins (including cephamycins) are produced by fungi and bacteria. Both antibiotics are synthesized from L-2-aminoadipate, L-cysteine and L-valine through a common pathway. It starts with the condensation of these three amino acids by the non-ribosomal peptide synthetase to form the tripeptide delta-(L-2-aminoadipyl)-L-cysteinyl-D-valine (ACV). The linear ACV tripeptide is then converted to bicyclic isopenicillin N by isopenicillin N synthase, in which the beta-lactam ring is formed. Isopenicillin N is the branch point of penicillin [MD:M00672] and cephalosporin [MD:M00673] pathways.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Penicillin and cephalosporin biosynthesis', 'Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin [PATH:map00311], Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C [PATH:map00311]', 'ko00311', 'list(REFERENCE = \"\", AUTHORS = \"Michal G.\", TITLE = \"Biochemical Pathways\", JOURNAL = \"Wiley (1999)\")', 'map00311', 'Penicillin and cephalosporin biosynthesis', 57, 1023, 1, 1, 55, 0, 1022, 1);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (38, '00330', 'Arginine and proline metabolism', 'Metabolism; Amino acid metabolism', 'Arginine and proline metabolism', 'Proline biosynthesis, glutamate => proline [PATH:map00330], Creatine pathway [PATH:map00330], Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine [PATH:map00330], Polyamine biosynthesis, arginine => ornithine => putrescine [PATH:map00330], GABA biosynthesis, eukaryotes, putrescine => GABA [PATH:map00330], GABA biosynthesis, prokaryotes, putrescine => GABA [PATH:map00330], Arginine succinyltransferase pathway, arginine => glutamate [PATH:map00330]', 'Hyperargininemia, Ornithinaemia, Hyperprolinemia, Snyder-Robinson syndrome, Guanidinoacetate methyltransferase deficiency, Cerebral creatine deficiency syndrome', 'GO: 0006525 0006560', 'ko00330', 'list(REFERENCE = \"PMID:5288244\", AUTHORS = \"Haake P, Allen GW.\", TITLE = \"Studies on phosphorylation by phosphoroguanidinates. The mechanism of action of creatine: ATP transphosphorylase (creatine kinase).\", JOURNAL = c(\"Proc Natl Acad Sci U S A 68:2691-3 (1971)\", \"DOI:10.1073/pnas.68.11.2691\")), list(REFERENCE = \"PMID:16499623\", AUTHORS = \"Kurihara S, Oda S, Kumagai H, Suzuki H.\", TITLE = \"Gamma-glutamyl-gamma-aminobutyrate hydrolase in the putrescine utilization pathway of Escherichia coli K-12.\", JOURNAL = c(\"FEMS Microbiol Lett 256:318-23 (2006)\", \"DOI:10.1111/j.1574-6968.2006.00137.x\")), list(REFERENCE = \"PMID:15590624\", AUTHORS = \"Kurihara S, Oda S, Kato K, Kim HG, Koyanagi T, Kumagai H, Suzuki H.\", TITLE = \"A novel putrescine utilization pathway involves gamma-glutamylated intermediates of Escherichia coli K-12.\", JOURNAL = c(\"J Biol Chem 280:4602-8 (2005)\", \"DOI:10.1074/jbc.M411114200\"))', 'map00330', 523, 5303, 248, 105, 123, 47, 5005, 298);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (39, '00331', 'Clavulanic acid biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Clavulanic acid biosynthesis', 'Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate [PATH:map00331]', 'D07711, Clavulanic acid (INN)', 'ko00331', 'list(REFERENCE = \"PMID:9614345\", AUTHORS = \"McGowan SJ, Bycroft BW, Salmond GP.\", TITLE = \"Bacterial production of carbapenems and clavams: evolution of beta-lactam antibiotic pathways.\", JOURNAL = c(\"Trends Microbiol 6:203-8 (1998)\", \"DOI:10.1016/S0966-842X(98)01251-7\")), list(REFERENCE = \"PMID:14623876\", AUTHORS = \"Caines ME, Elkins JM, Hewitson KS, Schofield CJ.\", TITLE = \"Crystal structure and mechanistic implications of N2-(2-carboxyethyl)arginine synthase, the first enzyme in the clavulanic acid biosynthesis pathway.\", JOURNAL = c(\"J Biol Chem 279:5685-92 (2004)\", \"DOI:10.1074/jbc.M310803200\"))', 'map00331', 'Clavulanic acid biosynthesis', 0, 7, 0, 0, 0, 0, 7, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (40, '00332', 'Carbapenem biosynthesis', 'Carbapenems are broad-spectrum beta-lactam antibiotics, which are often considered as the antibiotics of last resort. A naturally occurring carbapenem, thienamycin, was first discovered in Streptomyces cattleya. This diagram shows how a simple carbapenem, carbapenem-3-carboxylate, is synthesized from malonyl-CoA and pyrroline-5-carboxylate [MD:M00675]. For structurally complex carbapenems, such as thienamycin, olivanic acid, epi-thienamycin and carbapenems of the OA-6129 group, uncertainty remains about the mechanism and timing for the inversion of the C-5 carbapenam bridgehead, the desaturation of the C-2/C-3 bond and the attachment of the C-2 and C-6 side chains.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Carbapenem biosynthesis', 'Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate [PATH:map00332]', 'GO: 1901769', 'ko00332', 'list(REFERENCE = \"PMID:12848554\", AUTHORS = \"Stapon A, Li R, Townsend CA\", TITLE = \"Carbapenem biosynthesis: confirmation of stereochemical assignments and the role of CarC in the ring stereoinversion process from L-proline.\", JOURNAL = c(\"J Am Chem Soc 125:8486-93 (2003)\", \"DOI:10.1021/ja034248a\")), list(REFERENCE = \"PMID:15174175\", AUTHORS = \"Sleeman MC, Smith P, Kellam B, Chhabra SR, Bycroft BW, Schofield CJ\", TITLE = \"Biosynthesis of carbapenem antibiotics: new carbapenam substrates for carbapenem synthase (CarC).\", JOURNAL = c(\"Chembiochem 5:879-82 (2004)\", \"DOI:10.1002/cbic.200300908\")), list(REFERENCE = \"PMID:14625287\", AUTHORS = \"Sleeman MC, Schofield CJ\", TITLE = \"Carboxymethylproline synthase (CarB), an unusual carbon-carbon bond-forming enzyme of the crotonase superfamily involved in carbapenem biosynthesis.\", JOURNAL = c(\"J Biol Chem 279:6730-6 (2004)\", \"DOI:10.1074/jbc.M311824200\")), list(REFERENCE = \"PMID:19090510\", AUTHORS = \"Hamed RB, Batchelar ET, Mecinovic J, Claridge TD, Schofield CJ\", TITLE = \"Evidence that thienamycin biosynthesis proceeds via C-5 epimerization: ThnE catalyzes the formation of (2S,5S)-trans-carboxymethylproline.\", JOURNAL = c(\"Chembiochem 10:246-50 (2009)\", \"DOI:10.1002/cbic.200800652\")), list(REFERENCE = \"PMID:21913298\", AUTHORS = \"Bodner MJ, Li R, Phelan RM, Freeman MF, Moshos KA, Lloyd EP, Townsend CA\", TITLE = \"Definition of the common and divergent steps in carbapenem beta-lactam antibiotic biosynthesis.\", JOURNAL = c(\"Chembiochem 12:2159-65 (2011)\", \"DOI:10.1002/cbic.201100366\")), list(REFERENCE = \"PMID:12147472\", AUTHORS = \"Derzelle S, Duchaud E, Kunst F, Danchin A, Bertin P\", TITLE = \"Identification, characterization, and regulation of a cluster of genes involved in carbapenem biosynthesis in Photorhabdus luminescens.\", JOURNAL = c(\"Appl Environ Microbiol 68:3780-9 (2002)\", \"DOI:10.1128/AEM.68.8.3780-3789.2002\")), list(REFERENCE = \"PMID:21263049\", AUTHORS = \"Rodriguez M, Nunez LE, Brana AF, Mendez C, Salas JA, Blanco G\", TITLE = \"Mutational analysis of the thienamycin biosynthetic gene cluster from Streptomyces cattleya.\", JOURNAL = c(\"Antimicrob Agents Chemother 55:1638-49 (2011)\", \"DOI:10.1128/AAC.01366-10\")), list(REFERENCE = \"PMID:3988730\", AUTHORS = \"Williamson JM, Inamine E, Wilson KE, Douglas AW, Liesch JM, Albers-Schonberg G\", TITLE = \"Biosynthesis of the beta-lactam antibiotic, thienamycin, by Streptomyces cattleya.\", JOURNAL = \"J Biol Chem 260:4637-47 (1985)\"), list(REFERENCE = \"PMID:12725858\", AUTHORS = \"Nunez LE, Mendez C, Brana AF, Blanco G, Salas JA\", TITLE = \"The biosynthetic gene cluster for the beta-lactam carbapenem thienamycin in Streptomyces cattleya.\", JOURNAL = c(\"Chem Biol 10:301-11 (2003)\", \"DOI:10.1016/S1074-5521(03)00069-3\")), list(REFERENCE = \"PMID:20017478\", AUTHORS = \"Bodner MJ, Phelan RM, Freeman MF, Li R, Townsend CA\", TITLE = \"Non-heme iron oxygenases generate natural structural diversity in carbapenem antibiotics.\", JOURNAL = c(\"J Am Chem Soc 132:12-3 (2010)\", \"DOI:10.1021/ja907320n\")), list(REFERENCE = \"PMID:18678912\", AUTHORS = \"Freeman MF, Moshos KA, Bodner MJ, Li R, Townsend CA\", TITLE = \"Four enzymes define the incorporation of coenzyme A in thienamycin biosynthesis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:11128-33 (2008)\", \"DOI:10.1073/pnas.0804500105\")), list(REFERENCE = \"PMID:22706025\", AUTHORS = \"Buller AR, Labonte JW, Freeman MF, Wright NT, Schildbach JF, Townsend CA\", TITLE = \"Autoproteolytic activation of ThnT results in structural reorganization necessary for substrate binding and catalysis.\", JOURNAL = c(\"J Mol Biol 422:508-18 (2012)\", \"DOI:10.1016/j.jmb.2012.06.012\")), list(REFERENCE = \"PMID:24420617\", AUTHORS = \"Li R, Lloyd EP, Moshos KA, Townsend CA\", TITLE = \"Identification and characterization of the carbapenem MM 4550 and its gene cluster in Streptomyces argenteolus ATCC 11009.\", JOURNAL = c(\"Chembiochem 15:320-31 (2014)\", \"DOI:10.1002/cbic.201300319\"))', 'map00332', 130, 4171, 0, 4, 119, 7, 4097, 74);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (41, '00333', 'Prodigiosin biosynthesis', 'Prodiginines are red-pigmented natural antibiotics that are produced as secondary metabolites and have received renewed attention because of potential clinical interests. In Serratia sp. or actinomycetes such as Streptomyces coelicolor, the tripyrrole molecules of prodigiosin and undecylprodigiosin are formed by the condensation of 4-methoxy-2,2\'-bipyrrole-5-carbaldehyde and either 2-methyl-3-n-amyl-pyrrole [MD:M00837] or 2-undecylpyrrole [MD:M00838]. The Serratia pig gene cluster and the Streptomyces red gene cluster responsible for these biosynthesis pathways have been identified.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Prodigiosin biosynthesis', 'Prodigiosin biosynthesis, L-proline => prodigiosin [PATH:map00333], Undecylprodigiosin biosynthesis, L-proline => undecylprodigiosin [PATH:map00333]', 'ko00333', 'list(REFERENCE = \"PMID:15853884\", AUTHORS = \"Williamson NR, Simonsen HT, Ahmed RA, Goldet G, Slater H, Woodley L, Leeper FJ, Salmond GP\", TITLE = \"Biosynthesis of the red antibiotic, prodigiosin, in Serratia: identification of a novel 2-methyl-3-n-amyl-pyrrole (MAP) assembly pathway, definition of the terminal condensing enzyme, and implications for undecylprodigiosin biosynthesis in Streptomyces.\", JOURNAL = c(\"Mol Microbiol 56:971-89 (2005)\", \"DOI:10.1111/j.1365-2958.2005.04602.x\")), list(REFERENCE = \"PMID:11514230\", AUTHORS = \"Cerdeno AM, Bibb MJ, Challis GL\", TITLE = \"Analysis of the prodiginine biosynthesis gene cluster of Streptomyces coelicolor A3(2): new mechanisms for chain initiation and termination in modular multienzymes.\", JOURNAL = c(\"Chem Biol 8:817-29 (2001)\", \"DOI:10.1016/S1074-5521(01)00054-0\")), list(REFERENCE = \"PMID:15528645\", AUTHORS = \"Harris AK, Williamson NR, Slater H, Cox A, Abbasi S, Foulds I, Simonsen HT, Leeper FJ, Salmond GP\", TITLE = \"The Serratia gene cluster encoding biosynthesis of the red antibiotic, prodigiosin, shows species- and strain-dependent genome context variation.\", JOURNAL = c(\"Microbiology 150:3547-60 (2004)\", \"DOI:10.1099/mic.0.27222-0\")), list(REFERENCE = \"PMID:17109029\", AUTHORS = \"Williamson NR, Fineran PC, Leeper FJ, Salmond GP\", TITLE = \"The biosynthesis and regulation of bacterial prodiginines.\", JOURNAL = c(\"Nat Rev Microbiol 4:887-99 (2006)\", \"DOI:10.1038/nrmicro1531\"))', 'map00333', 'Prodigiosin biosynthesis', 0, 21, 0, 0, 0, 0, 21, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (42, '00340', 'Histidine metabolism', 'Metabolism; Amino acid metabolism', 'Histidine metabolism', 'Histidine biosynthesis, PRPP => histidine [PATH:map00340], Histidine degradation, histidine => N-formiminoglutamate => glutamate [PATH:map00340]', 'Histidinemia, Brunner syndrome, Tourette syndrome, Urocanase deficiency, Formiminotransferase deficiency', 'GO: 0006547', 'ko00340', 'map00340', 'Histidine metabolism', 499, 4725, 248, 105, 123, 23, 4465, 260);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (43, '00350', 'Tyrosine metabolism', 'Metabolism; Amino acid metabolism', 'Tyrosine metabolism', 'Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline [PATH:map00350], Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine [PATH:map00350], Tyrosine degradation, tyrosine => homogentisate [PATH:map00350], Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate [PATH:map00350]', 'Alkaptonuria, Tyrosinemia, Oculocutaneous albinism, Thyroid dyshormonogenesis, Brunner syndrome, Primary dystonia, Dopamine beta-hydroxylase deficiency, Aromatic L-amino acid decarboxylase deficiency', 'GO: 0006570', 'ko00350', 'list(REFERENCE = \"PMID:8550403\", AUTHORS = \"Prieto MA, Diaz E, Garcia JL.\", TITLE = \"Molecular characterization of the 4-hydroxyphenylacetate catabolic pathway of Escherichia coli W: engineering a mobile aromatic degradative cluster.\", JOURNAL = c(\"J Bacteriol 178:111-20 (1996)\", \"DOI:10.1128/JB.178.1.111-120.1996\")), list(REFERENCE = \"PMID:1194238\", AUTHORS = \"Sparnins VL, Dagley S.\", TITLE = \"Alternative routes of aromatic catabolism in Pseudomonas acidovorans and Pseudomonas putida: gallic acid as a substrate and inhibitor of dioxygenases.\", JOURNAL = \"J Bacteriol 124:1374-81 (1975)\"), list(REFERENCE = \"PMID:18435614\", AUTHORS = \"Ito S, Wakamatsu K\", TITLE = \"Chemistry of mixed melanogenesis--pivotal roles of dopaquinone.\", JOURNAL = c(\"Photochem Photobiol 84:582-92 (2008)\", \"DOI:10.1111/j.1751-1097.2007.00238.x\")), list(REFERENCE = \"PMID:11171088\", AUTHORS = \"Olivares C, Jimenez-Cervantes C, Lozano JA, Solano F, Garcia-Borron JC\", TITLE = \"The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase.\", JOURNAL = c(\"Biochem J 354:131-9 (2001)\", \"DOI:10.1042/bj3540131\"))', 'map00350', 509, 4807, 248, 105, 126, 30, 4519, 288);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (44, '00360', 'Phenylalanine metabolism', 'Metabolism; Amino acid metabolism', 'Phenylalanine metabolism', 'Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA [PATH:map00360], Phenylacetate degradation, phenylaxetate => acetyl-CoA/succinyl-CoA [PATH:map00360]', 'Tyrosinemia', 'GO: 0006558', 'ko00360', 'list(REFERENCE = \"\", AUTHORS = \"Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\", TITLE = \"[Cellular Functions and Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1997)\"), list(REFERENCE = \"PMID:10537203\", AUTHORS = \"Arai H, Yamamoto T, Ohishi T, Shimizu T, Nakata T, Kudo T.\", TITLE = \"Genetic organization and characteristics of the 3-(3-hydroxyphenyl)propionic acid degradation pathway of Comamonas testosteroni TA441.\", JOURNAL = c(\"Microbiology 145 ( Pt 10):2813-20 (1999)\", \"DOI:10.1099/00221287-145-10-2813\")), list(REFERENCE = \"PMID:9603882\", AUTHORS = \"Diaz E, Ferrandez A, Garcia JL.\", TITLE = \"Characterization of the hca cluster encoding the dioxygenolytic pathway for initial catabolism of 3-phenylpropionic acid in Escherichia coli K-12.\", JOURNAL = \"J Bacteriol 180:2915-23 (1998)\"), list(REFERENCE = \"PMID:9098055\", AUTHORS = \"Ferrandez A, Garcia JL, Diaz E.\", TITLE = \"Genetic characterization and expression in heterologous hosts of the 3-(3-hydroxyphenyl)propionate catabolic pathway of Escherichia coli K-12.\", JOURNAL = c(\"J Bacteriol 179:2573-81 (1997)\", \"DOI:10.1128/JB.179.8.2573-2581.1997\")), list(REFERENCE = \"PMID:19016485\", AUTHORS = \"Hwang JY, Park J, Seo JH, Cha M, Cho BK, Kim J, Kim BG\", TITLE = \"Simultaneous synthesis of 2-phenylethanol and L-homophenylalanine using aromatic transaminase with yeast Ehrlich pathway.\", JOURNAL = c(\"Biotechnol Bioeng 102:1323-9 (2009)\", \"DOI:10.1002/bit.22178\")), list(REFERENCE = \"PMID:20660314\", AUTHORS = \"Teufel R, Mascaraque V, Ismail W, Voss M, Perera J, Eisenreich W, Haehnel W, Fuchs G\", TITLE = \"Bacterial phenylalanine and phenylacetate catabolic pathway revealed.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 107:14390-5 (2010)\", \"DOI:10.1073/pnas.1005399107\"))', 'map00360', 504, 4797, 248, 105, 123, 28, 4519, 278);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (45, '00361', 'Chlorocyclohexane and chlorobenzene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Chlorocyclohexane and chlorobenzene degradation', 'Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map00361], Benzene degradation, benzene => catechol [PATH:map00361]', 'UMBBD: hch ghch dcz 2,4-d pcp 2,4,5-t tcb', 'ko00361', 'list(REFERENCE = \"PMID:10600501\", AUTHORS = \"Xun L, Bohuslavek J, Cai M.\", TITLE = \"Characterization of 2,6-dichloro-p-hydroquinone 1,2-dioxygenase (PcpA) of Sphingomonas chlorophenolica ATCC 39723.\", JOURNAL = c(\"Biochem Biophys Res Commun 266:322-5 (1999)\", \"DOI:10.1006/bbrc.1999.1805\")), list(REFERENCE = \"PMID:1987135\", AUTHORS = \"van der Meer JR, van Neerven AR, de Vries EJ, de Vos WM, Zehnder AJ.\", TITLE = \"Cloning and characterization of plasmid-encoded genes for the degradation of 1,2-dichloro-, 1,4-dichloro-, and 1,2,4-trichlorobenzene of Pseudomonas sp. strain P51.\", JOURNAL = c(\"J Bacteriol 173:6-15 (1991)\", \"DOI:10.1128/jb.173.1.6-15.1991\")), list(REFERENCE = \"PMID:10464214\", AUTHORS = \"Nagata Y, Futamura A, Miyauchi K, Takagi M.\", TITLE = \"Two different types of dehalogenases, LinA and LinB, involved in gamma-hexachlorocyclohexane degradation in Sphingomonas paucimobilis UT26 are localized in the periplasmic space without molecular processing.\", JOURNAL = \"J Bacteriol 181:5409-13 (1999)\"), list(REFERENCE = \"PMID:11423959\", AUTHORS = \"Nagata Y, Miyauchi K, Takagi M.\", TITLE = \"Complete analysis of genes and enzymes for gamma-hexachlorocyclohexane degradation in Sphingomonas paucimobilis UT26.\", JOURNAL = c(\"J Ind Microbiol Biotechnol 23:380-390 (1999)\", \"DOI:10.1038/sj/jim/2900736\")), list(REFERENCE = \"PMID:15060023\", AUTHORS = \"Dogra C, Raina V, Pal R, Suar M, Lal S, Gartemann KH, Holliger C, van der Meer JR, Lal R.\", TITLE = \"Organization of lin genes and IS6100 among different strains of hexachlorocyclohexane-degrading Sphingomonas paucimobilis: evidence for horizontal gene transfer.\", JOURNAL = c(\"J Bacteriol 186:2225-35 (2004)\", \"DOI:10.1128/JB.186.8.2225-2235.2004\")), list(REFERENCE = \"PMID:12676719\", AUTHORS = \"Nagata Y, Prokop Z, Marvanova S, Sykorova J, Monincova M, Tsuda M, Damborsky J.\", TITLE = \"Reconstruction of mycobacterial dehalogenase Rv2579 by cumulative mutagenesis of haloalkane dehalogenase LinB.\", JOURNAL = c(\"Appl Environ Microbiol 69:2349-55 (2003)\", \"DOI:10.1128/AEM.69.4.2349-2355.2003\")), list(REFERENCE = \"PMID:15489427\", AUTHORS = \"Vedler E, Vahter M, Heinaru A.\", TITLE = \"The completely sequenced plasmid pEST4011 contains a novel IncP1 backbone and a catabolic transposon harboring tfd genes for 2,4-dichlorophenoxyacetic acid degradation.\", JOURNAL = c(\"J Bacteriol 186:7161-74 (2004)\", \"DOI:10.1128/JB.186.21.7161-7174.2004\")), list(REFERENCE = \"PMID:9148781\", AUTHORS = \"Sommer C, Gorisch H.\", TITLE = \"Enzymology of the degradation of (di)chlorobenzenes by Xanthobacter flavus 14p1.\", JOURNAL = c(\"Arch Microbiol 167:384-91 (1997)\", \"DOI:10.1007/s002030050459\")), list(REFERENCE = \"PMID:12070765\", AUTHORS = \"Laemmli CM, Schonenberger R, Suter M, Zehnder AJ, van der Meer JR.\", TITLE = \"TfdD(II), one of the two chloromuconate cycloisomerases of Ralstonia eutropha JMP134 (pJP4), cannot efficiently convert 2-chloro- cis, cis-muconate to trans-dienelactone to allow growth on 3-chlorobenzoate.\", JOURNAL = c(\"Arch Microbiol 178:13-25 (2002)\", \"DOI:10.1007/s00203-002-0417-3\")), list(REFERENCE = \"PMID:16977465\", AUTHORS = \"Wu J, Hong Q, Han P, He J, Li S.\", TITLE = \"A gene linB2 responsible for the conversion of beta-HCH and 2,3,4,5,6-pentachlorocyclohexanol in Sphingomonas sp. BHC-A.\", JOURNAL = c(\"Appl Microbiol Biotechnol 73:1097-105 (2007)\", \"DOI:10.1007/s00253-006-0579-z\")), list(REFERENCE = \"PMID:9758802\", AUTHORS = \"Potrawfke T, Timmis KN, Wittich RM\", TITLE = \"Degradation of 1,2,3,4-tetrachlorobenzene by pseudomonas chlororaphis RW71\", JOURNAL = \"Appl Environ Microbiol 64:3798-806 (1998)\"), list(REFERENCE = \"PMID:11208799\", AUTHORS = \"Potrawfke T, Armengaud J, Wittich RM\", TITLE = \"Chlorocatechols substituted at positions 4 and 5 are substrates of the broad-spectrum chlorocatechol 1,2-dioxygenase of Pseudomonas chlororaphis RW71.\", JOURNAL = c(\"J Bacteriol 183:997-1011 (2001)\", \"DOI:10.1128/JB.183.3.997-1011.2001\"))', 'map00361', 'Chlorocyclohexane and chlorobenzene degradation', 0, 2764, 0, 0, 0, 0, 2677, 87);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (46, '00362', 'Benzoate degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Benzoate degradation', 'Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA [PATH:map00362], Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA [PATH:map00362], Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map00362], Benzene degradation, benzene => catechol [PATH:map00362], Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map00362], Catechol ortho-cleavage, catechol => 3-oxoadipate [PATH:map00362], Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map00362]', 'UMBBD: benz2 benz abs, GO: 0043639', 'ko00362', 'list(REFERENCE = \"PMID:19258534\", AUTHORS = \"Carmona M, Zamarro MT, Blazquez B, Durante-Rodriguez G, Juarez JF, Valderrama JA, Barragan MJ, Garcia JL, Diaz E\", TITLE = \"Anaerobic catabolism of aromatic compounds: a genetic and genomic view.\", JOURNAL = c(\"Microbiol Mol Biol Rev 73:71-133 (2009)\", \"DOI:10.1128/MMBR.00021-08\")), list(REFERENCE = \"PMID:12486039\", AUTHORS = \"Hara H, Masai E, Miyauchi K, Katayama Y, Fukuda M.\", TITLE = \"Characterization of the 4-carboxy-4-hydroxy-2-oxoadipate aldolase gene and operon structure of the protocatechuate 4,5-cleavage pathway genes in Sphingomonas paucimobilis SYK-6.\", JOURNAL = c(\"J Bacteriol 185:41-50 (2003)\", \"DOI:10.1128/JB.185.1.41-50.2003\")), list(REFERENCE = \"PMID:15277747\", AUTHORS = \"Maruyama K, Shibayama T, Ichikawa A, Sakou Y, Yamada S, Sugisaki H.\", TITLE = \"Cloning and characterization of the genes encoding enzymes for the protocatechuate meta-degradation pathway of Pseudomonas ochraceae NGJ1.\", JOURNAL = c(\"Biosci Biotechnol Biochem 68:1434-41 (2004)\", \"DOI:10.1271/bbb.68.1434\")), list(REFERENCE = \"PMID:10589735\", AUTHORS = \"Mampel J, Ruff J, Junker F, Cook AM.\", TITLE = \"The oxygenase component of the 2-aminobenzenesulfonate dioxygenase system from Alcaligenes sp. strain O-1.\", JOURNAL = c(\"Microbiology 145 ( Pt 11):3255-64 (1999)\", \"DOI:10.1099/00221287-145-11-3255\")), list(REFERENCE = \"PMID:8002948\", AUTHORS = \"Junker F, Field JA, Bangerter F, Ramsteiner K, Kohler HP, Joannou CL, Mason JR, Leisinger T, Cook AM.\", TITLE = \"Oxygenation and spontaneous deamination of 2-aminobenzenesulphonic acid in Alcaligenes sp. strain O-1 with subsequent meta ring cleavage and spontaneous desulphonation to 2-hydroxymuconic acid.\", JOURNAL = c(\"Biochem J 300 ( Pt 2):429-36 (1994)\", \"DOI:10.1042/bj3000429\")), list(REFERENCE = \"PMID:8990279\", AUTHORS = \"Harwood CS, Gibson J.\", TITLE = \"Shedding light on anaerobic benzene ring degradation: a process unique to prokaryotes?\", JOURNAL = c(\"J Bacteriol 179:301-9 (1997)\", \"DOI:10.1128/JB.179.2.301-309.1997\")), list(REFERENCE = \"PMID:17122342\", AUTHORS = \"Peters F, Shinoda Y, McInerney MJ, Boll M.\", TITLE = \"Cyclohexa-1,5-diene-1-carbonyl-coenzyme A (CoA) hydratases of Geobacter metallireducens and Syntrophus aciditrophicus: Evidence for a common benzoyl-CoA degradation pathway in facultative and strict anaerobes.\", JOURNAL = c(\"J Bacteriol 189:1055-60 (2007)\", \"DOI:10.1128/JB.01467-06\")), list(REFERENCE = \"PMID:11053377\", AUTHORS = \"Cowles CE, Nichols NN, Harwood CS.\", TITLE = \"BenR, a XylS homologue, regulates three different pathways of aromatic acid degradation in Pseudomonas putida.\", JOURNAL = c(\"J Bacteriol 182:6339-46 (2000)\", \"DOI:10.1128/JB.182.22.6339-6346.2000\")), list(REFERENCE = \"PMID:12514037\", AUTHORS = \"Smith MA, Weaver VB, Young DM, Ornston LN.\", TITLE = \"Genes for chlorogenate and hydroxycinnamate catabolism (hca) are linked to functionally related genes in the dca-pca-qui-pob-hca chromosomal cluster of Acinetobacter sp. strain ADP1.\", JOURNAL = c(\"Appl Environ Microbiol 69:524-32 (2003)\", \"DOI:10.1128/AEM.69.1.524-532.2003\")), list(REFERENCE = \"PMID:18312395\", AUTHORS = \"Kuntze K, Shinoda Y, Moutakki H, McInerney MJ, Vogt C, Richnow HH, Boll M\", TITLE = \"6-Oxocyclohex-1-ene-1-carbonyl-coenzyme A hydrolases from obligately anaerobic bacteria: characterization and identification of its gene as a functional marker for aromatic compounds degrading anaerobes.\", JOURNAL = c(\"Environ Microbiol 10:1547-56 (2008)\", \"DOI:10.1111/j.1462-2920.2008.01570.x\")), list(REFERENCE = \"PMID:10781543\", AUTHORS = \"Pelletier DA, Harwood CS\", TITLE = \"2-Hydroxycyclohexanecarboxyl coenzyme A dehydrogenase, an enzyme characteristic of the anaerobic benzoate degradation pathway used by Rhodopseudomonas palustris.\", JOURNAL = c(\"J Bacteriol 182:2753-60 (2000)\", \"DOI:10.1128/JB.182.10.2753-2760.2000\")), list(REFERENCE = \"PMID:11282627\", AUTHORS = \"Elshahed MS, Bhupathiraju VK, Wofford NQ, Nanny MA, McInerney MJ\", TITLE = \"Metabolism of benzoate, cyclohex-1-ene carboxylate, and cyclohexane carboxylate by \\\"Syntrophus aciditrophicus\\\" strain SB in syntrophic association with H(2)-using microorganisms.\", JOURNAL = c(\"Appl Environ Microbiol 67:1728-38 (2001)\", \"DOI:10.1128/AEM.67.4.1728-1738.2001\")), list(REFERENCE = \"PMID:21219457\", AUTHORS = \"Nogales J, Canales A, Jimenez-Barbero J, Serra B, Pingarron JM, Garcia JL, Diaz E\", TITLE = \"Unravelling the gallic acid degradation pathway in bacteria: the gal cluster from Pseudomonas putida.\", JOURNAL = c(\"Mol Microbiol 79:359-74 (2011)\", \"DOI:10.1111/j.1365-2958.2010.07448.x\"))', 'map00362', 'Benzoate degradation', 0, 4310, 0, 0, 0, 0, 4073, 237);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (47, '00363', 'Bisphenol degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Bisphenol degradation', 'UMBBD: tbp2 bpa hap bpf', 'ko00363', 'list(REFERENCE = \"PMID:15635150\", AUTHORS = \"Kitamura S, Suzuki T, Sanoh S, Kohta R, Jinno N, Sugihara K, Yoshihara S, Fujimoto N, Watanabe H, Ohta S.\", TITLE = \"Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds.\", JOURNAL = c(\"Toxicol Sci 84:249-59 (2005)\", \"DOI:10.1093/toxsci/kfi074\")), list(REFERENCE = \"PMID:9607780\", AUTHORS = \"Steinmetz R, Mitchner NA, Grant A, Allen DL, Bigsby RM, Ben-Jonathan N.\", TITLE = \"The xenoestrogen bisphenol A induces growth, differentiation, and c-fos gene expression in the female reproductive tract.\", JOURNAL = c(\"Endocrinology 139:2741-7 (1998)\", \"DOI:10.1210/endo.139.6.6027\")), list(REFERENCE = \"PMID:11259533\", AUTHORS = \"Elsby R, Maggs JL, Ashby J, Park BK.\", TITLE = \"Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans.\", JOURNAL = \"J Pharmacol Exp Ther 297:103-13 (2001)\"), list(REFERENCE = \"PMID:10831413\", AUTHORS = \"Ronen Z, Abeliovich A.\", TITLE = \"Anaerobic-aerobic process for microbial degradation of tetrabromobisphenol A.\", JOURNAL = c(\"Appl Environ Microbiol 66:2372-7 (2000)\", \"DOI:10.1128/AEM.66.6.2372-2377.2000\")), list(REFERENCE = \"PMID:14559264\", AUTHORS = \"Eriksson J, Rahm S, Green N, Bergman A, Jakobsson E.\", TITLE = \"Photochemical transformations of tetrabromobisphenol A and related phenols in water.\", JOURNAL = c(\"Chemosphere 54:117-26 (2004)\", \"DOI:10.1016/S0045-6535(03)00704-5\")), list(REFERENCE = \"PMID:12242676\", AUTHORS = \"Ike M, Chen MY, Jin CS, Fujita M.\", TITLE = \"Acute toxicity, mutagenicity, and estrogenicity of biodegradation products of bisphenol-A.\", JOURNAL = c(\"Environ Toxicol 17:457-61 (2002)\", \"DOI:10.1002/tox.10079\")), list(REFERENCE = \"PMID:8031091\", AUTHORS = \"Jones KH, Trudgill PW, Hopper DJ\", TITLE = \"4-Ethylphenol metabolism by Aspergillus fumigatus.\", JOURNAL = \"Appl Environ Microbiol 60:1978-83 (1994)\"), list(REFERENCE = \"PMID:18024680\", AUTHORS = \"Inoue D, Hara S, Kashihara M, Murai Y, Danzl E, Sei K, Tsunoi S, Fujita M, Ike M\", TITLE = \"Degradation of Bis(4-Hydroxyphenyl)methane (bisphenol F) by Sphingobium yanoikuyae strain FM-2 isolated from river water.\", JOURNAL = c(\"Appl Environ Microbiol 74:352-8 (2008)\", \"DOI:10.1128/AEM.01708-07\"))', 'map00363', 'Bisphenol degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 0, 2, 0, 0, 0, 0, 2, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (48, '00364', 'Fluorobenzoate degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Fluorobenzoate degradation', 'UMBBD: 3fb 4fb box dcb', 'ko00364', 'list(REFERENCE = \"PMID:16345496\", AUTHORS = \"Schreiber A, Hellwig M, Dorn E, Reineke W, Knackmuss HJ.\", TITLE = \"Critical Reactions in Fluorobenzoic Acid Degradation by Pseudomonas sp. B13.\", JOURNAL = \"Appl Environ Microbiol 39:58-67 (1980)\"), list(REFERENCE = \"PMID:12957954\", AUTHORS = \"Solyanikova IP, Moiseeva OV, Boeren S, Boersma MG, Kolomytseva MP, Vervoort J, Rietjens IM, Golovleva LA, van Berkel WJ.\", TITLE = \"Conversion of 2-fluoromuconate to cis-dienelactone by purified enzymes of Rhodococcus opacus 1cp.\", JOURNAL = c(\"Appl Environ Microbiol 69:5636-42 (2003)\", \"DOI:10.1128/AEM.69.9.5636-5642.2003\")), list(REFERENCE = \"PMID:16980423\", AUTHORS = \"Carvalho MF, Ferreira MI, Moreira IS, Castro PM, Janssen DB.\", TITLE = \"Degradation of fluorobenzene by Rhizobiales strain F11 via ortho cleavage of 4-fluorocatechol and catechol.\", JOURNAL = c(\"Appl Environ Microbiol 72:7413-7 (2006)\", \"DOI:10.1128/AEM.01162-06\")), list(REFERENCE = \"PMID:18355280\", AUTHORS = \"Chae JC, Song B, Zylstra GJ\", TITLE = \"Identification of genes coding for hydrolytic dehalogenation in the metagenome derived from a denitrifying 4-chlorobenzoate degrading consortium.\", JOURNAL = c(\"FEMS Microbiol Lett 281:203-9 (2008)\", \"DOI:10.1111/j.1574-6968.2008.01106.x\")), list(REFERENCE = \"\", AUTHORS = \"Rosenbrock P, Munch JC, Scheunert I, Dorfler U.\", TITLE = \"Biodegradation of the herbicide bromoxynil and its plant cell wall bound residues in an agricultural soil.\", JOURNAL = c(\"Pesticide Biochemistry and Physiology 78:49-57 (2004)\", \"DOI:10.1016/j.pestbp.2003.09.002\")), list(REFERENCE = \"PMID:1610174\", AUTHORS = \"Topp E, Xun LY, Orser CS.\", TITLE = \"Biodegradation of the herbicide bromoxynil (3,5-dibromo-4-hydroxybenzonitrile) by purified pentachlorophenol hydroxylase and whole cells of Flavobacterium sp. strain ATCC 39723 is accompanied by cyanogenesis.\", JOURNAL = \"Appl Environ Microbiol 58:502-6 (1992)\")', 'map00364', 'Fluorobenzoate degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 0, 2293, 0, 0, 0, 0, 2233, 60);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (49, '00365', 'Furfural degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Furfural degradation', 'ko00365', 'list(REFERENCE = \"PMID:22031465\", AUTHORS = \"Wierckx N, Koopman F, Ruijssenaars HJ, de Winde JH\", TITLE = \"Microbial degradation of furanic compounds: biochemistry, genetics, and impact.\", JOURNAL = c(\"Appl Microbiol Biotechnol 92:1095-105 (2011)\", \"DOI:10.1007/s00253-011-3632-5\")), list(REFERENCE = \"PMID:20194784\", AUTHORS = \"Koopman F, Wierckx N, de Winde JH, Ruijssenaars HJ\", TITLE = \"Identification and characterization of the furfural and 5-(hydroxymethyl)furfural degradation pathways of Cupriavidus basilensis HMF14.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 107:4919-24 (2010)\", \"DOI:10.1073/pnas.0913039107\"))', 'map00365', 'Furfural degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Furfural degradation', 0, 129, 0, 0, 0, 0, 126, 3);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (50, '00380', 'Tryptophan metabolism', 'Metabolism; Amino acid metabolism', 'Tryptophan metabolism', 'Melatonin biosynthesis, tryptophan => serotonin => melatonin [PATH:map00380], Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate [PATH:map00380], Glucosinolate biosynthesis, tryptophan => glucobrassicin [PATH:map00380]', 'Glutaric acidemia, Acatalasemia, Brunner syndrome, Delayed sleep phase syndrome, Aromatic L-amino acid decarboxylase deficiency, Primary congenital glaucoma, 3-Hydroxyacyl-CoA dehydrogenase deficiency, Hydroxykynureninuria, Vertebral, cardiac, renal, and limb defects syndrome', 'GO: 0006568 0009851', 'ko00380', 'list(REFERENCE = \"PMID:15749753\", AUTHORS = \"Woodward AW, Bartel B\", TITLE = \"Auxin: regulation, action, and interaction.\", JOURNAL = c(\"Ann Bot 95:707-35 (2005)\", \"DOI:10.1093/aob/mci083\"))', 'map00380', 521, 4648, 248, 105, 123, 45, 4412, 236);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (51, '00400', 'Phenylalanine, tyrosine and tryptophan biosynthesis', 'Metabolism; Amino acid metabolism', 'Phenylalanine, tyrosine and tryptophan biosynthesis', 'Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map00400], Tryptophan biosynthesis, chorismate => tryptophan [PATH:map00400], Phenylalanine biosynthesis, chorismate => phenylalanine [PATH:map00400], Tyrosine biosynthesis, chorismate => tyrosine [PATH:map00400], Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine [PATH:map00400]', 'Phenylketonuria', 'GO: 0009094 0006571 0000162', 'ko00400', 'map00400', 'Phenylalanine, tyrosine and tryptophan biosynthesis', 526, 5319, 248, 105, 123, 50, 5022, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (52, '00401', 'Novobiocin biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Novobiocin biosynthesis', 'D02333, Coumermycin (USAN)', 'GO: 0043642', 'ko00401', 'list(REFERENCE = \"PMID:12480894\", AUTHORS = \"Pojer F, Li SM, Heide L.\", TITLE = \"Molecular cloning and sequence analysis of the clorobiocin biosynthetic gene cluster: new insights into the biosynthesis of aminocoumarin antibiotics.\", JOURNAL = c(\"Microbiology 148:3901-11 (2002)\", \"DOI:10.1099/00221287-148-12-3901\")), list(REFERENCE = \"PMID:11325587\", AUTHORS = \"Chen H, Walsh CT.\", TITLE = \"Coumarin formation in novobiocin biosynthesis: beta-hydroxylation of the aminoacyl enzyme tyrosyl-S-NovH by a cytochrome P450 NovI.\", JOURNAL = c(\"Chem Biol 8:301-12 (2001)\", \"DOI:10.1016/S1074-5521(01)00009-6\")), list(REFERENCE = \"PMID:14622269\", AUTHORS = \"Schmutz E, Steffensky M, Schmidt J, Porzel A, Li SM, Heide L.\", TITLE = \"An unusual amide synthetase (CouL) from the coumermycin A1 biosynthetic gene cluster from Streptomyces rishiriensis DSM 40489.\", JOURNAL = c(\"Eur J Biochem 270:4413-9 (2003)\", \"DOI:10.1046/j.1432-1033.2003.03830.x\")), list(REFERENCE = \"PMID:12904558\", AUTHORS = \"Xu H, Kahlich R, Kammerer B, Heide L, Li SM.\", TITLE = \"CloN2, a novel acyltransferase involved in the attachment of the pyrrole-2-carboxyl moiety to the deoxysugar of clorobiocin.\", JOURNAL = c(\"Microbiology 149:2183-91 (2003)\", \"DOI:10.1099/mic.0.26314-0\")), list(REFERENCE = \"PMID:12436260\", AUTHORS = \"Xu H, Wang ZX, Schmidt J, Heide L, Li SM.\", TITLE = \"Genetic analysis of the biosynthesis of the pyrrole and carbamoyl moieties of coumermycin A1 and novobiocin.\", JOURNAL = c(\"Mol Genet Genomics 268:387-96 (2002)\", \"DOI:10.1007/s00438-002-0759-1\")), list(REFERENCE = \"PMID:14694473\", AUTHORS = \"Freel Meyers CL, Oberthur M, Xu H, Heide L, Kahne D, Walsh CT\", TITLE = \"Characterization of NovP and NovN: completion of novobiocin biosynthesis by sequential tailoring of the noviosyl ring.\", JOURNAL = c(\"Angew Chem Int Ed Engl 43:67-70 (2004)\", \"DOI:10.1002/anie.200352626\")), list(REFERENCE = \"PMID:12777382\", AUTHORS = \"Pojer F, Kahlich R, Kammerer B, Li SM, Heide L.\", TITLE = \"CloR, a bifunctional non-heme iron oxygenase involved in clorobiocin biosynthesis.\", JOURNAL = c(\"J Biol Chem 278:30661-8 (2003)\", \"DOI:10.1074/jbc.M303190200\")), list(REFERENCE = \"PMID:12368465\", AUTHORS = \"Li SM, Westrich L, Schmidt J, Kuhnt C, Heide L.\", TITLE = \"Methyltransferase genes in Streptomyces rishiriensis: new coumermycin derivatives from gene-inactivation experiments.\", JOURNAL = c(\"Microbiology 148:3317-26 (2002)\", \"DOI:10.1099/00221287-148-10-3317\")), list(REFERENCE = \"PMID:12618544\", AUTHORS = \"Pojer F, Wemakor E, Kammerer B, Chen H, Walsh CT, Li SM, Heide L.\", TITLE = \"CloQ, a prenyltransferase involved in clorobiocin biosynthesis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 100:2316-21 (2003)\", \"DOI:10.1073/pnas.0337708100\"))', 'map00401', 'Novobiocin biosynthesis', 0, 4668, 0, 0, 0, 0, 4398, 270);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (53, '00402', 'Benzoxazinoid biosynthesis', 'Benzoxazinoids (hydroxamic acids) are plant secondary metabolites that serve as important factors for host resistance against microbial pathogens and insects and for allelopathic effects. They are found in grass family and some eudicot families. The predominant benzoxazinoids are DIBOA and its 7-methoxy derivative DIMBOA, which are stored as glucosides in vacuoles. In maize, benzoxazinoid biosynthesis branches off from tryptophan biosynthesis at indole-3-glycerol phosphate, which is converted to indole by indole-3-glycerol phosphate lyase, BX1. Subsequently four cytochrome P450 monooxygenases (BX2-BX5) catalyze the introduction of four oxygen atoms into the indole moiety, yielding DIBOA. After glucosylation by UDP-glucosyltransferase (BX8/BX9), the glucoside is further modified by hydroxylation and O-methylation at C-7 to form DIMBOA-glucoside.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Benzoxazinoid biosynthesis', 'ko00402', 'list(REFERENCE = \"PMID:11106389\", AUTHORS = \"Frey M, Stettner C, Pare PW, Schmelz EA, Tumlinson JH, Gierl A.\", TITLE = \"An herbivore elicitor activates the gene for indole emission in maize.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 97:14801-6 (2000)\", \"DOI:10.1073/pnas.260499897\")), list(REFERENCE = \"PMID:11556781\", AUTHORS = \"Gierl A, Frey M.\", TITLE = \"Evolution of benzoxazinone biosynthesis and indole production in maize.\", JOURNAL = c(\"Planta 213:493-8 (2001)\", \"DOI:10.1007/s004250100594\")), list(REFERENCE = \"PMID:16260753\", AUTHORS = \"Nomura T, Ishihara A, Yanagita RC, Endo TR, Iwamura H.\", TITLE = \"Three genomes differentially contribute to the biosynthesis of benzoxazinones in hexaploid wheat.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 102:16490-5 (2005)\", \"DOI:10.1073/pnas.0505156102\")), list(REFERENCE = \"PMID:9235894\", AUTHORS = \"Frey M, Chomet P, Glawischnig E, Stettner C, Grun S, Winklmair A, Eisenreich W, Bacher A, Meeley RB, Briggs SP, Simcox K, Gierl A.\", TITLE = \"Analysis of a chemical plant defense mechanism in grasses.\", JOURNAL = c(\"Science 277:696-9 (1997)\", \"DOI:10.1126/science.277.5326.696\")), list(REFERENCE = \"PMID:12620350\", AUTHORS = \"Frey M, Huber K, Park WJ, Sicker D, Lindberg P, Meeley RB, Simmons CR, Yalpani N, Gierl A.\", TITLE = \"A 2-oxoglutarate-dependent dioxygenase is integrated in DIMBOA-biosynthesis.\", JOURNAL = c(\"Phytochemistry 62:371-6 (2003)\", \"DOI:10.1016/S0031-9422(02)00556-3\")), list(REFERENCE = \"PMID:11851909\", AUTHORS = \"von Rad U, Huttl R, Lottspeich F, Gierl A, Frey M.\", TITLE = \"Two glucosyltransferases are involved in detoxification of benzoxazinoids in maize.\", JOURNAL = c(\"Plant J 28:633-42 (2001)\", \"DOI:10.1046/j.1365-313x.2001.01161.x\")), list(REFERENCE = \"PMID:16666853\", AUTHORS = \"Bailey BA, Larson RL\", TITLE = \"Hydroxamic Acid glucosyltransferases from maize seedlings.\", JOURNAL = c(\"Plant Physiol 90:1071-6 (1989)\", \"DOI:10.1104/pp.90.3.1071\")), list(REFERENCE = \"PMID:18192444\", AUTHORS = \"Jonczyk R, Schmidt H, Osterrieder A, Fiesselmann A, Schullehner K, Haslbeck M, Sicker D, Hofmann D, Yalpani N, Simmons C, Frey M, Gierl A\", TITLE = \"Elucidation of the final reactions of DIMBOA-glucoside biosynthesis in maize: characterization of Bx6 and Bx7.\", JOURNAL = c(\"Plant Physiol 146:1053-63 (2008)\", \"DOI:10.1104/pp.107.111237\")), list(REFERENCE = \"PMID:19577780\", AUTHORS = \"Frey M, Schullehner K, Dick R, Fiesselmann A, Gierl A\", TITLE = \"Benzoxazinoid biosynthesis, a model for evolution of secondary metabolic pathways in plants.\", JOURNAL = c(\"Phytochemistry 70:1645-51 (2009)\", \"DOI:10.1016/j.phytochem.2009.05.012\"))', 'map00402', 'Benzoxazinoid biosynthesis', 'Benzoxazinoids (hydroxamic acids) are plant secondary metabolites that serve as important factors for host resistance against microbial pathogens and insects and for allelopathic effects. They are found in grass family and some eudicot families. The predominant benzoxazinoids are DIBOA and its 7-methoxy derivative DIMBOA, which are stored as glucosides in vacuoles. In maize, benzoxazinoid biosynthesis branches off from tryptophan biosynthesis at indole-3-glycerol phosphate, which is converted to indole by indole-3-glycerol phosphate lyase, BX1. Subsequently four cytochrome P450 monooxygenases (BX2-BX5) catalyze the introduction of four oxygen atoms into the indole moiety, yielding DIBOA. After glucosylation by UDP-glucosyltransferase (BX8/BX9), the glucoside is further modified by hydroxylation and O-methylation at C-7 to form DIMBOA-glucoside.', 4, 0, 0, 4, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (54, '00403', 'Indole diterpene alkaloid biosynthesis', 'Indole diterpene alkaloids are a group of meroterpenoids consisting of a partial diterpene structure with four isoprene units and an indole moiety. The common cyclic diterpene skeleton is derived from geranylgeranyl diphosphate (GGPP) and an indole moiety is derived from tryptophan or a tryptophan precursor. They are combined in the initial step of biosynthetic reactions that generate paspaline, the first stable and less modified form required for other forms. Most indole diterpene alkaloids have potent mammalian tremorgenic activities, such as ryegrass staggers in livestock, and some have anti-insect properties. This map shows examples of indole diterpene alkaloids isolated from filamentous fungi.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Indole diterpene alkaloid biosynthesis', 'Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline [PATH:map00403]', 'ko00403', 'list(REFERENCE = \"PMID:18262778\", AUTHORS = \"Saikia S, Nicholson MJ, Young C, Parker EJ, Scott B\", TITLE = \"The genetic basis for indole-diterpene chemical diversity in filamentous fungi.\", JOURNAL = c(\"Mycol Res 112:184-99 (2008)\", \"DOI:10.1016/j.mycres.2007.06.015\")), list(REFERENCE = \"PMID:16494875\", AUTHORS = \"Saikia S, Parker EJ, Koulman A, Scott B\", TITLE = \"Four gene products are required for the fungal synthesis of the indole-diterpene, paspaline.\", JOURNAL = c(\"FEBS Lett 580:1625-30 (2006)\", \"DOI:10.1016/j.febslet.2006.02.008\")), list(REFERENCE = \"PMID:17428785\", AUTHORS = \"Saikia S, Parker EJ, Koulman A, Scott B\", TITLE = \"Defining paxilline biosynthesis in Penicillium paxilli: functional characterization of two cytochrome P450 monooxygenases.\", JOURNAL = c(\"J Biol Chem 282:16829-37 (2007)\", \"DOI:10.1074/jbc.M701626200\")), list(REFERENCE = \"PMID:19801473\", AUTHORS = \"Nicholson MJ, Koulman A, Monahan BJ, Pritchard BL, Payne GA, Scott B\", TITLE = \"Identification of two aflatrem biosynthesis gene loci in Aspergillus flavus and metabolic engineering of Penicillium paxilli to elucidate their function.\", JOURNAL = c(\"Appl Environ Microbiol 75:7469-81 (2009)\", \"DOI:10.1128/AEM.02146-08\")), list(REFERENCE = \"PMID:22750140\", AUTHORS = \"Saikia S, Takemoto D, Tapper BA, Lane GA, Fraser K, Scott B\", TITLE = \"Functional analysis of an indole-diterpene gene cluster for lolitrem B biosynthesis in the grass endosymbiont Epichloe festucae.\", JOURNAL = c(\"FEBS Lett 586:2563-9 (2012)\", \"DOI:10.1016/j.febslet.2012.06.035\")), list(REFERENCE = \"PMID:23261604\", AUTHORS = \"Motoyama T, Hayashi T, Hirota H, Ueki M, Osada H\", TITLE = \"Terpendole E, a kinesin Eg5 inhibitor, is a key biosynthetic intermediate of indole-diterpenes in the producing fungus Chaunopycnis alba.\", JOURNAL = c(\"Chem Biol 19:1611-9 (2012)\", \"DOI:10.1016/j.chembiol.2012.10.010\"))', 'map00403', 'Indole diterpene alkaloid biosynthesis', 13, 0, 0, 0, 13, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (55, '00404', 'Staurosporine biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Staurosporine biosynthesis', 'Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A [PATH:map00404], Rebeccamycin biosynthesis, tryptophan => rebeccamycin [PATH:map00404], Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin [PATH:map00404], Staurosporine biosynthesis, tryptophan => staurosporine [PATH:map00404], Violacein biosynthesis, tryptophan => violacein [PATH:map00404]', 'ko00404', 'list(REFERENCE = \"PMID:17119643\", AUTHORS = \"Sanchez C, Mendez C, Salas JA\", TITLE = \"Indolocarbazole natural products: occurrence, biosynthesis, and biological activity.\", JOURNAL = c(\"Nat Prod Rep 23:1007-45 (2006)\", \"DOI:10.1039/b601930g\")), list(REFERENCE = \"PMID:12617516\", AUTHORS = \"Onaka H, Taniguchi S, Igarashi Y, Furumai T\", TITLE = \"Cloning of the staurosporine biosynthetic gene cluster from Streptomyces sp. TP-A0274 and its heterologous expression in Streptomyces lividans.\", JOURNAL = c(\"J Antibiot (Tokyo) 55:1063-71 (2002)\", \"DOI:10.7164/antibiotics.55.1063\")), list(REFERENCE = \"PMID:24038353\", AUTHORS = \"Lee ME, Aswani A, Han AS, Tomlin CJ, Dueber JE\", TITLE = \"Expression-level optimization of a multi-enzyme pathway in the absence of a high-throughput assay.\", JOURNAL = c(\"Nucleic Acids Res 41:10668-78 (2013)\", \"DOI:10.1093/nar/gkt809\")), list(REFERENCE = \"PMID:12619684\", AUTHORS = \"Onaka H, Taniguchi S, Igarashi Y, Furumai T\", TITLE = \"Characterization of the biosynthetic gene cluster of rebeccamycin from Lechevalieria aerocolonigenes ATCC 39243.\", JOURNAL = c(\"Biosci Biotechnol Biochem 67:127-38 (2003)\", \"DOI:10.1271/bbb.67.127\")), list(REFERENCE = \"PMID:9172332\", AUTHORS = \"Hammer PE, Hill DS, Lam ST, Van Pee KH, Ligon JM\", TITLE = \"Four genes from Pseudomonas fluorescens that encode the biosynthesis of pyrrolnitrin.\", JOURNAL = \"Appl Environ Microbiol 63:2147-54 (1997)\"), list(REFERENCE = \"PMID:23109474\", AUTHORS = \"Mundt K, Wollinsky B, Ruan HL, Zhu T, Li SM\", TITLE = \"Identification of the verruculogen prenyltransferase FtmPT3 by a combination of chemical, bioinformatic and biochemical approaches.\", JOURNAL = c(\"Chembiochem 13:2583-92 (2012)\", \"DOI:10.1002/cbic.201200523\"))', 'map00404', 'Staurosporine biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 3, 71, 0, 0, 3, 0, 71, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (56, '00405', 'Phenazine biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Phenazine biosynthesis', 'Pyocyanine biosynthesis, chorismate => pyocyanine [PATH:map00405]', 'ko00405', 'list(REFERENCE = \"PMID:23897464\", AUTHORS = \"Xu N, Ahuja EG, Janning P, Mavrodi DV, Thomashow LS, Blankenfeldt W\", TITLE = \"Trapped intermediates in crystals of the FMN-dependent oxidase PhzG provide insight into the final steps of phenazine biosynthesis.\", JOURNAL = c(\"Acta Crystallogr D Biol Crystallogr 69:1403-13 (2013)\", \"DOI:10.1107/S0907444913008354\")), list(REFERENCE = \"PMID:20352425\", AUTHORS = \"Pierson LS 3rd, Pierson EA\", TITLE = \"Metabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes.\", JOURNAL = c(\"Appl Microbiol Biotechnol 86:1659-70 (2010)\", \"DOI:10.1007/s00253-010-2509-3\")), list(REFERENCE = \"PMID:19053436\", AUTHORS = \"Ahuja EG, Janning P, Mentel M, Graebsch A, Breinbauer R, Hiller W, Costisella B, Thomashow LS, Mavrodi DV, Blankenfeldt W\", TITLE = \"PhzA/B catalyzes the formation of the tricycle in phenazine biosynthesis.\", JOURNAL = c(\"J Am Chem Soc 130:17053-61 (2008)\", \"DOI:10.1021/ja806325k\")), list(REFERENCE = \"PMID:19658148\", AUTHORS = \"Mentel M, Ahuja EG, Mavrodi DV, Breinbauer R, Thomashow LS, Blankenfeldt W\", TITLE = \"Of two make one: the biosynthesis of phenazines.\", JOURNAL = c(\"Chembiochem 10:2295-304 (2009)\", \"DOI:10.1002/cbic.200900323\")), list(REFERENCE = \"PMID:15502343\", AUTHORS = \"Parsons JF, Calabrese K, Eisenstein E, Ladner JE\", TITLE = \"Structure of the phenazine biosynthesis enzyme PhzG.\", JOURNAL = c(\"Acta Crystallogr D Biol Crystallogr 60:2110-3 (2004)\", \"DOI:10.1107/S0907444904022474\")), list(REFERENCE = \"PMID:11591691\", AUTHORS = \"Mavrodi DV, Bonsall RF, Delaney SM, Soule MJ, Phillips G, Thomashow LS\", TITLE = \"Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1.\", JOURNAL = c(\"J Bacteriol 183:6454-65 (2001)\", \"DOI:10.1128/JB.183.21.6454-6465.2001\"))', 'map00405', 'Phenazine biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 0, 684, 0, 0, 0, 0, 666, 18);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (57, '00410', 'beta-Alanine metabolism', 'Metabolism; Metabolism of other amino acids', 'beta-Alanine metabolism', 'Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA [PATH:map00410]', 'Snyder-Robinson syndrome, Malonyl-CoA decarboxylase deficiency, Methylmalonate semialdehyde dehydrogenase deficiency', 'GO: 0019482', 'ko00410', 'map00410', 'beta-Alanine metabolism', 507, 4444, 247, 105, 123, 32, 4158, 286);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (58, '00430', 'Taurine and hypotaurine metabolism', 'Metabolism; Metabolism of other amino acids', 'Taurine and hypotaurine metabolism', 'Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map00430]', 'GO: 0019530', 'ko00430', 'list(REFERENCE = \"PMID:12471498\", AUTHORS = \"Cook AM, Denger K.\", TITLE = \"Dissimilation of the C2 sulfonates.\", JOURNAL = c(\"Arch Microbiol 179:1-6 (2002)\", \"DOI:10.1007/s00203-002-0497-0\")), list(REFERENCE = \"PMID:11082195\", AUTHORS = \"Laue H, Cook AM.\", TITLE = \"Biochemical and molecular characterization of taurine:pyruvate aminotransferase from the anaerobe Bilophila wadsworthia.\", JOURNAL = c(\"Eur J Biochem 267:6841-8 (2000)\", \"DOI:10.1046/j.1432-1033.2000.01782.x\")), list(REFERENCE = \"PMID:12358600\", AUTHORS = \"Ruff J, Denger K, Cook AM.\", TITLE = \"Sulphoacetaldehyde acetyltransferase yields acetyl phosphate: purification from Alcaligenes defragrans and gene clusters in taurine degradation.\", JOURNAL = c(\"Biochem J 369:275-85 (2003)\", \"DOI:10.1042/BJ20021455\")), list(REFERENCE = \"PMID:15073291\", AUTHORS = \"Bruggemann C, Denger K, Cook AM, Ruff J.\", TITLE = \"Enzymes and genes of taurine and isethionate dissimilation in Paracoccus denitrificans.\", JOURNAL = c(\"Microbiology 150:805-16 (2004)\", \"DOI:10.1099/mic.0.26795-0\")), list(REFERENCE = \"PMID:15340795\", AUTHORS = \"Denger K, Weinitschke S, Hollemeyer K, Cook AM.\", TITLE = \"Sulfoacetate generated by Rhodopseudomonas palustris from taurine.\", JOURNAL = c(\"Arch Microbiol 182:254-8 (2004)\", \"DOI:10.1007/s00203-004-0678-0\")), list(REFERENCE = \"PMID:15184572\", AUTHORS = \"Denger K, Ruff J, Schleheck D, Cook AM.\", TITLE = \"Rhodococcus opacus expresses the xsc gene to utilize taurine as a carbon source or as a nitrogen source but not as a sulfur source.\", JOURNAL = c(\"Microbiology 150:1859-67 (2004)\", \"DOI:10.1099/mic.0.27077-0\")), list(REFERENCE = \"PMID:15883781\", AUTHORS = \"Styp von Rekowski K, Denger K, Cook AM.\", TITLE = \"Isethionate as a product from taurine during nitrogen-limited growth of Klebsiella oxytoca TauN1.\", JOURNAL = c(\"Arch Microbiol 183:325-30 (2005)\", \"DOI:10.1007/s00203-005-0776-7\")), list(REFERENCE = \"PMID:4297098\", AUTHORS = \"Jacobsen JG, Smith LH\", TITLE = \"Biochemistry and physiology of taurine and taurine derivatives.\", JOURNAL = c(\"Physiol Rev 48:424-511 (1968)\", \"DOI:10.1152/physrev.1968.48.2.424\"))', 'map00430', 'Taurine and hypotaurine metabolism', 498, 4840, 248, 104, 123, 23, 4714, 126);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (59, '00440', 'Phosphonate and phosphinate metabolism', 'Natural products containing carbon-phosphorous bonds, so-called C-P compounds, are derivatives of phosphonate and phosphinate with substitution of alkyl group for hydrogen of phosphorus-hydrogen bonds. C-P compounds have been found in many organisms, but only protists and bacteria, mostly Actinobacteria, have biosynthetic capacity. A common reaction in the biosynthetic pathway is C-P bond forming reaction from phosphoenolpyruvate (PEP) to phosphonopyruvate (PnPy) catalyzed by PEP phosphomutase. 2-Aminoethylphosphonate (AEP) is the most abundant C-P compound in the natural world. AEP derivatives include phosphonoprotein, phosphonoglycan, and phosphonolipid. Other known C-P compounds are bioactive substances used in medicine (antibiotics) and agriculture (herbicide) such as fosfomycin, FR-33289, rhizocticin, and bialaphos.', 'Metabolism; Metabolism of other amino acids', 'Phosphonate and phosphinate metabolism', 'Spondylometaphyseal dysplasia with cone-rod dystrophy', 'GO: 0019634', 'ko00440', 'list(REFERENCE = \"PMID:19489722\", AUTHORS = \"Metcalf WW, van der Donk WA\", TITLE = \"Biosynthesis of phosphonic and phosphinic acid natural products.\", JOURNAL = c(\"Annu Rev Biochem 78:65-94 (2009)\", \"DOI:10.1146/annurev.biochem.78.091707.100215\")), list(REFERENCE = \"PMID:19053721\", AUTHORS = \"Xiao Y, Lee K, Liu P\", TITLE = \"Syntheses of the P-methylase substrates of the bialaphos biosynthetic pathway.\", JOURNAL = c(\"Org Lett 10:5521-4 (2008)\", \"DOI:10.1021/ol802269x\")), list(REFERENCE = \"PMID:17168571\", AUTHORS = \"van der Donk WA\", TITLE = \"Rings, radicals, and regeneration: the early years of a bioorganic laboratory.\", JOURNAL = c(\"J Org Chem 71:9561-71 (2006)\", \"DOI:10.1021/jo0614240\")), list(REFERENCE = \"PMID:15616300\", AUTHORS = \"Blodgett JA, Zhang JK, Metcalf WW\", TITLE = \"Molecular cloning, sequence analysis, and heterologous expression of the phosphinothricin tripeptide biosynthetic gene cluster from Streptomyces viridochromogenes DSM 40736.\", JOURNAL = c(\"Antimicrob Agents Chemother 49:230-40 (2005)\", \"DOI:10.1128/AAC.49.1.230-240.2005\")), list(REFERENCE = \"PMID:15574905\", AUTHORS = \"Schwartz D, Berger S, Heinzelmann E, Muschko K, Welzel K, Wohlleben W\", TITLE = \"Biosynthetic gene cluster of the herbicide phosphinothricin tripeptide from Streptomyces viridochromogenes Tu494.\", JOURNAL = c(\"Appl Environ Microbiol 70:7093-102 (2004)\", \"DOI:10.1128/AEM.70.12.7093-7102.2004\"))', 'map00440', 520, 3277, 248, 100, 126, 46, 3204, 73);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (60, '00450', 'Selenocompound metabolism', 'Metabolism; Metabolism of other amino acids', 'Selenocompound metabolism', 'Homocystinuria, Hypermethioninemia, SEMD, Pakistani type, Methylcobalamin deficiency type G', 'ko00450', 'list(REFERENCE = \"PMID:21190829\", AUTHORS = \"Hoefig CS, Renko K, Kohrle J, Birringer M, Schomburg L\", TITLE = \"Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture.\", JOURNAL = c(\"J Nutr Biochem 22:945-55 (2011)\", \"DOI:10.1016/j.jnutbio.2010.08.006\")), list(REFERENCE = \"PMID:19051051\", AUTHORS = \"McKenzie MJ, Hunter DA, Pathirana R, Watson LM, Joyce NI, Matich AJ, Rowan DD, Brummell DA\", TITLE = \"Accumulation of an organic anticancer selenium compound in a transgenic Solanaceous species shows wider applicability of the selenocysteine methyltransferase transgene from selenium hyperaccumulators.\", JOURNAL = c(\"Transgenic Res 18:407-24 (2009)\", \"DOI:10.1007/s11248-008-9233-0\")), list(REFERENCE = \"PMID:20383543\", AUTHORS = \"Pinto JT, Lee JI, Sinha R, MacEwan ME, Cooper AJ\", TITLE = \"Chemopreventive mechanisms of alpha-keto acid metabolites of naturally occurring organoselenium compounds.\", JOURNAL = c(\"Amino Acids 41:29-41 (2011)\", \"DOI:10.1007/s00726-010-0578-3\")), list(REFERENCE = \"PMID:17451884\", AUTHORS = \"Suzuki KT, Kurasaki K, Suzuki N\", TITLE = \"Selenocysteine beta-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide.\", JOURNAL = c(\"Biochim Biophys Acta 1770:1053-61 (2007)\", \"DOI:10.1016/j.bbagen.2007.03.007\")), list(REFERENCE = \"PMID:11782468\", AUTHORS = \"Gromer S, Gross JH\", TITLE = \"Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase. Implications for the antitumor effects of selenium.\", JOURNAL = c(\"J Biol Chem 277:9701-6 (2002)\", \"DOI:10.1074/jbc.M109234200\"))', 'map00450', 'Selenocompound metabolism', 'Metabolism; Metabolism of other amino acids', 530, 5562, 248, 105, 128, 49, 5263, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (61, '00460', 'Cyanoamino acid metabolism', 'Metabolism; Metabolism of other amino acids', 'Cyanoamino acid metabolism', 'Cyanogenic glycoside biosynthesis, tyrosine => dhurrin [PATH:map00460]', 'GO: 0033052 0019756', 'ko00460', 'list(REFERENCE = \"PMID:11575729\", AUTHORS = \"Maruyama A, Saito K, Ishizawa K\", TITLE = \"Beta-cyanoalanine synthase and cysteine synthase from potato: molecular cloning, biochemical characterization, and spatial and hormonal regulation.\", JOURNAL = c(\"Plant Mol Biol 46:749-60 (2001)\", \"DOI:10.1023/A:1011629703784\")), list(REFERENCE = \"PMID:10636899\", AUTHORS = \"Andersen MD, Busk PK, Svendsen I, Moller BL\", TITLE = \"Cytochromes P-450 from cassava (Manihot esculenta Crantz) catalyzing the first steps in the biosynthesis of the cyanogenic glucosides linamarin and lotaustralin. Cloning, functional expression in Pichia pastoris, and substrate specificity of the isolated recombinant enzymes.\", JOURNAL = c(\"J Biol Chem 275:1966-75 (2000)\", \"DOI:10.1074/jbc.275.3.1966\")), list(REFERENCE = \"\", AUTHORS = \"Hickel A, Hasslacher M, Griengl H.\", TITLE = \"Hydroxynitrile lyases: Functions and properties\", JOURNAL = c(\"Physiologia Plantarum 98(4):891-898 (2006)\", \"DOI:10.1111/j.1399-3054.1996.tb06700.x\"))', 'map00460', 'Cyanoamino acid metabolism', 262, 4852, 0, 104, 128, 30, 4671, 181);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (62, '00471', 'D-Glutamine and D-glutamate metabolism', 'Metabolism; Metabolism of other amino acids', 'D-Glutamine and D-glutamate metabolism', 'Familial hyperinsulinemic hypoglycemia', 'ko00471', 'map00471', 'D-Glutamine and D-glutamate metabolism', 'Metabolism; Metabolism of other amino acids', 'D-Glutamine and D-glutamate metabolism', 247, 5335, 238, 0, 0, 9, 5067, 268);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (63, '00472', 'D-Arginine and D-ornithine metabolism', 'Metabolism; Metabolism of other amino acids', 'D-Arginine and D-ornithine metabolism', 'ko00472', 'map00472', 'D-Arginine and D-ornithine metabolism', 'Metabolism; Metabolism of other amino acids', 'D-Arginine and D-ornithine metabolism', 'ko00472', 333, 1946, 211, 6, 106, 10, 1925, 21);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (64, '00473', 'D-Alanine metabolism', 'Metabolism; Metabolism of other amino acids', 'D-Alanine metabolism', 'GO: 0046436', 'ko00473', 'map00473', 'D-Alanine metabolism', 'Metabolism; Metabolism of other amino acids', 'D-Alanine metabolism', 0, 4755, 0, 0, 0, 0, 4755, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (65, '00480', 'Glutathione metabolism', 'Metabolism; Metabolism of other amino acids', 'Glutathione metabolism', 'Glutathione biosynthesis, glutamate => glutathione [PATH:map00480]', 'Snyder-Robinson syndrome, Anemia due to disorders of glutathione metabolism, D-2-hydroxyglutaric aciduria, Glucose 6-phosphate dehydrogenase deficiency, Glutathione synthetase deficiency, 5-Oxoprolinase deficiency', 'GO: 0006749', 'ko00480', 'list(REFERENCE = \"PMID:12675513\", AUTHORS = \"Josch C, Klotz LO, Sies H.\", TITLE = \"Identification of cytosolic leucyl aminopeptidase (EC 3.4.11.1) as the major cysteinylglycine-hydrolysing activity in rat liver.\", JOURNAL = c(\"Biol Chem 384:213-8 (2003)\", \"DOI:10.1515/BC.2003.023\")), list(REFERENCE = \"PMID:18482986\", AUTHORS = \"Chu L, Lai Y, Xu X, Eddy S, Yang S, Song L, Kolodrubetz D.\", TITLE = \"A 52-kDa leucyl aminopeptidase from treponema denticola is a cysteinylglycinase that mediates the second step of glutathione metabolism.\", JOURNAL = c(\"J Biol Chem 283:19351-8 (2008)\", \"DOI:10.1074/jbc.M801034200\")), list(REFERENCE = \"PMID:14583094\", AUTHORS = \"Cappiello M, Lazzarotti A, Buono F, Scaloni A, D\'Ambrosio C, Amodeo P, Mendez BL, Pelosi P, Del Corso A, Mura U.\", TITLE = \"New role for leucyl aminopeptidase in glutathione turnover.\", JOURNAL = c(\"Biochem J 378:35-44 (2004)\", \"DOI:10.1042/BJ20031336\")), list(REFERENCE = \"PMID:11157967\", AUTHORS = \"Suzuki H, Kamatani S, Kim ES, Kumagai H.\", TITLE = \"Aminopeptidases A, B, and N and dipeptidase D are the four cysteinylglycinases of Escherichia coli K-12.\", JOURNAL = c(\"J Bacteriol 183:1489-90 (2001)\", \"DOI:10.1128/JB.183.4.1489-1490.2001\")), list(REFERENCE = \"PMID:15610825\", AUTHORS = \"Oza SL, Shaw MP, Wyllie S, Fairlamb AH.\", TITLE = \"Trypanothione biosynthesis in Leishmania major.\", JOURNAL = c(\"Mol Biochem Parasitol 139:107-16 (2005)\", \"DOI:10.1016/j.molbiopara.2004.10.004\")), list(REFERENCE = \"PMID:12049631\", AUTHORS = \"Oza SL, Ariyanayagam MR, Fairlamb AH.\", TITLE = \"Characterization of recombinant glutathionylspermidine synthetase/amidase from Crithidia fasciculata.\", JOURNAL = c(\"Biochem J 364:679-86 (2002)\", \"DOI:10.1042/BJ20011370\")), list(REFERENCE = \"PMID:9677355\", AUTHORS = \"Tetaud E, Manai F, Barrett MP, Nadeau K, Walsh CT, Fairlamb AH.\", TITLE = \"Cloning and characterization of the two enzymes responsible for trypanothione biosynthesis in Crithidia fasciculata.\", JOURNAL = c(\"J Biol Chem 273:19383-90 (1998)\", \"DOI:10.1074/jbc.273.31.19383\")), list(REFERENCE = \"PMID:12750367\", AUTHORS = \"Ariyanayagam MR, Oza SL, Mehlert A, Fairlamb AH.\", TITLE = \"Bis(glutathionyl)spermine and other novel trypanothione analogues in Trypanosoma cruzi.\", JOURNAL = c(\"J Biol Chem 278:27612-9 (2003)\", \"DOI:10.1074/jbc.M302750200\")), list(REFERENCE = \"PMID:12967709\", AUTHORS = \"Oza SL, Ariyanayagam MR, Aitcheson N, Fairlamb AH.\", TITLE = \"Properties of trypanothione synthetase from Trypanosoma brucei.\", JOURNAL = c(\"Mol Biochem Parasitol 131:25-33 (2003)\", \"DOI:10.1016/S0166-6851(03)00176-2\")), list(REFERENCE = \"PMID:12121990\", AUTHORS = \"Oza SL, Tetaud E, Ariyanayagam MR, Warnon SS, Fairlamb AH.\", TITLE = \"A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi.\", JOURNAL = c(\"J Biol Chem 277:35853-61 (2002)\", \"DOI:10.1074/jbc.M204403200\")), list(REFERENCE = \"PMID:15537651\", AUTHORS = \"Comini M, Menge U, Wissing J, Flohe L.\", TITLE = \"Trypanothione synthesis in crithidia revisited.\", JOURNAL = c(\"J Biol Chem 280:6850-60 (2005)\", \"DOI:10.1074/jbc.M404486200\")), list(REFERENCE = \"PMID:7813456\", AUTHORS = \"Hunter KJ, Le Quesne SA, Fairlamb AH.\", TITLE = \"Identification and biosynthesis of N1,N9-bis(glutathionyl)aminopropylcadaverine (homotrypanothione) in Trypanosoma cruzi.\", JOURNAL = c(\"Eur J Biochem 226:1019-27 (1994)\", \"DOI:10.1111/j.1432-1033.1994.t01-1-01019.x\")), list(REFERENCE = \"PMID:12751784\", AUTHORS = \"Krauth-Siegel RL, Meiering SK, Schmidt H.\", TITLE = \"The parasite-specific trypanothione metabolism of trypanosoma and leishmania.\", JOURNAL = c(\"Biol Chem 384:539-49 (2003)\", \"DOI:10.1515/BC.2003.062\")), list(REFERENCE = \"PMID:18395526\", AUTHORS = \"Krauth-Siegel RL, Comini MA.\", TITLE = \"Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism.\", JOURNAL = c(\"Biochim Biophys Acta 1780:1236-48 (2008)\", \"DOI:10.1016/j.bbagen.2008.03.006\")), list(REFERENCE = \"PMID:8892297\", AUTHORS = \"Krauth-Siegel RL, Ludemann H.\", TITLE = \"Reduction of dehydroascorbate by trypanothione.\", JOURNAL = c(\"Mol Biochem Parasitol 80:203-8 (1996)\", \"DOI:10.1016/0166-6851(96)02689-8\")), list(REFERENCE = \"PMID:11150302\", AUTHORS = \"Dormeyer M, Reckenfelderbaumer N, Ludemann H, Krauth-Siegel RL.\", TITLE = \"Trypanothione-dependent synthesis of deoxyribonucleotides by Trypanosoma brucei ribonucleotide reductase.\", JOURNAL = c(\"J Biol Chem 276:10602-6 (2001)\", \"DOI:10.1074/jbc.M010352200\")), list(REFERENCE = \"PMID:12949079\", AUTHORS = \"Schmidt H, Krauth-Siegel RL.\", TITLE = \"Functional and physicochemical characterization of the thioredoxin system in Trypanosoma brucei.\", JOURNAL = c(\"J Biol Chem 278:46329-36 (2003)\", \"DOI:10.1074/jbc.M305338200\")), list(REFERENCE = \"PMID:9851611\", AUTHORS = \"Tetaud E, Fairlamb AH.\", TITLE = \"Cloning, expression and reconstitution of the trypanothione-dependent peroxidase system of Crithidia fasciculata.\", JOURNAL = c(\"Mol Biochem Parasitol 96:111-23 (1998)\", \"DOI:10.1016/S0166-6851(98)00120-0\")), list(REFERENCE = \"PMID:12446213\", AUTHORS = \"Castro H, Sousa C, Santos M, Cordeiro-da-Silva A, Flohe L, Tomas AM.\", TITLE = \"Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum.\", JOURNAL = c(\"Free Radic Biol Med 33:1552-62 (2002)\", \"DOI:10.1016/S0891-5849(02)01089-4\")), list(REFERENCE = \"PMID:10713147\", AUTHORS = \"Wilkinson SR, Temperton NJ, Mondragon A, Kelly JM.\", TITLE = \"Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi.\", JOURNAL = c(\"J Biol Chem 275:8220-5 (2000)\", \"DOI:10.1074/jbc.275.11.8220\")), list(REFERENCE = \"PMID:17922848\", AUTHORS = \"Konig J, Fairlamb AH.\", TITLE = \"A comparative study of type I and type II tryparedoxin peroxidases in Leishmania major.\", JOURNAL = c(\"FEBS J 274:5643-58 (2007)\", \"DOI:10.1111/j.1742-4658.2007.06087.x\")), list(REFERENCE = \"PMID:12466271\", AUTHORS = \"Hillebrand H, Schmidt A, Krauth-Siegel RL.\", TITLE = \"A second class of peroxidases linked to the trypanothione metabolism.\", JOURNAL = c(\"J Biol Chem 278:6809-15 (2003)\", \"DOI:10.1074/jbc.M210392200\")), list(REFERENCE = \"PMID:14982633\", AUTHORS = \"Soksawatmaekhin W, Kuraishi A, Sakata K, Kashiwagi K, Igarashi K.\", TITLE = \"Excretion and uptake of cadaverine by CadB and its physiological functions in Escherichia coli.\", JOURNAL = c(\"Mol Microbiol 51:1401-12 (2004)\", \"DOI:10.1046/j.1365-2958.2003.03913.x\")), list(REFERENCE = \"PMID:6798961\", AUTHORS = \"Pegg AE, Shuttleworth K, Hibasami H.\", TITLE = \"Specificity of mammalian spermidine synthase and spermine synthase.\", JOURNAL = c(\"Biochem J 197:315-20 (1981)\", \"DOI:10.1042/bj1970315\"))', 'map00480', 531, 5466, 248, 105, 128, 50, 5205, 261);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (66, '00500', 'Starch and sucrose metabolism', 'Metabolism; Carbohydrate metabolism', 'Starch and sucrose metabolism', 'Trehalose biosynthesis, D-glucose 1P => trehalose [PATH:map00500], Glycogen biosynthesis, glucose-1P => glycogen/starch [PATH:map00500], Glycogen degradation, glycogen => glucose-6P [PATH:map00500]', 'Glycogen storage disease, Congenital sucrase-isomaltase deficiency, Generalized arterial calcification of infancy, Familial tumoral calcinosis, Cole disease, Hepatic glycogen storage disease, Muscle glycogen storage disease, Glycogen storage disease type III, Glycogen storage disease type IV, Glycogen storage disease type V, Glycogen storage disease type VI, Glycogen storage disease type 0b, Glycogen storage disease type 0a, Glycogen storage disease type XIV, Glycogen storage disease type XV, Trehalase deficiency', 'GO: 0005982 0005985', 'ko00500', 'map00500', 'Starch and sucrose metabolism', 531, 5416, 248, 105, 128, 50, 5124, 292);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (67, '00510', 'N-Glycan biosynthesis', 'N-glycans or asparagine-linked glycans are major constituents of glycoproteins in eukaryotes. N-glycans are covalently attached to asparagine with the consensus sequence of Asn-X-Ser/Thr by an N-glycosidic bond, GlcNAc b1- Asn. Biosynthesis of N-glycans begins on the cytoplasmic face of the ER membrane with the transferase reaction of UDP-GlcNAc and the lipid-like precursor P-Dol (dolichol phosphate) to generate GlcNAc a1- PP-Dol. After sequential addition of monosaccharides by ALG glycosyltransferases [MD:M00055], the N-glycan precursor is attached by the OST (oligosaccharyltransferase) complex to the polypeptide chain that is being synthesized and translocated through the ER membrane. The protein-bound N-glycan precursor is subsequently trimmed, extended, and modified in the ER and Golgi by a complex series of reactions catalyzed by membrane-bound glycosidases and glycosyltransferases. N-glycans thus synthesized are classified into three types: high-mannose type, complex type, and hybrid type. Defects in N-glycan biosynthesis lead to a variety of human diseases known as congenital disorders of glycosylation [DS:H00118 H00119].', 'Metabolism; Glycan biosynthesis and metabolism', 'N-Glycan biosynthesis', 'N-glycan precursor biosynthesis [PATH:map00510], N-glycosylation by oligosaccharyltransferase [PATH:map00510], N-glycan precursor trimming [PATH:map00510], N-glycan biosynthesis, high-mannose type [PATH:map00510], N-glycan biosynthesis, complex type [PATH:map00510]', 'Congenital disorders of glycosylation type I, Congenital disorders of glycosylation type II', 'GO: 0006487', 'ko00510', 'list(REFERENCE = \"PMID:9111134\", AUTHORS = \"Schutzbach JS.\", TITLE = \"The role of the lipid matrix in the biosynthesis of dolichyl-linked oligosaccharides.\", JOURNAL = c(\"Glycoconj J 14:175-82 (1997)\", \"DOI:10.1023/A:1018533620002\")), list(REFERENCE = \"PMID:12200473\", AUTHORS = \"Oriol R, Martinez-Duncker I, Chantret I, Mollicone R, Codogno P.\", TITLE = \"Common origin and evolution of glycosyltransferases using Dol-P-monosaccharides as donor substrate.\", JOURNAL = c(\"Mol Biol Evol 19:1451-63 (2002)\", \"DOI:10.1093/oxfordjournals.molbev.a004208\")), list(REFERENCE = \"PMID:12684507\", AUTHORS = \"Thiel C, Schwarz M, Peng J, Grzmil M, Hasilik M, Braulke T, Kohlschutter A, von Figura K, Lehle L, Korner C.\", TITLE = \"A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis.\", JOURNAL = c(\"J Biol Chem 278:22498-505 (2003)\", \"DOI:10.1074/jbc.M302850200\")), list(REFERENCE = \"PMID:11278778\", AUTHORS = \"Cipollo JF, Trimble RB, Chi JH, Yan Q, Dean N.\", TITLE = \"The yeast ALG11 gene specifies addition of the terminal alpha 1,2-Man to the Man5GlcNAc2-PP-dolichol N-glycosylation intermediate formed on the cytosolic side of the endoplasmic reticulum.\", JOURNAL = c(\"J Biol Chem 276:21828-40 (2001)\", \"DOI:10.1074/jbc.M010896200\")), list(REFERENCE = \"PMID:15987956\", AUTHORS = \"Frank CG, Aebi M.\", TITLE = \"ALG9 mannosyltransferase is involved in two different steps of lipid-linked oligosaccharide biosynthesis.\", JOURNAL = c(\"Glycobiology 15:1156-63 (2005)\", \"DOI:10.1093/glycob/cwj002\")), list(REFERENCE = \"PMID:16878994\", AUTHORS = \"O\'Reilly MK, Zhang G, Imperiali B.\", TITLE = \"In vitro evidence for the dual function of Alg2 and Alg11: essential mannosyltransferases in N-linked glycoprotein biosynthesis.\", JOURNAL = c(\"Biochemistry 45:9593-603 (2006)\", \"DOI:10.1021/bi060878o\"))', 526, 0, 248, 105, 123, 50, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (68, '00511', 'Other glycan degradation', 'Metabolism; Glycan biosynthesis and metabolism', 'Other glycan degradation', 'GM2 gangliosidoses, Gaucher disease, alpha-Mannosidosis, beta-Mannosidosis, Fucosidosis, Sialidosis, Aspartylglucosaminuria, GM1 gangliosidosis, Glycoproteinoses, Gangliosidosis, Tay-Sachs disease, Sandhoff disease', 'ko00511', 'map00511', 'Other glycan degradation', 'Metabolism; Glycan biosynthesis and metabolism', 'Other glycan degradation', 500, 2518, 248, 105, 121, 26, 2444, 74);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (69, '00512', 'Mucin type O-glycan biosynthesis', 'O-glycans are a class of glycans that modify serine or threonine residues of proteins. Biosynthesis of O-glycans starts from the transfer of N-acetylgalactosamine (GalNAc) to serine or threonine. The first GalNAc may be extended with sugars including galactose, N-acetylglucosamine, fucose, or sialic acid, but not mannose, glucose, or xylose. Depending on the sugars added, there are four common O-glycan core structures, cores 1 through 4, and an additional four, cores 5 though 8. Mucins are highly O-glycosylated glycoproteins ubiquitous in mucous secretions on cell surfaces and in body fluids. Mucin O-glycans can be branched, and many sugars or groups of sugars are antigenic. Important modifications of mucin O-glycans include O-acetylation of sialic acid and O-sulfation of galactose and N-acetylglucosamine.', 'Metabolism; Glycan biosynthesis and metabolism', 'Mucin type O-glycan biosynthesis', 'O-glycan biosynthesis, mucin type core [PATH:map00512]', 'Colorectal cancer, Tn syndrome, Familial tumoral calcinosis', 'GO: 0006493', 'ko00512', 'list(REFERENCE = \"PMID:10580130\", AUTHORS = \"Brockhausen I.\", TITLE = \"Pathways of O-glycan biosynthesis in cancer cells.\", JOURNAL = c(\"Biochim Biophys Acta 1473:67-95 (1999)\", \"DOI:10.1016/S0304-4165(99)00170-1\")), list(REFERENCE = \"PMID:11821425\", AUTHORS = \"Iwai T, Inaba N, Naundorf A, Zhang Y, Gotoh M, Iwasaki H, Kudo T, Togayachi A, Ishizuka Y, Nakanishi H, Narimatsu H.\", TITLE = \"Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans.\", JOURNAL = c(\"J Biol Chem 277:12802-9 (2002)\", \"DOI:10.1074/jbc.M112457200\")), list(REFERENCE = \"PMID:12626393\", AUTHORS = \"Korekane H, Taguchi T, Sakamoto Y, Honke K, Dohmae N, Salminen H, Toivonen S, Helin J, Takio K, Renkonen O, Taniguchi N.\", TITLE = \"Purification and cDNA cloning of UDP-GlcNAc:GlcNAcbeta1-3Galbeta1-4Glc(NAc)-R [GlcNAc to Gal]beta1,6N-acetylglucosaminyltransferase from rat small intestine: a major carrier of dIGnT activity in rat small intestine.\", JOURNAL = c(\"Glycobiology 13:387-400 (2003)\", \"DOI:10.1093/glycob/cwg044\")), list(REFERENCE = \"PMID:10350056\", AUTHORS = \"van Die I, van Tetering A, Schiphorst WE, Sato T, Furukawa K, van den Eijnden DH.\", TITLE = \"The acceptor substrate specificity of human beta4-galactosyltransferase V indicates its potential function in O-glycosylation.\", JOURNAL = c(\"FEBS Lett 450:52-6 (1999)\", \"DOI:10.1016/S0014-5793(99)00462-7\"))', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (70, '00513', 'Various types of N-glycan biosynthesis', 'Metabolism; Glycan biosynthesis and metabolism', 'Various types of N-glycan biosynthesis', 'N-glycosylation by oligosaccharyltransferase [PATH:map00513], N-glycan biosynthesis, high-mannose type [PATH:map00513]', 'Autosomal recessive mental retardation', 'GO: 0006487', 'ko00513', 'list(REFERENCE = \"PMID:11412862\", AUTHORS = \"Munro S.\", TITLE = \"What can yeast tell us about N-linked glycosylation in the Golgi apparatus?\", JOURNAL = c(\"FEBS Lett 498:223-7 (2001)\", \"DOI:10.1016/S0014-5793(01)02488-7\")), list(REFERENCE = \"PMID:9878803\", AUTHORS = \"Dean N.\", TITLE = \"Asparagine-linked glycosylation in the yeast Golgi.\", JOURNAL = c(\"Biochim Biophys Acta 1426:309-22 (1999)\", \"DOI:10.1016/S0304-4165(98)00132-9\")), list(REFERENCE = \"PMID:9878780\", AUTHORS = \"Herscovics A.\", TITLE = \"Processing glycosidases of Saccharomyces cerevisiae.\", JOURNAL = c(\"Biochim Biophys Acta 1426:275-85 (1999)\", \"DOI:10.1016/S0304-4165(98)00129-9\")), list(REFERENCE = \"PMID:9218445\", AUTHORS = \"Wang XH, Nakayama K, Shimma Y, Tanaka A, Jigami Y.\", TITLE = \"MNN6, a member of the KRE2/MNT1 family, is the gene for mannosylphosphate transfer in Saccharomyces cerevisiae.\", JOURNAL = c(\"J Biol Chem 272:18117-24 (1997)\", \"DOI:10.1074/jbc.272.29.18117\")), list(REFERENCE = \"PMID:9756928\", AUTHORS = \"Rayner JC, Munro S.\", TITLE = \"Identification of the MNN2 and MNN5 mannosyltransferases required for forming and extending the mannose branches of the outer chain mannans of Saccharomyces cerevisiae.\", JOURNAL = c(\"J Biol Chem 273:26836-43 (1998)\", \"DOI:10.1074/jbc.273.41.26836\")), list(REFERENCE = \"PMID:10037752\", AUTHORS = \"Jungmann J, Rayner JC, Munro S.\", TITLE = \"The Saccharomyces cerevisiae protein Mnn10p/Bed1p is a subunit of a Golgi mannosyltransferase complex.\", JOURNAL = c(\"J Biol Chem 274:6579-85 (1999)\", \"DOI:10.1074/jbc.274.10.6579\")), list(REFERENCE = \"PMID:8253757\", AUTHORS = \"Nakanishi-Shindo Y, Nakayama K, Tanaka A, Toda Y, Jigami Y.\", TITLE = \"Structure of the N-linked oligosaccharides that show the complete loss of alpha-1,6-polymannose outer chain from och1, och1 mnn1, and och1 mnn1 alg3 mutants of Saccharomyces cerevisiae.\", JOURNAL = \"J Biol Chem 268:26338-45 (1993)\"), list(REFERENCE = \"PMID:20233335\", AUTHORS = \"Gomord V, Fitchette AC, Menu-Bouaouiche L, Saint-Jore-Dupas C, Plasson C, Michaud D, Faye L\", TITLE = \"Plant-specific glycosylation patterns in the context of therapeutic protein production.\", JOURNAL = c(\"Plant Biotechnol J 8:564-87 (2010)\", \"DOI:10.1111/j.1467-7652.2009.00497.x\"))', 'map00513', 524, 0, 248, 105, 123, 48, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (71, '00514', 'Other types of O-glycan biosynthesis', 'O-linked glycosylation is the attachment of monosaccharides to the hydroxyl groups of amino acids, mostly serine and threonine, and is found in eukaryotes, archaea and bacteria. O-glycans exhibit diverse types of modifications where the innermost monosaccharide is N-acetylgalactosamine (map00512), mannose in mammals (map00515), and others (this map) including N-acetylglucosamine, fucose, glucose, galactose, mannose in yeast and arabinose in plants.', 'Metabolism; Glycan biosynthesis and metabolism', 'Other types of O-glycan biosynthesis', 'Limb-girdle muscular dystrophy, Dowling-Degos disease, Lysyl hydroxylase 3 deficiency', 'ko00514', 'list(REFERENCE = \"PMID:22669261\", AUTHORS = \"Kizuka Y, Oka S\", TITLE = \"Regulated expression and neural functions of human natural killer-1 (HNK-1) carbohydrate.\", JOURNAL = c(\"Cell Mol Life Sci 69:4135-47 (2012)\", \"DOI:10.1007/s00018-012-1036-z\")), list(REFERENCE = \"PMID:19429925\", AUTHORS = \"Lommel M, Strahl S\", TITLE = \"Protein O-mannosylation: conserved from bacteria to humans.\", JOURNAL = c(\"Glycobiology 19:816-28 (2009)\", \"DOI:10.1093/glycob/cwp066\"))', 'map00514', 'Other types of O-glycan biosynthesis', 492, 778, 248, 105, 127, 12, 774, 4);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (72, '00515', 'Mannose type O-glycan biosynthesis', 'Biosynthesis of mammalian O-mannosyl glycans is initiated by the transfer of mannose from mannose-P-Dol to serine or threonine residue, followed by extensions with N-acetylglucosamine (GlcNAc) and galactose (Gal) to generate core M1, M2 and M3 glycans. Core M1 and M2 glycans can then be further attached by fucose residues, sialic acid terminals and sulfatded glucuroinc acid terminals. Core M3 glycan is involved in the synthesis of alpha-dystroglycan, a heavily glycosylated protein found in muscle and brain tissues. Core M3 glycan contains a tandem repeat of ribitol 5-phosphate (Rbo5P) and -alpha3-GlcA-beta3-Xyl- repeating structures. Defects of genes encoding core glycans and modified core M3 glycans are associated with various congenital diseases, such as muscular dystrophies caused by reduced O-mannosylation of alpha-dystroglycan in skeletal muscles [DS:H00120].', 'Metabolism; Glycan biosynthesis and metabolism', 'Mannose type O-glycan biosynthesis', 'O-glycan biosynthesis, mannose type (core M3) [PATH:map00515]', 'Muscular dystrophy-dystroglycanopathy type A, Limb-girdle muscular dystrophy, Fukuyama congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy type C, Muscular dystrophy-dystroglycanopathy type B, Congenital muscular dystrophy type 1C, Congenital muscular dystrophy type 1D, Muscular dystrophy-dystroglycanopathy', 'GO: 0006493', 'ko00515', 'list(REFERENCE = \"PMID:24786756\", AUTHORS = \"Praissman JL, Wells L\", TITLE = \"Mammalian O-mannosylation pathway: glycan structures, enzymes, and protein substrates.\", JOURNAL = c(\"Biochemistry 53:3066-78 (2014)\", \"DOI:10.1021/bi500153y\")), list(REFERENCE = \"PMID:21945038\", AUTHORS = \"Stalnaker SH, Stuart R, Wells L\", TITLE = \"Mammalian O-mannosylation: unsolved questions of structure/function.\", JOURNAL = c(\"Curr Opin Struct Biol 21:603-9 (2011)\", \"DOI:10.1016/j.sbi.2011.09.001\")), list(REFERENCE = \"PMID:26923585\", AUTHORS = \"Kanagawa M, Kobayashi K, Tajiri M, Manya H, Kuga A, Yamaguchi Y, Akasaka-Manya K, Furukawa J, Mizuno M, Kawakami H, Shinohara Y, Wada Y, Endo T, Toda T\", TITLE = \"Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy.\", JOURNAL = c(\"Cell Rep 14:2209-23 (2016)\", \"DOI:10.1016/j.celrep.2016.02.017\")), list(REFERENCE = \"PMID:27733679\", AUTHORS = \"Manya H, Yamaguchi Y, Kanagawa M, Kobayashi K, Tajiri M, Akasaka-Manya K, Kawakami H, Mizuno M, Wada Y, Toda T, Endo T\", TITLE = \"The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol beta1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan.\", JOURNAL = c(\"J Biol Chem 291:24618-24627 (2016)\", \"DOI:10.1074/jbc.M116.751917\"))', 443, 783, 248, 56, 127, 12, 779, 4);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (73, '00520', 'Amino sugar and nucleotide sugar metabolism', 'Metabolism; Carbohydrate metabolism', 'Amino sugar and nucleotide sugar metabolism', 'Nucleotide sugar biosynthesis, glucose => UDP-glucose [PATH:map00520], Nucleotide sugar biosynthesis, galactose => UDP-galactose [PATH:map00520], Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N [PATH:map00520]', 'Galactosemia, Sialuria, Methemoglobinemia, Distal myopathy, Nonaka distal myopathy (NM), Congenital myasthenic syndrome, Glycogen storage disease type XIV', 'ko00520', 'list(REFERENCE = \"PMID:2793832\", AUTHORS = \"Wyk P, Reeves P\", TITLE = \"Identification and sequence of the gene for abequose synthase, which confers antigenic specificity on group B salmonellae: homology with galactose epimerase.\", JOURNAL = c(\"J Bacteriol 171:5687-93 (1989)\", \"DOI:10.1128/JB.171.10.5687-5693.1989\")), list(REFERENCE = \"PMID:8071227\", AUTHORS = \"Thorson JS, Lo SF, Ploux O, He X, Liu HW\", TITLE = \"Studies of the biosynthesis of 3,6-dideoxyhexoses: molecular cloning and characterization of the asc (ascarylose) region from Yersinia pseudotuberculosis serogroup VA.\", JOURNAL = c(\"J Bacteriol 176:5483-93 (1994)\", \"DOI:10.1128/JB.176.17.5483-5493.1994\")), list(REFERENCE = \"PMID:8444803\", AUTHORS = \"Kessler AC, Haase A, Reeves PR\", TITLE = \"Molecular analysis of the 3,6-dideoxyhexose pathway genes of Yersinia pseudotuberculosis serogroup IIA.\", JOURNAL = c(\"J Bacteriol 175:1412-22 (1993)\", \"DOI:10.1128/JB.175.5.1412-1422.1993\")), list(REFERENCE = \"PMID:9811644\", AUTHORS = \"Danese PN, Oliver GR, Barr K, Bowman GD, Rick PD, Silhavy TJ\", TITLE = \"Accumulation of the enterobacterial common antigen lipid II biosynthetic intermediate stimulates degP transcription in Escherichia coli.\", JOURNAL = \"J Bacteriol 180:5875-84 (1998)\"), list(REFERENCE = \"PMID:10931327\", AUTHORS = \"Skurnik M, Peippo A, Ervela E\", TITLE = \"Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1b.\", JOURNAL = c(\"Mol Microbiol 37:316-30 (2000)\", \"DOI:10.1046/j.1365-2958.2000.01993.x\")), list(REFERENCE = \"PMID:10984043\", AUTHORS = \"Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV\", TITLE = \"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.\", JOURNAL = c(\"Nature 406:959-64 (2000)\", \n\"DOI:10.1038/35023079\")), list(REFERENCE = \"PMID:11447132\", AUTHORS = \"Ringenberg M, Lichtensteiger C, Vimr E\", TITLE = \"Redirection of sialic acid metabolism in genetically engineered Escherichia coli.\", JOURNAL = c(\"Glycobiology 11:533-9 (2001)\", \"DOI:10.1093/glycob/11.7.533\")), list(REFERENCE = \"PMID:12562791\", AUTHORS = \"McCoy AJ, Sandlin RC, Maurelli AT\", TITLE = \"In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance.\", JOURNAL = c(\"J Bacteriol 185:1218-28 (2003)\", \"DOI:10.1128/JB.185.4.1218-1228.2003\")), list(REFERENCE = \"PMID:14450717\", AUTHORS = \"JACOBSON B, DAVIDSON EA\", TITLE = \"Biosynthesis of uronic acids by skin enzymes. I. Uridine diphosphate-D-glucuronic acid-5-epimerase.\", JOURNAL = \"J Biol Chem 237:638-42 (1962)\"), list(REFERENCE = \"PMID:15134748\", AUTHORS = \"Seifert GJ\", TITLE = \"Nucleotide sugar interconversions and cell wall biosynthesis: how to bring the inside to the outside.\", JOURNAL = c(\"Curr Opin Plant Biol 7:277-84 (2004)\", \"DOI:10.1016/j.pbi.2004.03.004\")), list(REFERENCE = \"PMID:15489439\", AUTHORS = \"Uehara T, Park JT\", TITLE = \"The N-acetyl-D-glucosamine kinase of Escherichia coli and its role in murein recycling.\", JOURNAL = c(\"J Bacteriol 186:7273-9 (2004)\", \"DOI:10.1128/JB.186.21.7273-7279.2004\")), list(REFERENCE = \"PMID:15695810\", AUTHORS = \"Breazeale SD, Ribeiro AA, McClerren AL, Raetz CR.\", TITLE = \"A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-Amino-4-deoxy-L-arabinose. Identification and function oF UDP-4-deoxy-4-formamido-L-arabinose.\", JOURNAL = c(\"J Biol Chem 280:14154-67 (2005)\", \"DOI:10.1074/jbc.M414265200\")), list(REFERENCE = \"PMID:15809294\", AUTHORS = \"Williams GJ, Breazeale SD, Raetz CR, Naismith JH.\", TITLE = \"Structure and function of both domains of ArnA, a dual function decarboxylase and a formyltransferase, involved in 4-amino-4-deoxy-L-arabinose biosynthesis.\", JOURNAL = c(\"J Biol Chem 280:23000-8 (2005)\", \"DOI:10.1074/jbc.M501534200\")), list(REFERENCE = \"PMID:16237198\", AUTHORS = \"Maliekal P, Vertommen D, Delpierre G, Van Schaftingen E\", TITLE = \"Identification of the sequence encoding N-acetylneuraminate-9-phosphate phosphatase.\", JOURNAL = c(\"Glycobiology 16:165-72 (2006)\", \"DOI:10.1093/glycob/cwj050\")), list(REFERENCE = \"PMID:16277754\", AUTHORS = \"Campbell CT, Yarema KJ\", TITLE = \"Large-scale approaches for glycobiology.\", JOURNAL = c(\"Genome Biol 6:236 (2005)\", \"DOI:10.1186/gb-2005-6-11-236\")), list(REFERENCE = \"PMID:16452451\", AUTHORS = \"Uehara T, Suefuji K, Jaeger T, Mayer C, Park JT\", TITLE = \"MurQ Etherase is required by Escherichia coli in order to metabolize anhydro-N-acetylmuramic acid obtained either from the environment or from its own cell wall.\", JOURNAL = c(\"J Bacteriol 188:1660-2 (2006)\", \"DOI:10.1128/JB.188.4.1660-1662.2006\")), list(REFERENCE = \"PMID:16995900\", AUTHORS = \"Lanot A, Hodge D, Jackson RG, George GL, Elias L, Lim EK, Vaistij FE, Bowles DJ\", TITLE = \"The glucosyltransferase UGT72E2 is responsible for monolignol 4-O-glucoside production in Arabidopsis thaliana.\", JOURNAL = c(\"Plant J 48:286-95 (2006)\", \"DOI:10.1111/j.1365-313X.2006.02872.x\")), list(REFERENCE = \"PMID:17085508\", AUTHORS = \"Muller R, Morant M, Jarmer H, Nilsson L, Nielsen TH\", TITLE = \"Genome-wide analysis of the Arabidopsis leaf transcriptome reveals interaction of phosphate and sugar metabolism.\", JOURNAL = c(\"Plant Physiol 143:156-71 (2007)\", \"DOI:10.1104/pp.106.090167\")), list(REFERENCE = \"PMID:17190829\", AUTHORS = \"Oka T, Nemoto T, Jigami Y\", TITLE = \"Functional analysis of Arabidopsis thaliana RHM2/MUM4, a multidomain protein involved in UDP-D-glucose to UDP-L-rhamnose conversion.\", JOURNAL = c(\"J Biol Chem 282:5389-403 (2007)\", \"DOI:10.1074/jbc.M610196200\")), list(REFERENCE = \"PMID:17827295\", AUTHORS = \"Greenberg DE, Porcella SF, Zelazny AM, Virtaneva K, Sturdevant DE, Kupko JJ 3rd, Barbian KD, Babar A, Dorward DW, Holland SM.\", TITLE = \"Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis.\", JOURNAL = c(\"J Bacteriol 189:8727-36 (2007)\", \"DOI:10.1128/JB.00793-07\")), list(REFERENCE = \"PMID:18199744\", AUTHORS = \"Kotake T, Hojo S, Tajima N, Matsuoka K, Koyama T, Tsumuraya Y\", TITLE = \"A bifunctional enzyme with L-fucokinase and GDP-L-fucose pyrophosphorylase activities salvages free L-fucose in Arabidopsis.\", JOURNAL = c(\"J Biol Chem 283:8125-35 (2008)\", \"DOI:10.1074/jbc.M710078200\")), list(REFERENCE = \"PMID:18304669\", AUTHORS = \"Vorholter FJ, Schneiker S, Goesmann A, Krause L, Bekel T, Kaiser O, Linke B, Patschkowski T, Ruckert C, Schmid J, Sidhu VK, Sieber V, Tauch A, Watt SA, Weisshaar B, Becker A, Niehaus K, Puhler A.\", TITLE = \"The genome of Xanthomonas campestris pv. campestris B100 and its use for the reconstruction of metabolic pathways involved in xanthan biosynthesis.\", JOURNAL = c(\"J Biotechnol 134:33-45 (2008)\", \"DOI:10.1016/j.jbiotec.2007.12.013\")), list(REFERENCE = \"PMID:11479276\", AUTHORS = \"Albermann C, Piepersberg W\", TITLE = \"Expression and identification of the RfbE protein from Vibrio cholerae O1 and its use for the enzymatic synthesis of GDP-D-perosamine.\", JOURNAL = c(\"Glycobiology 11:655-61 (2001)\", \"DOI:10.1093/glycob/11.8.655\"))', 'map00520', 'Amino sugar and nucleotide sugar metabolism', 531, 5498, 248, 105, 128, 50, 5200, 298);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (74, '00521', 'Streptomycin biosynthesis', 'Streptomycin is an aminocyclitol-aminoglycoside antibiotic produced by Streptomyces griseus. Streptomycin consists of aminocyclitol (streptidine), 6-deoxyhexose (streptose), and N-methyl-L-glucosamine moieties, which are formed by independent biosynthetic pathways. All of the moieties are derived from D-glucose. The streptidine moiety is synthesized via myo-inositol, which is then oxidized at C-1 and transaminated to give scyllo-inosamine. After phosphorylation, the compound is transamidinated by arginine. The same procedure is repeated at the C-3 position. The streptose moiety is made from D-glucose via a dTDP-glucose pathway. The exact biosynthetic route for the N-methyl-L-glucosamine moiety is unknown, though the biosynthetic gene cluster have been proposed.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Streptomycin biosynthesis', 'dTDP-L-rhamnose biosynthesis [PATH:map00521]', 'D08531, Streptomycin (INN)', 'GO: 0019872', 'ko00521', 'list(REFERENCE = \"PMID:19362651\", AUTHORS = \"Wehmeier UF, Piepersberg W\", TITLE = \"Enzymology of aminoglycoside biosynthesis-deduction from gene clusters.\", JOURNAL = c(\"Methods Enzymol 459:459-91 (2009)\", \"DOI:10.1016/S0076-6879(09)04619-9\")), list(REFERENCE = \"PMID:17390001\", AUTHORS = \"Flatt PM, Mahmud T\", TITLE = \"Biosynthesis of aminocyclitol-aminoglycoside antibiotics and related compounds.\", JOURNAL = c(\"Nat Prod Rep 24:358-92 (2007)\", \"DOI:10.1039/b603816f\")), list(REFERENCE = \"PMID:1698764\", AUTHORS = \"Walker JB\", TITLE = \"Possible evolutionary relationships between streptomycin and bluensomycin biosynthetic pathways: detection of novel inositol kinase and O-carbamoyltransferase activities.\", JOURNAL = c(\"J Bacteriol 172:5844-51 (1990)\", \"DOI:10.1128/JB.172.10.5844-5851.1990\")), list(REFERENCE = \"PMID:2995326\", AUTHORS = \"Ohnuki T, Imanaka T, Aiba S\", TITLE = \"Self-cloning in Streptomyces griseus of an str gene cluster for streptomycin biosynthesis and streptomycin resistance.\", JOURNAL = \"J Bacteriol 164:85-94 (1985)\"), list(REFERENCE = \"PMID:9238101\", AUTHORS = \"Ahlert J, Distler J, Mansouri K, Piepersberg W\", TITLE = \"Identification of stsC, the gene encoding the L-glutamine:scyllo-inosose aminotransferase from streptomycin-producing Streptomycetes.\", JOURNAL = c(\"Arch Microbiol 168:102-13 (1997)\", \"DOI:10.1007/s002030050475\")), list(REFERENCE = \"PMID:1377151\", AUTHORS = \"Distler J, Mansouri K, Mayer G, Stockmann M, Piepersberg W\", TITLE = \"Streptomycin biosynthesis and its regulation in Streptomycetes.\", JOURNAL = c(\"Gene 115:105-11 (1992)\", \"DOI:10.1016/0378-1119(92)90547-3\")), list(REFERENCE = \"PMID:1654502\", AUTHORS = \"Mansouri K, Piepersberg W.\", TITLE = \"Genetics of streptomycin production in Streptomyces griseus: nucleotide sequence of five genes, strFGHIK, including a phosphatase gene.\", JOURNAL = c(\"Mol Gen Genet 228:459-69 (1991)\", \"DOI:10.1007/BF00260640\")), list(REFERENCE = \"PMID:9922132\", AUTHORS = \"Fritsche E, Bergner A, Humm A, Piepersberg W, Huber R\", TITLE = \"Crystal structure of L-arginine:inosamine-phosphate amidinotransferase StrB1 from Streptomyces griseus: an enzyme involved in streptomycin biosynthesis.\", JOURNAL = c(\"Biochemistry 37:17664-72 (1998)\", \"DOI:10.1021/bi981949p\"))', 0, 5106, 0, 0, 0, 0, 4814, 292);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (75, '00522', 'Biosynthesis of 12-, 14- and 16-membered macrolides', 'Metabolism; Metabolism of terpenoids and polyketides', 'Biosynthesis of 12-, 14- and 16-membered macrolides', 'Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin [PATH:map00522], Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B [PATH:map00522], Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin [PATH:map00522], Pikromycin/methymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin [PATH:map00522], Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b [PATH:map00522]', 'D00140, Erythromycin (JP17/USP/INN), D02490, Tylosin (USP/INN), D03098, Berythromycin (USAN/INN)', 'ko00522', 'list(REFERENCE = \"PMID:19514004\", AUTHORS = \"Hertweck C\", TITLE = \"The biosynthetic logic of polyketide diversity.\", JOURNAL = c(\"Angew Chem Int Ed Engl 48:4688-716 (2009)\", \"DOI:10.1002/anie.200806121\")), list(REFERENCE = \"PMID:11918808\", AUTHORS = \"Long PF, Wilkinson CJ, Bisang CP, Cortes J, Dunster N, Oliynyk M, McCormick E, McArthur H, Mendez C, Salas JA, Staunton J, Leadlay PF\", TITLE = \"Engineering specificity of starter unit selection by the erythromycin-producing polyketide synthase.\", JOURNAL = c(\"Mol Microbiol 43:1215-25 (2002)\", \"DOI:10.1046/j.1365-2958.2002.02815.x\")), list(REFERENCE = \"PMID:10519556\", AUTHORS = \"Bisang C, Long PF, Cortes J, Westcott J, Crosby J, Matharu AL, Cox RJ, Simpson TJ, Staunton J, Leadlay PF\", TITLE = \"A chain initiation factor common to both modular and aromatic polyketide synthases.\", JOURNAL = c(\"Nature 401:502-5 (1999)\", \"DOI:10.1038/46829\")), list(REFERENCE = \"PMID:19362638\", AUTHORS = \"Katz L\", TITLE = \"The DEBS paradigm for type I modular polyketide synthases and beyond.\", JOURNAL = c(\"Methods Enzymol 459:113-42 (2009)\", \"DOI:10.1016/S0076-6879(09)04606-0\")), list(REFERENCE = \"PMID:17719493\", AUTHORS = \"Kittendorf JD, Beck BJ, Buchholz TJ, Seufert W, Sherman DH\", TITLE = \"Interrogating the molecular basis for multiple macrolactone ring formation by the pikromycin polyketide synthase.\", JOURNAL = c(\"Chem Biol 14:944-54 (2007)\", \"DOI:10.1016/j.chembiol.2007.07.013\")), list(REFERENCE = \"PMID:12031664\", AUTHORS = \"Beck BJ, Yoon YJ, Reynolds KA, Sherman DH\", TITLE = \"The hidden steps of domain skipping: macrolactone ring size determination in the pikromycin modular polyketide synthase.\", JOURNAL = c(\"Chem Biol 9:575-83 (2002)\", \"DOI:10.1016/S1074-5521(02)00146-1\")), list(REFERENCE = \"PMID:11223265\", AUTHORS = \"Chen S, Roberts JB, Xue Y, Sherman DH, Reynolds KA\", TITLE = \"The Streptomyces venezuelae pikAV gene contains a transcription unit essential for expression of enzymes involved in glycosylation of narbonolide and 10-deoxymethynolide.\", JOURNAL = c(\"Gene 263:255-64 (2001)\", \"DOI:10.1016/S0378-1119(00)00560-6\")), list(REFERENCE = \"PMID:12368286\", AUTHORS = \"Kim BS, Cropp TA, Beck BJ, Sherman DH, Reynolds KA\", TITLE = \"Biochemical evidence for an editing role of thioesterase II in the biosynthesis of the polyketide pikromycin.\", JOURNAL = c(\"J Biol Chem 277:48028-34 (2002)\", \"DOI:10.1074/jbc.M207770200\")), list(REFERENCE = \"PMID:11851473\", AUTHORS = \"Ikeda H, Omura S\", TITLE = \"Avermectin Biosynthesis.\", JOURNAL = c(\"Chem Rev 97:2591-2610 (1997)\", \"DOI:10.1021/cr960023p\")), list(REFERENCE = \"PMID:11780788\", AUTHORS = \"Ikeda H, Nonomiya T, Omura S\", TITLE = \"Organization of biosynthetic gene cluster for avermectin in Streptomyces avermitilis: analysis of enzymatic domains in four polyketide synthases.\", JOURNAL = c(\"J Ind Microbiol Biotechnol 27:170-6 (2001)\", \"DOI:10.1038/sj.jim.7000092\")), list(REFERENCE = \"PMID:10972798\", AUTHORS = \"Volchegursky Y, Hu Z, Katz L, McDaniel R\", TITLE = \"Biosynthesis of the anti-parasitic agent megalomicin: transformation of erythromycin to megalomicin in Saccharopolyspora erythraea.\", JOURNAL = c(\"Mol Microbiol 37:752-62 (2000)\", \"DOI:10.1046/j.1365-2958.2000.02059.x\")), list(REFERENCE = \"PMID:15870344\", AUTHORS = \"Peiru S, Menzella HG, Rodriguez E, Carney J, Gramajo H\", TITLE = \"Production of the potent antibacterial polyketide erythromycin C in Escherichia coli.\", JOURNAL = c(\"Appl Environ Microbiol 71:2539-47 (2005)\", \"DOI:10.1128/AEM.71.5.2539-2547.2005\")), list(REFERENCE = \"PMID:20418422\", AUTHORS = \"Useglio M, Peiru S, Rodriguez E, Labadie GR, Carney JR, Gramajo H\", TITLE = \"TDP-L-megosamine biosynthesis pathway elucidation and megalomicin a production in Escherichia coli.\", JOURNAL = c(\"Appl Environ Microbiol 76:3869-77 (2010)\", \"DOI:10.1128/AEM.03083-09\")), list(REFERENCE = \"PMID:11752428\", AUTHORS = \"Tsai SC, Miercke LJ, Krucinski J, Gokhale R, Chen JC, Foster PG, Cane DE, Khosla C, Stroud RM\", TITLE = \"Crystal structure of the macrocycle-forming thioesterase domain of the erythromycin polyketide synthase: versatility from a unique substrate channel.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 98:14808-13 (2001)\", \"DOI:10.1073/pnas.011399198\")), list(REFERENCE = \"PMID:19625248\", AUTHORS = \"Savino C, Montemiglio LC, Sciara G, Miele AE, Kendrew SG, Jemth P, Gianni S, Vallone B\", TITLE = \"Investigating the structural plasticity of a cytochrome P450: three-dimensional structures of P450 EryK and binding to its physiological substrate.\", JOURNAL = c(\"J Biol Chem 284:29170-9 (2009)\", \"DOI:10.1074/jbc.M109.003590\")), list(REFERENCE = \"PMID:8300527\", AUTHORS = \"Hsieh YJ, Kolattukudy PE.\", TITLE = \"Inhibition of erythromycin synthesis by disruption of malonyl-coenzyme A decarboxylase gene eryM in Saccharopolyspora erythraea.\", JOURNAL = c(\"J Bacteriol 176:714-24 (1994)\", \"DOI:10.1128/JB.176.3.714-724.1994\")), list(REFERENCE = \"PMID:8830278\", AUTHORS = \"Donadio S, Staver MJ, Katz L.\", TITLE = \"Erythromycin production in Saccharopolyspora erythraea does not require a functional propionyl-CoA carboxylase.\", JOURNAL = c(\"Mol Microbiol 19:977-84 (1996)\", \"DOI:10.1046/j.1365-2958.1996.439969.x\")), list(REFERENCE = \"PMID:9353926\", AUTHORS = \"Summers RG, Donadio S, Staver MJ, Wendt-Pienkowski E, Hutchinson CR, Katz L.\", TITLE = \"Sequencing and mutagenesis of genes from the erythromycin biosynthetic gene cluster of Saccharopolyspora erythraea that are involved in L-mycarose and D-desosamine production.\", JOURNAL = c(\"Microbiology 143:3251-62 (1997)\", \"DOI:10.1099/00221287-143-10-3251\")), list(REFERENCE = \"PMID:11476481\", AUTHORS = \"Rawlings BJ.\", TITLE = \"Type I polyketide biosynthesis in bacteria (part B).\", JOURNAL = c(\"Nat Prod Rep 18:231-81 (2001)\", \"DOI:10.1039/B100191O\")), list(REFERENCE = \"PMID:11336289\", AUTHORS = \"Rawlings BJ.\", TITLE = \"Type I polyketide biosynthesis in bacteria (Part A--erythromycin biosynthesis).\", JOURNAL = c(\"Nat Prod Rep 18:190-227 (2001)\", \"DOI:10.1039/b009329g\")), list(REFERENCE = \"PMID:20695498\", AUTHORS = \"Borisova SA, Liu HW\", TITLE = \"Characterization of glycosyltransferase DesVII and its auxiliary partner protein DesVIII in the methymycin/picromycin biosynthetic pathway.\", JOURNAL = c(\"Biochemistry 49:8071-84 (2010)\", \"DOI:10.1021/bi1007657\")), list(REFERENCE = \"PMID:17049185\", AUTHORS = \"Hong JS, Park SJ, Parajuli N, Park SR, Koh HS, Jung WS, Choi CY, Yoon YJ\", TITLE = \"Functional analysis of desVIII homologues involved in glycosylation of macrolide antibiotics by interspecies complementation.\", JOURNAL = c(\"Gene 386:123-30 (2007)\", \"DOI:10.1016/j.gene.2006.08.021\")), list(REFERENCE = \"PMID:16514147\", AUTHORS = \"Rodriguez E, Peiru S, Carney JR, Gramajo H\", TITLE = \"In vivo characterization of the dTDP-D-desosamine pathway of the megalomicin gene cluster from Micromonospora megalomicea.\", JOURNAL = c(\"Microbiology 152:667-73 (2006)\", \"DOI:10.1099/mic.0.28680-0\")), list(REFERENCE = \"PMID:22056329\", AUTHORS = \"Moncrieffe MC, Fernandez MJ, Spiteller D, Matsumura H, Gay NJ, Luisi BF, Leadlay PF\", TITLE = \"Structure of the glycosyltransferase EryCIII in complex with its activating P450 homologue EryCII.\", JOURNAL = c(\"J Mol Biol 415:92-101 (2012)\", \"DOI:10.1016/j.jmb.2011.10.036\")), list(REFERENCE = \"PMID:16218575\", AUTHORS = \"Yuan Y, Chung HS, Leimkuhler C, Walsh CT, Kahne D, Walker S\", TITLE = \"In vitro reconstitution of EryCIII activity for the preparation of unnatural macrolides.\", JOURNAL = c(\"J Am Chem Soc 127:14128-9 (2005)\", \"DOI:10.1021/ja053704n\")), list(REFERENCE = \"PMID:16825192\", AUTHORS = \"Sherman DH, Li S, Yermalitskaya LV, Kim Y, Smith JA, Waterman MR, Podust LM\", TITLE = \"The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae.\", JOURNAL = c(\"J Biol Chem 281:26289-97 (2006)\", \"DOI:10.1074/jbc.M605478200\")), list(REFERENCE = \"PMID:19124459\", AUTHORS = \"Li S, Ouellet H, Sherman DH, Podust LM\", TITLE = \"Analysis of transient and catalytic desosamine-binding pockets in cytochrome P-450 PikC from Streptomyces venezuelae.\", JOURNAL = c(\"J Biol Chem 284:5723-30 (2009)\", \"DOI:10.1074/jbc.M807592200\"))', 'map00522', 'Biosynthesis of 12-, 14- and 16-membered macrolides', 0, 4, 0, 0, 0, 0, 4, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (76, '00523', 'Polyketide sugar unit biosynthesis', 'Metabolism; Metabolism of terpenoids and polyketides', 'Polyketide sugar unit biosynthesis', 'dTDP-L-rhamnose biosynthesis [PATH:map00523], dTDP-6-deoxy-D-allose biosynthesis [PATH:map00523], dTDP-beta-L-noviose biosynthesis [PATH:map00523], dTDP-D-mycaminose biosynthesis [PATH:map00523], dTDP-D-desosamine biosynthesis [PATH:map00523], dTDP-L-mycarose biosynthesis [PATH:map00523], dTDP-L-oleandrose biosynthesis [PATH:map00523], dTDP-L-megosamine biosynthesis [PATH:map00523], dTDP-L-olivose biosynthesis [PATH:map00523], dTDP-D-forosamine biosynthesis [PATH:map00523], dTDP-D-angolosamine biosynthesis [PATH:map00523]', 'ko00523', 'list(REFERENCE = \"PMID:11336289\", AUTHORS = \"Rawlings BJ.\", TITLE = \"Type I polyketide biosynthesis in bacteria (Part A--erythromycin biosynthesis).\", JOURNAL = c(\"Nat Prod Rep 18:190-227 (2001)\", \"DOI:10.1039/b009329g\")), list(REFERENCE = \"PMID:11476481\", AUTHORS = \"Rawlings BJ.\", TITLE = \"Type I polyketide biosynthesis in bacteria (part B).\", JOURNAL = c(\"Nat Prod Rep 18:231-81 (2001)\", \"DOI:10.1039/B100191O\")), list(REFERENCE = \"PMID:11451669\", AUTHORS = \"Wohlert S, Lomovskaya N, Kulowski K, Fonstein L, Occi JL, Gewain KM, MacNeil DJ, Hutchinson CR\", TITLE = \"Insights about the biosynthesis of the avermectin deoxysugar L-oleandrose through heterologous expression of Streptomyces avermitilis deoxysugar genes in Streptomyces lividans.\", JOURNAL = c(\"Chem Biol 8:681-700 (2001)\", \"DOI:10.1016/S1074-5521(01)00043-6\")), list(REFERENCE = \"PMID:10658660\", AUTHORS = \"Bate N, Butler AR, Smith IP, Cundliffe E\", TITLE = \"The mycarose-biosynthetic genes of Streptomyces fradiae, producer of tylosin.\", JOURNAL = c(\"Microbiology 146 ( Pt 1):139-46 (2000)\", \"DOI:10.1099/00221287-146-1-139\")), list(REFERENCE = \"PMID:11553351\", AUTHORS = \"Amann S, Drager G, Rupprath C, Kirschning A, Elling L\", TITLE = \"(Chemo)enzymatic synthesis of dTDP-activated 2,6-dideoxysugars as building blocks of polyketide antibiotics.\", JOURNAL = c(\"Carbohydr Res 335:23-32 (2001)\", \"DOI:10.1016/S0008-6215(01)00195-1\")), list(REFERENCE = \"PMID:17460661\", AUTHORS = \"Thibodeaux CJ, Melancon CE, Liu HW\", TITLE = \"Unusual sugar biosynthesis and natural product glycodiversification.\", JOURNAL = c(\"Nature 446:1008-16 (2007)\", \"DOI:10.1038/nature05814\")), list(REFERENCE = \"PMID:10972798\", AUTHORS = \"Volchegursky Y, Hu Z, Katz L, McDaniel R\", TITLE = \"Biosynthesis of the anti-parasitic agent megalomicin: transformation of erythromycin to megalomicin in Saccharopolyspora erythraea.\", JOURNAL = c(\"Mol Microbiol 37:752-62 (2000)\", \"DOI:10.1046/j.1365-2958.2000.02059.x\")), list(REFERENCE = \"\", AUTHORS = \"Mironov VA, Sergienko OV, Nastasiak IN, Danilenko VN.\", TITLE = \"Biogenesis and regulation of biosynthesis of erythromycins in Saccharopolyspora.\", JOURNAL = c(\"Applied Biochemistry and Microbiology 40(6): 531-541 (2004)\", \"DOI:10.1023/B:ABIM.0000046985.66328.7a\")), list(REFERENCE = \"PMID:16514445\", AUTHORS = \"Tello M, Jakimowicz P, Errey JC, Freel Meyers CL, Walsh CT, Buttner MJ, Lawson DM, Field RA\", TITLE = \"Characterisation of Streptomyces spheroides NovW and revision of its functional assignment to a dTDP-6-deoxy-D-xylo-4-hexulose 3-epimerase.\", JOURNAL = c(\"Chem Commun (Camb) 1079-81 (2006)\", \"DOI:10.1039/b515763c\")), list(REFERENCE = \"PMID:15984840\", AUTHORS = \"Takahashi H, Liu YN, Chen H, Liu HW\", TITLE = \"Biosynthesis of TDP-l-mycarose: the specificity of a single enzyme governs the outcome of the pathway.\", JOURNAL = c(\"J Am Chem Soc 127:9340-1 (2005)\", \"DOI:10.1021/ja051409x\")), list(REFERENCE = \"PMID:10770761\", AUTHORS = \"Aguirrezabalaga I, Olano C, Allende N, Rodriguez L, Brana AF, Mendez C, Salas JA\", TITLE = \"Identification and expression of genes involved in biosynthesis of L-oleandrose and its intermediate L-olivose in the oleandomycin producer Streptomyces antibioticus.\", JOURNAL = c(\"Antimicrob Agents Chemother 44:1266-75 (2000)\", \"DOI:10.1128/AAC.44.5.1266-1275.2000\")), list(REFERENCE = \"PMID:11514520\", AUTHORS = \"Rodriguez L, Rodriguez D, Olano C, Brana AF, Mendez C, Salas JA\", TITLE = \"Functional analysis of OleY L-oleandrosyl 3-O-methyltransferase of the oleandomycin biosynthetic pathway in Streptomyces antibioticus.\", JOURNAL = c(\"J Bacteriol 183:5358-63 (2001)\", \"DOI:10.1128/JB.183.18.5358-5363.2001\")), list(REFERENCE = \"PMID:20418422\", AUTHORS = \"Useglio M, Peiru S, Rodriguez E, Labadie GR, Carney JR, Gramajo H\", TITLE = \"TDP-L-megosamine biosynthesis pathway elucidation and megalomicin a production in Escherichia coli.\", JOURNAL = c(\"Appl Environ Microbiol 76:3869-77 (2010)\", \"DOI:10.1128/AEM.03083-09\")), list(REFERENCE = \"PMID:12183628\", AUTHORS = \"Liu W, Christenson SD, Standage S, Shen B\", TITLE = \"Biosynthesis of the enediyne antitumor antibiotic C-1027.\", JOURNAL = c(\"Science 297:1170-3 (2002)\", \"DOI:10.1126/science.1072110\")), list(REFERENCE = \"PMID:17918933\", AUTHORS = \"Van Lanen SG, Oh TJ, Liu W, Wendt-Pienkowski E, Shen B\", TITLE = \"Characterization of the maduropeptin biosynthetic gene cluster from Actinomadura madurae ATCC 39144 supporting a unifying paradigm for enediyne biosynthesis.\", JOURNAL = c(\"J Am Chem Soc 129:13082-94 (2007)\", \"DOI:10.1021/ja073275o\")), list(REFERENCE = \"PMID:16873021\", AUTHORS = \"Gao Q, Zhang C, Blanchard S, Thorson JS\", TITLE = \"Deciphering indolocarbazole and enediyne aminodideoxypentose biosynthesis through comparative genomics: insights from the AT2433 biosynthetic locus.\", JOURNAL = c(\"Chem Biol 13:733-43 (2006)\", \"DOI:10.1016/j.chembiol.2006.05.009\")), list(REFERENCE = \"PMID:18807197\", AUTHORS = \"Simkhada D, Oh TJ, Kim EM, Yoo JC, Sohng JK\", TITLE = \"Cloning and characterization of CalS7 from Micromonospora echinospora sp. calichensis as a glucose-1-phosphate nucleotidyltransferase.\", JOURNAL = c(\"Biotechnol Lett 31:147-53 (2009)\", \"DOI:10.1007/s10529-008-9844-9\")), list(REFERENCE = \"PMID:24911465\", AUTHORS = \"Singh S, Peltier-Pain P, Tonelli M, Thorson JS\", TITLE = \"A general NMR-based strategy for the in situ characterization of sugar-nucleotide-dependent biosynthetic pathways.\", JOURNAL = c(\"Org Lett 16:3220-3 (2014)\", \"DOI:10.1021/ol501241a\")), list(REFERENCE = \"PMID:23662776\", AUTHORS = \"Singh S, Chang A, Helmich KE, Bingman CA, Wrobel RL, Beebe ET, Makino S, Aceti DJ, Dyer K, Hura GL, Sunkara M, Morris AJ, Phillips GN Jr, Thorson JS\", TITLE = \"Structural and functional characterization of CalS11, a TDP-rhamnose 3\'-O-methyltransferase involved in calicheamicin biosynthesis.\", JOURNAL = c(\"ACS Chem Biol 8:1632-9 (2013)\", \"DOI:10.1021/cb400068k\")), list(REFERENCE = \"PMID:20336235\", AUTHORS = \"Liang ZX\", TITLE = \"Complexity and simplicity in the biosynthesis of enediyne natural products.\", JOURNAL = c(\"Nat Prod Rep 27:499-528 (2010)\", \"DOI:10.1039/b908165h\")), list(REFERENCE = \"PMID:26240141\", AUTHORS = \"Singh S, Michalska K, Bigelow L, Endres M, Kharel MK, Babnigg G, Yennamalli RM, Bingman CA, Joachimiak A, Thorson JS, Phillips GN Jr\", TITLE = \"Structural Characterization of CalS8, a TDP-alpha-D-Glucose Dehydrogenase Involved in Calicheamicin Aminodideoxypentose Biosynthesis.\", JOURNAL = c(\"J Biol Chem 290:26249-58 (2015)\", \"DOI:10.1074/jbc.M115.673459\")), list(REFERENCE = \"PMID:26289554\", AUTHORS = \"Peltier-Pain P, Singh S, Thorson JS\", TITLE = \"Characterization of Early Enzymes Involved in TDP-Aminodideoxypentose Biosynthesis en Route to Indolocarbazole AT2433.\", JOURNAL = c(\"Chembiochem 16:2141-6 (2015)\", \"DOI:10.1002/cbic.201500365\")), list(REFERENCE = \"PMID:26061967\", AUTHORS = \"Singh S, Kim Y, Wang F, Bigelow L, Endres M, Kharel MK, Babnigg G, Bingman CA, Joachimiak A, Thorson JS, Phillips GN Jr\", TITLE = \"Structural characterization of AtmS13, a putative sugar aminotransferase involved in indolocarbazole AT2433 aminopentose biosynthesis.\", JOURNAL = c(\"Proteins 83:1547-54 (2015)\", \"DOI:10.1002/prot.24844\"))', 'map00523', 'Polyketide sugar unit biosynthesis', 'Metabolism; Metabolism of terpenoids and polyketides', 4, 3942, 4, 0, 0, 0, 3755, 187);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (77, '00524', 'Neomycin, kanamycin and gentamicin biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Neomycin, kanamycin and gentamicin biosynthesis', 'D00063, Tobramycin (JP17/USP), D02322, Apramycin (USAN/INN), D05140, Framycetin (INN), D07467, Paromomycin (INN), D07497, Bekanamycin (INN), D08219, Micronomicin (DCF), D08478, Ribostamycin (INN)', 'ko00524', 'list(REFERENCE = \"PMID:19362652\", AUTHORS = \"Kudo F, Eguchi T\", TITLE = \"Biosynthetic enzymes for the aminoglycosides butirosin and neomycin.\", JOURNAL = c(\"Methods Enzymol 459:493-519 (2009)\", \"DOI:10.1016/S0076-6879(09)04620-5\")), list(REFERENCE = \"PMID:19644520\", AUTHORS = \"Kudo F, Eguchi T\", TITLE = \"Biosynthetic genes for aminoglycoside antibiotics.\", JOURNAL = c(\"J Antibiot (Tokyo) 62:471-81 (2009)\", \"DOI:10.1038/ja.2009.76\")), list(REFERENCE = \"PMID:17879343\", AUTHORS = \"Nango E, Kumasaka T, Hirayama T, Tanaka N, Eguchi T\", TITLE = \"Structure of 2-deoxy-scyllo-inosose synthase, a key enzyme in the biosynthesis of 2-deoxystreptamine-containing aminoglycoside antibiotics, in complex with a mechanism-based inhibitor and NAD+.\", JOURNAL = c(\"Proteins 70:517-27 (2008)\", \"DOI:10.1002/prot.21526\")), list(REFERENCE = \"PMID:15839685\", AUTHORS = \"Yokoyama K, Kudo F, Kuwahara M, Inomata K, Tamegai H, Eguchi T, Kakinuma K\", TITLE = \"Stereochemical recognition of doubly functional aminotransferase in 2-deoxystreptamine biosynthesis.\", JOURNAL = c(\"J Am Chem Soc 127:5869-74 (2005)\", \"DOI:10.1021/ja0445948\")), list(REFERENCE = \"PMID:12374384\", AUTHORS = \"Tamegai H, Nango E, Kuwahara M, Yamamoto H, Ota Y, Kuriki H, Eguchi T, Kakinuma K\", TITLE = \"Identification of L-glutamine: 2-deoxy-scyllo-inosose aminotransferase required for the biosynthesis of butirosin in Bacillus circulans.\", JOURNAL = c(\"J Antibiot (Tokyo) 55:707-14 (2002)\", \"DOI:10.7164/antibiotics.55.707\")), list(REFERENCE = \"PMID:16506694\", AUTHORS = \"Kudo F, Yamamoto Y, Yokoyama K, Eguchi T, Kakinuma K\", TITLE = \"Biosynthesis of 2-deoxystreptamine by three crucial enzymes in Streptomyces fradiae NBRC 12773.\", JOURNAL = c(\"J Antibiot (Tokyo) 58:766-74 (2005)\", \"DOI:10.1038/ja.2005.104\")), list(REFERENCE = \"PMID:18672902\", AUTHORS = \"Yokoyama K, Ohmori D, Kudo F, Eguchi T\", TITLE = \"Mechanistic study on the reaction of a radical SAM dehydrogenase BtrN by electron paramagnetic resonance spectroscopy.\", JOURNAL = c(\"Biochemistry 47:8950-60 (2008)\", \"DOI:10.1021/bi800509x\")), list(REFERENCE = \"PMID:18001019\", AUTHORS = \"Yokoyama K, Numakura M, Kudo F, Ohmori D, Eguchi T\", TITLE = \"Characterization and mechanistic study of a radical SAM dehydrogenase in the biosynthesis of butirosin.\", JOURNAL = c(\"J Am Chem Soc 129:15147-55 (2007)\", \"DOI:10.1021/ja072481t\")), list(REFERENCE = \"PMID:18311744\", AUTHORS = \"Yokoyama K, Yamamoto Y, Kudo F, Eguchi T\", TITLE = \"Involvement of two distinct N-acetylglucosaminyltransferases and a dual-function deacetylase in neomycin biosynthesis.\", JOURNAL = c(\"Chembiochem 9:865-9 (2008)\", \"DOI:10.1002/cbic.200700717\")), list(REFERENCE = \"PMID:18802637\", AUTHORS = \"Fan Q, Huang F, Leadlay PF, Spencer JB\", TITLE = \"The neomycin biosynthetic gene cluster of Streptomyces fradiae NCIMB 8233: genetic and biochemical evidence for the roles of two glycosyltransferases and a deacetylase.\", JOURNAL = c(\"Org Biomol Chem 6:3306-14 (2008)\", \"DOI:10.1039/b808734b\")), list(REFERENCE = \"PMID:17226887\", AUTHORS = \"Truman AW, Huang F, Llewellyn NM, Spencer JB\", TITLE = \"Characterization of the enzyme BtrD from Bacillus circulans and revision of its functional assignment in the biosynthesis of butirosin.\", JOURNAL = c(\"Angew Chem Int Ed Engl 46:1462-4 (2007)\", \"DOI:10.1002/anie.200604194\")), list(REFERENCE = \"PMID:17482823\", AUTHORS = \"Kudo F, Fujii T, Kinoshita S, Eguchi T\", TITLE = \"Unique O-ribosylation in the biosynthesis of butirosin.\", JOURNAL = c(\"Bioorg Med Chem 15:4360-8 (2007)\", \"DOI:10.1016/j.bmc.2007.04.040\")), list(REFERENCE = \"PMID:12870817\", AUTHORS = \"Yukita T, Nishida H, Eguchi T, Kakinuma K\", TITLE = \"Biosynthesis of (2R)-4-amino-2-hydroxybutyric acid, unique and biologically significant substituent in butirosins.\", JOURNAL = c(\"J Antibiot (Tokyo) 56:497-500 (2003)\", \"DOI:10.7164/antibiotics.56.497\")), list(REFERENCE = \"PMID:15975512\", AUTHORS = \"Li Y, Llewellyn NM, Giri R, Huang F, Spencer JB\", TITLE = \"Biosynthesis of the unique amino acid side chain of butirosin: possible protective-group chemistry in an acyl carrier protein-mediated pathway.\", JOURNAL = c(\"Chem Biol 12:665-75 (2005)\", \"DOI:10.1016/j.chembiol.2005.04.010\")), list(REFERENCE = \"PMID:17462573\", AUTHORS = \"Llewellyn NM, Li Y, Spencer JB\", TITLE = \"Biosynthesis of butirosin: transfer and deprotection of the unique amino acid side chain.\", JOURNAL = c(\"Chem Biol 14:379-86 (2007)\", \"DOI:10.1016/j.chembiol.2007.02.005\")), list(REFERENCE = \"PMID:18685777\", AUTHORS = \"Llewellyn NM, Spencer JB\", TITLE = \"Chemoenzymatic acylation of aminoglycoside antibiotics.\", JOURNAL = c(\"Chem Commun (Camb) 3786-8 (2008)\", \"DOI:10.1039/b802248h\")), list(REFERENCE = \"PMID:19466609\", AUTHORS = \"Nepal KK, Oh TJ, Sohng JK\", TITLE = \"Heterologous production of paromamine in Streptomyces lividans TK24 using kanamycin biosynthetic genes from Streptomyces kanamyceticus ATCC12853.\", JOURNAL = c(\"Mol Cells 27:601-8 (2009)\", \"DOI:10.1007/s10059-009-0080-5\")), list(REFERENCE = \"PMID:21983602\", AUTHORS = \"Park JW, Park SR, Nepal KK, Han AR, Ban YH, Yoo YJ, Kim EJ, Kim EM, Kim D, Sohng JK, Yoon YJ\", TITLE = \"Discovery of parallel pathways of kanamycin biosynthesis allows antibiotic manipulation.\", JOURNAL = c(\"Nat Chem Biol 7:843-52 (2011)\", \"DOI:10.1038/nchembio.671\")), list(REFERENCE = \"\", AUTHORS = \"Arya DP (ed).\", TITLE = \"Aminoglycoside antibiotics: From chemical biology to drug discovery\", JOURNAL = \"Wiley-Interscience (2007)\"), list(REFERENCE = \"PMID:23179168\", AUTHORS = \"Park SR, Park JW, Ban YH, Sohng JK, Yoon YJ\", TITLE = \"2-Deoxystreptamine-containing aminoglycoside antibiotics: recent advances in the characterization and manipulation of their biosynthetic pathways.\", JOURNAL = c(\"Nat Prod Rep 30:11-20 (2013)\", \"DOI:10.1039/c2np20092a\")), list(REFERENCE = \"PMID:17119636\", AUTHORS = \"Llewellyn NM, Spencer JB\", TITLE = \"Biosynthesis of 2-deoxystreptamine-containing aminoglycoside antibiotics.\", JOURNAL = c(\"Nat Prod Rep 23:864-74 (2006)\", \"DOI:10.1039/b604709m\")), list(REFERENCE = \"PMID:26455715\", AUTHORS = \"Kudo F, Eguchi T\", TITLE = \"Aminoglycoside Antibiotics: New Insights into the Biosynthetic Machinery of Old Drugs.\", JOURNAL = c(\"Chem Rec 16:4-18 (2016)\", \"DOI:10.1002/tcr.201500210\")), list(REFERENCE = \"PMID:25600434\", AUTHORS = \"Takeishi R, Kudo F, Numakura M, Eguchi T\", TITLE = \"Epimerization at C-3\'\' in butirosin biosynthesis by an NAD(+) -dependent dehydrogenase BtrE and an NADPH-dependent reductase BtrF.\", JOURNAL = c(\"Chembiochem 16:487-95 (2015)\", \"DOI:10.1002/cbic.201402612\")), list(REFERENCE = \"PMID:27120352\", AUTHORS = \"Lv M, Ji X, Zhao J, Li Y, Zhang C, Su L, Ding W, Deng Z, Yu Y, Zhang Q\", TITLE = \"Characterization of a C3 Deoxygenation Pathway Reveals a Key Branch Point in Aminoglycoside Biosynthesis.\", JOURNAL = c(\"J Am Chem Soc 138:6427-35 (2016)\", \"DOI:10.1021/jacs.6b02221\")), list(REFERENCE = \"PMID:21689223\", AUTHORS = \"Clausnitzer D, Piepersberg W, Wehmeier UF\", TITLE = \"The oxidoreductases LivQ and NeoQ are responsible for the different 6\'-modifications in the aminoglycosides lividomycin and neomycin.\", JOURNAL = c(\"J Appl Microbiol 111:642-51 (2011)\", \"DOI:10.1111/j.1365-2672.2011.05082.x\")), list(REFERENCE = \"PMID:18550838\", AUTHORS = \"Park JW, Hong JS, Parajuli N, Jung WS, Park SR, Lim SK, Sohng JK, Yoon YJ\", TITLE = \"Genetic dissection of the biosynthetic route to gentamicin A2 by heterologous expression of its minimal gene set.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:8399-404 (2008)\", \"DOI:10.1073/pnas.0803164105\")), list(REFERENCE = \"PMID:25641167\", AUTHORS = \"Huang C, Huang F, Moison E, Guo J, Jian X, Duan X, Deng Z, Leadlay PF, Sun Y\", TITLE = \"Delineating the biosynthesis of gentamicin x2, the common precursor of the gentamicin C antibiotic complex.\", JOURNAL = c(\"Chem Biol 22:251-61 (2015)\", \"DOI:10.1016/j.chembiol.2014.12.012\")), list(REFERENCE = \"PMID:24746560\", AUTHORS = \"Guo J, Huang F, Huang C, Duan X, Jian X, Leeper F, Deng Z, Leadlay PF, Sun Y\", TITLE = \"Specificity and promiscuity at the branch point in gentamicin biosynthesis.\", JOURNAL = c(\"Chem Biol 21:608-18 (2014)\", \"DOI:10.1016/j.chembiol.2014.03.005\")), list(REFERENCE = \"PMID:26083124\", AUTHORS = \"Gu Y, Ni X, Ren J, Gao H, Wang D, Xia H\", TITLE = \"Biosynthesis of Epimers C2 and C2a in the Gentamicin C Complex.\", JOURNAL = c(\"Chembiochem 16:1933-42 (2015)\", \"DOI:10.1002/cbic.201500258\")), list(REFERENCE = \"PMID:23679096\", AUTHORS = \"Kim HJ, McCarty RM, Ogasawara Y, Liu YN, Mansoorabadi SO, LeVieux J, Liu HW\", TITLE = \"GenK-catalyzed C-6\' methylation in the biosynthesis of gentamicin: isolation and characterization of a cobalamin-dependent radical SAM enzyme.\", JOURNAL = c(\"J Am Chem Soc 135:8093-6 (2013)\", \"DOI:10.1021/ja312641f\"))', 'map00524', 'Neomycin, kanamycin and gentamicin biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 149, 30, 142, 0, 0, 7, 30, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (78, '00525', 'Acarbose and validamycin biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Acarbose and validamycin biosynthesis', 'Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose [PATH:map00525], Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A [PATH:map00525]', 'ko00525', 'list(REFERENCE = \"PMID:17390001\", AUTHORS = \"Flatt PM, Mahmud T\", TITLE = \"Biosynthesis of aminocyclitol-aminoglycoside antibiotics and related compounds.\", JOURNAL = c(\"Nat Prod Rep 24:358-92 (2007)\", \"DOI:10.1039/b603816f\")), list(REFERENCE = \"PMID:17661520\", AUTHORS = \"Mahmud T, Flatt PM, Wu X\", TITLE = \"Biosynthesis of unusual aminocyclitol-containing natural products.\", JOURNAL = c(\"J Nat Prod 70:1384-91 (2007)\", \"DOI:10.1021/np070210q\")), list(REFERENCE = \"PMID:22944206\", AUTHORS = \"Wendler S, Hurtgen D, Kalinowski J, Klein A, Niehaus K, Schulte F, Schwientek P, Wehlmann H, Wehmeier UF, Puhler A\", TITLE = \"The cytosolic and extracellular proteomes of Actinoplanes sp. SE50/110 led to the identification of gene products involved in acarbose metabolism.\", JOURNAL = c(\"J Biotechnol 167:178-89 (2013)\", \"DOI:10.1016/j.jbiotec.2012.08.011\")), list(REFERENCE = \"PMID:22443545\", AUTHORS = \"Schwientek P, Szczepanowski R, Ruckert C, Kalinowski J, Klein A, Selber K, Wehmeier UF, Stoye J, Puhler A\", TITLE = \"The complete genome sequence of the acarbose producer Actinoplanes sp. SE50/110.\", JOURNAL = c(\"BMC Genomics 13:112 (2012)\", \"DOI:10.1186/1471-2164-13-112\")), list(REFERENCE = \"PMID:17003911\", AUTHORS = \"Deng Z, Bai L\", TITLE = \"Antibiotic biosynthetic pathways and pathway engineering--a growing research field in China.\", JOURNAL = c(\"Nat Prod Rep 23:811-27 (2006)\", \"DOI:10.1039/b611140h\")), list(REFERENCE = \"PMID:21766819\", AUTHORS = \"Asamizu S, Yang J, Almabruk KH, Mahmud T\", TITLE = \"Pseudoglycosyltransferase catalyzes nonglycosidic C-N coupling in validamycin a biosynthesis.\", JOURNAL = c(\"J Am Chem Soc 133:12124-35 (2011)\", \"DOI:10.1021/ja203574u\")), list(REFERENCE = \"PMID:18648803\", AUTHORS = \"Choi WS, Wu X, Choeng YH, Mahmud T, Jeong BC, Lee SH, Chang YK, Kim CJ, Hong SK\", TITLE = \"Genetic organization of the putative salbostatin biosynthetic gene cluster including the 2-epi-5-epi-valiolone synthase gene in Streptomyces albus ATCC 21838.\", JOURNAL = c(\"Appl Microbiol Biotechnol 80:637-45 (2008)\", \"DOI:10.1007/s00253-008-1591-2\")), list(REFERENCE = \"PMID:19101977\", AUTHORS = \"Wu X, Flatt PM, Xu H, Mahmud T\", TITLE = \"Biosynthetic gene cluster of cetoniacytone A, an unusual aminocyclitol from the endosymbiotic Bacterium Actinomyces sp. Lu 9419.\", JOURNAL = c(\"Chembiochem 10:304-14 (2009)\", \"DOI:10.1002/cbic.200800527\"))', 'map00525', 'Acarbose and validamycin biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 0, 3748, 0, 0, 0, 0, 3582, 166);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (79, '00531', 'Glycosaminoglycan degradation', 'Metabolism; Glycan biosynthesis and metabolism', 'Glycosaminoglycan degradation', 'Dermatan sulfate degradation [PATH:map00531], Chondroitin sulfate degradation [PATH:map00531], Heparan sulfate degradation [PATH:map00531], Keratan sulfate degradation [PATH:map00531]', 'Mucopolysaccharidosis type IV, GM2 gangliosidoses, Mucopolysaccharidosis type I, Mucopolysaccharidosis type II, Mucopolysaccharidosis type III, Mucopolysaccharidosis type VI, Mucopolysaccharidosis type VII, Mucopolysaccharidosis type IX, GM1 gangliosidosis, Mucopolysaccharidosis, Gangliosidosis, Urofacial syndrome, Tay-Sachs disease, Sandhoff disease', 'ko00531', 'list(REFERENCE = \"PMID:27570\", AUTHORS = \"Greiling H, Stuhlsatz HW, Cantz M, Gehler J\", TITLE = \"Increased urinary excretion of keratan sulfate in fucosidosis.\", JOURNAL = \"J Clin Chem Clin Biochem 16:329-34 (1978)\"), list(REFERENCE = \"PMID:3161730\", AUTHORS = \"Fuchs W, Beck M, Kresse H\", TITLE = \"Intralysosomal formation and metabolic fate of N-acetylglucosamine 6-sulfate from keratan sulfate.\", JOURNAL = c(\"Eur J Biochem 151:551-6 (1985)\", \"DOI:10.1111/j.1432-1033.1985.tb09138.x\"))', 'map00531', 'Glycosaminoglycan degradation', 472, 0, 248, 96, 104, 24, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (80, '00532', 'Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate', 'Glycosaminoglycans (GAGs) are linear polysaccharide chains consisting of repeating disaccharide units and form proteglycans by covalently attaching to their core proteins. Chondroitin sulfate (CS) is a glycosaminoglycan with the disaccharide unit of beta-D-galactosamine (GalNAc) and beta-D-glucuronic acid (GlcA), and often modified with ester-linked sulfate at certain positions. Dermatan sulfate (DS) is a modified form of CS, in which a portion of D-glucuronate residues is epimerized to L-iduronates (IdoA). CS and DS are linked to serine residues in core proteins via a linkage tetrasaccharide formed by the transfer of xylose and three more residues [MD:M00057]. The assembly process of CS is initiated by transferring GalNAc residue to the linkage tetrasaccharide. The polymerization is catalyzed by bifunctional enzymes (chondroitin synthases) possessing both beta 1,3 glucuronosyltransferase and beta 1,4 N-acetylgalactosaminyltransferase activities [MD:M00058]. Chondroitin polymerization also requires the action of the chondroitin polymerizing factor. There are various O-sulfation patterns in CS and DS, where 4-O sulfation and 6-O sulfation of GalNAc and 2-O-sulfation of the uronic acids (GlcA / IdoA) are mainly found.', 'Metabolism; Glycan biosynthesis and metabolism', 'Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate', 'Glycosaminoglycan biosynthesis, linkage tetrasaccharide [PATH:map00532], Glycosaminoglycan biosynthesis, chondroitin sulfate backbone [PATH:map00532]', 'Desbuquois syndrome, Spondyloepiphyseal dysplasia with congenital joint dislocations, SEMD with joint laxity type, Spondyloocular syndrome, Temtamy preaxial brachydactyly syndrome, Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects, Ehlers-Danlos syndrome musculocontractural type', 'ko00532', 'list(REFERENCE = \"PMID:11042448\", AUTHORS = \"Sugahara K, Kitagawa H.\", TITLE = \"Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans.\", JOURNAL = c(\"Curr Opin Struct Biol 10:518-27 (2000)\", \"DOI:10.1016/S0959-440X(00)00125-1\")), list(REFERENCE = \"PMID:11274177\", AUTHORS = \"Li JP, Gong F, El Darwish K, Jalkanen M, Lindahl U.\", TITLE = \"Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate.\", JOURNAL = c(\"J Biol Chem 276:20069-77 (2001)\", \"DOI:10.1074/jbc.M011783200\")), list(REFERENCE = \"PMID:11099377\", AUTHORS = \"Gotting C, Kuhn J, Zahn R, Brinkmann T, Kleesiek K\", TITLE = \"Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II.\", JOURNAL = c(\"J Mol Biol 304:517-28 (2000)\", \"DOI:10.1006/jmbi.2000.4261\")), list(REFERENCE = \"PMID:10473568\", AUTHORS = \"Almeida R, Levery SB, Mandel U, Kresse H, Schwientek T, Bennett EP, Clausen H\", TITLE = \"Cloning and expression of a proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I. A seventh member of the human beta4-galactosyltransferase gene family.\", JOURNAL = c(\"J Biol Chem 274:26165-71 (1999)\", \"DOI:10.1074/jbc.274.37.26165\")), list(REFERENCE = \"PMID:11551958\", AUTHORS = \"Bai X, Zhou D, Brown JR, Crawford BE, Hennet T, Esko JD\", TITLE = \"Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6).\", JOURNAL = c(\"J Biol Chem 276:48189-95 (2001)\", \"DOI:10.1074/jbc.M107339200\")), list(REFERENCE = \"PMID:9506957\", AUTHORS = \"Kitagawa H, Tone Y, Tamura J, Neumann KW, Ogawa T, Oka S, Kawasaki T, Sugahara K\", TITLE = \"Molecular cloning and expression of glucuronyltransferase I involved in the biosynthesis of the glycosaminoglycan-protein linkage region of proteoglycans.\", JOURNAL = c(\"J Biol Chem 273:6615-8 (1998)\", \"DOI:10.1074/jbc.273.12.6615\")), list(REFERENCE = \"PMID:12512856\", AUTHORS = \"Silbert JE, Sugumaran G\", TITLE = \"Biosynthesis of chondroitin/dermatan sulfate.\", JOURNAL = c(\"IUBMB Life 54:177-86 (2002)\", \"DOI:10.1080/15216540214923\")), list(REFERENCE = \"PMID:17253960\", AUTHORS = \"Izumikawa T, Uyama T, Okuura Y, Sugahara K, Kitagawa H\", TITLE = \"Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor.\", JOURNAL = c(\"Biochem J 403:545-52 (2007)\", \"DOI:10.1042/BJ20061876\")), list(REFERENCE = \"PMID:12716890\", AUTHORS = \"Kitagawa H, Izumikawa T, Uyama T, Sugahara K\", TITLE = \"Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization.\", JOURNAL = c(\"J Biol Chem 278:23666-71 (2003)\", \"DOI:10.1074/jbc.M302493200\")), list(REFERENCE = \"PMID:21138417\", AUTHORS = \"Izumikawa T, Okuura Y, Koike T, Sakoda N, Kitagawa H\", TITLE = \"Chondroitin 4-O-sulfotransferase-1 regulates the chain length of chondroitin sulfate in co-operation with chondroitin N-acetylgalactosaminyltransferase-2.\", JOURNAL = c(\"Biochem J 434:321-31 (2011)\", \"DOI:10.1042/BJ20101456\")), list(REFERENCE = \"PMID:22899863\", AUTHORS = \"Malmstrom A, Bartolini B, Thelin MA, Pacheco B, Maccarana M\", TITLE = \"Iduronic Acid in chondroitin/dermatan sulfate: biosynthesis and biological function.\", JOURNAL = c(\"J Histochem Cytochem 60:916-25 (2012)\", \"DOI:10.1369/0022155412459857\")), list(REFERENCE = \"PMID:17928217\", AUTHORS = \"Sugahara K, Mikami T\", TITLE = \"Chondroitin/dermatan sulfate in the central nervous system.\", JOURNAL = c(\"Curr Opin Struct Biol 17:536-45 (2007)\", \"DOI:10.1016/j.sbi.2007.08.015\")), list(REFERENCE = \"PMID:14568616\", AUTHORS = \"Kusche-Gullberg M, Kjellen L\", TITLE = \"Sulfotransferases in glycosaminoglycan biosynthesis.\", JOURNAL = c(\"Curr Opin Struct Biol 13:605-11 (2003)\", \"DOI:10.1016/j.sbi.2003.08.002\")), list(REFERENCE = \"PMID:19661164\", AUTHORS = \"Pacheco B, Maccarana M, Malmstrom A\", TITLE = \"Dermatan 4-O-sulfotransferase 1 is pivotal in the formation of iduronic acid blocks in dermatan sulfate.\", JOURNAL = c(\"Glycobiology 19:1197-203 (2009)\", \"DOI:10.1093/glycob/cwp110\")), list(REFERENCE = \"PMID:17239763\", AUTHORS = \"Prabhakar V, Sasisekharan R\", TITLE = \"The biosynthesis and catabolism of galactosaminoglycans.\", JOURNAL = c(\"Adv Pharmacol 53:69-115 (2006)\", \"DOI:10.1016/S1054-3589(05)53005-9\")), list(REFERENCE = \"PMID:12847091\", AUTHORS = \"Mikami T, Mizumoto S, Kago N, Kitagawa H, Sugahara K\", TITLE = \"Specificities of three distinct human chondroitin/dermatan N-acetylgalactosamine 4-O-sulfotransferases demonstrated using partially desulfated dermatan sulfate as an acceptor: implication of differential roles in dermatan sulfate biosynthesis.\", JOURNAL = c(\"J Biol Chem 278:36115-27 (2003)\", \"DOI:10.1074/jbc.M306044200\"))', 'map00532', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (81, '00533', 'Glycosaminoglycan biosynthesis - keratan sulfate', 'Keratan sulfate (KS) is a glycosaminoglycan with the basic disaccharide unit of N-acetyllactosamine, Gal(b1-4)GlcNAc(b1-3), with sulfate esters at C-6 of GlcNAc and Gal residues. There are two types of KS distinguished by the protein linkage: type I for N-linked via the N-glycan core structure and type II for O-linked via the O-glycan core 2 structure.', 'Metabolism; Glycan biosynthesis and metabolism', 'Glycosaminoglycan biosynthesis - keratan sulfate', 'Macular corneal dystrophy', 'ko00533', 'list(REFERENCE = \"PMID:11030741\", AUTHORS = \"Funderburgh JL.\", TITLE = \"Keratan sulfate: structure, biosynthesis, and function.\", JOURNAL = c(\"Glycobiology 10:951-958 (2000)\", \"DOI:10.1093/glycob/10.10.951\")), list(REFERENCE = \"PMID:14706853\", AUTHORS = \"Seko A, Yamashita K.\", TITLE = \"beta1,3-N-Acetylglucosaminyltransferase-7 (beta3Gn-T7) acts efficiently on keratan sulfate-related glycans.\", JOURNAL = c(\"FEBS Lett 556:216-20 (2004)\", \"DOI:10.1016/S0014-5793(03)01440-6\")), list(REFERENCE = \"PMID:12511560\", AUTHORS = \"Seko A, Dohmae N, Takio K, Yamashita K.\", TITLE = \"Beta 1,4-galactosyltransferase (beta 4GalT)-IV is specific for GlcNAc 6-O-sulfate. Beta 4GalT-IV acts on keratan sulfate-related glycans and a precursor glycan of 6-sulfosialyl-Lewis X.\", JOURNAL = c(\"J Biol Chem 278:9150-8 (2003)\", \"DOI:10.1074/jbc.M211480200\"))', 'map00533', 'Glycosaminoglycan biosynthesis - keratan sulfate', 193, 0, 193, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (82, '00534', 'Glycosaminoglycan biosynthesis - heparan sulfate / heparin', 'Heparan sulfate (HS) and heparin (Hep) are glycosaminoglycans with repeating disaccharide units that consist of alternating residues of alpha-D-glucosamine (GlcN) and uronic acid, the latter being either beta-D-glucuronic acid (GlcA) or alpha-L-iduronic acid (IdoA). In these sugar residues, sulfation modification may be performed at various positions. Structural studies show that Hep possesses a higher degree of sulfation than HS. The biosynthesis of HS/Hep occurs with the addition of the first GlcNAc residue by EXTL3 glycosyltransferase after completion of tetrasaccharide linkage region attached to serine residue of a core protein. The chain polymeraization is then catalyzed by EXT1 and EXT2 transferases. As the chain polymerizes, HS/Hep undergoes a series of modification reactions including N-deacetylation, N-sulfation, epimerization, and subsequently O-sulfation. As final products of biosynthesis, HS is present in the form of hepran sulfate proteoglycan (HSPG) whereas Hep exists as a sugar chain without a core protein. The proteoglycan families with HS, as well as CS (chondroitin sulfate), DS (dermatan sulfate), and KS (keratan sulfate), are composed of two main types depending on the subcellular locations: cell membrane and extracellular matrix [BR:ko00535]. HS/Hep has been shown to bind to a variety of molecules, such as growth factors, chemokines, morphogens, and extracellular matrix components [BR:ko00536].', 'Metabolism; Glycan biosynthesis and metabolism', 'Glycosaminoglycan biosynthesis - heparan sulfate / heparin', 'Glycosaminoglycan biosynthesis, linkage tetrasaccharide [PATH:map00534], Glycosaminoglycan biosynthesis, heparan sulfate backbone [PATH:map00534]', 'Multiple exostoses, Desbuquois syndrome, SEMD with joint laxity type, Spondyloocular syndrome, Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects', 'ko00534', 'list(REFERENCE = \"PMID:11390981\", AUTHORS = \"Kim BT, Kitagawa H, Tamura J, Saito T, Kusche-Gullberg M, Lindahl U, Sugahara K\", TITLE = \"Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 98:7176-81 (2001)\", \"DOI:10.1073/pnas.131188498\")), list(REFERENCE = \"PMID:10318803\", AUTHORS = \"Kitagawa H, Shimakawa H, Sugahara K\", TITLE = \"The tumor suppressor EXT-like gene EXTL2 encodes an alpha1, 4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region. The key enzyme for the chain initiation of heparan sulfate.\", JOURNAL = c(\"J Biol Chem 274:13933-7 (1999)\", \"DOI:10.1074/jbc.274.20.13933\")), list(REFERENCE = \"PMID:9756849\", AUTHORS = \"Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K\", TITLE = \"The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate.\", JOURNAL = c(\"J Biol Chem 273:26265-8 (1998)\", \"DOI:10.1074/jbc.273.41.26265\")), list(REFERENCE = \"PMID:11274177\", AUTHORS = \"Li JP, Gong F, El Darwish K, Jalkanen M, Lindahl U.\", TITLE = \"Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate.\", JOURNAL = c(\"J Biol Chem 276:20069-77 (2001)\", \"DOI:10.1074/jbc.M011783200\")), list(REFERENCE = \"PMID:10742590\", AUTHORS = \"Habuchi O\", TITLE = \"Diversity and functions of glycosaminoglycan sulfotransferases.\", JOURNAL = c(\"Biochim Biophys Acta 1474:115-27 (2000)\", \"DOI:10.1016/S0304-4165(00)00016-7\")), list(REFERENCE = \"PMID:9151776\", AUTHORS = \"Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L\", TITLE = \"Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?\", JOURNAL = c(\"J Clin Invest 99:2062-70 (1997)\", \"DOI:10.1172/JCI119377\")), list(REFERENCE = \"PMID:9988768\", AUTHORS = \"Liu J, Shworak NW, Sinay P, Schwartz JJ, Zhang L, Fritze LM, Rosenberg RD\", TITLE = \"Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities.\", JOURNAL = c(\"J Biol Chem 274:5185-92 (1999)\", \"DOI:10.1074/jbc.274.8.5185\")), list(REFERENCE = \"PMID:10520990\", AUTHORS = \"Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG\", TITLE = \"A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.\", JOURNAL = c(\"Cell 99:13-22 (1999)\", \"DOI:10.1016/S0092-8674(00)80058-6\")), list(REFERENCE = \"PMID:15304505\", AUTHORS = \"Moon AF, Edavettal SC, Krahn JM, Munoz EM, Negishi M, Linhardt RJ, Liu J, Pedersen LC\", TITLE = \"Structural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1.\", JOURNAL = c(\"J Biol Chem 279:45185-93 (2004)\", \"DOI:10.1074/jbc.M405013200\")), list(REFERENCE = \"PMID:16099108\", AUTHORS = \"Chen J, Liu J\", TITLE = \"Characterization of the structure of antithrombin-binding heparan sulfate generated by heparan sulfate 3-O-sulfotransferase 5.\", JOURNAL = c(\"Biochim Biophys Acta 1725:190-200 (2005)\", \"DOI:10.1016/j.bbagen.2005.06.012\"))', 'map00534', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (83, '00540', 'Lipopolysaccharide biosynthesis', 'Lipopolysaccharide (LPS) is the major component of the outer membrane of Gram-negative bacteria consisting of three domains: a hydrophobic anchor called lipid A, a non-repeating core oligosaccharide (OS) and a repetitive glycan polymer called O-antigen or O-polysaccharide (O-PS). The enzymes for the biosynthesis of lipid A are well conserved among Gram-negative bacterial species [MD:M00060 M00866]. The core OS connecting lipid A with O-antigen is divided into inner and outer parts. Five core types, K-12 and R1-R4, are identified in Escherichia coli, with the common inner part composed of Kdo (ketodeoxyoctulosonic acid) and Hep (heptose) residues and the outer part made of various sugar residues. O-antigen is the most variable part used for serotyping of pathogenic Escherichia coli, where about 170 types are known. All three domains are involved in toxicity, pathogenicity, antimicrobial resistance and other activities.', 'Metabolism; Glycan biosynthesis and metabolism', 'Lipopolysaccharide biosynthesis', 'KDO2-lipid A biosynthesis, Raetz pathway, LpxL-LpxM type [PATH:map00540], CMP-KDO biosynthesis [PATH:map00540], ADP-L-glycero-D-manno-heptose biosynthesis [PATH:map00540], KDO2-lipid A biosynthesis, Raetz pathway, non-LpxL-LpxM type [PATH:map00540], KDO2-lipid A modification pathway [PATH:map00540]', 'GO: 0009103', 'ko00540', 'list(REFERENCE = \"PMID:9791168\", AUTHORS = \"Heinrichs DE, Yethon JA, Whitfield C.\", TITLE = \"Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica.\", JOURNAL = c(\"Mol Microbiol 30:221-32 (1998)\", \"DOI:10.1046/j.1365-2958.1998.01063.x\")), list(REFERENCE = \"PMID:11751812\", AUTHORS = \"Kneidinger B, Marolda C, Graninger M, Zamyatina A, McArthur F, Kosma P, Valvano MA, Messner P.\", TITLE = \"Biosynthesis pathway of ADP-L-glycero-beta-D-manno-heptose in Escherichia coli.\", JOURNAL = c(\"J Bacteriol 184:363-9 (2002)\", \"DOI:10.1128/JB.184.2.363-369.2002\")), list(REFERENCE = \"PMID:9587193\", AUTHORS = \"Wyckoff TJ, Raetz CR, Jackman JE.\", TITLE = \"Antibacterial and anti-inflammatory agents that target endotoxin.\", JOURNAL = c(\"Trends Microbiol 6:154-9 (1998)\", \"DOI:10.1016/S0966-842X(98)01230-X\")), list(REFERENCE = \"PMID:9765561\", AUTHORS = \"Shibayama K, Ohsuka S, Tanaka T, Arakawa Y, Ohta M.\", TITLE = \"Conserved structural regions involved in the catalytic mechanism of Escherichia coli K-12 WaaO (RfaI).\", JOURNAL = \"J Bacteriol 180:5313-8 (1998)\"), list(REFERENCE = \"PMID:12045108\", AUTHORS = \"Raetz CR, Whitfield C\", TITLE = \"Lipopolysaccharide endotoxins.\", JOURNAL = c(\"Annu Rev Biochem 71:635-700 (2002)\", \"DOI:10.1146/annurev.biochem.71.110601.135414\")), list(REFERENCE = \"PMID:24372821\", AUTHORS = \"Rubin EJ, O\'Brien JP, Ivanov PL, Brodbelt JS, Trent MS\", TITLE = \"Identification of a broad family of lipid A late acyltransferases with non-canonical substrate specificity.\", JOURNAL = c(\"Mol Microbiol 91:887-99 (2014)\", \"DOI:10.1111/mmi.12501\")), list(REFERENCE = \"PMID:20659292\", AUTHORS = \"Stead CM, Zhao J, Raetz CR, Trent MS\", TITLE = \"Removal of the outer Kdo from Helicobacter pylori lipopolysaccharide and its impact on the bacterial surface.\", JOURNAL = c(\"Mol Microbiol 78:837-52 (2010)\", \"DOI:10.1111/j.1365-2958.2010.07304.x\")), list(REFERENCE = \"PMID:30245684\", AUTHORS = \"Ebbensgaard A, Mordhorst H, Aarestrup FM, Hansen EB\", TITLE = \"The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides.\", JOURNAL = c(\"Front Microbiol 9:2153 (2018)\", \"DOI:10.3389/fmicb.2018.02153\")), list(REFERENCE = \"PMID:28630161\", AUTHORS = \"Botos I, Noinaj N, Buchanan SK\", TITLE = \"Insertion of proteins and lipopolysaccharide into the bacterial outer membrane.\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 372:20160224 (2017)\", \"DOI:10.1098/rstb.2016.0224\"))', 'map00540', 0, 3578, 0, 0, 0, 0, 3578, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (84, '00550', 'Peptidoglycan biosynthesis', 'Peptidoglycan is a macromolecule made of long aminosugar strands cross-linked by short peptides. It forms the cell wall in bacteria surrounding the cytoplasmic membrane. The glycan strands are typically comprised of repeating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) disaccharides. Each MurNAc is linked to a peptide of three to five amino acid residues. Disaccharide subunits are first assembled on the cytoplasmic side of the bacterial membrane on a polyisoprenoid anchor (lipid I and II). Polymerization of disaccharide subunits by transglycosylases and cross-linking of glycan strands by transpeptidases occur on the other side of the membrane. Bacterial cell wall biosynthesis inhibitors form a major class of antibiotics.', 'Metabolism; Glycan biosynthesis and metabolism', 'Peptidoglycan biosynthesis', 'ko00550', 'list(REFERENCE = \"PMID:18081839\", AUTHORS = \"Bouhss A, Trunkfield AE, Bugg TD, Mengin-Lecreulx D\", TITLE = \"The biosynthesis of peptidoglycan lipid-linked intermediates.\", JOURNAL = c(\"FEMS Microbiol Rev 32:208-33 (2008)\", \"DOI:10.1111/j.1574-6976.2007.00089.x\")), list(REFERENCE = \"PMID:18077448\", AUTHORS = \"Lloyd AJ, Gilbey AM, Blewett AM, De Pascale G, El Zoeiby A, Levesque RC, Catherwood AC, Tomasz A, Bugg TD, Roper DI, Dowson CG\", TITLE = \"Characterization of tRNA-dependent peptide bond formation by MurM in the synthesis of Streptococcus pneumoniae peptidoglycan.\", JOURNAL = c(\"J Biol Chem 283:6402-17 (2008)\", \"DOI:10.1074/jbc.M708105200\")), list(REFERENCE = \"PMID:18266853\", AUTHORS = \"Barreteau H, Kovac A, Boniface A, Sova M, Gobec S, Blanot D\", TITLE = \"Cytoplasmic steps of peptidoglycan biosynthesis.\", JOURNAL = c(\"FEMS Microbiol Rev 32:168-207 (2008)\", \"DOI:10.1111/j.1574-6976.2008.00104.x\")), list(REFERENCE = \"PMID:11699883\", AUTHORS = \"van Heijenoort J\", TITLE = \"Recent advances in the formation of the bacterial peptidoglycan monomer unit.\", JOURNAL = c(\"Nat Prod Rep 18:503-19 (2001)\", \"DOI:10.1039/a804532a\")), list(REFERENCE = \"PMID:11320055\", AUTHORS = \"van Heijenoort  J\", TITLE = \"Formation of the glycan chains in the synthesis of bacterial peptidoglycan.\", JOURNAL = c(\"Glycobiology 11:25R-36R (2001)\", \"DOI:10.1093/glycob/11.3.25R\"))', 'map00550', 'Peptidoglycan biosynthesis', 'Peptidoglycan is a macromolecule made of long aminosugar strands cross-linked by short peptides. It forms the cell wall in bacteria surrounding the cytoplasmic membrane. The glycan strands are typically comprised of repeating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) disaccharides. Each MurNAc is linked to a peptide of three to five amino acid residues. Disaccharide subunits are first assembled on the cytoplasmic side of the bacterial membrane on a polyisoprenoid anchor (lipid I and II). Polymerization of disaccharide subunits by transglycosylases and cross-linking of glycan strands by transpeptidases occur on the other side of the membrane. Bacterial cell wall biosynthesis inhibitors form a major class of antibiotics.', 0, 5080, 0, 0, 0, 0, 5080, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (85, '00561', 'Glycerolipid metabolism', 'Metabolism; Lipid metabolism', 'Glycerolipid metabolism', 'Triacylglycerol biosynthesis [PATH:map00561], Acylglycerol degradation [PATH:map00561]', 'Hyperlipoproteinemia, type I, Chronic recurrent multifocal osteomyelitis, Acute recurrent myoglobinuria, Nonalcoholic fatty liver disease, Glycerol kinase deficiency, Hepatic lipase deficiency, Pancreatic lipase deficiency', 'GO: 0045017 0046486 0046503', 'ko00561', 'list(REFERENCE = \"PMID:8662716\", AUTHORS = \"Norbeck J, Pahlman AK, Akhtar N, Blomberg A, Adler L.\", TITLE = \"Purification and characterization of two isoenzymes of DL-glycerol-3-phosphatase from Saccharomyces cerevisiae. Identification of the corresponding GPP1 and GPP2 genes and evidence for osmotic regulation of Gpp2p expression by the osmosensing mitogen-activated protein kinase signal transduction pathway.\", JOURNAL = c(\"J Biol Chem 271:13875-81 (1996)\", \"DOI:10.1074/jbc.271.23.13875\")), list(REFERENCE = \"PMID:8995384\", AUTHORS = \"Karlsson OP, Dahlqvist A, Vikstrom S, Wieslander A.\", TITLE = \"Lipid dependence and basic kinetics of the purified 1,2-diacylglycerol 3-glucosyltransferase from membranes of Acholeplasma laidlawii.\", JOURNAL = c(\"J Biol Chem 272:929-36 (1997)\", \"DOI:10.1074/jbc.272.2.929\")), list(REFERENCE = \"PMID:11294844\", AUTHORS = \"Berg S, Edman M, Li L, Wikstrom M, Wieslander A.\", TITLE = \"Sequence properties of the 1,2-diacylglycerol 3-glucosyltransferase from Acholeplasma laidlawii membranes. Recognition of a large group of lipid glycosyltransferases in eubacteria and archaea.\", JOURNAL = c(\"J Biol Chem 276:22056-63 (2001)\", \"DOI:10.1074/jbc.M102576200\"))', 'map00561', 531, 5261, 248, 105, 128, 50, 5111, 150);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (86, '00562', 'Inositol phosphate metabolism', 'Metabolism; Carbohydrate metabolism', 'Inositol phosphate metabolism', 'Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 [PATH:map00562], Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol [PATH:map00562], Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate [PATH:map00562]', 'Joubert syndrome, Lowe syndrome, Dent disease, Centronuclear myopathy, Fleck corneal dystrophy, VACTERL/VATER association, Activated PI3K-delta syndrome, Chondrodysplasia with joint dislocations, GPAPP type', 'GO: 0006020', 'ko00562', 'list(REFERENCE = \"PMID:14993306\", AUTHORS = \"Yoshida K, Yamaguchi M, Ikeda H, Omae K, Tsurusaki K, Fujita Y\", TITLE = \"The fifth gene of the iol operon of Bacillus subtilis, iolE, encodes 2-keto-myo-inositol dehydratase.\", JOURNAL = c(\"Microbiology 150:571-80 (2004)\", \"DOI:10.1099/mic.0.26768-0\")), list(REFERENCE = \"PMID:18310071\", AUTHORS = \"Yoshida K, Yamaguchi M, Morinaga T, Kinehara M, Ikeuchi M, Ashida H, Fujita Y.\", TITLE = \"myo-Inositol catabolism in Bacillus subtilis.\", JOURNAL = c(\"J Biol Chem 283:10415-24 (2008)\", \"DOI:10.1074/jbc.M708043200\"))', 'map00562', 531, 4828, 248, 105, 128, 50, 4550, 278);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (87, '00563', 'Glycosylphosphatidylinositol (GPI)-anchor biosynthesis', 'Cell surface proteins can be attached to the cell membrane via the glycolipid structure called glycosylphosphatidylinositol (GPI) anchor. Hundreds of GPI-anchored proteins have been identified in many eukaryotes ranging from protozoa and fungi to mammals. All protein-linked GPI anchors share a common core structure, characterized by the substructure Man (a1-4) GlcN (a1-6) myo-inositol-1P-lipid. Biosynthesis of GPI anchors proceeds in three stages: (i) preassembly of a GPI precursor in the ER membrane, (ii) attachment of the GPI to the C-terminus of a newly synthesized protein in the lumen of the ER, and (iii) lipid remodeling and/or carbohydrate side-chain modifications in the ER and the Golgi. Defects of GPI anchor biosynthesis gene result in a genetic disorder, paroxysmal nocturnal hemoglobinuria.', 'Metabolism; Glycan biosynthesis and metabolism', 'Glycosylphosphatidylinositol (GPI)-anchor biosynthesis', 'GPI-anchor biosynthesis, core oligosaccharide [PATH:map00563]', 'Paroxysmal nocturnal hemoglobinuria, PIGM-congenital disorder of glycosylation, Autosomal recessive mental retardation-42, Multiple congenital anomalies-hypotonia-seizures syndrome, CHIME syndrome, Hyperphosphatasia with mental retardation syndrome, Inherited glycosylphosphatidylinositol deficiencies', 'GO: 0006506', 'ko00563', 'list(REFERENCE = \"PMID:12655644\", AUTHORS = \"Eisenhaber B, Maurer-Stroh S, Novatchkova M, Schneider G, Eisenhaber F.\", TITLE = \"Enzymes and auxiliary factors for GPI lipid anchor biosynthesis and post-translational transfer to proteins.\", JOURNAL = c(\"Bioessays 25:367-85 (2003)\", \"DOI:10.1002/bies.10254\")), list(REFERENCE = \"PMID:11102867\", AUTHORS = \"Kinoshita T, Inoue N.\", TITLE = \"Dissecting and manipulating the pathway for glycosylphos-phatidylinositol-anchor biosynthesis.\", JOURNAL = c(\"Curr Opin Chem Biol 4:632-8 (2000)\", \"DOI:10.1016/S1367-5931(00)00151-4\")), list(REFERENCE = \"PMID:8253761\", AUTHORS = \"Fankhauser C, Homans SW, Thomas-Oates JE, McConville MJ, Desponds C, Conzelmann A, Ferguson MA.\", TITLE = \"Structures of glycosylphosphatidylinositol membrane anchors from Saccharomyces cerevisiae.\", JOURNAL = \"J Biol Chem 268:26365-74 (1993)\"), list(REFERENCE = \"PMID:14517336\", AUTHORS = \"Murakami Y, Siripanyapinyo U, Hong Y, Kang JY, Ishihara S, Nakakuma H, Maeda Y, Kinoshita T.\", TITLE = \"PIG-W is critical for inositol acylation but not for flipping of glycosylphosphatidylinositol-anchor.\", JOURNAL = c(\"Mol Biol Cell 14:4285-95 (2003)\", \"DOI:10.1091/mbc.E03-03-0193\")), list(REFERENCE = \"PMID:10329735\", AUTHORS = \"Benachour A, Sipos G, Flury I, Reggiori F, Canivenc-Gansel E, Vionnet C, Conzelmann A, Benghezal M.\", TITLE = \"Deletion of GPI7, a yeast gene required for addition of a side chain to the glycosylphosphatidylinositol (GPI) core structure, affects GPI protein transport, remodeling, and cell wall integrity.\", JOURNAL = c(\"J Biol Chem 274:15251-61 (1999)\", \"DOI:10.1074/jbc.274.21.15251\")), list(REFERENCE = \"PMID:14734546\", AUTHORS = \"Tanaka S, Maeda Y, Tashima Y, Kinoshita T.\", TITLE = \"Inositol deacylation of glycosylphosphatidylinositol-anchored proteins is mediated by mammalian PGAP1 and yeast Bst1p.\", JOURNAL = c(\"J Biol Chem 279:14256-63 (2004)\", \"DOI:10.1074/jbc.M313755200\")), list(REFERENCE = \"PMID:12802054\", AUTHORS = \"Hong Y, Ohishi K, Kang JY, Tanaka S, Inoue N, Nishimura J, Maeda Y, Kinoshita T.\", TITLE = \"Human PIG-U and yeast Cdc91p are the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins.\", JOURNAL = c(\"Mol Biol Cell 14:1780-9 (2003)\", \"DOI:10.1091/mbc.E02-12-0794\")), list(REFERENCE = \"PMID:12807000\", AUTHORS = \"Tanaka S, Maeda Y, Kinoshita T.\", TITLE = \"[Biosynthesis of GPI-anchored proteins]\", JOURNAL = \"Tanpakushitsu Kakusan Koso 48:990-6 (2003)\"), list(REFERENCE = \"PMID:15623507\", AUTHORS = \"Kang JY, Hong Y, Ashida H, Shishioh N, Murakami Y, Morita YS, Maeda Y, Kinoshita T.\", TITLE = \"PIG-V involved in transferring the second mannose in glycosylphosphatidylinositol.\", JOURNAL = c(\"J Biol Chem 280:9489-97 (2005)\", \"DOI:10.1074/jbc.M413867200\")), list(REFERENCE = \"PMID:15635094\", AUTHORS = \"Ashida H, Hong Y, Murakami Y, Shishioh N, Sugimoto N, Kim YU, Maeda Y, Kinoshita T.\", TITLE = \"Mammalian PIG-X and yeast Pbn1p are the essential components of glycosylphosphatidylinositol-mannosyltransferase I.\", JOURNAL = c(\"Mol Biol Cell 16:1439-48 (2005)\", \"DOI:10.1091/mbc.E04-09-0802\")), list(REFERENCE = \"PMID:24364251\", AUTHORS = \"Fujita M\", TITLE = \"[Biosynthesis and remodeling of GPI-anchored proteins].\", JOURNAL = \"Seikagaku 85:985-95 (2013)\"), list(REFERENCE = \"PMID:25509331\", AUTHORS = \"Kinoshita T\", TITLE = \"[Biochemistry of glycosylphosphatidylinositol (GPI) anchored proteins].\", JOURNAL = \"Seikagaku 86:626-36 (2014)\")', 525, 0, 248, 101, 128, 48, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (88, '00564', 'Glycerophospholipid metabolism', 'Metabolism; Lipid metabolism', 'Glycerophospholipid metabolism', 'Phosphatidylcholine (PC) biosynthesis, choline => PC [PATH:map00564], Phosphatidylcholine (PC) biosynthesis, PE => PC [PATH:map00564], Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE [PATH:map00564], Phosphatidylethanolamine (PE) biosynthesis, PA => PS => PE [PATH:map00564]', 'Lecithin:cholesterol acyltransferase deficiency, Rhizomelic chondrodysplasia punctata, Barth syndrome, Congenital myasthenic syndrome, Chronic recurrent multifocal osteomyelitis, Acute recurrent myoglobinuria, Spondylometaphyseal dysplasia with cone-rod dystrophy, Lenz-Majewski syndrome, PNPLA6-related disorders, Laurence-Moon syndrome, Boucher-Neuhauser syndrome', 'GO: 0006650 0046474 0046475', 'ko00564', 'list(REFERENCE = \"PMID:1512203\", AUTHORS = \"Racenis PV, Lai JL, Das AK, Mullick PC, Hajra AK, Greenberg ML.\", TITLE = \"The acyl dihydroxyacetone phosphate pathway enzymes for glycerolipid biosynthesis are present in the yeast Saccharomyces cerevisiae.\", JOURNAL = c(\"J Bacteriol 174:5702-10 (1992)\", \"DOI:10.1128/JB.174.17.5702-5710.1992\")), list(REFERENCE = \"PMID:10092508\", AUTHORS = \"Taniyama Y, Shibata S, Kita S, Horikoshi K, Fuse H, Shirafuji H, Sumino Y, Fujino M.\", TITLE = \"Cloning and expression of a novel lysophospholipase which structurally resembles lecithin cholesterol acyltransferase.\", JOURNAL = c(\"Biochem Biophys Res Commun 257:50-6 (1999)\", \"DOI:10.1006/bbrc.1999.0411\")), list(REFERENCE = \"PMID:10542045\", AUTHORS = \"Athenstaedt K, Daum G.\", TITLE = \"Phosphatidic acid, a key intermediate in lipid metabolism.\", JOURNAL = c(\"Eur J Biochem 266:1-16 (1999)\", \"DOI:10.1046/j.1432-1327.1999.00822.x\")), list(REFERENCE = \"PMID:12431977\", AUTHORS = \"Shields DJ, Lehner R, Agellon LB, Vance DE.\", TITLE = \"Membrane topography of human phosphatidylethanolamine N-methyltransferase.\", JOURNAL = c(\"J Biol Chem 278:2956-62 (2003)\", \"DOI:10.1074/jbc.M210904200\")), list(REFERENCE = \"PMID:14663079\", AUTHORS = \"Martinez-Morales F, Schobert M, Lopez-Lara IM, Geiger O.\", TITLE = \"Pathways for phosphatidylcholine biosynthesis in bacteria.\", JOURNAL = c(\"Microbiology 149:3461-71 (2003)\", \"DOI:10.1099/mic.0.26522-0\")), list(REFERENCE = \"PMID:15522832\", AUTHORS = \"Burgermeister M, Birner-Grunberger R, Nebauer R, Daum G.\", TITLE = \"Contribution of different pathways to the supply of phosphatidylethanolamine and phosphatidylcholine to mitochondrial membranes of the yeast Saccharomyces cerevisiae.\", JOURNAL = c(\"Biochim Biophys Acta 1686:161-8 (2004)\", \"DOI:10.1016/j.bbalip.2004.09.007\")), list(REFERENCE = \"PMID:1649829\", AUTHORS = \"Hsu L, Jackowski S, Rock CO\", TITLE = \"Isolation and characterization of Escherichia coli K-12 mutants lacking both 2-acyl-glycerophosphoethanolamine acyltransferase and acyl-acyl carrier protein synthetase activity.\", JOURNAL = \"J Biol Chem 266:13783-8 (1991)\"), list(REFERENCE = \"PMID:10938271\", AUTHORS = \"Stone SJ, Vance JE.\", TITLE = \"Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes.\", JOURNAL = c(\"J Biol Chem 275:34534-40 (2000)\", \"DOI:10.1074/jbc.M002865200\"))', 'map00564', 531, 5499, 248, 105, 128, 50, 5202, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (89, '00565', 'Ether lipid metabolism', 'Metabolism; Lipid metabolism', 'Ether lipid metabolism', 'Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid [PATH:map00565]', 'Rhizomelic chondrodysplasia punctata', 'ko00565', 'list(REFERENCE = \"PMID:11275267\", AUTHORS = \"Nagan N, Zoeller RA.\", TITLE = \"Plasmalogens: biosynthesis and functions.\", JOURNAL = c(\"Prog Lipid Res 40:199-229 (2001)\", \"DOI:10.1016/S0163-7827(01)00003-0\")), list(REFERENCE = \"PMID:11015622\", AUTHORS = \"Montrucchio G, Alloatti G, Camussi G.\", TITLE = \"Role of platelet-activating factor in cardiovascular pathophysiology.\", JOURNAL = c(\"Physiol Rev 80:1669-99 (2000)\", \"DOI:10.1152/physrev.2000.80.4.1669\")), list(REFERENCE = \"PMID:15788404\", AUTHORS = \"Sakagami H, Aoki J, Natori Y, Nishikawa K, Kakehi Y, Natori Y, Arai H.\", TITLE = \"Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family.\", JOURNAL = c(\"J Biol Chem 280:23084-93 (2005)\", \"DOI:10.1074/jbc.M413438200\"))', 'map00565', 'Ether lipid metabolism', 526, 1301, 248, 105, 126, 47, 1300, 1);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (90, '00571', 'Lipoarabinomannan (LAM) biosynthesis', 'Lipoarabinomannan (LAM), as well as structurally related lipomannan (LM) and phosphatidylinositol mannosides (PIMs), are major glycolipids found on the mycobacterial cell wall. LAM is synthesized from phosphatidylinositol (PI) and in a biochemical pathway of PI => PIMs => LM =>LAM. Structually, LAM and LM are an extension of PIMs containing an alpha1,6-linked mannan core with alpha1,2-monomannose side chains. The mannan core of LAM is in turn arabinosylated by a linear alpha1,5-linked Araf backbone, punctutated by alpha1,3-linked branching. LAM can be substituted by several capping motifs, which determine the ability of LAM to modulate the immune response through the interaction with different receptors containing C-type lectins (map04625). It has been shown that the immunomodulatory properties of LAM and related glycolipids contribute to the survival of Mycobacteriaum tuberculosis, the causative agent of tuberculosis (map05152).', 'Metabolism; Glycan biosynthesis and metabolism', 'Lipoarabinomannan (LAM) biosynthesis', 'ko00571', 'list(REFERENCE = \"PMID:26104198\", AUTHORS = \"Jankute M, Grover S, Birch HL, Besra GS\", TITLE = \"Genetics of Mycobacterial Arabinogalactan and Lipoarabinomannan Assembly.\", JOURNAL = c(\"Microbiol Spectr 2:MGM2-0013-2013 (2014)\", \"DOI:10.1128/microbiolspec.MGM2-0013-2013\")), list(REFERENCE = \"PMID:14627436\", AUTHORS = \"Morita YS, Patterson JH, Billman-Jacobe H, McConville MJ\", TITLE = \"Biosynthesis of mycobacterial phosphatidylinositol mannosides.\", JOURNAL = c(\"Biochem J 378:589-97 (2004)\", \"DOI:10.1042/BJ20031372\")), list(REFERENCE = \"PMID:26488279\", AUTHORS = \"Jankute M, Cox JA, Harrison J, Besra GS\", TITLE = \"Assembly of the Mycobacterial Cell Wall.\", JOURNAL = c(\"Annu Rev Microbiol 69:405-23 (2015)\", \"DOI:10.1146/annurev-micro-091014-104121\")), list(REFERENCE = \"PMID:20801880\", AUTHORS = \"Guerin ME, Kordulakova J, Alzari PM, Brennan PJ, Jackson M\", TITLE = \"Molecular basis of phosphatidyl-myo-inositol mannoside biosynthesis and regulation in mycobacteria.\", JOURNAL = c(\"J Biol Chem 285:33577-83 (2010)\", \"DOI:10.1074/jbc.R110.168328\")), list(REFERENCE = \"PMID:15228522\", AUTHORS = \"Briken V, Porcelli SA, Besra GS, Kremer L\", TITLE = \"Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.\", JOURNAL = c(\"Mol Microbiol 53:391-403 (2004)\", \"DOI:10.1111/j.1365-2958.2004.04183.x\")), list(REFERENCE = \"PMID:17956343\", AUTHORS = \"Alderwick LJ, Birch HL, Mishra AK, Eggeling L, Besra GS\", TITLE = \"Structure, function and biosynthesis of the Mycobacterium tuberculosis cell wall: arabinogalactan and lipoarabinomannan assembly with a view to discovering new drug targets.\", JOURNAL = c(\"Biochem Soc Trans 35:1325-8 (2007)\", \"DOI:10.1042/BST0351325\")), list(REFERENCE = \"PMID:21521247\", AUTHORS = \"Mishra AK, Driessen NN, Appelmelk BJ, Besra GS\", TITLE = \"Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction.\", JOURNAL = c(\"FEMS Microbiol Rev 35:1126-57 (2011)\", \"DOI:10.1111/j.1574-6976.2011.00276.x\")), list(REFERENCE = \"PMID:16803893\", AUTHORS = \"Morita YS, Sena CB, Waller RF, Kurokawa K, Sernee MF, Nakatani F, Haites RE, Billman-Jacobe H, McConville MJ, Maeda Y, Kinoshita T\", TITLE = \"PimE is a polyprenol-phosphate-mannose-dependent mannosyltransferase that transfers the fifth mannose of phosphatidylinositol mannoside in mycobacteria.\", JOURNAL = c(\"J Biol Chem 281:25143-55 (2006)\", \"DOI:10.1074/jbc.M604214200\")), list(REFERENCE = \"PMID:20843801\", AUTHORS = \"Batt SM, Jabeen T, Mishra AK, Veerapen N, Krumbach K, Eggeling L, Besra GS, Futterer K\", TITLE = \"Acceptor substrate discrimination in phosphatidyl-myo-inositol mannoside synthesis: structural and mutational analysis of mannosyltransferase Corynebacterium glutamicum PimB\'.\", JOURNAL = c(\"J Biol Chem 285:37741-52 (2010)\", \"DOI:10.1074/jbc.M110.165407\")), list(REFERENCE = \"PMID:19049470\", AUTHORS = \"Boonyarattanakalin S, Liu X, Michieletti M, Lepenies B, Seeberger PH\", TITLE = \"Chemical synthesis of all phosphatidylinositol mannoside (PIM) glycans from Mycobacterium tuberculosis.\", JOURNAL = c(\"J Am Chem Soc 130:16791-9 (2008)\", \"DOI:10.1021/ja806283e\")), list(REFERENCE = \"PMID:12063260\", AUTHORS = \"Guerardel Y, Maes E, Elass E, Leroy Y, Timmerman P, Besra GS, Locht C, Strecker G, Kremer L\", TITLE = \"Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1,3-mannopyranose side chains.\", JOURNAL = c(\"J Biol Chem 277:30635-48 (2002)\", \"DOI:10.1074/jbc.M204398200\"))', 'map00571', 'Lipoarabinomannan (LAM) biosynthesis', 'Lipoarabinomannan (LAM), as well as structurally related lipomannan (LM) and phosphatidylinositol mannosides (PIMs), are major glycolipids found on the mycobacterial cell wall. LAM is synthesized from phosphatidylinositol (PI) and in a biochemical pathway of PI => PIMs => LM =>LAM. Structually, LAM and LM are an extension of PIMs containing an alpha1,6-linked mannan core with alpha1,2-monomannose side chains. The mannan core of LAM is in turn arabinosylated by a linear alpha1,5-linked Araf backbone, punctutated by alpha1,3-linked branching. LAM can be substituted by several capping motifs, which determine the ability of LAM to modulate the immune response through the interaction with different receptors containing C-type lectins (map04625). It has been shown that the immunomodulatory properties of LAM and related glycolipids contribute to the survival of Mycobacteriaum tuberculosis, the causative agent of tuberculosis (map05152).', 0, 70, 0, 0, 0, 0, 70, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (91, '00572', 'Arabinogalactan biosynthesis - Mycobacterium', 'Just like lipoarabinomannan (map00571), arabinogalactan (AG) is a major heteropolysaccharide found on the mycobacterium cell wall. AG consists of a linear galactan chain of galactofuranosyl (Galf) residues covalently connected to peptidoglycan (PG), with branches of three similar arabinan chains comprising arabinofuranosyl (Araf) residues. The non-reducing ends of arabinans are often covalently attached to the long fatty acids of mycolic acids. Thus, the covalently linked network of PG and mycolylated AG, termed the mycolyl-arabinogalactan-peptidoglycan (mAGP) complex, forms an exceptionally robust cell wall and provides a permeability barrier to antibiotics.', 'Metabolism; Glycan biosynthesis and metabolism', 'Arabinogalactan biosynthesis - Mycobacterium', 'ko00572', 'list(REFERENCE = \"PMID:26104198\", AUTHORS = \"Jankute M, Grover S, Birch HL, Besra GS\", TITLE = \"Genetics of Mycobacterial Arabinogalactan and Lipoarabinomannan Assembly.\", JOURNAL = c(\"Microbiol Spectr 2:MGM2-0013-2013 (2014)\", \"DOI:10.1128/microbiolspec.MGM2-0013-2013\")), list(REFERENCE = \"PMID:26488279\", AUTHORS = \"Jankute M, Cox JA, Harrison J, Besra GS\", TITLE = \"Assembly of the Mycobacterial Cell Wall.\", JOURNAL = c(\"Annu Rev Microbiol 69:405-23 (2015)\", \"DOI:10.1146/annurev-micro-091014-104121\")), list(REFERENCE = \"PMID:24915502\", AUTHORS = \"Angala SK, Belardinelli JM, Huc-Claustre E, Wheat WH, Jackson M\", TITLE = \"The cell envelope glycoconjugates of Mycobacterium tuberculosis.\", JOURNAL = c(\"Crit Rev Biochem Mol Biol 49:361-99 (2014)\", \"DOI:10.3109/10409238.2014.925420\")), list(REFERENCE = \"PMID:18627460\", AUTHORS = \"Birch HL, Alderwick LJ, Bhatt A, Rittmann D, Krumbach K, Singh A, Bai Y, Lowary TL, Eggeling L, Besra GS\", TITLE = \"Biosynthesis of mycobacterial arabinogalactan: identification of a novel alpha(1--&gt;3) arabinofuranosyltransferase.\", JOURNAL = c(\"Mol Microbiol 69:1191-206 (2008)\", \"DOI:10.1111/j.1365-2958.2008.06354.x\")), list(REFERENCE = \"PMID:18055597\", AUTHORS = \"Belanova M, Dianiskova P, Brennan PJ, Completo GC, Rose NL, Lowary TL, Mikusova K\", TITLE = \"Galactosyl transferases in mycobacterial cell wall synthesis.\", JOURNAL = c(\"J Bacteriol 190:1141-5 (2008)\", \"DOI:10.1128/JB.01326-07\")), list(REFERENCE = \"PMID:16595677\", AUTHORS = \"Alderwick LJ, Seidel M, Sahm H, Besra GS, Eggeling L\", TITLE = \"Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis.\", JOURNAL = c(\"J Biol Chem 281:15653-61 (2006)\", \"DOI:10.1074/jbc.M600045200\")), list(REFERENCE = \"PMID:1906464\", AUTHORS = \"McNeil M, Daffe M, Brennan PJ\", TITLE = \"Location of the mycolyl ester substituents in the cell walls of mycobacteria.\", JOURNAL = \"J Biol Chem 266:13217-23 (1991)\"), list(REFERENCE = \"PMID:27417139\", AUTHORS = \"Grzegorzewicz AE, de Sousa-d\'Auria C, McNeil MR, Huc-Claustre E, Jones V, Petit C, Angala SK, Zemanova J, Wang Q, Belardinelli JM, Gao Q, Ishizaki Y, Mikusova K, Brennan PJ, Ronning DR, Chami M, Houssin C, Jackson M\", TITLE = \"Assembling of the Mycobacterium tuberculosis Cell Wall Core.\", JOURNAL = c(\"J Biol Chem 291:18867-79 (2016)\", \"DOI:10.1074/jbc.M116.739227\")), list(REFERENCE = \"PMID:21555513\", AUTHORS = \"Bhamidi S, Scherman MS, Jones V, Crick DC, Belisle JT, Brennan PJ, McNeil MR\", TITLE = \"Detailed structural and quantitative analysis reveals the spatial organization of the cell walls of in vivo grown Mycobacterium leprae and in vitro grown Mycobacterium tuberculosis.\", JOURNAL = c(\"J Biol Chem 286:23168-77 (2011)\", \"DOI:10.1074/jbc.M110.210534\"))', 'map00572', 'Arabinogalactan biosynthesis - Mycobacterium', 'Just like lipoarabinomannan (map00571), arabinogalactan (AG) is a major heteropolysaccharide found on the mycobacterium cell wall. AG consists of a linear galactan chain of galactofuranosyl (Galf) residues covalently connected to peptidoglycan (PG), with branches of three similar arabinan chains comprising arabinofuranosyl (Araf) residues. The non-reducing ends of arabinans are often covalently attached to the long fatty acids of mycolic acids. Thus, the covalently linked network of PG and mycolylated AG, termed the mycolyl-arabinogalactan-peptidoglycan (mAGP) complex, forms an exceptionally robust cell wall and provides a permeability barrier to antibiotics.', 0, 70, 0, 0, 0, 0, 70, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (92, '00590', 'Arachidonic acid metabolism', 'Metabolism; Lipid metabolism', 'Arachidonic acid metabolism', 'Diaphyseal dysplasia with anemia, Leukotriene C4 synthase deficiency', 'GO: 0019369', 'ko00590', 'list(REFERENCE = \"PMID:14636671\", AUTHORS = \"Spector AA, Fang X, Snyder GD, Weintraub NL.\", TITLE = \"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.\", JOURNAL = c(\"Prog Lipid Res 43:55-90 (2004)\", \"DOI:10.1016/S0163-7827(03)00049-3\")), list(REFERENCE = \"PMID:15292194\", AUTHORS = \"Harman CA, Rieke CJ, Garavito RM, Smith WL.\", TITLE = \"Crystal structure of arachidonic acid bound to a mutant of prostaglandin endoperoxide H synthase-1 that forms predominantly 11-hydroperoxyeicosatetraenoic acid.\", JOURNAL = c(\"J Biol Chem 279:42929-35 (2004)\", \"DOI:10.1074/jbc.M403013200\")), list(REFERENCE = \"PMID:15205388\", AUTHORS = \"Poloyac SM, Tortorici MA, Przychodzin DI, Reynolds RB, Xie W, Frye RF, Zemaitis MA.\", TITLE = \"The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney.\", JOURNAL = c(\"Drug Metab Dispos 32:727-33 (2004)\", \"DOI:10.1124/dmd.32.7.727\")), list(REFERENCE = \"PMID:14660610\", AUTHORS = \"Chuang SS, Helvig C, Taimi M, Ramshaw HA, Collop AH, Amad M, White JA, Petkovich M, Jones G, Korczak B.\", TITLE = \"CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids.\", JOURNAL = c(\"J Biol Chem 279:6305-14 (2004)\", \"DOI:10.1074/jbc.M311830200\")), list(REFERENCE = \"PMID:14626496\", AUTHORS = \"Sacerdoti D, Gatta A, McGiff JC.\", TITLE = \"Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.\", JOURNAL = c(\"Prostaglandins Other Lipid Mediat 72:51-71 (2003)\", \"DOI:10.1016/S1098-8823(03)00077-7\")), list(REFERENCE = \"PMID:14622984\", AUTHORS = \"Pfister SL, Spitzbarth N, Zeldin DC, Lafite P, Mansuy D, Campbell WB.\", TITLE = \"Rabbit aorta converts 15-HPETE to trihydroxyeicosatrienoic acids: potential role of cytochrome P450.\", JOURNAL = c(\"Arch Biochem Biophys 420:142-52 (2003)\", \"DOI:10.1016/j.abb.2003.09.026\")), list(REFERENCE = \"PMID:11679404\", AUTHORS = \"Fleming I.\", TITLE = \"Cytochrome p450 and vascular homeostasis.\", JOURNAL = c(\"Circ Res 89:753-62 (2001)\", \"DOI:10.1161/hh2101.099268\")), list(REFERENCE = \"PMID:11328810\", AUTHORS = \"Qu W, Bradbury JA, Tsao CC, Maronpot R, Harry GJ, Parker CE, Davis LS, Breyer MD, Waalkes MP, Falck JR, Chen J, Rosenberg RL, Zeldin DC.\", TITLE = \"Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain.\", JOURNAL = c(\"J Biol Chem 276:25467-79 (2001)\", \"DOI:10.1074/jbc.M100545200\")), list(REFERENCE = \"PMID:10908295\", AUTHORS = \"Tsao CC, Foley J, Coulter SJ, Maronpot R, Zeldin DC, Goldstein JA.\", TITLE = \"CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract.\", JOURNAL = c(\"Mol Pharmacol 58:279-87 (2000)\", \"DOI:10.1124/mol.58.2.279\")), list(REFERENCE = \"PMID:9812980\", AUTHORS = \"Pfister SL, Spitzbarth N, Nithipatikom K, Edgemond WS, Falck JR, Campbell WB.\", TITLE = \"Identification of the 11,14,15- and 11,12, 15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta.\", JOURNAL = c(\"J Biol Chem 273:30879-87 (1998)\", \"DOI:10.1074/jbc.273.47.30879\"))', 'map00590', 'Arachidonic acid metabolism', 517, 3154, 248, 105, 125, 39, 3148, 6);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (93, '00591', 'Linoleic acid metabolism', 'Metabolism; Lipid metabolism', 'Linoleic acid metabolism', 'ko00591', 'list(REFERENCE = \"PMID:14757320\", AUTHORS = \"Nowak G, Grant DF, Moran JH.\", TITLE = \"Linoleic acid epoxide promotes the maintenance of mitochondrial function and active Na+ transport following hypoxia.\", JOURNAL = c(\"Toxicol Lett 147:161-75 (2004)\", \"DOI:10.1016/j.toxlet.2003.11.002\")), list(REFERENCE = \"PMID:12909723\", AUTHORS = \"Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman SM.\", TITLE = \"The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 100:9968-73 (2003)\", \"DOI:10.1073/pnas.1631086100\")), list(REFERENCE = \"PMID:12324235\", AUTHORS = \"Spiteller G.\", TITLE = \"Do changes in the cell membrane structure induce the generation of lipid peroxidation products which serve as first signalling molecules in cell to cell communication?\", JOURNAL = c(\"Prostaglandins Leukot Essent Fatty Acids 67:151-62 (2002)\", \"DOI:10.1054/plef.2002.0413\")), list(REFERENCE = \"PMID:11302930\", AUTHORS = \"Jude AR, Little JM, Bull AW, Podgorski I, Radominska-Pandya A.\", TITLE = \"13-hydroxy- and 13-oxooctadecadienoic acids: novel substrates for human UDP-glucuronosyltransferases.\", JOURNAL = \"Drug Metab Dispos 29:652-5 (2001)\"), list(REFERENCE = \"PMID:9694817\", AUTHORS = \"Su C, Sahlin M, Oliw EH.\", TITLE = \"A protein radical and ferryl intermediates are generated by linoleate diol synthase, a ferric hemeprotein with dioxygenase and hydroperoxide isomerase activities.\", JOURNAL = c(\"J Biol Chem 273:20744-51 (1998)\", \"DOI:10.1074/jbc.273.33.20744\")), list(REFERENCE = \"PMID:1634517\", AUTHORS = \"Brodowsky ID, Hamberg M, Oliw EH.\", TITLE = \"A linoleic acid (8R)-dioxygenase and hydroperoxide isomerase of the fungus Gaeumannomyces graminis. Biosynthesis of (8R)-hydroxylinoleic acid and (7S,8S)-dihydroxylinoleic acid from (8R)-hydroperoxylinoleic acid.\", JOURNAL = \"J Biol Chem 267:14738-45 (1992)\"), list(REFERENCE = \"PMID:12226220\", AUTHORS = \"Hamberg M, Hamberg G.\", TITLE = \"Peroxygenase-Catalyzed Fatty Acid Epoxidation in Cereal Seeds (Sequential Oxidation of Linoleic Acid into 9(S),12(S),13(S)-Trihydroxy-10(E)-Octadecenoic Acid).\", JOURNAL = c(\"Plant Physiol 110:807-815 (1996)\", \"DOI:10.1104/pp.110.3.807\")), list(REFERENCE = \"PMID:8765137\", AUTHORS = \"Moghaddam M, Motoba K, Borhan B, Pinot F, Hammock BD.\", TITLE = \"Novel metabolic pathways for linoleic and arachidonic acid metabolism.\", JOURNAL = c(\"Biochim Biophys Acta 1290:327-39 (1996)\", \"DOI:10.1016/0304-4165(96)00037-2\"))', 'map00591', 'Linoleic acid metabolism', 'Metabolism; Lipid metabolism', 'Linoleic acid metabolism', 343, 205, 187, 96, 54, 6, 205, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (94, '00592', 'alpha-Linolenic acid metabolism', 'Metabolism; Lipid metabolism', 'alpha-Linolenic acid metabolism', 'Jasmonic acid biosynthesis [PATH:map00592]', 'ko00592', 'list(REFERENCE = \"PMID:17172287\", AUTHORS = \"Schilmiller AL, Koo AJ, Howe GA.\", TITLE = \"Functional diversification of acyl-coenzyme A oxidases in jasmonic acid biosynthesis and action.\", JOURNAL = c(\"Plant Physiol 143:812-24 (2007)\", \"DOI:10.1104/pp.106.092916\")), list(REFERENCE = \"PMID:15141068\", AUTHORS = \"Cruz Castillo M, Martinez C, Buchala A, Metraux JP, Leon J.\", TITLE = \"Gene-specific involvement of beta-oxidation in wound-activated responses in Arabidopsis.\", JOURNAL = c(\"Plant Physiol 135:85-94 (2004)\", \"DOI:10.1104/pp.104.039925\")), list(REFERENCE = \"PMID:17215350\", AUTHORS = \"Truman W, Bennett MH, Kubigsteltig I, Turnbull C, Grant M.\", TITLE = \"Arabidopsis systemic immunity uses conserved defense signaling pathways and is mediated by jasmonates.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 104:1075-80 (2007)\", \"DOI:10.1073/pnas.0605423104\")), list(REFERENCE = \"PMID:16116284\", AUTHORS = \"Kuroda H, Oshima T, Kaneda H, Takashio M.\", TITLE = \"Identification and functional analyses of two cDNAs that encode fatty acid 9-/13-hydroperoxide lyase (CYP74C) in rice.\", JOURNAL = c(\"Biosci Biotechnol Biochem 69:1545-54 (2005)\", \"DOI:10.1271/bbb.69.1545\")), list(REFERENCE = \"PMID:15670154\", AUTHORS = \"Hamberg M.\", TITLE = \"Hidden stereospecificity in the biosynthesis of divinyl ether fatty acids.\", JOURNAL = c(\"FEBS J 272:736-43 (2005)\", \"DOI:10.1111/j.1742-4658.2004.04510.x\")), list(REFERENCE = \"PMID:14522973\", AUTHORS = \"Hamberg M, Sanz A, Rodriguez MJ, Calvo AP, Castresana C.\", TITLE = \"Activation of the fatty acid alpha-dioxygenase pathway during bacterial infection of tobacco leaves. Formation of oxylipins protecting against cell death.\", JOURNAL = c(\"J Biol Chem 278:51796-805 (2003)\", \"DOI:10.1074/jbc.M310514200\")), list(REFERENCE = \"\", AUTHORS = \"Creelman RA, Mulpuri R.\", TITLE = \"The Oxylipin Pathway in Arabidopsis\", JOURNAL = c(\"The Arabidopsis Book 1:e0012 (2002)\", \"DOI:10.1199/tab.0012\"))', 'map00592', 'alpha-Linolenic acid metabolism', 'Metabolism; Lipid metabolism', 506, 3040, 246, 105, 127, 28, 2977, 63);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (95, '00600', 'Sphingolipid metabolism', 'Metabolism; Lipid metabolism', 'Sphingolipid metabolism', 'Lactosylceramide biosynthesis [PATH:map00600], Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid [PATH:map00600], Ceramide biosynthesis [PATH:map00600], Sphingosine biosynthesis [PATH:map00600], Sphingosine degradation [PATH:map00600]', 'Fabry disease, Gaucher disease, Metachromatic leukodystrophy, Krabbe disease, Niemann-Pick disease type A/B, Farber lipogranulomatosis, Sialidosis, Hereditary sensory and autonomic neuropathy, GM1 gangliosidosis, Sphingolipidosis, Defects in the degradation of sphingomyelin, Gangliosidosis', 'GO: 0006665 0030148', 'ko00600', 'list(REFERENCE = \"PMID:12011104\", AUTHORS = \"Merrill AH Jr.\", TITLE = \"De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway.\", JOURNAL = c(\"J Biol Chem 277:25843-6 (2002)\", \"DOI:10.1074/jbc.R200009200\")), list(REFERENCE = \"PMID:10652340\", AUTHORS = \"Tani M, Okino N, Mitsutake S, Tanigawa T, Izu H, Ito M.\", TITLE = \"Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized.\", JOURNAL = c(\"J Biol Chem 275:3462-8 (2000)\", \"DOI:10.1074/jbc.275.5.3462\")), list(REFERENCE = \"PMID:11305904\", AUTHORS = \"Hannun YA, Luberto C, Argraves KM.\", TITLE = \"Enzymes of sphingolipid metabolism: from modular to integrative signaling.\", JOURNAL = c(\"Biochemistry 40:4893-903 (2001)\", \"DOI:10.1021/bi002836k\")), list(REFERENCE = \"PMID:1495423\", AUTHORS = \"Merrill AH Jr, Wang E.\", TITLE = \"Enzymes of ceramide biosynthesis.\", JOURNAL = c(\"Methods Enzymol 209:427-37 (1992)\", \"DOI:10.1016/0076-6879(92)09053-6\")), list(REFERENCE = \"PMID:8457204\", AUTHORS = \"Hirschberg K, Rodger J, Futerman AH.\", TITLE = \"The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver.\", JOURNAL = c(\"Biochem J 290 ( Pt 3):751-7 (1993)\", \"DOI:10.1042/bj2900751\")), list(REFERENCE = \"PMID:10366774\", AUTHORS = \"Dickson RC, Lester RL.\", TITLE = \"Metabolism and selected functions of sphingolipids in the yeast Saccharomyces cerevisiae.\", JOURNAL = c(\"Biochim Biophys Acta 1438:305-21 (1999)\", \"DOI:10.1016/S1388-1981(99)00068-2\"))', 'map00600', 517, 2018, 248, 105, 128, 36, 1986, 32);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (96, '00601', 'Glycosphingolipid biosynthesis - lacto and neolacto series', 'Metabolism; Glycan biosynthesis and metabolism', 'Glycosphingolipid biosynthesis - lacto and neolacto series', 'Glycosphingolipid biosynthesis, lacto-series, LacCer => Lc4Cer [PATH:map00601], Glycosphingolipid biosynthesis, neolacto-series, LacCer => nLc4Cer [PATH:map00601]', 'Adult i phenotype, West syndrome', 'ko00601', 'map00601', 'Glycosphingolipid biosynthesis - lacto and neolacto series', 'Metabolism; Glycan biosynthesis and metabolism', 340, 8, 245, 92, 1, 2, 6, 2);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (97, '00603', 'Glycosphingolipid biosynthesis - globo and isoglobo series', 'Metabolism; Glycan biosynthesis and metabolism', 'Glycosphingolipid biosynthesis - globo and isoglobo series', 'Glycosphingolipid biosynthesis, globo-series, LacCer => Gb4Cer [PATH:map00603]', 'GM2 gangliosidoses, Fabry disease, Alpha-N-acetylgalactosaminidase deficiency, Glycoproteinoses', 'ko00603', 'list(REFERENCE = \"PMID:12716912\", AUTHORS = \"Saito S, Aoki H, Ito A, Ueno S, Wada T, Mitsuzuka K, Satoh M, Arai Y, Miyagi T.\", TITLE = \"Human alpha2,3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase.\", JOURNAL = c(\"J Biol Chem 278:26474-9 (2003)\", \"DOI:10.1074/jbc.M213223200\")), list(REFERENCE = \"PMID:10837462\", AUTHORS = \"Zhou D, Henion TR, Jungalwala FB, Berger EG, Hennet T.\", TITLE = \"The beta 1,3-galactosyltransferase beta 3GalT-V is a stage-specific embryonic antigen-3 (SSEA-3) synthase.\", JOURNAL = c(\"J Biol Chem 275:22631-4 (2000)\", \"DOI:10.1074/jbc.C000263200\")), list(REFERENCE = \"PMID:10748143\", AUTHORS = \"Kojima Y, Fukumoto S, Furukawa K, Okajima T, Wiels J, Yokoyama K, Suzuki Y, Urano T, Ohta M, Furukawa K.\", TITLE = \"Molecular cloning of globotriaosylceramide/CD77 synthase, aglycosyltransferase that initiates the synthesis of globo seriesglycosphingolipids.\", JOURNAL = c(\"J Biol Chem 275:15152-6 (2000)\", \"DOI:10.1074/jbc.M909620199\")), list(REFERENCE = \"PMID:10854428\", AUTHORS = \"Keusch JJ, Manzella SM, Nyame KA, Cummings RD, Baenziger JU.\", TITLE = \"Cloning of Gb3 synthase, the key enzyme in globo-series glycosphingolipidsynthesis, predicts a family of alpha 1, 4-glycosyltransferases conservedin plants, insects, and mammals.\", JOURNAL = c(\"J Biol Chem 275:25315-21 (2000)\", \"DOI:10.1074/jbc.M002630200\")), list(REFERENCE = \"PMID:10854427\", AUTHORS = \"Keusch JJ, Manzella SM, Nyame KA, Cummings RD, Baenziger JU\", TITLE = \"Expression cloning of a new member of the ABO blood group glycosyltransferases, iGb3 synthase, that directs the synthesis of isoglobo-glycosphingolipids.\", JOURNAL = c(\"J Biol Chem 275:25308-14 (2000)\", \"DOI:10.1074/jbc.M002629200\"))', 'map00603', 'Glycosphingolipid biosynthesis - globo and isoglobo series', 429, 0, 247, 95, 73, 14, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (98, '00604', 'Glycosphingolipid biosynthesis - ganglio series', 'Metabolism; Glycan biosynthesis and metabolism', 'Glycosphingolipid biosynthesis - ganglio series', 'Glycosphingolipid biosynthesis, ganglio series, LacCer => GT3 [PATH:map00604]', 'GM2 gangliosidoses, GM1 gangliosidosis, Gangliosidosis, Amish infantile epilepsy syndrome', 'ko00604', 'map00604', 'Glycosphingolipid biosynthesis - ganglio series', 'Metabolism; Glycan biosynthesis and metabolism', 376, 0, 248, 99, 0, 29, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (99, '00620', 'Pyruvate metabolism', 'Metabolism; Carbohydrate metabolism', 'Pyruvate metabolism', 'CAM (Crassulacean acid metabolism), dark [PATH:map00620], CAM (Crassulacean acid metabolism), light [PATH:map00620], C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map00620], Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map00620], Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map00620]', 'Pyruvate dehydrogenase complex deficiency, Pyruvate carboxylase deficiency, Pyruvate kinase deficiency, Glycogen storage disease type XI, Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-beta deficiency, Pyruvate dehydrogenase E2 deficiency, Dihydrolipoamide dehydrogenase deficiency', 'GO: 0006090', 'ko00620', 'list(REFERENCE = \"\", AUTHORS = \"Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\", TITLE = \"[Cellular Functions and Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1997)\")', 'map00620', 531, 5560, 248, 105, 128, 50, 5262, 298);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (100, '00621', 'Dioxin degradation', 'Dioxins and dioxin-like compounds, including PCDDs, PCDFs and PCBs, are persistent organic pollutants (POPs) that are resistant to environmental degradation. However, POPs can be degraded by certain microorganisms with acquisition of a novel set of enzymes, such as biphenyl degradation by Paraburkholderia xenovorans LB400 involving four novel enzymes encoded in operon-like structures [MD:M00543]. DDT, another POP, and carbazol are also known to be degraded in similar pathways.', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Dioxin degradation', 'Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate [PATH:map00621], Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate [PATH:map00621]', 'UMBBD: dpd dbf bph cbp car ddt', 'ko00621', 'list(REFERENCE = \"PMID:12450109\", AUTHORS = \"Nojiri H, Omori T.\", TITLE = \"Molecular bases of aerobic bacterial degradation of dioxins: involvement of angular dioxygenation.\", JOURNAL = c(\"Biosci Biotechnol Biochem 66:2001-16 (2002)\", \"DOI:10.1271/bbb.66.2001\")), list(REFERENCE = \"PMID:16775784\", AUTHORS = \"Jin S, Zhu T, Xu X, Xu Y.\", TITLE = \"Biodegradation of dibenzofuran by Janibacter terrae strain XJ-1.\", JOURNAL = c(\"Curr Microbiol 53:30-6 (2006)\", \"DOI:10.1007/s00284-005-0180-1\")), list(REFERENCE = \"PMID:12483604\", AUTHORS = \"Nojiri H, Habe H, Omori T.\", TITLE = \"Bacterial degradation of aromatic compounds via angular dioxygenation.\", JOURNAL = c(\"J Gen Appl Microbiol 47:279-305 (2001)\", \"DOI:10.2323/jgam.47.279\")), list(REFERENCE = \"PMID:11322788\", AUTHORS = \"Kasuga K, Habe H, Chung JS, Yoshida T, Nojiri H, Yamane H, Omori T.\", TITLE = \"Isolation and characterization of the genes encoding a novel oxygenase component of angular dioxygenase from the gram-positive dibenzofuran-degrader Terrabacter sp. strain DBF63.\", JOURNAL = c(\"Biochem Biophys Res Commun 283:195-204 (2001)\", \"DOI:10.1006/bbrc.2001.4763\")), list(REFERENCE = \"PMID:17142386\", AUTHORS = \"Vezina J, Barriault D, Sylvestre M\", TITLE = \"Family shuffling of soil DNA to change the regiospecificity of Burkholderia xenovorans LB400 biphenyl dioxygenase.\", JOURNAL = c(\"J Bacteriol 189:779-88 (2007)\", \"DOI:10.1128/JB.01267-06\")), list(REFERENCE = \"PMID:12501294\", AUTHORS = \"Ouchiyama N, Miyachi S, Omori T\", TITLE = \"Cloning and nucleotide sequence of carbazole catabolic genes from Pseudomonas stutzeri strain OM1, isolated from activated sludge.\", JOURNAL = c(\"J Gen Appl Microbiol 44:57-63 (1998)\", \"DOI:10.2323/jgam.44.57\")), list(REFERENCE = \"PMID:9244273\", AUTHORS = \"Sato SI, Ouchiyama N, Kimura T, Nojiri H, Yamane H, Omori T\", TITLE = \"Cloning of genes involved in carbazole degradation of Pseudomonas sp. strain CA10: nucleotide sequences of genes and characterization of meta-cleavage enzymes and hydrolase.\", JOURNAL = c(\"J Bacteriol 179:4841-9 (1997)\", \"DOI:10.1128/JB.179.15.4841-4849.1997\")), list(REFERENCE = \"PMID:23415487\", AUTHORS = \"Nguyen PA, Trinh TH, Fukumitsu Y, Shimodaira J, Miyauchi K, Tokuda M, Kasai D, Masai E, Fukuda M\", TITLE = \"Gene cluster and regulation system for 1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene (DDE) degradation in Janibacter sp.  TYM3221.\", JOURNAL = c(\"J Biosci Bioeng 116:91-100 (2013)\", \"DOI:10.1016/j.jbiosc.2013.01.007\"))', 'map00621', 0, 1139, 0, 0, 0, 0, 1135, 4);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (101, '00622', 'Xylene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Xylene degradation', 'Cymene degradation, p-cymene => p-cumate [PATH:map00622], Xylene degradation, xylene => methylbenzoate [PATH:map00622], Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate [PATH:map00622], Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map00622], Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map00622]', 'GO: 0042184, UMBBD: mxy oxy pxy pcy tol', 'ko00622', 'list(REFERENCE = \"PMID:11375157\", AUTHORS = \"Haddad S, Eby DM, Neidle EL.\", TITLE = \"Cloning and expression of the benzoate dioxygenase genes from Rhodococcus sp. strain 19070.\", JOURNAL = c(\"Appl Environ Microbiol 67:2507-14 (2001)\", \"DOI:10.1128/AEM.67.6.2507-2514.2001\")), list(REFERENCE = \"PMID:7768806\", AUTHORS = \"Kim E, Zylstra GJ\", TITLE = \"Molecular and biochemical characterization of two meta-cleavage dioxygenases involved in biphenyl and m-xylene degradation by Beijerinckia sp. strain B1.\", JOURNAL = c(\"J Bacteriol 177:3095-103 (1995)\", \"DOI:10.1128/JB.177.11.3095-3103.1995\")), list(REFERENCE = \"PMID:15127183\", AUTHORS = \"Morasch B, Schink B, Tebbe CC, Meckenstock RU\", TITLE = \"Degradation of o-xylene and m-xylene by a novel sulfate-reducer belonging to the genus Desulfotomaculum.\", JOURNAL = c(\"Arch Microbiol 181:407-17 (2004)\", \"DOI:10.1007/s00203-004-0672-6\")), list(REFERENCE = \"PMID:9150211\", AUTHORS = \"Eaton RW.\", TITLE = \"p-Cymene catabolic pathway in Pseudomonas putida F1: cloning and characterization of DNA encoding conversion of p-cymene to p-cumate.\", JOURNAL = c(\"J Bacteriol 179:3171-80 (1997)\", \"DOI:10.1128/JB.179.10.3171-3180.1997\")), list(REFERENCE = \"PMID:8631713\", AUTHORS = \"Eaton RW.\", TITLE = \"p-Cumate catabolic pathway in Pseudomonas putida Fl: cloning and characterization of DNA carrying the cmt operon.\", JOURNAL = c(\"J Bacteriol 178:1351-62 (1996)\", \"DOI:10.1128/JB.178.5.1351-1362.1996\"))', 'map00622', 'Xylene degradation', 0, 2333, 0, 0, 0, 0, 2266, 67);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (102, '00623', 'Toluene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Toluene degradation', 'Toluene degradation, anaerobic, toluene => benzoyl-CoA [PATH:map00623], Toluene degradation, toluene => benzoate [PATH:map00623], Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map00623]', 'GO: 0042203, UMBBD: tol tol2 tsa dct', 'ko00623', 'list(REFERENCE = \"PMID:15184119\", AUTHORS = \"Vardar G, Wood TK\", TITLE = \"Protein engineering of toluene-o-xylene monooxygenase from Pseudomonas stutzeri OX1 for synthesizing 4-methylresorcinol, methylhydroquinone, and pyrogallol.\", JOURNAL = c(\"Appl Environ Microbiol 70:3253-62 (2004)\", \"DOI:10.1128/AEM.70.6.3253-3262.2004\")), list(REFERENCE = \"PMID:10629170\", AUTHORS = \"Leuthner B, Heider J\", TITLE = \"Anaerobic toluene catabolism of Thauera aromatica: the bbs operon codes for enzymes of beta oxidation of the intermediate benzylsuccinate.\", JOURNAL = c(\"J Bacteriol 182:272-7 (2000)\", \"DOI:10.1128/JB.182.2.272-277.2000\")), list(REFERENCE = \"PMID:11418570\", AUTHORS = \"Leutwein C, Heider J\", TITLE = \"Succinyl-CoA:(R)-benzylsuccinate CoA-transferase: an enzyme of the anaerobic toluene catabolic pathway in denitrifying bacteria.\", JOURNAL = c(\"J Bacteriol 183:4288-95 (2001)\", \"DOI:10.1128/JB.183.14.4288-4295.2001\")), list(REFERENCE = \"PMID:15687214\", AUTHORS = \"Kuhner S, Wohlbrand L, Fritz I, Wruck W, Hultschig C, Hufnagel P, Kube M, Reinhardt R, Rabus R\", TITLE = \"Substrate-dependent regulation of anaerobic degradation pathways for toluene and ethylbenzene in a denitrifying bacterium, strain EbN1.\", JOURNAL = c(\"J Bacteriol 187:1493-503 (2005)\", \"DOI:10.1128/JB.187.4.1493-1503.2005\")), list(REFERENCE = \"PMID:2050632\", AUTHORS = \"Locher HH, Leisinger T, Cook AM\", TITLE = \"4-Toluene sulfonate methyl-monooxygenase from Comamonas testosteroni T-2: purification and some properties of the oxygenase component.\", JOURNAL = c(\"J Bacteriol 173:3741-8 (1991)\", \"DOI:10.1128/JB.173.12.3741-3748.1991\")), list(REFERENCE = \"PMID:8828208\", AUTHORS = \"Junker F, Saller E, Schlafli Oppenberg HR, Kroneck PM, Leisinger T, Cook AM\", TITLE = \"Degradative pathways for p-toluenecarboxylate and p-toluenesulfonate and their multicomponent oxygenases in Comamonas testosteroni strains PSB-4 and T-2.\", JOURNAL = c(\"Microbiology 142 ( Pt 9):2419-27 (1996)\", \"DOI:10.1099/00221287-142-9-2419\")), list(REFERENCE = \"PMID:10589735\", AUTHORS = \"Mampel J, Ruff J, Junker F, Cook AM.\", TITLE = \"The oxygenase component of the 2-aminobenzenesulfonate dioxygenase system from Alcaligenes sp. strain O-1.\", JOURNAL = c(\"Microbiology 145 ( Pt 11):3255-64 (1999)\", \"DOI:10.1099/00221287-145-11-3255\")), list(REFERENCE = \"PMID:9006050\", AUTHORS = \"Junker F, Kiewitz R, Cook AM\", TITLE = \"Characterization of the p-toluenesulfonate operon tsaMBCD and tsaR in Comamonas testosteroni T-2.\", JOURNAL = c(\"J Bacteriol 179:919-27 (1997)\", \"DOI:10.1128/JB.179.3.919-927.1997\"))', 'map00623', 'Toluene degradation', 0, 2365, 0, 0, 0, 0, 2302, 63);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (103, '00624', 'Polycyclic aromatic hydrocarbon degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Polycyclic aromatic hydrocarbon degradation', 'Phthalate degradation, phthalate => protocatechuate [PATH:map00624], Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate [PATH:map00624], Phthalate degradation, phthalate => protocatechuate [PATH:map00624]', 'UMBBD: flu ant pha pyr bap pth', 'ko00624', 'list(REFERENCE = \"PMID:11766961\", AUTHORS = \"Wattiau P, Bastiaens L, van Herwijnen R, Daal L, Parsons JR, Renard ME, Springael D, Cornelis GR.\", TITLE = \"Fluorene degradation by Sphingomonas sp. LB126 proceeds through protocatechuic acid: a genetic analysis.\", JOURNAL = c(\"Res Microbiol 152:861-72 (2001)\", \"DOI:10.1016/S0923-2508(01)01269-4\")), list(REFERENCE = \"PMID:15386141\", AUTHORS = \"Story SP, Kline EL, Hughes TA, Riley MB, Hayasaka SS.\", TITLE = \"Degradation of aromatic hydrocarbons by Sphingomonas paucimobilis strain EPA505.\", JOURNAL = c(\"Arch Environ Contam Toxicol 47:168-76 (2004)\", \"DOI:10.1007/s00244-004-3069-2\")), list(REFERENCE = \"PMID:15317800\", AUTHORS = \"Habe H, Chung JS, Kato H, Ayabe Y, Kasuga K, Yoshida T, Nojiri H, Yamane H, Omori T.\", TITLE = \"Characterization of the upper pathway genes for fluorene metabolism in Terrabacter sp. strain DBF63.\", JOURNAL = c(\"J Bacteriol 186:5938-44 (2004)\", \"DOI:10.1128/JB.186.17.5938-5944.2004\")), list(REFERENCE = \"PMID:12483604\", AUTHORS = \"Nojiri H, Habe H, Omori T.\", TITLE = \"Bacterial degradation of aromatic compounds via angular dioxygenation.\", JOURNAL = c(\"J Gen Appl Microbiol 47:279-305 (2001)\", \"DOI:10.2323/jgam.47.279\")), list(REFERENCE = \"PMID:17258432\", AUTHORS = \"Pagnout C, Frache G, Poupin P, Maunit B, Muller JF, Ferard JF.\", TITLE = \"Isolation and characterization of a gene cluster involved in PAH degradation in Mycobacterium sp. strain SNP11: expression in Mycobacterium smegmatis mc(2)155.\", JOURNAL = c(\"Res Microbiol 158:175-86 (2007)\", \"DOI:10.1016/j.resmic.2006.11.002\")), list(REFERENCE = \"PMID:11682202\", AUTHORS = \"Dean-Ross D, Moody JD, Freeman JP, Doerge DR, Cerniglia CE.\", TITLE = \"Metabolism of anthracene by a Rhodococcus species.\", JOURNAL = c(\"FEMS Microbiol Lett 204:205-11 (2001)\", \"DOI:10.1111/j.1574-6968.2001.tb10886.x\")), list(REFERENCE = \"PMID:11282593\", AUTHORS = \"Moody JD, Freeman JP, Doerge DR, Cerniglia CE.\", TITLE = \"Degradation of phenanthrene and anthracene by cell suspensions of Mycobacterium sp. strain PYR-1.\", JOURNAL = c(\"Appl Environ Microbiol 67:1476-83 (2001)\", \"DOI:10.1128/AEM.67.4.1476-1483.2001\")), list(REFERENCE = \"PMID:12513994\", AUTHORS = \"van Herwijnen R, Springael D, Slot P, Govers HA, Parsons JR.\", TITLE = \"Degradation of anthracene by Mycobacterium sp. strain LB501T proceeds via a novel pathway, through o-phthalic acid.\", JOURNAL = c(\"Appl Environ Microbiol 69:186-90 (2003)\", \"DOI:10.1128/AEM.69.1.186-190.2003\")), list(REFERENCE = \"PMID:19442441\", AUTHORS = \"Haritash AK, Kaushik CP\", TITLE = \"Biodegradation aspects of polycyclic aromatic hydrocarbons (PAHs): a review.\", JOURNAL = c(\"J Hazard Mater 169:1-15 (2009)\", \"DOI:10.1016/j.jhazmat.2009.03.137\")), list(REFERENCE = \"PMID:17041157\", AUTHORS = \"Liang Y, Gardner DR, Miller CD, Chen D, Anderson AJ, Weimer BC, Sims RC\", TITLE = \"Study of biochemical pathways and enzymes involved in pyrene degradation by Mycobacterium sp. strain KMS.\", JOURNAL = c(\"Appl Environ Microbiol 72:7821-8 (2006)\", \"DOI:10.1128/AEM.01274-06\")), list(REFERENCE = \"PMID:15488584\", AUTHORS = \"da Silva M, Esposito E, Moody JD, Canhos VP, Cerniglia CE\", TITLE = \"Metabolism of aromatic hydrocarbons by the filamentous fungus Cyclothyrium sp.\", JOURNAL = c(\"Chemosphere 57:943-52 (2004)\", \"DOI:10.1016/j.chemosphere.2004.07.051\")), list(REFERENCE = \"PMID:17085566\", AUTHORS = \"Kim SJ, Kweon O, Jones RC, Freeman JP, Edmondson RD, Cerniglia CE\", TITLE = \"Complete and integrated pyrene degradation pathway in Mycobacterium vanbaalenii PYR-1 based on systems biology.\", JOURNAL = c(\"J Bacteriol 189:464-72 (2007)\", \"DOI:10.1128/JB.01310-06\")), list(REFERENCE = \"PMID:9094229\", AUTHORS = \"Wunder T, Marr J, Kremer S, Sterner O, Anke H\", TITLE = \"1-Methoxypyrene and 1,6-dimethoxypyrene: two novel metabolites in fungal metabolism of polycyclic aromatic hydrocarbons.\", JOURNAL = c(\"Arch Microbiol 167:310-6 (1997)\", \"DOI:10.1007/s002030050449\")), list(REFERENCE = \"PMID:8572690\", AUTHORS = \"Schneider J, Grosser R, Jayasimhulu K, Xue W, Warshawsky D\", TITLE = \"Degradation of pyrene, benz[a]anthracene, and benzo[a]pyrene by Mycobacterium sp. strain RJGII-135, isolated from a former coal gasification site.\", JOURNAL = \"Appl Environ Microbiol 62:13-9 (1996)\"), list(REFERENCE = \"PMID:14711661\", AUTHORS = \"Moody JD, Freeman JP, Fu PP, Cerniglia CE\", TITLE = \"Degradation of benzo[a]pyrene by Mycobacterium vanbaalenii PYR-1.\", JOURNAL = c(\"Appl Environ Microbiol 70:340-5 (2004)\", \"DOI:10.1128/AEM.70.1.340-345.2004\")), list(REFERENCE = \"PMID:11371533\", AUTHORS = \"Eaton RW\", TITLE = \"Plasmid-encoded phthalate catabolic pathway in Arthrobacter keyseri 12B.\", JOURNAL = c(\"J Bacteriol 183:3689-703 (2001)\", \"DOI:10.1128/JB.183.12.3689-3703.2001\")), list(REFERENCE = \"PMID:26965627\", AUTHORS = \"Yoshida S, Hiraga K, Takehana T, Taniguchi I, Yamaji H, Maeda Y, Toyohara K, Miyamoto K, Kimura Y, Oda K\", TITLE = \"A bacterium that degrades and assimilates poly(ethylene terephthalate).\", JOURNAL = c(\"Science 351:1196-9 (2016)\", \"DOI:10.1126/science.aad6359\"))', 'map00624', 'Polycyclic aromatic hydrocarbon degradation', 0, 817, 0, 0, 0, 0, 812, 5);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (104, '00625', 'Chloroalkane and chloroalkene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Chloroalkane and chloroalkene degradation', 'UMBBD: tce tce2 tca atl dcm dce cpr caa', 'ko00625', 'list(REFERENCE = \"PMID:15294827\", AUTHORS = \"Muller JA, Rosner BM, Von Abendroth G, Meshulam-Simon G, McCarty PL, Spormann AM.\", TITLE = \"Molecular identification of the catabolic vinyl chloride reductase from Dehalococcoides sp. strain VS and its environmental distribution.\", JOURNAL = c(\"Appl Environ Microbiol 70:4880-8 (2004)\", \"DOI:10.1128/AEM.70.8.4880-4888.2004\")), list(REFERENCE = \"PMID:16957242\", AUTHORS = \"Lee PK, Johnson DR, Holmes VF, He J, Alvarez-Cohen L.\", TITLE = \"Reductive dehalogenase gene expression as a biomarker for physiological activity of Dehalococcoides spp.\", JOURNAL = c(\"Appl Environ Microbiol 72:6161-8 (2006)\", \"DOI:10.1128/AEM.01070-06\")), list(REFERENCE = \"PMID:15865156\", AUTHORS = \"Torz M, Beschkov V\", TITLE = \"Biodegradation of monochloroacetic acid used as a sole carbon and energy source by Xanthobacter autotrophicus GJ10 strain in batch and continuous culture.\", JOURNAL = c(\"Biodegradation 16:423-33 (2005)\", \"DOI:10.1007/s10532-004-3614-8\")), list(REFERENCE = \"PMID:10347028\", AUTHORS = \"Hage JC, Hartmans S\", TITLE = \"Monooxygenase-mediated 1,2-dichloroethane degradation by Pseudomonas sp. strain DCA1.\", JOURNAL = \"Appl Environ Microbiol 65:2466-70 (1999)\"), list(REFERENCE = \"PMID:9687453\", AUTHORS = \"Poelarends GJ, Wilkens M, Larkin MJ, van Elsas JD, Janssen DB.\", TITLE = \"Degradation of 1,3-dichloropropene by pseudomonas cichorii 170.\", JOURNAL = \"Appl Environ Microbiol 64:2931-6 (1998)\"), list(REFERENCE = \"PMID:12411705\", AUTHORS = \"Sun B, Griffin BM, Ayala-del-Rio HL, Hashsham SA, Tiedje JM\", TITLE = \"Microbial dehalorespiration with 1,1,1-trichloroethane.\", JOURNAL = c(\"Science 298:1023-5 (2002)\", \"DOI:10.1126/science.1074675\")), list(REFERENCE = \"PMID:11999413\", AUTHORS = \"Hashimoto A, Iwasaki K, Nakasugi N, Nakajima M, Yagi O\", TITLE = \"Degradation pathways of trichloroethylene and 1,1,1-trichloroethane by Mycobacterium sp. TA27.\", JOURNAL = c(\"Biosci Biotechnol Biochem 66:385-90 (2002)\", \"DOI:10.1271/bbb.66.385\")), list(REFERENCE = \"PMID:1768109\", AUTHORS = \"Newman LM, Wackett LP\", TITLE = \"Fate of 2,2,2-trichloroacetaldehyde (chloral hydrate) produced during trichloroethylene oxidation by methanotrophs.\", JOURNAL = \"Appl Environ Microbiol 57:2399-402 (1991)\"), list(REFERENCE = \"PMID:8981984\", AUTHORS = \"Newman LM, Wackett LP\", TITLE = \"Trichloroethylene oxidation by purified toluene 2-monooxygenase: products, kinetics, and turnover-dependent inactivation.\", JOURNAL = c(\"J Bacteriol 179:90-6 (1997)\", \"DOI:10.1128/JB.179.1.90-96.1997\"))', 'map00625', 'Chloroalkane and chloroalkene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 0, 4404, 0, 0, 0, 0, 4247, 157);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (105, '00626', 'Naphthalene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Naphthalene degradation', 'Naphthalene degradation, naphthalene => salicylate [PATH:map00626], Salicylate degradation, salicylate => gentisate [PATH:map00626]', 'UMBBD: naph nphs 1mna npa 2mna 2mna2', 'ko00626', 'list(REFERENCE = \"PMID:16461648\", AUTHORS = \"Kim SJ, Kweon O, Freeman JP, Jones RC, Adjei MD, Jhoo JW, Edmondson RD, Cerniglia CE.\", TITLE = \"Molecular cloning and expression of genes encoding a novel dioxygenase involved in low- and high-molecular-weight polycyclic aromatic hydrocarbon degradation in Mycobacterium vanbaalenii PYR-1.\", JOURNAL = c(\"Appl Environ Microbiol 72:1045-54 (2006)\", \"DOI:10.1128/AEM.72.2.1045-1054.2006\")), list(REFERENCE = \"PMID:8226631\", AUTHORS = \"Denome SA, Stanley DC, Olson ES, Young KD\", TITLE = \"Metabolism of dibenzothiophene and naphthalene in Pseudomonas strains: complete DNA sequence of an upper naphthalene catabolic pathway.\", JOURNAL = c(\"J Bacteriol 175:6890-901 (1993)\", \"DOI:10.1128/JB.175.21.6890-6901.1993\")), list(REFERENCE = \"PMID:1447127\", AUTHORS = \"Eaton RW, Chapman PJ\", TITLE = \"Bacterial metabolism of naphthalene: construction and use of recombinant bacteria to study ring cleavage of 1,2-dihydroxynaphthalene and subsequent reactions.\", JOURNAL = c(\"J Bacteriol 174:7542-54 (1992)\", \"DOI:10.1128/JB.174.23.7542-7554.1992\")), list(REFERENCE = \"PMID:8981987\", AUTHORS = \"Morawski B, Eaton RW, Rossiter JT, Guoping S, Griengl H, Ribbons DW\", TITLE = \"2-Naphthoate catabolic pathway in Burkholderia strain JT 1500.\", JOURNAL = c(\"J Bacteriol 179:115-21 (1997)\", \"DOI:10.1128/JB.179.1.115-121.1997\")), list(REFERENCE = \"PMID:15500985\", AUTHORS = \"Safinowski M, Meckenstock RU\", TITLE = \"Enzymatic reactions in anaerobic 2-methylnaphthalene degradation by the sulphate-reducing enrichment culture N 47.\", JOURNAL = c(\"FEMS Microbiol Lett 240:99-104 (2004)\", \"DOI:10.1016/j.femsle.2004.09.014\")), list(REFERENCE = \"PMID:11097910\", AUTHORS = \"Annweiler E, Materna A, Safinowski M, Kappler A, Richnow HH, Michaelis W, Meckenstock RU\", TITLE = \"Anaerobic degradation of 2-methylnaphthalene by a sulfate-reducing enrichment culture.\", JOURNAL = c(\"Appl Environ Microbiol 66:5329-33 (2000)\", \"DOI:10.1128/AEM.66.12.5329-5333.2000\")), list(REFERENCE = \"PMID:11823228\", AUTHORS = \"Annweiler E, Michaelis W, Meckenstock RU\", TITLE = \"Identical ring cleavage products during anaerobic degradation of naphthalene, 2-methylnaphthalene, and tetralin indicate a new metabolic pathway.\", JOURNAL = c(\"Appl Environ Microbiol 68:852-8 (2002)\", \"DOI:10.1128/AEM.68.2.852-858.2002\")), list(REFERENCE = \"PMID:15372028\", AUTHORS = \"Aitken CM, Jones DM, Larter SR\", TITLE = \"Anaerobic hydrocarbon biodegradation in deep subsurface oil reservoirs.\", JOURNAL = c(\"Nature 431:291-4 (2004)\", \"DOI:10.1038/nature02922\")), list(REFERENCE = \"PMID:19854898\", AUTHORS = \"Selesi D, Jehmlich N, von Bergen M, Schmidt F, Rattei T, Tischler P, Lueders T, Meckenstock RU\", TITLE = \"Combined genomic and proteomic approaches identify gene clusters involved in anaerobic 2-methylnaphthalene degradation in the sulfate-reducing enrichment culture N47.\", JOURNAL = c(\"J Bacteriol 192:295-306 (2010)\", \"DOI:10.1128/JB.00874-09\"))', 'map00626', 'Naphthalene degradation', 0, 3979, 0, 0, 0, 0, 3858, 121);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (106, '00627', 'Aminobenzoate degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Aminobenzoate degradation', 'Anthranilate degradation, anthranilate => catechol [PATH:map00627]', 'GO: 0043421, UMBBD: dcz 2,4-d pcp 2,4,5-t box dca', 'ko00627', 'list(REFERENCE = \"PMID:3078743\", AUTHORS = \"Fewson CA\", TITLE = \"Microbial metabolism of mandelate: a microcosm of diversity.\", JOURNAL = c(\"FEMS Microbiol Rev 4:85-110 (1988)\", \"DOI:10.1111/j.1574-6968.1988.tb02737.x\")), list(REFERENCE = \"PMID:12670968\", AUTHORS = \"McLeish MJ, Kneen MM, Gopalakrishna KN, Koo CW, Babbitt PC, Gerlt JA, Kenyon GL\", TITLE = \"Identification and characterization of a mandelamide hydrolase and an NAD(P)+-dependent benzaldehyde dehydrogenase from Pseudomonas putida ATCC 12633.\", JOURNAL = c(\"J Bacteriol 185:2451-6 (2003)\", \"DOI:10.1128/JB.185.8.2451-2456.2003\")), list(REFERENCE = \"PMID:8782397\", AUTHORS = \"Shimao M, Nakamura T, Okuda A, Harayama S.\", TITLE = \"Characteristics of transposon insertion mutants of mandelic acid-utilizing Pseudomonas putida strain A10L.\", JOURNAL = c(\"Biosci Biotechnol Biochem 60:1051-5 (1996)\", \"DOI:10.1271/bbb.60.1051\")), list(REFERENCE = \"PMID:11344134\", AUTHORS = \"Naidu D, Ragsdale SW.\", TITLE = \"Characterization of a three-component vanillate O-demethylase from Moorella thermoacetica.\", JOURNAL = c(\"J Bacteriol 183:3276-81 (2001)\", \"DOI:10.1128/JB.183.11.3276-3281.2001\")), list(REFERENCE = \"PMID:14711645\", AUTHORS = \"Toraya T, Oka T, Ando M, Yamanishi M, Nishihara H.\", TITLE = \"Novel pathway for utilization of cyclopropanecarboxylate by Rhodococcus rhodochrous.\", JOURNAL = c(\"Appl Environ Microbiol 70:224-8 (2004)\", \"DOI:10.1128/AEM.70.1.224-228.2004\"))', 'map00627', 'Aminobenzoate degradation', 0, 3853, 0, 0, 0, 0, 3622, 231);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (107, '00630', 'Glyoxylate and dicarboxylate metabolism', 'Metabolism; Carbohydrate metabolism', 'Glyoxylate and dicarboxylate metabolism', 'Glyoxylate cycle [PATH:map00630], Ethylmalonyl pathway [PATH:map00630], Photorespiration [PATH:map00630], Methylaspartate cycle [PATH:map00630], Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA [PATH:map00630]', 'Primary hyperoxaluria, Infantile cerebellar-retinal degeneration', 'ko00630', 'list(REFERENCE = \"PMID:10978349 (EC5.3.1.22)\", AUTHORS = \"Njau RK, Herndon CA, Hawes JW.\", TITLE = \"Novel beta -hydroxyacid dehydrogenases in Escherichia coli and Haemophilusinfluenzae.\", JOURNAL = c(\"J Biol Chem 275:38780-6 (2000)\", \"DOI:10.1074/jbc.M007432200\")), list(REFERENCE = \"PMID:18065535\", AUTHORS = \"Zarzycki J, Schlichting A, Strychalsky N, Muller M, Alber BE, Fuchs G\", TITLE = \"Mesaconyl-coenzyme A hydratase, a new enzyme of two central carbon metabolic pathways in bacteria.\", JOURNAL = c(\"J Bacteriol 190:1366-74 (2008)\", \"DOI:10.1128/JB.01621-07\")), list(REFERENCE = \"PMID:18819910\", AUTHORS = \"Erb TJ, Retey J, Fuchs G, Alber BE\", TITLE = \"Ethylmalonyl-CoA mutase from Rhodobacter sphaeroides defines a new subclade of coenzyme B12-dependent acyl-CoA mutases.\", JOURNAL = c(\"J Biol Chem 283:32283-93 (2008)\", \"DOI:10.1074/jbc.M805527200\")), list(REFERENCE = \"PMID:9596633\", AUTHORS = \"Coschigano KT, Melo-Oliveira R, Lim J, Coruzzi GM\", TITLE = \"Arabidopsis gls mutants and distinct Fd-GOGAT genes. Implications for photorespiration and primary nitrogen assimilation.\", JOURNAL = c(\"Plant Cell 10:741-52 (1998)\", \"DOI:10.1105/tpc.10.5.741\")), list(REFERENCE = \"PMID:16407450\", AUTHORS = \"Masclaux-Daubresse C, Reisdorf-Cren M, Pageau K, Lelandais M, Grandjean O, Kronenberger J, Valadier MH, Feraud M, Jouglet T, Suzuki A\", TITLE = \"Glutamine synthetase-glutamate synthase pathway and glutamate dehydrogenase play distinct roles in the sink-source nitrogen cycle in tobacco.\", JOURNAL = c(\"Plant Physiol 140:444-56 (2006)\", \"DOI:10.1104/pp.105.071910\")), list(REFERENCE = \"PMID:21252347\", AUTHORS = \"Khomyakova M, Bukmez O, Thomas LK, Erb TJ, Berg IA\", TITLE = \"A methylaspartate cycle in haloarchaea.\", JOURNAL = c(\"Science 331:334-7 (2011)\", \"DOI:10.1126/science.1196544\")), list(REFERENCE = \"PMID:11513957\", AUTHORS = \"Serrano JA, Bonete MJ\", TITLE = \"Sequencing, phylogenetic and transcriptional analysis of the glyoxylate bypass operon (ace) in the halophilic archaeon Haloferax volcanii.\", JOURNAL = c(\"Biochim Biophys Acta 1520:154-62 (2001)\", \"DOI:10.1016/S0167-4781(01)00263-9\"))', 'map00630', 'Glyoxylate and dicarboxylate metabolism', 530, 5493, 248, 105, 127, 50, 5197, 296);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (108, '00633', 'Nitrotoluene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Nitrotoluene degradation', 'UMBBD: tnt tnt2 dnt, GO: 0046260', 'ko00633', 'list(REFERENCE = \"\", AUTHORS = \"Esteve-Nunez A, Ramos JL.\", TITLE = \"Metabolism of 2,4,6-Trinitrotoluene by Pseudomonas sp. JLR11.\", JOURNAL = c(\"Environmental science & technology 32:3802-3808 (1998)\", \"DOI:10.1021/es9803308\")), list(REFERENCE = \"PMID:8534088\", AUTHORS = \"Gilcrease PC, Murphy VG.\", TITLE = \"Bioconversion of 2,4-diamino-6-nitrotoluene to a novel metabolite under anoxic and aerobic conditions.\", JOURNAL = \"Appl Environ Microbiol 61:4209-14 (1995)\"), list(REFERENCE = \"PMID:11527999\", AUTHORS = \"Esteve-Nunez A, Caballero A, Ramos JL.\", TITLE = \"Biological degradation of 2,4,6-trinitrotoluene.\", JOURNAL = c(\"Microbiol Mol Biol Rev 65:335-52, table of contents (2001)\", \"DOI:10.1128/MMBR.65.3.335-352.2001\")), list(REFERENCE = \"PMID:14751225\", AUTHORS = \"Fleischmann TJ, Walker KC, Spain JC, Hughes JB, Morrie Craig A.\", TITLE = \"Anaerobic transformation of 2,4,6-TNT by bovine ruminal microbes.\", JOURNAL = c(\"Biochem Biophys Res Commun 314:957-63 (2004)\", \"DOI:10.1016/j.bbrc.2003.12.193\")), list(REFERENCE = \"PMID:14753774\", AUTHORS = \"Borch T, Gerlach R.\", TITLE = \"Use of reversed-phase high-performance liquid chromatography-diode array detection for complete separation of 2,4,6-trinitrotoluene metabolites and EPA Method 8330 explosives: influence of temperature and an ion-pair reagent.\", JOURNAL = c(\"J Chromatogr A 1022:83-94 (2004)\", \"DOI:10.1016/j.chroma.2003.09.067\")), list(REFERENCE = \"PMID:15490158\", AUTHORS = \"Yin H, Wood TK, Smets BF.\", TITLE = \"Reductive transformation of TNT by Escherichia coli: pathway description.\", JOURNAL = c(\"Appl Microbiol Biotechnol 67:397-404 (2005)\", \"DOI:10.1007/s00253-004-1736-x\")), list(REFERENCE = \"PMID:16187099\", AUTHORS = \"Kutty R, Bennett GN.\", TITLE = \"Biochemical characterization of trinitrotoluene transforming oxygen-insensitive nitroreductases from Clostridium acetobutylicum ATCC 824.\", JOURNAL = c(\"Arch Microbiol 184:158-67 (2005)\", \"DOI:10.1007/s00203-005-0036-x\")), list(REFERENCE = \"PMID:16535610\", AUTHORS = \"Fiorella PD, Spain JC.\", TITLE = \"Transformation of 2,4,6-Trinitrotoluene by Pseudomonas pseudoalcaligenes JS52.\", JOURNAL = \"Appl Environ Microbiol 63:2007-2015 (1997)\"), list(REFERENCE = \"PMID:17504490\", AUTHORS = \"Gonzalez-Perez MM, van Dillewijn P, Wittich RM, Ramos JL.\", TITLE = \"Escherichia coli has multiple enzymes that attack TNT and release nitrogen for growth.\", JOURNAL = c(\"Environ Microbiol 9:1535-40 (2007)\", \"DOI:10.1111/j.1462-2920.2007.01272.x\")), list(REFERENCE = \"PMID:16535348\", AUTHORS = \"Noguera DR, Freedman DL\", TITLE = \"Reduction and Acetylation of 2,4-Dinitrotoluene by a Pseudomonas aeruginosa Strain.\", JOURNAL = \"Appl Environ Microbiol 62:2257-63 (1996)\"), list(REFERENCE = \"PMID:9922262\", AUTHORS = \"Haigler BE, Johnson GR, Suen WC, Spain JC\", TITLE = \"Biochemical and genetic evidence for meta-ring cleavage of 2,4, 5-trihydroxytoluene in Burkholderia sp. strain DNT.\", JOURNAL = \"J Bacteriol 181:965-72 (1999)\"), list(REFERENCE = \"PMID:12107140\", AUTHORS = \"Johnson GR, Jain RK, Spain JC\", TITLE = \"Origins of the 2,4-dinitrotoluene pathway.\", JOURNAL = c(\"J Bacteriol 184:4219-32 (2002)\", \"DOI:10.1128/JB.184.15.4219-4232.2002\"))', 'map00633', 'Nitrotoluene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 0, 2431, 0, 0, 0, 0, 2299, 132);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (109, '00640', 'Propanoate metabolism', 'Metabolism; Carbohydrate metabolism', 'Propanoate metabolism', 'Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA [PATH:map00640], Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA [PATH:map00640]', 'Propionic acidemia, Malonyl-CoA decarboxylase deficiency, Methylmalonate semialdehyde dehydrogenase deficiency', 'GO: 0019541', 'ko00640', 'map00640', 'Propanoate metabolism', 530, 5520, 248, 105, 128, 49, 5223, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (110, '00642', 'Ethylbenzene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Ethylbenzene degradation', 'UMBBD: ethb2 ethb', 'ko00642', 'list(REFERENCE = \"PMID:12420173\", AUTHORS = \"Rabus R, Kube M, Beck A, Widdel F, Reinhardt R.\", TITLE = \"Genes involved in the anaerobic degradation of ethylbenzene in a denitrifying bacterium, strain EbN1.\", JOURNAL = c(\"Arch Microbiol 178:506-16 (2002)\", \"DOI:10.1007/s00203-002-0487-2\")), list(REFERENCE = \"PMID:15551059\", AUTHORS = \"Rabus R, Kube M, Heider J, Beck A, Heitmann K, Widdel F, Reinhardt R.\", TITLE = \"The genome sequence of an anaerobic aromatic-degrading denitrifying bacterium, strain EbN1.\", JOURNAL = c(\"Arch Microbiol 183:27-36 (2005)\", \"DOI:10.1007/s00203-004-0742-9\"))', 'map00642', 'Ethylbenzene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 0, 151, 0, 0, 0, 0, 148, 3);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (111, '00643', 'Styrene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Styrene degradation', 'UMBBD: sty acr pao, GO: 0042207', 'ko00643', 'list(REFERENCE = \"PMID:11544206\", AUTHORS = \"Rodriguez-Saiz M, Barredo JL, Moreno MA, Fernandez-Canon JM, Penalva MA, Diez B.\", TITLE = \"Reduced function of a phenylacetate-oxidizing cytochrome p450 caused strong genetic improvement in early phylogeny of penicillin-producing strains.\", JOURNAL = c(\"J Bacteriol 183:5465-71 (2001)\", \"DOI:10.1128/JB.183.19.5465-5471.2001\")), list(REFERENCE = \"PMID:17189487\", AUTHORS = \"Ferrer-Sevillano F, Fernandez-Canon JM.\", TITLE = \"Novel phacB-encoded cytochrome P450 monooxygenase from Aspergillus nidulans with 3-hydroxyphenylacetate 6-hydroxylase and 3,4-dihydroxyphenylacetate 6-hydroxylase activities.\", JOURNAL = c(\"Eukaryot Cell 6:514-20 (2007)\", \"DOI:10.1128/EC.00226-06\"))', 'map00643', 'Styrene degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 0, 2928, 0, 0, 0, 0, 2849, 79);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (112, '00650', 'Butanoate metabolism', 'Metabolism; Carbohydrate metabolism', 'Butanoate metabolism', 'GABA (gamma-Aminobutyrate) shunt [PATH:map00650]', '3-Hydroxy-3-methylglutaryl-CoA lyase deficiency, Succinic semialdehyde dehydrogenase deficiency, Succinyl CoA:3-oxoacid CoA transferase (SCOT) deficiency, HMG-CoA synthase deficiency, L-2-hydroxyglutaric aciduria, 3-Hydroxyacyl-CoA dehydrogenase deficiency', 'ko00650', 'map00650', 'Butanoate metabolism', 'Metabolism; Carbohydrate metabolism', 507, 5333, 248, 105, 123, 31, 5038, 295);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (113, '00660', 'C5-Branched dibasic acid metabolism', 'Metabolism; Carbohydrate metabolism', 'C5-Branched dibasic acid metabolism', 'Isoleucine biosynthesis, pyruvate => 2-oxobutanoate [PATH:map00660]', 'ko00660', 'map00660', 'C5-Branched dibasic acid metabolism', 'Metabolism; Carbohydrate metabolism', 'C5-Branched dibasic acid metabolism', 228, 4725, 1, 105, 122, 0, 4473, 252);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (114, '00670', 'One carbon pool by folate', 'Metabolism; Metabolism of cofactors and vitamins', 'One carbon pool by folate', 'Tetrahydrofolate biosynthesis, GTP => THF [PATH:map00670], C1-unit interconversion, prokaryotes [PATH:map00670], C1-unit interconversion, eukaryotes [PATH:map00670]', 'Homocystinuria, Spina bifida, AICA-ribosiduria, Dihydrofolate reductase deficiency, Formiminotransferase deficiency, Methylcobalamin deficiency type G', 'ko00670', 'map00670', 'One carbon pool by folate', 'Metabolism; Metabolism of cofactors and vitamins', 526, 5521, 248, 105, 127, 46, 5226, 295);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (115, '00680', 'Methane metabolism', 'Methane is metabolized principally by methanotrophs and methanogens in the global carbon cycle. Methanotrophs consume methane as the only source of carbon, while methanogens produce methane as a metabolic byproduct. Methylotrophs, which are microorganisms that can obtain energy for growth by oxidizing one-carbon compounds, such as methanol and methane, are situated between methanotrophs and methanogens. Methanogens can obtain energy for growth by converting a limited number of substrates to methane under anaerobic conditions. Three types of methanogenic pathways are known: CO2 to methane [MD:M00567], methanol to methane [MD:M00356], and acetate to methane [MD:M00357]. Methanogens use 2-mercaptoethanesulfonate (CoM; coenzyme M) as the terminal methyl carrier in methanogenesis and have four enzymes for CoM biosynthesis [MD:M00358]. Coenzyme B-Coenzyme M heterodisulfide reductase (Hdr), requiring for the final reaction steps of methanogenic pathway, is divided into two types: cytoplasmic HdrABC in most methanogens and membrane-bound HdrED in Methanosarcina species. In methanotrophs and methyltrophs methane is oxidized to form formaldehyde, which is at the diverging point for further oxidation to CO2 for energy source and assimilation for biosynthesis. There are three pathways that convert formaldehyde to C2 or C3 compounds: serine pathway [MD:M00346], ribulose monophosphate pathway [MD:M00345], and xylulose monophosphate pathway [MD:M00344]. The first two pathways are found in prokaryotes and the third is found in yeast. As a special case of methylotrophs, various amines can be used as carbon sources in trimethylamine metabolism [MD:M00563].', 'Metabolism; Energy metabolism', 'Methane metabolism', 'Serine biosynthesis, glycerate-3P => serine [PATH:map00680], Methane oxidation, methanotroph, methane => formaldehyde [PATH:map00680], Formaldehyde assimilation, xylulose monophosphate pathway [PATH:map00680], Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map00680], Formaldehyde assimilation, serine pathway [PATH:map00680], Methanogenesis, methanol => methane [PATH:map00680], Methanogenesis, acetate => methane [PATH:map00680], Coenzyme M biosynthesis [PATH:map00680], F420 biosynthesis [PATH:map00680], Acetyl-CoA pathway, CO2 => acetyl-CoA [PATH:map00680], Methanogenesis, methylamine/dimethylamine/trimethylamine => methane [PATH:map00680], Methanogenesis, CO2 => methane [PATH:map00680], 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map00680]', 'Acatalasemia', 'GO: 0015947', 'ko00680', 'list(REFERENCE = \"PMID:11830598\", AUTHORS = \"Graham DE, Xu H, White RH\", TITLE = \"Identification of coenzyme M biosynthetic phosphosulfolactate synthase: a new family of sulfonate-biosynthesizing enzymes.\", JOURNAL = c(\"J Biol Chem 277:13421-9 (2002)\", \"DOI:10.1074/jbc.M201011200\")), list(REFERENCE = \"PMID:15168610\", AUTHORS = \"Deppenmeier U\", TITLE = \"The membrane-bound electron transport system of Methanosarcina species.\", JOURNAL = c(\"J Bioenerg Biomembr 36:55-64 (2004)\", \"DOI:10.1023/B:JOBB.0000019598.64642.97\")), list(REFERENCE = \"PMID:15353801\", AUTHORS = \"Hallam SJ, Putnam N, Preston CM, Detter JC, Rokhsar D, Richardson PM, DeLong EF\", TITLE = \"Reverse methanogenesis: testing the hypothesis with environmental genomics.\", JOURNAL = c(\"Science 305:1457-62 (2004)\", \"DOI:10.1126/science.1100025\")), list(REFERENCE = \"PMID:16024727\", AUTHORS = \"Welander PV, Metcalf WW\", TITLE = \"Loss of the mtr operon in Methanosarcina blocks growth on methanol, but not methanogenesis, and reveals an unknown methanogenic pathway.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 102:10664-9 (2005)\", \"DOI:10.1073/pnas.0502623102\")), list(REFERENCE = \"PMID:16278835\", AUTHORS = \"Yurimoto H, Kato N, Sakai Y\", TITLE = \"Assimilation, dissimilation, and detoxification of formaldehyde, a central metabolic intermediate of methylotrophic metabolism.\", JOURNAL = c(\"Chem Rec 5:367-75 (2005)\", \"DOI:10.1002/tcr.20056\")), list(REFERENCE = \"PMID:16385054\", AUTHORS = \"Fricke WF, Seedorf H, Henne A, Kruer M, Liesegang H, Hedderich R, Gottschalk G, Thauer RK.\", TITLE = \"The genome sequence of Methanosphaera stadtmanae reveals why this human intestinal archaeon is restricted to methanol and H2 for methane formation and ATP synthesis.\", JOURNAL = c(\"J Bacteriol 188:642-58 (2006)\", \"DOI:10.1128/JB.188.2.642-658.2006\")), list(REFERENCE = \"PMID:16428816\", AUTHORS = \"Kato N, Yurimoto H, Thauer RK\", TITLE = \"The physiological role of the ribulose monophosphate pathway in bacteria and archaea.\", JOURNAL = c(\"Biosci Biotechnol Biochem 70:10-21 (2006)\", \"DOI:10.1271/bbb.70.10\")), list(REFERENCE = \"PMID:18587410\", AUTHORS = \"Thauer RK, Kaster AK, Seedorf H, Buckel W, Hedderich R\", TITLE = \"Methanogenic archaea: ecologically relevant differences in energy conservation.\", JOURNAL = c(\"Nat Rev Microbiol 6:579-91 (2008)\", \"DOI:10.1038/nrmicro1931\")), list(REFERENCE = \"PMID:20437165\", AUTHORS = \"Liffourrena AS, Salvano MA, Lucchesi GI\", TITLE = \"Pseudomonas putida A ATCC 12633 oxidizes trimethylamine aerobically via two different pathways.\", JOURNAL = c(\"Arch Microbiol 192:471-6 (2010)\", \"DOI:10.1007/s00203-010-0577-5\"))', 128, 5545, 0, 0, 128, 0, 5248, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (116, '00710', 'Carbon fixation in photosynthetic organisms', 'Metabolism; Energy metabolism', 'Carbon fixation in photosynthetic organisms', 'Reductive pentose phosphate cycle (Calvin cycle) [PATH:map00710], Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P [PATH:map00710], Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P [PATH:map00710], CAM (Crassulacean acid metabolism), dark [PATH:map00710], CAM (Crassulacean acid metabolism), light [PATH:map00710], C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type [PATH:map00710], C4-dicarboxylic acid cycle, NAD - malic enzyme type [PATH:map00710], C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map00710]', 'ko00710', 'map00710', 'Carbon fixation in photosynthetic organisms', 'Metabolism; Energy metabolism', 'Carbon fixation in photosynthetic organisms', 108, 432, 0, 105, 0, 3, 432, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (117, '00720', 'Carbon fixation pathways in prokaryotes', 'Carbon fixation is an important pathway for autotrophs living in various environments. Plants and cyanobacteria fix CO2 as organic compounds using solar energy mainly by the reductive pentose phosphate cycle (also called Calvin cycle, Calvin-Benson cycle, or Calvin-Benson-Bassham cycle) [MD:M00165]. There are, at least, five additional carbon fixation pathways known to exist in autotrophic bacteria and archaea, which differ in reducing compounds, energy source, and oxygen sensitivity of enzymes. (i) The reductive citric acid cycle (Arnon-Buchanan cycle) [MD:M00173] is found in microaerophiles and anaerobes, such as green sulfur bacteria. In one complete turn of this cycle, four molecules of CO2 are fixed by the enzymes that are sensitive to oxygen, resulting in the production of one molecule of oxaloacetate, which is itself an intermediate of the cycle. (ii) The reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [MD:M00377] is found in strictly anaerobic bacteria and archaea (Proteobacteria, Planctomycetes, Spirochaetes, and Euryarchaeota), some of which are methane-forming. A bifunctional enzyme, carbon monoxide dehydrogenase/acetyl-CoA synthase, catalyzes the reactions from CO2 to CO and from CO2 to a methyl group, and then to generate acetyl-CoA. (iii) The 3-hydroxypropionate bicycle [MD:M00376] is found in some green non-sulphur bacteria of the family Chloroflexaceae. In one complete turn of this bicycle, three molecules of bicarbonate are converted into one molecule of pyruvate. In addition, this bicycle provides the secondary benefit of useful intermediates for biosynthesis: acetyl-CoA, glyoxylate, and succinyl-CoA. (iv) The hydroxypropionate-hydroxybutyrate cycle [MD:M00375] is found in aerobic Crenarchaeota, Acidianus, Metallosphaera, and Sulfolobales. Some of the intermediates and the carboxylation reactions are the same as in the 3-hydroxypropionate bicycle. One complete turn of this cycle generates two molecules of acetyl-CoA, one of which is reutilized in the the cycle and the other is removed for cell material biosynthesis. (v) The dicarboxylate-hydroxybutyrate cycle [MD:M00374] was named after its intermediates: succinate (a kind of dicarboxylate) and hydroxybutyrate. This cycle has been found only in Ignicoccus hospitals, a strictly anaerobic hyperthermophilic archaea. Recent genome study suggests that this cycle may exist in Desulfurococcales (to which Ignicoccus belongs) and Thermoproteales (a taxon close to the origin of archaea). The first half of the cycle, from acetyl-CoA to succinate-CoA, corresponds to the reductive citric acid cycle and the latter half of the cycle, from succinate-CoA to two molecules of acetyl-CoA, corresponds to the hydroxypropionate-hydroxybutyrate cycle.', 'Metabolism; Energy metabolism', 'Carbon fixation pathways in prokaryotes', 'Reductive citrate cycle (Arnon-Buchanan cycle) [PATH:map00720], Dicarboxylate-hydroxybutyrate cycle [PATH:map00720], Hydroxypropionate-hydroxybutylate cycle [PATH:map00720], 3-Hydroxypropionate bi-cycle [PATH:map00720], Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [PATH:map00720], Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map00720], Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate [PATH:map00720]', 'GO: 0015977', 'ko00720', 'list(REFERENCE = \"PMID:19955419\", AUTHORS = \"Zarzycki J, Brecht V, Muller M, Fuchs G\", TITLE = \"Identifying the missing steps of the autotrophic 3-hydroxypropionate CO2 fixation cycle in Chloroflexus aurantiacus.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 106:21317-22 (2009)\", \"DOI:10.1073/pnas.0908356106\")), list(REFERENCE = \"PMID:19429610\", AUTHORS = \"Teufel R, Kung JW, Kockelkorn D, Alber BE, Fuchs G\", TITLE = \"3-hydroxypropionyl-coenzyme A dehydratase and acryloyl-coenzyme A reductase, enzymes of the autotrophic 3-hydroxypropionate/4-hydroxybutyrate cycle in the Sulfolobales.\", JOURNAL = c(\"J Bacteriol 191:4572-81 (2009)\", \"DOI:10.1128/JB.00068-09\")), list(REFERENCE = \"PMID:18511565\", AUTHORS = \"Huber H, Gallenberger M, Jahn U, Eylert E, Berg IA, Kockelkorn D, Eisenreich W, Fuchs G\", TITLE = \"A dicarboxylate/4-hydroxybutyrate autotrophic carbon assimilation cycle in the hyperthermophilic Archaeum Ignicoccus hospitalis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:7851-6 (2008)\", \"DOI:10.1073/pnas.0801043105\")), list(REFERENCE = \"PMID:15838028\", AUTHORS = \"Hugler M, Wirsen CO, Fuchs G, Taylor CD, Sievert SM\", TITLE = \"Evidence for autotrophic CO2 fixation via the reductive tricarboxylic acid cycle by members of the epsilon subdivision of proteobacteria.\", JOURNAL = c(\"J Bacteriol 187:3020-7 (2005)\", \"DOI:10.1128/JB.187.9.3020-3027.2005\")), list(REFERENCE = \"PMID:11827525\", AUTHORS = \"Seravalli J, Kumar M, Ragsdale SW\", TITLE = \"Rapid kinetic studies of acetyl-CoA synthesis: evidence supporting the catalytic intermediacy of a paramagnetic NiFeC species in the autotrophic Wood-Ljungdahl pathway.\", JOURNAL = c(\"Biochemistry 41:1807-19 (2002)\", \"DOI:10.1021/bi011687i\")), list(REFERENCE = \"PMID:3096193\", AUTHORS = \"Ljungdahl LG\", TITLE = \"The autotrophic pathway of acetate synthesis in acetogenic bacteria.\", JOURNAL = c(\"Annu Rev Microbiol 40:415-50 (1986)\", \"DOI:10.1146/annurev.mi.40.100186.002215\"))', 'map00720', 0, 352, 0, 0, 0, 0, 55, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (118, '00730', 'Thiamine metabolism', 'Metabolism; Metabolism of cofactors and vitamins', 'Thiamine metabolism', 'Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P [PATH:map00730]', 'Thiamine pyrophosphokinase deficiency', 'GO: 0006772', 'ko00730', 'list(REFERENCE = \"PMID:15614489\", AUTHORS = \"Kawasaki Y, Onozuka M, Mizote T, Nosaka K.\", TITLE = \"Biosynthesis of hydroxymethylpyrimidine pyrophosphate in Saccharomyces cerevisiae.\", JOURNAL = c(\"Curr Genet 47:156-62 (2005)\", \"DOI:10.1007/s00294-004-0557-x\")), list(REFERENCE = \"PMID:14567704\", AUTHORS = \"Park JH, Dorrestein PC, Zhai H, Kinsland C, McLafferty FW, Begley TP.\", TITLE = \"Biosynthesis of the thiazole moiety of thiamin pyrophosphate (vitamin B1).\", JOURNAL = c(\"Biochemistry 42:12430-8 (2003)\", \"DOI:10.1021/bi034902z\")), list(REFERENCE = \"PMID:22616866\", AUTHORS = \"Begley TP, Ealick SE, McLafferty FW\", TITLE = \"Thiamin biosynthesis: still yielding fascinating biological chemistry.\", JOURNAL = c(\"Biochem Soc Trans 40:555-60 (2012)\", \"DOI:10.1042/BST20120084\")), list(REFERENCE = \"PMID:12777485\", AUTHORS = \"Wightman R, Meacock PA\", TITLE = \"The THI5 gene family of Saccharomyces cerevisiae: distribution of homologues among the hemiascomycetes and functional redundancy in the aerobic biosynthesis of thiamin from pyridoxine.\", JOURNAL = c(\"Microbiology 149:1447-60 (2003)\", \"DOI:10.1099/mic.0.26194-0\")), list(REFERENCE = \"PMID:22031445\", AUTHORS = \"Chatterjee A, Abeydeera ND, Bale S, Pai PJ, Dorrestein PC, Russell DH, Ealick SE, Begley TP\", TITLE = \"Saccharomyces cerevisiae THI4p is a suicide thiamine thiazole synthase.\", JOURNAL = c(\"Nature 478:542-6 (2011)\", \"DOI:10.1038/nature10503\")), list(REFERENCE = \"PMID:19348578\", AUTHORS = \"Jurgenson CT, Begley TP, Ealick SE\", TITLE = \"The structural and biochemical foundations of thiamin biosynthesis.\", JOURNAL = c(\"Annu Rev Biochem 78:569-603 (2009)\", \"DOI:10.1146/annurev.biochem.78.072407.102340\"))', 'map00730', 530, 5515, 248, 105, 127, 50, 5216, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (119, '00740', 'Riboflavin metabolism', 'Metabolism; Metabolism of cofactors and vitamins', 'Riboflavin metabolism', 'Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD [PATH:map00740]', 'Generalized arterial calcification of infancy, Acid phosphatase deficiency, Cole disease', 'GO: 0006771', 'ko00740', 'list(REFERENCE = \"PMID:12136096\", AUTHORS = \"Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS.\", TITLE = \"Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation.\", JOURNAL = c(\"Nucleic Acids Res 30:3141-51 (2002)\", \"DOI:10.1093/nar/30.14.3141\")), list(REFERENCE = \"PMID:11856310\", AUTHORS = \"Fischer M, Haase I, Feicht R, Richter G, Gerhardt S, Changeux JP, Huber R, Bacher A.\", TITLE = \"Biosynthesis of riboflavin: 6,7-dimethyl-8-ribityllumazine synthase of Schizosaccharomyces pombe.\", JOURNAL = c(\"Eur J Biochem 269:519-26 (2002)\", \"DOI:10.1046/j.0014-2956.2001.02674.x\")), list(REFERENCE = \"PMID:12867427\", AUTHORS = \"Haase I, Fischer M, Bacher A, Schramek N.\", TITLE = \"Temperature-dependent presteady state kinetics of lumazine synthase from the hyperthermophilic eubacterium Aquifex aeolicus.\", JOURNAL = c(\"J Biol Chem 278:37909-15 (2003)\", \"DOI:10.1074/jbc.M303090200\")), list(REFERENCE = \"PMID:16042598\", AUTHORS = \"Fischer M, Romisch W, Illarionov B, Eisenreich W, Bacher A.\", TITLE = \"Structures and reaction mechanisms of riboflavin synthases of eubacterial and archaeal origin.\", JOURNAL = c(\"Biochem Soc Trans 33:780-4 (2005)\", \"DOI:10.1042/BST0330780\"))', 'map00740', 518, 5398, 248, 105, 123, 42, 5102, 296);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (120, '00750', 'Vitamin B6 metabolism', 'Metabolism; Metabolism of cofactors and vitamins', 'Vitamin B6 metabolism', 'Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P [PATH:map00750]', 'Phosphoserine aminotransferase deficiency, Pyridoxamine-5\'-phosphate oxidase (PNPO) deficiency, Neu-Laxova syndrome', 'GO: 0042816', 'ko00750', 'list(REFERENCE = \"PMID:10753941\", AUTHORS = \"Tazoe M, Ichikawa K, Hoshino T.\", TITLE = \"Biosynthesis of vitamin B(6) in rhizobium.\", JOURNAL = c(\"J Biol Chem 275:11300-5 (2000)\", \"DOI:10.1074/jbc.275.15.11300\")), list(REFERENCE = \"PMID:9696782\", AUTHORS = \"Yang Y, Zhao G, Man TK, Winkler ME.\", TITLE = \"Involvement of the gapA- and epd (gapB)-encoded dehydrogenases in pyridoxal 5\'-phosphate coenzyme biosynthesis in Escherichia coli K-12.\", JOURNAL = \"J Bacteriol 180:4294-9 (1998)\"), list(REFERENCE = \"PMID:12269807\", AUTHORS = \"Yeh JI, Du S, Pohl E, Cane DE.\", TITLE = \"Multistate binding in pyridoxine 5\'-phosphate synthase: 1.96 A crystal structure in complex with 1-deoxy-D-xylulose phosphate.\", JOURNAL = c(\"Biochemistry 41:11649-57 (2002)\", \"DOI:10.1021/bi026292t\")), list(REFERENCE = \"PMID:10225425\", AUTHORS = \"Laber B, Maurer W, Scharf S, Stepusin K, Schmidt FS.\", TITLE = \"Vitamin B6 biosynthesis: formation of pyridoxine 5\'-phosphate from 4-(phosphohydroxy)-L-threonine and 1-deoxy-D-xylulose-5-phosphate by PdxA and PdxJ protein.\", JOURNAL = c(\"FEBS Lett 449:45-8 (1999)\", \"DOI:10.1016/S0014-5793(99)00393-2\")), list(REFERENCE = \"PMID:16157873\", AUTHORS = \"Tambasco-Studart M, Titiz O, Raschle T, Forster G, Amrhein N, Fitzpatrick TB.\", TITLE = \"Vitamin B6 biosynthesis in higher plants.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 102:13687-92 (2005)\", \"DOI:10.1073/pnas.0506228102\")), list(REFERENCE = \"PMID:22276911\", AUTHORS = \"Nagase T, Mugo AN, Chu HN, Yoshikane Y, Ohnishi K, Yagi T\", TITLE = \"The mll6786 gene encodes a repressor protein controlling the degradation pathway for vitamin B6 in Mesorhizobium loti.\", JOURNAL = c(\"FEMS Microbiol Lett 329:116-22 (2012)\", \"DOI:10.1111/j.1574-6968.2012.02510.x\"))', 'map00750', 516, 5091, 248, 105, 123, 40, 4821, 270);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (121, '00760', 'Nicotinate and nicotinamide metabolism', 'Metabolism; Metabolism of cofactors and vitamins', 'Nicotinate and nicotinamide metabolism', 'NAD biosynthesis, aspartate => NAD [PATH:map00760], Nicotinate degradation, nicotinate => fumarate [PATH:map00760], Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde [PATH:map00760], Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde [PATH:map00760]', 'Calcification of joints and arteries, Generalized arterial calcification of infancy, Cole disease, 2,4-Dienoyl-CoA reductase deficiency', 'UMBBD: nic, GO: 0006769', 'ko00760', 'list(REFERENCE = \"PMID:13475371\", AUTHORS = \"BEHRMAN EJ, STANIER RY.\", TITLE = \"The bacterial oxidation of nicotinic acid.\", JOURNAL = \"J Biol Chem 228:923-45 (1957)\"), list(REFERENCE = \"PMID:16894175\", AUTHORS = \"Alhapel A, Darley DJ, Wagener N, Eckel E, Elsner N, Pierik AJ.\", TITLE = \"Molecular and functional analysis of nicotinate catabolism in Eubacterium barkeri.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 103:12341-6 (2006)\", \"DOI:10.1073/pnas.0601635103\")), list(REFERENCE = \"PMID:11514508\", AUTHORS = \"Baitsch D, Sandu C, Brandsch R, Igloi GL.\", TITLE = \"Gene cluster on pAO1 of Arthrobacter nicotinovorans involved in degradation of the plant alkaloid nicotine: cloning, purification, and characterization of 2,6-dihydroxypyridine 3-hydroxylase.\", JOURNAL = c(\"J Bacteriol 183:5262-7 (2001)\", \"DOI:10.1128/JB.183.18.5262-5267.2001\")), list(REFERENCE = \"PMID:16321959\", AUTHORS = \"Sachelaru P, Schiltz E, Igloi GL, Brandsch R.\", TITLE = \"An alpha/beta-fold C--C bond hydrolase is involved in a central step of nicotine catabolism by Arthrobacter nicotinovorans.\", JOURNAL = c(\"J Bacteriol 187:8516-9 (2005)\", \"DOI:10.1128/JB.187.24.8516-8519.2005\")), list(REFERENCE = \"PMID:5835946\", AUTHORS = \"Gherna RL, Richardson SH, Rittenberg SC\", TITLE = \"The bacterial oxidation of nicotine. VI. The metabolism of 2,6-dihydroxypseudooxynicotine.\", JOURNAL = \"J Biol Chem 240:3669-74 (1965)\"), list(REFERENCE = \"PMID:21953451\", AUTHORS = \"Galeazzi L, Bocci P, Amici A, Brunetti L, Ruggieri S, Romine M, Reed S, Osterman AL, Rodionov DA, Sorci L, Raffaelli N\", TITLE = \"Identification of nicotinamide mononucleotide deamidase of the bacterial pyridine nucleotide cycle reveals a novel broadly conserved amidohydrolase family.\", JOURNAL = c(\"J Biol Chem 286:40365-75 (2011)\", \"DOI:10.1074/jbc.M111.275818\"))', 'map00760', 524, 5491, 248, 105, 126, 45, 5194, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (122, '00770', 'Pantothenate and CoA biosynthesis', 'Metabolism; Metabolism of cofactors and vitamins', 'Pantothenate and CoA biosynthesis', 'Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map00770], Pantothenate biosynthesis, valine/L-aspartate => pantothenate [PATH:map00770], Coenzyme A biosynthesis, pantothenate => CoA [PATH:map00770]', 'Core neuroacanthocytosis syndromes, Neurodegeneration with brain iron accumulation, Generalized arterial calcification of infancy, Cole disease, Pantothenate kinase-associated neurodegeneration, HARP syndrome', 'GO: 0015940 0015937', 'ko00770', 'map00770', 'Pantothenate and CoA biosynthesis', 525, 5494, 248, 105, 123, 49, 5200, 294);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (123, '00780', 'Biotin metabolism', 'Biotin (vitamin H or vitamin B7) is the essential cofactor of biotin-dependent carboxylases, such as pyruvate carboxylase and acetyl-CoA carboxylase. Mammals cannot synthesize biotin, while in bacteria, fungi, and plants it is synthesized from pimelate thioester through different pathways. In E. coli and many organisms, pimelate thioester is derived from malonyl-ACP. The pathway starts with the methylation to malonyl-ACP methyl ester, followed by the fatty acid chain elongation cycle to form pimeloyl-ACP methyl ester, which is then demethylated to form pimeloyl-ACP [MD:M00572]. Pimeloyl-ACP is converted to biotin through the final four steps in the biotin bicyclic ring assembly, which are conserved among biotin-producing organisms [MD:M00123]. In B. subtilis, biotin is derived from pimeloyl-ACP formed by oxidative cleavage of long-chain acyl-ACPs [MD:M00573]. Some bacteria synthesize biotin from pimeloyl-CoA derived from pimelate [MD:M00577]. Biotin is covalently attached to biotin-dependent carboxylase by biotin protein ligase, also known as holocarboxylase synthase in mammals, to form an active holocarboxylase. After degradation of the biotinylated carboxylase into biocytin, it is further degraded by biotinidase to release free biotin, which is recycled in holocarboxylase synthesis. Biotin is catabolized by beta-oxidation of the valeric acid side chain or oxidation of sulfur in the heterocyclic ring.', 'Metabolism; Metabolism of cofactors and vitamins', 'Biotin metabolism', 'Biotin biosynthesis, pimeloyl-ACP/CoA => biotin [PATH:map00780], Pimeloyl-ACP biosynthesis, BioC-BioH pathway, malonyl-ACP => pimeloyl-ACP [PATH:map00780], Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin [PATH:map00780], Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin [PATH:map00780]', 'Holocarboxylase synthetase deficiency, Biotinidase deficiency', 'GO: 0006768', 'ko00780', 'list(REFERENCE = \"PMID:21437340\", AUTHORS = \"Lin S, Cronan JE\", TITLE = \"Closing in on complete pathways of biotin biosynthesis.\", JOURNAL = c(\"Mol Biosyst 7:1811-21 (2011)\", \"DOI:10.1039/c1mb05022b\")), list(REFERENCE = \"PMID:22965231\", AUTHORS = \"Lin S, Cronan JE\", TITLE = \"The BioC O-methyltransferase catalyzes methyl esterification of malonyl-acyl carrier protein, an essential step in biotin synthesis.\", JOURNAL = c(\"J Biol Chem 287:37010-20 (2012)\", \"DOI:10.1074/jbc.M112.410290\")), list(REFERENCE = \"PMID:20693992\", AUTHORS = \"Lin S, Hanson RE, Cronan JE\", TITLE = \"Biotin synthesis begins by hijacking the fatty acid synthetic pathway.\", JOURNAL = c(\"Nat Chem Biol 6:682-8 (2010)\", \"DOI:10.1038/nchembio.420\")), list(REFERENCE = \"PMID:21435937\", AUTHORS = \"Cronan JE, Lin S\", TITLE = \"Synthesis of the alpha,omega-dicarboxylic acid precursor of biotin by the canonical fatty acid biosynthetic pathway.\", JOURNAL = c(\"Curr Opin Chem Biol 15:407-13 (2011)\", \"DOI:10.1016/j.cbpa.2011.03.001\")), list(REFERENCE = \"PMID:11368323\", AUTHORS = \"Stok JE, De Voss J\", TITLE = \"Expression, purification, and characterization of BioI: a carbon-carbon bond cleaving cytochrome P450 involved in biotin biosynthesis in Bacillus subtilis.\", JOURNAL = c(\"Arch Biochem Biophys 384:351-60 (2000)\", \"DOI:10.1006/abbi.2000.2067\")), list(REFERENCE = \"PMID:18838690\", AUTHORS = \"Cryle MJ, Schlichting I\", TITLE = \"Structural insights from a P450 Carrier Protein complex reveal how specificity is achieved in the P450(BioI) ACP complex.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:15696-701 (2008)\", \"DOI:10.1073/pnas.0805983105\")), list(REFERENCE = \"PMID:8763940\", AUTHORS = \"Bower S, Perkins JB, Yocum RR, Howitt CL, Rahaim P, Pero J\", TITLE = \"Cloning, sequencing, and characterization of the Bacillus subtilis biotin biosynthetic operon.\", JOURNAL = c(\"J Bacteriol 178:4122-30 (1996)\", \"DOI:10.1128/JB.178.14.4122-4130.1996\")), list(REFERENCE = \"PMID:1445232\", AUTHORS = \"Ploux O, Soularue P, Marquet A, Gloeckler R, Lemoine Y\", TITLE = \"Investigation of the first step of biotin biosynthesis in Bacillus sphaericus. Purification and characterization of the pimeloyl-CoA synthase, and uptake of pimelate.\", JOURNAL = c(\"Biochem J 287 ( Pt 3):685-90 (1992)\", \"DOI:10.1042/bj2870685\")), list(REFERENCE = \"PMID:12368242\", AUTHORS = \"Rodionov DA, Mironov AA, Gelfand MS\", TITLE = \"Conservation of the biotin regulon and the BirA regulatory signal in Eubacteria and Archaea.\", JOURNAL = c(\"Genome Res 12:1507-16 (2002)\", \"DOI:10.1101/gr.314502\")), list(REFERENCE = \"PMID:11320134\", AUTHORS = \"Sullivan JT, Brown SD, Yocum RR, Ronson CW\", TITLE = \"The bio operon on the acquired symbiosis island of Mesorhizobium sp. strain R7A includes a novel gene involved in pimeloyl-CoA synthesis.\", JOURNAL = c(\"Microbiology 147:1315-22 (2001)\", \"DOI:10.1099/00221287-147-5-1315\")), list(REFERENCE = \"PMID:12039741\", AUTHORS = \"Entcheva P, Phillips DA, Streit WR\", TITLE = \"Functional analysis of Sinorhizobium meliloti genes involved in biotin synthesis and transport.\", JOURNAL = c(\"Appl Environ Microbiol 68:2843-8 (2002)\", \"DOI:10.1128/AEM.68.6.2843-2848.2002\")), list(REFERENCE = \"PMID:19319844\", AUTHORS = \"Zempleni J, Wijeratne SS, Hassan YI\", TITLE = \"Biotin.\", JOURNAL = c(\"Biofactors 35:36-46 (2009)\", \"DOI:10.1002/biof.8\")), list(REFERENCE = \"PMID:9022537\", AUTHORS = \"Zempleni J, McCormick DB, Mock DM\", TITLE = \"Identification of biotin sulfone, bisnorbiotin methyl ketone, and tetranorbiotin-l-sulfoxide in human urine.\", JOURNAL = c(\"Am J Clin Nutr 65:508-11 (1997)\", \"DOI:10.1093/ajcn/65.2.508\")), list(REFERENCE = \"PMID:5775781\", AUTHORS = \"Iwahara S, McCormick DB, Wright LD, Li HC\", TITLE = \"Bacterial degradation of biotin. 3. Metabolism of 14C-carbonyl-labeled biotin.\", JOURNAL = \"J Biol Chem 244:1393-8 (1969)\"), list(REFERENCE = \"PMID:2180922\", AUTHORS = \"Pierson DE, Campbell A\", TITLE = \"Cloning and nucleotide sequence of bisC, the structural gene for biotin sulfoxide reductase in Escherichia coli.\", JOURNAL = c(\"J Bacteriol 172:2194-8 (1990)\", \"DOI:10.1128/JB.172.4.2194-2198.1990\")), list(REFERENCE = \"PMID:15601707\", AUTHORS = \"Ezraty B, Bos J, Barras F, Aussel L\", TITLE = \"Methionine sulfoxide reduction and assimilation in Escherichia coli: new role for the biotin sulfoxide reductase BisC.\", JOURNAL = c(\"J Bacteriol 187:231-7 (2005)\", \"DOI:10.1128/JB.187.1.231-237.2005\")), list(REFERENCE = \"PMID:374979\", AUTHORS = \"del Campillo-Campbell A, Dykhuizen D, Cleary PP\", TITLE = \"Enzymic reduction of d-biotin d-sulfoxide to d-biotin.\", JOURNAL = \"Methods Enzymol 62:379-85 (1979)\"), list(REFERENCE = \"PMID:9013576\", AUTHORS = \"Pollock VV, Barber MJ\", TITLE = \"Biotin sulfoxide reductase. Heterologous expression and characterization of a functional molybdopterin guanine dinucleotide-containing enzyme.\", JOURNAL = c(\"J Biol Chem 272:3355-62 (1997)\", \"DOI:10.1074/jbc.272.6.3355\")), list(REFERENCE = \"PMID:15366932\", AUTHORS = \"Nelson KJ, Rajagopalan KV\", TITLE = \"Studies on the interaction of NADPH with Rhodobacter sphaeroides biotin sulfoxide reductase.\", JOURNAL = c(\"Biochemistry 43:11226-37 (2004)\", \"DOI:10.1021/bi0490845\")), list(REFERENCE = \"PMID:16299174\", AUTHORS = \"Pinon V, Ravanel S, Douce R, Alban C\", TITLE = \"Biotin synthesis in plants. The first committed step of the pathway is catalyzed by a cytosolic 7-keto-8-aminopelargonic acid synthase.\", JOURNAL = c(\"Plant Physiol 139:1666-76 (2005)\", \"DOI:10.1104/pp.105.070144\"))', 517, 5329, 248, 105, 123, 41, 5041, 288);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (124, '00785', 'Lipoic acid metabolism', 'Metabolism; Metabolism of cofactors and vitamins', 'Lipoic acid metabolism', 'GO: 0009106', 'ko00785', 'list(REFERENCE = \"PMID:16246025\", AUTHORS = \"Gunther S, McMillan PJ, Wallace LJ, Muller S.\", TITLE = \"Plasmodium falciparum possesses organelle-specific alpha-keto acid dehydrogenase complexes and lipoylation pathways.\", JOURNAL = c(\"Biochem Soc Trans 33:977-80 (2005)\", \"DOI:10.1042/BST20050977\")), list(REFERENCE = \"PMID:11382754\", AUTHORS = \"Fujiwara K, Takeuchi S, Okamura-Ikeda K, Motokawa Y.\", TITLE = \"Purification, characterization, and cDNA cloning of lipoate-activating enzyme from bovine liver.\", JOURNAL = c(\"J Biol Chem 276:28819-23 (2001)\", \"DOI:10.1074/jbc.M101748200\")), list(REFERENCE = \"PMID:9808738\", AUTHORS = \"Yasuno R, Wada H.\", TITLE = \"Biosynthesis of lipoic acid in Arabidopsis: cloning and characterization of the cDNA for lipoic acid synthase.\", JOURNAL = c(\"Plant Physiol 118:935-43 (1998)\", \"DOI:10.1104/pp.118.3.935\")), list(REFERENCE = \"PMID:10671542\", AUTHORS = \"Gueguen V, Macherel D, Jaquinod M, Douce R, Bourguignon J.\", TITLE = \"Fatty acid and lipoic acid biosynthesis in higher plant mitochondria.\", JOURNAL = c(\"J Biol Chem 275:5016-25 (2000)\", \"DOI:10.1074/jbc.275.7.5016\")), list(REFERENCE = \"PMID:11427685\", AUTHORS = \"Wada M, Yasuno R, Jordan SW, Cronan JE Jr, Wada H.\", TITLE = \"Lipoic acid metabolism in Arabidopsis thaliana: cloning and characterization of a cDNA encoding lipoyltransferase.\", JOURNAL = c(\"Plant Cell Physiol 42:650-6 (2001)\", \"DOI:10.1093/pcp/pce081\")), list(REFERENCE = \"PMID:8206909\", AUTHORS = \"Morris TW, Reed KE, Cronan JE Jr.\", TITLE = \"Identification of the gene encoding lipoate-protein ligase A of Escherichia coli. Molecular cloning and characterization of the lplA gene and gene product.\", JOURNAL = \"J Biol Chem 269:16091-100 (1994)\"), list(REFERENCE = \"PMID:14700636\", AUTHORS = \"Zhao X, Miller JR, Jiang Y, Marletta MA, Cronan JE.\", TITLE = \"Assembly of the covalent linkage between lipoic acid and its cognate enzymes.\", JOURNAL = c(\"Chem Biol 10:1293-302 (2003)\", \"DOI:10.1016/j.chembiol.2003.11.016\")), list(REFERENCE = \"PMID:15642479\", AUTHORS = \"Nesbitt NM, Baleanu-Gogonea C, Cicchillo RM, Goodson K, Iwig DF, Broadwater JA, Haas JA, Fox BG, Booker SJ.\", TITLE = \"Expression, purification, and physical characterization of Escherichia coli lipoyl(octanoyl)transferase.\", JOURNAL = c(\"Protein Expr Purif 39:269-82 (2005)\", \"DOI:10.1016/j.pep.2004.10.021\")), list(REFERENCE = \"PMID:29191830\", AUTHORS = \"Solmonson A, DeBerardinis RJ\", TITLE = \"Lipoic acid metabolism and mitochondrial redox regulation.\", JOURNAL = c(\"J Biol Chem 293:7522-7530 (2018)\", \"DOI:10.1074/jbc.TM117.000259\")), list(REFERENCE = \"PMID:27074917\", AUTHORS = \"Cronan JE\", TITLE = \"Assembly of Lipoic Acid on Its Cognate Enzymes: an Extraordinary and Essential Biosynthetic Pathway.\", JOURNAL = c(\"Microbiol Mol Biol Rev 80:429-50 (2016)\", \"DOI:10.1128/MMBR.00073-15\")), list(REFERENCE = \"PMID:24777537\", AUTHORS = \"Mayr JA, Feichtinger RG, Tort F, Ribes A, Sperl W\", TITLE = \"Lipoic acid biosynthesis defects.\", JOURNAL = c(\"J Inherit Metab Dis 37:553-63 (2014)\", \"DOI:10.1007/s10545-014-9705-8\")), list(REFERENCE = \"PMID:29987032\", AUTHORS = \"Cao X, Zhu L, Song X, Hu Z, Cronan JE\", TITLE = \"Protein moonlighting elucidates the essential human pathway catalyzing lipoic acid assembly on its cognate enzymes.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 115:E7063-E7072 (2018)\", \"DOI:10.1073/pnas.1805862115\")), list(REFERENCE = \"PMID:24341803\", AUTHORS = \"Soreze Y, Boutron A, Habarou F, Barnerias C, Nonnenmacher L, Delpech H, Mamoune A, Chretien D, Hubert L, Bole-Feysot C, Nitschke P, Correia I, Sardet C, Boddaert N, Hamel Y, Delahodde A, Ottolenghi C, de Lonlay P\", TITLE = \"Mutations in human lipoyltransferase gene LIPT1 cause a Leigh disease with secondary deficiency for pyruvate and alpha-ketoglutarate dehydrogenase.\", JOURNAL = c(\"Orphanet J Rare Dis 8:192 (2013)\", \"DOI:10.1186/1750-1172-8-192\")), list(REFERENCE = \"PMID:28757203\", AUTHORS = \"Habarou F, Hamel Y, Haack TB, Feichtinger RG, Lebigot E, Marquardt I, Busiah K, Laroche C, Madrange M, Grisel C, Pontoizeau C, Eisermann M, Boutron A, Chretien D, Chadefaux-Vekemans B, Barouki R, Bole-Feysot C, Nitschke P, Goudin N, Boddaert N, Nemazanyy I, Delahodde A, Kolker S, Rodenburg RJ, Korenke GC, Meitinger T, Strom TM, Prokisch H, Rotig A, Ottolenghi C, Mayr JA, de Lonlay P\", TITLE = \"Biallelic Mutations in LIPT2 Cause a Mitochondrial Lipoylation Defect Associated with Severe Neonatal Encephalopathy.\", \n    JOURNAL = c(\"Am J Hum Genet 101:283-290 (2017)\", \"DOI:10.1016/j.ajhg.2017.07.001\")), list(REFERENCE = \"PMID:20508247\", AUTHORS = \"Spalding MD, Prigge ST\", TITLE = \"Lipoic acid metabolism in microbial pathogens.\", JOURNAL = c(\"Microbiol Mol Biol Rev 74:200-28 (2010)\", \"DOI:10.1128/MMBR.00008-10\")), list(REFERENCE = \"PMID:28543853\", AUTHORS = \"Guerra AJ, Afanador GA, Prigge ST\", TITLE = \"Crystal structure of lipoate-bound lipoate ligase 1, LipL1, from Plasmodium falciparum.\", JOURNAL = c(\"Proteins 85:1777-1783 (2017)\", \"DOI:10.1002/prot.25324\")), list(REFERENCE = \"PMID:25116855\", AUTHORS = \"Afanador GA, Matthews KA, Bartee D, Gisselberg JE, Walters MS, Freel Meyers CL, Prigge ST\", TITLE = \"Redox-dependent lipoylation of mitochondrial proteins in Plasmodium falciparum.\", JOURNAL = c(\"Mol Microbiol 94:156-71 (2014)\", \"DOI:10.1111/mmi.12753\")), list(REFERENCE = \"PMID:28836704\", AUTHORS = \"Afanador GA, Guerra AJ, Swift RP, Rodriguez RE, Bartee D, Matthews KA, Schon A, Freire E, Freel Meyers CL, Prigge ST\", TITLE = \"A novel lipoate attachment enzyme is shared by Plasmodium and Chlamydia species.\", JOURNAL = c(\"Mol Microbiol 106:439-451 (2017)\", \"DOI:10.1111/mmi.13776\")), list(REFERENCE = \"PMID:22607141\", AUTHORS = \"Storm J, Muller S\", TITLE = \"Lipoic acid metabolism of Plasmodium--a suitable drug target.\", JOURNAL = c(\"Curr Pharm Des 18:3480-9 (2012)\", \"DOI:10.2174/138161212801327266\")), list(REFERENCE = \"PMID:18069893\", AUTHORS = \"Gunther S, Wallace L, Patzewitz EM, McMillan PJ, Storm J, Wrenger C, Bissett R, Smith TK, Muller S\", TITLE = \"Apicoplast lipoic acid protein ligase B is not essential for Plasmodium falciparum.\", JOURNAL = c(\"PLoS Pathog 3:e189 (2007)\", \"DOI:10.1371/journal.ppat.0030189\")), list(REFERENCE = \"PMID:15225307\", AUTHORS = \"Wrenger C, Muller S\", TITLE = \"The human malaria parasite Plasmodium falciparum has distinct organelle-specific lipoylation pathways.\", JOURNAL = c(\"Mol Microbiol 53:103-13 (2004)\", \"DOI:10.1111/j.1365-2958.2004.04112.x\")), list(REFERENCE = \"PMID:21338420\", AUTHORS = \"Martin N, Christensen QH, Mansilla MC, Cronan JE, de Mendoza D\", TITLE = \"A novel two-gene requirement for the octanoyltransfer reaction of Bacillus subtilis lipoic acid biosynthesis.\", JOURNAL = c(\"Mol Microbiol 80:335-49 (2011)\", \"DOI:10.1111/j.1365-2958.2011.07597.x\")), list(REFERENCE = \"PMID:21338421\", AUTHORS = \"Christensen QH, Martin N, Mansilla MC, de Mendoza D, Cronan JE\", TITLE = \"A novel amidotransferase required for lipoic acid cofactor assembly in Bacillus subtilis.\", JOURNAL = c(\"Mol Microbiol 80:350-63 (2011)\", \"DOI:10.1111/j.1365-2958.2011.07598.x\"))', 'map00785', 'Lipoic acid metabolism', 'Metabolism; Metabolism of cofactors and vitamins', 520, 4920, 248, 105, 123, 44, 4756, 164);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (125, '00790', 'Folate biosynthesis', 'Metabolism; Metabolism of cofactors and vitamins', 'Folate biosynthesis', 'Tetrahydrofolate biosynthesis, GTP => THF [PATH:map00790], Tetrahydrofolate biosynthesis, mediated by ribA and trpF, GTP => THF [PATH:map00790], Tetrahydrofolate biosynthesis, mediated by PTPS, GTP => THF [PATH:map00790], Tetrahydrobiopterin biosynthesis, GTP => BH4 [PATH:map00790], L-threo-Tetrahydrobiopterin biosynthesis, GTP => L-threo-BH4 [PATH:map00790], Molybdenum cofactor biosynthesis, GTP => molybdenum cofactor [PATH:map00790]', 'Phenylketonuria, Hypophosphatasia, Primary dystonia, Dihydrofolate reductase deficiency, Molybdenum cofactor deficiency', 'GO: 0046656', 'ko00790', 'list(REFERENCE = \"\", AUTHORS = \"Nishizuka Y, Seyama Y, Ikai A, Ishimura Y, Kawaguchi A (eds).\", TITLE = \"[Cellular Functions and Metabolic Maps] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (1997)\"), list(REFERENCE = \"PMID:19675644\", AUTHORS = \"Schwarz G, Mendel RR, Ribbe MW\", TITLE = \"Molybdenum cofactors, enzymes and pathways.\", JOURNAL = c(\"Nature 460:839-47 (2009)\", \"DOI:10.1038/nature08302\")), list(REFERENCE = \"PMID:16632608\", AUTHORS = \"Hanzelmann P, Schindelin H\", TITLE = \"Binding of 5\'-GTP to the C-terminal FeS cluster of the radical S-adenosylmethionine enzyme MoaA provides insights into its mechanism.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 103:6829-34 (2006)\", \"DOI:10.1073/pnas.0510711103\")), list(REFERENCE = \"PMID:18092812\", AUTHORS = \"Daniels JN, Wuebbens MM, Rajagopalan KV, Schindelin H\", TITLE = \"Crystal structure of a molybdopterin synthase-precursor Z complex: insight into its sulfur transfer mechanism and its role in molybdenum cofactor deficiency.\", JOURNAL = c(\"Biochemistry 47:615-26 (2008)\", \"DOI:10.1021/bi701734g\")), list(REFERENCE = \"PMID:12571226\", AUTHORS = \"Wuebbens MM, Rajagopalan KV\", TITLE = \"Mechanistic and mutational studies of Escherichia coli molybdopterin synthase clarify the final step of molybdopterin biosynthesis.\", JOURNAL = c(\"J Biol Chem 278:14523-32 (2003)\", \"DOI:10.1074/jbc.M300453200\")), list(REFERENCE = \"PMID:21867484\", AUTHORS = \"Werner ER, Blau N, Thony B\", TITLE = \"Tetrahydrobiopterin: biochemistry and pathophysiology.\", JOURNAL = c(\"Biochem J 438:397-414 (2011)\", \"DOI:10.1042/BJ20110293\")), list(REFERENCE = \"PMID:12893295\", AUTHORS = \"Iino T, Tabata M, Takikawa S, Sawada H, Shintaku H, Ishikura S, Hara A\", TITLE = \"Tetrahydrobiopterin is synthesized from 6-pyruvoyl-tetrahydropterin by the human aldo-keto reductase AKR1 family members.\", JOURNAL = c(\"Arch Biochem Biophys 416:180-7 (2003)\", \"DOI:10.1016/S0003-9861(03)00295-9\")), list(REFERENCE = \"PMID:1902669\", AUTHORS = \"Park YS, Heizmann CW, Wermuth B, Levine RA, Steinerstauch P, Guzman J, Blau N\", TITLE = \"Human carbonyl and aldose reductases: new catalytic functions in tetrahydrobiopterin biosynthesis.\", JOURNAL = c(\"Biochem Biophys Res Commun 175:738-44 (1991)\", \"DOI:10.1016/0006-291X(91)91628-P\"))', 'map00790', 530, 5432, 248, 105, 128, 49, 5137, 295);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (126, '00791', 'Atrazine degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Atrazine degradation', 'UMBBD: atr cya cnm cpm, GO: 0019381', 'ko00791', 'list(REFERENCE = \"PMID:16597948\", AUTHORS = \"Shapir N, Cheng G, Sadowsky MJ, Wackett LP\", TITLE = \"Purification and characterization of TrzF: biuret hydrolysis by allophanate hydrolase supports growth.\", JOURNAL = c(\"Appl Environ Microbiol 72:2491-5 (2006)\", \"DOI:10.1128/AEM.72.4.2491-2495.2006\")), list(REFERENCE = \"PMID:16085834\", AUTHORS = \"Cheng G, Shapir N, Sadowsky MJ, Wackett LP.\", TITLE = \"Allophanate hydrolase, not urease, functions in bacterial cyanuric acid metabolism.\", JOURNAL = c(\"Appl Environ Microbiol 71:4437-45 (2005)\", \"DOI:10.1128/AEM.71.8.4437-4445.2005\")), list(REFERENCE = \"PMID:25847245\", AUTHORS = \"Li J, Biss M, Fu Y, Xu X, Moore SA, Xiao W\", TITLE = \"Two duplicated genes DDI2 and DDI3 in budding yeast encode a cyanamide hydratase and are induced by cyanamide.\", JOURNAL = c(\"J Biol Chem 290:12664-75 (2015)\", \"DOI:10.1074/jbc.M115.645408\"))', 'map00791', 'Atrazine degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 100, 855, 0, 0, 100, 0, 851, 4);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (127, '00830', 'Retinol metabolism', 'Metabolism; Metabolism of cofactors and vitamins', 'Retinol metabolism', 'Retinitis pigmentosa, Familial flecked retina syndrome, Leber congenital amaurosis, Hypercarotenemia and vitamin A deficiency, Retinal dystrophy, juvenile cataracts, and short stature syndrome', 'GO: 0006776', 'ko00830', 'list(REFERENCE = \"PMID:16968212\", AUTHORS = \"Travis GH, Golczak M, Moise AR, Palczewski K.\", TITLE = \"Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.\", JOURNAL = c(\"Annu Rev Pharmacol Toxicol 47:469-512 (2007)\", \"DOI:10.1146/annurev.pharmtox.47.120505.105225\")), list(REFERENCE = \"PMID:17618621\", AUTHORS = \"Muniz A, Villazana-Espinoza ET, Hatch AL, Trevino SG, Allen DM, Tsin AT.\", TITLE = \"A novel cone visual cycle in the cone-dominated retina.\", JOURNAL = c(\"Exp Eye Res 85:175-84 (2007)\", \"DOI:10.1016/j.exer.2007.05.003\")), list(REFERENCE = \"PMID:11093772\", AUTHORS = \"Marill J, Cresteil T, Lanotte M, Chabot GG.\", TITLE = \"Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.\", JOURNAL = c(\"Mol Pharmacol 58:1341-8 (2000)\", \"DOI:10.1124/mol.58.6.1341\")), list(REFERENCE = \"PMID:17893666\", AUTHORS = \"Nezzar H, Chiambaretta F, Marceau G, Blanchon L, Faye B, Dechelotte P, Rigal D, Sapin V.\", TITLE = \"Molecular and metabolic retinoid pathways in the human ocular surface.\", JOURNAL = \"Mol Vis 13:1641-50 (2007)\"), list(REFERENCE = \"PMID:16688755\", AUTHORS = \"Blomhoff R, Blomhoff HK.\", TITLE = \"Overview of retinoid metabolism and function.\", JOURNAL = c(\"J Neurobiol 66:606-30 (2006)\", \"DOI:10.1002/neu.20242\")), list(REFERENCE = \"PMID:16428379\", AUTHORS = \"Liden M, Eriksson U.\", TITLE = \"Understanding retinol metabolism: structure and function of retinol dehydrogenases.\", JOURNAL = c(\"J Biol Chem 281:13001-4 (2006)\", \"DOI:10.1074/jbc.R500027200\"))', 'map00830', 'Retinol metabolism', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (128, '00860', 'Porphyrin and chlorophyll metabolism', 'Metabolism; Metabolism of cofactors and vitamins', 'Porphyrin and chlorophyll metabolism', 'Heme biosynthesis, plants and bacteria, glutamate => heme [PATH:map00860], Cobalamin biosynthesis, cobinamide => cobalamin [PATH:map00860], Coenzyme F430 biosynthesis, sirohydrochlorin => coenzyme F430 [PATH:map00860], Siroheme biosynthesis, glutamate => siroheme [PATH:map00860], Heme biosynthesis, archaea, siroheme => heme [PATH:map00860], Heme biosynthesis, animals and fungi, glycine => heme [PATH:map00860]', 'Erythropoietic porphyria, Hepatic porphyria, Hyperbilirubinemia, Cytochrome c oxidase (COX) deficiency, Porphyria, Hyperbiliverdinemia, Crigler-Najjar syndrome, Gilbert syndrome, Aceruloplasminemia', 'GO: 0006778', 'ko00860', 'list(REFERENCE = \"PMID:9461500\", AUTHORS = \"Woodcock SC, Raux E, Levillayer F, Thermes C, Rambach A, Warren MJ.\", TITLE = \"Effect of mutations in the transmethylase and dehydrogenase/chelatase domains of sirohaem synthase (CysG) on sirohaem and cobalamin biosynthesis.\", JOURNAL = c(\"Biochem J 330:121-9 (1998)\", \"DOI:10.1042/bj3300121\")), list(REFERENCE = \"PMID:10217486\", AUTHORS = \"Johansson P, Hederstedt L\", TITLE = \"Organization of genes for tetrapyrrole biosynthesis in gram--positive bacteria.\", JOURNAL = c(\"Microbiology 145 ( Pt 3):529-38 (1999)\", \"DOI:10.1099/13500872-145-3-529\")), list(REFERENCE = \"PMID:10518530\", AUTHORS = \"Maggio-Hall LA, Escalante-Semerena JC.\", TITLE = \"In vitro synthesis of the nucleotide loop of cobalamin by Salmonella typhimurium enzymes.\", JOURNAL = c(\"Proc Natl Acad Sci USA 96:11798-803 (1999)\", \"DOI:10.1073/pnas.96.21.11798\")), list(REFERENCE = \"PMID:11007789\", AUTHORS = \"Roper JM, Raux E, Brindley AA, Schubert HL, Gharbia SE, Shah HN, Warren MJ.\", TITLE = \"The enigma of cobalamin (Vitamin B12) biosynthesis in Porphyromonas gingivalis. Identification and characterization of a functional corrin pathway.\", JOURNAL = c(\"J Biol Chem 275:40316-23 (2000)\", \"DOI:10.1074/jbc.M007146200\")), list(REFERENCE = \"PMID:12196148\", AUTHORS = \"Scott AI, Roessner CA.\", TITLE = \"Biosynthesis of cobalamin (vitamin B(12)).\", JOURNAL = c(\"Biochem Soc Trans 30:613-20 (2002)\", \"DOI:10.1042/bst0300613\")), list(REFERENCE = \"PMID:12195810\", AUTHORS = \"Warren MJ, Raux E, Schubert HL, Escalante-Semerena JC.\", TITLE = \"The biosynthesis of adenosylcobalamin (vitamin B12).\", JOURNAL = c(\"Nat Prod Rep 19:390-412 (2002)\", \"DOI:10.1039/b108967f\")), list(REFERENCE = \"PMID:12055304\", AUTHORS = \"Roessner CA, Huang KX, Warren MJ, Raux E, Scott AI.\", TITLE = \"Isolation and characterization of 14 additional genes specifying the anaerobic biosynthesis of cobalamin (vitamin B12) in Propionibacterium freudenreichii (P. shermanii).\", JOURNAL = c(\"Microbiology 148:1845-53 (2002)\", \"DOI:10.1099/00221287-148-6-1845\")), list(REFERENCE = \"PMID:11283349\", AUTHORS = \"Frankenberg N, Mukougawa K, Kohchi T, Lagarias JC.\", TITLE = \"Functional genomic analysis of the HY2 family of ferredoxin-dependent bilin reductases from oxygenic photosynthetic organisms.\", JOURNAL = c(\"Plant Cell 13:965-78 (2001)\", \"DOI:10.1105/tpc.13.4.965\")), list(REFERENCE = \"PMID:17506685\", AUTHORS = \"Chew AG, Bryant DA\", TITLE = \"Chlorophyll biosynthesis in bacteria: the origins of structural and functional diversity.\", JOURNAL = c(\"Annu Rev Microbiol 61:113-29 (2007)\", \"DOI:10.1146/annurev.micro.61.080706.093242\")), list(REFERENCE = \"PMID:16245042\", AUTHORS = \"Frigaard NU, Chew AG, Li H, Maresca JA, Bryant DA\", TITLE = \"Chlorobium tepidum: insights into the structure, physiology, and metabolism of a green sulfur bacterium derived from the complete genome sequence.\", JOURNAL = c(\"Photosynth Res 78:93-117 (2003)\", \"DOI:10.1023/B:PRES.0000004310.96189.b4\")), list(REFERENCE = \"PMID:23042036\", AUTHORS = \"Deery E, Schroeder S, Lawrence AD, Taylor SL, Seyedarabi A, Waterman J, Wilson KS, Brown D, Geeves MA, Howard MJ, Pickersgill RW, Warren MJ\", TITLE = \"An enzyme-trap approach allows isolation of intermediates in cobalamin biosynthesis.\", JOURNAL = c(\"Nat Chem Biol 8:933-40 (2012)\", \"DOI:10.1038/nchembio.1086\")), list(REFERENCE = \"PMID:23922391\", AUTHORS = \"Moore SJ, Lawrence AD, Biedendieck R, Deery E, Frank S, Howard MJ, Rigby SE, Warren MJ\", TITLE = \"Elucidation of the anaerobic pathway for the corrin component of cobalamin (vitamin B12).\", JOURNAL = c(\"Proc Natl Acad Sci U S A 110:14906-11 (2013)\", \"DOI:10.1073/pnas.1308098110\"))', 'map00860', 527, 5140, 248, 105, 127, 47, 4848, 292);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (129, '00900', 'Terpenoid backbone biosynthesis', 'Terpenoids, also known as isoprenoids, are a large class of natural products consisting of isoprene (C5) units. There are two biosynthetic pathways, the mevalonate pathway [MD:M00095] and the non-mevalonate pathway or the MEP/DOXP pathway [MD:M00096], for the terpenoid building blocks: isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). The action of prenyltransferases then generates higher-order building blocks: geranyl diphosphate (GPP), farsenyl diphosphate (FPP), and geranylgeranyl diphosphate (GGPP), which are the precursors of monoterpenoids (C10), sesquiterpenoids (C15), and diterpenoids (C20), respectively. Condensation of these building blocks gives rise to the precursors of sterols (C30) and carotenoids (C40). The MEP/DOXP pathway is absent in higher animals and fungi, but in green plants the MEP/DOXP and mevalonate pathways co-exist in separate cellular compartments. The MEP/DOXP pathway, operating in the plastids, is responsible for the formation of essential oil monoterpenes and linalyl acetate, some sesquiterpenes, diterpenes, and carotenoids and phytol. The mevalonate pathway, operating in the cytosol, gives rise to triterpenes, sterols, and most sesquiterpenes.', 'Metabolism; Metabolism of terpenoids and polyketides', 'Terpenoid backbone biosynthesis', 'C5 isoprenoid biosynthesis, mevalonate pathway [PATH:map00900], C5 isoprenoid biosynthesis, non-mevalonate pathway [PATH:map00900], C10-C20 isoprenoid biosynthesis, bacteria [PATH:map00900], C10-C20 isoprenoid biosynthesis, archaea [PATH:map00900], C10-C20 isoprenoid biosynthesis, plants [PATH:map00900], C10-C20 isoprenoid biosynthesis, non-plant eukaryotes [PATH:map00900], C5 isoprenoid biosynthesis, mevalonate pathway, archaea [PATH:map00900]', 'Mevalonate kinase deficiency, Retinitis pigmentosa, Restrictive dermopathy, Coenzyme Q10 deficiency, HMG-CoA synthase deficiency, Porokeratosis', 'GO: 0009240 0016091', 'ko00900', 'list(REFERENCE = \"PMID:12777052\", AUTHORS = \"Lange BM, Ghassemian M.\", TITLE = \"Genome organization in Arabidopsis thaliana: a survey for genes involved in isoprenoid and chlorophyll metabolism.\", JOURNAL = c(\"Plant Mol Biol 51:925-48 (2003)\", \"DOI:10.1023/A:1023005504702\")), list(REFERENCE = \"PMID:16262699\", AUTHORS = \"Saiki R, Nagata A, Kainou T, Matsuda H, Kawamukai M\", TITLE = \"Characterization of solanesyl and decaprenyl diphosphate synthases in mice and humans.\", JOURNAL = c(\"FEBS J 272:5606-22 (2005)\", \"DOI:10.1111/j.1742-4658.2005.04956.x\")), list(REFERENCE = \"PMID:9858571\", AUTHORS = \"Sato M, Sato K, Nishikawa S, Hirata A, Kato J, Nakano A\", TITLE = \"The yeast RER2 gene, identified by endoplasmic reticulum protein localization mutations, encodes cis-prenyltransferase, a key enzyme in dolichol synthesis.\", JOURNAL = c(\"Mol Cell Biol 19:471-83 (1999)\", \"DOI:10.1128/MCB.19.1.471\")), list(REFERENCE = \"PMID:24375100\", AUTHORS = \"Vannice JC, Skaff DA, Keightley A, Addo JK, Wyckoff GJ, Miziorko HM\", TITLE = \"Identification in Haloferax volcanii of phosphomevalonate decarboxylase and isopentenyl phosphate kinase as catalysts of the terminal enzyme reactions in an  archaeal alternate mevalonate pathway.\", JOURNAL = c(\"J Bacteriol 196:1055-63 (2014)\", \"DOI:10.1128/JB.01230-13\"))', 531, 5406, 248, 105, 128, 50, 5110, 296);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (130, '00901', 'Indole alkaloid biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Indole alkaloid biosynthesis', 'GO: 0009709', 'ko00901', 'list(REFERENCE = \"PMID:9622525\", AUTHORS = \"Rijhwani SK, Shanks JV.\", TITLE = \"Effect of elicitor dosage and exposure time on biosynthesis of indole alkaloids by Catharanthus roseus hairy root cultures.\", JOURNAL = c(\"Biotechnol Prog 14:442-9 (1998)\", \"DOI:10.1021/bp980029v\")), list(REFERENCE = \"PMID:4698228\", AUTHORS = \"Madyastha KM, Guarnaccia R, Baxter C, Coscia CJ.\", TITLE = \"S-Adenosyl-L-methionine: loganic acid methyltransferase. A carboxyl-alkylating enzyme from Vinca rosea.\", JOURNAL = \"J Biol Chem 248:2497-501 (1973)\"), list(REFERENCE = \"PMID:510306\", AUTHORS = \"Treimer JF, Zenk MH.\", TITLE = \"Purification and properties of strictosidine synthase, the key enzyme in indole alkaloid formation.\", JOURNAL = c(\"Eur J Biochem 101:225-33 (1979)\", \"DOI:10.1111/j.1432-1033.1979.tb04235.x\")), list(REFERENCE = \"PMID:10652285\", AUTHORS = \"Geerlings A, Ibanez MM, Memelink J, van Der Heijden R, Verpoorte R.\", TITLE = \"Molecular cloning and analysis of strictosidine beta-D-glucosidase, an enzyme in terpenoid indole alkaloid biosynthesis in Catharanthus roseus.\", JOURNAL = c(\"J Biol Chem 275:3051-6 (2000)\", \"DOI:10.1074/jbc.275.5.3051\")), list(REFERENCE = \"PMID:11128\", AUTHORS = \"Stockigt J, Treimer J, Zenk MH.\", TITLE = \"Synthesis of ajmalicine and related indole alkaloids by cell free extracts of Catharanthus roseus cell suspension cultures.\", JOURNAL = c(\"FEBS Lett 70:267-70 (1976)\", \"DOI:10.1016/0014-5793(76)80772-7\")), list(REFERENCE = \"PMID:12228585\", AUTHORS = \"St-Pierre B, De Luca V.\", TITLE = \"A Cytochrome P-450 Monooxygenase Catalyzes the First Step in the Conversion of Tabersonine to Vindoline in Catharanthus roseus.\", JOURNAL = c(\"Plant Physiol 109:131-139 (1995)\", \"DOI:10.1104/pp.109.1.131\")), list(REFERENCE = \"PMID:10481044\", AUTHORS = \"Schroder G, Unterbusch E, Kaltenbach M, Schmidt J, Strack D, De Luca V, Schroder J.\", TITLE = \"Light-induced cytochrome P450-dependent enzyme in indole alkaloid biosynthesis: tabersonine 16-hydroxylase.\", JOURNAL = c(\"FEBS Lett 458:97-102 (1999)\", \"DOI:10.1016/S0014-5793(99)01138-2\")), list(REFERENCE = \"PMID:9654153\", AUTHORS = \"Sottomayor M, Lopez-Serrano M, DiCosmo F, Ros Barcelo A.\", TITLE = \"Purification and characterization of alpha-3\',4\'-anhydrovinblastine synthase (peroxidase-like) from Catharanthus roseus (L.) G. Don.\", JOURNAL = c(\"FEBS Lett 428:299-303 (1998)\", \"DOI:10.1016/S0014-5793(98)00551-1\")), list(REFERENCE = \"PMID:1368411\", AUTHORS = \"Furuya T, Sakamoto K, Iida K, Asada Y, Yoshikawa T, Sakai S, Aimi N.\", TITLE = \"Biotransformation of tabersonine in cell suspension cultures of Catharanthus roseus.\", JOURNAL = c(\"Phytochemistry 31:3065-8 (1992)\", \"DOI:10.1016/0031-9422(92)83447-7\")), list(REFERENCE = \"PMID:11154328\", AUTHORS = \"Laflamme P, St-Pierre B, De Luca V.\", TITLE = \"Molecular and biochemical analysis of a madagascar periwinkle root-specific minovincinine-19-hydroxy-o-acetyltransferase.\", JOURNAL = c(\"Plant Physiol 125:189-98 (2001)\", \"DOI:10.1104/pp.125.1.189\")), list(REFERENCE = \"PMID:12150812\", AUTHORS = \"Jain S, Sinha A, Bhakuni DS.\", TITLE = \"The biosynthesis of beta-carboline and quinolizidine alkaloids of Alangium lamarckii.\", JOURNAL = c(\"Phytochemistry 60:853-9 (2002)\", \"DOI:10.1016/S0031-9422(02)00057-2\")), list(REFERENCE = \"PMID:28763571\", AUTHORS = \"Fricke J, Blei F, Hoffmeister D\", TITLE = \"Enzymatic Synthesis of Psilocybin.\", JOURNAL = c(\"Angew Chem Int Ed Engl 56:12352-12355 (2017)\", \"DOI:10.1002/anie.201705489\"))', 'map00901', 'Indole alkaloid biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 25, 0, 0, 9, 16, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (131, '00902', 'Monoterpenoid biosynthesis', 'Monoterpenoids (C10 terpenoids) are a group of terpenoids consisting of two isoprene units. They are derived from geranyl diphosphate (GPP). Most monoterpenoids are volatile oils with highly distinctive aromas and flavors, such as essential oils, turpentine, and oleoresins of coniferous plants. This map shows some examples. The monoterpene ketone l-menthone is specifically converted to l-menthol and d-neomenthol in mature peppermint leaves. The iridoids constitute a family of highly oxygenated monoterpenes, mixtures of which are present in many medicinal plants, such as valerian. They are derived from geraniol or nerol via oxidation of a terminal methyl group. The cyclopentane ring of loganin can itself be cleaved in a further P450-dependent step, leading to secologanin, which provides the carbon skeleton for many powerfully bioactive secondary metabolites of indole alkaloids.', 'Metabolism; Metabolism of terpenoids and polyketides', 'Monoterpenoid biosynthesis', 'GO: 0016099', 'ko00902', 'list(REFERENCE = \"PMID:15728344\", AUTHORS = \"Davis EM, Ringer KL, McConkey ME, Croteau R\", TITLE = \"Monoterpene metabolism. Cloning, expression, and characterization of menthone reductases from peppermint.\", JOURNAL = c(\"Plant Physiol 137:873-81 (2005)\", \"DOI:10.1104/pp.104.053306\")), list(REFERENCE = \"PMID:11375201\", AUTHORS = \"Duetz WA, Fjallman AH, Ren S, Jourdat C, Witholt B\", TITLE = \"Biotransformation of D-limonene to (+) trans-carveol by toluene-grown Rhodococcus opacus PWD4 cells.\", JOURNAL = c(\"Appl Environ Microbiol 67:2829-32 (2001)\", \"DOI:10.1128/AEM.67.6.2829-2832.2001\")), list(REFERENCE = \"PMID:15299125\", AUTHORS = \"Chen F, Ro DK, Petri J, Gershenzon J, Bohlmann J, Pichersky E, Tholl D\", TITLE = \"Characterization of a root-specific Arabidopsis terpene synthase responsible for the formation of the volatile monoterpene 1,8-cineole.\", JOURNAL = c(\"Plant Physiol 135:1956-66 (2004)\", \"DOI:10.1104/pp.104.044388\")), list(REFERENCE = \"PMID:1368150\", AUTHORS = \"Trudgill PW\", TITLE = \"Microbial metabolism of monoterpenes--recent developments.\", JOURNAL = c(\"Biodegradation 1:93-105 (1990)\", \"DOI:10.1007/BF00058829\")), list(REFERENCE = \"PMID:1864846\", AUTHORS = \"Ikeda H, Esaki N, Nakai S, Hashimoto K, Uesato S, Soda K, Fujita T\", TITLE = \"Acyclic monoterpene primary alcohol:NADP+ oxidoreductase of Rauwolfia serpentina cells: the key enzyme in biosynthesis of monoterpene alcohols.\", JOURNAL = \"J Biochem 109:341-7 (1991)\"), list(REFERENCE = \"PMID:10656401\", AUTHORS = \"Yamamoto H, Katano N, Ooi A, Inoue K.\", TITLE = \"Secologanin synthase which catalyzes the oxidative cleavage of loganin into secologanin is a cytochrome P450.\", JOURNAL = c(\"Phytochemistry 53:7-12 (2000)\", \"DOI:10.1016/S0031-9422(99)00471-9\")), list(REFERENCE = \"PMID:11524113\", AUTHORS = \"Katano N, Yamamoto H, Iio R, Inoue K.\", TITLE = \"7-Deoxyloganin 7-hydroxylase in Lonicera japonica cell cultures.\", JOURNAL = c(\"Phytochemistry 58:53-8 (2001)\", \"DOI:10.1016/S0031-9422(01)00181-9\"))', 'map00902', 'Monoterpenoid biosynthesis', 89, 0, 0, 89, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (132, '00903', 'Limonene and pinene degradation', 'Metabolism; Metabolism of terpenoids and polyketides', 'Limonene and pinene degradation', 'ko00903', 'list(REFERENCE = \"PMID:10224006\", AUTHORS = \"van der Werf MJ, Swarts HJ, de Bont JA\", TITLE = \"Rhodococcus erythropolis DCL14 contains a novel degradation pathway for limonene.\", JOURNAL = \"Appl Environ Microbiol 65:2092-102 (1999)\"), list(REFERENCE = \"PMID:10832640\", AUTHORS = \"van der Werf MJ, Boot AM\", TITLE = \"Metabolism of carveol and dihydrocarveol in Rhodococcus erythropolis DCL14.\", JOURNAL = c(\"Microbiology 146 ( Pt 5):1129-41 (2000)\", \"DOI:10.1099/00221287-146-5-1129\"))', 'map00903', 'Limonene and pinene degradation', 'Metabolism; Metabolism of terpenoids and polyketides', 'Limonene and pinene degradation', 95, 2579, 0, 95, 0, 0, 2579, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (133, '00904', 'Diterpenoid biosynthesis', 'Metabolism; Metabolism of terpenoids and polyketides', 'Diterpenoid biosynthesis', 'GO: 0016102', 'ko00904', 'list(REFERENCE = \"PMID:16137660\", AUTHORS = \"Long RM, Croteau R.\", TITLE = \"Preliminary assessment of the C13-side chain 2\'-hydroxylase involved in taxol biosynthesis.\", JOURNAL = c(\"Biochem Biophys Res Commun 338:410-7 (2005)\", \"DOI:10.1016/j.bbrc.2005.08.119\")), list(REFERENCE = \"PMID:12089320\", AUTHORS = \"Walker K, Long R, Croteau R.\", TITLE = \"The final acylation step in taxol biosynthesis: cloning of the taxoid C13-side-chain N-benzoyltransferase from Taxus.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 99:9166-71 (2002)\", \"DOI:10.1073/pnas.082115799\"))', 'map00904', 'Diterpenoid biosynthesis', 'Metabolism; Metabolism of terpenoids and polyketides', 108, 0, 0, 91, 17, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (134, '00905', 'Brassinosteroid biosynthesis', 'Brassinosteroids are a group of plant steroid hormones that regulate growth and development. More than fifty naturally occurring brassinosteroids have been identified in a wide range of plant species. The most abundant and widely occurring brassinosteroids are C28 steroids, and among them brassinolide (BL) is the most biologically active. Plants have multiple pathways for biosynthesis of BL, which are derived from the steroid biosynthetic pathway. Two pathways from campestanol to castasterone (CS), C6 oxidation and the late-C6 oxidation pathways, operate in many plants. Another branching pathway, the early-C22 oxidation pathway, was demonstrated using a brassinosteroid-deficient mutant of Arabidopsis thaliana. Recently, a new shortcut pathway from campesterol to 6-deoxotyphasterol was demonstrated by a functional analysis of cytochrome P450 monooxygenases responsible for brassinosteroid biosynthesis. Thus, at least four pathways are involved in the biosynthesis of CS, and CS is further metabolized to BL by lactonization of the B ring.', 'Metabolism; Metabolism of terpenoids and polyketides', 'Brassinosteroid biosynthesis', 'Castasterone biosynthesis, campesterol => castasterone [PATH:map00905]', 'GO: 0016132', 'ko00905', 'list(REFERENCE = \"\", AUTHORS = \"Koshiba K, Kamiya Y.\", TITLE = \"[Atarasii Syokubutuhorumon no Kagaku] (In Japanese)\", JOURNAL = \"Koudansya saientific:199-138 (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukuda H, Matida Y, Kamiya Y, Kakimoto T.\", TITLE = \"[Shinpan Syokubutuhorumon no Sigunarudentatu] (In Japanese)\", JOURNAL = \"Syujyunsya:165-186 (2004)\"), list(REFERENCE = \"PMID:12529536\", AUTHORS = \"Shimada Y, Goda H, Nakamura A, Takatsuto S, Fujioka S, Yoshida S.\", TITLE = \"Organ-specific expression of brassinosteroid-biosynthetic genes and distribution of endogenous brassinosteroids in Arabidopsis.\", JOURNAL = c(\"Plant Physiol 131:287-97 (2003)\", \"DOI:10.1104/pp.013029\")), list(REFERENCE = \"\", AUTHORS = \"Choe, S.\", TITLE = \"Brassinosteroid biosynthesis and inactivation.\", JOURNAL = \"Physiologia Plantarum 126:539-548 (2006)\"), list(REFERENCE = \"PMID:17138693\", AUTHORS = \"Ohnishi T, Szatmari AM, Watanabe B, Fujita S, Bancos S, Koncz C, Lafos M, Shibata K, Yokota T, Sakata K, Szekeres M, Mizutani M\", TITLE = \"C-23 hydroxylation by Arabidopsis CYP90C1 and CYP90D1 reveals a novel shortcut in brassinosteroid biosynthesis.\", JOURNAL = c(\"Plant Cell 18:3275-88 (2006)\", \"DOI:10.1105/tpc.106.045443\")), list(REFERENCE = \"PMID:17693126\", AUTHORS = \"Bishop GJ\", TITLE = \"Refining the plant steroid hormone biosynthesis pathway.\", JOURNAL = c(\"Trends Plant Sci 12:377-80 (2007)\", \"DOI:10.1016/j.tplants.2007.07.001\")), list(REFERENCE = \"PMID:15710611\", AUTHORS = \"Nomura T, Kushiro T, Yokota T, Kamiya Y, Bishop GJ, Yamaguchi S\", TITLE = \"The last reaction producing brassinolide is catalyzed by cytochrome P-450s, CYP85A3 in tomato and CYP85A2 in Arabidopsis.\", JOURNAL = c(\"J Biol Chem 280:17873-9 (2005)\", \"DOI:10.1074/jbc.M414592200\")), list(REFERENCE = \"PMID:18685225\", AUTHORS = \"Katsumata T, Hasegawa A, Fujiwara T, Komatsu T, Notomi M, Abe H, Natsume M, Kawaide H\", TITLE = \"Arabidopsis CYP85A2 catalyzes lactonization reactions in the biosynthesis of 2-deoxy-7-oxalactone brassinosteroids.\", JOURNAL = c(\"Biosci Biotechnol Biochem 72:2110-7 (2008)\", \"DOI:10.1271/bbb.80192\")), list(REFERENCE = \"PMID:15705958\", AUTHORS = \"Tanabe S, Ashikari M, Fujioka S, Takatsuto S, Yoshida S, Yano M, Yoshimura A, Kitano H, Matsuoka M, Fujisawa Y, Kato H, Iwasaki Y\", TITLE = \"A novel cytochrome P450 is implicated in brassinosteroid biosynthesis via the characterization of a rice dwarf mutant, dwarf11, with reduced seed length.\", JOURNAL = c(\"Plant Cell 17:776-90 (2005)\", \"DOI:10.1105/tpc.104.024950\")), list(REFERENCE = \"PMID:14615594\", AUTHORS = \"Hong Z, Ueguchi-Tanaka M, Umemura K, Uozu S, Fujioka S, Takatsuto S, Yoshida S, Ashikari M, Kitano H, Matsuoka M\", TITLE = \"A rice brassinosteroid-deficient mutant, ebisu dwarf (d2), is caused by a loss of function of a new member of cytochrome P450.\", JOURNAL = c(\"Plant Cell 15:2900-10 (2003)\", \"DOI:10.1105/tpc.014712\"))', 'map00905', 93, 0, 0, 93, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (135, '00906', 'Carotenoid biosynthesis', 'Metabolism; Metabolism of terpenoids and polyketides', 'Carotenoid biosynthesis', 'beta-Carotene biosynthesis, GGAP => beta-carotene [PATH:map00906], Abscisic acid biosynthesis, beta-carotene => abscisic acid [PATH:map00906]', 'GO: 0016117', 'ko00906', 'list(REFERENCE = \"\", AUTHORS = \"Takaichi S, Mimuro M, Tomita Y.\", TITLE = \"[Karotenoido-sono Tayousei to Seirikattsei] (In Japanese)\", JOURNAL = \"SHOKABO:109-156 (2006)\"), list(REFERENCE = \"\", AUTHORS = \"Fukuda H, Matida Y, Kamiya Y, Kakimoto T.\", TITLE = \"[Shinpan Syokubutuhorumon no Sigunarudentatu] (In Japanese)\", JOURNAL = \"Syujyunsya:165-186 (2004)\"), list(REFERENCE = \"\", AUTHORS = \"Takaichi S.\", TITLE = \"Distribution and biosynthesis of carotenoids in plants and photosynthetic bacteria.\", JOURNAL = c(\"Foods and Food Ingredients Journal of Japan 212-7:524-531 (2007)\", \"DOI:10.1007/978-1-4020-8815-5_6\")), list(REFERENCE = \"PMID:11804826 (Plant-Carotenoid pathway)\", AUTHORS = \"Seo M, Koshiba T.\", TITLE = \"Complex regulation of ABA biosynthesis in plants.\", JOURNAL = c(\"Trends Plant Sci 7:41-8 (2002)\", \"DOI:10.1016/S1360-1385(01)02187-2\")), list(REFERENCE = \"PMID:17085635 (Plant-Carotenoid pathway)\", AUTHORS = \"Cunningham FX Jr, Lee H, Gantt E.\", TITLE = \"Carotenoid biosynthesis in the primitive red alga Cyanidioschyzon merolae.\", JOURNAL = c(\"Eukaryot Cell 6:533-45 (2007)\", \"DOI:10.1128/EC.00265-06\")), list(REFERENCE = \"PMID:9914519 (Plant-Carotenoid pathway)\", AUTHORS = \"Bartley GE, Scolnik PA, Beyer P.\", TITLE = \"Two Arabidopsis thaliana carotene desaturases, phytoene desaturase and zeta-carotene desaturase, expressed in Escherichia coli, catalyze a poly-cis pathway to yield pro-lycopene.\", JOURNAL = c(\"Eur J Biochem 259:396-403 (1999)\", \"DOI:10.1046/j.1432-1327.1999.00051.x\")), list(REFERENCE = \"PMID:11884677 (Plant-Carotenoid pathway)\", AUTHORS = \"Park H, Kreunen SS, Cuttriss AJ, DellaPenna D, Pogson BJ.\", TITLE = \"Identification of the carotenoid isomerase provides insight into carotenoid biosynthesis, prolamellar body formation, and photomorphogenesis.\", JOURNAL = c(\"Plant Cell 14:321-32 (2002)\", \"DOI:10.1105/tpc.010302\")), list(REFERENCE = \"PMID:15557094 (Plant-Carotenoid pathway)\", AUTHORS = \"Isaacson T, Ohad I, Beyer P, Hirschberg J.\", TITLE = \"Analysis in vitro of the enzyme CRTISO establishes a poly-cis-carotenoid biosynthesis pathway in plants.\", JOURNAL = c(\"Plant Physiol 136:4246-55 (2004)\", \"DOI:10.1104/pp.104.052092\")), list(REFERENCE = \"PMID:12782726 (Plant-Carotenoid pathway)\", AUTHORS = \"Tian L, Magallanes-Lundback M, Musetti V, DellaPenna D.\", TITLE = \"Functional analysis of beta- and epsilon-ring carotenoid hydroxylases in Arabidopsis.\", JOURNAL = c(\"Plant Cell 15:1320-32 (2003)\", \"DOI:10.1105/tpc.011403\")), list(REFERENCE = \"PMID:14709673 (Plant-Carotenoid pathway)\", AUTHORS = \"Tian L, Musetti V, Kim J, Magallanes-Lundback M, DellaPenna D.\", TITLE = \"The Arabidopsis LUT1 locus encodes a member of the cytochrome p450 family that is required for carotenoid epsilon-ring hydroxylation activity.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 101:402-7 (2004)\", \"DOI:10.1073/pnas.2237237100\")), list(REFERENCE = \"PMID:7920703 (Plant-Carotenoid pathway)\", AUTHORS = \"Bouvier F, Hugueney P, d\'Harlingue A, Kuntz M, Camara B.\", TITLE = \"Xanthophyll biosynthesis in chromoplasts: isolation and molecular cloning of an enzyme catalyzing the conversion of 5,6-epoxycarotenoid into ketocarotenoid.\", JOURNAL = c(\"Plant J 6:45-54 (1994)\", \"DOI:10.1046/j.1365-313X.1994.6010045.x\")), list(REFERENCE = \"PMID:9159947 (Plant-Carotenoid pathway)\", AUTHORS = \"Schwartz SH, Leon-Kloosterziel KM, Koornneef M, Zeevaart JA.\", TITLE = \"Biochemical characterization of the aba2 and aba3 mutants in Arabidopsis thaliana.\", JOURNAL = c(\"Plant Physiol 114:161-6 (1997)\", \"DOI:10.1104/pp.114.1.161\")), list(REFERENCE = \"PMID:12114582 (Plant-Carotenoid pathway)\", AUTHORS = \"Xu ZJ, Nakajima M, Suzuki Y, Yamaguchi I.\", TITLE = \"Cloning and characterization of the abscisic acid-specific glucosyltransferase gene from adzuki bean seedlings.\", JOURNAL = c(\"Plant Physiol 129:1285-95 (2002)\", \"DOI:10.1104/pp.001784\")), list(REFERENCE = \"PMID:9808729 (Plant-Carotenoid pathway)\", AUTHORS = \"Krochko JE, Abrams GD, Loewen MK, Abrams SR, Cutler AJ.\", TITLE = \"(+)-Abscisic acid 8\'-hydroxylase is a cytochrome P450 monooxygenase\", JOURNAL = c(\"Plant Physiol 118:849-60 (1998)\", \"DOI:10.1104/pp.118.3.849\")), list(REFERENCE = \"PMID:10851005 (Purple bacteria-canthaxanthin,spirilloxanthin pathway)\", AUTHORS = \"Hannibal L, Lorquin J, D\'Ortoli NA, Garcia N, Chaintreuil C, Masson-Boivin C, Dreyfus B, Giraud E.\", TITLE = \"Isolation and characterization of canthaxanthin biosynthesis genes from the photosynthetic bacterium Bradyrhizobium sp. strain ORS278.\", JOURNAL = c(\"J Bacteriol 182:3850-3 (2000)\", \"DOI:10.1128/JB.182.13.3850-3853.2000\")), list(REFERENCE = \"PMID:12664193 (Purple bacteria-Spheroidene,spirilloxanthin pathway)\", AUTHORS = \"Pinta V, Ouchane S, Picaud M, Takaichi S, Astier C, Reiss-Husson F.\", TITLE = \"Characterization of unusual hydroxy- and ketocarotenoids in Rubrivivax gelatinosus: involvement of enzyme CrtF or CrtA.\", JOURNAL = c(\"Arch Microbiol 179:354-62 (2003)\", \"DOI:10.1007/s00203-003-0538-3\")), list(REFERENCE = \"PMID:7721699 (Purple bacteria-Spheroidene pathway)\", AUTHORS = \"Lang HP, Cogdell RJ, Takaichi S, Hunter CN.\", TITLE = \"Complete DNA sequence, specific Tn5 insertion map, and gene assignment of the carotenoid biosynthesis pathway of Rhodobacter sphaeroides.\", JOURNAL = c(\"J Bacteriol 177:2064-73 (1995)\", \"DOI:10.1128/JB.177.8.2064-2073.1995\")), list(REFERENCE = \"PMID:9636041 (Purple bacteria-Unusual spirilloxanthin pathway)\", AUTHORS = \"Komori M, Ghosh R, Takaichi S, Hu Y, Mizoguchi T, Koyama Y, Kuki M.\", TITLE = \"A null lesion in the rhodopin 3,4-desaturase of Rhodospirillum rubrum unmasks a cryptic branch of the carotenoid biosynthetic pathway.\", JOURNAL = c(\"Biochemistry 37:8987-94 (1998)\", \"DOI:10.1021/bi9730947\")), list(REFERENCE = \"PMID:14044829 (Purple bacteria-Okenone)\", AUTHORS = \"SCHMIDT K, LIAAENJENSEN S, SCHLEGEL HG.\", TITLE = \"[CAROTENOIDS IN THIORHODACEAE. I. OKENONEAS THE PRINCIPAL CAROTENOID IN CHROMATIUM OKENII PERTY.]\", JOURNAL = \"Arch Mikrobiol 46:117-26 (1963)\"), list(REFERENCE = \"PMID:4932469 (Purple bacteria-Rhodopinal)\", AUTHORS = \"Schmidt K.\", TITLE = \"Carotenoids of purple nonsulfur bacteria. Composition and biosynthesis of the carotenoids of some strains of Rhodopseudomonas acidophila, Rhodospirillum tenue, and Rhodocyclus purpureus.\", JOURNAL = c(\"Arch Mikrobiol 77:231-8 (1971)\", \"DOI:10.1007/BF00408115\")), list(REFERENCE = \"PMID:2254247 (Erwinia uredovora-Carotenoid pathway)\", AUTHORS = \"Misawa N, Nakagawa M, Kobayashi K, Yamano S, Izawa Y, Nakamura K, Harashima K.\", TITLE = \"Elucidation of the Erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products expressed in Escherichia coli.\", JOURNAL = c(\"J Bacteriol 172:6704-12 (1990)\", \"DOI:10.1128/JB.172.12.6704-6712.1990\")), list(REFERENCE = \"PMID:7588751 (Myxococcus xanthus-Carotenoid pathway)\", AUTHORS = \"Botella JA, Murillo FJ, Ruiz-Vazquez R.\", TITLE = \"A cluster of structural and regulatory genes for light-induced carotenogenesis in Myxococcus xanthus.\", JOURNAL = c(\"Eur J Biochem 233:238-48 (1995)\", \"DOI:10.1111/j.1432-1033.1995.238_1.x\")), list(REFERENCE = \"PMID:7592436 (Marine bacteria-Astaxanthin pathway)\", AUTHORS = \"Misawa N, Satomi Y, Kondo K, Yokoyama A, Kajiwara S, Saito T, Ohtani T, Miki W.\", TITLE = \"Structure and functional analysis of a marine bacterial carotenoid biosynthesis gene cluster and astaxanthin biosynthetic pathway proposed at the gene level.\", JOURNAL = c(\"J Bacteriol 177:6575-84 (1995)\", \"DOI:10.1128/JB.177.22.6575-6584.1995\")), list(REFERENCE = \"PMID:16020541 (Heriobacteria-Diapocarotene pathway)\", AUTHORS = \"Pelz A, Wieland KP, Putzbach K, Hentschel P, Albert K, Gotz F.\", TITLE = \"Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus.\", JOURNAL = c(\"J Biol Chem 280:32493-8 (2005)\", \"DOI:10.1074/jbc.M505070200\")), list(REFERENCE = \"PMID:8002598 (Heriobacteria-Diapocarotene pathway)\", AUTHORS = \"Wieland B, Feil C, Gloria-Maercker E, Thumm G, Lechner M, Bravo JM, Poralla K, Gotz F.\", TITLE = \"Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4\'-diaponeurosporene of Staphylococcus aureus.\", JOURNAL = c(\"J Bacteriol 176:7719-26 (1994)\", \"DOI:10.1128/JB.176.24.7719-7726.1994\")), list(REFERENCE = \"PMID:10395965 (Streptomyces griseus-Carotenoid pathway)\", AUTHORS = \"Krugel H, Krubasik P, Weber K, Saluz HP, Sandmann G.\", TITLE = \"Functional analysis of genes from Streptomyces griseus involved in the synthesis of isorenieratene, a carotenoid with aromatic end groups, revealed a novel type of carotenoid desaturase.\", JOURNAL = c(\"Biochim Biophys Acta 1439:57-64 (1999)\", \"DOI:10.1016/S1388-1981(99)00075-X\")), list(REFERENCE = \"PMID:11479383 (Cyanobacteria-Myxol pathway)\", AUTHORS = \"Takaichi S, Maoka T, Masamoto K.\", TITLE = \"Myxoxanthophyll in Synechocystis sp. PCC 6803 is myxol 2\'-dimethyl-fucoside, (3R,2\'S)-myxol 2\'-(2,4-di-O-methyl-alpha-L-fucoside), not rhamnoside.\", JOURNAL = c(\"Plant Cell Physiol 42:756-62 (2001)\", \"DOI:10.1093/pcp/pce098\")), list(REFERENCE = \"PMID:15695449 (Cyanobacteria-Myxol pathway)\", AUTHORS = \"Takaichi S, Mochimaru M, Maoka T, Katoh H.\", TITLE = \"Myxol and 4-ketomyxol 2\'-fucosides, not rhamnosides, from Anabaena sp. PCC 7120 and Nostoc punctiforme PCC 73102, and proposal for the biosynthetic pathway of carotenoids.\", JOURNAL = c(\"Plant Cell Physiol 46:497-504 (2005)\", \"DOI:10.1093/pcp/pci049\")), list(REFERENCE = \"PMID:9092504 (Cyanobacteria-Carotenoid pathway)\", AUTHORS = \"Fernandez-Gonzalez B, Sandmann G, Vioque A.\", TITLE = \"A new type of asymmetrically acting beta-carotene ketolase is required for the synthesis of echinenone in the cyanobacterium Synechocystis sp. PCC 6803.\", JOURNAL = c(\"J Biol Chem 272:9728-33 (1997)\", \"DOI:10.1074/jbc.272.15.9728\")), list(REFERENCE = \"PMID:16242129 (Cyanobacteria-Carotenoid pathway)\", AUTHORS = \"Mochimaru M, Masukawa H, Takaichi S.\", TITLE = \"The cyanobacterium Anabaena sp. PCC 7120 has two distinct beta-carotene ketolases: CrtO for echinenone and CrtW for ketomyxol synthesis.\", JOURNAL = c(\"FEBS Lett 579:6111-4 (2005)\", \"DOI:10.1016/j.febslet.2005.09.081\")), list(REFERENCE = \"PMID:7919981 (Cyanobacteria-Carotenoid pathway)\", AUTHORS = \"Cunningham FX Jr, Sun Z, Chamovitz D, Hirschberg J, Gantt E.\", TITLE = \"Molecular structure and enzymatic function of lycopene cyclase from the cyanobacterium Synechococcus sp strain PCC7942.\", JOURNAL = c(\"Plant Cell 6:1107-21 (1994)\", \"DOI:10.1105/tpc.6.8.1107\")), list(REFERENCE = \"PMID:15811329 (Cyanobacteria-Carotenoid pathway)\", AUTHORS = \"Tsuchiya T, Takaichi S, Misawa N, Maoka T, Miyashita H, Mimuro M.\", TITLE = \"The cyanobacterium Gloeobacter violaceus PCC 7421 uses bacterial-type phytoene desaturase in carotenoid biosynthesis.\", JOURNAL = c(\"FEBS Lett 579:2125-9 (2005)\", \"DOI:10.1016/j.febslet.2005.02.066\")), list(REFERENCE = \"PMID:15115301 (Green sulfer bacteria-Carotenoid pathway)\", AUTHORS = \"Hirabayashi H, Ishii T, Takaichi S, Inoue K, Uehara K.\", TITLE = \"The role of carotenoids in the photoadaptation of the brown-colored sulfur bacterium Chlorobium phaeobacteroides.\", JOURNAL = c(\"Photochem Photobiol 79:280-5 (2004)\", \"DOI:10.1111/j.1751-1097.2004.tb00396.x\")), list(REFERENCE = \"PMID:16923888 (Green sulfer bacteria-Carotenoid pathway)\", AUTHORS = \"Maresca JA, Bryant DA.\", TITLE = \"Two genes encoding new carotenoid-modifying enzymes in the green sulfur bacterium Chlorobium tepidum.\", JOURNAL = c(\"J Bacteriol 188:6217-23 (2006)\", \"DOI:10.1128/JB.00766-06\")), list(REFERENCE = \"PMID:15292122 (Green sulfer bacteria-Carotenoid pathway)\", AUTHORS = \"Frigaard NU, Maresca JA, Yunker CE, Jones AD, Bryant DA.\", TITLE = \"Genetic manipulation of carotenoid biosynthesis in the green sulfur bacterium Chlorobium tepidum.\", JOURNAL = c(\"J Bacteriol 186:5210-20 (2004)\", \"DOI:10.1128/JB.186.16.5210-5220.2004\")), list(REFERENCE = \"PMID:9297463 (Green sulfer bacteria-Carotenoid pathway)\", AUTHORS = \"Takaichi S, Wang ZY, Umetsu M, Nozawa T, Shimada K, Madigan MT.\", TITLE = \"New carotenoids from the thermophilic green sulfur bacterium Chlorobium tepidum: 1\',2\'-dihydro-gamma-carotene, 1\',2\'-dihydrochlorobactene, and OH-chlorobactene glucoside ester, and the carotenoid composition of different strains.\", JOURNAL = c(\"Arch Microbiol 168:270-6 (1997)\", \"DOI:10.1007/s002030050498\")), list(REFERENCE = \"PMID:8661926 (Thermophilic bacteria-Thermocryptoxanthins)\", AUTHORS = \"Yokoyama A, Shizuri Y, Hoshino T, Sandmann G.\", TITLE = \"Thermocryptoxanthins: novel intermediates in the carotenoid biosynthetic pathway of Thermus thermophilus\", JOURNAL = c(\"Arch Microbiol 165:342-5 (1996)\", \"DOI:10.1007/s002030050336\")), list(REFERENCE = \"PMID:12763034\", AUTHORS = \"Hemmi H, Ikejiri S, Nakayama T, Nishino T\", TITLE = \"Fusion-type lycopene beta-cyclase from a thermoacidophilic archaeon Sulfolobus solfataricus.\", JOURNAL = c(\"Biochem Biophys Res Commun 305:586-91 (2003)\", \"DOI:10.1016/S0006-291X(03)00798-8\"))', 'map00906', 'Carotenoid biosynthesis', 163, 2152, 0, 105, 58, 0, 2054, 98);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (136, '00908', 'Zeatin biosynthesis', 'Zeatin is a member of the cytokinin family, a class of phytohormones involved in various processes of growth and development in plants. Most abundant cytokinins are adenine-type, where the N6 position of adenine is substituted with an isoprenoid, such as in zeatin, or an aromatic side chain, such as in kinetin. Zeatin can be synthesized in two different pathways: the tRNA pathway and the AMP pathway. In the tRNA pathway zeatin is a recycled product of isopentenylated tRNAs. In the AMP pathway zeatin is synthesized from an isopentenyl donor, dimethylallyl diphosphate (DMAPP), and AMP, ADP, or ATP by isopentenyltransferases. After synthesis cytokinins can be glucosylated.', 'Metabolism; Metabolism of terpenoids and polyketides', 'Zeatin biosynthesis', 'GO: 0009691', 'ko00908', 'list(REFERENCE = \"PMID:14726522\", AUTHORS = \"Kasahara H, Takei K, Ueda N, Hishiyama S, Yamaya T, Kamiya Y, Yamaguchi S, Sakakibara H.\", TITLE = \"Distinct isoprenoid origins of cis- and trans-zeatin biosyntheses in Arabidopsis.\", JOURNAL = c(\"J Biol Chem 279:14049-54 (2004)\", \"DOI:10.1074/jbc.M314195200\")), list(REFERENCE = \"PMID:11313355\", AUTHORS = \"Takei K, Sakakibara H, Sugiyama T.\", TITLE = \"Identification of genes encoding adenylate isopentenyltransferase, a cytokinin biosynthesis enzyme, in Arabidopsis thaliana.\", JOURNAL = c(\"J Biol Chem 276:26405-10 (2001)\", \"DOI:10.1074/jbc.M102130200\")), list(REFERENCE = \"PMID:11479373\", AUTHORS = \"Kakimoto T.\", TITLE = \"Identification of plant cytokinin biosynthetic enzymes as dimethylallyl diphosphate:ATP/ADP isopentenyltransferases.\", JOURNAL = c(\"Plant Cell Physiol 42:677-85 (2001)\", \"DOI:10.1093/pcp/pce112\")), list(REFERENCE = \"PMID:15280363\", AUTHORS = \"Takei K, Yamaya T, Sakakibara H.\", TITLE = \"Arabidopsis CYP735A1 and CYP735A2 encode cytokinin hydroxylases that catalyze the biosynthesis of trans-Zeatin.\", JOURNAL = c(\"J Biol Chem 279:41866-72 (2004)\", \"DOI:10.1074/jbc.M406337200\")), list(REFERENCE = \"PMID:15342621\", AUTHORS = \"Hou B, Lim EK, Higgins GS, Bowles DJ.\", TITLE = \"N-glucosylation of cytokinins by glycosyltransferases of Arabidopsis thaliana.\", JOURNAL = c(\"J Biol Chem 279:47822-32 (2004)\", \"DOI:10.1074/jbc.M409569200\")), list(REFERENCE = \"PMID:9874810\", AUTHORS = \"Martin RC, Mok MC, Mok DW\", TITLE = \"Isolation of a cytokinin gene, ZOG1, encoding zeatin O-glucosyltransferase from Phaseolus lunatus.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 96:284-9 (1999)\", \"DOI:10.1073/pnas.96.1.284\")), list(REFERENCE = \"PMID:10364407\", AUTHORS = \"Martin RC, Mok MC, Mok DW\", TITLE = \"A gene encoding the cytokinin enzyme zeatin O-xylosyltransferase of Phaseolus vulgaris.\", JOURNAL = c(\"Plant Physiol 120:553-8 (1999)\", \"DOI:10.1104/pp.120.2.553\")), list(REFERENCE = \"PMID:12644686\", AUTHORS = \"Veach YK, Martin RC, Mok DW, Malbeck J, Vankova R, Mok MC\", TITLE = \"O-glucosylation of cis-zeatin in maize. Characterization of genes, enzymes, and endogenous cytokinins.\", JOURNAL = c(\"Plant Physiol 131:1374-80 (2003)\", \"DOI:10.1104/pp.017210\")), list(REFERENCE = \"PMID:14555694\", AUTHORS = \"Werner T, Motyka V, Laucou V, Smets R, Van Onckelen H, Schmulling T\", TITLE = \"Cytokinin-deficient transgenic Arabidopsis plants show multiple developmental alterations indicating opposite functions of cytokinins in the regulation of shoot and root meristem activity.\", JOURNAL = c(\"Plant Cell 15:2532-50 (2003)\", \"DOI:10.1105/tpc.014928\")), list(REFERENCE = \"PMID:17062755\", AUTHORS = \"Miyawaki K, Tarkowski P, Matsumoto-Kitano M, Kato T, Sato S, Tarkowska D, Tabata S, Sandberg G, Kakimoto T\", TITLE = \"Roles of Arabidopsis ATP/ADP isopentenyltransferases and tRNA isopentenyltransferases in cytokinin biosynthesis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 103:16598-603 (2006)\", \"DOI:10.1073/pnas.0603522103\"))', 'map00908', 'Zeatin biosynthesis', 91, 0, 0, 91, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (137, '00909', 'Sesquiterpenoid and triterpenoid biosynthesis', 'Sesquiterpenoids (C15 terpenoids) are a group of terpenoids consisting of three isoprene units. They are derive from farnesyl diphosphate (FPP) and can be cyclized to produce various skeletal structures. Sesquiterpenoid biosynthesis begins with the loss of diphosphate from FPP under the action of sesquiterpene synthesis enzymes, generating an allylic cation that is highly susceptible to intramolecular attacks. Cyclization of the farnesyl cation may take place onto either of the remaining double bonds with the result that 6-, 10-, or 11-membered rings may be formed. Many sesquiterpenoids have been isolated from plants, fungi, marine organisms, and Streptomyces species. This map shows a few examples of acyclic and cyclic sesquiterpenoids.', 'Metabolism; Metabolism of terpenoids and polyketides', 'Sesquiterpenoid and triterpenoid biosynthesis', 'GO: 0016106 0016104', 'ko00909', 'list(REFERENCE = \"PMID:9371761\", AUTHORS = \"Crock J, Wildung M, Croteau R\", TITLE = \"Isolation and bacterial expression of a sesquiterpene synthase cDNA clone from peppermint (Mentha x piperita, L.) that produces the aphid alarm pheromone (E)-beta-farnesene.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 94:12833-8 (1997)\", \"DOI:10.1073/pnas.94.24.12833\")), list(REFERENCE = \"PMID:18363779\", AUTHORS = \"Nagegowda DA, Gutensohn M, Wilkerson CG, Dudareva N\", TITLE = \"Two nearly identical terpene synthases catalyze the formation of nerolidol and linalool in snapdragon flowers.\", JOURNAL = c(\"Plant J 55:224-39 (2008)\", \"DOI:10.1111/j.1365-313X.2008.03496.x\")), list(REFERENCE = \"PMID:16579958\", AUTHORS = \"Bertea CM, Voster A, Verstappen FW, Maffei M, Beekwilder J, Bouwmeester HJ\", TITLE = \"Isoprenoid biosynthesis in Artemisia annua: cloning and heterologous expression of a germacrene A synthase from a glandular trichome cDNA library.\", JOURNAL = c(\"Arch Biochem Biophys 448:3-12 (2006)\", \"DOI:10.1016/j.abb.2006.02.026\")), list(REFERENCE = \"PMID:12011356\", AUTHORS = \"de Kraker JW, Franssen MC, Joerink M, de Groot A, Bouwmeester HJ\", TITLE = \"Biosynthesis of costunolide, dihydrocostunolide, and leucodin. Demonstration of cytochrome p450-catalyzed formation of the lactone ring present in sesquiterpene lactones of chicory.\", JOURNAL = c(\"Plant Physiol 129:257-68 (2002)\", \"DOI:10.1104/pp.010957\")), list(REFERENCE = \"PMID:17226502\", AUTHORS = \"Jaroszewski JW, Strom-Hansen T, Hansen SH, Thastrup O, Kofod H\", TITLE = \"On the botanical distribution of chiral forms of gossypol.\", JOURNAL = c(\"Planta Med 58:454-8 (1992)\", \"DOI:10.1055/s-2006-961512\")), list(REFERENCE = \"PMID:9442047\", AUTHORS = \"Steele CL, Crock J, Bohlmann J, Croteau R\", TITLE = \"Sesquiterpene synthases from grand fir (Abies grandis). Comparison of constitutive and wound-induced activities, and cDNA isolation, characterization, and bacterial expression of delta-selinene synthase and gamma-humulene synthase.\", JOURNAL = c(\"J Biol Chem 273:2078-89 (1998)\", \"DOI:10.1074/jbc.273.4.2078\")), list(REFERENCE = \"PMID:19030608\", AUTHORS = \"Fraga BM\", TITLE = \"Natural sesquiterpenoids.\", JOURNAL = c(\"Nat Prod Rep 25:1180-209 (2008)\", \"DOI:10.1039/b806216c\")), list(REFERENCE = \"PMID:21876149\", AUTHORS = \"Field B, Fiston-Lavier AS, Kemen A, Geisler K, Quesneville H, Osbourn AE\", TITLE = \"Formation of plant metabolic gene clusters within dynamic chromosomal regions.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 108:16116-21 (2011)\", \"DOI:10.1073/pnas.1109273108\")), list(REFERENCE = \"PMID:18356490\", AUTHORS = \"Field B, Osbourn AE\", TITLE = \"Metabolic diversification--independent assembly of operon-like gene clusters in different plants.\", JOURNAL = c(\"Science 320:543-7 (2008)\", \"DOI:10.1126/science.1154990\")), list(REFERENCE = \"PMID:15148404\", AUTHORS = \"Qi X, Bakht S, Leggett M, Maxwell C, Melton R, Osbourn A\", TITLE = \"A gene cluster for secondary metabolism in oat: implications for the evolution of metabolic diversity in plants.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 101:8233-8 (2004)\", \"DOI:10.1073/pnas.0401301101\"))', 'map00909', 'Sesquiterpenoid and triterpenoid biosynthesis', 226, 761, 0, 105, 121, 0, 698, 63);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (138, '00910', 'Nitrogen metabolism', 'The biological process of the nitrogen cycle is a complex interplay among many microorganisms catalyzing different reactions, where nitrogen is found in various oxidation states ranging from +5 in nitrate to -3 in ammonia. The core nitrogen cycle involves four reduction pathways and two oxidation pathways. Nitrogen fixation [MD:M00175] is the process of reducing atmospheric molecular nitrogen to ammonia, a biologically useful reduced form incorporated into amino acids and other vital compounds. The ability of fixing atmospheric nitrogen by the nitrogenase enzyme complex is present in restricted prokaryotes (diazotrophs). The other reduction pathways are assimilatory nitrate reduction [MD:M00531] and dissimilatory nitrate reduction [MD:M00530] both for conversion to ammonia, and denitrification [MD:M00529]. Denitrification is a respiration in which nitrate or nitrite is reduced as a terminal electron acceptor under low oxygen or anoxic conditions, producing gaseous nitrogen compounds (N2, NO and N2O) to the atmosphere. The two oxidation pathways are nitrification [MD:M00528] and anaerobic ammonium oxidation (anammox). Nitrification is the oxidation of ammonia (NH3) with oxygen into nitrite followed by the oxidation of nitrite into nitrate. The first step is performed by ammonia-oxidizing microorganisms (e.g., Nitrosomonas and Nitrosococcus) and the second step by nitrite-oxidizing microorganisms (e.g., Nitrobacter). Anammox is a biochemical process of oxidizing ammonium (NH4+) into dinitrogen gas (N2) using nitrite as an electron acceptor. It occurs in the anammoxosome, a membrane bound compartment inside the cytoplasm, of anammox bacteria (e.g., Planctomycetes).', 'Metabolism; Energy metabolism', 'Nitrogen metabolism', 'Nitrogen fixation, nitrogen => ammonia [PATH:map00910], Nitrification, ammonia => nitrite [PATH:map00910], Denitrification, nitrate => nitrogen [PATH:map00910], Dissimilatory nitrate reduction, nitrate => ammonia [PATH:map00910], Assimilatory nitrate reduction, nitrate => ammonia [PATH:map00910], Complete nitrification, comammox, ammonia => nitrite => nitrate [PATH:map00910]', 'Carbamoyl phosphate synthetase I deficiency, Congenital systemic glutamine deficiency', 'GO: 0006807', 'ko00910', 'list(REFERENCE = \"PMID:14702404\", AUTHORS = \"Scott JD, Ludwig RA\", TITLE = \"Azorhizobium caulinodans electron-transferring flavoprotein N electrochemically couples pyruvate dehydrogenase complex activity to N2 fixation.\", JOURNAL = c(\"Microbiology 150:117-26 (2004)\", \"DOI:10.1099/mic.0.26603-0\")), list(REFERENCE = \"PMID:17408485\", AUTHORS = \"Kneip C, Lockhart P, Voss C, Maier UG\", TITLE = \"Nitrogen fixation in eukaryotes--new models for symbiosis.\", JOURNAL = c(\"BMC Evol Biol 7:55 (2007)\", \"DOI:10.1186/1471-2148-7-55\")), list(REFERENCE = \"PMID:11004450\", AUTHORS = \"Whittaker M, Bergmann D, Arciero D, Hooper AB\", TITLE = \"Electron transfer during the oxidation of ammonia by the chemolithotrophic bacterium Nitrosomonas europaea.\", JOURNAL = c(\"Biochim Biophys Acta 1459:346-55 (2000)\", \"DOI:10.1016/S0005-2728(00)00171-7\")), list(REFERENCE = \"PMID:15528644\", AUTHORS = \"Cabello P, Roldan MD, Moreno-Vivian C\", TITLE = \"Nitrate reduction and the nitrogen cycle in archaea.\", JOURNAL = c(\"Microbiology 150:3527-46 (2004)\", \"DOI:10.1099/mic.0.27303-0\")), list(REFERENCE = \"PMID:11921398\", AUTHORS = \"Stolz JF, Basu P\", TITLE = \"Evolution of nitrate reductase: molecular and structural variations on a common function.\", JOURNAL = c(\"Chembiochem 3:198-206 (2002)\", \"DOI:10.1002/1439-7633(20020301)3:2/3<198::AID-CBIC198>3.0.CO;2-C\")), list(REFERENCE = \"PMID:18021072\", AUTHORS = \"Morozkina EV, Zvyagilskaya RA\", TITLE = \"Nitrate reductases: structure, functions, and effect of stress factors.\", JOURNAL = c(\"Biochemistry (Mosc) 72:1151-60 (2007)\", \"DOI:10.1134/S0006297907100124\")), list(REFERENCE = \"PMID:19247843\", AUTHORS = \"Jetten MS, Niftrik L, Strous M, Kartal B, Keltjens JT, Op den Camp HJ\", TITLE = \"Biochemistry and molecular biology of anammox bacteria.\", JOURNAL = c(\"Crit Rev Biochem Mol Biol 44:65-84 (2009)\", \"DOI:10.1080/10409230902722783\")), list(REFERENCE = \"PMID:22221911\", AUTHORS = \"Luesken FA, Wu ML, Op den Camp HJ, Keltjens JT, Stunnenberg H, Francoijs KJ, Strous M, Jetten MS\", TITLE = \"Effect of oxygen on the anaerobic methanotroph \'Candidatus Methylomirabilis oxyfera\': kinetic and transcriptional analysis.\", JOURNAL = c(\"Environ Microbiol 14:1024-34 (2012)\", \"DOI:10.1111/j.1462-2920.2011.02682.x\")), list(REFERENCE = \"PMID:26610024\", AUTHORS = \"Daims H, Lebedeva EV, Pjevac P, Han P, Herbold C, Albertsen M, Jehmlich N, Palatinszky M, Vierheilig J, Bulaev A, Kirkegaard RH, von Bergen M, Rattei T, Bendinger B, Nielsen PH, Wagner M\", TITLE = \"Complete nitrification by Nitrospira bacteria.\", JOURNAL = c(\"Nature 528:504-9 (2015)\", \"DOI:10.1038/nature16461\")), list(REFERENCE = \"PMID:26610025\", AUTHORS = \"van Kessel MA, Speth DR, Albertsen M, Nielsen PH, Op den Camp HJ, Kartal B, Jetten MS, Lucker S\", TITLE = \"Complete nitrification by a single microorganism.\", JOURNAL = c(\"Nature 528:555-9 (2015)\", \"DOI:10.1038/nature16459\"))', 519, 5104, 248, 105, 123, 43, 4813, 291);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (139, '00920', 'Sulfur metabolism', 'Sulfur is an essential element for life and the metabolism of organic sulfur compounds plays an important role in the global sulfur cycle. Sulfur occurs in various oxidation states ranging from +6 in sulfate to -2 in sulfide (H2S). Sulfate reduction can occur in both an energy consuming assimilatory pathway and an energy producing dissimilatory pathway. The assimilatory pathway, which is found in a wide range of organisms, produces reduced sulfur compounds for the biosynthesis of S-containing amino acids and does not lead to direct excretion of sulfide. In the dissimilatory pathway, which is restricted to obligatory anaerobic bacterial and archaeal lineages, sulfate (or sulfur) is the terminal electron acceptor of the respiratory chain producing large quantities of inorganic sulfide. Both pathways start from the activation of sulfate by reaction with ATP to form adenylyl sulfate (APS). In the assimilatory pathway [MD:M00176] APS is converted to 3\'-phosphoadenylyl sulfate (PAPS) and then reduced to sulfite, and sulfite is further reduced to sulfide by the assimilatory sulfite reductase. In the dissimilatory pathway [MD:M00596] APS is directly reduced to sulfite, and sulfite is further reduced to sulfide by the dissimilatory sulfite reductase. The capacity for oxidation of sulfur is quite widespread among bacteria and archaea, comprising phototrophs and chemolithoautotrophs. The SOX (sulfur-oxidation) system [MD:M00595] is a well-known sulfur oxidation pathway and is found in both photosynthetic and non-photosynthetic sulfur-oxidizing bacteria. Green sulfur bacteria and purple sulfur bacteria carry out anoxygenic photosynthesis with reduced sulfur compounds such as sulfide and elemental sulfur, as well as thiosulfate (in some species with the SOX system), as the electron donor for photoautotrophic growth. In some chemolithoautotrophic sulfur oxidizers (such as Thiobacillus denitrificans), it has been suggested that dissimilatory sulfur reduction enzymes operate in the reverse direction, forming a sulfur oxidation pathway from sulfite to APS and then to sulfate.', 'Metabolism; Energy metabolism', 'Sulfur metabolism', 'Cysteine biosynthesis, serine => cysteine [PATH:map00920], Assimilatory sulfate reduction, sulfate => H2S [PATH:map00920], Thiosulfate oxidation by SOX complex, thiosulfate => sulfate [PATH:map00920], Dissimilatory sulfate reduction, sulfate => H2S [PATH:map00920]', 'SEMD, Pakistani type, Sulfite oxidase deficiency, Chondrodysplasia with joint dislocations, GPAPP type', 'GO: 0006790', 'ko00920', 'list(REFERENCE = \"PMID:22982583\", AUTHORS = \"Grein F, Ramos AR, Venceslau SS, Pereira IA\", TITLE = \"Unifying concepts in anaerobic respiration: Insights from dissimilatory sulfur metabolism.\", JOURNAL = c(\"Biochim Biophys Acta 1827:145-60 (2013)\", \"DOI:10.1016/j.bbabio.2012.09.001\")), list(REFERENCE = \"PMID:22633058\", AUTHORS = \"Fauque GD, Barton LL\", TITLE = \"Hemoproteins in dissimilatory sulfate- and sulfur-reducing prokaryotes.\", JOURNAL = c(\"Adv Microb Physiol 60:1-90 (2012)\", \"DOI:10.1016/B978-0-12-398264-3.00001-2\")), list(REFERENCE = \"PMID:20143161\", AUTHORS = \"Sakurai H, Ogawa T, Shiga M, Inoue K\", TITLE = \"Inorganic sulfur oxidizing system in green sulfur bacteria.\", JOURNAL = c(\"Photosynth Res 104:163-76 (2010)\", \"DOI:10.1007/s11120-010-9531-2\")), list(REFERENCE = \"PMID:22092713\", AUTHORS = \"Falkenby LG, Szymanska M, Holkenbrink C, Habicht KS, Andersen JS, Miller M, Frigaard NU\", TITLE = \"Quantitative proteomics of Chlorobaculum tepidum: insights into the sulfur metabolism of a phototrophic green sulfur bacterium.\", JOURNAL = c(\"FEMS Microbiol Lett 323:142-50 (2011)\", \"DOI:10.1111/j.1574-6968.2011.02370.x\")), list(REFERENCE = \"PMID:21833341\", AUTHORS = \"Gregersen LH, Bryant DA, Frigaard NU\", TITLE = \"Mechanisms and evolution of oxidative sulfur metabolism in green sulfur bacteria.\", JOURNAL = c(\"Front Microbiol 2:116 (2011)\", \"DOI:10.3389/fmicb.2011.00116\")), list(REFERENCE = \"PMID:16452431\", AUTHORS = \"Beller HR, Chain PS, Letain TE, Chakicherla A, Larimer FW, Richardson PM, Coleman MA, Wood AP, Kelly DP.\", TITLE = \"The genome sequence of the obligately chemolithoautotrophic, facultatively anaerobic bacterium Thiobacillus denitrificans.\", JOURNAL = c(\"J Bacteriol 188:1473-88 (2006)\", \"DOI:10.1128/JB.188.4.1473-1488.2006\")), list(REFERENCE = \"PMID:9695921\", AUTHORS = \"Pott AS, Dahl C\", TITLE = \"Sirohaem sulfite reductase and other proteins encoded by genes at the dsr locus of Chromatium vinosum are involved in the oxidation of intracellular sulfur.\", JOURNAL = c(\"Microbiology 144 ( Pt 7):1881-94 (1998)\", \"DOI:10.1099/00221287-144-7-1881\")), list(REFERENCE = \"PMID:18929068\", AUTHORS = \"Frigaard NU, Dahl C\", TITLE = \"Sulfur metabolism in phototrophic sulfur bacteria.\", JOURNAL = c(\"Adv Microb Physiol 54:103-200 (2009)\", \"DOI:10.1016/S0065-2911(08)00002-7\"))', 505, 5087, 248, 105, 123, 29, 4800, 287);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (140, '00930', 'Caprolactam degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Caprolactam degradation', 'GO: 0019384, UMBBD: cap chx', 'ko00930', 'list(REFERENCE = \"PMID:11571189\", AUTHORS = \"Parke D, Garcia MA, Ornston LN\", TITLE = \"Cloning and genetic characterization of dca genes required for beta-oxidation of straight-chain dicarboxylic acids in Acinetobacter sp. strain ADP1.\", JOURNAL = c(\"Appl Environ Microbiol 67:4817-27 (2001)\", \"DOI:10.1128/AEM.67.10.4817-4827.2001\")), list(REFERENCE = \"PMID:12535077\", AUTHORS = \"Campbell JW, Morgan-Kiss RM, Cronan JE Jr\", TITLE = \"A new Escherichia coli metabolic competency: growth on fatty acids by a novel anaerobic beta-oxidation pathway.\", JOURNAL = c(\"Mol Microbiol 47:793-805 (2003)\", \"DOI:10.1046/j.1365-2958.2003.03341.x\")), list(REFERENCE = \"PMID:15658985\", AUTHORS = \"Brzostowicz PC, Walters DM, Jackson RE, Halsey KH, Ni H, Rouviere PE\", TITLE = \"Proposed involvement of a soluble methane monooxygenase homologue in the cyclohexane-dependent growth of a new Brachymonas species.\", JOURNAL = c(\"Environ Microbiol 7:179-90 (2005)\", \"DOI:10.1111/j.1462-2920.2004.00681.x\"))', 'map00930', 'Caprolactam degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 0, 2316, 0, 0, 0, 0, 2316, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (141, '00940', 'Phenylpropanoid biosynthesis', 'Phenylpropanoids are a group of plant secondary metabolites derived from phenylalanine and having a wide variety of functions both as structural and signaling molecules. Phenylalanine is first converted to cinnamic acid by deamination. It is followed by hydroxylation and frequent methylation to generate coumaric acid and other acids with a phenylpropane (C6-C3) unit. Reduction of the CoA-activated carboxyl groups of these acids results in the corresponding aldehydes and alcohols. The alcohols are called monolignols, the starting compounds for biosynthesis of lignin.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Phenylpropanoid biosynthesis', 'Monolignol biosynthesis, phenylalanine/tyrosine => monolignol [PATH:map00940], Flavanone biosynthesis, phenylalanine => naringenin [PATH:map00940]', 'GO: 0009699', 'ko00940', 'list(REFERENCE = \"PMID:14729911\", AUTHORS = \"Nair RB, Bastress KL, Ruegger MO, Denault JW, Chapple C.\", TITLE = \"The Arabidopsis thaliana REDUCED EPIDERMAL FLUORESCENCE1 gene encodes an aldehyde dehydrogenase involved in ferulic acid and sinapic acid biosynthesis.\", JOURNAL = c(\"Plant Cell 16:544-54 (2004)\", \"DOI:10.1105/tpc.017509\")), list(REFERENCE = \"PMID:14551235\", AUTHORS = \"Baucher M, Halpin C, Petit-Conil M, Boerjan W.\", TITLE = \"Lignin: genetic engineering and impact on pulping.\", JOURNAL = c(\"Crit Rev Biochem Mol Biol 38:305-50 (2003)\", \"DOI:10.1080/10409230391036757\")), list(REFERENCE = \"PMID:15878986\", AUTHORS = \"Rogers LA, Dubos C, Cullis IF, Surman C, Poole M, Willment J, Mansfield SD, Campbell MM.\", TITLE = \"Light, the circadian clock, and sugar perception in the control of lignin biosynthesis.\", JOURNAL = c(\"J Exp Bot 56:1651-63 (2005)\", \"DOI:10.1093/jxb/eri162\")), list(REFERENCE = \"PMID:12242395\", AUTHORS = \"Whetten R, Sederoff R.\", TITLE = \"Lignin Biosynthesis.\", JOURNAL = c(\"Plant Cell 7:1001-1013 (1995)\", \"DOI:10.1105/tpc.7.7.1001\")), list(REFERENCE = \"PMID:8972602\", AUTHORS = \"Lorenzen M, Racicot V, Strack D, Chapple C.\", TITLE = \"Sinapic acid ester metabolism in wild type and a sinapoylglucose-accumulating mutant of arabidopsis.\", JOURNAL = c(\"Plant Physiol 112:1625-30 (1996)\", \"DOI:10.1104/pp.112.4.1625\")), list(REFERENCE = \"PMID:1477555\", AUTHORS = \"Chapple CC, Vogt T, Ellis BE, Somerville CR.\", TITLE = \"An Arabidopsis mutant defective in the general phenylpropanoid pathway.\", JOURNAL = c(\"Plant Cell 4:1413-24 (1992)\", \"DOI:10.1105/tpc.4.11.1413\")), list(REFERENCE = \"PMID:14612585\", AUTHORS = \"Raes J, Rohde A, Christensen JH, Van de Peer Y, Boerjan W.\", TITLE = \"Genome-wide characterization of the lignification toolbox in Arabidopsis.\", JOURNAL = c(\"Plant Physiol 133:1051-71 (2003)\", \"DOI:10.1104/pp.103.026484\")), list(REFERENCE = \"PMID:14568076\", AUTHORS = \"Costa MA, Collins RE, Anterola AM, Cochrane FC, Davin LB, Lewis NG.\", TITLE = \"An in silico assessment of gene function and organization of the phenylpropanoid pathway metabolic networks in Arabidopsis thaliana and limitations thereof.\", JOURNAL = c(\"Phytochemistry 64:1097-112 (2003)\", \"DOI:10.1016/S0031-9422(03)00517-X\")), list(REFERENCE = \"PMID:10934215\", AUTHORS = \"Meyermans H, Morreel K, Lapierre C, Pollet B, De Bruyn A, Busson R, Herdewijn P, Devreese B, Van Beeumen J, Marita JM, Ralph J, Chen C, Burggraeve B, Van Montagu M, Messens E, Boerjan W.\", TITLE = \"Modifications in lignin and accumulation of phenolic glucosides in poplar xylem upon down-regulation of caffeoyl-coenzyme A O-methyltransferase, an enzyme involved in lignin biosynthesis.\", JOURNAL = c(\"J Biol Chem 275:36899-909 (2000)\", \"DOI:10.1074/jbc.M006915200\"\n)), list(REFERENCE = \"PMID:16027976\", AUTHORS = \"Gachon CM, Langlois-Meurinne M, Henry Y, Saindrenan P.\", TITLE = \"Transcriptional co-regulation of secondary metabolism enzymes in Arabidopsis: functional and evolutionary implications.\", JOURNAL = c(\"Plant Mol Biol 58:229-45 (2005)\", \"DOI:10.1007/s11103-005-5346-5\")), list(REFERENCE = \"PMID:10692459\", AUTHORS = \"Li L, Popko JL, Umezawa T, Chiang VL.\", TITLE = \"5-hydroxyconiferyl aldehyde modulates enzymatic methylation for syringyl monolignol formation, a new view of monolignol biosynthesis in angiosperms.\", JOURNAL = c(\"J Biol Chem 275:6537-45 (2000)\", \"DOI:10.1074/jbc.275.9.6537\")), list(REFERENCE = \"PMID:12009990\", AUTHORS = \"Yamauchi K, Yasuda S, Fukushima K.\", TITLE = \"Evidence for the biosynthetic pathway from sinapic acid to syringyl lignin using labeled sinapic acid with stable isotope at both methoxy groups in Robinia pseudoacacia and Nerium indicum.\", JOURNAL = c(\"J Agric Food Chem 50:3222-7 (2002)\", \"DOI:10.1021/jf011565x\")), list(REFERENCE = \"PMID:12084820\", AUTHORS = \"Eckardt NA.\", TITLE = \"Probing the mysteries of lignin biosynthesis: the crystal structure of caffeic acid/5-hydroxyferulic acid 3/5-O-methyltransferase provides new insights.\", JOURNAL = c(\"Plant Cell 14:1185-9 (2002)\", \"DOI:10.1105/tpc.140610\"))', 'map00940', 97, 0, 0, 97, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (142, '00941', 'Flavonoid biosynthesis', 'Flavonoids are a major class of plant secondary metabolites that serves a multitude of functions including pigments and antioxidant activity. Flavonoids are synthesized from phenylpropanoid derivatives by condensation with malonyl-CoA. For example, condensation of p-coumaroyl-CoA (C6-C3) with three malonyl-CoA (C3) molecules results in naringenin chalcone with a diphenylpropane (C6-C3-C6) unit, which is converted to naringenin with the flavone (2-phenylchromen-4-one) backbone by conjugate ring closure. These and further modifications yield a variety of structural forms including chalcones, flavanones, dihyroflavonols, and flavans, anthocyanins, flavones and flavonols, and isoflavonoids.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Flavonoid biosynthesis', 'Flavanone biosynthesis, phenylalanine => naringenin [PATH:map00941], Flavonoid biosynthesis, naringenin => pelargonidin [PATH:map00941]', 'GO: 0009813', 'ko00941', 'list(REFERENCE = \"PMID:16945088\", AUTHORS = \"Tsai CJ, Harding SA, Tschaplinski TJ, Lindroth RL, Yuan Y.\", TITLE = \"Genome-wide analysis of the structural genes regulating defense phenylpropanoid metabolism in Populus.\", JOURNAL = c(\"New Phytol 172:47-62 (2006)\", \"DOI:10.1111/j.1469-8137.2006.01798.x\")), list(REFERENCE = \"PMID:16367960\", AUTHORS = \"Ono E, Hatayama M, Isono Y, Sato T, Watanabe R, Yonekura-Sakakibara K, Fukuchi-Mizutani M, Tanaka Y, Kusumi T, Nishino T, Nakayama T.\", TITLE = \"Localization of a flavonoid biosynthetic polyphenol oxidase in vacuoles.\", JOURNAL = c(\"Plant J 45:133-43 (2006)\", \"DOI:10.1111/j.1365-313X.2005.02625.x\")), list(REFERENCE = \"PMID:16774647\", AUTHORS = \"Morreel K, Goeminne G, Storme V, Sterck L, Ralph J, Coppieters W, Breyne P, Steenackers M, Georges M, Messens E, Boerjan W.\", TITLE = \"Genetical metabolomics of flavonoid biosynthesis in Populus: a case study.\", JOURNAL = c(\"Plant J 47:224-37 (2006)\", \"DOI:10.1111/j.1365-313X.2006.02786.x\")), list(REFERENCE = \"PMID:16832053\", AUTHORS = \"Ono E, Fukuchi-Mizutani M, Nakamura N, Fukui Y, Yonekura-Sakakibara K, Yamaguchi M, Nakayama T, Tanaka T, Kusumi T, Tanaka Y.\", TITLE = \"Yellow flowers generated by expression of the aurone biosynthetic pathway.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 103:11075-80 (2006)\", \"DOI:10.1073/pnas.0604246103\")), list(REFERENCE = \"\", AUTHORS = \"Halbwirth H, Martens S, Wienand U, Forkmann G, Stich K.\", TITLE = \"Synthesis of (14C)-labeled 5-deoxyflavonoids and their application in the study of dihydroflavonol/leucoanthocyanidin interconversion by dihydroflavonol 4-reductase.\", JOURNAL = c(\"Plant Science 170(3): 587-595 (2006)\", \"DOI:10.1016/j.plantsci.2005.10.013\")), list(REFERENCE = \"PMID:15231405\", AUTHORS = \"Stevens JF, Page JE.\", TITLE = \"Xanthohumol and related prenylflavonoids from hops and beer: to your good health!\", JOURNAL = c(\"Phytochemistry 65:1317-30 (2004)\", \"DOI:10.1016/j.phytochem.2004.04.025\")), list(REFERENCE = \"\", AUTHORS = \"Ogata J, Itoh Y, Ishida M, Yoshida H, Ozeki Y.\", TITLE = \"Cloning and heterologous expression of cDNAs encoding flavonoid glucosyltransferases from Dianthus caryophyllus.\", JOURNAL = c(\"Plant Biotechnology 21(5):367-375 (2004)\", \"DOI:10.5511/plantbiotechnology.21.367\")), list(REFERENCE = \"PMID:12828368\", AUTHORS = \"Springob K, Nakajima J, Yamazaki M, Saito K.\", TITLE = \"Recent advances in the biosynthesis and accumulation of anthocyanins.\", JOURNAL = c(\"Nat Prod Rep 20:288-303 (2003)\", \"DOI:10.1039/b109542k\")), list(REFERENCE = \"PMID:12644647\", AUTHORS = \"Shimada N, Aoki T, Sato S, Nakamura Y, Tabata S, Ayabe S.\", TITLE = \"A cluster of genes encodes the two types of chalcone isomerase involved in the biosynthesis of general flavonoids and legume-specific 5-deoxy(iso)flavonoids in Lotus japonicus.\", JOURNAL = c(\"Plant Physiol 131:941-51 (2003)\", \"DOI:10.1104/pp.004820\")), list(REFERENCE = \"\", AUTHORS = \"Halbwirth H, Martens S, Wienand U, Forkmann G, Stich K.\", TITLE = \"Biochemical formation of anthocyanins in silk tissue of Zea mays.\", JOURNAL = c(\"Plant Science 164(4):489-495 (2003)\", \"DOI:10.1016/S0168-9452(02)00433-8\")), list(REFERENCE = \"\", AUTHORS = \"Martens S, Knott J, Seitz CA, Janvari L, Yu SN, Forkmann G.\", TITLE = \"Impact of biochemical pre-studies on specific metabolic engineering strategies of flavonoid biosynthesis in plant tissues.\", JOURNAL = c(\"Biochemical Engineering Journal 14(3):227-235 (2003)\", \"DOI:10.1016/S1369-703X(02)00224-3\")), list(REFERENCE = \"PMID:11073455\", AUTHORS = \"Nakayama T, Yonekura-Sakakibara K, Sato T, Kikuchi S, Fukui Y, Fukuchi-Mizutani M, Ueda T, Nakao M, Tanaka Y, Kusumi T, Nishino T.\", TITLE = \"Aureusidin synthase: a polyphenol oxidase homolog responsible for flower coloration.\", JOURNAL = c(\"Science 290:1163-6 (2000)\", \"DOI:10.1126/science.290.5494.1163\")), list(REFERENCE = \"PMID:16667183\", AUTHORS = \"Lewinsohn E, Britsch L, Mazur Y, Gressel J\", TITLE = \"Flavanone Glycoside Biosynthesis in Citrus: Chalcone Synthase, UDP-Glucose:Flavanone-7-O-Glucosyl-Transferase and -Rhamnosyl-Transferase Activities in Cell-Free Extracts.\", JOURNAL = c(\"Plant Physiol 91:1323-8 (1989)\", \"DOI:10.1104/pp.91.4.1323\"))', 'map00941', 91, 0, 0, 91, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (143, '00942', 'Anthocyanin biosynthesis', 'Anthocyanidins (aglycones) and anthocyanins (glycosides) are common plant pigments and belong to a structural subclass of flavonoids characterized by a 2-phenylbenzopyrylium unit. They are derived along the flavonoid modification pathways and further separated into three types, pelargonidin, cyanidin, and delphinidin, due to the different number of hydroxyl groups in the phenyl group.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Anthocyanin biosynthesis', 'GO: 0009718', 'ko00942', 'list(REFERENCE = \"PMID:17383962\", AUTHORS = \"Unno H, Ichimaida F, Suzuki H, Takahashi S, Tanaka Y, Saito A, Nishino T, Kusunoki M, Nakayama T.\", TITLE = \"Structural and mutational studies of anthocyanin malonyltransferases establish the features of BAHD enzyme catalysis.\", JOURNAL = c(\"J Biol Chem 282:15812-22 (2007)\", \"DOI:10.1074/jbc.M700638200\")), list(REFERENCE = \"PMID:16887235\", AUTHORS = \"Kogawa K, Kazuma K, Kato N, Noda N, Suzuki M.\", TITLE = \"Biosynthesis of malonylated flavonoid glycosides on the basis of malonyltransferase activity in the petals of Clitoria ternatea.\", JOURNAL = c(\"J Plant Physiol 164:886-94 (2007)\", \"DOI:10.1016/j.jplph.2006.05.006\")), list(REFERENCE = \"PMID:16945088\", AUTHORS = \"Tsai CJ, Harding SA, Tschaplinski TJ, Lindroth RL, Yuan Y.\", TITLE = \"Genome-wide analysis of the structural genes regulating defense phenylpropanoid metabolism in Populus.\", JOURNAL = c(\"New Phytol 172:47-62 (2006)\", \"DOI:10.1111/j.1469-8137.2006.01798.x\")), list(REFERENCE = \"PMID:15944692\", AUTHORS = \"Ogata J, Kanno Y, Itoh Y, Tsugawa H, Suzuki M.\", TITLE = \"Plant biochemistry: anthocyanin biosynthesis in roses.\", JOURNAL = c(\"Nature 435:757-8 (2005)\", \"DOI:10.1038/nature435757a\")), list(REFERENCE = \"PMID:15860422\", AUTHORS = \"Bowles D, Isayenkova J, Lim EK, Poppenberger B.\", TITLE = \"Glycosyltransferases: managers of small molecules.\", JOURNAL = c(\"Curr Opin Plant Biol 8:254-63 (2005)\", \"DOI:10.1016/j.pbi.2005.03.007\")), list(REFERENCE = \"PMID:15842621\", AUTHORS = \"Morita Y, Hoshino A, Kikuchi Y, Okuhara H, Ono E, Tanaka Y, Fukui Y, Saito N, Nitasaka E, Noguchi H, Iida S.\", TITLE = \"Japanese morning glory dusky mutants displaying reddish-brown or purplish-gray flowers are deficient in a novel glycosylation enzyme for anthocyanin biosynthesis, UDP-glucose:anthocyanidin 3-O-glucoside-2\'\'-O-glucosyltransferase, due to 4-bp insertions in the gene.\", JOURNAL = c(\"Plant J 42:353-63 (2005)\", \"DOI:10.1111/j.1365-313X.2005.02383.x\"\n)), list(REFERENCE = \"PMID:15509561\", AUTHORS = \"Sawada S, Suzuki H, Ichimaida F, Yamaguchi MA, Iwashita T, Fukui Y, Hemmi H, Nishino T, Nakayama T.\", TITLE = \"UDP-glucuronic acid:anthocyanin glucuronosyltransferase from red daisy (Bellis perennis) flowers. Enzymology and phylogenetics of a novel glucuronosyltransferase involved in flower pigment biosynthesis.\", JOURNAL = c(\"J Biol Chem 280:899-906 (2005)\", \"DOI:10.1074/jbc.M410537200\")), list(REFERENCE = \"PMID:15165190\", AUTHORS = \"Suzuki H, Sawada S, Watanabe K, Nagae S, Yamaguchi MA, Nakayama T, Nishino T.\", TITLE = \"Identification and characterization of a novel anthocyanin malonyltransferase from scarlet sage (Salvia splendens) flowers: an enzyme that is phylogenetically separated from other anthocyanin acyltransferases.\", JOURNAL = c(\"Plant J 38:994-1003 (2004)\", \"DOI:10.1111/j.1365-313X.2004.02101.x\")), list(REFERENCE = \"\", AUTHORS = \"Suzuki H, Nakayama T, Yamaguchi M, Nishino T.\", TITLE = \"cDNA cloning and characterization of two Dendranthema x morifolium anthocyanin malonyltransferases with different functional activities.\", JOURNAL = c(\"Plant Sci 166(1):89-96 (2004)\", \"DOI:10.1016/j.plantsci.2003.08.010\")), list(REFERENCE = \"\", AUTHORS = \"Nakayama T, Suzuki H, Nishino T.\", TITLE = \"Anthocyanin acyltransferases: specificities, mechanism, phylogenetics, and applications.\", JOURNAL = c(\"Journal of Molecular Catalysis B: Enzymatic 23(2-6):117-132 (2003)\", \"DOI:10.1016/S1381-1177(03)00078-X\")), list(REFERENCE = \"PMID:12857844\", AUTHORS = \"Fukuchi-Mizutani M, Okuhara H, Fukui Y, Nakao M, Katsumoto Y, Yonekura-Sakakibara K, Kusumi T, Hase T, Tanaka Y.\", TITLE = \"Biochemical and molecular characterization of a novel UDP-glucose:anthocyanin 3\'-O-glucosyltransferase, a key enzyme for blue anthocyanin biosynthesis, from gentian.\", JOURNAL = c(\"Plant Physiol 132:1652-63 (2003)\", \"DOI:10.1104/pp.102.018242\")), list(REFERENCE = \"PMID:12828368\", AUTHORS = \"Springob K, Nakajima J, Yamazaki M, Saito K.\", TITLE = \"Recent advances in the biosynthesis and accumulation of anthocyanins.\", JOURNAL = c(\"Nat Prod Rep 20:288-303 (2003)\", \"DOI:10.1039/b109542k\")), list(REFERENCE = \"PMID:11598135\", AUTHORS = \"Suzuki H, Nakayama T, Yonekura-Sakakibara K, Fukui Y, Nakamura N, Nakao M, Tanaka Y, Yamaguchi MA, Kusumi T, Nishino T\", TITLE = \"Malonyl-CoA:anthocyanin 5-O-glucoside-6\\\"\'-O-malonyltransferase from scarlet sage (Salvia splendens) flowers. Enzyme purification, gene cloning, expression, and characterization.\", JOURNAL = c(\"J Biol Chem 276:49013-9 (2001)\", \"DOI:10.1074/jbc.M108444200\")), list(REFERENCE = \"PMID:10536025\", AUTHORS = \"Burbulis IE, Winkel-Shirley B.\", TITLE = \"Interactions among enzymes of the Arabidopsis flavonoid biosynthetic pathway.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 96:12929-34 (1999)\", \"DOI:10.1073/pnas.96.22.12929\")), list(REFERENCE = \"PMID:10504566\", AUTHORS = \"Brugliera F, Barri-Rewell G, Holton TA, Mason JG.\", TITLE = \"Isolation and characterization of a flavonoid 3\'-hydroxylase cDNA clone corresponding to the Ht1 locus of Petunia hybrida.\", JOURNAL = c(\"Plant J 19:441-51 (1999)\", \"DOI:10.1046/j.1365-313X.1999.00539.x\")), list(REFERENCE = \"PMID:12226348\", AUTHORS = \"Boss PK, Davies C, Robinson SP.\", TITLE = \"Analysis of the Expression of Anthocyanin Pathway Genes in Developing Vitis vinifera L. cv Shiraz Grape Berries and the Implications for Pathway Regulation.\", JOURNAL = c(\"Plant Physiol 111:1059-1066 (1996)\", \"DOI:10.1104/pp.111.4.1059\")), list(REFERENCE = \"PMID:12242398\", AUTHORS = \"Holton TA, Cornish EC.\", TITLE = \"Genetics and Biochemistry of Anthocyanin Biosynthesis.\", JOURNAL = c(\"Plant Cell 7:1071-1083 (1995)\", \"DOI:10.1105/tpc.7.7.1071\")), list(REFERENCE = \"PMID:8130799\", AUTHORS = \"Kroon J, Souer E, de Graaff A, Xue Y, Mol J, Koes R.\", TITLE = \"Cloning and structural analysis of the anthocyanin pigmentation locus Rt of Petunia hybrida: characterization of insertion sequences in two mutant alleles.\", JOURNAL = c(\"Plant J 5:69-80 (1994)\", \"DOI:10.1046/j.1365-313X.1994.5010069.x\"))', 'map00942', 'Anthocyanin biosynthesis', 79, 0, 0, 79, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (144, '00943', 'Isoflavonoid biosynthesis', 'Isoflavonoids are biologically active compounds, such as phytoestrogens, produced by pea family plants. While flavonoids (in the narrow sense) have the 2-phenylchromen-4-one backbone, isoflavonoids have the 3-phenylchromen-4-one backbone with no hydroxyl group substitution at position 2. Isoflavonoids are derived from the flavonoid biosynthesis pathway via liquiritigenin or naringenin.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Isoflavonoid biosynthesis', 'GO: 0009717', 'ko00943', 'list(REFERENCE = \"PMID:11027686\", AUTHORS = \"Latunde-Dada AO, Cabello-Hurtado F, Czittrich N, Didierjean L, Schopfer C, Hertkorn N, Werck-Reichhart D, Ebel J.\", TITLE = \"Flavonoid 6-hydroxylase from soybean (Glycine max L.), a novel plant P-450 monooxygenase.\", JOURNAL = c(\"J Biol Chem 276:1688-95 (2001)\", \"DOI:10.1074/jbc.M006277200\")), list(REFERENCE = \"PMID:12179983\", AUTHORS = \"Baggett BR, Cooper JD, Hogan ET, Carper J, Paiva NL, Smith JT.\", TITLE = \"Profiling isoflavonoids found in legume root extracts using capillary electrophoresis.\", JOURNAL = c(\"Electrophoresis 23:1642-51 (2002)\", \"DOI:10.1002/1522-2683(200206)23:11<1642::AID-ELPS1642>3.0.CO;2-Y\")), list(REFERENCE = \"PMID:16996502\", AUTHORS = \"Akashi T, Koshimizu S, Aoki T, Ayabe S.\", TITLE = \"Identification of cDNAs encoding pterocarpan reductase involved in isoflavan phytoalexin biosynthesis in Lotus japonicus by EST mining.\", JOURNAL = c(\"FEBS Lett 580:5666-70 (2006)\", \"DOI:10.1016/j.febslet.2006.09.016\")), list(REFERENCE = \"PMID:14617078\", AUTHORS = \"Liu CJ, Huhman D, Sumner LW, Dixon RA.\", TITLE = \"Regiospecific hydroxylation of isoflavones by cytochrome p450 81E enzymes from Medicago truncatula.\", JOURNAL = c(\"Plant J 36:471-84 (2003)\", \"DOI:10.1046/j.1365-313X.2003.01893.x\")), list(REFERENCE = \"PMID:15082922\", AUTHORS = \"Dhaubhadel S, McGarvey BD, Williams R, Gijzen M.\", TITLE = \"Isoflavonoid biosynthesis and accumulation in developing soybean seeds.\", JOURNAL = c(\"Plant Mol Biol 53:733-43 (2003)\", \"DOI:10.1023/B:PLAN.0000023666.30358.ae\")), list(REFERENCE = \"PMID:11164575\", AUTHORS = \"Shimada N, Akashi T, Aoki T, Ayabe S.\", TITLE = \"Induction of isoflavonoid pathway in the model legume Lotus japonicus: molecular characterization of enzymes involved in phytoalexin biosynthesis.\", JOURNAL = c(\"Plant Sci 160:37-47 (2000)\", \"DOI:10.1016/S0168-9452(00)00355-1\")), list(REFERENCE = \"PMID:16667851\", AUTHORS = \"Preisig CL, Bell JN, Sun Y, Hrazdina G, Matthews DE, Vanetten HD\", TITLE = \"Biosynthesis of the Phytoalexin Pisatin : Isoflavone Reduction and Further Metabolism of the Product Sophorol by Extracts of Pisum sativum.\", JOURNAL = c(\"Plant Physiol 94:1444-8 (1990)\", \"DOI:10.1104/pp.94.3.1444\")), list(REFERENCE = \"PMID:17452423\", AUTHORS = \"Shimada N, Sato S, Akashi T, Nakamura Y, Tabata S, Ayabe S, Aoki T\", TITLE = \"Genome-wide analyses of the structural gene families involved in the legume-specific 5-deoxyisoflavonoid biosynthesis of Lotus japonicus.\", JOURNAL = c(\"DNA Res 14:25-36 (2007)\", \"DOI:10.1093/dnares/dsm004\")), list(REFERENCE = \"PMID:16924535\", AUTHORS = \"Lozovaya VV, Lygin AV, Zernova OV, Ulanov AV, Li S, Hartman GL, Widholm JM.\", TITLE = \"Modification of phenolic metabolism in soybean hairy roots through down regulation of chalcone synthase or isoflavone synthase.\", JOURNAL = c(\"Planta 225:665-79 (2007)\", \"DOI:10.1007/s00425-006-0368-z\")), list(REFERENCE = \"PMID:12207646\", AUTHORS = \"Sawada Y, Kinoshita K, Akashi T, Aoki T, Ayabe S.\", TITLE = \"Key amino acid residues required for aryl migration catalysed by the cytochrome P450 2-hydroxyisoflavanone synthase.\", JOURNAL = c(\"Plant J 31:555-64 (2002)\", \"DOI:10.1046/j.1365-313X.2002.01378.x\")), list(REFERENCE = \"PMID:16006598\", AUTHORS = \"Deavours BE, Dixon RA\", TITLE = \"Metabolic engineering of isoflavonoid biosynthesis in alfalfa.\", JOURNAL = c(\"Plant Physiol 138:2245-59 (2005)\", \"DOI:10.1104/pp.105.062539\")), list(REFERENCE = \"\", AUTHORS = \"Hinderer W, Flentje U, Barz W.\", TITLE = \"Microsomal isoflavone 2\'- and 3\'-hydroxylases from chickpea (Cicer arietinum L.) cell suspensions induced for pterocarpan phytoalexin formation.\", JOURNAL = c(\"FEBS letters 214(1):101-106 (1987)\", \"DOI:10.1016/0014-5793(87)80021-2\")), list(REFERENCE = \"\", AUTHORS = \"Aoki T, Akashi T, Ayabe S.\", TITLE = \"Flavonoids of leguminous plants: structure, biological activity, and biosynthesis.\", JOURNAL = c(\"Journal of Plant Research 113(4):475-488 (2000)\", \"DOI:10.1007/PL00013958\")), list(REFERENCE = \"\", AUTHORS = \"Barz W, Mackenbrock U.\", TITLE = \"Constitutive and elicitation induced metabolism of isoflavones and pterocarpans in chickpea (Cicer arietinum) cell suspension cultures.\", JOURNAL = c(\"Plant Cell, Tissue and Organ Culture 38(2-3):199-211 (1994)\", \"DOI:10.1007/BF00033878\")), list(REFERENCE = \"\", AUTHORS = \"Fischer D, Ebenau-Jehle C, Grisebach H.\", TITLE = \"Purification and characterization of pterocarpan synthase from elicitor-challenged soybean cell cultures.\", JOURNAL = c(\"Phytochemistry 29(9):2879-2882 (1990)\", \"DOI:10.1016/0031-9422(90)87096-D\")), list(REFERENCE = \"\", AUTHORS = \"Ayabe S, Akashi T.\", TITLE = \"Cytochrome P450s in flavonoid metabolism.\", JOURNAL = c(\"Phytochemistry Reviews 5(2-3):271-282 (2006)\", \"DOI:10.1007/s11101-006-9007-3\")), list(REFERENCE = \"PMID:24197106\", AUTHORS = \"Daniel S, Tiemann K, Wittkampf U, Bless W, Hinderer W, Barz W\", TITLE = \"Elicitor-induced metabolic changes in cell cultures of chickpea (Cicer arietinum L.) cultivars resistant and susceptible to Ascochyta rabiei : I. Investigations of enzyme activities involved in isoflavone and pterocarpan phytoalexin biosynthesis.\", JOURNAL = c(\"Planta 182:270-8 (1990)\", \"DOI:10.1007/BF00197121\"))', 'map00943', 'Isoflavonoid biosynthesis', 66, 0, 0, 66, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (145, '00944', 'Flavone and flavonol biosynthesis', 'Flavones and flavonols (3-hydroxyflavones) are common flavonoids in the plant kingdom. They are synthesized as part of the flavonoid modification pathways in aglycone and glucoside forms.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Flavone and flavonol biosynthesis', 'ko00944', 'list(REFERENCE = \"PMID:3994393\", AUTHORS = \"De Luca V, Ibrahim RK\", TITLE = \"Enzymatic synthesis of polymethylated flavonols in Chrysosplenium americanum. I. Partial purification and some properties of S-adenosyl-L-methionine:flavonol 3-, 6-, 7-, and 4\'-O-methyltransferases.\", JOURNAL = c(\"Arch Biochem Biophys 238:596-605 (1985)\", \"DOI:10.1016/0003-9861(85)90205-X\")), list(REFERENCE = \"PMID:6462109\", AUTHORS = \"Jourdan PS, Mansell RL\", TITLE = \"Isolation and partial characterization of three glucosyl transferases involved in the biosynthesis of flavonol triglucosides in Pisum sativum L.\", JOURNAL = c(\"Arch Biochem Biophys 213:434-43 (1982)\", \"DOI:10.1016/0003-9861(82)90569-0\")), list(REFERENCE = \"PMID:10567367\", AUTHORS = \"Miller KD, Guyon V, Evans JN, Shuttleworth WA, Taylor LP\", TITLE = \"Purification, cloning, and heterologous expression of a catalytically efficient flavonol 3-O-galactosyltransferase expressed in the male gametophyte of Petunia hybrida.\", JOURNAL = c(\"J Biol Chem 274:34011-9 (1999)\", \"DOI:10.1074/jbc.274.48.34011\")), list(REFERENCE = \"PMID:12482447\", AUTHORS = \"Cacace S, Schroder G, Wehinger E, Strack D, Schmidt J, Schroder J\", TITLE = \"A flavonol O-methyltransferase from Catharanthus roseus performing two sequential methylations.\", JOURNAL = c(\"Phytochemistry 62:127-37 (2003)\", \"DOI:10.1016/S0031-9422(02)00483-1\")), list(REFERENCE = \"PMID:15807784\", AUTHORS = \"Tohge T, Nishiyama Y, Hirai MY, Yano M, Nakajima J, Awazuhara M, Inoue E, Takahashi H, Goodenowe DB, Kitayama M, Noji M, Yamazaki M, Saito K\", TITLE = \"Functional genomics by integrated analysis of metabolome and transcriptome of Arabidopsis plants over-expressing an MYB transcription factor.\", JOURNAL = c(\"Plant J 42:218-35 (2005)\", \"DOI:10.1111/j.1365-313X.2005.02371.x\")), list(REFERENCE = \"PMID:17277900\", AUTHORS = \"Kubo H, Nawa N, Lupsea SA\", TITLE = \"Anthocyaninless1 gene of Arabidopsis thaliana encodes a UDP-glucose:flavonoid-3-O-glucosyltransferase.\", JOURNAL = c(\"J Plant Res 120:445-9 (2007)\", \"DOI:10.1007/s10265-006-0067-7\")), list(REFERENCE = \"PMID:24241851\", AUTHORS = \"Knogge W, Weissenbock G\", TITLE = \"Tissue-distribution of secondary phenolic biosynthesis in developing primary leaves of Avena sativa L.\", JOURNAL = c(\"Planta 167:196-205 (1986)\", \"DOI:10.1007/BF00391415\")), list(REFERENCE = \"PMID:24177970\", AUTHORS = \"Anhalt S, Weissenbock G\", TITLE = \"Subcellular localization of luteolin glucuronides and related enzymes in rye mesophyll.\", JOURNAL = c(\"Planta 187:83-8 (1992)\", \"DOI:10.1007/BF00201627\")), list(REFERENCE = \"\", AUTHORS = \"Suzuki H, Nakayama T, Nagae S, Yamaguchi M, Iwashita T, Fukui Y, Nishino T.\", TITLE = \"cDNA cloning and functional characterization of flavonol 3-O-glucoside-6\\\"-O-malonyltransferases from flowers of Verbena hybrida and Lamium purpureum.\", JOURNAL = c(\"J Mol Catal B 28:87-93 (2004)\", \"DOI:10.1016/j.molcatb.2004.01.005\"))', 'map00944', 'Flavone and flavonol biosynthesis', 'Flavones and flavonols (3-hydroxyflavones) are common flavonoids in the plant kingdom. They are synthesized as part of the flavonoid modification pathways in aglycone and glucoside forms.', 89, 0, 0, 89, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (146, '00945', 'Stilbenoid, diarylheptanoid and gingerol biosynthesis', 'Stilbenoids are a group of phenolic compounds, biosynthetically interrelated through their common origin from a C6-C2-C6 intermediate, such as resveratol found in grapes. Stilbenoids can also exist as glycosides (e.g., piceid). Combretastatins are potentially useful stilbenoid natural products with known antitumor activity. Diarylheptanoid is a compound group having phenyl rings at 1,7 positions of n-heptane (C6-C7-C6), such as curcumin found in the ginger family. [6]-Gingerol is a major active component of ginger and has diverse pharmacologic effects.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Stilbenoid, diarylheptanoid and gingerol biosynthesis', 'ko00945', 'list(REFERENCE = \"PMID:19258320\", AUTHORS = \"Katsuyama Y, Kita T, Funa N, Horinouchi S\", TITLE = \"Curcuminoid biosynthesis by two type III polyketide synthases in the herb Curcuma longa.\", JOURNAL = c(\"J Biol Chem 284:11160-70 (2009)\", \"DOI:10.1074/jbc.M900070200\")), list(REFERENCE = \"PMID:16890967\", AUTHORS = \"Ramirez-Ahumada Mdel C, Timmermann BN, Gang DR\", TITLE = \"Biosynthesis of curcuminoids and gingerols in turmeric (Curcuma longa) and ginger (Zingiber officinale): identification of curcuminoid synthase and hydroxycinnamoyl-CoA thioesterases.\", JOURNAL = c(\"Phytochemistry 67:2017-29 (2006)\", \"DOI:10.1016/j.phytochem.2006.06.028\")), list(REFERENCE = \"PMID:17509574\", AUTHORS = \"Masada S, Terasaka K, Mizukami H\", TITLE = \"A single amino acid in the PSPG-box plays an important role in the catalytic function of CaUGT2 (Curcumin glucosyltransferase), a Group D Family 1 glucosyltransferase from Catharanthus roseus.\", JOURNAL = c(\"FEBS Lett 581:2605-10 (2007)\", \"DOI:10.1016/j.febslet.2007.05.002\"))', 'map00945', 'Stilbenoid, diarylheptanoid and gingerol biosynthesis', 'Stilbenoids are a group of phenolic compounds, biosynthetically interrelated through their common origin from a C6-C2-C6 intermediate, such as resveratol found in grapes. Stilbenoids can also exist as glycosides (e.g., piceid). Combretastatins are potentially useful stilbenoid natural products with known antitumor activity. Diarylheptanoid is a compound group having phenyl rings at 1,7 positions of n-heptane (C6-C7-C6), such as curcumin found in the ginger family. [6]-Gingerol is a major active component of ginger and has diverse pharmacologic effects.', 91, 0, 0, 91, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (147, '00950', 'Isoquinoline alkaloid biosynthesis', 'Isoquinoline alkaloids are tyrosine-derived plant alkaloids with an isoquinoline skeleton. Among them benzylisoquinoline alkaloids form an important group with potent pharmacological activity, including analgesic compounds of morphine and codeine, and anti-infective agents of berberine, palmatine, and magnoflorine. Biosynthesis of isoquinoline alkaloids proceeds via decarboxylation of tyrosine or DOPA to yield dopamine, which together with 4-hydroxyphenylacetaldehyde, an aldehyde derived from tyrosine, is converted to reticuline, an important precursor of various benzylisoquinoline alkaloids.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Isoquinoline alkaloid biosynthesis', 'GO: 0033075', 'ko00950', 'list(REFERENCE = \"PMID:10811648\", AUTHORS = \"Morishige T, Tsujita T, Yamada Y, Sato F\", TITLE = \"Molecular characterization of the S-adenosyl-L-methionine:3\'-hydroxy-N-methylcoclaurine 4\'-O-methyltransferase involved in isoquinoline alkaloid biosynthesis in Coptis japonica.\", JOURNAL = c(\"J Biol Chem 275:23398-405 (2000)\", \"DOI:10.1074/jbc.M002439200\")), list(REFERENCE = \"PMID:12423366\", AUTHORS = \"Morishige T, Dubouzet E, Choi KB, Yazaki K, Sato F\", TITLE = \"Molecular cloning of columbamine O-methyltransferase from cultured Coptis japonica cells.\", JOURNAL = c(\"Eur J Biochem 269:5659-67 (2002)\", \"DOI:10.1046/j.1432-1033.2002.03275.x\")), list(REFERENCE = \"PMID:14675446\", AUTHORS = \"Ounaroon A, Decker G, Schmidt J, Lottspeich F, Kutchan TM\", TITLE = \"(R,S)-Reticuline 7-O-methyltransferase and (R,S)-norcoclaurine 6-O-methyltransferase of Papaver somniferum - cDNA cloning and characterization of methyl transfer enzymes of alkaloid biosynthesis in opium poppy.\", JOURNAL = c(\"Plant J 36:808-19 (2003)\", \"DOI:10.1046/j.1365-313X.2003.01928.x\")), list(REFERENCE = \"PMID:18230623\", AUTHORS = \"Ikezawa N, Iwasa K, Sato F\", TITLE = \"Molecular cloning and characterization of CYP80G2, a cytochrome P450 that catalyzes an intramolecular C-C phenol coupling of (S)-reticuline in magnoflorine biosynthesis, from cultured Coptis japonica cells.\", JOURNAL = c(\"J Biol Chem 283:8810-21 (2008)\", \"DOI:10.1074/jbc.M705082200\")), list(REFERENCE = \"PMID:18476877\", AUTHORS = \"Facchini PJ, De Luca V\", TITLE = \"Opium poppy and Madagascar periwinkle: model non-model systems to investigate alkaloid biosynthesis in plants.\", JOURNAL = c(\"Plant J 54:763-84 (2008)\", \"DOI:10.1111/j.1365-313X.2008.03438.x\")), list(REFERENCE = \"PMID:18492807\", AUTHORS = \"Minami H, Kim JS, Ikezawa N, Takemura T, Katayama T, Kumagai H, Sato F\", TITLE = \"Microbial production of plant benzylisoquinoline alkaloids.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:7393-8 (2008)\", \"DOI:10.1073/pnas.0802981105\")), list(REFERENCE = \"\", AUTHORS = \"Rueffer M, Bauer W, Zenk MH.\", TITLE = \"The formation of corydaline and related alkaloids in Corydalis cava in vivo and in vitro.\", JOURNAL = c(\"Can J Chem 72:170-175 (1994)\", \"DOI:10.1139/v94-026\")), list(REFERENCE = \"\", AUTHORS = \"Sekine Y, Crevelling C, Bell M, Brossi A.\", TITLE = \"Mammalian alkaloids: O-methylation of (+-)-norcoclaurine-1-carboxylic acid and related isoquinolines including (S)- and (R)-norcoclaurine with 14C-labeled S-adenosyl-L-methionine in presence of mammalian catechol O-methyltransferase.\", JOURNAL = c(\"Helvetica Chimica Acta 73(2):426-432 (1990)\", \"DOI:10.1002/hlca.19900730222\")), list(REFERENCE = \"\", AUTHORS = \"De-Eknamkul W, Tanahashi T, Zenk MH.\", TITLE = \"Enzymic 10-hydroxylation and 10-O-methylation of dihydrosanguinarine in dihydrochelirubine formation by Eschscholtzia.\", JOURNAL = c(\"Phytochemistry 31(8):2713-2717 (1992)\", \"DOI:10.1016/0031-9422(92)83617-8\")), list(REFERENCE = \"\", AUTHORS = \"Kammerer L, De-Eknamkul W, Zenk MH.\", TITLE = \"Enzymic 12-hydroxylation and 12-O-methylation of dihydrochelirubine in dihydromacarpine formation by Thalictrum bulgaricum.\", JOURNAL = c(\"Phytochemistry 36(6):1409-1416 (1994)\", \"DOI:10.1016/S0031-9422(00)89732-0\")), list(REFERENCE = \"PMID:24241413\", AUTHORS = \"Schumacher HM, Zenk MH\", TITLE = \"Partial purification and characterization of dihydrobenzophenanthridine oxidase from Eschscholtzia californica cell suspension cultures.\", JOURNAL = c(\"Plant Cell Rep 7:43-6 (1988)\", \"DOI:10.1007/BF00272975\")), list(REFERENCE = \"\", AUTHORS = \"Rueffer M, Zenk MH.\", TITLE = \"Enzymatic formation of protopines by a microsomal cytochrome P-450 system of Corydalis vaginans.\", JOURNAL = c(\"Tetrahedron Letters 28(44):5307-5310 (1987)\", \"DOI:10.1016/S0040-4039(00)96715-7\"))', 'map00950', 'Isoquinoline alkaloid biosynthesis', 105, 0, 0, 105, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (148, '00960', 'Tropane, piperidine and pyridine alkaloid biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Tropane, piperidine and pyridine alkaloid biosynthesis', 'UMBBD: caf, caf2', 'ko00960', 'map00960', 'Tropane, piperidine and pyridine alkaloid biosynthesis', 'Metabolism; Biosynthesis of other secondary metabolites', 'Tropane, piperidine and pyridine alkaloid biosynthesis', 105, 0, 0, 105, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (149, '00965', 'Betalain biosynthesis', 'Betalains are water-soluble nitrogen-containing pigments that are present in plants belonging to the order Caryophyllales (such as cactus and amaranth families) and in higher fungi. They contain betalamic acid as the chromophore and are classified into two types: betacyanins and betaxanthins. Betacyanins contain a cyclo-DOPA residue and exhibit red/violet coloration, while betaxanthins contain different amino acids or amino side chains and exhibit a yellow/orange coloration. The condensation of betalamic acid with amino acids (including cyclo-DOPA or amines) in plants is a spontaneous reaction, not an enzyme-catalyzed reaction.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Betalain biosynthesis', 'ko00965', 'list(REFERENCE = \"PMID:15805475\", AUTHORS = \"Gandia-Herrero F, Escribano J, Garcia-Carmona F\", TITLE = \"Betaxanthins as substrates for tyrosinase. An approach to the role of tyrosinase in the biosynthetic pathway of betalains.\", JOURNAL = c(\"Plant Physiol 138:421-32 (2005)\", \"DOI:10.1104/pp.104.057992\")), list(REFERENCE = \"PMID:16247652\", AUTHORS = \"Sasaki N, Abe Y, Wada K, Koda T, Goda Y, Adachi T, Ozeki Y\", TITLE = \"Amaranthin in feather cockscombs is synthesized via glucuronylation at the cyclo-DOPA glucoside step in the betacyanin biosynthetic pathway.\", JOURNAL = c(\"J Plant Res 118:439-42 (2005)\", \"DOI:10.1007/s10265-005-0237-z\")), list(REFERENCE = \"PMID:12620337\", AUTHORS = \"Strack D, Vogt T, Schliemann W\", TITLE = \"Recent advances in betalain research.\", JOURNAL = c(\"Phytochemistry 62:247-69 (2003)\", \"DOI:10.1016/S0031-9422(02)00564-2\")), list(REFERENCE = \"PMID:11855654\", AUTHORS = \"Vogt T\", TITLE = \"Substrate specificity and sequence analysis define a polyphyletic origin of betanidin 5- and 6-O-glucosyltransferase from Dorotheanthus bellidiformis.\", JOURNAL = c(\"Planta 214:492-5 (2002)\", \"DOI:10.1007/s00425-001-0685-1\"))', 'map00965', 'Betalain biosynthesis', 'Betalains are water-soluble nitrogen-containing pigments that are present in plants belonging to the order Caryophyllales (such as cactus and amaranth families) and in higher fungi. They contain betalamic acid as the chromophore and are classified into two types: betacyanins and betaxanthins. Betacyanins contain a cyclo-DOPA residue and exhibit red/violet coloration, while betaxanthins contain different amino acids or amino side chains and exhibit a yellow/orange coloration. The condensation of betalamic acid with amino acids (including cyclo-DOPA or amines) in plants is a spontaneous reaction, not an enzyme-catalyzed reaction.', 92, 0, 0, 92, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (150, '00966', 'Glucosinolate biosynthesis', 'Glucosinolates are biologically active secondary metabolites found in Brassicaceae (mustard family) and related families.These compounds are genetically variable within plant species and used as natural pesticides, such as against insect herbivores. All glucosinolates share a common structure consisting of a beta-thioglucose moiety, a sulfonated oxime moiety, and a variable aglycone side chain derived from an alpha-amino acid. Genes encoding glucosinolate biosynthetic enzymes have been identified in Arabidopsis thaliana by genetic polymorphisms and loss-of-function mutations. This map shows examples of side chain elongation in methionine-derived glucosinolates and the core pathway for biosynthesis of glucosinolates from amino acids.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Glucosinolate biosynthesis', 'Glucosinolate biosynthesis, tryptophan => glucobrassicin [PATH:map00966]', 'GO: 0019761', 'ko00966', 'list(REFERENCE = \"PMID:12049923\", AUTHORS = \"Wittstock U, Halkier BA\", TITLE = \"Glucosinolate research in the Arabidopsis era.\", JOURNAL = c(\"Trends Plant Sci 7:263-70 (2002)\", \"DOI:10.1016/S1360-1385(02)02273-2\")), list(REFERENCE = \"PMID:15913672\", AUTHORS = \"Windsor AJ, Reichelt M, Figuth A, Svatos A, Kroymann J, Kliebenstein DJ, Gershenzon J, Mitchell-Olds T\", TITLE = \"Geographic and evolutionary diversification of glucosinolates among near relatives of Arabidopsis thaliana (Brassicaceae).\", JOURNAL = c(\"Phytochemistry 66:1321-33 (2005)\", \"DOI:10.1016/j.phytochem.2005.04.016\")), list(REFERENCE = \"PMID:14740211\", AUTHORS = \"Textor S, Bartram S, Kroymann J, Falk KL, Hick A, Pickett JA, Gershenzon J\", TITLE = \"Biosynthesis of methionine-derived glucosinolates in Arabidopsis thaliana: recombinant expression and characterization of methylthioalkylmalate synthase, the condensing enzyme of the chain-elongation cycle.\", JOURNAL = c(\"Planta 218:1026-35 (2004)\", \"DOI:10.1007/s00425-003-1184-3\")), list(REFERENCE = \"PMID:15358770\", AUTHORS = \"Piotrowski M, Schemenewitz A, Lopukhina A, Muller A, Janowitz T, Weiler EW, Oecking C\", TITLE = \"Desulfoglucosinolate sulfotransferases from Arabidopsis thaliana catalyze the final step in the biosynthesis of the glucosinolate core structure.\", JOURNAL = c(\"J Biol Chem 279:50717-25 (2004)\", \"DOI:10.1074/jbc.M407681200\")), list(REFERENCE = \"PMID:12586901\", AUTHORS = \"Mikkelsen MD, Halkier BA\", TITLE = \"Metabolic engineering of valine- and isoleucine-derived glucosinolates in Arabidopsis expressing CYP79D2 from Cassava.\", JOURNAL = c(\"Plant Physiol 131:773-9 (2003)\", \"DOI:10.1104/pp.013425\")), list(REFERENCE = \"\", AUTHORS = \"Chen S, Andreasson E.\", TITLE = \"Update on glucosinolate metabolism and transport.\", JOURNAL = c(\"Plant Physiol Biochem 39:743-758 (2001)\", \"DOI:10.1016/S0981-9428(01)01301-8\"))', 'map00966', 100, 0, 0, 100, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (151, '00970', 'Aminoacyl-tRNA biosynthesis', 'Genetic Information Processing; Translation', 'Aminoacyl-tRNA biosynthesis', 'Charcot-Marie-Tooth disease, Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, Pontocerebellar hypoplasia, Myopathy with lactic acidosis and sideroblastic anaemia, MELAS Syndrome, Spastic ataxia, Myoclonic Epilepsy and Ragged-Red Fiber Disease, Infantile liver failure, Perrault syndrome, CAGSSS syndrome', 'ko00970', 'list(REFERENCE = \"PMID:18252769\", AUTHORS = \"Sheppard K, Yuan J, Hohn MJ, Jester B, Devine KM, Soll D\", TITLE = \"From one amino acid to another: tRNA-dependent amino acid biosynthesis.\", JOURNAL = c(\"Nucleic Acids Res 36:1813-25 (2008)\", \"DOI:10.1093/nar/gkn015\")), list(REFERENCE = \"PMID:15314242\", AUTHORS = \"Polycarpo C, Ambrogelly A, Berube A, Winbush SM, McCloskey JA, Crain PF, Wood JL, Soll D\", TITLE = \"An aminoacyl-tRNA synthetase that specifically activates pyrrolysine.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 101:12450-4 (2004)\", \"DOI:10.1073/pnas.0405362101\"))', 'map00970', 'Aminoacyl-tRNA biosynthesis', 'Genetic Information Processing; Translation', 531, 5574, 248, 105, 128, 50, 5275, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (152, '00980', 'Metabolism of xenobiotics by cytochrome P450', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Metabolism of xenobiotics by cytochrome P450', 'Cortisone reductase deficiency, Primary congenital glaucoma', 'ko00980', 'list(REFERENCE = \"PMID:12487150\", AUTHORS = \"Buckpitt A, Boland B, Isbell M, Morin D, Shultz M, Baldwin R, Chan K, Karlsson A, Lin C, Taff A, West J, Fanucchi M, Van Winkle L, Plopper C.\", TITLE = \"Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity.\", JOURNAL = c(\"Drug Metab Rev 34:791-820 (2002)\", \"DOI:10.1081/DMR-120015694\")), list(REFERENCE = \"PMID:10725110\", AUTHORS = \"Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ.\", TITLE = \"Role of quinones in toxicology.\", JOURNAL = c(\"Chem Res Toxicol 13:135-60 (2000)\", \"DOI:10.1021/tx9902082\")), list(REFERENCE = \"PMID:10570027\", AUTHORS = \"Halladay JS, Sauer JM, Sipes IG.\", TITLE = \"Metabolism and disposition of [(14)C]1-nitronaphthalene in male Sprague-Dawley rats.\", JOURNAL = \"Drug Metab Dispos 27:1456-65 (1999)\"), list(REFERENCE = \"PMID:10490505\", AUTHORS = \"Watt KC, Morin DM, Kurth MJ, Mercer RS, Plopper CG, Buckpitt AR.\", TITLE = \"Glutathione conjugation of electrophilic metabolites of 1-nitronaphthalene in rat tracheobronchial airways and liver: identification by mass spectrometry and proton nuclear magnetic resonance spectroscopy.\", JOURNAL = c(\"Chem Res Toxicol 12:831-9 (1999)\", \"DOI:10.1021/tx990023v\")), list(REFERENCE = \"PMID:15319346\", AUTHORS = \"Simmonds AC, Reilly CA, Baldwin RM, Ghanayem BI, Lanza DL, Yost GS, Collins KS, Forkert PG.\", TITLE = \"Bioactivation of 1,1-dichloroethylene to its epoxide by CYP2E1 and CYP2F enzymes.\", JOURNAL = \"Drug Metab Dispos 32:1032-9 (2004)\"), list(REFERENCE = \"PMID:15987776\", AUTHORS = \"Forkert PG, Baldwin RM, Millen B, Lash LH, Putt DA, Shultz MA, Collins KS.\", TITLE = \"Pulmonary bioactivation of trichloroethylene to chloral hydrate: relative contributions of CYP2E1, CYP2F, and CYP2B1.\", JOURNAL = c(\"Drug Metab Dispos 33:1429-37 (2005)\", \"DOI:10.1124/dmd.105.005074\")), list(REFERENCE = \"PMID:9107551\", AUTHORS = \"Wormhoudt LW, Commandeur JN, Ploemen JH, Abdoelgafoer RS, Makansi A, Van Bladeren PJ, Vermeulen NP.\", TITLE = \"Urinary thiodiacetic acid. A selective biomarker for the cytochrome P450-catalyzed oxidation of 1,2-dibromoethane in the rat.\", JOURNAL = \"Drug Metab Dispos 25:508-15 (1997)\"), list(REFERENCE = \"PMID:4395686\", AUTHORS = \"Brodie BB, Reid WD, Cho AK, Sipes G, Krishna G, Gillette JR.\", TITLE = \"Possible mechanism of liver necrosis caused by aromatic organic compounds.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 68:160-4 (1971)\", \"DOI:10.1073/pnas.68.1.160\")), list(REFERENCE = \"PMID:15298956\", AUTHORS = \"Lodovici M, Luceri C, Guglielmi F, Bacci C, Akpan V, Fonnesu ML, Boddi V, Dolara P.\", TITLE = \"Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.\", JOURNAL = \"Cancer Epidemiol Biomarkers Prev 13:1342-8 (2004)\"), list(REFERENCE = \"\", AUTHORS = \"Omura T, Ishimura Y, Fujii Y (eds).\", TITLE = \"[Molecular Biology of P450] (In Japanese)\", JOURNAL = \"Kodansya (2003)\")', 'map00980', 'Metabolism of xenobiotics by cytochrome P450', 'Metabolism; Xenobiotics biodegradation and metabolism', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (153, '00981', 'Insect hormone biosynthesis', 'Metabolism; Metabolism of terpenoids and polyketides', 'Insect hormone biosynthesis', 'ko00981', 'list(REFERENCE = \"PMID:15355237\", AUTHORS = \"Belles X, Martin D, Piulachs MD.\", TITLE = \"The mevalonate pathway and the synthesis of juvenile hormone in insects.\", JOURNAL = c(\"Annu Rev Entomol 50:181-99 (2005)\", \"DOI:10.1146/annurev.ento.50.071803.130356\")), list(REFERENCE = \"PMID:15026169\", AUTHORS = \"Gilbert LI.\", TITLE = \"Halloween genes encode P450 enzymes that mediate steroid hormone biosynthesis in Drosophila melanogaster.\", JOURNAL = c(\"Mol Cell Endocrinol 215:1-10 (2004)\", \"DOI:10.1016/j.mce.2003.11.003\")), list(REFERENCE = \"PMID:15350618\", AUTHORS = \"Warren JT, Petryk A, Marques G, Parvy JP, Shinoda T, Itoyama K, Kobayashi J, Jarcho M, Li Y, O\'Connor MB, Dauphin-Villemant C, Gilbert LI.\", TITLE = \"Phantom encodes the 25-hydroxylase of Drosophila melanogaster and Bombyx mori: a P450 enzyme critical in ecdysone biosynthesis.\", JOURNAL = c(\"Insect Biochem Mol Biol 34:991-1010 (2004)\", \"DOI:10.1016/j.ibmb.2004.06.009\")), list(REFERENCE = \"\", AUTHORS = \"Omura T, Ishimura Y, Fujii Y (eds).\", TITLE = \"[Molecular Biology of P450] (In Japanese)\", JOURNAL = \"Kodansya (2003)\")', 'map00981', 'Insect hormone biosynthesis', 'Metabolism; Metabolism of terpenoids and polyketides', 'Insect hormone biosynthesis', 71, 0, 71, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (154, '00982', 'Drug metabolism - cytochrome P450', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Drug metabolism - cytochrome P450', 'Poor drug metabolism, Coumarin resistance, Trimethylaminuria', 'ko00982', 'list(REFERENCE = \"\", AUTHORS = \"Kato R, Kamatari T (eds).\", TITLE = \"[Drug Metabolism] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (2000)\"), list(REFERENCE = \"PMID:16038189\", AUTHORS = \"Gjerde J, Kisanga ER, Hauglid M, Holm PI, Mellgren G, Lien EA.\", TITLE = \"Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.\", JOURNAL = c(\"J Chromatogr A 1082:6-14 (2005)\", \"DOI:10.1016/j.chroma.2005.01.004\")), list(REFERENCE = \"PMID:18043895\", AUTHORS = \"Buck MB, Coller JK, Murdter TE, Eichelbaum M, Knabbe C.\", TITLE = \"TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells.\", JOURNAL = c(\"Breast Cancer Res Treat 107:15-24 (2008)\", \"DOI:10.1007/s10549-007-9526-7\")), list(REFERENCE = \"PMID:16550168\", AUTHORS = \"Rodriguez-Antona C, Ingelman-Sundberg M.\", TITLE = \"Cytochrome P450 pharmacogenetics and cancer.\", JOURNAL = c(\"Oncogene 25:1679-91 (2006)\", \"DOI:10.1038/sj.onc.1209377\")), list(REFERENCE = \"PMID:16393888\", AUTHORS = \"Zhang J, Tian Q, Yung Chan S, Chuen Li S, Zhou S, Duan W, Zhu YZ.\", TITLE = \"Metabolism and transport of oxazaphosphorines and the clinical implications.\", JOURNAL = c(\"Drug Metab Rev 37:611-703 (2005)\", \"DOI:10.1080/03602530500364023\")), list(REFERENCE = \"PMID:11226815\", AUTHORS = \"Kosel M, Amey M, Aubert AC, Baumann P.\", TITLE = \"In vitro metabolism of citalopram by monoamine oxidase B in human blood.\", JOURNAL = c(\"Eur Neuropsychopharmacol 11:75-8 (2001)\", \"DOI:10.1016/S0924-977X(00)00128-0\")), list(REFERENCE = \"PMID:10575324\", AUTHORS = \"Olesen OV, Linnet K.\", TITLE = \"Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes.\", JOURNAL = c(\"Pharmacology 59:298-309 (1999)\", \"DOI:10.1159/000028333\")), list(REFERENCE = \"PMID:9698084\", AUTHORS = \"Rochat B, Kosel M, Boss G, Testa B, Gillet M, Baumann P.\", TITLE = \"Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver.\", JOURNAL = c(\"Biochem Pharmacol 56:15-23 (1998)\", \"DOI:10.1016/S0006-2952(98)00008-2\")), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"PMID:11504799\", AUTHORS = \"Oda Y, Kharasch ED.\", TITLE = \"Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation.\", JOURNAL = \"J Pharmacol Exp Ther 298:1021-32 (2001)\"), list(REFERENCE = \"PMID:10901707\", AUTHORS = \"Wang JS, Backman JT, Taavitsainen P, Neuvonen PJ, Kivisto KT.\", TITLE = \"Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans.\", JOURNAL = \"Drug Metab Dispos 28:959-65 (2000)\"), list(REFERENCE = \"PMID:12399158\", AUTHORS = \"Dieckhaus CM, Thompson CD, Roller SG, Macdonald TL.\", TITLE = \"Mechanisms of idiosyncratic drug reactions: the case of felbamate.\", JOURNAL = c(\"Chem Biol Interact 142:99-117 (2002)\", \"DOI:10.1016/S0009-2797(02)00057-1\")), list(REFERENCE = \"PMID:18463198\", AUTHORS = \"Pearce RE, Lu W, Wang Y, Uetrecht JP, Correia MA, Leeder JS\", TITLE = \"Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.\", JOURNAL = c(\"Drug Metab Dispos 36:1637-49 (2008)\", \"DOI:10.1124/dmd.107.019562\")), list(REFERENCE = \"PMID:12386121\", AUTHORS = \"Pearce RE, Vakkalagadda GR, Leeder JS.\", TITLE = \"Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites.\", JOURNAL = c(\"Drug Metab Dispos 30:1170-9 (2002)\", \"DOI:10.1124/dmd.30.11.1170\")), list(REFERENCE = \"PMID:10859160\", AUTHORS = \"Kumar S, Wong H, Yeung SA, Riggs KW, Abbott FS, Rurak DW.\", TITLE = \"Disposition of valproic acid in maternal, fetal, and newborn sheep. II: metabolism and renal elimination.\", JOURNAL = \"Drug Metab Dispos 28:857-64 (2000)\"), list(REFERENCE = \"\", AUTHORS = \"Bernad T, Joachim M.\", TITLE = \"Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology\", JOURNAL = \"Wiley-VCH (2003)\")', 'map00982', 'Drug metabolism - cytochrome P450', 'Metabolism; Xenobiotics biodegradation and metabolism', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (155, '00983', 'Drug metabolism - other enzymes', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Drug metabolism - other enzymes', 'Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidinase deficiency, Beta-ureidopropionase deficiency, Thiopurine S-methyltransferase deficiency (TPMT deficiency)', 'ko00983', 'list(REFERENCE = \"\", AUTHORS = \"Kato R, Kamatari T (eds).\", TITLE = \"[Drug Metabolism] (In Japanese)\", JOURNAL = \"Tokyo Kagaku Dojin (2000)\"), list(REFERENCE = \"PMID:15788214\", AUTHORS = \"Al Hadithy AF, de Boer NK, Derijks LJ, Escher JC, Mulder CJ, Brouwers JR.\", TITLE = \"Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.\", JOURNAL = c(\"Dig Liver Dis 37:282-97 (2005)\", \"DOI:10.1016/j.dld.2004.09.029\")), list(REFERENCE = \"PMID:16048561\", AUTHORS = \"Gearry RB, Barclay ML.\", TITLE = \"Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.\", JOURNAL = c(\"J Gastroenterol Hepatol 20:1149-57 (2005)\", \"DOI:10.1111/j.1440-1746.2005.03832.x\")), list(REFERENCE = \"PMID:16880012\", AUTHORS = \"Gilissen LP, Derijks LJ, Verhoeven HM, Bierau J, Hooymans PM, Hommes DW, Engels LG.\", TITLE = \"Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn\'s disease.\", JOURNAL = c(\"Dig Liver Dis 39:182-6 (2007)\", \"DOI:10.1016/j.dld.2006.05.026\")), list(REFERENCE = \"PMID:15514566\", AUTHORS = \"Fischel JL, Formento P, Ciccolini J, Etienne-Grimaldi MC, Milano G.\", TITLE = \"Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5\'-deoxy-5-fluorouridine on human keratinocytes.\", JOURNAL = \"Anticancer Drugs 15:969-74 (2004)\"), list(REFERENCE = \"PMID:10976516\", AUTHORS = \"Shimma N, Umeda I, Arasaki M, Murasaki C, Masubuchi K, Kohchi Y, Miwa M, Ura M, Sawada N, Tahara H, Kuruma I, Horii I, Ishitsuka H.\", TITLE = \"The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine.\", JOURNAL = c(\"Bioorg Med Chem 8:1697-706 (2000)\", \"DOI:10.1016/S0968-0896(00)00087-0\")), list(REFERENCE = \"PMID:15173095\", AUTHORS = \"Chung YL, Troy H, Judson IR, Leek R, Leach MO, Stubbs M, Harris AL, Griffiths JR\", TITLE = \"Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopy.\", JOURNAL = c(\"Clin Cancer Res 10:3863-70 (2004)\", \"DOI:10.1158/1078-0432.CCR-03-0237\")), list(REFERENCE = \"PMID:11489791\", AUTHORS = \"Mathijssen RH, van Alphen RJ, Verweij J, Loos WJ, Nooter K, Stoter G, Sparreboom A\", TITLE = \"Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).\", JOURNAL = \"Clin Cancer Res 7:2182-94 (2001)\"), list(REFERENCE = \"PMID:11379777\", AUTHORS = \"Kita T, Tanigawara Y, Chikazawa S, Hatanaka H, Sakaeda T, Komada F, Iwakawa S, Okumura K.\", TITLE = \"N-Acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients.\", JOURNAL = c(\"Biol Pharm Bull 24:544-9 (2001)\", \"DOI:10.1248/bpb.24.544\")), list(REFERENCE = \"PMID:24281184\", AUTHORS = \"Miura K, Kinouchi M, Ishida K, Fujibuchi W, Naitoh T, Ogawa H, Ando T, Yazaki N, Watanabe K, Haneda S, Shibata C, Sasaki I\", TITLE = \"5-fu metabolism in cancer and orally-administrable 5-fu drugs.\", JOURNAL = c(\"Cancers (Basel) 2:1717-30 (2010)\", \"DOI:10.3390/cancers2031717\")), list(REFERENCE = \"PMID:27709007\", AUTHORS = \"Wang P, Pradhan K, Zhong XB, Ma X\", TITLE = \"Isoniazid metabolism and hepatotoxicity.\", JOURNAL = c(\"Acta Pharm Sin B 6:384-392 (2016)\", \"DOI:10.1016/j.apsb.2016.07.014\")), list(REFERENCE = \"PMID:27232112\", AUTHORS = \"Klein DJ, Boukouvala S, McDonagh EM, Shuldiner SR, Laurieri N, Thorn CF, Altman RB, Klein TE\", TITLE = \"PharmGKB summary: isoniazid pathway, pharmacokinetics.\", JOURNAL = c(\"Pharmacogenet Genomics 26:436-44 (2016)\", \"DOI:10.1097/FPC.0000000000000232\")), list(REFERENCE = \"PMID:20195289\", AUTHORS = \"Yamada S, Richardson K, Tang M, Halaschek-Wiener J, Cook VJ, Fitzgerald JM, Elwood K, Marra F, Brooks-Wilson A\", TITLE = \"Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity.\", JOURNAL = c(\"Pharmacogenomics J 10:524-36 (2010)\", \"DOI:10.1038/tpj.2010.5\")), list(REFERENCE = \"PMID:20434429\", AUTHORS = \"Vlasits J, Jakopitsch C, Bernroitner M, Zamocky M, Furtmuller PG, Obinger C\", TITLE = \"Mechanisms of catalase activity of heme peroxidases.\", JOURNAL = c(\"Arch Biochem Biophys 500:74-81 (2010)\", \"DOI:10.1016/j.abb.2010.04.018\")), list(REFERENCE = \"PMID:26867495\", AUTHORS = \"Khan SR, Morgan AG, Michail K, Srivastava N, Whittal RM, Aljuhani N, Siraki AG\", TITLE = \"Metabolism of isoniazid by neutrophil myeloperoxidase leads to isoniazid-NAD(+) adduct formation: A comparison of the reactivity of isoniazid with its known human metabolites.\", JOURNAL = c(\"Biochem Pharmacol 106:46-55 (2016)\", \"DOI:10.1016/j.bcp.2016.02.003\")), list(REFERENCE = \"PMID:22846601\", AUTHORS = \"Forbes LV, Furtmuller PG, Khalilova I, Turner R, Obinger C, Kettle AJ\", TITLE = \"Isoniazid as a substrate and inhibitor of myeloperoxidase: identification of amine adducts and the influence of superoxide dismutase on their formation.\", JOURNAL = c(\"Biochem Pharmacol 84:949-60 (2012)\", \"DOI:10.1016/j.bcp.2012.07.020\")), list(REFERENCE = \"PMID:12069966\", AUTHORS = \"Nguyen M, Quemard A, Broussy S, Bernadou J, Meunier B\", TITLE = \"Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis.\", JOURNAL = c(\"Antimicrob Agents Chemother 46:2137-44 (2002)\", \"DOI:10.1128/AAC.46.7.2137-2144.2002\")), list(REFERENCE = \"PMID:9417034\", AUTHORS = \"Rozwarski DA, Grant GA, Barton DH, Jacobs WR Jr, Sacchettini JC\", TITLE = \"Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.\", JOURNAL = c(\"Science 279:98-102 (1998)\", \"DOI:10.1126/science.279.5347.98\")), list(REFERENCE = \"PMID:17636923\", AUTHORS = \"Argyrou A, Vetting MW, Blanchard JS\", TITLE = \"New insight into the mechanism of action of and resistance to isoniazid: interaction of Mycobacterium tuberculosis enoyl-ACP reductase with INH-NADP.\", JOURNAL = c(\"J Am Chem Soc 129:9582-3 (2007)\", \"DOI:10.1021/ja073160k\"))', 'map00983', 'Drug metabolism - other enzymes', 'Metabolism; Xenobiotics biodegradation and metabolism', 248, 70, 248, 0, 0, 0, 70, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (156, '00984', 'Steroid degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 'Steroid degradation', 'GO: 0006707', 'ko00984', 'list(REFERENCE = \"PMID:21924910\", AUTHORS = \"Ouellet H, Johnston JB, de Montellano PR\", TITLE = \"Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis.\", JOURNAL = c(\"Trends Microbiol 19:530-9 (2011)\", \"DOI:10.1016/j.tim.2011.07.009\")), list(REFERENCE = \"PMID:17264217\", AUTHORS = \"Van der Geize R, Yam K, Heuser T, Wilbrink MH, Hara H, Anderton MC, Sim E, Dijkhuizen L, Davies JE, Mohn WW, Eltis LD\", TITLE = \"A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 104:1947-52 (2007)\", \"DOI:10.1073/pnas.0605728104\")), list(REFERENCE = \"PMID:22045806\", AUTHORS = \"Thomas ST, VanderVen BC, Sherman DR, Russell DG, Sampson NS\", TITLE = \"Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism.\", JOURNAL = c(\"J Biol Chem 286:43668-78 (2011)\", \"DOI:10.1074/jbc.M111.313643\")), list(REFERENCE = \"PMID:20889498\", AUTHORS = \"Driscoll MD, McLean KJ, Levy C, Mast N, Pikuleva IA, Lafite P, Rigby SE, Leys D, Munro AW\", TITLE = \"Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.\", JOURNAL = c(\"J Biol Chem 285:38270-82 (2010)\", \"DOI:10.1074/jbc.M110.164293\")), list(REFERENCE = \"PMID:20843794\", AUTHORS = \"Johnston JB, Ouellet H, Ortiz de Montellano PR\", TITLE = \"Functional redundancy of steroid C26-monooxygenase activity in Mycobacterium tuberculosis revealed by biochemical and genetic analyses.\", JOURNAL = c(\"J Biol Chem 285:36352-60 (2010)\", \"DOI:10.1074/jbc.M110.161117\")), list(REFERENCE = \"PMID:17630785\", AUTHORS = \"Yang X, Dubnau E, Smith I, Sampson NS\", TITLE = \"Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase.\", JOURNAL = c(\"Biochemistry 46:9058-67 (2007)\", \"DOI:10.1021/bi700688x\")), list(REFERENCE = \"PMID:19875455\", AUTHORS = \"Lack NA, Yam KC, Lowe ED, Horsman GP, Owen RL, Sim E, Eltis LD\", TITLE = \"Characterization of a carbon-carbon hydrolase from Mycobacterium tuberculosis involved in cholesterol metabolism.\", JOURNAL = c(\"J Biol Chem 285:434-43 (2010)\", \"DOI:10.1074/jbc.M109.058081\")), list(REFERENCE = \"PMID:19843168\", AUTHORS = \"Kreit J, Sampson NS\", TITLE = \"Cholesterol oxidase: physiological functions.\", JOURNAL = c(\"FEBS J 276:6844-56 (2009)\", \"DOI:10.1111/j.1742-4658.2009.07378.x\")), list(REFERENCE = \"PMID:21056662\", AUTHORS = \"Horinouchi M, Hayashi T, Kudo T\", TITLE = \"Steroid degradation in Comamonas testosteroni.\", JOURNAL = c(\"J Steroid Biochem Mol Biol 129:4-14 (2012)\", \"DOI:10.1016/j.jsbmb.2010.10.008\")), list(REFERENCE = \"PMID:20554032\", AUTHORS = \"Horinouchi M, Kurita T, Hayashi T, Kudo T\", TITLE = \"Steroid degradation genes in Comamonas testosteroni TA441: Isolation of genes encoding a Delta4(5)-isomerase and 3alpha- and 3beta-dehydrogenases and evidence for a 100 kb steroid degradation gene hot spot.\", JOURNAL = c(\"J Steroid Biochem Mol Biol 122:253-63 (2010)\", \"DOI:10.1016/j.jsbmb.2010.06.002\"))', 'map00984', 'Steroid degradation', 'Metabolism; Xenobiotics biodegradation and metabolism', 0, 381, 0, 0, 0, 0, 381, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (157, '00998', 'Biosynthesis of secondary metabolites - other antibiotics', 'Metabolism; Biosynthesis of other secondary metabolites', 'Biosynthesis of secondary metabolites - other antibiotics', 'Cycloserine biosynthesis, arginine/serine => cycloserine [PATH:map00998], Bacilysin biosynthesis, prephenate => bacilysin [PATH:map00998], Terpentecin biosynthesis, GGAP => terpentecin [PATH:map00998], Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone [PATH:map00998], Aurachin biosynthesis, anthranilate => aurachin A [PATH:map00998], Kanosamine biosynthesis, glucose 6-phosphate => kanosamine [PATH:map00998]', 'ko00998', 'list(REFERENCE = \"PMID:23586652\", AUTHORS = \"Vetter ND, Langill DM, Anjum S, Boisvert-Martel J, Jagdhane RC, Omene E, Zheng H, van Straaten KE, Asiamah I, Krol ES, Sanders DA, Palmer DR\", TITLE = \"A previously unrecognized kanosamine biosynthesis pathway in Bacillus subtilis.\", JOURNAL = c(\"J Am Chem Soc 135:5970-3 (2013)\", \"DOI:10.1021/ja4010255\")), list(REFERENCE = \"PMID:19807062\", AUTHORS = \"Hollenhorst MA, Clardy J, Walsh CT\", TITLE = \"The ATP-dependent amide ligases DdaG and DdaF assemble the fumaramoyl-dipeptide scaffold of the dapdiamide antibiotics.\", JOURNAL = c(\"Biochemistry 48:10467-72 (2009)\", \"DOI:10.1021/bi9013165\")), list(REFERENCE = \"PMID:20086163\", AUTHORS = \"Kumagai T, Koyama Y, Oda K, Noda M, Matoba Y, Sugiyama M\", TITLE = \"Molecular cloning and heterologous expression of a biosynthetic gene cluster for the antitubercular agent D-cycloserine produced by Streptomyces lavendulae.\", JOURNAL = c(\"Antimicrob Agents Chemother 54:1132-9 (2010)\", \"DOI:10.1128/AAC.01226-09\")), list(REFERENCE = \"PMID:25644640\", AUTHORS = \"Ozcengiz G, Ogulur I\", TITLE = \"Biochemistry, genetics and regulation of bacilysin biosynthesis and its significance more than an antibiotic.\", JOURNAL = c(\"N Biotechnol 32:612-9 (2015)\", \"DOI:10.1016/j.nbt.2015.01.006\")), list(REFERENCE = \"PMID:17335090\", AUTHORS = \"Sandmann A, Dickschat J, Jenke-Kodama H, Kunze B, Dittmann E, Muller R\", TITLE = \"A Type II polyketide synthase from the gram-negative Bacterium Stigmatella aurantiaca is involved in Aurachin alkaloid biosynthesis.\", JOURNAL = c(\"Angew Chem Int Ed Engl 46:2712-6 (2007)\", \"DOI:10.1002/anie.200603513\")), list(REFERENCE = \"PMID:26359402\", AUTHORS = \"Lau W, Sattely ES\", TITLE = \"Six enzymes from mayapple that complete the biosynthetic pathway to the etoposide aglycone.\", JOURNAL = c(\"Science 349:1224-8 (2015)\", \"DOI:10.1126/science.aac7202\")), list(REFERENCE = \"PMID:27062037\", AUTHORS = \"Schwarz J, Konjik V, Jankowitsch F, Sandhoff R, Mack M\", TITLE = \"Identification of the Key Enzyme of Roseoflavin Biosynthesis.\", JOURNAL = c(\"Angew Chem Int Ed Engl 55:6103-6 (2016)\", \"DOI:10.1002/anie.201600581\")), list(REFERENCE = \"PMID:12138123\", AUTHORS = \"Hamano Y, Kuzuyama T, Itoh N, Furihata K, Seto H, Dairi T\", TITLE = \"Functional analysis of eubacterial diterpene cyclases responsible for biosynthesis of a diterpene antibiotic, terpentecin.\", JOURNAL = c(\"J Biol Chem 277:37098-104 (2002)\", \"DOI:10.1074/jbc.M206382200\")), list(REFERENCE = \"PMID:17017767\", AUTHORS = \"Quaderer R, Omura S, Ikeda H, Cane DE\", TITLE = \"Pentalenolactone biosynthesis. Molecular cloning and assignment of biochemical function to PtlI, a cytochrome P450 of Streptomyces avermitilis.\", JOURNAL = c(\"J Am Chem Soc 128:13036-7 (2006)\", \"DOI:10.1021/ja0639214\"))', 'map00998', 'Biosynthesis of secondary metabolites - other antibiotics', 'Metabolism; Biosynthesis of other secondary metabolites', 92, 572, 0, 90, 2, 0, 572, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (158, '00999', 'Biosynthesis of secondary metabolites - unclassified', 'Metabolism; Biosynthesis of other secondary metabolites', 'Biosynthesis of secondary metabolites - unclassified', 'Staphyloferrin B biosynthesis, L-serine => staphyloferrin B [PATH:map00999], Staphyloferrin A biosynthesis, L-ornithine => staphyloferrin A [PATH:map00999]', 'D10915, Cannabidiol (USAN/INN)', 'ko00999', 'list(REFERENCE = \"PMID:23653178\", AUTHORS = \"Xu W, Chooi YH, Choi JW, Li S, Vederas JC, Da Silva NA, Tang Y\", TITLE = \"LovG: the thioesterase required for dihydromonacolin L release and lovastatin nonaketide synthase turnover in lovastatin biosynthesis.\", JOURNAL = c(\"Angew Chem Int Ed Engl 52:6472-5 (2013)\", \"DOI:10.1002/anie.201302406\")), list(REFERENCE = \"PMID:17544411\", AUTHORS = \"Taura F, Sirikantaramas S, Shoyama Y, Yoshikai K, Shoyama Y, Morimoto S\", TITLE = \"Cannabidiolic-acid synthase, the chemotype-determining enzyme in the fiber-type Cannabis sativa.\", JOURNAL = c(\"FEBS Lett 581:2929-34 (2007)\", \"DOI:10.1016/j.febslet.2007.05.043\")), list(REFERENCE = \"PMID:17003031\", AUTHORS = \"Suzuki H, Ohnishi Y, Furusho Y, Sakuda S, Horinouchi S\", TITLE = \"Novel benzene ring biosynthesis from C(3) and C(4) primary metabolites by two enzymes.\", JOURNAL = c(\"J Biol Chem 281:36944-51 (2006)\", \"DOI:10.1074/jbc.M608103200\")), list(REFERENCE = \"PMID:19138128\", AUTHORS = \"Cotton JL, Tao J, Balibar CJ\", TITLE = \"Identification and characterization of the Staphylococcus aureus gene cluster coding for staphyloferrin A.\", JOURNAL = c(\"Biochemistry 48:1025-35 (2009)\", \"DOI:10.1021/bi801844c\")), list(REFERENCE = \"PMID:19775248\", AUTHORS = \"Cheung J, Beasley FC, Liu S, Lajoie GA, Heinrichs DE\", TITLE = \"Molecular characterization of staphyloferrin B biosynthesis in Staphylococcus aureus.\", JOURNAL = c(\"Mol Microbiol 74:594-608 (2009)\", \"DOI:10.1111/j.1365-2958.2009.06880.x\")), list(REFERENCE = \"PMID:22569263\", AUTHORS = \"Nagatoshi M, Terasaka K, Owaki M, Sota M, Inukai T, Nagatsu A, Mizukami H\", TITLE = \"UGT75L6 and UGT94E5 mediate sequential glucosylation of crocetin to crocin in Gardenia jasminoides.\", JOURNAL = c(\"FEBS Lett 586:1055-61 (2012)\", \"DOI:10.1016/j.febslet.2012.03.003\")), list(REFERENCE = \"PMID:19553373\", AUTHORS = \"Mazourek M, Pujar A, Borovsky Y, Paran I, Mueller L, Jahn MM\", TITLE = \"A dynamic interface for capsaicinoid systems biology.\", JOURNAL = c(\"Plant Physiol 150:1806-21 (2009)\", \"DOI:10.1104/pp.109.136549\"))', 'map00999', 'Biosynthesis of secondary metabolites - unclassified', 95, 545, 0, 91, 4, 0, 545, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (159, '01010', 'Overview of biosynthetic pathways', 'Overview of biosynthetic pathways', 'ko01010', 'map01010', 'Overview of biosynthetic pathways', 'Overview of biosynthetic pathways', 'ko01010', 'map01010', 'Overview of biosynthetic pathways', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (160, '01040', 'Biosynthesis of unsaturated fatty acids', 'Metabolism; Lipid metabolism', 'Biosynthesis of unsaturated fatty acids', 'Fatty acid elongation in endoplasmic reticulum [PATH:map01040], beta-Oxidation, peroxisome, VLCFA [PATH:map01040]', 'Peroxisomal beta-oxidation enzyme deficiency, Stargardt disease, Peroxisomal acyl-CoA oxidase deficiency, D-bifunctional protein deficiency', 'ko01040', 'list(REFERENCE = \"PMID:16564093\", AUTHORS = \"Jakobsson A, Westerberg R, Jacobsson A.\", TITLE = \"Fatty acid elongases in mammals: their regulation and roles in metabolism.\", JOURNAL = c(\"Prog Lipid Res 45:237-49 (2006)\", \"DOI:10.1016/j.plipres.2006.01.004\")), list(REFERENCE = \"PMID:12482854\", AUTHORS = \"Moon YA, Horton JD.\", TITLE = \"Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade.\", JOURNAL = c(\"J Biol Chem 278:7335-43 (2003)\", \"DOI:10.1074/jbc.M211684200\")), list(REFERENCE = \"PMID:12087109\", AUTHORS = \"Han G, Gable K, Kohlwein SD, Beaudoin F, Napier JA, Dunn TM.\", TITLE = \"The Saccharomyces cerevisiae YBR159w gene encodes the 3-ketoreductase of the microsomal fatty acid elongase.\", JOURNAL = c(\"J Biol Chem 277:35440-9 (2002)\", \"DOI:10.1074/jbc.M205620200\")), list(REFERENCE = \"PMID:11500517\", AUTHORS = \"Su HM, Moser AB, Moser HW, Watkins PA.\", TITLE = \"Peroxisomal straight-chain Acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis.\", JOURNAL = c(\"J Biol Chem 276:38115-20 (2001)\", \"DOI:10.1074/jbc.M106326200\")), list(REFERENCE = \"PMID:16766224\", AUTHORS = \"Huyghe S, Mannaerts GP, Baes M, Van Veldhoven PP.\", TITLE = \"Peroxisomal multifunctional protein-2: the enzyme, the patients and the knockout mouse model.\", JOURNAL = c(\"Biochim Biophys Acta 1761:973-94 (2006)\", \"DOI:10.1016/j.bbalip.2006.04.006\")), list(REFERENCE = \"PMID:17719544\", AUTHORS = \"Denic V, Weissman JS\", TITLE = \"A molecular caliper mechanism for determining very long-chain fatty acid length.\", JOURNAL = c(\"Cell 130:663-77 (2007)\", \"DOI:10.1016/j.cell.2007.06.031\")), list(REFERENCE = \"PMID:24184513\", AUTHORS = \"Ichi I, Kono N, Arita Y, Haga S, Arisawa K, Yamano M, Nagase M, Fujiwara Y, Arai H\", TITLE = \"Identification of genes and pathways involved in the synthesis of Mead acid (20:3n-9), an indicator of essential fatty acid deficiency.\", JOURNAL = c(\"Biochim Biophys Acta 1841:204-13 (2014)\", \"DOI:10.1016/j.bbalip.2013.10.013\")), list(REFERENCE = \"PMID:20018209\", AUTHORS = \"Guillou H, Zadravec D, Martin PG, Jacobsson A\", TITLE = \"The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice.\", JOURNAL = c(\"Prog Lipid Res 49:186-99 (2010)\", \"DOI:10.1016/j.plipres.2009.12.002\")), list(REFERENCE = \"PMID:22158834\", AUTHORS = \"Yu M, Benham A, Logan S, Brush RS, Mandal MN, Anderson RE, Agbaga MP\", TITLE = \"ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3.\", JOURNAL = c(\"J Lipid Res 53:494-504 (2012)\", \"DOI:10.1194/jlr.M021386\")), list(REFERENCE = \"PMID:28784662\", AUTHORS = \"Sawai M, Uchida Y, Ohno Y, Miyamoto M, Nishioka C, Itohara S, Sassa T, Kihara A\", TITLE = \"The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways.\", JOURNAL = c(\"J Biol Chem 292:15538-15551 (2017)\", \"DOI:10.1074/jbc.M117.803171\")), list(REFERENCE = \"PMID:20937905\", AUTHORS = \"Ohno Y, Suto S, Yamanaka M, Mizutani Y, Mitsutake S, Igarashi Y, Sassa T, Kihara A\", TITLE = \"ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 107:18439-44 (2010)\", \"DOI:10.1073/pnas.1005572107\")), list(REFERENCE = \"PMID:21959040\", AUTHORS = \"Naganuma T, Sato Y, Sassa T, Ohno Y, Kihara A\", TITLE = \"Biochemical characterization of the very long-chain fatty acid elongase ELOVL7.\", JOURNAL = c(\"FEBS Lett 585:3337-41 (2011)\", \"DOI:10.1016/j.febslet.2011.09.024\")), list(REFERENCE = \"PMID:19826053\", AUTHORS = \"Tamura K, Makino A, Hullin-Matsuda F, Kobayashi T, Furihata M, Chung S, Ashida S, Miki T, Fujioka T, Shuin T, Nakamura Y, Nakagawa H\", TITLE = \"Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.\", JOURNAL = c(\"Cancer Res 69:8133-40 (2009)\", \"DOI:10.1158/0008-5472.CAN-09-0775\")), list(REFERENCE = \"PMID:22562166\", AUTHORS = \"Uemura H\", TITLE = \"Synthesis and production of unsaturated and polyunsaturated fatty acids in yeast: current state and perspectives.\", JOURNAL = c(\"Appl Microbiol Biotechnol 95:1-12 (2012)\", \"DOI:10.1007/s00253-012-4105-1\")), list(REFERENCE = \"PMID:11734571\", AUTHORS = \"Ferdinandusse S, Denis S, Mooijer PA, Zhang Z, Reddy JK, Spector AA, Wanders RJ\", TITLE = \"Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid.\", JOURNAL = \"J Lipid Res 42:1987-95 (2001)\")', 'map01040', 'Biosynthesis of unsaturated fatty acids', 531, 2747, 248, 105, 128, 50, 2747, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (161, '01051', 'Biosynthesis of ansamycins', 'Metabolism; Metabolism of terpenoids and polyketides', 'Biosynthesis of ansamycins', 'D02549, Rifamycin (USAN/INN)', 'ko01051', 'list(REFERENCE = \"PMID:22193711\", AUTHORS = \"Kang Q, Shen Y, Bai L\", TITLE = \"Biosynthesis of 3,5-AHBA-derived natural products.\", JOURNAL = c(\"Nat Prod Rep 29:243-63 (2012)\", \"DOI:10.1039/c2np00019a\")), list(REFERENCE = \"PMID:21081954\", AUTHORS = \"Floss HG, Yu TW, Arakawa K\", TITLE = \"The biosynthesis of 3-amino-5-hydroxybenzoic acid (AHBA), the precursor of mC7N units in ansamycin and mitomycin antibiotics: a review.\", JOURNAL = c(\"J Antibiot (Tokyo) 64:35-44 (2011)\", \"DOI:10.1038/ja.2010.139\")), list(REFERENCE = \"PMID:12207504\", AUTHORS = \"Guo J, Frost JW\", TITLE = \"Kanosamine biosynthesis: a likely source of the aminoshikimate pathway\'s nitrogen atom.\", JOURNAL = c(\"J Am Chem Soc 124:10642-3 (2002)\", \"DOI:10.1021/ja026628m\")), list(REFERENCE = \"PMID:17076505\", AUTHORS = \"Wenzel SC, Williamson RM, Grunanger C, Xu J, Gerth K, Martinez RA, Moss SJ, Carroll BJ, Grond S, Unkefer CJ, Muller R, Floss HG\", TITLE = \"On the biosynthetic origin of methoxymalonyl-acyl carrier protein, the substrate for incorporation of \\\"glycolate\\\" units into ansamitocin and soraphen A.\", JOURNAL = c(\"J Am Chem Soc 128:14325-36 (2006)\", \"DOI:10.1021/ja064408t\")), list(REFERENCE = \"PMID:11996558\", AUTHORS = \"Kato Y, Bai L, Xue Q, Revill WP, Yu TW, Floss HG\", TITLE = \"Functional expression of genes involved in the biosynthesis of the novel polyketide chain extension unit, methoxymalonyl-acyl carrier protein, and engineered biosynthesis of 2-desmethyl-2-methoxy-6-deoxyerythronolide B.\", JOURNAL = c(\"J Am Chem Soc 124:5268-9 (2002)\", \"DOI:10.1021/ja0127483\")), list(REFERENCE = \"PMID:12060743\", AUTHORS = \"Yu TW, Bai L, Clade D, Hoffmann D, Toelzer S, Trinh KQ, Xu J, Moss SJ, Leistner E, Floss HG\", TITLE = \"The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 99:7968-73 (2002)\", \"DOI:10.1073/pnas.092697199\")), list(REFERENCE = \"PMID:14624546\", AUTHORS = \"Spiteller P, Bai L, Shang G, Carroll BJ, Yu TW, Floss HG\", TITLE = \"The post-polyketide synthase modification steps in the biosynthesis of the antitumor agent ansamitocin by Actinosynnema pretiosum.\", JOURNAL = c(\"J Am Chem Soc 125:14236-7 (2003)\", \"DOI:10.1021/ja038166y\")), list(REFERENCE = \"PMID:19292483\", AUTHORS = \"Taft F, Brunjes M, Knobloch T, Floss HG, Kirschning A\", TITLE = \"Timing of the Delta(10,12)-Delta(11,13) double bond migration during ansamitocin biosynthesis in Actinosynnema pretiosum.\", JOURNAL = c(\"J Am Chem Soc 131:3812-3 (2009)\", \"DOI:10.1021/ja8088923\")), list(REFERENCE = \"PMID:22195559\", AUTHORS = \"Li Y, Zhao P, Kang Q, Ma J, Bai L, Deng Z\", TITLE = \"Dual carbamoylations on the polyketide and glycosyl moiety by asm21 result in extended ansamitocin biosynthesis.\", JOURNAL = c(\"Chem Biol 18:1571-80 (2011)\", \"DOI:10.1016/j.chembiol.2011.11.007\")), list(REFERENCE = \"PMID:21681880\", AUTHORS = \"Wu Y, Kang Q, Shang G, Spiteller P, Carroll B, Yu TW, Su W, Bai L, Floss HG\", TITLE = \"N-methylation of the amide bond by methyltransferase asm10 in ansamitocin biosynthesis.\", JOURNAL = c(\"Chembiochem 12:1759-66 (2011)\", \"DOI:10.1002/cbic.201100062\")), list(REFERENCE = \"PMID:18721757\", AUTHORS = \"Zhao P, Bai L, Ma J, Zeng Y, Li L, Zhang Y, Lu C, Dai H, Wu Z, Li Y, Wu X, Chen G, Hao X, Shen Y, Deng Z, Floss HG\", TITLE = \"Amide N-glycosylation by Asm25, an N-glycosyltransferase of ansamitocins.\", JOURNAL = c(\"Chem Biol 15:863-74 (2008)\", \"DOI:10.1016/j.chembiol.2008.06.007\")), list(REFERENCE = \"PMID:12207505\", AUTHORS = \"Arakawa K, Muller R, Mahmud T, Yu TW, Floss HG\", TITLE = \"Characterization of the early stage aminoshikimate pathway in the formation of 3-amino-5-hydroxybenzoic acid: the RifN protein specifically converts kanosamine into kanosamine 6-phosphate.\", JOURNAL = c(\"J Am Chem Soc 124:10644-5 (2002)\", \"DOI:10.1021/ja0206339\")), list(REFERENCE = \"PMID:12888623\", AUTHORS = \"Watanabe K, Rude MA, Walsh CT, Khosla C\", TITLE = \"Engineered biosynthesis of an ansamycin polyketide precursor in Escherichia coli.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 100:9774-8 (2003)\", \"DOI:10.1073/pnas.1632167100\")), list(REFERENCE = \"PMID:15700959\", AUTHORS = \"Floss HG, Yu TW.\", TITLE = \"Rifamycin-mode of action, resistance, and biosynthesis.\", JOURNAL = c(\"Chem Rev 105:621-32 (2005)\", \"DOI:10.1021/cr030112j\")), list(REFERENCE = \"PMID:12623077\", AUTHORS = \"Xu J, Mahmud T, Floss HG\", TITLE = \"Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.\", JOURNAL = c(\"Arch Biochem Biophys 411:277-88 (2003)\", \"DOI:10.1016/S0003-9861(03)00004-3\")), list(REFERENCE = \"PMID:15791687\", AUTHORS = \"Xiong Y, Wu X, Mahmud T\", TITLE = \"A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.\", JOURNAL = c(\"Chembiochem 6:834-7 (2005)\", \"DOI:10.1002/cbic.200400387\")), list(REFERENCE = \"PMID:16079331\", AUTHORS = \"Xu J, Wan E, Kim CJ, Floss HG, Mahmud T\", TITLE = \"Identification of tailoring genes involved in the modification of the polyketide backbone of rifamycin B by Amycolatopsis mediterranei S699.\", JOURNAL = c(\"Microbiology 151:2515-28 (2005)\", \"DOI:10.1099/mic.0.28138-0\"))', 'map01051', 'Biosynthesis of ansamycins', 'Metabolism; Metabolism of terpenoids and polyketides', 0, 80, 0, 0, 0, 0, 80, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (162, '01052', 'Type I polyketide structures', 'Metabolism; Metabolism of terpenoids and polyketides', 'Type I polyketide structures', 'ko01052', 'map01052', 'Type I polyketide structures', 'Metabolism; Metabolism of terpenoids and polyketides', 'Type I polyketide structures', 'ko01052', 0, 43, 0, 0, 0, 0, 43, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (163, '01053', 'Biosynthesis of siderophore group nonribosomal peptides', 'Metabolism; Metabolism of terpenoids and polyketides', 'Biosynthesis of siderophore group nonribosomal peptides', 'ko01053', 'list(REFERENCE = \"PMID:12040125\", AUTHORS = \"Crosa JH, Walsh CT.\", TITLE = \"Genetics and assembly line enzymology of siderophore biosynthesis in bacteria.\", JOURNAL = c(\"Microbiol Mol Biol Rev 66:223-49 (2002)\", \"DOI:10.1128/MMBR.66.2.223-249.2002\")), list(REFERENCE = \"PMID:9818149\", AUTHORS = \"Gehring AM, DeMoll E, Fetherston JD, Mori I, Mayhew GF, Blattner FR, Walsh CT, Perry RD.\", TITLE = \"Iron acquisition in plague: modular logic in enzymatic biogenesis of yersiniabactin by Yersinia pestis.\", JOURNAL = c(\"Chem Biol 5:573-86 (1998)\", \"DOI:10.1016/S1074-5521(98)90115-6\")), list(REFERENCE = \"PMID:11029592\", AUTHORS = \"Silakowski B, Kunze B, Nordsiek G, Blocker H, Hofle G, Muller R.\", TITLE = \"The myxochelin iron transport regulon of the myxobacterium Stigmatella aurantiaca Sg a15.\", JOURNAL = c(\"Eur J Biochem 267:6476-85 (2000)\", \"DOI:10.1046/j.1432-1327.2000.01740.x\")), list(REFERENCE = \"PMID:11112537\", AUTHORS = \"Keating TA, Marshall CG, Walsh CT.\", TITLE = \"Vibriobactin biosynthesis in Vibrio cholerae: VibH is an amide synthase homologous to nonribosomal peptide synthetase condensation domains.\", JOURNAL = c(\"Biochemistry 39:15513-21 (2000)\", \"DOI:10.1021/bi001651a\")), list(REFERENCE = \"PMID:10692387\", AUTHORS = \"Hantash FM, Earhart CF.\", TITLE = \"Membrane association of the Escherichia coli enterobactin synthase proteins EntB/G, EntE, and EntF.\", JOURNAL = c(\"J Bacteriol 182:1768-73 (2000)\", \"DOI:10.1128/JB.182.6.1768-1773.2000\"))', 'map01053', 'Biosynthesis of siderophore group nonribosomal peptides', 'Metabolism; Metabolism of terpenoids and polyketides', 'Biosynthesis of siderophore group nonribosomal peptides', 11, 1275, 0, 0, 11, 0, 1273, 2);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (164, '01054', 'Nonribosomal peptide structures', 'Metabolism; Metabolism of terpenoids and polyketides', 'Nonribosomal peptide structures', 'ko01054', 'list(REFERENCE = \"PMID:9864322\", AUTHORS = \"Konz D, Doekel S, Marahiel MA.\", TITLE = \"Molecular and biochemical characterization of the protein template controlling biosynthesis of the lipopeptide lichenysin.\", JOURNAL = \"J Bacteriol 181:133-40 (1999)\"), list(REFERENCE = \"PMID:15109718\", AUTHORS = \"Moyne AL, Cleveland TE, Tuzun S.\", TITLE = \"Molecular characterization and analysis of the operon encoding the antifungal lipopeptide bacillomycin D.\", JOURNAL = c(\"FEMS Microbiol Lett 234:43-9 (2004)\", \"DOI:10.1016/j.femsle.2004.03.011\")), list(REFERENCE = \"PMID:9830033\", AUTHORS = \"Guenzi E, Galli G, Grgurina I, Gross DC, Grandi G.\", TITLE = \"Characterization of the syringomycin synthetase gene cluster. A link between prokaryotic and eukaryotic peptide synthetases.\", JOURNAL = c(\"J Biol Chem 273:32857-63 (1998)\", \"DOI:10.1074/jbc.273.49.32857\")), list(REFERENCE = \"PMID:9303382\", AUTHORS = \"de Crecy-Lagard V, Saurin W, Thibaut D, Gil P, Naudin L, Crouzet J, Blanc V\", TITLE = \"Streptogramin B biosynthesis in Streptomyces pristinaespiralis and Streptomyces virginiae: molecular characterization of the last structural peptide synthetase gene.\", JOURNAL = \"Antimicrob Agents Chemother 41:1904-9 (1997)\"), list(REFERENCE = \"PMID:11048953\", AUTHORS = \"Du L, Sanchez C, Chen M, Edwards DJ, Shen B.\", TITLE = \"The biosynthetic gene cluster for the antitumor drug bleomycin from Streptomyces verticillus ATCC15003 supporting functional interactions between nonribosomal peptide synthetases and a polyketide synthase.\", JOURNAL = c(\"Chem Biol 7:623-42 (2000)\", \"DOI:10.1016/S1074-5521(00)00011-9\")), list(REFERENCE = \"PMID:14766543\", AUTHORS = \"Rouhiainen L, Vakkilainen T, Siemer BL, Buikema W, Haselkorn R, Sivonen K\", TITLE = \"Genes coding for hepatotoxic heptapeptides (microcystins) in the cyanobacterium Anabaena strain 90.\", JOURNAL = c(\"Appl Environ Microbiol 70:686-92 (2004)\", \"DOI:10.1128/AEM.70.2.686-692.2004\")), list(REFERENCE = \"PMID:11001063\", AUTHORS = \"Trauger JW, Kohli RM, Mootz HD, Marahiel MA, Walsh CT.\", TITLE = \"Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase.\", JOURNAL = c(\"Nature 407:215-8 (2000)\", \"DOI:10.1038/35025116\"))', 'map01054', 'Nonribosomal peptide structures', 'Metabolism; Metabolism of terpenoids and polyketides', 'Nonribosomal peptide structures', 0, 1832, 0, 0, 0, 0, 1769, 63);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (165, '01055', 'Biosynthesis of vancomycin group antibiotics', 'Metabolism; Metabolism of terpenoids and polyketides', 'Biosynthesis of vancomycin group antibiotics', 'D00212, Vancomycin (USP)', 'ko01055', 'list(REFERENCE = \"PMID:24884615\", AUTHORS = \"Xu L, Huang H, Wei W, Zhong Y, Tang B, Yuan H, Zhu L, Huang W, Ge M, Yang S, Zheng H, Jiang W, Chen D, Zhao GP, Zhao W\", TITLE = \"Complete genome sequence and comparative genomic analyses of the vancomycin-producing Amycolatopsis orientalis.\", JOURNAL = c(\"BMC Genomics 15:363 (2014)\", \"DOI:10.1186/1471-2164-15-363\")), list(REFERENCE = \"PMID:12596194\", AUTHORS = \"Hubbard BK, Walsh CT.\", TITLE = \"Vancomycin assembly: nature\'s way.\", JOURNAL = c(\"Angew Chem Int Ed Engl 42:730-65 (2003)\", \"DOI:10.1002/anie.200390202\")), list(REFERENCE = \"PMID:11035791\", AUTHORS = \"Chen H, Thomas MG, Hubbard BK, Losey HC, Walsh CT, Burkart MD.\", TITLE = \"Deoxysugars in glycopeptide antibiotics: enzymatic synthesis of TDP-L-epivancosamine in chloroeremomycin biosynthesis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 97:11942-7 (2000)\", \"DOI:10.1073/pnas.210395097\")), list(REFERENCE = \"PMID:9545426\", AUTHORS = \"van Wageningen AM, Kirkpatrick PN, Williams DH, Harris BR, Kershaw JK, Lennard NJ, Jones M, Jones SJ, Solenberg PJ.\", TITLE = \"Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic.\", JOURNAL = c(\"Chem Biol 5:155-62 (1998)\", \"DOI:10.1016/S1074-5521(98)90060-6\"))', 'map01055', 'Biosynthesis of vancomycin group antibiotics', 'Metabolism; Metabolism of terpenoids and polyketides', 0, 346, 0, 0, 0, 0, 345, 1);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (166, '01056', 'Biosynthesis of type II polyketide backbone', 'Metabolism; Metabolism of terpenoids and polyketides', 'Biosynthesis of type II polyketide backbone', 'Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide [PATH:map01056]', 'ko01056', 'list(REFERENCE = \"PMID:10467738\", AUTHORS = \"Rawlings BJ\", TITLE = \"Biosynthesis of polyketides (other than actinomycete macrolides).\", JOURNAL = c(\"Nat Prod Rep 16:425-84 (1999)\", \"DOI:10.1039/A900566H\")), list(REFERENCE = \"PMID:17268612\", AUTHORS = \"Hertweck C, Luzhetskyy A, Rebets Y, Bechthold A\", TITLE = \"Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork.\", JOURNAL = c(\"Nat Prod Rep 24:162-90 (2007)\", \"DOI:10.1039/b507395m\")), list(REFERENCE = \"PMID:11902441\", AUTHORS = \"Moore BS, Hertweck C\", TITLE = \"Biosynthesis and attachment of novel bacterial polyketide synthase starter units.\", JOURNAL = c(\"Nat Prod Rep 19:70-99 (2002)\", \"DOI:10.1039/b003939j\")), list(REFERENCE = \"PMID:15286722\", AUTHORS = \"Keatinge-Clay AT, Maltby DA, Medzihradszky KF, Khosla C, Stroud RM\", TITLE = \"An antibiotic factory caught in action.\", JOURNAL = c(\"Nat Struct Mol Biol 11:888-93 (2004)\", \"DOI:10.1038/nsmb808\")), list(REFERENCE = \"PMID:18250311\", AUTHORS = \"Ridley CP, Lee HY, Khosla C\", TITLE = \"Evolution of polyketide synthases in bacteria.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:4595-600 (2008)\", \"DOI:10.1073/pnas.0710107105\")), list(REFERENCE = \"PMID:20522541\", AUTHORS = \"Pickens LB, Tang Y\", TITLE = \"Oxytetracycline biosynthesis.\", JOURNAL = c(\"J Biol Chem 285:27509-15 (2010)\", \"DOI:10.1074/jbc.R110.130419\")), list(REFERENCE = \"PMID:10551844\", AUTHORS = \"Petkovic H, Thamchaipenet A, Zhou LH, Hranueli D, Raspor P, Waterman PG, Hunter IS\", TITLE = \"Disruption of an aromatase/cyclase from the oxytetracycline gene cluster of Streptomyces rimosus results in production of novel polyketides with shorter chain lengths.\", JOURNAL = \"J Biol Chem 274:32829-34 (1999)\"), list(REFERENCE = \"PMID:20358042\", AUTHORS = \"Zhou H, Li Y, Tang Y\", TITLE = \"Cyclization of aromatic polyketides from bacteria and fungi.\", JOURNAL = c(\"Nat Prod Rep 27:839-68 (2010)\", \"DOI:10.1039/b911518h\")), list(REFERENCE = \"PMID:18205400\", AUTHORS = \"Korman TP, Tan YH, Wong J, Luo R, Tsai SC\", TITLE = \"Inhibition kinetics and emodin cocrystal structure of a type II polyketide ketoreductase.\", JOURNAL = c(\"Biochemistry 47:1837-47 (2008)\", \"DOI:10.1021/bi7016427\")), list(REFERENCE = \"PMID:9375253\", AUTHORS = \"Kantola J, Blanco G, Hautala A, Kunnari T, Hakala J, Mendez C, Ylihonko K, Mantsala P, Salas J\", TITLE = \"Folding of the polyketide chain is not dictated by minimal polyketide synthase in the biosynthesis of mithramycin and anthracycline.\", JOURNAL = c(\"Chem Biol 4:751-5 (1997)\", \"DOI:10.1016/S1074-5521(97)90313-6\")), list(REFERENCE = \"PMID:10509907\", AUTHORS = \"Kunnari T, Ylihonko K, Hautala A, Klika KD, Mantsala P, Hakala J\", TITLE = \"Incorrectly folded aromatic polyketides from polyketide reductase deficient mutants.\", JOURNAL = c(\"Bioorg Med Chem Lett 9:2639-42 (1999)\", \"DOI:10.1016/S0960-894X(99)00439-4\")), list(REFERENCE = \"PMID:19362634\", AUTHORS = \"Tsai SC, Ames BD\", TITLE = \"Structural enzymology of polyketide synthases.\", JOURNAL = c(\"Methods Enzymol 459:17-47 (2009)\", \"DOI:10.1016/S0076-6879(09)04602-3\")), list(REFERENCE = \"PMID:15544323\", AUTHORS = \"Korman TP, Hill JA, Vu TN, Tsai SC\", TITLE = \"Structural analysis of actinorhodin polyketide ketoreductase: cofactor binding and substrate specificity.\", JOURNAL = c(\"Biochemistry 43:14529-38 (2004)\", \"DOI:10.1021/bi048133a\")), list(REFERENCE = \"PMID:15458634\", AUTHORS = \"Hadfield AT, Limpkin C, Teartasin W, Simpson TJ, Crosby J, Crump MP\", TITLE = \"The crystal structure of the actIII actinorhodin polyketide reductase: proposed mechanism for ACP and polyketide binding.\", JOURNAL = c(\"Structure 12:1865-75 (2004)\", \"DOI:10.1016/j.str.2004.08.002\")), list(REFERENCE = \"PMID:10658662\", AUTHORS = \"Kantola J, Kunnari T, Hautala A, Hakala J, Ylihonko K, Mantsala P\", TITLE = \"Elucidation of anthracyclinone biosynthesis by stepwise cloning of genes for anthracyclines from three different Streptomyces spp.\", JOURNAL = c(\"Microbiology 146 ( Pt 1):155-63 (2000)\", \"DOI:10.1099/00221287-146-1-155\")), list(REFERENCE = \"PMID:2394677\", AUTHORS = \"Bartel PL, Zhu CB, Lampel JS, Dosch DC, Connors NC, Strohl WR, Beale JM Jr, Floss HG\", TITLE = \"Biosynthesis of anthraquinones by interspecies cloning of actinorhodin biosynthesis genes in streptomycetes: clarification of actinorhodin gene functions.\", JOURNAL = c(\"J Bacteriol 172:4816-26 (1990)\", \"DOI:10.1128/JB.172.9.4816-4826.1990\")), list(REFERENCE = \"PMID:16793516\", AUTHORS = \"Arthur CJ, Szafranska AE, Long J, Mills J, Cox RJ, Findlow SC, Simpson TJ, Crump MP, Crosby J\", TITLE = \"The malonyl transferase activity of type II polyketide synthase acyl carrier proteins.\", JOURNAL = c(\"Chem Biol 13:587-96 (2006)\", \"DOI:10.1016/j.chembiol.2006.03.010\")), list(REFERENCE = \"PMID:16263270\", AUTHORS = \"Schneider G\", TITLE = \"Enzymes in the biosynthesis of aromatic polyketide antibiotics.\", JOURNAL = c(\"Curr Opin Struct Biol 15:629-36 (2005)\", \"DOI:10.1016/j.sbi.2005.10.002\")), list(REFERENCE = \"PMID:1548230\", AUTHORS = \"Summers RG, Wendt-Pienkowski E, Motamedi H, Hutchinson CR\", TITLE = \"Nucleotide sequence of the tcmII-tcmIV region of the tetracenomycin C biosynthetic gene cluster of Streptomyces glaucescens and evidence that the tcmN gene encodes a multifunctional cyclase-dehydratase-O-methyl transferase.\", JOURNAL = c(\"J Bacteriol 174:1810-20 (1992)\", \"DOI:10.1128/JB.174.6.1810-1820.1992\")), list(REFERENCE = \"PMID:18388203\", AUTHORS = \"Ames BD, Korman TP, Zhang W, Smith P, Vu T, Tang Y, Tsai SC\", TITLE = \"Crystal structure and functional analysis of tetracenomycin ARO/CYC: implications for cyclization specificity of aromatic polyketides.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:5349-54 (2008)\", \"DOI:10.1073/pnas.0709223105\")), list(REFERENCE = \"PMID:17013601\", AUTHORS = \"Lombo F, Menendez N, Salas JA, Mendez C\", TITLE = \"The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.\", JOURNAL = c(\"Appl Microbiol Biotechnol 73:1-14 (2006)\", \"DOI:10.1007/s00253-006-0511-6\")), list(REFERENCE = \"\", AUTHORS = \"Krohn K (ed).\", TITLE = \"Anthracycline Chemistry and Biology I : Biological Occurence and Biosynthesis, Synthesis and Chemistry\", JOURNAL = \"Topics in Current Chemistry 282 (2008)\")', 'map01056', 'Biosynthesis of type II polyketide backbone', 'Metabolism; Metabolism of terpenoids and polyketides', 0, 97, 0, 0, 0, 0, 97, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (167, '01057', 'Biosynthesis of type II polyketide products', 'Metabolism; Metabolism of terpenoids and polyketides', 'Biosynthesis of type II polyketide products', 'Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin [PATH:map01057], Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline [PATH:map01057], Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone [PATH:map01057], Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin [PATH:map01057], Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C [PATH:map01057], Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A [PATH:map01057], Chlortetracycline biosynthesis, pretetramide => chlortetracycline [PATH:map01057]', 'D00201, Tetracycline (JAN/USP/INN), D00468, Plicamycin (USP/INN), D02756, Aclarubicin (USAN/INN), D03899, Doxorubicin (USAN/INN), D05198, Nogalamycin (USAN/INN), D07689, Chlortetracycline (INN), D07776, Daunorubicin (INN)', 'ko01057', 'list(REFERENCE = \"PMID:17227452\", AUTHORS = \"Taguchi T, Okamoto S, Lezhava A, Li A, Ochi K, Ebizuka Y, Ichinose K\", TITLE = \"Possible involvement of ActVI-ORFA in transcriptional regulation of actVI tailoring-step genes for actinorhodin biosynthesis.\", JOURNAL = c(\"FEMS Microbiol Lett 269:234-9 (2007)\", \"DOI:10.1111/j.1574-6968.2007.00627.x\")), list(REFERENCE = \"PMID:12855716\", AUTHORS = \"Ichinose K, Ozawa M, Itou K, Kunieda K, Ebizuka Y\", TITLE = \"Cloning, sequencing and heterologous expression of the medermycin biosynthetic gene cluster of Streptomyces sp. AM-7161: towards comparative analysis of the benzoisochromanequinone gene clusters.\", JOURNAL = c(\"Microbiology 149:1633-45 (2003)\", \"DOI:10.1099/mic.0.26310-0\")), list(REFERENCE = \"PMID:16169737\", AUTHORS = \"Li A, Itoh T, Taguchi T, Xiang T, Ebizuka Y, Ichinose K\", TITLE = \"Functional studies on a ketoreductase gene from Streptomyces sp. AM-7161 to control the stereochemistry in medermycin biosynthesis.\", JOURNAL = c(\"Bioorg Med Chem 13:6856-63 (2005)\", \"DOI:10.1016/j.bmc.2005.07.060\")), list(REFERENCE = \"PMID:9831526\", AUTHORS = \"Ichinose K, Bedford DJ, Tornus D, Bechthold A, Bibb MJ, Revill WP, Floss HG, Hopwood DA\", TITLE = \"The granaticin biosynthetic gene cluster of Streptomyces violaceoruber Tu22: sequence analysis and expression in a heterologous host.\", JOURNAL = c(\"Chem Biol 5:647-59 (1998)\", \"DOI:10.1016/S1074-5521(98)90292-7\")), list(REFERENCE = \"PMID:11851466\", AUTHORS = \"Hopwood DA\", TITLE = \"Genetic Contributions to Understanding Polyketide Synthases.\", JOURNAL = c(\"Chem Rev 97:2465-2498 (1997)\", \"DOI:10.1021/cr960034i\")), list(REFERENCE = \"PMID:7929165\", AUTHORS = \"Fernandez-Moreno MA, Martinez E, Caballero JL, Ichinose K, Hopwood DA, Malpartida F\", TITLE = \"DNA sequence and functions of the actVI region of the actinorhodin biosynthetic gene cluster of Streptomyces coelicolor A3(2).\", JOURNAL = \"J Biol Chem 269:24854-63 (1994)\"), list(REFERENCE = \"PMID:17579485\", AUTHORS = \"Itoh T, Taguchi T, Kimberley MR, Booker-Milburn KI, Stephenson GR, Ebizuka Y, Ichinose K\", TITLE = \"Actinorhodin biosynthesis: structural requirements for post-PKS tailoring intermediates revealed by functional analysis of ActVI-ORF1 reductase.\", JOURNAL = c(\"Biochemistry 46:8181-8 (2007)\", \"DOI:10.1021/bi700190p\")), list(REFERENCE = \"PMID:11325954\", AUTHORS = \"Ichinose K, Taguchi T, Bedford DJ, Ebizuka Y, Hopwood DA\", TITLE = \"Functional complementation of pyran ring formation in actinorhodin biosynthesis in Streptomyces coelicolor A3(2) by ketoreductase genes for granaticin biosynthesis.\", JOURNAL = c(\"J Bacteriol 183:3247-50 (2001)\", \"DOI:10.1128/JB.183.10.3247-3250.2001\")), list(REFERENCE = \"PMID:11707113\", AUTHORS = \"Taguchi T, Ebizuka Y, Hopwood DA, Ichinose K\", TITLE = \"A new mode of stereochemical control revealed by analysis of the biosynthesis of dihydrogranaticin in Streptomyces violaceoruber Tu22.\", JOURNAL = c(\"J Am Chem Soc 123:11376-80 (2001)\", \"DOI:10.1021/ja015981+\")), list(REFERENCE = \"PMID:15498668\", AUTHORS = \"Taguchi T, Kunieda K, Takeda-Shitaka M, Takaya D, Kawano N, Kimberley MR, Booker-Milburn KI, Stephenson GR, Umeyama H, Ebizuka Y, Ichinose K\", TITLE = \"Remarkably different structures and reaction mechanisms of ketoreductases for the opposite stereochemical control in the biosynthesis of BIQ antibiotics.\", JOURNAL = c(\"Bioorg Med Chem 12:5917-27 (2004)\", \"DOI:10.1016/j.bmc.2004.08.026\")), list(REFERENCE = \"PMID:19246012\", AUTHORS = \"Okamoto S, Taguchi T, Ochi K, Ichinose K\", TITLE = \"Biosynthesis of actinorhodin and related antibiotics: discovery of alternative routes for quinone formation encoded in the act gene cluster.\", JOURNAL = c(\"Chem Biol 16:226-36 (2009)\", \"DOI:10.1016/j.chembiol.2009.01.015\")), list(REFERENCE = \"PMID:18245777\", AUTHORS = \"Valton J, Mathevon C, Fontecave M, Niviere V, Ballou DP\", TITLE = \"Mechanism and regulation of the Two-component FMN-dependent monooxygenase ActVA-ActVB from Streptomyces coelicolor.\", JOURNAL = c(\"J Biol Chem 283:10287-96 (2008)\", \"DOI:10.1074/jbc.M709730200\")), list(REFERENCE = \"PMID:16267053\", AUTHORS = \"Valton J, Fontecave M, Douki T, Kendrew SG, Niviere V\", TITLE = \"An aromatic hydroxylation reaction catalyzed by a two-component FMN-dependent Monooxygenase. The ActVA-ActVB system from Streptomyces coelicolor.\", JOURNAL = c(\"J Biol Chem 281:27-35 (2006)\", \"DOI:10.1074/jbc.M506146200\")), list(REFERENCE = \"PMID:15297451\", AUTHORS = \"Valton J, Filisetti L, Fontecave M, Niviere V\", TITLE = \"A two-component flavin-dependent monooxygenase involved in actinorhodin biosynthesis in Streptomyces coelicolor.\", JOURNAL = c(\"J Biol Chem 279:44362-9 (2004)\", \"DOI:10.1074/jbc.M407722200\")), list(REFERENCE = \"PMID:20193654\", AUTHORS = \"Ellis HR\", TITLE = \"The FMN-dependent two-component monooxygenase systems.\", JOURNAL = c(\"Arch Biochem Biophys 497:1-12 (2010)\", \"DOI:10.1016/j.abb.2010.02.007\")), list(REFERENCE = \"PMID:12417584\", AUTHORS = \"Filisetti L, Fontecave M, Niviere V\", TITLE = \"Mechanism and substrate specificity of the flavin reductase ActVB from Streptomyces coelicolor.\", JOURNAL = c(\"J Biol Chem 278:296-303 (2003)\", \"DOI:10.1074/jbc.M209689200\")), list(REFERENCE = \"PMID:9209048\", AUTHORS = \"Kendrew SG, Hopwood DA, Marsh EN\", TITLE = \"Identification of a monooxygenase from Streptomyces coelicolor A3(2) involved in biosynthesis of actinorhodin: purification and characterization of the recombinant enzyme.\", JOURNAL = c(\"J Bacteriol 179:4305-10 (1997)\", \"DOI:10.1128/JB.179.13.4305-4310.1997\")), list(REFERENCE = \"PMID:12514126\", AUTHORS = \"Sciara G, Kendrew SG, Miele AE, Marsh NG, Federici L, Malatesta F, Schimperna G, Savino C, Vallone B\", TITLE = \"The structure of ActVA-Orf6, a novel type of monooxygenase involved in actinorhodin biosynthesis.\", JOURNAL = c(\"EMBO J 22:205-15 (2003)\", \"DOI:10.1093/emboj/cdg031\")), list(REFERENCE = \"PMID:20157809\", AUTHORS = \"Fetzner S, Steiner RA\", TITLE = \"Cofactor-independent oxidases and oxygenases.\", JOURNAL = c(\"Appl Microbiol Biotechnol 86:791-804 (2010)\", \"DOI:10.1007/s00253-010-2455-0\")), list(REFERENCE = \"\", AUTHORS = \"Krohn K (ed).\", TITLE = \"Anthracycline Chemistry and Biology I : Biological Occurence and Biosynthesis, Synthesis and Chemistry\", JOURNAL = \"Topics in Current Chemistry 282 (2008)\"), list(REFERENCE = \"PMID:11683270\", AUTHORS = \"Torkkell S, Kunnari T, Palmu K, Mantsala P, Hakala J, Ylihonko K\", TITLE = \"The entire nogalamycin biosynthetic gene cluster of Streptomyces nogalater: characterization of a 20-kb DNA region and generation of hybrid structures.\", JOURNAL = c(\"Mol Genet Genomics 266:276-88 (2001)\", \"DOI:10.1007/s004380100554\")), list(REFERENCE = \"PMID:20052967\", AUTHORS = \"Grocholski T, Koskiniemi H, Lindqvist Y, Mantsala P, Niemi J, Schneider G\", TITLE = \"Crystal structure of the cofactor-independent monooxygenase SnoaB from Streptomyces nogalater: implications for the reaction mechanism.\", JOURNAL = c(\"Biochemistry 49:934-44 (2010)\", \"DOI:10.1021/bi901985b\")), list(REFERENCE = \"PMID:19255477\", AUTHORS = \"Koskiniemi H, Grocholski T, Schneider G, Niemi J\", TITLE = \"Expression, purification and crystallization of the cofactor-independent monooxygenase SnoaB from the nogalamycin biosynthetic pathway.\", JOURNAL = c(\"Acta Crystallogr Sect F Struct Biol Cryst Commun 65:256-9 (2009)\", \"DOI:10.1107/S1744309109001389\")), list(REFERENCE = \"PMID:12399480\", AUTHORS = \"Chung JY, Fujii I, Harada S, Sankawa U, Ebizuka Y\", TITLE = \"Expression, purification, and characterization of AknX anthrone oxygenase, which is involved in aklavinone biosynthesis in Streptomyces galilaeus.\", JOURNAL = c(\"J Bacteriol 184:6115-22 (2002)\", \"DOI:10.1128/JB.184.22.6115-6122.2002\")), list(REFERENCE = \"PMID:7836284\", AUTHORS = \"Dickens ML, Ye J, Strohl WR\", TITLE = \"Analysis of clustered genes encoding both early and late steps in daunomycin biosynthesis by Streptomyces sp. strain C5.\", JOURNAL = c(\"J Bacteriol 177:536-43 (1995)\", \"DOI:10.1128/JB.177.3.536-543.1995\")), list(REFERENCE = \"PMID:10639368\", AUTHORS = \"Torkkell S, Kunnari T, Palmu K, Hakala J, Mantsala P, Ylihonko K\", TITLE = \"Identification of a cyclase gene dictating the C-9 stereochemistry of anthracyclines from Streptomyces nogalater.\", JOURNAL = c(\"Antimicrob Agents Chemother 44:396-9 (2000)\", \"DOI:10.1128/AAC.44.2.396-399.2000\")), list(REFERENCE = \"PMID:15071504\", AUTHORS = \"Sultana A, Kallio P, Jansson A, Wang JS, Niemi J, Mantsala P, Schneider G\", TITLE = \"Structure of the polyketide cyclase SnoaL reveals a novel mechanism for enzymatic aldol condensation.\", JOURNAL = c(\"EMBO J 23:1911-21 (2004)\", \"DOI:10.1038/sj.emboj.7600201\")), list(REFERENCE = \"PMID:16414075\", AUTHORS = \"Kallio P, Sultana A, Niemi J, Mantsala P, Schneider G\", TITLE = \"Crystal structure of the polyketide cyclase AknH with bound substrate and product analogue: implications for catalytic mechanism and product stereoselectivity.\", JOURNAL = c(\"J Mol Biol 357:210-20 (2006)\", \"DOI:10.1016/j.jmb.2005.12.064\")), list(REFERENCE = \"PMID:8655529\", AUTHORS = \"Dickens ML, Ye J, Strohl WR\", TITLE = \"Cloning, sequencing, and analysis of aklaviketone reductase from Streptomyces sp. strain C5.\", JOURNAL = c(\"J Bacteriol 178:3384-8 (1996)\", \"DOI:10.1128/JB.178.11.3384-3388.1996\")), list(REFERENCE = \"PMID:17685523\", AUTHORS = \"Leimkuhler C, Fridman M, Lupoli T, Walker S, Walsh CT, Kahne D\", TITLE = \"Characterization of rhodosaminyl transfer by the AknS/AknT glycosylation complex and its use in reconstituting the biosynthetic pathway of aclacinomycin A.\", JOURNAL = c(\"J Am Chem Soc 129:10546-50 (2007)\", \"DOI:10.1021/ja072909o\")), list(REFERENCE = \"PMID:15911373\", AUTHORS = \"Lu W, Leimkuhler C, Gatto GJ Jr, Kruger RG, Oberthur M, Kahne D, Walsh CT\", TITLE = \"AknT is an activating protein for the glycosyltransferase AknS in L-aminodeoxysugar transfer to the aglycone of aclacinomycin A.\", JOURNAL = c(\"Chem Biol 12:527-34 (2005)\", \"DOI:10.1016/j.chembiol.2005.02.016\")), list(REFERENCE = \"PMID:15078101\", AUTHORS = \"Lu W, Leimkuhler C, Oberthur M, Kahne D, Walsh CT\", TITLE = \"AknK is an L-2-deoxyfucosyltransferase in the biosynthesis of the anthracycline aclacinomycin A.\", JOURNAL = c(\"Biochemistry 43:4548-58 (2004)\", \"DOI:10.1021/bi035945i\")), list(REFERENCE = \"PMID:17395717\", AUTHORS = \"Alexeev I, Sultana A, Mantsala P, Niemi J, Schneider G\", TITLE = \"Aclacinomycin oxidoreductase (AknOx) from the biosynthetic pathway of the antibiotic aclacinomycin is an unusual flavoenzyme with a dual active site.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 104:6170-5 (2007)\", \"DOI:10.1073/pnas.0700579104\")), list(REFERENCE = \"PMID:19744497\", AUTHORS = \"Lindqvist Y, Koskiniemi H, Jansson A, Sandalova T, Schnell R, Liu Z, Mantsala P, Niemi J, Schneider G\", TITLE = \"Structural basis for substrate recognition and specificity in aklavinone-11-hydroxylase from rhodomycin biosynthesis.\", JOURNAL = c(\"J Mol Biol 393:966-77 (2009)\", \"DOI:10.1016/j.jmb.2009.09.003\")), list(REFERENCE = \"PMID:20116225\", AUTHORS = \"Malla S, Niraula NP, Singh B, Liou K, Sohng JK\", TITLE = \"Limitations in doxorubicin production from Streptomyces peucetius.\", JOURNAL = c(\"Microbiol Res 165:427-35 (2010)\", \"DOI:10.1016/j.micres.2009.11.006\")), list(REFERENCE = \"PMID:7592454\", AUTHORS = \"Otten SL, Liu X, Ferguson J, Hutchinson CR\", TITLE = \"Cloning and characterization of the Streptomyces peucetius dnrQS genes encoding a daunosamine biosynthesis enzyme and a glycosyl transferase involved in daunorubicin biosynthesis.\", JOURNAL = c(\"J Bacteriol 177:6688-92 (1995)\", \"DOI:10.1128/JB.177.22.6688-6692.1995\")), list(REFERENCE = \"PMID:19619853\", AUTHORS = \"Malla S, Niraula NP, Liou K, Sohng JK\", TITLE = \"Enhancement of doxorubicin production by expression of structural sugar biosynthesis and glycosyltransferase genes in Streptomyces peucetius.\", JOURNAL = c(\"J Biosci Bioeng 108:92-8 (2009)\", \"DOI:10.1016/j.jbiosc.2009.03.002\")), list(REFERENCE = \"PMID:9098063\", AUTHORS = \"Dickens ML, Priestley ND, Strohl WR\", TITLE = \"In vivo and in vitro bioconversion of epsilon-rhodomycinone glycoside to doxorubicin: functions of DauP, DauK, and DoxA.\", JOURNAL = c(\"J Bacteriol 179:2641-50 (1997)\", \"DOI:10.1128/JB.179.8.2641-2650.1997\")), list(REFERENCE = \"PMID:9864344\", AUTHORS = \"Lomovskaya N, Otten SL, Doi-Katayama Y, Fonstein L, Liu XC, Takatsu T, Inventi-Solari A, Filippini S, Torti F, Colombo AL, Hutchinson CR\", TITLE = \"Doxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene.\", JOURNAL = \"J Bacteriol 181:305-18 (1999)\"), list(REFERENCE = \"PMID:15548527\", AUTHORS = \"Jansson A, Koskiniemi H, Erola A, Wang J, Mantsala P, Schneider G, Niemi J\", TITLE = \"Aclacinomycin 10-hydroxylase is a novel substrate-assisted hydroxylase requiring S-adenosyl-L-methionine as cofactor.\", JOURNAL = c(\"J Biol Chem 280:3636-44 (2005)\", \"DOI:10.1074/jbc.M412095200\")), list(REFERENCE = \"PMID:11520231\", AUTHORS = \"Wohlert SE, Wendt-Pienkowski E, Bao W, Hutchinson CR\", TITLE = \"Production of aromatic minimal polyketides by the daunorubicin polyketide synthase genes reveals the incompatibility of the heterologous DpsY and JadI cyclases.\", JOURNAL = c(\"J Nat Prod 64:1077-80 (2001)\", \"DOI:10.1021/np010067f\")), list(REFERENCE = \"PMID:20358042\", AUTHORS = \"Zhou H, Li Y, Tang Y\", TITLE = \"Cyclization of aromatic polyketides from bacteria and fungi.\", JOURNAL = c(\"Nat Prod Rep 27:839-68 (2010)\", \"DOI:10.1039/b911518h\")), list(REFERENCE = \"PMID:17268612\", AUTHORS = \"Hertweck C, Luzhetskyy A, Rebets Y, Bechthold A\", TITLE = \"Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork.\", JOURNAL = c(\"Nat Prod Rep 24:162-90 (2007)\", \"DOI:10.1039/b507395m\")), list(REFERENCE = \"PMID:20422670\", AUTHORS = \"Chen Y, Fan K, He Y, Xu X, Peng Y, Yu T, Jia C, Yang K\", TITLE = \"Characterization of JadH as an FAD- and NAD(P)H-dependent bifunctional hydroxylase/dehydrase in jadomycin biosynthesis.\", JOURNAL = c(\"Chembiochem 11:1055-60 (2010)\", \"DOI:10.1002/cbic.201000178\")), list(REFERENCE = \"PMID:15776503\", AUTHORS = \"Rix U, Wang C, Chen Y, Lipata FM, Remsing Rix LL, Greenwell LM, Vining LC, Yang K, Rohr J\", TITLE = \"The oxidative ring cleavage in jadomycin biosynthesis: a multistep oxygenation cascade in a biosynthetic black box.\", JOURNAL = c(\"Chembiochem 6:838-45 (2005)\", \"DOI:10.1002/cbic.200400395\")), list(REFERENCE = \"PMID:15817470\", AUTHORS = \"Chen YH, Wang CC, Greenwell L, Rix U, Hoffmeister D, Vining LC, Rohr J, Yang KQ\", TITLE = \"Functional analyses of oxygenases in jadomycin biosynthesis and identification of JadH as a bifunctional oxygenase/dehydrase.\", JOURNAL = c(\"J Biol Chem 280:22508-14 (2005)\", \"DOI:10.1074/jbc.M414229200\")), list(REFERENCE = \"PMID:17570722\", AUTHORS = \"Borissow CN, Graham CL, Syvitski RT, Reid TR, Blay J, Jakeman DL\", TITLE = \"Stereochemical integrity of oxazolone ring-containing jadomycins.\", JOURNAL = c(\"Chembiochem 8:1198-203 (2007)\", \"DOI:10.1002/cbic.200700204\")), list(REFERENCE = \"PMID:17640665\", AUTHORS = \"Mittler M, Bechthold A, Schulz GE\", TITLE = \"Structure and action of the C-C bond-forming glycosyltransferase UrdGT2 involved in the biosynthesis of the antibiotic urdamycin.\", JOURNAL = c(\"J Mol Biol 372:67-76 (2007)\", \"DOI:10.1016/j.jmb.2007.06.005\")), list(REFERENCE = \"PMID:10662691\", AUTHORS = \"Trefzer A, Hoffmeister D, Kunzel E, Stockert S, Weitnauer G, Westrich L, Rix U, Fuchser J, Bindseil KU, Rohr J, Bechthold A\", TITLE = \"Function of glycosyltransferase genes involved in urdamycin A biosynthesis.\", JOURNAL = c(\"Chem Biol 7:133-42 (2000)\", \"DOI:10.1016/S1074-5521(00)00079-X\")), list(REFERENCE = \"PMID:11410375\", AUTHORS = \"Hoffmeister D, Ichinose K, Bechthold A\", TITLE = \"Two sequence elements of glycosyltransferases involved in urdamycin biosynthesis are responsible for substrate specificity and enzymatic activity.\", JOURNAL = c(\"Chem Biol 8:557-67 (2001)\", \"DOI:10.1016/S1074-5521(01)00039-4\")), list(REFERENCE = \"\", AUTHORS = \"Rohr J, Schonewolf M, Udvarnoki G, Eckardt K, Schumann G, Wagner C, Beale JM, Sorey SD.\", TITLE = \"Investigations on the biosynthesis of the angucycline group antibiotics aquayamycin and the urdamycins A and B. Results from the structural analysis of novel blocked mutant products.\", JOURNAL = c(\"J Org Chem 58:2547-51 (1993)\", \"DOI:10.1021/jo00061a032\")), list(REFERENCE = \"PMID:15651811\", AUTHORS = \"Zhu L, Ostash B, Rix U, Nur-E-Alam M, Mayers A, Luzhetskyy A, Mendez C, Salas JA, Bechthold A, Fedorenko V, Rohr J\", TITLE = \"Identification of the function of gene lndM2 encoding a bifunctional oxygenase-reductase involved in the biosynthesis of the antitumor antibiotic landomycin E by Streptomyces globisporus 1912 supports the originally assigned structure for landomycinone.\", JOURNAL = c(\"J Org Chem 70:631-8 (2005)\", \"DOI:10.1021/jo0483623\")), list(REFERENCE = \"PMID:17061307\", AUTHORS = \"Baig I, Kharel M, Kobylyanskyy A, Zhu L, Rebets Y, Ostash B, Luzhetskyy A, Bechthold A, Fedorenko VA, Rohr J\", TITLE = \"On the acceptor substrate of C-glycosyltransferase UrdGT2: three prejadomycin C-Glycosides from an engineered mutant of Streptomyces globisporus 1912 DeltalndE(urdGT2).\", JOURNAL = c(\"Angew Chem Int Ed Engl 45:7842-6 (2006)\", \"DOI:10.1002/anie.200603176\")), list(REFERENCE = \"PMID:15123249\", AUTHORS = \"Ostash B, Rix U, Rix LL, Liu T, Lombo F, Luzhetskyy A, Gromyko O, Wang C, Brana AF, Mendez C, Salas JA, Fedorenko V, Rohr J\", TITLE = \"Generation of new landomycins by combinatorial biosynthetic manipulation of the LndGT4 gene of the landomycin E cluster in S. globisporus.\", JOURNAL = c(\"Chem Biol 11:547-55 (2004)\", \"DOI:10.1016/j.chembiol.2004.03.011\")), list(REFERENCE = \"PMID:17013601\", AUTHORS = \"Lombo F, Menendez N, Salas JA, Mendez C\", TITLE = \"The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.\", JOURNAL = c(\"Appl Microbiol Biotechnol 73:1-14 (2006)\", \"DOI:10.1007/s00253-006-0511-6\")), list(REFERENCE = \"PMID:12022840\", AUTHORS = \"Trefzer A, Blanco G, Remsing L, Kunzel E, Rix U, Lipata F, Brana AF, Mendez C, Rohr J, Bechthold A, Salas JA\", TITLE = \"Rationally designed glycosylated premithramycins: hybrid aromatic polyketides using genes from three different biosynthetic pathways.\", JOURNAL = c(\"J Am Chem Soc 124:6056-62 (2002)\", \"DOI:10.1021/ja017385l\")), list(REFERENCE = \"PMID:10652287\", AUTHORS = \"Lozano MJ, Remsing LL, Quiros LM, Brana AF, Fernandez E, Sanchez C, Mendez C, Rohr J, Salas JA\", TITLE = \"Characterization of two polyketide methyltransferases involved in the biosynthesis of the antitumor drug mithramycin by Streptomyces argillaceus.\", JOURNAL = c(\"J Biol Chem 275:3065-74 (2000)\", \"DOI:10.1074/jbc.275.5.3065\")), list(REFERENCE = \"PMID:10660060\", AUTHORS = \"Blanco G, Fernandez E, Fernandez MJ, Brana AF, Weissbach U, Kunzel E, Rohr J, Mendez C, Salas JA\", TITLE = \"Characterization of two glycosyltransferases involved in early glycosylation steps during biosynthesis of the antitumor polyketide mithramycin by Streptomyces argillaceus.\", JOURNAL = c(\"Mol Gen Genet 262:991-1000 (2000)\", \"DOI:10.1007/PL00008667\")), list(REFERENCE = \"PMID:15712316\", AUTHORS = \"Nur-e-Alam M, Mendez C, Salas JA, Rohr J\", TITLE = \"Elucidation of the glycosylation sequence of mithramycin biosynthesis: isolation of 3A-deolivosylpremithramycin B and its conversion to premithramycin B by glycosyltransferase MtmGII.\", JOURNAL = c(\"Chembiochem 6:632-6 (2005)\", \"DOI:10.1002/cbic.200400309\")), list(REFERENCE = \"PMID:9733697\", AUTHORS = \"Fernandez E, Weissbach U, Sanchez Reillo C, Brana AF, Mendez C, Rohr J, Salas JA\", TITLE = \"Identification of two genes from Streptomyces argillaceus encoding glycosyltransferases involved in transfer of a disaccharide during biosynthesis of the antitumor drug mithramycin.\", JOURNAL = \"J Bacteriol 180:4929-37 (1998)\"), list(REFERENCE = \"PMID:19364090\", AUTHORS = \"Beam MP, Bosserman MA, Noinaj N, Wehenkel M, Rohr J\", TITLE = \"Crystal structure of Baeyer-Villiger monooxygenase MtmOIV, the key enzyme of the mithramycin biosynthetic pathway .\", JOURNAL = c(\"Biochemistry 48:4476-87 (2009)\", \"DOI:10.1021/bi8023509\")), list(REFERENCE = \"PMID:16511225\", AUTHORS = \"Wang C, Gibson M, Rohr J, Oliveira MA\", TITLE = \"Crystallization and X-ray diffraction properties of Baeyer-Villiger monooxygenase MtmOIV from the mithramycin biosynthetic pathway in Streptomyces argillaceus.\", JOURNAL = c(\"Acta Crystallogr Sect F Struct Biol Cryst Commun 61:1023-6 (2005)\", \"DOI:10.1107/S1744309105033221\")), list(REFERENCE = \"PMID:12813091\", AUTHORS = \"Rodriguez D, Quiros LM, Brana AF, Salas JA\", TITLE = \"Purification and characterization of a monooxygenase involved in the biosynthetic pathway of the antitumor drug mithramycin.\", JOURNAL = c(\"J Bacteriol 185:3962-5 (2003)\", \"DOI:10.1128/JB.185.13.3962-3965.2003\")), list(REFERENCE = \"PMID:11851469\", AUTHORS = \"Hutchinson CR\", TITLE = \"Biosynthetic Studies of Daunorubicin and Tetracenomycin C.\", JOURNAL = c(\"Chem Rev 97:2525-2536 (1997)\", \"DOI:10.1021/cr960022x\")), list(REFERENCE = \"PMID:8244926\", AUTHORS = \"Summers RG, Wendt-Pienkowski E, Motamedi H, Hutchinson CR\", TITLE = \"The tcmVI region of the tetracenomycin C biosynthetic gene cluster of Streptomyces glaucescens encodes the tetracenomycin F1 monooxygenase, tetracenomycin F2 cyclase, and, most likely, a second cyclase.\", JOURNAL = c(\"J Bacteriol 175:7571-80 (1993)\", \"DOI:10.1128/JB.175.23.7571-7580.1993\")), list(REFERENCE = \"PMID:8218177\", AUTHORS = \"Shen B, Hutchinson CR\", TITLE = \"Tetracenomycin F2 cyclase: intramolecular aldol condensation in the biosynthesis of tetracenomycin C in Streptomyces glaucescens.\", JOURNAL = c(\"Biochemistry 32:11149-54 (1993)\", \"DOI:10.1021/bi00092a026\")), list(REFERENCE = \"PMID:8329392\", AUTHORS = \"Shen B, Hutchinson CR\", TITLE = \"Tetracenomycin F1 monooxygenase: oxidation of a naphthacenone to a naphthacenequinone in the biosynthesis of tetracenomycin C in Streptomyces glaucescens.\", JOURNAL = c(\"Biochemistry 32:6656-63 (1993)\", \"DOI:10.1021/bi00077a019\")), list(REFERENCE = \"PMID:1548230\", AUTHORS = \"Summers RG, Wendt-Pienkowski E, Motamedi H, Hutchinson CR\", TITLE = \"Nucleotide sequence of the tcmII-tcmIV region of the tetracenomycin C biosynthetic gene cluster of Streptomyces glaucescens and evidence that the tcmN gene encodes a multifunctional cyclase-dehydratase-O-methyl transferase.\", JOURNAL = c(\"J Bacteriol 174:1810-20 (1992)\", \"DOI:10.1128/JB.174.6.1810-1820.1992\")), list(REFERENCE = \"PMID:18388203\", AUTHORS = \"Ames BD, Korman TP, Zhang W, Smith P, Vu T, Tang Y, Tsai SC\", TITLE = \"Crystal structure and functional analysis of tetracenomycin ARO/CYC: implications for cyclization specificity of aromatic polyketides.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:5349-54 (2008)\", \"DOI:10.1073/pnas.0709223105\")), list(REFERENCE = \"PMID:11009387\", AUTHORS = \"Rafanan ER Jr, Hutchinson CR, Shen B\", TITLE = \"Triple hydroxylation of tetracenomycin A2 to tetracenomycin C involving two molecules of O(2) and one molecule of H(2)O.\", JOURNAL = c(\"Org Lett 2:3225-7 (2000)\", \"DOI:10.1021/ol0002267\")), list(REFERENCE = \"PMID:18310024\", AUTHORS = \"Ramos A, Lombo F, Brana AF, Rohr J, Mendez C, Salas JA\", TITLE = \"Biosynthesis of elloramycin in Streptomyces olivaceus requires glycosylation by enzymes encoded outside the aglycon cluster.\", JOURNAL = c(\"Microbiology 154:781-8 (2008)\", \"DOI:10.1099/mic.0.2007/014035-0\")), list(REFERENCE = \"PMID:11376004\", AUTHORS = \"Patallo EP, Blanco G, Fischer C, Brana AF, Rohr J, Mendez C, Salas JA\", TITLE = \"Deoxysugar methylation during biosynthesis of the antitumor polyketide elloramycin by Streptomyces olivaceus. Characterization of three methyltransferase genes.\", JOURNAL = c(\"J Biol Chem 276:18765-74 (2001)\", \"DOI:10.1074/jbc.M101225200\"))', 'map01057', 'Biosynthesis of type II polyketide products', 0, 128, 0, 0, 0, 0, 128, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (168, '01058', 'Acridone alkaloid biosynthesis', 'Acridone alkaloids are anthranillic acid-derived plant alkaloids found in Rutaceae (rue family). Compounds in this class have been tested for antitumor and antimicrobial activities.', 'Metabolism; Biosynthesis of other secondary metabolites', 'Acridone alkaloid biosynthesis', 'ko01058', 'list(REFERENCE = \"\", AUTHORS = \"Funayama S.\", TITLE = \"[Arukaroido -Doku to Kusuri no Houko-] (In Japanese)\", JOURNAL = \"Kyouritu shuppan kabusikikaisya:183-187 (1998)\"), list(REFERENCE = \"\", AUTHORS = \"Dewick PM.\", TITLE = \"Medicinal Natural Products: A Biosynthetic Approach, Second Edition\", JOURNAL = \"John Wiley and Sons (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Harborne JB, Baxter H, Moss GP.\", TITLE = \"Phytochemical Dictionary: A Handbook of Bioactive Compounds from Plants, Second Edition\", JOURNAL = \"Taylor and Francis (1999)\"), list(REFERENCE = \"PMID:10217426\", AUTHORS = \"Lukacin R, Springob K, Urbanke C, Ernwein C, Schroder G, Schroder J, Matern U.\", TITLE = \"Native acridone synthases I and II from Ruta graveolens L. form homodimers\", JOURNAL = c(\"FEBS Lett 448:135-40 (1999)\", \"DOI:10.1016/S0014-5793(99)00355-5\"))', 'map01058', 'Acridone alkaloid biosynthesis', 'Acridone alkaloids are anthranillic acid-derived plant alkaloids found in Rutaceae (rue family). Compounds in this class have been tested for antitumor and antimicrobial activities.', 2, 0, 0, 2, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (169, '01059', 'Biosynthesis of enediyne antibiotics', 'Enediyne natural products are potent antitumor antibiotics produced by a variety of Actinomycetes. Enediyne has a unique structure consisting of three building blocks: aromatic, sugar and enediyne core. The enediyne core contains two acetylenic groups conjugated to a double bond in a 9- or 10-membered ring, and it is synthesized by an iterative type I polyketide synthase and other tailoring proteins [MD:M00824 M00825]. The 10-membered enediyne such as calicheamicin also contains an allylic trisulfide group, which acts as a trigger for diradical formation. This diagram shows the biosynthesis of C-1027, maduropeptin, neocarzinostatin, kedarcidin and calicheamicin. Some aromatic moieties are synthesized via iterative type I polyketide synthases, and others are derived from chorismate and aromatic amino acids such as tyrosine and azatyrosine [MD:M00829 M00830 M00831 M00834 M00826 M00827 M00828 M00832]. Finally, the aromatic and sugar building blocks are attached to the enediyne core by acyltransferases, condensation enzymes and glucosyltransferases [MD:M00833].', 'Metabolism; Metabolism of terpenoids and polyketides', 'Biosynthesis of enediyne antibiotics', '9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core [PATH:map01059], 10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core [PATH:map01059], C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA [PATH:map01059], C-1027 beta-amino acid moiety biosynthesis, tyrosine => 3-chloro-4,5-dihydroxy-beta-phenylalanyl-PCP [PATH:map01059], Maduropeptin beta-hydroxy acid moiety biosynthesis, tyrosine => 3-(4-hydroxyphenyl)-3-oxopropanoyl-PCP [PATH:map01059], 3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA [PATH:map01059], Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA [PATH:map01059], Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA [PATH:map01059], Kedarcidin 2-aza-3-chloro-beta-tyrosine moiety biosynthesis, azatyrosine => 2-aza-3-chloro-beta-tyrosyl-PCP [PATH:map01059], Calicheamicin biosynthesis, calicheamicinone => calicheamicin [PATH:map01059], Calicheamicin orsellinate moiety biosynthesis, malonyl-CoA => orsellinate-ACP => 5-iodo-2,3-dimethoxyorsellinate-ACP [PATH:map01059]', 'ko01059', 'list(REFERENCE = \"PMID:20336235\", AUTHORS = \"Liang ZX\", TITLE = \"Complexity and simplicity in the biosynthesis of enediyne natural products.\", JOURNAL = c(\"Nat Prod Rep 27:499-528 (2010)\", \"DOI:10.1039/b908165h\")), list(REFERENCE = \"PMID:18397168\", AUTHORS = \"Van Lanen SG, Shen B\", TITLE = \"Biosynthesis of enediyne antitumor antibiotics.\", JOURNAL = c(\"Curr Top Med Chem 8:448-59 (2008)\", \"DOI:10.2174/156802608783955656\")), list(REFERENCE = \"PMID:12183628\", AUTHORS = \"Liu W, Christenson SD, Standage S, Shen B\", TITLE = \"Biosynthesis of the enediyne antitumor antibiotic C-1027.\", JOURNAL = c(\"Science 297:1170-3 (2002)\", \"DOI:10.1126/science.1072110\")), list(REFERENCE = \"PMID:12183629\", AUTHORS = \"Ahlert J, Shepard E, Lomovskaya N, Zazopoulos E, Staffa A, Bachmann BO, Huang K, Fonstein L, Czisny A, Whitwam RE, Farnet CM, Thorson JS\", TITLE = \"The calicheamicin gene cluster and its iterative type I enediyne PKS.\", JOURNAL = c(\"Science 297:1173-6 (2002)\", \"DOI:10.1126/science.1072105\")), list(REFERENCE = \"PMID:17918933\", AUTHORS = \"Van Lanen SG, Oh TJ, Liu W, Wendt-Pienkowski E, Shen B\", TITLE = \"Characterization of the maduropeptin biosynthetic gene cluster from Actinomadura madurae ATCC 39144 supporting a unifying paradigm for enediyne biosynthesis.\", JOURNAL = c(\"J Am Chem Soc 129:13082-94 (2007)\", \"DOI:10.1021/ja073275o\")), list(REFERENCE = \"PMID:15797213\", AUTHORS = \"Liu W, Nonaka K, Nie L, Zhang J, Christenson SD, Bae J, Van Lanen SG, Zazopoulos E, Farnet CM, Yang CF, Shen B\", TITLE = \"The neocarzinostatin biosynthetic gene cluster from Streptomyces carzinostaticus ATCC 15944 involving two iterative type I polyketide synthases.\", JOURNAL = c(\"Chem Biol 12:293-302 (2005)\", \"DOI:10.1016/j.chembiol.2004.12.013\")), list(REFERENCE = \"PMID:23360970\", AUTHORS = \"Lohman JR, Huang SX, Horsman GP, Dilfer PE, Huang T, Chen Y, Wendt-Pienkowski E, Shen B\", TITLE = \"Cloning and sequencing of the kedarcidin biosynthetic gene cluster from Streptoalloteichus sp. ATCC 53650 revealing new insights into biosynthesis of the enediyne family of antitumor antibiotics.\", JOURNAL = c(\"Mol Biosyst 9:478-91 (2013)\", \"DOI:10.1039/c3mb25523a\")), list(REFERENCE = \"PMID:19362637\", AUTHORS = \"Horsman GP, Van Lanen SG, Shen B\", TITLE = \"Iterative type I polyketide synthases for enediyne core biosynthesis.\", JOURNAL = c(\"Methods Enzymol 459:97-112 (2009)\", \"DOI:10.1016/S0076-6879(09)04605-9\")), list(REFERENCE = \"PMID:20024241\", AUTHORS = \"Sun H, Kong R, Zhu D, Lu M, Ji Q, Liew CW, Lescar J, Zhong G, Liang ZX\", TITLE = \"Products of the iterative polyketide synthases in 9- and 10-membered enediyne biosynthesis.\", JOURNAL = c(\"Chem Commun (Camb) 7399-401 (2009)\", \"DOI:10.1039/b916751j\")), list(REFERENCE = \"PMID:18223152\", AUTHORS = \"Zhang J, Van Lanen SG, Ju J, Liu W, Dorrestein PC, Li W, Kelleher NL, Shen B\", TITLE = \"A phosphopantetheinylating polyketide synthase producing a linear polyene to initiate enediyne antitumor antibiotic biosynthesis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:1460-5 (2008)\", \"DOI:10.1073/pnas.0711625105\")), list(REFERENCE = \"PMID:19689130\", AUTHORS = \"Belecki K, Crawford JM, Townsend CA\", TITLE = \"Production of octaketide polyenes by the calicheamicin polyketide synthase CalE8: implications for the biosynthesis of enediyne core structures.\", JOURNAL = c(\"J Am Chem Soc 131:12564-6 (2009)\", \"DOI:10.1021/ja904391r\")), list(REFERENCE = \"PMID:19357082\", AUTHORS = \"Kotaka M, Kong R, Qureshi I, Ho QS, Sun H, Liew CW, Goh LP, Cheung P, Mu Y, Lescar J, Liang ZX\", TITLE = \"Structure and catalytic mechanism of the thioesterase CalE7 in enediyne biosynthesis.\", JOURNAL = c(\"J Biol Chem 284:15739-49 (2009)\", \"DOI:10.1074/jbc.M809669200\")), list(REFERENCE = \"PMID:24041368\", AUTHORS = \"Belecki K, Townsend CA\", TITLE = \"Biochemical determination of enzyme-bound metabolites: preferential accumulation of a programmed octaketide on the enediyne polyketide synthase CalE8.\", JOURNAL = c(\"J Am Chem Soc 135:14339-48 (2013)\", \"DOI:10.1021/ja406697t\")), list(REFERENCE = \"PMID:20534556\", AUTHORS = \"Horsman GP, Chen Y, Thorson JS, Shen B\", TITLE = \"Polyketide synthase chemistry does not direct biosynthetic divergence between 9- and 10-membered enediynes.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 107:11331-5 (2010)\", \"DOI:10.1073/pnas.1003442107\")), list(REFERENCE = \"PMID:25278375\", AUTHORS = \"Chen X, Ji R, Jiang X, Yang R, Liu F, Xin Y\", TITLE = \"Iterative type I polyketide synthases involved in enediyne natural product biosynthesis.\", JOURNAL = c(\"IUBMB Life 66:587-95 (2014)\", \"DOI:10.1002/iub.1316\")), list(REFERENCE = \"PMID:19856960\", AUTHORS = \"Lin S, Horsman GP, Chen Y, Li W, Shen B\", TITLE = \"Characterization of the SgcF epoxide hydrolase supporting an (R)-vicinal diol intermediate for enediyne antitumor antibiotic C-1027 biosynthesis.\", JOURNAL = c(\"J Am Chem Soc 131:16410-7 (2009)\", \"DOI:10.1021/ja901242s\")), list(REFERENCE = \"PMID:23844627\", AUTHORS = \"Horsman GP, Lechner A, Ohnishi Y, Moore BS, Shen B\", TITLE = \"Predictive model for epoxide hydrolase-generated stereochemistry in the biosynthesis of nine-membered enediyne antitumor antibiotics.\", JOURNAL = c(\"Biochemistry 52:5217-24 (2013)\", \"DOI:10.1021/bi400572a\")), list(REFERENCE = \"PMID:20704329\", AUTHORS = \"Lin S, Horsman GP, Shen B\", TITLE = \"Characterization of the epoxide hydrolase NcsF2 from the neocarzinostatin biosynthetic gene cluster.\", JOURNAL = c(\"Org Lett 12:3816-9 (2010)\", \"DOI:10.1021/ol101473t\")), list(REFERENCE = \"PMID:18182490\", AUTHORS = \"Van Lanen SG, Lin S, Shen B\", TITLE = \"Biosynthesis of the enediyne antitumor antibiotic C-1027 involves a new branching point in chorismate metabolism.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:494-9 (2008)\", \"DOI:10.1073/pnas.0708750105\")), list(REFERENCE = \"PMID:14580219\", AUTHORS = \"Christenson SD, Wu W, Spies MA, Shen B, Toney MD\", TITLE = \"Kinetic analysis of the 4-methylideneimidazole-5-one-containing tyrosine aminomutase in enediyne antitumor antibiotic C-1027 biosynthesis.\", JOURNAL = c(\"Biochemistry 42:12708-18 (2003)\", \"DOI:10.1021/bi035223r\")), list(REFERENCE = \"PMID:16887797\", AUTHORS = \"Van Lanen SG, Lin S, Dorrestein PC, Kelleher NL, Shen B\", TITLE = \"Substrate specificity of the adenylation enzyme SgcC1 involved in the biosynthesis of the enediyne antitumor antibiotic C-1027.\", JOURNAL = c(\"J Biol Chem 281:29633-40 (2006)\", \"DOI:10.1074/jbc.M605887200\")), list(REFERENCE = \"PMID:16104723\", AUTHORS = \"Van Lanen SG, Dorrestein PC, Christenson SD, Liu W, Ju J, Kelleher NL, Shen B\", TITLE = \"Biosynthesis of the beta-amino acid moiety of the enediyne antitumor antibiotic C-1027 featuring beta-amino acyl-S-carrier protein intermediates.\", JOURNAL = c(\"J Am Chem Soc 127:11594-5 (2005)\", \"DOI:10.1021/ja052871k\")), list(REFERENCE = \"PMID:18426211\", AUTHORS = \"Lin S, Van Lanen SG, Shen B\", TITLE = \"Characterization of the two-component, FAD-dependent monooxygenase SgcC that requires carrier protein-tethered substrates for the biosynthesis of the enediyne antitumor antibiotic C-1027.\", JOURNAL = c(\"J Am Chem Soc 130:6616-23 (2008)\", \"DOI:10.1021/ja710601d\")), list(REFERENCE = \"PMID:19817865\", AUTHORS = \"Van Lanen SG, Lin S, Horsman GP, Shen B\", TITLE = \"Characterization of SgcE6, the flavin reductase component supporting FAD-dependent halogenation and hydroxylation in the biosynthesis of the enediyne antitumor antibiotic C-1027.\", JOURNAL = c(\"FEMS Microbiol Lett 300:237-41 (2009)\", \"DOI:10.1111/j.1574-6968.2009.01802.x\")), list(REFERENCE = \"PMID:23034235\", AUTHORS = \"Lohman JR, Shen B\", TITLE = \"4-methylideneimidazole-5-one-containing aminomutases in enediyne biosynthesis.\", JOURNAL = c(\"Methods Enzymol 516:299-319 (2012)\", \"DOI:10.1016/B978-0-12-394291-3.00007-1\")), list(REFERENCE = \"PMID:20718468\", AUTHORS = \"Ling J, Horsman GP, Huang SX, Luo Y, Lin S, Shen B\", TITLE = \"Enediyne antitumor antibiotic maduropeptin biosynthesis featuring a C-methyltransferase that acts on a CoA-tethered aromatic substrate.\", JOURNAL = c(\"J Am Chem Soc 132:12534-6 (2010)\", \"DOI:10.1021/ja1050814\")), list(REFERENCE = \"PMID:23633564\", AUTHORS = \"Huang SX, Lohman JR, Huang T, Shen B\", TITLE = \"A new member of the 4-methylideneimidazole-5-one-containing aminomutase family from the enediyne kedarcidin biosynthetic pathway.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 110:8069-74 (2013)\", \"DOI:10.1073/pnas.1304733110\")), list(REFERENCE = \"PMID:18561189\", AUTHORS = \"McCoy JG, Johnson HD, Singh S, Bingman CA, Lei IK, Thorson JS, Phillips GN Jr\", TITLE = \"Structural characterization of CalO2: a putative orsellinic acid P450 oxidase in the calicheamicin biosynthetic pathway.\", JOURNAL = c(\"Proteins 74:50-60 (2009)\", \"DOI:10.1002/prot.22131\")), list(REFERENCE = \"PMID:24978950\", AUTHORS = \"Singh S, Nandurkar NS, Thorson JS\", TITLE = \"Characterization of the calicheamicin orsellinate C2-O-methyltransferase CalO6.\", JOURNAL = c(\"Chembiochem 15:1418-21 (2014)\", \"DOI:10.1002/cbic.201402119\")), list(REFERENCE = \"PMID:21358050\", AUTHORS = \"Chang A, Singh S, Bingman CA, Thorson JS, Phillips GN Jr\", TITLE = \"Structural characterization of CalO1: a putative orsellinic acid methyltransferase in the calicheamicin-biosynthetic pathway.\", JOURNAL = c(\"Acta Crystallogr D Biol Crystallogr 67:197-203 (2011)\", \"DOI:10.1107/S090744491100360X\"))', 'map01059', 'Biosynthesis of enediyne antibiotics', 0, 202, 0, 0, 0, 0, 200, 2);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (170, '01060', 'Biosynthesis of plant secondary metabolites', 'Biosynthesis of plant secondary metabolites', 'ko01060', 'map01060', 'Biosynthesis of plant secondary metabolites', 'Biosynthesis of plant secondary metabolites', 'ko01060', 'map01060', 'Biosynthesis of plant secondary metabolites', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (171, '01061', 'Biosynthesis of phenylpropanoids', 'Biosynthesis of phenylpropanoids', 'ko01061', 'map01061', 'Biosynthesis of phenylpropanoids', 'Biosynthesis of phenylpropanoids', 'ko01061', 'map01061', 'Biosynthesis of phenylpropanoids', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (172, '01062', 'Biosynthesis of terpenoids and steroids', 'Biosynthesis of terpenoids and steroids', 'ko01062', 'map01062', 'Biosynthesis of terpenoids and steroids', 'Biosynthesis of terpenoids and steroids', 'ko01062', 'map01062', 'Biosynthesis of terpenoids and steroids', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (173, '01063', 'Biosynthesis of alkaloids derived from shikimate pathway', 'Biosynthesis of alkaloids derived from shikimate pathway', 'ko01063', 'map01063', 'Biosynthesis of alkaloids derived from shikimate pathway', 'Biosynthesis of alkaloids derived from shikimate pathway', 'ko01063', 'map01063', 'Biosynthesis of alkaloids derived from shikimate pathway', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (174, '01064', 'Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid', 'Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid', 'ko01064', 'map01064', 'Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid', 'Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid', 'ko01064', 'map01064', 'Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (175, '01065', 'Biosynthesis of alkaloids derived from histidine and purine', 'Biosynthesis of alkaloids derived from histidine and purine', 'ko01065', 'map01065', 'Biosynthesis of alkaloids derived from histidine and purine', 'Biosynthesis of alkaloids derived from histidine and purine', 'ko01065', 'map01065', 'Biosynthesis of alkaloids derived from histidine and purine', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (176, '01066', 'Biosynthesis of alkaloids derived from terpenoid and polyketide', 'Biosynthesis of alkaloids derived from terpenoid and polyketide', 'ko01066', 'map01066', 'Biosynthesis of alkaloids derived from terpenoid and polyketide', 'Biosynthesis of alkaloids derived from terpenoid and polyketide', 'ko01066', 'map01066', 'Biosynthesis of alkaloids derived from terpenoid and polyketide', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (177, '01070', 'Biosynthesis of plant hormones', 'Biosynthesis of plant hormones', 'ko01070', 'list(REFERENCE = \"\", AUTHORS = \"Fukuda H, Matida Y, Kamiya Y, Kakimoto T.\", TITLE = \"[Shinpan Syokubutuhorumon no Sigunarudentatu] (In Japanese)\", JOURNAL = \"Syujyunsya:165-186 (2004)\")', 'map01070', 'Biosynthesis of plant hormones', 'Biosynthesis of plant hormones', 'ko01070', 'list(REFERENCE = \"\", AUTHORS = \"Fukuda H, Matida Y, Kamiya Y, Kakimoto T.\", TITLE = \"[Shinpan Syokubutuhorumon no Sigunarudentatu] (In Japanese)\", JOURNAL = \"Syujyunsya:165-186 (2004)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (178, '01100', 'Metabolic pathways', 'Metabolic pathways', 'Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate [PATH:map01100], Glycolysis, core module involving three-carbon compounds [PATH:map01100], Gluconeogenesis, oxaloacetate => fructose-6P [PATH:map01100], Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map01100], PRPP biosynthesis, ribose 5P => PRPP [PATH:map01100], Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map01100], Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map01100], Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map01100], Citrate cycle (TCA cycle, Krebs cycle) [PATH:map01100], Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map01100], Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:map01100], Glyoxylate cycle [PATH:map01100], Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA [PATH:map01100], Glucuronate pathway (uronate pathway) [PATH:map01100], Proline biosynthesis, glutamate => proline [PATH:map01100], Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine [PATH:map01100], Methionine biosynthesis, apartate => homoserine => methionine [PATH:map01100], Threonine biosynthesis, aspartate => homoserine => threonine [PATH:map01100], Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map01100], Serine biosynthesis, glycerate-3P => serine [PATH:map01100], Cysteine biosynthesis, serine => cysteine [PATH:map01100], Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map01100], Tryptophan biosynthesis, chorismate => tryptophan [PATH:map01100], Phenylalanine biosynthesis, chorismate => phenylalanine [PATH:map01100], Tyrosine biosynthesis, chorismate => tyrosine [PATH:map01100], Histidine biosynthesis, PRPP => histidine [PATH:map01100], GABA (gamma-Aminobutyrate) shunt [PATH:map01100], Ornithine biosynthesis, glutamate => ornithine [PATH:map01100], Urea cycle [PATH:map01100], Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine [PATH:map01100], Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine [PATH:map01100], Lysine degradation, lysine => saccharopine => acetoacetyl-CoA [PATH:map01100], Ectoine biosynthesis, aspartate => ectoine [PATH:map01100], Methionine salvage pathway [PATH:map01100], Methionine degradation [PATH:map01100], Leucine degradation, leucine => acetoacetate + acetyl-CoA [PATH:map01100], Melatonin biosynthesis, tryptophan => serotonin => melatonin [PATH:map01100], Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate [PATH:map01100], Monolignol biosynthesis, phenylalanine/tyrosine => monolignol [PATH:map01100], Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine [PATH:map01100], Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline [PATH:map01100], Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine [PATH:map01100], Tyrosine degradation, tyrosine => homogentisate [PATH:map01100], Histidine degradation, histidine => N-formiminoglutamate => glutamate [PATH:map01100], Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate [PATH:map01100], Creatine pathway [PATH:map01100], Inosine monophosphate biosynthesis, PRPP + glutamine => IMP [PATH:map01100], Adenine ribonucleotide biosynthesis, IMP => ADP,ATP [PATH:map01100], Guanine ribonucleotide biosynthesis IMP => GDP,GTP [PATH:map01100], Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP [PATH:map01100], Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP [PATH:map01100], Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP [PATH:map01100], N-glycan precursor biosynthesis [PATH:map01100], O-glycan biosynthesis, mucin type core [PATH:map01100], Glycosaminoglycan biosynthesis, linkage tetrasaccharide [PATH:map01100], Glycosaminoglycan biosynthesis, chondroitin sulfate backbone [PATH:map01100], Glycosaminoglycan biosynthesis, heparan sulfate backbone [PATH:map01100], KDO2-lipid A biosynthesis, Raetz pathway, LpxL-LpxM type [PATH:map01100], D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P [PATH:map01100], CMP-KDO biosynthesis [PATH:map01100], ADP-L-glycero-D-manno-heptose biosynthesis [PATH:map01100], GPI-anchor biosynthesis, core oligosaccharide [PATH:map01100], Lactosylceramide biosynthesis [PATH:map01100], Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid [PATH:map01100], Glycosphingolipid biosynthesis, globo-series, LacCer => Gb4Cer [PATH:map01100], Glycosphingolipid biosynthesis, ganglio series, LacCer => GT3 [PATH:map01100], Glycosphingolipid biosynthesis, lacto-series, LacCer => Lc4Cer [PATH:map01100], Glycosphingolipid biosynthesis, neolacto-series, LacCer => nLc4Cer [PATH:map01100], N-glycosylation by oligosaccharyltransferase [PATH:map01100], N-glycan precursor trimming [PATH:map01100], N-glycan biosynthesis, high-mannose type [PATH:map01100], N-glycan biosynthesis, complex type [PATH:map01100], Dermatan sulfate degradation [PATH:map01100], Chondroitin sulfate degradation [PATH:map01100], Heparan sulfate degradation [PATH:map01100], Keratan sulfate degradation [PATH:map01100], Pectin degradation [PATH:map01100], Fatty acid biosynthesis, initiation [PATH:map01100], Fatty acid biosynthesis, elongation [PATH:map01100], Fatty acid elongation in mitochondria [PATH:map01100], beta-Oxidation, acyl-CoA synthesis [PATH:map01100], beta-Oxidation [PATH:map01100], Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone [PATH:map01100], Triacylglycerol biosynthesis [PATH:map01100], Phosphatidylcholine (PC) biosynthesis, choline => PC [PATH:map01100], Phosphatidylcholine (PC) biosynthesis, PE => PC [PATH:map01100], Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE [PATH:map01100], Phosphatidylethanolamine (PE) biosynthesis, PA => PS => PE [PATH:map01100], Ceramide biosynthesis [PATH:map01100], C5 isoprenoid biosynthesis, mevalonate pathway [PATH:map01100], C5 isoprenoid biosynthesis, non-mevalonate pathway [PATH:map01100], beta-Carotene biosynthesis, GGAP => beta-carotene [PATH:map01100], Acylglycerol degradation [PATH:map01100], Sphingosine biosynthesis [PATH:map01100], Sphingosine degradation [PATH:map01100], Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol [PATH:map01100], Ergocalciferol biosynthesis [PATH:map01100], Cholecalciferol biosynthesis [PATH:map01100], Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate [PATH:map01100], Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate [PATH:map01100], Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone [PATH:map01100], C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone [PATH:map01100], C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone [PATH:map01100], C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone [PATH:map01100], Tocopherol/tocotorienol biosynthesis [PATH:map01100], Jasmonic acid biosynthesis [PATH:map01100], Ascorbate biosynthesis, plants, glucose-6P => ascorbate [PATH:map01100], NAD biosynthesis, aspartate => NAD [PATH:map01100], Menaquinone biosynthesis, chorismate => menaquinol [PATH:map01100], Ubiquinone biosynthesis, prokaryotes, chorismate => ubiquinone [PATH:map01100], Glutathione biosynthesis, glutamate => glutathione [PATH:map01100], Pantothenate biosynthesis, valine/L-aspartate => pantothenate [PATH:map01100], Coenzyme A biosynthesis, pantothenate => CoA [PATH:map01100], Heme biosynthesis, plants and bacteria, glutamate => heme [PATH:map01100], Cobalamin biosynthesis, cobinamide => cobalamin [PATH:map01100], Biotin biosynthesis, pimeloyl-ACP/CoA => biotin [PATH:map01100], Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P [PATH:map01100], Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD [PATH:map01100], Tetrahydrofolate biosynthesis, GTP => THF [PATH:map01100], Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P [PATH:map01100], Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate => ubiquinone [PATH:map01100], Ascorbate biosynthesis, animals, glucose-1P => ascorbate [PATH:map01100], Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 [PATH:map01100], Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol [PATH:map01100], Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate [PATH:map01100], Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine [PATH:map01100], Polyamine biosynthesis, arginine => ornithine => putrescine [PATH:map01100], GABA biosynthesis, eukaryotes, putrescine => GABA [PATH:map01100], GABA biosynthesis, prokaryotes, putrescine => GABA [PATH:map01100], Flavanone biosynthesis, phenylalanine => naringenin [PATH:map01100], Flavonoid biosynthesis, naringenin => pelargonidin [PATH:map01100], C1-unit interconversion, prokaryotes [PATH:map01100], C1-unit interconversion, eukaryotes [PATH:map01100], Reductive pentose phosphate cycle (Calvin cycle) [PATH:map01100], Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P [PATH:map01100], Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P [PATH:map01100], CAM (Crassulacean acid metabolism), dark [PATH:map01100], CAM (Crassulacean acid metabolism), light [PATH:map01100], C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type [PATH:map01100], C4-dicarboxylic acid cycle, NAD - malic enzyme type [PATH:map01100], C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map01100], Reductive citrate cycle (Arnon-Buchanan cycle) [PATH:map01100], Methane oxidation, methanotroph, methane => formaldehyde [PATH:map01100], Nitrogen fixation, nitrogen => ammonia [PATH:map01100], Assimilatory sulfate reduction, sulfate => H2S [PATH:map01100], Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map01100], Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map01100], Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map01100], Cysteine biosynthesis, homocysteine + serine => cysteine [PATH:map01100], Formaldehyde assimilation, xylulose monophosphate pathway [PATH:map01100], Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map01100], Formaldehyde assimilation, serine pathway [PATH:map01100], Methanogenesis, methanol => methane [PATH:map01100], Methanogenesis, acetate => methane [PATH:map01100], Coenzyme M biosynthesis [PATH:map01100], C10-C20 isoprenoid biosynthesis, bacteria [PATH:map01100], C10-C20 isoprenoid biosynthesis, archaea [PATH:map01100], C10-C20 isoprenoid biosynthesis, plants [PATH:map01100], C10-C20 isoprenoid biosynthesis, non-plant eukaryotes [PATH:map01100], Ethylene biosynthesis, methionine => ethylene [PATH:map01100], Cyanogenic glycoside biosynthesis, tyrosine => dhurrin [PATH:map01100], Glucosinolate biosynthesis, tryptophan => glucobrassicin [PATH:map01100], Castasterone biosynthesis, campesterol => castasterone [PATH:map01100], Abscisic acid biosynthesis, beta-carotene => abscisic acid [PATH:map01100], Ethylmalonyl pathway [PATH:map01100], Dicarboxylate-hydroxybutyrate cycle [PATH:map01100], Hydroxypropionate-hydroxybutylate cycle [PATH:map01100], 3-Hydroxypropionate bi-cycle [PATH:map01100], Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [PATH:map01100], F420 biosynthesis [PATH:map01100], Fatty acid elongation in endoplasmic reticulum [PATH:map01100], Toluene degradation, anaerobic, toluene => benzoyl-CoA [PATH:map01100], Cymene degradation, p-cymene => p-cumate [PATH:map01100], Acetyl-CoA pathway, CO2 => acetyl-CoA [PATH:map01100], Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map01100], Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate [PATH:map01100], Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine [PATH:map01100], Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine [PATH:map01100], Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine [PATH:map01100], Nitrification, ammonia => nitrite [PATH:map01100], Denitrification, nitrate => nitrogen [PATH:map01100], Dissimilatory nitrate reduction, nitrate => ammonia [PATH:map01100], Assimilatory nitrate reduction, nitrate => ammonia [PATH:map01100], Photorespiration [PATH:map01100], Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate [PATH:map01100], Naphthalene degradation, naphthalene => salicylate [PATH:map01100], Isoleucine biosynthesis, pyruvate => 2-oxobutanoate [PATH:map01100], Xylene degradation, xylene => methylbenzoate [PATH:map01100], Toluene degradation, toluene => benzoate [PATH:map01100], Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate [PATH:map01100], Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA [PATH:map01100], Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA [PATH:map01100], Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate [PATH:map01100], Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate [PATH:map01100], Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA [PATH:map01100], Purine degradation, xanthine => urea [PATH:map01100], Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map01100], Benzene degradation, benzene => catechol [PATH:map01100], Nucleotide sugar biosynthesis, glucose => UDP-glucose [PATH:map01100], Ascorbate degradation, ascorbate => D-xylulose-5P [PATH:map01100], Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map01100], D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P [PATH:map01100], Nucleotide sugar biosynthesis, galactose => UDP-galactose [PATH:map01100], Betaine biosynthesis, choline => betaine [PATH:map01100], Methanogenesis, methylamine/dimethylamine/trimethylamine => methane [PATH:map01100], Trehalose biosynthesis, D-glucose 1P => trehalose [PATH:map01100], Methanogenesis, CO2 => methane [PATH:map01100], Catechol ortho-cleavage, catechol => 3-oxoadipate [PATH:map01100], Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map01100], Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine [PATH:map01100], Pimeloyl-ACP biosynthesis, BioC-BioH pathway, malonyl-ACP => pimeloyl-ACP [PATH:map01100], Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin [PATH:map01100], Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin [PATH:map01100], Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map01100], Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map01100], Thiosulfate oxidation by SOX complex, thiosulfate => sulfate [PATH:map01100], Dissimilatory sulfate reduction, sulfate => H2S [PATH:map01100], 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map01100], Cysteine biosynthesis, methionine => cysteine [PATH:map01100], Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate [PATH:map01100], Nicotinate degradation, nicotinate => fumarate [PATH:map01100], Phthalate degradation, phthalate => protocatechuate [PATH:map01100], Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate [PATH:map01100], D-Galacturonate degradation (fungi), D-galacturonate => glycerol [PATH:map01100], D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P [PATH:map01100], Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P [PATH:map01100], Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map01100], Phthalate degradation, phthalate => protocatechuate [PATH:map01100], Anthranilate degradation, anthranilate => catechol [PATH:map01100], Salicylate degradation, salicylate => gentisate [PATH:map01100], Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline [PATH:map01100], Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin [PATH:map01100], Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate [PATH:map01100], Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate [PATH:map01100], Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A [PATH:map01100], Methylaspartate cycle [PATH:map01100], Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA [PATH:map01100], Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N [PATH:map01100], Ornithine biosynthesis, mediated by LysW, glutamate => ornithine [PATH:map01100], Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin [PATH:map01100], Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B [PATH:map01100], Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin [PATH:map01100], Pikromycin/methymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin [PATH:map01100], Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b [PATH:map01100], Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide [PATH:map01100], Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin [PATH:map01100], Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline [PATH:map01100], Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone [PATH:map01100], Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin [PATH:map01100], Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C [PATH:map01100], Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A [PATH:map01100], Cycloserine biosynthesis, arginine/serine => cycloserine [PATH:map01100], Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A [PATH:map01100], Bacilysin biosynthesis, prephenate => bacilysin [PATH:map01100], Terpentecin biosynthesis, GGAP => terpentecin [PATH:map01100], Rebeccamycin biosynthesis, tryptophan => rebeccamycin [PATH:map01100], Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin [PATH:map01100], dTDP-L-rhamnose biosynthesis [PATH:map01100], dTDP-6-deoxy-D-allose biosynthesis [PATH:map01100], dTDP-beta-L-noviose biosynthesis [PATH:map01100], dTDP-D-mycaminose biosynthesis [PATH:map01100], dTDP-D-desosamine biosynthesis [PATH:map01100], dTDP-L-mycarose biosynthesis [PATH:map01100], dTDP-L-oleandrose biosynthesis [PATH:map01100], dTDP-L-megosamine biosynthesis [PATH:map01100], dTDP-L-olivose biosynthesis [PATH:map01100], dTDP-D-forosamine biosynthesis [PATH:map01100], dTDP-D-angolosamine biosynthesis [PATH:map01100], Complete nitrification, comammox, ammonia => nitrite => nitrate [PATH:map01100], Staurosporine biosynthesis, tryptophan => staurosporine [PATH:map01100], Violacein biosynthesis, tryptophan => violacein [PATH:map01100], Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde [PATH:map01100], Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde [PATH:map01100], Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose [PATH:map01100], Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A [PATH:map01100], Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone [PATH:map01100], Chlortetracycline biosynthesis, pretetramide => chlortetracycline [PATH:map01100], 9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core [PATH:map01100], 10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core [PATH:map01100], C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA [PATH:map01100], 3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA [PATH:map01100], Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA [PATH:map01100], Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA [PATH:map01100], Calicheamicin biosynthesis, calicheamicinone => calicheamicin [PATH:map01100], Calicheamicin orsellinate moiety biosynthesis, malonyl-CoA => orsellinate-ACP => 5-iodo-2,3-dimethoxyorsellinate-ACP [PATH:map01100], Pyocyanine biosynthesis, chorismate => pyocyanine [PATH:map01100], Coenzyme F430 biosynthesis, sirohydrochlorin => coenzyme F430 [PATH:map01100], Prodigiosin biosynthesis, L-proline => prodigiosin [PATH:map01100], Undecylprodigiosin biosynthesis, L-proline => undecylprodigiosin [PATH:map01100], Tetrahydrofolate biosynthesis, mediated by ribA and trpF, GTP => THF [PATH:map01100], Tetrahydrofolate biosynthesis, mediated by PTPS, GTP => THF [PATH:map01100], Tetrahydrobiopterin biosynthesis, GTP => BH4 [PATH:map01100], L-threo-Tetrahydrobiopterin biosynthesis, GTP => L-threo-BH4 [PATH:map01100], Arginine biosynthesis, ornithine => arginine [PATH:map01100], Arginine biosynthesis, glutamate => acetylcitrulline => arginine [PATH:map01100], Siroheme biosynthesis, glutamate => siroheme [PATH:map01100], Heme biosynthesis, archaea, siroheme => heme [PATH:map01100], Aurachin biosynthesis, anthranilate => aurachin A [PATH:map01100], Glycogen biosynthesis, glucose-1P => glycogen/starch [PATH:map01100], Glycogen degradation, glycogen => glucose-6P [PATH:map01100], beta-Oxidation, peroxisome, VLCFA [PATH:map01100], beta-Oxidation, peroxisome, tri/dihydroxycholestanoyl-CoA => choloyl/chenodeoxycholoyl-CoA [PATH:map01100], KDO2-lipid A biosynthesis, Raetz pathway, non-LpxL-LpxM type [PATH:map01100], KDO2-lipid A modification pathway [PATH:map01100], Heme biosynthesis, animals and fungi, glycine => heme [PATH:map01100], O-glycan biosynthesis, mannose type (core M3) [PATH:map01100], Fatty acid biosynthesis in mitochondria, animals [PATH:map01100], Fatty acid biosynthesis in mitochondria, fungi [PATH:map01100], Staphyloferrin B biosynthesis, L-serine => staphyloferrin B [PATH:map01100], Staphyloferrin A biosynthesis, L-ornithine => staphyloferrin A [PATH:map01100], Kanosamine biosynthesis, glucose 6-phosphate => kanosamine [PATH:map01100]', 'Desmosterolosis, Urofacial syndrome, SEMD, Pakistani type, Multiple cutaneous and uterine leiomyomata, Calcification of joints and arteries, Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, Arts syndrome, Generalized arterial calcification of infancy', 'ko01100', 'map01100', 'Metabolic pathways', 'Metabolic pathways', 'Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate [PATH:map01100], Glycolysis, core module involving three-carbon compounds [PATH:map01100], Gluconeogenesis, oxaloacetate => fructose-6P [PATH:map01100], Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map01100], PRPP biosynthesis, ribose 5P => PRPP [PATH:map01100], Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map01100], Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map01100], Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map01100], Citrate cycle (TCA cycle, Krebs cycle) [PATH:map01100], Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map01100], Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:map01100], Glyoxylate cycle [PATH:map01100], Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA [PATH:map01100], Glucuronate pathway (uronate pathway) [PATH:map01100], Proline biosynthesis, glutamate => proline [PATH:map01100], Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine [PATH:map01100], Methionine biosynthesis, apartate => homoserine => methionine [PATH:map01100], Threonine biosynthesis, aspartate => homoserine => threonine [PATH:map01100], Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map01100], Serine biosynthesis, glycerate-3P => serine [PATH:map01100], Cysteine biosynthesis, serine => cysteine [PATH:map01100], Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map01100], Tryptophan biosynthesis, chorismate => tryptophan [PATH:map01100], Phenylalanine biosynthesis, chorismate => phenylalanine [PATH:map01100], Tyrosine biosynthesis, chorismate => tyrosine [PATH:map01100], Histidine biosynthesis, PRPP => histidine [PATH:map01100], GABA (gamma-Aminobutyrate) shunt [PATH:map01100], Ornithine biosynthesis, glutamate => ornithine [PATH:map01100], Urea cycle [PATH:map01100], Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine [PATH:map01100], Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine [PATH:map01100], Lysine degradation, lysine => saccharopine => acetoacetyl-CoA [PATH:map01100], Ectoine biosynthesis, aspartate => ectoine [PATH:map01100], Methionine salvage pathway [PATH:map01100], Methionine degradation [PATH:map01100], Leucine degradation, leucine => acetoacetate + acetyl-CoA [PATH:map01100], Melatonin biosynthesis, tryptophan => serotonin => melatonin [PATH:map01100], Tryptophan metabolism, tryptophan => kynurenine => 2-aminomuconate [PATH:map01100], Monolignol biosynthesis, phenylalanine/tyrosine => monolignol [PATH:map01100], Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine [PATH:map01100], Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline [PATH:map01100], Thyroid hormone biosynthesis, tyrosine => triiodothyronine/thyroxine [PATH:map01100], Tyrosine degradation, tyrosine => homogentisate [PATH:map01100], Histidine degradation, histidine => N-formiminoglutamate => glutamate [PATH:map01100], Pyrimidine degradation, uracil => beta-alanine, thymine => 3-aminoisobutanoate [PATH:map01100], Creatine pathway [PATH:map01100], Inosine monophosphate biosynthesis, PRPP + glutamine => IMP [PATH:map01100], Adenine ribonucleotide biosynthesis, IMP => ADP,ATP [PATH:map01100], Guanine ribonucleotide biosynthesis IMP => GDP,GTP [PATH:map01100], Uridine monophosphate biosynthesis, glutamine (+ PRPP) => UMP [PATH:map01100], Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP [PATH:map01100], Pyrimidine deoxyribonuleotide biosynthesis, CDP/CTP => dCDP/dCTP,dTDP/dTTP [PATH:map01100], N-glycan precursor biosynthesis [PATH:map01100], O-glycan biosynthesis, mucin type core [PATH:map01100], Glycosaminoglycan biosynthesis, linkage tetrasaccharide [PATH:map01100], Glycosaminoglycan biosynthesis, chondroitin sulfate backbone [PATH:map01100], Glycosaminoglycan biosynthesis, heparan sulfate backbone [PATH:map01100], KDO2-lipid A biosynthesis, Raetz pathway, LpxL-LpxM type [PATH:map01100], D-Glucuronate degradation, D-glucuronate => pyruvate + D-glyceraldehyde 3P [PATH:map01100], CMP-KDO biosynthesis [PATH:map01100], ADP-L-glycero-D-manno-heptose biosynthesis [PATH:map01100], GPI-anchor biosynthesis, core oligosaccharide [PATH:map01100], Lactosylceramide biosynthesis [PATH:map01100], Sulfoglycolipids biosynthesis, ceramide/1-alkyl-2-acylglycerol => sulfatide/seminolipid [PATH:map01100], Glycosphingolipid biosynthesis, globo-series, LacCer => Gb4Cer [PATH:map01100], Glycosphingolipid biosynthesis, ganglio series, LacCer => GT3 [PATH:map01100], Glycosphingolipid biosynthesis, lacto-series, LacCer => Lc4Cer [PATH:map01100], Glycosphingolipid biosynthesis, neolacto-series, LacCer => nLc4Cer [PATH:map01100], N-glycosylation by oligosaccharyltransferase [PATH:map01100], N-glycan precursor trimming [PATH:map01100], N-glycan biosynthesis, high-mannose type [PATH:map01100], N-glycan biosynthesis, complex type [PATH:map01100], Dermatan sulfate degradation [PATH:map01100], Chondroitin sulfate degradation [PATH:map01100], Heparan sulfate degradation [PATH:map01100], Keratan sulfate degradation [PATH:map01100], Pectin degradation [PATH:map01100], Fatty acid biosynthesis, initiation [PATH:map01100], Fatty acid biosynthesis, elongation [PATH:map01100], Fatty acid elongation in mitochondria [PATH:map01100], beta-Oxidation, acyl-CoA synthesis [PATH:map01100], beta-Oxidation [PATH:map01100], Ketone body biosynthesis, acetyl-CoA => acetoacetate/3-hydroxybutyrate/acetone [PATH:map01100], Triacylglycerol biosynthesis [PATH:map01100], Phosphatidylcholine (PC) biosynthesis, choline => PC [PATH:map01100], Phosphatidylcholine (PC) biosynthesis, PE => PC [PATH:map01100], Phosphatidylethanolamine (PE) biosynthesis, ethanolamine => PE [PATH:map01100], Phosphatidylethanolamine (PE) biosynthesis, PA => PS => PE [PATH:map01100], Ceramide biosynthesis [PATH:map01100], C5 isoprenoid biosynthesis, mevalonate pathway [PATH:map01100], C5 isoprenoid biosynthesis, non-mevalonate pathway [PATH:map01100], beta-Carotene biosynthesis, GGAP => beta-carotene [PATH:map01100], Acylglycerol degradation [PATH:map01100], Sphingosine biosynthesis [PATH:map01100], Sphingosine degradation [PATH:map01100], Cholesterol biosynthesis, squalene 2,3-epoxide => cholesterol [PATH:map01100], Ergocalciferol biosynthesis [PATH:map01100], Cholecalciferol biosynthesis [PATH:map01100], Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate [PATH:map01100], Conjugated bile acid biosynthesis, cholate => taurocholate/glycocholate [PATH:map01100], Steroid hormone biosynthesis, cholesterol => prognenolone => progesterone [PATH:map01100], C21-Steroid hormone biosynthesis, progesterone => corticosterone/aldosterone [PATH:map01100], C21-Steroid hormone biosynthesis, progesterone => cortisol/cortisone [PATH:map01100], C19/C18-Steroid hormone biosynthesis, pregnenolone => androstenedione => estrone [PATH:map01100], Tocopherol/tocotorienol biosynthesis [PATH:map01100], Jasmonic acid biosynthesis [PATH:map01100], Ascorbate biosynthesis, plants, glucose-6P => ascorbate [PATH:map01100], NAD biosynthesis, aspartate => NAD [PATH:map01100], Menaquinone biosynthesis, chorismate => menaquinol [PATH:map01100], Ubiquinone biosynthesis, prokaryotes, chorismate => ubiquinone [PATH:map01100], Glutathione biosynthesis, glutamate => glutathione [PATH:map01100], Pantothenate biosynthesis, valine/L-aspartate => pantothenate [PATH:map01100], Coenzyme A biosynthesis, pantothenate => CoA [PATH:map01100], Heme biosynthesis, plants and bacteria, glutamate => heme [PATH:map01100], Cobalamin biosynthesis, cobinamide => cobalamin [PATH:map01100], Biotin biosynthesis, pimeloyl-ACP/CoA => biotin [PATH:map01100], Pyridoxal biosynthesis, erythrose-4P => pyridoxal-5P [PATH:map01100], Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD [PATH:map01100], Tetrahydrofolate biosynthesis, GTP => THF [PATH:map01100], Thiamine biosynthesis, AIR => thiamine-P/thiamine-2P [PATH:map01100], Ubiquinone biosynthesis, eukaryotes, 4-hydroxybenzoate => ubiquinone [PATH:map01100], Ascorbate biosynthesis, animals, glucose-1P => ascorbate [PATH:map01100], Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4 [PATH:map01100], Inositol phosphate metabolism, Ins(1,3,4,5)P4 => Ins(1,3,4)P3 => myo-inositol [PATH:map01100], Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate [PATH:map01100], Polyamine biosynthesis, arginine => agmatine => putrescine => spermidine [PATH:map01100], Polyamine biosynthesis, arginine => ornithine => putrescine [PATH:map01100], GABA biosynthesis, eukaryotes, putrescine => GABA [PATH:map01100], GABA biosynthesis, prokaryotes, putrescine => GABA [PATH:map01100], Flavanone biosynthesis, phenylalanine => naringenin [PATH:map01100], Flavonoid biosynthesis, naringenin => pelargonidin [PATH:map01100], C1-unit interconversion, prokaryotes [PATH:map01100], C1-unit interconversion, eukaryotes [PATH:map01100], Reductive pentose phosphate cycle (Calvin cycle) [PATH:map01100], Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P [PATH:map01100], Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P [PATH:map01100], CAM (Crassulacean acid metabolism), dark [PATH:map01100], CAM (Crassulacean acid metabolism), light [PATH:map01100], C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type [PATH:map01100], C4-dicarboxylic acid cycle, NAD - malic enzyme type [PATH:map01100], C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map01100], Reductive citrate cycle (Arnon-Buchanan cycle) [PATH:map01100], Methane oxidation, methanotroph, methane => formaldehyde [PATH:map01100], Nitrogen fixation, nitrogen => ammonia [PATH:map01100], Assimilatory sulfate reduction, sulfate => H2S [PATH:map01100], Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map01100], Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map01100], Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map01100], Cysteine biosynthesis, homocysteine + serine => cysteine [PATH:map01100], Formaldehyde assimilation, xylulose monophosphate pathway [PATH:map01100], Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map01100], Formaldehyde assimilation, serine pathway [PATH:map01100], Methanogenesis, methanol => methane [PATH:map01100], Methanogenesis, acetate => methane [PATH:map01100], Coenzyme M biosynthesis [PATH:map01100], C10-C20 isoprenoid biosynthesis, bacteria [PATH:map01100], C10-C20 isoprenoid biosynthesis, archaea [PATH:map01100], C10-C20 isoprenoid biosynthesis, plants [PATH:map01100], C10-C20 isoprenoid biosynthesis, non-plant eukaryotes [PATH:map01100], Ethylene biosynthesis, methionine => ethylene [PATH:map01100], Cyanogenic glycoside biosynthesis, tyrosine => dhurrin [PATH:map01100], Glucosinolate biosynthesis, tryptophan => glucobrassicin [PATH:map01100], Castasterone biosynthesis, campesterol => castasterone [PATH:map01100], Abscisic acid biosynthesis, beta-carotene => abscisic acid [PATH:map01100], Ethylmalonyl pathway [PATH:map01100], Dicarboxylate-hydroxybutyrate cycle [PATH:map01100], Hydroxypropionate-hydroxybutylate cycle [PATH:map01100], 3-Hydroxypropionate bi-cycle [PATH:map01100], Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [PATH:map01100], F420 biosynthesis [PATH:map01100], Fatty acid elongation in endoplasmic reticulum [PATH:map01100], Toluene degradation, anaerobic, toluene => benzoyl-CoA [PATH:map01100], Cymene degradation, p-cymene => p-cumate [PATH:map01100], Acetyl-CoA pathway, CO2 => acetyl-CoA [PATH:map01100], Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map01100], Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate [PATH:map01100], Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine [PATH:map01100], Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine [PATH:map01100], Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine [PATH:map01100], Nitrification, ammonia => nitrite [PATH:map01100], Denitrification, nitrate => nitrogen [PATH:map01100], Dissimilatory nitrate reduction, nitrate => ammonia [PATH:map01100], Assimilatory nitrate reduction, nitrate => ammonia [PATH:map01100], Photorespiration [PATH:map01100], Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate [PATH:map01100], Naphthalene degradation, naphthalene => salicylate [PATH:map01100], Isoleucine biosynthesis, pyruvate => 2-oxobutanoate [PATH:map01100], Xylene degradation, xylene => methylbenzoate [PATH:map01100], Toluene degradation, toluene => benzoate [PATH:map01100], Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate [PATH:map01100], Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA [PATH:map01100], Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA [PATH:map01100], Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate [PATH:map01100], Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate [PATH:map01100], Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA [PATH:map01100], Purine degradation, xanthine => urea [PATH:map01100], Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map01100], Benzene degradation, benzene => catechol [PATH:map01100], Nucleotide sugar biosynthesis, glucose => UDP-glucose [PATH:map01100], Ascorbate degradation, ascorbate => D-xylulose-5P [PATH:map01100], Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map01100], D-galactonate degradation, De Ley-Doudoroff pathway, D-galactonate => glycerate-3P [PATH:map01100], Nucleotide sugar biosynthesis, galactose => UDP-galactose [PATH:map01100], Betaine biosynthesis, choline => betaine [PATH:map01100], Methanogenesis, methylamine/dimethylamine/trimethylamine => methane [PATH:map01100], Trehalose biosynthesis, D-glucose 1P => trehalose [PATH:map01100], Methanogenesis, CO2 => methane [PATH:map01100], Catechol ortho-cleavage, catechol => 3-oxoadipate [PATH:map01100], Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map01100], Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine [PATH:map01100], Pimeloyl-ACP biosynthesis, BioC-BioH pathway, malonyl-ACP => pimeloyl-ACP [PATH:map01100], Biotin biosynthesis, BioI pathway, long-chain-acyl-ACP => pimeloyl-ACP => biotin [PATH:map01100], Biotin biosynthesis, BioW pathway, pimelate => pimeloyl-CoA => biotin [PATH:map01100], Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map01100], Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map01100], Thiosulfate oxidation by SOX complex, thiosulfate => sulfate [PATH:map01100], Dissimilatory sulfate reduction, sulfate => H2S [PATH:map01100], 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map01100], Cysteine biosynthesis, methionine => cysteine [PATH:map01100], Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate [PATH:map01100], Nicotinate degradation, nicotinate => fumarate [PATH:map01100], Phthalate degradation, phthalate => protocatechuate [PATH:map01100], Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate [PATH:map01100], D-Galacturonate degradation (fungi), D-galacturonate => glycerol [PATH:map01100], D-Galacturonate degradation (bacteria), D-galacturonate => pyruvate + D-glyceraldehyde 3P [PATH:map01100], Galactose degradation, Leloir pathway, galactose => alpha-D-glucose-1P [PATH:map01100], Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map01100], Phthalate degradation, phthalate => protocatechuate [PATH:map01100], Anthranilate degradation, anthranilate => catechol [PATH:map01100], Salicylate degradation, salicylate => gentisate [PATH:map01100], Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline [PATH:map01100], Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin [PATH:map01100], Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate [PATH:map01100], Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate [PATH:map01100], Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A [PATH:map01100], Methylaspartate cycle [PATH:map01100], Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA [PATH:map01100], Undecaprenylphosphate alpha-L-Ara4N biosynthesis, UDP-GlcA => undecaprenyl phosphate alpha-L-Ara4N [PATH:map01100], Ornithine biosynthesis, mediated by LysW, glutamate => ornithine [PATH:map01100], Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin [PATH:map01100], Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B [PATH:map01100], Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin [PATH:map01100], Pikromycin/methymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin [PATH:map01100], Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b [PATH:map01100], Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide [PATH:map01100], Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin [PATH:map01100], Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline [PATH:map01100], Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone [PATH:map01100], Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin [PATH:map01100], Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C [PATH:map01100], Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A [PATH:map01100], Cycloserine biosynthesis, arginine/serine => cycloserine [PATH:map01100], Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A [PATH:map01100], Bacilysin biosynthesis, prephenate => bacilysin [PATH:map01100], Terpentecin biosynthesis, GGAP => terpentecin [PATH:map01100], Rebeccamycin biosynthesis, tryptophan => rebeccamycin [PATH:map01100], Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin [PATH:map01100], dTDP-L-rhamnose biosynthesis [PATH:map01100], dTDP-6-deoxy-D-allose biosynthesis [PATH:map01100], dTDP-beta-L-noviose biosynthesis [PATH:map01100], dTDP-D-mycaminose biosynthesis [PATH:map01100], dTDP-D-desosamine biosynthesis [PATH:map01100], dTDP-L-mycarose biosynthesis [PATH:map01100], dTDP-L-oleandrose biosynthesis [PATH:map01100], dTDP-L-megosamine biosynthesis [PATH:map01100], dTDP-L-olivose biosynthesis [PATH:map01100], dTDP-D-forosamine biosynthesis [PATH:map01100], dTDP-D-angolosamine biosynthesis [PATH:map01100], Complete nitrification, comammox, ammonia => nitrite => nitrate [PATH:map01100], Staurosporine biosynthesis, tryptophan => staurosporine [PATH:map01100], Violacein biosynthesis, tryptophan => violacein [PATH:map01100], Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde [PATH:map01100], Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde [PATH:map01100], Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose [PATH:map01100], Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A [PATH:map01100], Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone [PATH:map01100], Chlortetracycline biosynthesis, pretetramide => chlortetracycline [PATH:map01100], 9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core [PATH:map01100], 10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core [PATH:map01100], C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA [PATH:map01100], 3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA [PATH:map01100], Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA [PATH:map01100], Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA [PATH:map01100], Calicheamicin biosynthesis, calicheamicinone => calicheamicin [PATH:map01100], Calicheamicin orsellinate moiety biosynthesis, malonyl-CoA => orsellinate-ACP => 5-iodo-2,3-dimethoxyorsellinate-ACP [PATH:map01100], Pyocyanine biosynthesis, chorismate => pyocyanine [PATH:map01100], Coenzyme F430 biosynthesis, sirohydrochlorin => coenzyme F430 [PATH:map01100], Prodigiosin biosynthesis, L-proline => prodigiosin [PATH:map01100], Undecylprodigiosin biosynthesis, L-proline => undecylprodigiosin [PATH:map01100], Tetrahydrofolate biosynthesis, mediated by ribA and trpF, GTP => THF [PATH:map01100], Tetrahydrofolate biosynthesis, mediated by PTPS, GTP => THF [PATH:map01100], Tetrahydrobiopterin biosynthesis, GTP => BH4 [PATH:map01100], L-threo-Tetrahydrobiopterin biosynthesis, GTP => L-threo-BH4 [PATH:map01100], Arginine biosynthesis, ornithine => arginine [PATH:map01100], Arginine biosynthesis, glutamate => acetylcitrulline => arginine [PATH:map01100], Siroheme biosynthesis, glutamate => siroheme [PATH:map01100], Heme biosynthesis, archaea, siroheme => heme [PATH:map01100], Aurachin biosynthesis, anthranilate => aurachin A [PATH:map01100], Glycogen biosynthesis, glucose-1P => glycogen/starch [PATH:map01100], Glycogen degradation, glycogen => glucose-6P [PATH:map01100], beta-Oxidation, peroxisome, VLCFA [PATH:map01100], beta-Oxidation, peroxisome, tri/dihydroxycholestanoyl-CoA => choloyl/chenodeoxycholoyl-CoA [PATH:map01100], KDO2-lipid A biosynthesis, Raetz pathway, non-LpxL-LpxM type [PATH:map01100], KDO2-lipid A modification pathway [PATH:map01100], Heme biosynthesis, animals and fungi, glycine => heme [PATH:map01100], O-glycan biosynthesis, mannose type (core M3) [PATH:map01100], Fatty acid biosynthesis in mitochondria, animals [PATH:map01100], Fatty acid biosynthesis in mitochondria, fungi [PATH:map01100], Staphyloferrin B biosynthesis, L-serine => staphyloferrin B [PATH:map01100], Staphyloferrin A biosynthesis, L-ornithine => staphyloferrin A [PATH:map01100], Kanosamine biosynthesis, glucose 6-phosphate => kanosamine [PATH:map01100]', 531, 5573, 248, 105, 128, 50, 5274, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (179, '01110', 'Biosynthesis of secondary metabolites', 'Biosynthesis of secondary metabolites', 'Glyoxylate cycle [PATH:map01110], Threonine biosynthesis, aspartate => homoserine => threonine [PATH:map01110], Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map01110], Cysteine biosynthesis, serine => cysteine [PATH:map01110], Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map01110], Tryptophan biosynthesis, chorismate => tryptophan [PATH:map01110], Phenylalanine biosynthesis, chorismate => phenylalanine [PATH:map01110], Histidine biosynthesis, PRPP => histidine [PATH:map01110], Monolignol biosynthesis, phenylalanine/tyrosine => monolignol [PATH:map01110], Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine [PATH:map01110], C5 isoprenoid biosynthesis, mevalonate pathway [PATH:map01110], C5 isoprenoid biosynthesis, non-mevalonate pathway [PATH:map01110], beta-Carotene biosynthesis, GGAP => beta-carotene [PATH:map01110], Tocopherol/tocotorienol biosynthesis [PATH:map01110], Jasmonic acid biosynthesis [PATH:map01110], Ascorbate biosynthesis, plants, glucose-6P => ascorbate [PATH:map01110], Menaquinone biosynthesis, chorismate => menaquinol [PATH:map01110], Ubiquinone biosynthesis, prokaryotes, chorismate => ubiquinone [PATH:map01110], Pantothenate biosynthesis, valine/L-aspartate => pantothenate [PATH:map01110], Heme biosynthesis, plants and bacteria, glutamate => heme [PATH:map01110], Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD [PATH:map01110], Flavanone biosynthesis, phenylalanine => naringenin [PATH:map01110], Flavonoid biosynthesis, naringenin => pelargonidin [PATH:map01110], C10-C20 isoprenoid biosynthesis, bacteria [PATH:map01110], C10-C20 isoprenoid biosynthesis, archaea [PATH:map01110], C10-C20 isoprenoid biosynthesis, plants [PATH:map01110], C10-C20 isoprenoid biosynthesis, non-plant eukaryotes [PATH:map01110], Ethylene biosynthesis, methionine => ethylene [PATH:map01110], Cyanogenic glycoside biosynthesis, tyrosine => dhurrin [PATH:map01110], Glucosinolate biosynthesis, tryptophan => glucobrassicin [PATH:map01110], Castasterone biosynthesis, campesterol => castasterone [PATH:map01110], Abscisic acid biosynthesis, beta-carotene => abscisic acid [PATH:map01110], Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map01110], Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine [PATH:map01110], Photorespiration [PATH:map01110], Trehalose biosynthesis, D-glucose 1P => trehalose [PATH:map01110], Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline [PATH:map01110], Siroheme biosynthesis, glutamate => siroheme [PATH:map01110], Heme biosynthesis, archaea, siroheme => heme [PATH:map01110], C5 isoprenoid biosynthesis, mevalonate pathway, archaea [PATH:map01110]', 'ko01110', 'map01110', 'Biosynthesis of secondary metabolites', 'Biosynthesis of secondary metabolites', 'Glyoxylate cycle [PATH:map01110], Threonine biosynthesis, aspartate => homoserine => threonine [PATH:map01110], Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map01110], Cysteine biosynthesis, serine => cysteine [PATH:map01110], Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map01110], Tryptophan biosynthesis, chorismate => tryptophan [PATH:map01110], Phenylalanine biosynthesis, chorismate => phenylalanine [PATH:map01110], Histidine biosynthesis, PRPP => histidine [PATH:map01110], Monolignol biosynthesis, phenylalanine/tyrosine => monolignol [PATH:map01110], Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine [PATH:map01110], C5 isoprenoid biosynthesis, mevalonate pathway [PATH:map01110], C5 isoprenoid biosynthesis, non-mevalonate pathway [PATH:map01110], beta-Carotene biosynthesis, GGAP => beta-carotene [PATH:map01110], Tocopherol/tocotorienol biosynthesis [PATH:map01110], Jasmonic acid biosynthesis [PATH:map01110], Ascorbate biosynthesis, plants, glucose-6P => ascorbate [PATH:map01110], Menaquinone biosynthesis, chorismate => menaquinol [PATH:map01110], Ubiquinone biosynthesis, prokaryotes, chorismate => ubiquinone [PATH:map01110], Pantothenate biosynthesis, valine/L-aspartate => pantothenate [PATH:map01110], Heme biosynthesis, plants and bacteria, glutamate => heme [PATH:map01110], Riboflavin biosynthesis, GTP => riboflavin/FMN/FAD [PATH:map01110], Flavanone biosynthesis, phenylalanine => naringenin [PATH:map01110], Flavonoid biosynthesis, naringenin => pelargonidin [PATH:map01110], C10-C20 isoprenoid biosynthesis, bacteria [PATH:map01110], C10-C20 isoprenoid biosynthesis, archaea [PATH:map01110], C10-C20 isoprenoid biosynthesis, plants [PATH:map01110], C10-C20 isoprenoid biosynthesis, non-plant eukaryotes [PATH:map01110], Ethylene biosynthesis, methionine => ethylene [PATH:map01110], Cyanogenic glycoside biosynthesis, tyrosine => dhurrin [PATH:map01110], Glucosinolate biosynthesis, tryptophan => glucobrassicin [PATH:map01110], Castasterone biosynthesis, campesterol => castasterone [PATH:map01110], Abscisic acid biosynthesis, beta-carotene => abscisic acid [PATH:map01110], Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map01110], Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine [PATH:map01110], Photorespiration [PATH:map01110], Trehalose biosynthesis, D-glucose 1P => trehalose [PATH:map01110], Paspaline biosynthesis, geranylgeranyl-PP + indoleglycerol phosphate => paspaline [PATH:map01110], Siroheme biosynthesis, glutamate => siroheme [PATH:map01110], Heme biosynthesis, archaea, siroheme => heme [PATH:map01110], C5 isoprenoid biosynthesis, mevalonate pathway, archaea [PATH:map01110]', 'ko01110', 283, 5573, 0, 105, 128, 50, 5274, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (180, '01120', 'Microbial metabolism in diverse environments', 'Microbial metabolism in diverse environments', 'Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map01120], Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map01120], Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map01120], Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map01120], Ectoine biosynthesis, aspartate => ectoine [PATH:map01120], Reductive pentose phosphate cycle (Calvin cycle) [PATH:map01120], Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P [PATH:map01120], Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P [PATH:map01120], CAM (Crassulacean acid metabolism), dark [PATH:map01120], CAM (Crassulacean acid metabolism), light [PATH:map01120], C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type [PATH:map01120], C4-dicarboxylic acid cycle, NAD - malic enzyme type [PATH:map01120], C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map01120], Reductive citrate cycle (Arnon-Buchanan cycle) [PATH:map01120], Methane oxidation, methanotroph, methane => formaldehyde [PATH:map01120], Nitrogen fixation, nitrogen => ammonia [PATH:map01120], Assimilatory sulfate reduction, sulfate => H2S [PATH:map01120], Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map01120], Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map01120], Formaldehyde assimilation, xylulose monophosphate pathway [PATH:map01120], Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map01120], Formaldehyde assimilation, serine pathway [PATH:map01120], Methanogenesis, methanol => methane [PATH:map01120], Methanogenesis, acetate => methane [PATH:map01120], Coenzyme M biosynthesis [PATH:map01120], Ethylmalonyl pathway [PATH:map01120], Dicarboxylate-hydroxybutyrate cycle [PATH:map01120], Hydroxypropionate-hydroxybutylate cycle [PATH:map01120], 3-Hydroxypropionate bi-cycle [PATH:map01120], Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [PATH:map01120], F420 biosynthesis [PATH:map01120], Toluene degradation, anaerobic, toluene => benzoyl-CoA [PATH:map01120], Cymene degradation, p-cymene => p-cumate [PATH:map01120], Acetyl-CoA pathway, CO2 => acetyl-CoA [PATH:map01120], Nitrification, ammonia => nitrite [PATH:map01120], Denitrification, nitrate => nitrogen [PATH:map01120], Dissimilatory nitrate reduction, nitrate => ammonia [PATH:map01120], Assimilatory nitrate reduction, nitrate => ammonia [PATH:map01120], Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate [PATH:map01120], Naphthalene degradation, naphthalene => salicylate [PATH:map01120], Xylene degradation, xylene => methylbenzoate [PATH:map01120], Toluene degradation, toluene => benzoate [PATH:map01120], Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate [PATH:map01120], Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA [PATH:map01120], Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA [PATH:map01120], Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate [PATH:map01120], Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate [PATH:map01120], Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA [PATH:map01120], Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map01120], Benzene degradation, benzene => catechol [PATH:map01120], Ascorbate degradation, ascorbate => D-xylulose-5P [PATH:map01120], Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map01120], Methanogenesis, methylamine/dimethylamine/trimethylamine => methane [PATH:map01120], Methanogenesis, CO2 => methane [PATH:map01120], Catechol ortho-cleavage, catechol => 3-oxoadipate [PATH:map01120], Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map01120], Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map01120], Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map01120], Thiosulfate oxidation by SOX complex, thiosulfate => sulfate [PATH:map01120], Dissimilatory sulfate reduction, sulfate => H2S [PATH:map01120], 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map01120], Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate [PATH:map01120], Nicotinate degradation, nicotinate => fumarate [PATH:map01120], Phthalate degradation, phthalate => protocatechuate [PATH:map01120], Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate [PATH:map01120], Phthalate degradation, phthalate => protocatechuate [PATH:map01120], Anthranilate degradation, anthranilate => catechol [PATH:map01120], Salicylate degradation, salicylate => gentisate [PATH:map01120], Methylaspartate cycle [PATH:map01120], Complete nitrification, comammox, ammonia => nitrite => nitrate [PATH:map01120], Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde [PATH:map01120], Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde [PATH:map01120], Coenzyme F430 biosynthesis, sirohydrochlorin => coenzyme F430 [PATH:map01120]', 'ko01120', 'map01120', 'Microbial metabolism in diverse environments', 'Microbial metabolism in diverse environments', 'Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map01120], Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map01120], Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map01120], Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map01120], Ectoine biosynthesis, aspartate => ectoine [PATH:map01120], Reductive pentose phosphate cycle (Calvin cycle) [PATH:map01120], Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P [PATH:map01120], Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P [PATH:map01120], CAM (Crassulacean acid metabolism), dark [PATH:map01120], CAM (Crassulacean acid metabolism), light [PATH:map01120], C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type [PATH:map01120], C4-dicarboxylic acid cycle, NAD - malic enzyme type [PATH:map01120], C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map01120], Reductive citrate cycle (Arnon-Buchanan cycle) [PATH:map01120], Methane oxidation, methanotroph, methane => formaldehyde [PATH:map01120], Nitrogen fixation, nitrogen => ammonia [PATH:map01120], Assimilatory sulfate reduction, sulfate => H2S [PATH:map01120], Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map01120], Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map01120], Formaldehyde assimilation, xylulose monophosphate pathway [PATH:map01120], Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map01120], Formaldehyde assimilation, serine pathway [PATH:map01120], Methanogenesis, methanol => methane [PATH:map01120], Methanogenesis, acetate => methane [PATH:map01120], Coenzyme M biosynthesis [PATH:map01120], Ethylmalonyl pathway [PATH:map01120], Dicarboxylate-hydroxybutyrate cycle [PATH:map01120], Hydroxypropionate-hydroxybutylate cycle [PATH:map01120], 3-Hydroxypropionate bi-cycle [PATH:map01120], Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [PATH:map01120], F420 biosynthesis [PATH:map01120], Toluene degradation, anaerobic, toluene => benzoyl-CoA [PATH:map01120], Cymene degradation, p-cymene => p-cumate [PATH:map01120], Acetyl-CoA pathway, CO2 => acetyl-CoA [PATH:map01120], Nitrification, ammonia => nitrite [PATH:map01120], Denitrification, nitrate => nitrogen [PATH:map01120], Dissimilatory nitrate reduction, nitrate => ammonia [PATH:map01120], Assimilatory nitrate reduction, nitrate => ammonia [PATH:map01120], Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate [PATH:map01120], Naphthalene degradation, naphthalene => salicylate [PATH:map01120], Xylene degradation, xylene => methylbenzoate [PATH:map01120], Toluene degradation, toluene => benzoate [PATH:map01120], Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate [PATH:map01120], Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA [PATH:map01120], Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA [PATH:map01120], Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate [PATH:map01120], Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate [PATH:map01120], Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA [PATH:map01120], Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map01120], Benzene degradation, benzene => catechol [PATH:map01120], Ascorbate degradation, ascorbate => D-xylulose-5P [PATH:map01120], Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map01120], Methanogenesis, methylamine/dimethylamine/trimethylamine => methane [PATH:map01120], Methanogenesis, CO2 => methane [PATH:map01120], Catechol ortho-cleavage, catechol => 3-oxoadipate [PATH:map01120], Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map01120], Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map01120], Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map01120], Thiosulfate oxidation by SOX complex, thiosulfate => sulfate [PATH:map01120], Dissimilatory sulfate reduction, sulfate => H2S [PATH:map01120], 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map01120], Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate [PATH:map01120], Nicotinate degradation, nicotinate => fumarate [PATH:map01120], Phthalate degradation, phthalate => protocatechuate [PATH:map01120], Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate [PATH:map01120], Phthalate degradation, phthalate => protocatechuate [PATH:map01120], Anthranilate degradation, anthranilate => catechol [PATH:map01120], Salicylate degradation, salicylate => gentisate [PATH:map01120], Methylaspartate cycle [PATH:map01120], Complete nitrification, comammox, ammonia => nitrite => nitrate [PATH:map01120], Nicotine degradation, pyridine pathway, nicotine => 2,6-dihydroxypyridine/succinate semialdehyde [PATH:map01120], Nicotine degradation, pyrrolidine pathway, nicotine => succinate semialdehyde [PATH:map01120], Coenzyme F430 biosynthesis, sirohydrochlorin => coenzyme F430 [PATH:map01120]', 'ko01120', 0, 5573, 0, 0, 0, 0, 5274, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (181, '01130', 'Biosynthesis of antibiotics', 'Biosynthesis of antibiotics', 'Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map01130], Ergocalciferol biosynthesis [PATH:map01130], C10-C20 isoprenoid biosynthesis, bacteria [PATH:map01130], Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin [PATH:map01130], Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C [PATH:map01130], Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate [PATH:map01130], Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate [PATH:map01130], Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A [PATH:map01130], Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin [PATH:map01130], Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B [PATH:map01130], Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin [PATH:map01130], Pikromycin/methymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin [PATH:map01130], Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b [PATH:map01130], Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide [PATH:map01130], Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin [PATH:map01130], Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline [PATH:map01130], Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone [PATH:map01130], Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin [PATH:map01130], Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C [PATH:map01130], Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A [PATH:map01130], Cycloserine biosynthesis, arginine/serine => cycloserine [PATH:map01130], Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A [PATH:map01130], Bacilysin biosynthesis, prephenate => bacilysin [PATH:map01130], Terpentecin biosynthesis, GGAP => terpentecin [PATH:map01130], Rebeccamycin biosynthesis, tryptophan => rebeccamycin [PATH:map01130], Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin [PATH:map01130], dTDP-L-rhamnose biosynthesis [PATH:map01130], dTDP-6-deoxy-D-allose biosynthesis [PATH:map01130], dTDP-beta-L-noviose biosynthesis [PATH:map01130], dTDP-D-mycaminose biosynthesis [PATH:map01130], dTDP-D-desosamine biosynthesis [PATH:map01130], dTDP-L-mycarose biosynthesis [PATH:map01130], dTDP-L-oleandrose biosynthesis [PATH:map01130], dTDP-L-megosamine biosynthesis [PATH:map01130], dTDP-L-olivose biosynthesis [PATH:map01130], dTDP-D-forosamine biosynthesis [PATH:map01130], dTDP-D-angolosamine biosynthesis [PATH:map01130], Staurosporine biosynthesis, tryptophan => staurosporine [PATH:map01130], Violacein biosynthesis, tryptophan => violacein [PATH:map01130], Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose [PATH:map01130], Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A [PATH:map01130], Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone [PATH:map01130], Chlortetracycline biosynthesis, pretetramide => chlortetracycline [PATH:map01130], 9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core [PATH:map01130], 10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core [PATH:map01130], C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA [PATH:map01130], C-1027 beta-amino acid moiety biosynthesis, tyrosine => 3-chloro-4,5-dihydroxy-beta-phenylalanyl-PCP [PATH:map01130], Maduropeptin beta-hydroxy acid moiety biosynthesis, tyrosine => 3-(4-hydroxyphenyl)-3-oxopropanoyl-PCP [PATH:map01130], 3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA [PATH:map01130], Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA [PATH:map01130], Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA [PATH:map01130], Kedarcidin 2-aza-3-chloro-beta-tyrosine moiety biosynthesis, azatyrosine => 2-aza-3-chloro-beta-tyrosyl-PCP [PATH:map01130], Calicheamicin biosynthesis, calicheamicinone => calicheamicin [PATH:map01130], Calicheamicin orsellinate moiety biosynthesis, malonyl-CoA => orsellinate-ACP => 5-iodo-2,3-dimethoxyorsellinate-ACP [PATH:map01130], Pyocyanine biosynthesis, chorismate => pyocyanine [PATH:map01130], Prodigiosin biosynthesis, L-proline => prodigiosin [PATH:map01130], Undecylprodigiosin biosynthesis, L-proline => undecylprodigiosin [PATH:map01130], Aurachin biosynthesis, anthranilate => aurachin A [PATH:map01130], C5 isoprenoid biosynthesis, mevalonate pathway, archaea [PATH:map01130]', 'ko01130', 'map01130', 'Biosynthesis of antibiotics', 'Biosynthesis of antibiotics', 'Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map01130], Ergocalciferol biosynthesis [PATH:map01130], C10-C20 isoprenoid biosynthesis, bacteria [PATH:map01130], Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin [PATH:map01130], Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C [PATH:map01130], Clavaminate biosynthesis, arginine + glyceraldehyde-3P => clavaminate [PATH:map01130], Carbapenem-3-carboxylate biosynthesis, pyrroline-5-carboxylate + malonyl-CoA => carbapenem-3-carboxylate [PATH:map01130], Nocardicin A biosynthesis, L-pHPG + arginine + serine => nocardicin A [PATH:map01130], Tylosin biosynthesis, methylmalonyl-CoA + malonyl-CoA => tylactone => tylosin [PATH:map01130], Erythromycin biosynthesis, propanoyl-CoA + methylmalonyl-CoA => deoxyerythronolide B => erythromycin A/B [PATH:map01130], Oleandomycin biosynthesis, malonyl-CoA + methylmalonyl-CoA => 8,8a-deoxyoleandolide => oleandomycin [PATH:map01130], Pikromycin/methymycin biosynthesis, methylmalonyl-CoA + malonyl-CoA => narbonolide/10-deoxymethynolide => pikromycin/methymycin [PATH:map01130], Avermectin biosynthesis, 2-methylbutanoyl-CoA/isobutyryl-CoA => 6,8a-Seco-6,8a-deoxy-5-oxoavermectin 1a/1b aglycone => avermectin A1a/B1a/A1b/B1b [PATH:map01130], Type II polyketide backbone biosynthesis, acyl-CoA + malonyl-CoA => polyketide [PATH:map01130], Dihydrokalafungin biosynthesis, octaketide => dihydrokalafungin [PATH:map01130], Tetracycline/oxytetracycline biosynthesis, pretetramide => tetracycline/oxytetracycline [PATH:map01130], Nogalavinone/aklavinone biosynthesis, deoxynogalonate/deoxyaklanonate => nogalavinone/aklavinone [PATH:map01130], Mithramycin biosynthesis, 4-demethylpremithramycinone => mithramycin [PATH:map01130], Tetracenomycin C/8-demethyltetracenomycin C biosynthesis, tetracenomycin F2 => tetracenomycin C/8-demethyltetracenomycin C [PATH:map01130], Elloramycin biosynthesis, 8-demethyltetracenomycin C => elloramycin A [PATH:map01130], Cycloserine biosynthesis, arginine/serine => cycloserine [PATH:map01130], Fumitremorgin alkaloid biosynthesis, tryptophan + proline => fumitremorgin C/A [PATH:map01130], Bacilysin biosynthesis, prephenate => bacilysin [PATH:map01130], Terpentecin biosynthesis, GGAP => terpentecin [PATH:map01130], Rebeccamycin biosynthesis, tryptophan => rebeccamycin [PATH:map01130], Pyrrolnitrin biosynthesis, tryptophan => pyrrolnitrin [PATH:map01130], dTDP-L-rhamnose biosynthesis [PATH:map01130], dTDP-6-deoxy-D-allose biosynthesis [PATH:map01130], dTDP-beta-L-noviose biosynthesis [PATH:map01130], dTDP-D-mycaminose biosynthesis [PATH:map01130], dTDP-D-desosamine biosynthesis [PATH:map01130], dTDP-L-mycarose biosynthesis [PATH:map01130], dTDP-L-oleandrose biosynthesis [PATH:map01130], dTDP-L-megosamine biosynthesis [PATH:map01130], dTDP-L-olivose biosynthesis [PATH:map01130], dTDP-D-forosamine biosynthesis [PATH:map01130], dTDP-D-angolosamine biosynthesis [PATH:map01130], Staurosporine biosynthesis, tryptophan => staurosporine [PATH:map01130], Violacein biosynthesis, tryptophan => violacein [PATH:map01130], Acarbose biosynthesis, sedoheptulopyranose-7P => acarbose [PATH:map01130], Validamycin A biosynthesis, sedoheptulopyranose-7P => validamycin A [PATH:map01130], Pentalenolactone biosynthesis, farnesyl-PP => pentalenolactone [PATH:map01130], Chlortetracycline biosynthesis, pretetramide => chlortetracycline [PATH:map01130], 9-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 9-membered enediyne core [PATH:map01130], 10-membered enediyne core biosynthesis, malonyl-CoA => 3-hydroxyhexadeca-4,6,8,10,12,14-hexaenoyl-ACP => 10-membered enediyne core [PATH:map01130], C-1027 benzoxazolinate moiety biosynthesis, chorismate => benzoxazolinyl-CoA [PATH:map01130], C-1027 beta-amino acid moiety biosynthesis, tyrosine => 3-chloro-4,5-dihydroxy-beta-phenylalanyl-PCP [PATH:map01130], Maduropeptin beta-hydroxy acid moiety biosynthesis, tyrosine => 3-(4-hydroxyphenyl)-3-oxopropanoyl-PCP [PATH:map01130], 3,6-Dimethylsalicylyl-CoA biosynthesis, malonyl-CoA => 6-methylsalicylate => 3,6-dimethylsalicylyl-CoA [PATH:map01130], Neocarzinostatin naphthoate moiety biosynthesis, malonyl-CoA => 2-hydroxy-5-methyl-1-naphthoate => 2-hydroxy-7-methoxy-5-methyl-1-naphthoyl-CoA [PATH:map01130], Kedarcidin 2-hydroxynaphthoate moiety biosynthesis, malonyl-CoA => 3,6,8-trihydroxy-2-naphthoate => 3-hydroxy-7,8-dimethoxy-6-isopropoxy-2-naphthoyl-CoA [PATH:map01130], Kedarcidin 2-aza-3-chloro-beta-tyrosine moiety biosynthesis, azatyrosine => 2-aza-3-chloro-beta-tyrosyl-PCP [PATH:map01130], Calicheamicin biosynthesis, calicheamicinone => calicheamicin [PATH:map01130], Calicheamicin orsellinate moiety biosynthesis, malonyl-CoA => orsellinate-ACP => 5-iodo-2,3-dimethoxyorsellinate-ACP [PATH:map01130], Pyocyanine biosynthesis, chorismate => pyocyanine [PATH:map01130], Prodigiosin biosynthesis, L-proline => prodigiosin [PATH:map01130], Undecylprodigiosin biosynthesis, L-proline => undecylprodigiosin [PATH:map01130], Aurachin biosynthesis, anthranilate => aurachin A [PATH:map01130], C5 isoprenoid biosynthesis, mevalonate pathway, archaea [PATH:map01130]', 'ko01130', 178, 5572, 0, 0, 128, 50, 5273, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (182, '01200', 'Carbon metabolism', 'Carbon metabolism is the most basic aspect of life. This map presents an overall view of central carbon metabolism, where the number of carbons is shown for each compound denoted by a circle, excluding a cofactor (CoA, CoM, THF, or THMPT) that is replaced by an asterisk. The map contains carbon utilization pathways of glycolysis (map00010), pentose phosphate pathway (map00030), and citrate cycle (map00020), and six known carbon fixation pathways (map00710 and map00720) as well as some pathways of methane metabolism (map00680). The six carbon fixation pathways are: (1) reductive pentose phosphate cycle (Calvin cycle) in plants and cyanobacteria that perform oxygenic photosynthesis, (2) reductive citrate cycle in photosynthetic green sulfur bacteria and some chemolithoautotrophs, (3) 3-hydroxypropionate bi-cycle in photosynthetic green nonsulfur bacteria, two variants of 4-hydroxybutyrate pathways in Crenarchaeota called (4) hydroxypropionate-hydroxybutyrate cycle and (5) dicarboxylate-hydroxybutyrate cycle, and (6) reductive acetyl-CoA pathway in methanogenic bacteria.', 'Carbon metabolism', 'Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate [PATH:map01200], Glycolysis, core module involving three-carbon compounds [PATH:map01200], Pentose phosphate pathway (Pentose phosphate cycle) [PATH:map01200], PRPP biosynthesis, ribose 5P => PRPP [PATH:map01200], Pentose phosphate pathway, oxidative phase, glucose 6P => ribulose 5P [PATH:map01200], Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map01200], Entner-Doudoroff pathway, glucose-6P => glyceraldehyde-3P + pyruvate [PATH:map01200], Citrate cycle (TCA cycle, Krebs cycle) [PATH:map01200], Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map01200], Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate [PATH:map01200], Glyoxylate cycle [PATH:map01200], Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA [PATH:map01200], Serine biosynthesis, glycerate-3P => serine [PATH:map01200], Cysteine biosynthesis, serine => cysteine [PATH:map01200], Reductive pentose phosphate cycle (Calvin cycle) [PATH:map01200], Reductive pentose phosphate cycle, ribulose-5P => glyceraldehyde-3P [PATH:map01200], Reductive pentose phosphate cycle, glyceraldehyde-3P => ribulose-5P [PATH:map01200], CAM (Crassulacean acid metabolism), dark [PATH:map01200], CAM (Crassulacean acid metabolism), light [PATH:map01200], C4-dicarboxylic acid cycle, phosphoenolpyruvate carboxykinase type [PATH:map01200], C4-dicarboxylic acid cycle, NAD - malic enzyme type [PATH:map01200], C4-dicarboxylic acid cycle, NADP - malic enzyme type [PATH:map01200], Reductive citrate cycle (Arnon-Buchanan cycle) [PATH:map01200], Methane oxidation, methanotroph, methane => formaldehyde [PATH:map01200], Pyruvate oxidation, pyruvate => acetyl-CoA [PATH:map01200], Semi-phosphorylative Entner-Doudoroff pathway, gluconate => glycerate-3P [PATH:map01200], Non-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate [PATH:map01200], Formaldehyde assimilation, xylulose monophosphate pathway [PATH:map01200], Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map01200], Formaldehyde assimilation, serine pathway [PATH:map01200], Methanogenesis, methanol => methane [PATH:map01200], Methanogenesis, acetate => methane [PATH:map01200], Ethylmalonyl pathway [PATH:map01200], Dicarboxylate-hydroxybutyrate cycle [PATH:map01200], Hydroxypropionate-hydroxybutylate cycle [PATH:map01200], 3-Hydroxypropionate bi-cycle [PATH:map01200], Reductive acetyl-CoA pathway (Wood-Ljungdahl pathway) [PATH:map01200], Acetyl-CoA pathway, CO2 => acetyl-CoA [PATH:map01200], Photorespiration [PATH:map01200], Methanogenesis, methylamine/dimethylamine/trimethylamine => methane [PATH:map01200], Methanogenesis, CO2 => methane [PATH:map01200], Phosphate acetyltransferase-acetate kinase pathway, acetyl-CoA => acetate [PATH:map01200], Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map01200], Incomplete reductive citrate cycle, acetyl-CoA => oxoglutarate [PATH:map01200], Semi-phosphorylative Entner-Doudoroff pathway, gluconate/galactonate => glycerate-3P [PATH:map01200], Methylaspartate cycle [PATH:map01200], Propanoyl-CoA metabolism, propanoyl-CoA => succinyl-CoA [PATH:map01200]', 'ko01200', 'map01200', 'Carbon metabolism', 'Carbon metabolism is the most basic aspect of life. This map presents an overall view of central carbon metabolism, where the number of carbons is shown for each compound denoted by a circle, excluding a cofactor (CoA, CoM, THF, or THMPT) that is replaced by an asterisk. The map contains carbon utilization pathways of glycolysis (map00010), pentose phosphate pathway (map00030), and citrate cycle (map00020), and six known carbon fixation pathways (map00710 and map00720) as well as some pathways of methane metabolism (map00680). The six carbon fixation pathways are: (1) reductive pentose phosphate cycle (Calvin cycle) in plants and cyanobacteria that perform oxygenic photosynthesis, (2) reductive citrate cycle in photosynthetic green sulfur bacteria and some chemolithoautotrophs, (3) 3-hydroxypropionate bi-cycle in photosynthetic green nonsulfur bacteria, two variants of 4-hydroxybutyrate pathways in Crenarchaeota called (4) hydroxypropionate-hydroxybutyrate cycle and (5) dicarboxylate-hydroxybutyrate cycle, and (6) reductive acetyl-CoA pathway in methanogenic bacteria.', 'Carbon metabolism', 531, 5572, 248, 105, 128, 50, 5273, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (183, '01210', '2-Oxocarboxylic acid metabolism', '2-Oxocarboxylic acids, also called 2-oxo acids and alpha-keto acids, are the most elementary set of metabolites that includes pyruvate (2-oxopropanoate), 2-oxobutanoate, oxaloacetate (2-oxosuccinate) and 2-oxoglutarate. This diagram illustrates the architecture of chain extension and modification reaction modules for 2-oxocarboxylic acids. The chain extension module RM001 is a tricarboxylic pathway where acetyl-CoA derived carbon is used to extend the chain length by one. The chain modification modules RM002 (including RM032) and RM033, together with a reductive amination step (RC00006 or RC00036), generate basic and branched-chain amino acids, respectively. The modification module RM030 is used in the biosynthesis of glucosinolates, a class of plant secondary metabolites, for conversion to oxime followed by addition of thio-glucose moiety. Furthermore, the chain extension from 2-oxoadipate to 2-oxosuberate is followed by coenzyme B biosynthesis in methonogenic archaea.', '2-Oxocarboxylic acid metabolism', 'Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map01210], Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map01210], Ornithine biosynthesis, glutamate => ornithine [PATH:map01210], Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine [PATH:map01210], Ectoine biosynthesis, aspartate => ectoine [PATH:map01210], Glucosinolate biosynthesis, tryptophan => glucobrassicin [PATH:map01210], Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map01210], Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate [PATH:map01210], Isoleucine biosynthesis, pyruvate => 2-oxobutanoate [PATH:map01210], 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map01210], Ornithine biosynthesis, mediated by LysW, glutamate => ornithine [PATH:map01210]', 'ko01210', 'map01210', '2-Oxocarboxylic acid metabolism', '2-Oxocarboxylic acids, also called 2-oxo acids and alpha-keto acids, are the most elementary set of metabolites that includes pyruvate (2-oxopropanoate), 2-oxobutanoate, oxaloacetate (2-oxosuccinate) and 2-oxoglutarate. This diagram illustrates the architecture of chain extension and modification reaction modules for 2-oxocarboxylic acids. The chain extension module RM001 is a tricarboxylic pathway where acetyl-CoA derived carbon is used to extend the chain length by one. The chain modification modules RM002 (including RM032) and RM033, together with a reductive amination step (RC00006 or RC00036), generate basic and branched-chain amino acids, respectively. The modification module RM030 is used in the biosynthesis of glucosinolates, a class of plant secondary metabolites, for conversion to oxime followed by addition of thio-glucose moiety. Furthermore, the chain extension from 2-oxoadipate to 2-oxosuberate is followed by coenzyme B biosynthesis in methonogenic archaea.', '2-Oxocarboxylic acid metabolism', 524, 5342, 248, 105, 123, 48, 5045, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (184, '01212', 'Fatty acid metabolism', 'Fatty acid metabolism', 'Fatty acid biosynthesis, initiation [PATH:map01212], Fatty acid biosynthesis, elongation [PATH:map01212], Fatty acid elongation in mitochondria [PATH:map01212], beta-Oxidation, acyl-CoA synthesis [PATH:map01212], beta-Oxidation [PATH:map01212], Fatty acid elongation in endoplasmic reticulum [PATH:map01212], beta-Oxidation, peroxisome, VLCFA [PATH:map01212], Fatty acid biosynthesis in mitochondria, animals [PATH:map01212], Fatty acid biosynthesis in mitochondria, fungi [PATH:map01212]', 'SBCAD deficiency, VLCAD deficiency, MCAD deficiency, Mitochondrial trifunctional protein deficiency, SCAD deficiency, Carnitine palmitoyltransferase I deficiency, Carnitine palmitoyltransferase II deficiency, Santavuori-Haltia disease', 'ko01212', 'map01212', 'Fatty acid metabolism', 'Fatty acid metabolism', 'Fatty acid biosynthesis, initiation [PATH:map01212], Fatty acid biosynthesis, elongation [PATH:map01212], Fatty acid elongation in mitochondria [PATH:map01212], beta-Oxidation, acyl-CoA synthesis [PATH:map01212], beta-Oxidation [PATH:map01212], Fatty acid elongation in endoplasmic reticulum [PATH:map01212], beta-Oxidation, peroxisome, VLCFA [PATH:map01212], Fatty acid biosynthesis in mitochondria, animals [PATH:map01212], Fatty acid biosynthesis in mitochondria, fungi [PATH:map01212]', 531, 5311, 248, 105, 128, 50, 5062, 249);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (185, '01220', 'Degradation of aromatic compounds', 'Microorganisms are known to be capable of degrading diverse chemical substances including man-made chemicals in the environment that are mostly aromatic compounds. This diagram illustrates combination patterns of reaction modules for biodegradation of aromatic compounds, consisting of three main types of ring dihydroxylation modules, followed by meta- or ortho-cleavage modules, together with an optional preprocessing module for converting methyl group to carboxyl group on the aromatic ring.', 'Degradation of aromatic compounds', 'Methane oxidation, methanotroph, methane => formaldehyde [PATH:map01220], Toluene degradation, anaerobic, toluene => benzoyl-CoA [PATH:map01220], Cymene degradation, p-cymene => p-cumate [PATH:map01220], Homoprotocatechuate degradation, homoprotocatechuate => 2-oxohept-3-enedioate [PATH:map01220], Naphthalene degradation, naphthalene => salicylate [PATH:map01220], Xylene degradation, xylene => methylbenzoate [PATH:map01220], Toluene degradation, toluene => benzoate [PATH:map01220], Cumate degradation, p-cumate => 2-oxopent-4-enoate + 2-methylpropanoate [PATH:map01220], Benzoate degradation, cyclohexanecarboxylic acid =>pimeloyl-CoA [PATH:map01220], Benzoyl-CoA degradation, benzoyl-CoA => 3-hydroxypimeloyl-CoA [PATH:map01220], Biphenyl degradation, biphenyl => 2-oxopent-4-enoate + benzoate [PATH:map01220], Carbazole degradation, carbazole => 2-oxopent-4-enoate + anthranilate [PATH:map01220], Trans-cinnamate degradation, trans-cinnamate => acetyl-CoA [PATH:map01220], Benzene/toluene degradation, benzene => catechol / toluene => 3-methylcatechol [PATH:map01220], Benzene degradation, benzene => catechol [PATH:map01220], Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:map01220], Catechol ortho-cleavage, catechol => 3-oxoadipate [PATH:map01220], Catechol meta-cleavage, catechol => acetyl-CoA / 4-methylcatechol => propanoyl-CoA [PATH:map01220], Phthalate degradation, phthalate => protocatechuate [PATH:map01220], Terephthalate degradation, terephthalate => 3,4-dihydroxybenzoate [PATH:map01220], Phthalate degradation, phthalate => protocatechuate [PATH:map01220]', 'ko01220', 'map01220', 'Degradation of aromatic compounds', 'Microorganisms are known to be capable of degrading diverse chemical substances including man-made chemicals in the environment that are mostly aromatic compounds. This diagram illustrates combination patterns of reaction modules for biodegradation of aromatic compounds, consisting of three main types of ring dihydroxylation modules, followed by meta- or ortho-cleavage modules, together with an optional preprocessing module for converting methyl group to carboxyl group on the aromatic ring.', 'Degradation of aromatic compounds', 0, 4704, 0, 0, 0, 0, 4496, 208);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (186, '01230', 'Biosynthesis of amino acids', 'This map presents a modular architecture of the biosynthesis pathways of twenty amino acids, which may be viewed as consisting of the core part and its extensions. The core part is the KEGG module for conversion of three-carbon compounds from glyceraldehyde-3P to pyruvate [MD:M00002], together with the pathways around serine and glycine. This KEGG module is the most conserved one in the KEGG MODULE database and is found in almost all the completely sequenced genomes. The extensions are the pathways containing the reaction modules RM001, RM033, RM032, and RM002 for biosynthesis of branched-chain amino acids (left) and basic amino acids (bottom), and the pathways for biosynthesis of histidine and aromatic amino acids (top right). It is interesting to note that the so-called essential amino acids that cannot be synthesized in human and other organisms generally appear in these extensions. Furthermore, the bottom extension of basic amino acids appears to be most divergent containing multiple pathways for lysine biosynthesis and multiple gene sets for arginine biosynthesis.', 'Biosynthesis of amino acids', 'Glycolysis, core module involving three-carbon compounds [PATH:map01230], PRPP biosynthesis, ribose 5P => PRPP [PATH:map01230], Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P [PATH:map01230], Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate [PATH:map01230], Proline biosynthesis, glutamate => proline [PATH:map01230], Lysine biosynthesis, succinyl-DAP pathway, aspartate => lysine [PATH:map01230], Methionine biosynthesis, apartate => homoserine => methionine [PATH:map01230], Threonine biosynthesis, aspartate => homoserine => threonine [PATH:map01230], Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:map01230], Serine biosynthesis, glycerate-3P => serine [PATH:map01230], Cysteine biosynthesis, serine => cysteine [PATH:map01230], Shikimate pathway, phosphoenolpyruvate + erythrose-4P => chorismate [PATH:map01230], Tryptophan biosynthesis, chorismate => tryptophan [PATH:map01230], Phenylalanine biosynthesis, chorismate => phenylalanine [PATH:map01230], Tyrosine biosynthesis, chorismate => tyrosine [PATH:map01230], Histidine biosynthesis, PRPP => histidine [PATH:map01230], Ornithine biosynthesis, glutamate => ornithine [PATH:map01230], Urea cycle [PATH:map01230], Lysine biosynthesis, AAA pathway, 2-oxoglutarate => 2-aminoadipate => lysine [PATH:map01230], Lysine biosynthesis, mediated by LysW, 2-aminoadipate => lysine [PATH:map01230], Ectoine biosynthesis, aspartate => ectoine [PATH:map01230], Tyrosine biosynthesis, prephanate => pretyrosine => tyrosine [PATH:map01230], Cysteine biosynthesis, homocysteine + serine => cysteine [PATH:map01230], Formaldehyde assimilation, ribulose monophosphate pathway [PATH:map01230], Leucine biosynthesis, 2-oxoisovalerate => 2-oxoisocaproate [PATH:map01230], Lysine biosynthesis, 2-oxoglutarate => 2-oxoadipate [PATH:map01230], Lysine biosynthesis, acetyl-DAP pathway, aspartate => lysine [PATH:map01230], Lysine biosynthesis, DAP dehydrogenase pathway, aspartate => lysine [PATH:map01230], Lysine biosynthesis, DAP aminotransferase pathway, aspartate => lysine [PATH:map01230], Isoleucine biosynthesis, pyruvate => 2-oxobutanoate [PATH:map01230], Isoleucine biosynthesis, threonine => 2-oxobutanoate => isoleucine [PATH:map01230], Pentose phosphate pathway, archaea, fructose 6P => ribose 5P [PATH:map01230], 2-Oxocarboxylic acid chain extension, 2-oxoglutarate => 2-oxoadipate => 2-oxopimelate => 2-oxosuberate [PATH:map01230], Cysteine biosynthesis, methionine => cysteine [PATH:map01230], Ornithine biosynthesis, mediated by LysW, glutamate => ornithine [PATH:map01230], Arginine biosynthesis, ornithine => arginine [PATH:map01230], Arginine biosynthesis, glutamate => acetylcitrulline => arginine [PATH:map01230]', 'ko01230', 'map01230', 'Biosynthesis of amino acids', 'This map presents a modular architecture of the biosynthesis pathways of twenty amino acids, which may be viewed as consisting of the core part and its extensions. The core part is the KEGG module for conversion of three-carbon compounds from glyceraldehyde-3P to pyruvate [MD:M00002], together with the pathways around serine and glycine. This KEGG module is the most conserved one in the KEGG MODULE database and is found in almost all the completely sequenced genomes. The extensions are the pathways containing the reaction modules RM001, RM033, RM032, and RM002 for biosynthesis of branched-chain amino acids (left) and basic amino acids (bottom), and the pathways for biosynthesis of histidine and aromatic amino acids (top right). It is interesting to note that the so-called essential amino acids that cannot be synthesized in human and other organisms generally appear in these extensions. Furthermore, the bottom extension of basic amino acids appears to be most divergent containing multiple pathways for lysine biosynthesis and multiple gene sets for arginine biosynthesis.', 'Biosynthesis of amino acids', 531, 5571, 248, 105, 128, 50, 5272, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (187, '01501', 'beta-Lactam resistance', 'The beta-lactam antibiotics are the most widely used group of antibiotics, which exert their effect by interfering with the structural crosslinking of peptidoglycans in bacterial cell walls. Over the past decades, a rapid increase in the number of beta-lactam-resistant clinical isolates is observed. Bacterial resistance to beta-lactam antibiotics can be achieved by any of the following strategies: producing inactivating enzymes called beta-lactamases, altering the beta-lactam targets of penicillin-binding proteins (PBPs), reducing transport of beta-lactams into the periplasmic space via changes in porins, and using the mechanisms for exclusion of beta-lactams by way of efflux pumps. Resistance may result from intrinsic properties of organisms, through gene mutations, and through plasmid- and transposon-specified genes.', 'Human Diseases; Drug resistance: antimicrobial', 'beta-Lactam resistance', 'Methicillin resistance [PATH:map01501], beta-Lactam resistance, Bla system [PATH:map01501], Multidrug resistance, efflux pump AdeABC [PATH:map01501], Carbapenem resistance [PATH:map01501]', 'ko01501', 'list(REFERENCE = \"PMID:23034325\", AUTHORS = \"Fernandez L, Hancock RE\", TITLE = \"Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.\", JOURNAL = c(\"Clin Microbiol Rev 25:661-81 (2012)\", \"DOI:10.1128/CMR.00043-12\")), list(REFERENCE = \"PMID:21149619\", AUTHORS = \"Muller C, Plesiat P, Jeannot K\", TITLE = \"A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and beta-lactams in Pseudomonas aeruginosa.\", JOURNAL = c(\"Antimicrob Agents Chemother 55:1211-21 (2011)\", \"DOI:10.1128/AAC.01252-10\")), list(REFERENCE = \"PMID:20351243\", AUTHORS = \"Tanabe M, Nimigean CM, Iverson TM\", TITLE = \"Structural basis for solute transport, nucleotide regulation, and immunological recognition of Neisseria meningitidis PorB.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 107:6811-6 (2010)\", \"DOI:10.1073/pnas.0912115107\")), list(REFERENCE = \"PMID:9797206\", AUTHORS = \"Gill MJ, Simjee S, Al-Hattawi K, Robertson BD, Easmon CS, Ison CA\", TITLE = \"Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus.\", JOURNAL = \"Antimicrob Agents Chemother 42:2799-803 (1998)\"), list(REFERENCE = \"PMID:23163477\", AUTHORS = \"Johnson JW, Fisher JF, Mobashery S\", TITLE = \"Bacterial cell-wall recycling.\", JOURNAL = c(\"Ann N Y Acad Sci 1277:54-75 (2013)\", \"DOI:10.1111/j.1749-6632.2012.06813.x\")), list(REFERENCE = \"PMID:22438804\", AUTHORS = \"Amoroso A, Boudet J, Berzigotti S, Duval V, Teller N, Mengin-Lecreulx D, Luxen A, Simorre JP, Joris B\", TITLE = \"A peptidoglycan fragment triggers beta-lactam resistance in Bacillus licheniformis.\", JOURNAL = c(\"PLoS Pathog 8:e1002571 (2012)\", \"DOI:10.1371/journal.ppat.1002571\")), list(REFERENCE = \"PMID:19154333\", AUTHORS = \"Sala C, Haouz A, Saul FA, Miras I, Rosenkrands I, Alzari PM, Cole ST\", TITLE = \"Genome-wide regulon and crystal structure of BlaI (Rv1846c) from Mycobacterium tuberculosis.\", JOURNAL = c(\"Mol Microbiol 71:1102-16 (2009)\", \"DOI:10.1111/j.1365-2958.2008.06583.x\")), list(REFERENCE = \"PMID:18248419\", AUTHORS = \"Zapun A, Contreras-Martel C, Vernet T\", TITLE = \"Penicillin-binding proteins and beta-lactam resistance.\", JOURNAL = c(\"FEMS Microbiol Rev 32:361-85 (2008)\", \"DOI:10.1111/j.1574-6976.2007.00095.x\")), list(REFERENCE = \"PMID:19258280\", AUTHORS = \"Vettoretti L, Plesiat P, Muller C, El Garch F, Phan G, Attree I, Ducruix A, Llanes C\", TITLE = \"Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.\", JOURNAL = c(\"Antimicrob Agents Chemother 53:1987-97 (2009)\", \"DOI:10.1128/AAC.01024-08\")), list(REFERENCE = \"PMID:15387820\", AUTHORS = \"Cao L, Srikumar R, Poole K\", TITLE = \"MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719.\", JOURNAL = c(\"Mol Microbiol 53:1423-36 (2004)\", \"DOI:10.1111/j.1365-2958.2004.04210.x\")), list(REFERENCE = \"PMID:11895293\", AUTHORS = \"Poole K, Srikumar R\", TITLE = \"Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance.\", JOURNAL = c(\"Curr Top Med Chem 1:59-71 (2001)\", \"DOI:10.2174/1568026013395605\")), list(REFERENCE = \"PMID:15855496\", AUTHORS = \"Sobel ML, Hocquet D, Cao L, Plesiat P, Poole K\", TITLE = \"Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa.\", JOURNAL = c(\"Antimicrob Agents Chemother 49:1782-6 (2005)\", \"DOI:10.1128/AAC.49.5.1782-1786.2005\")), list(REFERENCE = \"PMID:15105114\", AUTHORS = \"Kaczmarek FS, Gootz TD, Dib-Hajj F, Shang W, Hallowell S, Cronan M\", TITLE = \"Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin.\", JOURNAL = c(\"Antimicrob Agents Chemother 48:1630-9 (2004)\", \"DOI:10.1128/AAC.48.5.1630-1639.2004\")), list(REFERENCE = \"PMID:16048914\", AUTHORS = \"Dean CR, Narayan S, Daigle DM, Dzink-Fox JL, Puyang X, Bracken KR, Dean KE, Weidmann B, Yuan Z, Jain R, Ryder NS\", TITLE = \"Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415.\", JOURNAL = c(\"Antimicrob Agents Chemother 49:3129-35 (2005)\", \"DOI:10.1128/AAC.49.8.3129-3135.2005\")), list(REFERENCE = \"PMID:22371895\", AUTHORS = \"Rosenfeld N, Bouchier C, Courvalin P, Perichon B\", TITLE = \"Expression of the resistance-nodulation-cell division pump AdeIJK in Acinetobacter baumannii is regulated by AdeN, a TetR-type regulator.\", JOURNAL = c(\"Antimicrob Agents Chemother 56:2504-10 (2012)\", \"DOI:10.1128/AAC.06422-11\")), list(REFERENCE = \"PMID:21173183\", AUTHORS = \"Coyne S, Courvalin P, Perichon B\", TITLE = \"Efflux-mediated antibiotic resistance in Acinetobacter spp.\", JOURNAL = c(\"Antimicrob Agents Chemother 55:947-53 (2011)\", \"DOI:10.1128/AAC.01388-10\")), list(REFERENCE = \"PMID:19026770\", AUTHORS = \"Nikaido H, Takatsuka Y\", TITLE = \"Mechanisms of RND multidrug efflux pumps.\", JOURNAL = c(\"Biochim Biophys Acta 1794:769-81 (2009)\", \"DOI:10.1016/j.bbapap.2008.10.004\")), list(REFERENCE = \"PMID:17277059\", AUTHORS = \"Truong-Bolduc QC, Hooper DC\", TITLE = \"The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus.\", JOURNAL = c(\"J Bacteriol 189:2996-3005 (2007)\", \"DOI:10.1128/JB.01819-06\")), list(REFERENCE = \"PMID:12222968\", AUTHORS = \"Sauvage E, Kerff F, Fonze E, Herman R, Schoot B, Marquette JP, Taburet Y, Prevost D, Dumas J, Leonard G, Stefanic P, Coyette J, Charlier P\", TITLE = \"The 2.4-A crystal structure of the penicillin-resistant penicillin-binding protein PBP5fm from Enterococcus faecium in complex with benzylpenicillin.\", JOURNAL = c(\"Cell Mol Life Sci 59:1223-32 (2002)\", \"DOI:10.1007/s00018-002-8500-0\")), list(REFERENCE = \"PMID:16143832\", AUTHORS = \"Fuda CC, Fisher JF, Mobashery S\", TITLE = \"Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome.\", JOURNAL = c(\"Cell Mol Life Sci 62:2617-33 (2005)\", \"DOI:10.1007/s00018-005-5148-6\"))', 'map01501', 'beta-Lactam resistance', 89, 5023, 0, 1, 88, 0, 5011, 12);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (188, '01502', 'Vancomycin resistance', 'c(\"Vancomycin (VCM) is a glycopeptide antibiotic agent that inhibits the synthesis of peptidolgycan in the production of bacterial cell walls. It is active in most Gram-positive bacteria and acts by binding to the D-Ala-D-Ala C-terminus of pentapeptide, thus blocking the addition of subunits to the peptidoglycan backbone. The resistance to VCM was first described among enterococci in the late 1980s in Europe. Subsequently, vancomycin-resistant enteococci (VRE) have been observed in many countries. The genes encoding resistance are carried on plasmids that can tranfer themselves from cell to cell and on tranponsons that can jump from plamids to the chromosome. Up to now, at least six resistance operon types are characterized, namely VanA, VanB, VanC, VanD, VanE and VanG. The VanA and VanB operons are detected on plasmids or in the chromosome, whereas the rest are found in the chromosome. In addition, Streptomyces, which is non-pathogenic, non-glycopeptide-producing actinomycete, also shows high-level resistance to VCM. In Streptomyces, novel genes (vanK and vanJ) are characterized with no counterparts found in the resistance clusters of pathogenic bacteria.\", \n\"The expression of vancomycin resistance pathway is induced by the VanS-VanR two component system, and D-Ala-D-Lac or D-Ala-D-Ser dipsipeptides are formed in place of D-Ala-D-Ala dipeptide. Thus, VCM cannot bind to pentadepsipeptide[D-Lac] or pentadepsipeptide[D-Ser]. The D-Ala-D-Lac variation shows high levels of resistance to VCM, especially in VanA type, wheras the D-Ala-D-Ser variation shows low levels of resistance. The modified pepidoglycan can interact with cross-linking enzymes (PBPs), thus cell wall is successfully formed.\"\n)', 'Human Diseases; Drug resistance: antimicrobial', 'Vancomycin resistance', 'Vancomycin resistance, D-Ala-D-Lac type [PATH:map01502], Vancomycin resistance, D-Ala-D-Ser type [PATH:map01502]', 'ko01502', 'list(REFERENCE = \"PMID:16323116\", AUTHORS = \"Courvalin P\", TITLE = \"Vancomycin resistance in gram-positive cocci.\", JOURNAL = c(\"Clin Infect Dis 42 Suppl 1:S25-34 (2006)\", \"DOI:10.1086/491711\")), list(REFERENCE = \"PMID:22913355\", AUTHORS = \"Chancey ST, Zahner D, Stephens DS\", TITLE = \"Acquired inducible antimicrobial resistance in Gram-positive bacteria.\", JOURNAL = c(\"Future Microbiol 7:959-78 (2012)\", \"DOI:10.2217/fmb.12.63\")), list(REFERENCE = \"PMID:8899966\", AUTHORS = \"Arthur M, Reynolds P, Courvalin P\", TITLE = \"Glycopeptide resistance in enterococci.\", JOURNAL = c(\"Trends Microbiol 4:401-7 (1996)\", \"DOI:10.1016/0966-842X(96)10063-9\")), list(REFERENCE = \"PMID:11023964\", AUTHORS = \"Cetinkaya Y, Falk P, Mayhall CG\", TITLE = \"Vancomycin-resistant enterococci.\", JOURNAL = c(\"Clin Microbiol Rev 13:686-707 (2000)\", \"DOI:10.1128/CMR.13.4.686-707.2000\")), list(REFERENCE = \"PMID:7854121\", AUTHORS = \"Reynolds PE, Depardieu F, Dutka-Malen S, Arthur M, Courvalin P\", TITLE = \"Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine.\", JOURNAL = c(\"Mol Microbiol 13:1065-70 (1994)\", \"DOI:10.1111/j.1365-2958.1994.tb00497.x\")), list(REFERENCE = \"PMID:8631706\", AUTHORS = \"Evers S, Courvalin P\", TITLE = \"Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583.\", JOURNAL = c(\"J Bacteriol 178:1302-9 (1996)\", \"DOI:10.1128/JB.178.5.1302-1309.1996\")), list(REFERENCE = \"PMID:10564477\", AUTHORS = \"Reynolds PE, Arias CA, Courvalin P\", TITLE = \"Gene vanXYC encodes D,D -dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174.\", JOURNAL = c(\"Mol Microbiol 34:341-9 (1999)\", \"DOI:10.1046/j.1365-2958.1999.01604.x\")), list(REFERENCE = \"PMID:12047383\", AUTHORS = \"Podmore AH, Reynolds PE\", TITLE = \"Purification and characterization of VanXY(C), a D,D-dipeptidase/D,D-carboxypeptidase in vancomycin-resistant Enterococcus gallinarum BM4174.\", JOURNAL = c(\"Eur J Biochem 269:2740-6 (2002)\", \"DOI:10.1046/j.1432-1033.2002.02946.x\")), list(REFERENCE = \"PMID:15616270\", AUTHORS = \"Reynolds PE, Courvalin P\", TITLE = \"Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine.\", JOURNAL = c(\"Antimicrob Agents Chemother 49:21-5 (2005)\", \"DOI:10.1128/AAC.49.1.21-25.2005\")), list(REFERENCE = \"PMID:10878136\", AUTHORS = \"Arias CA, Weisner J, Blackburn JM, Reynolds PE\", TITLE = \"Serine and alanine racemase activities of VanT: a protein necessary for vancomycin resistance in Enterococcus gallinarum BM4174.\", JOURNAL = c(\"Microbiology 146 ( Pt 7):1727-34 (2000)\", \"DOI:10.1099/00221287-146-7-1727\")), list(REFERENCE = \"PMID:18792691\", AUTHORS = \"Hong HJ, Hutchings MI, Buttner MJ\", TITLE = \"Vancomycin resistance VanS/VanR two-component systems.\", JOURNAL = c(\"Adv Exp Med Biol 631:200-13 (2008)\", \"DOI:10.1007/978-0-387-78885-2_14\")), list(REFERENCE = \"PMID:14617152\", AUTHORS = \"Depardieu F, Bonora MG, Reynolds PE, Courvalin P\", TITLE = \"The vanG glycopeptide resistance operon from Enterococcus faecalis revisited.\", JOURNAL = c(\"Mol Microbiol 50:931-48 (2003)\", \"DOI:10.1046/j.1365-2958.2003.03737.x\")), list(REFERENCE = \"PMID:11036060\", AUTHORS = \"McKessar SJ, Berry AM, Bell JM, Turnidge JD, Paton JC\", TITLE = \"Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis.\", JOURNAL = c(\"Antimicrob Agents Chemother 44:3224-8 (2000)\", \"DOI:10.1128/AAC.44.11.3224-3228.2000\")), list(REFERENCE = \"PMID:23836175\", AUTHORS = \"Kwun MJ, Novotna G, Hesketh AR, Hill L, Hong HJ\", TITLE = \"In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall.\", JOURNAL = c(\"Antimicrob Agents Chemother 57:4470-80 (2013)\", \"DOI:10.1128/AAC.00523-13\")), list(REFERENCE = \"PMID:15130128\", AUTHORS = \"Hong HJ, Hutchings MI, Neu JM, Wright GD, Paget MS, Buttner MJ\", TITLE = \"Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.\", JOURNAL = c(\"Mol Microbiol 52:1107-21 (2004)\", \"DOI:10.1111/j.1365-2958.2004.04032.x\")), list(REFERENCE = \"PMID:15632111\", AUTHORS = \"Hong HJ, Hutchings MI, Hill LM, Buttner MJ\", TITLE = \"The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor.\", JOURNAL = c(\"J Biol Chem 280:13055-61 (2005)\", \"DOI:10.1074/jbc.M413801200\")), list(REFERENCE = \"PMID:16420361\", AUTHORS = \"Hutchings MI, Hong HJ, Buttner MJ\", TITLE = \"The vancomycin resistance VanRS two-component signal transduction system of Streptomyces coelicolor.\", JOURNAL = c(\"Mol Microbiol 59:923-35 (2006)\", \"DOI:10.1111/j.1365-2958.2005.04953.x\")), list(REFERENCE = \"PMID:21569315\", AUTHORS = \"Hesketh A, Hill C, Mokhtar J, Novotna G, Tran N, Bibb M, Hong HJ\", TITLE = \"Genome-wide dynamics of a bacterial response to antibiotics that target the cell envelope.\", JOURNAL = c(\"BMC Genomics 12:226 (2011)\", \"DOI:10.1186/1471-2164-12-226\")), list(REFERENCE = \"PMID:20383152\", AUTHORS = \"Koteva K, Hong HJ, Wang XD, Nazi I, Hughes D, Naldrett MJ, Buttner MJ, Wright GD\", TITLE = \"A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor.\", JOURNAL = c(\"Nat Chem Biol 6:327-9 (2010)\", \"DOI:10.1038/nchembio.350\"))', 'map01502', 'Vancomycin resistance', 95, 5133, 0, 94, 1, 0, 5064, 69);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (189, '01503', 'Cationic antimicrobial peptide (CAMP) resistance', 'Cationic antimicrobial peptides (CAMPs) play an important role in host defense against microbial infection and are key components of the innate immune response. These are found among all classes of life ranging from prokaryotes to humans. In addition to the natural peptides, thousands of synthetic variants have been produced. CAMPs weaken the integrity of the bacterial inner and outer membranes and subsequently kill bacterial cells. On the other hand, bacteria have developed a number of mechanisms against CAMPs. These resistance mechanisms include decreased affinity to CAMPs by substitution of anionic cell surface constituents with cationic molecules; biosynthesis and crosslinking of cell envelope components; external trapping mechanisms that bind or neutralize the CAMPs by direct secretion of proteins, or the release of CAMPs binding molecules from the host cell surface; membrane efflux pumps; and production of peptidases.', 'Human Diseases; Drug resistance: antimicrobial', 'Cationic antimicrobial peptide (CAMP) resistance', 'Cationic antimicrobial peptide (CAMP) resistance, dltABCD operon [PATH:map01503], Cationic antimicrobial peptide (CAMP) resistance, lysyl-phosphatidylglycerol (L-PG) synthase MprF [PATH:map01503], Cationic antimicrobial peptide (CAMP) resistance, VraFG transporter [PATH:map01503]', 'ko01503', 'list(REFERENCE = \"PMID:16450883\", AUTHORS = \"Nizet V\", TITLE = \"Antimicrobial peptide resistance mechanisms of human bacterial pathogens.\", JOURNAL = \"Curr Issues Mol Biol 8:11-26 (2006)\"), list(REFERENCE = \"PMID:22339775\", AUTHORS = \"Gruenheid S, Le Moual H\", TITLE = \"Resistance to antimicrobial peptides in Gram-negative bacteria.\", JOURNAL = c(\"FEMS Microbiol Lett 330:81-9 (2012)\", \"DOI:10.1111/j.1574-6968.2012.02528.x\")), list(REFERENCE = \"PMID:25419466\", AUTHORS = \"Nawrocki KL, Crispell EK, McBride SM\", TITLE = \"Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria.\", JOURNAL = c(\"Antibiotics (Basel) 3:461-492 (2014)\", \"DOI:10.3390/antibiotics3040461\")), list(REFERENCE = \"PMID:22799636\", AUTHORS = \"Anaya-Lopez JL, Lopez-Meza JE, Ochoa-Zarzosa A\", TITLE = \"Bacterial resistance to cationic antimicrobial peptides.\", JOURNAL = c(\"Crit Rev Microbiol 39:180-95 (2013)\", \"DOI:10.3109/1040841X.2012.699025\")), list(REFERENCE = \"PMID:23748343\", AUTHORS = \"Needham BD, Trent MS\", TITLE = \"Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis.\", JOURNAL = c(\"Nat Rev Microbiol 11:467-81 (2013)\", \"DOI:10.1038/nrmicro3047\")), list(REFERENCE = \"PMID:17928292\", AUTHORS = \"Yan A, Guan Z, Raetz CR\", TITLE = \"An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli.\", JOURNAL = c(\"J Biol Chem 282:36077-89 (2007)\", \"DOI:10.1074/jbc.M706172200\")), list(REFERENCE = \"PMID:15695810\", AUTHORS = \"Breazeale SD, Ribeiro AA, McClerren AL, Raetz CR.\", TITLE = \"A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-Amino-4-deoxy-L-arabinose. Identification and function oF UDP-4-deoxy-4-formamido-L-arabinose.\", JOURNAL = c(\"J Biol Chem 280:14154-67 (2005)\", \"DOI:10.1074/jbc.M414265200\")), list(REFERENCE = \"PMID:25505462\", AUTHORS = \"Olaitan AO, Morand S, Rolain JM\", TITLE = \"Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria.\", JOURNAL = c(\"Front Microbiol 5:643 (2014)\", \"DOI:10.3389/fmicb.2014.00643\")), list(REFERENCE = \"PMID:21645016\", AUTHORS = \"Martinez JL, Rojo F\", TITLE = \"Metabolic regulation of antibiotic resistance.\", JOURNAL = c(\"FEMS Microbiol Rev 35:768-89 (2011)\", \"DOI:10.1111/j.1574-6976.2011.00282.x\")), list(REFERENCE = \"PMID:20843473\", AUTHORS = \"Falagas ME, Rafailidis PI, Matthaiou DK\", TITLE = \"Resistance to polymyxins: Mechanisms, frequency and treatment options.\", JOURNAL = c(\"Drug Resist Updat 13:132-8 (2010)\", \"DOI:10.1016/j.drup.2010.05.002\")), list(REFERENCE = \"PMID:19243444\", AUTHORS = \"Gooderham WJ, Hancock RE\", TITLE = \"Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa.\", JOURNAL = c(\"FEMS Microbiol Rev 33:279-94 (2009)\", \"DOI:10.1111/j.1574-6976.2008.00135.x\")), list(REFERENCE = \"PMID:15205413\", AUTHORS = \"Lee H, Hsu FF, Turk J, Groisman EA\", TITLE = \"The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica.\", JOURNAL = c(\"J Bacteriol 186:4124-33 (2004)\", \"DOI:10.1128/JB.186.13.4124-4133.2004\")), list(REFERENCE = \"PMID:24034668\", AUTHORS = \"Wang D, Seeve C, Pierson LS 3rd, Pierson EA\", TITLE = \"Transcriptome profiling reveals links between ParS/ParR, MexEF-OprN, and quorum sensing in the regulation of adaptation and virulence in Pseudomonas aeruginosa.\", JOURNAL = c(\"BMC Genomics 14:618 (2013)\", \"DOI:10.1186/1471-2164-14-618\")), list(REFERENCE = \"PMID:22123691\", AUTHORS = \"Falord M, Karimova G, Hiron A, Msadek T\", TITLE = \"GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus.\", JOURNAL = c(\"Antimicrob Agents Chemother 56:1047-58 (2012)\", \"DOI:10.1128/AAC.05054-11\")), list(REFERENCE = \"PMID:16715050\", AUTHORS = \"Rowley G, Spector M, Kormanec J, Roberts M\", TITLE = \"Pushing the envelope: extracytoplasmic stress responses in bacterial pathogens.\", JOURNAL = c(\"Nat Rev Microbiol 4:383-94 (2006)\", \"DOI:10.1038/nrmicro1394\")), list(REFERENCE = \"PMID:23267440\", AUTHORS = \"Piek S, Kahler CM\", TITLE = \"A comparison of the endotoxin biosynthesis and protein oxidation pathways in the biogenesis of the outer membrane of Escherichia coli and Neisseria meningitidis.\", JOURNAL = c(\"Front Cell Infect Microbiol 2:162 (2012)\", \"DOI:10.3389/fcimb.2012.00162\")), list(REFERENCE = \"PMID:25294881\", AUTHORS = \"Weatherspoon-Griffin N, Yang D, Kong W, Hua Z, Shi Y\", TITLE = \"The CpxR/CpxA two-component regulatory system up-regulates the multidrug resistance cascade to facilitate Escherichia coli resistance to a model antimicrobial peptide.\", JOURNAL = c(\"J Biol Chem 289:32571-82 (2014)\", \"DOI:10.1074/jbc.M114.565762\")), list(REFERENCE = \"PMID:22092948\", AUTHORS = \"Vogt SL, Raivio TL\", TITLE = \"Just scratching the surface: an expanding view of the Cpx envelope stress response.\", JOURNAL = c(\"FEMS Microbiol Lett 326:2-11 (2012)\", \"DOI:10.1111/j.1574-6968.2011.02406.x\")), list(REFERENCE = \"PMID:22072973\", AUTHORS = \"Shelton CL, Raffel FK, Beatty WL, Johnson SM, Mason KM\", TITLE = \"Sap transporter mediated import and subsequent degradation of antimicrobial peptides in Haemophilus.\", JOURNAL = c(\"PLoS Pathog 7:e1002360 (2011)\", \"DOI:10.1371/journal.ppat.1002360\")), list(REFERENCE = \"PMID:19609257\", AUTHORS = \"Otto M\", TITLE = \"Staphylococcus epidermidis--the \'accidental\' pathogen.\", JOURNAL = c(\"Nat Rev Microbiol 7:555-67 (2009)\", \"DOI:10.1038/nrmicro2182\")), list(REFERENCE = \"PMID:21986630\", AUTHORS = \"Yang SJ, Bayer AS, Mishra NN, Meehl M, Ledala N, Yeaman MR, Xiong YQ, Cheung AL\", TITLE = \"The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides.\", JOURNAL = c(\"Infect Immun 80:74-81 (2012)\", \"DOI:10.1128/IAI.05669-11\")), list(REFERENCE = \"PMID:12366839\", AUTHORS = \"Schmidtchen A, Frick IM, Andersson E, Tapper H, Bjorck L\", TITLE = \"Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37.\", JOURNAL = c(\"Mol Microbiol 46:157-68 (2002)\", \"DOI:10.1046/j.1365-2958.2002.03146.x\")), list(REFERENCE = \"PMID:23554414\", AUTHORS = \"Beceiro A, Tomas M, Bou G\", TITLE = \"Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?\", JOURNAL = c(\"Clin Microbiol Rev 26:185-230 (2013)\", \"DOI:10.1128/CMR.00059-12\"))', 'map01503', 'Cationic antimicrobial peptide (CAMP) resistance', 0, 4782, 0, 0, 0, 0, 4750, 32);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (190, '01521', 'EGFR tyrosine kinase inhibitor resistance', 'EGFR is a tyrosine kinase that participates in the regulation of cellular homeostasis. EGFR also serves as a stimulus for cancer growth. EGFR gene mutations and protein overexpression, both of which activate down- stream pathways, are associated with cancers, especially lung cancer. Several tyrosine kinase inhibitor (TKI) therapies against EGFR are currently administered and are initially effective in cancer patients who have EGFR mutations or aberrant activation of EGFR. However, the development of TKI resistance is common and results in the recurrence of tumors. Studies over the last decade have identified mechanisms that drive resistance to EGFR TKI treatment. Most outstanding mechanisms are: the secondary EGFR mutation (T790M), activation of alternative pathways (c-Met, HGF, AXL), aberrance of the downstream pathways (K-RAS mutations, loss of PTEN), impairment of the EGFR-TKIs-mediated apoptosis pathway (BCL2-like 11/BIM deletion polymorphism), histologic transformation, etc.', 'Human Diseases; Drug resistance: antineoplastic', 'EGFR tyrosine kinase inhibitor resistance', 'ko01521', 'list(REFERENCE = \"PMID:26579470\", AUTHORS = \"Huang L, Fu L\", TITLE = \"Mechanisms of resistance to EGFR tyrosine kinase inhibitors.\", JOURNAL = c(\"Acta Pharm Sin B 5:390-401 (2015)\", \"DOI:10.1016/j.apsb.2015.07.001\")), list(REFERENCE = \"PMID:23358468\", AUTHORS = \"Hrustanovic G, Lee BJ, Bivona TG\", TITLE = \"Mechanisms of resistance to EGFR targeted therapies.\", JOURNAL = c(\"Cancer Biol Ther 14:304-14 (2013)\", \"DOI:10.4161/cbt.23627\")), list(REFERENCE = \"PMID:25232485\", AUTHORS = \"Lin Y, Wang X, Jin H\", TITLE = \"EGFR-TKI resistance in NSCLC patients: mechanisms and strategies.\", JOURNAL = \"Am J Cancer Res 4:411-35 (2014)\"), list(REFERENCE = \"PMID:19632948\", AUTHORS = \"Nguyen KS, Kobayashi S, Costa DB\", TITLE = \"Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.\", JOURNAL = c(\"Clin Lung Cancer 10:281-9 (2009)\", \"DOI:10.3816/CLC.2009.n.039\")), list(REFERENCE = \"PMID:18483355\", AUTHORS = \"Engelman JA, Janne PA\", TITLE = \"Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.\", JOURNAL = c(\"Clin Cancer Res 14:2895-9 (2008)\", \"DOI:10.1158/1078-0432.CCR-07-2248\")), list(REFERENCE = \"PMID:23401451\", AUTHORS = \"Ohashi K, Maruvka YE, Michor F, Pao W\", TITLE = \"Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease.\", JOURNAL = c(\"J Clin Oncol 31:1070-80 (2013)\", \"DOI:10.1200/JCO.2012.43.3912\")), list(REFERENCE = \"PMID:24307395\", AUTHORS = \"Carrera S, Buque A, Azkona E, Aresti U, Calvo B, Sancho A, Arruti M, Nuno M, Rubio I, de Lobera AR, Lopez C, Vivanco GL\", TITLE = \"Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies.\", JOURNAL = c(\"Clin Transl Oncol 16:339-50 (2014)\", \"DOI:10.1007/s12094-013-1143-9\")), list(REFERENCE = \"PMID:22970367\", AUTHORS = \"Lin L, Bivona TG\", TITLE = \"Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC Patients.\", JOURNAL = c(\"Chemother Res Pract 2012:817297 (2012)\", \"DOI:10.1155/2012/817297\")), list(REFERENCE = \"\", AUTHORS = \"Song X.\", TITLE = \"Targeting PI3K/AKT/mTOR pathway and mutant EGFR to overcome resistance to tyrosine kinase inhibitors in mutant EGFR-mediated lung cancer\", JOURNAL = c(\"Onco Reviews 1(1):13-19 (2013)\", \"DOI:10.14259/or.v1i1.81\")), list(REFERENCE = \"PMID:24202392\", AUTHORS = \"Chong CR, Janne PA\", TITLE = \"The quest to overcome resistance to EGFR-targeted therapies in cancer.\", JOURNAL = c(\"Nat Med 19:1389-400 (2013)\", \"DOI:10.1038/nm.3388\")), list(REFERENCE = \"PMID:20551942\", AUTHORS = \"Wheeler DL, Dunn EF, Harari PM\", TITLE = \"Understanding resistance to EGFR inhibitors-impact on future treatment strategies.\", JOURNAL = c(\"Nat Rev Clin Oncol 7:493-507 (2010)\", \"DOI:10.1038/nrclinonc.2010.97\")), list(REFERENCE = \"PMID:23361103\", AUTHORS = \"Gonzalez de Castro D, Clarke PA, Al-Lazikani B, Workman P\", TITLE = \"Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.\", JOURNAL = c(\"Clin Pharmacol Ther 93:252-9 (2013)\", \"DOI:10.1038/clpt.2012.237\")), list(REFERENCE = \"PMID:20966921\", AUTHORS = \"Pao W, Chmielecki J\", TITLE = \"Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer.\", JOURNAL = c(\"Nat Rev Cancer 10:760-74 (2010)\", \"DOI:10.1038/nrc2947\")), list(REFERENCE = \"PMID:22956644\", AUTHORS = \"Takezawa K, Pirazzoli V, Arcila ME, Nebhan CA, Song X, de Stanchina E, Ohashi K, Janjigian YY, Spitzler PJ, Melnick MA, Riely GJ, Kris MG, Miller VA, Ladanyi M, Politi K, Pao W\", TITLE = \"HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.\", JOURNAL = c(\"Cancer Discov 2:922-33 (2012)\", \"DOI:10.1158/2159-8290.CD-12-0108\")), list(REFERENCE = \"PMID:16843264\", AUTHORS = \"Zhou BB, Peyton M, He B, Liu C, Girard L, Caudler E, Lo Y, Baribaud F, Mikami I, Reguart N, Yang G, Li Y, Yao W, Vaddi K, Gazdar AF, Friedman SM, Jablons DM, Newton RC, Fridman JS, Minna JD, Scherle PA\", TITLE = \"Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.\", JOURNAL = c(\"Cancer Cell 10:39-50 (2006)\", \"DOI:10.1016/j.ccr.2006.05.024\")), list(REFERENCE = \"PMID:22474259\", AUTHORS = \"Logue JS, Morrison DK\", TITLE = \"Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy.\", JOURNAL = c(\"Genes Dev 26:641-50 (2012)\", \"DOI:10.1101/gad.186965.112\")), list(REFERENCE = \"PMID:24493829\", AUTHORS = \"Costa C, Molina MA, Drozdowskyj A, Gimenez-Capitan A, Bertran-Alamillo J, Karachaliou N, Gervais R, Massuti B, Wei J, Moran T, Majem M, Felip E, Carcereny E, Garcia-Campelo R, Viteri S, Taron M, Ono M, Giannikopoulos P, Bivona T, Rosell R\", TITLE = \"The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial.\", JOURNAL = c(\"Clin Cancer Res 20:2001-10 (2014)\", \n\"DOI:10.1158/1078-0432.CCR-13-2233\")), list(REFERENCE = \"PMID:23071030\", AUTHORS = \"Blakely CM, Bivona TG\", TITLE = \"Resiliency of lung cancers to EGFR inhibitor treatment unveiled, offering opportunities to divide and conquer EGFR inhibitor resistance.\", JOURNAL = c(\"Cancer Discov 2:872-5 (2012)\", \"DOI:10.1158/2159-8290.CD-12-0387\")), list(REFERENCE = \"PMID:25337673\", AUTHORS = \"Wu X, Liu X, Koul S, Lee CY, Zhang Z, Halmos B\", TITLE = \"AXL kinase as a novel target for cancer therapy.\", JOURNAL = c(\"Oncotarget 5:9546-63 (2014)\", \"DOI:10.18632/oncotarget.2542\")), list(REFERENCE = \"PMID:17554333\", AUTHORS = \"Arteaga CL\", TITLE = \"HER3 and mutant EGFR meet MET.\", JOURNAL = c(\"Nat Med 13:675-7 (2007)\", \"DOI:10.1038/nm0607-675\"))', 'map01521', 'EGFR tyrosine kinase inhibitor resistance', 'EGFR is a tyrosine kinase that participates in the regulation of cellular homeostasis. EGFR also serves as a stimulus for cancer growth. EGFR gene mutations and protein overexpression, both of which activate down- stream pathways, are associated with cancers, especially lung cancer. Several tyrosine kinase inhibitor (TKI) therapies against EGFR are currently administered and are initially effective in cancer patients who have EGFR mutations or aberrant activation of EGFR. However, the development of TKI resistance is common and results in the recurrence of tumors. Studies over the last decade have identified mechanisms that drive resistance to EGFR TKI treatment. Most outstanding mechanisms are: the secondary EGFR mutation (T790M), activation of alternative pathways (c-Met, HGF, AXL), aberrance of the downstream pathways (K-RAS mutations, loss of PTEN), impairment of the EGFR-TKIs-mediated apoptosis pathway (BCL2-like 11/BIM deletion polymorphism), histologic transformation, etc.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (191, '01522', 'Endocrine resistance', 'Endocrine therapy is a key treatment strategy to control or eradicate hormone-responsive breast cancer. The most commonly used endocrine therapy agents are selective estrogen receptor modulators (SERMs, e.g. tamoxifen), estrogen synthesis inhibitors (e.g. aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane), and selective estrogen receptor down-regulators (SERDs, e.g. fulvestrant). However, resistance to these agents has become a major clinical obstacle. Mechanisms of endocrine resistance include loss of ER-alpha expression, altered expression of coactivators or coregulators that play a critical role in ER-mediated gene transcription, ligand-independent growth factor signaling cascades that activate kinases and ER-phosphorylation, altered availability of active tamoxifen metabolites regulated by drug-metabolizing enzymes, such as CYP2D6, and deregulation of the cell cycle and apoptotic machinery.', 'Human Diseases; Drug resistance: antineoplastic', 'Endocrine resistance', 'Estrogen resistance syndrome', 'ko01522', 'list(REFERENCE = \"PMID:23344024\", AUTHORS = \"Garcia-Becerra R, Santos N, Diaz L, Camacho J\", TITLE = \"Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.\", JOURNAL = c(\"Int J Mol Sci 14:108-45 (2012)\", \"DOI:10.3390/ijms14010108\")), list(REFERENCE = \"PMID:19701242\", AUTHORS = \"Musgrove EA, Sutherland RL\", TITLE = \"Biological determinants of endocrine resistance in breast cancer.\", JOURNAL = c(\"Nat Rev Cancer 9:631-43 (2009)\", \"DOI:10.1038/nrc2713\")), list(REFERENCE = \"PMID:22015292\", AUTHORS = \"Giuliano M, Schifp R, Osborne CK, Trivedi MV\", TITLE = \"Biological mechanisms and clinical implications of endocrine resistance in breast cancer.\", JOURNAL = c(\"Breast 20 Suppl 3:S42-9 (2011)\", \"DOI:10.1016/S0960-9776(11)70293-4\")), list(REFERENCE = \"PMID:25907219\", AUTHORS = \"Ma CX, Reinert T, Chmielewska I, Ellis MJ\", TITLE = \"Mechanisms of aromatase inhibitor resistance.\", JOURNAL = c(\"Nat Rev Cancer 15:261-75 (2015)\", \"DOI:10.1038/nrc3920\")), list(REFERENCE = \"PMID:24841429\", AUTHORS = \"Viedma-Rodriguez R, Baiza-Gutman L, Salamanca-Gomez F, Diaz-Zaragoza M, Martinez-Hernandez G, Ruiz Esparza-Garrido R, Velazquez-Flores MA, Arenas-Aranda D\", TITLE = \"Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review).\", JOURNAL = c(\"Oncol Rep 32:3-15 (2014)\", \"DOI:10.3892/or.2014.3190\")), list(REFERENCE = \"PMID:26849149\", AUTHORS = \"Luqmani YA, Alam-Eldin N\", TITLE = \"Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem.\", JOURNAL = c(\"Med Princ Pract 25 Suppl 2:28-40 (2016)\", \"DOI:10.1159/000444451\")), list(REFERENCE = \"PMID:22771991\", AUTHORS = \"Bianco S, Gevry N\", TITLE = \"Endocrine resistance in breast cancer: from cellular signaling pathways to epigenetic mechanisms.\", JOURNAL = c(\"Transcription 3:165-70 (2012)\", \"DOI:10.4161/trns.20496\")), list(REFERENCE = \"PMID:20887199\", AUTHORS = \"Osborne CK, Schiff R\", TITLE = \"Mechanisms of endocrine resistance in breast cancer.\", JOURNAL = c(\"Annu Rev Med 62:233-47 (2011)\", \"DOI:10.1146/annurev-med-070909-182917\")), list(REFERENCE = \"PMID:23714450\", AUTHORS = \"Miller TW\", TITLE = \"Endocrine resistance: what do we know?\", JOURNAL = c(\"Am Soc Clin Oncol Educ Book 0011300037 (2013)\", \"DOI:10.1200/EdBook_AM.2013.33.e37\")), list(REFERENCE = \"PMID:23625614\", AUTHORS = \"Lonning PE, Eikesdal HP\", TITLE = \"Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved.\", JOURNAL = c(\"Endocr Relat Cancer 20:R183-201 (2013)\", \"DOI:10.1530/ERC-13-0099\")), list(REFERENCE = \"PMID:26473850\", AUTHORS = \"Egeland NG, Lunde S, Jonsdottir K, Lende TH, Cronin-Fenton D, Gilje B, Janssen EA, Soiland H\", TITLE = \"The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients.\", JOURNAL = c(\"Int J Mol Sci 16:24243-75 (2015)\", \"DOI:10.3390/ijms161024243\")), list(REFERENCE = \"PMID:24130921\", AUTHORS = \"Chang M\", TITLE = \"Tamoxifen resistance in breast cancer.\", JOURNAL = c(\"Biomol Ther (Seoul) 20:256-67 (2012)\", \"DOI:10.4062/biomolther.2012.20.3.256\")), list(REFERENCE = \"PMID:18804516\", AUTHORS = \"Zilli M, Grassadonia A, Tinari N, Di Giacobbe A, Gildetti S, Giampietro J, Natoli C, Iacobelli S\", TITLE = \"Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer.\", JOURNAL = c(\"Biochim Biophys Acta 1795:62-81 (2009)\", \"DOI:10.1016/j.bbcan.2008.08.003\")), list(REFERENCE = \"PMID:24289103\", AUTHORS = \"Mo Z, Liu M, Yang F, Luo H, Li Z, Tu G, Yang G\", TITLE = \"GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer.\", JOURNAL = c(\"Breast Cancer Res 15:R114 (2013)\", \"DOI:10.1186/bcr3581\")), list(REFERENCE = \"PMID:24415977\", AUTHORS = \"Hasson SP, Rubinek T, Ryvo L, Wolf I\", TITLE = \"Endocrine resistance in breast cancer: focus on the phosphatidylinositol 3-kinase/akt/mammalian target of rapamycin signaling pathway.\", JOURNAL = c(\"Breast Care (Basel) 8:248-55 (2013)\", \"DOI:10.1159/000354757\")), list(REFERENCE = \"PMID:15613444\", AUTHORS = \"Ring A, Dowsett M\", TITLE = \"Mechanisms of tamoxifen resistance.\", JOURNAL = c(\"Endocr Relat Cancer 11:643-58 (2004)\", \"DOI:10.1677/erc.1.00776\")), list(REFERENCE = \"PMID:24565562\", AUTHORS = \"Ribeiro JR, Freiman RN\", TITLE = \"Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.\", JOURNAL = c(\"J Steroid Biochem Mol Biol 143:160-73 (2014)\", \"DOI:10.1016/j.jsbmb.2014.02.010\")), list(REFERENCE = \"PMID:20960099\", AUTHORS = \"Wang D, Hu L, Zhang G, Zhang L, Chen C\", TITLE = \"G protein-coupled receptor 30 in tumor development.\", JOURNAL = c(\"Endocrine 38:29-37 (2010)\", \"DOI:10.1007/s12020-010-9363-z\")), list(REFERENCE = \"PMID:26122181\", AUTHORS = \"Jeselsohn R, Buchwalter G, De Angelis C, Brown M, Schiff R\", TITLE = \"ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer.\", JOURNAL = c(\"Nat Rev Clin Oncol 12:573-83 (2015)\", \"DOI:10.1038/nrclinonc.2015.117\"))', 'map01522', 'Endocrine resistance', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (192, '01523', 'Antifolate resistance', 'Since the 1940s, antifolates have played a pivotal role in drug treatment of malignant, microbial, parasitic and chronic inflammatory diseases. The molecular basis of the anti-proliferative activity of antifolates relies on inhibition of key enzymes in folate metabolism, which results in disruption of purine and thymidylate biosynthesis, inhibition of DNA replication and cell death. The anti-inflammatory properties of antifolate have been most strongly related to its ability to block the release of pro-inflammatory cytokines such as tumour necrosis factor (TNF)-alpha or interleukin (IL)-1beta. Cells may develop resistance to an antifolate drug by virtue of impaired drug transport into cells, augmented drug export, impaired activation of antifolates through polyglutamylation, augmented hydrolysis of antifolate polyglutamates, increased expression and mutation of target enzymes, and the augmentation of cellular tetrahydrofolate-cofactor pools in cells.', 'Human Diseases; Drug resistance: antineoplastic', 'Antifolate resistance', 'ko01523', 'list(REFERENCE = \"PMID:22921318\", AUTHORS = \"Gonen N, Assaraf YG\", TITLE = \"Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance.\", JOURNAL = c(\"Drug Resist Updat 15:183-210 (2012)\", \"DOI:10.1016/j.drup.2012.07.002\")), list(REFERENCE = \"PMID:17333344\", AUTHORS = \"Assaraf YG\", TITLE = \"Molecular basis of antifolate resistance.\", JOURNAL = c(\"Cancer Metastasis Rev 26:153-81 (2007)\", \"DOI:10.1007/s10555-007-9049-z\")), list(REFERENCE = \"PMID:26920997\", AUTHORS = \"Municio C, Soler Palacios B, Estrada-Capetillo L, Benguria A, Dopazo A, Garcia-Lorenzo E, Fernandez-Arroyo S, Joven J, Miranda-Carus ME, Gonzalez-Alvaro I, Puig-Kroger A\", TITLE = \"Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis.\", JOURNAL = c(\"Ann Rheum Dis 75:2157-2165 (2016)\", \"DOI:10.1136/annrheumdis-2015-208736\")), list(REFERENCE = \"PMID:24732946\", AUTHORS = \"Wilson PM, Danenberg PV, Johnston PG, Lenz HJ, Ladner RD\", TITLE = \"Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.\", JOURNAL = c(\"Nat Rev Clin Oncol 11:282-98 (2014)\", \"DOI:10.1038/nrclinonc.2014.51\")), list(REFERENCE = \"PMID:18297517\", AUTHORS = \"Fotoohi AK, Albertioni F\", TITLE = \"Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells.\", JOURNAL = c(\"Leuk Lymphoma 49:410-26 (2008)\", \"DOI:10.1080/10428190701824569\")), list(REFERENCE = \"PMID:17203006\", AUTHORS = \"van der Heijden JW, Dijkmans BA, Scheper RJ, Jansen G\", TITLE = \"Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside.\", JOURNAL = c(\"Nat Clin Pract Rheumatol 3:26-34 (2007)\", \"DOI:10.1038/ncprheum0380\")), list(REFERENCE = \"PMID:17092765\", AUTHORS = \"Assaraf YG\", TITLE = \"The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.\", JOURNAL = c(\"Drug Resist Updat 9:227-46 (2006)\", \"DOI:10.1016/j.drup.2006.09.001\")), list(REFERENCE = \"\", AUTHORS = \"Mauritz R.\", TITLE = \"Determinants of antifolate and 5-fluorouracil efficacy\", JOURNAL = \"Biochemistry\"), list(REFERENCE = \"\", AUTHORS = \"del-Campo LS, Montenegro MF, Saez-Ayala M, Fernandez-Perez MP, Cabezas-Herrera J, Rodriquez-Lopez JN.\", TITLE = \"Cellular and molecular mechanisms of methotrexate resistance in melanoma\", JOURNAL = c(\"Intech\", \"DOI:10.5772/52414\")), list(REFERENCE = \"PMID:16380836\", AUTHORS = \"Walling J\", TITLE = \"From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates.\", JOURNAL = c(\"Invest New Drugs 24:37-77 (2006)\", \"DOI:10.1007/s10637-005-4541-1\")), list(REFERENCE = \"PMID:22954694\", AUTHORS = \"Desmoulin SK, Hou Z, Gangjee A, Matherly LH\", TITLE = \"The human proton-coupled folate transporter: Biology and therapeutic applications to cancer.\", JOURNAL = c(\"Cancer Biol Ther 13:1355-73 (2012)\", \"DOI:10.4161/cbt.22020\")), list(REFERENCE = \"PMID:16491071\", AUTHORS = \"Cheok MH, Evans WE\", TITLE = \"Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.\", JOURNAL = c(\"Nat Rev Cancer 6:117-29 (2006)\", \"DOI:10.1038/nrc1800\")), list(REFERENCE = \"PMID:23987246\", AUTHORS = \"van der Heijden JW, Assaraf YG, Gerards AH, Oerlemans R, Lems WF, Scheper RJ, Dijkmans BA, Jansen G\", TITLE = \"Methotrexate analogues display enhanced inhibition of TNF-alpha production in whole blood from RA patients.\", JOURNAL = c(\"Scand J Rheumatol 43:9-16 (2014)\", \"DOI:10.3109/03009742.2013.797490\")), list(REFERENCE = \"PMID:8793930\", AUTHORS = \"Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino JR\", TITLE = \"Intrinsic and acquired resistance to methotrexate in acute leukemia.\", JOURNAL = c(\"N Engl J Med 335:1041-8 (1996)\", \"DOI:10.1056/NEJM199610033351408\")), list(REFERENCE = \"PMID:15117425\", AUTHORS = \"Adjei AA\", TITLE = \"Pharmacology and mechanism of action of pemetrexed.\", JOURNAL = c(\"Clin Lung Cancer 5 Suppl 2:S51-5 (2004)\", \"DOI:10.3816/CLC.2004.s.003\")), list(REFERENCE = \"PMID:14576850\", AUTHORS = \"Zhao R, Goldman ID\", TITLE = \"Resistance to antifolates.\", JOURNAL = c(\"Oncogene 22:7431-57 (2003)\", \"DOI:10.1038/sj.onc.1206946\")), list(REFERENCE = \"PMID:21317831\", AUTHORS = \"Mikkelsen TS, Thorn CF, Yang JJ, Ulrich CM, French D, Zaza G, Dunnenberger HM, Marsh S, McLeod HL, Giacomini K, Becker ML, Gaedigk R, Leeder JS, Kager L, Relling MV, Evans W, Klein TE, Altman RB\", TITLE = \"PharmGKB summary: methotrexate pathway.\", JOURNAL = c(\"Pharmacogenet Genomics 21:679-86 (2011)\", \"DOI:10.1097/FPC.0b013e328343dd93\")), list(REFERENCE = \"PMID:23897011\", AUTHORS = \"Blits M, Jansen G, Assaraf YG, van de Wiel MA, Lems WF, Nurmohamed MT, van Schaardenburg D, Voskuyl AE, Wolbink GJ, Vosslamber S, Verweij CL\", TITLE = \"Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis.\", JOURNAL = c(\"Arthritis Rheum 65:2791-802 (2013)\", \"DOI:10.1002/art.38094\")), list(REFERENCE = \"PMID:11509639\", AUTHORS = \"Majumdar S, Aggarwal BB\", TITLE = \"Methotrexate suppresses NF-kappaB activation through inhibition of IkappaBalpha phosphorylation and degradation.\", JOURNAL = c(\"J Immunol 167:2911-20 (2001)\", \"DOI:10.4049/jimmunol.167.5.2911\"))', 'map01523', 'Antifolate resistance', 'Since the 1940s, antifolates have played a pivotal role in drug treatment of malignant, microbial, parasitic and chronic inflammatory diseases. The molecular basis of the anti-proliferative activity of antifolates relies on inhibition of key enzymes in folate metabolism, which results in disruption of purine and thymidylate biosynthesis, inhibition of DNA replication and cell death. The anti-inflammatory properties of antifolate have been most strongly related to its ability to block the release of pro-inflammatory cytokines such as tumour necrosis factor (TNF)-alpha or interleukin (IL)-1beta. Cells may develop resistance to an antifolate drug by virtue of impaired drug transport into cells, augmented drug export, impaired activation of antifolates through polyglutamylation, augmented hydrolysis of antifolate polyglutamates, increased expression and mutation of target enzymes, and the augmentation of cellular tetrahydrofolate-cofactor pools in cells.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (193, '01524', 'Platinum drug resistance', 'Platinum-based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of solid malignancies, including testicular, ovarian, head and neck, colorectal, bladder and lung cancers. The mechanism of action of Platinum-based drugs involves covalent binding to purine DNA bases, which primarily leads to cellular apoptosis. Their clinical success is, however, limited due to severe side effects and intrinsic or acquired resistance to the treatment. Platinum resistance could arise from decreased drug influx, increased drug efflux, intracellular detoxification by glutathione, etc., decreased binding (e.g., due to high intracellular pH), increased DNA repair, decreased mismatch repair, defective apoptosis, and altered oncogene expression.', 'Human Diseases; Drug resistance: antineoplastic', 'Platinum drug resistance', 'ko01524', 'list(REFERENCE = \"PMID:14576837\", AUTHORS = \"Siddik ZH\", TITLE = \"Cisplatin: mode of cytotoxic action and molecular basis of resistance.\", JOURNAL = c(\"Oncogene 22:7265-79 (2003)\", \"DOI:10.1038/sj.onc.1206933\")), list(REFERENCE = \"PMID:26184483\", AUTHORS = \"Martinez-Balibrea E, Martinez-Cardus A, Gines A, Ruiz de Porras V, Moutinho C, Layos L, Manzano JL, Buges C, Bystrup S, Esteller M, Abad A\", TITLE = \"Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance.\", JOURNAL = c(\"Mol Cancer Ther 14:1767-76 (2015)\", \"DOI:10.1158/1535-7163.MCT-14-0636\")), list(REFERENCE = \"PMID:17625587\", AUTHORS = \"Kelland L\", TITLE = \"The resurgence of platinum-based cancer chemotherapy.\", JOURNAL = c(\"Nat Rev Cancer 7:573-84 (2007)\", \"DOI:10.1038/nrc2167\")), list(REFERENCE = \"PMID:26886018\", AUTHORS = \"Dilruba S, Kalayda GV\", TITLE = \"Platinum-based drugs: past, present and future.\", JOURNAL = c(\"Cancer Chemother Pharmacol 77:1103-24 (2016)\", \"DOI:10.1007/s00280-016-2976-z\")), list(REFERENCE = \"PMID:23442359\", AUTHORS = \"Lu HP, Chao CC\", TITLE = \"Cancer cells acquire resistance to anticancer drugs: an update.\", JOURNAL = c(\"Biomed J 35:464-72 (2012)\", \"DOI:10.4103/2319-4170.104411\")), list(REFERENCE = \"PMID:24074238\", AUTHORS = \"Koster R, van Vugt MA, Timmer-Bosscha H, Gietema JA, de Jong S\", TITLE = \"Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.\", JOURNAL = c(\"Expert Rev Mol Med 15:e12 (2013)\", \"DOI:10.1017/erm.2013.13\")), list(REFERENCE = \"PMID:21892204\", AUTHORS = \"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G\", TITLE = \"Molecular mechanisms of cisplatin resistance.\", JOURNAL = c(\"Oncogene 31:1869-83 (2012)\", \"DOI:10.1038/onc.2011.384\")), list(REFERENCE = \"PMID:17336087\", AUTHORS = \"Stewart DJ\", TITLE = \"Mechanisms of resistance to cisplatin and carboplatin.\", JOURNAL = c(\"Crit Rev Oncol Hematol 63:12-31 (2007)\", \"DOI:10.1016/j.critrevonc.2007.02.001\")), list(REFERENCE = \"PMID:20647037\", AUTHORS = \"Koberle B, Tomicic MT, Usanova S, Kaina B\", TITLE = \"Cisplatin resistance: preclinical findings and clinical implications.\", JOURNAL = c(\"Biochim Biophys Acta 1806:172-82 (2010)\", \"DOI:10.1016/j.bbcan.2010.07.004\")), list(REFERENCE = \"PMID:25546083\", AUTHORS = \"Jacobsen C, Honecker F\", TITLE = \"Cisplatin resistance in germ cell tumours: models and mechanisms.\", JOURNAL = c(\"Andrology 3:111-21 (2015)\", \"DOI:10.1111/andr.299\")), list(REFERENCE = \"PMID:14609433\", AUTHORS = \"Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK\", TITLE = \"Chemoresistance in human ovarian cancer: the role of apoptotic regulators.\", JOURNAL = c(\"Reprod Biol Endocrinol 1:66 (2003)\", \"DOI:10.1186/1477-7827-1-66\")), list(REFERENCE = \"\", AUTHORS = \"Sousa GF, Wlodarczyk SR, Monteiro G.\", TITLE = \"Carboplatin: molecular mechanisms of action associated with chemoresistance.\", JOURNAL = c(\"Brazillian Journal of Pharmaceutical Sciences 50 (2014)\", \"DOI:10.1590/S1984-82502014000400004\")), list(REFERENCE = \"PMID:24874729\", AUTHORS = \"Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G\", TITLE = \"Systems biology of cisplatin resistance: past, present and future.\", JOURNAL = c(\"Cell Death Dis 5:e1257 (2014)\", \"DOI:10.1038/cddis.2013.428\")), list(REFERENCE = \"PMID:25058905\", AUTHORS = \"Dasari S, Tchounwou PB\", TITLE = \"Cisplatin in cancer therapy: molecular mechanisms of action.\", JOURNAL = c(\"Eur J Pharmacol 740:364-78 (2014)\", \"DOI:10.1016/j.ejphar.2014.07.025\")), list(REFERENCE = \"PMID:20811617\", AUTHORS = \"Basu A, Krishnamurthy S\", TITLE = \"Cellular responses to Cisplatin-induced DNA damage.\", JOURNAL = c(\"J Nucleic Acids 2010:201367 (2010)\", \"DOI:10.4061/2010/201367\")), list(REFERENCE = \"PMID:19190080\", AUTHORS = \"Chaudhry P, Asselin E\", TITLE = \"Resistance to chemotherapy and hormone therapy in endometrial cancer.\", JOURNAL = c(\"Endocr Relat Cancer 16:363-80 (2009)\", \"DOI:10.1677/ERC-08-0266\")), list(REFERENCE = \"PMID:26867799\", AUTHORS = \"Li X, Lin Z, Zhang B, Guo L, Liu S, Li H, Zhang J, Ye Q\", TITLE = \"beta-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1.\", JOURNAL = c(\"Sci Rep 6:21010 (2016)\", \"DOI:10.1038/srep21010\")), list(REFERENCE = \"PMID:15607932\", AUTHORS = \"Safaei R, Howell SB\", TITLE = \"Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.\", JOURNAL = c(\"Crit Rev Oncol Hematol 53:13-23 (2005)\", \"DOI:10.1016/j.critrevonc.2004.09.007\"))', 'map01524', 'Platinum drug resistance', 'Platinum-based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of solid malignancies, including testicular, ovarian, head and neck, colorectal, bladder and lung cancers. The mechanism of action of Platinum-based drugs involves covalent binding to purine DNA bases, which primarily leads to cellular apoptosis. Their clinical success is, however, limited due to severe side effects and intrinsic or acquired resistance to the treatment. Platinum resistance could arise from decreased drug influx, increased drug efflux, intracellular detoxification by glutathione, etc., decreased binding (e.g., due to high intracellular pH), increased DNA repair, decreased mismatch repair, defective apoptosis, and altered oncogene expression.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (194, '02010', 'ABC transporters', 'The ATP-binding cassette (ABC) transporters form one of the largest known protein families, and are widespread in bacteria, archaea, and eukaryotes. They couple ATP hydrolysis to active transport of a wide variety of substrates such as ions, sugars, lipids, sterols, peptides, proteins, and drugs. The structure of a prokaryotic ABC transporter usually consists of three components; typically two integral membrane proteins each having six transmembrane segments, two peripheral proteins that bind and hydrolyze ATP, and a periplasmic (or lipoprotein) substrate-binding protein. Many of the genes for the three components form operons as in fact observed in many bacterial and archaeal genomes. On the other hand, in a typical eukaryotic ABC transporter, the membrane spanning protein and the ATP-binding protein are fused, forming a multi-domain protein with the membrane-spanning domain (MSD) and the nucleotide-binding domain (NBD).', 'Environmental Information Processing; Membrane transport', 'ABC transporters', 'Sitosterolemia, Tangier disease, Adrenoleukodystrophy, Hyperbilirubinemia, Cystic fibrosis, Pseudoxanthoma elasticum, Harlequin ichthyosis, Stargardt disease, Hypoalphalipoproteinemia, Bare lymphocyte syndrome type1, Congenital bilateral absence of vas deferens, Gallbladder disease, Familial hyperinsulinemic hypoglycemia, Dubin-Johnson syndrome', 'GO: 0043190 0043191 0043192, TC: 3.A.1', 'ko02010', 'list(REFERENCE = \"PMID:9799792\", AUTHORS = \"Tomii K, Kanehisa M.\", TITLE = \"A comparative analysis of ABC transporters in complete microbial genomes.\", JOURNAL = c(\"Genome Res 8:1048-59 (1998)\", \"DOI:10.1101/gr.8.10.1048\")), list(REFERENCE = \"PMID:18424520\", AUTHORS = \"Sperandeo P, Lau FK, Carpentieri A, De Castro C, Molinaro A, Deho G, Silhavy TJ, Polissi A\", TITLE = \"Functional analysis of the protein machinery required for transport of lipopolysaccharide to the outer membrane of Escherichia coli.\", JOURNAL = c(\"J Bacteriol 190:4460-9 (2008)\", \"DOI:10.1128/JB.00270-08\")), list(REFERENCE = \"PMID:18375759\", AUTHORS = \"Ruiz N, Gronenberg LS, Kahne D, Silhavy TJ\", TITLE = \"Identification of two inner-membrane proteins required for the transport of lipopolysaccharide to the outer membrane of Escherichia coli.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:5537-42 (2008)\", \"DOI:10.1073/pnas.0801196105\")), list(REFERENCE = \"PMID:10557362\", AUTHORS = \"Omata T, Price GD, Badger MR, Okamura M, Gohta S, Ogawa T\", TITLE = \"Identification of an ATP-binding cassette transporter involved in bicarbonate uptake in the cyanobacterium Synechococcus sp. strain PCC 7942.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 96:13571-6 (1999)\", \"DOI:10.1073/pnas.96.23.13571\")), list(REFERENCE = \"PMID:11731493\", AUTHORS = \"Quintero MJ, Montesinos ML, Herrero A, Flores E\", TITLE = \"Identification of genes encoding amino acid permeases by inactivation of selected ORFs from the Synechocystis genomic sequence.\", JOURNAL = c(\"Genome Res 11:2034-40 (2001)\", \"DOI:10.1101/gr.196301\")), list(REFERENCE = \"PMID:16135226\", AUTHORS = \"Picossi S, Montesinos ML, Pernil R, Lichtle C, Herrero A, Flores E\", TITLE = \"ABC-type neutral amino acid permease N-I is required for optimal diazotrophic growth and is repressed in the heterocysts of Anabaena sp. strain PCC 7120.\", JOURNAL = c(\"Mol Microbiol 57:1582-92 (2005)\", \"DOI:10.1111/j.1365-2958.2005.04791.x\")), list(REFERENCE = \"PMID:11929526\", AUTHORS = \"Valladares A, Montesinos ML, Herrero A, Flores E.\", TITLE = \"An ABC-type, high-affinity urea permease identified in cyanobacteria.\", JOURNAL = c(\"Mol Microbiol 43:703-15 (2002)\", \"DOI:10.1046/j.1365-2958.2002.02778.x\")), list(REFERENCE = \"PMID:18326572\", AUTHORS = \"Richard-Fogal CL, Frawley ER, Kranz RG\", TITLE = \"Topology and function of CcmD in cytochrome c maturation.\", JOURNAL = c(\"J Bacteriol 190:3489-93 (2008)\", \"DOI:10.1128/JB.00146-08\")), list(REFERENCE = \"PMID:16109926\", AUTHORS = \"Suzuki H, Koyanagi T, Izuka S, Onishi A, Kumagai H\", TITLE = \"The yliA, -B, -C, and -D genes of Escherichia coli K-12 encode a novel glutathione importer with an ATP-binding cassette.\", JOURNAL = c(\"J Bacteriol 187:5861-7 (2005)\", \"DOI:10.1128/JB.187.17.5861-5867.2005\")), list(REFERENCE = \"PMID:17873039\", AUTHORS = \"Novikova M, Metlitskaya A, Datsenko K, Kazakov T, Kazakov A, Wanner B, Severinov K\", TITLE = \"The Escherichia coli Yej transporter is required for the uptake of translation inhibitor microcin C.\", JOURNAL = c(\"J Bacteriol 189:8361-5 (2007)\", \"DOI:10.1128/JB.01028-07\")), list(REFERENCE = \"PMID:17214741\", AUTHORS = \"Tikhonova EB, Devroy VK, Lau SY, Zgurskaya HI\", TITLE = \"Reconstitution of the Escherichia coli macrolide transporter: the periplasmic membrane fusion protein MacA stimulates the ATPase activity of MacB.\", JOURNAL = c(\"Mol Microbiol 63:895-910 (2007)\", \"DOI:10.1111/j.1365-2958.2006.05549.x\")), list(REFERENCE = \"PMID:18805970\", AUTHORS = \"Yamanaka H, Kobayashi H, Takahashi E, Okamoto K\", TITLE = \"MacAB is involved in the secretion of Escherichia coli heat-stable enterotoxin II.\", JOURNAL = c(\"J Bacteriol 190:7693-8 (2008)\", \"DOI:10.1128/JB.00853-08\"))', 'map02010', 521, 5522, 248, 105, 122, 46, 5228, 294);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (195, '02020', 'Two-component system', 'Two-component signal transduction systems enable bacteria to sense, respond, and adapt to changes in their environment or in their intracellular state. Each two-component system consists of a sensor protein-histidine kinase (HK) and a response regulator (RR). In the prototypical two-component pathway, the sensor HK phosphorylates its own conserved His residue in response to a signal(s) in the environment. Subsequently, the phosphoryl group of HK is transferred onto a specific Asp residue on the RR. The activated RR can then effect changes in cellular physiology, often by regulating gene expression. Two-component pathways thus often enable cells to sense and respond to stimuli by inducing changes in transcription.', 'Environmental Information Processing; Signal transduction', 'Two-component system', 'Vancomycin resistance, D-Ala-D-Lac type [PATH:map02020], Vancomycin resistance, D-Ala-D-Ser type [PATH:map02020]', 'GO: 0000160', 'ko02020', 'list(REFERENCE = \"PMID:15522865\", AUTHORS = \"Yamamoto K, Hirao K, Oshima T, Aiba H, Utsumi R, Ishihama A.\", TITLE = \"Functional characterization in vitro of all two-component signal transduction systems from Escherichia coli.\", JOURNAL = c(\"J Biol Chem 280:1448-56 (2005)\", \"DOI:10.1074/jbc.M410104200\")), list(REFERENCE = \"PMID:16030210\", AUTHORS = \"Abdel-Fattah WR, Chen Y, Eldakak A, Hulett FM.\", TITLE = \"Bacillus subtilis phosphorylated PhoP: direct activation of the E(sigma)A- and repression of the E(sigma)E-responsive phoB-PS+V promoters during pho response.\", JOURNAL = c(\"J Bacteriol 187:5166-78 (2005)\", \"DOI:10.1128/JB.187.15.5166-5178.2005\")), list(REFERENCE = \"PMID:15813739\", AUTHORS = \"Navarre WW, Halsey TA, Walthers D, Frye J, McClelland M, Potter JL, Kenney LJ, Gunn JS, Fang FC, Libby SJ.\", TITLE = \"Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ.\", JOURNAL = c(\"Mol Microbiol 56:492-508 (2005)\", \"DOI:10.1111/j.1365-2958.2005.04553.x\")), list(REFERENCE = \"PMID:11973328\", AUTHORS = \"Cai SJ, Inouye M.\", TITLE = \"EnvZ-OmpR interaction and osmoregulation in Escherichia coli.\", JOURNAL = c(\"J Biol Chem 277:24155-61 (2002)\", \"DOI:10.1074/jbc.M110715200\")), list(REFERENCE = \"PMID:16077119\", AUTHORS = \"Batchelor E, Walthers D, Kenney LJ, Goulian M.\", TITLE = \"The Escherichia coli CpxA-CpxR envelope stress response system regulates expression of the porins ompF and ompC.\", JOURNAL = c(\"J Bacteriol 187:5723-31 (2005)\", \"DOI:10.1128/JB.187.16.5723-5731.2005\")), list(REFERENCE = \"PMID:12107133\", AUTHORS = \"Nagakubo S, Nishino K, Hirata T, Yamaguchi A.\", TITLE = \"The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC.\", JOURNAL = c(\"J Bacteriol 184:4161-7 (2002)\", \"DOI:10.1128/JB.184.15.4161-4167.2002\")), list(REFERENCE = \"PMID:15322361\", AUTHORS = \"Hagiwara D, Yamashino T, Mizuno T.\", TITLE = \"A Genome-wide view of the Escherichia coli BasS-BasR two-component system implicated in iron-responses.\", JOURNAL = c(\"Biosci Biotechnol Biochem 68:1758-67 (2004)\", \"DOI:10.1271/bbb.68.1758\")), list(REFERENCE = \"PMID:11004187\", AUTHORS = \"Munson GP, Lam DL, Outten FW, O\'Halloran TV.\", TITLE = \"Identification of a copper-responsive two-component system on the chromosome of Escherichia coli K-12.\", JOURNAL = c(\"J Bacteriol 182:5864-71 (2000)\", \"DOI:10.1128/JB.182.20.5864-5871.2000\")), list(REFERENCE = \"PMID:11929534\", AUTHORS = \"Sperandio V, Torres AG, Kaper JB.\", TITLE = \"Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli.\", JOURNAL = c(\"Mol Microbiol 43:809-21 (2002)\", \"DOI:10.1046/j.1365-2958.2002.02803.x\")), list(REFERENCE = \"PMID:14604015\", AUTHORS = \"Epstein W.\", TITLE = \"The roles and regulation of potassium in bacteria.\", JOURNAL = c(\"Prog Nucleic Acid Res Mol Biol 75:293-320 (2003)\", \"DOI:10.1016/S0079-6603(03)75008-9\")), list(REFERENCE = \"PMID:10648521\", AUTHORS = \"Ansaldi M, Simon G, Lepelletier M, Mejean V.\", TITLE = \"The TorR high-affinity binding site plays a key role in both torR autoregulation and torCAD operon expression in Escherichia coli.\", JOURNAL = c(\"J Bacteriol 182:961-6 (2000)\", \"DOI:10.1128/JB.182.4.961-966.2000\")), list(REFERENCE = \"PMID:15326287\", AUTHORS = \"Malpica R, Franco B, Rodriguez C, Kwon O, Georgellis D.\", TITLE = \"Identification of a quinone-sensitive redox switch in the ArcB sensor kinase.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 101:13318-23 (2004)\", \"DOI:10.1073/pnas.0403064101\")), list(REFERENCE = \"PMID:2666399\", AUTHORS = \"Widenhorn KA, Somers JM, Kay WW.\", TITLE = \"Genetic regulation of the tricarboxylate transport operon (tctI) of Salmonella typhimurium.\", JOURNAL = c(\"J Bacteriol 171:4436-41 (1989)\", \"DOI:10.1128/JB.171.8.4436-4441.1989\")), list(REFERENCE = \"PMID:11555295\", AUTHORS = \"Hyyrylainen HL, Bolhuis A, Darmon E, Muukkonen L, Koski P, Vitikainen M, Sarvas M, Pragai Z, Bron S, van Dijl JM, Kontinen VP.\", TITLE = \"A novel two-component regulatory system in Bacillus subtilis for the survival of severe secretion stress.\", JOURNAL = c(\"Mol Microbiol 41:1159-72 (2001)\", \"DOI:10.1046/j.1365-2958.2001.02576.x\")), list(REFERENCE = \"PMID:10972837\", AUTHORS = \"Zhang X, Hulett FM.\", TITLE = \"ResD signal transduction regulator of aerobic respiration in Bacillus subtilis: ctaA promoter regulation.\", JOURNAL = c(\"Mol Microbiol 37:1208-19 (2000)\", \"DOI:10.1046/j.1365-2958.2000.02076.x\")), list(REFERENCE = \"PMID:15937169\", AUTHORS = \"Senadheera MD, Guggenheim B, Spatafora GA, Huang YC, Choi J, Hung DC, Treglown JS, Goodman SD, Ellen RP, Cvitkovitch DG.\", TITLE = \"A VicRK signal transduction system in Streptococcus mutans affects gtfBCD, gbpB, and ftf expression, biofilm formation, and genetic competence development.\", JOURNAL = c(\"J Bacteriol 187:4064-76 (2005)\", \"DOI:10.1128/JB.187.12.4064-4076.2005\")), list(REFERENCE = \"PMID:15601704\", AUTHORS = \"He H, Zahrt TC.\", TITLE = \"Identification and characterization of a regulatory sequence recognized by Mycobacterium tuberculosis persistence regulator MprA.\", JOURNAL = c(\"J Bacteriol 187:202-12 (2005)\", \"DOI:10.1128/JB.187.1.202-212.2005\")), list(REFERENCE = \"PMID:17448786\", AUTHORS = \"Hutchings MI\", TITLE = \"Unusual two-component signal transduction pathways in the actinobacteria.\", JOURNAL = c(\"Adv Appl Microbiol 61:1-26 (2007)\", \"DOI:10.1016/S0065-2164(06)61001-0\")), list(REFERENCE = \"PMID:19308662\", AUTHORS = \"Kramer R\", TITLE = \"Osmosensing and osmosignaling in Corynebacterium glutamicum.\", JOURNAL = c(\"Amino Acids 37:487-97 (2009)\", \"DOI:10.1007/s00726-009-0271-6\")), list(REFERENCE = \"PMID:7751278\", AUTHORS = \"Eraso JM, Kaplan S.\", TITLE = \"Oxygen-insensitive synthesis of the photosynthetic membranes of Rhodobacter sphaeroides: a mutant histidine kinase.\", JOURNAL = c(\"J Bacteriol 177:2695-706 (1995)\", \"DOI:10.1128/JB.177.10.2695-2706.1995\")), list(REFERENCE = \"PMID:10089160\", AUTHORS = \"Haydel SE, Dunlap NE, Benjamin WH Jr.\", TITLE = \"In vitro evidence of two-component system phosphorylation between the Mycobacterium tuberculosis TrcR/TrcS proteins.\", JOURNAL = c(\"Microb Pathog 26:195-206 (1999)\", \"DOI:10.1006/mpat.1998.0265\")), list(REFERENCE = \"PMID:11673427\", AUTHORS = \"Quisel JD, Burkholder WF, Grossman AD.\", TITLE = \"In vivo effects of sporulation kinases on mutant Spo0A proteins in Bacillus subtilis.\", JOURNAL = c(\"J Bacteriol 183:6573-8 (2001)\", \"DOI:10.1128/JB.183.22.6573-6578.2001\")), list(REFERENCE = \"PMID:11889485\", AUTHORS = \"Kaspar S, Bott M.\", TITLE = \"The sensor kinase CitA (DpiB) of Escherichia coli functions as a high-affinity citrate receptor.\", JOURNAL = c(\"Arch Microbiol 177:313-21 (2002)\", \"DOI:10.1007/s00203-001-0393-z\")), list(REFERENCE = \"PMID:12167640\", AUTHORS = \"Janausch IG, Garcia-Moreno I, Unden G.\", TITLE = \"Function of DcuS from Escherichia coli as a fumarate-stimulated histidine protein kinase in vitro.\", JOURNAL = c(\"J Biol Chem 277:39809-14 (2002)\", \"DOI:10.1074/jbc.M204482200\")), list(REFERENCE = \"PMID:8550490\", AUTHORS = \"Brunskill EW, Bayles KW.\", TITLE = \"Identification and molecular characterization of a putative regulatory locus that affects autolysis in Staphylococcus aureus.\", JOURNAL = c(\"J Bacteriol 178:611-8 (1996)\", \"DOI:10.1128/JB.178.3.611-618.1996\")), list(REFERENCE = \"PMID:10940023\", AUTHORS = \"Fujimoto DF, Brunskill EW, Bayles KW.\", TITLE = \"Analysis of genetic elements controlling Staphylococcus aureus lrgAB expression: potential role of DNA topology in SarA regulation.\", JOURNAL = c(\"J Bacteriol 182:4822-8 (2000)\", \"DOI:10.1128/JB.182.17.4822-4828.2000\")), list(REFERENCE = \"PMID:11807079\", AUTHORS = \"Dufour P, Jarraud S, Vandenesch F, Greenland T, Novick RP, Bes M, Etienne J, Lina G.\", TITLE = \"High genetic variability of the agr locus in Staphylococcus species.\", JOURNAL = c(\"J Bacteriol 184:1180-6 (2002)\", \"DOI:10.1128/JB.184.4.1180-1186.2002\")), list(REFERENCE = \"PMID:8501030\", AUTHORS = \"Rabin RS, Stewart V.\", TITLE = \"Dual response regulators (NarL and NarP) interact with dual sensors (NarX and NarQ) to control nitrate- and nitrite-regulated gene expression in Escherichia coli K-12.\", JOURNAL = c(\"J Bacteriol 175:3259-68 (1993)\", \"DOI:10.1128/JB.175.11.3259-3268.1993\")), list(REFERENCE = \"PMID:9220011\", AUTHORS = \"Chiang RC, Cavicchioli R, Gunsalus RP.\", TITLE = \"\'Locked-on\' and \'locked-off\' signal transduction mutations in the periplasmic domain of the Escherichia coli NarQ and NarX sensors affect nitrate- and nitrite-dependent regulation by NarL and NarP.\", JOURNAL = c(\"Mol Microbiol 24:1049-60 (1997)\", \"DOI:10.1046/j.1365-2958.1997.4131779.x\")), list(REFERENCE = \"PMID:12107138\", AUTHORS = \"Verhamme DT, Postma PW, Crielaard W, Hellingwerf KJ.\", TITLE = \"Cooperativity in signal transfer through the Uhp system of Escherichia coli.\", JOURNAL = c(\"J Bacteriol 184:4205-10 (2002)\", \"DOI:10.1128/JB.184.15.4205-4210.2002\")), list(REFERENCE = \"PMID:13129944\", AUTHORS = \"Hagiwara D, Sugiura M, Oshima T, Mori H, Aiba H, Yamashino T, Mizuno T.\", TITLE = \"Genome-wide analyses revealing a signaling network of the RcsC-YojN-RcsB phosphorelay system in Escherichia coli.\", JOURNAL = c(\"J Bacteriol 185:5735-46 (2003)\", \"DOI:10.1128/JB.185.19.5735-5746.2003\")), list(REFERENCE = \"PMID:12951338\", AUTHORS = \"Hirakawa H, Nishino K, Yamada J, Hirata T, Yamaguchi A.\", TITLE = \"Beta-lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli.\", JOURNAL = c(\"J Antimicrob Chemother 52:576-82 (2003)\", \"DOI:10.1093/jac/dkg406\")), list(REFERENCE = \"PMID:12193630\", AUTHORS = \"Suzuki K, Wang X, Weilbacher T, Pernestig AK, Melefors O, Georgellis D, Babitzke P, Romeo T.\", TITLE = \"Regulatory circuitry of the CsrA/CsrB and BarA/UvrY systems of Escherichia coli.\", JOURNAL = c(\"J Bacteriol 184:5130-40 (2002)\", \"DOI:10.1128/JB.184.18.5130-5140.2002\")), list(REFERENCE = \"PMID:10923791\", AUTHORS = \"Kato A, Ohnishi H, Yamamoto K, Furuta E, Tanabe H, Utsumi R.\", TITLE = \"Transcription of emrKY is regulated by the EvgA-EvgS two-component system in Escherichia coli K-12.\", JOURNAL = c(\"Biosci Biotechnol Biochem 64:1203-9 (2000)\", \"DOI:10.1271/bbb.64.1203\")), list(REFERENCE = \"PMID:14679219\", AUTHORS = \"Ansaldi M, Dubnau D.\", TITLE = \"Diversifying selection at the Bacillus quorum-sensing locus and determinants of modification specificity during synthesis of the ComX pheromone.\", JOURNAL = c(\"J Bacteriol 186:15-21 (2004)\", \"DOI:10.1128/JB.186.1.15-21.2004\")), list(REFERENCE = \"PMID:16035234\", AUTHORS = \"Gabdrakhmanova L, Vishniakov I, Sharipova M, Balaban N, Kostrov S, Leshchinskaya I.\", TITLE = \"Salt stress induction of glutamyl endopeptidase biosynthesis in Bacillus intermedius.\", JOURNAL = c(\"Microbiol Res 160:233-42 (2005)\", \"DOI:10.1016/j.micres.2004.05.005\")), list(REFERENCE = \"PMID:11285232\", AUTHORS = \"Aguilar PS, Hernandez-Arriaga AM, Cybulski LE, Erazo AC, de Mendoza D.\", TITLE = \"Molecular basis of thermosensing: a two-component signal transduction thermometer in Bacillus subtilis.\", JOURNAL = c(\"EMBO J 20:1681-91 (2001)\", \"DOI:10.1093/emboj/20.7.1681\")), list(REFERENCE = \"PMID:12864861\", AUTHORS = \"Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K.\", TITLE = \"Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus.\", JOURNAL = c(\"Mol Microbiol 49:807-21 (2003)\", \"DOI:10.1046/j.1365-2958.2003.03599.x\")), list(REFERENCE = \"PMID:15073296\", AUTHORS = \"Saini DK, Malhotra V, Dey D, Pant N, Das TK, Tyagi JS.\", TITLE = \"DevR-DevS is a bona fide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR.\", JOURNAL = c(\"Microbiology 150:865-75 (2004)\", \"DOI:10.1099/mic.0.26218-0\")), list(REFERENCE = \"PMID:12426351\", AUTHORS = \"Fedtke I, Kamps A, Krismer B, Gotz F.\", TITLE = \"The nitrate reductase and nitrite reductase operons and the narT gene of Staphylococcus carnosus are positively controlled by the novel two-component system NreBC.\", JOURNAL = c(\"J Bacteriol 184:6624-34 (2002)\", \"DOI:10.1128/JB.184.23.6624-6634.2002\")), list(REFERENCE = \"PMID:8416895\", AUTHORS = \"Shiau SP, Chen P, Reitzer LJ.\", TITLE = \"Effects of insertions and deletions in glnG (ntrC) of Escherichia coli on nitrogen regulator I-dependent DNA binding and transcriptional activation.\", JOURNAL = c(\"J Bacteriol 175:190-9 (1993)\", \"DOI:10.1128/JB.175.1.190-199.1993\")), list(REFERENCE = \"PMID:11243806\", AUTHORS = \"Leonhartsberger S, Huber A, Lottspeich F, Bock A.\", TITLE = \"The hydH/G Genes from Escherichia coli code for a zinc and lead responsive two-component regulatory system.\", JOURNAL = c(\"J Mol Biol 307:93-105 (2001)\", \"DOI:10.1006/jmbi.2000.4451\")), list(REFERENCE = \"PMID:15200682\", AUTHORS = \"Lioliou EE, Kyriakidis DA.\", TITLE = \"The role of bacterial antizyme: From an inhibitory protein to AtoC transcriptional regulator.\", JOURNAL = c(\"Microb Cell Fact 3:8 (2004)\", \"DOI:10.1186/1475-2859-3-8\")), list(REFERENCE = \"PMID:15773991\", AUTHORS = \"Yamamoto K, Ishihama A\", TITLE = \"Transcriptional response of Escherichia coli to external copper.\", JOURNAL = c(\"Mol Microbiol 56:215-27 (2005)\", \"DOI:10.1111/j.1365-2958.2005.04532.x\")), list(REFERENCE = \"PMID:10585546\", AUTHORS = \"Ashby MK, Mullineaux CW\", TITLE = \"Cyanobacterial ycf27 gene products regulate energy transfer from phycobilisomes to photosystems I and II.\", JOURNAL = c(\"FEMS Microbiol Lett 181:253-60 (1999)\", \"DOI:10.1111/j.1574-6968.1999.tb08852.x\")), list(REFERENCE = \"PMID:11849552\", AUTHORS = \"Lopez-Maury L, Garcia-Dominguez M, Florencio FJ, Reyes JC\", TITLE = \"A two-component signal transduction system involved in nickel sensing in the cyanobacterium Synechocystis sp. PCC 6803.\", JOURNAL = c(\"Mol Microbiol 43:247-56 (2002)\", \"DOI:10.1046/j.1365-2958.2002.02741.x\")), list(REFERENCE = \"PMID:17526710\", AUTHORS = \"Glover RT, Kriakov J, Garforth SJ, Baughn AD, Jacobs WR Jr\", TITLE = \"The two-component regulatory system senX3-regX3 regulates phosphate-dependent gene expression in Mycobacterium smegmatis.\", JOURNAL = c(\"J Bacteriol 189:5495-503 (2007)\", \"DOI:10.1128/JB.00190-07\")), list(REFERENCE = \"PMID:15175302\", AUTHORS = \"Hsiao HY, He Q, Van Waasbergen LG, Grossman AR\", TITLE = \"Control of photosynthetic and high-light-responsive genes by the histidine kinase DspA: negative and positive regulation and interactions between signal transduction pathways.\", JOURNAL = c(\"J Bacteriol 186:3882-8 (2004)\", \"DOI:10.1128/JB.186.12.3882-3888.2004\")), list(REFERENCE = \"PMID:12626498\", AUTHORS = \"Mutsuda M, Michel KP, Zhang X, Montgomery BL, Golden SS\", TITLE = \"Biochemical properties of CikA, an unusual phytochrome-like histidine protein kinase that resets the circadian clock in Synechococcus elongatus PCC 7942.\", JOURNAL = c(\"J Biol Chem 278:19102-10 (2003)\", \"DOI:10.1074/jbc.M213255200\")), list(REFERENCE = \"PMID:9278513\", AUTHORS = \"Yeh KC, Wu SH, Murphy JT, Lagarias JC\", TITLE = \"A cyanobacterial phytochrome two-component light sensory system.\", JOURNAL = c(\"Science 277:1505-8 (1997)\", \"DOI:10.1126/science.277.5331.1505\")), list(REFERENCE = \"PMID:7635815\", AUTHORS = \"Niu S, Jiang SQ, Hong J\", TITLE = \"Salmonella typhimurium pgtB mutants conferring constitutive expression of phosphoglycerate transporter pgtP independent of pgtC.\", JOURNAL = c(\"J Bacteriol 177:4297-302 (1995)\", \"DOI:10.1128/JB.177.15.4297-4302.1995\")), list(REFERENCE = \"PMID:16882723\", AUTHORS = \"Takai N, Nakajima M, Oyama T, Kito R, Sugita C, Sugita M, Kondo T, Iwasaki H\", TITLE = \"A KaiC-associating SasA-RpaA two-component regulatory system as a major circadian timing mediator in cyanobacteria.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 103:12109-14 (2006)\", \"DOI:10.1073/pnas.0602955103\")), list(REFERENCE = \"PMID:11803016\", AUTHORS = \"Janausch IG, Zientz E, Tran QH, Kroger A, Unden G\", TITLE = \"C4-dicarboxylate carriers and sensors in bacteria.\", JOURNAL = c(\"Biochim Biophys Acta 1553:39-56 (2002)\", \"DOI:10.1016/S0005-2728(01)00233-X\")), list(REFERENCE = \"PMID:18725229\", AUTHORS = \"Zhou YF, Nan B, Nan J, Ma Q, Panjikar S, Liang YH, Wang Y, Su XD\", TITLE = \"C4-dicarboxylates sensing mechanism revealed by the crystal structures of DctB sensor domain.\", JOURNAL = c(\"J Mol Biol 383:49-61 (2008)\", \"DOI:10.1016/j.jmb.2008.08.010\")), list(REFERENCE = \"PMID:14523104 (Staphylococcus)\", AUTHORS = \"Novick RP, Jiang D\", TITLE = \"The staphylococcal saeRS system coordinates environmental signals with agr quorum sensing.\", JOURNAL = c(\"Microbiology 149:2709-17 (2003)\", \"DOI:10.1099/mic.0.26575-0\")), list(REFERENCE = \"PMID:17981963 (Pseudomonas)\", AUTHORS = \"Leech AJ, Sprinkle A, Wood L, Wozniak DJ, Ohman DE\", TITLE = \"The NtrC family regulator AlgB, which controls alginate biosynthesis in mucoid Pseudomonas aeruginosa, binds directly to the algD promoter.\", JOURNAL = c(\"J Bacteriol 190:581-9 (2008)\", \"DOI:10.1128/JB.01307-07\")), list(REFERENCE = \"PMID:18455986 (Caulobacter)\", AUTHORS = \"Paul R, Jaeger T, Abel S, Wiederkehr I, Folcher M, Biondi EG, Laub MT, Jenal U\", TITLE = \"Allosteric regulation of histidine kinases by their cognate response regulator determines cell fate.\", JOURNAL = c(\"Cell 133:452-61 (2008)\", \"DOI:10.1016/j.cell.2008.02.045\")), list(REFERENCE = \"PMID:15101991 (Pseudomonas)\", AUTHORS = \"Whitchurch CB, Leech AJ, Young MD, Kennedy D, Sargent JL, Bertrand JJ, Semmler AB, Mellick AS, Martin PR, Alm RA, Hobbs M, Beatson SA, Huang B, Nguyen L, Commolli JC, Engel JN, Darzins A, Mattick JS.\", TITLE = \"Characterization of a complex chemosensory signal transduction system which controls twitching motility in Pseudomonas aeruginosa.\", JOURNAL = c(\"Mol Microbiol 52:873-93 (2004)\", \"DOI:10.1111/j.1365-2958.2004.04026.x\")), list(REFERENCE = \"PMID:15170479 (Synechocystis)\", AUTHORS = \"Yoshihara S, Ikeuchi M.\", TITLE = \"Phototactic motility in the unicellular cyanobacterium Synechocystis sp. PCC 6803.\", JOURNAL = c(\"Photochem Photobiol Sci 3:512-8 (2004)\", \"DOI:10.1039/b402320j\")), list(REFERENCE = \"PMID:12039966 (Synechocystis)\", AUTHORS = \"Ogawa T, Bao DH, Katoh H, Shibata M, Pakrasi HB, Bhattacharyya-Pakrasi M\", TITLE = \"A two-component signal transduction pathway regulates manganese homeostasis in Synechocystis 6803, a photosynthetic organism.\", JOURNAL = c(\"J Biol Chem 277:28981-6 (2002)\", \"DOI:10.1074/jbc.M204175200\")), list(REFERENCE = \"PMID:12417709 (Synechocystis)\", AUTHORS = \"Yamaguchi K, Suzuki I, Yamamoto H, Lyukevich A, Bodrova I, Los DA, Piven I, Zinchenko V, Kanehisa M, Murata N\", TITLE = \"A two-component Mn2+-sensing system negatively regulates expression of the mntCAB operon in Synechocystis.\", JOURNAL = c(\"Plant Cell 14:2901-13 (2002)\", \"DOI:10.1105/tpc.006262\")), list(REFERENCE = \"PMID:15273097 (Bacillus)\", AUTHORS = \"Mascher T, Zimmer SL, Smith TA, Helmann JD\", TITLE = \"Antibiotic-inducible promoter regulated by the cell envelope stress-sensing two-component system LiaRS of Bacillus subtilis.\", JOURNAL = c(\"Antimicrob Agents Chemother 48:2888-96 (2004)\", \"DOI:10.1128/AAC.48.8.2888-2896.2004\")), list(REFERENCE = \"PMID:15856219 (Bacillus)\", AUTHORS = \"Hyyrylainen HL, Sarvas M, Kontinen VP\", TITLE = \"Transcriptome analysis of the secretion stress response of Bacillus subtilis.\", JOURNAL = c(\"Appl Microbiol Biotechnol 67:389-96 (2005)\", \"DOI:10.1007/s00253-005-1898-1\")), list(REFERENCE = \"PMID:15941986 (Bacillus)\", AUTHORS = \"Serizawa M, Sekiguchi J\", TITLE = \"The Bacillus subtilis YdfHI two-component system regulates the transcription of ydfJ, a member of the RND superfamily.\", JOURNAL = c(\"Microbiology 151:1769-78 (2005)\", \"DOI:10.1099/mic.0.27619-0\")), list(REFERENCE = \"PMID:12890034 (Bacillus)\", AUTHORS = \"Ohki R, Giyanto, Tateno K, Masuyama W, Moriya S, Kobayashi K, Ogasawara N\", TITLE = \"The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis.\", JOURNAL = c(\"Mol Microbiol 49:1135-44 (2003)\", \"DOI:10.1046/j.1365-2958.2003.03653.x\")), list(REFERENCE = \"PMID:17322186 (Bacillus)\", AUTHORS = \"Ogura M, Tsukahara K, Hayashi K, Tanaka T\", TITLE = \"The Bacillus subtilis NatK-NatR two-component system regulates expression of the natAB operon encoding an ABC transporter for sodium ion extrusion.\", JOURNAL = c(\"Microbiology 153:667-75 (2007)\", \"DOI:10.1099/mic.0.2006/003673-0\")), list(REFERENCE = \"PMID:10972810 (Bacillus)\", AUTHORS = \"Yamamoto H, Murata M, Sekiguchi J\", TITLE = \"The CitST two-component system regulates the expression of the Mg-citrate transporter in Bacillus subtilis.\", JOURNAL = c(\"Mol Microbiol 37:898-912 (2000)\", \"DOI:10.1046/j.1365-2958.2000.02055.x\")), list(REFERENCE = \"PMID:15995196 (Bacillus)\", AUTHORS = \"Satomura T, Shimura D, Asai K, Sadaie Y, Hirooka K, Fujita Y\", TITLE = \"Enhancement of glutamine utilization in Bacillus subtilis through the GlnK-GlnL two-component regulatory system.\", JOURNAL = c(\"J Bacteriol 187:4813-21 (2005)\", \"DOI:10.1128/JB.187.14.4813-4821.2005\")), list(REFERENCE = \"PMID:12949160 (Bacillus)\", AUTHORS = \"Doan T, Servant P, Tojo S, Yamaguchi H, Lerondel G, Yoshida K, Fujita Y, Aymerich S\", TITLE = \"The Bacillus subtilis ywkA gene encodes a malic enzyme and its transcription is activated by the YufL/YufM two-component system in response to malate.\", JOURNAL = c(\"Microbiology 149:2331-43 (2003)\", \"DOI:10.1099/mic.0.26256-0\")), list(REFERENCE = \"PMID:12949159 (Bacillus)\", AUTHORS = \"Tanaka K, Kobayashi K, Ogasawara N\", TITLE = \"The Bacillus subtilis YufLM two-component system regulates the expression of the malate transporters MaeN (YufR) and YflS, and is essential for utilization of malate in minimal medium.\", JOURNAL = c(\"Microbiology 149:2317-29 (2003)\", \"DOI:10.1099/mic.0.26257-0\")), list(REFERENCE = \"PMID:10708364 (Bacillus)\", AUTHORS = \"Asai K, Baik SH, Kasahara Y, Moriya S, Ogasawara N\", TITLE = \"Regulation of the transport system for C4-dicarboxylic acids in Bacillus subtilis.\", JOURNAL = c(\"Microbiology 146 ( Pt 2):263-71 (2000)\", \"DOI:10.1099/00221287-146-2-263\")), list(REFERENCE = \"PMID:8455557 (Rhodobacter)\", AUTHORS = \"Hamblin MJ, Shaw JG, Kelly DJ\", TITLE = \"Sequence analysis and interposon mutagenesis of a sensor-kinase (DctS) and response-regulator (DctR) controlling synthesis of the high-affinity C4-dicarboxylate transport system in Rhodobacter capsulatus.\", JOURNAL = c(\"Mol Gen Genet 237:215-24 (1993)\", \"DOI:10.1007/BF00282803\")), list(REFERENCE = \"PMID:9287004 (Rhodobacter)\", AUTHORS = \"Forward JA, Behrendt MC, Wyborn NR, Cross R, Kelly DJ\", TITLE = \"TRAP transporters: a new family of periplasmic solute transport systems encoded by the dctPQM genes of Rhodobacter capsulatus and by homologs in diverse gram-negative bacteria.\", JOURNAL = c(\"J Bacteriol 179:5482-93 (1997)\", \"DOI:10.1128/JB.179.17.5482-5493.1997\")), list(REFERENCE = \"PMID:16820295\", AUTHORS = \"Martin B, Quentin Y, Fichant G, Claverys JP\", TITLE = \"Independent evolution of competence regulatory cascades in streptococci?\", JOURNAL = c(\"Trends Microbiol 14:339-45 (2006)\", \"DOI:10.1016/j.tim.2006.06.007\")), list(REFERENCE = \"PMID:10231485\", AUTHORS = \"Hensel M, Hinsley AP, Nikolaus T, Sawers G, Berks BC\", TITLE = \"The genetic basis of tetrathionate respiration in Salmonella typhimurium.\", JOURNAL = c(\"Mol Microbiol 32:275-87 (1999)\", \"DOI:10.1046/j.1365-2958.1999.01345.x\")), list(REFERENCE = \"PMID:18028314\", AUTHORS = \"Guvener ZT, Harwood CS\", TITLE = \"Subcellular location characteristics of the Pseudomonas aeruginosa GGDEF protein, WspR, indicate that it produces cyclic-di-GMP in response to growth on surfaces.\", JOURNAL = c(\"Mol Microbiol 66:1459-73 (2007)\", \"DOI:10.1111/j.1365-2958.2007.06008.x\")), list(REFERENCE = \"PMID:17339222\", AUTHORS = \"Bantinaki E, Kassen R, Knight CG, Robinson Z, Spiers AJ, Rainey PB\", TITLE = \"Adaptive divergence in experimental populations of Pseudomonas fluorescens. III. Mutational origins of wrinkly spreader diversity.\", JOURNAL = c(\"Genetics 176:441-53 (2007)\", \"DOI:10.1534/genetics.106.069906\")), list(REFERENCE = \"PMID:11069677\", AUTHORS = \"Jiang M, Shao W, Perego M, Hoch JA\", TITLE = \"Multiple histidine kinases regulate entry into stationary phase and sporulation in Bacillus subtilis.\", JOURNAL = c(\"Mol Microbiol 38:535-42 (2000)\", \"DOI:10.1046/j.1365-2958.2000.02148.x\")), list(REFERENCE = \"PMID:19781638\", AUTHORS = \"Jenal U\", TITLE = \"The role of proteolysis in the Caulobacter crescentus cell cycle and development.\", JOURNAL = c(\"Res Microbiol 160:687-95 (2009)\", \"DOI:10.1016/j.resmic.2009.09.006\")), list(REFERENCE = \"PMID:19246239\", AUTHORS = \"Jenal U, Galperin MY\", TITLE = \"Single domain response regulators: molecular switches with emerging roles in cell organization and dynamics.\", JOURNAL = c(\"Curr Opin Microbiol 12:152-60 (2009)\", \"DOI:10.1016/j.mib.2009.01.010\")), list(REFERENCE = \"PMID:16640581\", AUTHORS = \"Drepper T, Wiethaus J, Giaourakis D, Gross S, Schubert B, Vogt M, Wiencek Y, McEwan AG, Masepohl B\", TITLE = \"Cross-talk towards the response regulator NtrC controlling nitrogen metabolism in Rhodobacter capsulatus.\", JOURNAL = c(\"FEMS Microbiol Lett 258:250-6 (2006)\", \"DOI:10.1111/j.1574-6968.2006.00228.x\")), list(REFERENCE = \"PMID:1661370\", AUTHORS = \"Pawlowski K, Klosse U, de Bruijn FJ\", TITLE = \"Characterization of a novel Azorhizobium caulinodans ORS571 two-component regulatory system, NtrY/NtrX, involved in nitrogen fixation and metabolism.\", JOURNAL = c(\"Mol Gen Genet 231:124-38 (1991)\", \"DOI:10.1007/BF00293830\")), list(REFERENCE = \"PMID:18422428\", AUTHORS = \"Chatterjee S, Almeida RP, Lindow S\", TITLE = \"Living in two worlds: the plant and insect lifestyles of Xylella fastidiosa.\", JOURNAL = c(\"Annu Rev Phytopathol 46:243-71 (2008)\", \"DOI:10.1146/annurev.phyto.45.062806.094342\")), list(REFERENCE = \"PMID:18506032\", AUTHORS = \"Dow M\", TITLE = \"Diversification of the function of cell-to-cell signaling in regulation of virulence within plant pathogenic xanthomonads.\", JOURNAL = c(\"Sci Signal 1:pe23 (2008)\", \"DOI:10.1126/stke.121pe23\")), list(REFERENCE = \"PMID:17902112\", AUTHORS = \"Colnaghi Simionato AV, da Silva DS, Lambais MR, Carrilho E\", TITLE = \"Characterization of a putative Xylella fastidiosa diffusible signal factor by HRGC-EI-MS.\", JOURNAL = c(\"J Mass Spectrom 42:1375-81 (2007)\", \"DOI:10.1002/jms.1325\")), list(REFERENCE = \"PMID:19203648\", AUTHORS = \"Miller LD, Russell MH, Alexandre G\", TITLE = \"Diversity in bacterial chemotactic responses and niche adaptation.\", JOURNAL = c(\"Adv Appl Microbiol 66:53-75 (2009)\", \"DOI:10.1016/S0065-2164(08)00803-4\")), list(REFERENCE = \"PMID:8760916\", AUTHORS = \"Eder S, Shi L, Jensen K, Yamane K, Hulett FM\", TITLE = \"A Bacillus subtilis secreted phosphodiesterase/alkaline phosphatase is the product of a Pho regulon gene, phoD.\", JOURNAL = c(\"Microbiology 142 ( Pt 8):2041-7 (1996)\", \"DOI:10.1099/13500872-142-8-2041\"))', 'map02020', 0, 5503, 0, 0, 0, 0, 5208, 295);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (196, '02024', 'Quorum sensing', 'Quorum sensing (QS) is a regulatory system that allows bacteria to share information about cell density and adjust gene expression accordingly. All QS bacteria produce and release chemical signal molecules called autoinducers (AIs) that increase in concentration as a function of cell density. The most commonly studied AIs belong to one of the following three categories: acylated homoserine lactones, also referred to as AI-1, used by Gram-negative bacteria; peptide signals, used by Gram-positive bacteria; and AI-2, used by both Gram-negative and Gram-positive bacteria. QS can be divided into at least 4 steps: production of AIs by the bacterial cell; release of AIs, either actively or passively, into the surrounding environment; recognition of AIs by specific receptors; and leading to changes in gene regulation once they exceed a threshold concentration. The processes controlled by QS include virulence, competence, conjugation, antibiotic production, motility, sporulation, and biofilm formation.', 'Cellular Processes; Cellular community - prokaryotes', 'Quorum sensing', 'GO: 0009372', 'ko02024', 'list(REFERENCE = \"PMID:22712853\", AUTHORS = \"Pereira CS, Thompson JA, Xavier KB\", TITLE = \"AI-2-mediated signalling in bacteria.\", JOURNAL = c(\"FEMS Microbiol Rev 37:156-81 (2013)\", \"DOI:10.1111/j.1574-6976.2012.00345.x\")), list(REFERENCE = \"PMID:23965960\", AUTHORS = \"Verma SC, Miyashiro T\", TITLE = \"Quorum sensing in the squid-Vibrio symbiosis.\", JOURNAL = c(\"Int J Mol Sci 14:16386-401 (2013)\", \"DOI:10.3390/ijms140816386\")), list(REFERENCE = \"PMID:24348467\", AUTHORS = \"Norsworthy AN, Visick KL\", TITLE = \"Gimme shelter: how Vibrio fischeri successfully navigates an animal\'s multiple environments.\", JOURNAL = c(\"Front Microbiol 4:356 (2013)\", \"DOI:10.3389/fmicb.2013.00356\")), list(REFERENCE = \"PMID:24065108\", AUTHORS = \"Papaioannou E, Utari PD, Quax WJ\", TITLE = \"Choosing an appropriate infection model to study quorum sensing inhibition in Pseudomonas infections.\", JOURNAL = c(\"Int J Mol Sci 14:19309-40 (2013)\", \"DOI:10.3390/ijms140919309\")), list(REFERENCE = \"PMID:20738404\", AUTHORS = \"Heeb S, Fletcher MP, Chhabra SR, Diggle SP, Williams P, Camara M\", TITLE = \"Quinolones: from antibiotics to autoinducers.\", JOURNAL = c(\"FEMS Microbiol Rev 35:247-74 (2011)\", \"DOI:10.1111/j.1574-6976.2010.00247.x\")), list(REFERENCE = \"PMID:25866808\", AUTHORS = \"Rasamiravaka T, Labtani Q, Duez P, El Jaziri M\", TITLE = \"The formation of biofilms by Pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control mechanisms.\", JOURNAL = c(\"Biomed Res Int 2015:759348 (2015)\", \"DOI:10.1155/2015/759348\")), list(REFERENCE = \"PMID:11544214\", AUTHORS = \"Whiteley M, Greenberg EP\", TITLE = \"Promoter specificity elements in Pseudomonas aeruginosa quorum-sensing-controlled genes.\", JOURNAL = c(\"J Bacteriol 183:5529-34 (2001)\", \"DOI:10.1128/JB.183.19.5529-5534.2001\")), list(REFERENCE = \"PMID:11497469\", AUTHORS = \"Chin-A-Woeng TF, van den Broek D, de Voer G, van der Drift KM, Tuinman S, Thomas-Oates JE, Lugtenberg BJ, Bloemberg GV\", TITLE = \"Phenazine-1-carboxamide production in the biocontrol strain Pseudomonas chlororaphis PCL1391 is regulated by multiple factors secreted into the growth medium.\", JOURNAL = c(\"Mol Plant Microbe Interact 14:969-79 (2001)\", \"DOI:10.1094/MPMI.2001.14.8.969\")), list(REFERENCE = \"PMID:19696934\", AUTHORS = \"Hughes DT, Clarke MB, Yamamoto K, Rasko DA, Sperandio V\", TITLE = \"The QseC adrenergic signaling cascade in Enterohemorrhagic E. coli (EHEC).\", JOURNAL = c(\"PLoS Pathog 5:e1000553 (2009)\", \"DOI:10.1371/journal.ppat.1000553\")), list(REFERENCE = \"PMID:22144490\", AUTHORS = \"Njoroge J, Sperandio V\", TITLE = \"Enterohemorrhagic Escherichia coli virulence regulation by two bacterial adrenergic kinases, QseC and QseE.\", JOURNAL = c(\"Infect Immun 80:688-703 (2012)\", \"DOI:10.1128/IAI.05921-11\")), list(REFERENCE = \"PMID:23160491\", AUTHORS = \"Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, Moreira CG, Sperandio V\", TITLE = \"Fucose sensing regulates bacterial intestinal colonization.\", JOURNAL = c(\"Nature 492:113-7 (2012)\", \"DOI:10.1038/nature11623\")), list(REFERENCE = \"PMID:22778415\", AUTHORS = \"Hirakawa H, Harwood CS, Pechter KB, Schaefer AL, Greenberg EP\", TITLE = \"Antisense RNA that affects Rhodopseudomonas palustris quorum-sensing signal receptor expression.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 109:12141-6 (2012)\", \"DOI:10.1073/pnas.1200243109\")), list(REFERENCE = \"PMID:14617175\", AUTHORS = \"Danino VE, Wilkinson A, Edwards A, Downie JA\", TITLE = \"Recipient-induced transfer of the symbiotic plasmid pRL1JI in Rhizobium leguminosarum bv. viciae is regulated by a quorum-sensing relay.\", JOURNAL = c(\"Mol Microbiol 50:511-25 (2003)\", \"DOI:10.1046/j.1365-2958.2003.03699.x\")), list(REFERENCE = \"PMID:12448738\", AUTHORS = \"Wisniewski-Dye F, Downie JA\", TITLE = \"Quorum-sensing in Rhizobium.\", JOURNAL = c(\"Antonie Van Leeuwenhoek 81:397-407 (2002)\", \"DOI:10.1023/A:1020501104051\")), list(REFERENCE = \"PMID:10368158\", AUTHORS = \"Rodelas B, Lithgow JK, Wisniewski-Dye F, Hardman A, Wilkinson A, Economou A, Williams P, Downie JA\", TITLE = \"Analysis of quorum-sensing-dependent control of rhizosphere-expressed (rhi) genes in Rhizobium leguminosarum bv. viciae.\", JOURNAL = \"J Bacteriol 181:3816-23 (1999)\"), list(REFERENCE = \"PMID:24550924\", AUTHORS = \"Lang J, Faure D\", TITLE = \"Functions and regulation of quorum-sensing in Agrobacterium tumefaciens.\", JOURNAL = c(\"Front Plant Sci 5:14 (2014)\", \"DOI:10.3389/fpls.2014.00014\")), list(REFERENCE = \"PMID:23710277\", AUTHORS = \"Planamente S, Morera S, Faure D\", TITLE = \"In planta fitness-cost of the Atu4232-regulon encoding for a selective GABA-binding sensor in Agrobacterium.\", JOURNAL = c(\"Commun Integr Biol 6:e23692 (2013)\", \"DOI:10.4161/cib.23692\")), list(REFERENCE = \"PMID:16943991\", AUTHORS = \"Barnard AM, Salmond GP\", TITLE = \"Quorum sensing in Erwinia species.\", JOURNAL = c(\"Anal Bioanal Chem 387:415-23 (2007)\", \"DOI:10.1007/s00216-006-0701-1\")), list(REFERENCE = \"PMID:17360277\", AUTHORS = \"Barnard AM, Bowden SD, Burr T, Coulthurst SJ, Monson RE, Salmond GP\", TITLE = \"Quorum sensing, virulence and secondary metabolite production in plant soft-rotting bacteria.\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 362:1165-83 (2007)\", \"DOI:10.1098/rstb.2007.2042\")), list(REFERENCE = \"PMID:19843225\", AUTHORS = \"Carlier A, Burbank L, von Bodman SB\", TITLE = \"Identification and characterization of three novel EsaI/EsaR quorum-sensing controlled stewartan exopolysaccharide biosynthetic genes in Pantoea stewartii ssp. stewartii.\", JOURNAL = c(\"Mol Microbiol 74:903-13 (2009)\", \"DOI:10.1111/j.1365-2958.2009.06906.x\")), list(REFERENCE = \"PMID:7665477\", AUTHORS = \"Beck von Bodman S, Farrand SK\", TITLE = \"Capsular polysaccharide biosynthesis and pathogenicity in Erwinia stewartii require induction by an N-acylhomoserine lactone autoinducer.\", JOURNAL = c(\"J Bacteriol 177:5000-8 (1995)\", \"DOI:10.1128/JB.177.17.5000-5008.1995\")), list(REFERENCE = \"PMID:19761612\", AUTHORS = \"O\'Grady EP, Viteri DF, Malott RJ, Sokol PA\", TITLE = \"Reciprocal regulation by the CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia.\", JOURNAL = c(\"BMC Genomics 10:441 (2009)\", \"DOI:10.1186/1471-2164-10-441\")), list(REFERENCE = \"PMID:16041013\", AUTHORS = \"Malott RJ, Baldwin A, Mahenthiralingam E, Sokol PA\", TITLE = \"Characterization of the cciIR quorum-sensing system in Burkholderia cenocepacia.\", JOURNAL = c(\"Infect Immun 73:4982-92 (2005)\", \"DOI:10.1128/IAI.73.8.4982-4992.2005\")), list(REFERENCE = \"PMID:22949660\", AUTHORS = \"Deng Y, Schmid N, Wang C, Wang J, Pessi G, Wu D, Lee J, Aguilar C, Ahrens CH, Chang C, Song H, Eberl L, Zhang LH\", TITLE = \"Cis-2-dodecenoic acid receptor RpfR links quorum-sensing signal perception with regulation of virulence through cyclic dimeric guanosine monophosphate turnover.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 109:15479-84 (2012)\", \"DOI:10.1073/pnas.1205037109\")), list(REFERENCE = \"PMID:23799665\", AUTHORS = \"Suppiger A, Schmid N, Aguilar C, Pessi G, Eberl L\", TITLE = \"Two quorum sensing systems control biofilm formation and virulence in members of the Burkholderia cepacia complex.\", JOURNAL = c(\"Virulence 4:400-9 (2013)\", \"DOI:10.4161/viru.25338\")), list(REFERENCE = \"PMID:21166386\", AUTHORS = \"Deng Y, Wu J, Tao F, Zhang LH\", TITLE = \"Listening to a new language: DSF-based quorum sensing in Gram-negative bacteria.\", JOURNAL = c(\"Chem Rev 111:160-73 (2011)\", \"DOI:10.1021/cr100354f\")), list(REFERENCE = \"PMID:21227698\", AUTHORS = \"Ryan RP, Dow JM\", TITLE = \"Communication with a growing family: diffusible signal factor (DSF) signaling in bacteria.\", JOURNAL = c(\"Trends Microbiol 19:145-52 (2011)\", \"DOI:10.1016/j.tim.2010.12.003\")), list(REFERENCE = \"PMID:15522077\", AUTHORS = \"Kim J, Kim JG, Kang Y, Jang JY, Jog GJ, Lim JY, Kim S, Suga H, Nagamatsu T, Hwang I\", TITLE = \"Quorum sensing and the LysR-type transcriptional activator ToxR regulate toxoflavin biosynthesis and transport in Burkholderia glumae.\", JOURNAL = c(\"Mol Microbiol 54:921-34 (2004)\", \"DOI:10.1111/j.1365-2958.2004.04338.x\")), list(REFERENCE = \"PMID:17376080\", AUTHORS = \"Kim J, Kang Y, Choi O, Jeong Y, Jeong JE, Lim JY, Kim M, Moon JS, Suga H, Hwang I\", TITLE = \"Regulation of polar flagellum genes is mediated by quorum sensing and FlhDC in Burkholderia glumae.\", JOURNAL = c(\"Mol Microbiol 64:165-79 (2007)\", \"DOI:10.1111/j.1365-2958.2007.05646.x\")), list(REFERENCE = \"PMID:21622734\", AUTHORS = \"Stauff DL, Bassler BL\", TITLE = \"Quorum sensing in Chromobacterium violaceum: DNA recognition and gene regulation by the CviR receptor.\", JOURNAL = c(\"J Bacteriol 193:3871-8 (2011)\", \"DOI:10.1128/JB.05125-11\")), list(REFERENCE = \"PMID:21504831\", AUTHORS = \"Chen G, Swem LR, Swem DL, Stauff DL, O\'Loughlin CT, Jeffrey PD, Bassler BL, Hughson FM\", TITLE = \"A strategy for antagonizing quorum sensing.\", JOURNAL = c(\"Mol Cell 42:199-209 (2011)\", \"DOI:10.1016/j.molcel.2011.04.003\")), list(REFERENCE = \"PMID:16513747\", AUTHORS = \"Hao G, Burr TJ\", TITLE = \"Regulation of long-chain N-acyl-homoserine lactones in Agrobacterium vitis.\", JOURNAL = c(\"J Bacteriol 188:2173-83 (2006)\", \"DOI:10.1128/JB.188.6.2173-2183.2006\")), list(REFERENCE = \"PMID:20514483\", AUTHORS = \"Savka MA, Le PT, Burr TJ\", TITLE = \"LasR receptor for detection of long-chain quorum-sensing signals: identification of N-acyl-homoserine lactones encoded by the avsI locus of Agrobacterium vitis.\", JOURNAL = c(\"Curr Microbiol 62:101-10 (2011)\", \"DOI:10.1007/s00284-010-9679-1\")), list(REFERENCE = \"PMID:26579084\", AUTHORS = \"Le KY, Otto M\", TITLE = \"Quorum-sensing regulation in staphylococci-an overview.\", JOURNAL = c(\"Front Microbiol 6:1174 (2015)\", \"DOI:10.3389/fmicb.2015.01174\")), list(REFERENCE = \"PMID:18851841\", AUTHORS = \"Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, Sturdevant DE, Ricklefs SM, Li M, Otto M\", TITLE = \"RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus.\", JOURNAL = c(\"Mol Cell 32:150-8 (2008)\", \"DOI:10.1016/j.molcel.2008.08.005\")), list(REFERENCE = \"PMID:25714717\", AUTHORS = \"Darkoh C, DuPont HL, Norris SJ, Kaplan HB\", TITLE = \"Toxin synthesis by Clostridium difficile is regulated through quorum signaling.\", JOURNAL = c(\"MBio 6:e02569 (2015)\", \"DOI:10.1128/mBio.02569-14\")), list(REFERENCE = \"PMID:25824838\", AUTHORS = \"Vidal JE, Shak JR, Canizalez-Roman A\", TITLE = \"The CpAL quorum sensing system regulates production of hemolysins CPA and PFO to build Clostridium perfringens biofilms.\", JOURNAL = c(\"Infect Immun 83:2430-42 (2015)\", \"DOI:10.1128/IAI.00240-15\")), list(REFERENCE = \"PMID:19363118\", AUTHORS = \"Ohtani K, Yuan Y, Hassan S, Wang R, Wang Y, Shimizu T\", TITLE = \"Virulence gene regulation by the agr system in Clostridium perfringens.\", JOURNAL = c(\"J Bacteriol 191:3919-27 (2009)\", \"DOI:10.1128/JB.01455-08\")), list(REFERENCE = \"PMID:22736963\", AUTHORS = \"Li YH, Tian X\", TITLE = \"Quorum sensing and bacterial social interactions in biofilms.\", JOURNAL = c(\"Sensors (Basel) 12:2519-38 (2012)\", \"DOI:10.3390/s120302519\")), list(REFERENCE = \"PMID:22407687\", AUTHORS = \"Berg KH, Biornstad TJ, Johnsborg O, Havarstein LS\", TITLE = \"Properties and biological role of streptococcal fratricins.\", JOURNAL = c(\"Appl Environ Microbiol 78:3515-22 (2012)\", \"DOI:10.1128/AEM.00098-12\")), list(REFERENCE = \"PMID:25475081\", AUTHORS = \"Conrads G, de Soet JJ, Song L, Henne K, Sztajer H, Wagner-Dobler I, Zeng AP\", TITLE = \"Comparing the cariogenic species Streptococcus sobrinus and S. mutans on whole genome level.\", JOURNAL = c(\"J Oral Microbiol 6:26189 (2014)\", \"DOI:10.3402/jom.v6.26189\")), list(REFERENCE = \"PMID:25309879\", AUTHORS = \"Jimenez JC, Federle MJ\", TITLE = \"Quorum sensing in group A Streptococcus.\", JOURNAL = c(\"Front Cell Infect Microbiol 4:127 (2014)\", \"DOI:10.3389/fcimb.2014.00127\")), list(REFERENCE = \"PMID:24118108\", AUTHORS = \"Cook LC, Federle MJ\", TITLE = \"Peptide pheromone signaling in Streptococcus and Enterococcus.\", JOURNAL = c(\"FEMS Microbiol Rev 38:473-92 (2014)\", \"DOI:10.1111/1574-6976.12046\")), list(REFERENCE = \"PMID:9680220\", AUTHORS = \"Podbielski A, Leonard BA\", TITLE = \"The group A streptococcal dipeptide permease (Dpp) is involved in the uptake of essential amino acids and affects the expression of cysteine protease.\", JOURNAL = c(\"Mol Microbiol 28:1323-34 (1998)\", \"DOI:10.1046/j.1365-2958.1998.00898.x\")), list(REFERENCE = \"PMID:8885277\", AUTHORS = \"Podbielski A, Pohl B, Woischnik M, Korner C, Schmidt KH, Rozdzinski E, Leonard BA\", TITLE = \"Molecular characterization of group A streptococcal (GAS) oligopeptide permease (opp) and its effect on cysteine protease production.\", JOURNAL = c(\"Mol Microbiol 21:1087-99 (1996)\", \"DOI:10.1046/j.1365-2958.1996.661421.x\")), list(REFERENCE = \"PMID:22636768\", AUTHORS = \"Anbalagan S, Dmitriev A, McShan WM, Dunman PM, Chaussee MS\", TITLE = \"Growth phase-dependent modulation of Rgg binding specificity in Streptococcus pyogenes.\", JOURNAL = c(\"J Bacteriol 194:3961-71 (2012)\", \"DOI:10.1128/JB.06709-11\")), list(REFERENCE = \"PMID:22016844\", AUTHORS = \"Clewell DB\", TITLE = \"Tales of conjugation and sex pheromones: A plasmid and enterococcal odyssey.\", JOURNAL = c(\"Mob Genet Elements 1:38-54 (2011)\", \"DOI:10.4161/mge.1.1.15409\")), list(REFERENCE = \"PMID:20734751\", AUTHORS = \"Wardal E, Sadowy E, Hryniewicz W\", TITLE = \"Complex nature of enterococcal pheromone-responsive plasmids.\", JOURNAL = \"Pol J Microbiol 59:79-87 (2010)\"), list(REFERENCE = \"PMID:19683678\", AUTHORS = \"Roux A, Payne SM, Gilmore MS\", TITLE = \"Microbial telesensing: probing the environment for friends, foes, and food.\", JOURNAL = c(\"Cell Host Microbe 6:115-24 (2009)\", \"DOI:10.1016/j.chom.2009.07.004\")), list(REFERENCE = \"PMID:25089349\", AUTHORS = \"Slamti L, Perchat S, Huillet E, Lereclus D\", TITLE = \"Quorum sensing in Bacillus thuringiensis is required for completion of a full infectious cycle in the insect.\", JOURNAL = c(\"Toxins (Basel) 6:2239-55 (2014)\", \"DOI:10.3390/toxins6082239\")), list(REFERENCE = \"PMID:20030732\", AUTHORS = \"Lopez D, Kolter R\", TITLE = \"Extracellular signals that define distinct and coexisting cell fates in Bacillus subtilis.\", JOURNAL = c(\"FEMS Microbiol Rev 34:134-49 (2010)\", \"DOI:10.1111/j.1574-6976.2009.00199.x\")), list(REFERENCE = \"PMID:12897006\", AUTHORS = \"Stephenson S, Mueller C, Jiang M, Perego M\", TITLE = \"Molecular analysis of Phr peptide processing in Bacillus subtilis.\", JOURNAL = c(\"J Bacteriol 185:4861-71 (2003)\", \"DOI:10.1128/JB.185.16.4861-4871.2003\")), list(REFERENCE = \"PMID:17666034\", AUTHORS = \"Lanigan-Gerdes S, Dooley AN, Faull KF, Lazazzera BA\", TITLE = \"Identification of subtilisin, Epr and Vpr as enzymes that produce CSF, an extracellular signalling peptide of Bacillus subtilis.\", JOURNAL = c(\"Mol Microbiol 65:1321-33 (2007)\", \"DOI:10.1111/j.1365-2958.2007.05869.x\")), list(REFERENCE = \"PMID:15374644\", AUTHORS = \"Kleerebezem M\", TITLE = \"Quorum sensing control of lantibiotic production; nisin and subtilin autoregulate their own biosynthesis.\", JOURNAL = c(\"Peptides 25:1405-14 (2004)\", \"DOI:10.1016/j.peptides.2003.10.021\")), list(REFERENCE = \"PMID:23125205\", AUTHORS = \"Rutherford ST, Bassler BL\", TITLE = \"Bacterial quorum sensing: its role in virulence and possibilities for its control.\", JOURNAL = c(\"Cold Spring Harb Perspect Med 2:a012427 (2012)\", \"DOI:10.1101/cshperspect.a012427\")), list(REFERENCE = \"PMID:23471618\", AUTHORS = \"LaSarre B, Federle MJ\", TITLE = \"Exploiting quorum sensing to confuse bacterial pathogens.\", JOURNAL = c(\"Microbiol Mol Biol Rev 77:73-111 (2013)\", \"DOI:10.1128/MMBR.00046-12\")), list(REFERENCE = \"PMID:18781869\", AUTHORS = \"Sifri CD\", TITLE = \"Healthcare epidemiology: quorum sensing: bacteria talk sense.\", JOURNAL = c(\"Clin Infect Dis 47:1070-6 (2008)\", \"DOI:10.1086/592072\"))', 'map02024', 'Quorum sensing', 0, 5564, 0, 0, 0, 0, 5265, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (197, '02025', 'Biofilm formation - Pseudomonas aeruginosa', 'Surface colonization and subsequent biofilm formation and development provide numerous advantages to microorganisms. The main key actors relevant in the regulation of biofilm formation by Pseudomonas aeruginosa include cAMP/Vfr signaling, quorum sensing (QS) systems, Gac/Rsm pathway, and c-di-GMP signaling. cAMP/Vfr signaling regulates the transcription of hundreds of genes encoding diverse virulence factors, including the type 2 secretion system and type 3 secretion system and their associated toxins, type IV pili, and flagella. It is demonstrated that the accumulation of cAMP inhibits the attachment phase of biofilm formation. The QS systems are arranged hierarchically with the las system positively regulating both the rhl and PQS systems. These three QS systems are involved in the regulation of virulence factor production, biofilm maturation, and motility phenotypes. GacS/GacA two-component system is promoting the expression of two small regulatory RNAs, RsmY and RsmZ, which sequester the translational repressor RsmA. Titration of RsmA induces the production of sessile and biofilm determinants, whereas free RsmA leads to a planktonic and more virulent lifestyle. c-di-GMP is a ubiquitous bacterial second messenger. Synthesis and degradation of c-di-GMP is facilitated by diguanylate cyclases (DGC) and phosphodiesterases (PDE). High intracellular levels of c-di-GMP evoke the processes leading to the production of biofilm matrix, while a decrease in its level causes an increase in cell motility and transition into the planktonic forms of growth.', 'Cellular Processes; Cellular community - prokaryotes', 'Biofilm formation - Pseudomonas aeruginosa', 'ko02025', 'list(REFERENCE = \"PMID:22354680\", AUTHORS = \"Coggan KA, Wolfgang MC\", TITLE = \"Global regulatory pathways and cross-talk control pseudomonas aeruginosa environmental lifestyle and virulence phenotype.\", JOURNAL = \"Curr Issues Mol Biol 14:47-70 (2012)\"), list(REFERENCE = \"PMID:25866808\", AUTHORS = \"Rasamiravaka T, Labtani Q, Duez P, El Jaziri M\", TITLE = \"The formation of biofilms by Pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control mechanisms.\", JOURNAL = c(\"Biomed Res Int 2015:759348 (2015)\", \"DOI:10.1155/2015/759348\")), list(REFERENCE = \"PMID:27129226\", AUTHORS = \"Valentini M, Filloux A\", TITLE = \"Biofilms and Cyclic di-GMP (c-di-GMP) Signaling: Lessons from Pseudomonas aeruginosa and Other Bacteria.\", JOURNAL = c(\"J Biol Chem 291:12547-55 (2016)\", \"DOI:10.1074/jbc.R115.711507\")), list(REFERENCE = \"PMID:19287449\", AUTHORS = \"Hengge R\", TITLE = \"Principles of c-di-GMP signalling in bacteria.\", JOURNAL = c(\"Nat Rev Microbiol 7:263-73 (2009)\", \"DOI:10.1038/nrmicro2109\")), list(REFERENCE = \"PMID:25666534\", AUTHORS = \"Liang ZX\", TITLE = \"The expanding roles of c-di-GMP in the biosynthesis of exopolysaccharides and secondary metabolites.\", JOURNAL = c(\"Nat Prod Rep 32:663-83 (2015)\", \"DOI:10.1039/c4np00086b\")), list(REFERENCE = \"PMID:20345659\", AUTHORS = \"Fulcher NB, Holliday PM, Klem E, Cann MJ, Wolfgang MC\", TITLE = \"The Pseudomonas aeruginosa Chp chemosensory system regulates intracellular cAMP levels by modulating adenylate cyclase activity.\", JOURNAL = c(\"Mol Microbiol 76:889-904 (2010)\", \"DOI:10.1111/j.1365-2958.2010.07135.x\")), list(REFERENCE = \"PMID:26929300\", AUTHORS = \"Marsden AE, Intile PJ, Schulmeyer KH, Simmons-Patterson ER, Urbanowski ML, Wolfgang MC, Yahr TL\", TITLE = \"Vfr Directly Activates exsA Transcription To Regulate Expression of the Pseudomonas aeruginosa Type III Secretion System.\", JOURNAL = c(\"J Bacteriol 198:1442-50 (2016)\", \"DOI:10.1128/JB.00049-16\")), list(REFERENCE = \"PMID:19426209\", AUTHORS = \"Brencic A, Lory S\", TITLE = \"Determination of the regulon and identification of novel mRNA targets of Pseudomonas aeruginosa RsmA.\", JOURNAL = c(\"Mol Microbiol 72:612-32 (2009)\", \"DOI:10.1111/j.1365-2958.2009.06670.x\")), list(REFERENCE = \"PMID:18256026\", AUTHORS = \"Hsu JL, Chen HC, Peng HL, Chang HY\", TITLE = \"Characterization of the histidine-containing phosphotransfer protein B-mediated multistep phosphorelay system in Pseudomonas aeruginosa PAO1.\", JOURNAL = c(\"J Biol Chem 283:9933-44 (2008)\", \"DOI:10.1074/jbc.M708836200\")), list(REFERENCE = \"PMID:18028314\", AUTHORS = \"Guvener ZT, Harwood CS\", TITLE = \"Subcellular location characteristics of the Pseudomonas aeruginosa GGDEF protein, WspR, indicate that it produces cyclic-di-GMP in response to growth on surfaces.\", JOURNAL = c(\"Mol Microbiol 66:1459-73 (2007)\", \"DOI:10.1111/j.1365-2958.2007.06008.x\")), list(REFERENCE = \"PMID:20735777\", AUTHORS = \"Irie Y, Starkey M, Edwards AN, Wozniak DJ, Romeo T, Parsek MR\", TITLE = \"Pseudomonas aeruginosa biofilm matrix polysaccharide Psl is regulated transcriptionally by RpoS and post-transcriptionally by RsmA.\", JOURNAL = c(\"Mol Microbiol 78:158-72 (2010)\", \"DOI:10.1111/j.1365-2958.2010.07320.x\"))', 'map02025', 'Biofilm formation - Pseudomonas aeruginosa', 'Surface colonization and subsequent biofilm formation and development provide numerous advantages to microorganisms. The main key actors relevant in the regulation of biofilm formation by Pseudomonas aeruginosa include cAMP/Vfr signaling, quorum sensing (QS) systems, Gac/Rsm pathway, and c-di-GMP signaling. cAMP/Vfr signaling regulates the transcription of hundreds of genes encoding diverse virulence factors, including the type 2 secretion system and type 3 secretion system and their associated toxins, type IV pili, and flagella. It is demonstrated that the accumulation of cAMP inhibits the attachment phase of biofilm formation. The QS systems are arranged hierarchically with the las system positively regulating both the rhl and PQS systems. These three QS systems are involved in the regulation of virulence factor production, biofilm maturation, and motility phenotypes. GacS/GacA two-component system is promoting the expression of two small regulatory RNAs, RsmY and RsmZ, which sequester the translational repressor RsmA. Titration of RsmA induces the production of sessile and biofilm determinants, whereas free RsmA leads to a planktonic and more virulent lifestyle. c-di-GMP is a ubiquitous bacterial second messenger. Synthesis and degradation of c-di-GMP is facilitated by diguanylate cyclases (DGC) and phosphodiesterases (PDE). High intracellular levels of c-di-GMP evoke the processes leading to the production of biofilm matrix, while a decrease in its level causes an increase in cell motility and transition into the planktonic forms of growth.', 0, 110, 0, 0, 0, 0, 110, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (198, '02026', 'Biofilm formation - Escherichia coli', 'Bacteria inhabiting a biofilm are protected from physical stress, antimicrobials, and the host immune system, and thereby cause severe medical, environmental, and technical problems. Biofilm formation in Escherichia coli is regulated by two inversely controlled transcriptional feedforward cascades, the FlhDC/FliA cascade and the sigmaS/MlrA/CsgD cascade, which are active in post-exponentially growing and in stationary phase cells, respectively. Their final outputs, flagella production or the synthesis of the biofilm matrix components curli and cellulose, are mutually exclusive due to complementary sigma factor requirements, the abundant DNA-binding regulator FliZ, and opposite regulation by c-di-GMP. The RNA-binding protein CsrA, a central component of the global regulatory system, inhibits synthesis of the poly-N-acetyl-glucosamine (PGA) exopolysaccharide and glycogen and stimulates the expression of the flagellar master regulator FlhDC. CsrA activity is counteracted by two sRNAs, CsrB and CsrC. The lower figure shows that FlhDC, sigmaS, and CsgD, the transcription factors that control large regulons involved in flagellar and biofilm formation, serve as regulatory hubs for multiple environmental signal integration with a series of sRNAs providing distinct inputs.', 'Cellular Processes; Cellular community - prokaryotes', 'Biofilm formation - Escherichia coli', 'ko02026', 'list(REFERENCE = \"PMID:25028968\", AUTHORS = \"Mika F, Hengge R\", TITLE = \"Small RNAs in the control of RpoS, CsgD, and biofilm architecture of Escherichia coli.\", JOURNAL = c(\"RNA Biol 11:494-507 (2014)\", \"DOI:10.4161/rna.28867\")), list(REFERENCE = \"PMID:23443158\", AUTHORS = \"Mika F, Hengge R\", TITLE = \"Small Regulatory RNAs in the Control of Motility and Biofilm Formation in E. coli and Salmonella.\", JOURNAL = c(\"Int J Mol Sci 14:4560-79 (2013)\", \"DOI:10.3390/ijms14034560\")), list(REFERENCE = \"PMID:19287449\", AUTHORS = \"Hengge R\", TITLE = \"Principles of c-di-GMP signalling in bacteria.\", JOURNAL = c(\"Nat Rev Microbiol 7:263-73 (2009)\", \"DOI:10.1038/nrmicro2109\")), list(REFERENCE = \"PMID:23178000\", AUTHORS = \"Chambers JR, Sauer K\", TITLE = \"Small RNAs and their role in biofilm formation.\", JOURNAL = c(\"Trends Microbiol 21:39-49 (2013)\", \"DOI:10.1016/j.tim.2012.10.008\")), list(REFERENCE = \"PMID:24724055\", AUTHORS = \"Martinez LC, Vadyvaloo V\", TITLE = \"Mechanisms of post-transcriptional gene regulation in bacterial biofilms.\", JOURNAL = c(\"Front Cell Infect Microbiol 4:38 (2014)\", \"DOI:10.3389/fcimb.2014.00038\")), list(REFERENCE = \"PMID:23023210\", AUTHORS = \"Kalia D, Merey G, Nakayama S, Zheng Y, Zhou J, Luo Y, Guo M, Roembke BT, Sintim HO\", TITLE = \"Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis.\", JOURNAL = c(\"Chem Soc Rev 42:305-41 (2013)\", \"DOI:10.1039/c2cs35206k\")), list(REFERENCE = \"PMID:24217225\", AUTHORS = \"Seyll E, Van Melderen L\", TITLE = \"The ribonucleoprotein Csr network.\", JOURNAL = c(\"Int J Mol Sci 14:22117-31 (2013)\", \"DOI:10.3390/ijms141122117\")), list(REFERENCE = \"PMID:18765794\", AUTHORS = \"Pesavento C, Becker G, Sommerfeldt N, Possling A, Tschowri N, Mehlis A, Hengge R\", TITLE = \"Inverse regulatory coordination of motility and curli-mediated adhesion in Escherichia coli.\", JOURNAL = c(\"Genes Dev 22:2434-46 (2008)\", \"DOI:10.1101/gad.475808\")), list(REFERENCE = \"PMID:16427772\", AUTHORS = \"Huang YH, Ferrieres L, Clarke DJ\", TITLE = \"The role of the Rcs phosphorelay in Enterobacteriaceae.\", JOURNAL = c(\"Res Microbiol 157:206-12 (2006)\", \"DOI:10.1016/j.resmic.2005.11.005\")), list(REFERENCE = \"PMID:17557827\", AUTHORS = \"Li J, Attila C, Wang L, Wood TK, Valdes JJ, Bentley WE\", TITLE = \"Quorum sensing in Escherichia coli is signaled by AI-2/LsrR: effects on small RNA and biofilm architecture.\", JOURNAL = c(\"J Bacteriol 189:6011-20 (2007)\", \"DOI:10.1128/JB.00014-07\"))', 'map02026', 'Biofilm formation - Escherichia coli', 'Bacteria inhabiting a biofilm are protected from physical stress, antimicrobials, and the host immune system, and thereby cause severe medical, environmental, and technical problems. Biofilm formation in Escherichia coli is regulated by two inversely controlled transcriptional feedforward cascades, the FlhDC/FliA cascade and the sigmaS/MlrA/CsgD cascade, which are active in post-exponentially growing and in stationary phase cells, respectively. Their final outputs, flagella production or the synthesis of the biofilm matrix components curli and cellulose, are mutually exclusive due to complementary sigma factor requirements, the abundant DNA-binding regulator FliZ, and opposite regulation by c-di-GMP. The RNA-binding protein CsrA, a central component of the global regulatory system, inhibits synthesis of the poly-N-acetyl-glucosamine (PGA) exopolysaccharide and glycogen and stimulates the expression of the flagellar master regulator FlhDC. CsrA activity is counteracted by two sRNAs, CsrB and CsrC. The lower figure shows that FlhDC, sigmaS, and CsgD, the transcription factors that control large regulons involved in flagellar and biofilm formation, serve as regulatory hubs for multiple environmental signal integration with a series of sRNAs providing distinct inputs.', 0, 68, 0, 0, 0, 0, 68, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (199, '02030', 'Bacterial chemotaxis', 'Chemotaxis is the process by which cells sense chemical gradients in their environment and then move towards more favorable conditions. In chemotaxis, events at the receptors control autophosphorylation of the CheA histidine kinase, and the phosphohistidine is the substrate for the response regulator CheY, which catalyzes the transfer of the phosphoryl group to a conserved aspartate. The resulting CheY-P can interact with the switch mechanism in the motor. This interaction causes a change in behavior, such as in direction or speed of rotation of flagella.', 'Cellular Processes; Cell motility', 'Bacterial chemotaxis', 'GO: 0006935', 'ko02030', 'list(REFERENCE = \"PMID:12011078\", AUTHORS = \"Kristich CJ, Ordal GW.\", TITLE = \"Bacillus subtilis CheD is a chemoreceptor modification enzyme required for chemotaxis.\", JOURNAL = c(\"J Biol Chem 277:25356-62 (2002)\", \"DOI:10.1074/jbc.M201334200\")), list(REFERENCE = \"PMID:11722727\", AUTHORS = \"Kirby JR, Kristich CJ, Saulmon MM, Zimmer MA, Garrity LF, Zhulin IB, Ordal GW.\", TITLE = \"CheC is related to the family of flagellar switch proteins and acts independently from CheD to control chemotaxis in Bacillus subtilis.\", JOURNAL = c(\"Mol Microbiol 42:573-85 (2001)\", \"DOI:10.1046/j.1365-2958.2001.02581.x\")), list(REFERENCE = \"PMID:12920116\", AUTHORS = \"Szurmant H, Bunn MW, Cannistraro VJ, Ordal GW.\", TITLE = \"Bacillus subtilis hydrolyzes CheY-P at the location of its action, the flagellar switch.\", JOURNAL = c(\"J Biol Chem 278:48611-6 (2003)\", \"DOI:10.1074/jbc.M306180200\")), list(REFERENCE = \"PMID:14749334\", AUTHORS = \"Szurmant H, Muff TJ, Ordal GW.\", TITLE = \"Bacillus subtilis CheC and FliY are members of a novel class of CheY-P-hydrolyzing proteins in the chemotactic signal transduction cascade.\", JOURNAL = c(\"J Biol Chem 279:21787-92 (2004)\", \"DOI:10.1074/jbc.M311497200\")), list(REFERENCE = \"PMID:11158445\", AUTHORS = \"Yoshihara S, Geng X, Okamoto S, Yura K, Murata T, Go M, Ohmori M, Ikeuchi M.\", TITLE = \"Mutational analysis of genes involved in pilus structure, motility and transformation competency in the unicellular motile cyanobacterium Synechocystis sp. PCC 6803.\", JOURNAL = c(\"Plant Cell Physiol 42:63-73 (2001)\", \"DOI:10.1093/pcp/pce007\")), list(REFERENCE = \"PMID:8104179\", AUTHORS = \"Darzins A.\", TITLE = \"The pilG gene product, required for Pseudomonas aeruginosa pilus production and twitching motility, is homologous to the enteric, single-domain response regulator CheY.\", JOURNAL = c(\"J Bacteriol 175:5934-44 (1993)\", \"DOI:10.1128/JB.175.18.5934-5944.1993\")), list(REFERENCE = \"PMID:15187186\", AUTHORS = \"Szurmant H, Ordal GW\", TITLE = \"Diversity in chemotaxis mechanisms among the bacteria and archaea.\", JOURNAL = c(\"Microbiol Mol Biol Rev 68:301-19 (2004)\", \"DOI:10.1128/MMBR.68.2.301-319.2004\")), list(REFERENCE = \"PMID:18774298\", AUTHORS = \"Rao CV, Glekas GD, Ordal GW\", TITLE = \"The three adaptation systems of Bacillus subtilis chemotaxis.\", JOURNAL = c(\"Trends Microbiol 16:480-7 (2008)\", \"DOI:10.1016/j.tim.2008.07.003\")), list(REFERENCE = \"PMID:18990184\", AUTHORS = \"Muff TJ, Ordal GW\", TITLE = \"The diverse CheC-type phosphatases: chemotaxis and beyond.\", JOURNAL = c(\"Mol Microbiol 70:1054-61 (2008)\", \"DOI:10.1111/j.1365-2958.2008.06482.x\")), list(REFERENCE = \"PMID:19203648\", AUTHORS = \"Miller LD, Russell MH, Alexandre G\", TITLE = \"Diversity in bacterial chemotactic responses and niche adaptation.\", JOURNAL = c(\"Adv Appl Microbiol 66:53-75 (2009)\", \"DOI:10.1016/S0065-2164(08)00803-4\"))', 'map02030', 'Bacterial chemotaxis', 0, 3394, 0, 0, 0, 0, 3253, 141);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (200, '02040', 'Flagellar assembly', 'Cellular Processes; Cell motility', 'Flagellar assembly', 'ko02040', 'list(REFERENCE = \"PMID:24970213\", AUTHORS = \"Morimoto YV, Minamino T\", TITLE = \"Structure and function of the bi-directional bacterial flagellar motor.\", JOURNAL = c(\"Biomolecules 4:217-34 (2014)\", \"DOI:10.3390/biom4010217\")), list(REFERENCE = \"PMID:11520608\", AUTHORS = \"Aizawa SI.\", TITLE = \"Bacterial flagella and type III secretion systems.\", JOURNAL = c(\"FEMS Microbiol Lett 202:157-64 (2001)\", \"DOI:10.1111/j.1574-6968.2001.tb10797.x\")), list(REFERENCE = \"PMID:11934612\", AUTHORS = \"Aldridge P, Hughes KT.\", TITLE = \"Regulation of flagellar assembly.\", JOURNAL = c(\"Curr Opin Microbiol 5:160-5 (2002)\", \"DOI:10.1016/S1369-5274(02)00302-8\")), list(REFERENCE = \"PMID:15060055\", AUTHORS = \"Van Arnam JS, McMurry JL, Kihara M, Macnab RM\", TITLE = \"Analysis of an engineered Salmonella flagellar fusion protein, FliR-FlhB.\", JOURNAL = c(\"J Bacteriol 186:2495-8 (2004)\", \"DOI:10.1128/JB.186.8.2495-2498.2004\"))', 'map02040', 'Flagellar assembly', 'Cellular Processes; Cell motility', 'Flagellar assembly', 0, 2850, 0, 0, 0, 0, 2850, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (201, '02060', 'Phosphotransferase system (PTS)', 'The phosphoenolpyruvate (PEP)-dependent phosphotransferase system (PTS) is a major mechanism used by bacteria for uptake of carbohydrates, particularly hexoses, hexitols, and disaccharides, where the source of energy is from PEP. The PTS consists of two general components, enzyme I (EI) and histidine phosphocarrier protein (HPr), and of membrane-bound sugar specific permeases (enzymes II). Each enzyme II (EII) complex consists of one or two hydrophobic integral membrane domains (domains C and D) and two hydrophilic domains (domains A and B). EII complexes may exist as distinct proteins or as a single multidomain protein. The PTS catalyzes the uptake of carbohydrates and their conversion into their respective phosphoesters during transport. There are four successive phosphoryl transfers in the PTS. Initial autophosphorylation of EI, using PEP as a substrate, is followed by transfer of the phosphoryl group from EI to HPr. EIIA catalyzes the self-phosphoryl transfer from HPr after which the phosphoryl group is transferred to histidine or cysteine residues of EIIB. The sugar is transported through the membrane-bound EIIC and is phosphorylated by the appropriate sugar-specific EIIB.', 'Environmental Information Processing; Membrane transport', 'Phosphotransferase system (PTS)', 'GO: 0009401, TC: 4.A', 'ko02060', 'list(REFERENCE = \"PMID:11361076\", AUTHORS = \"Darbon E, Galinier A, Le Coq D, Deutscher J.\", TITLE = \"Phosphotransfer functions mutated Bacillus subtilis HPr-like protein Crh carrying a histidine in the active site.\", JOURNAL = \"J Mol Microbiol Biotechnol 3:439-44 (2001)\"), list(REFERENCE = \"PMID:15060041\", AUTHORS = \"Dahl U, Jaeger T, Nguyen BT, Sattler JM, Mayer C.\", TITLE = \"Identification of a phosphotransferase system of Escherichia coli required for growth on N-acetylmuramic acid.\", JOURNAL = c(\"J Bacteriol 186:2385-92 (2004)\", \"DOI:10.1128/JB.186.8.2385-2392.2004\")), list(REFERENCE = \"PMID:2117666\", AUTHORS = \"Martin-Verstraete I, Debarbouille M, Klier A, Rapoport G\", TITLE = \"Levanase operon of Bacillus subtilis includes a fructose-specific phosphotransferase system regulating the expression of the operon.\", JOURNAL = c(\"J Mol Biol 214:657-71 (1990)\", \"DOI:10.1016/0022-2836(90)90284-S\")), list(REFERENCE = \"PMID:12603740\", AUTHORS = \"Kristich CJ, Glekas GD, Ordal GW.\", TITLE = \"The conserved cytoplasmic module of the transmembrane chemoreceptor McpC mediates carbohydrate chemotaxis in Bacillus subtilis.\", JOURNAL = c(\"Mol Microbiol 47:1353-66 (2003)\", \"DOI:10.1046/j.1365-2958.2003.03375.x\")), list(REFERENCE = \"PMID:14645248\", AUTHORS = \"Sampaio MM, Chevance F, Dippel R, Eppler T, Schlegel A, Boos W, Lu YJ, Rock CO.\", TITLE = \"Phosphotransferase-mediated transport of the osmolyte 2-O-alpha-mannosyl-D-glycerate in Escherichia coli occurs by the product of the mngA (hrsA) gene and is regulated by the mngR (farR) gene product acting as repressor.\", JOURNAL = c(\"J Biol Chem 279:5537-48 (2004)\", \"DOI:10.1074/jbc.M310980200\")), list(REFERENCE = \"PMID:15608210\", AUTHORS = \"Keseler IM, Collado-Vides J, Gama-Castro S, Ingraham J, Paley S, Paulsen IT, Peralta-Gil M, Karp PD.\", TITLE = \"EcoCyc: a comprehensive database resource for Escherichia coli.\", JOURNAL = c(\"Nucleic Acids Res 33:D334-7 (2005)\", \"DOI:10.1093/nar/gki108\")), list(REFERENCE = \"PMID:18156259\", AUTHORS = \"Mukherjee A, Mammel MK, LeClerc JE, Cebula TA.\", TITLE = \"Altered utilization of N-acetyl-D-galactosamine by Escherichia coli O157:H7 from the 2006 spinach outbreak.\", JOURNAL = c(\"J Bacteriol 190:1710-7 (2008)\", \"DOI:10.1128/JB.01737-07\")), list(REFERENCE = \"PMID:10931310\", AUTHORS = \"Brinkkotter A, Kloss H, Alpert C, Lengeler JW.\", TITLE = \"Pathways for the utilization of N-acetyl-galactosamine and galactosamine in Escherichia coli.\", JOURNAL = c(\"Mol Microbiol 37:125-35 (2000)\", \"DOI:10.1046/j.1365-2958.2000.01969.x\")), list(REFERENCE = \"PMID:11361063\", AUTHORS = \"Tchieu JH, Norris V, Edwards JS, Saier MH Jr.\", TITLE = \"The complete phosphotranferase system in Escherichia coli.\", JOURNAL = \"J Mol Microbiol Biotechnol 3:329-46 (2001)\"), list(REFERENCE = \"PMID:16233138\", AUTHORS = \"Kotrba P, Inui M, Yukawa H.\", TITLE = \"Bacterial phosphotransferase system (PTS) in carbohydrate uptake and control of carbon metabolism.\", JOURNAL = c(\"J Biosci Bioeng 92:502-17 (2001)\", \"DOI:10.1016/S1389-1723(01)80308-X\"))', 'map02060', 'Phosphotransferase system (PTS)', 0, 4028, 0, 0, 0, 0, 3998, 30);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (202, '03008', 'Ribosome biogenesis in eukaryotes', 'Ribosomes are the cellular factories responsible for making proteins. In eukaryotes, ribosome biogenesis involves the production and correct assembly of four rRNAs and about 80 ribosomal proteins. It requires hundreds of factors not present in the mature particle. In the absence of these proteins, ribosome biogenesis is stalled and cell growth is terminated even under optimal growth conditions. The primary pre-rRNA transcript is assembled into the 90S pre-ribosome, which contains both 40S and 60S assembly factors. Within this complex, the pre-rRNA is cleaved. pre-60S ribosomes are subjected to several sequential processing steps in the nucleoplasm involving numerous assembly intermediates before it is exported to the cytoplasm and matured into the 60S ribosomal subunit. The pre-40S ribosome is matured to the small ribosomal subunit in the cytoplasm by cleavage.', 'Genetic Information Processing; Translation', 'Ribosome biogenesis in eukaryotes', 'Spinocerebellar ataxia (SCA), Shwachman-Diamond syndrome, Dyskeratosis congenita, Metaphyseal dysplasia without hypotrichosis, Treacher Collins syndrome, Primary open angle glaucoma, Bowen-Conradi syndrome, Alopecia neurologic defects and endocrinopathy syndrome, Hoyeraal-Hreidarsson syndrome, Aplasia cutis congenita, Cartilage-hair hypoplasia, Anauxetic dysplasia, North American Indian childhood cirrhosis', 'ko03008', 'list(REFERENCE = \"PMID:20174677\", AUTHORS = \"Freed EF, Bleichert F, Dutca LM, Baserga SJ\", TITLE = \"When ribosomes go bad: diseases of ribosome biogenesis.\", JOURNAL = c(\"Mol Biosyst 6:481-93 (2010)\", \"DOI:10.1039/b919670f\")), list(REFERENCE = \"PMID:17515605\", AUTHORS = \"Perez-Fernandez J, Roman A, De Las Rivas J, Bustelo XR, Dosil M\", TITLE = \"The 90S preribosome is a multimodular structure that is assembled through a hierarchical mechanism.\", JOURNAL = c(\"Mol Cell Biol 27:5414-29 (2007)\", \"DOI:10.1128/MCB.00380-07\")), list(REFERENCE = \"PMID:19850913\", AUTHORS = \"Strunk BS, Karbstein K\", TITLE = \"Powering through ribosome assembly.\", JOURNAL = c(\"RNA 15:2083-104 (2009)\", \"DOI:10.1261/rna.1792109\")), list(REFERENCE = \"PMID:15120992\", AUTHORS = \"Granneman S, Baserga SJ\", TITLE = \"Ribosome biogenesis: of knobs and RNA processing.\", JOURNAL = c(\"Exp Cell Res 296:43-50 (2004)\", \"DOI:10.1016/j.yexcr.2004.03.016\")), list(REFERENCE = \"PMID:19879902\", AUTHORS = \"Kressler D, Hurt E, Bassler J\", TITLE = \"Driving ribosome assembly.\", JOURNAL = c(\"Biochim Biophys Acta 1803:673-83 (2010)\", \"DOI:10.1016/j.bbamcr.2009.10.009\"))', 'map03008', 'Ribosome biogenesis in eukaryotes', 531, 0, 248, 105, 128, 50, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (203, '03010', 'Ribosome', 'Genetic Information Processing; Translation', 'Ribosome', 'Diamond-Blackfan anemia, Congenital asplenia, 5q- syndrome', 'ko03010', 'list(REFERENCE = \"PMID:10476961\", AUTHORS = \"Ban N, Nissen P, Hansen J, Capel M, Moore PB, Steitz TA.\", TITLE = \"Placement of protein and RNA structures into a 5 A-resolution map of the 50S ribosomal subunit.\", JOURNAL = c(\"Nature 400:841-847 (1999)\", \"DOI:10.1038/23641\")), list(REFERENCE = \"PMID:10476960\", AUTHORS = \"Clemons WM Jr, May JL, Wimberly BT, McCutcheon JP, Capel MS, Ramakrishnan V.\", TITLE = \"Structure of a bacterial 30S ribosomal subunit at 5.5 A resolution.\", JOURNAL = c(\"Nature 400:833-840 (1999)\", \"DOI:10.1038/23631\")), list(REFERENCE = \"PMID:10497122\", AUTHORS = \"Cate JH, Yusupov MM, Yusupova GZ, Earnest TN, Noller HF.\", TITLE = \"X-ray crystal structures of 70S ribosome functional complexes.\", JOURNAL = c(\"Science 285:2095-2104 (1999)\", \"DOI:10.1126/science.285.5436.2095\")), list(REFERENCE = \"PMID:10937989\", AUTHORS = \"Ban N, Nissen P, Hansen J, Moore PB, Steitz TA.\", TITLE = \"The complete atomic structure of the large ribosomal subunit at 2.4 A resolution.\", JOURNAL = c(\"Science 289:905-920 (2000)\", \"DOI:10.1126/science.289.5481.905\")), list(REFERENCE = \"PMID:10937990\", AUTHORS = \"Nissen P, Hansen J, Ban N, Moore PB, Steitz TA.\", TITLE = \"The structural basis of ribosome activity in peptide bond synthesis.\", JOURNAL = c(\"Science 289:920-930 (2000)\", \"DOI:10.1126/science.289.5481.920\")), list(REFERENCE = \"PMID:11014182\", AUTHORS = \"Wimberly BT, Brodersen DE, Clemons WM Jr, Morgan-Warren RJ, Carter AP, Vonrhein C, Hartsch T, Ramakrishnan V.\", TITLE = \"Structure of the 30S ribosomal subunit.\", JOURNAL = c(\"Nature 407:327-339 (2000)\", \"DOI:10.1038/35030006\")), list(REFERENCE = \"PMID:11014183\", AUTHORS = \"Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V.\", TITLE = \"Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics.\", JOURNAL = c(\"Nature 407:340-348 (2000)\", \"DOI:10.1038/35030019\"))', 'map03010', 'Ribosome', 'Genetic Information Processing; Translation', 531, 5574, 248, 105, 128, 50, 5275, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (204, '03013', 'RNA transport', 'RNA transport from the nucleus to the cytoplasm is fundamental for gene expression. The different RNA species that are produced in the nucleus are exported through the nuclear pore complexes (NPCs) via mobile export receptors. The majority of RNAs, such as tRNAs, rRNAs, and U snRNAs, are transported by specific export receptors, which belong to the karyopherin-beta family proteins. A feature of karyopherins is their regulation by the small GTPase Ran. However, general mRNA export is mechanistically different. Nuclear export of mRNAs is functionally coupled to different steps in gene expression processes, such as transcription, splicing, 3\'-end formation and even translation.', 'Genetic Information Processing; Translation', 'RNA transport', 'Spinal muscular atrophy, Fragile X syndrome, Leukoencephalopathy with vanishing white matter, Infantile bilateral striatal necrosis, Fragile X tremor/ataxia syndrome, MEHMO syndrome, Beaulieu-Boycott-Innes syndrome', 'GO: 0050658', 'ko03013', 'list(REFERENCE = \"PMID:15519698\", AUTHORS = \"Rodriguez MS, Dargemont C, Stutz F\", TITLE = \"Nuclear export of RNA.\", JOURNAL = c(\"Biol Cell 96:639-55 (2004)\", \"DOI:10.1016/j.biolcel.2004.04.014\")), list(REFERENCE = \"PMID:20733056\", AUTHORS = \"Suzuki T, Izumi H, Ohno M\", TITLE = \"Cajal body surveillance of U snRNA export complex assembly.\", JOURNAL = c(\"J Cell Biol 190:603-12 (2010)\", \"DOI:10.1083/jcb.201004109\")), list(REFERENCE = \"PMID:18313922\", AUTHORS = \"Palancade B, Doye V\", TITLE = \"Sumoylating and desumoylating enzymes at nuclear pores: underpinning their unexpected duties?\", JOURNAL = c(\"Trends Cell Biol 18:174-83 (2008)\", \"DOI:10.1016/j.tcb.2008.02.001\")), list(REFERENCE = \"PMID:17401408\", AUTHORS = \"Pellizzoni L\", TITLE = \"Chaperoning ribonucleoprotein biogenesis in health and disease.\", JOURNAL = c(\"EMBO Rep 8:340-5 (2007)\", \"DOI:10.1038/sj.embor.7400941\")), list(REFERENCE = \"PMID:10872469\", AUTHORS = \"Gingras AC, Raught B, Sonenberg N\", TITLE = \"eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.\", JOURNAL = c(\"Annu Rev Biochem 68:913-63 (1999)\", \"DOI:10.1146/annurev.biochem.68.1.913\")), list(REFERENCE = \"PMID:11018020\", AUTHORS = \"Asano K, Clayton J, Shalev A, Hinnebusch AG\", TITLE = \"A multifactor complex of eukaryotic initiation factors, eIF1, eIF2, eIF3, eIF5, and initiator tRNA(Met) is an important translation initiation intermediate in vivo.\", JOURNAL = c(\"Genes Dev 14:2534-46 (2000)\", \"DOI:10.1101/gad.831800\")), list(REFERENCE = \"PMID:9548260\", AUTHORS = \"Craig AW, Haghighat A, Yu AT, Sonenberg N\", TITLE = \"Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation.\", JOURNAL = c(\"Nature 392:520-3 (1998)\", \"DOI:10.1038/33198\")), list(REFERENCE = \"PMID:15901496\", AUTHORS = \"Reed R, Cheng H\", TITLE = \"TREX, SR proteins and export of mRNA.\", JOURNAL = c(\"Curr Opin Cell Biol 17:269-73 (2005)\", \"DOI:10.1016/j.ceb.2005.04.011\")), list(REFERENCE = \"PMID:16314458\", AUTHORS = \"Tange TO, Shibuya T, Jurica MS, Moore MJ\", TITLE = \"Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core.\", JOURNAL = c(\"RNA 11:1869-83 (2005)\", \"DOI:10.1261/rna.2155905\"))', 'map03013', 531, 0, 248, 105, 128, 50, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (205, '03015', 'mRNA surveillance pathway', 'The mRNA surveillance pathway is a quality control mechanism that detects and degrades abnormal mRNAs. These pathways include nonsense-mediated mRNA decay (NMD), nonstop mRNA decay (NSD), and no-go decay (NGD). NMD is a mechanism that eliminates mRNAs containing premature translation-termination codons (PTCs). In vertebrates, PTCs trigger efficient NMD when located upstream of an exon junction complex (EJC). Upf3, together with Upf1 and Upf2, may signal the presence of the PTC to the 5\'end of the transcript, resulting in decapping and rapid exonucleolytic digestion of the mRNA. In the NSD pathway, which targets mRNAs lacking termination codons, the ribosome is believed to translate through the 3\' untranslated region and stall at the end of the poly(A) tail. NSD involves an eRF3-like protein, Ski7p, which is hypothesized to bind the empty A site of the ribosome and recruit the exosome to degrade the mRNA from the 3\' end. NGD targets mRNAs with stalls in translation elongation for endonucleolytic cleavage in a process involving the Dom34 and Hbs1 proteins.', 'Genetic Information Processing; Translation', 'mRNA surveillance pathway', 'Oculopharyngeal muscular dystrophy, Pontocerebellar hypoplasia', 'GO: 0071028', 'ko03015', 'list(REFERENCE = \"PMID:15040442\", AUTHORS = \"Maquat LE\", TITLE = \"Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 5:89-99 (2004)\", \"DOI:10.1038/nrm1310\")), list(REFERENCE = \"PMID:16723977\", AUTHORS = \"Amrani N, Sachs MS, Jacobson A\", TITLE = \"Early nonsense: mRNA decay solves a translational problem.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 7:415-25 (2006)\", \"DOI:10.1038/nrm1942\")), list(REFERENCE = \"PMID:17183357\", AUTHORS = \"Eulalio A, Behm-Ansmant I, Izaurralde E\", TITLE = \"P bodies: at the crossroads of post-transcriptional pathways.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 8:9-22 (2007)\", \"DOI:10.1038/nrm2080\")), list(REFERENCE = \"PMID:18158581\", AUTHORS = \"Mandel CR, Bai Y, Tong L\", TITLE = \"Protein factors in pre-mRNA 3\'-end processing.\", JOURNAL = c(\"Cell Mol Life Sci 65:1099-122 (2008)\", \"DOI:10.1007/s00018-007-7474-3\")), list(REFERENCE = \"PMID:16715045\", AUTHORS = \"Clement SL, Lykke-Andersen J\", TITLE = \"No mercy for messages that mess with the ribosome.\", JOURNAL = c(\"Nat Struct Mol Biol 13:299-301 (2006)\", \"DOI:10.1038/nsmb0406-299\"))', 'map03015', 531, 294, 248, 105, 128, 50, 0, 294);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (206, '03018', 'RNA degradation', 'The correct processing, quality control and turnover of cellular RNA molecules are critical to many aspects in the expression of genetic information. In eukaryotes, two major pathways of mRNA decay exist and both pathways are initiated by poly(A) shortening of the mRNA. In the 5\' to 3\' pathway, this is followed by decapping which then permits the 5\' to 3\' exonucleolytic degradation of transcripts. In the 3\' to 5\' pathway, the exosome, a large multisubunit complex, plays a key role. The exosome exists in archaeal cells, too. In bacteria, endoribonuclease E, a key enzyme involved in RNA decay and processing, organizes a protein complex called degradosome. RNase E or R interacts with the phosphate-dependent exoribonuclease polynucleotide phosphorylase, DEAD-box helicases, and additional factors in the RNA-degrading complex.', 'Genetic Information Processing; Folding, sorting and degradation', 'RNA degradation', 'Pontocerebellar hypoplasia, Al-Raqad syndrome', 'GO: 0006401', 'ko03018', 'list(REFERENCE = \"PMID:19239894\", AUTHORS = \"Houseley J, Tollervey D\", TITLE = \"The many pathways of RNA degradation.\", JOURNAL = c(\"Cell 136:763-76 (2009)\", \"DOI:10.1016/j.cell.2009.01.019\")), list(REFERENCE = \"PMID:16968219\", AUTHORS = \"Buttner K, Wenig K, Hopfner KP\", TITLE = \"The exosome: a macromolecular cage for controlled RNA degradation.\", JOURNAL = c(\"Mol Microbiol 61:1372-9 (2006)\", \"DOI:10.1111/j.1365-2958.2006.05331.x\")), list(REFERENCE = \"PMID:16939780\", AUTHORS = \"Schilders G, van Dijk E, Raijmakers R, Pruijn GJ\", TITLE = \"Cell and molecular biology of the exosome: how to make or break an RNA.\", JOURNAL = c(\"Int Rev Cytol 251:159-208 (2006)\", \"DOI:10.1016/S0074-7696(06)51005-8\")), list(REFERENCE = \"PMID:17471261\", AUTHORS = \"Hartung S, Hopfner KP\", TITLE = \"The exosome, plugged.\", JOURNAL = c(\"EMBO Rep 8:456-7 (2007)\", \"DOI:10.1038/sj.embor.7400961\")), list(REFERENCE = \"PMID:17447862\", AUTHORS = \"Carpousis AJ\", TITLE = \"The RNA degradosome of Escherichia coli: an mRNA-degrading machine assembled on RNase E.\", JOURNAL = c(\"Annu Rev Microbiol 61:71-87 (2007)\", \"DOI:10.1146/annurev.micro.61.080706.093440\")), list(REFERENCE = \"PMID:16766188\", AUTHORS = \"Marcaida MJ, DePristo MA, Chandran V, Carpousis AJ, Luisi BF\", TITLE = \"The RNA degradosome: life in the fast lane of adaptive molecular evolution.\", JOURNAL = c(\"Trends Biochem Sci 31:359-65 (2006)\", \"DOI:10.1016/j.tibs.2006.05.005\")), list(REFERENCE = \"PMID:17560162\", AUTHORS = \"Condon C\", TITLE = \"Maturation and degradation of RNA in bacteria.\", JOURNAL = c(\"Curr Opin Microbiol 10:271-8 (2007)\", \"DOI:10.1016/j.mib.2007.05.008\"))', 'map03018', 531, 5573, 248, 105, 128, 50, 5274, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (207, '03020', 'RNA polymerase', 'Genetic Information Processing; Transcription', 'RNA polymerase', 'Treacher Collins syndrome', 'GO: 0000428', 'ko03020', 'list(REFERENCE = \"PMID:10499798\", AUTHORS = \"Zhang G, Campbell EA, Minakhin L, Richter C, Severinov K, Darst SA.\", TITLE = \"Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 A resolution.\", JOURNAL = c(\"Cell 98:811-824 (1999)\", \"DOI:10.1016/S0092-8674(00)81515-9\")), list(REFERENCE = \"PMID:10784442\", AUTHORS = \"Cramer P, Bushnell DA, Fu J, Gnatt AL, Maier-Davis B, Thompson NE, Burgess RR, Edwards AM, David PR, Kornberg RD.\", TITLE = \"Architecture of RNA polymerase II and implications for the transcription mechanism.\", JOURNAL = c(\"Science 288:640-649 (2000)\", \"DOI:10.1126/science.288.5466.640\")), list(REFERENCE = \"PMID:19880312\", AUTHORS = \"Hirata A, Murakami KS\", TITLE = \"Archaeal RNA polymerase.\", JOURNAL = c(\"Curr Opin Struct Biol 19:724-31 (2009)\", \"DOI:10.1016/j.sbi.2009.10.006\")), list(REFERENCE = \"PMID:18573085\", AUTHORS = \"Cramer P, Armache KJ, Baumli S, Benkert S, Brueckner F, Buchen C, Damsma GE, Dengl S, Geiger SR, Jasiak AJ, Jawhari A, Jennebach S, Kamenski T, Kettenberger H, Kuhn CD, Lehmann E, Leike K, Sydow JF, Vannini A\", TITLE = \"Structure of eukaryotic RNA polymerases.\", JOURNAL = c(\"Annu Rev Biophys 37:337-52 (2008)\", \"DOI:10.1146/annurev.biophys.37.032807.130008\"))', 'map03020', 'RNA polymerase', 531, 5567, 248, 105, 128, 50, 5268, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (208, '03022', 'Basal transcription factors', 'Genetic Information Processing; Transcription', 'Basal transcription factors', 'Trichothiodystrophy, Wiedemann-Steiner syndrome', 'GO: 0005668 0005669 0005672 0005673 0005674 0005675', 'ko03022', 'list(REFERENCE = \"PMID:16858867\", AUTHORS = \"Thomas MC, Chiang CM\", TITLE = \"The general transcription machinery and general cofactors.\", JOURNAL = c(\"Crit Rev Biochem Mol Biol 41:105-78 (2006)\", \"DOI:10.1080/10409230600648736\")), list(REFERENCE = \"PMID:12516863\", AUTHORS = \"Martinez E\", TITLE = \"Multi-protein complexes in eukaryotic gene transcription.\", JOURNAL = c(\"Plant Mol Biol 50:925-47 (2002)\", \"DOI:10.1023/A:1021258713850\")), list(REFERENCE = \"PMID:19308322\", AUTHORS = \"Cler E, Papai G, Schultz P, Davidson I\", TITLE = \"Recent advances in understanding the structure and function of general transcription factor TFIID.\", JOURNAL = c(\"Cell Mol Life Sci 66:2123-34 (2009)\", \"DOI:10.1007/s00018-009-0009-3\")), list(REFERENCE = \"PMID:10838567\", AUTHORS = \"Malik S, Roeder RG.\", TITLE = \"Transcriptional regulation through Mediator-like coactivators in yeast and metazoan cells.\", JOURNAL = c(\"Trends Biochem Sci 25:277-283 (2000)\", \"DOI:10.1016/S0968-0004(00)01596-6\"))', 'map03022', 'Basal transcription factors', 531, 299, 248, 105, 128, 50, 0, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (209, '03030', 'DNA replication', 'A complex network of interacting proteins and enzymes is required for DNA replication. Generally, DNA replication follows a multistep enzymatic pathway. At the DNA replication fork, a DNA helicase (DnaB or MCM complex) precedes the DNA synthetic machinery and unwinds the duplex parental DNA in cooperation with the SSB or RPA. On the leading strand, replication occurs continuously in a 5 to 3 direction, whereas on the lagging strand, DNA replication occurs discontinuously by synthesis and joining of short Okazaki fragments. In prokaryotes, the leading strand replication apparatus consists of a DNA polymerase (pol III core), a sliding clamp (beta), and a clamp loader (gamma delta complex). The DNA primase (DnaG) is needed to form RNA primers. Normally, during replication of the lagging-strand DNA template, an RNA primer is removed either by an RNase H or by the 5 to 3 exonuclease activity of DNA pol I, and the DNA ligase joins the Okazaki fragments. In eukaryotes, three DNA polymerases (alpha, delta, and epsilon) have been identified. DNA primase forms a permanent complex with DNA polymerase alpha. PCNA and RFC function as a clamp and a clamp loader. FEN 1 and RNase H1 remove the RNA from the Okazaki fragments and DNA ligase I joins the DNA.', 'Genetic Information Processing; Replication and repair', 'DNA replication', 'Aicardi-Goutieres syndrome', 'ko03030', 'list(REFERENCE = \"PMID:8087839\", AUTHORS = \"Stillman B.\", TITLE = \"Smart machines at the DNA replication fork.\", JOURNAL = c(\"Cell 78:725-8 (1994)\", \"DOI:10.1016/S0092-8674(94)90362-X\")), list(REFERENCE = \"PMID:9759502\", AUTHORS = \"Waga S, Stillman B.\", TITLE = \"The DNA replication fork in eukaryotic cells.\", JOURNAL = c(\"Annu Rev Biochem 67:721-51 (1998)\", \"DOI:10.1146/annurev.biochem.67.1.721\"))', 'map03030', 'DNA replication', 531, 5570, 248, 105, 128, 50, 5271, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (210, '03040', 'Spliceosome', 'After transcription, eukaryotic mRNA precursors contain protein-coding exons and noncoding introns. In the following splicing, introns are excised and exons are joined by a macromolecular complex, the spliceosome. The standard spliceosome is made up of five small nuclear ribonucleoproteins (snRNPs), U1, U2, U4, U5, and U6 snRNPs, and several spliceosome-associated proteins (SAPs). Spliceosomes are not a simple stable complex, but a dynamic family of particles that assemble on the mRNA precursor and help fold it into a conformation that allows transesterification to proceed. Various spliceosome forms (e.g. A-, B- and C-complexes) have been identified.', 'Genetic Information Processing; Transcription', 'Spliceosome', 'Retinitis pigmentosa, Acrofacial dysostosis, Myelodysplastic syndrome, Mandibulofacial dysostosis with microcephaly, Burn-McKeown syndrome, Cerebrocostomandibular syndrome, Renpenning syndrome', 'GO: 0005681', 'ko03040', 'list(REFERENCE = \"PMID:19239890\", AUTHORS = \"Wahl MC, Will CL, Luhrmann R\", TITLE = \"The spliceosome: design principles of a dynamic RNP machine.\", JOURNAL = c(\"Cell 136:701-18 (2009)\", \"DOI:10.1016/j.cell.2009.02.009\")), list(REFERENCE = \"PMID:10978320\", AUTHORS = \"Morris DP, Greenleaf AL\", TITLE = \"The splicing factor, Prp40, binds the phosphorylated carboxyl-terminal domain of RNA polymerase II.\", JOURNAL = c(\"J Biol Chem 275:39935-43 (2000)\", \"DOI:10.1074/jbc.M004118200\")), list(REFERENCE = \"PMID:17537823\", AUTHORS = \"Chen YI, Moore RE, Ge HY, Young MK, Lee TD, Stevens SW\", TITLE = \"Proteomic analysis of in vivo-assembled pre-mRNA splicing complexes expands the catalog of participating factors.\", JOURNAL = c(\"Nucleic Acids Res 35:3928-44 (2007)\", \"DOI:10.1093/nar/gkm347\")), list(REFERENCE = \"PMID:19733268\", AUTHORS = \"Ritchie DB, Schellenberg MJ, MacMillan AM\", TITLE = \"Spliceosome structure: piece by piece.\", JOURNAL = c(\"Biochim Biophys Acta 1789:624-33 (2009)\", \"DOI:10.1016/j.bbagrm.2009.08.010\"))', 'map03040', 531, 0, 248, 105, 128, 50, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (211, '03050', 'Proteasome', 'The proteasome is a protein-destroying apparatus involved in many essential cellular functions, such as regulation of cell cycle, cell differentiation, signal transduction pathways, antigen processing for appropriate immune responses, stress signaling, inflammatory responses, and apoptosis. It is capable of degrading a variety of cellular proteins in a rapid and timely fashion and most substrate proteins are modified by ubiquitin before their degradation by the proteasome. The proteasome is a large protein complex consisting of a proteolytic core called the 20S particle and ancillary factors that regulate its activity in various ways. The most common form is the 26S proteasome containing one 20S core particle and two 19S regulatory particles that enable the proteasome to degrade ubiquitinated proteins by an ATP-dependent mechanism. Another form is the immunoproteasome containing two 11S regulatory particles, PA28 alpha and PA28 beta, which are induced by interferon gamma under the conditions of intensified immune response. Other regulatory particles include PA28 gamma and PA200. Although PA28 gamma also belongs to a family of activators of the 20S proteasome, it is localized within the nucleus and forms a homoheptamer. PA28 gamma has been implicated in the regulation of cell cycle progression and apoptosis. PA200 has been identified as a large nuclear protein that stimulates proteasomal hydrolysis of peptides.', 'Genetic Information Processing; Folding, sorting and degradation', 'Proteasome', 'Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, Autoinflammation lipodystrophy and dermatosis syndrome', 'GO: 0000502', 'ko03050', 'list(REFERENCE = \"PMID:16338359\", AUTHORS = \"Hirano Y, Murata S, Tanaka K\", TITLE = \"Large- and small-scale purification of mammalian 26S proteasomes.\", JOURNAL = c(\"Methods Enzymol 399:227-40 (2005)\", \"DOI:10.1016/S0076-6879(05)99015-0\")), list(REFERENCE = \"PMID:18497808\", AUTHORS = \"Saeki Y, Tanaka K\", TITLE = \"Cell biology: two hands for degradation.\", JOURNAL = c(\"Nature 453:460-1 (2008)\", \"DOI:10.1038/453460a\")), list(REFERENCE = \"PMID:16919475\", AUTHORS = \"Smith DM, Benaroudj N, Goldberg A\", TITLE = \"Proteasomes and their associated ATPases: a destructive combination.\", JOURNAL = c(\"J Struct Biol 156:72-83 (2006)\", \"DOI:10.1016/j.jsb.2006.04.012\")), list(REFERENCE = \"PMID:16181324\", AUTHORS = \"Strehl B, Seifert U, Kruger E, Heink S, Kuckelkorn U, Kloetzel PM\", TITLE = \"Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing.\", JOURNAL = c(\"Immunol Rev 207:19-30 (2005)\", \"DOI:10.1111/j.0105-2896.2005.00308.x\")), list(REFERENCE = \"PMID:16922378\", AUTHORS = \"Isono E, Toh-e A\", TITLE = \"[Biogenesis of the 26S proteasome in the yeast Saccharomyces cerevisiae]\", JOURNAL = \"Tanpakushitsu Kakusan Koso 51:1224-9 (2006)\"), list(REFERENCE = \"PMID:16922379\", AUTHORS = \"Hirano Y, Murata S\", TITLE = \"[Mechanism of the assembly of mammalian 20S proteasome]\", JOURNAL = \"Tanpakushitsu Kakusan Koso 51:1230-5 (2006)\"), list(REFERENCE = \"PMID:16922380\", AUTHORS = \"Saeki Y, Yashiroda H\", TITLE = \"[Diversity of proteasome activators]\", JOURNAL = \"Tanpakushitsu Kakusan Koso 51:1236-40 (2006)\"), list(REFERENCE = \"PMID:19483713\", AUTHORS = \"Darwin KH\", TITLE = \"Prokaryotic ubiquitin-like protein (Pup), proteasomes and pathogenesis.\", JOURNAL = c(\"Nat Rev Microbiol 7:485-91 (2009)\", \"DOI:10.1038/nrmicro2148\"))', 'map03050', 531, 687, 248, 105, 128, 50, 388, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (212, '03060', 'Protein export', 'The protein export is the active transport of proteins from the cytoplasm to the exterior of the cell, or to the periplasmic compartment in Gram-negative bacteria. The sec dependent pathway is the general protein export system that transports newly synthesized proteins into or across the cell membrane. The translocation channel is formed from a conserved trimeric membrane protein complex, called the Sec61/SecY complex. The twin-arginine translocation (Tat) pathway is another protein transport system that transports folded proteins in bacteria, archaea, and chloroplasts. Many Tat systems comprise three functionally different membrane proteins, TatA, TatB, and TatC, but TatA and TatE seem to have overlapping functions, with TatA having by far the more important role.', 'Genetic Information Processing; Folding, sorting and degradation', 'Protein export', 'GO: 0043952 0043953', 'ko03060', 'list(REFERENCE = \"PMID:10087917\", AUTHORS = \"Dalbey RE, Robinson C.\", TITLE = \"Protein translocation into and across the bacterial plasma membrane and the plant thylakoid membrane.\", JOURNAL = c(\"Trends Biochem Sci 24:17-22 (1999)\", \"DOI:10.1016/S0968-0004(98)01333-4\")), list(REFERENCE = \"PMID:10652088\", AUTHORS = \"Berks BC, Sargent F, Palmer T.\", TITLE = \"The Tat protein export pathway.\", JOURNAL = c(\"Mol Microbiol 35:260-74 (2000)\", \"DOI:10.1046/j.1365-2958.2000.01719.x\")), list(REFERENCE = \"PMID:10747959\", AUTHORS = \"Wexler M, Sargent F, Jack RL, Stanley NR, Bogsch EG, Robinson C, Berks BC, Palmer T.\", TITLE = \"TatD is a cytoplasmic protein with DNase activity. No requirement for TatD family proteins in sec-independent protein export.\", JOURNAL = c(\"J Biol Chem 275:16717-22 (2000)\", \"DOI:10.1074/jbc.M000800200\")), list(REFERENCE = \"PMID:11007775\", AUTHORS = \"Jongbloed JD, Martin U, Antelmann H, Hecker M, Tjalsma H, Venema G, Bron S, van Dijl JM, Muller J.\", TITLE = \"TatC is a specificity determinant for protein secretion via the twin-arginine translocation pathway.\", JOURNAL = c(\"J Biol Chem 275:41350-7 (2000)\", \"DOI:10.1074/jbc.M004887200\")), list(REFERENCE = \"PMID:18046402\", AUTHORS = \"Rapoport TA\", TITLE = \"Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes.\", JOURNAL = c(\"Nature 450:663-9 (2007)\", \"DOI:10.1038/nature06384\")), list(REFERENCE = \"PMID:17368028\", AUTHORS = \"Flower AM\", TITLE = \"The SecY translocation complex: convergence of genetics and structure.\", JOURNAL = c(\"Trends Microbiol 15:203-10 (2007)\", \"DOI:10.1016/j.tim.2007.03.001\")), list(REFERENCE = \"PMID:16212506\", AUTHORS = \"Osborne AR, Rapoport TA, van den Berg B\", TITLE = \"Protein translocation by the Sec61/SecY channel.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 21:529-50 (2005)\", \"DOI:10.1146/annurev.cellbio.21.012704.133214\")), list(REFERENCE = \"PMID:12475201\", AUTHORS = \"Paetzel M, Karla A, Strynadka NC, Dalbey RE\", TITLE = \"Signal peptidases.\", JOURNAL = c(\"Chem Rev 102:4549-80 (2002)\", \"DOI:10.1021/cr010166y\")), list(REFERENCE = \"PMID:10924740\", AUTHORS = \"Paetzel M, Dalbey RE, Strynadka NC\", TITLE = \"The structure and mechanism of bacterial type I signal peptidases. A novel antibiotic target.\", JOURNAL = c(\"Pharmacol Ther 87:27-49 (2000)\", \"DOI:10.1016/S0163-7258(00)00064-4\")), list(REFERENCE = \"PMID:17259602\", AUTHORS = \"Ng SY, Chaban B, VanDyke DJ, Jarrell KF\", TITLE = \"Archaeal signal peptidases.\", JOURNAL = c(\"Microbiology 153:305-14 (2007)\", \"DOI:10.1099/mic.0.2006/003087-0\")), list(REFERENCE = \"PMID:19299134\", AUTHORS = \"Desvaux M, Hebraud M, Talon R, Henderson IR\", TITLE = \"Secretion and subcellular localizations of bacterial proteins: a semantic awareness issue.\", JOURNAL = c(\"Trends Microbiol 17:139-45 (2009)\", \"DOI:10.1016/j.tim.2009.01.004\")), list(REFERENCE = \"PMID:15063851\", AUTHORS = \"Nakatogawa H, Murakami A, Ito K\", TITLE = \"Control of SecA and SecM translation by protein secretion.\", JOURNAL = c(\"Curr Opin Microbiol 7:145-50 (2004)\", \"DOI:10.1016/j.mib.2004.01.001\"))', 'map03060', 'Protein export', 531, 5555, 248, 105, 128, 50, 5256, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (213, '03070', 'Bacterial secretion system', 'Gram-negative bacteria secrete a wide range of proteins whose functions include biogenesis of organelles, such as pilli and flagella, nutrient acquisition, virulence, and efflux of drugs and other toxins. Six distinct secretion systems have been shown to mediate protein export through the inner and outer membranes of Gram-negative bacteria. These pathways are highly conserved throughout the Gram-negative bacterial species. In Gram-positive bacteria, secreted proteins are commonly translocated across the single membrane by the Sec pathway or the two-arginine (Tat) pathway.', 'Environmental Information Processing; Membrane transport', 'Bacterial secretion system', 'GO: 0030253 0015628 0030254 0030255 0046819 0033103 0044098 0043952 0043953', 'ko03070', 'list(REFERENCE = \"PMID:11173102\", AUTHORS = \"Kim JF.\", TITLE = \"Revisiting the chlamydial type III protein secretion system: clues to the origin of type III protein secretion.\", JOURNAL = c(\"Trends Genet 17:65-9 (2001)\", \"DOI:10.1016/S0168-9525(00)02175-2\")), list(REFERENCE = \"PMID:11309112\", AUTHORS = \"Plano GV, Day JB, Ferracci F.\", TITLE = \"Type III export: new uses for an old pathway.\", JOURNAL = c(\"Mol Microbiol 40:284-93 (2001)\", \"DOI:10.1046/j.1365-2958.2001.02354.x\")), list(REFERENCE = \"PMID:11413015\", AUTHORS = \"Gauthier A, Finlay BB.\", TITLE = \"Bacterial pathogenesis: the answer to virulence is in the pore.\", JOURNAL = c(\"Curr Biol 11:R264-7 (2001)\", \"DOI:10.1016/S0960-9822(01)00134-8\")), list(REFERENCE = \"PMID:10047550\", AUTHORS = \"Burns DL.\", TITLE = \"Biochemistry of type IV secretion.\", JOURNAL = c(\"Curr Opin Microbiol 2:25-9 (1999)\", \"DOI:10.1016/S1369-5274(99)80004-6\")), list(REFERENCE = \"PMID:10920394\", AUTHORS = \"Christie PJ, Vogel JP.\", TITLE = \"Bacterial type IV secretion: conjugation systems adapted to deliver effector molecules to host cells.\", JOURNAL = c(\"Trends Microbiol 8:354-60 (2000)\", \"DOI:10.1016/S0966-842X(00)01792-3\")), list(REFERENCE = \"PMID:11309113\", AUTHORS = \"Christie PJ.\", TITLE = \"Type IV secretion: intercellular transfer of macromolecules by systems ancestrally related to conjugation machines.\", JOURNAL = c(\"Mol Microbiol 40:294-305 (2001)\", \"DOI:10.1046/j.1365-2958.2001.02302.x\")), list(REFERENCE = \"PMID:10481178\", AUTHORS = \"Nunn D.\", TITLE = \"Bacterial type II protein export and pilus biogenesis: more than just homologies?\", JOURNAL = c(\"Trends Cell Biol 9:402-8 (1999)\", \"DOI:10.1016/S0962-8924(99)01634-7\")), list(REFERENCE = \"PMID:11309111\", AUTHORS = \"Sandkvist M.\", TITLE = \"Biology of type II secretion.\", JOURNAL = c(\"Mol Microbiol 40:271-83 (2001)\", \"DOI:10.1046/j.1365-2958.2001.02403.x\")), list(REFERENCE = \"PMID:11349009\", AUTHORS = \"Sandkvist M.\", TITLE = \"Type II secretion and pathogenesis.\", JOURNAL = c(\"Infect Immun 69:3523-35 (2001)\", \"DOI:10.1128/IAI.69.6.3523-3535.2001\")), list(REFERENCE = \"PMID:15546664\", AUTHORS = \"Delepelaire P\", TITLE = \"Type I secretion in gram-negative bacteria.\", JOURNAL = c(\"Biochim Biophys Acta 1694:149-61 (2004)\", \"DOI:10.1016/j.bbamcr.2004.05.001\")), list(REFERENCE = \"PMID:18406342\", AUTHORS = \"Hazes B, Frost L\", TITLE = \"Towards a systems biology approach to study type II/IV secretion systems.\", JOURNAL = c(\"Biochim Biophys Acta 1778:1839-50 (2008)\", \"DOI:10.1016/j.bbamem.2008.03.011\")), list(REFERENCE = \"PMID:16448494\", AUTHORS = \"Johnson TL, Abendroth J, Hol WG, Sandkvist M\", TITLE = \"Type II secretion: from structure to function.\", JOURNAL = c(\"FEMS Microbiol Lett 255:175-86 (2006)\", \"DOI:10.1111/j.1574-6968.2006.00102.x\")), list(REFERENCE = \"PMID:15546665\", AUTHORS = \"Filloux A\", TITLE = \"The underlying mechanisms of type II protein secretion.\", JOURNAL = c(\"Biochim Biophys Acta 1694:163-79 (2004)\", \"DOI:10.1016/j.bbamcr.2004.05.003\")), list(REFERENCE = \"PMID:19396170\", AUTHORS = \"Spreter T, Yip CK, Sanowar S, Andre I, Kimbrough TG, Vuckovic M, Pfuetzner RA, Deng W, Yu AC, Finlay BB, Baker D, Miller SI, Strynadka NC\", TITLE = \"A conserved structural motif mediates formation of the periplasmic rings in the type III secretion system.\", JOURNAL = c(\"Nat Struct Mol Biol 16:468-76 (2009)\", \"DOI:10.1038/nsmb.1603\")), list(REFERENCE = \"PMID:15590783\", AUTHORS = \"Ghosh P\", TITLE = \"Process of protein transport by the type III secretion system.\", JOURNAL = c(\"Microbiol Mol Biol Rev 68:771-95 (2004)\", \"DOI:10.1128/MMBR.68.4.771-795.2004\")), list(REFERENCE = \"PMID:12360191\", AUTHORS = \"Cornelis GR\", TITLE = \"The Yersinia Ysc-Yop \'type III\' weaponry.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 3:742-52 (2002)\", \"DOI:10.1038/nrm932\")), list(REFERENCE = \"PMID:17215876\", AUTHORS = \"Baron C\", TITLE = \"VirB8: a conserved type IV secretion system assembly factor and drug target.\", JOURNAL = c(\"Biochem Cell Biol 84:890-9 (2006)\", \"DOI:10.1139/o06-148\")), list(REFERENCE = \"PMID:17943123\", AUTHORS = \"Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, Misselwitz R, Berger J, Sewald N, Konig W, Backert S\", TITLE = \"Helicobacter exploits integrin for type IV secretion and kinase activation.\", JOURNAL = c(\"Nature 449:862-6 (2007)\", \"DOI:10.1038/nature06187\")), list(REFERENCE = \"PMID:16092524\", AUTHORS = \"Christie PJ, Cascales E\", TITLE = \"Structural and dynamic properties of bacterial type IV secretion systems (review).\", JOURNAL = c(\"Mol Membr Biol 22:51-61 (2005)\", \"DOI:10.1080/09687860500063316\")), list(REFERENCE = \"PMID:15546668\", AUTHORS = \"Christie PJ\", TITLE = \"Type IV secretion: the Agrobacterium VirB/D4 and related conjugation systems.\", JOURNAL = c(\"Biochim Biophys Acta 1694:219-34 (2004)\", \"DOI:10.1016/j.bbamcr.2004.02.013\")), list(REFERENCE = \"PMID:15590781\", AUTHORS = \"Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala\'Aldeen D\", TITLE = \"Type V protein secretion pathway: the autotransporter story.\", JOURNAL = c(\"Microbiol Mol Biol Rev 68:692-744 (2004)\", \"DOI:10.1128/MMBR.68.4.692-744.2004\")), list(REFERENCE = \"PMID:9778731\", AUTHORS = \"Henderson IR, Navarro-Garcia F, Nataro JP\", TITLE = \"The great escape: structure and function of the autotransporter proteins.\", JOURNAL = c(\"Trends Microbiol 6:370-8 (1998)\", \"DOI:10.1016/S0966-842X(98)01318-3\")), list(REFERENCE = \"PMID:18524912\", AUTHORS = \"Filloux A, Hachani A, Bleves S\", TITLE = \"The bacterial type VI secretion machine: yet another player for protein transport across membranes.\", JOURNAL = c(\"Microbiology 154:1570-83 (2008)\", \"DOI:10.1099/mic.0.2008/016840-0\")), list(REFERENCE = \"PMID:19251641\", AUTHORS = \"Leiman PG, Basler M, Ramagopal UA, Bonanno JB, Sauder JM, Pukatzki S, Burley SK, Almo SC, Mekalanos JJ\", TITLE = \"Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 106:4154-9 (2009)\", \"DOI:10.1073/pnas.0813360106\")), list(REFERENCE = \"PMID:17603507\", AUTHORS = \"Kulasekara HD, Miller SI\", TITLE = \"Threonine phosphorylation times bacterial secretion.\", JOURNAL = c(\"Nat Cell Biol 9:734-6 (2007)\", \"DOI:10.1038/ncb0707-734\")), list(REFERENCE = \"PMID:18078384\", AUTHORS = \"Driessen AJ, Nouwen N\", TITLE = \"Protein translocation across the bacterial cytoplasmic membrane.\", JOURNAL = c(\"Annu Rev Biochem 77:643-67 (2008)\", \"DOI:10.1146/annurev.biochem.77.061606.160747\")), list(REFERENCE = \"PMID:14641032\", AUTHORS = \"Pool MR\", TITLE = \"Getting to the membrane: how is co-translational protein targeting to the endoplasmic reticulum regulated?\", JOURNAL = c(\"Biochem Soc Trans 31:1232-7 (2003)\", \"DOI:10.1042/bst0311232\")), list(REFERENCE = \"PMID:19299134\", AUTHORS = \"Desvaux M, Hebraud M, Talon R, Henderson IR\", TITLE = \"Secretion and subcellular localizations of bacterial proteins: a semantic awareness issue.\", JOURNAL = c(\"Trends Microbiol 17:139-45 (2009)\", \"DOI:10.1016/j.tim.2009.01.004\")), list(REFERENCE = \"PMID:15063851\", AUTHORS = \"Nakatogawa H, Murakami A, Ito K\", TITLE = \"Control of SecA and SecM translation by protein secretion.\", JOURNAL = c(\"Curr Opin Microbiol 7:145-50 (2004)\", \"DOI:10.1016/j.mib.2004.01.001\"))', 'map03070', 'Bacterial secretion system', 0, 5555, 0, 0, 0, 0, 5256, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (214, '03320', 'PPAR signaling pathway', 'Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that are activated by fatty acids and their derivatives. PPAR has three subtypes (PPARalpha, beta/delta, and gamma) showing different expression patterns in vertebrates. Each of them is encoded in a separate gene and binds fatty acids and eicosanoids. PPARalpha plays a role in the clearance of circulating or cellular lipids via the regulation of gene expression involved in lipid metabolism in liver and skeletal muscle. PPARbeta/delta is involved in lipid oxidation and cell proliferation. PPARgamma promotes adipocyte differentiation to enhance blood glucose uptake.', 'Organismal Systems; Endocrine system', 'PPAR signaling pathway', 'Cerebrotendinous xanthomatosis, Hyperlipoproteinemia, type I, Hyperlipoproteinemia, type V, Peroxisomal beta-oxidation enzyme deficiency, Type 2 diabetes mellitus, Familial partial lipodystrophy, Leukoencephalopathy with dystonia and motor neuropathy, Hypoalphalipoproteinemia, Adiponectin deficiency, CD36 deficiency, Hyperalphalipoproteinemia, Glycerol kinase deficiency, Peroxisomal acyl-CoA oxidase deficiency, Genetic obesity', 'ko03320', 'list(REFERENCE = \"PMID:15828220\", AUTHORS = \"Takahashi N, Goto T, Kusudo T, Moriyama T, Kawada T.\", TITLE = \"[The structures and functions of peroxisome proliferator-activated receptors (PPARs)]\", JOURNAL = \"Nippon Rinsho 63:557-64 (2005)\"), list(REFERENCE = \"PMID:15828221\", AUTHORS = \"Fujii H.\", TITLE = \"[PPARs-mediated intracellular signal transduction]\", JOURNAL = \"Nippon Rinsho 63:565-71 (2005)\"), list(REFERENCE = \"PMID:15828222\", AUTHORS = \"Takada I, Kato S.\", TITLE = \"[PPARs target genes]\", JOURNAL = \"Nippon Rinsho 63:573-7 (2005)\"), list(REFERENCE = \"PMID:15828223\", AUTHORS = \"Inoue H.\", TITLE = \"[Endogenous ligands for PPARs]\", JOURNAL = \"Nippon Rinsho 63:578-83 (2005)\"), list(REFERENCE = \"PMID:16476485\", AUTHORS = \"Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W.\", TITLE = \"From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.\", JOURNAL = c(\"Prog Lipid Res 45:120-59 (2006)\", \"DOI:10.1016/j.plipres.2005.12.002\")), list(REFERENCE = \"PMID:16601267\", AUTHORS = \"Desvergne B, Michalik L, Wahli W.\", TITLE = \"Transcriptional regulation of metabolism.\", JOURNAL = c(\"Physiol Rev 86:465-514 (2006)\", \"DOI:10.1152/physrev.00025.2005\")), list(REFERENCE = \"PMID:14999402\", AUTHORS = \"Mandard S, Muller M, Kersten S.\", TITLE = \"Peroxisome proliferator-activated receptor alpha target genes.\", JOURNAL = c(\"Cell Mol Life Sci 61:393-416 (2004)\", \"DOI:10.1007/s00018-003-3216-3\")), list(REFERENCE = \"PMID:10529898\", AUTHORS = \"Desvergne B, Wahli W.\", TITLE = \"Peroxisome proliferator-activated receptors: nuclear control of metabolism.\", JOURNAL = c(\"Endocr Rev 20:649-88 (1999)\", \"DOI:10.1210/edrv.20.5.0380\")), list(REFERENCE = \"PMID:15673477\", AUTHORS = \"Savage DB.\", TITLE = \"PPARgamma as a metabolic regulator: insights from genomics and pharmacology.\", JOURNAL = c(\"Expert Rev Mol Med 2005:1-16 (2005)\", \"DOI:10.1017/S1462399405008793\")), list(REFERENCE = \"PMID:16511590\", AUTHORS = \"Semple RK, Chatterjee VK, O\'Rahilly S.\", TITLE = \"PPAR gamma and human metabolic disease.\", JOURNAL = c(\"J Clin Invest 116:581-9 (2006)\", \"DOI:10.1172/JCI28003\")), list(REFERENCE = \"PMID:16360030\", AUTHORS = \"Lehrke M, Lazar MA.\", TITLE = \"The many faces of PPARgamma.\", JOURNAL = c(\"Cell 123:993-9 (2005)\", \"DOI:10.1016/j.cell.2005.11.026\")), list(REFERENCE = \"PMID:11921433\", AUTHORS = \"Hauner H.\", TITLE = \"The mode of action of thiazolidinediones.\", JOURNAL = c(\"Diabetes Metab Res Rev 18 Suppl 2:S10-5 (2002)\", \"DOI:10.1002/dmrr.249\"))', 'map03320', 'PPAR signaling pathway', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (215, '03410', 'Base excision repair', 'Base excision repair (BER) is the predominant DNA damage repair pathway for the processing of small base lesions, derived from oxidation and alkylation damages. BER is normally defined as DNA repair initiated by lesion-specific DNA glycosylases and completed by either of the two sub-pathways: short-patch BER where only one nucleotide is replaced and long-patch BER where 2-13 nucleotides are replaced. Each sub-pathway of BER relies on the formation of protein complexes that assemble at the site of the DNA lesion and facilitate repair in a coordinated fashion. This process of complex formation appears to provide an increase in specificity and efficiency to the BER pathway, thereby facilitating the maintenance of genome integrity by preventing the accumulation of highly toxic repair intermediates.', 'Genetic Information Processing; Replication and repair', 'Base excision repair', 'Familial adenomatous polyposis, Ataxia-telangiectasia-like syndrome', 'GO: 0006284 0006285 0006286 0006287 0006288', 'ko03410', 'list(REFERENCE = \"PMID:17893748\", AUTHORS = \"Krwawicz J, Arczewska KD, Speina E, Maciejewska A, Grzesiuk E.\", TITLE = \"Bacterial DNA repair genes and their eukaryotic homologues: 1. Mutations in genes involved in base excision repair (BER) and DNA-end processors and their implication in mutagenesis and human disease.\", JOURNAL = \"Acta Biochim Pol 54:413-34 (2007)\"), list(REFERENCE = \"PMID:17337257\", AUTHORS = \"Almeida KH, Sobol RW.\", TITLE = \"A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification.\", JOURNAL = c(\"DNA Repair (Amst) 6:695-711 (2007)\", \"DOI:10.1016/j.dnarep.2007.01.009\")), list(REFERENCE = \"PMID:21665970\", AUTHORS = \"Moen MN, Knaevelsrud I, Haugland GT, Grosvik K, Birkeland NK, Klungland A, Bjelland S\", TITLE = \"Uracil-DNA glycosylase of Thermoplasma acidophilum directs long-patch base excision repair, which is promoted by deoxynucleoside triphosphates and ATP/ADP, into short-patch repair.\", JOURNAL = c(\"J Bacteriol 193:4495-508 (2011)\", \"DOI:10.1128/JB.00233-11\")), list(REFERENCE = \"PMID:11436317\", AUTHORS = \"Ikeda S, Seki S.\", TITLE = \"[Base excision repair: DNA glycosylase and AP endonuclease] Japanese\", JOURNAL = \"Tanpakushitsu Kakusan Koso 46:916-23 (2001)\")', 'map03410', 531, 5536, 248, 105, 128, 50, 5237, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (216, '03420', 'Nucleotide excision repair', 'Nucleotide excision repair (NER) is a mechanism to recognize and repair bulky DNA damage caused by compounds, environmental carcinogens, and exposure to UV-light. In humans hereditary defects in the NER pathway are linked to at least three diseases: xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD). The repair of damaged DNA involves at least 30 polypeptides within two different sub-pathways of NER known as transcription-coupled repair (TCR-NER) and global genome repair (GGR-NER). TCR refers to the expedited repair of lesions located in the actively transcribed strand of genes by RNA polymerase II (RNAP II). In GGR-NER the first step of damage recognition involves XPC-hHR23B complex together with XPE complex (in prokaryotes, uvrAB complex). The following steps of GGR-NER and TCR-NER are similar.', 'Genetic Information Processing; Replication and repair', 'Nucleotide excision repair', 'Cockayne syndrome, Disorders of nucleotide excision repair, Xeroderma pigmentosum, Ataxia-telangiectasia-like syndrome, UV-sensitive syndrome', 'GO: 0006289', 'ko03420', 'list(REFERENCE = \"PMID:11436314\", AUTHORS = \"Sugasawa K.\", TITLE = \"[Molecular mechanism of mammalian nucleotide excision repair] Japanese\", JOURNAL = \"Tanpakushitsu Kakusan Koso 46:893-901 (2001)\"), list(REFERENCE = \"PMID:11436316\", AUTHORS = \"Nakatsu Y.\", TITLE = \"[Transcription-coupled repair and Cockayne syndrome] Japanese\", JOURNAL = \"Tanpakushitsu Kakusan Koso 46:908-15 (2001)\"), list(REFERENCE = \"PMID:11436323\", AUTHORS = \"Nakagawa N, Masui R, Kuramitsu S.\", TITLE = \"[Structure and function of DNA repair enzyme UvrB from Thermus thermophilus HB8] Japanese\", JOURNAL = \"Tanpakushitsu Kakusan Koso 46:968-75 (2001)\"), list(REFERENCE = \"PMID:17276014\", AUTHORS = \"Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ.\", TITLE = \"Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship.\", JOURNAL = c(\"Neuroscience 145:1388-96 (2007)\", \"DOI:10.1016/j.neuroscience.2006.12.020\")), list(REFERENCE = \"PMID:17884153\", AUTHORS = \"Saldivar JS, Wu X, Follen M, Gershenson D.\", TITLE = \"Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity.\", JOURNAL = c(\"Gynecol Oncol 107:S56-71 (2007)\", \"DOI:10.1016/j.ygyno.2007.07.043\")), list(REFERENCE = \"PMID:16922398\", AUTHORS = \"Sugasawa K.\", TITLE = \"[DNA repair pathways involving Cul4A ubiquitin ligases] Japanese\", JOURNAL = \"Tanpakushitsu Kakusan Koso 51:1339-44 (2006)\"), list(REFERENCE = \"PMID:18018633\", AUTHORS = \"Ito S, Ando D, Tanaka K.\", TITLE = \"[Cross-talk between DNA repair and transcription: molecular mechanism and disorders] Japanese\", JOURNAL = \"Tanpakushitsu Kakusan Koso 52:1823-31 (2007)\")', 'map03420', 531, 5532, 248, 105, 128, 50, 5233, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (217, '03430', 'Mismatch repair', 'c(\"DNA mismatch repair (MMR) is a highly conserved biological pathway that plays a key role in maintaining genomic stability. MMR corrects DNA mismatches generated during DNA replication, thereby preventing mutations from becoming permanent in dividing cells. MMR also suppresses homologous recombination and was recently shown to play a role in DNA damage signaling. Defects in MMR are associated with genome-wide instability, predisposition to certain types of cancer including HNPCC, resistance to certain chemotherapeutic agents, and abnormalities in meiosis and sterility in mammalian systems.\", \n\"The Escherichia coli MMR pathway has been extensively studied and is well characterized. In E. coli, the mismatch-activated MutS-MutL-ATP complex licenses MutH to incise the nearest unmethylated GATC sequence. UvrD and an exonuclease generate a gap. This gap is filled by pol III and DNA ligase. The GATC sites are then methylated by Dam. Several human MMR proteins have been identified based on their homology to E. coli MMR proteins. These include human homologs of MutS and MutL. Although E. coli MutS and MutL proteins are homodimers, human MutS and MutL homologs are heterodimers. The role of hemimethylated dGATC sites as a signal for strand discrimination is not conserved from E. coli to human. Human MMR is presumed to be nick-directed in vivo, and is thought to discriminate daughter and template strands using a strand-specific nick.\"\n)', 'Genetic Information Processing; Replication and repair', 'Mismatch repair', 'Mismatch repair deficiency', 'GO: 0006298', 'ko03430', 'list(REFERENCE = \"PMID:16612326\", AUTHORS = \"Jiricny J.\", TITLE = \"The multifaceted mismatch-repair system.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 7:335-46 (2006)\", \"DOI:10.1038/nrm1907\")), list(REFERENCE = \"PMID:18157157\", AUTHORS = \"Li GM.\", TITLE = \"Mechanisms and functions of DNA mismatch repair.\", JOURNAL = c(\"Cell Res 18:85-98 (2008)\", \"DOI:10.1038/cr.2007.115\")), list(REFERENCE = \"PMID:11920679\", AUTHORS = \"Marti TM, Kunz C, Fleck O.\", TITLE = \"DNA mismatch repair and mutation avoidance pathways.\", JOURNAL = c(\"J Cell Physiol 191:28-41 (2002)\", \"DOI:10.1002/jcp.10077\")), list(REFERENCE = \"PMID:11436301\", AUTHORS = \"Ikejima M, Shimada T.\", TITLE = \"[Molecular mechanism of mismatch repair] Japanese\", JOURNAL = \"Tanpakushitsu Kakusan Koso 46:1124-9 (2001)\")', 'map03430', 531, 5559, 248, 105, 128, 50, 5260, 299);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (218, '03440', 'Homologous recombination', 'Homologous recombination (HR) is essential for the accurate repair of DNA double-strand breaks (DSBs), potentially lethal lesions. HR takes place in the late S-G2 phase of the cell cycle and involves the generation of a single-stranded region of DNA, followed by strand invasion, formation of a Holliday junction, DNA synthesis using the intact strand as a template, branch migration and resolution. It is investigated that RecA/Rad51 family proteins play a central role. The breast cancer susceptibility protein Brca2 and the RecQ helicase BLM (Bloom syndrome mutated) are tumor suppressors that maintain genome integrity, at least in part, through HR.', 'Genetic Information Processing; Replication and repair', 'Homologous recombination', 'Ataxia telangiectasia, Immunodeficiency associated with DNA repair defects, Defects in RecQ helicases, Congenital mirror movements, Nijmegen syndrome, Bloom syndrome, Ataxia-telangiectasia-like syndrome', 'GO: 0000724', 'ko03440', 'list(REFERENCE = \"PMID:18086882\", AUTHORS = \"Maloisel L, Fabre F, Gangloff S.\", TITLE = \"DNA polymerase delta is preferentially recruited during homologous recombination to promote heteroduplex DNA extension.\", JOURNAL = c(\"Mol Cell Biol 28:1373-82 (2008)\", \"DOI:10.1128/MCB.01651-07\")), list(REFERENCE = \"PMID:17571595\", AUTHORS = \"Haruta-Takahashi N, Iwasaki H.\", TITLE = \"[Recombination mediators] Japanese\", JOURNAL = \"Seikagaku 79:449-53 (2007)\"), list(REFERENCE = \"PMID:18430459\", AUTHORS = \"Ouyang KJ, Woo LL, Ellis NA.\", TITLE = \"Homologous recombination and maintenance of genome integrity: Cancer and aging through the prism of human RecQ helicases.\", JOURNAL = c(\"Mech Ageing Dev 129:425-40 (2008)\", \"DOI:10.1016/j.mad.2008.03.003\")), list(REFERENCE = \"PMID:15902993\", AUTHORS = \"Kawabata M, Kawabata T, Nishibori M.\", TITLE = \"Role of recA/RAD51 family proteins in mammals.\", JOURNAL = c(\"Acta Med Okayama 59:1-9 (2005)\", \"DOI:10.18926/AMO/31987\")), list(REFERENCE = \"PMID:12589470\", AUTHORS = \"Prado F, Cortes-Ledesma F, Huertas P, Aguilera A.\", TITLE = \"Mitotic recombination in Saccharomyces cerevisiae.\", JOURNAL = c(\"Curr Genet 42:185-98 (2003)\", \"DOI:10.1007/s00294-002-0346-3\")), list(REFERENCE = \"PMID:16935872\", AUTHORS = \"Heyer WD, Li X, Rolfsmeier M, Zhang XP.\", TITLE = \"Rad54: the Swiss Army knife of homologous recombination?\", JOURNAL = c(\"Nucleic Acids Res 34:4115-25 (2006)\", \"DOI:10.1093/nar/gkl481\")), list(REFERENCE = \"PMID:17395553\", AUTHORS = \"Michel B, Boubakri H, Baharoglu Z, LeMasson M, Lestini R.\", TITLE = \"Recombination proteins and rescue of arrested replication forks.\", JOURNAL = c(\"DNA Repair (Amst) 6:967-80 (2007)\", \"DOI:10.1016/j.dnarep.2007.02.016\"))', 'map03440', 531, 5495, 248, 105, 128, 50, 5251, 244);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (219, '03450', 'Non-homologous end-joining', 'Nonhomologous end joining (NHEJ) eliminates DNA double-strand breaks (DSBs) by direct ligation. NHEJ involves binding of the KU heterodimer to double-stranded DNA ends, recruitment of DNA-PKcs (MRX complex in yeast), processing of ends, and recruitment of the DNA ligase IV (LIG4)-XRCC4 complex, which brings about ligation. A recent study shows that bacteria accomplish NHEJ using just two proteins (Ku and DNA ligase), whereas eukaryotes require many factors. NHEJ repairs DSBs at all stages of the cell cycle, bringing about the ligation of two DNA DSBs without the need for sequence homology, and so is error-prone.', 'Genetic Information Processing; Replication and repair', 'Non-homologous end-joining', 'Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, Nijmegen syndrome, LIG4 syndrome', 'GO: 0006303', 'ko03450', 'list(REFERENCE = \"PMID:16971555\", AUTHORS = \"Gennery AR.\", TITLE = \"Primary immunodeficiency syndromes associated with defective DNA double-strand break repair.\", JOURNAL = c(\"Br Med Bull 77-78:71-85 (2006)\", \"DOI:10.1093/bmb/ldl006\")), list(REFERENCE = \"PMID:17589524\", AUTHORS = \"Zhang Y, Hefferin ML, Chen L, Shim EY, Tseng HM, Kwon Y, Sung P, Lee SE, Tomkinson AE.\", TITLE = \"Role of Dnl4-Lif1 in nonhomologous end-joining repair complex assembly and suppression of homologous recombination.\", JOURNAL = c(\"Nat Struct Mol Biol 14:639-46 (2007)\", \"DOI:10.1038/nsmb1261\")), list(REFERENCE = \"PMID:16895466\", AUTHORS = \"Wyman C, Kanaar R.\", TITLE = \"DNA double-strand break repair: all\'s well that ends well.\", JOURNAL = c(\"Annu Rev Genet 40:363-83 (2006)\", \"DOI:10.1146/annurev.genet.40.110405.090451\")), list(REFERENCE = \"PMID:15578053\", AUTHORS = \"Weller GR, Brandt VL, Roth DB.\", TITLE = \"Doing more with less in bacterial DNA repair.\", JOURNAL = c(\"Nat Struct Mol Biol 11:1158-9 (2004)\", \"DOI:10.1038/nsmb1204-1158\")), list(REFERENCE = \"PMID:12215643\", AUTHORS = \"Weller GR, Kysela B, Roy R, Tonkin LM, Scanlan E, Della M, Devine SK, Day JP, Wilkinson A, d\'Adda di Fagagna F, Devine KM, Bowater RP, Jeggo PA, Jackson SP, Doherty AJ.\", TITLE = \"Identification of a DNA nonhomologous end-joining complex in bacteria.\", JOURNAL = c(\"Science 297:1686-9 (2002)\", \"DOI:10.1126/science.1074584\")), list(REFERENCE = \"PMID:17506672\", AUTHORS = \"Pitcher RS, Brissett NC, Doherty AJ.\", TITLE = \"Nonhomologous end-joining in bacteria: a microbial perspective.\", JOURNAL = c(\"Annu Rev Microbiol 61:259-82 (2007)\", \"DOI:10.1146/annurev.micro.61.080706.093354\"))', 'map03450', 531, 1315, 248, 105, 128, 50, 1297, 18);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (220, '03460', 'Fanconi anemia pathway', 'The Fanconi anemia pathway is required for the efficient repair of damaged DNA, especially interstrand cross-links (ICLs). DNA ICL is directly recognized by FANCM and associated proteins, that recruit the FA core complex. The FA core complex monoubiquitinates FANCD2 and FANCI. The monoubiquitinated FANCD2/FANCI becomes an active form and interacts with a series of DNA repair proteins and facilitates downstream repair pathways. Fanconi anemia is caused by mutations in one of at least 13 FA genes and is characterized by congenital growth abnormalities, bone marrow failure and cancer predisposition.', 'Genetic Information Processing; Replication and repair', 'Fanconi anemia pathway', 'Fanconi anemia, Seckel syndrome, Bloom syndrome', 'GO: 0043240', 'ko03460', 'list(REFERENCE = \"PMID:18047734\", AUTHORS = \"Jacquemont C, Taniguchi T\", TITLE = \"The Fanconi anemia pathway and ubiquitin.\", JOURNAL = c(\"BMC Biochem 8 Suppl 1:S10 (2007)\", \"DOI:10.1186/1471-2091-8-S1-S10\")), list(REFERENCE = \"PMID:19805513\", AUTHORS = \"Bhagwat N, Olsen AL, Wang AT, Hanada K, Stuckert P, Kanaar R, D\'Andrea A, Niedernhofer LJ, McHugh PJ\", TITLE = \"XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.\", JOURNAL = c(\"Mol Cell Biol 29:6427-37 (2009)\", \"DOI:10.1128/MCB.00086-09\")), list(REFERENCE = \"PMID:21701511\", AUTHORS = \"Deans AJ, West SC\", TITLE = \"DNA interstrand crosslink repair and cancer.\", JOURNAL = c(\"Nat Rev Cancer 11:467-80 (2011)\", \"DOI:10.1038/nrc3088\")), list(REFERENCE = \"PMID:20064461\", AUTHORS = \"Deans AJ, West SC\", TITLE = \"FANCM connects the genome instability disorders Bloom\'s Syndrome and Fanconi Anemia.\", JOURNAL = c(\"Mol Cell 36:943-53 (2009)\", \"DOI:10.1016/j.molcel.2009.12.006\")), list(REFERENCE = \"PMID:20039786\", AUTHORS = \"Muniandy PA, Liu J, Majumdar A, Liu ST, Seidman MM\", TITLE = \"DNA interstrand crosslink repair in mammalian cells: step by step.\", JOURNAL = c(\"Crit Rev Biochem Mol Biol 45:23-49 (2010)\", \"DOI:10.3109/10409230903501819\")), list(REFERENCE = \"PMID:18518821\", AUTHORS = \"Ciccia A, McDonald N, West SC\", TITLE = \"Structural and functional relationships of the XPF/MUS81 family of proteins.\", JOURNAL = c(\"Annu Rev Biochem 77:259-87 (2008)\", \"DOI:10.1146/annurev.biochem.77.070306.102408\"))', 'map03460', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (221, '04010', 'MAPK signaling pathway', 'The mitogen-activated protein kinase (MAPK) cascade is a highly conserved module that is involved in various cellular functions, including cell proliferation, differentiation and migration. Mammals express at least four distinctly regulated groups of MAPKs, extracellular signal-related kinases (ERK)-1/2, Jun amino-terminal kinases (JNK1/2/3), p38 proteins (p38alpha/beta/gamma/delta) and ERK5, that are activated by specific MAPKKs: MEK1/2 for ERK1/2, MKK3/6 for the p38, MKK4/7 (JNKK1/2) for the JNKs, and MEK5 for ERK5. Each MAPKK, however, can be activated by more than one MAPKKK, increasing the complexity and diversity of MAPK signalling. Presumably each MAPKKK confers responsiveness to distinct stimuli. For example, activation of ERK1/2 by growth factors depends on the MAPKKK c-Raf, but other MAPKKKs may activate ERK1/2 in response to pro-inflammatory stimuli.', 'Environmental Information Processing; Signal transduction', 'MAPK signaling pathway', 'Frontotemporal lobar degeneration, Hereditary sensory and autonomic neuropathy, Multiple synostosis syndrome, FGFR3-related short limb skeletal dysplasia, Noonan syndrome and related disorders, Parkes Weber syndrome, Hereditary lymphedema, Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID), Coffin-Lowry syndrome, Myofibrillar myopathies, Lacrimo-auriculo-dento-digital syndrome, Incontinentia pigmenti, Aplasia of lacrimal and salivary glands, Brugada syndrome, Hypokalemic periodic paralysis (HypoPP), Episodic ataxias, Hemiplegic migraine, Congenital stationary night blindness, Loeys-Dietz syndrome, Familial thoracic aortic aneurysm and dissection, Idiopathic generalized epilepsies, Li-Fraumeni syndrome, Cocoon syndrome, FG syndrome, Tumor necrosis factor receptor-associated periodic syndrome, Congenital central hypoventilation syndrome, CATSHL syndrome, Choroid plexus papilloma, Familial tumoral calcinosis, Trigonocephaly, Hereditary gingival fibromatosis, Chronic idiopathic intestinal pseudo-obstruction, Rienhoff syndrome, Neurofibromatosis type 1, Langerhans cell histiocytosis, Noonan syndrome, Cardiofaciocutaneous syndrome, Trichomegaly, Leopard syndrome, Capillary malformation-arteriovenous malformation, Atelosteogenesis type I and III, Boomerang dysplasia, Hypochondroplasia, SADDAN, Watson syndrome, Neurofibromatosis-Noonan syndrome, Frontometaphyseal dysplasia', 'GO: 0000165', 'ko04010', 'list(REFERENCE = \"PMID:11749383\", AUTHORS = \"Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, Wright A, Vanderbilt C, Cobb MH.\", TITLE = \"MAP kinases.\", JOURNAL = c(\"Chem Rev 101:2449-76 (2001)\", \"DOI:10.1021/cr000241p\")), list(REFERENCE = \"PMID:12191611\", AUTHORS = \"Tanoue T, Nishida E.\", TITLE = \"Docking interactions in the mitogen-activated protein kinase cascades.\", JOURNAL = c(\"Pharmacol Ther 93:193-202 (2002)\", \"DOI:10.1016/S0163-7258(02)00188-2\")), list(REFERENCE = \"PMID:12947395\", AUTHORS = \"Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S.\", TITLE = \"MAPK pathways in radiation responses.\", JOURNAL = c(\"Oncogene 22:5885-96 (2003)\", \"DOI:10.1038/sj.onc.1206701\")), list(REFERENCE = \"PMID:12676795\", AUTHORS = \"Huang EJ, Reichardt LF.\", TITLE = \"Trk receptors: roles in neuronal signal transduction.\", JOURNAL = c(\"Annu Rev Biochem 72:609-42 (2003)\", \"DOI:10.1146/annurev.biochem.72.121801.161629\")), list(REFERENCE = \"PMID:11369511\", AUTHORS = \"Harper SJ, LoGrasso P.\", TITLE = \"Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38.\", JOURNAL = c(\"Cell Signal 13:299-310 (2001)\", \"DOI:10.1016/S0898-6568(01)00148-6\")), list(REFERENCE = \"PMID:12390245\", AUTHORS = \"Takeda K, Ichijo H\", TITLE = \"Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system.\", JOURNAL = c(\"Genes Cells 7:1099-111 (2002)\", \"DOI:10.1046/j.1365-2443.2002.00591.x\")), list(REFERENCE = \"PMID:14597384\", AUTHORS = \"Yang SH, Sharrocks AD, Whitmarsh AJ.\", TITLE = \"Transcriptional regulation by the MAP kinase signaling cascades.\", JOURNAL = c(\"Gene 320:3-21 (2003)\", \"DOI:10.1016/S0378-1119(03)00816-3\")), list(REFERENCE = \"PMID:12566928\", AUTHORS = \"Zhu X, Lee HG, Raina AK, Perry G, Smith MA.\", TITLE = \"The role of mitogen-activated protein kinase pathways in Alzheimer\'s disease.\", JOURNAL = c(\"Neurosignals 11:270-81 (2002)\", \"DOI:10.1159/000067426\")), list(REFERENCE = \"PMID:12849693\", AUTHORS = \"Cho H, Lee J, Kwak NJ, Lee KH, Rha S, Kim YH, Cho YY, Yang KH, Kim K, Lim Y.\", TITLE = \"Silica induces nuclear factor-kappaB activation through TAK1 and NIK in Rat2 cell line.\", JOURNAL = c(\"Toxicol Lett 143:323-30 (2003)\", \"DOI:10.1016/S0378-4274(03)00193-0\")), list(REFERENCE = \"PMID:20602996\", AUTHORS = \"Lemmon MA, Schlessinger J\", TITLE = \"Cell signaling by receptor tyrosine kinases.\", JOURNAL = c(\"Cell 141:1117-34 (2010)\", \"DOI:10.1016/j.cell.2010.06.011\")), list(REFERENCE = \"PMID:22367796\", AUTHORS = \"Skaper SD\", TITLE = \"The neurotrophin family of neurotrophic factors: an overview.\", JOURNAL = c(\"Methods Mol Biol 846:1-12 (2012)\", \"DOI:10.1007/978-1-61779-536-7_1\")), list(REFERENCE = \"PMID:23085193\", AUTHORS = \"Chu WM\", TITLE = \"Tumor necrosis factor.\", JOURNAL = c(\"Cancer Lett 328:222-5 (2013)\", \"DOI:10.1016/j.canlet.2012.10.014\")), list(REFERENCE = \"PMID:22296764\", AUTHORS = \"Newton K, Dixit VM\", TITLE = \"Signaling in innate immunity and inflammation.\", JOURNAL = c(\"Cold Spring Harb Perspect Biol 4:a006049 (2012)\", \"DOI:10.1101/cshperspect.a006049\")), list(REFERENCE = \"PMID:19483709\", AUTHORS = \"Gaestel M, Kotlyarov A, Kracht M\", TITLE = \"Targeting innate immunity protein kinase signalling in inflammation.\", JOURNAL = c(\"Nat Rev Drug Discov 8:480-99 (2009)\", \"DOI:10.1038/nrd2829\")), list(REFERENCE = \"PMID:23664135\", AUTHORS = \"Ajibade AA, Wang HY, Wang RF\", TITLE = \"Cell type-specific function of TAK1 in innate immune signaling.\", JOURNAL = c(\"Trends Immunol 34:307-16 (2013)\", \"DOI:10.1016/j.it.2013.03.007\")), list(REFERENCE = \"PMID:24892271\", AUTHORS = \"Turner MD, Nedjai B, Hurst T, Pennington DJ\", TITLE = \"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease.\", JOURNAL = c(\"Biochim Biophys Acta 1843:2563-2582 (2014)\", \"DOI:10.1016/j.bbamcr.2014.05.014\"))', 'map04010', 151, 0, 151, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (222, '04011', 'MAPK signaling pathway - yeast', 'The S. cerevisiae genome encodes multiple MAP kinase orthologs. One (Fus3) mediates cellular response to peptide pheromones. Another (Kss1) permits adjustment to nutrient limiting conditions. A third (Hog1) is necessary for survival under hyperosmotic conditions. A fourth (Slt2/Mpk1) is required for repair of injuries to the cell wall. As in mammalian cells, these pathways consist of a conserved module in which three kinases phosphorylate each other in sequence. The MAPK is phosphorylated by the MAPK/ERK kinase (MAPKK/MEK), which is itself phosphorylated by a MEK kinase (MAPKKK/MEKK).', 'Environmental Information Processing; Signal transduction', 'MAPK signaling pathway - yeast', 'GO: 0000165', 'ko04011', 'list(REFERENCE = \"PMID:15690603\", AUTHORS = \"Bardwell L\", TITLE = \"A walk-through of the yeast mating pheromone response pathway.\", JOURNAL = c(\"Peptides 26:339-50 (2005)\", \"DOI:10.1016/j.peptides.2004.10.002\")), list(REFERENCE = \"PMID:15944456\", AUTHORS = \"Levin DE\", TITLE = \"Cell wall integrity signaling in Saccharomyces cerevisiae.\", JOURNAL = c(\"Microbiol Mol Biol Rev 69:262-91 (2005)\", \"DOI:10.1128/MMBR.69.2.262-291.2005\")), list(REFERENCE = \"PMID:22174182\", AUTHORS = \"Levin DE\", TITLE = \"Regulation of cell wall biogenesis in Saccharomyces cerevisiae: the cell wall integrity signaling pathway.\", JOURNAL = c(\"Genetics 189:1145-75 (2011)\", \"DOI:10.1534/genetics.111.128264\")), list(REFERENCE = \"PMID:17875410\", AUTHORS = \"Hohmann S, Krantz M, Nordlander B\", TITLE = \"Yeast osmoregulation.\", JOURNAL = c(\"Methods Enzymol 428:29-45 (2007)\", \"DOI:10.1016/S0076-6879(07)28002-4\")), list(REFERENCE = \"PMID:23028184\", AUTHORS = \"Saito H, Posas F\", TITLE = \"Response to hyperosmotic stress.\", JOURNAL = c(\"Genetics 192:289-318 (2012)\", \"DOI:10.1534/genetics.112.140863\")), list(REFERENCE = \"PMID:22219507\", AUTHORS = \"Cullen PJ, Sprague GF Jr\", TITLE = \"The regulation of filamentous growth in yeast.\", JOURNAL = c(\"Genetics 190:23-49 (2012)\", \"DOI:10.1534/genetics.111.127456\")), list(REFERENCE = \"PMID:9841672\", AUTHORS = \"Gustin MC, Albertyn J, Alexander M, Davenport K\", TITLE = \"MAP kinase pathways in the yeast Saccharomyces cerevisiae.\", JOURNAL = \"Microbiol Mol Biol Rev 62:1264-300 (1998)\"), list(REFERENCE = \"PMID:17604854\", AUTHORS = \"Chen RE, Thorner J\", TITLE = \"Function and regulation in MAPK signaling pathways: lessons learned from the yeast Saccharomyces cerevisiae.\", JOURNAL = c(\"Biochim Biophys Acta 1773:1311-40 (2007)\", \"DOI:10.1016/j.bbamcr.2007.05.003\"))', 'map04011', 'MAPK signaling pathway - yeast', 128, 0, 0, 0, 128, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (223, '04012', 'ErbB signaling pathway', 'The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, differentiation, cell motility, and survival. Ligand binding to the four closely related members of this RTK family -epidermal growth factor receptor (EGFR, also known as ErbB-1 or HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4)-induces the formation of receptor homo- and heterodimers and the activation of the intrinsic kinase domain, resulting in phosphorylation on specific tyrosine residues (pY) within the cytoplasmic tail. Signaling effectors containing binding pockets for pY-containing peptides are recruited to activated receptors and induce the various signaling pathways. The Shc- and/or Grb2-activated mitogen-activated protein kinase (MAPK) pathway is a common target downstream of all ErbB receptors. Similarly, the phosphatidylinositol-3-kinase (PI-3K) pathway is directly or indirectly activated by most ErbBs. Several cytoplasmic docking proteins appear to be recruited by specific ErbB receptors and less exploited by others. These include the adaptors Crk, Nck, the phospholipase C gamma (PLCgamma), the intracellular tyrosine kinase Src, or the Cbl E3 ubiquitin protein ligase.', 'Environmental Information Processing; Signal transduction', 'ErbB signaling pathway', 'Growth hormone insensitivity with immunodeficiency, Pituitary adenomas, CBL syndrome', 'ko04012', 'list(REFERENCE = \"PMID:14967450\", AUTHORS = \"Marmor MD, Skaria KB, Yarden Y.\", TITLE = \"Signal transduction and oncogenesis by ErbB/HER receptors.\", JOURNAL = c(\"Int J Radiat Oncol Biol Phys 58:903-13 (2004)\", \"DOI:10.1016/j.ijrobp.2003.06.002\")), list(REFERENCE = \"PMID:11252954\", AUTHORS = \"Yarden Y, Sliwkowski MX.\", TITLE = \"Untangling the ErbB signalling network.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 2:127-37 (2001)\", \"DOI:10.1038/35052073\")), list(REFERENCE = \"PMID:16829981\", AUTHORS = \"Citri A, Yarden Y.\", TITLE = \"EGF-ERBB signalling: towards the systems level.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 7:505-16 (2006)\", \"DOI:10.1038/nrm1962\")), list(REFERENCE = \"PMID:17000658\", AUTHORS = \"Scaltriti M, Baselga J.\", TITLE = \"The epidermal growth factor receptor pathway: a model for targeted therapy.\", JOURNAL = c(\"Clin Cancer Res 12:5268-72 (2006)\", \"DOI:10.1158/1078-0432.CCR-05-1554\")), list(REFERENCE = \"PMID:16377102\", AUTHORS = \"Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS.\", TITLE = \"Epidermal growth factor receptor (EGFR) signaling in cancer.\", JOURNAL = c(\"Gene 366:2-16 (2006)\", \"DOI:10.1016/j.gene.2005.10.018\")), list(REFERENCE = \"PMID:14744244\", AUTHORS = \"Holbro T, Hynes NE.\", TITLE = \"ErbB receptors: directing key signaling networks throughout life.\", JOURNAL = c(\"Annu Rev Pharmacol Toxicol 44:195-217 (2004)\", \"DOI:10.1146/annurev.pharmtox.44.101802.121440\")), list(REFERENCE = \"PMID:12851486\", AUTHORS = \"Liang J, Slingerland JM.\", TITLE = \"Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.\", JOURNAL = c(\"Cell Cycle 2:339-45 (2003)\", \"DOI:10.4161/cc.2.4.433\")), list(REFERENCE = \"PMID:15864276\", AUTHORS = \"Hynes NE, Lane HA.\", TITLE = \"ERBB receptors and cancer: the complexity of targeted inhibitors.\", JOURNAL = c(\"Nat Rev Cancer 5:341-54 (2005)\", \"DOI:10.1038/nrc1609\")), list(REFERENCE = \"PMID:16729045\", AUTHORS = \"Oda K, Matsuoka Y, Funahashi A, Kitano H.\", TITLE = \"A comprehensive pathway map of epidermal growth factor receptor signaling.\", JOURNAL = c(\"Mol Syst Biol 1:2005.0010 (2005)\", \"DOI:10.1038/msb4100014\")), list(REFERENCE = \"PMID:16729043\", AUTHORS = \"Schulze WX, Deng L, Mann M.\", TITLE = \"Phosphotyrosine interactome of the ErbB-receptor kinase family.\", JOURNAL = c(\"Mol Syst Biol 1:2005.0008 (2005)\", \"DOI:10.1038/msb4100012\")), list(REFERENCE = \"PMID:10880430\", AUTHORS = \"Olayioye MA, Neve RM, Lane HA, Hynes NE.\", TITLE = \"The ErbB signaling network: receptor heterodimerization in development and cancer.\", JOURNAL = c(\"EMBO J 19:3159-67 (2000)\", \"DOI:10.1093/emboj/19.13.3159\")), list(REFERENCE = \"PMID:9872057\", AUTHORS = \"McCarty JH.\", TITLE = \"The Nck SH2/SH3 adaptor protein: a regulator of multiple intracellular signal transduction events.\", JOURNAL = c(\"Bioessays 20:913-21 (1998)\", \"DOI:10.1002/(SICI)1521-1878(199811)20:11<913::AID-BIES6>3.0.CO;2-T\")), list(REFERENCE = \"PMID:15863494\", AUTHORS = \"Clark DE, Williams CC, Duplessis TT, Moring KL, Notwick AR, Long W, Lane WS, Beuvink I, Hynes NE, Jones FE.\", TITLE = \"ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events.\", JOURNAL = c(\"J Biol Chem 280:24175-80 (2005)\", \"DOI:10.1074/jbc.M414044200\")), list(REFERENCE = \"PMID:10490623\", AUTHORS = \"Muthuswamy SK, Gilman M, Brugge JS.\", TITLE = \"Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.\", JOURNAL = c(\"Mol Cell Biol 19:6845-57 (1999)\", \"DOI:10.1128/MCB.19.10.6845\")), list(REFERENCE = \"PMID:9642287\", AUTHORS = \"Hashimoto Y, Katayama H, Kiyokawa E, Ota S, Kurata T, Gotoh N, Otsuka N, Shibata M, Matsuda M.\", TITLE = \"Phosphorylation of CrkII adaptor protein at tyrosine 221 by epidermal growth factor receptor.\", JOURNAL = c(\"J Biol Chem 273:17186-91 (1998)\", \"DOI:10.1074/jbc.273.27.17186\"))', 'map04012', 'ErbB signaling pathway', 151, 0, 151, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (224, '04013', 'MAPK signaling pathway - fly', 'The mitogen-activated protein kinase (MAPK) signaling cascades that are highly conserved from yeast to mammals use protein phosphorylation to convey signals intracellularly, and play a crucial role in mitosis, apoptosis, motility and metabolism. In fruit fly, three major classes of MAPK pathways have been distinguished with little or no redundancy, including extracellular signal-regulated kinase (ERK) / Rolled, c-Jun N-terminal kinase (JNK) / Bsk, and p38 kinase. Signals from growth factors or mitogens are dominantly transduced by the ERK pathway, whereas the JNK and p38 pathways are activated mostly by environmental stresses. The MAPK signaling cascades are typically linked to regulation of gene expression, because transcription factors are often the targets of regulatory phosphorylation events.', 'Environmental Information Processing; Signal transduction', 'MAPK signaling pathway - fly', 'GO: 0000165', 'ko04013', 'list(REFERENCE = \"PMID:23732470\", AUTHORS = \"Sopko R, Perrimon N\", TITLE = \"Receptor tyrosine kinases in Drosophila development.\", JOURNAL = c(\"Cold Spring Harb Perspect Biol 5:a009050 (2013)\", \"DOI:10.1101/cshperspect.a009050\")), list(REFERENCE = \"PMID:15704136\", AUTHORS = \"Li WX\", TITLE = \"Functions and mechanisms of receptor tyrosine kinase Torso signaling: lessons from Drosophila embryonic terminal development.\", JOURNAL = c(\"Dev Dyn 232:656-72 (2005)\", \"DOI:10.1002/dvdy.20295\")), list(REFERENCE = \"PMID:12648473\", AUTHORS = \"Shilo BZ\", TITLE = \"Signaling by the Drosophila epidermal growth factor receptor pathway during development.\", JOURNAL = c(\"Exp Cell Res 284:140-9 (2003)\", \"DOI:10.1016/S0014-4827(02)00094-0\")), list(REFERENCE = \"PMID:10771085\", AUTHORS = \"Raabe T\", TITLE = \"The sevenless signaling pathway: variations of a common theme.\", JOURNAL = c(\"Biochim Biophys Acta 1496:151-63 (2000)\", \"DOI:10.1016/S0167-4889(00)00020-3\")), list(REFERENCE = \"PMID:23109363\", AUTHORS = \"Rios-Barrera LD, Riesgo-Escovar JR\", TITLE = \"Regulating cell morphogenesis: the Drosophila Jun N-terminal kinase pathway.\", JOURNAL = c(\"Genesis 51:147-62 (2013)\", \"DOI:10.1002/dvg.22354\")), list(REFERENCE = \"PMID:24981286\", AUTHORS = \"Igaki T, Miura M\", TITLE = \"The Drosophila TNF ortholog Eiger: emerging physiological roles and evolution of the TNF system.\", JOURNAL = c(\"Semin Immunol 26:267-74 (2014)\", \"DOI:10.1016/j.smim.2014.05.003\")), list(REFERENCE = \"PMID:16014325\", AUTHORS = \"Zhuang ZH, Zhou Y, Yu MC, Silverman N, Ge BX\", TITLE = \"Regulation of Drosophila p38 activation by specific MAP2 kinase and MAP3 kinase in response to different stimuli.\", JOURNAL = c(\"Cell Signal 18:441-8 (2006)\", \"DOI:10.1016/j.cellsig.2005.05.013\")), list(REFERENCE = \"PMID:10557109\", AUTHORS = \"Stronach BE, Perrimon N\", TITLE = \"Stress signaling in Drosophila.\", JOURNAL = c(\"Oncogene 18:6172-82 (1999)\", \"DOI:10.1038/sj.onc.1203125\"))', 'map04013', 'MAPK signaling pathway - fly', 64, 0, 64, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (225, '04014', 'Ras signaling pathway', 'The Ras proteins are GTPases that function as molecular switches for signaling pathways regulating cell proliferation, survival, growth, migration, differentiation or cytoskeletal dynamism. Ras proteins transduce signals from extracellular growth factors by cycling between inactive GDP-bound and active GTP-bound states. The exchange of GTP for GDP on RAS is regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Activated RAS (RAS-GTP) regulates multiple cellular functions through effectors including Raf, phosphatidylinositol 3-kinase (PI3K) and Ral guanine nucleotide-dissociation stimulator (RALGDS).', 'Environmental Information Processing; Signal transduction', 'Ras signaling pathway', 'FGFR3-related short limb skeletal dysplasia, Autosomal dominant mental retardation, Neurofibromatosis type 1, Noonan syndrome, Costello syndrome, Leopard syndrome, Hypochondroplasia, SADDAN, Watson syndrome, Neurofibromatosis-Noonan syndrome', 'GO: 0032318', 'ko04014', 'list(REFERENCE = \"PMID:18568040\", AUTHORS = \"Karnoub AE, Weinberg RA\", TITLE = \"Ras oncogenes: split personalities.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 9:517-31 (2008)\", \"DOI:10.1038/nrm2438\")), list(REFERENCE = \"PMID:12778136\", AUTHORS = \"Malumbres M, Barbacid M\", TITLE = \"RAS oncogenes: the first 30 years.\", JOURNAL = c(\"Nat Rev Cancer 3:459-65 (2003)\", \"DOI:10.1038/nrc1097\")), list(REFERENCE = \"PMID:21686117\", AUTHORS = \"Cox AD, Der CJ\", TITLE = \"Ras history: The saga continues.\", JOURNAL = c(\"Small GTPases 1:2-27 (2010)\", \"DOI:10.4161/sgtp.1.1.12178\")), list(REFERENCE = \"PMID:12642680\", AUTHORS = \"Cox AD, Der CJ\", TITLE = \"Ras family signaling: therapeutic targeting.\", JOURNAL = c(\"Cancer Biol Ther 1:599-606 (2002)\", \"DOI:10.4161/cbt.306\")), list(REFERENCE = \"PMID:17428555\", AUTHORS = \"Rajalingam K, Schreck R, Rapp UR, Albert S\", TITLE = \"Ras oncogenes and their downstream targets.\", JOURNAL = c(\"Biochim Biophys Acta 1773:1177-95 (2007)\", \"DOI:10.1016/j.bbamcr.2007.01.012\")), list(REFERENCE = \"PMID:17384584\", AUTHORS = \"Schubbert S, Shannon K, Bollag G\", TITLE = \"Hyperactive Ras in developmental disorders and cancer.\", JOURNAL = c(\"Nat Rev Cancer 7:295-308 (2007)\", \"DOI:10.1038/nrc2109\")), list(REFERENCE = \"PMID:22233291\", AUTHORS = \"Poulogiannis G, Luo F, Arends MJ\", TITLE = \"RAS signalling in the colorectum in health and disease.\", JOURNAL = c(\"Cell Commun Adhes 19:1-9 (2012)\", \"DOI:10.3109/15419061.2011.649380\")), list(REFERENCE = \"PMID:22020205\", AUTHORS = \"Berndt N, Hamilton AD, Sebti SM\", TITLE = \"Targeting protein prenylation for cancer therapy.\", JOURNAL = c(\"Nat Rev Cancer 11:775-91 (2011)\", \"DOI:10.1038/nrc3151\")), list(REFERENCE = \"PMID:21196257\", AUTHORS = \"Overmeyer JH, Maltese WA\", TITLE = \"Death pathways triggered by activated Ras in cancer cells.\", JOURNAL = c(\"Front Biosci (Landmark Ed) 16:1693-713 (2011)\", \"DOI:10.2741/3814\")), list(REFERENCE = \"PMID:16869784\", AUTHORS = \"Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, McCormick F\", TITLE = \"Cancer targets in the Ras pathway.\", JOURNAL = c(\"Cold Spring Harb Symp Quant Biol 70:461-7 (2005)\", \"DOI:10.1101/sqb.2005.70.044\")), list(REFERENCE = \"PMID:14663478\", AUTHORS = \"Cox AD, Der CJ\", TITLE = \"The dark side of Ras: regulation of apoptosis.\", JOURNAL = c(\"Oncogene 22:8999-9006 (2003)\", \"DOI:10.1038/sj.onc.1207111\")), list(REFERENCE = \"PMID:18413813\", AUTHORS = \"Braun BS, Shannon K\", TITLE = \"Targeting Ras in myeloid leukemias.\", JOURNAL = c(\"Clin Cancer Res 14:2249-52 (2008)\", \"DOI:10.1158/1078-0432.CCR-07-1005\")), list(REFERENCE = \"PMID:20420946\", AUTHORS = \"Pino MS, Chung DC\", TITLE = \"The chromosomal instability pathway in colon cancer.\", JOURNAL = c(\"Gastroenterology 138:2059-72 (2010)\", \"DOI:10.1053/j.gastro.2009.12.065\")), list(REFERENCE = \"PMID:12217381\", AUTHORS = \"Schrader JW, Schallhorn A, Grill B, Guo X\", TITLE = \"Activation of small GTPases of the Ras and Rho family by growth factors active on mast cells.\", JOURNAL = c(\"Mol Immunol 38:1181-6 (2002)\", \"DOI:10.1016/S0161-5890(02)00060-3\")), list(REFERENCE = \"PMID:22189424\", AUTHORS = \"Ahearn IM, Haigis K, Bar-Sagi D, Philips MR\", TITLE = \"Regulating the regulator: post-translational modification of RAS.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 13:39-51 (2012)\", \"DOI:10.1038/nrm3255\")), list(REFERENCE = \"PMID:11313946\", AUTHORS = \"Ehrhardt GR, Korherr C, Wieler JS, Knaus M, Schrader JW\", TITLE = \"A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.\", JOURNAL = c(\"Oncogene 20:188-97 (2001)\", \"DOI:10.1038/sj.onc.1204053\")), list(REFERENCE = \"PMID:16966426\", AUTHORS = \"Goldfinger LE, Ptak C, Jeffery ED, Shabanowitz J, Hunt DF, Ginsberg MH\", TITLE = \"RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration.\", JOURNAL = c(\"J Cell Biol 174:877-88 (2006)\", \"DOI:10.1083/jcb.200603111\")), list(REFERENCE = \"PMID:23506953\", AUTHORS = \"Kortum RL, Rouquette-Jazdanian AK, Samelson LE\", TITLE = \"Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells.\", JOURNAL = c(\"Trends Immunol 34:259-68 (2013)\", \"DOI:10.1016/j.it.2013.02.004\")), list(REFERENCE = \"PMID:15572660\", AUTHORS = \"Roberts DM, Anderson AL, Hidaka M, Swetenburg RL, Patterson C, Stanford WL, Bautch VL\", TITLE = \"A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.\", JOURNAL = c(\"Mol Cell Biol 24:10515-28 (2004)\", \"DOI:10.1128/MCB.24.24.10515-10528.2004\")), list(REFERENCE = \"PMID:10712923\", AUTHORS = \"Reuther GW, Der CJ\", TITLE = \"The Ras branch of small GTPases: Ras family members don\'t fall far from the tree.\", JOURNAL = c(\"Curr Opin Cell Biol 12:157-65 (2000)\", \"DOI:10.1016/S0955-0674(99)00071-X\")), list(REFERENCE = \"PMID:21111786\", AUTHORS = \"Fernandez-Medarde A, Santos E\", TITLE = \"The RasGrf family of mammalian guanine nucleotide exchange factors.\", JOURNAL = c(\"Biochim Biophys Acta 1815:170-88 (2011)\", \"DOI:10.1016/j.bbcan.2010.11.001\")), list(REFERENCE = \"PMID:18437264\", AUTHORS = \"Iwashita S, Song SY\", TITLE = \"RasGAPs: a crucial regulator of extracellular stimuli for homeostasis of cellular functions.\", JOURNAL = c(\"Mol Biosyst 4:213-22 (2008)\", \"DOI:10.1039/b716357f\")), list(REFERENCE = \"PMID:15062121\", AUTHORS = \"Ory S, Morrison DK\", TITLE = \"Signal transduction: implications for Ras-dependent ERK signaling.\", JOURNAL = c(\"Curr Biol 14:R277-8 (2004)\", \"DOI:10.1016/j.cub.2004.03.023\")), list(REFERENCE = \"PMID:19091743\", AUTHORS = \"Matheny SA, White MA\", TITLE = \"Signaling threshold regulation by the Ras effector IMP.\", JOURNAL = c(\"J Biol Chem 284:11007-11 (2009)\", \"DOI:10.1074/jbc.R800082200\")), list(REFERENCE = \"PMID:20602996\", AUTHORS = \"Lemmon MA, Schlessinger J\", TITLE = \"Cell signaling by receptor tyrosine kinases.\", JOURNAL = c(\"Cell 141:1117-34 (2010)\", \"DOI:10.1016/j.cell.2010.06.011\")), list(REFERENCE = \"PMID:22367796\", AUTHORS = \"Skaper SD\", TITLE = \"The neurotrophin family of neurotrophic factors: an overview.\", JOURNAL = c(\"Methods Mol Biol 846:1-12 (2012)\", \"DOI:10.1007/978-1-61779-536-7_1\"))', 'map04014', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (226, '04015', 'Rap1 signaling pathway', 'Rap1 is a small GTPase that controls diverse processes, such as cell adhesion, cell-cell junction formation and cell polarity. Like all G proteins, Rap1 cycles between an inactive GDP-bound and an active GTP-bound conformation. A variety of extracellular signals control this cycle through the regulation of several unique guanine nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs). Rap1 plays a dominant role in the control of cell-cell and cell-matrix interactions by regulating the function of integrins and other adhesion molecules in various cell types. Rap1 also regulates MAP kinase (MAPK) activity in a manner highly dependent on the context of cell types.', 'Environmental Information Processing; Signal transduction', 'Rap1 signaling pathway', 'FGFR3-related short limb skeletal dysplasia, Hereditary lymphedema, Hypochondroplasia, SADDAN', 'GO: 0007264', 'ko04015', 'list(REFERENCE = \"PMID:17182900\", AUTHORS = \"Kooistra MR, Dube N, Bos JL\", TITLE = \"Rap1: a key regulator in cell-cell junction formation.\", JOURNAL = c(\"J Cell Sci 120:17-22 (2007)\", \"DOI:10.1242/jcs.03306\")), list(REFERENCE = \"PMID:11331911\", AUTHORS = \"Bos JL, de Rooij J, Reedquist KA\", TITLE = \"Rap1 signalling: adhering to new models.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 2:369-77 (2001)\", \"DOI:10.1038/35073073\")), list(REFERENCE = \"PMID:17383543\", AUTHORS = \"Minato N, Kometani K, Hattori M\", TITLE = \"Regulation of immune responses and hematopoiesis by the Rap1 signal.\", JOURNAL = c(\"Adv Immunol 93:229-64 (2007)\", \"DOI:10.1016/S0065-2776(06)93006-5\")), list(REFERENCE = \"PMID:15780587\", AUTHORS = \"Bos JL\", TITLE = \"Linking Rap to cell adhesion.\", JOURNAL = c(\"Curr Opin Cell Biol 17:123-8 (2005)\", \"DOI:10.1016/j.ceb.2005.02.009\")), list(REFERENCE = \"PMID:12508104\", AUTHORS = \"Caron E\", TITLE = \"Cellular functions of the Rap1 GTP-binding protein: a pattern emerges.\", JOURNAL = c(\"J Cell Sci 116:435-40 (2003)\", \"DOI:10.1242/jcs.00238\")), list(REFERENCE = \"PMID:10579920\", AUTHORS = \"Zwartkruis FJ, Bos JL\", TITLE = \"Ras and Rap1: two highly related small GTPases with distinct function.\", JOURNAL = c(\"Exp Cell Res 253:157-65 (1999)\", \"DOI:10.1006/excr.1999.4695\")), list(REFERENCE = \"PMID:14607972\", AUTHORS = \"Hattori M, Minato N\", TITLE = \"Rap1 GTPase: functions, regulation, and malignancy.\", JOURNAL = c(\"J Biochem 134:479-84 (2003)\", \"DOI:10.1093/jb/mvg180\")), list(REFERENCE = \"PMID:19159611\", AUTHORS = \"Pannekoek WJ, Kooistra MR, Zwartkruis FJ, Bos JL\", TITLE = \"Cell-cell junction formation: the role of Rap1 and Rap1 guanine nucleotide exchange factors.\", JOURNAL = c(\"Biochim Biophys Acta 1788:790-6 (2009)\", \"DOI:10.1016/j.bbamem.2008.12.010\")), list(REFERENCE = \"PMID:19615876\", AUTHORS = \"Boettner B, Van Aelst L\", TITLE = \"Control of cell adhesion dynamics by Rap1 signaling.\", JOURNAL = c(\"Curr Opin Cell Biol 21:684-93 (2009)\", \"DOI:10.1016/j.ceb.2009.06.004\")), list(REFERENCE = \"PMID:15803158\", AUTHORS = \"Xia Z, Storm DR.\", TITLE = \"The role of calmodulin as a signal integrator for synaptic plasticity.\", JOURNAL = c(\"Nat Rev Neurosci 6:267-76 (2005)\", \"DOI:10.1038/nrn1647\")), list(REFERENCE = \"PMID:17624948\", AUTHORS = \"Mor A, Dustin ML, Philips MR\", TITLE = \"Small GTPases and LFA-1 reciprocally modulate adhesion and signaling.\", JOURNAL = c(\"Immunol Rev 218:114-25 (2007)\", \"DOI:10.1111/j.1600-065X.2007.00538.x\")), list(REFERENCE = \"PMID:17624944\", AUTHORS = \"Burbach BJ, Medeiros RB, Mueller KL, Shimizu Y\", TITLE = \"T-cell receptor signaling to integrins.\", JOURNAL = c(\"Immunol Rev 218:65-81 (2007)\", \"DOI:10.1111/j.1600-065X.2007.00527.x\")), list(REFERENCE = \"PMID:12765839\", AUTHORS = \"Stork PJ\", TITLE = \"Does Rap1 deserve a bad Rap?\", JOURNAL = c(\"Trends Biochem Sci 28:267-75 (2003)\", \"DOI:10.1016/S0968-0004(03)00087-2\")), list(REFERENCE = \"PMID:12351703\", AUTHORS = \"Banihashemi B, Albert PR\", TITLE = \"Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.\", JOURNAL = c(\"Mol Endocrinol 16:2393-404 (2002)\", \"DOI:10.1210/me.2001-0220\")), list(REFERENCE = \"PMID:18363565\", AUTHORS = \"Banno A, Ginsberg MH\", TITLE = \"Integrin activation.\", JOURNAL = c(\"Biochem Soc Trans 36:229-34 (2008)\", \"DOI:10.1042/BST0360229\")), list(REFERENCE = \"PMID:19710505\", AUTHORS = \"Doebele RC, Schulze-Hoepfner FT, Hong J, Chlenski A, Zeitlin BD, Goel K, Gomes S, Liu Y, Abe MK, Nor JE, Lingen MW, Rosner MR\", TITLE = \"A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis.\", JOURNAL = c(\"Blood 114:4592-600 (2009)\", \"DOI:10.1182/blood-2009-04-217042\")), list(REFERENCE = \"PMID:21402149\", AUTHORS = \"Breckler M, Berthouze M, Laurent AC, Crozatier B, Morel E, Lezoualc\'h F\", TITLE = \"Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications.\", JOURNAL = c(\"Cell Signal 23:1257-66 (2011)\", \"DOI:10.1016/j.cellsig.2011.03.007\"))', 'map04015', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (227, '04016', 'MAPK signaling pathway - plant', 'Mitogen-activated protein kinase (MAPK) cascades, the evolutionarily conserved signaling modules in all eukaryotes, serve in transducing extracellular signals to the nucleus or cytoplasm for appropriate cellular responses, including cell division, differentiation, programmed cell death, and adaption to various stresses. In plant, several cascades are triggered by different biotic and abiotic stress stimuli such as pathogen infection, wounding, low temperature, drought, osmotic shock, high salinity, and reactive oxygen species. MAPK pathways also play pivotal roles in processes such as hormonal and developmental signaling. Multiple functional pathways initiated from distinct receptors often share the same kinase components while maintaining their signaling specificity. In contrast to those of animals and fungi, all the plant MAPK genes that have been reported belong to extracellular signal-regulated kinase (ERK) subfamily.', 'Environmental Information Processing; Signal transduction', 'MAPK signaling pathway - plant', 'GO: 0000165', 'ko04016', 'list(REFERENCE = \"PMID:11875555\", AUTHORS = \"Asai T, Tena G, Plotnikova J, Willmann MR, Chiu WL, Gomez-Gomez L, Boller T, Ausubel FM, Sheen J\", TITLE = \"MAP kinase signalling cascade in Arabidopsis innate immunity.\", JOURNAL = c(\"Nature 415:977-83 (2002)\", \"DOI:10.1038/415977a\")), list(REFERENCE = \"PMID:12119167\", AUTHORS = \"\", TITLE = \"Mitogen-activated protein kinase cascades in plants: a new nomenclature.\", JOURNAL = c(\"Trends Plant Sci 7:301-8 (2002)\", \"DOI:10.1016/S1360-1385(02)02302-6\")), list(REFERENCE = \"PMID:18570633\", AUTHORS = \"Colcombet J, Hirt H\", TITLE = \"Arabidopsis MAPKs: a complex signalling network involved in multiple biological processes.\", JOURNAL = c(\"Biochem J 413:217-26 (2008)\", \"DOI:10.1042/BJ20080625\")), list(REFERENCE = \"PMID:18692429\", AUTHORS = \"Kendrick MD, Chang C\", TITLE = \"Ethylene signaling: new levels of complexity and regulation.\", JOURNAL = c(\"Curr Opin Plant Biol 11:479-85 (2008)\", \"DOI:10.1016/j.pbi.2008.06.011\")), list(REFERENCE = \"PMID:20441529\", AUTHORS = \"Rodriguez MC, Petersen M, Mundy J\", TITLE = \"Mitogen-activated protein kinase signaling in plants.\", JOURNAL = c(\"Annu Rev Plant Biol 61:621-49 (2010)\", \"DOI:10.1146/annurev-arplant-042809-112252\")), list(REFERENCE = \"PMID:20980831\", AUTHORS = \"Taj G, Agarwal P, Grant M, Kumar A\", TITLE = \"MAPK machinery in plants: recognition and response to different stresses through multiple signal transduction pathways.\", JOURNAL = c(\"Plant Signal Behav 5:1370-8 (2010)\", \"DOI:10.4161/psb.5.11.13020\")), list(REFERENCE = \"PMID:23263767\", AUTHORS = \"Meng X, Wang H, He Y, Liu Y, Walker JC, Torii KU, Zhang S\", TITLE = \"A MAPK cascade downstream of ERECTA receptor-like protein kinase regulates Arabidopsis inflorescence architecture by promoting localized cell proliferation.\", JOURNAL = c(\"Plant Cell 24:4948-60 (2012)\", \"DOI:10.1105/tpc.112.104695\")), list(REFERENCE = \"PMID:25720833\", AUTHORS = \"Danquah A, de Zelicourt A, Boudsocq M, Neubauer J, Frei Dit Frey N, Leonhardt N, Pateyron S, Gwinner F, Tamby JP, Ortiz-Masia D, Marcote MJ, Hirt H, Colcombet J\", TITLE = \"Identification and characterization of an ABA-activated MAP kinase cascade in Arabidopsis thaliana.\", JOURNAL = c(\"Plant J 82:232-44 (2015)\", \"DOI:10.1111/tpj.12808\"))', 'map04016', 'MAPK signaling pathway - plant', 105, 0, 0, 105, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (228, '04020', 'Calcium signaling pathway', 'c(\"Ca2+ that enters the cell from the outside is a principal source of signal Ca2+. Entry of Ca2+ is driven by the presence of a large electrochemical gradient across the plasma membrane. Cells use this external source of signal Ca2+ by activating various entry channels with widely different properties. The voltage-operated channels (VOCs) are found in excitable cells and generate the rapid Ca2+ fluxes that control fast cellular processes. There are many other Ca2+-entry channels, such as the receptor-operated channels (ROCs), for example the NMDA (N-methyl-D-aspartate) receptors (NMDARs) that respond to glutamate. There also are second-messenger-operated channels (SMOCs) and store-operated channels (SOCs).\", \n\"The other principal source of Ca2+ for signalling is the internal stores that are located primarily in the endoplasmic/sarcoplasmic reticulum (ER/SR), in which inositol-1,4,5-trisphosphate receptors (IP3Rs) or ryanodine receptors (RYRs) regulate the release of Ca2+. The principal activator of these channels is Ca2+ itself and this process of Ca2+-induced Ca2+ release is central to the mechanism of Ca2+ signalling. Various second messengers or modulators also control the release of Ca2+. IP3, which is generated by pathways using different isoforms of phospholipase C (PLCbeta, delta, epsilon, gamma and zeta), regulates the IP3Rs. Cyclic ADP-ribose (cADPR) releases Ca2+ via RYRs. Nicotinic acid adenine dinucleotide phosphate (NAADP) may activate a distinct Ca2+ release mechanism on separate acidic Ca2+ stores. Ca2+ release via the NAADP-sensitive mechanism may also feedback onto either RYRs or IP3Rs. cADPR and NAADP are generated by CD38. This enzyme might be sensitive to the cellular metabolism, as ATP and NADH inhibit it.\", \n\"The influx of Ca2+ from the environment or release from internal stores causes a very rapid and dramatic increase in cytoplasmic calcium concentration, which has been widely exploited for signal transduction. Some proteins, such as troponin C (TnC) involved in muscle contraction, directly bind to and sense Ca2+. However, in other cases Ca2+ is sensed through intermediate calcium sensors such as calmodulin (CALM).\")', 'Environmental Information Processing; Signal transduction', 'Calcium signaling pathway', 'Progressive osseous heteroplasia, Central core disease, Darier disease, Brugada syndrome, Hypokalemic periodic paralysis (HypoPP), Episodic ataxias, Acrokeratosis verruciformis, Waardenburg syndrome, Hemiplegic migraine, Congenital stationary night blindness, Familial thoracic aortic aneurysm and dissection, ABCD syndrome, Hirschsprung disease, Precocious puberty, Catecholaminergic polymorphic ventricular tachycardia, Brody myopathy, Nonsyndromic congenital nail disorder, Multi-minicore disease, Primary aldosteronism, Familial male-limited precocious puberty, Familial hypocalciuric hypercalcemia, Tubular aggregate myopathy, Stormorken syndrome, Isolated anhidrosis with normal sweat glands', 'GO: 0019722', 'ko04020', 'list(REFERENCE = \"PMID:12838335\", AUTHORS = \"Berridge MJ, Bootman MD, Roderick HL.\", TITLE = \"Calcium signalling: dynamics, homeostasis and remodelling.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 4:517-29 (2003)\", \"DOI:10.1038/nrm1155\")), list(REFERENCE = \"PMID:11413485\", AUTHORS = \"Berridge MJ, Lipp P, Bootman MD.\", TITLE = \"The versatility and universality of calcium signalling.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 1:11-21 (2000)\", \"DOI:10.1038/35036035\")), list(REFERENCE = \"PMID:15111104\", AUTHORS = \"Wang MC, Dolphin A, Kitmitto A.\", TITLE = \"L-type voltage-gated calcium channels: understanding function through structure.\", JOURNAL = c(\"FEBS Lett 564:245-50 (2004)\", \"DOI:10.1016/S0014-5793(04)00253-4\")), list(REFERENCE = \"PMID:11299192\", AUTHORS = \"Ferrier GR, Howlett SE.\", TITLE = \"Cardiac excitation-contraction coupling: role of membrane potential in regulation of contraction.\", JOURNAL = c(\"Am J Physiol Heart Circ Physiol 280:H1928-44 (2001)\", \"DOI:10.1152/ajpheart.2001.280.5.H1928\")), list(REFERENCE = \"PMID:11698232\", AUTHORS = \"Keef KD, Hume JR, Zhong J.\", TITLE = \"Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases.\", JOURNAL = c(\"Am J Physiol Cell Physiol 281:C1743-56 (2001)\", \"DOI:10.1152/ajpcell.2001.281.6.C1743\")), list(REFERENCE = \"PMID:8125957\", AUTHORS = \"Hell JW, Appleyard SM, Yokoyama CT, Warner C, Catterall WA.\", TITLE = \"Differential phosphorylation of two size forms of the N-type calcium channel alpha 1 subunit which have different COOH termini.\", JOURNAL = \"J Biol Chem 269:7390-6 (1994)\"), list(REFERENCE = \"PMID:15000521\", AUTHORS = \"Yunker AM.\", TITLE = \"Modulation and pharmacology of low voltage-activated (\\\"T-Type\\\") calcium channels.\", JOURNAL = c(\"J Bioenerg Biomembr 35:577-98 (2003)\", \"DOI:10.1023/B:JOBB.0000008025.65675.37\")), list(REFERENCE = \"PMID:9149541\", AUTHORS = \"Yakel JL.\", TITLE = \"Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription.\", JOURNAL = c(\"Trends Pharmacol Sci 18:124-34 (1997)\", \"DOI:10.1016/S0165-6147(97)01046-8\")), list(REFERENCE = \"PMID:10997573\", AUTHORS = \"Fukunaga K, Miyamoto E.\", TITLE = \"A working model of CaM kinase II activity in hippocampal long-term potentiation and memory.\", JOURNAL = c(\"Neurosci Res 38:3-17 (2000)\", \"DOI:10.1016/S0168-0102(00)00139-5\")), list(REFERENCE = \"PMID:9235901\", AUTHORS = \"Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ.\", TITLE = \"Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase.\", JOURNAL = c(\"J Biol Chem 272:19125-32 (1997)\", \"DOI:10.1074/jbc.272.31.19125\")), list(REFERENCE = \"PMID:7861177\", AUTHORS = \"Furuichi T, Mikoshiba K.\", TITLE = \"Inositol 1, 4, 5-trisphosphate receptor-mediated Ca2+ signaling in the brain.\", JOURNAL = c(\"J Neurochem 64:953-60 (1995)\", \"DOI:10.1046/j.1471-4159.1995.64030953.x\")), list(REFERENCE = \"PMID:14572802\", AUTHORS = \"Bruce JI, Straub SV, Yule DI.\", TITLE = \"Crosstalk between cAMP and Ca2+ signaling in non-excitable cells.\", JOURNAL = c(\"Cell Calcium 34:431-44 (2003)\", \"DOI:10.1016/S0143-4160(03)00150-7\")), list(REFERENCE = \"PMID:10331643\", AUTHORS = \"Lee HC, Munshi C, Graeff R.\", TITLE = \"Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.\", JOURNAL = \"Mol Cell Biochem 193:89-98 (1999)\"), list(REFERENCE = \"PMID:11080247\", AUTHORS = \"Crompton M.\", TITLE = \"Mitochondrial intermembrane junctional complexes and their role in cell death.\", JOURNAL = c(\"J Physiol 529 Pt 1:11-21 (2000)\", \"DOI:10.1111/j.1469-7793.2000.00011.x\")), list(REFERENCE = \"PMID:10508738\", AUTHORS = \"Grewal SS, York RD, Stork PJ.\", TITLE = \"Extracellular-signal-regulated kinase signalling in neurons.\", JOURNAL = c(\"Curr Opin Neurobiol 9:544-53 (1999)\", \"DOI:10.1016/S0959-4388(99)00010-0\")), list(REFERENCE = \"PMID:12972622\", AUTHORS = \"Trushin SA, Pennington KN, Carmona EM, Asin S, Savoy DN, Billadeau DD, Paya CV.\", TITLE = \"Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.\", JOURNAL = c(\"Mol Cell Biol 23:7068-81 (2003)\", \"DOI:10.1128/MCB.23.19.7068-7081.2003\")), list(REFERENCE = \"PMID:14517314\", AUTHORS = \"Hutchins JR, Dikovskaya D, Clarke PR.\", TITLE = \"Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.\", JOURNAL = c(\"Mol Biol Cell 14:4003-14 (2003)\", \"DOI:10.1091/mbc.E03-02-0061\")), list(REFERENCE = \"PMID:21338471\", AUTHORS = \"Tornquist K\", TITLE = \"Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells.\", JOURNAL = c(\"Acta Physiol (Oxf) 204:151-7 (2012)\", \"DOI:10.1111/j.1748-1716.2011.02265.x\")), list(REFERENCE = \"PMID:22129055\", AUTHORS = \"Feske S\", TITLE = \"Immunodeficiency due to defects in store-operated calcium entry.\", JOURNAL = c(\"Ann N Y Acad Sci 1238:74-90 (2011)\", \"DOI:10.1111/j.1749-6632.2011.06240.x\")), list(REFERENCE = \"PMID:22002090\", AUTHORS = \"Giachini FR, Lima VV, Hannan JL, Carneiro FS, Webb RC, Tostes RC\", TITLE = \"STIM1/Orai1-mediated store-operated Ca2+ entry: the tip of the iceberg.\", JOURNAL = c(\"Braz J Med Biol Res 44:1080-7 (2011)\", \"DOI:10.1590/S0100-879X2011007500133\")), list(REFERENCE = \"PMID:19172794\", AUTHORS = \"Baba Y, Kurosaki T\", TITLE = \"[Regulation of store-operated calcium entry by STIM1].\", JOURNAL = \"Seikagaku 80:1123-8 (2008)\"), list(REFERENCE = \"PMID:19475418\", AUTHORS = \"Galione A, Evans AM, Ma J, Parrington J, Arredouani A, Cheng X, Zhu MX\", TITLE = \"The acid test: the discovery of two-pore channels (TPCs) as NAADP-gated endolysosomal Ca(2+) release channels.\", JOURNAL = c(\"Pflugers Arch 458:869-76 (2009)\", \"DOI:10.1007/s00424-009-0682-y\")), list(REFERENCE = \"PMID:19434403\", AUTHORS = \"Beard NA, Wei L, Dulhunty AF\", TITLE = \"Ca(2+) signaling in striated muscle: the elusive roles of triadin, junctin, and calsequestrin.\", JOURNAL = c(\"Eur Biophys J 39:27-36 (2009)\", \"DOI:10.1007/s00249-009-0449-6\")), list(REFERENCE = \"PMID:26228554\", AUTHORS = \"Marty I\", TITLE = \"Triadin regulation of the ryanodine receptor complex.\", JOURNAL = c(\"J Physiol 593:3261-6 (2015)\", \"DOI:10.1113/jphysiol.2014.281147\")), list(REFERENCE = \"PMID:20807542\", AUTHORS = \"Arvanitis DA, Vafiadaki E, Sanoudou D, Kranias EG\", TITLE = \"Histidine-rich calcium binding protein: the new regulator of sarcoplasmic reticulum calcium cycling.\", JOURNAL = c(\"J Mol Cell Cardiol 50:43-9 (2011)\", \"DOI:10.1016/j.yjmcc.2010.08.021\"))', 'map04020', 151, 0, 151, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (229, '04022', 'cGMP-PKG signaling pathway', 'Cyclic GMP (cGMP) is the intracellular second messenger that mediates the action of nitric oxide (NO) and natriuretic peptides (NPs), regulating a broad array of physiologic processes. The elevated intracellular cGMP level exerts its physiological action through two forms of cGMP-dependent protein kinase (PKG), cGMP-regulated phosphodiesterases (PDE2, PDE3) and cGMP-gated cation channels, among which PKGs might be the primary mediator. PKG1 isoform-specific activation of established substrates leads to reduction of cytosolic calcium concentration and/or decrease in the sensitivity of myofilaments to Ca2+ (Ca2+-desensitization), resulting in smooth muscle relaxation. In cardiac myocyte, PKG directly phosphorylates a member of the transient potential receptor canonical channel family, TRPC6, suppressing this nonselective ion channel\'s Ca2+ conductance, G-alpha-q agonist-induced NFAT activation, and myocyte hypertrophic responses. PKG also opens mitochondrial ATP-sensitive K+ (mitoKATP) channels and subsequent release of ROS triggers cardioprotection.', 'Environmental Information Processing; Signal transduction', 'cGMP-PKG signaling pathway', 'Coronary artery disease', 'GO: 0070305', 'ko04022', 'list(REFERENCE = \"PMID:20716671\", AUTHORS = \"Francis SH, Busch JL, Corbin JD, Sibley D\", TITLE = \"cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.\", JOURNAL = c(\"Pharmacol Rev 62:525-63 (2010)\", \"DOI:10.1124/pr.110.002907\")), list(REFERENCE = \"PMID:16439998\", AUTHORS = \"Feil R, Kemp-Harper B\", TITLE = \"cGMP signalling: from bench to bedside. Conference on cGMP generators, effectors and therapeutic implications.\", JOURNAL = c(\"EMBO Rep 7:149-53 (2006)\", \"DOI:10.1038/sj.embor.7400627\")), list(REFERENCE = \"PMID:22785374\", AUTHORS = \"Takimoto E\", TITLE = \"Cyclic GMP-dependent signaling in cardiac myocytes.\", JOURNAL = c(\"Circ J 76:1819-25 (2012)\", \"DOI:10.1253/circj.CJ-12-0664\")), list(REFERENCE = \"PMID:16371594\", AUTHORS = \"Hofmann F, Feil R, Kleppisch T, Schlossmann J\", TITLE = \"Function of cGMP-dependent protein kinases as revealed by gene deletion.\", JOURNAL = c(\"Physiol Rev 86:1-23 (2006)\", \"DOI:10.1152/physrev.00015.2005\")), list(REFERENCE = \"PMID:21685243\", AUTHORS = \"Kuebler WM\", TITLE = \"The Janus-faced regulation of endothelial permeability by cyclic GMP.\", JOURNAL = c(\"Am J Physiol Lung Cell Mol Physiol 301:L157-60 (2011)\", \"DOI:10.1152/ajplung.00192.2011\")), list(REFERENCE = \"PMID:21666108\", AUTHORS = \"Schlossmann J, Desch M\", TITLE = \"IRAG and novel PKG targeting in the cardiovascular system.\", JOURNAL = c(\"Am J Physiol Heart Circ Physiol 301:H672-82 (2011)\", \"DOI:10.1152/ajpheart.00198.2011\")), list(REFERENCE = \"PMID:16460276\", AUTHORS = \"Murthy KS\", TITLE = \"Signaling for contraction and relaxation in smooth muscle of the gut.\", JOURNAL = c(\"Annu Rev Physiol 68:345-74 (2006)\", \"DOI:10.1146/annurev.physiol.68.040504.094707\")), list(REFERENCE = \"PMID:22965426\", AUTHORS = \"Sanders KM, Koh SD, Ro S, Ward SM\", TITLE = \"Regulation of gastrointestinal motility--insights from smooth muscle biology.\", JOURNAL = c(\"Nat Rev Gastroenterol Hepatol 9:633-45 (2012)\", \"DOI:10.1038/nrgastro.2012.168\")), list(REFERENCE = \"PMID:20024580\", AUTHORS = \"Gao Y\", TITLE = \"The multiple actions of NO.\", JOURNAL = c(\"Pflugers Arch 459:829-39 (2010)\", \"DOI:10.1007/s00424-009-0773-9\")), list(REFERENCE = \"PMID:9003029\", AUTHORS = \"Wang X, Robinson PJ\", TITLE = \"Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system.\", JOURNAL = c(\"J Neurochem 68:443-56 (1997)\", \"DOI:10.1046/j.1471-4159.1997.68020443.x\")), list(REFERENCE = \"PMID:19306895\", AUTHORS = \"Tsai EJ, Kass DA\", TITLE = \"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.\", JOURNAL = c(\"Pharmacol Ther 122:216-38 (2009)\", \"DOI:10.1016/j.pharmthera.2009.02.009\")), list(REFERENCE = \"PMID:20388537\", AUTHORS = \"Villanueva C, Giulivi C\", TITLE = \"Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease.\", JOURNAL = c(\"Free Radic Biol Med 49:307-16 (2010)\", \"DOI:10.1016/j.freeradbiomed.2010.04.004\")), list(REFERENCE = \"PMID:15894227\", AUTHORS = \"Schlossmann J, Hofmann F\", TITLE = \"cGMP-dependent protein kinases in drug discovery.\", JOURNAL = c(\"Drug Discov Today 10:627-34 (2005)\", \"DOI:10.1016/S1359-6446(05)03406-9\")), list(REFERENCE = \"PMID:18040025\", AUTHORS = \"Kass DA, Champion HC, Beavo JA\", TITLE = \"Phosphodiesterase type 5: expanding roles in cardiovascular regulation.\", JOURNAL = c(\"Circ Res 101:1084-95 (2007)\", \"DOI:10.1161/CIRCRESAHA.107.162511\")), list(REFERENCE = \"PMID:16815627\", AUTHORS = \"Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG\", TITLE = \"Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future.\", JOURNAL = c(\"Eur Urol 50:1194-207; discussion 1207 (2006)\", \"DOI:10.1016/j.eururo.2006.05.025\")), list(REFERENCE = \"PMID:12524221\", AUTHORS = \"Yan C, Kim D, Aizawa T, Berk BC\", TITLE = \"Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator.\", JOURNAL = c(\"Arterioscler Thromb Vasc Biol 23:26-36 (2003)\", \"DOI:10.1161/01.ATV.0000046231.17365.9D\")), list(REFERENCE = \"PMID:17643091\", AUTHORS = \"McKinsey TA, Kass DA\", TITLE = \"Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface.\", JOURNAL = c(\"Nat Rev Drug Discov 6:617-35 (2007)\", \"DOI:10.1038/nrd2193\")), list(REFERENCE = \"PMID:19961855\", AUTHORS = \"Koitabashi N, Aiba T, Hesketh GG, Rowell J, Zhang M, Takimoto E, Tomaselli GF, Kass DA\", TITLE = \"Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition.\", JOURNAL = c(\"J Mol Cell Cardiol 48:713-24 (2010)\", \"DOI:10.1016/j.yjmcc.2009.11.015\")), list(REFERENCE = \"PMID:18006449\", AUTHORS = \"Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD\", TITLE = \"cGMP signalling in pre- and post-conditioning: the role of mitochondria.\", JOURNAL = c(\"Cardiovasc Res 77:344-52 (2008)\", \"DOI:10.1093/cvr/cvm050\")), list(REFERENCE = \"PMID:19176601\", AUTHORS = \"Boengler K, Schulz R, Heusch G\", TITLE = \"Loss of cardioprotection with ageing.\", JOURNAL = c(\"Cardiovasc Res 83:247-61 (2009)\", \"DOI:10.1093/cvr/cvp033\")), list(REFERENCE = \"PMID:18757523\", AUTHORS = \"Gao Y, Portugal AD, Liu J, Negash S, Zhou W, Tian J, Xiang R, Longo LD, Raj JU\", TITLE = \"Preservation of cGMP-induced relaxation of pulmonary veins of fetal lambs exposed to chronic high altitude hypoxia: role of PKG and Rho kinase.\", JOURNAL = c(\"Am J Physiol Lung Cell Mol Physiol 295:L889-96 (2008)\", \"DOI:10.1152/ajplung.00463.2007\")), list(REFERENCE = \"PMID:11522789\", AUTHORS = \"Li Z, Xi X, Du X\", TITLE = \"A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin alpha IIbbeta3.\", JOURNAL = c(\"J Biol Chem 276:42226-32 (2001)\", \"DOI:10.1074/jbc.M106129200\")), list(REFERENCE = \"PMID:23212367\", AUTHORS = \"Xie J, Cha SK, An SW, Kuro-O M, Birnbaumer L, Huang CL\", TITLE = \"Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart.\", JOURNAL = c(\"Nat Commun 3:1238 (2012)\", \"DOI:10.1038/ncomms2240\"))', 'map04022', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (230, '04024', 'cAMP signaling pathway', 'cAMP is one of the most common and universal second messengers, and its formation is promoted by adenylyl cyclase (AC) activation after ligation of G protein-coupled receptors (GPCRs) by ligands including hormones, neurotransmitters, and other signaling molecules. cAMP regulates pivotal physiologic processes including metabolism, secretion, calcium homeostasis, muscle contraction, cell fate, and gene transcription. cAMP acts directly on three main targets: protein kinase A (PKA), the exchange protein activated by cAMP (Epac), and cyclic nucleotide-gated ion channels (CNGCs). PKA modulates, via phosphorylation, a number of cellular substrates, including transcription factors, ion channels, transporters, exchangers, intracellular Ca2+ -handling proteins, and the contractile machinery. Epac proteins function as guanine nucleotide exchange factors (GEFs) for both Rap1 and Rap2. Various effector proteins, including adaptor proteins implicated in modulation of the actin cytoskeleton, regulators of G proteins of the Rho family, and phospholipases, relay signaling downstream from Rap.', 'Environmental Information Processing; Signal transduction', 'cAMP signaling pathway', 'Autosomal dominant mental retardation, Eating Disorders, Acrodysostosis, Absorptive hypercalciuria', 'GO: 0019933', 'ko04024', 'list(REFERENCE = \"PMID:11493633\", AUTHORS = \"Fimia GM, Sassone-Corsi P\", TITLE = \"Cyclic AMP signalling.\", JOURNAL = \"J Cell Sci 114:1971-2 (2001)\"), list(REFERENCE = \"PMID:18323530\", AUTHORS = \"Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M\", TITLE = \"Cyclic AMP: master regulator of innate immune cell function.\", JOURNAL = c(\"Am J Respir Cell Mol Biol 39:127-32 (2008)\", \"DOI:10.1165/rcmb.2008-0091TR\")), list(REFERENCE = \"PMID:24281338\", AUTHORS = \"Oldenburger A, Maarsingh H, Schmidt M\", TITLE = \"Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung.\", JOURNAL = c(\"Pharmaceuticals (Basel) 5:1291-331 (2012)\", \"DOI:10.3390/ph5121291\")), list(REFERENCE = \"PMID:24613710\", AUTHORS = \"Ahuja M, Jha A, Maleth J, Park S, Muallem S\", TITLE = \"cAMP and Ca signaling in secretory epithelia: Crosstalk and synergism.\", JOURNAL = c(\"Cell Calcium 55:385-393 (2014)\", \"DOI:10.1016/j.ceca.2014.01.006\")), list(REFERENCE = \"PMID:22082266\", AUTHORS = \"Shirshev SV\", TITLE = \"Role of Epac proteins in mechanisms of cAMP-dependent immunoregulation.\", JOURNAL = c(\"Biochemistry (Mosc) 76:981-98 (2011)\", \"DOI:10.1134/S000629791109001X\")), list(REFERENCE = \"PMID:18176800\", AUTHORS = \"Roscioni SS, Elzinga CR, Schmidt M\", TITLE = \"Epac: effectors and biological functions.\", JOURNAL = c(\"Naunyn Schmiedebergs Arch Pharmacol 377:345-57 (2008)\", \"DOI:10.1007/s00210-007-0246-7\")), list(REFERENCE = \"PMID:24450633\", AUTHORS = \"Roberts OL, Dart C\", TITLE = \"cAMP signalling in the vasculature: the role of Epac (exchange protein directly activated by cAMP).\", JOURNAL = c(\"Biochem Soc Trans 42:89-97 (2014)\", \"DOI:10.1042/BST20130253\")), list(REFERENCE = \"PMID:16765984\", AUTHORS = \"Schaub MC, Hefti MA, Zaugg M\", TITLE = \"Integration of calcium with the signaling network in cardiac myocytes.\", JOURNAL = c(\"J Mol Cell Cardiol 41:183-214 (2006)\", \"DOI:10.1016/j.yjmcc.2006.04.005\")), list(REFERENCE = \"PMID:19874988\", AUTHORS = \"Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J\", TITLE = \"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.\", JOURNAL = c(\"J Am Coll Cardiol 54:1747-62 (2009)\", \"DOI:10.1016/j.jacc.2009.05.015\")), list(REFERENCE = \"PMID:15142747\", AUTHORS = \"Saucerman JJ, McCulloch AD\", TITLE = \"Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation.\", JOURNAL = c(\"Prog Biophys Mol Biol 85:261-78 (2004)\", \"DOI:10.1016/j.pbiomolbio.2004.01.005\")), list(REFERENCE = \"PMID:21212391\", AUTHORS = \"Yang JH, Saucerman JJ\", TITLE = \"Computational models reduce complexity and accelerate insight into cardiac signaling networks.\", JOURNAL = c(\"Circ Res 108:85-97 (2011)\", \"DOI:10.1161/CIRCRESAHA.110.223602\")), list(REFERENCE = \"PMID:22022314\", AUTHORS = \"Taggart P, Boyett MR, Logantha S, Lambiase PD\", TITLE = \"Anger, emotion, and arrhythmias: from brain to heart.\", JOURNAL = c(\"Front Physiol 2:67 (2011)\", \"DOI:10.3389/fphys.2011.00067\")), list(REFERENCE = \"PMID:21852968\", AUTHORS = \"Bozzi Y, Dunleavy M, Henshall DC\", TITLE = \"Cell signaling underlying epileptic behavior.\", JOURNAL = c(\"Front Behav Neurosci 5:45 (2011)\", \"DOI:10.3389/fnbeh.2011.00045\")), list(REFERENCE = \"PMID:10880354\", AUTHORS = \"Lizcano JM, Morrice N, Cohen P\", TITLE = \"Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155.\", JOURNAL = c(\"Biochem J 349:547-57 (2000)\", \"DOI:10.1042/bj3490547\")), list(REFERENCE = \"PMID:21744067\", AUTHORS = \"Gerlo S, Kooijman R, Beck IM, Kolmus K, Spooren A, Haegeman G\", TITLE = \"Cyclic AMP: a selective modulator of NF-kappaB action.\", JOURNAL = c(\"Cell Mol Life Sci 68:3823-41 (2011)\", \"DOI:10.1007/s00018-011-0757-8\")), list(REFERENCE = \"PMID:7688165\", AUTHORS = \"Lauder JM\", TITLE = \"Neurotransmitters as growth regulatory signals: role of receptors and second messengers.\", JOURNAL = c(\"Trends Neurosci 16:233-40 (1993)\", \"DOI:10.1016/0166-2236(93)90162-F\")), list(REFERENCE = \"PMID:17077866\", AUTHORS = \"Voglis G, Tavernarakis N\", TITLE = \"The role of synaptic ion channels in synaptic plasticity.\", JOURNAL = c(\"EMBO Rep 7:1104-10 (2006)\", \"DOI:10.1038/sj.embor.7400830\")), list(REFERENCE = \"PMID:21346730\", AUTHORS = \"Altarejos JY, Montminy M\", TITLE = \"CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 12:141-51 (2011)\", \"DOI:10.1038/nrm3072\")), list(REFERENCE = \"PMID:24062645\", AUTHORS = \"Bozzi Y, Borrelli E\", TITLE = \"The role of dopamine signaling in epileptogenesis.\", JOURNAL = c(\"Front Cell Neurosci 7:157 (2013)\", \"DOI:10.3389/fncel.2013.00157\")), list(REFERENCE = \"PMID:14715909\", AUTHORS = \"Ceulemans H, Bollen M\", TITLE = \"Functional diversity of protein phosphatase-1, a cellular economizer and reset button.\", JOURNAL = c(\"Physiol Rev 84:1-39 (2004)\", \"DOI:10.1152/physrev.00013.2003\")), list(REFERENCE = \"PMID:16571352\", AUTHORS = \"Lipinski RJ, Gipp JJ, Zhang J, Doles JD, Bushman W\", TITLE = \"Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling.\", JOURNAL = c(\"Exp Cell Res 312:1925-38 (2006)\", \"DOI:10.1016/j.yexcr.2006.02.019\")), list(REFERENCE = \"PMID:21693691\", AUTHORS = \"Lasala C, Schteingart HF, Arouche N, Bedecarras P, Grinspon RP, Picard JY, Josso N, di Clemente N, Rey RA\", TITLE = \"SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Mullerian gene expression in the testicular prepubertal Sertoli cell line SMAT1.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 301:E539-47 (2011)\", \"DOI:10.1152/ajpendo.00187.2011\")), list(REFERENCE = \"PMID:19460777\", AUTHORS = \"Rosenkranz AC, Rauch BH, Freidel K, Schror K\", TITLE = \"Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT.\", JOURNAL = c(\"Cardiovasc Res 83:778-84 (2009)\", \"DOI:10.1093/cvr/cvp163\")), list(REFERENCE = \"PMID:11117527\", AUTHORS = \"Lazennec G, Canaple L, Saugy D, Wahli W\", TITLE = \"Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.\", JOURNAL = c(\"Mol Endocrinol 14:1962-75 (2000)\", \"DOI:10.1210/mend.14.12.0575\")), list(REFERENCE = \"PMID:16460276\", AUTHORS = \"Murthy KS\", TITLE = \"Signaling for contraction and relaxation in smooth muscle of the gut.\", JOURNAL = c(\"Annu Rev Physiol 68:345-74 (2006)\", \"DOI:10.1146/annurev.physiol.68.040504.094707\")), list(REFERENCE = \"PMID:18064650\", AUTHORS = \"Birukova AA, Zagranichnaya T, Alekseeva E, Bokoch GM, Birukov KG\", TITLE = \"Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.\", JOURNAL = c(\"J Cell Physiol 215:715-24 (2008)\", \"DOI:10.1002/jcp.21354\")), list(REFERENCE = \"PMID:9204709\", AUTHORS = \"Houslay MD, Milligan G\", TITLE = \"Tailoring cAMP-signalling responses through isoform multiplicity.\", JOURNAL = c(\"Trends Biochem Sci 22:217-24 (1997)\", \"DOI:10.1016/S0968-0004(97)01050-5\"))', 'map04024', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (231, '04060', 'Cytokine-cytokine receptor interaction', 'Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, differentiation, cell death, angiogenesis, and development and repair processes aimed at the restoration of homeostasis. Cytokines are released by various cells in the body, usually in response to an activating stimulus, and they induce responses through binding to specific receptors on the cell surface of target cells. Cytokines can be grouped by structure into different families and their receptors can likewise be grouped.', 'Environmental Information Processing; Signaling molecules and interaction', 'Cytokine-cytokine receptor interaction', 'Chemokine receptor defect, Congenital amegakaryocytic thrombocytopenia, Crohn disease, Leprosy, Type 1 diabetes mellitus, Persistent Mullerian duct syndrome, Heterotaxy, Hypohidrotic ectodermal dysplasia, Loeys-Dietz syndrome, Familial thoracic aortic aneurysm and dissection, Tumor necrosis factor receptor-associated periodic syndrome, Cold-induced sweating syndrome, Juvenile polyposis syndrome, Hereditary mixed polyposis syndrome, Chronic mucocutaneous candidiasis, Congenital pulmonary alveolar proteinosis, Primary localized cutaneous amyloidosis, Inflammatory bowel disease (IBD), Ulcerative colitis, Castleman disease, Juvenile idiopathic arthritis, Laron syndrome, Kowarski syndrome, Leptin deficiency, Leptin receptor deficiency, Craniosynostosis and dental anomalies', 'ko04060', 'list(REFERENCE = \"PMID:24892271\", AUTHORS = \"Turner MD, Nedjai B, Hurst T, Pennington DJ\", TITLE = \"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease.\", JOURNAL = c(\"Biochim Biophys Acta 1843:2563-2582 (2014)\", \"DOI:10.1016/j.bbamcr.2014.05.014\")), list(REFERENCE = \"PMID:21106488\", AUTHORS = \"Brocker C, Thompson D, Matsumoto A, Nebert DW, Vasiliou V\", TITLE = \"Evolutionary divergence and functions of the human interleukin (IL) gene family.\", JOURNAL = c(\"Hum Genomics 5:30-55 (2010)\", \"DOI:10.1186/1479-7364-5-1-30\")), list(REFERENCE = \"PMID:27577879\", AUTHORS = \"Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, Duan S, Eiwegger T, Eljaszewicz A, Ferstl R, Frei R, Garbani M, Globinska A, Hess L, Huitema C, Kubo T, Komlosi Z, Konieczna P, Kovacs N, Kucuksezer UC, Meyer N, Morita H, Olzhausen J, O\'Mahony L, Pezer M, Prati M, Rebane A, Rhyner C, Rinaldi A, Sokolowska M, Stanic B, Sugita K, Treis A, van de Veen W, Wanke K, Wawrzyniak M, Wawrzyniak P, Wirz OF, Zakzuk JS, Akdis CA\", TITLE = \"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases.\", \n    JOURNAL = c(\"J Allergy Clin Immunol 138:984-1010 (2016)\", \"DOI:10.1016/j.jaci.2016.06.033\")), list(REFERENCE = \"PMID:15500860\", AUTHORS = \"Boulanger MJ, Garcia KC\", TITLE = \"Shared cytokine signaling receptors: structural insights from the gp130 system.\", JOURNAL = c(\"Adv Protein Chem 68:107-46 (2004)\", \"DOI:10.1016/S0065-3233(04)68004-1\")), list(REFERENCE = \"PMID:16034365\", AUTHORS = \"Allan SM, Tyrrell PJ, Rothwell NJ\", TITLE = \"Interleukin-1 and neuronal injury.\", JOURNAL = c(\"Nat Rev Immunol 5:629-40 (2005)\", \"DOI:10.1038/nri1664\")), list(REFERENCE = \"PMID:23847622\", AUTHORS = \"Lopetuso LR, Chowdhry S, Pizarro TT\", TITLE = \"Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease.\", JOURNAL = c(\"Front Immunol 4:181 (2013)\", \"DOI:10.3389/fimmu.2013.00181\")), list(REFERENCE = \"PMID:21349428\", AUTHORS = \"Iwakura Y, Ishigame H, Saijo S, Nakae S\", TITLE = \"Functional specialization of interleukin-17 family members.\", JOURNAL = c(\"Immunity 34:149-62 (2011)\", \"DOI:10.1016/j.immuni.2011.02.012\")), list(REFERENCE = \"PMID:17530315\", AUTHORS = \"Fischer P, Hilfiker-Kleiner D\", TITLE = \"Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.\", JOURNAL = c(\"Basic Res Cardiol 102:279-97 (2007)\", \"DOI:10.1007/s00395-007-0658-z\")), list(REFERENCE = \"PMID:24381786\", AUTHORS = \"Richards CD\", TITLE = \"The enigmatic cytokine oncostatin m and roles in disease.\", JOURNAL = c(\"ISRN Inflamm 2013:512103 (2013)\", \"DOI:10.1155/2013/512103\")), list(REFERENCE = \"PMID:18926762\", AUTHORS = \"Zhang Q, Putheti P, Zhou Q, Liu Q, Gao W\", TITLE = \"Structures and biological functions of IL-31 and IL-31 receptors.\", JOURNAL = c(\"Cytokine Growth Factor Rev 19:347-56 (2008)\", \"DOI:10.1016/j.cytogfr.2008.08.003\")), list(REFERENCE = \"PMID:21155715\", AUTHORS = \"Meenhuis A, Verwijmeren C, Roovers O, Touw IP\", TITLE = \"The deubiquitinating enzyme DUB2A enhances CSF3 signalling by attenuating lysosomal routing of the CSF3 receptor.\", JOURNAL = c(\"Biochem J 434:343-51 (2011)\", \"DOI:10.1042/BJ20101628\")), list(REFERENCE = \"PMID:22410872\", AUTHORS = \"de Weerd NA, Nguyen T\", TITLE = \"The interferons and their receptors--distribution and regulation.\", JOURNAL = c(\"Immunol Cell Biol 90:483-91 (2012)\", \"DOI:10.1038/icb.2012.9\")), list(REFERENCE = \"PMID:12949498\", AUTHORS = \"Aggarwal BB\", TITLE = \"Signalling pathways of the TNF superfamily: a double-edged sword.\", JOURNAL = c(\"Nat Rev Immunol 3:745-56 (2003)\", \"DOI:10.1038/nri1184\")), list(REFERENCE = \"PMID:12189384\", AUTHORS = \"Ashkenazi A\", TITLE = \"Targeting death and decoy receptors of the tumour-necrosis factor superfamily.\", JOURNAL = c(\"Nat Rev Cancer 2:420-30 (2002)\", \"DOI:10.1038/nrc821\")), list(REFERENCE = \"PMID:26115564\", AUTHORS = \"Seeger P, Musso T, Sozzani S\", TITLE = \"The TGF-beta superfamily in dendritic cell biology.\", JOURNAL = c(\"Cytokine Growth Factor Rev 26:647-57 (2015)\", \"DOI:10.1016/j.cytogfr.2015.06.002\")), list(REFERENCE = \"PMID:23612460\", AUTHORS = \"Wakefield LM, Hill CS\", TITLE = \"Beyond TGFbeta: roles of other TGFbeta superfamily members in cancer.\", JOURNAL = c(\"Nat Rev Cancer 13:328-41 (2013)\", \"DOI:10.1038/nrc3500\")), list(REFERENCE = \"PMID:22710174\", AUTHORS = \"Mueller TD, Nickel J\", TITLE = \"Promiscuity and specificity in BMP receptor activation.\", JOURNAL = c(\"FEBS Lett 586:1846-59 (2012)\", \"DOI:10.1016/j.febslet.2012.02.043\"))', 'map04060', 'Cytokine-cytokine receptor interaction', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (232, '04061', 'Viral protein interaction with cytokine and cytokine receptor', 'Viruses have evolved diverse mechanisms to evade detection and destruction by the immune system, including copying and repurposing host cytokine and cytokine receptor genes. Viral cytokines and cytokine receptors, together with a group of structurally unique, soluble, cytokine-binding or cytokine receptor-binding proteins, represent the three major molecular strategies for subversion and modulation of the host cytokine networks mainly in large DNA viruses. Viral cytokines and cytokine receptor homologs, including other binding proteins, may activate or inhibit cytokine signaling and possibly affect different aspects of immunity.', 'Environmental Information Processing; Signaling molecules and interaction', 'Viral protein interaction with cytokine and cytokine receptor', 'ko04061', 'list(REFERENCE = \"PMID:12511874\", AUTHORS = \"Alcami A\", TITLE = \"Viral mimicry of cytokines, chemokines and their receptors.\", JOURNAL = c(\"Nat Rev Immunol 3:36-50 (2003)\", \"DOI:10.1038/nri980\")), list(REFERENCE = \"PMID:28848041\", AUTHORS = \"Pontejo SM, Murphy PM\", TITLE = \"Chemokines encoded by herpesviruses.\", JOURNAL = c(\"J Leukoc Biol 102:1199-1217 (2017)\", \"DOI:10.1189/jlb.4RU0417-145RR\")), list(REFERENCE = \"PMID:25805993\", AUTHORS = \"de Munnik SM, Smit MJ, Leurs R, Vischer HF\", TITLE = \"Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.\", JOURNAL = c(\"Front Pharmacol 6:40 (2015)\", \"DOI:10.3389/fphar.2015.00040\")), list(REFERENCE = \"PMID:24445563\", AUTHORS = \"Vischer HF, Siderius M, Leurs R, Smit MJ\", TITLE = \"Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?\", JOURNAL = c(\"Nat Rev Drug Discov 13:123-39 (2014)\", \"DOI:10.1038/nrd4189\")), list(REFERENCE = \"PMID:9325239\", AUTHORS = \"Smith CA, Smith TD, Smolak PJ, Friend D, Hagen H, Gerhart M, Park L, Pickup DJ, Torrance D, Mohler K, Schooley K, Goodwin RG\", TITLE = \"Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors.\", JOURNAL = c(\"Virology 236:316-27 (1997)\", \"DOI:10.1006/viro.1997.8730\")), list(REFERENCE = \"PMID:9621074\", AUTHORS = \"Isegawa Y, Ping Z, Nakano K, Sugimoto N, Yamanishi K\", TITLE = \"Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor.\", JOURNAL = \"J Virol 72:6104-12 (1998)\"), list(REFERENCE = \"PMID:9600978\", AUTHORS = \"Damon I, Murphy PM, Moss B\", TITLE = \"Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 95:6403-7 (1998)\", \"DOI:10.1073/pnas.95.11.6403\")), list(REFERENCE = \"PMID:16365449\", AUTHORS = \"Dewin DR, Catusse J, Gompels UA\", TITLE = \"Identification and characterization of U83A viral chemokine, a broad and potent beta-chemokine agonist for human CCRs with unique selectivity and inhibition by spliced isoform.\", JOURNAL = c(\"J Immunol 176:544-56 (2006)\", \"DOI:10.4049/jimmunol.176.1.544\")), list(REFERENCE = \"PMID:16332987\", AUTHORS = \"Fitzsimons CP, Gompels UA, Verzijl D, Vischer HF, Mattick C, Leurs R, Smit MJ\", TITLE = \"Chemokine-directed trafficking of receptor stimulus to different g proteins: selective inducible and constitutive signaling by human herpesvirus 6-encoded chemokine receptor U51.\", JOURNAL = c(\"Mol Pharmacol 69:888-98 (2006)\", \"DOI:10.1124/mol.105.015222\")), list(REFERENCE = \"PMID:15536129\", AUTHORS = \"Wang D, Bresnahan W, Shenk T\", TITLE = \"Human cytomegalovirus encodes a highly specific RANTES decoy receptor.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 101:16642-7 (2004)\", \"DOI:10.1073/pnas.0407233101\")), list(REFERENCE = \"PMID:22319442\", AUTHORS = \"Viejo-Borbolla A, Martinez-Martin N, Nel HJ, Rueda P, Martin R, Blanco S, Arenzana-Seisdedos F, Thelen M, Fallon PG, Alcami A\", TITLE = \"Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses.\", JOURNAL = c(\"PLoS Pathog 8:e1002497 (2012)\", \"DOI:10.1371/journal.ppat.1002497\")), list(REFERENCE = \"PMID:16581912\", AUTHORS = \"Alejo A, Ruiz-Arguello MB, Ho Y, Smith VP, Saraiva M, Alcami A\", TITLE = \"A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 103:5995-6000 (2006)\", \"DOI:10.1073/pnas.0510462103\")), list(REFERENCE = \"PMID:15890946\", AUTHORS = \"Tadagaki K, Nakano K, Yamanishi K\", TITLE = \"Human herpesvirus 7 open reading frames U12 and U51 encode functional beta-chemokine receptors.\", JOURNAL = c(\"J Virol 79:7068-76 (2005)\", \"DOI:10.1128/JVI.79.11.7068-7076.2005\")), list(REFERENCE = \"PMID:12960231\", AUTHORS = \"Lee C, Liu QH, Tomkowicz B, Yi Y, Freedman BD, Collman RG\", TITLE = \"Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways.\", JOURNAL = c(\"J Leukoc Biol 74:676-82 (2003)\", \"DOI:10.1189/jlb.0503206\")), list(REFERENCE = \"PMID:14645913\", AUTHORS = \"Najarro P, Lee HJ, Fox J, Pease J, Smith GL\", TITLE = \"Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1.\", JOURNAL = c(\"J Gen Virol 84:3325-36 (2003)\", \"DOI:10.1099/vir.0.19591-0\")), list(REFERENCE = \"PMID:16528029\", AUTHORS = \"Najarro P, Gubser C, Hollinshead M, Fox J, Pease J, Smith GL\", TITLE = \"Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue.\", JOURNAL = c(\"J Gen Virol 87:809-16 (2006)\", \"DOI:10.1099/vir.0.81427-0\")), list(REFERENCE = \"PMID:18286574\", AUTHORS = \"Catusse J, Spinks J, Mattick C, Dyer A, Laing K, Fitzsimons C, Smit MJ, Gompels UA\", TITLE = \"Immunomodulation by herpesvirus U51A chemokine receptor via CCL5 and FOG-2 down-regulation plus XCR1 and CCR7 mimicry in human leukocytes.\", JOURNAL = c(\"Eur J Immunol 38:763-77 (2008)\", \"DOI:10.1002/eji.200737618\")), list(REFERENCE = \"PMID:8992974\", AUTHORS = \"Liu Y, de Waal Malefyt R, Briere F, Parham C, Bridon JM, Banchereau J, Moore KW, Xu J\", TITLE = \"The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor.\", JOURNAL = \"J Immunol 158:604-13 (1997)\"), list(REFERENCE = \"PMID:15837194\", AUTHORS = \"Yoon SI, Jones BC, Logsdon NJ, Walter MR\", TITLE = \"Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain.\", JOURNAL = c(\"Structure 13:551-64 (2005)\", \"DOI:10.1016/j.str.2005.01.016\")), list(REFERENCE = \"PMID:10677520\", AUTHORS = \"Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S\", TITLE = \"Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10).\", JOURNAL = c(\"Proc Natl Acad Sci U S A 97:1695-700 (2000)\", \"DOI:10.1073/pnas.97.4.1695\")), list(REFERENCE = \"PMID:15280480\", AUTHORS = \"Chang WL, Baumgarth N, Yu D, Barry PA\", TITLE = \"Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality.\", JOURNAL = c(\"J Virol 78:8720-31 (2004)\", \"DOI:10.1128/JVI.78.16.8720-8731.2004\")), list(REFERENCE = \"PMID:11238858\", AUTHORS = \"Li H, Wang H, Nicholas J\", TITLE = \"Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling.\", JOURNAL = c(\"J Virol 75:3325-34 (2001)\", \"DOI:10.1128/JVI.75.7.3325-3334.2001\")), list(REFERENCE = \"PMID:11468184\", AUTHORS = \"Nicot C, Mulloy JC, Ferrari MG, Johnson JM, Fu K, Fukumoto R, Trovato R, Fullen J, Leonard WJ, Franchini G\", TITLE = \"HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells.\", JOURNAL = \"Blood 98:823-9 (2001)\"), list(REFERENCE = \"PMID:10500212\", AUTHORS = \"Xiang Y, Moss B\", TITLE = \"IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 96:11537-42 (1999)\", \"DOI:10.1073/pnas.96.20.11537\")), list(REFERENCE = \"PMID:15166422\", AUTHORS = \"Bartlett NW, Dumoutier L, Renauld JC, Kotenko SV, McVey CE, Lee HJ, Smith GL\", TITLE = \"A new member of the interleukin 10-related cytokine family encoded by a poxvirus.\", JOURNAL = c(\"J Gen Virol 85:1401-12 (2004)\", \"DOI:10.1099/vir.0.79980-0\")), list(REFERENCE = \"PMID:9557689\", AUTHORS = \"Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose RF, Armitage RJ, Spriggs MK\", TITLE = \"The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.\", JOURNAL = \"J Virol 72:4015-21 (1998)\"), list(REFERENCE = \"PMID:17229074\", AUTHORS = \"Snow AL, Martinez OM\", TITLE = \"Epstein-Barr virus: evasive maneuvers in the development of PTLD.\", JOURNAL = c(\"Am J Transplant 7:271-7 (2007)\", \"DOI:10.1111/j.1600-6143.2006.01650.x\")), list(REFERENCE = \"PMID:22826234\", AUTHORS = \"Shim AH, Chang RA, Chen X, Longnecker R, He X\", TITLE = \"Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 109:12962-7 (2012)\", \"DOI:10.1073/pnas.1205309109\")), list(REFERENCE = \"PMID:11934887\", AUTHORS = \"Filippova M, Song H, Connolly JL, Dermody TS, Duerksen-Hughes PJ\", TITLE = \"The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.\", JOURNAL = c(\"J Biol Chem 277:21730-9 (2002)\", \"DOI:10.1074/jbc.M200113200\")), list(REFERENCE = \"PMID:12676996\", AUTHORS = \"Brunetti CR, Paulose-Murphy M, Singh R, Qin J, Barrett JW, Tardivel A, Schneider P, Essani K, McFadden G\", TITLE = \"A secreted high-affinity inhibitor of human TNF from Tanapox virus.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 100:4831-6 (2003)\", \"DOI:10.1073/pnas.0737244100\")), list(REFERENCE = \"PMID:18723002\", AUTHORS = \"Sciortino MT, Medici MA, Marino-Merlo F, Zaccaria D, Giuffre-Cuculletto M, Venuti A, Grelli S, Bramanti P, Mastino A\", TITLE = \"Involvement of gD/HVEM interaction in NF-kB-dependent inhibition of apoptosis by HSV-1 gD.\", JOURNAL = c(\"Biochem Pharmacol 76:1522-32 (2008)\", \"DOI:10.1016/j.bcp.2008.07.030\")), list(REFERENCE = \"PMID:23498957\", AUTHORS = \"Smith W, Tomasec P, Aicheler R, Loewendorf A, Nemcovicova I, Wang EC, Stanton RJ, Macauley M, Norris P, Willen L, Ruckova E, Nomoto A, Schneider P, Hahn G, Zajonc DM, Ware CF, Wilkinson GW, Benedict CA\", TITLE = \"Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses.\", JOURNAL = c(\"Cell Host Microbe 13:324-35 (2013)\", \"DOI:10.1016/j.chom.2013.02.003\"))', 'map04061', 'Viral protein interaction with cytokine and cytokine receptor', 'Viruses have evolved diverse mechanisms to evade detection and destruction by the immune system, including copying and repurposing host cytokine and cytokine receptor genes. Viral cytokines and cytokine receptors, together with a group of structurally unique, soluble, cytokine-binding or cytokine receptor-binding proteins, represent the three major molecular strategies for subversion and modulation of the host cytokine networks mainly in large DNA viruses. Viral cytokines and cytokine receptor homologs, including other binding proteins, may activate or inhibit cytokine signaling and possibly affect different aspects of immunity.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (233, '04062', 'Chemokine signaling pathway', 'c(\"Inflammatory immune response requires the recruitment of leukocytes to the site of inflammation upon foreign insult. Chemokines are small chemoattractant peptides that provide directional cues for the cell trafficking and thus are vital for protective host response. In addition, chemokines regulate plethora of biological processes of hematopoietic cells to lead cellular activation, differentiation and survival.\", \"The chemokine signal is transduced by chemokine receptors (G-protein coupled receptors) expressed on the immune cells. After receptor activation, the alpha- and beta-gamma-subunits of G protein dissociate to activate diverse downstream pathways resulting in cellular polarization and actin reorganization. Various members of small GTPases are involved in this process. Induction of nitric oxide and production of reactive oxygen species are as well regulated by chemokine signal via calcium mobilization and diacylglycerol production.\"\n)', 'Organismal Systems; Immune system', 'Chemokine signaling pathway', 'Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID), Incontinentia pigmenti, Cocoon syndrome, Growth hormone insensitivity with immunodeficiency, Chronic mucocutaneous candidiasis', 'GO: 0070098', 'ko04062', 'list(REFERENCE = \"PMID:12495636\", AUTHORS = \"Wong MM, Fish EN\", TITLE = \"Chemokines: attractive mediators of the immune response.\", JOURNAL = c(\"Semin Immunol 15:5-14 (2003)\", \"DOI:10.1016/S1044-5323(02)00123-9\")), list(REFERENCE = \"PMID:11872087\", AUTHORS = \"Curnock AP, Logan MK, Ward SG\", TITLE = \"Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.\", JOURNAL = c(\"Immunology 105:125-36 (2002)\", \"DOI:10.1046/j.1365-2567.2002.01345.x\")), list(REFERENCE = \"PMID:12069927\", AUTHORS = \"Olson TS, Ley K\", TITLE = \"Chemokines and chemokine receptors in leukocyte trafficking.\", JOURNAL = c(\"Am J Physiol Regul Integr Comp Physiol 283:R7-28 (2002)\", \"DOI:10.1152/ajpregu.00738.2001\")), list(REFERENCE = \"PMID:17169327\", AUTHORS = \"Busillo JM, Benovic JL\", TITLE = \"Regulation of CXCR4 signaling.\", JOURNAL = c(\"Biochim Biophys Acta 1768:952-63 (2007)\", \"DOI:10.1016/j.bbamem.2006.11.002\")), list(REFERENCE = \"PMID:11244042\", AUTHORS = \"Mellado M, Rodriguez-Frade JM, Manes S, Martinez-A C\", TITLE = \"Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation.\", JOURNAL = c(\"Annu Rev Immunol 19:397-421 (2001)\", \"DOI:10.1146/annurev.immunol.19.1.397\")), list(REFERENCE = \"PMID:8576262\", AUTHORS = \"Knall C, Young S, Nick JA, Buhl AM, Worthen GS, Johnson GL\", TITLE = \"Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils.\", JOURNAL = c(\"J Biol Chem 271:2832-8 (1996)\", \"DOI:10.1074/jbc.271.5.2832\")), list(REFERENCE = \"PMID:17537990\", AUTHORS = \"Patrussi L, Ulivieri C, Lucherini OM, Paccani SR, Gamberucci A, Lanfrancone L, Pelicci PG, Baldari CT\", TITLE = \"p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells.\", JOURNAL = c(\"Blood 110:1730-8 (2007)\", \"DOI:10.1182/blood-2007-01-068411\")), list(REFERENCE = \"PMID:18662984\", AUTHORS = \"Sai J, Raman D, Liu Y, Wikswo J, Richmond A\", TITLE = \"Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis.\", JOURNAL = c(\"J Biol Chem 283:26538-47 (2008)\", \"DOI:10.1074/jbc.M805611200\")), list(REFERENCE = \"PMID:10852130\", AUTHORS = \"Hauck CR, Klingbeil CK, Schlaepfer DD\", TITLE = \"Focal adhesion kinase functions as a receptor-proximal signaling component required for directed cell migration.\", JOURNAL = c(\"Immunol Res 21:293-303 (2000)\", \"DOI:10.1385/IR:21:2-3:293\")), list(REFERENCE = \"PMID:14625285\", AUTHORS = \"Chandrasekar B, Bysani S, Mummidi S\", TITLE = \"CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation.\", JOURNAL = c(\"J Biol Chem 279:3188-96 (2004)\", \"DOI:10.1074/jbc.M311660200\")), list(REFERENCE = \"PMID:17371236\", AUTHORS = \"Smith L, Webb A, Ward SG\", TITLE = \"T-lymphocyte navigation and migration: beyond the PI3K paradigm.\", JOURNAL = c(\"Biochem Soc Trans 35:193-8 (2007)\", \"DOI:10.1042/BST0350193\")), list(REFERENCE = \"PMID:16144840\", AUTHORS = \"Huttenrauch F, Pollok-Kopp B, Oppermann M\", TITLE = \"G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers.\", JOURNAL = c(\"J Biol Chem 280:37503-15 (2005)\", \"DOI:10.1074/jbc.M500535200\")), list(REFERENCE = \"PMID:18711432\", AUTHORS = \"Thelen M, Stein JV\", TITLE = \"How chemokines invite leukocytes to dance.\", JOURNAL = c(\"Nat Immunol 9:953-9 (2008)\", \"DOI:10.1038/ni.f.207\")), list(REFERENCE = \"PMID:19159344\", AUTHORS = \"Ward SG, Marelli-Berg FM\", TITLE = \"Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation.\", JOURNAL = c(\"Biochem J 418:13-27 (2009)\", \"DOI:10.1042/BJ20081969\")), list(REFERENCE = \"PMID:15803148\", AUTHORS = \"Schwartzberg PL, Finkelstein LD, Readinger JA\", TITLE = \"TEC-family kinases: regulators of T-helper-cell differentiation.\", JOURNAL = c(\"Nat Rev Immunol 5:284-95 (2005)\", \"DOI:10.1038/nri1591\")), list(REFERENCE = \"PMID:15771581\", AUTHORS = \"Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL.\", TITLE = \"Tec family kinases in T lymphocyte development and function.\", JOURNAL = c(\"Annu Rev Immunol 23:549-600 (2005)\", \"DOI:10.1146/annurev.immunol.22.012703.104743\")), list(REFERENCE = \"PMID:17496928\", AUTHORS = \"Ticchioni M, Essafi M, Jeandel PY, Davi F, Cassuto JP, Deckert M, Bernard A\", TITLE = \"Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a.\", JOURNAL = c(\"Oncogene 26:7081-91 (2007)\", \"DOI:10.1038/sj.onc.1210519\")), list(REFERENCE = \"PMID:9765254\", AUTHORS = \"Korchak HM, Rossi MW, Kilpatrick LE\", TITLE = \"Selective role for beta-protein kinase C in signaling for O-2 generation but not degranulation or adherence in differentiated HL60 cells.\", JOURNAL = c(\"J Biol Chem 273:27292-9 (1998)\", \"DOI:10.1074/jbc.273.42.27292\")), list(REFERENCE = \"PMID:15046611\", AUTHORS = \"Johnson Z, Power CA, Weiss C, Rintelen F, Ji H, Ruckle T, Camps M, Wells TN, Schwarz MK, Proudfoot AE, Rommel C\", TITLE = \"Chemokine inhibition--why, when, where, which and how?\", JOURNAL = c(\"Biochem Soc Trans 32:366-77 (2004)\", \"DOI:10.1042/bst0320366\")), list(REFERENCE = \"PMID:12051620\", AUTHORS = \"Zhelev DV, Alteraifi A\", TITLE = \"Signaling in the motility responses of the human neutrophil.\", JOURNAL = c(\"Ann Biomed Eng 30:356-70 (2002)\", \"DOI:10.1114/1.1477446\")), list(REFERENCE = \"PMID:17675482\", AUTHORS = \"Bach TL, Chen QM, Kerr WT, Wang Y, Lian L, Choi JK, Wu D, Kazanietz MG, Koretzky GA, Zigmond S, Abrams CS\", TITLE = \"Phospholipase cbeta is critical for T cell chemotaxis.\", JOURNAL = c(\"J Immunol 179:2223-7 (2007)\", \"DOI:10.4049/jimmunol.179.4.2223\")), list(REFERENCE = \"PMID:14607270\", AUTHORS = \"Hornstein I, Alcover A, Katzav S\", TITLE = \"Vav proteins, masters of the world of cytoskeleton organization.\", JOURNAL = c(\"Cell Signal 16:1-11 (2004)\", \"DOI:10.1016/S0898-6568(03)00110-4\"))', 'map04062', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (234, '04064', 'NF-kappa B signaling pathway', 'Nuclear factor-kappa B (NF-kappa B) is the generic name of a family of transcription factors that function as dimers and regulate genes involved in immunity, inflammation and cell survival. There are several pathways leading to NF-kappa B-activation. The canonical pathway is induced by tumour necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1) or byproducts of bacterial and viral infections. This pathway relies on IKK- mediated IkappaB-alpha phosphorylation on Ser32 and 36, leading to its degradation, which allows the p50/p65 NF-kappa B dimer to enter the nucleus and activate gene transcription. Atypical pathways are IKK-independent and rely on phosphorylation of IkappaB-alpha on Tyr42 or on Ser residues in IkappaB-alpha PEST domain. The non-canonical pathway is triggered by particular members of the TNFR superfamily, such as lymphotoxin-beta (LT-beta) or BAFF. It involves NIK and IKK-alpha-mediated p100 phosphorylation and processing to p52, resulting in nuclear translocation of p52/RelB heterodimers.', 'Environmental Information Processing; Signal transduction', 'NF-kappa B signaling pathway', 'Autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation, Familial expansile osteolysis', 'ko04064', 'list(REFERENCE = \"PMID:21772278\", AUTHORS = \"Oeckinghaus A, Hayden MS, Ghosh S\", TITLE = \"Crosstalk in NF-kappaB signaling pathways.\", JOURNAL = c(\"Nat Immunol 12:695-708 (2011)\", \"DOI:10.1038/ni.2065\")), list(REFERENCE = \"PMID:19203223\", AUTHORS = \"Gloire G, Piette J\", TITLE = \"Redox regulation of nuclear post-translational modifications during NF-kappaB activation.\", JOURNAL = c(\"Antioxid Redox Signal 11:2209-22 (2009)\", \"DOI:10.1089/ARS.2009.2463\")), list(REFERENCE = \"PMID:17183360\", AUTHORS = \"Perkins ND\", TITLE = \"Integrating cell-signalling pathways with NF-kappaB and IKK function.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 8:49-62 (2007)\", \"DOI:10.1038/nrm2083\")), list(REFERENCE = \"PMID:16264088\", AUTHORS = \"Lindstrom TM, Bennett PR\", TITLE = \"The role of nuclear factor kappa B in human labour.\", JOURNAL = c(\"Reproduction 130:569-81 (2005)\", \"DOI:10.1530/rep.1.00197\")), list(REFERENCE = \"PMID:22017430\", AUTHORS = \"Razani B, Reichardt AD, Cheng G\", TITLE = \"Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives.\", JOURNAL = c(\"Immunol Rev 244:44-54 (2011)\", \"DOI:10.1111/j.1600-065X.2011.01059.x\")), list(REFERENCE = \"PMID:21173796\", AUTHORS = \"Sun SC\", TITLE = \"Non-canonical NF-kappaB signaling pathway.\", JOURNAL = c(\"Cell Res 21:71-85 (2011)\", \"DOI:10.1038/cr.2010.177\")), list(REFERENCE = \"PMID:17431096\", AUTHORS = \"Neumann M, Naumann M\", TITLE = \"Beyond IkappaBs: alternative regulation of NF-kappaB activity.\", JOURNAL = c(\"FASEB J 21:2642-54 (2007)\", \"DOI:10.1096/fj.06-7615rev\")), list(REFERENCE = \"PMID:22119011\", AUTHORS = \"Verhelst K, Carpentier I, Beyaert R\", TITLE = \"Regulation of TNF-induced NF-kappaB activation by different cytoplasmic ubiquitination events.\", JOURNAL = c(\"Cytokine Growth Factor Rev 22:277-86 (2011)\", \"DOI:10.1016/j.cytogfr.2011.11.002\")), list(REFERENCE = \"PMID:22017435\", AUTHORS = \"Rickert RC, Jellusova J, Miletic AV\", TITLE = \"Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.\", JOURNAL = c(\"Immunol Rev 244:115-33 (2011)\", \"DOI:10.1111/j.1600-065X.2011.01067.x\")), list(REFERENCE = \"PMID:21232019\", AUTHORS = \"Naude PJ, den Boer JA, Luiten PG, Eisel UL\", TITLE = \"Tumor necrosis factor receptor cross-talk.\", JOURNAL = c(\"FEBS J 278:888-98 (2011)\", \"DOI:10.1111/j.1742-4658.2011.08017.x\")), list(REFERENCE = \"PMID:16984817\", AUTHORS = \"Grivennikov SI, Kuprash DV, Liu ZG, Nedospasov SA\", TITLE = \"Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms.\", JOURNAL = c(\"Int Rev Cytol 252:129-61 (2006)\", \"DOI:10.1016/S0074-7696(06)52002-9\")), list(REFERENCE = \"PMID:16356770\", AUTHORS = \"Wada T, Nakashima T, Hiroshi N, Penninger JM\", TITLE = \"RANKL-RANK signaling in osteoclastogenesis and bone disease.\", JOURNAL = c(\"Trends Mol Med 12:17-25 (2006)\", \"DOI:10.1016/j.molmed.2005.11.007\")), list(REFERENCE = \"PMID:17098202\", AUTHORS = \"Schulze-Luehrmann J, Ghosh S\", TITLE = \"Antigen-receptor signaling to nuclear factor kappa B.\", JOURNAL = c(\"Immunity 25:701-15 (2006)\", \"DOI:10.1016/j.immuni.2006.10.010\")), list(REFERENCE = \"PMID:15134788\", AUTHORS = \"Weil R, Israel A\", TITLE = \"T-cell-receptor- and B-cell-receptor-mediated activation of NF-kappaB in lymphocytes.\", JOURNAL = c(\"Curr Opin Immunol 16:374-81 (2004)\", \"DOI:10.1016/j.coi.2004.03.003\")), list(REFERENCE = \"PMID:15905862\", AUTHORS = \"Siebenlist U, Brown K, Claudio E\", TITLE = \"Control of lymphocyte development by nuclear factor-kappaB.\", JOURNAL = c(\"Nat Rev Immunol 5:435-45 (2005)\", \"DOI:10.1038/nri1629\")), list(REFERENCE = \"PMID:14657271\", AUTHORS = \"Lucas PC, McAllister-Lucas LM, Nunez G\", TITLE = \"NF-kappaB signaling in lymphocytes: a new cast of characters.\", JOURNAL = c(\"J Cell Sci 117:31-9 (2004)\", \"DOI:10.1242/jcs.00904\")), list(REFERENCE = \"PMID:19726767\", AUTHORS = \"Khan WN\", TITLE = \"B cell receptor and BAFF receptor signaling regulation of B cell homeostasis.\", JOURNAL = c(\"J Immunol 183:3561-7 (2009)\", \"DOI:10.4049/jimmunol.0800933\")), list(REFERENCE = \"PMID:19302050\", AUTHORS = \"Vallabhapurapu S, Karin M\", TITLE = \"Regulation and function of NF-kappaB transcription factors in the immune system.\", JOURNAL = c(\"Annu Rev Immunol 27:693-733 (2009)\", \"DOI:10.1146/annurev.immunol.021908.132641\")), list(REFERENCE = \"PMID:17047224\", AUTHORS = \"Hacker H, Karin M\", TITLE = \"Regulation and function of IKK and IKK-related kinases.\", JOURNAL = c(\"Sci STKE 2006:re13 (2006)\", \"DOI:10.1126/stke.3572006re13\")), list(REFERENCE = \"PMID:21872579\", AUTHORS = \"Sabatel H, Pirlot C, Piette J, Habraken Y\", TITLE = \"Importance of PIKKs in NF-kappaB activation by genotoxic stress.\", JOURNAL = c(\"Biochem Pharmacol 82:1371-83 (2011)\", \"DOI:10.1016/j.bcp.2011.07.105\")), list(REFERENCE = \"PMID:21187855\", AUTHORS = \"Miyamoto S\", TITLE = \"Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage.\", JOURNAL = c(\"Cell Res 21:116-30 (2011)\", \"DOI:10.1038/cr.2010.179\")), list(REFERENCE = \"PMID:18832076\", AUTHORS = \"Brzoska K, Szumiel I\", TITLE = \"Signalling loops and linear pathways: NF-kappaB activation in response to genotoxic stress.\", JOURNAL = c(\"Mutagenesis 24:1-8 (2009)\", \"DOI:10.1093/mutage/gen056\")), list(REFERENCE = \"PMID:17607554\", AUTHORS = \"Wu ZH, Miyamoto S\", TITLE = \"Many faces of NF-kappaB signaling induced by genotoxic stress.\", JOURNAL = c(\"J Mol Med (Berl) 85:1187-202 (2007)\", \"DOI:10.1007/s00109-007-0227-9\")), list(REFERENCE = \"PMID:22390971\", AUTHORS = \"Maelfait J, Beyaert R\", TITLE = \"Emerging role of ubiquitination in antiviral RIG-I signaling.\", JOURNAL = c(\"Microbiol Mol Biol Rev 76:33-45 (2012)\", \"DOI:10.1128/MMBR.05012-11\")), list(REFERENCE = \"PMID:18613837\", AUTHORS = \"Ware CF\", TITLE = \"Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.\", JOURNAL = c(\"Immunol Rev 223:186-201 (2008)\", \"DOI:10.1111/j.1600-065X.2008.00629.x\")), list(REFERENCE = \"PMID:15546385\", AUTHORS = \"Schneider K, Potter KG, Ware CF\", TITLE = \"Lymphotoxin and LIGHT signaling pathways and target genes.\", JOURNAL = c(\"Immunol Rev 202:49-66 (2004)\", \"DOI:10.1111/j.0105-2896.2004.00206.x\")), list(REFERENCE = \"PMID:22152226\", AUTHORS = \"Remouchamps C, Boutaffala L, Ganeff C, Dejardin E\", TITLE = \"Biology and signal transduction pathways of the Lymphotoxin-alphabeta/LTbetaR system.\", JOURNAL = c(\"Cytokine Growth Factor Rev 22:301-10 (2011)\", \"DOI:10.1016/j.cytogfr.2011.11.007\")), list(REFERENCE = \"PMID:21135871\", AUTHORS = \"Liu S, Chen ZJ\", TITLE = \"Expanding role of ubiquitination in NF-kappaB signaling.\", JOURNAL = c(\"Cell Res 21:6-21 (2011)\", \"DOI:10.1038/cr.2010.170\")), list(REFERENCE = \"PMID:19489733\", AUTHORS = \"Skaug B, Jiang X, Chen ZJ\", TITLE = \"The role of ubiquitin in NF-kappaB regulatory pathways.\", JOURNAL = c(\"Annu Rev Biochem 78:769-96 (2009)\", \"DOI:10.1146/annurev.biochem.78.070907.102750\")), list(REFERENCE = \"PMID:20300215\", AUTHORS = \"Wertz IE, Dixit VM\", TITLE = \"Signaling to NF-kappaB: regulation by ubiquitination.\", JOURNAL = c(\"Cold Spring Harb Perspect Biol 2:a003350 (2010)\", \"DOI:10.1101/cshperspect.a003350\")), list(REFERENCE = \"PMID:11875461\", AUTHORS = \"Karin M, Lin A\", TITLE = \"NF-kappaB at the crossroads of life and death.\", JOURNAL = c(\"Nat Immunol 3:221-7 (2002)\", \"DOI:10.1038/ni0302-221\")), list(REFERENCE = \"PMID:12654254\", AUTHORS = \"Lin A, Karin M\", TITLE = \"NF-kappaB in cancer: a marked target.\", JOURNAL = c(\"Semin Cancer Biol 13:107-14 (2003)\", \"DOI:10.1016/S1044-579X(02)00128-1\")), list(REFERENCE = \"PMID:16251197\", AUTHORS = \"Morlon A, Munnich A, Smahi A\", TITLE = \"TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.\", JOURNAL = c(\"Hum Mol Genet 14:3751-7 (2005)\", \"DOI:10.1093/hmg/ddi405\")), list(REFERENCE = \"PMID:24070496\", AUTHORS = \"Sadier A, Viriot L, Pantalacci S, Laudet V\", TITLE = \"The ectodysplasin pathway: from diseases to adaptations.\", JOURNAL = c(\"Trends Genet 30:24-31 (2014)\", \"DOI:10.1016/j.tig.2013.08.006\")), list(REFERENCE = \"PMID:26260321\", AUTHORS = \"Verhelst K, Gardam S, Borghi A, Kreike M, Carpentier I, Beyaert R\", TITLE = \"XEDAR activates the non-canonical NF-kappaB pathway.\", JOURNAL = c(\"Biochem Biophys Res Commun 465:275-80 (2015)\", \"DOI:10.1016/j.bbrc.2015.08.019\")), list(REFERENCE = \"PMID:27508514\", AUTHORS = \"McDaniel DK, Eden K, Ringel VM, Allen IC\", TITLE = \"Emerging Roles for Noncanonical NF-kappaB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.\", JOURNAL = c(\"Inflamm Bowel Dis 22:2265-79 (2016)\", \"DOI:10.1097/MIB.0000000000000858\")), list(REFERENCE = \"PMID:12787560\", AUTHORS = \"Mikkola ML, Thesleff I\", TITLE = \"Ectodysplasin signaling in development.\", JOURNAL = c(\"Cytokine Growth Factor Rev 14:211-24 (2003)\", \"DOI:10.1016/S1359-6101(03)00020-0\"))', 'map04064', 'NF-kappa B signaling pathway', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (235, '04066', 'HIF-1 signaling pathway', 'Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that functions as a master regulator of oxygen homeostasis. It consists of two subunits: an inducibly-expressed HIF-1alpha subunit and a constitutively-expressed HIF-1beta subunit. Under normoxia, HIF-1 alpha undergoes hydroxylation at specific prolyl residues which leads to an immediate ubiquitination and subsequent proteasomal degradation of the subunit. In contrast, under hypoxia, HIF-1 alpha subunit becomes stable and interacts with coactivators such as p300/CBP to modulate its transcriptional activity. Eventually, HIF-1 acts as a master regulator of numerous hypoxia-inducible genes under hypoxic conditions. The target genes of HIF-1 encode proteins that increase O2 delivery and mediate adaptive responses to O2 deprivation. Despite its name, HIF-1 is induced not only in response to reduced oxygen availability but also by other stimulants, such as nitric oxide, or various growth factors.', 'Environmental Information Processing; Signal transduction', 'HIF-1 signaling pathway', 'Diabetic retinopathy, Malignant paraganglioma, Avascular necrosis of femoral head, Glucocorticoid-induced osteonecrosis, Cutaneous and mucosal venous malformation', 'ko04066', 'list(REFERENCE = \"PMID:20836033\", AUTHORS = \"Semenza GL\", TITLE = \"Oxygen homeostasis.\", JOURNAL = c(\"Wiley Interdiscip Rev Syst Biol Med 2:336-61 (2010)\", \"DOI:10.1002/wsbm.69\")), list(REFERENCE = \"PMID:17955264\", AUTHORS = \"Mole DR, Ratcliffe PJ\", TITLE = \"Cellular oxygen sensing in health and disease.\", JOURNAL = c(\"Pediatr Nephrol 23:681-94 (2008)\", \"DOI:10.1007/s00467-007-0632-x\")), list(REFERENCE = \"PMID:18498744\", AUTHORS = \"Kaelin WG Jr, Ratcliffe PJ\", TITLE = \"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.\", JOURNAL = c(\"Mol Cell 30:393-402 (2008)\", \"DOI:10.1016/j.molcel.2008.04.009\")), list(REFERENCE = \"PMID:22205687\", AUTHORS = \"Palazon A, Aragones J, Morales-Kastresana A, de Landazuri MO, Melero I\", TITLE = \"Molecular pathways: hypoxia response in immune cells fighting or promoting cancer.\", JOURNAL = c(\"Clin Cancer Res 18:1207-13 (2012)\", \"DOI:10.1158/1078-0432.CCR-11-1591\")), list(REFERENCE = \"PMID:20965423\", AUTHORS = \"Majmundar AJ, Wong WJ, Simon MC\", TITLE = \"Hypoxia-inducible factors and the response to hypoxic stress.\", JOURNAL = c(\"Mol Cell 40:294-309 (2010)\", \"DOI:10.1016/j.molcel.2010.09.022\")), list(REFERENCE = \"PMID:22562152\", AUTHORS = \"Greer SN, Metcalf JL, Wang Y, Ohh M\", TITLE = \"The updated biology of hypoxia-inducible factor.\", JOURNAL = c(\"EMBO J 31:2448-60 (2012)\", \"DOI:10.1038/emboj.2012.125\")), list(REFERENCE = \"PMID:15448722\", AUTHORS = \"Zagorska A, Dulak J\", TITLE = \"HIF-1: the knowns and unknowns of hypoxia sensing.\", JOURNAL = \"Acta Biochim Pol 51:563-85 (2004)\"), list(REFERENCE = \"PMID:19364912\", AUTHORS = \"Semenza GL\", TITLE = \"Regulation of oxygen homeostasis by hypoxia-inducible factor 1.\", JOURNAL = c(\"Physiology (Bethesda) 24:97-106 (2009)\", \"DOI:10.1152/physiol.00045.2008\")), list(REFERENCE = \"PMID:16234508\", AUTHORS = \"Wenger RH, Stiehl DP, Camenisch G\", TITLE = \"Integration of oxygen signaling at the consensus HRE.\", JOURNAL = c(\"Sci STKE 2005:re12 (2005)\", \"DOI:10.1126/stke.3062005re12\")), list(REFERENCE = \"PMID:15031665\", AUTHORS = \"Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW\", TITLE = \"Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.\", JOURNAL = c(\"Exp Mol Med 36:1-12 (2004)\", \"DOI:10.1038/emm.2004.1\")), list(REFERENCE = \"PMID:18259201\", AUTHORS = \"Weidemann A, Johnson RS\", TITLE = \"Biology of HIF-1alpha.\", JOURNAL = c(\"Cell Death Differ 15:621-7 (2008)\", \"DOI:10.1038/cdd.2008.12\")), list(REFERENCE = \"PMID:11902584\", AUTHORS = \"Harris AL\", TITLE = \"Hypoxia--a key regulatory factor in tumour growth.\", JOURNAL = c(\"Nat Rev Cancer 2:38-47 (2002)\", \"DOI:10.1038/nrc704\")), list(REFERENCE = \"PMID:19147540\", AUTHORS = \"Knaup KX, Jozefowski K, Schmidt R, Bernhardt WM, Weidemann A, Juergensen JS, Warnecke C, Eckardt KU, Wiesener MS\", TITLE = \"Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability.\", JOURNAL = c(\"Mol Cancer Res 7:88-98 (2009)\", \"DOI:10.1158/1541-7786.MCR-08-0288\")), list(REFERENCE = \"PMID:18505681\", AUTHORS = \"Kaluz S, Kaluzova M, Stanbridge EJ\", TITLE = \"Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element.\", JOURNAL = c(\"Clin Chim Acta 395:6-13 (2008)\", \"DOI:10.1016/j.cca.2008.05.002\")), list(REFERENCE = \"PMID:20679415\", AUTHORS = \"Cadenas S, Aragones J, Landazuri MO\", TITLE = \"Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease.\", JOURNAL = c(\"Cardiovasc Res 88:219-28 (2010)\", \"DOI:10.1093/cvr/cvq256\")), list(REFERENCE = \"PMID:19861159\", AUTHORS = \"Berchner-Pfannschmidt U, Tug S, Kirsch M, Fandrey J\", TITLE = \"Oxygen-sensing under the influence of nitric oxide.\", JOURNAL = c(\"Cell Signal 22:349-56 (2010)\", \"DOI:10.1016/j.cellsig.2009.10.004\"))', 'map04066', 'HIF-1 signaling pathway', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (236, '04068', 'FoxO signaling pathway', 'The forkhead box O (FOXO) family of transcription factors regulates the expression of genes in cellular physiological events including apoptosis, cell-cycle control, glucose metabolism, oxidative stress resistance, and longevity. A central regulatory mechanism of FOXO proteins is phosphorylation by the serine-threonine kinase Akt/protein kinase B (Akt/PKB), downstream of phosphatidylinositol 3-kinase (PI3K), in response to insulin or several growth factors. Phosphorylation at three conserved residues results in the export of FOXO proteins from the nucleus to the cytoplasm, thereby decreasing expression of FOXO target genes. In contrast, the stress-activated c-Jun N-terminal kinase (JNK) and the energy sensing AMP-activated protein kinase (AMPK), upon oxidative and nutrient stress stimuli phosphorylate and activate FoxOs. Aside from PKB, JNK and AMPK, FOXOs are regulated by multiple players through several post-translational modifications, including phosphorylation, but also acetylation, methylation and ubiquitylation.', 'Environmental Information Processing; Signal transduction', 'FoxO signaling pathway', 'Rienhoff syndrome, Diabetic nephropathy', 'GO: 0009267', 'ko04068', 'list(REFERENCE = \"PMID:17470511\", AUTHORS = \"Glauser DA, Schlegel W\", TITLE = \"The emerging role of FOXO transcription factors in pancreatic beta cells.\", JOURNAL = c(\"J Endocrinol 193:195-207 (2007)\", \"DOI:10.1677/JOE-06-0191\")), list(REFERENCE = \"PMID:17522590\", AUTHORS = \"van der Horst A, Burgering BM\", TITLE = \"Stressing the role of FoxO proteins in lifespan and disease.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 8:440-50 (2007)\", \"DOI:10.1038/nrm2190\")), list(REFERENCE = \"PMID:21440011\", AUTHORS = \"Zhang X, Tang N, Hadden TJ, Rishi AK\", TITLE = \"Akt, FoxO and regulation of apoptosis.\", JOURNAL = c(\"Biochim Biophys Acta 1813:1978-86 (2011)\", \"DOI:10.1016/j.bbamcr.2011.03.010\")), list(REFERENCE = \"PMID:23325358\", AUTHORS = \"Eijkelenboom A, Burgering BM\", TITLE = \"FOXOs: signalling integrators for homeostasis maintenance.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 14:83-97 (2013)\", \"DOI:10.1038/nrm3507\")), list(REFERENCE = \"PMID:17569704\", AUTHORS = \"Daitoku H, Fukamizu A\", TITLE = \"FOXO transcription factors in the regulatory networks of longevity.\", JOURNAL = c(\"J Biochem 141:769-74 (2007)\", \"DOI:10.1093/jb/mvm104\")), list(REFERENCE = \"PMID:19701188\", AUTHORS = \"Hedrick SM\", TITLE = \"The cunning little vixen: Foxo and the cycle of life and death.\", JOURNAL = c(\"Nat Immunol 10:1057-63 (2009)\", \"DOI:10.1038/ni.1784\")), list(REFERENCE = \"PMID:15516968\", AUTHORS = \"Coffer PJ, Burgering BM\", TITLE = \"Forkhead-box transcription factors and their role in the immune system.\", JOURNAL = c(\"Nat Rev Immunol 4:889-99 (2004)\", \"DOI:10.1038/nri1488\")), list(REFERENCE = \"PMID:22902436\", AUTHORS = \"Ro SH, Liu D, Yeo H, Paik JH\", TITLE = \"FoxOs in neural stem cell fate decision.\", JOURNAL = c(\"Arch Biochem Biophys 534:55-63 (2013)\", \"DOI:10.1016/j.abb.2012.07.017\")), list(REFERENCE = \"PMID:18403263\", AUTHORS = \"Maiese K, Chong ZZ, Shang YC\", TITLE = \"OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.\", JOURNAL = c(\"Trends Mol Med 14:219-27 (2008)\", \"DOI:10.1016/j.molmed.2008.03.002\")), list(REFERENCE = \"PMID:23801966\", AUTHORS = \"Hagenbuchner J, Ausserlechner MJ\", TITLE = \"Mitochondria and FOXO3: breath or die.\", JOURNAL = c(\"Front Physiol 4:147 (2013)\", \"DOI:10.3389/fphys.2013.00147\")), list(REFERENCE = \"PMID:18045156\", AUTHORS = \"Maiese K, Chong ZZ, Shang YC\", TITLE = \"\\\"Sly as a FOXO\\\": new paths with Forkhead signaling in the brain.\", JOURNAL = c(\"Curr Neurovasc Res 4:295-302 (2007)\", \"DOI:10.2174/156720207782446306\")), list(REFERENCE = \"PMID:22761423\", AUTHORS = \"Oh HM, Yu CR, Dambuza I, Marrero B, Egwuagu CE\", TITLE = \"STAT3 protein interacts with Class O Forkhead transcription factors in the cytoplasm and regulates nuclear/cytoplasmic localization of FoxO1 and FoxO3a proteins in CD4(+) T cells.\", JOURNAL = c(\"J Biol Chem 287:30436-43 (2012)\", \"DOI:10.1074/jbc.M112.359661\")), list(REFERENCE = \"PMID:21238503\", AUTHORS = \"Huang H, Tindall DJ\", TITLE = \"Regulation of FOXO protein stability via ubiquitination and proteasome degradation.\", JOURNAL = c(\"Biochim Biophys Acta 1813:1961-4 (2011)\", \"DOI:10.1016/j.bbamcr.2011.01.007\")), list(REFERENCE = \"PMID:16288288\", AUTHORS = \"Greer EL, Brunet A\", TITLE = \"FOXO transcription factors at the interface between longevity and tumor suppression.\", JOURNAL = c(\"Oncogene 24:7410-25 (2005)\", \"DOI:10.1038/sj.onc.1209086\")), list(REFERENCE = \"PMID:15084259\", AUTHORS = \"Seoane J, Le HV, Shen L, Anderson SA, Massague J\", TITLE = \"Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.\", JOURNAL = c(\"Cell 117:211-23 (2004)\", \"DOI:10.1016/S0092-8674(04)00298-3\")), list(REFERENCE = \"PMID:18951090\", AUTHORS = \"Yamagata K, Daitoku H, Takahashi Y, Namiki K, Hisatake K, Kako K, Mukai H, Kasuya Y, Fukamizu A\", TITLE = \"Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt.\", JOURNAL = c(\"Mol Cell 32:221-31 (2008)\", \"DOI:10.1016/j.molcel.2008.09.013\")), list(REFERENCE = \"PMID:16964248\", AUTHORS = \"van der Horst A, de Vries-Smits AM, Brenkman AB, van Triest MH, van den Broek N, Colland F, Maurice MM, Burgering BM\", TITLE = \"FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP.\", JOURNAL = c(\"Nat Cell Biol 8:1064-73 (2006)\", \"DOI:10.1038/ncb1469\")), list(REFERENCE = \"PMID:21613825\", AUTHORS = \"Zhang Y, Gan B, Liu D, Paik JH\", TITLE = \"FoxO family members in cancer.\", JOURNAL = c(\"Cancer Biol Ther 12:253-9 (2011)\", \"DOI:10.4161/cbt.12.4.15954\")), list(REFERENCE = \"PMID:15005655\", AUTHORS = \"Van Der Heide LP, Hoekman MF, Smidt MP\", TITLE = \"The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.\", JOURNAL = c(\"Biochem J 380:297-309 (2004)\", \"DOI:10.1042/BJ20040167\"))', 'map04068', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (237, '04070', 'Phosphatidylinositol signaling system', 'Environmental Information Processing; Signal transduction', 'Phosphatidylinositol signaling system', 'Joubert syndrome, Lowe syndrome, Dent disease, Centronuclear myopathy, Fleck corneal dystrophy, VACTERL/VATER association, Nonsyndromic congenital nail disorder, Chondrodysplasia with joint dislocations, GPAPP type', 'ko04070', 'list(REFERENCE = \"PMID:19580826\", AUTHORS = \"Sasaki T, Takasuga S, Sasaki J, Kofuji S, Eguchi S, Yamazaki M, Suzuki A\", TITLE = \"Mammalian phosphoinositide kinases and phosphatases.\", JOURNAL = c(\"Prog Lipid Res 48:307-43 (2009)\", \"DOI:10.1016/j.plipres.2009.06.001\")), list(REFERENCE = \"PMID:19439500\", AUTHORS = \"Shears SB\", TITLE = \"Diphosphoinositol polyphosphates: metabolic messengers?\", JOURNAL = c(\"Mol Pharmacol 76:236-52 (2009)\", \"DOI:10.1124/mol.109.055897\"))', 'map04070', 'Phosphatidylinositol signaling system', 'Environmental Information Processing; Signal transduction', 531, 0, 248, 105, 128, 50, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (238, '04071', 'Sphingolipid signaling pathway', 'Sphingomyelin (SM) and its metabolic products are now known to have second messenger functions in a variety of cellular signaling pathways. Particularly, the sphingolipid metabolites, ceramide (Cer) and sphingosine-1-phosphate (S1P), have emerged as a new class of potent bioactive molecules. Ceramide can be generated de novo or by hydrolysis of membrane sphingomyelin by sphingomyelinase (SMase). Ceramide is subsequently metabolized by ceramidase to generate sphingosine (Sph) which in turn produces S1P through phosphorylation by sphingosine kinases 1 and 2 (SphK1, 2). Both ceramide and S1P regulate cellular responses to stress, with generally opposing effects. S1P functions as a growth and survival factor, acting as a ligand for a family of G protein-coupled receptors, whereas ceramide activates intrinsic and extrinsic apoptotic pathways through receptor-independent mechanisms.', 'Environmental Information Processing; Signal transduction', 'Sphingolipid signaling pathway', 'ko04071', 'list(REFERENCE = \"PMID:18216770\", AUTHORS = \"Hannun YA, Obeid LM\", TITLE = \"Principles of bioactive lipid signalling: lessons from sphingolipids.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 9:139-50 (2008)\", \"DOI:10.1038/nrm2329\")), list(REFERENCE = \"PMID:17161984\", AUTHORS = \"Taha TA, Mullen TD, Obeid LM\", TITLE = \"A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death.\", JOURNAL = c(\"Biochim Biophys Acta 1758:2027-36 (2006)\", \"DOI:10.1016/j.bbamem.2006.10.018\")), list(REFERENCE = \"PMID:23919551\", AUTHORS = \"Liu J, Beckman BS, Foroozesh M\", TITLE = \"A review of ceramide analogs as potential anticancer agents.\", JOURNAL = c(\"Future Med Chem 5:1405-21 (2013)\", \"DOI:10.4155/fmc.13.107\")), list(REFERENCE = \"PMID:18675379\", AUTHORS = \"Kono M, Allende ML, Proia RL\", TITLE = \"Sphingosine-1-phosphate regulation of mammalian development.\", JOURNAL = c(\"Biochim Biophys Acta 1781:435-41 (2008)\", \"DOI:10.1016/j.bbalip.2008.07.001\")), list(REFERENCE = \"PMID:18403224\", AUTHORS = \"Olivera A\", TITLE = \"Unraveling the complexities of sphingosine-1-phosphate function: the mast cell model.\", JOURNAL = c(\"Prostaglandins Other Lipid Mediat 86:1-11 (2008)\", \"DOI:10.1016/j.prostaglandins.2008.02.005\")), list(REFERENCE = \"PMID:25309325\", AUTHORS = \"Brunkhorst R, Vutukuri R, Pfeilschifter W\", TITLE = \"Fingolimod for the treatment of neurological diseases-state of play and future perspectives.\", JOURNAL = c(\"Front Cell Neurosci 8:283 (2014)\", \"DOI:10.3389/fncel.2014.00283\")), list(REFERENCE = \"PMID:15999095\", AUTHORS = \"Rosen H, Goetzl EJ\", TITLE = \"Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.\", JOURNAL = c(\"Nat Rev Immunol 5:560-70 (2005)\", \"DOI:10.1038/nri1650\")), list(REFERENCE = \"PMID:10880336\", AUTHORS = \"Pyne S, Pyne NJ\", TITLE = \"Sphingosine 1-phosphate signalling in mammalian cells.\", JOURNAL = c(\"Biochem J 349:385-402 (2000)\", \"DOI:10.1042/bj3490385\")), list(REFERENCE = \"PMID:21705677\", AUTHORS = \"Egom EE, Mohamed TM, Mamas MA, Shi Y, Liu W, Chirico D, Stringer SE, Ke Y, Shaheen M, Wang T, Chacko S, Wang X, Solaro RJ, Fath-Ordoubadi F, Cartwright EJ, Lei M\", TITLE = \"Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.\", JOURNAL = c(\"Am J Physiol Heart Circ Physiol 301:H1487-95 (2011)\", \"DOI:10.1152/ajpheart.01003.2010\")), list(REFERENCE = \"PMID:15451787\", AUTHORS = \"Jin ZQ, Goetzl EJ, Karliner JS\", TITLE = \"Sphingosine kinase activation mediates ischemic preconditioning in murine heart.\", JOURNAL = c(\"Circulation 110:1980-9 (2004)\", \"DOI:10.1161/01.CIR.0000143632.06471.93\")), list(REFERENCE = \"PMID:17913601\", AUTHORS = \"Melendez AJ\", TITLE = \"Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets.\", JOURNAL = c(\"Biochim Biophys Acta 1784:66-75 (2008)\", \"DOI:10.1016/j.bbapap.2007.07.013\")), list(REFERENCE = \"PMID:22654878\", AUTHORS = \"Halova I, Draberova L, Draber P\", TITLE = \"Mast cell chemotaxis - chemoattractants and signaling pathways.\", JOURNAL = c(\"Front Immunol 3:119 (2012)\", \"DOI:10.3389/fimmu.2012.00119\")), list(REFERENCE = \"PMID:17438574\", AUTHORS = \"Kraft S, Kinet JP\", TITLE = \"New developments in FcepsilonRI regulation, function and inhibition.\", JOURNAL = c(\"Nat Rev Immunol 7:365-78 (2007)\", \"DOI:10.1038/nri2072\")), list(REFERENCE = \"PMID:16470226\", AUTHORS = \"Gilfillan AM, Tkaczyk C.\", TITLE = \"Integrated signalling pathways for mast-cell activation.\", JOURNAL = c(\"Nat Rev Immunol 6:218-30 (2006)\", \"DOI:10.1038/nri1782\")), list(REFERENCE = \"PMID:11418646\", AUTHORS = \"Osawa Y, Banno Y, Nagaki M, Brenner DA, Naiki T, Nozawa Y, Nakashima S, Moriwaki H\", TITLE = \"TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes.\", JOURNAL = c(\"J Immunol 167:173-80 (2001)\", \"DOI:10.4049/jimmunol.167.1.173\")), list(REFERENCE = \"PMID:20534702\", AUTHORS = \"Montfort A, Martin PG, Levade T, Benoist H, Segui B\", TITLE = \"FAN (factor associated with neutral sphingomyelinase activation), a moonlighting protein in TNF-R1 signaling.\", JOURNAL = c(\"J Leukoc Biol 88:897-903 (2010)\", \"DOI:10.1189/jlb.0410188\")), list(REFERENCE = \"PMID:11001563\", AUTHORS = \"Chatterjee S\", TITLE = \"Neutral sphingomyelinase: past, present and future.\", JOURNAL = c(\"Chem Phys Lipids 102:79-96 (1999)\", \"DOI:10.1016/S0009-3084(99)00077-8\"))', 'map04071', 'Sphingolipid signaling pathway', 'Sphingomyelin (SM) and its metabolic products are now known to have second messenger functions in a variety of cellular signaling pathways. Particularly, the sphingolipid metabolites, ceramide (Cer) and sphingosine-1-phosphate (S1P), have emerged as a new class of potent bioactive molecules. Ceramide can be generated de novo or by hydrolysis of membrane sphingomyelin by sphingomyelinase (SMase). Ceramide is subsequently metabolized by ceramidase to generate sphingosine (Sph) which in turn produces S1P through phosphorylation by sphingosine kinases 1 and 2 (SphK1, 2). Both ceramide and S1P regulate cellular responses to stress, with generally opposing effects. S1P functions as a growth and survival factor, acting as a ligand for a family of G protein-coupled receptors, whereas ceramide activates intrinsic and extrinsic apoptotic pathways through receptor-independent mechanisms.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (239, '04072', 'Phospholipase D signaling pathway', 'Phospholipase D (PLD) is an essential enzyme responsible for the production of the lipid second messenger phosphatidic acid (PA), which is involved in fundamental cellular processes, including membrane trafficking, actin cytoskeleton remodeling, cell proliferation and cell survival. PLD activity can be stimulated by a large number of cell surface receptors and is elaborately regulated by intracellular factors, including protein kinase C isoforms, small GTPases of the ARF, Rho and Ras families and the phosphoinositide, phosphatidylinositol 4,5-bisphosphate (PIP2). The PLD-produced PA activates signaling proteins and acts as a node within the membrane to which signaling proteins translocate. Several signaling proteins, including Raf-1 and mTOR, directly bind PA to mediate translocation or activation, respectively.', 'Environmental Information Processing; Signal transduction', 'Phospholipase D signaling pathway', 'ko04072', 'list(REFERENCE = \"PMID:17245604\", AUTHORS = \"Oude Weernink PA, Lopez de Jesus M, Schmidt M\", TITLE = \"Phospholipase D signaling: orchestration by PIP2 and small GTPases.\", JOURNAL = c(\"Naunyn Schmiedebergs Arch Pharmacol 374:399-411 (2007)\", \"DOI:10.1007/s00210-007-0131-4\")), list(REFERENCE = \"PMID:21936578\", AUTHORS = \"Selvy PE, Lavieri RR, Lindsley CW, Brown HA\", TITLE = \"Phospholipase D: enzymology, functionality, and chemical modulation.\", JOURNAL = c(\"Chem Rev 111:6064-119 (2011)\", \"DOI:10.1021/cr200296t\")), list(REFERENCE = \"PMID:24995811\", AUTHORS = \"Brandenburg LO, Pufe T, Koch T\", TITLE = \"Role of phospholipase d in g-protein coupled receptor function.\", JOURNAL = c(\"Membranes (Basel) 4:302-18 (2014)\", \"DOI:10.3390/membranes4030302\")), list(REFERENCE = \"PMID:17054901\", AUTHORS = \"Oude Weernink PA, Han L, Jakobs KH, Schmidt M\", TITLE = \"Dynamic phospholipid signaling by G protein-coupled receptors.\", JOURNAL = c(\"Biochim Biophys Acta 1768:888-900 (2007)\", \"DOI:10.1016/j.bbamem.2006.09.012\")), list(REFERENCE = \"PMID:24990952\", AUTHORS = \"Foster DA, Salloum D, Menon D, Frias MA\", TITLE = \"Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).\", JOURNAL = c(\"J Biol Chem 289:22583-8 (2014)\", \"DOI:10.1074/jbc.R114.566091\")), list(REFERENCE = \"PMID:16143829\", AUTHORS = \"Jenkins GM, Frohman MA\", TITLE = \"Phospholipase D: a lipid centric review.\", JOURNAL = c(\"Cell Mol Life Sci 62:2305-16 (2005)\", \"DOI:10.1007/s00018-005-5195-z\")), list(REFERENCE = \"PMID:19815110\", AUTHORS = \"Metcalfe DD, Peavy RD, Gilfillan AM\", TITLE = \"Mechanisms of mast cell signaling in anaphylaxis.\", JOURNAL = c(\"J Allergy Clin Immunol 124:639-46; quiz 647-8 (2009)\", \"DOI:10.1016/j.jaci.2009.08.035\")), list(REFERENCE = \"PMID:18936782\", AUTHORS = \"Kalesnikoff J, Galli SJ\", TITLE = \"New developments in mast cell biology.\", JOURNAL = c(\"Nat Immunol 9:1215-23 (2008)\", \"DOI:10.1038/ni.f.216\")), list(REFERENCE = \"PMID:12217395\", AUTHORS = \"Cockcroft S, Way G, O\'Luanaigh N, Pardo R, Sarri E, Fensome A\", TITLE = \"Signalling role for ARF and phospholipase D in mast cell exocytosis stimulated by crosslinking of the high affinity FcepsilonR1 receptor.\", JOURNAL = c(\"Mol Immunol 38:1277-82 (2002)\", \"DOI:10.1016/S0161-5890(02)00075-5\")), list(REFERENCE = \"PMID:19410013\", AUTHORS = \"Lee CS, Kim KL, Jang JH, Choi YS, Suh PG, Ryu SH\", TITLE = \"The roles of phospholipase D in EGFR signaling.\", JOURNAL = c(\"Biochim Biophys Acta 1791:862-8 (2009)\", \"DOI:10.1016/j.bbalip.2009.04.007\")), list(REFERENCE = \"PMID:16622417\", AUTHORS = \"Lee CS, Kim IS, Park JB, Lee MN, Lee HY, Suh PG, Ryu SH\", TITLE = \"The phox homology domain of phospholipase D activates dynamin GTPase activity and accelerates EGFR endocytosis.\", JOURNAL = c(\"Nat Cell Biol 8:477-84 (2006)\", \"DOI:10.1038/ncb1401\")), list(REFERENCE = \"PMID:14769825\", AUTHORS = \"Kam Y, Exton JH\", TITLE = \"Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid.\", JOURNAL = c(\"FASEB J 18:311-9 (2004)\", \"DOI:10.1096/fj.03-0731com\")), list(REFERENCE = \"PMID:9310372\", AUTHORS = \"Kozawa O, Blume-Jensen P, Heldin CH, Ronnstrand L\", TITLE = \"Involvement of phosphatidylinositol 3\'-kinase in stem-cell-factor-induced phospholipase D activation and arachidonic acid release.\", JOURNAL = c(\"Eur J Biochem 248:149-55 (1997)\", \"DOI:10.1111/j.1432-1033.1997.00149.x\")), list(REFERENCE = \"PMID:11042115\", AUTHORS = \"Slaaby R, Du G, Altshuller YM, Frohman MA, Seedorf K\", TITLE = \"Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase C gamma and protein kinase C alpha signalling cascade.\", JOURNAL = c(\"Biochem J 351 Pt 3:613-9 (2000)\", \"DOI:10.1042/bj3510613\")), list(REFERENCE = \"PMID:11991733\", AUTHORS = \"Fahimi-Vahid M, Gosau N, Michalek C, Han L, Jakobs KH, Schmidt M, Roberts N, Avkiran M, Wieland T\", TITLE = \"Distinct signaling pathways mediate cardiomyocyte phospholipase D stimulation by endothelin-1 and thrombin.\", JOURNAL = c(\"J Mol Cell Cardiol 34:441-53 (2002)\", \"DOI:10.1006/jmcc.2002.1525\")), list(REFERENCE = \"PMID:10666319\", AUTHORS = \"Freeman EJ\", TITLE = \"The Ang II-induced growth of vascular smooth muscle cells involves a phospholipase D-mediated signaling mechanism.\", JOURNAL = c(\"Arch Biochem Biophys 374:363-70 (2000)\", \"DOI:10.1006/abbi.1999.1608\")), list(REFERENCE = \"PMID:9119890\", AUTHORS = \"Naro F, Donchenko V, Minotti S, Zolla L, Molinaro M, Adamo S\", TITLE = \"Role of phospholipase C and D signalling pathways in vasopressin-dependent myogenic differentiation.\", JOURNAL = c(\"J Cell Physiol 171:34-42 (1997)\", \"DOI:10.1002/(SICI)1097-4652(199704)171:1<34::AID-JCP5>3.0.CO;2-I\")), list(REFERENCE = \"PMID:10807766\", AUTHORS = \"Murdoch C, Finn A\", TITLE = \"Chemokine receptors and their role in inflammation and infectious diseases.\", JOURNAL = \"Blood 95:3032-43 (2000)\"), list(REFERENCE = \"PMID:8135758\", AUTHORS = \"Sugiyama T, Sakai T, Nozawa Y, Oka N\", TITLE = \"Prostaglandin F2 alpha-stimulated phospholipase D activation in osteoblast-like MC3T3-E1 cells: involvement in sustained 1,2-diacylglycerol production.\", JOURNAL = c(\"Biochem J 298 ( Pt 2):479-84 (1994)\", \"DOI:10.1042/bj2980479\")), list(REFERENCE = \"PMID:17210675\", AUTHORS = \"Foster DA\", TITLE = \"Regulation of mTOR by phosphatidic acid?\", JOURNAL = c(\"Cancer Res 67:1-4 (2007)\", \"DOI:10.1158/0008-5472.CAN-06-3016\")), list(REFERENCE = \"PMID:15310762\", AUTHORS = \"Delon C, Manifava M, Wood E, Thompson D, Krugmann S, Pyne S, Ktistakis NT\", TITLE = \"Sphingosine kinase 1 is an intracellular effector of phosphatidic acid.\", JOURNAL = c(\"J Biol Chem 279:44763-74 (2004)\", \"DOI:10.1074/jbc.M405771200\")), list(REFERENCE = \"PMID:23076158\", AUTHORS = \"Park JB, Lee CS, Jang JH, Ghim J, Kim YJ, You S, Hwang D, Suh PG, Ryu SH\", TITLE = \"Phospholipase signalling networks in cancer.\", JOURNAL = c(\"Nat Rev Cancer 12:782-92 (2012)\", \"DOI:10.1038/nrc3379\")), list(REFERENCE = \"PMID:19264150\", AUTHORS = \"Foster DA\", TITLE = \"Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.\", JOURNAL = c(\"Biochim Biophys Acta 1791:949-55 (2009)\", \"DOI:10.1016/j.bbalip.2009.02.009\"))', 'map04072', 'Phospholipase D signaling pathway', 'Phospholipase D (PLD) is an essential enzyme responsible for the production of the lipid second messenger phosphatidic acid (PA), which is involved in fundamental cellular processes, including membrane trafficking, actin cytoskeleton remodeling, cell proliferation and cell survival. PLD activity can be stimulated by a large number of cell surface receptors and is elaborately regulated by intracellular factors, including protein kinase C isoforms, small GTPases of the ARF, Rho and Ras families and the phosphoinositide, phosphatidylinositol 4,5-bisphosphate (PIP2). The PLD-produced PA activates signaling proteins and acts as a node within the membrane to which signaling proteins translocate. Several signaling proteins, including Raf-1 and mTOR, directly bind PA to mediate translocation or activation, respectively.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (240, '04075', 'Plant hormone signal transduction', 'Environmental Information Processing; Signal transduction', 'Plant hormone signal transduction', 'GO: 0009734 0009736 0009738 0009742 0009867 0009873 0010476', 'ko04075', 'list(REFERENCE = \"PMID:19686081\", AUTHORS = \"Chapman EJ, Estelle M\", TITLE = \"Mechanism of auxin-regulated gene expression in plants.\", JOURNAL = c(\"Annu Rev Genet 43:265-85 (2009)\", \"DOI:10.1146/annurev-genet-102108-134148\")), list(REFERENCE = \"PMID:16212609\", AUTHORS = \"Brenner WG, Romanov GA, Kollmer I, Burkle L, Schmulling T\", TITLE = \"Immediate-early and delayed cytokinin response genes of Arabidopsis thaliana identified by genome-wide expression profiling reveal novel cytokinin-sensitive processes and suggest cytokinin action through transcriptional cascades.\", JOURNAL = c(\"Plant J 44:314-33 (2005)\", \"DOI:10.1111/j.1365-313X.2005.02530.x\")), list(REFERENCE = \"PMID:16227453\", AUTHORS = \"Mason MG, Mathews DE, Argyros DA, Maxwell BB, Kieber JJ, Alonso JM, Ecker JR, Schaller GE\", TITLE = \"Multiple type-B response regulators mediate cytokinin signal transduction in Arabidopsis.\", JOURNAL = c(\"Plant Cell 17:3007-18 (2005)\", \"DOI:10.1105/tpc.105.035451\")), list(REFERENCE = \"PMID:19470587\", AUTHORS = \"Harberd NP, Belfield E, Yasumura Y\", TITLE = \"The angiosperm gibberellin-GID1-DELLA growth regulatory mechanism: how an \\\"inhibitor of an inhibitor\\\" enables flexible response to fluctuating environments.\", JOURNAL = c(\"Plant Cell 21:1328-39 (2009)\", \"DOI:10.1105/tpc.109.066969\")), list(REFERENCE = \"PMID:17965273\", AUTHORS = \"Hirano K, Nakajima M, Asano K, Nishiyama T, Sakakibara H, Kojima M, Katoh E, Xiang H, Tanahashi T, Hasebe M, Banks JA, Ashikari M, Kitano H, Ueguchi-Tanaka M, Matsuoka M\", TITLE = \"The GID1-mediated gibberellin perception mechanism is conserved in the Lycophyte Selaginella moellendorffii but not in the Bryophyte Physcomitrella patens.\", JOURNAL = c(\"Plant Cell 19:3058-79 (2007)\", \"DOI:10.1105/tpc.107.051524\")), list(REFERENCE = \"PMID:19805022\", AUTHORS = \"Umezawa T, Sugiyama N, Mizoguchi M, Hayashi S, Myouga F, Yamaguchi-Shinozaki K, Ishihama Y, Hirayama T, Shinozaki K\", TITLE = \"Type 2C protein phosphatases directly regulate abscisic acid-activated protein kinases in Arabidopsis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 106:17588-93 (2009)\", \"DOI:10.1073/pnas.0907095106\")), list(REFERENCE = \"PMID:15753119\", AUTHORS = \"Chen YF, Etheridge N, Schaller GE\", TITLE = \"Ethylene signal transduction.\", JOURNAL = c(\"Ann Bot 95:901-15 (2005)\", \"DOI:10.1093/aob/mci100\")), list(REFERENCE = \"PMID:12628921\", AUTHORS = \"Ouaked F, Rozhon W, Lecourieux D, Hirt H\", TITLE = \"A MAPK pathway mediates ethylene signaling in plants.\", JOURNAL = c(\"EMBO J 22:1282-8 (2003)\", \"DOI:10.1093/emboj/cdg131\")), list(REFERENCE = \"PMID:20192752\", AUTHORS = \"Kim TW, Wang ZY\", TITLE = \"Brassinosteroid signal transduction from receptor kinases to transcription factors.\", JOURNAL = c(\"Annu Rev Plant Biol 61:681-704 (2010)\", \"DOI:10.1146/annurev.arplant.043008.092057\")), list(REFERENCE = \"PMID:19734888\", AUTHORS = \"Kim TW, Guan S, Sun Y, Deng Z, Tang W, Shang JX, Sun Y, Burlingame AL, Wang ZY\", TITLE = \"Brassinosteroid signal transduction from cell-surface receptor kinases to nuclear transcription factors.\", JOURNAL = c(\"Nat Cell Biol 11:1254-60 (2009)\", \"DOI:10.1038/ncb1970\")), list(REFERENCE = \"PMID:20360743\", AUTHORS = \"Pauwels L, Barbero GF, Geerinck J, Tilleman S, Grunewald W, Perez AC, Chico JM, Bossche RV, Sewell J, Gil E, Garcia-Casado G, Witters E, Inze D, Long JA, De Jaeger G, Solano R, Goossens A\", TITLE = \"NINJA connects the co-repressor TOPLESS to jasmonate signalling.\", JOURNAL = c(\"Nature 464:788-91 (2010)\", \"DOI:10.1038/nature08854\")), list(REFERENCE = \"PMID:18583180\", AUTHORS = \"Katsir L, Chung HS, Koo AJ, Howe GA\", TITLE = \"Jasmonate signaling: a conserved mechanism of hormone sensing.\", JOURNAL = c(\"Curr Opin Plant Biol 11:428-35 (2008)\", \"DOI:10.1016/j.pbi.2008.05.004\")), list(REFERENCE = \"PMID:12897257\", AUTHORS = \"Johnson C, Boden E, Arias J\", TITLE = \"Salicylic acid and NPR1 induce the recruitment of trans-activating TGA factors to a defense gene promoter in Arabidopsis.\", JOURNAL = c(\"Plant Cell 15:1846-58 (2003)\", \"DOI:10.1105/tpc.012211\"))', 'map04075', 'Plant hormone signal transduction', 'Environmental Information Processing; Signal transduction', 102, 0, 0, 102, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (241, '04080', 'Neuroactive ligand-receptor interaction', 'Environmental Information Processing; Signaling molecules and interaction', 'Neuroactive ligand-receptor interaction', 'Thyroid hormone resistance syndrome, Hypogonadotropic hypogonadism, Woolly hair, Primary failure of tooth eruption, Waardenburg syndrome, Hyperekplexia, Congenital myasthenic syndrome, Febrile seizures, Congenital stationary night blindness, Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE), ABCD syndrome, Hirschsprung disease, Precocious puberty, Multiple pterygium syndrome, Ovarian hyperstimulation syndrome, Plasminogen deficiency, Isolated follicle-stimulating hormone deficiency, Nephrogenic syndrome of inappropriate antidiuresis, Alcohol dependence, Schizophrenia, Neurosis, Syndrome of inappropriate secretion of antidiuretic hormone, Disorders of antidiuretic hormone (ADH) secretion, Hypopituitarism, Glucocorticoid resistance syndrome, Attention deficit hyperactivity disorder (ADHD), Laron syndrome, Kowarski syndrome, Leptin deficiency, Leptin receptor deficiency, Genetic obesity', 'ko04080', 'map04080', 'Neuroactive ligand-receptor interaction', 'Environmental Information Processing; Signaling molecules and interaction', 'Neuroactive ligand-receptor interaction', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (242, '04110', 'Cell cycle', 'c(\"Mitotic cell cycle progression is accomplished through a reproducible sequence of events, DNA replication (S phase) and mitosis (M phase) separated temporally by gaps known as G1 and G2 phases. Cyclin-dependent kinases (CDKs) are key regulatory enzymes, each consisting of a catalytic CDK subunit and an activating cyclin subunit. CDKs regulate the cell\'s progression through the phases of the cell cycle by modulating the activity of key substrates. Downstream targets of CDKs include transcription factor E2F and its regulator Rb. Precise activation and inactivation of CDKs at specific points in the cell cycle are required for orderly cell division. Cyclin-CDK inhibitors (CKIs), such as p16Ink4a, p15Ink4b, p27Kip1, and p21Cip1, are involved in the negative regulation of CDK activities, thus providing a pathway through which the cell cycle is negatively regulated.\", \n\" Eukaryotic cells respond to DNA damage by activating signaling pathways that promote cell cycle arrest and DNA repair. In response to DNA damage, the checkpoint kinase ATM phosphorylates and activates Chk2, which in turn directly phosphorylates and activates p53 tumor suppressor protein. p53 and its transcriptional targets play an important role in both G1 and G2 checkpoints. ATR-Chk1-mediated protein degradation of Cdc25A protein phosphatase is also a mechanism conferring intra-S-phase checkpoint activation.\"\n)', 'Cellular Processes; Cell growth and death', 'Cell cycle', 'Ataxia telangiectasia, Type 2 diabetes mellitus, Cornelia de Lange syndrome, Beckwith-Wiedemann syndrome, Li-Fraumeni syndrome, Seckel syndrome, Choroid plexus papilloma, Juvenile polyposis syndrome, Pituitary adenomas, Mosaic variegated aneuploidy syndrome, Rienhoff syndrome, Tonsillar cancer, Retinoblastoma, Meier-Gorlin syndrome, Myhre syndrome', 'GO: 0000278', 'ko04110', 'list(REFERENCE = \"PMID:7908906\", AUTHORS = \"Matsuoka S, Yamaguchi M, Matsukage A\", TITLE = \"D-type cyclin-binding regions of proliferating cell nuclear antigen.\", JOURNAL = \"J Biol Chem 269:11030-6 (1994)\"), list(REFERENCE = \"PMID:8242749\", AUTHORS = \"Welch PJ, Wang JY\", TITLE = \"A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.\", JOURNAL = c(\"Cell 75:779-90 (1993)\", \"DOI:10.1016/0092-8674(93)90497-E\")), list(REFERENCE = \"PMID:16936746\", AUTHORS = \"Macaluso M, Montanari M, Giordano A\", TITLE = \"Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes.\", JOURNAL = c(\"Oncogene 25:5263-7 (2006)\", \"DOI:10.1038/sj.onc.1209680\")), list(REFERENCE = \"PMID:15838516\", AUTHORS = \"Cobrinik D\", TITLE = \"Pocket proteins and cell cycle control.\", JOURNAL = c(\"Oncogene 24:2796-809 (2005)\", \"DOI:10.1038/sj.onc.1208619\")), list(REFERENCE = \"PMID:17568790\", AUTHORS = \"Boutros R, Lobjois V, Ducommun B\", TITLE = \"CDC25 phosphatases in cancer cells: key players? Good targets?\", JOURNAL = c(\"Nat Rev Cancer 7:495-507 (2007)\", \"DOI:10.1038/nrc2169\")), list(REFERENCE = \"PMID:9832503\", AUTHORS = \"Diehl JA, Cheng M, Roussel MF, Sherr CJ\", TITLE = \"Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.\", JOURNAL = c(\"Genes Dev 12:3499-511 (1998)\", \"DOI:10.1101/gad.12.22.3499\")), list(REFERENCE = \"PMID:19020303\", AUTHORS = \"Klein EA, Assoian RK\", TITLE = \"Transcriptional regulation of the cyclin D1 gene at a glance.\", JOURNAL = c(\"J Cell Sci 121:3853-7 (2008)\", \"DOI:10.1242/jcs.039131\")), list(REFERENCE = \"PMID:10385618\", AUTHORS = \"Sherr CJ, Roberts JM\", TITLE = \"CDK inhibitors: positive and negative regulators of G1-phase progression.\", JOURNAL = c(\"Genes Dev 13:1501-12 (1999)\", \"DOI:10.1101/gad.13.12.1501\")), list(REFERENCE = \"PMID:12809600\", AUTHORS = \"Shi Y, Massague J.\", TITLE = \"Mechanisms of TGF-beta signaling from cell membrane to the nucleus.\", JOURNAL = c(\"Cell 113:685-700 (2003)\", \"DOI:10.1016/S0092-8674(03)00432-X\")), list(REFERENCE = \"PMID:12925736\", AUTHORS = \"Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H, Hatakeyama S, Nakayama K, Nakayama KI\", TITLE = \"Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 100:10231-6 (2003)\", \"DOI:10.1073/pnas.1831009100\")), list(REFERENCE = \"PMID:16212951\", AUTHORS = \"Bond M, Sala-Newby GB, Wu YJ, Newby AC\", TITLE = \"Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation.\", JOURNAL = c(\"Cardiovasc Res 69:198-206 (2006)\", \"DOI:10.1016/j.cardiores.2005.08.020\")), list(REFERENCE = \"PMID:15838523\", AUTHORS = \"Harris SL, Levine AJ.\", TITLE = \"The p53 pathway: positive and negative feedback loops.\", JOURNAL = c(\"Oncogene 24:2899-908 (2005)\", \"DOI:10.1038/sj.onc.1208615\")), list(REFERENCE = \"PMID:11099028\", AUTHORS = \"Vogelstein B, Lane D, Levine AJ\", TITLE = \"Surfing the p53 network.\", JOURNAL = c(\"Nature 408:307-10 (2000)\", \"DOI:10.1038/35042675\")), list(REFERENCE = \"PMID:7973727\", AUTHORS = \"Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O\'Connor PM, Fornace AJ Jr\", TITLE = \"Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.\", JOURNAL = c(\"Science 266:1376-80 (1994)\", \"DOI:10.1126/science.7973727\")), list(REFERENCE = \"PMID:9889196\", AUTHORS = \"Petersen BO, Lukas J, Sorensen CS, Bartek J, Helin K\", TITLE = \"Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.\", JOURNAL = c(\"EMBO J 18:396-410 (1999)\", \"DOI:10.1093/emboj/18.2.396\")), list(REFERENCE = \"PMID:17018296\", AUTHORS = \"Sheu YJ, Stillman B\", TITLE = \"Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression.\", JOURNAL = c(\"Mol Cell 24:101-13 (2006)\", \"DOI:10.1016/j.molcel.2006.07.033\")), list(REFERENCE = \"PMID:9029154\", AUTHORS = \"Martinez AM, Afshar M, Martin F, Cavadore JC, Labbe JC, Doree M\", TITLE = \"Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity.\", JOURNAL = c(\"EMBO J 16:343-54 (1997)\", \"DOI:10.1093/emboj/16.2.343\")), list(REFERENCE = \"PMID:15876871\", AUTHORS = \"Lolli G, Johnson LN\", TITLE = \"CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?\", JOURNAL = c(\"Cell Cycle 4:572-7 (2005)\", \"DOI:10.4161/cc.4.4.1607\")), list(REFERENCE = \"PMID:17426725\", AUTHORS = \"Musacchio A, Salmon ED\", TITLE = \"The spindle-assembly checkpoint in space and time.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 8:379-93 (2007)\", \"DOI:10.1038/nrm2163\")), list(REFERENCE = \"PMID:12573239\", AUTHORS = \"Uhlmann F\", TITLE = \"Chromosome cohesion and separation: from men and molecules.\", JOURNAL = c(\"Curr Biol 13:R104-14 (2003)\", \"DOI:10.1016/S0960-9822(03)00039-3\")), list(REFERENCE = \"PMID:15568976\", AUTHORS = \"Stegmeier F, Amon A\", TITLE = \"Closing mitosis: the functions of the Cdc14 phosphatase and its regulation.\", JOURNAL = c(\"Annu Rev Genet 38:203-32 (2004)\", \"DOI:10.1146/annurev.genet.38.072902.093051\")), list(REFERENCE = \"PMID:9618481\", AUTHORS = \"Moustakas A, Kardassis D\", TITLE = \"Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 95:6733-8 (1998)\", \"DOI:10.1073/pnas.95.12.6733\"))', 'map04110', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (243, '04111', 'Cell cycle - yeast', 'Mitotic cell cycle progression is accomplished through a reproducible sequence of events, DNA replication (S phase) and mitosis (M phase) separated temporally by gaps (G1 and G2 phases). G1, S, and G2 phases are collectively known as interphase. In yeast Cdc28 is the catalytic subunit of the cyclin-dependent kinase (CDK). At G1 phase Cdc28 associates with G1-cyclins Cln1 to Cln3, while B-type cyclins Clb1 to Clb6 regulate Cdc28 during S, G2, and M phases. Cln3/Cdc28 activity is required for cells to pass through \'start\', the commitment point in G1. When Cln3/Cdc28 accumulates more than a certain threshold, SBF (Swi4/Swi6) and MBF (Mbp1/Swi6) are activated, promoting transcription of Cln1, Cln2, and other genes required for S-phase progression. Cln1 and Cln2 interacting with Cdc28 promote activation of B-type cyclin associated CDK, which drives DNA replication and entry into mitosis. Specifically, Cdc28 association with Clb2 and Clb1 promotes entry into mitosis. Cells suffering from DNA damage, spindle misorientation, or spindle assembly defect do not undergo the metaphase-anaphase transition for chromosome segregation and fail to exit from mitosis. The spindle assembly checkpoint activates Mad2, which in turn prevents chromosome segregation by inhibiting degradation of the securin Pds1. Moreover, Pds1 is phosphorylated and stabilized in response to DNA damage in a Chk1-dependent manner. The spindle checkpoint is also involved in the Cdc14 release from the nucleolus. Cdc14 dephosphorylates Swi5, Sic1, and Cdh1, leading to inhibition of Cdc28 and degradation of cyclin required for mitotic exit.', 'Cellular Processes; Cell growth and death', 'Cell cycle - yeast', 'GO: 0000278', 'ko04111', 'list(REFERENCE = \"PMID:11967159\", AUTHORS = \"Devault A, Vallen EA, Yuan T, Green S, Bensimon A, Schwob E\", TITLE = \"Identification of Tah11/Sid2 as the ortholog of the replication licensing factor Cdt1 in Saccharomyces cerevisiae.\", JOURNAL = c(\"Curr Biol 12:689-94 (2002)\", \"DOI:10.1016/S0960-9822(02)00768-6\")), list(REFERENCE = \"PMID:15210110\", AUTHORS = \"de Bruin RA, McDonald WH, Kalashnikova TI, Yates J 3rd, Wittenberg C\", TITLE = \"Cln3 activates G1-specific transcription via phosphorylation of the SBF bound repressor Whi5.\", JOURNAL = c(\"Cell 117:887-98 (2004)\", \"DOI:10.1016/j.cell.2004.05.025\")), list(REFERENCE = \"PMID:15210111\", AUTHORS = \"Costanzo M, Nishikawa JL, Tang X, Millman JS, Schub O, Breitkreuz K, Dewar D, Rupes I, Andrews B, Tyers M\", TITLE = \"CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast.\", JOURNAL = c(\"Cell 117:899-913 (2004)\", \"DOI:10.1016/j.cell.2004.05.024\")), list(REFERENCE = \"PMID:12464633\", AUTHORS = \"Pramila T, Miles S, GuhaThakurta D, Jemiolo D, Breeden LL\", TITLE = \"Conserved homeodomain proteins interact with MADS box protein Mcm1 to restrict ECB-dependent transcription to the M/G1 phase of the cell cycle.\", JOURNAL = c(\"Genes Dev 16:3034-45 (2002)\", \"DOI:10.1101/gad.1034302\")), list(REFERENCE = \"PMID:15060174\", AUTHORS = \"Schwickart M, Havlis J, Habermann B, Bogdanova A, Camasses A, Oelschlaegel T, Shevchenko A, Zachariae W\", TITLE = \"Swm1/Apc13 is an evolutionarily conserved subunit of the anaphase-promoting complex stabilizing the association of Cdc16 and Cdc27.\", JOURNAL = c(\"Mol Cell Biol 24:3562-76 (2004)\", \"DOI:10.1128/MCB.24.8.3562-3576.2004\")), list(REFERENCE = \"PMID:15797380\", AUTHORS = \"Penkner AM, Prinz S, Ferscha S, Klein F\", TITLE = \"Mnd2, an essential antagonist of the anaphase-promoting complex during meiotic prophase.\", JOURNAL = c(\"Cell 120:789-801 (2005)\", \"DOI:10.1016/j.cell.2005.01.017\")), list(REFERENCE = \"PMID:18598214\", AUTHORS = \"Pesin JA, Orr-Weaver TL\", TITLE = \"Regulation of APC/C activators in mitosis and meiosis.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 24:475-99 (2008)\", \"DOI:10.1146/annurev.cellbio.041408.115949\")), list(REFERENCE = \"PMID:7588610\", AUTHORS = \"Dirick L, Bohm T, Nasmyth K\", TITLE = \"Roles and regulation of Cln-Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae.\", JOURNAL = \"EMBO J 14:4803-13 (1995)\"), list(REFERENCE = \"PMID:16285853\", AUTHORS = \"Bahler J\", TITLE = \"Cell-cycle control of gene expression in budding and fission yeast.\", JOURNAL = c(\"Annu Rev Genet 39:69-94 (2005)\", \"DOI:10.1146/annurev.genet.39.110304.095808\")), list(REFERENCE = \"PMID:8066461\", AUTHORS = \"Peter M, Herskowitz I\", TITLE = \"Direct inhibition of the yeast cyclin-dependent kinase Cdc28-Cln by Far1.\", JOURNAL = c(\"Science 265:1228-31 (1994)\", \"DOI:10.1126/science.8066461\")), list(REFERENCE = \"PMID:9367986\", AUTHORS = \"Henchoz S, Chi Y, Catarin B, Herskowitz I, Deshaies RJ, Peter M\", TITLE = \"Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast.\", JOURNAL = c(\"Genes Dev 11:3046-60 (1997)\", \"DOI:10.1101/gad.11.22.3046\")), list(REFERENCE = \"PMID:9346239\", AUTHORS = \"Feldman RM, Correll CC, Kaplan KB, Deshaies RJ\", TITLE = \"A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p.\", JOURNAL = c(\"Cell 91:221-30 (1997)\", \"DOI:10.1016/S0092-8674(00)80404-3\")), list(REFERENCE = \"PMID:7954792\", AUTHORS = \"Schwob E, Bohm T, Mendenhall MD, Nasmyth K\", TITLE = \"The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae.\", JOURNAL = c(\"Cell 79:233-44 (1994)\", \"DOI:10.1016/0092-8674(94)90193-7\")), list(REFERENCE = \"PMID:9841670\", AUTHORS = \"Mendenhall MD, Hodge AE\", TITLE = \"Regulation of Cdc28 cyclin-dependent protein kinase activity during the cell cycle of the yeast Saccharomyces cerevisiae.\", JOURNAL = \"Microbiol Mol Biol Rev 62:1191-243 (1998)\"), list(REFERENCE = \"PMID:10465783\", AUTHORS = \"Zachariae W, Nasmyth K\", TITLE = \"Whose end is destruction: cell division and the anaphase-promoting complex.\", JOURNAL = c(\"Genes Dev 13:2039-58 (1999)\", \"DOI:10.1101/gad.13.16.2039\")), list(REFERENCE = \"PMID:11269496\", AUTHORS = \"Jares P, Donaldson A, Blow JJ\", TITLE = \"The Cdc7/Dbf4 protein kinase: target of the S phase checkpoint?\", JOURNAL = c(\"EMBO Rep 1:319-22 (2000)\", \"DOI:10.1093/embo-reports/kvd076\")), list(REFERENCE = \"PMID:10512865\", AUTHORS = \"Elsasser S, Chi Y, Yang P, Campbell JL\", TITLE = \"Phosphorylation controls timing of Cdc6p destruction: A biochemical analysis.\", JOURNAL = c(\"Mol Biol Cell 10:3263-77 (1999)\", \"DOI:10.1091/mbc.10.10.3263\")), list(REFERENCE = \"PMID:10213692\", AUTHORS = \"Skowyra D, Koepp DM, Kamura T, Conrad MN, Conaway RC, Conaway JW, Elledge SJ, Harper JW\", TITLE = \"Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1.\", JOURNAL = c(\"Science 284:662-5 (1999)\", \"DOI:10.1126/science.284.5414.662\")), list(REFERENCE = \"PMID:16487340\", AUTHORS = \"Mouillon JM, Persson BL\", TITLE = \"New aspects on phosphate sensing and signalling in Saccharomyces cerevisiae.\", JOURNAL = c(\"FEMS Yeast Res 6:171-6 (2006)\", \"DOI:10.1111/j.1567-1364.2006.00036.x\")), list(REFERENCE = \"PMID:15965243\", AUTHORS = \"Bean JM, Siggia ED, Cross FR\", TITLE = \"High functional overlap between MluI cell-cycle box binding factor and Swi4/6 cell-cycle box binding factor in the G1/S transcriptional program in Saccharomyces cerevisiae.\", JOURNAL = c(\"Genetics 171:49-61 (2005)\", \"DOI:10.1534/genetics.105.044560\")), list(REFERENCE = \"PMID:9024629\", AUTHORS = \"Deshaies RJ\", TITLE = \"Phosphorylation and proteolysis: partners in the regulation of cell division in budding yeast.\", JOURNAL = c(\"Curr Opin Genet Dev 7:7-16 (1997)\", \"DOI:10.1016/S0959-437X(97)80103-7\")), list(REFERENCE = \"PMID:15920482\", AUTHORS = \"Asano S, Park JE, Sakchaisri K, Yu LR, Song S, Supavilai P, Veenstra TD, Lee KS\", TITLE = \"Concerted mechanism of Swe1/Wee1 regulation by multiple kinases in budding yeast.\", JOURNAL = c(\"EMBO J 24:2194-204 (2005)\", \"DOI:10.1038/sj.emboj.7600683\")), list(REFERENCE = \"PMID:9716410\", AUTHORS = \"Kaiser P, Sia RA, Bardes EG, Lew DJ, Reed SI\", TITLE = \"Cdc34 and the F-box protein Met30 are required for degradation of the Cdk-inhibitory kinase Swe1.\", JOURNAL = c(\"Genes Dev 12:2587-97 (1998)\", \"DOI:10.1101/gad.12.16.2587\")), list(REFERENCE = \"PMID:9925642\", AUTHORS = \"Barral Y, Parra M, Bidlingmaier S, Snyder M\", TITLE = \"Nim1-related kinases coordinate cell cycle progression with the organization of the peripheral cytoskeleton in yeast.\", JOURNAL = c(\"Genes Dev 13:176-87 (1999)\", \"DOI:10.1101/gad.13.2.176\")), list(REFERENCE = \"PMID:10469560\", AUTHORS = \"Taylor SS\", TITLE = \"Chromosome segregation: dual control ensures fidelity.\", JOURNAL = c(\"Curr Biol 9:R562-4 (1999)\", \"DOI:10.1016/S0960-9822(99)80355-8\")), list(REFERENCE = \"PMID:14616062\", AUTHORS = \"Lew DJ, Burke DJ\", TITLE = \"The spindle assembly and spindle position checkpoints.\", JOURNAL = c(\"Annu Rev Genet 37:251-82 (2003)\", \"DOI:10.1146/annurev.genet.37.042203.120656\")), list(REFERENCE = \"PMID:14514882\", AUTHORS = \"Simanis V\", TITLE = \"Events at the end of mitosis in the budding and fission yeasts.\", JOURNAL = c(\"J Cell Sci 116:4263-75 (2003)\", \"DOI:10.1242/jcs.00807\")), list(REFERENCE = \"PMID:8131744\", AUTHORS = \"Toyn JH, Johnston LH\", TITLE = \"The Dbf2 and Dbf20 protein kinases of budding yeast are activated after the metaphase to anaphase cell cycle transition.\", JOURNAL = \"EMBO J 13:1103-13 (1994)\"), list(REFERENCE = \"PMID:11146641\", AUTHORS = \"Amon A\", TITLE = \"Together until separin do us part.\", JOURNAL = c(\"Nat Cell Biol 3:E12-4 (2001)\", \"DOI:10.1038/35050642\")), list(REFERENCE = \"PMID:10882066\", AUTHORS = \"Ciosk R, Shirayama M, Shevchenko A, Tanaka T, Toth A, Shevchenko A, Nasmyth K\", TITLE = \"Cohesin\'s binding to chromosomes depends on a separate complex consisting of Scc2 and Scc4 proteins.\", JOURNAL = c(\"Mol Cell 5:243-54 (2000)\", \"DOI:10.1016/S1097-2765(00)80420-7\")), list(REFERENCE = \"PMID:10811823\", AUTHORS = \"Freeman L, Aragon-Alcaide L, Strunnikov A\", TITLE = \"The condensin complex governs chromosome condensation and mitotic transmission of rDNA.\", JOURNAL = c(\"J Cell Biol 149:811-24 (2000)\", \"DOI:10.1083/jcb.149.4.811\")), list(REFERENCE = \"PMID:18616603\", AUTHORS = \"Fu Y, Pastushok L, Xiao W\", TITLE = \"DNA damage-induced gene expression in Saccharomyces cerevisiae.\", JOURNAL = c(\"FEMS Microbiol Rev 32:908-26 (2008)\", \"DOI:10.1111/j.1574-6976.2008.00126.x\")), list(REFERENCE = \"PMID:19230642\", AUTHORS = \"Friedel AM, Pike BL, Gasser SM\", TITLE = \"ATR/Mec1: coordinating fork stability and repair.\", JOURNAL = c(\"Curr Opin Cell Biol 21:237-44 (2009)\", \"DOI:10.1016/j.ceb.2009.01.017\")), list(REFERENCE = \"PMID:19457865\", AUTHORS = \"Chen SH, Zhou H\", TITLE = \"Reconstitution of Rad53 activation by Mec1 through adaptor protein Mrc1.\", JOURNAL = c(\"J Biol Chem 284:18593-604 (2009)\", \"DOI:10.1074/jbc.M109.018242\")), list(REFERENCE = \"PMID:19021755\", AUTHORS = \"Amon A\", TITLE = \"A decade of Cdc14--a personal perspective. Delivered on 9 July 2007 at the 32nd FEBS Congress in Vienna, Austria.\", JOURNAL = c(\"FEBS J 275:5774-84 (2008)\", \"DOI:10.1111/j.1742-4658.2008.06693.x\"))', 'map04111', 'Cell cycle - yeast', 128, 0, 0, 0, 128, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (244, '04112', 'Cell cycle - Caulobacter', 'Cell cycle progression of Caulobacter crescentus is implemented by an elaborate transcriptional regulatory network. During the life cycle, Caulobacter divides asymmetrically producing two distinct cell types with specialized development programs. The sessile stalked cell immediately initiates a new round of division cycle, whereas the motile swarmer cell remains in the G1 phase for a defined interval before differentiating into the stalked cell and entering into the S phase. The division process is centered around three master regulator proteins, DnaA, GcrA, and CtrA. DnaA and GcrA together drive the synthesis of proteins needed to complete DNA replication. CtrA controls the transcription of a diverse group of genes, which are required for essential morphological, metabolic, and cell cycle events.', 'Cellular Processes; Cell growth and death', 'Cell cycle - Caulobacter', 'GO: 0000278', 'ko04112', 'list(REFERENCE = \"PMID:18685108\", AUTHORS = \"Shen X, Collier J, Dill D, Shapiro L, Horowitz M, McAdams HH\", TITLE = \"Architecture and inherent robustness of a bacterial cell-cycle control system.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:11340-5 (2008)\", \"DOI:10.1073/pnas.0805258105\")), list(REFERENCE = \"PMID:20197497\", AUTHORS = \"Curtis PD, Brun YV\", TITLE = \"Getting in the loop: regulation of development in Caulobacter crescentus.\", JOURNAL = c(\"Microbiol Mol Biol Rev 74:13-41 (2010)\", \"DOI:10.1128/MMBR.00040-09\")), list(REFERENCE = \"PMID:15031731\", AUTHORS = \"Skerker JM, Laub MT\", TITLE = \"Cell-cycle progression and the generation of asymmetry in Caulobacter crescentus.\", JOURNAL = c(\"Nat Rev Microbiol 2:325-37 (2004)\", \"DOI:10.1038/nrmicro864\")), list(REFERENCE = \"PMID:19246239\", AUTHORS = \"Jenal U, Galperin MY\", TITLE = \"Single domain response regulators: molecular switches with emerging roles in cell organization and dynamics.\", JOURNAL = c(\"Curr Opin Microbiol 12:152-60 (2009)\", \"DOI:10.1016/j.mib.2009.01.010\")), list(REFERENCE = \"PMID:19854671\", AUTHORS = \"Thanbichler M\", TITLE = \"Spatial regulation in Caulobacter crescentus.\", JOURNAL = c(\"Curr Opin Microbiol 12:715-21 (2009)\", \"DOI:10.1016/j.mib.2009.09.013\")), list(REFERENCE = \"PMID:19781638\", AUTHORS = \"Jenal U\", TITLE = \"The role of proteolysis in the Caulobacter crescentus cell cycle and development.\", JOURNAL = c(\"Res Microbiol 160:687-95 (2009)\", \"DOI:10.1016/j.resmic.2009.09.006\")), list(REFERENCE = \"PMID:19287449\", AUTHORS = \"Hengge R\", TITLE = \"Principles of c-di-GMP signalling in bacteria.\", JOURNAL = c(\"Nat Rev Microbiol 7:263-73 (2009)\", \"DOI:10.1038/nrmicro2109\")), list(REFERENCE = \"PMID:19687139\", AUTHORS = \"Goley ED, Toro E, McAdams HH, Shapiro L\", TITLE = \"Dynamic chromosome organization and protein localization coordinate the regulatory circuitry that drives the bacterial cell cycle.\", JOURNAL = c(\"Cold Spring Harb Symp Quant Biol 74:55-64 (2009)\", \"DOI:10.1101/sqb.2009.74.005\")), list(REFERENCE = \"PMID:19680425\", AUTHORS = \"Li S, Brazhnik P, Sobral B, Tyson JJ\", TITLE = \"Temporal controls of the asymmetric cell division cycle in Caulobacter crescentus.\", JOURNAL = c(\"PLoS Comput Biol 5:e1000463 (2009)\", \"DOI:10.1371/journal.pcbi.1000463\"))', 'map04112', 'Cell cycle - Caulobacter', 0, 10, 0, 0, 0, 0, 10, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (245, '04113', 'Meiosis - yeast', 'During meiosis, a single round of DNA replication is followed by two rounds of chromosome segregation, called meiosis I and meiosis II. At meiosis I, one pair of sister chromatids recombines with, then segregates from, its homologous pair, while the sister chromatids segregate from each other at meoisis II. In yeast, the switch to enter growth phase or meiosis phase is controlled by nutritional signals. At the onset of meiosis, nutritional signaling pathways converge on transcriptional regulation of Ime1. Ime1 is a transcriptional activator to promote expression of early meiosis-specific genes required for pre-meiotic DNA replication and meiotic recombination. Two of the early meiosis-specific genes, a transcriptional activator, Ndt80, and a CDK2 homolog, Ime2, are required for the transcription of middle meiosis-specific genes, which includes B-type cyclin genes and genes involved in spore wall formation. Polo-like kinase Cdc5, whose expression is activated by Ndt80, is required for the critical step in meiotic progression. Cdc5 regulates sister-kinetochore co-orientation by promoting the localization of Mam1 and Lrs4, components of the co-orientation complex, to kinetochores. Cdc5 also phosphorylates the meiotic cohesin subunit Rec8, which is essential for its cleavage and removal by separase. Moreover, Cdc5 promotes the release of protein phosphatase Cdc14 from the nuclezus, which is required for anaphase I spindle disassembly and exit from meiosis I. The centromeric protein Sgo1 is a key regulator of meiotic chromosome segregation. Sgo1 with PP2A may protect pericentromeric but not arm cohesion of sister chromatids during meiosis I. Sgo1 then disappears at meiosis II to allow sister chromatids to separate.', 'Cellular Processes; Cell growth and death', 'Meiosis - yeast', 'GO: 0051321', 'ko04113', 'list(REFERENCE = \"PMID:12730290\", AUTHORS = \"Honigberg SM, Purnapatre K\", TITLE = \"Signal pathway integration in the switch from the mitotic cell cycle to meiosis in yeast.\", JOURNAL = c(\"J Cell Sci 116:2137-47 (2003)\", \"DOI:10.1242/jcs.00460\")), list(REFERENCE = \"PMID:12722950\", AUTHORS = \"Kassir Y, Adir N, Boger-Nadjar E, Raviv NG, Rubin-Bejerano I, Sagee S, Shenhar G\", TITLE = \"Transcriptional regulation of meiosis in budding yeast.\", JOURNAL = c(\"Int Rev Cytol 224:111-71 (2003)\", \"DOI:10.1016/S0074-7696(05)24004-4\")), list(REFERENCE = \"PMID:15258924\", AUTHORS = \"Honigberg SM\", TITLE = \"Ime2p and Cdc28p: co-pilots driving meiotic development.\", JOURNAL = c(\"J Cell Biochem 92:1025-33 (2004)\", \"DOI:10.1002/jcb.20131\")), list(REFERENCE = \"PMID:16546077\", AUTHORS = \"Hochwagen A, Amon A\", TITLE = \"Checking your breaks: surveillance mechanisms of meiotic recombination.\", JOURNAL = c(\"Curr Biol 16:R217-28 (2006)\", \"DOI:10.1016/j.cub.2006.03.009\")), list(REFERENCE = \"PMID:18832063\", AUTHORS = \"Hollingsworth NM\", TITLE = \"Deconstructing meiosis one kinase at a time: polo pushes past pachytene.\", JOURNAL = c(\"Genes Dev 22:2596-600 (2008)\", \"DOI:10.1101/gad.1727508\")), list(REFERENCE = \"PMID:18832066\", AUTHORS = \"Sourirajan A, Lichten M\", TITLE = \"Polo-like kinase Cdc5 drives exit from pachytene during budding yeast meiosis.\", JOURNAL = c(\"Genes Dev 22:2627-32 (2008)\", \"DOI:10.1101/gad.1711408\")), list(REFERENCE = \"PMID:10973068\", AUTHORS = \"Roeder GS, Bailis JM\", TITLE = \"The pachytene checkpoint.\", JOURNAL = c(\"Trends Genet 16:395-403 (2000)\", \"DOI:10.1016/S0168-9525(00)02080-1\")), list(REFERENCE = \"PMID:15173822\", AUTHORS = \"Barr FA, Sillje HH, Nigg EA\", TITLE = \"Polo-like kinases and the orchestration of cell division.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 5:429-40 (2004)\", \"DOI:10.1038/nrm1401\")), list(REFERENCE = \"PMID:12963824\", AUTHORS = \"Lee BH, Amon A\", TITLE = \"Polo kinase--meiotic cell cycle coordinator.\", JOURNAL = c(\"Cell Cycle 2:400-2 (2003)\", \"DOI:10.4161/cc.2.5.475\")), list(REFERENCE = \"PMID:12737807\", AUTHORS = \"Buonomo SB, Rabitsch KP, Fuchs J, Gruber S, Sullivan M, Uhlmann F, Petronczki M, Toth A, Nasmyth K\", TITLE = \"Division of the nucleolus and its release of CDC14 during anaphase of meiosis I depends on separase, SPO12, and SLK19.\", JOURNAL = c(\"Dev Cell 4:727-39 (2003)\", \"DOI:10.1016/S1534-5807(03)00129-1\")), list(REFERENCE = \"PMID:15797379\", AUTHORS = \"Oelschlaegel T, Schwickart M, Matos J, Bogdanova A, Camasses A, Havlis J, Shevchenko A, Zachariae W\", TITLE = \"The yeast APC/C subunit Mnd2 prevents premature sister chromatid separation triggered by the meiosis-specific APC/C-Ama1.\", JOURNAL = c(\"Cell 120:773-88 (2005)\", \"DOI:10.1016/j.cell.2005.01.032\")), list(REFERENCE = \"PMID:16759372\", AUTHORS = \"Dai W, Wang X\", TITLE = \"The Yin and Yang of centromeric cohesion of sister chromatids: mitotic kinases meet protein phosphatase 2A.\", JOURNAL = c(\"Cell Div 1:9 (2006)\", \"DOI:10.1186/1747-1028-1-9\")), list(REFERENCE = \"PMID:19299562\", AUTHORS = \"Clift D, Bizzari F, Marston AL\", TITLE = \"Shugoshin prevents cohesin cleavage by PP2A(Cdc55)-dependent inhibition of separase.\", JOURNAL = c(\"Genes Dev 23:766-80 (2009)\", \"DOI:10.1101/gad.507509\")), list(REFERENCE = \"PMID:18598214\", AUTHORS = \"Pesin JA, Orr-Weaver TL\", TITLE = \"Regulation of APC/C activators in mitosis and meiosis.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 24:475-99 (2008)\", \"DOI:10.1146/annurev.cellbio.041408.115949\")), list(REFERENCE = \"PMID:18946082\", AUTHORS = \"Diamond AE, Park JS, Inoue I, Tachikawa H, Neiman AM\", TITLE = \"The anaphase promoting complex targeting subunit Ama1 links meiotic exit to cytokinesis during sporulation in Saccharomyces cerevisiae.\", JOURNAL = c(\"Mol Biol Cell 20:134-45 (2009)\", \"DOI:10.1091/mbc.E08-06-0615\"))', 'map04113', 'Meiosis - yeast', 128, 0, 0, 0, 128, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (246, '04114', 'Oocyte meiosis', 'During meiosis, a single round of DNA replication is followed by two rounds of chromosome segregation, called meiosis I and meiosis II. At meiosis I, homologous chromosomes recombine and then segregate to opposite poles, while the sister chromatids segregate from each other at meoisis II. In vertebrates, immature oocytes are arrested at the PI (prophase of meiosis I). The resumption of meiosis is stimulated by progesterone, which carries the oocyte through two consecutive M-phases (MI and MII) to a second arrest at MII. The key activity driving meiotic progression is the MPF (maturation-promoting factor), a heterodimer of CDC2 (cell division cycle 2 kinase) and cyclin B. In PI-arrested oocytes, MPF is initially inactive and is activated by the dual-specificity CDC25C phosphatase as the result of new synthesis of Mos induced by progesterone. MPF activation mediates the transition from the PI arrest to MI. The subsequent decrease in MPF levels, required to exit from MI into interkinesis, is induced by a negative feedback loop, where CDC2 brings about the activation of the APC (anaphase-promoting complex), which mediates destruction of cyclin B. Re-activation of MPF for MII requires re-accumulation of high levels of cyclin B as well as the inactivation of the APC by newly synthesized Emi2 and other components of the CSF (cytostatic factor), such as cyclin E or high levels of Mos. CSF antagonizes the ubiquitin ligase activity of the APC, preventing cyclin B destruction and meiotic exit until fertilization occurs. Fertilization triggers a transient increase in cytosolic free Ca2+, which leads to CSF inactivation and cyclin B destruction through the APC. Then eggs are released from MII into the first embryonic cell cycle.', 'Cellular Processes; Cell growth and death', 'Oocyte meiosis', 'Coffin-Lowry syndrome, Cornelia de Lange syndrome, Growth delay due to insulin-like growth factor I resistance, Chronic atrial and intestinal dysrhythmia', 'GO: 0051321', 'ko04114', 'list(REFERENCE = \"PMID:16760654\", AUTHORS = \"Haccard O, Jessus C\", TITLE = \"Oocyte maturation, Mos and cyclins--a matter of synthesis: two functionally redundant ways to induce meiotic maturation.\", JOURNAL = c(\"Cell Cycle 5:1152-9 (2006)\", \"DOI:10.4161/cc.5.11.2800\")), list(REFERENCE = \"PMID:15182704\", AUTHORS = \"Crane R, Gadea B, Littlepage L, Wu H, Ruderman JV\", TITLE = \"Aurora A, meiosis and mitosis.\", JOURNAL = c(\"Biol Cell 96:215-29 (2004)\", \"DOI:10.1016/j.biolcel.2003.09.008\")), list(REFERENCE = \"PMID:15136768\", AUTHORS = \"Perdiguero E, Nebreda AR\", TITLE = \"Regulation of Cdc25C activity during the meiotic G2/M transition.\", JOURNAL = c(\"Cell Cycle 3:733-7 (2004)\", \"DOI:10.4161/cc.3.6.906\")), list(REFERENCE = \"PMID:17480229\", AUTHORS = \"Perry JA, Kornbluth S\", TITLE = \"Cdc25 and Wee1: analogous opposites?\", JOURNAL = c(\"Cell Div 2:12 (2007)\", \"DOI:10.1186/1747-1028-2-12\")), list(REFERENCE = \"PMID:15182701\", AUTHORS = \"Jessus C, Ozon R\", TITLE = \"How does Xenopus oocyte acquire its competence to undergo meiotic maturation?\", JOURNAL = c(\"Biol Cell 96:187-92 (2004)\", \"DOI:10.1016/j.biolcel.2003.12.007\")), list(REFERENCE = \"PMID:16518630\", AUTHORS = \"Revenkova E, Jessberger R\", TITLE = \"Shaping meiotic prophase chromosomes: cohesins and synaptonemal complex proteins.\", JOURNAL = c(\"Chromosoma 115:235-40 (2006)\", \"DOI:10.1007/s00412-006-0060-x\")), list(REFERENCE = \"PMID:18631137\", AUTHORS = \"Belloc E, Pique M, Mendez R\", TITLE = \"Sequential waves of polyadenylation and deadenylation define a translation circuit that drives meiotic progression.\", JOURNAL = c(\"Biochem Soc Trans 36:665-70 (2008)\", \"DOI:10.1042/BST0360665\")), list(REFERENCE = \"PMID:18598214\", AUTHORS = \"Pesin JA, Orr-Weaver TL\", TITLE = \"Regulation of APC/C activators in mitosis and meiosis.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 24:475-99 (2008)\", \"DOI:10.1146/annurev.cellbio.041408.115949\")), list(REFERENCE = \"PMID:18550795\", AUTHORS = \"Tang W, Wu JQ, Guo Y, Hansen DV, Perry JA, Freel CD, Nutt L, Jackson PK, Kornbluth S\", TITLE = \"Cdc2 and Mos regulate Emi2 stability to promote the meiosis I-meiosis II transition.\", JOURNAL = c(\"Mol Biol Cell 19:3536-43 (2008)\", \"DOI:10.1091/mbc.E08-04-0417\")), list(REFERENCE = \"PMID:18946022\", AUTHORS = \"Wu JQ, Kornbluth S\", TITLE = \"Across the meiotic divide - CSF activity in the post-Emi2/XErp1 era.\", JOURNAL = c(\"J Cell Sci 121:3509-14 (2008)\", \"DOI:10.1242/jcs.036855\")), list(REFERENCE = \"PMID:16554437\", AUTHORS = \"Schmidt A, Rauh NR, Nigg EA, Mayer TU\", TITLE = \"Cytostatic factor: an activity that puts the cell cycle on hold.\", JOURNAL = c(\"J Cell Sci 119:1213-8 (2006)\", \"DOI:10.1242/jcs.02919\")), list(REFERENCE = \"PMID:18096427\", AUTHORS = \"Vogt E, Kirsch-Volders M, Parry J, Eichenlaub-Ritter U\", TITLE = \"Spindle formation, chromosome segregation and the spindle checkpoint in mammalian oocytes and susceptibility to meiotic error.\", JOURNAL = c(\"Mutat Res 651:14-29 (2008)\", \"DOI:10.1016/j.mrgentox.2007.10.015\")), list(REFERENCE = \"PMID:18311174\", AUTHORS = \"Perry AC, Verlhac MH\", TITLE = \"Second meiotic arrest and exit in frogs and mice.\", JOURNAL = c(\"EMBO Rep 9:246-51 (2008)\", \"DOI:10.1038/embor.2008.22\")), list(REFERENCE = \"PMID:14691134\", AUTHORS = \"Tunquist BJ, Eyers PA, Chen LG, Lewellyn AL, Maller JL\", TITLE = \"Spindle checkpoint proteins Mad1 and Mad2 are required for cytostatic factor-mediated metaphase arrest.\", JOURNAL = c(\"J Cell Biol 163:1231-42 (2003)\", \"DOI:10.1083/jcb.200306153\")), list(REFERENCE = \"PMID:14517314\", AUTHORS = \"Hutchins JR, Dikovskaya D, Clarke PR.\", TITLE = \"Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.\", JOURNAL = c(\"Mol Biol Cell 14:4003-14 (2003)\", \"DOI:10.1091/mbc.E03-02-0061\"))', 'map04114', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (247, '04115', 'p53 signaling pathway', 'p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways.', 'Cellular Processes; Cell growth and death', 'p53 signaling pathway', 'Type 2 diabetes mellitus, Li-Fraumeni syndrome, Lymphangioleiomyomatosis, Tuberous sclerosis complex, Seckel syndrome, Choroid plexus papilloma, Plasminogen activator inhibitor type 1 deficiency, VACTERL/VATER association', 'ko04115', 'list(REFERENCE = \"PMID:16557269\", AUTHORS = \"Levine AJ, Hu W, Feng Z.\", TITLE = \"The P53 pathway: what questions remain to be explored?\", JOURNAL = c(\"Cell Death Differ 13:1027-36 (2006)\", \"DOI:10.1038/sj.cdd.4401910\")), list(REFERENCE = \"PMID:15838523\", AUTHORS = \"Harris SL, Levine AJ.\", TITLE = \"The p53 pathway: positive and negative feedback loops.\", JOURNAL = c(\"Oncogene 24:2899-908 (2005)\", \"DOI:10.1038/sj.onc.1208615\")), list(REFERENCE = \"PMID:11747320\", AUTHORS = \"Balint E E, Vousden KH.\", TITLE = \"Activation and activities of the p53 tumour suppressor protein.\", JOURNAL = c(\"Br J Cancer 85:1813-23 (2001)\", \"DOI:10.1054/bjoc.2001.2128\")), list(REFERENCE = \"PMID:11313928\", AUTHORS = \"Taylor WR, Stark GR.\", TITLE = \"Regulation of the G2/M transition by p53.\", JOURNAL = c(\"Oncogene 20:1803-15 (2001)\", \"DOI:10.1038/sj.onc.1204252\")), list(REFERENCE = \"PMID:15116721\", AUTHORS = \"Hofseth LJ, Hussain SP, Harris CC.\", TITLE = \"p53: 25 years after its discovery.\", JOURNAL = c(\"Trends Pharmacol Sci 25:177-81 (2004)\", \"DOI:10.1016/j.tips.2004.02.009\")), list(REFERENCE = \"PMID:12505356\", AUTHORS = \"Pietenpol JA, Stewart ZA.\", TITLE = \"Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.\", JOURNAL = c(\"Toxicology 181-182:475-81 (2002)\", \"DOI:10.1016/S0300-483X(02)00460-2\")), list(REFERENCE = \"PMID:10714958\", AUTHORS = \"Tokino T, Nakamura Y.\", TITLE = \"The role of p53-target genes in human cancer.\", JOURNAL = c(\"Crit Rev Oncol Hematol 33:1-6 (2000)\", \"DOI:10.1016/S1040-8428(99)00051-7\")), list(REFERENCE = \"PMID:16697662\", AUTHORS = \"Hermeking H, Benzinger A.\", TITLE = \"14-3-3 proteins in cell cycle regulation.\", JOURNAL = c(\"Semin Cancer Biol 16:183-92 (2006)\", \"DOI:10.1016/j.semcancer.2006.03.002\")), list(REFERENCE = \"PMID:16915296\", AUTHORS = \"Sherr CJ.\", TITLE = \"Divorcing ARF and p53: an unsettled case.\", JOURNAL = c(\"Nat Rev Cancer 6:663-73 (2006)\", \"DOI:10.1038/nrc1954\")), list(REFERENCE = \"PMID:17409411\", AUTHORS = \"Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ.\", TITLE = \"The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.\", JOURNAL = c(\"Cancer Res 67:3043-53 (2007)\", \"DOI:10.1158/0008-5472.CAN-06-4149\")), list(REFERENCE = \"PMID:26037915\", AUTHORS = \"Resnick-Silverman L, Manfredi JJ\", TITLE = \"Two Faces of SIVA.\", JOURNAL = c(\"Cancer Discov 5:581-3 (2015)\", \"DOI:10.1158/2159-8290.CD-15-0484\")), list(REFERENCE = \"PMID:19584092\", AUTHORS = \"Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R\", TITLE = \"Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.\", JOURNAL = c(\"J Cell Sci 122:2651-61 (2009)\", \"DOI:10.1242/jcs.049940\")), list(REFERENCE = \"PMID:19240372\", AUTHORS = \"Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV\", TITLE = \"The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis.\", JOURNAL = c(\"J Carcinog 8:2 (2009)\", \"DOI:10.4103/1477-3163.45389\")), list(REFERENCE = \"PMID:12135761\", AUTHORS = \"Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N\", TITLE = \"A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).\", JOURNAL = c(\"FEBS Lett 524:163-71 (2002)\", \"DOI:10.1016/S0014-5793(02)03049-1\"))', 'map04115', 'p53 signaling pathway', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (248, '04120', 'Ubiquitin mediated proteolysis', 'Protein ubiquitination plays an important role in eukaryotic cellular processes. It mainly functions as a signal for 26S proteasome dependent protein degradation. The addition of ubiquitin to proteins being degraded is performed by a reaction cascade consisting of three enzymes, named E1 (ubiquitin activating enzyme), E2 (ubiquitin conjugating enzyme), and E3 (ubiquitin ligase). Each E3 has specificity to its substrate, or proteins to be targeted by ubiquitination. Many E3s are discovered in eukaryotes and they are classified into four types: HECT type, U-box type, single RING-finger type, and multi-subunit RING-finger type. Multi-subunit RING-finger E3s are exemplified by cullin-Rbx E3s and APC/C. They consist of a RING-finger-containing subunit (RBX1 or RBX2) that functions to bind E2s, a scaffold-like cullin molecule, adaptor proteins, and a target recognizing subunit that binds substrates.', 'Genetic Information Processing; Folding, sorting and degradation', 'Ubiquitin mediated proteolysis', '3M syndrome, von Hippel-Lindau syndrome, Opitz-GBBB syndrome, Limb-girdle muscular dystrophy, Syndromic X-linked mental retardation, Syndromic multisystem autoimmune disease, Mulibrey nanism, Angelman syndrome, UV-sensitive syndrome, Macrocephaly, dysmorphic facies, and psychomotor retardation', 'GO: 0016567', 'ko04120', 'list(REFERENCE = \"PMID:16922370 (Japanese)\", AUTHORS = \"Kamura T.\", TITLE = \"[Cullin-based E3 family] Japanese\", JOURNAL = \"Tanpakushitsu Kakusan Koso 51:1167-72 (2006)\"), list(REFERENCE = \"PMID:16922408 (Japanese)\", AUTHORS = \"Matsuda N.\", TITLE = \"[Overview: hereditary disorders caused by dysfunction of ubiquitylation]\", JOURNAL = \"Tanpakushitsu Kakusan Koso 51:1402-7 (2006)\"), list(REFERENCE = \"PMID:16922367 (Japanese)\", AUTHORS = \"Tokunaga F.\", TITLE = \"[E2 ubiquitin-conjugating enzymes: structures and functions]\", JOURNAL = \"Tanpakushitsu Kakusan Koso 51:1150-6 (2006)\"), list(REFERENCE = \"PMID:16816840\", AUTHORS = \"Nalepa G, Rolfe M, Harper JW.\", TITLE = \"Drug discovery in the ubiquitin-proteasome system.\", JOURNAL = c(\"Nat Rev Drug Discov 5:596-613 (2006)\", \"DOI:10.1038/nrd2056\")), list(REFERENCE = \"PMID:16405856\", AUTHORS = \"Hsu YJ, Goodman SR.\", TITLE = \"Spectrin and ubiquitination: a review.\", JOURNAL = \"Cell Mol Biol (Noisy-le-grand) Suppl 51:OL801-7 (2005)\"), list(REFERENCE = \"PMID:12944364\", AUTHORS = \"Hatakeyama S, Nakayama KI.\", TITLE = \"Ubiquitylation as a quality control system for intracellular proteins.\", JOURNAL = c(\"J Biochem 134:1-8 (2003)\", \"DOI:10.1093/jb/mvg106\")), list(REFERENCE = \"PMID:17588513\", AUTHORS = \"Lee J, Zhou P.\", TITLE = \"DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase.\", JOURNAL = c(\"Mol Cell 26:775-80 (2007)\", \"DOI:10.1016/j.molcel.2007.06.001\"))', 'map04120', 531, 0, 248, 105, 128, 50, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (249, '04122', 'Sulfur relay system', 'Ubiquitin and ubiquitin-like proteins (Ubls) are signalling messengers that control many cellular functions, such as cell proliferation, apoptosis, and DNA repair. It is suggested that Ub-protein modification evolved from prokaryotic sulfurtransfer systems. Molybdenum cofactor (Moco) and thiamin are sulfur-containing cofactors whose biosynthesis includes a key sulfur transfer step that uses unique sulfur carrier proteins, MoaD and ThiS. Ubiquitin, MoaD, and ThiS are all structurally related proteins whose C-termini are activated through adenylation by homologous E1-like enzymes. s2T biosynthesis may share similar chemistry with Moco and thiamin synthesis. In Saccharomyces cerevisiae, Urm1 and Uba4 function as part of a ubl protein conjugation system, though they have sequence homology to bacterial sulfur-transfer enzymes and the ability to function in sulfur transfer.', 'Genetic Information Processing; Folding, sorting and degradation', 'Sulfur relay system', 'Xanthinuria, Infantile liver failure', 'ko04122', 'list(REFERENCE = \"PMID:19151091\", AUTHORS = \"Noma A, Sakaguchi Y, Suzuki T\", TITLE = \"Mechanistic characterization of the sulfur-relay system for eukaryotic 2-thiouridine biogenesis at tRNA wobble positions.\", JOURNAL = c(\"Nucleic Acids Res 37:1335-52 (2009)\", \"DOI:10.1093/nar/gkn1023\")), list(REFERENCE = \"PMID:16859499\", AUTHORS = \"Iyer LM, Burroughs AM, Aravind L\", TITLE = \"The prokaryotic antecedents of the ubiquitin-signaling system and the early evolution of ubiquitin-like beta-grasp domains.\", JOURNAL = c(\"Genome Biol 7:R60 (2006)\", \"DOI:10.1186/gb-2006-7-7-r60\")), list(REFERENCE = \"PMID:19675644\", AUTHORS = \"Schwarz G, Mendel RR, Ribbe MW\", TITLE = \"Molybdenum cofactors, enzymes and pathways.\", JOURNAL = c(\"Nature 460:839-47 (2009)\", \"DOI:10.1038/nature08302\"))', 'map04122', 'Sulfur relay system', 530, 5404, 248, 105, 128, 49, 5107, 297);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (250, '04130', 'SNARE interactions in vesicular transport', 'Genetic Information Processing; Folding, sorting and degradation', 'SNARE interactions in vesicular transport', 'Pseudohypoparathyroidism, CEDNIK syndrome', 'ko04130', 'list(REFERENCE = \"PMID:16882042\", AUTHORS = \"Yoshizawa AC, Kawashima S, Okuda S, Fujita M, Itoh M, Moriya Y, Hattori M, Kanehisa M\", TITLE = \"Extracting sequence motifs and the phylogenetic features of SNARE-dependent membrane traffic.\", JOURNAL = c(\"Traffic 7:1104-18 (2006)\", \"DOI:10.1111/j.1600-0854.2006.00451.x\")), list(REFERENCE = \"PMID:10839363\", AUTHORS = \"Scales SJ, Chen YA, Yoo BY, Patel SM, Doung YC, Scheller RH.\", TITLE = \"SNAREs contribute to the specificity of membrane fusion.\", JOURNAL = c(\"Neuron 26:457-64 (2000)\", \"DOI:10.1016/S0896-6273(00)81177-0\")), list(REFERENCE = \"PMID:11737951\", AUTHORS = \"Teng FY, Wang Y, Tang BL.\", TITLE = \"The syntaxins.\", JOURNAL = c(\"Genome Biol 2:REVIEWS3012 (2001)\", \"DOI:10.1186/gb-2001-2-11-reviews3012\")), list(REFERENCE = \"PMID:11115874\", AUTHORS = \"Sanderfoot AA, Assaad FF, Raikhel NV.\", TITLE = \"The Arabidopsis genome. An abundance of soluble N-ethylmaleimide-sensitive factor adaptor protein receptors.\", JOURNAL = c(\"Plant Physiol 124:1558-69 (2000)\", \"DOI:10.1104/pp.124.4.1558\")), list(REFERENCE = \"PMID:15342965\", AUTHORS = \"Uemura T, Ueda T, Ohniwa RL, Nakano A, Takeyasu K, Sato MH.\", TITLE = \"Systematic analysis of SNARE molecules in Arabidopsis: dissection of the post-Golgi network in plant cells.\", JOURNAL = c(\"Cell Struct Funct 29:49-65 (2004)\", \"DOI:10.1247/csf.29.49\")), list(REFERENCE = \"PMID:10872468\", AUTHORS = \"Jahn R, Sudhof TC.\", TITLE = \"Membrane fusion and exocytosis.\", JOURNAL = c(\"Annu Rev Biochem 68:863-911 (1999)\", \"DOI:10.1146/annurev.biochem.68.1.863\")), list(REFERENCE = \"PMID:11306253\", AUTHORS = \"Pelham HR.\", TITLE = \"SNAREs and the specificity of membrane fusion.\", JOURNAL = c(\"Trends Cell Biol 11:99-101 (2001)\", \"DOI:10.1016/S0962-8924(01)01929-8\")), list(REFERENCE = \"PMID:11104523\", AUTHORS = \"Armstrong J\", TITLE = \"Membrane traffic between genomes.\", JOURNAL = c(\"Genome Biol 1:REVIEWS104 (2000)\", \"DOI:10.1186/gb-2000-1-1-reviews104\")), list(REFERENCE = \"PMID:11237004\", AUTHORS = \"Bock JB, Matern HT, Peden AA, Scheller RH.\", TITLE = \"A genomic perspective on membrane compartment organization.\", JOURNAL = c(\"Nature 409:839-41 (2001)\", \"DOI:10.1038/35057024\")), list(REFERENCE = \"PMID:11252968\", AUTHORS = \"Chen YA, Scheller RH.\", TITLE = \"SNARE-mediated membrane fusion.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 2:98-106 (2001)\", \"DOI:10.1038/35052017\")), list(REFERENCE = \"PMID:9763449\", AUTHORS = \"Seron K, Tieaho V, Prescianotto-Baschong C, Aust T, Blondel MO, Guillaud P, Devilliers G, Rossanese OW, Glick BS, Riezman H, Keranen S, Haguenauer-Tsapis R.\", TITLE = \"A yeast t-SNARE involved in endocytosis.\", JOURNAL = c(\"Mol Biol Cell 9:2873-89 (1998)\", \"DOI:10.1091/mbc.9.10.2873\")), list(REFERENCE = \"PMID:10213783\", AUTHORS = \"Sanderfoot AA, Raikhel NV.\", TITLE = \"The specificity of vesicle trafficking: coat proteins and SNAREs.\", JOURNAL = c(\"Plant Cell 11:629-42 (1999)\", \"DOI:10.1105/tpc.11.4.629\")), list(REFERENCE = \"PMID:9565594\", AUTHORS = \"Abeliovich H, Grote E, Novick P, Ferro-Novick S.\", TITLE = \"Tlg2p, a yeast syntaxin homolog that resides on the Golgi and endocytic structures.\", JOURNAL = c(\"J Biol Chem 273:11719-27 (1998)\", \"DOI:10.1074/jbc.273.19.11719\")), list(REFERENCE = \"PMID:9553086\", AUTHORS = \"Advani RJ, Bae HR, Bock JB, Chao DS, Doung YC, Prekeris R, Yoo JS, Scheller RH.\", TITLE = \"Seven novel mammalian SNARE proteins localize to distinct membrane compartments.\", JOURNAL = c(\"J Biol Chem 273:10317-24 (1998)\", \"DOI:10.1074/jbc.273.17.10317\")), list(REFERENCE = \"PMID:10459012\", AUTHORS = \"Advani RJ, Yang B, Prekeris R, Lee KC, Klumperman J, Scheller RH.\", TITLE = \"VAMP-7 mediates vesicular transport from endosomes to lysosomes.\", JOURNAL = c(\"J Cell Biol 146:765-76 (1999)\", \"DOI:10.1083/jcb.146.4.765\")), list(REFERENCE = \"PMID:12893879\", AUTHORS = \"Burri L, Varlamov O, Doege CA, Hofmann K, Beilharz T, Rothman JE, Sollner TH, Lithgow T.\", TITLE = \"A SNARE required for retrograde transport to the endoplasmic reticulum.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 100:9873-7 (2003)\", \"DOI:10.1073/pnas.1734000100\")), list(REFERENCE = \"PMID:10085287\", AUTHORS = \"Chao DS, Hay JC, Winnick S, Prekeris R, Klumperman J, Scheller RH.\", TITLE = \"SNARE membrane trafficking dynamics in vivo.\", JOURNAL = c(\"J Cell Biol 144:869-81 (1999)\", \"DOI:10.1083/jcb.144.5.869\")), list(REFERENCE = \"PMID:10397773\", AUTHORS = \"Coe JG, Lim AC, Xu J, Hong W.\", TITLE = \"A role for Tlg1p in the transport of proteins within the Golgi apparatus of Saccharomyces cerevisiae.\", JOURNAL = c(\"Mol Biol Cell 10:2407-23 (1999)\", \"DOI:10.1091/mbc.10.7.2407\")), list(REFERENCE = \"PMID:11445562\", AUTHORS = \"Dilcher M, Kohler B, von Mollard GF.\", TITLE = \"Genetic interactions with the yeast Q-SNARE VTI1 reveal novel functions for the R-SNARE YKT6.\", JOURNAL = c(\"J Biol Chem 276:34537-44 (2001)\", \"DOI:10.1074/jbc.M101551200\")), list(REFERENCE = \"PMID:12853481\", AUTHORS = \"Dilcher M, Veith B, Chidambaram S, Hartmann E, Schmitt HD, Fischer von Mollard G.\", TITLE = \"Use1p is a yeast SNARE protein required for retrograde traffic to the ER.\", JOURNAL = c(\"EMBO J 22:3664-74 (2003)\", \"DOI:10.1093/emboj/cdg339\")), list(REFERENCE = \"PMID:9446565\", AUTHORS = \"Fischer von Mollard G, Stevens TH.\", TITLE = \"A human homolog can functionally replace the yeast vesicle-associated SNARE Vti1p in two vesicle transport pathways.\", JOURNAL = c(\"J Biol Chem 273:2624-30 (1998)\", \"DOI:10.1074/jbc.273.5.2624\")), list(REFERENCE = \"PMID:10359592\", AUTHORS = \"Fischer von Mollard G, Stevens TH.\", TITLE = \"The Saccharomyces cerevisiae v-SNARE Vti1p is required for multiple membrane transport pathways to the vacuole.\", JOURNAL = c(\"Mol Biol Cell 10:1719-32 (1999)\", \"DOI:10.1091/mbc.10.6.1719\")), list(REFERENCE = \"PMID:9614185\", AUTHORS = \"Galli T, Zahraoui A, Vaidyanathan VV, Raposo G, Tian JM, Karin M, Niemann H, Louvard D.\", TITLE = \"A novel tetanus neurotoxin-insensitive vesicle-associated membrane protein in SNARE complexes of the apical plasma membrane of epithelial cells.\", JOURNAL = c(\"Mol Biol Cell 9:1437-48 (1998)\", \"DOI:10.1091/mbc.9.6.1437\")), list(REFERENCE = \"PMID:11208059\", AUTHORS = \"Gerrard SR, Mecklem AB, Stevens TH.\", TITLE = \"The yeast endosomal t-SNARE, Pep12p, functions in the absence of its transmembrane domain.\", JOURNAL = c(\"Traffic 1:45-55 (2000)\", \"DOI:10.1034/j.1600-0854.2000.010108.x\")), list(REFERENCE = \"PMID:10379359\", AUTHORS = \"Gerst JE.\", TITLE = \"SNAREs and SNARE regulators in membrane fusion and exocytosis.\", JOURNAL = c(\"Cell Mol Life Sci 55:707-34 (1999)\", \"DOI:10.1007/s000180050328\")), list(REFERENCE = \"PMID:11029060\", AUTHORS = \"Gurunathan S, Chapman-Shimshoni D, Trajkovic S, Gerst JE.\", TITLE = \"Yeast exocytic v-SNAREs confer endocytosis.\", JOURNAL = c(\"Mol Biol Cell 11:3629-43 (2000)\", \"DOI:10.1091/mbc.11.10.3629\")), list(REFERENCE = \"PMID:10788491\", AUTHORS = \"Hatsuzawa K, Hirose H, Tani K, Yamamoto A, Scheller RH, Tagaya M.\", TITLE = \"Syntaxin 18, a SNAP receptor that functions in the endoplasmic reticulum, intermediate compartment, and cis-Golgi vesicle trafficking.\", JOURNAL = c(\"J Biol Chem 275:13713-20 (2000)\", \"DOI:10.1074/jbc.275.18.13713\")), list(REFERENCE = \"PMID:8621431\", AUTHORS = \"Hay JC, Hirling H, Scheller RH.\", TITLE = \"Mammalian vesicle trafficking proteins of the endoplasmic reticulum and Golgi apparatus.\", JOURNAL = c(\"J Biol Chem 271:5671-9 (1996)\", \"DOI:10.1074/jbc.271.10.5671\")), list(REFERENCE = \"PMID:9647643\", AUTHORS = \"Hay JC, Klumperman J, Oorschot V, Steegmaier M, Kuo CS, Scheller RH.\", TITLE = \"Localization, dynamics, and protein interactions reveal distinct roles for ER and Golgi SNAREs.\", JOURNAL = c(\"J Cell Biol 141:1489-502 (1998)\", \"DOI:10.1083/jcb.141.7.1489\")), list(REFERENCE = \"PMID:9427746\", AUTHORS = \"Holthuis JC, Nichols BJ, Dhruvakumar S, Pelham HR.\", TITLE = \"Two syntaxin homologues in the TGN/endosomal system of yeast.\", JOURNAL = c(\"EMBO J 17:113-26 (1998)\", \"DOI:10.1093/emboj/17.1.113\")), list(REFERENCE = \"PMID:9843576\", AUTHORS = \"Holthuis JC, Nichols BJ, Pelham HR.\", TITLE = \"The syntaxin Tlg1p mediates trafficking of chitin synthase III to polarized growth sites in yeast.\", JOURNAL = c(\"Mol Biol Cell 9:3383-97 (1998)\", \"DOI:10.1091/mbc.9.12.3383\")), list(REFERENCE = \"PMID:12600315\", AUTHORS = \"Jahn R, Lang T, Sudhof TC.\", TITLE = \"Membrane fusion.\", JOURNAL = c(\"Cell 112:519-33 (2003)\", \"DOI:10.1016/S0092-8674(03)00112-0\")), list(REFERENCE = \"PMID:10097106\", AUTHORS = \"Lafont F, Verkade P, Galli T, Wimmer C, Louvard D, Simons K.\", TITLE = \"Raft association of SNAP receptors acting in apical trafficking in Madin-Darby canine kidney cells.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 96:3734-8 (1999)\", \"DOI:10.1073/pnas.96.7.3734\")), list(REFERENCE = \"PMID:9214619\", AUTHORS = \"Lewis MJ, Rayner JC, Pelham HR.\", TITLE = \"A novel SNARE complex implicated in vesicle fusion with the endoplasmic reticulum.\", JOURNAL = c(\"EMBO J 16:3017-24 (1997)\", \"DOI:10.1093/emboj/16.11.3017\")), list(REFERENCE = \"PMID:9647644\", AUTHORS = \"Low SH, Chapin SJ, Wimmer C, Whiteheart SW, Komuves LG, Mostov KE, Weimbs T.\", TITLE = \"The SNARE machinery is involved in apical plasma membrane trafficking in MDCK cells.\", JOURNAL = c(\"J Cell Biol 141:1503-13 (1998)\", \"DOI:10.1083/jcb.141.7.1503\")), list(REFERENCE = \"PMID:9452464\", AUTHORS = \"Low SH, Roche PA, Anderson HA, van Ijzendoorn SC, Zhang M, Mostov KE, Weimbs T.\", TITLE = \"Targeting of SNAP-23 and SNAP-25 in polarized epithelial cells.\", JOURNAL = c(\"J Biol Chem 273:3422-30 (1998)\", \"DOI:10.1074/jbc.273.6.3422\")), list(REFERENCE = \"PMID:12669082\", AUTHORS = \"Mostov K, Su T, ter Beest M.\", TITLE = \"Polarized epithelial membrane traffic: conservation and plasticity.\", JOURNAL = c(\"Nat Cell Biol 5:287-93 (2003)\", \"DOI:10.1038/ncb0403-287\")), list(REFERENCE = \"PMID:10873817\", AUTHORS = \"Mostov KE, Verges M, Altschuler Y.\", TITLE = \"Membrane traffic in polarized epithelial cells.\", JOURNAL = c(\"Curr Opin Cell Biol 12:483-90 (2000)\", \"DOI:10.1016/S0955-0674(00)00120-4\")), list(REFERENCE = \"PMID:10982406\", AUTHORS = \"Mullock BM, Smith CW, Ihrke G, Bright NA, Lindsay M, Parkinson EJ, Brooks DA, Parton RG, James DE, Luzio JP, Piper RC.\", TITLE = \"Syntaxin 7 is localized to late endosome compartments, associates with Vamp 8, and Is required for late endosome-lysosome fusion.\", JOURNAL = c(\"Mol Biol Cell 11:3137-53 (2000)\", \"DOI:10.1091/mbc.11.9.3137\")), list(REFERENCE = \"PMID:9817754\", AUTHORS = \"Prekeris R, Klumperman J, Chen YA, Scheller RH.\", TITLE = \"Syntaxin 13 mediates cycling of plasma membrane proteins via tubulovesicular recycling endosomes.\", JOURNAL = c(\"J Cell Biol 143:957-71 (1998)\", \"DOI:10.1083/jcb.143.4.957\")), list(REFERENCE = \"PMID:10564279\", AUTHORS = \"Prekeris R, Yang B, Oorschot V, Klumperman J, Scheller RH.\", TITLE = \"Differential roles of syntaxin 7 and syntaxin 8 in endosomal trafficking.\", JOURNAL = c(\"Mol Biol Cell 10:3891-908 (1999)\", \"DOI:10.1091/mbc.10.11.3891\")), list(REFERENCE = \"PMID:9707576\", AUTHORS = \"Sanderfoot AA, Ahmed SU, Marty-Mazars D, Rapoport I, Kirchhausen T, Marty F, Raikhel NV.\", TITLE = \"A putative vacuolar cargo receptor partially colocalizes with AtPEP12p on a prevacuolar compartment in Arabidopsis roots.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 95:9920-5 (1998)\", \"DOI:10.1073/pnas.95.17.9920\")), list(REFERENCE = \"PMID:11739776\", AUTHORS = \"Sanderfoot AA, Kovaleva V, Bassham DC, Raikhel NV.\", TITLE = \"Interactions between syntaxins identify at least five SNARE complexes within the Golgi/prevacuolar system of the Arabidopsis cell.\", JOURNAL = c(\"Mol Biol Cell 12:3733-43 (2001)\", \"DOI:10.1091/mbc.12.12.3733\")), list(REFERENCE = \"PMID:10557242\", AUTHORS = \"Sanderfoot AA, Kovaleva V, Zheng H, Raikhel NV.\", TITLE = \"The t-SNARE AtVAM3p resides on the prevacuolar compartment in Arabidopsis root cells.\", JOURNAL = c(\"Plant Physiol 121:929-38 (1999)\", \"DOI:10.1104/pp.121.3.929\")), list(REFERENCE = \"PMID:11251103\", AUTHORS = \"Sanderfoot AA, Pilgrim M, Adam L, Raikhel NV.\", TITLE = \"Disruption of individual members of Arabidopsis syntaxin gene families indicates each has essential functions.\", JOURNAL = c(\"Plant Cell 13:659-66 (2001)\", \"DOI:10.1105/tpc.13.3.659\")), list(REFERENCE = \"PMID:9305917\", AUTHORS = \"Sato MH, Nakamura N, Ohsumi Y, Kouchi H, Kondo M, Hara-Nishimura I, Nishimura M, Wada Y.\", TITLE = \"The AtVAM3 encodes a syntaxin-related molecule implicated in the vacuolar assembly in Arabidopsis thaliana.\", JOURNAL = c(\"J Biol Chem 272:24530-5 (1997)\", \"DOI:10.1074/jbc.272.39.24530\")), list(REFERENCE = \"PMID:9710615\", AUTHORS = \"Sato TK, Darsow T, Emr SD.\", TITLE = \"Vam7p, a SNAP-25-like molecule, and Vam3p, a syntaxin homolog, function together in yeast vacuolar protein trafficking.\", JOURNAL = c(\"Mol Cell Biol 18:5308-19 (1998)\", \"DOI:10.1128/MCB.18.9.5308\")), list(REFERENCE = \"PMID:9813082\", AUTHORS = \"Spang A, Schekman R.\", TITLE = \"Reconstitution of retrograde transport from the Golgi to the ER in vitro.\", JOURNAL = c(\"J Cell Biol 143:589-99 (1998)\", \"DOI:10.1083/jcb.143.3.589\")), list(REFERENCE = \"PMID:10359608\", AUTHORS = \"Steegmaier M, Klumperman J, Foletti DL, Yoo JS, Scheller RH.\", TITLE = \"Vesicle-associated membrane protein 4 is implicated in trans-Golgi network vesicle trafficking.\", JOURNAL = c(\"Mol Biol Cell 10:1957-72 (1999)\", \"DOI:10.1091/mbc.10.6.1957\")), list(REFERENCE = \"PMID:11208143\", AUTHORS = \"Steegmaier M, Lee KC, Prekeris R, Scheller RH.\", TITLE = \"SNARE protein trafficking in polarized MDCK cells.\", JOURNAL = c(\"Traffic 1:553-60 (2000)\", \"DOI:10.1034/j.1600-0854.2000.010705.x\")), list(REFERENCE = \"PMID:9852078\", AUTHORS = \"Steegmaier M, Yang B, Yoo JS, Huang B, Shen M, Yu S, Luo Y, Scheller RH.\", TITLE = \"Three novel proteins of the syntaxin/SNAP-25 family.\", JOURNAL = c(\"J Biol Chem 273:34171-9 (1998)\", \"DOI:10.1074/jbc.273.51.34171\")), list(REFERENCE = \"PMID:10683148\", AUTHORS = \"Subramaniam VN, Loh E, Horstmann H, Habermann A, Xu Y, Coe J, Griffiths G, Hong W.\", TITLE = \"Preferential association of syntaxin 8 with the early endosome.\", JOURNAL = \"J Cell Sci 113 ( Pt 6):997-1008 (2000)\"), list(REFERENCE = \"PMID:9507000\", AUTHORS = \"Tang BL, Tan AE, Lim LK, Lee SS, Low DY, Hong W.\", TITLE = \"Syntaxin 12, a member of the syntaxin family localized to the endosome.\", JOURNAL = c(\"J Biol Chem 273:6944-50 (1998)\", \"DOI:10.1074/jbc.273.12.6944\")), list(REFERENCE = \"PMID:9628864\", AUTHORS = \"Ungermann C, Wickner W.\", TITLE = \"Vam7p, a vacuolar SNAP-25 homolog, is required for SNARE complex integrity and vacuole docking and fusion.\", JOURNAL = c(\"EMBO J 17:3269-76 (1998)\", \"DOI:10.1093/emboj/17.12.3269\")), list(REFERENCE = \"PMID:10036234\", AUTHORS = \"Valdez AC, Cabaniols JP, Brown MJ, Roche PA.\", TITLE = \"Syntaxin 11 is associated with SNAP-23 on late endosomes and the trans-Golgi network.\", JOURNAL = \"J Cell Sci 112 ( Pt 6):845-54 (1999)\"), list(REFERENCE = \"PMID:9199167\", AUTHORS = \"von Mollard GF, Nothwehr SF, Stevens TH.\", TITLE = \"The yeast v-SNARE Vti1p mediates two vesicle transport pathways through interactions with the t-SNAREs Sed5p and Pep12p.\", JOURNAL = c(\"J Cell Biol 137:1511-24 (1997)\", \"DOI:10.1083/jcb.137.7.1511\")), list(REFERENCE = \"PMID:11278762\", AUTHORS = \"Wade N, Bryant NJ, Connolly LM, Simpson RJ, Luzio JP, Piper RC, James DE.\", TITLE = \"Syntaxin 7 complexes with mouse Vps10p tail interactor 1b, syntaxin 6, vesicle-associated membrane protein (VAMP)8, and VAMP7 in b16 melanoma cells.\", JOURNAL = c(\"J Biol Chem 276:19820-7 (2001)\", \"DOI:10.1074/jbc.M010838200\")), list(REFERENCE = \"PMID:11555414\", AUTHORS = \"Wendler F, Tooze S.\", TITLE = \"Syntaxin 6: the promiscuous behaviour of a SNARE protein.\", JOURNAL = c(\"Traffic 2:606-11 (2001)\", \"DOI:10.1034/j.1600-0854.2001.20903.x\")), list(REFERENCE = \"PMID:9614193\", AUTHORS = \"Wong SH, Zhang T, Xu Y, Subramaniam VN, Griffiths G, Hong W.\", TITLE = \"Endobrevin, a novel synaptobrevin/VAMP-like protein preferentially associated with the early endosome.\", JOURNAL = c(\"Mol Biol Cell 9:1549-63 (1998)\", \"DOI:10.1091/mbc.9.6.1549\")), list(REFERENCE = \"PMID:11035026\", AUTHORS = \"Xu D, Joglekar AP, Williams AL, Hay JC.\", TITLE = \"Subunit structure of a mammalian ER/Golgi SNARE complex.\", JOURNAL = c(\"J Biol Chem 275:39631-9 (2000)\", \"DOI:10.1074/jbc.M007684200\")), list(REFERENCE = \"PMID:11323436\", AUTHORS = \"Zhang T, Hong W.\", TITLE = \"Ykt6 forms a SNARE complex with syntaxin 5, GS28, and Bet1 and participates in a late stage in endoplasmic reticulum-Golgi transport.\", JOURNAL = c(\"J Biol Chem 276:27480-7 (2001)\", \"DOI:10.1074/jbc.M102786200\")), list(REFERENCE = \"PMID:12068098\", AUTHORS = \"Zheng H, Bednarek SY, Sanderfoot AA, Alonso J, Ecker JR, Raikhel NV.\", TITLE = \"NPSN11 is a cell plate-associated SNARE protein that interacts with the syntaxin KNOLLE.\", JOURNAL = c(\"Plant Physiol 129:530-9 (2002)\", \"DOI:10.1104/pp.003970\")), list(REFERENCE = \"PMID:10397763\", AUTHORS = \"Zheng H, von Mollard GF, Kovaleva V, Stevens TH, Raikhel NV.\", TITLE = \"The plant vesicle-associated SNARE AtVTI1a likely mediates vesicle transport from the trans-Golgi network to the prevacuolar compartment.\", JOURNAL = c(\"Mol Biol Cell 10:2251-64 (1999)\", \"DOI:10.1091/mbc.10.7.2251\"))', 'map04130', 'SNARE interactions in vesicular transport', 'Genetic Information Processing; Folding, sorting and degradation', 530, 0, 248, 105, 128, 49, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (251, '04136', 'Autophagy - other', 'Autophagy is a degradative pathway for the removal of cytoplasmic materials in eukaryotic cells, and is characterized by the formation of a double-membrane structure called the autophagosome, either in a housekeeping capacity or during stress and senescence. The process of autophagy could be divided into several stages: induction, vesicle nucleation, elongation and closure, and fusion and digestion. Most essential autophagic machineries are conserved throughout eukaryotes (see map04140 for animals and map04138 for fungi). This map is for other eukaryotes including plants and protists, where autophagy related genes (ATGs) play similar roles in the life cycle. However, autophagy has been relatively less studied in lower eukaryotes.', 'Cellular Processes; Transport and catabolism', 'Autophagy - other', 'GO: 0006914', 'ko04136', 'list(REFERENCE = \"PMID:20962583\", AUTHORS = \"Duszenko M, Ginger ML, Brennand A, Gualdron-Lopez M, Colombo MI, Coombs GH, Coppens I, Jayabalasingham B, Langsley G, de Castro SL, Menna-Barreto R, Mottram JC, Navarro M, Rigden DJ, Romano PS, Stoka V, Turk B, Michels PA\", TITLE = \"Autophagy in protists.\", JOURNAL = c(\"Autophagy 7:127-58 (2011)\", \"DOI:10.4161/auto.7.2.13310\")), list(REFERENCE = \"PMID:21660427\", AUTHORS = \"Avin-Wittenberg T, Honig A, Galili G\", TITLE = \"Variations on a theme: plant autophagy in comparison to yeast and mammals.\", JOURNAL = c(\"Protoplasma 249:285-99 (2012)\", \"DOI:10.1007/s00709-011-0296-z\")), list(REFERENCE = \"PMID:22242963\", AUTHORS = \"Liu Y, Bassham DC\", TITLE = \"Autophagy: pathways for self-eating in plant cells.\", JOURNAL = c(\"Annu Rev Plant Biol 63:215-37 (2012)\", \"DOI:10.1146/annurev-arplant-042811-105441\")), list(REFERENCE = \"PMID:22764279\", AUTHORS = \"Yoshimoto K\", TITLE = \"Beginning to understand autophagy, an intracellular self-degradation system in plants.\", JOURNAL = c(\"Plant Cell Physiol 53:1355-65 (2012)\", \"DOI:10.1093/pcp/pcs099\")), list(REFERENCE = \"PMID:24563201\", AUTHORS = \"Li F, Chung T, Vierstra RD\", TITLE = \"AUTOPHAGY-RELATED11 plays a critical role in general autophagy- and senescence-induced mitophagy in Arabidopsis.\", JOURNAL = c(\"Plant Cell 26:788-807 (2014)\", \"DOI:10.1105/tpc.113.120014\")), list(REFERENCE = \"PMID:26598298\", AUTHORS = \"Michaeli S, Galili G, Genschik P, Fernie AR, Avin-Wittenberg T\", TITLE = \"Autophagy in Plants--What\'s New on the Menu?\", JOURNAL = c(\"Trends Plant Sci 21:134-44 (2016)\", \"DOI:10.1016/j.tplants.2015.10.008\")), list(REFERENCE = \"PMID:26614870\", AUTHORS = \"Yang X, Bassham DC\", TITLE = \"New Insight into the Mechanism and Function of Autophagy in Plant Cells.\", JOURNAL = c(\"Int Rev Cell Mol Biol 320:1-40 (2015)\", \"DOI:10.1016/bs.ircmb.2015.07.005\"))', 'map04136', 'Autophagy - other', 529, 0, 248, 105, 127, 49, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (252, '04137', 'Mitophagy - animal', 'Mitochondria act as the energy powerhouse of the cell, and are essential for eukaryotic cells to grow and function normally. However, deleterious byproducts of oxidative phosphorylation process called reactive oxidative species (ROS) lead to mitochondrial dysfunction. If the damage is too excessive to be repaired, such mitochondria are selectively recognized and targeted for degradation by a specific mode of autophagy, termed mitophagy. The loss of the mitochondrial membrane potential can induce mitophagy, involving the kinase PINK1 and the E3 ligase Parkin. PINK1 serves as the sensor for the mitochondrial depolarization and recruits Parkin, followed by ubiquitin-dependent recruitment of mitophagy receptors. There are also several PINK1/Parkin-independent mitophagy pathways, in which a group of LIR-containing receptors are required in response to different stimuli. Mitophagy contributes to the maintenance of a healthy mitochondrial network and the prevention of programmed cell death.', 'Cellular Processes; Transport and catabolism', 'Mitophagy - animal', 'GO: 0000422', 'ko04137', 'list(REFERENCE = \"PMID:25611507\", AUTHORS = \"Pickrell AM, Youle RJ\", TITLE = \"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\'s disease.\", JOURNAL = c(\"Neuron 85:257-73 (2015)\", \"DOI:10.1016/j.neuron.2014.12.007\")), list(REFERENCE = \"PMID:25995186\", AUTHORS = \"Durcan TM, Fon EA\", TITLE = \"The three \'P\'s of mitophagy: PARKIN, PINK1, and post-translational modifications.\", JOURNAL = c(\"Genes Dev 29:989-99 (2015)\", \"DOI:10.1101/gad.262758.115\")), list(REFERENCE = \"PMID:25999423\", AUTHORS = \"Shirihai OS, Song M, Dorn GW 2nd\", TITLE = \"How mitochondrial dynamism orchestrates mitophagy.\", JOURNAL = c(\"Circ Res 116:1835-49 (2015)\", \"DOI:10.1161/CIRCRESAHA.116.306374\")), list(REFERENCE = \"PMID:26611876\", AUTHORS = \"Hamacher-Brady A, Brady NR\", TITLE = \"Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy.\", JOURNAL = c(\"Cell Mol Life Sci 73:775-95 (2016)\", \"DOI:10.1007/s00018-015-2087-8\")), list(REFERENCE = \"PMID:26882551\", AUTHORS = \"Yamano K, Matsuda N, Tanaka K\", TITLE = \"The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradation.\", JOURNAL = c(\"EMBO Rep 17:300-16 (2016)\", \"DOI:10.15252/embr.201541486\")), list(REFERENCE = \"PMID:27021519\", AUTHORS = \"Yamaguchi O, Murakawa T, Nishida K, Otsu K\", TITLE = \"Receptor-mediated mitophagy.\", JOURNAL = c(\"J Mol Cell Cardiol 95:50-6 (2016)\", \"DOI:10.1016/j.yjmcc.2016.03.010\")), list(REFERENCE = \"PMID:27443527\", AUTHORS = \"Roberts RF, Tang MY, Fon EA, Durcan TM\", TITLE = \"Defending the mitochondria: The pathways of mitophagy and mitochondrial-derived vesicles.\", JOURNAL = c(\"Int J Biochem Cell Biol 79:427-436 (2016)\", \"DOI:10.1016/j.biocel.2016.07.020\")), list(REFERENCE = \"PMID:27701735\", AUTHORS = \"Arena G, Valente EM\", TITLE = \"PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease.\", JOURNAL = c(\"J Pathol 241:251-263 (2017)\", \"DOI:10.1002/path.4815\"))', 'map04137', 'Mitophagy - animal', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (253, '04138', 'Autophagy - yeast', 'Autophagy is a non-selective and bulk intracellular degradation system of eukaryotic cells and is highly conserved from yeast to human. In this process, the double-membrane vesicle, known as autophagosome, is formed and sequesters organelles or portions of cytosol. The autophagosome is subsequently fused with the vacuole for breakdown by resident hydrolases, and the resulting metabolites are delivered for reuse. In yeast, nutrient withdrawal is the primary stimulus that induces autophagy. Autophagy plays a central role in normal development and cell homeostasis of yeast.', 'Cellular Processes; Transport and catabolism', 'Autophagy - yeast', 'GO: 0006914', 'ko04138', 'list(REFERENCE = \"PMID:11099404\", AUTHORS = \"Klionsky DJ, Emr SD.\", TITLE = \"Autophagy as a regulated pathway of cellular degradation.\", JOURNAL = c(\"Science 290:1717-21 (2000)\", \"DOI:10.1126/science.290.5497.1717\")), list(REFERENCE = \"PMID:15752997\", AUTHORS = \"Thompson AR, Vierstra RD.\", TITLE = \"Autophagic recycling: lessons from yeast help define the process in plants.\", JOURNAL = c(\"Curr Opin Plant Biol 8:165-73 (2005)\", \"DOI:10.1016/j.pbi.2005.01.013\")), list(REFERENCE = \"PMID:15928708\", AUTHORS = \"Lum JJ, DeBerardinis RJ, Thompson CB.\", TITLE = \"Autophagy in metazoans: cell survival in the land of plenty.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 6:439-48 (2005)\", \"DOI:10.1038/nrm1660\")), list(REFERENCE = \"PMID:15978794\", AUTHORS = \"Reggiori F, Klionsky DJ.\", TITLE = \"Autophagosomes: biogenesis from scratch?\", JOURNAL = c(\"Curr Opin Cell Biol 17:415-22 (2005)\", \"DOI:10.1016/j.ceb.2005.06.007\")), list(REFERENCE = \"PMID:16200202\", AUTHORS = \"Levine B, Yuan J.\", TITLE = \"Autophagy in cell death: an innocent convict?\", JOURNAL = c(\"J Clin Invest 115:2679-88 (2005)\", \"DOI:10.1172/JCI26390\")), list(REFERENCE = \"PMID:19491929\", AUTHORS = \"Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y\", TITLE = \"Dynamics and diversity in autophagy mechanisms: lessons from yeast.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 10:458-67 (2009)\", \"DOI:10.1038/nrm2708\")), list(REFERENCE = \"PMID:19653858\", AUTHORS = \"He C, Klionsky DJ\", TITLE = \"Regulation mechanisms and signaling pathways of autophagy.\", JOURNAL = c(\"Annu Rev Genet 43:67-93 (2009)\", \"DOI:10.1146/annurev-genet-102808-114910\")), list(REFERENCE = \"PMID:19802558\", AUTHORS = \"Yang Z, Klionsky DJ\", TITLE = \"An overview of the molecular mechanism of autophagy.\", JOURNAL = c(\"Curr Top Microbiol Immunol 335:1-32 (2009)\", \"DOI:10.1007/978-3-642-00302-8_1\")), list(REFERENCE = \"PMID:21187343\", AUTHORS = \"Chen Y, Klionsky DJ\", TITLE = \"The regulation of autophagy - unanswered questions.\", JOURNAL = c(\"J Cell Sci 124:161-70 (2011)\", \"DOI:10.1242/jcs.064576\")), list(REFERENCE = \"PMID:21801009\", AUTHORS = \"Mizushima N, Yoshimori T, Ohsumi Y\", TITLE = \"The role of Atg proteins in autophagosome formation.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 27:107-32 (2011)\", \"DOI:10.1146/annurev-cellbio-092910-154005\")), list(REFERENCE = \"PMID:23733851\", AUTHORS = \"Reggiori F, Klionsky DJ\", TITLE = \"Autophagic processes in yeast: mechanism, machinery and regulation.\", JOURNAL = c(\"Genetics 194:341-61 (2013)\", \"DOI:10.1534/genetics.112.149013\")), list(REFERENCE = \"PMID:24928445\", AUTHORS = \"Jin M, Klionsky DJ\", TITLE = \"Regulation of autophagy: modulation of the size and number of autophagosomes.\", JOURNAL = c(\"FEBS Lett 588:2457-63 (2014)\", \"DOI:10.1016/j.febslet.2014.06.015\")), list(REFERENCE = \"PMID:25948417\", AUTHORS = \"Noda NN, Fujioka Y\", TITLE = \"Atg1 family kinases in autophagy initiation.\", JOURNAL = c(\"Cell Mol Life Sci 72:3083-96 (2015)\", \"DOI:10.1007/s00018-015-1917-z\"))', 'map04138', 'Autophagy - yeast', 128, 0, 0, 0, 128, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (254, '04139', 'Mitophagy - yeast', 'Mitophagy, which refers to the selective elimination of impaired or excessive mitochondria, is considered to be the main mechanism for mitochondria quality and quantity control. In yeast, oxidative stress or inhibition of TOR induces expression of Agt32, the indispensable mitochondrial outer membrane receptor. Direct phosphorylation of Atg32 by CK2 triggers mitophagy, and two mitogen-activated protein kinase (MAPK) signal transduction pathways are also important in this process. Atg11 is an adaptor protein for selective autophagy, and recruits the cargo to the phagophore assembly site (PAS), where the autophagosome is generated. Then Atg32-Atg8 interaction enhances the formation of the autophagosome surrounding the mitochondria, which finally fuses with vacuoles for degradation. Atg32-Atg11 interaction may also be regulated by Yme1-mediated processing of Atg32, as well as by mitochondrial fission machinery. Some factors have been suggested to positively or negatively regulate the mitophagy via different mechanisms, including Atg1, Atg33, Mss4, Fmc1, Mdm38, Mip1, and Ubp3-Bre5 deubiquitination complex.', 'Cellular Processes; Transport and catabolism', 'Mitophagy - yeast', 'GO: 0000422', 'ko04139', 'list(REFERENCE = \"PMID:25603537\", AUTHORS = \"Kanki T, Furukawa K, Yamashita S\", TITLE = \"Mitophagy in yeast: Molecular mechanisms and physiological role.\", JOURNAL = c(\"Biochim Biophys Acta 1853:2756-65 (2015)\", \"DOI:10.1016/j.bbamcr.2015.01.005\")), list(REFERENCE = \"PMID:25753536\", AUTHORS = \"Muller M, Lu K, Reichert AS\", TITLE = \"Mitophagy and mitochondrial dynamics in Saccharomyces cerevisiae.\", JOURNAL = c(\"Biochim Biophys Acta 1853:2766-74 (2015)\", \"DOI:10.1016/j.bbamcr.2015.02.024\")), list(REFERENCE = \"PMID:19619494\", AUTHORS = \"Okamoto K, Kondo-Okamoto N, Ohsumi Y\", TITLE = \"Mitochondria-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy.\", JOURNAL = c(\"Dev Cell 17:87-97 (2009)\", \"DOI:10.1016/j.devcel.2009.06.013\")), list(REFERENCE = \"PMID:19619495\", AUTHORS = \"Kanki T, Wang K, Cao Y, Baba M, Klionsky DJ\", TITLE = \"Atg32 is a mitochondrial protein that confers selectivity during mitophagy.\", JOURNAL = c(\"Dev Cell 17:98-109 (2009)\", \"DOI:10.1016/j.devcel.2009.06.014\")), list(REFERENCE = \"PMID:21576396\", AUTHORS = \"Mao K, Wang K, Zhao M, Xu T, Klionsky DJ\", TITLE = \"Two MAPK-signaling pathways are required for mitophagy in Saccharomyces cerevisiae.\", JOURNAL = c(\"J Cell Biol 193:755-67 (2011)\", \"DOI:10.1083/jcb.201102092\")), list(REFERENCE = \"PMID:21757540\", AUTHORS = \"Aoki Y, Kanki T, Hirota Y, Kurihara Y, Saigusa T, Uchiumi T, Kang D\", TITLE = \"Phosphorylation of Serine 114 on Atg32 mediates mitophagy.\", JOURNAL = c(\"Mol Biol Cell 22:3206-17 (2011)\", \"DOI:10.1091/mbc.E11-02-0145\")), list(REFERENCE = \"PMID:23897086\", AUTHORS = \"Kanki T, Kurihara Y, Jin X, Goda T, Ono Y, Aihara M, Hirota Y, Saigusa T, Aoki Y, Uchiumi T, Kang D\", TITLE = \"Casein kinase 2 is essential for mitophagy.\", JOURNAL = c(\"EMBO Rep 14:788-94 (2013)\", \"DOI:10.1038/embor.2013.114\")), list(REFERENCE = \"PMID:22308029\", AUTHORS = \"Kondo-Okamoto N, Noda NN, Suzuki SW, Nakatogawa H, Takahashi I, Matsunami M, Hashimoto A, Inagaki F, Ohsumi Y, Okamoto K\", TITLE = \"Autophagy-related protein 32 acts as autophagic degron and directly initiates mitophagy.\", JOURNAL = c(\"J Biol Chem 287:10631-8 (2012)\", \"DOI:10.1074/jbc.M111.299917\")), list(REFERENCE = \"PMID:23810512\", AUTHORS = \"Mao K, Wang K, Liu X, Klionsky DJ\", TITLE = \"The scaffold protein Atg11 recruits fission machinery to drive selective mitochondria degradation by autophagy.\", JOURNAL = c(\"Dev Cell 26:9-18 (2013)\", \"DOI:10.1016/j.devcel.2013.05.024\")), list(REFERENCE = \"PMID:24025448\", AUTHORS = \"Wang K, Jin M, Liu X, Klionsky DJ\", TITLE = \"Proteolytic processing of Atg32 by the mitochondrial i-AAA protease Yme1 regulates mitophagy.\", JOURNAL = c(\"Autophagy 9:1828-36 (2013)\", \"DOI:10.4161/auto.26281\")), list(REFERENCE = \"PMID:17166847\", AUTHORS = \"Tal R, Winter G, Ecker N, Klionsky DJ, Abeliovich H\", TITLE = \"Aup1p, a yeast mitochondrial protein phosphatase homolog, is required for efficient stationary phase mitophagy and cell survival.\", JOURNAL = c(\"J Biol Chem 282:5617-24 (2007)\", \"DOI:10.1074/jbc.M605940200\")), list(REFERENCE = \"PMID:19793921\", AUTHORS = \"Kanki T, Wang K, Baba M, Bartholomew CR, Lynch-Day MA, Du Z, Geng J, Mao K, Yang Z, Yen WL, Klionsky DJ\", TITLE = \"A genomic screen for yeast mutants defective in selective mitochondria autophagy.\", JOURNAL = c(\"Mol Biol Cell 20:4730-8 (2009)\", \"DOI:10.1091/mbc.E09-03-0225\")), list(REFERENCE = \"PMID:22977244\", AUTHORS = \"Wang K, Yang Z, Liu X, Mao K, Nair U, Klionsky DJ\", TITLE = \"Phosphatidylinositol 4-kinases are required for autophagic membrane trafficking.\", JOURNAL = c(\"J Biol Chem 287:37964-72 (2012)\", \"DOI:10.1074/jbc.M112.371591\")), list(REFERENCE = \"PMID:15947785\", AUTHORS = \"Priault M, Salin B, Schaeffer J, Vallette FM, di Rago JP, Martinou JC\", TITLE = \"Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast.\", JOURNAL = c(\"Cell Death Differ 12:1613-21 (2005)\", \"DOI:10.1038/sj.cdd.4401697\")), list(REFERENCE = \"PMID:17541427\", AUTHORS = \"Nowikovsky K, Reipert S, Devenish RJ, Schweyen RJ\", TITLE = \"Mdm38 protein depletion causes loss of mitochondrial K+/H+ exchange activity, osmotic swelling and mitophagy.\", JOURNAL = c(\"Cell Death Differ 14:1647-56 (2007)\", \"DOI:10.1038/sj.cdd.4402167\")), list(REFERENCE = \"PMID:17404498\", AUTHORS = \"Zhang Y, Qi H, Taylor R, Xu W, Liu LF, Jin S\", TITLE = \"The role of autophagy in mitochondria maintenance: characterization of mitochondrial functions in autophagy-deficient S. cerevisiae strains.\", JOURNAL = c(\"Autophagy 3:337-46 (2007)\", \"DOI:10.4161/auto.4127\")), list(REFERENCE = \"PMID:25704822\", AUTHORS = \"Muller M, Kotter P, Behrendt C, Walter E, Scheckhuber CQ, Entian KD, Reichert AS\", TITLE = \"Synthetic quantitative array technology identifies the Ubp3-Bre5 deubiquitinase complex as a negative regulator of mitophagy.\", JOURNAL = c(\"Cell Rep 10:1215-25 (2015)\", \"DOI:10.1016/j.celrep.2015.01.044\"))', 'map04139', 'Mitophagy - yeast', 128, 0, 0, 0, 128, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (255, '04140', 'Autophagy - animal', 'Autophagy (or macroautophagy) is a cellular catabolic pathway involving in protein degradation, organelle turnover, and non-selective breakdown of cytoplasmic components, which is evolutionarily conserved among eukaryotes and exquisitely regulated. This progress initiates with production of the autophagosome, a double-membrane intracellular structure of reticular origin that engulfs cytoplasmic contents and ultimately fuses with lysosomes for cargo degradation. Autophagy is regulated in response to extra- or intracellular stress and signals such as starvation, growth factor deprivation and ER stress. Constitutive level of autophagy plays an important role in cellular homeostasis and maintains quality control of essential cellular components.', 'Cellular Processes; Transport and catabolism', 'Autophagy - animal', 'Crohn disease, Inflammatory bowel disease (IBD), Cathepsin D deficiency', 'GO: 0006914', 'ko04140', 'list(REFERENCE = \"PMID:15325584\", AUTHORS = \"Meijer AJ, Codogno P.\", TITLE = \"Regulation and role of autophagy in mammalian cells.\", JOURNAL = c(\"Int J Biochem Cell Biol 36:2445-62 (2004)\", \"DOI:10.1016/j.biocel.2004.02.002\")), list(REFERENCE = \"PMID:16099218\", AUTHORS = \"Deretic V.\", TITLE = \"Autophagy in innate and adaptive immunity.\", JOURNAL = c(\"Trends Immunol 26:523-8 (2005)\", \"DOI:10.1016/j.it.2005.08.003\")), list(REFERENCE = \"PMID:16200202\", AUTHORS = \"Levine B, Yuan J.\", TITLE = \"Autophagy in cell death: an innocent convict?\", JOURNAL = c(\"J Clin Invest 115:2679-88 (2005)\", \"DOI:10.1172/JCI26390\")), list(REFERENCE = \"PMID:15325588\", AUTHORS = \"Tanida I, Ueno T, Kominami E.\", TITLE = \"LC3 conjugation system in mammalian autophagy.\", JOURNAL = c(\"Int J Biochem Cell Biol 36:2503-18 (2004)\", \"DOI:10.1016/j.biocel.2004.05.009\")), list(REFERENCE = \"PMID:15928708\", AUTHORS = \"Lum JJ, DeBerardinis RJ, Thompson CB.\", TITLE = \"Autophagy in metazoans: cell survival in the land of plenty.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 6:439-48 (2005)\", \"DOI:10.1038/nrm1660\")), list(REFERENCE = \"PMID:15978794\", AUTHORS = \"Reggiori F, Klionsky DJ.\", TITLE = \"Autophagosomes: biogenesis from scratch?\", JOURNAL = c(\"Curr Opin Cell Biol 17:415-22 (2005)\", \"DOI:10.1016/j.ceb.2005.06.007\")), list(REFERENCE = \"PMID:11099404\", AUTHORS = \"Klionsky DJ, Emr SD.\", TITLE = \"Autophagy as a regulated pathway of cellular degradation.\", JOURNAL = c(\"Science 290:1717-21 (2000)\", \"DOI:10.1126/science.290.5497.1717\")), list(REFERENCE = \"PMID:16125113\", AUTHORS = \"Bechet D, Tassa A, Taillandier D, Combaret L, Attaix D.\", TITLE = \"Lysosomal proteolysis in skeletal muscle.\", JOURNAL = c(\"Int J Biochem Cell Biol 37:2098-114 (2005)\", \"DOI:10.1016/j.biocel.2005.02.029\")), list(REFERENCE = \"PMID:19653858\", AUTHORS = \"He C, Klionsky DJ\", TITLE = \"Regulation mechanisms and signaling pathways of autophagy.\", JOURNAL = c(\"Annu Rev Genet 43:67-93 (2009)\", \"DOI:10.1146/annurev-genet-102808-114910\")), list(REFERENCE = \"PMID:19802558\", AUTHORS = \"Yang Z, Klionsky DJ\", TITLE = \"An overview of the molecular mechanism of autophagy.\", JOURNAL = c(\"Curr Top Microbiol Immunol 335:1-32 (2009)\", \"DOI:10.1007/978-3-642-00302-8_1\")), list(REFERENCE = \"PMID:20034776\", AUTHORS = \"Yang Z, Klionsky DJ\", TITLE = \"Mammalian autophagy: core molecular machinery and signaling regulation.\", JOURNAL = c(\"Curr Opin Cell Biol 22:124-31 (2010)\", \"DOI:10.1016/j.ceb.2009.11.014\")), list(REFERENCE = \"PMID:21187343\", AUTHORS = \"Chen Y, Klionsky DJ\", TITLE = \"The regulation of autophagy - unanswered questions.\", JOURNAL = c(\"J Cell Sci 124:161-70 (2011)\", \"DOI:10.1242/jcs.064576\")), list(REFERENCE = \"PMID:21801009\", AUTHORS = \"Mizushima N, Yoshimori T, Ohsumi Y\", TITLE = \"The role of Atg proteins in autophagosome formation.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 27:107-32 (2011)\", \"DOI:10.1146/annurev-cellbio-092910-154005\")), list(REFERENCE = \"PMID:24343578\", AUTHORS = \"Russell RC, Yuan HX, Guan KL\", TITLE = \"Autophagy regulation by nutrient signaling.\", JOURNAL = c(\"Cell Res 24:42-57 (2014)\", \"DOI:10.1038/cr.2013.166\")), list(REFERENCE = \"PMID:25948417\", AUTHORS = \"Noda NN, Fujioka Y\", TITLE = \"Atg1 family kinases in autophagy initiation.\", JOURNAL = c(\"Cell Mol Life Sci 72:3083-96 (2015)\", \"DOI:10.1007/s00018-015-1917-z\"))', 'map04140', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (256, '04141', 'Protein processing in endoplasmic reticulum', 'The endoplasmic reticulum (ER) is a subcellular organelle where proteins are folded with the help of lumenal chaperones. Newly synthesized peptides enter the ER via the sec61 pore and are glycosylated. Correctly folded proteins are packaged into transport vesicles that shuttle them to the Golgi complex. Misfolded proteins are retained within the ER lumen in complex with molecular chaperones. Proteins that are terminally misfolded bind to BiP and are directed toward degradation through the proteasome in a process called ER-associated degradation (ERAD). Accumulation of misfolded proteins in the ER causes ER stress and activates a signaling pathway called the unfolded protein response (UPR). In certain severe situations, however, the protective mechanisms activated by the UPR are not sufficient to restore normal ER function and cells die by apoptosis.', 'Genetic Information Processing; Folding, sorting and degradation', 'Protein processing in endoplasmic reticulum', 'Frontotemporal lobar degeneration, Congenital disorders of glycosylation type I, Combined deficiency of factors V and VIII, Leprosy, Type 2 diabetes mellitus, Polycystic liver disease, Distal myopathy, Myofibrillar myopathies, Ichthyosis follicularis, alopecia, and photophobia syndrome, Wolcott-Rallison syndrome, Wolfram syndrome, Congenital dyserythropoietic anemias (CDAs), Chylomicron retention disease, Cranio-lenticulo-sutural dysplasia, Cataract, Marinesco-Sjogren syndrome, Machado-Joseph disease, Cole-Carpenter syndrome, Kufs disease, Deafness, dystonia, and cerebral hypomyelination', 'GO: 0030433 0034976', 'ko04141', 'list(REFERENCE = \"PMID:19491040\", AUTHORS = \"Naidoo N\", TITLE = \"ER and aging-Protein folding and the ER stress response.\", JOURNAL = c(\"Ageing Res Rev 8:150-9 (2009)\", \"DOI:10.1016/j.arr.2009.03.001\")), list(REFERENCE = \"PMID:18023214\", AUTHORS = \"Malhotra JD, Kaufman RJ\", TITLE = \"The endoplasmic reticulum and the unfolded protein response.\", JOURNAL = c(\"Semin Cell Dev Biol 18:716-31 (2007)\", \"DOI:10.1016/j.semcdb.2007.09.003\")), list(REFERENCE = \"PMID:20347046\", AUTHORS = \"Maattanen P, Gehring K, Bergeron JJ, Thomas DY\", TITLE = \"Protein quality control in the ER: the recognition of misfolded proteins.\", JOURNAL = c(\"Semin Cell Dev Biol 21:500-11 (2010)\", \"DOI:10.1016/j.semcdb.2010.03.006\")), list(REFERENCE = \"PMID:20219571\", AUTHORS = \"Stolz A, Wolf DH\", TITLE = \"Endoplasmic reticulum associated protein degradation: a chaperone assisted journey to hell.\", JOURNAL = c(\"Biochim Biophys Acta 1803:694-705 (2010)\", \"DOI:10.1016/j.bbamcr.2010.02.005\")), list(REFERENCE = \"PMID:20112977\", AUTHORS = \"Dejgaard K, Theberge JF, Heath-Engel H, Chevet E, Tremblay ML, Thomas DY\", TITLE = \"Organization of the Sec61 translocon, studied by high resolution native electrophoresis.\", JOURNAL = c(\"J Proteome Res 9:1763-71 (2010)\", \"DOI:10.1021/pr900900x\"))', 'map04141', 531, 0, 248, 105, 128, 50, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (257, '04142', 'Lysosome', 'Lysosomes are membrane-delimited organelles in animal cells serving as the cell\'s main digestive compartment to which all sorts of macromolecules are delivered for degradation. They contain more than 40 hydrolases in an acidic environment (pH of about 5). After synthesis in the ER, lysosomal enzymes are decorated with mannose-6-phosphate residues, which are recognized by mannose-6-phosphate receptors in the trans-Golgi network. They are packaged into clathrin-coated vesicles and are transported to late endosomes. Substances for digestion are acquired by the lysosomes via a series of processes including endocytosis, phagocytosis, and autophagy.', 'Cellular Processes; Transport and catabolism', 'Lysosome', 'Mucopolysaccharidosis type IV, GM2 gangliosidoses, Fabry disease, Gaucher disease, Metachromatic leukodystrophy, Mucopolysaccharidosis type I, Mucopolysaccharidosis type II, Mucopolysaccharidosis type III, Mucopolysaccharidosis type VI, Mucopolysaccharidosis type VII, Mucopolysaccharidosis type IX, Krabbe disease, Niemann-Pick disease type C, Niemann-Pick disease type A/B, Farber lipogranulomatosis, alpha-Mannosidosis, beta-Mannosidosis, Fucosidosis, Sialidosis, Mucolipidosis II, Mucolipidosis IV, Aspartylglucosaminuria, Alpha-N-acetylgalactosaminidase deficiency, Sialuria, Lysosomal acid lipase deficiency, Neuronal ceroid lipofuscinosis, Danon disease, Hermansky-Pudlak syndrome, Hereditary spastic paraplegia, Multiple sulfatase deficiency, Pycnodysostosis, Papillon-Lefevre syndrome, Cystinosis, Galactosialidosis, GM1 gangliosidosis, Mucopolysaccharidosis, Glycoproteinoses, Sphingolipidosis, Defects in the degradation of sphingomyelin, Lysosomal cysteine protease deficiencies, Gangliosidosis, Haim-Munk syndrome, Tropical calcific pancreatitis, Acid phosphatase deficiency, Hypochromic microcytic anemia, Combined SAP deficiency, Lysosomal storage disease, Muscle glycogen storage disease, Glycogen storage disease type II, Prepubertal periodontitis, Mucolipidosis III, MEDNIK syndrome, Batten disease, Kufs disease, Santavuori-Haltia disease, Cathepsin D deficiency', 'GO: 0005764', 'ko04142', 'list(REFERENCE = \"\", AUTHORS = \"Alberts B,  Johnson A, Lewis J, Raff M, Roberts K, Walter P\", TITLE = \"Molecular Biology of the Cell 4th ed.\", JOURNAL = \"Garland Science (2002)\"), list(REFERENCE = \"PMID:12628346\", AUTHORS = \"Eskelinen EL, Tanaka Y, Saftig P\", TITLE = \"At the acidic edge: emerging functions for lysosomal membrane proteins.\", JOURNAL = c(\"Trends Cell Biol 13:137-45 (2003)\", \"DOI:10.1016/S0962-8924(03)00005-9\")), list(REFERENCE = \"PMID:1883197\", AUTHORS = \"Neufeld EF\", TITLE = \"Lysosomal storage diseases.\", JOURNAL = c(\"Annu Rev Biochem 60:257-80 (1991)\", \"DOI:10.1146/annurev.bi.60.070191.001353\")), list(REFERENCE = \"PMID:2943218\", AUTHORS = \"von Figura K, Hasilik A\", TITLE = \"Lysosomal enzymes and their receptors.\", JOURNAL = c(\"Annu Rev Biochem 55:167-93 (1986)\", \"DOI:10.1146/annurev.bi.55.070186.001123\")), list(REFERENCE = \"PMID:15987739\", AUTHORS = \"Janvier K, Bonifacino JS\", TITLE = \"Role of the endocytic machinery in the sorting of lysosome-associated membrane proteins.\", JOURNAL = c(\"Mol Biol Cell 16:4231-42 (2005)\", \"DOI:10.1091/mbc.E05-03-0213\")), list(REFERENCE = \"PMID:18635948\", AUTHORS = \"Vergarajauregui S, Puertollano R\", TITLE = \"Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy.\", JOURNAL = c(\"Autophagy 4:832-4 (2008)\", \"DOI:10.4161/auto.6567\"))', 'map04142', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (258, '04144', 'Endocytosis', 'Endocytosis is a mechanism for cells to remove ligands, nutrients, and plasma membrane (PM) proteins, and lipids from the cell surface, bringing them into the cell interior. Transmembrane proteins entering through clathrin-dependent endocytosis (CDE) have sequences in their cytoplasmic domains that bind to the APs (adaptor-related protein complexes) and enable their rapid removal from the PM. In addition to APs and clathrin, there are numerous accessory proteins including dynamin. Depending on the various proteins that enter the endosome membrane, these cargoes are sorted to distinct destinations. Some cargoes, such as nutrient receptors, are recycled back to the PM. Ubiquitylated membrane proteins, such as activated growth-factor receptors, are sorted into intraluminal vesicles and eventually end up in the lysosome lumen via multivesicular endosomes (MVEs). There are distinct mechanisms of clathrin-independent endocytosis (CIE) depending upon the cargo and the cell type.', 'Cellular Processes; Transport and catabolism', 'Endocytosis', 'Frontotemporal lobar degeneration, Familial hypercholesterolemia, Hereditary sensory and autonomic neuropathy, Hereditary spastic paraplegia, Limb-girdle muscular dystrophy 1C, Limb-girdle muscular dystrophy, Lacrimo-auriculo-dento-digital syndrome, Centronuclear myopathy, Loeys-Dietz syndrome, Syndromic multisystem autoimmune disease, Neurodegeneration due to cerebral folate transport deficiency, Hyperlipoproteinemia type IIa, Wiskott-Aldrich syndrome, Familial autosomal recessive hypercholesterolemia, Rippling muscle disease, Idiopathic hyperCKemia, Distal myopathy, Tateyama type, CBL syndrome', 'GO: 0006897', 'ko04144', 'list(REFERENCE = \"PMID:19007773\", AUTHORS = \"Acconcia F, Sigismund S, Polo S\", TITLE = \"Ubiquitin in trafficking: the network at work.\", JOURNAL = c(\"Exp Cell Res 315:1610-8 (2009)\", \"DOI:10.1016/j.yexcr.2008.10.014\")), list(REFERENCE = \"PMID:18647649\", AUTHORS = \"Donaldson JG, Porat-Shliom N, Cohen LA\", TITLE = \"Clathrin-independent endocytosis: a unique platform for cell signaling and PM remodeling.\", JOURNAL = c(\"Cell Signal 21:1-6 (2009)\", \"DOI:10.1016/j.cellsig.2008.06.020\")), list(REFERENCE = \"PMID:15261671\", AUTHORS = \"Sorkin A\", TITLE = \"Cargo recognition during clathrin-mediated endocytosis: a team effort.\", JOURNAL = c(\"Curr Opin Cell Biol 16:392-9 (2004)\", \"DOI:10.1016/j.ceb.2004.06.001\")), list(REFERENCE = \"PMID:19325624\", AUTHORS = \"Raiborg C, Stenmark H\", TITLE = \"The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins.\", JOURNAL = c(\"Nature 458:445-52 (2009)\", \"DOI:10.1038/nature07961\")), list(REFERENCE = \"PMID:20110990\", AUTHORS = \"Scita G, Di Fiore PP\", TITLE = \"The endocytic matrix.\", JOURNAL = c(\"Nature 463:464-73 (2010)\", \"DOI:10.1038/nature08910\")), list(REFERENCE = \"PMID:15687999\", AUTHORS = \"Le Roy C, Wrana JL\", TITLE = \"Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 6:112-26 (2005)\", \"DOI:10.1038/nrm1571\")), list(REFERENCE = \"PMID:19924646\", AUTHORS = \"Jovic M, Sharma M, Rahajeng J, Caplan S\", TITLE = \"The early endosome: a busy sorting station for proteins at the crossroads.\", JOURNAL = c(\"Histol Histopathol 25:99-112 (2010)\", \"DOI:10.14670/HH-25.99\")), list(REFERENCE = \"PMID:16203612\", AUTHORS = \"Pietiainen VM, Marjomaki V, Heino J, Hyypia T\", TITLE = \"Viral entry, lipid rafts and caveosomes.\", JOURNAL = c(\"Ann Med 37:394-403 (2005)\", \"DOI:10.1080/07853890510011976\")), list(REFERENCE = \"PMID:19696797\", AUTHORS = \"Grant BD, Donaldson JG\", TITLE = \"Pathways and mechanisms of endocytic recycling.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 10:597-608 (2009)\", \"DOI:10.1038/nrm2755\")), list(REFERENCE = \"PMID:22193161\", AUTHORS = \"Cullen PJ, Korswagen HC\", TITLE = \"Sorting nexins provide diversity for retromer-dependent trafficking events.\", JOURNAL = c(\"Nat Cell Biol 14:29-37 (2012)\", \"DOI:10.1038/ncb2374\"))', 'map04144', 531, 0, 248, 105, 128, 50, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (259, '04145', 'Phagosome', 'Phagocytosis is the process of taking in relatively large particles by a cell, and is a central mechanism in the tissue remodeling, inflammation, and defense against infectious agents. A phagosome is formed when the specific receptors on the phagocyte surface recognize ligands on the particle surface. After formation, nascent phagosomes progressively acquire digestive characteristics. This maturation of phagosomes involves regulated interaction with the other membrane organelles, including recycling endosomes, late endosomes and lysosomes. The fusion of phagosomes and lysosomes releases toxic products that kill most bacteria and degrade them into fragments. However, some bacteria have strategies to escape the bactericidal mechanisms associated with phagocytosis and survive within host phagocytes.', 'Cellular Processes; Transport and catabolism', 'Phagosome', 'Hereditary sensory and autonomic neuropathy, Asphyxiating thoracic dystrophy, Congenital fibrosis of the extraocular muscles, Fleck corneal dystrophy, Bare lymphocyte syndrome type1, CD36 deficiency, Chronic mucocutaneous candidiasis, Immune thrombocytopenia, Juvenile-onset dystonia, Myeloperoxidase deficiency', 'GO: 0045335', 'ko04145', 'list(REFERENCE = \"PMID:15894272\", AUTHORS = \"Stuart LM, Ezekowitz RA\", TITLE = \"Phagocytosis: elegant complexity.\", JOURNAL = c(\"Immunity 22:539-50 (2005)\", \"DOI:10.1016/j.immuni.2005.05.002\")), list(REFERENCE = \"PMID:10684585\", AUTHORS = \"Tjelle TE, Lovdal T, Berg T\", TITLE = \"Phagosome dynamics and function.\", JOURNAL = c(\"Bioessays 22:255-63 (2000)\", \"DOI:10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R\")), list(REFERENCE = \"PMID:18492791\", AUTHORS = \"Dupuy AG, Caron E\", TITLE = \"Integrin-dependent phagocytosis: spreading from microadhesion to new concepts.\", JOURNAL = c(\"J Cell Sci 121:1773-83 (2008)\", \"DOI:10.1242/jcs.018036\")), list(REFERENCE = \"PMID:15036145\", AUTHORS = \"Brumell JH, Grinstein S\", TITLE = \"Salmonella redirects phagosomal maturation.\", JOURNAL = c(\"Curr Opin Microbiol 7:78-84 (2004)\", \"DOI:10.1016/j.mib.2003.12.005\")), list(REFERENCE = \"PMID:17245426\", AUTHORS = \"Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S\", TITLE = \"LAMP proteins are required for fusion of lysosomes with phagosomes.\", JOURNAL = c(\"EMBO J 26:313-24 (2007)\", \"DOI:10.1038/sj.emboj.7601511\")), list(REFERENCE = \"PMID:17637737\", AUTHORS = \"Luzio JP, Pryor PR, Bright NA\", TITLE = \"Lysosomes: fusion and function.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 8:622-32 (2007)\", \"DOI:10.1038/nrm2217\")), list(REFERENCE = \"PMID:18513324\", AUTHORS = \"Sumimoto H\", TITLE = \"Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species.\", JOURNAL = c(\"FEBS J 275:3249-77 (2008)\", \"DOI:10.1111/j.1742-4658.2008.06488.x\"))', 'map04145', 531, 0, 248, 105, 128, 50, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (260, '04146', 'Peroxisome', 'Peroxisomes are essential organelles that play a key role in redox signalling and lipid homeostasis. They contribute to many crucial metabolic processes such as fatty acid oxidation, biosynthesis of ether lipids and free radical detoxification. The biogenesis of peroxisomes starts with the early peroxins PEX3, PEX16 and PEX19 and proceeds via several steps. The import of membrane proteins into peroxisomes needs PEX19 for recognition, targeting and insertion via docking at PEX3. Matrix proteins in the cytosol are recognized by peroxisomal targeting signals (PTS) and transported to the docking complex at the peroxisomal membrane. Peroxisomes\' deficiencies lead to severe and often fatal inherited peroxisomal disorders (PD). PDs are usually classified in two groups. The first group is disorders of peroxisome biogenesis which include Zellweger syndrome, and the second group is single peroxisomal enzyme deficiencies.', 'Cellular Processes; Transport and catabolism', 'Peroxisome', 'Refsum disease, Adrenoleukodystrophy, Neonatal adrenoleukodystrophy, Acatalasemia, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Peroxisomal beta-oxidation enzyme deficiency, Congenital bile acid synthesis defect, Leukoencephalopathy with dystonia and motor neuropathy, Roussy-Levy syndrome, Malonyl-CoA decarboxylase deficiency, Zellweger syndrome, Peroxisomal acyl-CoA oxidase deficiency, D-bifunctional protein deficiency, Alpha-methylacyl-CoA racemase deficiency, Peroxisomal fatty acyl-CoA reductase 1 disorder', 'GO: 0005777', 'ko04146', 'list(REFERENCE = \"PMID:17055078\", AUTHORS = \"Wanders RJ, Waterham HR\", TITLE = \"Peroxisomal disorders: the single peroxisomal enzyme deficiencies.\", JOURNAL = c(\"Biochim Biophys Acta 1763:1707-20 (2006)\", \"DOI:10.1016/j.bbamcr.2006.08.010\")), list(REFERENCE = \"PMID:17055079\", AUTHORS = \"Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW\", TITLE = \"Peroxisome biogenesis disorders.\", JOURNAL = c(\"Biochim Biophys Acta 1763:1733-48 (2006)\", \"DOI:10.1016/j.bbamcr.2006.09.010\")), list(REFERENCE = \"PMID:17010456\", AUTHORS = \"Rottensteiner H, Theodoulou FL\", TITLE = \"The ins and outs of peroxisomes: co-ordination of membrane transport and peroxisomal metabolism.\", JOURNAL = c(\"Biochim Biophys Acta 1763:1527-40 (2006)\", \"DOI:10.1016/j.bbamcr.2006.08.012\")), list(REFERENCE = \"PMID:16631601\", AUTHORS = \"Iida R, Yasuda T, Tsubota E, Takatsuka H, Matsuki T, Kishi K\", TITLE = \"Human Mpv17-like protein is localized in peroxisomes and regulates expression of antioxidant enzymes.\", JOURNAL = c(\"Biochem Biophys Res Commun 344:948-54 (2006)\", \"DOI:10.1016/j.bbrc.2006.04.008\")), list(REFERENCE = \"\", AUTHORS = \"Kleinman R, Goulet OJ, Mieli-Vergani G, Sanderson I, Sherman P, Shneider B.\", TITLE = \"Walker\'s Pediatric Gastrointestinal Disease (5th edition)\", JOURNAL = \"B.C.Decker (2008)\")', 'map04146', 531, 0, 248, 105, 128, 50, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (261, '04150', 'mTOR signaling pathway', 'The mammalian (mechanistic) target of rapamycin (mTOR) is a highly conserved serine/threonine protein kinase, which exists in two complexes termed mTOR complex 1 (mTORC1) and 2 (mTORC2). mTORC1 contains mTOR, Raptor, PRAS40, Deptor, mLST8, Tel2 and Tti1. mTORC1 is activated by the presence of growth factors, amino acids, energy status, stress and oxygen levels to regulate several biological processes, including lipid metabolism, autophagy, protein synthesis and ribosome biogenesis. On the other hand, mTORC2, which consists of mTOR, mSin1, Rictor, Protor, Deptor, mLST8, Tel2 and Tti1, responds to growth factors and controls cytoskeletal organization, metabolism and survival.', 'Environmental Information Processing; Signal transduction', 'mTOR signaling pathway', 'Peutz-Jeghers syndrome, Lymphangioleiomyomatosis, Tuberous sclerosis complex, Polyhydramnios, megalencephaly, and symptomatic epilepsy, Focal cortical dysplasia of Taylor, Renal angiomyolipoma, Subependymal giant cell astrocytoma, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, Hypoinsulinemic hypoglycemia with hemihypertrophy, Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi, Smith-Kingsmore syndrome, Autism, Proteus syndrome, Megalencephaly-capillary malformation syndrome, Familial focal epilepsy with variable foci, DDOD syndrome, CLAPO syndrome', 'ko04150', 'list(REFERENCE = \"PMID:27304501\", AUTHORS = \"Kennedy BK, Lamming DW\", TITLE = \"The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging.\", JOURNAL = c(\"Cell Metab 23:990-1003 (2016)\", \"DOI:10.1016/j.cmet.2016.05.009\")), list(REFERENCE = \"PMID:24556838\", AUTHORS = \"Shimobayashi M, Hall MN\", TITLE = \"Making new contacts: the mTOR network in metabolism and signalling crosstalk.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 15:155-62 (2014)\", \"DOI:10.1038/nrm3757\")), list(REFERENCE = \"PMID:25242279\", AUTHORS = \"Huang K, Fingar DC\", TITLE = \"Growing knowledge of the mTOR signaling network.\", JOURNAL = c(\"Semin Cell Dev Biol 36:79-90 (2014)\", \"DOI:10.1016/j.semcdb.2014.09.011\")), list(REFERENCE = \"PMID:26269525\", AUTHORS = \"Bockaert J, Marin P\", TITLE = \"mTOR in Brain Physiology and Pathologies.\", JOURNAL = c(\"Physiol Rev 95:1157-87 (2015)\", \"DOI:10.1152/physrev.00038.2014\")), list(REFERENCE = \"PMID:26185979\", AUTHORS = \"Caron A, Richard D, Laplante M\", TITLE = \"The Roles of mTOR Complexes in Lipid Metabolism.\", JOURNAL = c(\"Annu Rev Nutr 35:321-48 (2015)\", \"DOI:10.1146/annurev-nutr-071714-034355\")), list(REFERENCE = \"PMID:26658722\", AUTHORS = \"Shimobayashi M, Hall MN\", TITLE = \"Multiple amino acid sensing inputs to mTORC1.\", JOURNAL = c(\"Cell Res 26:7-20 (2016)\", \"DOI:10.1038/cr.2015.146\")), list(REFERENCE = \"PMID:24698685\", AUTHORS = \"Bar-Peled L, Sabatini DM\", TITLE = \"Regulation of mTORC1 by amino acids.\", JOURNAL = c(\"Trends Cell Biol 24:400-6 (2014)\", \"DOI:10.1016/j.tcb.2014.03.003\")), list(REFERENCE = \"PMID:26046644\", AUTHORS = \"Fingar DC\", TITLE = \"Rag Ubiquitination Recruits a GATOR1: Attenuation of Amino Acid-Induced mTORC1 Signaling.\", JOURNAL = c(\"Mol Cell 58:713-5 (2015)\", \"DOI:10.1016/j.molcel.2015.05.029\")), list(REFERENCE = \"PMID:26700098\", AUTHORS = \"Cai H, Dong LQ, Liu F\", TITLE = \"Recent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects.\", JOURNAL = c(\"Trends Pharmacol Sci 37:303-17 (2016)\", \"DOI:10.1016/j.tips.2015.11.011\")), list(REFERENCE = \"PMID:24842496\", AUTHORS = \"Eyre TA, Collins GP, Goldstone AH, Cwynarski K\", TITLE = \"Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies.\", JOURNAL = c(\"Br J Haematol 166:336-51 (2014)\", \"DOI:10.1111/bjh.12945\")), list(REFERENCE = \"PMID:23465396\", AUTHORS = \"Jewell JL, Guan KL\", TITLE = \"Nutrient signaling to mTOR and cell growth.\", JOURNAL = c(\"Trends Biochem Sci 38:233-42 (2013)\", \"DOI:10.1016/j.tibs.2013.01.004\")), list(REFERENCE = \"PMID:23421405\", AUTHORS = \"Wood TL, Bercury KK, Cifelli SE, Mursch LE, Min J, Dai J, Macklin WB\", TITLE = \"mTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development.\", JOURNAL = c(\"ASN Neuro 5:e00108 (2013)\", \"DOI:10.1042/AN20120092\")), list(REFERENCE = \"PMID:23694989\", AUTHORS = \"Kim SG, Buel GR, Blenis J\", TITLE = \"Nutrient regulation of the mTOR complex 1 signaling pathway.\", JOURNAL = c(\"Mol Cells 35:463-73 (2013)\", \"DOI:10.1007/s10059-013-0138-2\")), list(REFERENCE = \"PMID:19812304\", AUTHORS = \"Laplante M, Sabatini DM\", TITLE = \"mTOR signaling at a glance.\", JOURNAL = c(\"J Cell Sci 122:3589-94 (2009)\", \"DOI:10.1242/jcs.051011\")), list(REFERENCE = \"PMID:16756488\", AUTHORS = \"Alessi DR, Sakamoto K, Bayascas JR\", TITLE = \"LKB1-dependent signaling pathways.\", JOURNAL = c(\"Annu Rev Biochem 75:137-63 (2006)\", \"DOI:10.1146/annurev.biochem.75.103004.142702\")), list(REFERENCE = \"PMID:27027448\", AUTHORS = \"Dan HC, Antonia RJ, Baldwin AS\", TITLE = \"PI3K/Akt promotes feedforward mTORC2 activation through IKKalpha.\", JOURNAL = c(\"Oncotarget 7:21064-75 (2016)\", \"DOI:10.18632/oncotarget.8383\")), list(REFERENCE = \"PMID:28283069\", AUTHORS = \"Saxton RA, Sabatini DM\", TITLE = \"mTOR Signaling in Growth, Metabolism, and Disease.\", JOURNAL = c(\"Cell 168:960-976 (2017)\", \"DOI:10.1016/j.cell.2017.02.004\"))', 'map04150', 'mTOR signaling pathway', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (262, '04151', 'PI3K-Akt signaling pathway', 'The phosphatidylinositol 3\' -kinase(PI3K)-Akt signaling pathway is activated by many types of cellular stimuli or toxic insults and regulates fundamental cellular functions such as transcription, translation, proliferation, growth, and survival. The binding of growth factors to their receptor tyrosine kinase (RTK) or G protein-coupled receptors (GPCR) stimulates class Ia and Ib PI3K isoforms, respectively. PI3K catalyzes the production of phosphatidylinositol-3,4,5-triphosphate (PIP3) at the cell membrane. PIP3 in turn serves as a second messenger that helps to activate Akt. Once active, Akt can control key cellular processes by phosphorylating substrates involved in apoptosis, protein synthesis, metabolism, and cell cycle.', 'Environmental Information Processing; Signal transduction', 'PI3K-Akt signaling pathway', 'FGFR3-related short limb skeletal dysplasia, Type II collagenopathies, Hereditary lymphedema, Myosclerosis, Bethlem myopathy, Collagen VI myopathy, SHORT syndrome, Activated PI3K-delta syndrome, Hyperprolactinemia, Mast-cell leukemia, Macrothrombocytopenia, Ullrich disease, Hypoinsulinemic hypoglycemia with hemihypertrophy, Infantile myofibromatosis, Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi, Laron syndrome, Kowarski syndrome, Insulin-like growth factor I deficiency, Cutaneous and mucosal venous malformation, Achondrogenesis type II, Hypochondroplasia, SADDAN, Kniest dysplasia, Czech dysplasia, Stickler syndrome, Proteus syndrome, CLAPO syndrome', 'GO: 0043491', 'ko04151', 'list(REFERENCE = \"PMID:16847462\", AUTHORS = \"Engelman JA, Luo J, Cantley LC\", TITLE = \"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.\", JOURNAL = c(\"Nat Rev Genet 7:606-19 (2006)\", \"DOI:10.1038/nrg1879\")), list(REFERENCE = \"PMID:15784165\", AUTHORS = \"Song G, Ouyang G, Bao S\", TITLE = \"The activation of Akt/PKB signaling pathway and cell survival.\", JOURNAL = c(\"J Cell Mol Med 9:59-71 (2005)\", \"DOI:10.1111/j.1582-4934.2005.tb00337.x\")), list(REFERENCE = \"PMID:21620960\", AUTHORS = \"Hers I, Vincent EE, Tavare JM\", TITLE = \"Akt signalling in health and disease.\", JOURNAL = c(\"Cell Signal 23:1515-27 (2011)\", \"DOI:10.1016/j.cellsig.2011.05.004\")), list(REFERENCE = \"PMID:18842113\", AUTHORS = \"Duronio V\", TITLE = \"The life of a cell: apoptosis regulation by the PI3K/PKB pathway.\", JOURNAL = c(\"Biochem J 415:333-44 (2008)\", \"DOI:10.1042/BJ20081056\")), list(REFERENCE = \"PMID:16248975\", AUTHORS = \"Kim D, Chung J.\", TITLE = \"Akt: versatile mediator of cell survival and beyond.\", JOURNAL = \"J Biochem Mol Biol 35:106-15 (2002)\"), list(REFERENCE = \"PMID:12660731\", AUTHORS = \"Koyasu S\", TITLE = \"The role of PI3K in immune cells.\", JOURNAL = c(\"Nat Immunol 4:313-9 (2003)\", \"DOI:10.1038/ni0403-313\")), list(REFERENCE = \"PMID:12669022\", AUTHORS = \"Okkenhaug K, Vanhaesebroeck B.\", TITLE = \"PI3K in lymphocyte development, differentiation and activation.\", JOURNAL = c(\"Nat Rev Immunol 3:317-30 (2003)\", \"DOI:10.1038/nri1056\")), list(REFERENCE = \"PMID:15209374\", AUTHORS = \"Richardson CJ, Schalm SS, Blenis J\", TITLE = \"PI3-kinase and TOR: PIKTORing cell growth.\", JOURNAL = c(\"Semin Cell Dev Biol 15:147-59 (2004)\", \"DOI:10.1016/j.semcdb.2003.12.023\")), list(REFERENCE = \"PMID:21440011\", AUTHORS = \"Zhang X, Tang N, Hadden TJ, Rishi AK\", TITLE = \"Akt, FoxO and regulation of apoptosis.\", JOURNAL = c(\"Biochim Biophys Acta 1813:1978-86 (2011)\", \"DOI:10.1016/j.bbamcr.2011.03.010\")), list(REFERENCE = \"PMID:21779440\", AUTHORS = \"Georgescu MM\", TITLE = \"PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.\", JOURNAL = c(\"Genes Cancer 1:1170-7 (2010)\", \"DOI:10.1177/1947601911407325\")), list(REFERENCE = \"PMID:12531180\", AUTHORS = \"West KA, Castillo SS, Dennis PA\", TITLE = \"Activation of the PI3K/Akt pathway and chemotherapeutic resistance.\", JOURNAL = c(\"Drug Resist Updat 5:234-48 (2002)\", \"DOI:10.1016/S1368-7646(02)00120-6\")), list(REFERENCE = \"PMID:9838078\", AUTHORS = \"Wymann MP, Pirola L\", TITLE = \"Structure and function of phosphoinositide 3-kinases.\", JOURNAL = c(\"Biochim Biophys Acta 1436:127-50 (1998)\", \"DOI:10.1016/S0005-2760(98)00139-8\")), list(REFERENCE = \"PMID:12048182\", AUTHORS = \"Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M\", TITLE = \"Regulation of Raf-Akt Cross-talk.\", JOURNAL = c(\"J Biol Chem 277:31099-106 (2002)\", \"DOI:10.1074/jbc.M111974200\")), list(REFERENCE = \"PMID:16187290\", AUTHORS = \"Kikani CK, Dong LQ, Liu F\", TITLE = \"\\\"New\\\"-clear functions of PDK1: beyond a master kinase in the cytosol?\", JOURNAL = c(\"J Cell Biochem 96:1157-62 (2005)\", \"DOI:10.1002/jcb.20651\")), list(REFERENCE = \"PMID:11357143\", AUTHORS = \"Blume-Jensen P, Hunter T\", TITLE = \"Oncogenic kinase signalling.\", JOURNAL = c(\"Nature 411:355-65 (2001)\", \"DOI:10.1038/35077225\")), list(REFERENCE = \"PMID:15505410\", AUTHORS = \"Osaki M, Oshimura M, Ito H\", TITLE = \"PI3K-Akt pathway: its functions and alterations in human cancer.\", JOURNAL = c(\"Apoptosis 9:667-76 (2004)\", \"DOI:10.1023/B:APPT.0000045801.15585.dd\")), list(REFERENCE = \"PMID:17360849\", AUTHORS = \"Noguchi M, Ropars V, Roumestand C, Suizu F\", TITLE = \"Proto-oncogene TCL1: more than just a coactivator for Akt.\", JOURNAL = c(\"FASEB J 21:2273-84 (2007)\", \"DOI:10.1096/fj.06-7684com\")), list(REFERENCE = \"PMID:20602996\", AUTHORS = \"Lemmon MA, Schlessinger J\", TITLE = \"Cell signaling by receptor tyrosine kinases.\", JOURNAL = c(\"Cell 141:1117-34 (2010)\", \"DOI:10.1016/j.cell.2010.06.011\")), list(REFERENCE = \"PMID:22367796\", AUTHORS = \"Skaper SD\", TITLE = \"The neurotrophin family of neurotrophic factors: an overview.\", JOURNAL = c(\"Methods Mol Biol 846:1-12 (2012)\", \"DOI:10.1007/978-1-61779-536-7_1\"))', 'map04151', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (263, '04152', 'AMPK signaling pathway', 'AMP-activated protein kinase (AMPK) is a serine threonine kinase that is highly conserved through evolution. AMPK system acts as a sensor of cellular energy status. It is activated by increases in the cellular AMP:ATP ratio caused by metabolic stresses that either interfere with ATP production (eg, deprivation for glucose or oxygen) or that accelerate ATP consumption (eg, muscle contraction). Several upstream kinases, including liver kinase B1 (LKB1), calcium/calmodulin kinase kinase-beta (CaMKK beta), and TGF-beta-activated kinase-1 (TAK-1), can activate AMPK by phosphorylating a threonine residue on its catalytic alpha-subunit. Once activated, AMPK leads to a concomitant inhibition of energy-consuming biosynthetic pathways, such as protein, fatty acid and glycogen synthesis, and activation of ATP-producing catabolic pathways, such as fatty acid oxidation and glycolysis.', 'Environmental Information Processing; Signal transduction', 'AMPK signaling pathway', 'Glycogen storage disease of heart, Leptin deficiency, Leptin receptor deficiency', 'GO: 2000479', 'ko04152', 'list(REFERENCE = \"PMID:19584320\", AUTHORS = \"Steinberg GR, Kemp BE\", TITLE = \"AMPK in Health and Disease.\", JOURNAL = c(\"Physiol Rev 89:1025-78 (2009)\", \"DOI:10.1152/physrev.00011.2008\")), list(REFERENCE = \"PMID:15509864\", AUTHORS = \"Hardie DG.\", TITLE = \"The AMP-activated protein kinase pathway--new players upstream and downstream.\", JOURNAL = c(\"J Cell Sci 117:5479-87 (2004)\", \"DOI:10.1242/jcs.01540\")), list(REFERENCE = \"PMID:23747347\", AUTHORS = \"Russo GL, Russo M, Ungaro P\", TITLE = \"AMP-activated protein kinase: a target for old drugs against diabetes and cancer.\", JOURNAL = c(\"Biochem Pharmacol 86:339-50 (2013)\", \"DOI:10.1016/j.bcp.2013.05.023\")), list(REFERENCE = \"PMID:19393004\", AUTHORS = \"Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S\", TITLE = \"AMPK in the brain: its roles in energy balance and neuroprotection.\", JOURNAL = c(\"J Neurochem 109 Suppl 1:17-23 (2009)\", \"DOI:10.1111/j.1471-4159.2009.05916.x\")), list(REFERENCE = \"PMID:20010958\", AUTHORS = \"Li J, McCullough LD\", TITLE = \"Effects of AMP-activated protein kinase in cerebral ischemia.\", JOURNAL = c(\"J Cereb Blood Flow Metab 30:480-92 (2010)\", \"DOI:10.1038/jcbfm.2009.255\")), list(REFERENCE = \"PMID:22700795\", AUTHORS = \"Sanchez AM, Candau RB, Csibi A, Pagano AF, Raibon A, Bernardi H\", TITLE = \"The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis.\", JOURNAL = c(\"Am J Physiol Cell Physiol 303:C475-85 (2012)\", \"DOI:10.1152/ajpcell.00125.2012\")), list(REFERENCE = \"PMID:16644802\", AUTHORS = \"Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F\", TITLE = \"Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.\", JOURNAL = c(\"J Physiol 574:41-53 (2006)\", \"DOI:10.1113/jphysiol.2006.108506\")), list(REFERENCE = \"PMID:19629071\", AUTHORS = \"Shackelford DB, Shaw RJ\", TITLE = \"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.\", JOURNAL = c(\"Nat Rev Cancer 9:563-75 (2009)\", \"DOI:10.1038/nrc2676\")), list(REFERENCE = \"PMID:22885100\", AUTHORS = \"Chung JH, Manganiello V, Dyck JR\", TITLE = \"Resveratrol as a calorie restriction mimetic: therapeutic implications.\", JOURNAL = c(\"Trends Cell Biol 22:546-54 (2012)\", \"DOI:10.1016/j.tcb.2012.07.004\")), list(REFERENCE = \"PMID:20357764\", AUTHORS = \"Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T\", TITLE = \"Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.\", JOURNAL = c(\"Nature 464:1313-9 (2010)\", \"DOI:10.1038/nature08991\")), list(REFERENCE = \"PMID:17307971\", AUTHORS = \"Towler MC, Hardie DG\", TITLE = \"AMP-activated protein kinase in metabolic control and insulin signaling.\", JOURNAL = c(\"Circ Res 100:328-41 (2007)\", \"DOI:10.1161/01.RES.0000256090.42690.05\")), list(REFERENCE = \"PMID:23899560\", AUTHORS = \"Richter EA, Hargreaves M\", TITLE = \"Exercise, GLUT4, and skeletal muscle glucose uptake.\", JOURNAL = c(\"Physiol Rev 93:993-1017 (2013)\", \"DOI:10.1152/physrev.00038.2012\")), list(REFERENCE = \"PMID:16054041\", AUTHORS = \"Kahn BB, Alquier T, Carling D, Hardie DG\", TITLE = \"AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.\", JOURNAL = c(\"Cell Metab 1:15-25 (2005)\", \"DOI:10.1016/j.cmet.2004.12.003\")), list(REFERENCE = \"PMID:23565491\", AUTHORS = \"Minokoshi Y, Toda C, Okamoto S\", TITLE = \"Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle.\", JOURNAL = c(\"Indian J Endocrinol Metab 16:S562-8 (2012)\", \"DOI:10.4103/2230-8210.105573\")), list(REFERENCE = \"PMID:16723978\", AUTHORS = \"Guggino WB, Stanton BA\", TITLE = \"New insights into cystic fibrosis: molecular switches that regulate CFTR.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 7:426-36 (2006)\", \"DOI:10.1038/nrm1949\")), list(REFERENCE = \"PMID:16479585\", AUTHORS = \"Cheng A, Saltiel AR\", TITLE = \"More TORC for the gluconeogenic engine.\", JOURNAL = c(\"Bioessays 28:231-4 (2006)\", \"DOI:10.1002/bies.20375\")), list(REFERENCE = \"PMID:19197243\", AUTHORS = \"Herrero-Martin G, Hoyer-Hansen M, Garcia-Garcia C, Fumarola C, Farkas T, Lopez-Rivas A, Jaattela M\", TITLE = \"TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells.\", JOURNAL = c(\"EMBO J 28:677-85 (2009)\", \"DOI:10.1038/emboj.2009.8\")), list(REFERENCE = \"PMID:19724019\", AUTHORS = \"Morris DL, Rui L\", TITLE = \"Recent advances in understanding leptin signaling and leptin resistance.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 297:E1247-59 (2009)\", \"DOI:10.1152/ajpendo.00274.2009\")), list(REFERENCE = \"PMID:18725075\", AUTHORS = \"Minokoshi Y, Shiuchi T, Lee S, Suzuki A, Okamoto S\", TITLE = \"Role of hypothalamic AMP-kinase in food intake regulation.\", JOURNAL = c(\"Nutrition 24:786-90 (2008)\", \"DOI:10.1016/j.nut.2008.06.002\")), list(REFERENCE = \"PMID:23024365\", AUTHORS = \"Miyamoto L, Ebihara K, Kusakabe T, Aotani D, Yamamoto-Kataoka S, Sakai T, Aizawa-Abe M, Yamamoto Y, Fujikura J, Hayashi T, Hosoda K, Nakao K\", TITLE = \"Leptin activates hepatic 5\'-AMP-activated protein kinase through sympathetic nervous system and alpha1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin.\", JOURNAL = c(\"J Biol Chem 287:40441-7 (2012)\", \"DOI:10.1074/jbc.M112.384545\"))', 'map04152', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (264, '04210', 'Apoptosis', 'Apoptosis is a genetically programmed process for the elimination of damaged or redundant cells by activation of caspases (aspartate-specific cysteine proteases). The onset of apoptosis is controlled by numerous interrelating processes. The \'extrinsic\' pathway involves stimulation of members of the tumor necrosis factor (TNF) receptor subfamily, such as TNFRI, CD95/Fas or TRAILR (death receptors), located at the cell surface, by their specific ligands, such as TNF-alpha, FasL or TRAIL, respectively. The \'intrinsic\' pathway is activated mainly by non-receptor stimuli, such as DNA damage, ER stress, metabolic stress, UV radiation or growth-factor deprivation. The central event in the \'intrinsic\' pathway is the mitochondrial outer membrane permeabilization (MOMP), which leads to the release of cytochrome c. These two pathways converge at the level of effector caspases, such as caspase-3 and caspase-7. The third major pathway is initiated by the constituents of cytotoxic granules (e.g. Perforin and Granzyme B) that are released by CTLs (cytotoxic T-cells) and NK (natural killer) cells. Granzyme B, similarly to the caspases, cleaves its substrates after aspartic acid residues, suggesting that this protease has the ability to activate members of the caspase family directly. It is the balance between the pro-apoptotic and anti-apoptotic signals that eventually determines whether cells will undergo apoptosis, survive or proliferate. TNF family of ligands activates anti-apoptotic or cell-survival signals as well as apoptotic signals. NGF and Interleukin-3 promotes the survival, proliferation and differentiation of neurons or hematopoietic cells, respectively. Withdrawal of these growth factors leads to cell death, as described above.', 'Cellular Processes; Cell growth and death', 'Apoptosis', 'Autoimmune lymphoproliferative syndromes, Hereditary sensory and autonomic neuropathy, Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID), Incontinentia pigmenti, Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, Li-Fraumeni syndrome, Cocoon syndrome, Tumor necrosis factor receptor-associated periodic syndrome, Choroid plexus papilloma, Pituitary adenomas, X-linked lymphoproliferative syndrome, Cathepsin D deficiency', 'GO: 0006915', 'ko04210', 'list(REFERENCE = \"PMID:26615431\", AUTHORS = \"Savitskaya MA, Onishchenko GE\", TITLE = \"Mechanisms of Apoptosis.\", JOURNAL = c(\"Biochemistry (Mosc) 80:1393-417 (2015)\", \"DOI:10.1134/S0006297915110012\")), list(REFERENCE = \"PMID:23803157\", AUTHORS = \"Schleich K, Lavrik IN\", TITLE = \"Mathematical modeling of apoptosis.\", JOURNAL = c(\"Cell Commun Signal 11:44 (2013)\", \"DOI:10.1186/1478-811X-11-44\")), list(REFERENCE = \"PMID:15654015\", AUTHORS = \"Lavrik I, Golks A, Krammer PH\", TITLE = \"Death receptor signaling.\", JOURNAL = c(\"J Cell Sci 118:265-7 (2005)\", \"DOI:10.1242/jcs.01610\")), list(REFERENCE = \"PMID:15725726\", AUTHORS = \"Jin Z, El-Deiry WS\", TITLE = \"Overview of cell death signaling pathways.\", JOURNAL = c(\"Cancer Biol Ther 4:139-63 (2005)\", \"DOI:10.4161/cbt.4.2.1508\")), list(REFERENCE = \"PMID:15322527\", AUTHORS = \"Benn SC, Woolf CJ\", TITLE = \"Adult neuron survival strategies--slamming on the brakes.\", JOURNAL = c(\"Nat Rev Neurosci 5:686-700 (2004)\", \"DOI:10.1038/nrn1477\")), list(REFERENCE = \"PMID:12838338\", AUTHORS = \"Orrenius S, Zhivotovsky B, Nicotera P\", TITLE = \"Regulation of cell death: the calcium-apoptosis link.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 4:552-65 (2003)\", \"DOI:10.1038/nrm1150\")), list(REFERENCE = \"PMID:19148180\", AUTHORS = \"Clarke P, Tyler KL\", TITLE = \"Apoptosis in animal models of virus-induced disease.\", JOURNAL = c(\"Nat Rev Microbiol 7:144-55 (2009)\", \"DOI:10.1038/nrmicro2071\")), list(REFERENCE = \"PMID:22429822\", AUTHORS = \"Wen X, Lin ZQ, Liu B, Wei YQ\", TITLE = \"Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer.\", JOURNAL = c(\"Cell Prolif 45:217-24 (2012)\", \"DOI:10.1111/j.1365-2184.2012.00814.x\")), list(REFERENCE = \"PMID:25526085\", AUTHORS = \"Shalini S, Dorstyn L, Dawar S, Kumar S\", TITLE = \"Old, new and emerging functions of caspases.\", JOURNAL = c(\"Cell Death Differ 22:526-39 (2015)\", \"DOI:10.1038/cdd.2014.216\")), list(REFERENCE = \"PMID:15601572\", AUTHORS = \"Philchenkov A\", TITLE = \"Caspases: potential targets for regulating cell death.\", JOURNAL = c(\"J Cell Mol Med 8:432-44 (2004)\", \"DOI:10.1111/j.1582-4934.2004.tb00468.x\")), list(REFERENCE = \"PMID:9894605\", AUTHORS = \"Stroh C, Schulze-Osthoff K\", TITLE = \"Death by a thousand cuts: an ever increasing list of caspase substrates.\", JOURNAL = c(\"Cell Death Differ 5:997-1000 (1998)\", \"DOI:10.1038/sj.cdd.4400451\")), list(REFERENCE = \"PMID:23070002\", AUTHORS = \"Safa AR\", TITLE = \"c-FLIP, a master anti-apoptotic regulator.\", JOURNAL = \"Exp Oncol 34:176-84 (2012)\"), list(REFERENCE = \"PMID:18304445\", AUTHORS = \"Jeong SY, Seol DW\", TITLE = \"The role of mitochondria in apoptosis.\", JOURNAL = \"BMB Rep 41:11-22 (2008)\"), list(REFERENCE = \"PMID:20533903\", AUTHORS = \"Parsons MJ, Green DR\", TITLE = \"Mitochondria in cell death.\", JOURNAL = c(\"Essays Biochem 47:99-114 (2010)\", \"DOI:10.1042/bse0470099\")), list(REFERENCE = \"PMID:15719025\", AUTHORS = \"Strasser A\", TITLE = \"The role of BH3-only proteins in the immune system.\", JOURNAL = c(\"Nat Rev Immunol 5:189-200 (2005)\", \"DOI:10.1038/nri1568\")), list(REFERENCE = \"PMID:24278747\", AUTHORS = \"Schonthal AH\", TITLE = \"Endoplasmic reticulum stress: its role in disease and novel prospects for therapy.\", JOURNAL = c(\"Scientifica (Cairo) 2012:857516 (2012)\", \"DOI:10.6064/2012/857516\")), list(REFERENCE = \"PMID:21145844\", AUTHORS = \"Malhi H, Kaufman RJ\", TITLE = \"Endoplasmic reticulum stress in liver disease.\", JOURNAL = c(\"J Hepatol 54:795-809 (2011)\", \"DOI:10.1016/j.jhep.2010.11.005\")), list(REFERENCE = \"PMID:18023214\", AUTHORS = \"Malhotra JD, Kaufman RJ\", TITLE = \"The endoplasmic reticulum and the unfolded protein response.\", JOURNAL = c(\"Semin Cell Dev Biol 18:716-31 (2007)\", \"DOI:10.1016/j.semcdb.2007.09.003\")), list(REFERENCE = \"PMID:16397578\", AUTHORS = \"Wu J, Kaufman RJ\", TITLE = \"From acute ER stress to physiological roles of the Unfolded Protein Response.\", JOURNAL = c(\"Cell Death Differ 13:374-84 (2006)\", \"DOI:10.1038/sj.cdd.4401840\")), list(REFERENCE = \"PMID:21914490\", AUTHORS = \"Repnik U, Stoka V, Turk V, Turk B\", TITLE = \"Lysosomes and lysosomal cathepsins in cell death.\", JOURNAL = c(\"Biochim Biophys Acta 1824:22-33 (2012)\", \"DOI:10.1016/j.bbapap.2011.08.016\")), list(REFERENCE = \"PMID:22465226\", AUTHORS = \"Cesen MH, Pegan K, Spes A, Turk B\", TITLE = \"Lysosomal pathways to cell death and their therapeutic applications.\", JOURNAL = c(\"Exp Cell Res 318:1245-51 (2012)\", \"DOI:10.1016/j.yexcr.2012.03.005\")), list(REFERENCE = \"PMID:26231733\", AUTHORS = \"Dashzeveg N, Yoshida K\", TITLE = \"Cell death decision by p53 via control of the mitochondrial membrane.\", JOURNAL = c(\"Cancer Lett 367:108-12 (2015)\", \"DOI:10.1016/j.canlet.2015.07.019\")), list(REFERENCE = \"PMID:22075987\", AUTHORS = \"Bouchier-Hayes L, Green DR\", TITLE = \"Caspase-2: the orphan caspase.\", JOURNAL = c(\"Cell Death Differ 19:51-7 (2012)\", \"DOI:10.1038/cdd.2011.157\")), list(REFERENCE = \"PMID:18238895\", AUTHORS = \"Baptiste-Okoh N, Barsotti AM, Prives C\", TITLE = \"A role for caspase 2 and PIDD in the process of p53-mediated apoptosis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:1937-42 (2008)\", \"DOI:10.1073/pnas.0711800105\")), list(REFERENCE = \"PMID:12949498\", AUTHORS = \"Aggarwal BB\", TITLE = \"Signalling pathways of the TNF superfamily: a double-edged sword.\", JOURNAL = c(\"Nat Rev Immunol 3:745-56 (2003)\", \"DOI:10.1038/nri1184\")), list(REFERENCE = \"PMID:14737178\", AUTHORS = \"Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA.\", TITLE = \"JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.\", JOURNAL = c(\"Leukemia 18:189-218 (2004)\", \"DOI:10.1038/sj.leu.2403241\")), list(REFERENCE = \"PMID:9916983\", AUTHORS = \"Dragovich T, Rudin CM, Thompson CB\", TITLE = \"Signal transduction pathways that regulate cell survival and cell death.\", JOURNAL = c(\"Oncogene 17:3207-13 (1998)\", \"DOI:10.1038/sj.onc.1202587\")), list(REFERENCE = \"PMID:11520933\", AUTHORS = \"Sofroniew MV, Howe CL, Mobley WC\", TITLE = \"Nerve growth factor signaling, neuroprotection, and neural repair.\", JOURNAL = c(\"Annu Rev Neurosci 24:1217-81 (2001)\", \"DOI:10.1146/annurev.neuro.24.1.1217\")), list(REFERENCE = \"PMID:24769728\", AUTHORS = \"Kristiansen M, Ham J\", TITLE = \"Programmed cell death during neuronal development: the sympathetic neuron model.\", JOURNAL = c(\"Cell Death Differ 21:1025-35 (2014)\", \"DOI:10.1038/cdd.2014.47\")), list(REFERENCE = \"PMID:18208375\", AUTHORS = \"Logue SE, Martin SJ\", TITLE = \"Caspase activation cascades in apoptosis.\", JOURNAL = c(\"Biochem Soc Trans 36:1-9 (2008)\", \"DOI:10.1042/BST0360001\")), list(REFERENCE = \"PMID:19770840\", AUTHORS = \"Boivin WA, Cooper DM, Hiebert PR, Granville DJ\", TITLE = \"Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.\", JOURNAL = c(\"Lab Invest 89:1195-220 (2009)\", \"DOI:10.1038/labinvest.2009.91\")), list(REFERENCE = \"PMID:20075940\", AUTHORS = \"Cullen SP, Brunet M, Martin SJ\", TITLE = \"Granzymes in cancer and immunity.\", JOURNAL = c(\"Cell Death Differ 17:616-23 (2010)\", \"DOI:10.1038/cdd.2009.206\"))', 'map04210', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (265, '04211', 'Longevity regulating pathway', 'Regulation of longevity depends on genetic and environmental factors. Caloric restriction (CR), that is limiting food intake, is recognized in mammals as the best characterized and most reproducible strategy for extending lifespan. Four pathways have been implicated in mediating the CR effect. These are the insulin like growth factor (IGF-1)/insulin signaling pathway, the sirtuin pathway, the adenosine monophosphate (AMP) activated protein kinase (AMPK) pathway and the target of rapamycin (TOR) pathway. The collective response of these pathways to CR is believed to promote cellular fitness and ultimately longevity via activation of autophagy, stress defense mechanisms, and survival pathways while attenuating proinflammatory mediators and cellular growth. Furthermore, there is evidence supporting that life span extension can be achieved with pharmacologic agents that mimic the effects of caloric restriction, such as rapamycin, via mTOR signaling blockade, resveratrol, by activating SIRT1 activity, and metformin, which seems to be a robust stimulator of AMPK activity. As an aging suppressor, Klotho is an important molecule in aging processes and its overexpression results in longevity.', 'Organismal Systems; Aging', 'Longevity regulating pathway', 'Diabetic nephropathy', 'ko04211', 'list(REFERENCE = \"PMID:22618766\", AUTHORS = \"Barzilai N, Huffman DM, Muzumdar RH, Bartke A\", TITLE = \"The critical role of metabolic pathways in aging.\", JOURNAL = c(\"Diabetes 61:1315-22 (2012)\", \"DOI:10.2337/db11-1300\")), list(REFERENCE = \"PMID:20395504\", AUTHORS = \"Fontana L, Partridge L, Longo VD\", TITLE = \"Extending healthy life span--from yeast to humans.\", JOURNAL = c(\"Science 328:321-6 (2010)\", \"DOI:10.1126/science.1172539\")), list(REFERENCE = \"PMID:21779512\", AUTHORS = \"Feng Z, Lin M, Wu R\", TITLE = \"The Regulation of Aging and Longevity: A New and Complex Role of p53.\", JOURNAL = c(\"Genes Cancer 2:443-52 (2011)\", \"DOI:10.1177/1947601911410223\")), list(REFERENCE = \"PMID:20336132\", AUTHORS = \"Kenyon CJ\", TITLE = \"The genetics of ageing.\", JOURNAL = c(\"Nature 464:504-12 (2010)\", \"DOI:10.1038/nature08980\")), list(REFERENCE = \"PMID:24905167\", AUTHORS = \"Cheng CW, Adams GB, Perin L, Wei M, Zhou X, Lam BS, Da Sacco S, Mirisola M, Quinn DI, Dorff TB, Kopchick JJ, Longo VD\", TITLE = \"Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression.\", JOURNAL = c(\"Cell Stem Cell 14:810-23 (2014)\", \"DOI:10.1016/j.stem.2014.04.014\")), list(REFERENCE = \"PMID:25832544\", AUTHORS = \"Morris BJ, Willcox DC, Donlon TA, Willcox BJ\", TITLE = \"FOXO3: A Major Gene for Human Longevity - A Mini-Review.\", JOURNAL = c(\"Gerontology 61:515-25 (2015)\", \"DOI:10.1159/000375235\")), list(REFERENCE = \"PMID:23939249\", AUTHORS = \"Pyo JO, Yoo SM, Ahn HH, Nah J, Hong SH, Kam TI, Jung S, Jung YK\", TITLE = \"Overexpression of Atg5 in mice activates autophagy and extends lifespan.\", JOURNAL = c(\"Nat Commun 4:2300 (2013)\", \"DOI:10.1038/ncomms3300\")), list(REFERENCE = \"PMID:25654554\", AUTHORS = \"Madeo F, Zimmermann A, Maiuri MC, Kroemer G\", TITLE = \"Essential role for autophagy in life span extension.\", JOURNAL = c(\"J Clin Invest 125:85-93 (2015)\", \"DOI:10.1172/JCI73946\")), list(REFERENCE = \"PMID:23061800\", AUTHORS = \"Passtoors WM, Beekman M, Deelen J, van der Breggen R, Maier AB, Guigas B, Derhovanessian E, van Heemst D, de Craen AJ, Gunn DA, Pawelec G, Slagboom PE\", TITLE = \"Gene expression analysis of mTOR pathway: association with human longevity.\", JOURNAL = c(\"Aging Cell 12:24-31 (2013)\", \"DOI:10.1111/acel.12015\")), list(REFERENCE = \"PMID:23594965\", AUTHORS = \"Markaki M, Tavernarakis N\", TITLE = \"Metabolic control by target of rapamycin and autophagy during ageing - a mini-review.\", JOURNAL = c(\"Gerontology 59:340-8 (2013)\", \"DOI:10.1159/000348599\")), list(REFERENCE = \"PMID:17701476\", AUTHORS = \"Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J\", TITLE = \"Sirtuins: the \'magnificent seven\', function, metabolism and longevity.\", JOURNAL = c(\"Ann Med 39:335-45 (2007)\", \"DOI:10.1080/07853890701408194\")), list(REFERENCE = \"PMID:20103737\", AUTHORS = \"Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y\", TITLE = \"AMPK and SIRT1: a long-standing partnership?\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 298:E751-60 (2010)\", \"DOI:10.1152/ajpendo.00745.2009\")), list(REFERENCE = \"PMID:20357764\", AUTHORS = \"Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T\", TITLE = \"Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.\", JOURNAL = c(\"Nature 464:1313-9 (2010)\", \"DOI:10.1038/nature08991\")), list(REFERENCE = \"PMID:25824609\", AUTHORS = \"Ramis MR, Esteban S, Miralles A, Tan DX, Reiter RJ\", TITLE = \"Caloric restriction, resveratrol and melatonin: Role of SIRT1 and implications for aging and related-diseases.\", JOURNAL = c(\"Mech Ageing Dev 146-148:28-41 (2015)\", \"DOI:10.1016/j.mad.2015.03.008\")), list(REFERENCE = \"PMID:19262508\", AUTHORS = \"Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J\", TITLE = \"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.\", JOURNAL = c(\"Nature 458:1056-60 (2009)\", \"DOI:10.1038/nature07813\")), list(REFERENCE = \"PMID:24997879\", AUTHORS = \"Esmaili S, Xu A, George J\", TITLE = \"The multifaceted and controversial immunometabolic actions of adiponectin.\", JOURNAL = c(\"Trends Endocrinol Metab 25:444-51 (2014)\", \"DOI:10.1016/j.tem.2014.06.001\")), list(REFERENCE = \"PMID:20848587\", AUTHORS = \"Mouchiroud L, Molin L, Dalliere N, Solari F\", TITLE = \"Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging.\", JOURNAL = c(\"Biofactors 36:377-82 (2010)\", \"DOI:10.1002/biof.127\")), list(REFERENCE = \"PMID:22983298\", AUTHORS = \"Tucci P\", TITLE = \"Caloric restriction: is mammalian life extension linked to p53?\", JOURNAL = c(\"Aging (Albany NY) 4:525-34 (2012)\", \"DOI:10.18632/aging.100481\")), list(REFERENCE = \"PMID:18692468\", AUTHORS = \"Budanov AV, Karin M\", TITLE = \"p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling.\", JOURNAL = c(\"Cell 134:451-60 (2008)\", \"DOI:10.1016/j.cell.2008.06.028\")), list(REFERENCE = \"PMID:25601466\", AUTHORS = \"Sopjani M, Rinnerthaler M, Kruja J, Dermaku-Sopjani M\", TITLE = \"Intracellular signaling of the aging suppressor protein Klotho.\", JOURNAL = c(\"Curr Mol Med 15:27-37 (2015)\", \"DOI:10.2174/1566524015666150114111258\")), list(REFERENCE = \"PMID:18946478\", AUTHORS = \"Longo VD, Lieber MR, Vijg J\", TITLE = \"Turning anti-ageing genes against cancer.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 9:903-10 (2008)\", \"DOI:10.1038/nrm2526\"))', 'map04211', 'Longevity regulating pathway', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (266, '04212', 'Longevity regulating pathway - worm', 'The nematode Caenorhabditis elegans has proven to be a very useful tool for studying the genetics of longevity due to its simple biology. Over 70 genes have been found to influence lifespan in this worm. The majority of the genes could be placed into canonical longevity pathways including insulin/IGF, germline, TOR signaling, and mitochondrial respiration. The insulin/IGF-1 signaling (IIS) pathway is a central regulator of life span. Transcription factors regulated by the IIS and the TOR-S6K pathways are implicated in the anti-aging effects of Dietary restriction (DR). Lifespan extension via germline removal depends on at least four signaling mechanisms: reduced TOR signaling, DAF-16/FOXO regulation, increased steroid signaling via the DAF-36/DAF-9/DAF-12 pathway, and increased NHR-80/HNF-4 signaling. The mitochondrial unfolded protein response (UPRmt), a mitochondrial stress response, can be regarded as a hormetic mechanism that extends lifespan in spite of mitochondrial dysfunction. Longevity- promoting compounds such as rapamycin and resveratrol also induce mitonuclear imbalance that activates the UPRmt.', 'Organismal Systems; Aging', 'Longevity regulating pathway - worm', 'ko04212', 'list(REFERENCE = \"PMID:22939742\", AUTHORS = \"Lapierre LR, Hansen M\", TITLE = \"Lessons from C. elegans: signaling pathways for longevity.\", JOURNAL = c(\"Trends Endocrinol Metab 23:637-44 (2012)\", \"DOI:10.1016/j.tem.2012.07.007\")), list(REFERENCE = \"PMID:23633911\", AUTHORS = \"Yanos ME, Bennett CF, Kaeberlein M\", TITLE = \"Genome-Wide RNAi Longevity Screens in Caenorhabditis elegans.\", JOURNAL = c(\"Curr Genomics 13:508-18 (2012)\", \"DOI:10.2174/138920212803251391\")), list(REFERENCE = \"PMID:23063987\", AUTHORS = \"Antebi A\", TITLE = \"Regulation of longevity by the reproductive system.\", JOURNAL = c(\"Exp Gerontol 48:596-602 (2013)\", \"DOI:10.1016/j.exger.2012.09.009\")), list(REFERENCE = \"PMID:25988171\", AUTHORS = \"Khodakarami A, Saez I, Mels J, Vilchez D\", TITLE = \"Mediation of organismal aging and somatic proteostasis by the germline.\", JOURNAL = c(\"Front Mol Biosci 2:3 (2015)\", \"DOI:10.3389/fmolb.2015.00003\")), list(REFERENCE = \"PMID:23312280\", AUTHORS = \"Hansen M, Flatt T, Aguilaniu H\", TITLE = \"Reproduction, fat metabolism, and life span: what is the connection?\", JOURNAL = c(\"Cell Metab 17:10-9 (2013)\", \"DOI:10.1016/j.cmet.2012.12.003\")), list(REFERENCE = \"PMID:23870130\", AUTHORS = \"Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Canto C, Mottis A, Jo YS, Viswanathan M, Schoonjans K, Guarente L, Auwerx J\", TITLE = \"The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling.\", JOURNAL = c(\"Cell 154:430-41 (2013)\", \"DOI:10.1016/j.cell.2013.06.016\")), list(REFERENCE = \"PMID:24141218\", AUTHORS = \"Jasper H\", TITLE = \"Sirtuins: Longevity focuses on NAD+.\", JOURNAL = c(\"Nat Chem Biol 9:666-7 (2013)\", \"DOI:10.1038/nchembio.1369\")), list(REFERENCE = \"PMID:23870118\", AUTHORS = \"Karpac J, Jasper H\", TITLE = \"Aging: seeking mitonuclear balance.\", JOURNAL = c(\"Cell 154:271-3 (2013)\", \"DOI:10.1016/j.cell.2013.06.046\")), list(REFERENCE = \"PMID:24930971\", AUTHORS = \"Jensen MB, Jasper H\", TITLE = \"Mitochondrial proteostasis in the control of aging and longevity.\", JOURNAL = c(\"Cell Metab 20:214-25 (2014)\", \"DOI:10.1016/j.cmet.2014.05.006\")), list(REFERENCE = \"PMID:24699406\", AUTHORS = \"Munkacsy E, Rea SL\", TITLE = \"The paradox of mitochondrial dysfunction and extended longevity.\", JOURNAL = c(\"Exp Gerontol 56:221-33 (2014)\", \"DOI:10.1016/j.exger.2014.03.016\")), list(REFERENCE = \"PMID:15767565\", AUTHORS = \"Oh SW, Mukhopadhyay A, Svrzikapa N, Jiang F, Davis RJ, Tissenbaum HA\", TITLE = \"JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 102:4494-9 (2005)\", \"DOI:10.1073/pnas.0500749102\")), list(REFERENCE = \"PMID:12845331\", AUTHORS = \"Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, Li H, Kenyon C\", TITLE = \"Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans.\", JOURNAL = c(\"Nature 424:277-83 (2003)\", \"DOI:10.1038/nature01789\")), list(REFERENCE = \"PMID:21909281\", AUTHORS = \"Rizki G, Iwata TN, Li J, Riedel CG, Picard CL, Jan M, Murphy CT, Lee SS\", TITLE = \"The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO.\", JOURNAL = c(\"PLoS Genet 7:e1002235 (2011)\", \"DOI:10.1371/journal.pgen.1002235\")), list(REFERENCE = \"PMID:16530049\", AUTHORS = \"Wolff S, Ma H, Burch D, Maciel GA, Hunter T, Dillin A\", TITLE = \"SMK-1, an essential regulator of DAF-16-mediated longevity.\", JOURNAL = c(\"Cell 124:1039-53 (2006)\", \"DOI:10.1016/j.cell.2005.12.042\")), list(REFERENCE = \"PMID:23116063\", AUTHORS = \"Barna J, Princz A, Kosztelnik M, Hargitai B, Takacs-Vellai K, Vellai T\", TITLE = \"Heat shock factor-1 intertwines insulin/IGF-1, TGF-beta and cGMP signaling to control development and aging.\", JOURNAL = c(\"BMC Dev Biol 12:32 (2012)\", \"DOI:10.1186/1471-213X-12-32\")), list(REFERENCE = \"PMID:12750521\", AUTHORS = \"Hsu AL, Murphy CT, Kenyon C\", TITLE = \"Regulation of aging and age-related disease by DAF-16 and heat-shock factor.\", JOURNAL = c(\"Science 300:1142-5 (2003)\", \"DOI:10.1126/science.1083701\")), list(REFERENCE = \"PMID:16251270\", AUTHORS = \"An JH, Vranas K, Lucke M, Inoue H, Hisamoto N, Matsumoto K, Blackwell TK\", TITLE = \"Regulation of the Caenorhabditis elegans oxidative stress defense protein SKN-1 by glycogen synthase kinase-3.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 102:16275-80 (2005)\", \"DOI:10.1073/pnas.0508105102\")), list(REFERENCE = \"PMID:16166371\", AUTHORS = \"Inoue H, Hisamoto N, An JH, Oliveira RP, Nishida E, Blackwell TK, Matsumoto K\", TITLE = \"The C. elegans p38 MAPK pathway regulates nuclear localization of the transcription factor SKN-1 in oxidative stress response.\", JOURNAL = c(\"Genes Dev 19:2278-83 (2005)\", \"DOI:10.1101/gad.1324805\")), list(REFERENCE = \"PMID:21241450\", AUTHORS = \"Leiser SF, Begun A, Kaeberlein M\", TITLE = \"HIF-1 modulates longevity and healthspan in a temperature-dependent manner.\", JOURNAL = c(\"Aging Cell 10:318-26 (2011)\", \"DOI:10.1111/j.1474-9726.2011.00672.x\"))', 'map04212', 'Longevity regulating pathway - worm', 'The nematode Caenorhabditis elegans has proven to be a very useful tool for studying the genetics of longevity due to its simple biology. Over 70 genes have been found to influence lifespan in this worm. The majority of the genes could be placed into canonical longevity pathways including insulin/IGF, germline, TOR signaling, and mitochondrial respiration. The insulin/IGF-1 signaling (IIS) pathway is a central regulator of life span. Transcription factors regulated by the IIS and the TOR-S6K pathways are implicated in the anti-aging effects of Dietary restriction (DR). Lifespan extension via germline removal depends on at least four signaling mechanisms: reduced TOR signaling, DAF-16/FOXO regulation, increased steroid signaling via the DAF-36/DAF-9/DAF-12 pathway, and increased NHR-80/HNF-4 signaling. The mitochondrial unfolded protein response (UPRmt), a mitochondrial stress response, can be regarded as a hormetic mechanism that extends lifespan in spite of mitochondrial dysfunction. Longevity- promoting compounds such as rapamycin and resveratrol also induce mitonuclear imbalance that activates the UPRmt.', 6, 0, 6, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (267, '04213', 'Longevity regulating pathway - multiple species', 'Aging is a complex process of accumulation of molecular, cellular, and organ damage, leading to loss of function and increased vulnerability to disease and death. Despite the complexity of aging, recent work has shown that dietary restriction (DR) and genetic down-regulation of nutrient-sensing pathways, namely IIS (insulin/insulin-like growth factor signalling) and TOR (target-of- rapamycin) can substantially increase healthy life span of laboratory model organisms. These nutrient signaling pathways are conserved in various organisms. In worms, flies, and mammals, DR reduces signalling through IIS/TOR pathways, deactivating the PI3K/Akt/TOR intracellular signalling cascade and consequently activating the antiaging FOXO family transcription factor(s). In yeast, the effects of DR on life- span extension are associated with reduced activities of the TOR/Sch9 and Ras/PKA pathways and require the serine-threonine kinase Rim15 and transcription factors Gis1 and Msn2/4. These transcription factors (FOXO, DAF-16, Gis1, and Msn2/4) transactivate genes involved in resistance to oxidative stress, energy metabolism, DNA damage repair, glucose metabolism, autophagy and protection of proteins by chaperones.', 'Organismal Systems; Aging', 'Longevity regulating pathway - multiple species', 'ko04213', 'list(REFERENCE = \"PMID:20395504\", AUTHORS = \"Fontana L, Partridge L, Longo VD\", TITLE = \"Extending healthy life span--from yeast to humans.\", JOURNAL = c(\"Science 328:321-6 (2010)\", \"DOI:10.1126/science.1172539\")), list(REFERENCE = \"PMID:20098959\", AUTHORS = \"Parrella E, Longo VD\", TITLE = \"Insulin/IGF-I and related signaling pathways regulate aging in nondividing cells: from yeast to the mammalian brain.\", JOURNAL = c(\"ScientificWorldJournal 10:161-77 (2010)\", \"DOI:10.1100/tsw.2010.8\")), list(REFERENCE = \"PMID:26682004\", AUTHORS = \"Santos J, Leitao-Correia F, Sousa MJ, Leao C\", TITLE = \"Dietary Restriction and Nutrient Balance in Aging.\", JOURNAL = c(\"Oxid Med Cell Longev 2016:4010357 (2016)\", \"DOI:10.1155/2016/4010357\")), list(REFERENCE = \"PMID:18946478\", AUTHORS = \"Longo VD, Lieber MR, Vijg J\", TITLE = \"Turning anti-ageing genes against cancer.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 9:903-10 (2008)\", \"DOI:10.1038/nrm2526\")), list(REFERENCE = \"PMID:16304601\", AUTHORS = \"Longo VD, Mitteldorf J, Skulachev VP\", TITLE = \"Programmed and altruistic ageing.\", JOURNAL = c(\"Nat Rev Genet 6:866-72 (2005)\", \"DOI:10.1038/nrg1706\")), list(REFERENCE = \"PMID:12610293\", AUTHORS = \"Longo VD, Finch CE\", TITLE = \"Evolutionary medicine: from dwarf model systems to healthy centenarians?\", JOURNAL = c(\"Science 299:1342-6 (2003)\", \"DOI:10.1126/science.1077991\")), list(REFERENCE = \"PMID:25153840\", AUTHORS = \"Mirzaei H, Suarez JA, Longo VD\", TITLE = \"Protein and amino acid restriction, aging and disease: from yeast to humans.\", JOURNAL = c(\"Trends Endocrinol Metab 25:558-66 (2014)\", \"DOI:10.1016/j.tem.2014.07.002\")), list(REFERENCE = \"PMID:20336132\", AUTHORS = \"Kenyon CJ\", TITLE = \"The genetics of ageing.\", JOURNAL = c(\"Nature 464:504-12 (2010)\", \"DOI:10.1038/nature08980\")), list(REFERENCE = \"PMID:20097433\", AUTHORS = \"Longo VD, Fontana L\", TITLE = \"Calorie restriction and cancer prevention: metabolic and molecular mechanisms.\", JOURNAL = c(\"Trends Pharmacol Sci 31:89-98 (2010)\", \"DOI:10.1016/j.tips.2009.11.004\")), list(REFERENCE = \"PMID:22094419\", AUTHORS = \"Longo VD, Fabrizio P\", TITLE = \"Chronological aging in Saccharomyces cerevisiae.\", JOURNAL = c(\"Subcell Biochem 57:101-21 (2012)\", \"DOI:10.1007/978-94-007-2561-4_5\")), list(REFERENCE = \"PMID:26525455\", AUTHORS = \"Bitto A, Wang AM, Bennett CF, Kaeberlein M\", TITLE = \"Biochemical Genetic Pathways that Modulate Aging in Multiple Species.\", JOURNAL = c(\"Cold Spring Harb Perspect Med 5:a025114 (2015)\", \"DOI:10.1101/cshperspect.a025114\")), list(REFERENCE = \"PMID:18373439\", AUTHORS = \"Mair W, Dillin A\", TITLE = \"Aging and survival: the genetics of life span extension by dietary restriction.\", JOURNAL = c(\"Annu Rev Biochem 77:727-54 (2008)\", \"DOI:10.1146/annurev.biochem.77.061206.171059\")), list(REFERENCE = \"PMID:17701476\", AUTHORS = \"Dali-Youcef N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J\", TITLE = \"Sirtuins: the \'magnificent seven\', function, metabolism and longevity.\", JOURNAL = c(\"Ann Med 39:335-45 (2007)\", \"DOI:10.1080/07853890701408194\")), list(REFERENCE = \"PMID:21909281\", AUTHORS = \"Rizki G, Iwata TN, Li J, Riedel CG, Picard CL, Jan M, Murphy CT, Lee SS\", TITLE = \"The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO.\", JOURNAL = c(\"PLoS Genet 7:e1002235 (2011)\", \"DOI:10.1371/journal.pgen.1002235\")), list(REFERENCE = \"PMID:23615258\", AUTHORS = \"Lee SH, Min KJ\", TITLE = \"Caloric restriction and its mimetics.\", JOURNAL = c(\"BMB Rep 46:181-7 (2013)\", \"DOI:10.5483/BMBRep.2013.46.4.033\")), list(REFERENCE = \"PMID:15768047\", AUTHORS = \"Bordone L, Guarente L\", TITLE = \"Calorie restriction, SIRT1 and metabolism: understanding longevity.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 6:298-305 (2005)\", \"DOI:10.1038/nrm1616\")), list(REFERENCE = \"PMID:21841070\", AUTHORS = \"Canto C, Auwerx J\", TITLE = \"Calorie restriction: is AMPK a key sensor and effector?\", JOURNAL = c(\"Physiology (Bethesda) 26:214-24 (2011)\", \"DOI:10.1152/physiol.00010.2011\")), list(REFERENCE = \"PMID:14534077\", AUTHORS = \"Barbieri M, Bonafe M, Franceschi C, Paolisso G\", TITLE = \"Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 285:E1064-71 (2003)\", \"DOI:10.1152/ajpendo.00296.2003\")), list(REFERENCE = \"PMID:17684529\", AUTHORS = \"Russell SJ, Kahn CR\", TITLE = \"Endocrine regulation of ageing.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 8:681-91 (2007)\", \"DOI:10.1038/nrm2234\"))', 'map04213', 'Longevity regulating pathway - multiple species', 'Aging is a complex process of accumulation of molecular, cellular, and organ damage, leading to loss of function and increased vulnerability to disease and death. Despite the complexity of aging, recent work has shown that dietary restriction (DR) and genetic down-regulation of nutrient-sensing pathways, namely IIS (insulin/insulin-like growth factor signalling) and TOR (target-of- rapamycin) can substantially increase healthy life span of laboratory model organisms. These nutrient signaling pathways are conserved in various organisms. In worms, flies, and mammals, DR reduces signalling through IIS/TOR pathways, deactivating the PI3K/Akt/TOR intracellular signalling cascade and consequently activating the antiaging FOXO family transcription factor(s). In yeast, the effects of DR on life- span extension are associated with reduced activities of the TOR/Sch9 and Ras/PKA pathways and require the serine-threonine kinase Rim15 and transcription factors Gis1 and Msn2/4. These transcription factors (FOXO, DAF-16, Gis1, and Msn2/4) transactivate genes involved in resistance to oxidative stress, energy metabolism, DNA damage repair, glucose metabolism, autophagy and protection of proteins by chaperones.', 167, 0, 135, 0, 32, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (268, '04214', 'Apoptosis - fly', 'Apoptosis, or programmed cell death, is a critical factor in homeostasis in all multicellular organisms, playing a crucial role in removing excess unwanted cells without stimulation of an immune response. Caspases are the central components of the apoptotic response. In Drosophila, Dark promotes activation of the initiator caspase Dronc. Drosophila inhibitor of apoptosis protein 1 (DIAP1) inhibits Dronc and the effector caspases Drice and Dcp-1. RHG family proteins such as Rpr, Hid, Grim, Sickle, and Jafrac-2 promote cell death, in part by disrupting DIAP1\'s ability to inhibit caspase activity. Proapoptotic proteins such as caspases and RHG proteins are regulated through multiple pathways. The Drosophila steroid hormone ecdysone mediates cell death by controling the up-regulation of a number of proapoptotic genes. Cytotoxic stress such as DNA damage can activate P53, which in turn induces the expression of RHG genes. Eiger can initiate cell death through an IAP-sensitive cell death pathway via JNK signaling. Hid, a member of the RHG family, is negatively regulated by the epidermal growth factor (EGF) receptor-dependent survival signaling and positively regulated by the tumor suppressors Hippo, Salvador, and Warts.', 'Cellular Processes; Cell growth and death', 'Apoptosis - fly', 'ko04214', 'list(REFERENCE = \"PMID:16842034\", AUTHORS = \"Hay BA, Guo M\", TITLE = \"Caspase-dependent cell death in Drosophila.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 22:623-50 (2006)\", \"DOI:10.1146/annurev.cellbio.21.012804.093845\")), list(REFERENCE = \"PMID:15573123\", AUTHORS = \"Hay BA, Huh JR, Guo M\", TITLE = \"The genetics of cell death: approaches, insights and opportunities in Drosophila.\", JOURNAL = c(\"Nat Rev Genet 5:911-22 (2004)\", \"DOI:10.1038/nrg1491\")), list(REFERENCE = \"PMID:15082313\", AUTHORS = \"Kumar S, Cakouros D\", TITLE = \"Transcriptional control of the core cell-death machinery.\", JOURNAL = c(\"Trends Biochem Sci 29:193-9 (2004)\", \"DOI:10.1016/j.tibs.2004.02.001\")), list(REFERENCE = \"PMID:25991373\", AUTHORS = \"Fuchs Y, Steller H\", TITLE = \"Live to die another way: modes of programmed cell death and the signals emanating from dying cells.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 16:329-44 (2015)\", \"DOI:10.1038/nrm3999\")), list(REFERENCE = \"PMID:25668151\", AUTHORS = \"Arya R, White K\", TITLE = \"Cell death in development: Signaling pathways and core mechanisms.\", JOURNAL = c(\"Semin Cell Dev Biol 39:12-9 (2015)\", \"DOI:10.1016/j.semcdb.2015.02.001\")), list(REFERENCE = \"PMID:14744432\", AUTHORS = \"Danial NN, Korsmeyer SJ\", TITLE = \"Cell death: critical control points.\", JOURNAL = c(\"Cell 116:205-19 (2004)\", \"DOI:10.1016/S0092-8674(04)00046-7\")), list(REFERENCE = \"PMID:12006672\", AUTHORS = \"Gorski S, Marra M\", TITLE = \"Programmed cell death takes flight: genetic and genomic approaches to gene discovery in Drosophila.\", JOURNAL = c(\"Physiol Genomics 9:59-69 (2002)\", \"DOI:10.1152/physiolgenomics.00114.2001\")), list(REFERENCE = \"PMID:12072176\", AUTHORS = \"Richardson H, Kumar S\", TITLE = \"Death to flies: Drosophila as a model system to study programmed cell death.\", JOURNAL = c(\"J Immunol Methods 265:21-38 (2002)\", \"DOI:10.1016/S0022-1759(02)00068-6\")), list(REFERENCE = \"PMID:21338340\", AUTHORS = \"Kuranaga E\", TITLE = \"Caspase signaling in animal development.\", JOURNAL = c(\"Dev Growth Differ 53:137-48 (2011)\", \"DOI:10.1111/j.1440-169X.2010.01237.x\")), list(REFERENCE = \"PMID:20978240\", AUTHORS = \"Bergmann A, Steller H\", TITLE = \"Apoptosis, stem cells, and tissue regeneration.\", JOURNAL = c(\"Sci Signal 3:re8 (2010)\", \"DOI:10.1126/scisignal.3145re8\")), list(REFERENCE = \"PMID:15520809\", AUTHORS = \"Riedl SJ, Shi Y\", TITLE = \"Molecular mechanisms of caspase regulation during apoptosis.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 5:897-907 (2004)\", \"DOI:10.1038/nrm1496\")), list(REFERENCE = \"PMID:14996492\", AUTHORS = \"Igaki T, Miura M\", TITLE = \"Role of Bcl-2 family members in invertebrates.\", JOURNAL = c(\"Biochim Biophys Acta 1644:73-81 (2004)\", \"DOI:10.1016/j.bbamcr.2003.09.007\")), list(REFERENCE = \"PMID:26679112\", AUTHORS = \"Clavier A, Rincheval-Arnold A, Colin J, Mignotte B, Guenal I\", TITLE = \"Apoptosis in Drosophila: which role for mitochondria?\", JOURNAL = c(\"Apoptosis 21:239-51 (2016)\", \"DOI:10.1007/s10495-015-1209-y\")), list(REFERENCE = \"PMID:20950655\", AUTHORS = \"Abdelwahid E, Rolland S, Teng X, Conradt B, Hardwick JM, White K\", TITLE = \"Mitochondrial involvement in cell death of non-mammalian eukaryotes.\", JOURNAL = c(\"Biochim Biophys Acta 1813:597-607 (2011)\", \"DOI:10.1016/j.bbamcr.2010.10.008\")), list(REFERENCE = \"PMID:25299777\", AUTHORS = \"Demay Y, Perochon J, Szuplewski S, Mignotte B, Gaumer S\", TITLE = \"The PERK pathway independently triggers apoptosis and a Rac1/Slpr/JNK/Dilp8 signaling favoring tissue homeostasis in a chronic ER stress Drosophila model.\", JOURNAL = c(\"Cell Death Dis 5:e1452 (2014)\", \"DOI:10.1038/cddis.2014.403\")), list(REFERENCE = \"PMID:15657059\", AUTHORS = \"Kilpatrick ZE, Cakouros D, Kumar S\", TITLE = \"Ecdysone-mediated up-regulation of the effector caspase DRICE is required for hormone-dependent apoptosis in Drosophila cells.\", JOURNAL = c(\"J Biol Chem 280:11981-6 (2005)\", \"DOI:10.1074/jbc.M413971200\")), list(REFERENCE = \"PMID:12070100\", AUTHORS = \"Yu SY, Yoo SJ, Yang L, Zapata C, Srinivasan A, Hay BA, Baker NE\", TITLE = \"A pathway of signals regulating effector and initiator caspases in the developing Drosophila eye.\", JOURNAL = \"Development 129:3269-78 (2002)\"), list(REFERENCE = \"PMID:10074440\", AUTHORS = \"McNeill H, Downward J\", TITLE = \"Apoptosis: Ras to the rescue in the fly eye.\", JOURNAL = c(\"Curr Biol 9:R176-9 (1999)\", \"DOI:10.1016/S0960-9822(99)80107-9\")), list(REFERENCE = \"PMID:19223855\", AUTHORS = \"Narasimamurthy R, Geuking P, Ingold K, Willen L, Schneider P, Basler K\", TITLE = \"Structure-function analysis of Eiger, the Drosophila TNF homolog.\", JOURNAL = c(\"Cell Res 19:392-4 (2009)\", \"DOI:10.1038/cr.2009.16\")), list(REFERENCE = \"PMID:23408884\", AUTHORS = \"Liu B, Behura SK, Clem RJ, Schneemann A, Becnel J, Severson DW, Zhou L\", TITLE = \"P53-mediated rapid induction of apoptosis conveys resistance to viral infection in Drosophila melanogaster.\", JOURNAL = c(\"PLoS Pathog 9:e1003137 (2013)\", \"DOI:10.1371/journal.ppat.1003137\")), list(REFERENCE = \"PMID:12198495\", AUTHORS = \"Kuranaga E, Kanuka H, Igaki T, Sawamoto K, Ichijo H, Okano H, Miura M\", TITLE = \"Reaper-mediated inhibition of DIAP1-induced DTRAF1 degradation results in activation of JNK in Drosophila.\", JOURNAL = c(\"Nat Cell Biol 4:705-10 (2002)\", \"DOI:10.1038/ncb842\")), list(REFERENCE = \"PMID:19330035\", AUTHORS = \"Creagh EM, Brumatti G, Sheridan C, Duriez PJ, Taylor RC, Cullen SP, Adrain C, Martin SJ\", TITLE = \"Bicaudal is a conserved substrate for Drosophila and mammalian caspases and is essential for cell survival.\", JOURNAL = c(\"PLoS One 4:e5055 (2009)\", \"DOI:10.1371/journal.pone.0005055\")), list(REFERENCE = \"PMID:19554451\", AUTHORS = \"Bilak A, Su TT\", TITLE = \"Regulation of Drosophila melanogaster pro-apoptotic gene hid.\", JOURNAL = c(\"Apoptosis 14:943-9 (2009)\", \"DOI:10.1007/s10495-009-0374-2\"))', 'map04214', 'Apoptosis - fly', 'Apoptosis, or programmed cell death, is a critical factor in homeostasis in all multicellular organisms, playing a crucial role in removing excess unwanted cells without stimulation of an immune response. Caspases are the central components of the apoptotic response. In Drosophila, Dark promotes activation of the initiator caspase Dronc. Drosophila inhibitor of apoptosis protein 1 (DIAP1) inhibits Dronc and the effector caspases Drice and Dcp-1. RHG family proteins such as Rpr, Hid, Grim, Sickle, and Jafrac-2 promote cell death, in part by disrupting DIAP1\'s ability to inhibit caspase activity. Proapoptotic proteins such as caspases and RHG proteins are regulated through multiple pathways. The Drosophila steroid hormone ecdysone mediates cell death by controling the up-regulation of a number of proapoptotic genes. Cytotoxic stress such as DNA damage can activate P53, which in turn induces the expression of RHG genes. Eiger can initiate cell death through an IAP-sensitive cell death pathway via JNK signaling. Hid, a member of the RHG family, is negatively regulated by the epidermal growth factor (EGF) receptor-dependent survival signaling and positively regulated by the tumor suppressors Hippo, Salvador, and Warts.', 64, 0, 64, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (269, '04215', 'Apoptosis - multiple species', 'Apoptosis is an evolutionarily conserved process used by multicellular organisms to developmentally regulate cell number or to eliminate cells that are potentially detrimental to the organism. The major players are caspases, caspase inhibitors, members of the Bcl-2 family of pro- and anti-apoptotic proteins and adaptors of the Ced-4/APAF-1 type. Mammals, by comparison with Caenorhabditis and Drosophila, exhibit highly complex extrinsic and intrinsic pathways for apoptosis induction. However, recent analyses of whole genome sequences from cnidarians (e.g. Hydra) suggest that the caspase and Bcl-2 families were already highly complex in cnidarians and that Caenorhabditis and Drosophila lost many of the genes involved in apoptosis.', 'Cellular Processes; Cell growth and death', 'Apoptosis - multiple species', 'GO: 0006915', 'ko04215', 'list(REFERENCE = \"PMID:25991373\", AUTHORS = \"Fuchs Y, Steller H\", TITLE = \"Live to die another way: modes of programmed cell death and the signals emanating from dying cells.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 16:329-44 (2015)\", \"DOI:10.1038/nrm3999\")), list(REFERENCE = \"PMID:15082313\", AUTHORS = \"Kumar S, Cakouros D\", TITLE = \"Transcriptional control of the core cell-death machinery.\", JOURNAL = c(\"Trends Biochem Sci 29:193-9 (2004)\", \"DOI:10.1016/j.tibs.2004.02.001\")), list(REFERENCE = \"PMID:20978240\", AUTHORS = \"Bergmann A, Steller H\", TITLE = \"Apoptosis, stem cells, and tissue regeneration.\", JOURNAL = c(\"Sci Signal 3:re8 (2010)\", \"DOI:10.1126/scisignal.3145re8\")), list(REFERENCE = \"PMID:23457257\", AUTHORS = \"Zmasek CM, Godzik A\", TITLE = \"Evolution of the animal apoptosis network.\", JOURNAL = c(\"Cold Spring Harb Perspect Biol 5:a008649 (2013)\", \"DOI:10.1101/cshperspect.a008649\")), list(REFERENCE = \"PMID:15963254\", AUTHORS = \"Twomey C, McCarthy JV\", TITLE = \"Pathways of apoptosis and importance in development.\", JOURNAL = c(\"J Cell Mol Med 9:345-59 (2005)\", \"DOI:10.1111/j.1582-4934.2005.tb00360.x\")), list(REFERENCE = \"PMID:10578171\", AUTHORS = \"Nicholson DW\", TITLE = \"Caspase structure, proteolytic substrates, and function during apoptotic cell death.\", JOURNAL = c(\"Cell Death Differ 6:1028-42 (1999)\", \"DOI:10.1038/sj.cdd.4400598\")), list(REFERENCE = \"PMID:19659442\", AUTHORS = \"Wang C, Youle RJ\", TITLE = \"The role of mitochondria in apoptosis*.\", JOURNAL = c(\"Annu Rev Genet 43:95-118 (2009)\", \"DOI:10.1146/annurev-genet-102108-134850\")), list(REFERENCE = \"PMID:20028968\", AUTHORS = \"Choi D, Woo M\", TITLE = \"Executioners of apoptosis in pancreatic {beta}-cells: not just for cell death.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 298:E735-41 (2010)\", \"DOI:10.1152/ajpendo.00696.2009\")), list(REFERENCE = \"PMID:11858838\", AUTHORS = \"Joza N, Kroemer G, Penninger JM\", TITLE = \"Genetic analysis of the mammalian cell death machinery.\", JOURNAL = c(\"Trends Genet 18:142-9 (2002)\", \"DOI:10.1016/S0168-9525(01)02618-X\")), list(REFERENCE = \"PMID:15107838\", AUTHORS = \"Yan N, Wu JW, Chai J, Li W, Shi Y\", TITLE = \"Molecular mechanisms of DrICE inhibition by DIAP1 and removal of inhibition by Reaper, Hid and Grim.\", JOURNAL = c(\"Nat Struct Mol Biol 11:420-8 (2004)\", \"DOI:10.1038/nsmb764\")), list(REFERENCE = \"PMID:22689371\", AUTHORS = \"Reiter S, Crescenzi M, Galliot B, Buzgariu W\", TITLE = \"Hydra, a versatile model to study the homeostatic and developmental functions of cell death.\", JOURNAL = c(\"Int J Dev Biol 56:593-604 (2012)\", \"DOI:10.1387/ijdb.123499sr\")), list(REFERENCE = \"PMID:20479784\", AUTHORS = \"Lasi M, Pauly B, Schmidt N, Cikala M, Stiening B, Kasbauer T, Zenner G, Popp T, Wagner A, Knapp RT, Huber AH, Grunert M, Soding J, David CN, Bottger A\", TITLE = \"The molecular cell death machinery in the simple cnidarian Hydra includes an expanded caspase family and pro- and anti-apoptotic Bcl-2 proteins.\", JOURNAL = c(\"Cell Res 20:812-25 (2010)\", \"DOI:10.1038/cr.2010.66\")), list(REFERENCE = \"PMID:20041301\", AUTHORS = \"Lasi M, David CN, Bottger A\", TITLE = \"Apoptosis in pre-Bilaterians: Hydra as a model.\", JOURNAL = c(\"Apoptosis 15:269-78 (2010)\", \"DOI:10.1007/s10495-009-0442-7\")), list(REFERENCE = \"PMID:25862972\", AUTHORS = \"Romero A, Novoa B, Figueras A\", TITLE = \"The complexity of apoptotic cell death in mollusks: An update.\", JOURNAL = c(\"Fish Shellfish Immunol 46:79-87 (2015)\", \"DOI:10.1016/j.fsi.2015.03.038\")), list(REFERENCE = \"PMID:21150934\", AUTHORS = \"Potts MB, Cameron S\", TITLE = \"Cell lineage and cell death: Caenorhabditis elegans and cancer research.\", JOURNAL = c(\"Nat Rev Cancer 11:50-8 (2011)\", \"DOI:10.1038/nrc2984\")), list(REFERENCE = \"PMID:24393571\", AUTHORS = \"Lee EF, Young ND, Lim NT, Gasser RB, Fairlie WD\", TITLE = \"Apoptosis in schistosomes: toward novel targets for the treatment of schistosomiasis.\", JOURNAL = c(\"Trends Parasitol 30:75-84 (2014)\", \"DOI:10.1016/j.pt.2013.12.005\"))', 'map04215', 'Apoptosis - multiple species', 143, 0, 143, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (270, '04216', 'Ferroptosis', 'Ferroptosis is a regulated form of cell death and characterized by a production of reactive oxygen species (ROS) from accumulated iron and lipid peroxidation. It can be induced by experimental compounds (e.g.,erastin, RSL3) or clinical drugs(e.g., sulfasalazine, sorafenib) in cancer cell and certain normal cells. It is involved in multiple physiological and pathological processes, such as cancer cell death, neurodegenerative disease, tissue damage and acute renal failure.', 'Cellular Processes; Cell growth and death', 'Ferroptosis', 'Aceruloplasminemia, Glutathione synthetase deficiency', 'GO: 0097707', 'ko04216', 'list(REFERENCE = \"PMID:26775689\", AUTHORS = \"Conrad M, Angeli JP, Vandenabeele P, Stockwell BR\", TITLE = \"Regulated necrosis: disease relevance and therapeutic opportunities.\", JOURNAL = c(\"Nat Rev Drug Discov 15:348-66 (2016)\", \"DOI:10.1038/nrd.2015.6\")), list(REFERENCE = \"PMID:26653790\", AUTHORS = \"Yang WS, Stockwell BR\", TITLE = \"Ferroptosis: Death by Lipid Peroxidation.\", JOURNAL = c(\"Trends Cell Biol 26:165-76 (2016)\", \"DOI:10.1016/j.tcb.2015.10.014\")), list(REFERENCE = \"PMID:27842066\", AUTHORS = \"Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, Kapralov AA, Amoscato AA, Jiang J, Anthonymuthu T, Mohammadyani D, Yang Q, Proneth B, Klein-Seetharaman J, Watkins S, Bahar I, Greenberger J, Mallampalli RK, Stockwell BR, Tyurina YY, Conrad M, Bayir H\", TITLE = \"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis.\", JOURNAL = c(\"Nat Chem Biol 13:81-90 (2017)\", \"DOI:10.1038/nchembio.2238\")), list(REFERENCE = \"PMID:27842067\", AUTHORS = \"D\'Herde K, Krysko DV\", TITLE = \"Ferroptosis: Oxidized PEs trigger death.\", JOURNAL = c(\"Nat Chem Biol 13:4-5 (2017)\", \"DOI:10.1038/nchembio.2261\")), list(REFERENCE = \"PMID:28082232\", AUTHORS = \"Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S\", TITLE = \"Ferroptosis and cell death mechanisms in Parkinson\'s disease.\", JOURNAL = c(\"Neurochem Int 104:34-48 (2017)\", \"DOI:10.1016/j.neuint.2017.01.004\")), list(REFERENCE = \"PMID:26725301\", AUTHORS = \"Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y\", TITLE = \"Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease.\", JOURNAL = c(\"Trends Biochem Sci 41:274-86 (2016)\", \"DOI:10.1016/j.tibs.2015.11.012\")), list(REFERENCE = \"PMID:26794443\", AUTHORS = \"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D\", TITLE = \"Ferroptosis: process and function.\", JOURNAL = c(\"Cell Death Differ 23:369-79 (2016)\", \"DOI:10.1038/cdd.2015.158\")), list(REFERENCE = \"PMID:27791175\", AUTHORS = \"Murphy ME\", TITLE = \"Ironing out how p53 regulates ferroptosis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 113:12350-12352 (2016)\", \"DOI:10.1073/pnas.1615159113\")), list(REFERENCE = \"PMID:28129536\", AUTHORS = \"Muckenthaler MU, Rivella S, Hentze MW, Galy B\", TITLE = \"A Red Carpet for Iron Metabolism.\", JOURNAL = c(\"Cell 168:344-361 (2017)\", \"DOI:10.1016/j.cell.2016.12.034\")), list(REFERENCE = \"PMID:27860262\", AUTHORS = \"Yu H, Guo P, Xie X, Wang Y, Chen G\", TITLE = \"Ferroptosis, a new form of cell death, and its relationships with tumourous diseases.\", JOURNAL = c(\"J Cell Mol Med 21:648-657 (2017)\", \"DOI:10.1111/jcmm.13008\")), list(REFERENCE = \"PMID:27314071\", AUTHORS = \"Wang SJ, Ou Y, Jiang L, Gu W\", TITLE = \"Ferroptosis: A missing puzzle piece in the p53 blueprint?\", JOURNAL = c(\"Mol Cell Oncol 3:e1046581 (2016)\", \"DOI:10.1080/23723556.2015.1046581\")), list(REFERENCE = \"PMID:27048822\", AUTHORS = \"Cao JY, Dixon SJ\", TITLE = \"Mechanisms of ferroptosis.\", JOURNAL = c(\"Cell Mol Life Sci 73:2195-209 (2016)\", \"DOI:10.1007/s00018-016-2194-1\")), list(REFERENCE = \"PMID:26436293\", AUTHORS = \"Mancias JD, Pontano Vaites L, Nissim S, Biancur DE, Kim AJ, Wang X, Liu Y, Goessling W, Kimmelman AC, Harper JW\", TITLE = \"Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis.\", JOURNAL = c(\"Elife 4:e10308 (2015)\", \"DOI:10.7554/eLife.10308\")), list(REFERENCE = \"PMID:28066232\", AUTHORS = \"Wang YQ, Chang SY, Wu Q, Gou YJ, Jia L, Cui YM, Yu P, Shi ZH, Wu WS, Gao G, Chang YZ\", TITLE = \"The Protective Role of Mitochondrial Ferritin on Erastin-Induced Ferroptosis.\", JOURNAL = c(\"Front Aging Neurosci 8:308 (2016)\", \"DOI:10.3389/fnagi.2016.00308\")), list(REFERENCE = \"PMID:26405158\", AUTHORS = \"Kwon MY, Park E, Lee SJ, Chung SW\", TITLE = \"Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death.\", JOURNAL = c(\"Oncotarget 6:24393-403 (2015)\", \"DOI:10.18632/oncotarget.5162\")), list(REFERENCE = \"PMID:22632964\", AUTHORS = \"Reed JC, Pellecchia M\", TITLE = \"Ironing out cell death mechanisms.\", JOURNAL = c(\"Cell 149:963-5 (2012)\", \"DOI:10.1016/j.cell.2012.05.009\"))', 'map04216', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (271, '04217', 'Necroptosis', 'Necroptosis is a programmed form of necrosis. It can be initiated by different stimuli, such as tumor necrosis factor (TNF), TNF-related apoptosis-inducing ligand (TRAIL), Fas ligand (FasL), interferon (IFN), LPS, viral DNA or RNA, DNA-damage agent and requires the kinase activity of receptor-interacting protein 1 (RIPK1) and RIPK3. Its execution involves ROS generation, calcium overload, the opening of the mitochondrial permeability transition pore, mitochondrial fission, inflammatory response and chromatinolysis. Necroptosis participates in many pathogenesis of diseases, including neurological diseases, retinal disorders, acute kidney injury, inflammatory diseases and microbial infections.', 'Cellular Processes; Cell growth and death', 'Necroptosis', 'Encephalopathy due to defective mitochondrial and peroxisomal fission', 'ko04217', 'list(REFERENCE = \"PMID:20823910\", AUTHORS = \"Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G\", TITLE = \"Molecular mechanisms of necroptosis: an ordered cellular explosion.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 11:700-14 (2010)\", \"DOI:10.1038/nrm2970\")), list(REFERENCE = \"PMID:26008591\", AUTHORS = \"Brenner D, Blaser H, Mak TW\", TITLE = \"Regulation of tumour necrosis factor signalling: live or let die.\", JOURNAL = c(\"Nat Rev Immunol 15:362-74 (2015)\", \"DOI:10.1038/nri3834\")), list(REFERENCE = \"PMID:26775689\", AUTHORS = \"Conrad M, Angeli JP, Vandenabeele P, Stockwell BR\", TITLE = \"Regulated necrosis: disease relevance and therapeutic opportunities.\", JOURNAL = c(\"Nat Rev Drug Discov 15:348-66 (2016)\", \"DOI:10.1038/nrd.2015.6\")), list(REFERENCE = \"PMID:24129419\", AUTHORS = \"Ofengeim D, Yuan J\", TITLE = \"Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 14:727-36 (2013)\", \"DOI:10.1038/nrm3683\")), list(REFERENCE = \"PMID:27158445\", AUTHORS = \"Murphy JM, Vince JE\", TITLE = \"Post-translational control of RIPK3 and MLKL mediated necroptotic cell death.\", JOURNAL = c(\"F1000Res 4:F1000 Faculty Rev-1297 (2015)\", \"DOI:10.12688/f1000research.7046.1\")), list(REFERENCE = \"PMID:24452471\", AUTHORS = \"Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P\", TITLE = \"Regulated necrosis: the expanding network of non-apoptotic cell death pathways.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 15:135-47 (2014)\", \"DOI:10.1038/nrm3737\")), list(REFERENCE = \"PMID:27368376\", AUTHORS = \"Dondelinger Y, Hulpiau P, Saeys Y, Bertrand MJ, Vandenabeele P\", TITLE = \"An evolutionary perspective on the necroptotic pathway.\", JOURNAL = c(\"Trends Cell Biol 26:721-32 (2016)\", \"DOI:10.1016/j.tcb.2016.06.004\")), list(REFERENCE = \"PMID:27746097\", AUTHORS = \"Thapa RJ, Ingram JP, Ragan KB, Nogusa S, Boyd DF, Benitez AA, Sridharan H, Kosoff R, Shubina M, Landsteiner VJ, Andrake M, Vogel P, Sigal LJ, tenOever BR, Thomas PG, Upton JW, Balachandran S\", TITLE = \"DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death.\", JOURNAL = c(\"Cell Host Microbe 20:674-681 (2016)\", \"DOI:10.1016/j.chom.2016.09.014\")), list(REFERENCE = \"PMID:27984721\", AUTHORS = \"Yuan J, Najafov A, Py BF\", TITLE = \"Roles of Caspases in Necrotic Cell Death.\", JOURNAL = c(\"Cell 167:1693-1704 (2016)\", \"DOI:10.1016/j.cell.2016.11.047\")), list(REFERENCE = \"PMID:28138137\", AUTHORS = \"Jorgensen I, Rayamajhi M, Miao EA\", TITLE = \"Programmed cell death as a defence against infection.\", JOURNAL = c(\"Nat Rev Immunol 17:151-164 (2017)\", \"DOI:10.1038/nri.2016.147\")), list(REFERENCE = \"PMID:20354226\", AUTHORS = \"Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T\", TITLE = \"The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.\", JOURNAL = c(\"Sci Signal 3:re4 (2010)\", \"DOI:10.1126/scisignal.3115re4\")), list(REFERENCE = \"PMID:22075985\", AUTHORS = \"Vanlangenakker N, Vanden Berghe T, Vandenabeele P\", TITLE = \"Many stimuli pull the necrotic trigger, an overview.\", JOURNAL = c(\"Cell Death Differ 19:75-86 (2012)\", \"DOI:10.1038/cdd.2011.164\")), list(REFERENCE = \"PMID:23913919\", AUTHORS = \"Moriwaki K, Chan FK\", TITLE = \"RIP3: a molecular switch for necrosis and inflammation.\", JOURNAL = c(\"Genes Dev 27:1640-9 (2013)\", \"DOI:10.1101/gad.223321.113\")), list(REFERENCE = \"PMID:25146926\", AUTHORS = \"Humphries F, Yang S, Wang B, Moynagh PN\", TITLE = \"RIP kinases: key decision makers in cell death and innate immunity.\", JOURNAL = c(\"Cell Death Differ 22:225-36 (2015)\", \"DOI:10.1038/cdd.2014.126\")), list(REFERENCE = \"PMID:28126382\", AUTHORS = \"Wegner KW, Saleh D, Degterev A\", TITLE = \"Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.\", JOURNAL = c(\"Trends Pharmacol Sci 38:202-225 (2017)\", \"DOI:10.1016/j.tips.2016.12.005\")), list(REFERENCE = \"PMID:27545878\", AUTHORS = \"Kupka S, De Miguel D, Draber P, Martino L, Surinova S, Rittinger K, Walczak H\", TITLE = \"SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.\", JOURNAL = c(\"Cell Rep 16:2271-80 (2016)\", \"DOI:10.1016/j.celrep.2016.07.086\")), list(REFERENCE = \"PMID:27219062\", AUTHORS = \"Goodall ML, Fitzwalter BE, Zahedi S, Wu M, Rodriguez D, Mulcahy-Levy JM, Green DR, Morgan M, Cramer SD, Thorburn A\", TITLE = \"The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis.\", JOURNAL = c(\"Dev Cell 37:337-49 (2016)\", \"DOI:10.1016/j.devcel.2016.04.018\")), list(REFERENCE = \"PMID:19910467\", AUTHORS = \"Xu G, Tan X, Wang H, Sun W, Shi Y, Burlingame S, Gu X, Cao G, Zhang T, Qin J, Yang J\", TITLE = \"Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1.\", JOURNAL = c(\"J Biol Chem 285:969-78 (2010)\", \"DOI:10.1074/jbc.M109.042689\")), list(REFERENCE = \"PMID:26971869\", AUTHORS = \"Jacobsen AV, Silke J\", TITLE = \"The importance of being chaperoned: HSP90 and necroptosis.\", JOURNAL = c(\"Cell Chem Biol 23:205-7 (2016)\", \"DOI:10.1016/j.chembiol.2016.02.003\")), list(REFERENCE = \"PMID:25988900\", AUTHORS = \"Gurung P, Man SM, Kanneganti TD\", TITLE = \"A20 is a regulator of necroptosis.\", JOURNAL = c(\"Nat Immunol 16:596-7 (2015)\", \"DOI:10.1038/ni.3174\")), list(REFERENCE = \"PMID:28025046\", AUTHORS = \"Feng N, Anderson ME\", TITLE = \"CaMKII is a nodal signal for multiple programmed cell death pathways in heart.\", JOURNAL = c(\"J Mol Cell Cardiol 103:102-109 (2017)\", \"DOI:10.1016/j.yjmcc.2016.12.007\")), list(REFERENCE = \"PMID:19696789\", AUTHORS = \"Zhivotovsky B, Galluzzi L, Kepp O, Kroemer G\", TITLE = \"Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery.\", JOURNAL = c(\"Cell Death Differ 16:1419-25 (2009)\", \"DOI:10.1038/cdd.2009.118\")), list(REFERENCE = \"PMID:23898178\", AUTHORS = \"Thapa RJ, Nogusa S, Chen P, Maki JL, Lerro A, Andrake M, Rall GF, Degterev A, Balachandran S\", TITLE = \"Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 110:E3109-18 (2013)\", \"DOI:10.1073/pnas.1301218110\")), list(REFERENCE = \"PMID:21576359\", AUTHORS = \"Thapa RJ, Basagoudanavar SH, Nogusa S, Irrinki K, Mallilankaraman K, Slifker MJ, Beg AA, Madesh M, Balachandran S\", TITLE = \"NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis.\", JOURNAL = c(\"Mol Cell Biol 31:2934-46 (2011)\", \"DOI:10.1128/MCB.05445-11\")), list(REFERENCE = \"PMID:24565922\", AUTHORS = \"Sridharan H, Upton JW\", TITLE = \"Programmed necrosis in microbial pathogenesis.\", JOURNAL = c(\"Trends Microbiol 22:199-207 (2014)\", \"DOI:10.1016/j.tim.2014.01.005\")), list(REFERENCE = \"PMID:21738214\", AUTHORS = \"Cabon L, Galan-Malo P, Bouharrour A, Delavallee L, Brunelle-Navas MN, Lorenzo HK, Gross A, Susin SA\", TITLE = \"BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activation.\", JOURNAL = c(\"Cell Death Differ 19:245-56 (2012)\", \"DOI:10.1038/cdd.2011.91\")), list(REFERENCE = \"PMID:20697198\", AUTHORS = \"Baritaud M, Boujrad H, Lorenzo HK, Krantic S, Susin SA\", TITLE = \"Histone H2AX: The missing link in AIF-mediated caspase-independent programmed necrosis.\", JOURNAL = c(\"Cell Cycle 9:3166-73 (2010)\", \"DOI:10.4161/cc.9.16.12887\")), list(REFERENCE = \"PMID:28279333\", AUTHORS = \"Upton JW, Kaiser WJ\", TITLE = \"DAI Another Way: Necroptotic Control of Viral Infection.\", JOURNAL = c(\"Cell Host Microbe 21:290-293 (2017)\", \"DOI:10.1016/j.chom.2017.01.016\")), list(REFERENCE = \"PMID:26086143\", AUTHORS = \"Silke J, Rickard JA, Gerlic M\", TITLE = \"The diverse role of RIP kinases in necroptosis and inflammation.\", JOURNAL = c(\"Nat Immunol 16:689-97 (2015)\", \"DOI:10.1038/ni.3206\")), list(REFERENCE = \"PMID:28388403\", AUTHORS = \"Guo H, Kaiser WJ\", TITLE = \"ESCRTing Necroptosis.\", JOURNAL = c(\"Cell 169:186-187 (2017)\", \"DOI:10.1016/j.cell.2017.03.030\")), list(REFERENCE = \"PMID:28388412\", AUTHORS = \"Gong YN, Guy C, Olauson H, Becker JU, Yang M, Fitzgerald P, Linkermann A, Green DR\", TITLE = \"ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences.\", JOURNAL = c(\"Cell 169:286-300.e16 (2017)\", \"DOI:10.1016/j.cell.2017.03.020\")), list(REFERENCE = \"PMID:27999433\", AUTHORS = \"Petrie EJ, Hildebrand JM, Murphy JM\", TITLE = \"Insane in the membrane: a structural perspective of MLKL function in necroptosis.\", JOURNAL = c(\"Immunol Cell Biol 95:152-159 (2017)\", \"DOI:10.1038/icb.2016.125\")), list(REFERENCE = \"PMID:24316671\", AUTHORS = \"Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, Ward Y, Wu LG, Liu ZG\", TITLE = \"Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis.\", JOURNAL = c(\"Nat Cell Biol 16:55-65 (2014)\", \"DOI:10.1038/ncb2883\")), list(REFERENCE = \"PMID:25693118\", AUTHORS = \"Lawlor KE, Khan N, Mildenhall A, Gerlic M, Croker BA, D\'Cruz AA, Hall C, Kaur Spall S, Anderton H, Masters SL, Rashidi M, Wicks IP, Alexander WS, Mitsuuchi Y, Benetatos CA, Condon SM, Wong WW, Silke J, Vaux DL, Vince JE\", TITLE = \"RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.\", JOURNAL = c(\"Nat Commun 6:6282 (2015)\", \"DOI:10.1038/ncomms7282\")), list(REFERENCE = \"PMID:27974745\", AUTHORS = \"Shlomovitz I, Zargrian S, Gerlic M\", TITLE = \"Mechanisms of RIPK3-induced inflammation.\", JOURNAL = c(\"Immunol Cell Biol 95:166-172 (2017)\", \"DOI:10.1038/icb.2016.124\"))', 'map04217', 'Necroptosis', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (272, '04218', 'Cellular senescence', 'Cellular senescence is a state of irreversible cellular arrest and can be triggered by a number of factors, such as telomere shortening, oncogene activation, irradiation, DNA damage and oxidative stress. It is characterized by enlarged flattened morphology, senescence-associated beta-galactosidase (SA-b-gal) activity, secretion of inflammatory cytokines, growth factors and matrix metalloproteinases, as part of the senescence-associated secretory phenotype (SASP). Cellular senescence is functionally associated with many biological processes including aging, tumor suppression, placental biology, embryonic development, and wound healing.', 'Cellular Processes; Cell growth and death', 'Cellular senescence', 'Ataxia telangiectasia', 'GO: 0090398', 'ko04218', 'list(REFERENCE = \"PMID:24954210\", AUTHORS = \"Munoz-Espin D, Serrano M\", TITLE = \"Cellular senescence: from physiology to pathology.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 15:482-96 (2014)\", \"DOI:10.1038/nrm3823\")), list(REFERENCE = \"PMID:26646499\", AUTHORS = \"Childs BG, Durik M, Baker DJ, van Deursen JM\", TITLE = \"Cellular senescence in aging and age-related disease: from mechanisms to therapy.\", JOURNAL = c(\"Nat Med 21:1424-35 (2015)\", \"DOI:10.1038/nm.4000\")), list(REFERENCE = \"PMID:26105537\", AUTHORS = \"Sharpless NE, Sherr CJ\", TITLE = \"Forging a signature of in vivo senescence.\", JOURNAL = c(\"Nat Rev Cancer 15:397-408 (2015)\", \"DOI:10.1038/nrc3960\")), list(REFERENCE = \"PMID:26435346\", AUTHORS = \"Fridlyanskaya I, Alekseenko L, Nikolsky N\", TITLE = \"Senescence as a general cellular response to stress: A mini-review.\", JOURNAL = c(\"Exp Gerontol 72:124-8 (2015)\", \"DOI:10.1016/j.exger.2015.09.021\")), list(REFERENCE = \"PMID:27417123\", AUTHORS = \"Lujambio A\", TITLE = \"To clear, or not to clear (senescent cells)? That is the question.\", JOURNAL = c(\"Bioessays 38 Suppl 1:S56-64 (2016)\", \"DOI:10.1002/bies.201670910\")), list(REFERENCE = \"PMID:26564316\", AUTHORS = \"Di Mitri D, Alimonti A\", TITLE = \"Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer.\", JOURNAL = c(\"Trends Cell Biol 26:215-26 (2016)\", \"DOI:10.1016/j.tcb.2015.10.005\")), list(REFERENCE = \"PMID:27574725\", AUTHORS = \"Francica P, Aebersold DM, Medova M\", TITLE = \"Senescence as biologic endpoint following pharmacological targeting of receptor tyrosine kinases in cancer.\", JOURNAL = c(\"Biochem Pharmacol 126:1-12 (2017)\", \"DOI:10.1016/j.bcp.2016.08.022\")), list(REFERENCE = \"PMID:23982440\", AUTHORS = \"Bartling B\", TITLE = \"Cellular senescence in normal and premature lung aging.\", JOURNAL = c(\"Z Gerontol Geriatr 46:613-22 (2013)\", \"DOI:10.1007/s00391-013-0543-3\")), list(REFERENCE = \"PMID:24238962\", AUTHORS = \"Munoz-Espin D, Canamero M, Maraver A, Gomez-Lopez G, Contreras J, Murillo-Cuesta S, Rodriguez-Baeza A, Varela-Nieto I, Ruberte J, Collado M, Serrano M\", TITLE = \"Programmed cell senescence during mammalian embryonic development.\", JOURNAL = c(\"Cell 155:1104-18 (2013)\", \"DOI:10.1016/j.cell.2013.10.019\")), list(REFERENCE = \"PMID:26697828\", AUTHORS = \"Herranz N, Gallage S, Gil J\", TITLE = \"TORn about SASP regulation.\", JOURNAL = c(\"Cell Cycle 14:3771-2 (2015)\", \"DOI:10.1080/15384101.2015.1105694\")), list(REFERENCE = \"PMID:28410770\", AUTHORS = \"Martin N, Bernard D\", TITLE = \"Calcium signaling and cellular senescence.\", JOURNAL = c(\"Cell Calcium S0143-4160(17)30049-0 (2017)\", \"DOI:10.1016/j.ceca.2017.04.001\")), list(REFERENCE = \"PMID:25764980\", AUTHORS = \"Farfariello V, Iamshanova O, Germain E, Fliniaux I, Prevarskaya N\", TITLE = \"Calcium homeostasis in cancer: A focus on senescence.\", JOURNAL = c(\"Biochim Biophys Acta 1853:1974-9 (2015)\", \"DOI:10.1016/j.bbamcr.2015.03.005\")), list(REFERENCE = \"PMID:24062309\", AUTHORS = \"McCarthy DA, Clark RR, Bartling TR, Trebak M, Melendez JA\", TITLE = \"Redox control of the senescence regulator interleukin-1alpha and the secretory phenotype.\", JOURNAL = c(\"J Biol Chem 288:32149-59 (2013)\", \"DOI:10.1074/jbc.M113.493841\")), list(REFERENCE = \"PMID:27288568\", AUTHORS = \"Donninger H, Schmidt ML, Mezzanotte J, Barnoud T, Clark GJ\", TITLE = \"Ras signaling through RASSF proteins.\", JOURNAL = c(\"Semin Cell Dev Biol 58:86-95 (2016)\", \"DOI:10.1016/j.semcdb.2016.06.007\")), list(REFERENCE = \"PMID:28455242\", AUTHORS = \"Barnoud T, Schmidt ML, Donninger H, Clark GJ\", TITLE = \"The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.\", JOURNAL = c(\"Cancer Lett 400:30-36 (2017)\", \"DOI:10.1016/j.canlet.2017.04.030\")), list(REFERENCE = \"PMID:26404840\", AUTHORS = \"Kang C, Xu Q, Martin TD, Li MZ, Demaria M, Aron L, Lu T, Yankner BA, Campisi J, Elledge SJ\", TITLE = \"The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4.\", JOURNAL = c(\"Science 349:aaa5612 (2015)\", \"DOI:10.1126/science.aaa5612\")), list(REFERENCE = \"PMID:26777575\", AUTHORS = \"Cao X, Li M\", TITLE = \"A New Pathway for Senescence Regulation.\", JOURNAL = c(\"Genomics Proteomics Bioinformatics 13:333-5 (2015)\", \"DOI:10.1016/j.gpb.2015.11.002\")), list(REFERENCE = \"PMID:25564883\", AUTHORS = \"Gire V, Dulic V\", TITLE = \"Senescence from G2 arrest, revisited.\", JOURNAL = c(\"Cell Cycle 14:297-304 (2015)\", \"DOI:10.1080/15384101.2014.1000134\")), list(REFERENCE = \"PMID:24981831\", AUTHORS = \"Mowla SN, Lam EW, Jat PS\", TITLE = \"Cellular senescence and aging: the role of B-MYB.\", JOURNAL = c(\"Aging Cell 13:773-9 (2014)\", \"DOI:10.1111/acel.12242\")), list(REFERENCE = \"PMID:22546858\", AUTHORS = \"Yao H, Chung S, Hwang JW, Rajendrasozhan S, Sundar IK, Dean DA, McBurney MW, Guarente L, Gu W, Ronty M, Kinnula VL, Rahman I\", TITLE = \"SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice.\", JOURNAL = c(\"J Clin Invest 122:2032-45 (2012)\", \"DOI:10.1172/JCI60132\")), list(REFERENCE = \"PMID:23542362\", AUTHORS = \"Hwang JW, Yao H, Caito S, Sundar IK, Rahman I\", TITLE = \"Redox regulation of SIRT1 in inflammation and cellular senescence.\", JOURNAL = c(\"Free Radic Biol Med 61:95-110 (2013)\", \"DOI:10.1016/j.freeradbiomed.2013.03.015\"))', 'map04218', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (273, '04260', 'Cardiac muscle contraction', 'Contraction of the heart is a complex process initiated by the electrical excitation of cardiac myocytes (excitation-contraction coupling, ECC). In cardiac myocytes, Ca2+ influx induced by activation of voltage-dependent L-type Ca channels (DHP receptors) upon membrane depolarization triggers the release of Ca2+ via Ca2+ release channels (ryanodine receptors) of sarcoplasmic reticulum (SR) through a Ca2+ -induced Ca release (CICR) mechanism. Ca2+ ions released via the CICR mechanism diffuse through the cytosolic space to contractile proteins to bind to troponinC resulting in the release of inhibition induced by troponinI. The Ca2+ binding to troponinC thereby triggers the sliding of thin and thick filaments, that is, the activation of a crossbridge and subsequent cardiac force development and/or cell shortening. Recovery occurs as Ca2+ is pumped out of the cell by the Na+/Ca2+ exchanger (NCX) or is returned to the sarcoplasmic reticulum (SR) by sarco(endo)plasmic Ca2+ -ATPase (SERCA) pumps on the non-junctional region of the SR.', 'Organismal Systems; Circulatory system', 'Cardiac muscle contraction', 'Distal myopathy, Scapuloperoneal myopathy, Nemaline myopathy, Congenital fiber type disproportion, Cap myopathy, Myosin storage myopathy, Brugada syndrome, Hypokalemic periodic paralysis (HypoPP), Hemiplegic migraine, Distal arthrogryposis, Primary dystonia, Catecholaminergic polymorphic ventricular tachycardia, Left ventricular noncompaction, Restrictive cardiomyopathy, Kearns-Sayre syndrome, Cytochrome c oxidase (COX) deficiency, Mitochondrial complex III deficiency', 'GO: 0060048', 'ko04260', 'list(REFERENCE = \"PMID:17988210\", AUTHORS = \"Bers DM\", TITLE = \"Calcium cycling and signaling in cardiac myocytes.\", JOURNAL = c(\"Annu Rev Physiol 70:23-49 (2008)\", \"DOI:10.1146/annurev.physiol.70.113006.100455\")), list(REFERENCE = \"PMID:11805843\", AUTHORS = \"Bers DM\", TITLE = \"Cardiac excitation-contraction coupling.\", JOURNAL = c(\"Nature 415:198-205 (2002)\", \"DOI:10.1038/415198a\")), list(REFERENCE = \"PMID:16799263\", AUTHORS = \"Endoh M\", TITLE = \"Signal transduction and Ca2+ signaling in intact myocardium.\", JOURNAL = c(\"J Pharmacol Sci 100:525-37 (2006)\", \"DOI:10.1254/jphs.CPJ06009X\")), list(REFERENCE = \"PMID:18981594\", AUTHORS = \"Endoh M\", TITLE = \"Cardiac Ca2+ signaling and Ca2+ sensitizers.\", JOURNAL = c(\"Circ J 72:1915-25 (2008)\", \"DOI:10.1253/circj.CJ-08-0838\")), list(REFERENCE = \"PMID:16552170\", AUTHORS = \"Bers DM, Despa S\", TITLE = \"Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts.\", JOURNAL = c(\"J Pharmacol Sci 100:315-22 (2006)\", \"DOI:10.1254/jphs.CPJ06001X\")), list(REFERENCE = \"PMID:10747208\", AUTHORS = \"Gordon AM, Homsher E, Regnier M\", TITLE = \"Regulation of contraction in striated muscle.\", JOURNAL = c(\"Physiol Rev 80:853-924 (2000)\", \"DOI:10.1152/physrev.2000.80.2.853\")), list(REFERENCE = \"PMID:16701909\", AUTHORS = \"Phrommintikul A, Chattipakorn N\", TITLE = \"Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death.\", JOURNAL = c(\"Int J Cardiol 112:142-52 (2006)\", \"DOI:10.1016/j.ijcard.2005.11.106\")), list(REFERENCE = \"PMID:16096350\", AUTHORS = \"Lacinova L\", TITLE = \"Voltage-dependent calcium channels.\", JOURNAL = \"Gen Physiol Biophys 24 Suppl 1:1-78 (2005)\"), list(REFERENCE = \"PMID:12763850\", AUTHORS = \"Lingrel J, Moseley A, Dostanic I, Cougnon M, He S, James P, Woo A, O\'Connor K, Neumann J\", TITLE = \"Functional roles of the alpha isoforms of the Na,K-ATPase.\", JOURNAL = c(\"Ann N Y Acad Sci 986:354-9 (2003)\", \"DOI:10.1111/j.1749-6632.2003.tb07214.x\")), list(REFERENCE = \"PMID:11294886\", AUTHORS = \"Berg JS, Powell BC, Cheney RE\", TITLE = \"A millennial myosin census.\", JOURNAL = c(\"Mol Biol Cell 12:780-94 (2001)\", \"DOI:10.1091/mbc.12.4.780\")), list(REFERENCE = \"PMID:15736582\", AUTHORS = \"Parmacek MS, Solaro RJ\", TITLE = \"Biology of the troponin complex in cardiac myocytes.\", JOURNAL = c(\"Prog Cardiovasc Dis 47:159-76 (2004)\", \"DOI:10.1016/j.pcad.2004.07.003\")), list(REFERENCE = \"PMID:14659803\", AUTHORS = \"Yamashita H, Sugiura S, Fujita H, Yasuda S, Nagai R, Saeki Y, Sunagawa K, Sugi H\", TITLE = \"Myosin light chain isoforms modify force-generating ability of cardiac myosin by changing the kinetics of actin-myosin interaction.\", JOURNAL = c(\"Cardiovasc Res 60:580-8 (2003)\", \"DOI:10.1016/j.cardiores.2003.09.011\")), list(REFERENCE = \"PMID:19403607\", AUTHORS = \"Pritchard TJ, Kranias EG\", TITLE = \"Junctin and the histidine-rich Ca2+ binding protein: potential roles in heart failure and arrhythmogenesis.\", JOURNAL = c(\"J Physiol 587:3125-33 (2009)\", \"DOI:10.1113/jphysiol.2009.172171\")), list(REFERENCE = \"PMID:28596175\", AUTHORS = \"Landstrom AP, Dobrev D, Wehrens XHT\", TITLE = \"Calcium Signaling and Cardiac Arrhythmias.\", JOURNAL = c(\"Circ Res 120:1969-1993 (2017)\", \"DOI:10.1161/CIRCRESAHA.117.310083\"))', 'map04260', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (274, '04261', 'Adrenergic signaling in cardiomyocytes', 'Cardiac myocytes express at least six subtypes of adrenergic receptor (AR) which include three subtypes of beta-AR (beta-1, beta-2, beta-3) and three subtypes of the alpha-1-AR (alpha-1A, alpha-1B, and alpha-1C). In the human heart the beta-1-AR is the pre- dominate receptor. Acute sympathetic stimulation of cardiac beta-1-ARs induces positive inotropic and chronotropic effects, the most effective mechanism to acutely increase output of the heart, by coupling to Gs, formation of cAMP by adenylyl cyclase (AC), and PKA- dependent phosphorylation of various target proteins (e.g., ryanodine receptor [RyR]; phospholamban [PLB], troponin I [TnI], and the L-type Ca2+ channel [LTCC]). Chronic beta-1-AR stimulation is detrimental and induces cardiomyocyte hypertrophy and apoptosis. beta-2-AR coupled to Gs exerts a proapoptotic action as well as beta-1-AR, while beta-2-AR coupled to Gi exerts an antiapoptotic action.', 'Organismal Systems; Circulatory system', 'Adrenergic signaling in cardiomyocytes', 'Long QT syndrome, Atrial fibrillation, Autosomal dominant mental retardation, Catecholaminergic polymorphic ventricular tachycardia, Jervell and Lange-Nielsen syndrome', 'GO: 0001997', 'ko04261', 'list(REFERENCE = \"PMID:19883653\", AUTHORS = \"Grimm M, Brown JH\", TITLE = \"Beta-adrenergic receptor signaling in the heart: role of CaMKII.\", JOURNAL = c(\"J Mol Cell Cardiol 48:322-30 (2010)\", \"DOI:10.1016/j.yjmcc.2009.10.016\")), list(REFERENCE = \"PMID:21212391\", AUTHORS = \"Yang JH, Saucerman JJ\", TITLE = \"Computational models reduce complexity and accelerate insight into cardiac signaling networks.\", JOURNAL = c(\"Circ Res 108:85-97 (2011)\", \"DOI:10.1161/CIRCRESAHA.110.223602\")), list(REFERENCE = \"PMID:16765984\", AUTHORS = \"Schaub MC, Hefti MA, Zaugg M\", TITLE = \"Integration of calcium with the signaling network in cardiac myocytes.\", JOURNAL = c(\"J Mol Cell Cardiol 41:183-214 (2006)\", \"DOI:10.1016/j.yjmcc.2006.04.005\")), list(REFERENCE = \"PMID:22022314\", AUTHORS = \"Taggart P, Boyett MR, Logantha S, Lambiase PD\", TITLE = \"Anger, emotion, and arrhythmias: from brain to heart.\", JOURNAL = c(\"Front Physiol 2:67 (2011)\", \"DOI:10.3389/fphys.2011.00067\")), list(REFERENCE = \"PMID:17988210\", AUTHORS = \"Bers DM\", TITLE = \"Calcium cycling and signaling in cardiac myocytes.\", JOURNAL = c(\"Annu Rev Physiol 70:23-49 (2008)\", \"DOI:10.1146/annurev.physiol.70.113006.100455\")), list(REFERENCE = \"PMID:20923637\", AUTHORS = \"Soltis AR, Saucerman JJ\", TITLE = \"Synergy between CaMKII substrates and beta-adrenergic signaling in regulation of cardiac myocyte Ca(2+) handling.\", JOURNAL = c(\"Biophys J 99:2038-47 (2010)\", \"DOI:10.1016/j.bpj.2010.08.016\")), list(REFERENCE = \"PMID:12439640\", AUTHORS = \"Wallukat G\", TITLE = \"The beta-adrenergic receptors.\", JOURNAL = c(\"Herz 27:683-90 (2002)\", \"DOI:10.1007/s00059-002-2434-z\")), list(REFERENCE = \"PMID:11604549\", AUTHORS = \"Xiao RP\", TITLE = \"Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.\", JOURNAL = c(\"Sci STKE 2001:re15 (2001)\", \"DOI:10.1126/stke.2001.104.re15\")), list(REFERENCE = \"PMID:10571541\", AUTHORS = \"Xiao RP, Cheng H, Zhou YY, Kuschel M, Lakatta EG\", TITLE = \"Recent advances in cardiac beta(2)-adrenergic signal transduction.\", JOURNAL = c(\"Circ Res 85:1092-100 (1999)\", \"DOI:10.1161/01.RES.85.11.1092\")), list(REFERENCE = \"PMID:15979723\", AUTHORS = \"Zheng M, Zhu W, Han Q, Xiao RP\", TITLE = \"Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling.\", JOURNAL = c(\"Pharmacol Ther 108:257-68 (2005)\", \"DOI:10.1016/j.pharmthera.2005.04.006\")), list(REFERENCE = \"PMID:17826821\", AUTHORS = \"Kuzumoto M, Takeuchi A, Nakai H, Oka C, Noma A, Matsuoka S\", TITLE = \"Simulation analysis of intracellular Na+ and Cl- homeostasis during beta 1-adrenergic stimulation of cardiac myocyte.\", JOURNAL = c(\"Prog Biophys Mol Biol 96:171-86 (2008)\", \"DOI:10.1016/j.pbiomolbio.2007.07.005\")), list(REFERENCE = \"PMID:11805843\", AUTHORS = \"Bers DM\", TITLE = \"Cardiac excitation-contraction coupling.\", JOURNAL = c(\"Nature 415:198-205 (2002)\", \"DOI:10.1038/415198a\")), list(REFERENCE = \"PMID:20658186\", AUTHORS = \"Ho D, Yan L, Iwatsubo K, Vatner DE, Vatner SF\", TITLE = \"Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.\", JOURNAL = c(\"Heart Fail Rev 15:495-512 (2010)\", \"DOI:10.1007/s10741-010-9183-5\")), list(REFERENCE = \"PMID:15142747\", AUTHORS = \"Saucerman JJ, McCulloch AD\", TITLE = \"Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation.\", JOURNAL = c(\"Prog Biophys Mol Biol 85:261-78 (2004)\", \"DOI:10.1016/j.pbiomolbio.2004.01.005\")), list(REFERENCE = \"PMID:15765137\", AUTHORS = \"Yano M, Ikeda Y, Matsuzaki M\", TITLE = \"Altered intracellular Ca2+ handling in heart failure.\", JOURNAL = c(\"J Clin Invest 115:556-64 (2005)\", \"DOI:10.1172/JCI24159\")), list(REFERENCE = \"PMID:15232578\", AUTHORS = \"Wehrens XH, Marks AR\", TITLE = \"Novel therapeutic approaches for heart failure by normalizing calcium cycling.\", JOURNAL = c(\"Nat Rev Drug Discov 3:565-73 (2004)\", \"DOI:10.1038/nrd1440\")), list(REFERENCE = \"PMID:19874988\", AUTHORS = \"Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J\", TITLE = \"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.\", JOURNAL = c(\"J Am Coll Cardiol 54:1747-62 (2009)\", \"DOI:10.1016/j.jacc.2009.05.015\")), list(REFERENCE = \"PMID:18407781\", AUTHORS = \"Barry SP, Davidson SM, Townsend PA\", TITLE = \"Molecular regulation of cardiac hypertrophy.\", JOURNAL = c(\"Int J Biochem Cell Biol 40:2023-39 (2008)\", \"DOI:10.1016/j.biocel.2008.02.020\"))', 'map04261', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (275, '04270', 'Vascular smooth muscle contraction', 'c(\"The vascular smooth muscle cell (VSMC) is a highly specialized cell whose principal function is contraction. On contraction, VSMCs shorten, thereby decreasing the diameter of a blood vessel to regulate the blood flow and pressure.\", \"The principal mechanisms that regulate the contractile state of VSMCs are changes in cytosolic Ca2+ concentration ([Ca2+]c). In response to vasoconstrictor stimuli, Ca2+ is mobilized from intracellular stores and/or the extracellular space to increase [Ca2+]c in VSMCs. The increase in [Ca2+]c, in turn, activates the Ca2+-CaM-MLCK pathway and stimulates MLC20 phosphorylation, leading to myosin-actin interactions and, hence, the development of contractile force. The sensitivity of contractile myofilaments or MLC20 phosphorylation to Ca2+ can be secondarily modulated by other signaling pathways. During receptor stimulation, the contractile force is greatly enhanced by the inhibition of myosin phosphatase. Rho/Rho kinase, PKC, and arachidonic acid have been proposed to play a pivotal role in this enhancement.\", \n\"The signaling events that mediate relaxation include the removal of a contractile agonist (passive relaxation) and activation of cyclic nucleotide-dependent signaling pathways in the continued presence of a contractile agonist (active relaxation). Active relaxation occurs through the inhibition of both Ca2+ mobilization and myofilament Ca2+ sensitivity in VSMCs.\")', 'Organismal Systems; Circulatory system', 'Vascular smooth muscle contraction', 'Brugada syndrome, Atrial fibrillation, Hypokalemic periodic paralysis (HypoPP), Familial thoracic aortic aneurysm and dissection, Generalized epilepsy and paroxysmal dyskinesia, Moyamoya disease, Patent ductus arteriosus', 'GO: 0014829', 'ko04270', 'list(REFERENCE = \"PMID:17458653\", AUTHORS = \"Akata T\", TITLE = \"Cellular and molecular mechanisms regulating vascular tone. Part 2: regulatory mechanisms modulating Ca2+ mobilization and/or myofilament Ca2+ sensitivity in vascular smooth muscle cells.\", JOURNAL = c(\"J Anesth 21:232-42 (2007)\", \"DOI:10.1007/s00540-006-0488-4\")), list(REFERENCE = \"PMID:12689814\", AUTHORS = \"Ogut O, Brozovich FV\", TITLE = \"Regulation of force in vascular smooth muscle.\", JOURNAL = c(\"J Mol Cell Cardiol 35:347-55 (2003)\", \"DOI:10.1016/S0022-2828(03)00045-2\")), list(REFERENCE = \"PMID:16339747\", AUTHORS = \"Hilgers RH, Webb RC\", TITLE = \"Molecular aspects of arterial smooth muscle contraction: focus on Rho.\", JOURNAL = c(\"Exp Biol Med (Maywood) 230:829-35 (2005)\", \"DOI:10.1177/153537020523001107\")), list(REFERENCE = \"PMID:12693609\", AUTHORS = \"Schlossmann J, Feil R, Hofmann F\", TITLE = \"Signaling through NO and cGMP-dependent protein kinases.\", JOURNAL = c(\"Ann Med 35:21-7 (2003)\", \"DOI:10.1080/07853890310004093\")), list(REFERENCE = \"PMID:16870827\", AUTHORS = \"Mehta PK, Griendling KK\", TITLE = \"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.\", JOURNAL = c(\"Am J Physiol Cell Physiol 292:C82-97 (2007)\", \"DOI:10.1152/ajpcell.00287.2006\")), list(REFERENCE = \"PMID:19120701\", AUTHORS = \"Kim HR, Appel S, Vetterkind S, Gangopadhyay SS, Morgan KG\", TITLE = \"Smooth muscle signalling pathways in health and disease.\", JOURNAL = c(\"J Cell Mol Med 12:2165-80 (2008)\", \"DOI:10.1111/j.1582-4934.2008.00552.x\")), list(REFERENCE = \"PMID:11165670\", AUTHORS = \"Fukata Y, Amano M, Kaibuchi K\", TITLE = \"Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.\", JOURNAL = c(\"Trends Pharmacol Sci 22:32-9 (2001)\", \"DOI:10.1016/S0165-6147(00)01596-0\")), list(REFERENCE = \"PMID:17158339\", AUTHORS = \"Dimopoulos GJ, Semba S, Kitazawa K, Eto M, Kitazawa T\", TITLE = \"Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.\", JOURNAL = c(\"Circ Res 100:121-9 (2007)\", \"DOI:10.1161/01.RES.0000253902.90489.df\")), list(REFERENCE = \"PMID:17200683\", AUTHORS = \"Hynynen MM, Khalil RA\", TITLE = \"The vascular endothelin system in hypertension--recent patents and discoveries.\", JOURNAL = \"Recent Pat Cardiovasc Drug Discov 1:95-108 (2006)\"), list(REFERENCE = \"PMID:15269340\", AUTHORS = \"Brain SD, Grant AD\", TITLE = \"Vascular actions of calcitonin gene-related peptide and adrenomedullin.\", JOURNAL = c(\"Physiol Rev 84:903-34 (2004)\", \"DOI:10.1152/physrev.00037.2003\")), list(REFERENCE = \"PMID:11773611\", AUTHORS = \"Roman RJ\", TITLE = \"P-450 metabolites of arachidonic acid in the control of cardiovascular function.\", JOURNAL = c(\"Physiol Rev 82:131-85 (2002)\", \"DOI:10.1152/physrev.00021.2001\")), list(REFERENCE = \"PMID:18040024\", AUTHORS = \"Surks HK\", TITLE = \"cGMP-dependent protein kinase I and smooth muscle relaxation: a tale of two isoforms.\", JOURNAL = c(\"Circ Res 101:1078-80 (2007)\", \"DOI:10.1161/CIRCRESAHA.107.165779\")), list(REFERENCE = \"PMID:15026027\", AUTHORS = \"Vanhoutte PM\", TITLE = \"Endothelium-dependent hyperpolarizations: the history.\", JOURNAL = c(\"Pharmacol Res 49:503-8 (2004)\", \"DOI:10.1016/j.phrs.2003.11.015\")), list(REFERENCE = \"PMID:10221985\", AUTHORS = \"Davis MJ, Hill MA\", TITLE = \"Signaling mechanisms underlying the vascular myogenic response.\", JOURNAL = c(\"Physiol Rev 79:387-423 (1999)\", \"DOI:10.1152/physrev.1999.79.2.387\")), list(REFERENCE = \"PMID:11679404\", AUTHORS = \"Fleming I.\", TITLE = \"Cytochrome p450 and vascular homeostasis.\", JOURNAL = c(\"Circ Res 89:753-62 (2001)\", \"DOI:10.1161/hh2101.099268\")), list(REFERENCE = \"PMID:10911373\", AUTHORS = \"Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP\", TITLE = \"Molecular mechanism of cGMP-mediated smooth muscle relaxation.\", JOURNAL = c(\"J Cell Physiol 184:409-20 (2000)\", \"DOI:10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K\")), list(REFERENCE = \"PMID:18552454\", AUTHORS = \"Ko EA, Han J, Jung ID, Park WS\", TITLE = \"Physiological roles of K+ channels in vascular smooth muscle cells.\", JOURNAL = c(\"J Smooth Muscle Res 44:65-81 (2008)\", \"DOI:10.1540/jsmr.44.65\")), list(REFERENCE = \"PMID:18703404\", AUTHORS = \"Woodard GE, Rosado JA\", TITLE = \"Natriuretic peptides in vascular physiology and pathology.\", JOURNAL = c(\"Int Rev Cell Mol Biol 268:59-93 (2008)\", \"DOI:10.1016/S1937-6448(08)00803-4\")), list(REFERENCE = \"PMID:11709400\", AUTHORS = \"Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG\", TITLE = \"Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide.\", JOURNAL = c(\"Am J Physiol Heart Circ Physiol 281:H2337-65 (2001)\", \"DOI:10.1152/ajpheart.2001.281.6.H2337\")), list(REFERENCE = \"PMID:15725705\", AUTHORS = \"Hirano K, Hirano M, Kanaide H\", TITLE = \"Regulation of myosin phosphorylation and myofilament Ca2+ sensitivity in vascular smooth muscle.\", JOURNAL = c(\"J Smooth Muscle Res 40:219-36 (2004)\", \"DOI:10.1540/jsmr.40.219\")), list(REFERENCE = \"PMID:9458738\", AUTHORS = \"Freeman EJ, Ruehr ML, Dorman RV\", TITLE = \"ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells.\", JOURNAL = c(\"Am J Physiol 274:C282-8 (1998)\", \"DOI:10.1152/ajpcell.1998.274.1.C282\")), list(REFERENCE = \"PMID:12060106\", AUTHORS = \"Murphy TV, Spurrell BE, Hill MA\", TITLE = \"Cellular signalling in arteriolar myogenic constriction: involvement of tyrosine phosphorylation pathways.\", JOURNAL = c(\"Clin Exp Pharmacol Physiol 29:612-9 (2002)\", \"DOI:10.1046/j.1440-1681.2002.03698.x\"))', 'map04270', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (276, '04310', 'Wnt signaling pathway', 'Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.', 'Environmental Information Processing; Signal transduction', 'Wnt signaling pathway', 'Frontotemporal lobar degeneration, Type 2 diabetes mellitus, Worth type autosomal dominant osteosclerosis, Osteoporosis-pseudoglioma syndrome, Robinow syndrome, Sclerosteosis, Familial exudative vitreoretinopathy, Mullerian agenesis, Tooth agenesis, Tetra-amelia, Odontoonychodermal dysplasia, Acne inversa, Oligodontia-colorectal cancer syndrome, Li-Fraumeni syndrome, Caudal duplication anomaly, Pilomatricoma, Focal dermal hypoplasia, Caudal regression syndrome and Sirenomelia, Choroid plexus papilloma, Juvenile polyposis syndrome, Familial adenomatous polyposis, Vesicoureteral reflux, Nonsyndromic congenital nail disorder, Medulloblastoma, Coronary artery disease, Hyperostosis corticalis generalisata, Myhre syndrome, Autism, Hepatoblastoma, SERKAL syndrome, Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, Keipert syndrome', 'GO: 0016055', 'ko04310', 'list(REFERENCE = \"PMID:14635791\", AUTHORS = \"Hatsell S, Rowlands T, Hiremath M, Cowin P.\", TITLE = \"Beta-catenin and Tcfs in mammary development and cancer.\", JOURNAL = c(\"J Mammary Gland Biol Neoplasia 8:145-58 (2003)\", \"DOI:10.1023/A:1025944723047\")), list(REFERENCE = \"PMID:14745971\", AUTHORS = \"Yang Y.\", TITLE = \"Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.\", JOURNAL = c(\"Birth Defects Res Part C Embryo Today 69:305-17 (2003)\", \"DOI:10.1002/bdrc.10026\")), list(REFERENCE = \"PMID:12446114\", AUTHORS = \"Kalderon D.\", TITLE = \"Similarities between the Hedgehog and Wnt signaling pathways.\", JOURNAL = c(\"Trends Cell Biol 12:523-31 (2002)\", \"DOI:10.1016/S0962-8924(02)02388-7\")), list(REFERENCE = \"PMID:14530294\", AUTHORS = \"Nusse R.\", TITLE = \"Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.\", JOURNAL = c(\"Development 130:5297-305 (2003)\", \"DOI:10.1242/dev.00821\")), list(REFERENCE = \"PMID:15102436\", AUTHORS = \"Jope RS, Johnson GV.\", TITLE = \"The glamour and gloom of glycogen synthase kinase-3.\", JOURNAL = c(\"Trends Biochem Sci 29:95-102 (2004)\", \"DOI:10.1016/j.tibs.2003.12.004\")), list(REFERENCE = \"PMID:12967557\", AUTHORS = \"Veeman MT, Axelrod JD, Moon RT.\", TITLE = \"A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.\", JOURNAL = c(\"Dev Cell 5:367-77 (2003)\", \"DOI:10.1016/S1534-5807(03)00266-1\")), list(REFERENCE = \"PMID:11433294\", AUTHORS = \"Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.\", TITLE = \"PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.\", JOURNAL = c(\"Nat Cell Biol 3:628-36 (2001)\", \"DOI:10.1038/35083016\")), list(REFERENCE = \"PMID:23256519\", AUTHORS = \"Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E\", TITLE = \"The way Wnt works: Components and mechanism.\", JOURNAL = c(\"Growth Factors 31:1-31 (2013)\", \"DOI:10.3109/08977194.2012.752737\")), list(REFERENCE = \"PMID:19482104\", AUTHORS = \"Carethers JM\", TITLE = \"Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.\", JOURNAL = c(\"Gastroenterology 137:33-6 (2009)\", \"DOI:10.1053/j.gastro.2009.05.011\")), list(REFERENCE = \"PMID:18838381\", AUTHORS = \"Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG\", TITLE = \"The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.\", JOURNAL = c(\"J Biol Chem 283:33053-8 (2008)\", \"DOI:10.1074/jbc.M804039200\")), list(REFERENCE = \"PMID:23151663\", AUTHORS = \"Niehrs C\", TITLE = \"The complex world of WNT receptor signalling.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 13:767-79 (2012)\", \"DOI:10.1038/nrm3470\")), list(REFERENCE = \"PMID:28522145\", AUTHORS = \"Abou Ziki MD, Mani A\", TITLE = \"Wnt signaling, a novel pathway regulating blood pressure? State of the art review.\", JOURNAL = c(\"Atherosclerosis 262:171-178 (2017)\", \"DOI:10.1016/j.atherosclerosis.2017.05.001\")), list(REFERENCE = \"PMID:25808920\", AUTHORS = \"He Y, Ki H, Kim H, Kim K\", TITLE = \"delta-Catenin interacts with LEF-1 and negatively regulates its transcriptional activity.\", JOURNAL = c(\"Cell Biol Int 39:954-61 (2015)\", \"DOI:10.1002/cbin.10465\"))', 'map04310', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (277, '04320', 'Dorso-ventral axis formation', 'Organismal Systems; Development and regeneration', 'Dorso-ventral axis formation', 'ko04320', 'map04320', 'Dorso-ventral axis formation', 'Organismal Systems; Development and regeneration', 'Dorso-ventral axis formation', 'ko04320', 64, 0, 64, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (278, '04330', 'Notch signaling pathway', 'The Notch signaling pathway is an evolutionarily conserved, intercellular signaling mechanism essential for proper embryonic development in all metazoan organisms in the Animal kingdom. The Notch proteins (Notch1-Notch4 in vertebrates) are single-pass receptors that are activated by the Delta (or Delta-like) and Jagged/Serrate families of membrane-bound ligands. They are transported to the plasma membrane as cleaved, but otherwise intact polypeptides. Interaction with ligand leads to two additional proteolytic cleavages that liberate the Notch intracellular domain (NICD) from the plasma membrane. The NICD translocates to the nucleus, where it forms a complex with the DNA binding protein CSL, displacing a histone deacetylase (HDAc)-co-repressor (CoR) complex from CSL. Components of an activation complex, such as MAML1 and histone acetyltransferases (HATs), are recruited to the NICD-CSL complex, leading to the transcriptional activation of Notch target genes.', 'Environmental Information Processing; Signal transduction', 'Notch signaling pathway', 'Frontotemporal lobar degeneration, Type 2 diabetes mellitus, Spondylocostal dysostosis, Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL), Tetralogy of Fallot, Alagille syndrome, Bicuspid aortic valve, Hajdu-Cheney syndrome, Acne inversa, Adams-Oliver syndrome, Salivary gland cancer, Lateral meningocele syndrome, Infantile myofibromatosis', 'GO: 0007219', 'ko04330', 'list(REFERENCE = \"PMID:15288257\", AUTHORS = \"Hansson EM, Lendahl U, Chapman G.\", TITLE = \"Notch signaling in development and disease.\", JOURNAL = c(\"Semin Cancer Biol 14:320-8 (2004)\", \"DOI:10.1016/j.semcancer.2004.04.011\")), list(REFERENCE = \"PMID:15300010\", AUTHORS = \"Callahan R, Egan SE.\", TITLE = \"Notch signaling in mammary development and oncogenesis.\", JOURNAL = c(\"J Mammary Gland Biol Neoplasia 9:145-63 (2004)\", \"DOI:10.1023/B:JOMG.0000037159.63644.81\")), list(REFERENCE = \"PMID:15288258\", AUTHORS = \"Zweidler-McKay PA, Pear WS.\", TITLE = \"Notch and T cell malignancy.\", JOURNAL = c(\"Semin Cancer Biol 14:329-40 (2004)\", \"DOI:10.1016/j.semcancer.2004.04.012\")), list(REFERENCE = \"PMID:15288260\", AUTHORS = \"Wu L, Griffin JD.\", TITLE = \"Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis.\", JOURNAL = c(\"Semin Cancer Biol 14:348-56 (2004)\", \"DOI:10.1016/j.semcancer.2004.04.014\")), list(REFERENCE = \"PMID:15585829\", AUTHORS = \"Tsukumo S, Yasutomo K.\", TITLE = \"Notch governing mature T cell differentiation.\", JOURNAL = c(\"J Immunol 173:7109-13 (2004)\", \"DOI:10.4049/jimmunol.173.12.7109\")), list(REFERENCE = \"PMID:12464310\", AUTHORS = \"Haltiwanger RS.\", TITLE = \"Regulation of signal transduction pathways in development by glycosylation.\", JOURNAL = c(\"Curr Opin Struct Biol 12:593-8 (2002)\", \"DOI:10.1016/S0959-440X(02)00371-8\")), list(REFERENCE = \"PMID:15272268\", AUTHORS = \"Koo EH, Kopan R.\", TITLE = \"Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration.\", JOURNAL = c(\"Nat Med 10 Suppl:S26-33 (2004)\", \"DOI:10.1038/nm1065\")), list(REFERENCE = \"PMID:11896183\", AUTHORS = \"Okano H, Imai T, Okabe M.\", TITLE = \"Musashi: a translational regulator of cell fate.\", JOURNAL = \"J Cell Sci 115:1355-9 (2002)\"), list(REFERENCE = \"PMID:12417415\", AUTHORS = \"Haltiwanger RS, Stanley P.\", TITLE = \"Modulation of receptor signaling by glycosylation: fringe is an O-fucose-beta1,3-N-acetylglucosaminyltransferase.\", JOURNAL = c(\"Biochim Biophys Acta 1573:328-35 (2002)\", \"DOI:10.1016/S0304-4165(02)00400-2\")), list(REFERENCE = \"PMID:12015972\", AUTHORS = \"Das G, Reynolds-Kenneally J, Mlodzik M.\", TITLE = \"The atypical cadherin Flamingo links Frizzled and Notch signaling in planar polarity establishment in the Drosophila eye.\", JOURNAL = c(\"Dev Cell 2:655-66 (2002)\", \"DOI:10.1016/S1534-5807(02)00147-8\")), list(REFERENCE = \"PMID:10028969\", AUTHORS = \"Cooper MT, Bray SJ.\", TITLE = \"Frizzled regulation of Notch signalling polarizes cell fate in the Drosophila eye.\", JOURNAL = c(\"Nature 397:526-30 (1999)\", \"DOI:10.1038/17395\")), list(REFERENCE = \"PMID:12681948\", AUTHORS = \"Tanigaki K, Kuroda K, Han H, Honjo T.\", TITLE = \"Regulation of B cell development by Notch/RBP-J signaling.\", JOURNAL = c(\"Semin Immunol 15:113-9 (2003)\", \"DOI:10.1016/S1044-5323(03)00008-3\"))', 'map04330', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (279, '04340', 'Hedgehog signaling pathway', 'The Hedgehog (Hh) signaling pathway has numerous roles in the control of cell proliferation, tissue patterning, stem cell maintenance and development. The primary cilium is an important center for transduction of the Hedgehog signal in vertebrates. In Hh\'s absence, the Ptch receptor localizes to the cilium, where it inhibits Smo activation. Gli proteins are phosphorylated by PKA, CKI and GSK3B and partially degraded into truncated Gli repressor form (GliR) that suppresses Hh target gene transcription in the nucleus. In Hh\'s presence, Ptch disappears from the cilium, and activated Smo contributes to the translocation of the protein complex Gli, Sufu, Kif7 to ciliary tip, where Gli dissociates from the negative regulator Sufu. The production of Gli activator form (GliA) occurs and the increased nuclear accumulation of GliA results in activation transcription of Hh target genes.', 'Environmental Information Processing; Signal transduction', 'Hedgehog signaling pathway', 'Acrocallosal syndrome, Holoprosencephaly, Brachydactyly, Pallister-Hall syndrome, Ellis-van Creveld syndrome, Joubert syndrome, Odontoonychodermal dysplasia, Solitary median maxillary central incisor syndrome, Acrocapitofemoral dysplasia, Triphalangeal thumb-polysyndactyly syndrome, Donnai-Barrow syndrome, Basal cell nevus syndrome, Schizencephaly, Polysyndactyly, Medulloblastoma, Weyers acrodental dysostosis, Greig cephalopolysyndactyly syndrome, Preaxial polydactyly', 'ko04340', 'list(REFERENCE = \"PMID:26875496\", AUTHORS = \"Xavier GM, Seppala M, Barrell W, Birjandi AA, Geoghegan F, Cobourne MT\", TITLE = \"Hedgehog receptor function during craniofacial development.\", JOURNAL = c(\"Dev Biol 415:198-215 (2016)\", \"DOI:10.1016/j.ydbio.2016.02.009\")), list(REFERENCE = \"PMID:23719536\", AUTHORS = \"Briscoe J, Therond PP\", TITLE = \"The mechanisms of Hedgehog signalling and its roles in development and disease.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 14:416-29 (2013)\", \"DOI:10.1038/nrm3598\")), list(REFERENCE = \"PMID:26077918\", AUTHORS = \"Alman BA\", TITLE = \"The role of hedgehog signalling in skeletal health and disease.\", JOURNAL = c(\"Nat Rev Rheumatol 11:552-60 (2015)\", \"DOI:10.1038/nrrheum.2015.84\")), list(REFERENCE = \"PMID:26064136\", AUTHORS = \"Mooney CJ, Hakimjavadi R, Fitzpatrick E, Kennedy E, Walls D, Morrow D, Redmond EM, Cahill PA\", TITLE = \"Hedgehog and Resident Vascular Stem Cell Fate.\", JOURNAL = c(\"Stem Cells Int 2015:468428 (2015)\", \"DOI:10.1155/2015/468428\")), list(REFERENCE = \"PMID:23799571\", AUTHORS = \"Sasai N, Briscoe J\", TITLE = \"Primary cilia and graded Sonic Hedgehog signaling.\", JOURNAL = c(\"Wiley Interdiscip Rev Dev Biol 1:753-72 (2012)\", \"DOI:10.1002/wdev.43\")), list(REFERENCE = \"PMID:20708941\", AUTHORS = \"Heretsch P, Tzagkaroulaki L, Giannis A\", TITLE = \"Modulators of the hedgehog signaling pathway.\", JOURNAL = c(\"Bioorg Med Chem 18:6613-24 (2010)\", \"DOI:10.1016/j.bmc.2010.07.038\")), list(REFERENCE = \"PMID:22534646\", AUTHORS = \"Anderson E, Peluso S, Lettice LA, Hill RE\", TITLE = \"Human limb abnormalities caused by disruption of hedgehog signaling.\", JOURNAL = c(\"Trends Genet 28:364-73 (2012)\", \"DOI:10.1016/j.tig.2012.03.012\")), list(REFERENCE = \"PMID:18583599\", AUTHORS = \"Rohatgi R, Scott MP\", TITLE = \"Cell biology. Arrestin\' movement in cilia.\", JOURNAL = c(\"Science 320:1726-7 (2008)\", \"DOI:10.1126/science.1160448\")), list(REFERENCE = \"PMID:24925320\", AUTHORS = \"Yue S, Tang LY, Tang Y, Tang Y, Shen QH, Ding J, Chen Y, Zhang Z, Yu TT, Zhang YE, Cheng SY\", TITLE = \"Requirement of Smurf-mediated endocytosis of Patched1 in sonic hedgehog signal reception.\", JOURNAL = c(\"Elife 3:e02555 (2014)\", \"DOI:10.7554/eLife.02555\")), list(REFERENCE = \"PMID:22056910\", AUTHORS = \"Ok CY, Singh RR, Vega F\", TITLE = \"Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms.\", JOURNAL = c(\"Am J Pathol 180:2-11 (2012)\", \"DOI:10.1016/j.ajpath.2011.09.009\")), list(REFERENCE = \"PMID:26366162\", AUTHORS = \"Hsia EY, Gui Y, Zheng X\", TITLE = \"Regulation of Hedgehog signaling by ubiquitination.\", JOURNAL = c(\"Front Biol (Beijing) 10:203-220 (2015)\", \"DOI:10.1007/s11515-015-1343-5\")), list(REFERENCE = \"PMID:29290584\", AUTHORS = \"Pusapati GV, Kong JH, Patel BB, Krishnan A, Sagner A, Kinnebrew M, Briscoe J, Aravind L, Rohatgi R\", TITLE = \"CRISPR Screens Uncover Genes that Regulate Target Cell Sensitivity to the Morphogen Sonic Hedgehog.\", JOURNAL = c(\"Dev Cell 44:113-129.e8 (2018)\", \"DOI:10.1016/j.devcel.2017.12.003\"))', 'map04340', 'Hedgehog signaling pathway', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (280, '04341', 'Hedgehog signaling pathway - fly', 'Hedgehog (Hh) signaling plays essential roles in embryonic development and adult tissue homeostasis. It is first elucidated by genetic studies in Drosophila and the core of the Hh signaling pathway is conserved in evolution. The Hh signaling components include an important complex composed of Cos2, Fu, SuFu and Ci. In the absence of Hh, Ptc inhibits Smo and the complex promotes the formation of the Ci\'s repressor form CiR. In the presentation of Hh, binding Hh to Ptc relieves Smo repression, which results in Ci\'s activation and then the increased transcription of Hh target genes in the nucleus.', 'Environmental Information Processing; Signal transduction', 'Hedgehog signaling pathway - fly', 'ko04341', 'list(REFERENCE = \"PMID:20530542\", AUTHORS = \"Wilson CW, Chuang PT\", TITLE = \"Mechanism and evolution of cytosolic Hedgehog signal transduction.\", JOURNAL = c(\"Development 137:2079-94 (2010)\", \"DOI:10.1242/dev.045021\")), list(REFERENCE = \"PMID:23719536\", AUTHORS = \"Briscoe J, Therond PP\", TITLE = \"The mechanisms of Hedgehog signalling and its roles in development and disease.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 14:416-29 (2013)\", \"DOI:10.1038/nrm3598\")), list(REFERENCE = \"PMID:18379584\", AUTHORS = \"Aikin RA, Ayers KL, Therond PP\", TITLE = \"The role of kinases in the Hedgehog signalling pathway.\", JOURNAL = c(\"EMBO Rep 9:330-6 (2008)\", \"DOI:10.1038/embor.2008.38\")), list(REFERENCE = \"PMID:21502959\", AUTHORS = \"Ingham PW, Nakano Y, Seger C\", TITLE = \"Mechanisms and functions of Hedgehog signalling across the metazoa.\", JOURNAL = c(\"Nat Rev Genet 12:393-406 (2011)\", \"DOI:10.1038/nrg2984\")), list(REFERENCE = \"PMID:17102630\", AUTHORS = \"Jiang J\", TITLE = \"Regulation of Hh/Gli signaling by dual ubiquitin pathways.\", JOURNAL = c(\"Cell Cycle 5:2457-63 (2006)\", \"DOI:10.4161/cc.5.21.3406\")), list(REFERENCE = \"PMID:26366162\", AUTHORS = \"Hsia EY, Gui Y, Zheng X\", TITLE = \"Regulation of Hedgehog signaling by ubiquitination.\", JOURNAL = c(\"Front Biol (Beijing) 10:203-220 (2015)\", \"DOI:10.1007/s11515-015-1343-5\")), list(REFERENCE = \"PMID:16740475\", AUTHORS = \"Zhang Q, Zhang L, Wang B, Ou CY, Chien CT, Jiang J\", TITLE = \"A hedgehog-induced BTB protein modulates hedgehog signaling by degrading Ci/Gli transcription factor.\", JOURNAL = c(\"Dev Cell 10:719-29 (2006)\", \"DOI:10.1016/j.devcel.2006.05.004\")), list(REFERENCE = \"PMID:26263855\", AUTHORS = \"Zhou Z, Xu C, Chen P, Liu C, Pang S, Yao X, Zhang Q\", TITLE = \"Stability of HIB-Cul3 E3 ligase adaptor HIB Is Regulated by Self-degradation and Availability of Its Substrates.\", JOURNAL = c(\"Sci Rep 5:12709 (2015)\", \"DOI:10.1038/srep12709\"))', 'map04341', 'Hedgehog signaling pathway - fly', 'Hedgehog (Hh) signaling plays essential roles in embryonic development and adult tissue homeostasis. It is first elucidated by genetic studies in Drosophila and the core of the Hh signaling pathway is conserved in evolution. The Hh signaling components include an important complex composed of Cos2, Fu, SuFu and Ci. In the absence of Hh, Ptc inhibits Smo and the complex promotes the formation of the Ci\'s repressor form CiR. In the presentation of Hh, binding Hh to Ptc relieves Smo repression, which results in Ci\'s activation and then the increased transcription of Hh target genes in the nucleus.', 64, 0, 64, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (281, '04350', 'TGF-beta signaling pathway', 'The transforming growth factor-beta (TGF-beta) family members, which include TGF-betas, activins and bone morphogenetic proteins (BMPs), are structurally related secreted cytokines found in species ranging from worms and insects to mammals. A wide spectrum of cellular functions such as proliferation, apoptosis, differentiation and migration are regulated by TGF-beta family members. TGF-beta family member binds to the Type II receptor and recruits Type I, whereby Type II receptor phosphorylates and activates Type I. The Type I receptor, in turn, phosphorylates receptor-activated Smads ( R-Smads: Smad1, Smad2, Smad3, Smad5, and Smad8). Once phosphorylated, R-Smads associate with the co-mediator Smad, Smad4, and the heteromeric complex then translocates into the nucleus. In the nucleus, Smad complexes activate specific genes through cooperative interactions with other DNA-binding and coactivator (or co-repressor) proteins.', 'Environmental Information Processing; Signal transduction', 'TGF-beta signaling pathway', 'Type 2 diabetes mellitus, Fibrodysplasia ossificans progressiva, Ossification of the posterior longitudinal ligament of spine, Camurati-Engelmann disease, Grebe dysplasia, Fibular hypoplasia and complex brachydactyly, Acromesomelic dysplasia, Demirhan type, Brachydactyly, Angel shaped phalangoepiphyseal dysplasia, Multiple synostosis syndrome, Hereditary hemorrhagic telangiectasia, Bicuspid aortic valve, Persistent Mullerian duct syndrome, Axenfeld-Rieger syndrome, Heterotaxy, Tarsal-carpal coalition syndrome, Loeys-Dietz syndrome, Familial thoracic aortic aneurysm and dissection, Klippel-Feil syndrome, Stapes ankylosis with broad thumb and toes, Congenital stromal corneal dystrophy, Juvenile polyposis syndrome, Hereditary mixed polyposis syndrome, Ring dermoid of cornea, Rienhoff syndrome, Primary pulmonary hypertension, Pulmonary arterial hypertension, Myhre syndrome', 'GO: 0007179', 'ko04350', 'list(REFERENCE = \"PMID:12809600\", AUTHORS = \"Shi Y, Massague J.\", TITLE = \"Mechanisms of TGF-beta signaling from cell membrane to the nucleus.\", JOURNAL = c(\"Cell 113:685-700 (2003)\", \"DOI:10.1016/S0092-8674(03)00432-X\")), list(REFERENCE = \"PMID:14534577\", AUTHORS = \"Derynck R, Zhang YE.\", TITLE = \"Smad-dependent and Smad-independent pathways in TGF-beta family signalling.\", JOURNAL = c(\"Nature 425:577-84 (2003)\", \"DOI:10.1038/nature02006\")), list(REFERENCE = \"PMID:11252892\", AUTHORS = \"Massague J.\", TITLE = \"How cells read TGF-beta signals.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 1:169-78 (2000)\", \"DOI:10.1038/35043051\")), list(REFERENCE = \"PMID:14557817\", AUTHORS = \"Siegel PM, Massague J.\", TITLE = \"Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.\", JOURNAL = c(\"Nat Rev Cancer 3:807-21 (2003)\", \"DOI:10.1038/nrc1208\")), list(REFERENCE = \"PMID:14769828\", AUTHORS = \"Shimasaki S, Moore RK, Otsuka F, Erickson GF.\", TITLE = \"The bone morphogenetic protein system in mammalian reproduction.\", JOURNAL = c(\"Endocr Rev 25:72-101 (2004)\", \"DOI:10.1210/er.2003-0007\")), list(REFERENCE = \"PMID:11252746\", AUTHORS = \"De Robertis EM, Larrain J, Oelgeschlager M, Wessely O.\", TITLE = \"The establishment of Spemann\'s organizer and patterning of the vertebrate embryo.\", JOURNAL = c(\"Nat Rev Genet 1:171-81 (2000)\", \"DOI:10.1038/35042039\")), list(REFERENCE = \"PMID:12163231\", AUTHORS = \"Gumienny TL, Padgett RW.\", TITLE = \"The other side of TGF-beta superfamily signal regulation: thinking outside the cell.\", JOURNAL = c(\"Trends Endocrinol Metab 13:295-9 (2002)\", \"DOI:10.1016/S1043-2760(02)00615-X\")), list(REFERENCE = \"PMID:11836504\", AUTHORS = \"Hamada H, Meno C, Watanabe D, Saijoh Y.\", TITLE = \"Establishment of vertebrate left-right asymmetry.\", JOURNAL = c(\"Nat Rev Genet 3:103-13 (2002)\", \"DOI:10.1038/nrg732\")), list(REFERENCE = \"PMID:12466190\", AUTHORS = \"Chang H, Brown CW, Matzuk MM.\", TITLE = \"Genetic analysis of the mammalian transforming growth factor-beta superfamily.\", JOURNAL = c(\"Endocr Rev 23:787-823 (2002)\", \"DOI:10.1210/er.2002-0003\")), list(REFERENCE = \"PMID:10021351\", AUTHORS = \"Morita K, Chow KL, Ueno N.\", TITLE = \"Regulation of body length and male tail ray pattern formation of Caenorhabditis elegans by a member of TGF-beta family.\", JOURNAL = \"Development 126:1337-47 (1999)\"), list(REFERENCE = \"PMID:9847239\", AUTHORS = \"Krishna S, Maduzia LL, Padgett RW.\", TITLE = \"Specificity of TGFbeta signaling is conferred by distinct type I receptors and their associated SMAD proteins in Caenorhabditis elegans.\", JOURNAL = \"Development 126:251-60 (1999)\"), list(REFERENCE = \"PMID:15063168\", AUTHORS = \"Chen Y, Mironova E, Whitaker LL, Edwards L, Yost HJ, Ramsdell AF.\", TITLE = \"ALK4 functions as a receptor for multiple TGF beta-related ligands to regulate left-right axis determination and mesoderm induction in Xenopus.\", JOURNAL = c(\"Dev Biol 268:280-94 (2004)\", \"DOI:10.1016/j.ydbio.2003.12.035\")), list(REFERENCE = \"PMID:10519551\", AUTHORS = \"Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J, Niehrs C\", TITLE = \"Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.\", JOURNAL = c(\"Nature 401:480-5 (1999)\", \"DOI:10.1038/46794\")), list(REFERENCE = \"PMID:19758997\", AUTHORS = \"Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y, Chen YG\", TITLE = \"Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling.\", JOURNAL = c(\"J Biol Chem 284:30097-104 (2009)\", \"DOI:10.1074/jbc.M109.049304\")), list(REFERENCE = \"PMID:8093006\", AUTHORS = \"Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E\", TITLE = \"Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.\", JOURNAL = \"Biochem J 302 ( Pt 2):527-34 (1994)\"), list(REFERENCE = \"PMID:10934147\", AUTHORS = \"Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, Lorenz HP, Hedrick MH, Mackool RJ, Plaas A, Kim SJ, Longaker MT, Freymiller E, Ting K\", TITLE = \"Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair.\", JOURNAL = \"Am J Pathol 157:423-33 (2000)\"), list(REFERENCE = \"PMID:16642010\", AUTHORS = \"Anderson GJ, Frazer DM\", TITLE = \"Iron metabolism meets signal transduction.\", JOURNAL = c(\"Nat Genet 38:503-4 (2006)\", \"DOI:10.1038/ng0506-503\")), list(REFERENCE = \"PMID:26735394\", AUTHORS = \"Canali S, Core AB, Zumbrennen-Bullough KB, Merkulova M, Wang CY, Schneyer AL, Pietrangelo A, Babitt JL\", TITLE = \"Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.\", JOURNAL = c(\"Endocrinology 157:1146-62 (2016)\", \"DOI:10.1210/en.2015-1747\")), list(REFERENCE = \"PMID:26160612\", AUTHORS = \"Ganz T, Nemeth E\", TITLE = \"Iron homeostasis in host defence and inflammation.\", JOURNAL = c(\"Nat Rev Immunol 15:500-10 (2015)\", \"DOI:10.1038/nri3863\")), list(REFERENCE = \"PMID:15975920\", AUTHORS = \"Babitt JL, Zhang Y, Samad TA, Xia Y, Tang J, Campagna JA, Schneyer AL, Woolf CJ, Lin HY\", TITLE = \"Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor.\", JOURNAL = c(\"J Biol Chem 280:29820-7 (2005)\", \"DOI:10.1074/jbc.M503511200\")), list(REFERENCE = \"PMID:15671031\", AUTHORS = \"Samad TA, Rebbapragada A, Bell E, Zhang Y, Sidis Y, Jeong SJ, Campagna JA, Perusini S, Fabrizio DA, Schneyer AL, Lin HY, Brivanlou AH, Attisano L, Woolf CJ\", TITLE = \"DRAGON, a bone morphogenetic protein co-receptor.\", JOURNAL = c(\"J Biol Chem 280:14122-9 (2005)\", \"DOI:10.1074/jbc.M410034200\"))', 'map04350', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (282, '04360', 'Axon guidance', 'Axon guidance represents a key stage in the formation of neuronal network. Axons are guided by a variety of guidance factors, such as netrins, ephrins, Slits, and semaphorins. These guidance cues are read by growth cone receptors, and signal transduction pathways downstream of these receptors converge onto the Rho GTPases to elicit changes in cytoskeletal organization that determine which way the growth cone will turn.', 'Organismal Systems; Development and regeneration', 'Axon guidance', 'Nemaline myopathy, Chromosme 5p deletion syndrome, L1 syndrome, Congenital mirror movements, Congenital hydrocephalus, Capillary malformation-arteriovenous malformation, MASA syndrome', 'GO: 0007411', 'ko04360', 'list(REFERENCE = \"PMID:14682358\", AUTHORS = \"Guan KL, Rao Y.\", TITLE = \"Signalling mechanisms mediating neuronal responses to guidance cues.\", JOURNAL = c(\"Nat Rev Neurosci 4:941-56 (2003)\", \"DOI:10.1038/nrn1254\")), list(REFERENCE = \"PMID:15630019\", AUTHORS = \"Govek EE, Newey SE, Van Aelst L.\", TITLE = \"The role of the Rho GTPases in neuronal development.\", JOURNAL = c(\"Genes Dev 19:1-49 (2005)\", \"DOI:10.1101/gad.1256405\")), list(REFERENCE = \"PMID:12677003\", AUTHORS = \"Huber AB, Kolodkin AL, Ginty DD, Cloutier JF.\", TITLE = \"Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance.\", JOURNAL = c(\"Annu Rev Neurosci 26:509-63 (2003)\", \"DOI:10.1146/annurev.neuro.26.010302.081139\")), list(REFERENCE = \"PMID:15818466\", AUTHORS = \"Negishi M, Oinuma I, Katoh H.\", TITLE = \"Plexins: axon guidance and signal transduction.\", JOURNAL = c(\"Cell Mol Life Sci 62:1363-71 (2005)\", \"DOI:10.1007/s00018-005-5018-2\")), list(REFERENCE = \"PMID:15363605\", AUTHORS = \"Huot J.\", TITLE = \"Ephrin signaling in axon guidance.\", JOURNAL = c(\"Prog Neuropsychopharmacol Biol Psychiatry 28:813-8 (2004)\", \"DOI:10.1016/j.pnpbp.2004.05.025\")), list(REFERENCE = \"PMID:11891122\", AUTHORS = \"Patel BN, Van Vactor DL.\", TITLE = \"Axon guidance: the cytoplasmic tail.\", JOURNAL = c(\"Curr Opin Cell Biol 14:221-9 (2002)\", \"DOI:10.1016/S0955-0674(02)00308-3\")), list(REFERENCE = \"PMID:11687826\", AUTHORS = \"Yu TW, Bargmann CI.\", TITLE = \"Dynamic regulation of axon guidance.\", JOURNAL = c(\"Nat Neurosci 4 Suppl:1169-76 (2001)\", \"DOI:10.1038/nn748\")), list(REFERENCE = \"PMID:12471249\", AUTHORS = \"Dickson BJ.\", TITLE = \"Molecular mechanisms of axon guidance.\", JOURNAL = c(\"Science 298:1959-64 (2002)\", \"DOI:10.1126/science.1072165\")), list(REFERENCE = \"PMID:15960985\", AUTHORS = \"Barallobre MJ, Pascual M, Del Rio JA, Soriano E.\", TITLE = \"The Netrin family of guidance factors: emphasis on Netrin-1 signalling.\", JOURNAL = c(\"Brain Res Brain Res Rev 49:22-47 (2005)\", \"DOI:10.1016/j.brainresrev.2004.11.003\")), list(REFERENCE = \"PMID:15084255\", AUTHORS = \"Sabatier C, Plump AS, Le Ma, Brose K, Tamada A, Murakami F, Lee EY, Tessier-Lavigne M.\", TITLE = \"The divergent Robo family protein rig-1/Robo3 is a negative regulator of slit responsiveness required for midline crossing by commissural axons.\", JOURNAL = c(\"Cell 117:157-69 (2004)\", \"DOI:10.1016/S0092-8674(04)00303-4\")), list(REFERENCE = \"PMID:25374504\", AUTHORS = \"Fujita Y, Yamashita T\", TITLE = \"Axon growth inhibition by RhoA/ROCK in the central nervous system.\", JOURNAL = c(\"Front Neurosci 8:338 (2014)\", \"DOI:10.3389/fnins.2014.00338\")), list(REFERENCE = \"PMID:17169551\", AUTHORS = \"Yamashita T, Mueller BK, Hata K\", TITLE = \"Neogenin and repulsive guidance molecule signaling in the central nervous system.\", JOURNAL = c(\"Curr Opin Neurobiol 17:29-34 (2007)\", \"DOI:10.1016/j.conb.2006.12.001\"))', 'map04360', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (283, '04361', 'Axon regeneration', 'Many mature central nervous system (CNS) neurons in non-mammals, such as C. elegans, Drosophila, and zebrafish, are able to regenerate after injuries. The MAPK cascade, DLK-1/MKK-4/PMK-3/MAK2, is identified as an essential signaling pathway involved in axon regeneration in C. elegans. Calcium influx, which is triggered by axotomy, is implicated in DLK-1 activation. Another MAP kinase pathway, MLK-1/MEK-1/KGB-1, acts in parallel with the DLK-1 pathway to control growth-cone formation after axotomy. SVH-1, a homolog of the mammalian hepatocyte growth factor and its receptor SVH-2 function upstream of the MLK-1 pathway to promote axon regeneration. There are also inhibitors of regeneration, such as lin-12/Notch and efa-6. It is possible that the C. elegans pathways that inhibit regeneration function to stabilize the mature, uninjured nervous system.', 'Organismal Systems; Development and regeneration', 'Axon regeneration', 'ko04361', 'list(REFERENCE = \"PMID:28213159\", AUTHORS = \"Hisamoto N, Matsumoto K\", TITLE = \"Signal transduction cascades in axon regeneration: insights from C. elegans.\", JOURNAL = c(\"Curr Opin Genet Dev 44:54-60 (2017)\", \"DOI:10.1016/j.gde.2017.01.010\")), list(REFERENCE = \"PMID:21907582\", AUTHORS = \"Chen L, Chisholm AD\", TITLE = \"Axon regeneration mechanisms: insights from C. elegans.\", JOURNAL = c(\"Trends Cell Biol 21:577-84 (2011)\", \"DOI:10.1016/j.tcb.2011.08.003\")), list(REFERENCE = \"PMID:23846598\", AUTHORS = \"Saijilafu, Zhang BY, Zhou FQ\", TITLE = \"Signaling pathways that regulate axon regeneration.\", JOURNAL = c(\"Neurosci Bull 29:411-20 (2013)\", \"DOI:10.1007/s12264-013-1357-4\")), list(REFERENCE = \"PMID:22974301\", AUTHORS = \"El Bejjani R, Hammarlund M\", TITLE = \"Neural regeneration in Caenorhabditis elegans.\", JOURNAL = c(\"Annu Rev Genet 46:499-513 (2012)\", \"DOI:10.1146/annurev-genet-110711-155550\")), list(REFERENCE = \"PMID:23844582\", AUTHORS = \"Chisholm AD\", TITLE = \"Cytoskeletal dynamics in Caenorhabditis elegans axon regeneration.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 29:271-97 (2013)\", \"DOI:10.1146/annurev-cellbio-101512-122311\")), list(REFERENCE = \"PMID:24794753\", AUTHORS = \"Hammarlund M, Jin Y\", TITLE = \"Axon regeneration in C. elegans.\", JOURNAL = c(\"Curr Opin Neurobiol 27:199-207 (2014)\", \"DOI:10.1016/j.conb.2014.04.001\")), list(REFERENCE = \"PMID:25792136\", AUTHORS = \"Pastuhov SI, Hisamoto N, Matsumoto K\", TITLE = \"MAP kinase cascades regulating axon regeneration in C. elegans.\", JOURNAL = c(\"Proc Jpn Acad Ser B Phys Biol Sci 91:63-75 (2015)\", \"DOI:10.2183/pjab.91.63\")), list(REFERENCE = \"PMID:26484536\", AUTHORS = \"Li C, Hisamoto N, Matsumoto K\", TITLE = \"Axon Regeneration Is Regulated by Ets-C/EBP Transcription Complexes Generated by Activation of the cAMP/Ca2+ Signaling Pathways.\", JOURNAL = c(\"PLoS Genet 11:e1005603 (2015)\", \"DOI:10.1371/journal.pgen.1005603\")), list(REFERENCE = \"PMID:26339988\", AUTHORS = \"Chen L, Chuang M, Koorman T, Boxem M, Jin Y, Chisholm AD\", TITLE = \"Axon injury triggers EFA-6 mediated destabilization of axonal microtubules via TACC and doublecortin like kinase.\", JOURNAL = c(\"Elife 4 (2015)\", \"DOI:10.7554/eLife.08695\")), list(REFERENCE = \"PMID:23072806\", AUTHORS = \"Pastuhov SI, Fujiki K, Nix P, Kanao S, Bastiani M, Matsumoto K, Hisamoto N\", TITLE = \"Endocannabinoid-Goalpha signalling inhibits axon regeneration in Caenorhabditis elegans by antagonizing Gqalpha-PKC-JNK signalling.\", JOURNAL = c(\"Nat Commun 3:1136 (2012)\", \"DOI:10.1038/ncomms2136\")), list(REFERENCE = \"PMID:24606896\", AUTHORS = \"Belin S, Norsworthy M, He Z\", TITLE = \"Independent control of aging and axon regeneration.\", JOURNAL = c(\"Cell Metab 19:354-6 (2014)\", \"DOI:10.1016/j.cmet.2014.02.014\")), list(REFERENCE = \"PMID:24440228\", AUTHORS = \"Byrne AB, Walradt T, Gardner KE, Hubbert A, Reinke V, Hammarlund M\", TITLE = \"Insulin/IGF1 signaling inhibits age-dependent axon regeneration.\", JOURNAL = c(\"Neuron 81:561-73 (2014)\", \"DOI:10.1016/j.neuron.2013.11.019\")), list(REFERENCE = \"PMID:22284174\", AUTHORS = \"Po MD, Calarco JA, Zhen M\", TITLE = \"Releasing the inner inhibition for axon regeneration.\", JOURNAL = c(\"Neuron 73:207-9 (2012)\", \"DOI:10.1016/j.neuron.2012.01.002\")), list(REFERENCE = \"PMID:22284182\", AUTHORS = \"El Bejjani R, Hammarlund M\", TITLE = \"Notch signaling inhibits axon regeneration.\", JOURNAL = c(\"Neuron 73:268-78 (2012)\", \"DOI:10.1016/j.neuron.2011.11.017\")), list(REFERENCE = \"PMID:18296652\", AUTHORS = \"Gabel CV, Antoine F, Chuang CF, Samuel AD, Chang C\", TITLE = \"Distinct cellular and molecular mechanisms mediate initial axon development and adult-stage axon regeneration in C. elegans.\", JOURNAL = c(\"Development 135:1129-36 (2008)\", \"DOI:10.1242/dev.013995\")), list(REFERENCE = \"PMID:24431434\", AUTHORS = \"Hubert T, Wu Z, Chisholm AD, Jin Y\", TITLE = \"S6 kinase inhibits intrinsic axon regeneration capacity via AMP kinase in Caenorhabditis elegans.\", JOURNAL = c(\"J Neurosci 34:758-63 (2014)\", \"DOI:10.1523/JNEUROSCI.2886-13.2014\")), list(REFERENCE = \"PMID:23599497\", AUTHORS = \"Zou Y, Chiu H, Zinovyeva A, Ambros V, Chuang CF, Chang C\", TITLE = \"Developmental decline in neuronal regeneration by the progressive change of two intrinsic timers.\", JOURNAL = c(\"Science 340:372-376 (2013)\", \"DOI:10.1126/science.1231321\")), list(REFERENCE = \"PMID:23599470\", AUTHORS = \"Nix P, Bastiani M\", TITLE = \"Neuroscience. Heterochronic genes turn back the clock in old neurons.\", JOURNAL = c(\"Science 340:282-3 (2013)\", \"DOI:10.1126/science.1237921\"))', 'map04361', 'Axon regeneration', 'Many mature central nervous system (CNS) neurons in non-mammals, such as C. elegans, Drosophila, and zebrafish, are able to regenerate after injuries. The MAPK cascade, DLK-1/MKK-4/PMK-3/MAK2, is identified as an essential signaling pathway involved in axon regeneration in C. elegans. Calcium influx, which is triggered by axotomy, is implicated in DLK-1 activation. Another MAP kinase pathway, MLK-1/MEK-1/KGB-1, acts in parallel with the DLK-1 pathway to control growth-cone formation after axotomy. SVH-1, a homolog of the mammalian hepatocyte growth factor and its receptor SVH-2 function upstream of the MLK-1 pathway to promote axon regeneration. There are also inhibitors of regeneration, such as lin-12/Notch and efa-6. It is possible that the C. elegans pathways that inhibit regeneration function to stabilize the mature, uninjured nervous system.', 6, 0, 6, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (284, '04370', 'VEGF signaling pathway', 'There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells and it is considered to be a crucial signal transducer in both physiologic and pathologic angiogenesis. The binding of VEGF to VEGFR-2 leads to a cascade of different signaling pathways, resulting in the up-regulation of genes involved in mediating the proliferation and migration of endothelial cells and promoting their survival and vascular permeability. For example, the binding of VEGF to VEGFR-2 leads to dimerization of the receptor, followed by intracellular activation of the PLCgamma;PKC-Raf kinase-MEK-mitogen-activated protein kinase (MAPK) pathway and subsequent initiation of DNA synthesis and cell growth, whereas activation of the phosphatidylinositol 3\' -kinase (PI3K)-Akt pathway leads to increased endothelial-cell survival. Activation of PI3K, FAK, and p38 MAPK is implicated in cell migration signaling.', 'Environmental Information Processing; Signal transduction', 'VEGF signaling pathway', 'Infantile hemangioma, Avascular necrosis of femoral head', 'GO: 0048010', 'ko04370', 'list(REFERENCE = \"PMID:13678960\", AUTHORS = \"Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L.\", TITLE = \"VEGF-receptor signal transduction.\", JOURNAL = c(\"Trends Biochem Sci 28:488-94 (2003)\", \"DOI:10.1016/S0968-0004(03)00193-2\")), list(REFERENCE = \"PMID:11741095\", AUTHORS = \"Matsumoto T, Claesson-Welsh L.\", TITLE = \"VEGF receptor signal transduction.\", JOURNAL = c(\"Sci STKE 2001:RE21 (2001)\", \"DOI:10.1126/stke.2001.112.re21\")), list(REFERENCE = \"PMID:15602010\", AUTHORS = \"Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA.\", TITLE = \"Vascular endothelial growth factor and angiogenesis.\", JOURNAL = c(\"Pharmacol Rev 56:549-80 (2004)\", \"DOI:10.1124/pr.56.4.3\")), list(REFERENCE = \"PMID:16104843\", AUTHORS = \"Takahashi H, Shibuya M.\", TITLE = \"The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.\", JOURNAL = c(\"Clin Sci (Lond) 109:227-41 (2005)\", \"DOI:10.1042/CS20040370\")), list(REFERENCE = \"PMID:14641020\", AUTHORS = \"Zachary I.\", TITLE = \"VEGF signalling: integration and multi-tasking in endothelial cell biology.\", JOURNAL = c(\"Biochem Soc Trans 31:1171-7 (2003)\", \"DOI:10.1042/bst0311171\")), list(REFERENCE = \"PMID:15338053\", AUTHORS = \"Munoz-Chapuli R, Quesada AR, Angel Medina M.\", TITLE = \"Angiogenesis and signal transduction in endothelial cells.\", JOURNAL = c(\"Cell Mol Life Sci 61:2224-43 (2004)\", \"DOI:10.1007/s00018-004-4070-7\")), list(REFERENCE = \"PMID:14724572\", AUTHORS = \"Lamalice L, Houle F, Jourdan G, Huot J.\", TITLE = \"Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.\", JOURNAL = c(\"Oncogene 23:434-45 (2004)\", \"DOI:10.1038/sj.onc.1207034\")), list(REFERENCE = \"PMID:12391145\", AUTHORS = \"Shu X, Wu W, Mosteller RD, Broek D.\", TITLE = \"Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases.\", JOURNAL = c(\"Mol Cell Biol 22:7758-68 (2002)\", \"DOI:10.1128/MCB.22.22.7758-7768.2002\"))', 'map04370', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (285, '04371', 'Apelin signaling pathway', 'Apelin is an endogenous peptide capable of binding the apelin receptor (APJ), which was originally described as an orphan G-protein-coupled receptor. Apelin and APJ are widely expressed in various tissues and organ systems. They are implicated in different key physiological processes such as angiogenesis, cardiovascular functions, cell proliferation and energy metabolism regulation. On the other hand, this ligand receptor couple is also involved in several pathologies including diabetes, obesity, cardiovascular disease and cancer.', 'Environmental Information Processing; Signal transduction', 'Apelin signaling pathway', 'Familial partial lipodystrophy, Absorptive hypercalciuria', 'GO: 0060183', 'ko04371', 'list(REFERENCE = \"PMID:26143239\", AUTHORS = \"Yang P, Maguire JJ, Davenport AP\", TITLE = \"Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.\", JOURNAL = c(\"Trends Pharmacol Sci 36:560-7 (2015)\", \"DOI:10.1016/j.tips.2015.06.002\")), list(REFERENCE = \"PMID:22140623\", AUTHORS = \"Andersen CU, Hilberg O, Mellemkjaer S, Nielsen-Kudsk JE, Simonsen U\", TITLE = \"Apelin and pulmonary hypertension.\", JOURNAL = c(\"Pulm Circ 1:334-46 (2011)\", \"DOI:10.4103/2045-8932.87299\")), list(REFERENCE = \"PMID:25275559\", AUTHORS = \"Chapman NA, Dupre DJ, Rainey JK\", TITLE = \"The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.\", JOURNAL = c(\"Biochem Cell Biol 92:431-40 (2014)\", \"DOI:10.1139/bcb-2014-0072\")), list(REFERENCE = \"PMID:18272138\", AUTHORS = \"Japp AG, Newby DE\", TITLE = \"The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.\", JOURNAL = c(\"Biochem Pharmacol 75:1882-92 (2008)\", \"DOI:10.1016/j.bcp.2007.12.015\")), list(REFERENCE = \"PMID:25652330\", AUTHORS = \"Folino A, Montarolo PG, Samaja M, Rastaldo R\", TITLE = \"Effects of apelin on the cardiovascular system.\", JOURNAL = c(\"Heart Fail Rev 20:505-18 (2015)\", \"DOI:10.1007/s10741-015-9475-x\")), list(REFERENCE = \"PMID:23943882\", AUTHORS = \"O\'Carroll AM, Lolait SJ, Harris LE, Pope GR\", TITLE = \"The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis.\", JOURNAL = c(\"J Endocrinol 219:R13-35 (2013)\", \"DOI:10.1530/JOE-13-0227\")), list(REFERENCE = \"PMID:23973488\", AUTHORS = \"Liu QF, Yu HW, You L, Liu MX, Li KY, Tao GZ\", TITLE = \"Apelin-13-induced proliferation and migration induced of rat vascular smooth muscle cells is mediated by the upregulation of Egr-1.\", JOURNAL = c(\"Biochem Biophys Res Commun 439:235-40 (2013)\", \"DOI:10.1016/j.bbrc.2013.08.051\")), list(REFERENCE = \"PMID:26254105\", AUTHORS = \"Novakova V, Sandhu GS, Dragomir-Daescu D, Klabusay M\", TITLE = \"Apelinergic system in endothelial cells and its role in angiogenesis in myocardial ischemia.\", JOURNAL = c(\"Vascul Pharmacol 76:1-10 (2016)\", \"DOI:10.1016/j.vph.2015.08.005\")), list(REFERENCE = \"PMID:21725702\", AUTHORS = \"Castan-Laurell I, Dray C, Attane C, Duparc T, Knauf C, Valet P\", TITLE = \"Apelin, diabetes, and obesity.\", JOURNAL = c(\"Endocrine 40:1-9 (2011)\", \"DOI:10.1007/s12020-011-9507-9\")), list(REFERENCE = \"PMID:23924696\", AUTHORS = \"Li L, Li L, Xie F, Zhang Z, Guo Y, Tang G, Lv D, Lu Q, Chen L, Li J\", TITLE = \"Jagged-1/Notch3 signaling transduction pathway is involved in apelin-13-induced vascular smooth muscle cells proliferation.\", JOURNAL = c(\"Acta Biochim Biophys Sin (Shanghai) 45:875-81 (2013)\", \"DOI:10.1093/abbs/gmt085\")), list(REFERENCE = \"PMID:24990699\", AUTHORS = \"Wu D, He L, Chen L\", TITLE = \"Apelin/APJ system: a promising therapy target for hypertension.\", JOURNAL = c(\"Mol Biol Rep 41:6691-703 (2014)\", \"DOI:10.1007/s11033-014-3552-4\")), list(REFERENCE = \"PMID:20539939\", AUTHORS = \"Liu C, Su T, Li F, Li L, Qin X, Pan W, Feng F, Chen F, Liao D, Chen L\", TITLE = \"PI3K/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13.\", JOURNAL = c(\"Acta Biochim Biophys Sin (Shanghai) 42:396-402 (2010)\", \"DOI:10.1093/abbs/gmq035\")), list(REFERENCE = \"PMID:26607438\", AUTHORS = \"Xie F, Liu W, Feng F, Li X, He L, Lv D, Qin X, Li L, Li L, Chen L\", TITLE = \"Apelin-13 promotes cardiomyocyte hypertrophy via PI3K-Akt-ERK1/2-p70S6K and PI3K-induced autophagy.\", JOURNAL = c(\"Acta Biochim Biophys Sin (Shanghai) 47:969-80 (2015)\", \"DOI:10.1093/abbs/gmv111\")), list(REFERENCE = \"PMID:27979574\", AUTHORS = \"Lu L, Wu D, Li L, Chen L\", TITLE = \"Apelin/APJ system: A bifunctional target for cardiac hypertrophy.\", JOURNAL = c(\"Int J Cardiol 230:164-170 (2017)\", \"DOI:10.1016/j.ijcard.2016.11.215\")), list(REFERENCE = \"PMID:16182514\", AUTHORS = \"Carmen GY, Victor SM\", TITLE = \"Signalling mechanisms regulating lipolysis.\", JOURNAL = c(\"Cell Signal 18:401-8 (2006)\", \"DOI:10.1016/j.cellsig.2005.08.009\")), list(REFERENCE = \"PMID:27650065\", AUTHORS = \"Hu H, He L, Li L, Chen L\", TITLE = \"Apelin/APJ system as a therapeutic target in diabetes and its complications.\", JOURNAL = c(\"Mol Genet Metab 119:20-7 (2016)\", \"DOI:10.1016/j.ymgme.2016.07.012\")), list(REFERENCE = \"PMID:25914650\", AUTHORS = \"Bertrand C, Valet P, Castan-Laurell I\", TITLE = \"Apelin and energy metabolism.\", JOURNAL = c(\"Front Physiol 6:115 (2015)\", \"DOI:10.3389/fphys.2015.00115\")), list(REFERENCE = \"PMID:26385179\", AUTHORS = \"Yao F, Lv YC, Zhang M, Xie W, Tan YL, Gong D, Cheng HP, Liu D, Li L, Liu XY, Zheng XL, Tang CK\", TITLE = \"Apelin-13 impedes foam cell formation by activating Class III PI3K/Beclin-1-mediated autophagic pathway.\", JOURNAL = c(\"Biochem Biophys Res Commun 466:637-43 (2015)\", \"DOI:10.1016/j.bbrc.2015.09.045\")), list(REFERENCE = \"PMID:22842084\", AUTHORS = \"Than A, Cheng Y, Foh LC, Leow MK, Lim SC, Chuah YJ, Kang Y, Chen P\", TITLE = \"Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways.\", JOURNAL = c(\"Mol Cell Endocrinol 362:227-41 (2012)\", \"DOI:10.1016/j.mce.2012.07.002\")), list(REFERENCE = \"PMID:24055369\", AUTHORS = \"Yu XH, Tang ZB, Liu LJ, Qian H, Tang SL, Zhang DW, Tian GP, Tang CK\", TITLE = \"Apelin and its receptor APJ in cardiovascular diseases.\", JOURNAL = c(\"Clin Chim Acta 428:1-8 (2014)\", \"DOI:10.1016/j.cca.2013.09.001\")), list(REFERENCE = \"PMID:25931124\", AUTHORS = \"Than A, He HL, Chua SH, Xu D, Sun L, Leow MK, Chen P\", TITLE = \"Apelin Enhances Brown Adipogenesis and Browning of White Adipocytes.\", JOURNAL = c(\"J Biol Chem 290:14679-91 (2015)\", \"DOI:10.1074/jbc.M115.643817\")), list(REFERENCE = \"PMID:25139773\", AUTHORS = \"Fu J, Li Z, Zhang H, Mao Y, Wang A, Wang X, Zou Z, Zhang X\", TITLE = \"Molecular pathways regulating the formation of brown-like adipocytes in white adipose tissue.\", JOURNAL = c(\"Diabetes Metab Res Rev 31:433-52 (2015)\", \"DOI:10.1002/dmrr.2600\")), list(REFERENCE = \"PMID:21464822\", AUTHORS = \"Aharoni-Simon M, Hann-Obercyger M, Pen S, Madar Z, Tirosh O\", TITLE = \"Fatty liver is associated with impaired activity of PPARgamma-coactivator 1alpha (PGC1alpha) and mitochondrial biogenesis in mice.\", JOURNAL = c(\"Lab Invest 91:1018-28 (2011)\", \"DOI:10.1038/labinvest.2011.55\")), list(REFERENCE = \"PMID:22995518\", AUTHORS = \"McLean DL, Kim J, Kang Y, Shi H, Atkins GB, Jain MK, Chun HJ\", TITLE = \"Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells--brief report.\", JOURNAL = c(\"Arterioscler Thromb Vasc Biol 32:2640-3 (2012)\", \"DOI:10.1161/ATVBAHA.112.300317\")), list(REFERENCE = \"PMID:22028387\", AUTHORS = \"Pchejetski D, Foussal C, Alfarano C, Lairez O, Calise D, Guilbeau-Frugier C, Schaak S, Seguelas MH, Wanecq E, Valet P, Parini A, Kunduzova O\", TITLE = \"Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1.\", JOURNAL = c(\"Eur Heart J 33:2360-9 (2012)\", \"DOI:10.1093/eurheartj/ehr389\")), list(REFERENCE = \"PMID:26944568\", AUTHORS = \"Huang S, Chen L, Lu L, Li L\", TITLE = \"The apelin-APJ axis: A novel potential therapeutic target for organ fibrosis.\", JOURNAL = c(\"Clin Chim Acta 456:81-8 (2016)\", \"DOI:10.1016/j.cca.2016.02.025\")), list(REFERENCE = \"PMID:19093215\", AUTHORS = \"Liu G, Han J, Profirovic J, Strekalova E, Voyno-Yasenetskaya TA\", TITLE = \"Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis.\", JOURNAL = c(\"Angiogenesis 12:1-15 (2009)\", \"DOI:10.1007/s10456-008-9123-3\")), list(REFERENCE = \"PMID:23603510\", AUTHORS = \"Kang Y, Kim J, Anderson JP, Wu J, Gleim SR, Kundu RK, McLean DL, Kim JD, Park H, Jin SW, Hwa J, Quertermous T, Chun HJ\", TITLE = \"Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development.\", JOURNAL = c(\"Circ Res 113:22-31 (2013)\", \"DOI:10.1161/CIRCRESAHA.113.301324\")), list(REFERENCE = \"PMID:25164121\", AUTHORS = \"Wang LY, Diao ZL, Zhang DL, Zheng JF, Zhang QD, Ding JX, Liu WH\", TITLE = \"The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis.\", JOURNAL = c(\"Amino Acids 46:2693-704 (2014)\", \"DOI:10.1007/s00726-014-1826-8\")), list(REFERENCE = \"PMID:26756969\", AUTHORS = \"Zhou Y, Deng L, Zhao D, Chen L, Yao Z, Guo X, Liu X, Lv L, Leng B, Xu W, Qiao G, Shan H\", TITLE = \"MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13.\", JOURNAL = c(\"J Cell Mol Med 20:495-505 (2016)\", \"DOI:10.1111/jcmm.12754\")), list(REFERENCE = \"PMID:27825851\", AUTHORS = \"Zhong JC, Zhang ZZ, Wang W, McKinnie SM, Vederas JC, Oudit GY\", TITLE = \"Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases.\", JOURNAL = c(\"Biochim Biophys Acta 1863:1942-1950 (2017)\", \"DOI:10.1016/j.bbadis.2016.11.007\"))', 'map04371', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (286, '04380', 'Osteoclast differentiation', 'The osteoclasts, multinucleared cells originating from the hematopoietic monocyte-macrophage lineage, are responsible for bone resorption. Osteoclastogenesis is mainly regulated by signaling pathways activated by RANK and immune receptors, whose ligands are expressed on the surface of osteoblasts. Signaling from RANK changes gene expression patterns through transcription factors like NFATc1 and characterizes the active osteoclast.', 'Organismal Systems; Development and regeneration', 'Osteoclast differentiation', 'Osteopetrosis, Paget disease of bone, Nasu-Hakola disease, Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID), Incontinentia pigmenti, Loeys-Dietz syndrome, Cocoon syndrome, Aplastic anemia, Tietz syndrome, Immune thrombocytopenia, Osteoporosis, Familial expansile osteolysis', 'GO: 0030316', 'ko04380', 'list(REFERENCE = \"PMID:16313349\", AUTHORS = \"Takayanagi H, Sato K, Takaoka A, Taniguchi T\", TITLE = \"Interplay between interferon and other cytokine systems in bone metabolism.\", JOURNAL = c(\"Immunol Rev 208:181-93 (2005)\", \"DOI:10.1111/j.0105-2896.2005.00337.x\")), list(REFERENCE = \"PMID:20392226\", AUTHORS = \"Takayanagi H\", TITLE = \"New immune connections in osteoclast formation.\", JOURNAL = c(\"Ann N Y Acad Sci 1192:117-23 (2010)\", \"DOI:10.1111/j.1749-6632.2009.05303.x\")), list(REFERENCE = \"PMID:19585227\", AUTHORS = \"Nakashima T, Takayanagi H\", TITLE = \"Osteoimmunology: crosstalk between the immune and bone systems.\", JOURNAL = c(\"J Clin Immunol 29:555-67 (2009)\", \"DOI:10.1007/s10875-009-9316-6\")), list(REFERENCE = \"PMID:18722561\", AUTHORS = \"Caetano-Lopes J, Canhao H, Fonseca JE\", TITLE = \"Osteoimmunology--the hidden immune regulation of bone.\", JOURNAL = c(\"Autoimmun Rev 8:250-5 (2009)\", \"DOI:10.1016/j.autrev.2008.07.038\")), list(REFERENCE = \"PMID:18451259\", AUTHORS = \"Lorenzo J, Horowitz M, Choi Y\", TITLE = \"Osteoimmunology: interactions of the bone and immune system.\", JOURNAL = c(\"Endocr Rev 29:403-40 (2008)\", \"DOI:10.1210/er.2007-0038\")), list(REFERENCE = \"PMID:17869613\", AUTHORS = \"David JP\", TITLE = \"Osteoimmunology: a view from the bone.\", JOURNAL = c(\"Adv Immunol 95:149-65 (2007)\", \"DOI:10.1016/S0065-2776(07)95005-1\")), list(REFERENCE = \"PMID:16313342\", AUTHORS = \"Jimi E, Ghosh S\", TITLE = \"Role of nuclear factor-kappaB in the immune system and bone.\", JOURNAL = c(\"Immunol Rev 208:80-7 (2005)\", \"DOI:10.1111/j.0105-2896.2005.00329.x\")), list(REFERENCE = \"PMID:12748652\", AUTHORS = \"Boyle WJ, Simonet WS, Lacey DL\", TITLE = \"Osteoclast differentiation and activation.\", JOURNAL = c(\"Nature 423:337-42 (2003)\", \"DOI:10.1038/nature01658\")), list(REFERENCE = \"PMID:17633024\", AUTHORS = \"Darnay BG, Besse A, Poblenz AT, Lamothe B, Jacoby JJ\", TITLE = \"TRAFs in RANK signaling.\", JOURNAL = c(\"Adv Exp Med Biol 597:152-9 (2007)\", \"DOI:10.1007/978-0-387-70630-6_12\")), list(REFERENCE = \"PMID:15122243\", AUTHORS = \"Baron R\", TITLE = \"Arming the osteoclast.\", JOURNAL = c(\"Nat Med 10:458-60 (2004)\", \"DOI:10.1038/nm0504-458\")), list(REFERENCE = \"PMID:17380158\", AUTHORS = \"Takayanagi H\", TITLE = \"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.\", JOURNAL = c(\"Nat Rev Immunol 7:292-304 (2007)\", \"DOI:10.1038/nri2062\")), list(REFERENCE = \"PMID:20703218\", AUTHORS = \"Krum SA, Chang J, Miranda-Carboni G, Wang CY\", TITLE = \"Novel functions for NFkappaB: inhibition of bone formation.\", JOURNAL = c(\"Nat Rev Rheumatol 6:607-11 (2010)\", \"DOI:10.1038/nrrheum.2010.133\")), list(REFERENCE = \"PMID:15817678\", AUTHORS = \"Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY\", TITLE = \"A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation.\", JOURNAL = c(\"Blood 106:852-9 (2005)\", \"DOI:10.1182/blood-2004-09-3662\")), list(REFERENCE = \"PMID:18329366\", AUTHORS = \"Shinohara M, Koga T, Okamoto K, Sakaguchi S, Arai K, Yasuda H, Takai T, Kodama T, Morio T, Geha RS, Kitamura D, Kurosaki T, Ellmeier W, Takayanagi H\", TITLE = \"Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals.\", JOURNAL = c(\"Cell 132:794-806 (2008)\", \"DOI:10.1016/j.cell.2007.12.037\")), list(REFERENCE = \"PMID:15546140\", AUTHORS = \"Takayanagi H, Kim S, Koga T, Taniguchi T\", TITLE = \"Stat1-mediated cytoplasmic attenuation in osteoimmunology.\", JOURNAL = c(\"J Cell Biochem 94:232-40 (2005)\", \"DOI:10.1002/jcb.20316\")), list(REFERENCE = \"PMID:18382763\", AUTHORS = \"Jin W, Chang M, Paul EM, Babu G, Lee AJ, Reiley W, Wright A, Zhang M, You J, Sun SC\", TITLE = \"Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.\", JOURNAL = c(\"J Clin Invest 118:1858-66 (2008)\", \"DOI:10.1172/JCI34257\")), list(REFERENCE = \"PMID:16184196\", AUTHORS = \"Bai S, Kitaura H, Zhao H, Chen J, Muller JM, Schule R, Darnay B, Novack DV, Ross FP, Teitelbaum SL\", TITLE = \"FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.\", JOURNAL = c(\"J Clin Invest 115:2742-51 (2005)\", \"DOI:10.1172/JCI24921\")), list(REFERENCE = \"PMID:12110142\", AUTHORS = \"Takayanagi H, Kim S, Taniguchi T\", TITLE = \"Signaling crosstalk between RANKL and interferons in osteoclast differentiation.\", JOURNAL = c(\"Arthritis Res 4 Suppl 3:S227-32 (2002)\", \"DOI:10.1186/ar581\"))', 'map04380', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (287, '04390', 'Hippo signaling pathway', 'Hippo signaling is an evolutionarily conserved signaling pathway that controls organ size from flies to humans. In humans and mice, the pathway consists of the MST1 and MST2 kinases, their cofactor Salvador and LATS1 and LATS2. In response to high cell densities, activated LATS1/2 phosphorylates the transcriptional coactivators YAP and TAZ, promoting its cytoplasmic localization, leading to cell apoptosis and restricting organ size overgrowth. When the Hippo pathway is inactivated at low cell density, YAP/TAZ translocates into the nucleus to bind to the transcription enhancer factor (TEAD/TEF) family of transcriptional factors to promote cell growth and proliferation. YAP/TAZ also interacts with other transcriptional factors or signaling molecules, by which Hippo pathway-mediated processes are interconnected with those of other key signaling cascades, such as those mediated by TGF-beta and Wnt growth factors.', 'Environmental Information Processing; Signal transduction', 'Hippo signaling pathway', 'Loeys-Dietz syndrome, Sveinsson chorioretinal atrophy (SCRA), Rienhoff syndrome, Neurofibromatosis type 2', 'GO: 0035329', 'ko04390', 'list(REFERENCE = \"PMID:22750148\", AUTHORS = \"Schroeder MC, Halder G\", TITLE = \"Regulation of the Hippo pathway by cell architecture and mechanical signals.\", JOURNAL = c(\"Semin Cell Dev Biol 23:803-11 (2012)\", \"DOI:10.1016/j.semcdb.2012.06.001\")), list(REFERENCE = \"PMID:21808241\", AUTHORS = \"Zhao B, Tumaneng K, Guan KL\", TITLE = \"The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.\", JOURNAL = c(\"Nat Cell Biol 13:877-83 (2011)\", \"DOI:10.1038/ncb2303\")), list(REFERENCE = \"PMID:21874053\", AUTHORS = \"Mauviel A, Nallet-Staub F, Varelas X\", TITLE = \"Integrating developmental signals: a Hippo in the (path)way.\", JOURNAL = c(\"Oncogene 31:1743-56 (2012)\", \"DOI:10.1038/onc.2011.363\")), list(REFERENCE = \"PMID:21084559\", AUTHORS = \"Zhao B, Li L, Guan KL\", TITLE = \"Hippo signaling at a glance.\", JOURNAL = c(\"J Cell Sci 123:4001-6 (2010)\", \"DOI:10.1242/jcs.069070\")), list(REFERENCE = \"PMID:20439427\", AUTHORS = \"Zhao B, Li L, Lei Q, Guan KL\", TITLE = \"The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.\", JOURNAL = c(\"Genes Dev 24:862-74 (2010)\", \"DOI:10.1101/gad.1909210\")), list(REFERENCE = \"PMID:23034192\", AUTHORS = \"Tremblay AM, Camargo FD\", TITLE = \"Hippo signaling in mammalian stem cells.\", JOURNAL = c(\"Semin Cell Dev Biol 23:818-26 (2012)\", \"DOI:10.1016/j.semcdb.2012.08.001\")), list(REFERENCE = \"PMID:21138973\", AUTHORS = \"Halder G, Johnson RL\", TITLE = \"Hippo signaling: growth control and beyond.\", JOURNAL = c(\"Development 138:9-22 (2011)\", \"DOI:10.1242/dev.045500\")), list(REFERENCE = \"PMID:22658639\", AUTHORS = \"Ramos A, Camargo FD\", TITLE = \"The Hippo signaling pathway and stem cell biology.\", JOURNAL = c(\"Trends Cell Biol 22:339-46 (2012)\", \"DOI:10.1016/j.tcb.2012.04.006\")), list(REFERENCE = \"PMID:20951342\", AUTHORS = \"Pan D\", TITLE = \"The hippo signaling pathway in development and cancer.\", JOURNAL = c(\"Dev Cell 19:491-505 (2010)\", \"DOI:10.1016/j.devcel.2010.09.011\")), list(REFERENCE = \"PMID:21324984\", AUTHORS = \"Bao Y, Hata Y, Ikeda M, Withanage K\", TITLE = \"Mammalian Hippo pathway: from development to cancer and beyond.\", JOURNAL = c(\"J Biochem 149:361-79 (2011)\", \"DOI:10.1093/jb/mvr021\")), list(REFERENCE = \"PMID:18955139\", AUTHORS = \"Zhao B, Lei QY, Guan KL\", TITLE = \"The Hippo-YAP pathway: new connections between regulation of organ size and cancer.\", JOURNAL = c(\"Curr Opin Cell Biol 20:638-46 (2008)\", \"DOI:10.1016/j.ceb.2008.10.001\")), list(REFERENCE = \"PMID:20945341\", AUTHORS = \"Chan SW, Lim CJ, Chen L, Chong YF, Huang C, Song H, Hong W\", TITLE = \"The Hippo pathway in biological control and cancer development.\", JOURNAL = c(\"J Cell Physiol 226:928-39 (2011)\", \"DOI:10.1002/jcp.22435\")), list(REFERENCE = \"PMID:18328423\", AUTHORS = \"Zeng Q, Hong W\", TITLE = \"The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals.\", JOURNAL = c(\"Cancer Cell 13:188-92 (2008)\", \"DOI:10.1016/j.ccr.2008.02.011\")), list(REFERENCE = \"PMID:19846288\", AUTHORS = \"Badouel C, Garg A, McNeill H\", TITLE = \"Herding Hippos: regulating growth in flies and man.\", JOURNAL = c(\"Curr Opin Cell Biol 21:837-43 (2009)\", \"DOI:10.1016/j.ceb.2009.09.010\")), list(REFERENCE = \"PMID:17975546\", AUTHORS = \"Buttitta LA, Edgar BA\", TITLE = \"How size is controlled: from Hippos to Yorkies.\", JOURNAL = c(\"Nat Cell Biol 9:1225-7 (2007)\", \"DOI:10.1038/ncb1107-1225\")), list(REFERENCE = \"PMID:22683405\", AUTHORS = \"Liu AM, Wong KF, Jiang X, Qiao Y, Luk JM\", TITLE = \"Regulators of mammalian Hippo pathway in cancer.\", JOURNAL = c(\"Biochim Biophys Acta 1826:357-64 (2012)\", \"DOI:10.1016/j.bbcan.2012.05.006\")), list(REFERENCE = \"PMID:22830020\", AUTHORS = \"Fausti F, Di Agostino S, Sacconi A, Strano S, Blandino G\", TITLE = \"Hippo and rassf1a Pathways: A Growing Affair.\", JOURNAL = c(\"Mol Biol Int 2012:307628 (2012)\", \"DOI:10.1155/2012/307628\")), list(REFERENCE = \"PMID:22895435\", AUTHORS = \"Halder G, Dupont S, Piccolo S\", TITLE = \"Transduction of mechanical and cytoskeletal cues by YAP and TAZ.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 13:591-600 (2012)\", \"DOI:10.1038/nrm3416\")), list(REFERENCE = \"PMID:22153608\", AUTHORS = \"Varelas X, Wrana JL\", TITLE = \"Coordinating developmental signaling: novel roles for the Hippo pathway.\", JOURNAL = c(\"Trends Cell Biol 22:88-96 (2012)\", \"DOI:10.1016/j.tcb.2011.10.002\")), list(REFERENCE = \"PMID:21376238\", AUTHORS = \"Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, Kreger BT, Vasioukhin V, Avruch J, Brummelkamp TR, Camargo FD\", TITLE = \"Yap1 acts downstream of alpha-catenin to control epidermal proliferation.\", JOURNAL = c(\"Cell 144:782-95 (2011)\", \"DOI:10.1016/j.cell.2011.02.031\"))', 'map04390', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (288, '04391', 'Hippo signaling pathway - fly', 'Hippo signaling is an evolutionarily conserved signaling pathway that controls organ size during development from flies to humans. The core of the drosophila pathway is a kinase cascade consisting of four proteins including Hippo, Salvador, Warts and Mats. Upon activation by stimuli such as high cell density in cell culture, the Hippo pathway kinase cascade phosphorylates and inhibits the transcriptional co-activator Yorkie, thereby promoting cell apoptosis and restricting organ size overgrowth. When the Hippo pathway is inactivated, Yorkie translocates into the nucleus to bind to transcriptional factors to promote cell growth and proliferation.', 'Environmental Information Processing; Signal transduction', 'Hippo signaling pathway - fly', 'GO: 0035329', 'ko04391', 'list(REFERENCE = \"PMID:21138973\", AUTHORS = \"Halder G, Johnson RL\", TITLE = \"Hippo signaling: growth control and beyond.\", JOURNAL = c(\"Development 138:9-22 (2011)\", \"DOI:10.1242/dev.045500\")), list(REFERENCE = \"PMID:20439427\", AUTHORS = \"Zhao B, Li L, Lei Q, Guan KL\", TITLE = \"The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.\", JOURNAL = c(\"Genes Dev 24:862-74 (2010)\", \"DOI:10.1101/gad.1909210\")), list(REFERENCE = \"PMID:20951342\", AUTHORS = \"Pan D\", TITLE = \"The hippo signaling pathway in development and cancer.\", JOURNAL = c(\"Dev Cell 19:491-505 (2010)\", \"DOI:10.1016/j.devcel.2010.09.011\")), list(REFERENCE = \"PMID:22750148\", AUTHORS = \"Schroeder MC, Halder G\", TITLE = \"Regulation of the Hippo pathway by cell architecture and mechanical signals.\", JOURNAL = c(\"Semin Cell Dev Biol 23:803-11 (2012)\", \"DOI:10.1016/j.semcdb.2012.06.001\")), list(REFERENCE = \"PMID:21808241\", AUTHORS = \"Zhao B, Tumaneng K, Guan KL\", TITLE = \"The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.\", JOURNAL = c(\"Nat Cell Biol 13:877-83 (2011)\", \"DOI:10.1038/ncb2303\")), list(REFERENCE = \"PMID:22035868\", AUTHORS = \"Yin M, Zhang L\", TITLE = \"Hippo signaling: a hub of growth control, tumor suppression and pluripotency maintenance.\", JOURNAL = c(\"J Genet Genomics 38:471-81 (2011)\", \"DOI:10.1016/j.jgg.2011.09.009\")), list(REFERENCE = \"PMID:20945341\", AUTHORS = \"Chan SW, Lim CJ, Chen L, Chong YF, Huang C, Song H, Hong W\", TITLE = \"The Hippo pathway in biological control and cancer development.\", JOURNAL = c(\"J Cell Physiol 226:928-39 (2011)\", \"DOI:10.1002/jcp.22435\")), list(REFERENCE = \"PMID:21415026\", AUTHORS = \"Hilman D, Gat U\", TITLE = \"The evolutionary history of YAP and the hippo/YAP pathway.\", JOURNAL = c(\"Mol Biol Evol 28:2403-17 (2011)\", \"DOI:10.1093/molbev/msr065\")), list(REFERENCE = \"PMID:18955139\", AUTHORS = \"Zhao B, Lei QY, Guan KL\", TITLE = \"The Hippo-YAP pathway: new connections between regulation of organ size and cancer.\", JOURNAL = c(\"Curr Opin Cell Biol 20:638-46 (2008)\", \"DOI:10.1016/j.ceb.2008.10.001\")), list(REFERENCE = \"PMID:19846288\", AUTHORS = \"Badouel C, Garg A, McNeill H\", TITLE = \"Herding Hippos: regulating growth in flies and man.\", JOURNAL = c(\"Curr Opin Cell Biol 21:837-43 (2009)\", \"DOI:10.1016/j.ceb.2009.09.010\")), list(REFERENCE = \"PMID:19164949\", AUTHORS = \"Zhang L, Yue T, Jiang J\", TITLE = \"Hippo signaling pathway and organ size control.\", JOURNAL = \"Fly (Austin) 3:68-73 (2009)\"), list(REFERENCE = \"PMID:17318211\", AUTHORS = \"Harvey K, Tapon N\", TITLE = \"The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network.\", JOURNAL = c(\"Nat Rev Cancer 7:182-91 (2007)\", \"DOI:10.1038/nrc2070\")), list(REFERENCE = \"PMID:19517570\", AUTHORS = \"Kango-Singh M, Singh A\", TITLE = \"Regulation of organ size: insights from the Drosophila Hippo signaling pathway.\", JOURNAL = c(\"Dev Dyn 238:1627-37 (2009)\", \"DOI:10.1002/dvdy.21996\")), list(REFERENCE = \"PMID:21145886\", AUTHORS = \"Sun G, Irvine KD\", TITLE = \"Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors.\", JOURNAL = c(\"Dev Biol 350:139-51 (2011)\", \"DOI:10.1016/j.ydbio.2010.11.036\")), list(REFERENCE = \"PMID:22830020\", AUTHORS = \"Fausti F, Di Agostino S, Sacconi A, Strano S, Blandino G\", TITLE = \"Hippo and rassf1a Pathways: A Growing Affair.\", JOURNAL = c(\"Mol Biol Int 2012:307628 (2012)\", \"DOI:10.1155/2012/307628\")), list(REFERENCE = \"PMID:20452772\", AUTHORS = \"Oh H, Irvine KD\", TITLE = \"Yorkie: the final destination of Hippo signaling.\", JOURNAL = c(\"Trends Cell Biol 20:410-7 (2010)\", \"DOI:10.1016/j.tcb.2010.04.005\")), list(REFERENCE = \"PMID:17975546\", AUTHORS = \"Buttitta LA, Edgar BA\", TITLE = \"How size is controlled: from Hippos to Yorkies.\", JOURNAL = c(\"Nat Cell Biol 9:1225-7 (2007)\", \"DOI:10.1038/ncb1107-1225\")), list(REFERENCE = \"PMID:21213102\", AUTHORS = \"Chen L, Loh PG, Song H\", TITLE = \"Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway.\", JOURNAL = c(\"Protein Cell 1:1073-83 (2010)\", \"DOI:10.1007/s13238-010-0138-3\")), list(REFERENCE = \"PMID:19733165\", AUTHORS = \"Oh H, Reddy BV, Irvine KD\", TITLE = \"Phosphorylation-independent repression of Yorkie in Fat-Hippo signaling.\", JOURNAL = c(\"Dev Biol 335:188-97 (2009)\", \"DOI:10.1016/j.ydbio.2009.08.026\")), list(REFERENCE = \"PMID:18952051\", AUTHORS = \"Badouel C, McNeill H\", TITLE = \"Apical junctions and growth control in Drosophila.\", JOURNAL = c(\"Biochim Biophys Acta 1788:755-60 (2009)\", \"DOI:10.1016/j.bbamem.2008.08.026\"))', 'map04391', 'Hippo signaling pathway - fly', 64, 0, 64, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (289, '04392', 'Hippo signaling pathway - multiple species', 'Hippo signaling pathways control diverse aspects of cell proliferation, survival, and morphogenesis in eukaryotes. The core organization of these networks is conserved over a billion years of evolution, with related forms described in animals and fungi. In Drosophila and mammals, Hippo/MST co-operate with Mats/Mob1 and Salvador/WW45 to activate Warts/LATS, which negatively regulates Yorkie/YAP. Yorkie/YAP interact with Scalloped/TEAD to promote gene transcriptions and control organ size through the balance between cell proliferation and apoptosis. In C. elegans, WTS-1 YAP-1 EGL-44 axis is conserved and regulates thermotolerance and healthy lifespan. In S. cerevisiae, the LATS-related Dbf2 or Dbf20 kinase in complex with Mob1 controls mitotic exit and cytokinesis, and the Hippo/MST family of kinases, STE-20, modulates Tec1, the putative yeast TEAD ortholog.', 'Environmental Information Processing; Signal transduction', 'Hippo signaling pathway - multiple species', 'Hennekam lymphangiectasia-lymphedema syndrome', 'GO: 0035329', 'ko04392', 'list(REFERENCE = \"PMID:21415026\", AUTHORS = \"Hilman D, Gat U\", TITLE = \"The evolutionary history of YAP and the hippo/YAP pathway.\", JOURNAL = c(\"Mol Biol Evol 28:2403-17 (2011)\", \"DOI:10.1093/molbev/msr065\")), list(REFERENCE = \"PMID:24715453\", AUTHORS = \"Varelas X\", TITLE = \"The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.\", JOURNAL = c(\"Development 141:1614-26 (2014)\", \"DOI:10.1242/dev.102376\")), list(REFERENCE = \"PMID:21808241\", AUTHORS = \"Zhao B, Tumaneng K, Guan KL\", TITLE = \"The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal.\", JOURNAL = c(\"Nat Cell Biol 13:877-83 (2011)\", \"DOI:10.1038/ncb2303\")), list(REFERENCE = \"PMID:21138973\", AUTHORS = \"Halder G, Johnson RL\", TITLE = \"Hippo signaling: growth control and beyond.\", JOURNAL = c(\"Development 138:9-22 (2011)\", \"DOI:10.1242/dev.045500\")), list(REFERENCE = \"PMID:20951342\", AUTHORS = \"Pan D\", TITLE = \"The hippo signaling pathway in development and cancer.\", JOURNAL = c(\"Dev Cell 19:491-505 (2010)\", \"DOI:10.1016/j.devcel.2010.09.011\")), list(REFERENCE = \"PMID:20439427\", AUTHORS = \"Zhao B, Li L, Lei Q, Guan KL\", TITLE = \"The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.\", JOURNAL = c(\"Genes Dev 24:862-74 (2010)\", \"DOI:10.1101/gad.1909210\")), list(REFERENCE = \"PMID:22830020\", AUTHORS = \"Fausti F, Di Agostino S, Sacconi A, Strano S, Blandino G\", TITLE = \"Hippo and rassf1a Pathways: A Growing Affair.\", JOURNAL = c(\"Mol Biol Int 2012:307628 (2012)\", \"DOI:10.1155/2012/307628\")), list(REFERENCE = \"PMID:25966461\", AUTHORS = \"Gogl G, Schneider KD, Yeh BJ, Alam N, Nguyen Ba AN, Moses AM, Hetenyi C, Remenyi A, Weiss EL\", TITLE = \"The Structure of an NDR/LATS Kinase-Mob Complex Reveals a Novel Kinase-Coactivator System and Substrate Docking Mechanism.\", JOURNAL = c(\"PLoS Biol 13:e1002146 (2015)\", \"DOI:10.1371/journal.pbio.1002146\")), list(REFERENCE = \"PMID:23396260\", AUTHORS = \"Iwasa H, Maimaiti S, Kuroyanagi H, Kawano S, Inami K, Timalsina S, Ikeda M, Nakagawa K, Hata Y\", TITLE = \"Yes-associated protein homolog, YAP-1, is involved in the thermotolerance and aging in the nematode Caenorhabditis elegans.\", JOURNAL = c(\"Exp Cell Res 319:931-45 (2013)\", \"DOI:10.1016/j.yexcr.2013.01.020\")), list(REFERENCE = \"PMID:23843471\", AUTHORS = \"Yang Z, Hata Y\", TITLE = \"What is the Hippo pathway? Is the Hippo pathway conserved in Caenorhabditis elegans?\", JOURNAL = c(\"J Biochem 154:207-9 (2013)\", \"DOI:10.1093/jb/mvt060\")), list(REFERENCE = \"PMID:24594661\", AUTHORS = \"Hotz M, Barral Y\", TITLE = \"The Mitotic Exit Network: new turns on old pathways.\", JOURNAL = c(\"Trends Cell Biol 24:145-52 (2014)\", \"DOI:10.1016/j.tcb.2013.09.010\")), list(REFERENCE = \"PMID:23579499\", AUTHORS = \"Rock JM, Lim D, Stach L, Ogrodowicz RW, Keck JM, Jones MH, Wong CC, Yates JR 3rd, Winey M, Smerdon SJ, Yaffe MB, Amon A\", TITLE = \"Activation of the yeast Hippo pathway by phosphorylation-dependent assembly of signaling complexes.\", JOURNAL = c(\"Science 340:871-5 (2013)\", \"DOI:10.1126/science.1235822\")), list(REFERENCE = \"PMID:22525225\", AUTHORS = \"Hergovich A, Hemmings BA\", TITLE = \"Hippo signalling in the G2/M cell cycle phase: lessons learned from the yeast MEN and SIN pathways.\", JOURNAL = c(\"Semin Cell Dev Biol 23:794-802 (2012)\", \"DOI:10.1016/j.semcdb.2012.04.001\")), list(REFERENCE = \"PMID:19826484\", AUTHORS = \"Wang Y, Abu Irqeba A, Ayalew M, Suntay K\", TITLE = \"Sumoylation of transcription factor Tec1 regulates signaling of mitogen-activated protein kinase pathways in yeast.\", JOURNAL = c(\"PLoS One 4:e7456 (2009)\", \"DOI:10.1371/journal.pone.0007456\"))', 'map04392', 167, 0, 135, 0, 32, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (290, '04510', 'Focal adhesion', 'Cell-matrix adhesions play essential roles in important biological processes including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival. At the cell-extracellular matrix contact points, specialized structures are formed and termed focal adhesions, where bundles of actin filaments are anchored to transmembrane receptors of the integrin family through a multi-molecular complex of junctional plaque proteins. Some of the constituents of focal adhesions participate in the structural link between membrane receptors and the actin cytoskeleton, while others are signalling molecules, including different protein kinases and phosphatases, their substrates, and various adapter proteins. Integrin signaling is dependent upon the non-receptor tyrosine kinase activities of the FAK and src proteins as well as the adaptor protein functions of FAK, src and Shc to initiate downstream signaling events. These signalling events culminate in reorganization of the actin cytoskeleton; a prerequisite for changes in cell shape and motility, and gene expression. Similar morphological alterations and modulation of gene expression are initiated by the binding of growth factors to their respective receptors, emphasizing the considerable crosstalk between adhesion- and growth factor-mediated signalling.', 'Cellular Processes; Cellular community - eukaryotes', 'Focal adhesion', 'Glanzmann thrombasthenia, Type II collagenopathies, Hereditary lymphedema, Limb-girdle muscular dystrophy 1C, Pierson syndrome, Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC), Alport syndrome, Benign familial hematuria, Epidermolysis bullosa, junctional, Congenital muscular dystrophies (CMD/MDC), Limb-girdle muscular dystrophy, Myofibrillar myopathies, Familial thoracic aortic aneurysm and dissection, Ehlers-Danlos syndrome, Vitreoretinal degeneration, Laryngo onycho cutaneous syndrome, Porencephaly, Brain small vessel disease with hemorrhage, FG syndrome, Pilomatricoma, VACTERL/VATER association, Hypomagnesemia, Juvenile-onset dystonia, Glomerulopathy with fibronectin deposits, Growth delay due to insulin-like growth factor I resistance, Chronic idiopathic intestinal pseudo-obstruction, Myosclerosis, Bethlem myopathy, Collagen VI myopathy, Legg-Calve-Perthes Disease, Macrothrombocytopenia, Ullrich disease, Larsen syndrome, Atelosteogenesis type I and III, Achondrogenesis type II, Boomerang dysplasia, Kniest dysplasia, Czech dysplasia, Stickler syndrome, Rippling muscle disease, Idiopathic hyperCKemia, Distal myopathy, Tateyama type, Ehlers-Danlos syndrome cardiac valvular type, Ehlers-Danlos syndrome arthrochalasia type', 'GO: 0005925', 'ko04510', 'list(REFERENCE = \"PMID:14756624\", AUTHORS = \"Berman AE, Kozlova NI, Morozevich GE.\", TITLE = \"Integrins: structure and signaling.\", JOURNAL = \"Biochemistry (Mosc) 68:1284-99 (2003)\"), list(REFERENCE = \"PMID:15179030\", AUTHORS = \"Lee JW, Juliano R.\", TITLE = \"Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways.\", JOURNAL = \"Mol Cells 17:188-202 (2004)\"), list(REFERENCE = \"PMID:11573199\", AUTHORS = \"Danen EH, Yamada KM.\", TITLE = \"Fibronectin, integrins, and growth control.\", JOURNAL = c(\"J Cell Physiol 189:1-13 (2001)\", \"DOI:10.1002/jcp.1137\")), list(REFERENCE = \"PMID:15459662\", AUTHORS = \"Guo W, Giancotti FG.\", TITLE = \"Integrin signalling during tumour progression.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 5:816-26 (2004)\", \"DOI:10.1038/nrm1490\")), list(REFERENCE = \"PMID:11229600\", AUTHORS = \"Petit V, Thiery JP.\", TITLE = \"Focal adhesions: structure and dynamics.\", JOURNAL = c(\"Biol Cell 92:477-94 (2000)\", \"DOI:10.1016/S0248-4900(00)01101-1\")), list(REFERENCE = \"PMID:12235283\", AUTHORS = \"Stupack DG, Cheresh DA.\", TITLE = \"Get a ligand, get a life: integrins, signaling and cell survival.\", JOURNAL = c(\"J Cell Sci 115:3729-38 (2002)\", \"DOI:10.1242/jcs.00071\")), list(REFERENCE = \"PMID:12640026\", AUTHORS = \"Parsons JT.\", TITLE = \"Focal adhesion kinase: the first ten years.\", JOURNAL = c(\"J Cell Sci 116:1409-16 (2003)\", \"DOI:10.1242/jcs.00373\")), list(REFERENCE = \"PMID:15688067\", AUTHORS = \"Mitra SK, Hanson DA, Schlaepfer DD.\", TITLE = \"Focal adhesion kinase: in command and control of cell motility.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 6:56-68 (2005)\", \"DOI:10.1038/nrm1549\")), list(REFERENCE = \"PMID:14519391\", AUTHORS = \"Comoglio PM, Boccaccio C, Trusolino L.\", TITLE = \"Interactions between growth factor receptors and adhesion molecules: breaking the rules.\", JOURNAL = c(\"Curr Opin Cell Biol 15:565-71 (2003)\", \"DOI:10.1016/S0955-0674(03)00096-6\")), list(REFERENCE = \"PMID:15108811\", AUTHORS = \"Schlaepfer DD, Mitra SK.\", TITLE = \"Multiple connections link FAK to cell motility and invasion.\", JOURNAL = c(\"Curr Opin Genet Dev 14:92-101 (2004)\", \"DOI:10.1016/j.gde.2003.12.002\")), list(REFERENCE = \"PMID:14744429\", AUTHORS = \"Burridge K, Wennerberg K.\", TITLE = \"Rho and Rac take center stage.\", JOURNAL = c(\"Cell 116:167-79 (2004)\", \"DOI:10.1016/S0092-8674(04)00003-0\")), list(REFERENCE = \"PMID:11082269\", AUTHORS = \"Schmitz AA, Govek EE, Bottner B, Van Aelst L.\", TITLE = \"Rho GTPases: signaling, migration, and invasion.\", JOURNAL = c(\"Exp Cell Res 261:1-12 (2000)\", \"DOI:10.1006/excr.2000.5049\")), list(REFERENCE = \"PMID:10698680\", AUTHORS = \"Vanhaesebroeck B, Alessi DR.\", TITLE = \"The PI3K-PDK1 connection: more than just a road to PKB.\", JOURNAL = c(\"Biochem J 346 Pt 3:561-76 (2000)\", \"DOI:10.1042/bj3460561\")), list(REFERENCE = \"PMID:11882383\", AUTHORS = \"Nicholson KM, Anderson NG.\", TITLE = \"The protein kinase B/Akt signalling pathway in human malignancy.\", JOURNAL = c(\"Cell Signal 14:381-95 (2002)\", \"DOI:10.1016/S0898-6568(01)00271-6\")), list(REFERENCE = \"PMID:15053919\", AUTHORS = \"Oloumi A, McPhee T, Dedhar S.\", TITLE = \"Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase.\", JOURNAL = c(\"Biochim Biophys Acta 1691:1-15 (2004)\", \"DOI:10.1016/j.bbamcr.2003.12.002\")), list(REFERENCE = \"PMID:11146675\", AUTHORS = \"Turner CE.\", TITLE = \"Paxillin and focal adhesion signalling.\", JOURNAL = c(\"Nat Cell Biol 2:E231-6 (2000)\", \"DOI:10.1038/35046659\")), list(REFERENCE = \"PMID:15034601\", AUTHORS = \"Hlobilkova A, Knillova J, Bartek J, Lukas J, Kolar Z.\", TITLE = \"The mechanism of action of the tumour suppressor gene PTEN.\", JOURNAL = \"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147:19-25 (2003)\")', 'map04510', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (291, '04512', 'ECM-receptor interaction', 'The extracellular matrix (ECM) consists of a complex mixture of structural and functional macromolecules and serves an important role in tissue and organ morphogenesis and in the maintenance of cell and tissue structure and function. Specific interactions between cells and the ECM are mediated by transmembrane molecules, mainly integrins and perhaps also proteoglycans, CD36, or other cell-surface-associated components. These interactions lead to a direct or indirect control of cellular activities such as adhesion, migration, differentiation, proliferation, and apoptosis. In addition, integrins function as mechanoreceptors and provide a force-transmitting physical link between the ECM and the cytoskeleton. Integrins are a family of glycosylated, heterodimeric transmembrane adhesion receptors that consist of noncovalently bound alpha- and beta-subunits.', 'Environmental Information Processing; Signaling molecules and interaction', 'ECM-receptor interaction', 'Hemophilia, Bernard-Soulier syndrome, Glanzmann thrombasthenia, Type II collagenopathies, Pierson syndrome, Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC), Alport syndrome, Benign familial hematuria, Epidermolysis bullosa, junctional, Congenital myasthenic syndrome, Ehlers-Danlos syndrome, Vitreoretinal degeneration, Laryngo onycho cutaneous syndrome, Porencephaly, Brain small vessel disease with hemorrhage, Glomerulopathy with fibronectin deposits, Myosclerosis, Bethlem myopathy, Collagen VI myopathy, Legg-Calve-Perthes Disease, Schwartz-Jampel syndrome, Ullrich disease, Merosin-deficient congenital muscular dystrophy, Achondrogenesis type II, Kniest dysplasia, Czech dysplasia, Stickler syndrome, Ehlers-Danlos syndrome cardiac valvular type, Ehlers-Danlos syndrome arthrochalasia type', 'GO: 0005201', 'ko04512', 'list(REFERENCE = \"PMID:11572082\", AUTHORS = \"van der Flier A, Sonnenberg A.\", TITLE = \"Function and interactions of integrins.\", JOURNAL = c(\"Cell Tissue Res 305:285-98 (2001)\", \"DOI:10.1007/s004410100417\")), list(REFERENCE = \"PMID:12921709\", AUTHORS = \"Reddy KV, Mangale SS.\", TITLE = \"Integrin receptors: the dynamic modulators of endometrial function.\", JOURNAL = c(\"Tissue Cell 35:260-73 (2003)\", \"DOI:10.1016/S0040-8166(03)00039-9\")), list(REFERENCE = \"PMID:12125070\", AUTHORS = \"Milner R, Campbell IL.\", TITLE = \"The integrin family of cell adhesion molecules has multiple functions within the CNS.\", JOURNAL = c(\"J Neurosci Res 69:286-91 (2002)\", \"DOI:10.1002/jnr.10321\")), list(REFERENCE = \"PMID:12796473\", AUTHORS = \"Cichy J, Pure E.\", TITLE = \"The liberation of CD44.\", JOURNAL = c(\"J Cell Biol 161:839-43 (2003)\", \"DOI:10.1083/jcb.200302098\")), list(REFERENCE = \"PMID:7698997\", AUTHORS = \"Elenius K, Jalkanen M.\", TITLE = \"Function of the syndecans--a family of cell surface proteoglycans.\", JOURNAL = \"J Cell Sci 107 ( Pt 11):2975-82 (1994)\"), list(REFERENCE = \"PMID:10617638\", AUTHORS = \"Son YJ, Scranton TW, Sunderland WJ, Baek SJ, Miner JH, Sanes JR, Carlson SS.\", TITLE = \"The synaptic vesicle protein SV2 is complexed with an alpha5-containing laminin on the nerve terminal surface.\", JOURNAL = c(\"J Biol Chem 275:451-60 (2000)\", \"DOI:10.1074/jbc.275.1.451\")), list(REFERENCE = \"PMID:15036264\", AUTHORS = \"Sid B, Sartelet H, Bellon G, El Btaouri H, Rath G, Delorme N, Haye B, Martiny L.\", TITLE = \"Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth.\", JOURNAL = c(\"Crit Rev Oncol Hematol 49:245-58 (2004)\", \"DOI:10.1016/j.critrevonc.2003.09.009\")), list(REFERENCE = \"PMID:15381249\", AUTHORS = \"Canobbio I, Balduini C, Torti M.\", TITLE = \"Signalling through the platelet glycoprotein Ib-V-IX complex.\", JOURNAL = c(\"Cell Signal 16:1329-44 (2004)\", \"DOI:10.1016/j.cellsig.2004.05.008\")), list(REFERENCE = \"PMID:11331578\", AUTHORS = \"Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fassler R.\", TITLE = \"Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen.\", JOURNAL = c(\"EMBO J 20:2120-30 (2001)\", \"DOI:10.1093/emboj/20.9.2120\")), list(REFERENCE = \"PMID:12736199\", AUTHORS = \"Martin PT.\", TITLE = \"Dystroglycan glycosylation and its role in matrix binding in skeletal muscle.\", JOURNAL = c(\"Glycobiology 13:55R-66R (2003)\", \"DOI:10.1093/glycob/cwg076\")), list(REFERENCE = \"PMID:15229478\", AUTHORS = \"Toole BP.\", TITLE = \"Hyaluronan: from extracellular glue to pericellular cue.\", JOURNAL = c(\"Nat Rev Cancer 4:528-39 (2004)\", \"DOI:10.1038/nrc1391\")), list(REFERENCE = \"PMID:12845610\", AUTHORS = \"Bosman FT, Stamenkovic I.\", TITLE = \"Functional structure and composition of the extracellular matrix.\", JOURNAL = c(\"J Pathol 200:423-8 (2003)\", \"DOI:10.1002/path.1437\")), list(REFERENCE = \"PMID:29079659\", AUTHORS = \"van der Ven AT, Vivante A, Hildebrandt F\", TITLE = \"Novel Insights into the Pathogenesis of Monogenic Congenital Anomalies of the Kidney and Urinary Tract.\", JOURNAL = c(\"J Am Soc Nephrol 29:36-50 (2018)\", \"DOI:10.1681/ASN.2017050561\"))', 'map04512', 248, 0, 248, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (292, '04514', 'Cell adhesion molecules (CAMs)', 'Cell adhesion molecules are (glyco)proteins expressed on the cell surface and play a critical role in a wide array of biologic processes that include hemostasis, the immune response, inflammation, embryogenesis, and development of neuronal tissue. There are four main groups: the integrin family, the immunoglobulin superfamily, selectins, and cadherins. Membrane proteins that mediate immune cell&#8211;cell interactions fall into different categories, namely those involved in antigen recognition, costimulation and cellular adhesion. Furthermore cell-cell adhesions are important for brain morphology and highly coordinated brain functions such as memory and learning. During early development of the nervous system, neurons elongate their axons towards their targets and establish and maintain synapses through formation of cell-cell adhesions. Cell-cell adhesions also underpin axon-axon contacts and link neurons with supporting schwann cells and oligodendrocytes.', 'Environmental Information Processing; Signaling molecules and interaction', 'Cell adhesion molecules (CAMs)', 'Epidermolysis bullosa, junctional, Ectodermal dysplasia, ectrodactyly, and macular dystrophy, Neonatal ichthyosis-sclerosing cholangitis (NISCH) syndrome, Pitt-Hopkins syndrome, Congenital hypotrichosis with juvenile macular dystrophy, Vitreoretinal degeneration, Band-like calcification with simplified gyration and polymicrogyria, L1 syndrome, Roussy-Levy syndrome, Hypomagnesemia, Multiple sclerosis, Congenital hydrocephalus, Asperger syndrome, Wagner syndrome, Autism, MASA syndrome', 'GO: 0050839', 'ko04514', 'list(REFERENCE = \"PMID:14690046\", AUTHORS = \"Barclay AN.\", TITLE = \"Membrane proteins with immunoglobulin-like domains--a master superfamily of interaction molecules.\", JOURNAL = c(\"Semin Immunol 15:215-23 (2003)\", \"DOI:10.1016/S1044-5323(03)00047-2\")), list(REFERENCE = \"PMID:11910893\", AUTHORS = \"Sharpe AH, Freeman GJ.\", TITLE = \"The B7-CD28 superfamily.\", JOURNAL = c(\"Nat Rev Immunol 2:116-26 (2002)\", \"DOI:10.1038/nri727\")), list(REFERENCE = \"PMID:9597126\", AUTHORS = \"Grewal IS, Flavell RA.\", TITLE = \"CD40 and CD154 in cell-mediated immunity.\", JOURNAL = c(\"Annu Rev Immunol 16:111-35 (1998)\", \"DOI:10.1146/annurev.immunol.16.1.111\")), list(REFERENCE = \"PMID:16034094\", AUTHORS = \"Dardalhon V, Schubart AS, Reddy J, Meyers JH, Monney L, Sabatos CA, Ahuja R, Nguyen K, Freeman GJ, Greenfield EA, Sobel RA, Kuchroo VK.\", TITLE = \"CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions.\", JOURNAL = c(\"J Immunol 175:1558-65 (2005)\", \"DOI:10.4049/jimmunol.175.3.1558\")), list(REFERENCE = \"PMID:12234363\", AUTHORS = \"Montoya MC, Sancho D, Vicente-Manzanares M, Sanchez-Madrid F.\", TITLE = \"Cell adhesion and polarity during immune interactions.\", JOURNAL = c(\"Immunol Rev 186:68-82 (2002)\", \"DOI:10.1034/j.1600-065X.2002.18607.x\")), list(REFERENCE = \"PMID:15071551\", AUTHORS = \"Dejana E.\", TITLE = \"Endothelial cell-cell junctions: happy together.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 5:261-70 (2004)\", \"DOI:10.1038/nrm1357\")), list(REFERENCE = \"PMID:14519386\", AUTHORS = \"Bazzoni G.\", TITLE = \"The JAM family of junctional adhesion molecules.\", JOURNAL = c(\"Curr Opin Cell Biol 15:525-30 (2003)\", \"DOI:10.1016/S0955-0674(03)00104-2\")), list(REFERENCE = \"PMID:10798271\", AUTHORS = \"Becker BF, Heindl B, Kupatt C, Zahler S.\", TITLE = \"Endothelial function and hemostasis.\", JOURNAL = c(\"Z Kardiol 89:160-7 (2000)\", \"DOI:10.1007/PL00007320\")), list(REFERENCE = \"PMID:9150551\", AUTHORS = \"Elangbam CS, Qualls CW Jr, Dahlgren RR.\", TITLE = \"Cell adhesion molecules--update.\", JOURNAL = c(\"Vet Pathol 34:61-73 (1997)\", \"DOI:10.1177/030098589703400113\")), list(REFERENCE = \"PMID:12810109\", AUTHORS = \"Muller WA.\", TITLE = \"Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response.\", JOURNAL = c(\"Trends Immunol 24:327-34 (2003)\", \"DOI:10.1016/S1471-4906(03)00117-0\")), list(REFERENCE = \"PMID:14519398\", AUTHORS = \"Yamagata M, Sanes JR, Weiner JA.\", TITLE = \"Synaptic adhesion molecules.\", JOURNAL = c(\"Curr Opin Cell Biol 15:621-32 (2003)\", \"DOI:10.1016/S0955-0674(03)00107-8\")), list(REFERENCE = \"PMID:15882774\", AUTHORS = \"Ethell IM, Pasquale EB.\", TITLE = \"Molecular mechanisms of dendritic spine development and remodeling.\", JOURNAL = c(\"Prog Neurobiol 75:161-205 (2005)\", \"DOI:10.1016/j.pneurobio.2005.02.003\")), list(REFERENCE = \"PMID:11050419\", AUTHORS = \"Benson DL, Schnapp LM, Shapiro L, Huntley GW.\", TITLE = \"Making memories stick: cell-adhesion molecules in synaptic plasticity.\", JOURNAL = c(\"Trends Cell Biol 10:473-82 (2000)\", \"DOI:10.1016/S0962-8924(00)01838-9\")), list(REFERENCE = \"PMID:11860281\", AUTHORS = \"Rosdahl JA, Mourton TL, Brady-Kalnay SM.\", TITLE = \"Protein kinase C delta (PKCdelta) is required for protein tyrosine phosphatase mu (PTPmu)-dependent neurite outgrowth.\", JOURNAL = c(\"Mol Cell Neurosci 19:292-306 (2002)\", \"DOI:10.1006/mcne.2001.1071\")), list(REFERENCE = \"PMID:10964748\", AUTHORS = \"Dunican DJ, Doherty P.\", TITLE = \"The generation of localized calcium rises mediated by cell adhesion molecules and their role in neuronal growth cone motility.\", JOURNAL = c(\"Mol Cell Biol Res Commun 3:255-63 (2000)\", \"DOI:10.1006/mcbr.2000.0225\")), list(REFERENCE = \"PMID:12367625\", AUTHORS = \"Girault JA, Peles E.\", TITLE = \"Development of nodes of Ranvier.\", JOURNAL = c(\"Curr Opin Neurobiol 12:476-85 (2002)\", \"DOI:10.1016/S0959-4388(02)00370-7\")), list(REFERENCE = \"PMID:10664064\", AUTHORS = \"Arroyo EJ, Scherer SS.\", TITLE = \"On the molecular architecture of myelinated fibers.\", JOURNAL = c(\"Histochem Cell Biol 113:1-18 (2000)\", \"DOI:10.1007/s004180050001\")), list(REFERENCE = \"PMID:14556710\", AUTHORS = \"Salzer JL.\", TITLE = \"Polarized domains of myelinated axons.\", JOURNAL = c(\"Neuron 40:297-318 (2003)\", \"DOI:10.1016/S0896-6273(03)00628-7\")), list(REFERENCE = \"PMID:15561584\", AUTHORS = \"Irie K, Shimizu K, Sakisaka T, Ikeda W, Takai Y.\", TITLE = \"Roles and modes of action of nectins in cell-cell adhesion.\", JOURNAL = c(\"Semin Cell Dev Biol 15:643-56 (2004)\", \"DOI:10.1016/j.semcdb.2004.09.002\")), list(REFERENCE = \"PMID:15551862\", AUTHORS = \"Nakanishi H, Takai Y.\", TITLE = \"Roles of nectins in cell adhesion, migration and polarization.\", JOURNAL = c(\"Biol Chem 385:885-92 (2004)\", \"DOI:10.1515/BC.2004.116\")), list(REFERENCE = \"PMID:15115723\", AUTHORS = \"Siu MK, Cheng CY.\", TITLE = \"Extracellular matrix: recent advances on its role in junction dynamics in the seminiferous epithelium during spermatogenesis.\", JOURNAL = c(\"Biol Reprod 71:375-91 (2004)\", \"DOI:10.1095/biolreprod.104.028225\")), list(REFERENCE = \"PMID:15056568\", AUTHORS = \"Lee NP, Cheng CY.\", TITLE = \"Adaptors, junction dynamics, and spermatogenesis.\", JOURNAL = c(\"Biol Reprod 71:392-404 (2004)\", \"DOI:10.1095/biolreprod.104.027268\")), list(REFERENCE = \"PMID:15728677\", AUTHORS = \"Inagaki M, Irie K, Ishizaki H, Tanaka-Okamoto M, Morimoto K, Inoue E, Ohtsuka T, Miyoshi J, Takai Y.\", TITLE = \"Roles of cell-adhesion molecules nectin 1 and nectin 3 in ciliary body development.\", JOURNAL = c(\"Development 132:1525-37 (2005)\", \"DOI:10.1242/dev.01697\")), list(REFERENCE = \"PMID:12500939\", AUTHORS = \"Marthiens V, Gavard J, Lambert M, Mege RM.\", TITLE = \"Cadherin-based cell adhesion in neuromuscular development.\", JOURNAL = c(\"Biol Cell 94:315-26 (2002)\", \"DOI:10.1016/S0248-4900(02)00005-9\")), list(REFERENCE = \"PMID:15923648\", AUTHORS = \"Krauss RS, Cole F, Gaio U, Takaesu G, Zhang W, Kang JS.\", TITLE = \"Close encounters: regulation of vertebrate skeletal myogenesis by cell-cell contact.\", JOURNAL = c(\"J Cell Sci 118:2355-62 (2005)\", \"DOI:10.1242/jcs.02397\"))', 'map04514', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (293, '04520', 'Adherens junction', 'Cell-cell adherens junctions (AJs), the most common type of intercellular adhesions, are important for maintaining tissue architecture and cell polarity and can limit cell movement and proliferation. At AJs, E-cadherin serves as an essential cell adhesion molecules (CAMs). The cytoplasmic tail binds beta-catenin, which in turn binds alpha-catenin. Alpha-catenin is associated with F-actin bundles directly and indirectly. The integrity of the cadherin-catenin complex is negatively regulated by phosphorylation of beta-catenin by receptor tyrosine kinases (RTKs) and cytoplasmic tyrosine kinases (Fer, Fyn, Yes, and Src), which leads to dissociation of the cadherin-catenin complex. Integrity of this complex is positively regulated by beta -catenin phosphorylation by casein kinase II, and dephosphorylation by protein tyrosine phosphatases. Changes in the phosphorylation state of beta-catenin affect cell-cell adhesion, cell migration and the level of signaling beta-catenin. Wnt signaling acts as a positive regulator of beta-catenin by inhibiting beta-catenin degradation, which stabilizes beta-catenin, and causes its accumulation. Cadherin may acts as a negative regulator of signaling beta-catenin as it binds beta-catenin at the cell surface and thereby sequesters it from the nucleus. Nectins also function as CAMs at AJs, but are more highly concentrated at AJs than E-cadherin. Nectins transduce signals through Cdc42 and Rac, which reorganize the actin cytoskeleton, regulate the formation of AJs, and strengthen cell-cell adhesion.', 'Cellular Processes; Cellular community - eukaryotes', 'Adherens junction', 'Piebaldism, Ectodermal dysplasia-syndactyly syndrome, Leprechaunism, Waardenburg syndrome, Loeys-Dietz syndrome, Familial thoracic aortic aneurysm and dissection, Rabson-Mendenhall syndrome, Pilomatricoma, Juvenile polyposis syndrome, Trigonocephaly, Insulin-resistant diabetes mellitus with acanthosis nigricans, Juvenile-onset dystonia, Growth delay due to insulin-like growth factor I resistance', 'GO: 0005912', 'ko04520', 'list(REFERENCE = \"PMID:15001769\", AUTHORS = \"Nelson WJ, Nusse R.\", TITLE = \"Convergence of Wnt, beta-catenin, and cadherin pathways.\", JOURNAL = c(\"Science 303:1483-7 (2004)\", \"DOI:10.1126/science.1094291\")), list(REFERENCE = \"PMID:10204118\", AUTHORS = \"Potter E, Bergwitz C, Brabant G.\", TITLE = \"The cadherin-catenin system: implications for growth and differentiation of endocrine tissues.\", JOURNAL = c(\"Endocr Rev 20:207-39 (1999)\", \"DOI:10.1210/edrv.20.2.0362\")), list(REFERENCE = \"PMID:10959047\", AUTHORS = \"Beavon IR.\", TITLE = \"The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation.\", JOURNAL = c(\"Eur J Cancer 36:1607-20 (2000)\", \"DOI:10.1016/S0959-8049(00)00158-1\")), list(REFERENCE = \"PMID:15489912\", AUTHORS = \"Reynolds AB, Roczniak-Ferguson A.\", TITLE = \"Emerging roles for p120-catenin in cell adhesion and cancer.\", JOURNAL = c(\"Oncogene 23:7947-56 (2004)\", \"DOI:10.1038/sj.onc.1208161\")), list(REFERENCE = \"PMID:11171368\", AUTHORS = \"Angst BD, Marcozzi C, Magee AI.\", TITLE = \"The cadherin superfamily: diversity in form and function.\", JOURNAL = \"J Cell Sci 114:629-41 (2001)\"), list(REFERENCE = \"PMID:11984870\", AUTHORS = \"Lilien J, Balsamo J, Arregui C, Xu G.\", TITLE = \"Turn-off, drop-out: functional state switching of cadherins.\", JOURNAL = c(\"Dev Dyn 224:18-29 (2002)\", \"DOI:10.1002/dvdy.10087\")), list(REFERENCE = \"PMID:12640114\", AUTHORS = \"Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia de Herreros A, Dunach M.\", TITLE = \"p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.\", JOURNAL = c(\"Mol Cell Biol 23:2287-97 (2003)\", \"DOI:10.1128/MCB.23.7.2287-2297.2003\")), list(REFERENCE = \"PMID:14623871\", AUTHORS = \"Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze\'ev A.\", TITLE = \"Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK.\", JOURNAL = c(\"J Cell Biol 163:847-57 (2003)\", \"DOI:10.1083/jcb.200308162\")), list(REFERENCE = \"PMID:11703922\", AUTHORS = \"Ciruna B, Rossant J.\", TITLE = \"FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak.\", JOURNAL = c(\"Dev Cell 1:37-49 (2001)\", \"DOI:10.1016/S1534-5807(01)00017-X\")), list(REFERENCE = \"PMID:12665527\", AUTHORS = \"Peinado H, Quintanilla M, Cano A.\", TITLE = \"Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.\", JOURNAL = c(\"J Biol Chem 278:21113-23 (2003)\", \"DOI:10.1074/jbc.M211304200\")), list(REFERENCE = \"PMID:10890911\", AUTHORS = \"Labbe E, Letamendia A, Attisano L.\", TITLE = \"Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 97:8358-63 (2000)\", \"DOI:10.1073/pnas.150152697\")), list(REFERENCE = \"PMID:15551862\", AUTHORS = \"Nakanishi H, Takai Y.\", TITLE = \"Roles of nectins in cell adhesion, migration and polarization.\", JOURNAL = c(\"Biol Chem 385:885-92 (2004)\", \"DOI:10.1515/BC.2004.116\")), list(REFERENCE = \"PMID:15561584\", AUTHORS = \"Irie K, Shimizu K, Sakisaka T, Ikeda W, Takai Y.\", TITLE = \"Roles and modes of action of nectins in cell-cell adhesion.\", JOURNAL = c(\"Semin Cell Dev Biol 15:643-56 (2004)\", \"DOI:10.1016/j.semcdb.2004.09.002\"))', 'map04520', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (294, '04530', 'Tight junction', 'Tight junctions (TJs) are essential for establishing a selectively permeable barrier to diffusion through the paracellular space between neighboring cells. TJs are composed of at least three types of transmembrane protein -occludin, claudin and junctional adhesion molecules (JAMs)- and a cytoplasmic \'plaque\' consisting of many different proteins that form large complexes. These are proposed to be involved in junction assembly, barrier regulation, cell polarity, gene transcription, and other pathways.', 'Cellular Processes; Cellular community - eukaryotes', 'Tight junction', 'MYH9-related disease, Epstein syndrome, Limb-girdle muscular dystrophy, Distal myopathy, Progressive familial intrahepatic cholestasis, Scapuloperoneal myopathy, Myosin storage myopathy, Neonatal ichthyosis-sclerosing cholangitis (NISCH) syndrome, Familial thoracic aortic aneurysm and dissection, Distal arthrogryposis, Band-like calcification with simplified gyration and polymicrogyria, Trismus-pseudocamptodactyly syndrome, FG syndrome, Pilomatricoma, Thrombocytopenia (THC), VACTERL/VATER association, Hypomagnesemia, Inclusion body myopathy 3, Juvenile-onset dystonia, Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, Congenital hydrocephalus, May-Hegglin anomaly, Fechtner syndrome', 'GO: 0005923', 'ko04530', 'list(REFERENCE = \"PMID:27353478\", AUTHORS = \"Zihni C, Mills C, Matter K, Balda MS\", TITLE = \"Tight junctions: from simple barriers to multifunctional molecular gates.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 17:564-80 (2016)\", \"DOI:10.1038/nrm.2016.80\")), list(REFERENCE = \"PMID:22169974\", AUTHORS = \"Martin-Belmonte F, Perez-Moreno M\", TITLE = \"Epithelial cell polarity, stem cells and cancer.\", JOURNAL = c(\"Nat Rev Cancer 12:23-38 (2011)\", \"DOI:10.1038/nrc3169\")), list(REFERENCE = \"PMID:17525755\", AUTHORS = \"Weber C, Fraemohs L, Dejana E\", TITLE = \"The role of junctional adhesion molecules in vascular inflammation.\", JOURNAL = c(\"Nat Rev Immunol 7:467-77 (2007)\", \"DOI:10.1038/nri2096\")), list(REFERENCE = \"PMID:15820555\", AUTHORS = \"Miyoshi J, Takai Y\", TITLE = \"Molecular perspective on tight-junction assembly and epithelial polarity.\", JOURNAL = c(\"Adv Drug Deliv Rev 57:815-55 (2005)\", \"DOI:10.1016/j.addr.2005.01.008\")), list(REFERENCE = \"PMID:16650994\", AUTHORS = \"Mertens AE, Pegtel DM, Collard JG\", TITLE = \"Tiam1 takes PARt in cell polarity.\", JOURNAL = c(\"Trends Cell Biol 16:308-16 (2006)\", \"DOI:10.1016/j.tcb.2006.04.001\")), list(REFERENCE = \"PMID:16771626\", AUTHORS = \"Shin K, Fogg VC, Margolis B\", TITLE = \"Tight junctions and cell polarity.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 22:207-35 (2006)\", \"DOI:10.1146/annurev.cellbio.22.010305.104219\")), list(REFERENCE = \"PMID:17182900\", AUTHORS = \"Kooistra MR, Dube N, Bos JL\", TITLE = \"Rap1: a key regulator in cell-cell junction formation.\", JOURNAL = c(\"J Cell Sci 120:17-22 (2007)\", \"DOI:10.1242/jcs.03306\")), list(REFERENCE = \"PMID:17950242\", AUTHORS = \"Gonzalez-Mariscal L, Tapia R, Chamorro D\", TITLE = \"Crosstalk of tight junction components with signaling pathways.\", JOURNAL = c(\"Biochim Biophys Acta 1778:729-56 (2008)\", \"DOI:10.1016/j.bbamem.2007.08.018\")), list(REFERENCE = \"PMID:18005931\", AUTHORS = \"Assemat E, Bazellieres E, Pallesi-Pocachard E, Le Bivic A, Massey-Harroche D\", TITLE = \"Polarity complex proteins.\", JOURNAL = c(\"Biochim Biophys Acta 1778:614-30 (2008)\", \"DOI:10.1016/j.bbamem.2007.08.029\")), list(REFERENCE = \"PMID:18946474\", AUTHORS = \"Iden S, Collard JG\", TITLE = \"Crosstalk between small GTPases and polarity proteins in cell polarization.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 9:846-59 (2008)\", \"DOI:10.1038/nrm2521\")), list(REFERENCE = \"PMID:20094051\", AUTHORS = \"Rosse C, Linch M, Kermorgant S, Cameron AJ, Boeckeler K, Parker PJ\", TITLE = \"PKC and the control of localized signal dynamics.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 11:103-12 (2010)\", \"DOI:10.1038/nrm2847\")), list(REFERENCE = \"PMID:20134025\", AUTHORS = \"Terry S, Nie M, Matter K, Balda MS\", TITLE = \"Rho signaling and tight junction functions.\", JOURNAL = c(\"Physiology (Bethesda) 25:16-26 (2010)\", \"DOI:10.1152/physiol.00034.2009\")), list(REFERENCE = \"PMID:21283798\", AUTHORS = \"Russ PK, Pino CJ, Williams CS, Bader DM, Haselton FR, Chang MS\", TITLE = \"Bves modulates tight junction associated signaling.\", JOURNAL = c(\"PLoS One 6:e14563 (2011)\", \"DOI:10.1371/journal.pone.0014563\")), list(REFERENCE = \"PMID:21781017\", AUTHORS = \"Citi S, Spadaro D, Schneider Y, Stutz J, Pulimeno P\", TITLE = \"Regulation of small GTPases at epithelial cell-cell junctions.\", JOURNAL = c(\"Mol Membr Biol 28:427-44 (2011)\", \"DOI:10.3109/09687688.2011.603101\")), list(REFERENCE = \"PMID:22896795\", AUTHORS = \"Lickert H, Van Campenhout CA\", TITLE = \"Evolution of the Discs large gene family provides new insights into the establishment of apical epithelial polarity and the etiology of mental retardation.\", JOURNAL = c(\"Commun Integr Biol 5:287-90 (2012)\", \"DOI:10.4161/cib.19792\")), list(REFERENCE = \"PMID:22928510\", AUTHORS = \"Spadaro D, Tapia R, Pulimeno P, Citi S\", TITLE = \"The control of gene expression and cell proliferation by the epithelial apical junctional complex.\", JOURNAL = c(\"Essays Biochem 53:83-93 (2012)\", \"DOI:10.1042/bse0530083\")), list(REFERENCE = \"PMID:24548561\", AUTHORS = \"Moleirinho S, Guerrant W, Kissil JL\", TITLE = \"The Angiomotins--from discovery to function.\", JOURNAL = c(\"FEBS Lett 588:2693-703 (2014)\", \"DOI:10.1016/j.febslet.2014.02.006\")), list(REFERENCE = \"PMID:24651541\", AUTHORS = \"Rodriguez-Boulan E, Macara IG\", TITLE = \"Organization and execution of the epithelial polarity programme.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 15:225-42 (2014)\", \"DOI:10.1038/nrm3775\")), list(REFERENCE = \"PMID:25152334\", AUTHORS = \"Gonzalez-Mariscal L, Dominguez-Calderon A, Raya-Sandino A, Ortega-Olvera JM, Vargas-Sierra O, Martinez-Revollar G\", TITLE = \"Tight junctions and the regulation of gene expression.\", JOURNAL = c(\"Semin Cell Dev Biol 36:213-23 (2014)\", \"DOI:10.1016/j.semcdb.2014.08.009\")), list(REFERENCE = \"PMID:25469537\", AUTHORS = \"Mack NA, Georgiou M\", TITLE = \"The interdependence of the Rho GTPases and apicobasal cell polarity.\", JOURNAL = c(\"Small GTPases 5:10 (2014)\", \"DOI:10.4161/21541248.2014.973768\")), list(REFERENCE = \"PMID:25483301\", AUTHORS = \"Citi S, Guerrera D, Spadaro D, Shah J\", TITLE = \"Epithelial junctions and Rho family GTPases: the zonular signalosome.\", JOURNAL = c(\"Small GTPases 5:1-15 (2014)\", \"DOI:10.4161/21541248.2014.973760\")), list(REFERENCE = \"PMID:25757376\", AUTHORS = \"Zihni C, Terry SJ\", TITLE = \"RhoGTPase signalling at epithelial tight junctions: Bridging the GAP between polarity and cancer.\", JOURNAL = c(\"Int J Biochem Cell Biol 64:120-5 (2015)\", \"DOI:10.1016/j.biocel.2015.02.020\")), list(REFERENCE = \"PMID:22892070\", AUTHORS = \"Nakano A, Takashima S\", TITLE = \"LKB1 and AMP-activated protein kinase: regulators of cell polarity.\", JOURNAL = c(\"Genes Cells 17:737-47 (2012)\", \"DOI:10.1111/j.1365-2443.2012.01629.x\")), list(REFERENCE = \"PMID:12042308\", AUTHORS = \"Patrie KM, Drescher AJ, Welihinda A, Mundel P, Margolis B\", TITLE = \"Interaction of two actin-binding proteins, synaptopodin and alpha-actinin-4, with the tight junction protein MAGI-1.\", JOURNAL = c(\"J Biol Chem 277:30183-90 (2002)\", \"DOI:10.1074/jbc.M203072200\")), list(REFERENCE = \"PMID:18094055\", AUTHORS = \"Yamamura R, Nishimura N, Nakatsuji H, Arase S, Sasaki T\", TITLE = \"The interaction of JRAB/MICAL-L2 with Rab8 and Rab13 coordinates the assembly of tight junctions and adherens junctions.\", JOURNAL = c(\"Mol Biol Cell 19:971-83 (2008)\", \"DOI:10.1091/mbc.E07-06-0551\")), list(REFERENCE = \"PMID:23885123\", AUTHORS = \"Monteiro AC, Sumagin R, Rankin CR, Leoni G, Mina MJ, Reiter DM, Stehle T, Dermody TS, Schaefer SA, Hall RA, Nusrat A, Parkos CA\", TITLE = \"JAM-A associates with ZO-2, afadin, and PDZ-GEF1 to activate Rap2c and regulate epithelial barrier function.\", JOURNAL = c(\"Mol Biol Cell 24:2849-60 (2013)\", \"DOI:10.1091/mbc.E13-06-0298\"))', 'map04530', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (295, '04540', 'Gap junction', 'Gap junctions contain intercellular channels that allow direct communication between the cytosolic compartments of adjacent cells. Each gap junction channel is formed by docking of two \'hemichannels\', each containing six connexins, contributed by each neighboring cell. These channels permit the direct transfer of small molecules including ions, amino acids, nucleotides, second messengers and other metabolites between adjacent cells. Gap junctional communication is essential for many physiological events, including embryonic development, electrical coupling, metabolic transport, apoptosis, and tissue homeostasis. Communication through Gap Junction is sensitive to a variety of stimuli, including changes in the level of intracellular Ca2+, pH, transjunctional applied voltage and phosphorylation/dephosphorylation processes. This figure represents the possible activation routes of different protein kinases involved in Cx43 and Cx36 phosphorylation.', 'Cellular Processes; Cellular community - eukaryotes', 'Gap junction', 'Congenital fibrosis of the extraocular muscles, Syndactyly, Hypomagnesemia, Hypoplastic left heart syndrome', 'GO: 0005921', 'ko04540', 'list(REFERENCE = \"PMID:14506308\", AUTHORS = \"Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC.\", TITLE = \"Plasma membrane channels formed by connexins: their regulation and functions.\", JOURNAL = c(\"Physiol Rev 83:1359-400 (2003)\", \"DOI:10.1152/physrev.00007.2003\")), list(REFERENCE = \"PMID:15033580\", AUTHORS = \"Warn-Cramer BJ, Lau AF.\", TITLE = \"Regulation of gap junctions by tyrosine protein kinases.\", JOURNAL = c(\"Biochim Biophys Acta 1662:81-95 (2004)\", \"DOI:10.1016/j.bbamem.2003.10.018\")), list(REFERENCE = \"PMID:9535909\", AUTHORS = \"Warn-Cramer BJ, Cottrell GT, Burt JM, Lau AF.\", TITLE = \"Regulation of connexin-43 gap junctional intercellular communication by mitogen-activated protein kinase.\", JOURNAL = c(\"J Biol Chem 273:9188-96 (1998)\", \"DOI:10.1074/jbc.273.15.9188\")), list(REFERENCE = \"PMID:10751659\", AUTHORS = \"Roerig B, Feller MB.\", TITLE = \"Neurotransmitters and gap junctions in developing neural circuits.\", JOURNAL = c(\"Brain Res Brain Res Rev 32:86-114 (2000)\", \"DOI:10.1016/S0165-0173(99)00069-7\")), list(REFERENCE = \"PMID:10873290\", AUTHORS = \"Hatton GI.\", TITLE = \"Synaptic modulation of neuronal coupling.\", JOURNAL = c(\"Cell Biol Int 22:765-80 (1998)\", \"DOI:10.1006/cbir.1998.0386\")), list(REFERENCE = \"PMID:12566218\", AUTHORS = \"Cruciani V, Mikalsen SO.\", TITLE = \"Connexins, gap junctional intercellular communication and kinases.\", JOURNAL = c(\"Biol Cell 94:433-43 (2002)\", \"DOI:10.1016/S0248-4900(02)00014-X\")), list(REFERENCE = \"PMID:15094344\", AUTHORS = \"Giepmans BN.\", TITLE = \"Gap junctions and connexin-interacting proteins.\", JOURNAL = c(\"Cardiovasc Res 62:233-45 (2004)\", \"DOI:10.1016/j.cardiores.2003.12.009\")), list(REFERENCE = \"PMID:15955302\", AUTHORS = \"Laird DW.\", TITLE = \"Connexin phosphorylation as a regulatory event linked to gap junction internalization and degradation.\", JOURNAL = c(\"Biochim Biophys Acta 1711:172-82 (2005)\", \"DOI:10.1016/j.bbamem.2004.09.009\")), list(REFERENCE = \"PMID:15033579\", AUTHORS = \"Peracchia C.\", TITLE = \"Chemical gating of gap junction channels; roles of calcium, pH and calmodulin.\", JOURNAL = c(\"Biochim Biophys Acta 1662:61-80 (2004)\", \"DOI:10.1016/j.bbamem.2003.10.020\")), list(REFERENCE = \"PMID:15033578\", AUTHORS = \"Bukauskas FF, Verselis VK.\", TITLE = \"Gap junction channel gating.\", JOURNAL = c(\"Biochim Biophys Acta 1662:42-60 (2004)\", \"DOI:10.1016/j.bbamem.2004.01.008\"))', 'map04540', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (296, '04550', 'Signaling pathways regulating pluripotency of stem cells', 'Pluripotent stem cells (PSCs) are basic cells with an indefinite self-renewal capacity and the potential to generate all the cell types of the three germinal layers. The types of PSCs known to date include embryonic stem (ES) and induced pluripotent stem (iPS) cells. ES cells are derived from the inner cell mass (ICM) of blastocyst-stage embryos. iPS cells are generated by reprogramming somatic cells back to pluripotent state with defined reprogramming factors, Oct4, Sox2, Klf4 and c-Myc (also known as Yamanaka factors). PSCs including ES cells and iPS cells are categorized into two groups by their morphology, gene expression profile and external signal dependence. Conventional mouse-type ES/iPS cells are called \'naive state\' cells. They are mainly maintained under the control of LIF and BMP signaling. On the other hand, human-type ES/iPS cells, which are in need of Activin and FGF signaling, are termed \'primed state\'. However, these signaling pathways converge towards the activation of a core transcriptional network that is similar in both groups and involves OCt4, Nanog and Sox2. The three transcription factors and their downstream target genes coordinately promote self-renewal and pluripotency.', 'Cellular Processes; Cellular community - eukaryotes', 'Signaling pathways regulating pluripotency of stem cells', 'Myelodysplastic syndrome, Hereditary congenital facial paresis, Adermatoglyphia, Basan syndrome', 'GO: 2000036', 'ko04550', 'list(REFERENCE = \"\", AUTHORS = \"Bhartiya D, Lenka N (ed).\", TITLE = \"Pluripotent Stem Cells\", JOURNAL = c(\"InTech (2013)\", \"DOI:10.5772/45917\")), list(REFERENCE = \"PMID:24147644\", AUTHORS = \"Hassani SN, Totonchi M, Gourabi H, Scholer HR, Baharvand H\", TITLE = \"Signaling roadmap modulating naive and primed pluripotency.\", JOURNAL = c(\"Stem Cells Dev 23:193-208 (2014)\", \"DOI:10.1089/scd.2013.0368\")), list(REFERENCE = \"PMID:18295576\", AUTHORS = \"Jaenisch R, Young R\", TITLE = \"Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.\", JOURNAL = c(\"Cell 132:567-82 (2008)\", \"DOI:10.1016/j.cell.2008.01.015\")), list(REFERENCE = \"PMID:17647265\", AUTHORS = \"Zhang H, Wang ZZ\", TITLE = \"Mechanisms that mediate stem cell self-renewal and differentiation.\", JOURNAL = c(\"J Cell Biochem 103:709-18 (2008)\", \"DOI:10.1002/jcb.21460\")), list(REFERENCE = \"PMID:24910449\", AUTHORS = \"Itoh F, Watabe T, Miyazono K\", TITLE = \"Roles of TGF-beta family signals in the fate determination of pluripotent stem cells.\", JOURNAL = c(\"Semin Cell Dev Biol 32C:98-106 (2014)\", \"DOI:10.1016/j.semcdb.2014.05.017\")), list(REFERENCE = \"PMID:23653415\", AUTHORS = \"Saunders A, Faiola F, Wang J\", TITLE = \"Concise review: pursuing self-renewal and pluripotency with the stem cell factor Nanog.\", JOURNAL = c(\"Stem Cells 31:1227-36 (2013)\", \"DOI:10.1002/stem.1384\")), list(REFERENCE = \"PMID:20705693\", AUTHORS = \"Kuijk EW, Chuva de Sousa Lopes SM, Geijsen N, Macklon N, Roelen BA\", TITLE = \"The different shades of mammalian pluripotent stem cells.\", JOURNAL = c(\"Hum Reprod Update 17:254-71 (2011)\", \"DOI:10.1093/humupd/dmq035\")), list(REFERENCE = \"PMID:18220859\", AUTHORS = \"Okita K, Yamanaka S\", TITLE = \"Intracellular signaling pathways regulating pluripotency of embryonic stem cells.\", JOURNAL = c(\"Curr Stem Cell Res Ther 1:103-11 (2006)\", \"DOI:10.2174/157488806775269061\")), list(REFERENCE = \"PMID:19571885\", AUTHORS = \"Niwa H, Ogawa K, Shimosato D, Adachi K\", TITLE = \"A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells.\", JOURNAL = c(\"Nature 460:118-22 (2009)\", \"DOI:10.1038/nature08113\")), list(REFERENCE = \"PMID:23370346\", AUTHORS = \"Nakai-Futatsugi Y, Niwa H\", TITLE = \"Transcription factor network in embryonic stem cells: heterogeneity under the stringency.\", JOURNAL = c(\"Biol Pharm Bull 36:166-70 (2013)\", \"DOI:10.1248/bpb.b12-00958\")), list(REFERENCE = \"PMID:22649650\", AUTHORS = \"Medvedev SP, Shevchenko AI, Zakian SM\", TITLE = \"Molecular basis of Mammalian embryonic stem cell pluripotency and self-renewal.\", JOURNAL = \"Acta Naturae 2:30-46 (2010)\"), list(REFERENCE = \"PMID:19551525\", AUTHORS = \"Scheper W, Copray S\", TITLE = \"The molecular mechanism of induced pluripotency: a two-stage switch.\", JOURNAL = c(\"Stem Cell Rev 5:204-23 (2009)\", \"DOI:10.1007/s12015-009-9077-x\")), list(REFERENCE = \"PMID:16153702\", AUTHORS = \"Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA\", TITLE = \"Core transcriptional regulatory circuitry in human embryonic stem cells.\", JOURNAL = c(\"Cell 122:947-56 (2005)\", \"DOI:10.1016/j.cell.2005.08.020\")), list(REFERENCE = \"PMID:24315442\", AUTHORS = \"Wang L, Miao YL, Zheng X, Lackford B, Zhou B, Han L, Yao C, Ward JM, Burkholder A, Lipchina I, Fargo DC, Hochedlinger K, Shi Y, Williams CJ, Hu G\", TITLE = \"The THO complex regulates pluripotency gene mRNA export and controls embryonic stem cell self-renewal and somatic cell reprogramming.\", JOURNAL = c(\"Cell Stem Cell 13:676-90 (2013)\", \"DOI:10.1016/j.stem.2013.10.008\")), list(REFERENCE = \"PMID:24957798\", AUTHORS = \"Hasegawa Y, Tang D, Takahashi N, Hayashizaki Y, Forrest AR, Suzuki H\", TITLE = \"CCL2 enhances pluripotency of human induced pluripotent stem cells by activating hypoxia related genes.\", JOURNAL = c(\"Sci Rep 4:5228 (2014)\", \"DOI:10.1038/srep05228\")), list(REFERENCE = \"PMID:23585347\", AUTHORS = \"Sui L, Bouwens L, Mfopou JK\", TITLE = \"Signaling pathways during maintenance and definitive endoderm differentiation of embryonic stem cells.\", JOURNAL = c(\"Int J Dev Biol 57:1-12 (2013)\", \"DOI:10.1387/ijdb.120115ls\")), list(REFERENCE = \"PMID:19427042\", AUTHORS = \"Do JT, Scholer HR\", TITLE = \"Regulatory circuits underlying pluripotency and reprogramming.\", JOURNAL = c(\"Trends Pharmacol Sci 30:296-302 (2009)\", \"DOI:10.1016/j.tips.2009.03.003\")), list(REFERENCE = \"PMID:17211451\", AUTHORS = \"Pan G, Thomson JA\", TITLE = \"Nanog and transcriptional networks in embryonic stem cell pluripotency.\", JOURNAL = c(\"Cell Res 17:42-9 (2007)\", \"DOI:10.1038/sj.cr.7310125\")), list(REFERENCE = \"PMID:16518401\", AUTHORS = \"Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH\", TITLE = \"The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells.\", JOURNAL = c(\"Nat Genet 38:431-40 (2006)\", \"DOI:10.1038/ng1760\")), list(REFERENCE = \"PMID:18414030\", AUTHORS = \"Loh YH, Ng JH, Ng HH\", TITLE = \"Molecular framework underlying pluripotency.\", JOURNAL = c(\"Cell Cycle 7:885-91 (2008)\", \"DOI:10.4161/cc.7.7.5636\")), list(REFERENCE = \"PMID:22298652\", AUTHORS = \"Greenow K, Clarke AR\", TITLE = \"Controlling the stem cell compartment and regeneration in vivo: the role of pluripotency pathways.\", JOURNAL = c(\"Physiol Rev 92:75-99 (2012)\", \"DOI:10.1152/physrev.00040.2010\"))', 'map04550', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (297, '04610', 'Complement and coagulation cascades', 'The complement system is a proteolytic cascade in blood plasma and a mediator of innate immunity, a nonspecific defense mechanism against pathogens. There are three pathways of complement activation: the classical pathway, the lectin pathway, and the alternative pathway. All of these pathways generate a crucial enzymatic activity that, in turn, generates the effector molecules of complement. The main consequences of complement activation are the opsonization of pathogens, the recruitment of inflammatory and immunocompetent cells, and the direct killing of pathogens. Blood coagulation is another series of proenzyme-to-serine protease conversions, culminating the formation of thrombin, the enzyme responsible for the conversion of soluble fibrinogen to the insoluble fibrin clot. Protease-activated receptors, such as those activated by thrombin, are members of G protein-coupled receptors and function as a mediator of innate immunity. The kallikrein-kinin system is an endogenous metabolic cascade, triggering of which results in the release of vasoactive kinins (bradykinin-related peptides). Kinin peptides are implicated in many physiological and pathological processes including the regulation of blood pressure and sodium homeostasis, inflammatory processes, and the cardioprotective effects of preconditioning.', 'Organismal Systems; Immune system', 'Complement and coagulation cascades', 'Classic complement pathway component defects, Late complement pathway defects, Alternative complement pathway component defects, Mannose-binding lectin pathway component defects, Complement regulatory protein defects, Hemophilia, Factor V deficiency, Afibrinogenemia, Inherited thrombophilia, Age-related macular degeneration, Factor XI deficiency, Factor XII deficiency, Factor XIII deficiency, Alpha-2-plasmin inhibitor (a2-PI) deficiency, Hereditary angioedema, Fletcher factor deficiency, Alpha-1-antitrypsin deficiency, Plasminogen activator inhibitor type 1 deficiency, Plasminogen deficiency, Congenital prothrombin deficiency, Antithrombin III deficiency, Atypical hemolytic uremic syndrome, Membranoproliferative glomerulonephritis, 3MC syndrome, von Willebrand disease, Basal laminar drusen, Ehlers-Danlos syndrome periodontal type, Factor VII deficiency, Factor X deficiency', 'ko04610', 'list(REFERENCE = \"PMID:26489954\", AUTHORS = \"Bajic G, Degn SE, Thiel S, Andersen GR\", TITLE = \"Complement activation, regulation, and molecular basis for complement-related diseases.\", JOURNAL = c(\"EMBO J 34:2735-57 (2015)\", \"DOI:10.15252/embj.201591881\")), list(REFERENCE = \"PMID:25568220\", AUTHORS = \"Mathern DR, Heeger PS\", TITLE = \"Molecules Great and Small: The Complement System.\", JOURNAL = c(\"Clin J Am Soc Nephrol 10:1636-50 (2015)\", \"DOI:10.2215/CJN.06230614\")), list(REFERENCE = \"PMID:26082779\", AUTHORS = \"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT\", TITLE = \"Complement System Part I - Molecular Mechanisms of Activation and Regulation.\", JOURNAL = c(\"Front Immunol 6:262 (2015)\", \"DOI:10.3389/fimmu.2015.00262\")), list(REFERENCE = \"PMID:21811895\", AUTHORS = \"Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD\", TITLE = \"Interactions between coagulation and complement--their role in inflammation.\", JOURNAL = c(\"Semin Immunopathol 34:151-65 (2012)\", \"DOI:10.1007/s00281-011-0280-x\")), list(REFERENCE = \"PMID:25705421\", AUTHORS = \"Kurosawa S, Stearns-Kurosawa DJ\", TITLE = \"Complement, thrombotic microangiopathy and disseminated intravascular coagulation.\", JOURNAL = c(\"J Intensive Care 2:65 (2014)\", \"DOI:10.1186/s40560-014-0061-4\")), list(REFERENCE = \"PMID:23110467\", AUTHORS = \"Hillmeister P, Persson PB\", TITLE = \"The Kallikrein-Kinin system.\", JOURNAL = c(\"Acta Physiol (Oxf) 206:215-9 (2012)\", \"DOI:10.1111/apha.12007\")), list(REFERENCE = \"PMID:17635716\", AUTHORS = \"Rau JC, Beaulieu LM, Huntington JA, Church FC\", TITLE = \"Serpins in thrombosis, hemostasis and fibrinolysis.\", JOURNAL = c(\"J Thromb Haemost 5 Suppl 1:102-15 (2007)\", \"DOI:10.1111/j.1538-7836.2007.02516.x\")), list(REFERENCE = \"PMID:26324800\", AUTHORS = \"Crooks MG, Hart SP\", TITLE = \"Coagulation and anticoagulation in idiopathic pulmonary fibrosis.\", JOURNAL = c(\"Eur Respir Rev 24:392-9 (2015)\", \"DOI:10.1183/16000617.00008414\")), list(REFERENCE = \"PMID:23911436\", AUTHORS = \"Christiaans SC, Wagener BM, Esmon CT, Pittet JF\", TITLE = \"Protein C and acute inflammation: a clinical and biological perspective.\", JOURNAL = c(\"Am J Physiol Lung Cell Mol Physiol 305:L455-66 (2013)\", \"DOI:10.1152/ajplung.00093.2013\")), list(REFERENCE = \"PMID:24924409\", AUTHORS = \"Alberelli MA, De Candia E\", TITLE = \"Functional role of protease activated receptors in vascular biology.\", JOURNAL = c(\"Vascul Pharmacol 62:72-81 (2014)\", \"DOI:10.1016/j.vph.2014.06.001\")), list(REFERENCE = \"PMID:20027185\", AUTHORS = \"Smith HW, Marshall CJ\", TITLE = \"Regulation of cell signalling by uPAR.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 11:23-36 (2010)\", \"DOI:10.1038/nrm2821\")), list(REFERENCE = \"PMID:23564577\", AUTHORS = \"Ricklin D, Lambris JD\", TITLE = \"Complement in immune and inflammatory disorders: pathophysiological mechanisms.\", JOURNAL = c(\"J Immunol 190:3831-8 (2013)\", \"DOI:10.4049/jimmunol.1203487\")), list(REFERENCE = \"PMID:23564578\", AUTHORS = \"Ricklin D, Lambris JD\", TITLE = \"Complement in immune and inflammatory disorders: therapeutic interventions.\", JOURNAL = c(\"J Immunol 190:3839-47 (2013)\", \"DOI:10.4049/jimmunol.1203200\")), list(REFERENCE = \"PMID:25309880\", AUTHORS = \"Loof TG, Deicke C, Medina E\", TITLE = \"The role of coagulation/fibrinolysis during Streptococcus pyogenes infection.\", JOURNAL = c(\"Front Cell Infect Microbiol 4:128 (2014)\", \"DOI:10.3389/fcimb.2014.00128\"))', 'map04610', 'Complement and coagulation cascades', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (298, '04611', 'Platelet activation', 'Platelets play a key and beneficial role for primary hemostasis on the disruption of the integrity of vessel wall. Platelet adhesion and activation at sites of vascular wall injury is initiated by adhesion to adhesive macromolecules, such as collagen and von Willebrand factor (vWF), or by soluble platelet agonists, such as ADP, thrombin, and thromboxane A2. Different receptors are stimulated by various agonists, almost converging in increasing intracellular Ca2+ concentration that stimulate platelet shape change and granule secretion and ultimately induce the \"inside-out\" signaling process leading to activation of the ligand-binding function of integrin alpha IIb beta 3. Binding of alpha IIb beta 3 to its ligands, mainly fibrinogen, mediates platelet adhesion and aggregation and triggers \"outside-in\" signaling, resulting in platelet spreading, additional granule secretion, stabilization of platelet adhesion and aggregation, and clot retraction.', 'Organismal Systems; Immune system', 'Platelet activation', 'Macrothrombocytopenia, von Willebrand disease, Platelet-type von Willebrand disease, Noonan-like syndrome with loose anagen hair, Tubular aggregate myopathy, Stormorken syndrome', 'GO: 0030168', 'ko04611', 'list(REFERENCE = \"PMID:21071698\", AUTHORS = \"Li Z, Delaney MK, O\'Brien KA, Du X\", TITLE = \"Signaling during platelet adhesion and activation.\", JOURNAL = c(\"Arterioscler Thromb Vasc Biol 30:2341-9 (2010)\", \"DOI:10.1161/ATVBAHA.110.207522\")), list(REFERENCE = \"PMID:22119499\", AUTHORS = \"Broos K, De Meyer SF, Feys HB, Vanhoorelbeke K, Deckmyn H\", TITLE = \"Blood platelet biochemistry.\", JOURNAL = c(\"Thromb Res 129:245-9 (2012)\", \"DOI:10.1016/j.thromres.2011.11.002\")), list(REFERENCE = \"PMID:16149014\", AUTHORS = \"Jurk K, Kehrel BE\", TITLE = \"Platelets: physiology and biochemistry.\", JOURNAL = c(\"Semin Thromb Hemost 31:381-92 (2005)\", \"DOI:10.1055/s-2005-916671\")), list(REFERENCE = \"PMID:17158345\", AUTHORS = \"Offermanns S\", TITLE = \"Activation of platelet function through G protein-coupled receptors.\", JOURNAL = c(\"Circ Res 99:1293-304 (2006)\", \"DOI:10.1161/01.RES.0000251742.71301.16\")), list(REFERENCE = \"PMID:18174460\", AUTHORS = \"Varga-Szabo D, Pleines I, Nieswandt B\", TITLE = \"Cell adhesion mechanisms in platelets.\", JOURNAL = c(\"Arterioscler Thromb Vasc Biol 28:403-12 (2008)\", \"DOI:10.1161/ATVBAHA.107.150474\")), list(REFERENCE = \"PMID:18550847\", AUTHORS = \"Yin H, Liu J, Li Z, Berndt MC, Lowell CA, Du X\", TITLE = \"Src family tyrosine kinase Lyn mediates VWF/GPIb-IX-induced platelet activation via the cGMP signaling pathway.\", JOURNAL = c(\"Blood 112:1139-46 (2008)\", \"DOI:10.1182/blood-2008-02-140970\")), list(REFERENCE = \"PMID:19630797\", AUTHORS = \"Bergmeier W, Stefanini L\", TITLE = \"Novel molecules in calcium signaling in platelets.\", JOURNAL = c(\"J Thromb Haemost 7 Suppl 1:187-90 (2009)\", \"DOI:10.1111/j.1538-7836.2009.03379.x\")), list(REFERENCE = \"PMID:18544684\", AUTHORS = \"Cifuni SM, Wagner DD, Bergmeier W\", TITLE = \"CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets.\", JOURNAL = c(\"Blood 112:1696-703 (2008)\", \"DOI:10.1182/blood-2008-02-139733\")), list(REFERENCE = \"PMID:23106920\", AUTHORS = \"Heemskerk JW, Mattheij NJ, Cosemans JM\", TITLE = \"Platelet-based coagulation: different populations, different functions.\", JOURNAL = c(\"J Thromb Haemost 11:2-16 (2013)\", \"DOI:10.1111/jth.12045\")), list(REFERENCE = \"PMID:19286885\", AUTHORS = \"Rivera J, Lozano ML, Navarro-Nunez L, Vicente V\", TITLE = \"Platelet receptors and signaling in the dynamics of thrombus formation.\", JOURNAL = c(\"Haematologica 94:700-11 (2009)\", \"DOI:10.3324/haematol.2008.003178\")), list(REFERENCE = \"PMID:18363565\", AUTHORS = \"Banno A, Ginsberg MH\", TITLE = \"Integrin activation.\", JOURNAL = c(\"Biochem Soc Trans 36:229-34 (2008)\", \"DOI:10.1042/BST0360229\")), list(REFERENCE = \"PMID:20089227\", AUTHORS = \"Angiolillo DJ, Ferreiro JL\", TITLE = \"Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions.\", JOURNAL = \"Rev Esp Cardiol 63:60-76 (2010)\"), list(REFERENCE = \"PMID:22701130\", AUTHORS = \"Joo SJ\", TITLE = \"Mechanisms of Platelet Activation and Integrin alphaIIbeta3.\", JOURNAL = c(\"Korean Circ J 42:295-301 (2012)\", \"DOI:10.4070/kcj.2012.42.5.295\")), list(REFERENCE = \"PMID:20002545\", AUTHORS = \"Harper MT, Poole AW\", TITLE = \"Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation.\", JOURNAL = c(\"J Thromb Haemost 8:454-62 (2010)\", \"DOI:10.1111/j.1538-7836.2009.03722.x\")), list(REFERENCE = \"PMID:23805129\", AUTHORS = \"Fitch-Tewfik JL, Flaumenhaft R\", TITLE = \"Platelet granule exocytosis: a comparison with chromaffin cells.\", JOURNAL = c(\"Front Endocrinol (Lausanne) 4:77 (2013)\", \"DOI:10.3389/fendo.2013.00077\")), list(REFERENCE = \"PMID:18641368\", AUTHORS = \"Boylan B, Gao C, Rathore V, Gill JC, Newman DK, Newman PJ\", TITLE = \"Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.\", JOURNAL = c(\"Blood 112:2780-6 (2008)\", \"DOI:10.1182/blood-2008-02-142125\"))', 'map04611', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (299, '04612', 'Antigen processing and presentation', 'Organismal Systems; Immune system', 'Antigen processing and presentation', 'Leprosy, Lysosomal cysteine protease deficiencies, Tropical calcific pancreatitis, Bare lymphocyte syndrome type1, Bare lymphocyte syndrome type2, Aplastic anemia, Inflammatory bowel disease (IBD), Hypercatabolic hypoproteinemia, Ankylosing spondylitis', 'GO: 0019885 0019886 0042591', 'ko04612', 'list(REFERENCE = \"PMID:15771591\", AUTHORS = \"Trombetta ES, Mellman I.\", TITLE = \"Cell biology of antigen processing in vitro and in vivo.\", JOURNAL = c(\"Annu Rev Immunol 23:975-1028 (2005)\", \"DOI:10.1146/annurev.immunol.22.012703.104538\")), list(REFERENCE = \"PMID:15814328\", AUTHORS = \"Inaba K, Inaba M.\", TITLE = \"Antigen recognition and presentation by dendritic cells.\", JOURNAL = c(\"Int J Hematol 81:181-7 (2005)\", \"DOI:10.1532/IJH97.04200\")), list(REFERENCE = \"PMID:11905820\", AUTHORS = \"Heath WR, Carbone FR.\", TITLE = \"Cross-presentation in viral immunity and self-tolerance.\", JOURNAL = c(\"Nat Rev Immunol 1:126-34 (2001)\", \"DOI:10.1038/35100512\")), list(REFERENCE = \"PMID:15304636\", AUTHORS = \"Abele R, Tampe R.\", TITLE = \"The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing.\", JOURNAL = c(\"Physiology (Bethesda) 19:216-24 (2004)\", \"DOI:10.1152/physiol.00002.2004\")), list(REFERENCE = \"PMID:16200082\", AUTHORS = \"Reith W, LeibundGut-Landmann S, Waldburger JM.\", TITLE = \"Regulation of MHC class II gene expression by the class II transactivator.\", JOURNAL = c(\"Nat Rev Immunol 5:793-806 (2005)\", \"DOI:10.1038/nri1708\")), list(REFERENCE = \"PMID:12776207\", AUTHORS = \"Honey K, Rudensky AY.\", TITLE = \"Lysosomal cysteine proteases regulate antigen presentation.\", JOURNAL = c(\"Nat Rev Immunol 3:472-82 (2003)\", \"DOI:10.1038/nri1110\")), list(REFERENCE = \"PMID:12974477\", AUTHORS = \"Sercarz EE, Maverakis E.\", TITLE = \"Mhc-guided processing: binding of large antigen fragments.\", JOURNAL = c(\"Nat Rev Immunol 3:621-9 (2003)\", \"DOI:10.1038/nri1149\")), list(REFERENCE = \"PMID:15224093\", AUTHORS = \"Ackerman AL, Cresswell P.\", TITLE = \"Cellular mechanisms governing cross-presentation of exogenous antigens.\", JOURNAL = c(\"Nat Immunol 5:678-84 (2004)\", \"DOI:10.1038/ni1082\")), list(REFERENCE = \"PMID:16181333\", AUTHORS = \"Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA.\", TITLE = \"Mechanisms of MHC class I-restricted antigen processing and cross-presentation.\", JOURNAL = c(\"Immunol Rev 207:145-57 (2005)\", \"DOI:10.1111/j.0105-2896.2005.00316.x\")), list(REFERENCE = \"PMID:15653312\", AUTHORS = \"Zika E, Ting JP.\", TITLE = \"Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes.\", JOURNAL = c(\"Curr Opin Immunol 17:58-64 (2005)\", \"DOI:10.1016/j.coi.2004.11.008\")), list(REFERENCE = \"PMID:11244040\", AUTHORS = \"Reith W, Mach B.\", TITLE = \"The bare lymphocyte syndrome and the regulation of MHC expression.\", JOURNAL = c(\"Annu Rev Immunol 19:331-73 (2001)\", \"DOI:10.1146/annurev.immunol.19.1.331\")), list(REFERENCE = \"PMID:15745856\", AUTHORS = \"Lizee G, Basha G, Jefferies WA.\", TITLE = \"Tails of wonder: endocytic-sorting motifs key for exogenous antigen presentation.\", JOURNAL = c(\"Trends Immunol 26:141-9 (2005)\", \"DOI:10.1016/j.it.2005.01.005\")), list(REFERENCE = \"PMID:15224094\", AUTHORS = \"Watts C.\", TITLE = \"The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.\", JOURNAL = c(\"Nat Immunol 5:685-92 (2004)\", \"DOI:10.1038/ni1088\")), list(REFERENCE = \"PMID:15653315\", AUTHORS = \"Kaufmann SH, Schaible UE.\", TITLE = \"Antigen presentation and recognition in bacterial infections.\", JOURNAL = c(\"Curr Opin Immunol 17:79-87 (2005)\", \"DOI:10.1016/j.coi.2004.12.004\")), list(REFERENCE = \"PMID:20010787\", AUTHORS = \"Groettrup M, Kirk CJ, Basler M\", TITLE = \"Proteasomes in immune cells: more than peptide producers?\", JOURNAL = c(\"Nat Rev Immunol 10:73-8 (2010)\", \"DOI:10.1038/nri2687\"))', 'map04612', 'Antigen processing and presentation', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (300, '04614', 'Renin-angiotensin system', 'The renin-angiotensin system (RAS) is a peptidergic system with endocrine characteristics regarding to the regulation of the blood pressure and hydro-electrolytic balance. In the classical RAS, the enzyme renin cleaves its substrate angiotensinogen (Agt) forming the decapeptide angiotensin I that is in turn cleaved by angiotensin-converting enzyme (ACE) to produce the angiotensin II (Ang II), a key player of this system. Ang II activates its AT1 receptor (AT1R), the principal receptor that mediates the majority of the known actions of Ang II in the kidney, including vasoconstriction, renal sodium (Na+) reabsorption, and aldosterone secretion, increasing blood pressure and contributing to the development of hypertension. In addition to (ACE)/Ang II/AT1R and AT2R axis, other signaling pathways in the RAS, such as ACE2/angiotensin-(1-7)/Mas and Ang IV/IRAP, and other active peptide of the RAS, with physiological relevance as Ang III, Ang A and alamandine, are now widely recognized.', 'Organismal Systems; Endocrine system', 'Renin-angiotensin system', 'Autosomal dominant tubulointerstitial kidney disease, Renal tubular dysgenesis, Diabetic nephropathy, Diabetic retinopathy, Familial juvenile hyperuricemic nephropathy', 'GO: 0002003', 'ko04614', 'list(REFERENCE = \"PMID:17229979\", AUTHORS = \"Kramkowski K, Mogielnicki A, Buczko W.\", TITLE = \"The physiological significance of the alternative pathways of angiotensin II production.\", JOURNAL = \"J Physiol Pharmacol 57:529-39 (2006)\"), list(REFERENCE = \"PMID:15549172\", AUTHORS = \"Danilczyk U, Eriksson U, Oudit GY, Penninger JM.\", TITLE = \"Physiological roles of angiotensin-converting enzyme 2.\", JOURNAL = c(\"Cell Mol Life Sci 61:2714-9 (2004)\", \"DOI:10.1007/s00018-004-4241-6\")), list(REFERENCE = \"PMID:15549171\", AUTHORS = \"Warner FJ, Smith AI, Hooper NM, Turner AJ.\", TITLE = \"Angiotensin-converting enzyme-2: a molecular and cellular perspective.\", JOURNAL = c(\"Cell Mol Life Sci 61:2704-13 (2004)\", \"DOI:10.1007/s00018-004-4240-7\")), list(REFERENCE = \"PMID:15833268\", AUTHORS = \"Kurdi M, De Mello WC, Booz GW.\", TITLE = \"Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.\", JOURNAL = c(\"Int J Biochem Cell Biol 37:1357-67 (2005)\", \"DOI:10.1016/j.biocel.2005.01.012\")), list(REFERENCE = \"PMID:15109615\", AUTHORS = \"Burrell LM, Johnston CI, Tikellis C, Cooper ME.\", TITLE = \"ACE2, a new regulator of the renin-angiotensin system.\", JOURNAL = c(\"Trends Endocrinol Metab 15:166-9 (2004)\", \"DOI:10.1016/j.tem.2004.03.001\")), list(REFERENCE = \"PMID:16555051\", AUTHORS = \"von Bohlen und Halbach O, Albrecht D.\", TITLE = \"The CNS renin-angiotensin system.\", JOURNAL = c(\"Cell Tissue Res 326:599-616 (2006)\", \"DOI:10.1007/s00441-006-0190-8\")), list(REFERENCE = \"PMID:12793984\", AUTHORS = \"Schmaier AH\", TITLE = \"The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.\", JOURNAL = c(\"Am J Physiol Regul Integr Comp Physiol 285:R1-13 (2003)\", \"DOI:10.1152/ajpregu.00535.2002\")), list(REFERENCE = \"PMID:12419208\", AUTHORS = \"Eriksson U, Danilczyk U, Penninger JM.\", TITLE = \"Just the beginning: novel functions for angiotensin-converting enzymes.\", JOURNAL = c(\"Curr Biol 12:R745-52 (2002)\", \"DOI:10.1016/S0960-9822(02)01255-1\")), list(REFERENCE = \"PMID:16286563\", AUTHORS = \"Dielis AW, Smid M, Spronk HM, Hamulyak K, Kroon AA, ten Cate H, de Leeuw PW.\", TITLE = \"The prothrombotic paradox of hypertension: role of the renin-angiotensin and kallikrein-kinin systems.\", JOURNAL = c(\"Hypertension 46:1236-42 (2005)\", \"DOI:10.1161/01.HYP.0000193538.20705.23\")), list(REFERENCE = \"PMID:16581295\", AUTHORS = \"Kuba K, Imai Y, Penninger JM.\", TITLE = \"Angiotensin-converting enzyme 2 in lung diseases.\", JOURNAL = c(\"Curr Opin Pharmacol 6:271-6 (2006)\", \"DOI:10.1016/j.coph.2006.03.001\")), list(REFERENCE = \"PMID:12505055\", AUTHORS = \"Erdos EG, Jackman HL, Brovkovych V, Tan F, Deddish PA.\", TITLE = \"Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin.\", JOURNAL = c(\"J Mol Cell Cardiol 34:1569-76 (2002)\", \"DOI:10.1006/jmcc.2002.2080\")), list(REFERENCE = \"PMID:12372844\", AUTHORS = \"Shrimpton CN, Smith AI, Lew RA.\", TITLE = \"Soluble metalloendopeptidases and neuroendocrine signaling.\", JOURNAL = c(\"Endocr Rev 23:647-64 (2002)\", \"DOI:10.1210/er.2001-0032\")), list(REFERENCE = \"PMID:12019279\", AUTHORS = \"Jackman HL, Massad MG, Sekosan M, Tan F, Brovkovych V, Marcic BM, Erdos EG.\", TITLE = \"Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A.\", JOURNAL = c(\"Hypertension 39:976-81 (2002)\", \"DOI:10.1161/01.HYP.0000017283.67962.02\")), list(REFERENCE = \"PMID:15173164\", AUTHORS = \"Lundequist A, Tchougounova E, Abrink M, Pejler G.\", TITLE = \"Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II.\", JOURNAL = c(\"J Biol Chem 279:32339-44 (2004)\", \"DOI:10.1074/jbc.M405576200\")), list(REFERENCE = \"PMID:17362841\", AUTHORS = \"Kehoe PG, Wilcock GK.\", TITLE = \"Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer\'s disease?\", JOURNAL = c(\"Lancet Neurol 6:373-8 (2007)\", \"DOI:10.1016/S1474-4422(07)70077-7\")), list(REFERENCE = \"PMID:25332897\", AUTHORS = \"Ferrao FM, Lara LS, Lowe J\", TITLE = \"Renin-angiotensin system in the kidney: What is new?\", JOURNAL = c(\"World J Nephrol 3:64-76 (2014)\", \"DOI:10.5527/wjn.v3.i3.64\")), list(REFERENCE = \"PMID:24273531\", AUTHORS = \"Zhuo JL, Ferrao FM, Zheng Y, Li XC\", TITLE = \"New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms.\", JOURNAL = c(\"Front Endocrinol (Lausanne) 4:166 (2013)\", \"DOI:10.3389/fendo.2013.00166\")), list(REFERENCE = \"PMID:21951628\", AUTHORS = \"Unger T, Paulis L, Sica DA\", TITLE = \"Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.\", JOURNAL = c(\"Eur Heart J 32:2739-47 (2011)\", \"DOI:10.1093/eurheartj/ehr253\")), list(REFERENCE = \"PMID:18793332\", AUTHORS = \"Fyhrquist F, Saijonmaa O\", TITLE = \"Renin-angiotensin system revisited.\", JOURNAL = c(\"J Intern Med 264:224-36 (2008)\", \"DOI:10.1111/j.1365-2796.2008.01981.x\")), list(REFERENCE = \"PMID:23692861\", AUTHORS = \"Yugandhar VG, Clark MA\", TITLE = \"Angiotensin III: a physiological relevant peptide of the renin angiotensin system.\", JOURNAL = c(\"Peptides 46:26-32 (2013)\", \"DOI:10.1016/j.peptides.2013.04.014\")), list(REFERENCE = \"PMID:24760442\", AUTHORS = \"Etelvino GM, Peluso AA, Santos RA\", TITLE = \"New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D.\", JOURNAL = c(\"Curr Hypertens Rep 16:433 (2014)\", \"DOI:10.1007/s11906-014-0433-0\"))', 'map04614', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (301, '04620', 'Toll-like receptor signaling pathway', 'Specific families of pattern recognition receptors are responsible for detecting microbial pathogens and generating innate immune responses. Toll-like receptors (TLRs) are membrane-bound receptors identified as homologs of Toll in Drosophila. Mammalian TLRs are expressed on innate immune cells, such as macrophages and dendritic cells, and respond to the membrane components of Gram-positive or Gram-negative bacteria. Pathogen recognition by TLRs provokes rapid activation of innate immunity by inducing production of proinflammatory cytokines and upregulation of costimulatory molecules. TLR signaling pathways are separated into two groups: a MyD88-dependent pathway that leads to the production of proinflammatory cytokines with quick activation of NF-{kappa}B and MAPK, and a MyD88-independent pathway associated with the induction of IFN-beta and IFN-inducible genes, and maturation of dendritic cells with slow activation of NF-{kappa}B and MAPK.', 'Organismal Systems; Immune system', 'Toll-like receptor signaling pathway', 'Defects of toll-like receptor signaling, Pycnodysostosis, Leprosy, Lysosomal cysteine protease deficiencies, Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, Cocoon syndrome, Chronic mucocutaneous candidiasis, Sjogren syndrome', 'ko04620', 'list(REFERENCE = \"PMID:17275323\", AUTHORS = \"Kawai T, Akira S.\", TITLE = \"TLR signaling.\", JOURNAL = c(\"Semin Immunol 19:24-32 (2007)\", \"DOI:10.1016/j.smim.2006.12.004\")), list(REFERENCE = \"PMID:17457343\", AUTHORS = \"O\'Neill LA, Bowie AG.\", TITLE = \"The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.\", JOURNAL = c(\"Nat Rev Immunol 7:353-64 (2007)\", \"DOI:10.1038/nri2079\")), list(REFERENCE = \"PMID:16932750\", AUTHORS = \"Honda K, Taniguchi T.\", TITLE = \"IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.\", JOURNAL = c(\"Nat Rev Immunol 6:644-58 (2006)\", \"DOI:10.1038/nri1900\")), list(REFERENCE = \"PMID:17395581\", AUTHORS = \"Uematsu S, Akira S.\", TITLE = \"Toll-like receptors and Type I interferons.\", JOURNAL = c(\"J Biol Chem 282:15319-23 (2007)\", \"DOI:10.1074/jbc.R700009200\")), list(REFERENCE = \"PMID:16497588\", AUTHORS = \"Akira S, Uematsu S, Takeuchi O.\", TITLE = \"Pathogen recognition and innate immunity.\", JOURNAL = c(\"Cell 124:783-801 (2006)\", \"DOI:10.1016/j.cell.2006.02.015\")), list(REFERENCE = \"PMID:14698224\", AUTHORS = \"Yamamoto M, Takeda K, Akira S.\", TITLE = \"TIR domain-containing adaptors define the specificity of TLR signaling.\", JOURNAL = c(\"Mol Immunol 40:861-8 (2004)\", \"DOI:10.1016/j.molimm.2003.10.006\")), list(REFERENCE = \"PMID:12734364\", AUTHORS = \"Means TK, Hayashi F, Smith KD, Aderem A, Luster AD.\", TITLE = \"The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.\", JOURNAL = c(\"J Immunol 170:5165-75 (2003)\", \"DOI:10.4049/jimmunol.170.10.5165\")), list(REFERENCE = \"PMID:14751764\", AUTHORS = \"Aderem A, Smith KD.\", TITLE = \"A systems approach to dissecting immunity and inflammation.\", JOURNAL = c(\"Semin Immunol 16:55-67 (2004)\", \"DOI:10.1016/j.smim.2003.10.002\")), list(REFERENCE = \"PMID:17637696\", AUTHORS = \"Banerjee A, Gerondakis S.\", TITLE = \"Coordinating TLR-activated signaling pathways in cells of the immune system.\", JOURNAL = c(\"Immunol Cell Biol 85:420-4 (2007)\", \"DOI:10.1038/sj.icb.7100098\")), list(REFERENCE = \"PMID:17507094\", AUTHORS = \"Loniewski KJ, Patial S, Parameswaran N.\", TITLE = \"Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.\", JOURNAL = c(\"Mol Immunol 44:3715-23 (2007)\", \"DOI:10.1016/j.molimm.2007.04.002\")), list(REFERENCE = \"PMID:11101877\", AUTHORS = \"Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG.\", TITLE = \"Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway.\", JOURNAL = c(\"Nat Immunol 1:533-40 (2000)\", \"DOI:10.1038/82797\")), list(REFERENCE = \"PMID:16924467\", AUTHORS = \"Uematsu S, Akira S.\", TITLE = \"Toll-like receptors and innate immunity.\", JOURNAL = c(\"J Mol Med 84:712-25 (2006)\", \"DOI:10.1007/s00109-006-0084-y\"))', 'map04620', 'Toll-like receptor signaling pathway', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (302, '04621', 'NOD-like receptor signaling pathway', 'Specific families of pattern recognition receptors are responsible for detecting various pathogens and generating innate immune responses. The intracellular NOD-like receptor (NLR) family contains more than 20 members in mammals and plays a pivotal role in the recognition of intracellular ligands. NOD1 and NOD2, two prototypic NLRs, sense the cytosolic presence of the bacterial peptidoglycan fragments that escaped from endosomal compartments, driving the activation of NF-{kappa}B and MAPK, cytokine production and apoptosis. On the other hand, a different set of NLRs induces caspase-1 activation through the assembly of multiprotein complexes called inflammasomes. The activated of caspase-1 regulates maturation of the pro-inflammatory cytokines IL-1B, IL-18 and drives pyroptosis.', 'Organismal Systems; Immune system', 'NOD-like receptor signaling pathway', 'Cryopyrin associated periodic syndrome, Blau syndrome, Crohn disease, Pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome, Familial Mediterranean fever, Cocoon syndrome, Chronic mucocutaneous candidiasis, Sarcoidosis, early-onset, Vitiligo, Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis, STING-associated vasculopathy with onset in infancy, Autoinflammation with infantile enterocolitis, Encephalopathy due to defective mitochondrial and peroxisomal fission', 'ko04621', 'list(REFERENCE = \"PMID:23124073\", AUTHORS = \"Vandenabeele P, Bertrand MJ\", TITLE = \"The role of the IAP E3 ubiquitin ligases in regulating pattern-recognition receptor signalling.\", JOURNAL = c(\"Nat Rev Immunol 12:833-44 (2012)\", \"DOI:10.1038/nri3325\")), list(REFERENCE = \"PMID:16493424\", AUTHORS = \"Strober W, Murray PJ, Kitani A, Watanabe T\", TITLE = \"Signalling pathways and molecular interactions of NOD1 and NOD2.\", JOURNAL = c(\"Nat Rev Immunol 6:9-20 (2006)\", \"DOI:10.1038/nri1747\")), list(REFERENCE = \"PMID:24718315\", AUTHORS = \"Estornes Y, Bertrand MJ\", TITLE = \"IAPs, regulators of innate immunity and inflammation.\", JOURNAL = c(\"Semin Cell Dev Biol 39:106-14 (2015)\", \"DOI:10.1016/j.semcdb.2014.03.035\")), list(REFERENCE = \"PMID:24707857\", AUTHORS = \"Jakopin Z\", TITLE = \"Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.\", JOURNAL = c(\"J Med Chem 57:6897-918 (2014)\", \"DOI:10.1021/jm401841p\")), list(REFERENCE = \"PMID:25526305\", AUTHORS = \"Caruso R, Warner N, Inohara N, Nunez G\", TITLE = \"NOD1 and NOD2: signaling, host defense, and inflammatory disease.\", JOURNAL = c(\"Immunity 41:898-908 (2014)\", \"DOI:10.1016/j.immuni.2014.12.010\")), list(REFERENCE = \"PMID:19767725\", AUTHORS = \"Murray PJ\", TITLE = \"Beyond peptidoglycan for Nod2.\", JOURNAL = c(\"Nat Immunol 10:1053-4 (2009)\", \"DOI:10.1038/ni1009-1053\")), list(REFERENCE = \"PMID:20643110\", AUTHORS = \"Lecat A, Piette J, Legrand-Poels S\", TITLE = \"The protein Nod2: an innate receptor more complex than previously assumed.\", JOURNAL = c(\"Biochem Pharmacol 80:2021-31 (2010)\", \"DOI:10.1016/j.bcp.2010.07.016\")), list(REFERENCE = \"PMID:26655628\", AUTHORS = \"Man SM, Kanneganti TD\", TITLE = \"Converging roles of caspases in inflammasome activation, cell death and innate immunity.\", JOURNAL = c(\"Nat Rev Immunol 16:7-21 (2016)\", \"DOI:10.1038/nri.2015.7\")), list(REFERENCE = \"PMID:27291964\", AUTHORS = \"Broz P, Dixit VM\", TITLE = \"Inflammasomes: mechanism of assembly, regulation and signalling.\", JOURNAL = c(\"Nat Rev Immunol 16:407-20 (2016)\", \"DOI:10.1038/nri.2016.58\")), list(REFERENCE = \"PMID:25879280\", AUTHORS = \"Man SM, Kanneganti TD\", TITLE = \"Regulation of inflammasome activation.\", JOURNAL = c(\"Immunol Rev 265:6-21 (2015)\", \"DOI:10.1111/imr.12296\")), list(REFERENCE = \"PMID:26549800\", AUTHORS = \"Jo EK, Kim JK, Shin DM, Sasakawa C\", TITLE = \"Molecular mechanisms regulating NLRP3 inflammasome activation.\", JOURNAL = c(\"Cell Mol Immunol 13:148-59 (2016)\", \"DOI:10.1038/cmi.2015.95\")), list(REFERENCE = \"PMID:23846113\", AUTHORS = \"Broz P, Monack DM\", TITLE = \"Newly described pattern recognition receptors team up against intracellular pathogens.\", JOURNAL = c(\"Nat Rev Immunol 13:551-65 (2013)\", \"DOI:10.1038/nri3479\")), list(REFERENCE = \"PMID:22430786\", AUTHORS = \"Rathinam VA, Vanaja SK, Fitzgerald KA\", TITLE = \"Regulation of inflammasome signaling.\", JOURNAL = c(\"Nat Immunol 13:333-42 (2012)\", \"DOI:10.1038/ni.2237\")), list(REFERENCE = \"PMID:24840700\", AUTHORS = \"Sutterwala FS, Haasken S, Cassel SL\", TITLE = \"Mechanism of NLRP3 inflammasome activation.\", JOURNAL = c(\"Ann N Y Acad Sci 1319:82-95 (2014)\", \"DOI:10.1111/nyas.12458\")), list(REFERENCE = \"PMID:23702978\", AUTHORS = \"Latz E, Xiao TS, Stutz A\", TITLE = \"Activation and regulation of the inflammasomes.\", JOURNAL = c(\"Nat Rev Immunol 13:397-411 (2013)\", \"DOI:10.1038/nri3452\")), list(REFERENCE = \"PMID:25145756\", AUTHORS = \"Blander JM\", TITLE = \"A long-awaited merger of the pathways mediating host defence and programmed cell death.\", JOURNAL = c(\"Nat Rev Immunol 14:601-18 (2014)\", \"DOI:10.1038/nri3720\")), list(REFERENCE = \"PMID:23215645\", AUTHORS = \"von Moltke J, Ayres JS, Kofoed EM, Chavarria-Smith J, Vance RE\", TITLE = \"Recognition of bacteria by inflammasomes.\", JOURNAL = c(\"Annu Rev Immunol 31:73-106 (2013)\", \"DOI:10.1146/annurev-immunol-032712-095944\")), list(REFERENCE = \"PMID:25330206\", AUTHORS = \"Abais JM, Xia M, Zhang Y, Boini KM, Li PL\", TITLE = \"Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?\", JOURNAL = c(\"Antioxid Redox Signal 22:1111-29 (2015)\", \"DOI:10.1089/ars.2014.5994\")), list(REFERENCE = \"PMID:25879288\", AUTHORS = \"Storek KM, Monack DM\", TITLE = \"Bacterial recognition pathways that lead to inflammasome activation.\", JOURNAL = c(\"Immunol Rev 265:112-29 (2015)\", \"DOI:10.1111/imr.12289\")), list(REFERENCE = \"PMID:27012466\", AUTHORS = \"Hu H, Sun SC\", TITLE = \"Ubiquitin signaling in immune responses.\", JOURNAL = c(\"Cell Res 26:457-83 (2016)\", \"DOI:10.1038/cr.2016.40\")), list(REFERENCE = \"PMID:26121197\", AUTHORS = \"Guo H, Callaway JB, Ting JP\", TITLE = \"Inflammasomes: mechanism of action, role in disease, and therapeutics.\", JOURNAL = c(\"Nat Med 21:677-87 (2015)\", \"DOI:10.1038/nm.3893\")), list(REFERENCE = \"PMID:26482951\", AUTHORS = \"Man SM, Kanneganti TD\", TITLE = \"Gasdermin D: the long-awaited executioner of pyroptosis.\", JOURNAL = c(\"Cell Res 25:1183-4 (2015)\", \"DOI:10.1038/cr.2015.124\")), list(REFERENCE = \"PMID:22819539\", AUTHORS = \"Rathinam VA, Vanaja SK, Waggoner L, Sokolovska A, Becker C, Stuart LM, Leong JM, Fitzgerald KA\", TITLE = \"TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria.\", JOURNAL = c(\"Cell 150:606-19 (2012)\", \"DOI:10.1016/j.cell.2012.07.007\")), list(REFERENCE = \"PMID:21575908\", AUTHORS = \"Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B\", TITLE = \"IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection.\", JOURNAL = c(\"Cell Host Microbe 9:363-75 (2011)\", \"DOI:10.1016/j.chom.2011.04.008\")), list(REFERENCE = \"PMID:29148036\", AUTHORS = \"Heilig R, Broz P\", TITLE = \"Function and mechanism of the pyrin inflammasome.\", JOURNAL = c(\"Eur J Immunol 48:230-238 (2018)\", \"DOI:10.1002/eji.201746947\"))', 'map04621', 'NOD-like receptor signaling pathway', 145, 12, 145, 0, 0, 0, 12, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (303, '04622', 'RIG-I-like receptor signaling pathway', 'Specific families of pattern recognition receptors are responsible for detecting viral pathogens and generating innate immune responses. Non-self RNA appearing in a cell as a result of intracellular viral replication is recognized by a family of cytosolic RNA helicases termed RIG-I-like receptors (RLRs). The RLR proteins include RIG-I, MDA5, and LGP2 and are expressed in both immune and nonimmune cells. Upon recognition of viral nucleic acids, RLRs recruit specific intracellular adaptor proteins to initiate signaling pathways that lead to the synthesis of type I interferon and other inflammatory cytokines, which are important for eliminating viruses.', 'Organismal Systems; Immune system', 'RIG-I-like receptor signaling pathway', 'Aicardi-Goutieres syndrome, Brooke-Spiegler syndrome, Cocoon syndrome, STING-associated vasculopathy with onset in infancy', 'ko04622', 'list(REFERENCE = \"PMID:15208624\", AUTHORS = \"Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T\", TITLE = \"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.\", JOURNAL = c(\"Nat Immunol 5:730-7 (2004)\", \"DOI:10.1038/ni1087\")), list(REFERENCE = \"PMID:18272355\", AUTHORS = \"Takeuchi O, Akira S\", TITLE = \"MDA5/RIG-I and virus recognition.\", JOURNAL = c(\"Curr Opin Immunol 20:17-22 (2008)\", \"DOI:10.1016/j.coi.2008.01.002\")), list(REFERENCE = \"PMID:19120475\", AUTHORS = \"Yoneyama M, Fujita T\", TITLE = \"RNA recognition and signal transduction by RIG-I-like receptors.\", JOURNAL = c(\"Immunol Rev 227:54-65 (2009)\", \"DOI:10.1111/j.1600-065X.2008.00727.x\")), list(REFERENCE = \"PMID:19539500\", AUTHORS = \"Nakhaei P, Genin P, Civas A, Hiscott J\", TITLE = \"RIG-I-like receptors: sensing and responding to RNA virus infection.\", JOURNAL = c(\"Semin Immunol 21:215-22 (2009)\", \"DOI:10.1016/j.smim.2009.05.001\")), list(REFERENCE = \"PMID:18549796\", AUTHORS = \"Moore CB, Ting JP\", TITLE = \"Regulation of mitochondrial antiviral signaling pathways.\", JOURNAL = c(\"Immunity 28:735-9 (2008)\", \"DOI:10.1016/j.immuni.2008.05.005\")), list(REFERENCE = \"PMID:19615405\", AUTHORS = \"Barral PM, Sarkar D, Su ZZ, Barber GN, DeSalle R, Racaniello VR, Fisher PB\", TITLE = \"Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.\", JOURNAL = c(\"Pharmacol Ther 124:219-34 (2009)\", \"DOI:10.1016/j.pharmthera.2009.06.012\")), list(REFERENCE = \"PMID:19120476\", AUTHORS = \"Schlee M, Hartmann E, Coch C, Wimmenauer V, Janke M, Barchet W, Hartmann G\", TITLE = \"Approaching the RNA ligand for RIG-I?\", JOURNAL = c(\"Immunol Rev 227:66-74 (2009)\", \"DOI:10.1111/j.1600-065X.2008.00724.x\")), list(REFERENCE = \"PMID:18591413\", AUTHORS = \"Saito T, Gale M Jr\", TITLE = \"Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity.\", JOURNAL = c(\"J Exp Med 205:1523-7 (2008)\", \"DOI:10.1084/jem.20081210\")), list(REFERENCE = \"PMID:19076341\", AUTHORS = \"Kawai T, Akira S\", TITLE = \"Toll-like receptor and RIG-I-like receptor signaling.\", JOURNAL = c(\"Ann N Y Acad Sci 1143:1-20 (2008)\", \"DOI:10.1196/annals.1443.020\")), list(REFERENCE = \"PMID:18439848\", AUTHORS = \"Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J, Poeck H, Bscheider M, Hartmann G, Konig M, Kalinke U, Pasparakis M, Tschopp J\", TITLE = \"TRADD protein is an essential component of the RIG-like helicase antiviral pathway.\", JOURNAL = c(\"Immunity 28:651-61 (2008)\", \"DOI:10.1016/j.immuni.2008.03.013\")), list(REFERENCE = \"PMID:18984593\", AUTHORS = \"Yoshida R, Takaesu G, Yoshida H, Okamoto F, Yoshioka T, Choi Y, Akira S, Kawai T, Yoshimura A, Kobayashi T\", TITLE = \"TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway.\", JOURNAL = c(\"J Biol Chem 283:36211-20 (2008)\", \"DOI:10.1074/jbc.M806576200\")), list(REFERENCE = \"PMID:19224920\", AUTHORS = \"Mikkelsen SS, Jensen SB, Chiliveru S, Melchjorsen J, Julkunen I, Gaestel M, Arthur JS, Flavell RA, Ghosh S, Paludan SR\", TITLE = \"RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1.\", JOURNAL = c(\"J Biol Chem 284:10774-82 (2009)\", \"DOI:10.1074/jbc.M807272200\"))', 'map04622', 'RIG-I-like receptor signaling pathway', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (304, '04623', 'Cytosolic DNA-sensing pathway', 'Specific families of pattern recognition receptors are responsible for detecting foreign DNA from invading microbes or host cells and generating innate immune responses. DAI is the first identified sensor of cytosolic DNA which activates the IRF and NF-{kappa}B transcription factors, leading to production of type I interferon and other cytokines. The second type of cytoplasmic DNA sensor is AIM2. Upon sensing DNA, AIM2 triggers the assembly of the inflammasome, culminating in interleukin maturation. In addition to these receptors, there is a mechanism to sense foreign DNA, with the host RNA polymerase III converting the DNA into RNA for recognition by the RNA sensor RIG-I. These pathways provide various means to alert the cell.', 'Organismal Systems; Immune system', 'Cytosolic DNA-sensing pathway', 'Aicardi-Goutieres syndrome, Familial chilblain lupus (FCL), Dyschromatosis symmetrica hereditaria, Cocoon syndrome, Retinal vasculopathy with cerebral leukodystrophy, STING-associated vasculopathy with onset in infancy', 'ko04623', 'list(REFERENCE = \"PMID:19362700\", AUTHORS = \"Yanai H, Savitsky D, Tamura T, Taniguchi T\", TITLE = \"Regulation of the cytosolic DNA-sensing system in innate immunity: a current view.\", JOURNAL = c(\"Curr Opin Immunol 21:17-22 (2009)\", \"DOI:10.1016/j.coi.2009.01.005\")), list(REFERENCE = \"PMID:19497760\", AUTHORS = \"Vilaysane A, Muruve DA\", TITLE = \"The innate immune response to DNA.\", JOURNAL = c(\"Semin Immunol 21:208-14 (2009)\", \"DOI:10.1016/j.smim.2009.05.006\")), list(REFERENCE = \"PMID:18573338\", AUTHORS = \"Takeshita F, Ishii KJ\", TITLE = \"Intracellular DNA sensors in immunity.\", JOURNAL = c(\"Curr Opin Immunol 20:383-8 (2008)\", \"DOI:10.1016/j.coi.2008.05.009\")), list(REFERENCE = \"PMID:19122387\", AUTHORS = \"Takaoka A, Shinohara S\", TITLE = \"DNA sensors in innate immune system.\", JOURNAL = c(\"Uirusu 58:37-46 (2008)\", \"DOI:10.2222/jsv.58.37\")), list(REFERENCE = \"PMID:18280611\", AUTHORS = \"Takaoka A, Taniguchi T\", TITLE = \"Cytosolic DNA recognition for triggering innate immune responses.\", JOURNAL = c(\"Adv Drug Deliv Rev 60:847-57 (2008)\", \"DOI:10.1016/j.addr.2007.12.002\")), list(REFERENCE = \"PMID:18941233\", AUTHORS = \"Kaiser WJ, Upton JW, Mocarski ES\", TITLE = \"Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors.\", JOURNAL = c(\"J Immunol 181:6427-34 (2008)\", \"DOI:10.4049/jimmunol.181.9.6427\")), list(REFERENCE = \"PMID:19590578\", AUTHORS = \"Rebsamen M, Heinz LX, Meylan E, Michallet MC, Schroder K, Hofmann K, Vazquez J, Benedict CA, Tschopp J\", TITLE = \"DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB.\", JOURNAL = c(\"EMBO Rep 10:916-22 (2009)\", \"DOI:10.1038/embor.2009.109\")), list(REFERENCE = \"PMID:18375758\", AUTHORS = \"Wang Z, Choi MK, Ban T, Yanai H, Negishi H, Lu Y, Tamura T, Takaoka A, Nishikura K, Taniguchi T\", TITLE = \"Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:5477-82 (2008)\", \"DOI:10.1073/pnas.0801295105\")), list(REFERENCE = \"PMID:18724932\", AUTHORS = \"Stetson DB, Ko JS, Heidmann T, Medzhitov R\", TITLE = \"Trex1 prevents cell-intrinsic initiation of autoimmunity.\", JOURNAL = c(\"Cell 134:587-98 (2008)\", \"DOI:10.1016/j.cell.2008.06.032\")), list(REFERENCE = \"PMID:19321146\", AUTHORS = \"Schroder K, Muruve DA, Tschopp J\", TITLE = \"Innate immunity: cytoplasmic DNA sensing by the AIM2 inflammasome.\", JOURNAL = c(\"Curr Biol 19:R262-5 (2009)\", \"DOI:10.1016/j.cub.2009.02.011\")), list(REFERENCE = \"PMID:19567913\", AUTHORS = \"Krieg AM\", TITLE = \"AIMing 2 detect foreign DNA.\", JOURNAL = c(\"Sci Signal 2:pe39 (2009)\", \"DOI:10.1126/scisignal.277pe39\")), list(REFERENCE = \"PMID:19665965\", AUTHORS = \"O\'Neill LA\", TITLE = \"DNA makes RNA makes innate immunity.\", JOURNAL = c(\"Cell 138:428-30 (2009)\", \"DOI:10.1016/j.cell.2009.07.021\")), list(REFERENCE = \"PMID:16286919\", AUTHORS = \"Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, Sato S, Yamamoto M, Uematsu S, Kawai T, Takeuchi O, Akira S\", TITLE = \"A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.\", JOURNAL = c(\"Nat Immunol 7:40-8 (2006)\", \"DOI:10.1038/ni1282\")), list(REFERENCE = \"PMID:19767723\", AUTHORS = \"Cao X\", TITLE = \"New DNA-sensing pathway feeds RIG-I with RNA.\", JOURNAL = c(\"Nat Immunol 10:1049-51 (2009)\", \"DOI:10.1038/ni1009-1049\")), list(REFERENCE = \"PMID:23258413\", AUTHORS = \"Sun L, Wu J, Du F, Chen X, Chen ZJ\", TITLE = \"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.\", JOURNAL = c(\"Science 339:786-91 (2013)\", \"DOI:10.1126/science.1232458\"))', 'map04623', 'Cytosolic DNA-sensing pathway', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (305, '04624', 'Toll and Imd signaling pathway', 'Insects, such as Drosophila, have evolved complex mechanisms to combat microbial infection. TOLL and IMD pathways are responsible for the immune response that functions through the production of antimicrobial peptides (AMPs). The TOLL pathway mainly detects fungi, Gram-positive bacteria and virulence factors (proteases et al.). Activation of the TOLL pathway results in degradation of Cactus and localization of Dorsal and Dif to the nucleus. On the other hand, the IMD pathway responses to Gram-negative bacteria and leads to the activation of Relish. Dorsal, Dif and Relish induce the transcriptional up-regulation of AMPs in the nucleus.', 'Organismal Systems; Immune system', 'Toll and Imd signaling pathway', 'ko04624', 'list(REFERENCE = \"PMID:22824741\", AUTHORS = \"Merkling SH, van Rij RP\", TITLE = \"Beyond RNAi: antiviral defense strategies in Drosophila and mosquito.\", JOURNAL = c(\"J Insect Physiol 59:159-70 (2013)\", \"DOI:10.1016/j.jinsphys.2012.07.004\")), list(REFERENCE = \"PMID:21209287\", AUTHORS = \"Valanne S, Wang JH, Ramet M\", TITLE = \"The Drosophila Toll signaling pathway.\", JOURNAL = c(\"J Immunol 186:649-56 (2011)\", \"DOI:10.4049/jimmunol.1002302\")), list(REFERENCE = \"PMID:21625362\", AUTHORS = \"Silverman N, Paquette N, Aggarwal K\", TITLE = \"Specificity and signaling in the Drosophila immune response.\", JOURNAL = \"Invertebrate Surviv J 6:163-174 (2009)\"), list(REFERENCE = \"PMID:22076558\", AUTHORS = \"Royet J, Gupta D, Dziarski R\", TITLE = \"Peptidoglycan recognition proteins: modulators of the microbiome and inflammation.\", JOURNAL = c(\"Nat Rev Immunol 11:837-51 (2011)\", \"DOI:10.1038/nri3089\")), list(REFERENCE = \"PMID:25421701\", AUTHORS = \"Buchon N, Silverman N, Cherry S\", TITLE = \"Immunity in Drosophila melanogaster--from microbial recognition to whole-organism physiology.\", JOURNAL = c(\"Nat Rev Immunol 14:796-810 (2014)\", \"DOI:10.1038/nri3763\")), list(REFERENCE = \"PMID:17948019\", AUTHORS = \"Ferrandon D, Imler JL, Hetru C, Hoffmann JA\", TITLE = \"The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections.\", JOURNAL = c(\"Nat Rev Immunol 7:862-74 (2007)\", \"DOI:10.1038/nri2194\")), list(REFERENCE = \"PMID:25674081\", AUTHORS = \"Stokes BA, Yadav S, Shokal U, Smith LC, Eleftherianos I\", TITLE = \"Bacterial and fungal pattern recognition receptors in homologous innate signaling pathways of insects and mammals.\", JOURNAL = c(\"Front Microbiol 6:19 (2015)\", \"DOI:10.3389/fmicb.2015.00019\")), list(REFERENCE = \"PMID:22368770\", AUTHORS = \"Igboin CO, Griffen AL, Leys EJ\", TITLE = \"The Drosophila melanogaster host model.\", JOURNAL = c(\"J Oral Microbiol 4:JOM-4-10368 (2012)\", \"DOI:10.3402/jom.v4i0.10368\")), list(REFERENCE = \"PMID:23893105\", AUTHORS = \"Buchon N, Broderick NA, Lemaitre B\", TITLE = \"Gut homeostasis in a microbial world: insights from Drosophila melanogaster.\", JOURNAL = c(\"Nat Rev Microbiol 11:615-26 (2013)\", \"DOI:10.1038/nrmicro3074\")), list(REFERENCE = \"PMID:26290570\", AUTHORS = \"Handu M, Kaduskar B, Ravindranathan R, Soory A, Giri R, Elango VB, Gowda H, Ratnaparkhi GS\", TITLE = \"SUMO-Enriched Proteome for Drosophila Innate Immune Response.\", JOURNAL = c(\"G3 (Bethesda) 5:2137-54 (2015)\", \"DOI:10.1534/g3.115.020958\")), list(REFERENCE = \"PMID:23632253\", AUTHORS = \"Lindsay SA, Wasserman SA\", TITLE = \"Conventional and non-conventional Drosophila Toll signaling.\", JOURNAL = c(\"Dev Comp Immunol 42:16-24 (2014)\", \"DOI:10.1016/j.dci.2013.04.011\")), list(REFERENCE = \"PMID:22549468\", AUTHORS = \"Meinander A, Runchel C, Tenev T, Chen L, Kim CH, Ribeiro PS, Broemer M, Leulier F, Zvelebil M, Silverman N, Meier P\", TITLE = \"Ubiquitylation of the initiator caspase DREDD is required for innate immune signalling.\", JOURNAL = c(\"EMBO J 31:2770-83 (2012)\", \"DOI:10.1038/emboj.2012.121\")), list(REFERENCE = \"PMID:24706930\", AUTHORS = \"Myllymaki H, Valanne S, Ramet M\", TITLE = \"The Drosophila imd signaling pathway.\", JOURNAL = c(\"J Immunol 192:3455-62 (2014)\", \"DOI:10.4049/jimmunol.1303309\")), list(REFERENCE = \"PMID:17343912\", AUTHORS = \"Valanne S, Kleino A, Myllymaki H, Vuoristo J, Ramet M\", TITLE = \"Iap2 is required for a sustained response in the Drosophila Imd pathway.\", JOURNAL = c(\"Dev Comp Immunol 31:991-1001 (2007)\", \"DOI:10.1016/j.dci.2007.01.004\")), list(REFERENCE = \"PMID:15556270\", AUTHORS = \"Levy F, Rabel D, Charlet M, Bulet P, Hoffmann JA, Ehret-Sabatier L\", TITLE = \"Peptidomic and proteomic analyses of the systemic immune response of Drosophila.\", JOURNAL = c(\"Biochimie 86:607-16 (2004)\", \"DOI:10.1016/j.biochi.2004.07.007\"))', 'map04624', 'Toll and Imd signaling pathway', 'Insects, such as Drosophila, have evolved complex mechanisms to combat microbial infection. TOLL and IMD pathways are responsible for the immune response that functions through the production of antimicrobial peptides (AMPs). The TOLL pathway mainly detects fungi, Gram-positive bacteria and virulence factors (proteases et al.). Activation of the TOLL pathway results in degradation of Cactus and localization of Dorsal and Dif to the nucleus. On the other hand, the IMD pathway responses to Gram-negative bacteria and leads to the activation of Relish. Dorsal, Dif and Relish induce the transcriptional up-regulation of AMPs in the nucleus.', 64, 0, 64, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (306, '04625', 'C-type lectin receptor signaling pathway', 'C-type lectin receptors (CLRs) are a large superfamily of proteins characterized by the presence of one or more C-type lectin-like domains (CTLDs). CLRs function as pattern-recognition receptors (PRRs) for pathogen-derived ligands in dendric cells, macrophages, neutrophils, etc., such as Dectin-1 and Dectin-2 for recognition of fungi-derived B-glucan and high mannose-type carbohydrates. Upon ligand binding, CLRs stimulate intracellular signaling cascades that induce the production of inflammatory cytokines and chemokines, consequently triggering innate and adaptive immunity to pathogens.', 'Organismal Systems; Immune system', 'C-type lectin receptor signaling pathway', 'ko04625', 'list(REFERENCE = \"PMID:27291962\", AUTHORS = \"Geijtenbeek TB, Gringhuis SI\", TITLE = \"C-type lectin receptors in the control of T helper cell differentiation.\", JOURNAL = c(\"Nat Rev Immunol 16:433-48 (2016)\", \"DOI:10.1038/nri.2016.55\")), list(REFERENCE = \"PMID:21350579\", AUTHORS = \"Hajishengallis G, Lambris JD\", TITLE = \"Microbial manipulation of receptor crosstalk in innate immunity.\", JOURNAL = c(\"Nat Rev Immunol 11:187-200 (2011)\", \"DOI:10.1038/nri2918\")), list(REFERENCE = \"PMID:28604735\", AUTHORS = \"Iliev ID, Leonardi I\", TITLE = \"Fungal dysbiosis: immunity and interactions at mucosal barriers.\", JOURNAL = c(\"Nat Rev Immunol 17:635-646 (2017)\", \"DOI:10.1038/nri.2017.55\")), list(REFERENCE = \"PMID:25002863\", AUTHORS = \"Richardson MB, Williams SJ\", TITLE = \"MCL and Mincle: C-Type Lectin Receptors That Sense Damaged Self and Pathogen-Associated Molecular Patterns.\", JOURNAL = c(\"Front Immunol 5:288 (2014)\", \"DOI:10.3389/fimmu.2014.00288\")), list(REFERENCE = \"PMID:21924922\", AUTHORS = \"Vautier S, MacCallum DM, Brown GD\", TITLE = \"C-type lectin receptors and cytokines in fungal immunity.\", JOURNAL = c(\"Cytokine 58:89-99 (2012)\", \"DOI:10.1016/j.cyto.2011.08.031\")), list(REFERENCE = \"PMID:22170181\", AUTHORS = \"Gauglitz GG, Callenberg H, Weindl G, Korting HC\", TITLE = \"Host defence against Candida albicans and the role of pattern-recognition receptors.\", JOURNAL = c(\"Acta Derm Venereol 92:291-8 (2012)\", \"DOI:10.2340/00015555-1250\")), list(REFERENCE = \"PMID:22973279\", AUTHORS = \"Cunha C, Carvalho A, Esposito A, Bistoni F, Romani L\", TITLE = \"DAMP signaling in fungal infections and diseases.\", JOURNAL = c(\"Front Immunol 3:286 (2012)\", \"DOI:10.3389/fimmu.2012.00286\")), list(REFERENCE = \"PMID:29449845\", AUTHORS = \"Tang J, Lin G, Langdon WY, Tao L, Zhang J\", TITLE = \"Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity.\", JOURNAL = c(\"Front Immunol 9:123 (2018)\", \"DOI:10.3389/fimmu.2018.00123\")), list(REFERENCE = \"PMID:27999992\", AUTHORS = \"Mayer S, Raulf MK, Lepenies B\", TITLE = \"C-type lectins: their network and roles in pathogen recognition and immunity.\", JOURNAL = c(\"Histochem Cell Biol 147:223-237 (2017)\", \"DOI:10.1007/s00418-016-1523-7\")), list(REFERENCE = \"PMID:23570314\", AUTHORS = \"Plato A, Willment JA, Brown GD\", TITLE = \"C-type lectin-like receptors of the dectin-1 cluster: ligands and signaling pathways.\", JOURNAL = c(\"Int Rev Immunol 32:134-56 (2013)\", \"DOI:10.3109/08830185.2013.777065\")), list(REFERENCE = \"PMID:22344277\", AUTHORS = \"Dupaul-Chicoine J, Saleh M\", TITLE = \"A new path to IL-1beta production controlled by caspase-8.\", JOURNAL = c(\"Nat Immunol 13:211-2 (2012)\", \"DOI:10.1038/ni.2241\")), list(REFERENCE = \"PMID:24009832\", AUTHORS = \"Batbayar S, Lee DH, Kim HW\", TITLE = \"Immunomodulation of Fungal beta-Glucan in Host Defense Signaling by Dectin-1.\", JOURNAL = c(\"Biomol Ther (Seoul) 20:433-45 (2012)\", \"DOI:10.4062/biomolther.2012.20.5.433\")), list(REFERENCE = \"PMID:28606994\", AUTHORS = \"Bendickova K, Tidu F, Fric J\", TITLE = \"Calcineurin-NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy.\", JOURNAL = c(\"EMBO Mol Med 9:990-999 (2017)\", \"DOI:10.15252/emmm.201707698\")), list(REFERENCE = \"PMID:18998127\", AUTHORS = \"den Dunnen J, Gringhuis SI, Geijtenbeek TB\", TITLE = \"Innate signaling by the C-type lectin DC-SIGN dictates immune responses.\", JOURNAL = c(\"Cancer Immunol Immunother 58:1149-57 (2009)\", \"DOI:10.1007/s00262-008-0615-1\")), list(REFERENCE = \"PMID:28640912\", AUTHORS = \"Marakalala MJ, Ndlovu H\", TITLE = \"Signaling C-type lectin receptors in antimycobacterial immunity.\", JOURNAL = c(\"PLoS Pathog 13:e1006333 (2017)\", \"DOI:10.1371/journal.ppat.1006333\")), list(REFERENCE = \"PMID:24867235\", AUTHORS = \"Gringhuis SI, Kaptein TM, Wevers BA, Mesman AW, Geijtenbeek TB\", TITLE = \"Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKepsilon- and CYLD-dependent Bcl3 activation.\", JOURNAL = c(\"Nat Commun 5:3898 (2014)\", \"DOI:10.1038/ncomms4898\")), list(REFERENCE = \"PMID:19521399\", AUTHORS = \"Geijtenbeek TB, Gringhuis SI\", TITLE = \"Signalling through C-type lectin receptors: shaping immune responses.\", JOURNAL = c(\"Nat Rev Immunol 9:465-79 (2009)\", \"DOI:10.1038/nri2569\")), list(REFERENCE = \"PMID:19122653\", AUTHORS = \"Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, Bruijns SC, Geijtenbeek TB\", TITLE = \"Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk.\", JOURNAL = c(\"Nat Immunol 10:203-13 (2009)\", \"DOI:10.1038/ni.1692\"))', 'map04625', 'C-type lectin receptor signaling pathway', 'C-type lectin receptors (CLRs) are a large superfamily of proteins characterized by the presence of one or more C-type lectin-like domains (CTLDs). CLRs function as pattern-recognition receptors (PRRs) for pathogen-derived ligands in dendric cells, macrophages, neutrophils, etc., such as Dectin-1 and Dectin-2 for recognition of fungi-derived B-glucan and high mannose-type carbohydrates. Upon ligand binding, CLRs stimulate intracellular signaling cascades that induce the production of inflammatory cytokines and chemokines, consequently triggering innate and adaptive immunity to pathogens.', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (307, '04626', 'Plant-pathogen interaction', 'Plants lack animal-like adaptive immunity mechanisms, and therefore have evolved a specific system with multiple layers against invading pathogens. The primary response includes the perception of pathogens by cell-surface pattern-recognition receptors (PRRs) and is referred to as PAMP-triggered immunity (PTI). Activation of FLS2 and EFR triggers MAPK signaling pathway that activates defense genes for antimictobial compounds. The increase in the cytosolic Ca2+ concentration is also a regulator for production of reactive oxygen species and localized programmed cell death/hypersensitive response. The secondary response is called effector-triggered immunity (ETI). Pathogens can acquire the ability to suppress PTI by directly injecting effector proteins into the plant cell through secretion systems. In addition, pathogens can manipulate plant hormone signaling pathways to evade host immune responses using coronatine toxin. Some plants possess specific intracellular surveillance proteins (R proteins) to monitor the presence of pathogen virulence proteins. This ETI occurs with localized programmed cell death to arrest pathogen growth, resulting in cultivar-specific disease resistance.', 'Organismal Systems; Environmental adaptation', 'Plant-pathogen interaction', 'ko04626', 'list(REFERENCE = \"PMID:18206360\", AUTHORS = \"Zipfel C\", TITLE = \"Pattern-recognition receptors in plant innate immunity.\", JOURNAL = c(\"Curr Opin Immunol 20:10-6 (2008)\", \"DOI:10.1016/j.coi.2007.11.003\")), list(REFERENCE = \"PMID:19748302\", AUTHORS = \"Chinchilla D, Shan L, He P, de Vries S, Kemmerling B\", TITLE = \"One for all: the receptor-associated kinase BAK1.\", JOURNAL = c(\"Trends Plant Sci 14:535-41 (2009)\", \"DOI:10.1016/j.tplants.2009.08.002\")), list(REFERENCE = \"PMID:19423812\", AUTHORS = \"Boller T, He SY\", TITLE = \"Innate immunity in plants: an arms race between pattern recognition receptors in plants and effectors in microbial pathogens.\", JOURNAL = c(\"Science 324:742-4 (2009)\", \"DOI:10.1126/science.1171647\")), list(REFERENCE = \"PMID:19794842\", AUTHORS = \"Ma W, Smigel A, Verma R, Berkowitz GA\", TITLE = \"Cyclic nucleotide gated channels and related signaling components in plant innate immunity.\", JOURNAL = c(\"Plant Signal Behav 4:277-82 (2009)\", \"DOI:10.4161/psb.4.4.8103\")), list(REFERENCE = \"PMID:11875555\", AUTHORS = \"Asai T, Tena G, Plotnikova J, Willmann MR, Chiu WL, Gomez-Gomez L, Boller T, Ausubel FM, Sheen J\", TITLE = \"MAP kinase signalling cascade in Arabidopsis innate immunity.\", JOURNAL = c(\"Nature 415:977-83 (2002)\", \"DOI:10.1038/415977a\")), list(REFERENCE = \"PMID:15922649\", AUTHORS = \"Zipfel C, Felix G\", TITLE = \"Plants and animals: a different taste for microbes?\", JOURNAL = c(\"Curr Opin Plant Biol 8:353-60 (2005)\", \"DOI:10.1016/j.pbi.2005.05.004\")), list(REFERENCE = \"PMID:17451411\", AUTHORS = \"He P, Shan L, Sheen J\", TITLE = \"Elicitation and suppression of microbe-associated molecular pattern-triggered immunity in plant-microbe interactions.\", JOURNAL = c(\"Cell Microbiol 9:1385-96 (2007)\", \"DOI:10.1111/j.1462-5822.2007.00944.x\")), list(REFERENCE = \"PMID:17876517\", AUTHORS = \"de Wit PJ\", TITLE = \"How plants recognize pathogens and defend themselves.\", JOURNAL = c(\"Cell Mol Life Sci 64:2726-32 (2007)\", \"DOI:10.1007/s00018-007-7284-7\")), list(REFERENCE = \"PMID:16497589\", AUTHORS = \"Chisholm ST, Coaker G, Day B, Staskawicz BJ\", TITLE = \"Host-microbe interactions: shaping the evolution of the plant immune response.\", JOURNAL = c(\"Cell 124:803-14 (2006)\", \"DOI:10.1016/j.cell.2006.02.008\")), list(REFERENCE = \"PMID:16677430\", AUTHORS = \"McHale L, Tan X, Koehl P, Michelmore RW\", TITLE = \"Plant NBS-LRR proteins: adaptable guards.\", JOURNAL = c(\"Genome Biol 7:212 (2006)\", \"DOI:10.1186/gb-2006-7-4-212\")), list(REFERENCE = \"PMID:11459065\", AUTHORS = \"Dangl JL, Jones JD\", TITLE = \"Plant pathogens and integrated defence responses to infection.\", JOURNAL = c(\"Nature 411:826-33 (2001)\", \"DOI:10.1038/35081161\")), list(REFERENCE = \"PMID:17108957\", AUTHORS = \"Jones JD, Dangl JL\", TITLE = \"The plant immune system.\", JOURNAL = c(\"Nature 444:323-9 (2006)\", \"DOI:10.1038/nature05286\")), list(REFERENCE = \"PMID:16697674\", AUTHORS = \"da Cunha L, McFall AJ, Mackey D\", TITLE = \"Innate immunity in plants: a continuum of layered defenses.\", JOURNAL = c(\"Microbes Infect 8:1372-81 (2006)\", \"DOI:10.1016/j.micinf.2005.12.018\")), list(REFERENCE = \"PMID:15862106\", AUTHORS = \"Mudgett MB\", TITLE = \"New insights to the function of phytopathogenic bacterial type III effectors in plants.\", JOURNAL = c(\"Annu Rev Plant Biol 56:509-31 (2005)\", \"DOI:10.1146/annurev.arplant.56.032604.144218\")), list(REFERENCE = \"PMID:17714518\", AUTHORS = \"Ma W, Berkowitz GA\", TITLE = \"The grateful dead: calcium and cell death in plant innate immunity.\", JOURNAL = c(\"Cell Microbiol 9:2571-85 (2007)\", \"DOI:10.1111/j.1462-5822.2007.01031.x\")), list(REFERENCE = \"PMID:14711430\", AUTHORS = \"Schulze-Lefert P\", TITLE = \"Plant immunity: the origami of receptor activation.\", JOURNAL = c(\"Curr Biol 14:R22-4 (2004)\", \"DOI:10.1016/j.cub.2003.12.017\")), list(REFERENCE = \"PMID:9868361\", AUTHORS = \"Van der Biezen EA, Jones JD\", TITLE = \"Plant disease-resistance proteins and the gene-for-gene concept.\", JOURNAL = c(\"Trends Biochem Sci 23:454-6 (1998)\", \"DOI:10.1016/S0968-0004(98)01311-5\")), list(REFERENCE = \"PMID:16936700\", AUTHORS = \"Abramovitch RB, Anderson JC, Martin GB\", TITLE = \"Bacterial elicitation and evasion of plant innate immunity.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 7:601-11 (2006)\", \"DOI:10.1038/nrm1984\"))', 'map04626', 'Plant-pathogen interaction', 'Plants lack animal-like adaptive immunity mechanisms, and therefore have evolved a specific system with multiple layers against invading pathogens. The primary response includes the perception of pathogens by cell-surface pattern-recognition receptors (PRRs) and is referred to as PAMP-triggered immunity (PTI). Activation of FLS2 and EFR triggers MAPK signaling pathway that activates defense genes for antimictobial compounds. The increase in the cytosolic Ca2+ concentration is also a regulator for production of reactive oxygen species and localized programmed cell death/hypersensitive response. The secondary response is called effector-triggered immunity (ETI). Pathogens can acquire the ability to suppress PTI by directly injecting effector proteins into the plant cell through secretion systems. In addition, pathogens can manipulate plant hormone signaling pathways to evade host immune responses using coronatine toxin. Some plants possess specific intracellular surveillance proteins (R proteins) to monitor the presence of pathogen virulence proteins. This ETI occurs with localized programmed cell death to arrest pathogen growth, resulting in cultivar-specific disease resistance.', 88, 11, 0, 88, 0, 0, 11, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (308, '04630', 'JAK-STAT signaling pathway', 'The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in animals, from humans to flies. In mammals, the JAK/STAT pathway is the principal signaling mechanism for a wide array of cytokines and growth factors. Following the binding of cytokines to their cognate receptor, STATs are activated by members of the JAK family of tyrosine kinases. Once activated, they dimerize and translocate to the nucleus and modulate the expression of target genes. In addition to the activation of STATs, JAKs mediate the recruitment of other molecules such as the MAP kinases, PI3 kinase etc. These molecules process downstream signals via the Ras-Raf-MAP kinase and PI3 kinase pathways which results in the activation of additional transcription factors.', 'Environmental Information Processing; Signal transduction', 'JAK-STAT signaling pathway', 'Crohn disease, Type 1 diabetes mellitus, Growth hormone insensitivity with immunodeficiency, Cold-induced sweating syndrome, Metachondromatosis, Chronic mucocutaneous candidiasis, Congenital pulmonary alveolar proteinosis, Primary localized cutaneous amyloidosis, Inflammatory bowel disease (IBD), Hyperprolactinemia, Ulcerative colitis, Castleman disease, Sjogren syndrome, Myelofibrosis, Juvenile idiopathic arthritis, Laron syndrome, Kowarski syndrome, Leptin deficiency, Leptin receptor deficiency, Craniosynostosis and dental anomalies', 'GO: 0007259', 'ko04630', 'list(REFERENCE = \"PMID:22383755\", AUTHORS = \"Harrison DA\", TITLE = \"The Jak/STAT pathway.\", JOURNAL = c(\"Cold Spring Harb Perspect Biol 4:a011205 (2012)\", \"DOI:10.1101/cshperspect.a011205\")), list(REFERENCE = \"PMID:22339650\", AUTHORS = \"Kiu H, Nicholson SE\", TITLE = \"Biology and significance of the JAK/STAT signalling pathways.\", JOURNAL = c(\"Growth Factors 30:88-106 (2012)\", \"DOI:10.3109/08977194.2012.660936\")), list(REFERENCE = \"PMID:21372217\", AUTHORS = \"Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I\", TITLE = \"Direct effects of type I interferons on cells of the immune system.\", JOURNAL = c(\"Clin Cancer Res 17:2619-27 (2011)\", \"DOI:10.1158/1078-0432.CCR-10-1114\")), list(REFERENCE = \"PMID:25217450\", AUTHORS = \"Fish EN, Platanias LC\", TITLE = \"Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.\", JOURNAL = c(\"Mol Cancer Res 12:1691-703 (2014)\", \"DOI:10.1158/1541-7786.MCR-14-0450\")), list(REFERENCE = \"PMID:21034406\", AUTHORS = \"Ivanenkov YA, Balakin KV, Lavrovsky Y\", TITLE = \"Small molecule inhibitors of NF-kB and JAK/STAT signal transduction pathways as promising anti-inflammatory therapeutics.\", JOURNAL = c(\"Mini Rev Med Chem 11:55-78 (2011)\", \"DOI:10.2174/138955711793564079\")), list(REFERENCE = \"PMID:25587654\", AUTHORS = \"O\'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A\", TITLE = \"The JAK-STAT pathway: impact on human disease and therapeutic intervention.\", JOURNAL = c(\"Annu Rev Med 66:311-28 (2015)\", \"DOI:10.1146/annurev-med-051113-024537\")), list(REFERENCE = \"PMID:24069565\", AUTHORS = \"Zoranovic T, Grmai L, Bach EA\", TITLE = \"Regulation of proliferation, cell competition, and cellular growth by the Drosophila JAK-STAT pathway.\", JOURNAL = c(\"JAKSTAT 2:e25408 (2013)\", \"DOI:10.4161/jkst.25408\")), list(REFERENCE = \"PMID:16204702\", AUTHORS = \"Ungureanu D, Silvennoinen O\", TITLE = \"SLIM trims STATs: ubiquitin E3 ligases provide insights for specificity in the regulation of cytokine signaling.\", JOURNAL = c(\"Sci STKE 2005:pe49 (2005)\", \"DOI:10.1126/stke.3042005pe49\")), list(REFERENCE = \"PMID:23735217\", AUTHORS = \"Richard AJ, Stephens JM\", TITLE = \"The role of JAK-STAT signaling in adipose tissue function.\", JOURNAL = c(\"Biochim Biophys Acta 1842:431-9 (2014)\", \"DOI:10.1016/j.bbadis.2013.05.030\")), list(REFERENCE = \"PMID:24606160\", AUTHORS = \"Sun Y, Lehmbecker A, Kalkuhl A, Deschl U, Sun W, Rohn K, Tzvetanova ID, Nave KA, Baumgartner W, Ulrich R\", TITLE = \"STAT3 represents a molecular switch possibly inducing astroglial instead of oligodendroglial differentiation of oligodendroglial progenitor cells in Theiler\'s murine encephalomyelitis.\", JOURNAL = c(\"Neuropathol Appl Neurobiol 41:347-70 (2015)\", \"DOI:10.1111/nan.12133\")), list(REFERENCE = \"PMID:10851053\", AUTHORS = \"Hirano T, Ishihara K, Hibi M\", TITLE = \"Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.\", JOURNAL = c(\"Oncogene 19:2548-56 (2000)\", \"DOI:10.1038/sj.onc.1203551\")), list(REFERENCE = \"PMID:11114747\", AUTHORS = \"Rane SG, Reddy EP\", TITLE = \"Janus kinases: components of multiple signaling pathways.\", JOURNAL = c(\"Oncogene 19:5662-79 (2000)\", \"DOI:10.1038/sj.onc.1203925\")), list(REFERENCE = \"PMID:8682149\", AUTHORS = \"Heim MH\", TITLE = \"The Jak-STAT pathway: specific signal transduction from the cell membrane to the nucleus.\", JOURNAL = c(\"Eur J Clin Invest 26:1-12 (1996)\", \"DOI:10.1046/j.1365-2362.1996.103248.x\"))', 'map04630', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (309, '04640', 'Hematopoietic cell lineage', 'Blood-cell development progresses from a hematopoietic stem cell (HSC), which can undergo either self-renewal or differentiation into a multilineage committed progenitor cell: a common lymphoid progenitor (CLP) or a common myeloid progenitor (CMP). A CLP gives rise to the lymphoid lineage of white blood cells or leukocytes-the natural killer (NK) cells and the T and B lymphocytes. A CMP gives rise to the myeloid lineage, which comprises the rest of the leukocytes, the erythrocytes (red blood cells), and the megakaryocytes that produce platelets important in blood clotting. Cells undergoing these differentiation process express a stage- and lineage-specific set of surface markers. Therefore cellular stages are identified by the specific expression patterns of these genes.', 'Organismal Systems; Immune system', 'Hematopoietic cell lineage', 'Hemophilia, Bernard-Soulier syndrome, Castleman disease', 'ko04640', 'list(REFERENCE = \"\", AUTHORS = \"Janeway CA Jr, Travers P, Walport M, Shlomchik MJ\", TITLE = \"Immunobiology - International editon: The immune system in health and disease\", JOURNAL = \"Harcourt Publishers Ltd, a subsidiary of Harcourt International Ltd (2001)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Abe T\", TITLE = \"[Atlas of malignancies in hematopoietic organ - Morphology, immunology, chromosome and gene] (Japanese)\", JOURNAL = \"Nihonijishinhousya (2000)\"), list(REFERENCE = \"PMID:15771582\", AUTHORS = \"Rothenberg EV, Taghon T.\", TITLE = \"Molecular genetics of T cell development.\", JOURNAL = c(\"Annu Rev Immunol 23:601-49 (2005)\", \"DOI:10.1146/annurev.immunol.23.021704.115737\")), list(REFERENCE = \"PMID:12415312\", AUTHORS = \"Ceredig R, Rolink T.\", TITLE = \"A positive look at double-negative thymocytes.\", JOURNAL = c(\"Nat Rev Immunol 2:888-97 (2002)\", \"DOI:10.1038/nri937\")), list(REFERENCE = \"PMID:15156179\", AUTHORS = \"de Bruijn MF, Speck NA.\", TITLE = \"Core-binding factors in hematopoiesis and immune function.\", JOURNAL = c(\"Oncogene 23:4238-48 (2004)\", \"DOI:10.1038/sj.onc.1207763\")), list(REFERENCE = \"PMID:14985712\", AUTHORS = \"Radtke F, Wilson A, Mancini SJ, MacDonald HR.\", TITLE = \"Notch regulation of lymphocyte development and function.\", JOURNAL = c(\"Nat Immunol 5:247-53 (2004)\", \"DOI:10.1038/ni1045\")), list(REFERENCE = \"PMID:12360214\", AUTHORS = \"Spits H.\", TITLE = \"Development of alphabeta T cells in the human thymus.\", JOURNAL = c(\"Nat Rev Immunol 2:760-72 (2002)\", \"DOI:10.1038/nri913\")), list(REFERENCE = \"PMID:9927518\", AUTHORS = \"Di Santo JP, Aifantis I, Rosmaraki E, Garcia C, Feinberg J, Fehling HJ, Fischer A, von Boehmer H, Rocha B.\", TITLE = \"The common cytokine receptor gamma chain and the pre-T cell receptor provide independent but critically overlapping signals in early alpha/beta T cell development.\", JOURNAL = c(\"J Exp Med 189:563-74 (1999)\", \"DOI:10.1084/jem.189.3.563\")), list(REFERENCE = \"PMID:11905810\", AUTHORS = \"Mak TW, Penninger JM, Ohashi PS.\", TITLE = \"Knockout mice: a paradigm shift in modern immunology.\", JOURNAL = c(\"Nat Rev Immunol 1:11-9 (2001)\", \"DOI:10.1038/35095551\")), list(REFERENCE = \"PMID:15738953\", AUTHORS = \"Shapiro-Shelef M, Calame K.\", TITLE = \"Regulation of plasma-cell development.\", JOURNAL = c(\"Nat Rev Immunol 5:230-42 (2005)\", \"DOI:10.1038/nri1572\")), list(REFERENCE = \"PMID:14670296\", AUTHORS = \"Maillard I, Adler SH, Pear WS.\", TITLE = \"Notch and the immune system.\", JOURNAL = c(\"Immunity 19:781-91 (2003)\", \"DOI:10.1016/S1074-7613(03)00325-X\")), list(REFERENCE = \"PMID:15629410\", AUTHORS = \"Alpdogan O, van den Brink MR.\", TITLE = \"IL-7 and IL-15: therapeutic cytokines for immunodeficiency.\", JOURNAL = c(\"Trends Immunol 26:56-64 (2005)\", \"DOI:10.1016/j.it.2004.11.002\"))', 'map04640', 'Hematopoietic cell lineage', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (310, '04650', 'Natural killer cell mediated cytotoxicity', 'Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.', 'Organismal Systems; Immune system', 'Natural killer cell mediated cytotoxicity', 'NK cell defects, Leprosy, Cherubism, Metachondromatosis, X-linked lymphoproliferative syndrome', 'GO: 0042267', 'ko04650', 'list(REFERENCE = \"PMID:15607802\", AUTHORS = \"Chiesa S, Tomasello E, Vivier E, Vely F.\", TITLE = \"Coordination of activating and inhibitory signals in natural killer cells.\", JOURNAL = c(\"Mol Immunol 42:477-84 (2005)\", \"DOI:10.1016/j.molimm.2004.07.030\")), list(REFERENCE = \"PMID:16109839\", AUTHORS = \"Maghazachi AA.\", TITLE = \"Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.\", JOURNAL = c(\"Pharmacol Rev 57:339-57 (2005)\", \"DOI:10.1124/pr.57.3.5\")), list(REFERENCE = \"PMID:15567854\", AUTHORS = \"Vivier E, Nunes JA, Vely F.\", TITLE = \"Natural killer cell signaling pathways.\", JOURNAL = c(\"Science 306:1517-9 (2004)\", \"DOI:10.1126/science.1103478\")), list(REFERENCE = \"PMID:12205470\", AUTHORS = \"Colucci F, Di Santo JP, Leibson PJ.\", TITLE = \"Natural killer cell activation in mice and men: different triggers for similar weapons?\", JOURNAL = c(\"Nat Immunol 3:807-13 (2002)\", \"DOI:10.1038/ni0902-807\")), list(REFERENCE = \"PMID:11062493\", AUTHORS = \"Perussia B.\", TITLE = \"Signaling for cytotoxicity.\", JOURNAL = c(\"Nat Immunol 1:372-4 (2000)\", \"DOI:10.1038/80808\")), list(REFERENCE = \"PMID:15607806\", AUTHORS = \"Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.\", TITLE = \"Activation of NK cell cytotoxicity.\", JOURNAL = c(\"Mol Immunol 42:501-10 (2005)\", \"DOI:10.1016/j.molimm.2004.07.034\")), list(REFERENCE = \"PMID:11895890\", AUTHORS = \"Djeu JY, Jiang K, Wei S.\", TITLE = \"A view to a kill: signals triggering cytotoxicity.\", JOURNAL = \"Clin Cancer Res 8:636-40 (2002)\"), list(REFERENCE = \"PMID:12530970\", AUTHORS = \"Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.\", TITLE = \"Nature\'s TRAIL--on a path to cancer immunotherapy.\", JOURNAL = c(\"Immunity 18:1-6 (2003)\", \"DOI:10.1016/S1074-7613(02)00502-2\")), list(REFERENCE = \"PMID:16177799\", AUTHORS = \"Colonna M.\", TITLE = \"Fine-tuning NK cell responses: it\'s a family affair.\", JOURNAL = c(\"Nat Immunol 6:961-2 (2005)\", \"DOI:10.1038/ni1005-961\")), list(REFERENCE = \"PMID:8942070\", AUTHORS = \"Bonnema JD, Leibson PJ.\", TITLE = \"Signal transduction during NK cell activation.\", JOURNAL = \"Chem Immunol 64:28-43 (1996)\"), list(REFERENCE = \"PMID:16002670\", AUTHORS = \"Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.\", TITLE = \"Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.\", JOURNAL = c(\"J Immunol 175:749-54 (2005)\", \"DOI:10.4049/jimmunol.175.2.749\")), list(REFERENCE = \"PMID:9143705\", AUTHORS = \"Rao A, Luo C, Hogan PG.\", TITLE = \"Transcription factors of the NFAT family: regulation and function.\", JOURNAL = c(\"Annu Rev Immunol 15:707-47 (1997)\", \"DOI:10.1146/annurev.immunol.15.1.707\")), list(REFERENCE = \"PMID:14710949\", AUTHORS = \"Wu J, Lanier LL.\", TITLE = \"Natural killer cells and cancer.\", JOURNAL = c(\"Adv Cancer Res 90:127-56 (2003)\", \"DOI:10.1016/S0065-230X(03)90004-2\")), list(REFERENCE = \"PMID:11905813\", AUTHORS = \"Cerwenka A, Lanier LL.\", TITLE = \"Natural killer cells, viruses and cancer.\", JOURNAL = c(\"Nat Rev Immunol 1:41-9 (2001)\", \"DOI:10.1038/35095564\")), list(REFERENCE = \"PMID:11836514\", AUTHORS = \"Blott EJ, Griffiths GM.\", TITLE = \"Secretory lysosomes.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 3:122-31 (2002)\", \"DOI:10.1038/nrm732\")), list(REFERENCE = \"PMID:12766758\", AUTHORS = \"Lieberman J.\", TITLE = \"The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.\", JOURNAL = c(\"Nat Rev Immunol 3:361-70 (2003)\", \"DOI:10.1038/nri1083\")), list(REFERENCE = \"PMID:12752668\", AUTHORS = \"Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.\", TITLE = \"Granzyme B: a natural born killer.\", JOURNAL = c(\"Immunol Rev 193:31-8 (2003)\", \"DOI:10.1034/j.1600-065X.2003.00044.x\")), list(REFERENCE = \"PMID:15618404\", AUTHORS = \"Liu D, Xu L, Yang F, Li D, Gong F, Xu T.\", TITLE = \"Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 102:123-7 (2005)\", \"DOI:10.1073/pnas.0405737102\")), list(REFERENCE = \"PMID:9862693\", AUTHORS = \"Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.\", TITLE = \"Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.\", JOURNAL = \"J Immunol 161:6648-56 (1998)\"), list(REFERENCE = \"PMID:11390470\", AUTHORS = \"Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.\", TITLE = \"Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.\", JOURNAL = c(\"J Immunol 166:7219-28 (2001)\", \"DOI:10.4049/jimmunol.166.12.7219\"))', 'map04650', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (311, '04657', 'IL-17 signaling pathway', 'The interleukin 17 (IL-17) family, a subset of cytokines consisting of IL-17A-F, plays crucial roles in both acute and chronic inflammatory responses. IL-17A, the hallmark cytokine of the newly defined T helper 17 (TH17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease, whereas IL-17F is mainly involved in mucosal host defense mechanisms. IL-17E (IL-25) is an amplifier of Th2 immune responses. IL-17C has biological functions similar to those of IL-17A. The functions of IL-17B and IL-17D remain largely elusive. The IL-17 family signals via their correspondent receptors and activates downstream pathways that include NF-kappaB, MAPKs and C/EBPs to induce the expression of antimicrobial peptides, cytokines and chemokines. The receptor proximal adaptor Act1 (an NF-kappaB activator 1) is considered as the master mediator in IL-17A signaling. It is likely that Act1 is a common signal adaptor also shared by other members mediated signalings in this family.', 'Organismal Systems; Immune system', 'IL-17 signaling pathway', 'GO: 0097400', 'ko04657', 'list(REFERENCE = \"PMID:23917206\", AUTHORS = \"Song X, Qian Y\", TITLE = \"IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases.\", JOURNAL = c(\"Cell Signal 25:2335-47 (2013)\", \"DOI:10.1016/j.cellsig.2013.07.021\")), list(REFERENCE = \"PMID:23557798\", AUTHORS = \"Song X, Qian Y\", TITLE = \"The activation and regulation of IL-17 receptor mediated signaling.\", JOURNAL = c(\"Cytokine 62:175-82 (2013)\", \"DOI:10.1016/j.cyto.2013.03.014\")), list(REFERENCE = \"PMID:24011563\", AUTHORS = \"Gu C, Wu L, Li X\", TITLE = \"IL-17 family: cytokines, receptors and signaling.\", JOURNAL = c(\"Cytokine 64:477-85 (2013)\", \"DOI:10.1016/j.cyto.2013.07.022\")), list(REFERENCE = \"PMID:25145755\", AUTHORS = \"Gaffen SL, Jain R, Garg AV, Cua DJ\", TITLE = \"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.\", JOURNAL = c(\"Nat Rev Immunol 14:585-600 (2014)\", \"DOI:10.1038/nri3707\")), list(REFERENCE = \"PMID:21349428\", AUTHORS = \"Iwakura Y, Ishigame H, Saijo S, Nakae S\", TITLE = \"Functional specialization of interleukin-17 family members.\", JOURNAL = c(\"Immunity 34:149-62 (2011)\", \"DOI:10.1016/j.immuni.2011.02.012\")), list(REFERENCE = \"PMID:20514051\", AUTHORS = \"Qian Y, Kang Z, Liu C, Li X\", TITLE = \"IL-17 signaling in host defense and inflammatory diseases.\", JOURNAL = c(\"Cell Mol Immunol 7:328-33 (2010)\", \"DOI:10.1038/cmi.2010.27\")), list(REFERENCE = \"PMID:22324470\", AUTHORS = \"Zhu S, Qian Y\", TITLE = \"IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.\", JOURNAL = c(\"Clin Sci (Lond) 122:487-511 (2012)\", \"DOI:10.1042/CS20110496\")), list(REFERENCE = \"PMID:26252407\", AUTHORS = \"Zenobia C, Hajishengallis G\", TITLE = \"Basic biology and role of interleukin-17 in immunity and inflammation.\", JOURNAL = c(\"Periodontol 2000 69:142-59 (2015)\", \"DOI:10.1111/prd.12083\")), list(REFERENCE = \"PMID:21074482\", AUTHORS = \"Reynolds JM, Angkasekwinai P, Dong C\", TITLE = \"IL-17 family member cytokines: regulation and function in innate immunity.\", JOURNAL = c(\"Cytokine Growth Factor Rev 21:413-23 (2010)\", \"DOI:10.1016/j.cytogfr.2010.10.002\")), list(REFERENCE = \"PMID:21852080\", AUTHORS = \"Gaffen SL\", TITLE = \"Recent advances in the IL-17 cytokine family.\", JOURNAL = c(\"Curr Opin Immunol 23:613-9 (2011)\", \"DOI:10.1016/j.coi.2011.07.006\")), list(REFERENCE = \"PMID:18701318\", AUTHORS = \"Gaffen SL\", TITLE = \"An overview of IL-17 function and signaling.\", JOURNAL = c(\"Cytokine 43:402-7 (2008)\", \"DOI:10.1016/j.cyto.2008.07.017\")), list(REFERENCE = \"PMID:21155836\", AUTHORS = \"Hu Y, Shen F, Crellin NK, Ouyang W\", TITLE = \"The IL-17 pathway as a major therapeutic target in autoimmune diseases.\", JOURNAL = c(\"Ann N Y Acad Sci 1217:60-76 (2011)\", \"DOI:10.1111/j.1749-6632.2010.05825.x\")), list(REFERENCE = \"PMID:20383173\", AUTHORS = \"Xu S, Cao X\", TITLE = \"Interleukin-17 and its expanding biological functions.\", JOURNAL = c(\"Cell Mol Immunol 7:164-74 (2010)\", \"DOI:10.1038/cmi.2010.21\")), list(REFERENCE = \"PMID:20177959\", AUTHORS = \"Pappu R, Ramirez-Carrozzi V, Ota N, Ouyang W, Hu Y\", TITLE = \"The IL-17 family cytokines in immunity and disease.\", JOURNAL = c(\"J Clin Immunol 30:185-95 (2010)\", \"DOI:10.1007/s10875-010-9369-6\")), list(REFERENCE = \"PMID:19575028\", AUTHORS = \"Gaffen SL\", TITLE = \"Structure and signalling in the IL-17 receptor family.\", JOURNAL = c(\"Nat Rev Immunol 9:556-67 (2009)\", \"DOI:10.1038/nri2586\")), list(REFERENCE = \"PMID:18178098\", AUTHORS = \"Shen F, Gaffen SL\", TITLE = \"Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.\", JOURNAL = c(\"Cytokine 41:92-104 (2008)\", \"DOI:10.1016/j.cyto.2007.11.013\")), list(REFERENCE = \"PMID:23116200\", AUTHORS = \"Doyle MS, Collins ES, FitzGerald OM, Pennington SR\", TITLE = \"New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis.\", JOURNAL = c(\"Arthritis Res Ther 14:226 (2012)\", \"DOI:10.1186/ar4071\")), list(REFERENCE = \"PMID:17027518\", AUTHORS = \"Gaffen SL, Kramer JM, Yu JJ, Shen F\", TITLE = \"The IL-17 cytokine family.\", JOURNAL = c(\"Vitam Horm 74:255-82 (2006)\", \"DOI:10.1016/S0083-6729(06)74010-9\")), list(REFERENCE = \"PMID:21130872\", AUTHORS = \"Chang SH, Dong C\", TITLE = \"Signaling of interleukin-17 family cytokines in immunity and inflammation.\", JOURNAL = c(\"Cell Signal 23:1069-75 (2011)\", \"DOI:10.1016/j.cellsig.2010.11.022\")), list(REFERENCE = \"PMID:17921324\", AUTHORS = \"Cortez DM, Feldman MD, Mummidi S, Valente AJ, Steffensen B, Vincenti M, Barnes JL, Chandrasekar B\", TITLE = \"IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.\", JOURNAL = c(\"Am J Physiol Heart Circ Physiol 293:H3356-65 (2007)\", \"DOI:10.1152/ajpheart.00928.2007\")), list(REFERENCE = \"PMID:22851696\", AUTHORS = \"Qu F, Gao H, Zhu S, Shi P, Zhang Y, Liu Y, Jallal B, Yao Y, Shi Y, Qian Y\", TITLE = \"TRAF6-dependent Act1 phosphorylation by the IkappaB kinase-related kinases suppresses interleukin-17-induced NF-kappaB activation.\", JOURNAL = c(\"Mol Cell Biol 32:3925-37 (2012)\", \"DOI:10.1128/MCB.00268-12\")), list(REFERENCE = \"PMID:17177681\", AUTHORS = \"Sharkhuu T, Matthaei KI, Forbes E, Mahalingam S, Hogan SP, Hansbro PM, Foster PS\", TITLE = \"Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.\", JOURNAL = c(\"Clin Exp Allergy 36:1575-83 (2006)\", \"DOI:10.1111/j.1365-2222.2006.02595.x\"))', 'map04657', 'IL-17 signaling pathway', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (312, '04658', 'Th1 and Th2 cell differentiation', 'Immunity to different classes of microorganisms is orchestrated by separate lineages of effector T helper (TH)-cells, which differentiate from naive CD4+ precursor cells in response to cues provided by antigen presenting cells (APC) and include T helper type 1 (Th1) and Th2. Th1 cells are characterized by the transcription factor T-bet and signal transducer and activator of transcription (STAT) 4, and the production of IFN-gamma. These cells stimulate strong cell-mediated immune responses, particularly against intracellular pathogens. On the other hand, transcription factors like GATA-3 and STAT6 drive the generation of Th2 cells that produce IL-4, IL-5 and IL-13 and are necessary for inducing the humoral response to combat parasitic helminths (type 2 immunity) and isotype switching to IgG1 and IgE. The balance between Th1/Th2 subsets determines the susceptibility to disease states, where the improper development of Th2 cells can lead to allergy, while an overactive Th1 response can lead to autoimmunity.', 'Organismal Systems; Immune system', 'Th1 and Th2 cell differentiation', 'Adams-Oliver syndrome', 'GO: 0045063, 0045064', 'ko04658', 'list(REFERENCE = \"PMID:19375293\", AUTHORS = \"Amsen D, Spilianakis CG, Flavell RA\", TITLE = \"How are T(H)1 and T(H)2 effector cells made?\", JOURNAL = c(\"Curr Opin Immunol 21:153-60 (2009)\", \"DOI:10.1016/j.coi.2009.03.010\")), list(REFERENCE = \"PMID:22044277\", AUTHORS = \"Knosp CA, Johnston JA\", TITLE = \"Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins.\", JOURNAL = c(\"Immunology 135:101-11 (2012)\", \"DOI:10.1111/j.1365-2567.2011.03520.x\")), list(REFERENCE = \"PMID:11752608\", AUTHORS = \"Dong C, Flavell RA\", TITLE = \"Control of T helper cell differentiation--in search of master genes.\", JOURNAL = c(\"Sci STKE 2000:pe1 (2000)\", \"DOI:10.1126/stke.2000.49.pe1\")), list(REFERENCE = \"PMID:11121747\", AUTHORS = \"O\'Garra A, Arai N\", TITLE = \"The molecular basis of T helper 1 and T helper 2 cell differentiation.\", JOURNAL = c(\"Trends Cell Biol 10:542-50 (2000)\", \"DOI:10.1016/S0962-8924(00)01856-0\")), list(REFERENCE = \"PMID:23624818\", AUTHORS = \"Hong CC, Yao S, McCann SE, Dolnick RY, Wallace PK, Gong Z, Quan L, Lee KP, Evans SS, Repasky EA, Edge SB, Ambrosone CB\", TITLE = \"Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers.\", JOURNAL = c(\"Breast Cancer Res Treat 139:477-88 (2013)\", \"DOI:10.1007/s10549-013-2549-3\")), list(REFERENCE = \"PMID:23405903\", AUTHORS = \"Kolls JK\", TITLE = \"CD4(+) T-cell subsets and host defense in the lung.\", JOURNAL = c(\"Immunol Rev 252:156-63 (2013)\", \"DOI:10.1111/imr.12030\")), list(REFERENCE = \"PMID:20969597\", AUTHORS = \"Zhu J, Paul WE\", TITLE = \"Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors.\", JOURNAL = c(\"Immunol Rev 238:247-62 (2010)\", \"DOI:10.1111/j.1600-065X.2010.00951.x\")), list(REFERENCE = \"PMID:19151746\", AUTHORS = \"Wilson CB, Rowell E, Sekimata M\", TITLE = \"Epigenetic control of T-helper-cell differentiation.\", JOURNAL = c(\"Nat Rev Immunol 9:91-105 (2009)\", \"DOI:10.1038/nri2487\")), list(REFERENCE = \"PMID:15819694\", AUTHORS = \"Callard RE, Yates AJ\", TITLE = \"Immunology and mathematics: crossing the divide.\", JOURNAL = c(\"Immunology 115:21-33 (2005)\", \"DOI:10.1111/j.1365-2567.2005.02142.x\")), list(REFERENCE = \"PMID:24113868\", AUTHORS = \"Lazarevic V, Glimcher LH, Lord GM\", TITLE = \"T-bet: a bridge between innate and adaptive immunity.\", JOURNAL = c(\"Nat Rev Immunol 13:777-89 (2013)\", \"DOI:10.1038/nri3536\")), list(REFERENCE = \"PMID:12171942\", AUTHORS = \"Weigmann B, Neurath MF\", TITLE = \"T-bet and mucosal Th1 responses in the gastrointestinal tract.\", JOURNAL = c(\"Gut 51:301-3 (2002)\", \"DOI:10.1136/gut.51.3.301\")), list(REFERENCE = \"PMID:19362457\", AUTHORS = \"Adamson AS, Collins K, Laurence A, O\'Shea JJ\", TITLE = \"The Current STATus of lymphocyte signaling: new roles for old players.\", JOURNAL = c(\"Curr Opin Immunol 21:161-6 (2009)\", \"DOI:10.1016/j.coi.2009.03.013\")), list(REFERENCE = \"PMID:20065998\", AUTHORS = \"Zhu J\", TITLE = \"Transcriptional regulation of Th2 cell differentiation.\", JOURNAL = c(\"Immunol Cell Biol 88:244-9 (2010)\", \"DOI:10.1038/icb.2009.114\")), list(REFERENCE = \"PMID:26044597\", AUTHORS = \"Zhu J\", TITLE = \"T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production.\", JOURNAL = c(\"Cytokine 75:14-24 (2015)\", \"DOI:10.1016/j.cyto.2015.05.010\")), list(REFERENCE = \"PMID:19151747\", AUTHORS = \"Ho IC, Tai TS, Pai SY\", TITLE = \"GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation.\", JOURNAL = c(\"Nat Rev Immunol 9:125-35 (2009)\", \"DOI:10.1038/nri2476\")), list(REFERENCE = \"PMID:19165228\", AUTHORS = \"Amsen D, Antov A, Flavell RA\", TITLE = \"The different faces of Notch in T-helper-cell differentiation.\", JOURNAL = c(\"Nat Rev Immunol 9:116-24 (2009)\", \"DOI:10.1038/nri2488\")), list(REFERENCE = \"PMID:23336087\", AUTHORS = \"Pahan K, Mondal S\", TITLE = \"Crosstalk between Nitric Oxide and T helper cells.\", JOURNAL = \"J Clin Cell Immunol 3:e109 (2012)\"), list(REFERENCE = \"PMID:22566933\", AUTHORS = \"Schmidt A, Oberle N, Krammer PH\", TITLE = \"Molecular mechanisms of treg-mediated T cell suppression.\", JOURNAL = c(\"Front Immunol 3:51 (2012)\", \"DOI:10.3389/fimmu.2012.00051\"))', 'map04658', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (313, '04659', 'Th17 cell differentiation', 'Interleukin (IL)-17-producing helper T (Th17) cells serve as a subset of CD4+ T cells involved in epithelial cell- and neutrophil mediated immune responses against extracellular microbes and in the pathogenesis of autoimmune diseases. In vivo, Th17 differentiation requires antigen presentation and co-stimulation, and activation of antigen presenting-cells (APCs) to produce TGF-beta, IL-6, IL-1, IL-23 and IL-21. This initial activation results in the activation and up-regulation of STAT3, ROR(gamma)t and other transcriptional factors in CD4+ T cells, which bind to the promoter regions of the IL-17, IL-21 and IL-22 genes and induce IL-17, IL-21 and IL-22. In contrast, the differentiation of Th17 cells and their IL-17 expression are negatively regulated by IL-2, Th2 cytokine IL-4, IL-27 and Th1 cytokine IFN-gamma through STAT5, STAT6 and STAT1 activation, respectively. Retinoid acid and the combination of IL-2 and TGF-beta upregulate Foxp3, which also downregulates cytokines like IL-17 and IL-21. The inhibition of Th17 differentiation may serve as a protective strategy to \'fine-tune\' the expression IL-17 so it does not cause excessive inflammation. Thus, balanced differentiation of Th cells is crucial for immunity and host protection.', 'Organismal Systems; Immune system', 'Th17 cell differentiation', 'IPEX syndrome', 'GO: 0072539', 'ko04659', 'list(REFERENCE = \"PMID:23325835\", AUTHORS = \"Muranski P, Restifo NP\", TITLE = \"Essentials of Th17 cell commitment and plasticity.\", JOURNAL = c(\"Blood 121:2402-14 (2013)\", \"DOI:10.1182/blood-2012-09-378653\")), list(REFERENCE = \"PMID:19379825\", AUTHORS = \"O\'Shea JJ, Steward-Tharp SM, Laurence A, Watford WT, Wei L, Adamson AS, Fan S\", TITLE = \"Signal transduction and Th17 cell differentiation.\", JOURNAL = c(\"Microbes Infect 11:599-611 (2009)\", \"DOI:10.1016/j.micinf.2009.04.007\")), list(REFERENCE = \"PMID:21084214\", AUTHORS = \"Hirahara K, Ghoreschi K, Laurence A, Yang XP, Kanno Y, O\'Shea JJ\", TITLE = \"Signal transduction pathways and transcriptional regulation in Th17 cell differentiation.\", JOURNAL = c(\"Cytokine Growth Factor Rev 21:425-34 (2010)\", \"DOI:10.1016/j.cytogfr.2010.10.006\")), list(REFERENCE = \"PMID:18166487\", AUTHORS = \"Chen Z, Laurence A, O\'Shea JJ\", TITLE = \"Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation.\", JOURNAL = c(\"Semin Immunol 19:400-8 (2007)\", \"DOI:10.1016/j.smim.2007.10.015\")), list(REFERENCE = \"PMID:22640807\", AUTHORS = \"Maddur MS, Miossec P, Kaveri SV, Bayry J\", TITLE = \"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.\", JOURNAL = c(\"Am J Pathol 181:8-18 (2012)\", \"DOI:10.1016/j.ajpath.2012.03.044\")), list(REFERENCE = \"PMID:23036716\", AUTHORS = \"Hemdan NY, Birkenmeier G, Wichmann G\", TITLE = \"Key molecules in the differentiation and commitment program of T helper 17 (Th17) cells up-to-date.\", JOURNAL = c(\"Immunol Lett 148:97-109 (2012)\", \"DOI:10.1016/j.imlet.2012.09.007\")), list(REFERENCE = \"PMID:18408735\", AUTHORS = \"Dong C\", TITLE = \"TH17 cells in development: an updated view of their molecular identity and genetic programming.\", JOURNAL = c(\"Nat Rev Immunol 8:337-48 (2008)\", \"DOI:10.1038/nri2295\")), list(REFERENCE = \"PMID:20054607\", AUTHORS = \"Torchinsky MB, Blander JM\", TITLE = \"T helper 17 cells: discovery, function, and physiological trigger.\", JOURNAL = c(\"Cell Mol Life Sci 67:1407-21 (2010)\", \"DOI:10.1007/s00018-009-0248-3\")), list(REFERENCE = \"PMID:19381306\", AUTHORS = \"Jetten AM\", TITLE = \"Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism.\", JOURNAL = c(\"Nucl Recept Signal 7:e003 (2009)\", \"DOI:10.1621/nrs.07003\")), list(REFERENCE = \"PMID:22133865\", AUTHORS = \"Oestreich KJ, Weinmann AS\", TITLE = \"T-bet employs diverse regulatory mechanisms to repress transcription.\", JOURNAL = c(\"Trends Immunol 33:78-83 (2012)\", \"DOI:10.1016/j.it.2011.10.005\")), list(REFERENCE = \"PMID:24325586\", AUTHORS = \"Manni ML, Robinson KM, Alcorn JF\", TITLE = \"A tale of two cytokines: IL-17 and IL-22 in asthma and infection.\", JOURNAL = c(\"Expert Rev Respir Med 8:25-42 (2014)\", \"DOI:10.1586/17476348.2014.854167\")), list(REFERENCE = \"PMID:21776333\", AUTHORS = \"Sha Y, Markovic-Plese S\", TITLE = \"A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases.\", JOURNAL = c(\"Self Nonself 2:35-42 (2011)\", \"DOI:10.4161/self.2.1.15639\")), list(REFERENCE = \"PMID:20488727\", AUTHORS = \"Nakayama T, Yamashita M\", TITLE = \"The TCR-mediated signaling pathways that control the direction of helper T cell differentiation.\", JOURNAL = c(\"Semin Immunol 22:303-9 (2010)\", \"DOI:10.1016/j.smim.2010.04.010\")), list(REFERENCE = \"PMID:21151104\", AUTHORS = \"Lazarevic V, Chen X, Shim JH, Hwang ES, Jang E, Bolm AN, Oukka M, Kuchroo VK, Glimcher LH\", TITLE = \"T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat.\", JOURNAL = c(\"Nat Immunol 12:96-104 (2011)\", \"DOI:10.1038/ni.1969\")), list(REFERENCE = \"PMID:22754770\", AUTHORS = \"Pan F, Barbi J, Pardoll DM\", TITLE = \"Hypoxia-inducible factor 1: A link between metabolism and T cell differentiation and a potential therapeutic target.\", JOURNAL = c(\"Oncoimmunology 1:510-515 (2012)\", \"DOI:10.4161/onci.19457\")), list(REFERENCE = \"PMID:18362914\", AUTHORS = \"Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, Stockinger B\", TITLE = \"The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins.\", JOURNAL = c(\"Nature 453:106-9 (2008)\", \"DOI:10.1038/nature06881\")), list(REFERENCE = \"PMID:17768419\", AUTHORS = \"Deenick EK, Tangye SG\", TITLE = \"Autoimmunity: IL-21: a new player in Th17-cell differentiation.\", JOURNAL = c(\"Immunol Cell Biol 85:503-5 (2007)\", \"DOI:10.1038/sj.icb.7100114\")), list(REFERENCE = \"PMID:26253381\", AUTHORS = \"Meka RR, Venkatesha SH, Dudics S, Acharya B, Moudgil KD\", TITLE = \"IL-27-induced modulation of autoimmunity and its therapeutic potential.\", JOURNAL = c(\"Autoimmun Rev 14:1131-41 (2015)\", \"DOI:10.1016/j.autrev.2015.08.001\")), list(REFERENCE = \"PMID:16200068\", AUTHORS = \"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C\", TITLE = \"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.\", JOURNAL = c(\"Nat Immunol 6:1133-41 (2005)\", \"DOI:10.1038/ni1261\")), list(REFERENCE = \"PMID:22324470\", AUTHORS = \"Zhu S, Qian Y\", TITLE = \"IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.\", JOURNAL = c(\"Clin Sci (Lond) 122:487-511 (2012)\", \"DOI:10.1042/CS20110496\"))', 'map04659', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (314, '04660', 'T cell receptor signaling pathway', 'Activation of T lymphocytes is a key event for an efficient response of the immune system. It requires the involvement of the T-cell receptor (TCR) as well as costimulatory molecules such as CD28. Engagement of these receptors through the interaction with a foreign antigen associated with major histocompatibility complex molecules and CD28 counter-receptors B7.1/B7.2, respectively, results in a series of signaling cascades. These cascades comprise an array of protein-tyrosine kinases, phosphatases, GTP-binding proteins and adaptor proteins that regulate generic and specialised functions, leading to T-cell proliferation, cytokine production and differentiation into effector cells.', 'Organismal Systems; Immune system', 'T cell receptor signaling pathway', 'Type 1 diabetes mellitus, Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID), Incontinentia pigmenti, Cocoon syndrome, Activated PI3K-delta syndrome, Rasmussen encephalitis, Lymphoproliferative syndrome 1', 'GO: 0050852', 'ko04660', 'list(REFERENCE = \"PMID:15122199\", AUTHORS = \"Chen L.\", TITLE = \"Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity.\", JOURNAL = c(\"Nat Rev Immunol 4:336-47 (2004)\", \"DOI:10.1038/nri1349\")), list(REFERENCE = \"PMID:15928679\", AUTHORS = \"Macian F.\", TITLE = \"NFAT proteins: key regulators of T-cell development and function.\", JOURNAL = c(\"Nat Rev Immunol 5:472-84 (2005)\", \"DOI:10.1038/nri1632\")), list(REFERENCE = \"PMID:15771581\", AUTHORS = \"Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL.\", TITLE = \"Tec family kinases in T lymphocyte development and function.\", JOURNAL = c(\"Annu Rev Immunol 23:549-600 (2005)\", \"DOI:10.1146/annurev.immunol.22.012703.104743\")), list(REFERENCE = \"PMID:15084594\", AUTHORS = \"Huang Y, Wange RL.\", TITLE = \"T cell receptor signaling: beyond complex complexes.\", JOURNAL = c(\"J Biol Chem 279:28827-30 (2004)\", \"DOI:10.1074/jbc.R400012200\")), list(REFERENCE = \"PMID:14656980\", AUTHORS = \"Schmitz ML, Bacher S, Dienz O.\", TITLE = \"NF-kappaB activation pathways induced by T cell costimulation.\", JOURNAL = c(\"FASEB J 17:2187-93 (2003)\", \"DOI:10.1096/fj.02-1100rev\")), list(REFERENCE = \"PMID:11905831\", AUTHORS = \"Alegre ML, Frauwirth KA, Thompson CB.\", TITLE = \"T-cell regulation by CD28 and CTLA-4.\", JOURNAL = c(\"Nat Rev Immunol 1:220-8 (2001)\", \"DOI:10.1038/35105024\")), list(REFERENCE = \"PMID:15286727\", AUTHORS = \"Horejsi V, Zhang W, Schraven B.\", TITLE = \"Transmembrane adaptor proteins: organizers of immunoreceptor signalling.\", JOURNAL = c(\"Nat Rev Immunol 4:603-16 (2004)\", \"DOI:10.1038/nri1414\")), list(REFERENCE = \"PMID:15343367\", AUTHORS = \"Baniyash M.\", TITLE = \"TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response.\", JOURNAL = c(\"Nat Rev Immunol 4:675-87 (2004)\", \"DOI:10.1038/nri1434\")), list(REFERENCE = \"PMID:15099566\", AUTHORS = \"Sechi AS, Wehland J.\", TITLE = \"Interplay between TCR signalling and actin cytoskeleton dynamics.\", JOURNAL = c(\"Trends Immunol 25:257-65 (2004)\", \"DOI:10.1016/j.it.2004.03.003\")), list(REFERENCE = \"PMID:12669022\", AUTHORS = \"Okkenhaug K, Vanhaesebroeck B.\", TITLE = \"PI3K in lymphocyte development, differentiation and activation.\", JOURNAL = c(\"Nat Rev Immunol 3:317-30 (2003)\", \"DOI:10.1038/nri1056\")), list(REFERENCE = \"PMID:15489916\", AUTHORS = \"Palacios EH, Weiss A.\", TITLE = \"Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation.\", JOURNAL = c(\"Oncogene 23:7990-8000 (2004)\", \"DOI:10.1038/sj.onc.1208074\")), list(REFERENCE = \"PMID:12133805\", AUTHORS = \"Kane LP, Lin J, Weiss A.\", TITLE = \"It\'s all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation.\", JOURNAL = c(\"Trends Immunol 23:413-20 (2002)\", \"DOI:10.1016/S1471-4906(02)02264-0\")), list(REFERENCE = \"PMID:14647476\", AUTHORS = \"Acuto O, Michel F.\", TITLE = \"CD28-mediated co-stimulation: a quantitative support for TCR signalling.\", JOURNAL = c(\"Nat Rev Immunol 3:939-51 (2003)\", \"DOI:10.1038/nri1248\")), list(REFERENCE = \"PMID:15308211\", AUTHORS = \"Finkelstein LD, Schwartzberg PL.\", TITLE = \"Tec kinases: shaping T-cell activation through actin.\", JOURNAL = c(\"Trends Cell Biol 14:443-51 (2004)\", \"DOI:10.1016/j.tcb.2003.07.001\")), list(REFERENCE = \"PMID:15345216\", AUTHORS = \"Duan L, Reddi AL, Ghosh A, Dimri M, Band H.\", TITLE = \"The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling.\", JOURNAL = c(\"Immunity 21:7-17 (2004)\", \"DOI:10.1016/j.immuni.2004.06.012\")), list(REFERENCE = \"PMID:14617194\", AUTHORS = \"Schrum AG, Turka LA, Palmer E.\", TITLE = \"Surface T-cell antigen receptor expression and availability for long-term antigenic signaling.\", JOURNAL = c(\"Immunol Rev 196:7-24 (2003)\", \"DOI:10.1046/j.1600-065X.2003.00083.x\")), list(REFERENCE = \"PMID:19132916\", AUTHORS = \"Smith-Garvin JE, Koretzky GA, Jordan MS\", TITLE = \"T cell activation.\", JOURNAL = c(\"Annu Rev Immunol 27:591-619 (2009)\", \"DOI:10.1146/annurev.immunol.021908.132706\")), list(REFERENCE = \"PMID:12195013\", AUTHORS = \"Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO\", TITLE = \"Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 99:11796-801 (2002)\", \"DOI:10.1073/pnas.092284399\")), list(REFERENCE = \"PMID:19290929\", AUTHORS = \"Blonska M, Lin X\", TITLE = \"CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.\", JOURNAL = c(\"Immunol Rev 228:199-211 (2009)\", \"DOI:10.1111/j.1600-065X.2008.00749.x\")), list(REFERENCE = \"PMID:17395537\", AUTHORS = \"Rebeaud F, Hailfinger S, Thome M\", TITLE = \"Dlgh1 and Carma1 MAGUK proteins contribute to signal specificity downstream of TCR activation.\", JOURNAL = c(\"Trends Immunol 28:196-200 (2007)\", \"DOI:10.1016/j.it.2007.03.004\")), list(REFERENCE = \"PMID:16799472\", AUTHORS = \"Ashwell JD\", TITLE = \"The many paths to p38 mitogen-activated protein kinase activation in the immune system.\", JOURNAL = c(\"Nat Rev Immunol 6:532-40 (2006)\", \"DOI:10.1038/nri1865\")), list(REFERENCE = \"PMID:17187070\", AUTHORS = \"Round JL, Humphries LA, Tomassian T, Mittelstadt P, Zhang M, Miceli MC\", TITLE = \"Scaffold protein Dlgh1 coordinates alternative p38 kinase activation, directing T cell receptor signals toward NFAT but not NF-kappaB transcription factors.\", JOURNAL = c(\"Nat Immunol 8:154-61 (2007)\", \"DOI:10.1038/ni1422\"))', 'map04660', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (315, '04662', 'B cell receptor signaling pathway', 'B cells are an important component of adaptive immunity. They produce and secrete millions of different antibody molecules, each of which recognizes a different (foreign) antigen. The B cell receptor (BCR) is an integral membrane protein complex that is composed of two immunoglobulin (Ig) heavy chains, two Ig light chains and two heterodimers of Ig-alpha and Ig-beta. After BCR ligation by antigen, three main protein tyrosine kinases (PTKs) -the SRC-family kinase LYN, SYK and the TEC-family kinase BTK- are activated. Phosphatidylinositol 3-kinase (PI3K) and phospholipase C-gamma 2 (PLC-gamma 2) are important downstream effectors of BCR signalling. This signalling ultimately results in the expression of immediate early genes that further activate the expression of other genes involved in B cell proliferation, differentiation and Ig production as well as other processes.', 'Organismal Systems; Immune system', 'B cell receptor signaling pathway', 'Osteoporosis, lymphedema, anhydrotic ectodermal dysplasia with immunodeficiency (OLEDAID), Incontinentia pigmenti, Cocoon syndrome, Activated PI3K-delta syndrome', 'GO: 0050853', 'ko04662', 'list(REFERENCE = \"PMID:12461567\", AUTHORS = \"Niiro H, Clark EA.\", TITLE = \"Regulation of B-cell fate by antigen-receptor signals.\", JOURNAL = c(\"Nat Rev Immunol 2:945-56 (2002)\", \"DOI:10.1038/nri955\")), list(REFERENCE = \"PMID:10358768\", AUTHORS = \"Kurosaki T.\", TITLE = \"Genetic analysis of B cell antigen receptor signaling.\", JOURNAL = c(\"Annu Rev Immunol 17:555-92 (1999)\", \"DOI:10.1146/annurev.immunol.17.1.555\")), list(REFERENCE = \"PMID:15886119\", AUTHORS = \"Nitschke L.\", TITLE = \"The role of CD22 and other inhibitory co-receptors in B-cell activation.\", JOURNAL = c(\"Curr Opin Immunol 17:290-7 (2005)\", \"DOI:10.1016/j.coi.2005.03.005\")), list(REFERENCE = \"PMID:15752555\", AUTHORS = \"Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM.\", TITLE = \"Complement: central to innate immunity and bridging to adaptive responses.\", JOURNAL = c(\"Immunol Lett 97:171-9 (2005)\", \"DOI:10.1016/j.imlet.2004.11.010\")), list(REFERENCE = \"PMID:12033741\", AUTHORS = \"Kurosaki T.\", TITLE = \"Regulation of B-cell signal transduction by adaptor proteins.\", JOURNAL = c(\"Nat Rev Immunol 2:354-63 (2002)\", \"DOI:10.1038/nri801\")), list(REFERENCE = \"PMID:15364057\", AUTHORS = \"Nitschke L, Tsubata T.\", TITLE = \"Molecular interactions regulate BCR signal inhibition by CD22 and CD72.\", JOURNAL = c(\"Trends Immunol 25:543-50 (2004)\", \"DOI:10.1016/j.it.2004.08.002\")), list(REFERENCE = \"PMID:15771577\", AUTHORS = \"Jumaa H, Hendriks RW, Reth M.\", TITLE = \"B cell signaling and tumorigenesis.\", JOURNAL = c(\"Annu Rev Immunol 23:415-45 (2005)\", \"DOI:10.1146/annurev.immunol.23.021704.115606\")), list(REFERENCE = \"PMID:15886112\", AUTHORS = \"Rickert RC.\", TITLE = \"Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.\", JOURNAL = c(\"Curr Opin Immunol 17:237-43 (2005)\", \"DOI:10.1016/j.coi.2005.03.001\")), list(REFERENCE = \"PMID:15457440\", AUTHORS = \"Zouali M, Sarmay G\", TITLE = \"B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.\", JOURNAL = c(\"Arthritis Rheum 50:2730-41 (2004)\", \"DOI:10.1002/art.20487\")), list(REFERENCE = \"PMID:15322145\", AUTHORS = \"Chiles TC.\", TITLE = \"Regulation and function of cyclin D2 in B lymphocyte subsets.\", JOURNAL = c(\"J Immunol 173:2901-7 (2004)\", \"DOI:10.4049/jimmunol.173.5.2901\")), list(REFERENCE = \"PMID:15626471\", AUTHORS = \"Allam A, Marshall AJ\", TITLE = \"Role of the adaptor proteins Bam32, TAPP1 and TAPP2 in lymphocyte activation.\", JOURNAL = c(\"Immunol Lett 97:7-17 (2005)\", \"DOI:10.1016/j.imlet.2004.09.019\")), list(REFERENCE = \"PMID:12119152\", AUTHORS = \"Gold MR\", TITLE = \"To make antibodies or not: signaling by the B-cell antigen receptor.\", JOURNAL = c(\"Trends Pharmacol Sci 23:316-24 (2002)\", \"DOI:10.1016/S0165-6147(02)02045-X\")), list(REFERENCE = \"PMID:9697839\", AUTHORS = \"Fu C, Turck CW, Kurosaki T, Chan AC\", TITLE = \"BLNK: a central linker protein in B cell activation.\", JOURNAL = c(\"Immunity 9:93-103 (1998)\", \"DOI:10.1016/S1074-7613(00)80591-9\")), list(REFERENCE = \"PMID:11163197\", AUTHORS = \"Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T\", TITLE = \"BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation.\", JOURNAL = c(\"Immunity 13:817-27 (2000)\", \"DOI:10.1016/S1074-7613(00)00079-0\")), list(REFERENCE = \"PMID:18086859\", AUTHORS = \"Shinohara H, Maeda S, Watarai H, Kurosaki T\", TITLE = \"IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells.\", JOURNAL = c(\"J Exp Med 204:3285-93 (2007)\", \"DOI:10.1084/jem.20070379\"))', 'map04662', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (316, '04664', 'Fc epsilon RI signaling pathway', 'Fc epsilon RI-mediated signaling pathways in mast cells are initiated by the interaction of antigen (Ag) with IgE bound to the extracellular domain of the alpha chain of Fc epsilon RI. The activation pathways are regulated both positively and negatively by the interactions of numerous signaling molecules. Mast cells that are thus activated release preformed granules which contain biogenic amines (especially histamines) and proteoglycans (especially heparin). The activation of phospholipase A2 causes the release of membrane lipids followed by development of lipid mediators such as leukotrienes (LTC4, LTD4 and LTE4) and prostaglandins (especially PDG2). There is also secretion of cytokines, the most important of which are TNF-alpha, IL-4 and IL-5. These mediators and cytokines contribute to inflammatory responses.', 'Organismal Systems; Immune system', 'Fc epsilon RI signaling pathway', 'Activated PI3K-delta syndrome', 'GO: 0045576', 'ko04664', 'list(REFERENCE = \"PMID:12360215\", AUTHORS = \"Kawakami T, Galli SJ.\", TITLE = \"Regulation of mast-cell and basophil function and survival by IgE.\", JOURNAL = c(\"Nat Rev Immunol 2:773-86 (2002)\", \"DOI:10.1038/nri914\")), list(REFERENCE = \"PMID:14630197\", AUTHORS = \"Siraganian RP.\", TITLE = \"Mast cell signal transduction from the high-affinity IgE receptor.\", JOURNAL = c(\"Curr Opin Immunol 15:639-46 (2003)\", \"DOI:10.1016/j.coi.2003.09.010\")), list(REFERENCE = \"\", AUTHORS = \"Janeway CA, Travers P, Walport M, Shlomchik MJ.\", TITLE = \"Immunobiology 6th edition\", JOURNAL = \"Garland Science Publishing (2005)\"), list(REFERENCE = \"PMID:10586892\", AUTHORS = \"Turner H, Kinet JP.\", TITLE = \"Signalling through the high-affinity IgE receptor Fc epsilonRI.\", JOURNAL = \"Nature 402:B24-30 (1999)\"), list(REFERENCE = \"PMID:16470226\", AUTHORS = \"Gilfillan AM, Tkaczyk C.\", TITLE = \"Integrated signalling pathways for mast-cell activation.\", JOURNAL = c(\"Nat Rev Immunol 6:218-30 (2006)\", \"DOI:10.1038/nri1782\")), list(REFERENCE = \"PMID:11079101\", AUTHORS = \"Nadler MJ, Matthews SA, Turner H, Kinet JP.\", TITLE = \"Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function.\", JOURNAL = c(\"Adv Immunol 76:325-55 (2000)\", \"DOI:10.1016/S0065-2776(01)76022-1\")), list(REFERENCE = \"PMID:11449275\", AUTHORS = \"Gu H, Saito K, Klaman LD, Shen J, Fleming T, Wang Y, Pratt JC, Lin G, Lim B, Kinet JP, Neel BG.\", TITLE = \"Essential role for Gab2 in the allergic response.\", JOURNAL = c(\"Nature 412:186-90 (2001)\", \"DOI:10.1038/35084076\")), list(REFERENCE = \"PMID:12145654\", AUTHORS = \"Nadler MJ, Kinet JP.\", TITLE = \"Uncovering new complexities in mast cell signaling.\", JOURNAL = c(\"Nat Immunol 3:707-8 (2002)\", \"DOI:10.1038/ni0802-707\"))', 'map04664', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (317, '04666', 'Fc gamma R-mediated phagocytosis', 'Phagocytosis plays an essential role in host-defense mechanisms through the uptake and destruction of infectious pathogens. Specialized cell types including macrophages, neutrophils, and monocytes take part in this process in higher organisms. After opsonization with antibodies (IgG), foreign extracellular materials are recognized by Fc gamma receptors. Cross-linking of Fc gamma receptors initiates a variety of signals mediated by tyrosine phosphorylation of multiple proteins, which lead through the actin cytoskeleton rearrangements and membrane remodeling to the formation of phagosomes. Nascent phagosomes undergo a process of maturation that involves fusion with lysosomes. The acquisition of lysosomal proteases and release of reactive oxygen species are crucial for digestion of engulfed materials in phagosomes.', 'Organismal Systems; Immune system', 'Fc gamma R-mediated phagocytosis', 'Chronic granulomatous disease, Nemaline myopathy, Immune thrombocytopenia, Activated PI3K-delta syndrome', 'GO: 0006909', 'ko04666', 'list(REFERENCE = \"PMID:12488490\", AUTHORS = \"Garcia-Garcia E, Rosales C\", TITLE = \"Signal transduction during Fc receptor-mediated phagocytosis.\", JOURNAL = c(\"J Leukoc Biol 72:1092-108 (2002)\", \"DOI:10.1189/jlb.72.6.1092\")), list(REFERENCE = \"PMID:11708889\", AUTHORS = \"Cox D, Greenberg S\", TITLE = \"Phagocytic signaling strategies: Fc(gamma)receptor-mediated phagocytosis as a model system.\", JOURNAL = c(\"Semin Immunol 13:339-45 (2001)\", \"DOI:10.1006/smim.2001.0330\")), list(REFERENCE = \"PMID:15466916\", AUTHORS = \"Swanson JA, Hoppe AD\", TITLE = \"The coordination of signaling during Fc receptor-mediated phagocytosis.\", JOURNAL = c(\"J Leukoc Biol 76:1093-103 (2004)\", \"DOI:10.1189/jlb.0804439\")), list(REFERENCE = \"PMID:11244038\", AUTHORS = \"Ravetch JV, Bolland S\", TITLE = \"IgG Fc receptors.\", JOURNAL = c(\"Annu Rev Immunol 19:275-90 (2001)\", \"DOI:10.1146/annurev.immunol.19.1.275\")), list(REFERENCE = \"PMID:18322649\", AUTHORS = \"Groves E, Dart AE, Covarelli V, Caron E\", TITLE = \"Molecular mechanisms of phagocytic uptake in mammalian cells.\", JOURNAL = c(\"Cell Mol Life Sci 65:1957-76 (2008)\", \"DOI:10.1007/s00018-008-7578-4\")), list(REFERENCE = \"PMID:10376013\", AUTHORS = \"Kwiatkowska K, Sobota A\", TITLE = \"Signaling pathways in phagocytosis.\", JOURNAL = c(\"Bioessays 21:422-31 (1999)\", \"DOI:10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#\")), list(REFERENCE = \"PMID:10577498\", AUTHORS = \"Greenberg S\", TITLE = \"Modular components of phagocytosis.\", JOURNAL = c(\"J Leukoc Biol 66:712-7 (1999)\", \"DOI:10.1002/jlb.66.5.712\")), list(REFERENCE = \"PMID:10224668\", AUTHORS = \"Lennartz MR\", TITLE = \"Phospholipases and phagocytosis: the role of phospholipid-derived second messengers in phagocytosis.\", JOURNAL = c(\"Int J Biochem Cell Biol 31:415-30 (1999)\", \"DOI:10.1016/S1357-2725(98)00108-3\")), list(REFERENCE = \"PMID:11228151\", AUTHORS = \"May RC, Machesky LM\", TITLE = \"Phagocytosis and the actin cytoskeleton.\", JOURNAL = \"J Cell Sci 114:1061-77 (2001)\"), list(REFERENCE = \"PMID:17050193\", AUTHORS = \"Joshi T, Butchar JP, Tridandapani S\", TITLE = \"Fcgamma receptor signaling in phagocytes.\", JOURNAL = c(\"Int J Hematol 84:210-6 (2006)\", \"DOI:10.1532/IJH97.06140\")), list(REFERENCE = \"PMID:17308335\", AUTHORS = \"Lee WL, Cosio G, Ireton K, Grinstein S\", TITLE = \"Role of CrkII in Fcgamma receptor-mediated phagocytosis.\", JOURNAL = c(\"J Biol Chem 282:11135-43 (2007)\", \"DOI:10.1074/jbc.M700823200\")), list(REFERENCE = \"PMID:11304556\", AUTHORS = \"Uchida H, Kondo A, Yoshimura Y, Mazaki Y, Sabe H\", TITLE = \"PAG3/Papalpha/KIAA0400, a GTPase-activating protein for ADP-ribosylation factor (ARF), regulates ARF6 in Fcgamma receptor-mediated phagocytosis of macrophages.\", JOURNAL = c(\"J Exp Med 193:955-66 (2001)\", \"DOI:10.1084/jem.193.8.955\")), list(REFERENCE = \"PMID:15485887\", AUTHORS = \"Ganesan LP, Wei G, Pengal RA, Moldovan L, Moldovan N, Ostrowski MC, Tridandapani S\", TITLE = \"The serine/threonine kinase Akt Promotes Fc gamma receptor-mediated phagocytosis in murine macrophages through the activation of p70S6 kinase.\", JOURNAL = c(\"J Biol Chem 279:54416-25 (2004)\", \"DOI:10.1074/jbc.M408188200\")), list(REFERENCE = \"PMID:9545263\", AUTHORS = \"Melendez A, Floto RA, Gillooly DJ, Harnett MM, Allen JM\", TITLE = \"FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking.\", JOURNAL = c(\"J Biol Chem 273:9393-402 (1998)\", \"DOI:10.1074/jbc.273.16.9393\")), list(REFERENCE = \"PMID:12821647\", AUTHORS = \"Gu H, Botelho RJ, Yu M, Grinstein S, Neel BG\", TITLE = \"Critical role for scaffolding adapter Gab2 in Fc gamma R-mediated phagocytosis.\", JOURNAL = c(\"J Cell Biol 161:1151-61 (2003)\", \"DOI:10.1083/jcb.200212158\")), list(REFERENCE = \"PMID:9417101\", AUTHORS = \"Dana R, Leto TL, Malech HL, Levy R\", TITLE = \"Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase.\", JOURNAL = c(\"J Biol Chem 273:441-5 (1998)\", \"DOI:10.1074/jbc.273.1.441\")), list(REFERENCE = \"PMID:10601359\", AUTHORS = \"Gold ES, Underhill DM, Morrissette NS, Guo J, McNiven MA, Aderem A\", TITLE = \"Dynamin 2 is required for phagocytosis in macrophages.\", JOURNAL = c(\"J Exp Med 190:1849-56 (1999)\", \"DOI:10.1084/jem.190.12.1849\")), list(REFERENCE = \"PMID:10755615\", AUTHORS = \"Gold ES, Morrissette NS, Underhill DM, Guo J, Bassetti M, Aderem A\", TITLE = \"Amphiphysin IIm, a novel amphiphysin II isoform, is required for macrophage phagocytosis.\", JOURNAL = c(\"Immunity 12:285-92 (2000)\", \"DOI:10.1016/S1074-7613(00)80181-8\")), list(REFERENCE = \"PMID:10586078\", AUTHORS = \"Raeder EM, Mansfield PJ, Hinkovska-Galcheva V, Shayman JA, Boxer LA\", TITLE = \"Syk activation initiates downstream signaling events during human polymorphonuclear leukocyte phagocytosis.\", JOURNAL = \"J Immunol 163:6785-93 (1999)\"), list(REFERENCE = \"PMID:9581795\", AUTHORS = \"Sanchez-Mejorada G, Rosales C\", TITLE = \"Signal transduction by immunoglobulin Fc receptors.\", JOURNAL = c(\"J Leukoc Biol 63:521-33 (1998)\", \"DOI:10.1002/jlb.63.5.521\")), list(REFERENCE = \"\", AUTHORS = \"Rosales C (ed).\", TITLE = \"Molecular Mechanisms of Phagocytosis\", JOURNAL = \"Springer (2005)\")', 'map04666', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (318, '04668', 'TNF signaling pathway', 'Tumor necrosis factor (TNF), as a critical cytokine, can induce a wide range of intracellular signal pathways including apoptosis and cell survival as well as inflammation and immunity. Activated TNF is assembled to a homotrimer and binds to its receptors (TNFR1, TNFR2) resulting in the trimerization of TNFR1 or TNFR2. TNFR1 is expressed by nearly all cells and is the major receptor for TNF (also called TNF-alpha). In contrast, TNFR2 is expressed in limited cells such as CD4 and CD8 T lymphocytes, endothelial cells, microglia, oligodendrocytes, neuron subtypes, cardiac myocytes, thymocytes and human mesenchymal stem cells. It is the receptor for both TNF and LTA (also called TNF-beta). Upon binding of the ligand, TNFR mediates the association of some adaptor proteins such as TRADD or TRAF2, which in turn initiate recruitment of signal transducers. TNFR1 signaling induces activation of many genes, primarily controlled by two distinct pathways, NF-kappa B pathway and the MAPK cascade, or apoptosis and necroptosis. TNFR2 signaling activates NF-kappa B pathway including PI3K-dependent NF-kappa B pathway and JNK pathway leading to survival.', 'Environmental Information Processing; Signal transduction', 'TNF signaling pathway', 'Encephalopathy due to defective mitochondrial and peroxisomal fission', 'GO: 0033209', 'ko04668', 'list(REFERENCE = \"PMID:23085193\", AUTHORS = \"Chu WM\", TITLE = \"Tumor necrosis factor.\", JOURNAL = c(\"Cancer Lett 328:222-5 (2013)\", \"DOI:10.1016/j.canlet.2012.10.014\")), list(REFERENCE = \"PMID:23531747\", AUTHORS = \"Shuh M, Bohorquez H, Loss GE Jr, Cohen AJ\", TITLE = \"Tumor Necrosis Factor-alpha: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury.\", JOURNAL = \"Ochsner J 13:119-30 (2013)\"), list(REFERENCE = \"PMID:11897488\", AUTHORS = \"MacEwan DJ\", TITLE = \"TNF receptor subtype signalling: differences and cellular consequences.\", JOURNAL = c(\"Cell Signal 14:477-92 (2002)\", \"DOI:10.1016/S0898-6568(01)00262-5\")), list(REFERENCE = \"PMID:22296764\", AUTHORS = \"Newton K, Dixit VM\", TITLE = \"Signaling in innate immunity and inflammation.\", JOURNAL = c(\"Cold Spring Harb Perspect Biol 4:a006049 (2012)\", \"DOI:10.1101/cshperspect.a006049\")), list(REFERENCE = \"PMID:10581243\", AUTHORS = \"Pomerantz JL, Baltimore D\", TITLE = \"NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.\", JOURNAL = c(\"EMBO J 18:6694-704 (1999)\", \"DOI:10.1093/emboj/18.23.6694\")), list(REFERENCE = \"PMID:21232019\", AUTHORS = \"Naude PJ, den Boer JA, Luiten PG, Eisel UL\", TITLE = \"Tumor necrosis factor receptor cross-talk.\", JOURNAL = c(\"FEBS J 278:888-98 (2011)\", \"DOI:10.1111/j.1742-4658.2011.08017.x\")), list(REFERENCE = \"PMID:20489699\", AUTHORS = \"Faustman D, Davis M\", TITLE = \"TNF receptor 2 pathway: drug target for autoimmune diseases.\", JOURNAL = c(\"Nat Rev Drug Discov 9:482-93 (2010)\", \"DOI:10.1038/nrd3030\")), list(REFERENCE = \"PMID:14532286\", AUTHORS = \"Chan FK, Shisler J, Bixby JG, Felices M, Zheng L, Appel M, Orenstein J, Moss B, Lenardo MJ\", TITLE = \"A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses.\", JOURNAL = c(\"J Biol Chem 278:51613-21 (2003)\", \"DOI:10.1074/jbc.M305633200\"))', 'map04668', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (319, '04670', 'Leukocyte transendothelial migration', 'Leukocyte migaration from the blood into tissues is vital for immune surveillance and inflammation. During this diapedesis of leukocytes, the leukocytes bind to endothelial cell adhesion molecules (CAM) and then migrate across the vascular endothelium. A leukocyte adherent to CAMs on the endothelial cells moves forward by leading-edge protrusion and retraction of its tail. In this process, alphaL /beta2 integrin activates through Vav1, RhoA, which subsequently activates the kinase p160ROCK. ROCK activation leads to MLC phosphorylation, resulting in retraction of the actin cytoskeleton. Moreover, Leukocytes activate endothelial cell signals that stimulate endothelial cell retraction during localized dissociation of the endothelial cell junctions. ICAM-1-mediated signals activate an endothelial cell calcium flux and PKC, which are required for ICAM-1 dependent leukocyte migration. VCAM-1 is involved in the opening of the \"endothelial passage\" through which leukocytes can extravasate. In this regard, VCAM-1 ligation induces NADPH oxidase activation and the production of reactive oxygen species (ROS) in a Rac-mediated manner, with subsequent activation of matrix metallopoteinases and loss of VE-cadherin-mediated adhesion.', 'Organismal Systems; Immune system', 'Leukocyte transendothelial migration', 'Leukocyte adhesion deficiency, Neonatal ichthyosis-sclerosing cholangitis (NISCH) syndrome, Band-like calcification with simplified gyration and polymicrogyria, Pilomatricoma, Metachondromatosis, Juvenile-onset dystonia, Activated PI3K-delta syndrome', 'GO: 0050900', 'ko04670', 'list(REFERENCE = \"PMID:14976004\", AUTHORS = \"van Buul JD, Hordijk PL.\", TITLE = \"Signaling in leukocyte transendothelial migration.\", JOURNAL = c(\"Arterioscler Thromb Vasc Biol 24:824-33 (2004)\", \"DOI:10.1161/01.ATV.0000122854.76267.5c\")), list(REFERENCE = \"PMID:15604886\", AUTHORS = \"Wittchen ES, van Buul JD, Burridge K, Worthylake RA.\", TITLE = \"Trading spaces: Rap, Rac, and Rho as architects of transendothelial migration.\", JOURNAL = \"Curr Opin Hematol 12:14-21 (2005)\"), list(REFERENCE = \"PMID:14977592\", AUTHORS = \"Barreiro O, Vicente-Manzanares M, Urzainqui A, Yanez-Mo M, Sanchez-Madrid F.\", TITLE = \"Interactive protrusive structures during leukocyte adhesion and transendothelial migration.\", JOURNAL = c(\"Front Biosci 9:1849-63 (2004)\", \"DOI:10.2741/1285\")), list(REFERENCE = \"PMID:15629883\", AUTHORS = \"Cook-Mills JM, Deem TL.\", TITLE = \"Active participation of endothelial cells in inflammation.\", JOURNAL = c(\"J Leukoc Biol 77:487-95 (2005)\", \"DOI:10.1189/jlb.0904554\")), list(REFERENCE = \"PMID:15173832\", AUTHORS = \"Imhof BA, Aurrand-Lions M.\", TITLE = \"Adhesion mechanisms regulating the migration of monocytes.\", JOURNAL = c(\"Nat Rev Immunol 4:432-44 (2004)\", \"DOI:10.1038/nri1375\")), list(REFERENCE = \"PMID:15265790\", AUTHORS = \"Deem TL, Cook-Mills JM.\", TITLE = \"Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species.\", JOURNAL = c(\"Blood 104:2385-93 (2004)\", \"DOI:10.1182/blood-2004-02-0665\")), list(REFERENCE = \"PMID:10975856\", AUTHORS = \"Etienne-Manneville S, Manneville JB, Adamson P, Wilbourn B, Greenwood J, Couraud PO.\", TITLE = \"ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines.\", JOURNAL = c(\"J Immunol 165:3375-83 (2000)\", \"DOI:10.4049/jimmunol.165.6.3375\")), list(REFERENCE = \"PMID:12540948\", AUTHORS = \"Chavakis T, Preissner KT, Santoso S.\", TITLE = \"Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle.\", JOURNAL = c(\"Thromb Haemost 89:13-7 (2003)\", \"DOI:10.1055/s-0037-1613537\")), list(REFERENCE = \"PMID:15771581\", AUTHORS = \"Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL.\", TITLE = \"Tec family kinases in T lymphocyte development and function.\", JOURNAL = c(\"Annu Rev Immunol 23:549-600 (2005)\", \"DOI:10.1146/annurev.immunol.22.012703.104743\"))', 'map04670', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (320, '04672', 'Intestinal immune network for IgA production', 'The intestine is the largest lymphoid tissue in the body. One striking feature of intestinal immunity is its ability to generate great amounts of noninflammatory immunoglobulin A (IgA) antibodies that serve as the first line of defense against microorganisms. The basic map of IgA production includes induction of mucosal B cells in the Peyer\'s patches, circulation through the bloodstream and homing to intestinal mucosa of IgA-commited plasma cells, and local antibody production for export across the intestinal membranes. Multiple cytokines, including TGF-{beta}, IL-10, IL-4, IL-5, and IL-6, are required to promote IgA class switching and terminal differentiation process of the B cells. Secreted IgA promotes immune exclusion by entrapping dietary antigens and microorganisms in the mucus and functions for neutralization of toxins and pathogenic microbes.', 'Organismal Systems; Immune system', 'Intestinal immune network for IgA production', 'GO: 0002387', 'ko04672', 'list(REFERENCE = \"PMID:12511876\", AUTHORS = \"Fagarasan S, Honjo T\", TITLE = \"Intestinal IgA synthesis: regulation of front-line body defences.\", JOURNAL = c(\"Nat Rev Immunol 3:63-72 (2003)\", \"DOI:10.1038/nri982\")), list(REFERENCE = \"PMID:19079156\", AUTHORS = \"Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P\", TITLE = \"The immune geography of IgA induction and function.\", JOURNAL = c(\"Mucosal Immunol 1:11-22 (2008)\", \"DOI:10.1038/mi.2007.6\")), list(REFERENCE = \"PMID:15971106\", AUTHORS = \"Kunisawa J, Kiyono H\", TITLE = \"A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense.\", JOURNAL = c(\"Cell Mol Life Sci 62:1308-21 (2005)\", \"DOI:10.1007/s00018-005-5035-1\")), list(REFERENCE = \"PMID:18549797\", AUTHORS = \"Cerutti A, Rescigno M\", TITLE = \"The biology of intestinal immunoglobulin A responses.\", JOURNAL = c(\"Immunity 28:740-50 (2008)\", \"DOI:10.1016/j.immuni.2008.05.001\")), list(REFERENCE = \"PMID:18243016\", AUTHORS = \"Tsuji M, Suzuki K, Kinoshita K, Fagarasan S\", TITLE = \"Dynamic interactions between bacteria and immune cells leading to intestinal IgA synthesis.\", JOURNAL = c(\"Semin Immunol 20:59-66 (2008)\", \"DOI:10.1016/j.smim.2007.12.003\")), list(REFERENCE = \"PMID:17182536\", AUTHORS = \"Corthesy B\", TITLE = \"Roundtrip ticket for secretory IgA: role in mucosal homeostasis?\", JOURNAL = c(\"J Immunol 178:27-32 (2007)\", \"DOI:10.4049/jimmunol.178.1.27\")), list(REFERENCE = \"PMID:18838301\", AUTHORS = \"Suzuki K, Fagarasan S\", TITLE = \"How host-bacterial interactions lead to IgA synthesis in the gut.\", JOURNAL = c(\"Trends Immunol 29:523-31 (2008)\", \"DOI:10.1016/j.it.2008.08.001\")), list(REFERENCE = \"PMID:19079167\", AUTHORS = \"Mora JR, von Andrian UH\", TITLE = \"Differentiation and homing of IgA-secreting cells.\", JOURNAL = c(\"Mucosal Immunol 1:96-109 (2008)\", \"DOI:10.1038/mi.2007.14\")), list(REFERENCE = \"PMID:17161619\", AUTHORS = \"Suzuki K, Ha SA, Tsuji M, Fagarasan S\", TITLE = \"Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut.\", JOURNAL = c(\"Semin Immunol 19:127-35 (2007)\", \"DOI:10.1016/j.smim.2006.10.001\")), list(REFERENCE = \"PMID:18483500\", AUTHORS = \"Cerutti A\", TITLE = \"The regulation of IgA class switching.\", JOURNAL = c(\"Nat Rev Immunol 8:421-34 (2008)\", \"DOI:10.1038/nri2322\"))', 'map04672', 'Intestinal immune network for IgA production', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (321, '04710', 'Circadian rhythm', 'Circadian rhythm is an internal biological clock, which enables to sustain an approximately 24-hour rhythm in the absence of environmental cues. In mammals, the circadian clock mechanism consists of cell-autonomous transcription-translation feedback loops that drive rhythmic, 24-hour expression patterns of core clock components. The first negative feedback loop is a rhythmic transcription of period genes (PER1, PER2, and PER3) and chryptochrome genes (CRY1 and CRY2). PER and CRY proteins form a heterodimer, which acts on the CLOCK/BMAL1 heterodimer to repress its own transcription. PER and CRY proteins are phosphorylated by casein kinase epsilon (CKIepsilon), which leads to degradation and restarting of the cycle. The second loop is a positive feedback loop driven by the CLOCK/BMAL1 heterodimer, which initiates transcription of target genes containing E-box cis-regulatory enhancer sequences.', 'Organismal Systems; Environmental adaptation', 'Circadian rhythm', 'Familial advanced sleep phase syndrome, Delayed sleep phase syndrome', 'GO: 0007623', 'ko04710', 'list(REFERENCE = \"PMID:11165242\", AUTHORS = \"Camacho F, Cilio M, Guo Y, Virshup DM, Patel K, Khorkova O, Styren S, Morse B, Yao Z, Keesler GA.\", TITLE = \"Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2.\", JOURNAL = c(\"FEBS Lett 489:159-65 (2001)\", \"DOI:10.1016/S0014-5793(00)02434-0\")), list(REFERENCE = \"PMID:12015613\", AUTHORS = \"Panda S, Hogenesch JB, Kay SA.\", TITLE = \"Circadian rhythms from flies to human.\", JOURNAL = c(\"Nature 417:329-35 (2002)\", \"DOI:10.1038/417329a\")), list(REFERENCE = \"PMID:11687489\", AUTHORS = \"Harmer SL, Panda S, Kay SA.\", TITLE = \"Molecular bases of circadian rhythms.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 17:215-53 (2001)\", \"DOI:10.1146/annurev.cellbio.17.1.215\")), list(REFERENCE = \"PMID:11533719\", AUTHORS = \"Young MW, Kay SA.\", TITLE = \"Time zones: a comparative genetics of circadian clocks.\", JOURNAL = c(\"Nat Rev Genet 2:702-15 (2001)\", \"DOI:10.1038/35088576\")), list(REFERENCE = \"PMID:12397359\", AUTHORS = \"Honma S, Kawamoto T, Takagi Y, Fujimoto K, Sato F, Noshiro M, Kato Y, Honma K.\", TITLE = \"Dec1 and Dec2 are regulators of the mammalian molecular clock.\", JOURNAL = c(\"Nature 419:841-4 (2002)\", \"DOI:10.1038/nature01123\")), list(REFERENCE = \"PMID:12150932\", AUTHORS = \"Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, Schibler U.\", TITLE = \"The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator.\", JOURNAL = c(\"Cell 110:251-60 (2002)\", \"DOI:10.1016/S0092-8674(02)00825-5\")), list(REFERENCE = \"PMID:12724733\", AUTHORS = \"Fu L, Lee CC.\", TITLE = \"The circadian clock: pacemaker and tumour suppressor.\", JOURNAL = c(\"Nat Rev Cancer 3:350-61 (2003)\", \"DOI:10.1038/nrc1072\")), list(REFERENCE = \"PMID:12507418\", AUTHORS = \"Schibler U, Sassone-Corsi P.\", TITLE = \"A web of circadian pacemakers.\", JOURNAL = c(\"Cell 111:919-22 (2002)\", \"DOI:10.1016/S0092-8674(02)01225-4\")), list(REFERENCE = \"PMID:10864977\", AUTHORS = \"Hogenesch JB, Gu YZ, Moran SM, Shimomura K, Radcliffe LA, Takahashi JS, Bradfield CA.\", TITLE = \"The basic helix-loop-helix-PAS protein MOP9 is a brain-specific heterodimeric partner of circadian and hypoxia factors.\", JOURNAL = c(\"J Neurosci 20:RC83 (2000)\", \"DOI:10.1523/JNEUROSCI.20-13-j0002.2000\")), list(REFERENCE = \"PMID:15917222\", AUTHORS = \"Shirogane T, Jin J, Ang XL, Harper JW\", TITLE = \"SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein.\", JOURNAL = c(\"J Biol Chem 280:26863-72 (2005)\", \"DOI:10.1074/jbc.M502862200\")), list(REFERENCE = \"PMID:17463251\", AUTHORS = \"Busino L, Bassermann F, Maiolica A, Lee C, Nolan PM, Godinho SI, Draetta GF, Pagano M\", TITLE = \"SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins.\", JOURNAL = c(\"Science 316:900-4 (2007)\", \"DOI:10.1126/science.1141194\")), list(REFERENCE = \"PMID:18802415\", AUTHORS = \"Takahashi JS, Hong HK, Ko CH, McDearmon EL\", TITLE = \"The genetics of mammalian circadian order and disorder: implications for physiology and disease.\", JOURNAL = c(\"Nat Rev Genet 9:764-75 (2008)\", \"DOI:10.1038/nrg2430\")), list(REFERENCE = \"PMID:17586087\", AUTHORS = \"Mertens I, Husson SJ, Janssen T, Lindemans M, Schoofs L\", TITLE = \"PACAP and PDF signaling in the regulation of mammalian and insect circadian rhythms.\", JOURNAL = c(\"Peptides 28:1775-83 (2007)\", \"DOI:10.1016/j.peptides.2007.05.005\"))', 'map04710', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (322, '04711', 'Circadian rhythm - fly', 'Circadian rhythm is an internal biological clock, which enables to sustain an approximately 24-hour rhythm in the absence of environmental cues. In the fruit fly Drosophila melanogaster, seven genes that contribute to the central clock function are known: period (per), timeless (tim), Clock (Clk), cycle (cyc), vrille (vri), double-time (dbt), and shaggy (sgg). The core of the circadian clock consists of molecular feedback loops where per and tim gene products (PER and TIM proteins) eventually turn off their own transcription. The CLK/CYC heterodimer activates transcription of per and tim genes, while the PER and TIM repressor proteins accumulate in the cytoplasm. After nuclear entry of PER and TIM, transcription is inhibited by direct binding of the PER/TIM heterodimer to the CLK/CYC heterodimer. This shutoff lasts until the PER and TIM proteins are degraded allowing a new round of transcription to occur.', 'Organismal Systems; Environmental adaptation', 'Circadian rhythm - fly', 'GO: 0007623', 'ko04711', 'list(REFERENCE = \"PMID:12015613\", AUTHORS = \"Panda S, Hogenesch JB, Kay SA.\", TITLE = \"Circadian rhythms from flies to human.\", JOURNAL = c(\"Nature 417:329-35 (2002)\", \"DOI:10.1038/417329a\")), list(REFERENCE = \"PMID:11687489\", AUTHORS = \"Harmer SL, Panda S, Kay SA.\", TITLE = \"Molecular bases of circadian rhythms.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 17:215-53 (2001)\", \"DOI:10.1146/annurev.cellbio.17.1.215\")), list(REFERENCE = \"PMID:11533719\", AUTHORS = \"Young MW, Kay SA.\", TITLE = \"Time zones: a comparative genetics of circadian clocks.\", JOURNAL = c(\"Nat Rev Genet 2:702-15 (2001)\", \"DOI:10.1038/35088576\")), list(REFERENCE = \"PMID:12581523\", AUTHORS = \"Cyran SA, Buchsbaum AM, Reddy KL, Lin MC, Glossop NR, Hardin PE, Young MW, Storti RV, Blau J.\", TITLE = \"vrille, Pdp1, and dClock form a second feedback loop in the Drosophila circadian clock.\", JOURNAL = c(\"Cell 112:329-41 (2003)\", \"DOI:10.1016/S0092-8674(03)00074-6\")), list(REFERENCE = \"PMID:16351879\", AUTHORS = \"Helfrich-Forster C\", TITLE = \"The circadian system of Drosophila melanogaster and its light input pathways.\", JOURNAL = c(\"Zoology (Jena) 105:297-312 (2002)\", \"DOI:10.1078/0944-2006-00074\")), list(REFERENCE = \"PMID:12486701\", AUTHORS = \"Stanewsky R\", TITLE = \"Genetic analysis of the circadian system in Drosophila melanogaster and mammals.\", JOURNAL = c(\"J Neurobiol 54:111-47 (2003)\", \"DOI:10.1002/neu.10164\")), list(REFERENCE = \"PMID:28388438\", AUTHORS = \"Lee J, Yoo E, Lee H, Park K, Hur JH, Lim C\", TITLE = \"LSM12 and ME31B/DDX6 Define Distinct Modes of Posttranscriptional Regulation by ATAXIN-2 Protein Complex in Drosophila Circadian Pacemaker Neurons.\", JOURNAL = c(\"Mol Cell 66:129-140.e7 (2017)\", \"DOI:10.1016/j.molcel.2017.03.004\"))', 'map04711', 'Circadian rhythm - fly', 64, 0, 64, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (323, '04712', 'Circadian rhythm - plant', 'The circadian system is an endogenous rhythm with the period of about 24 hours to provide temporal organization of biological activity. In Arabidopsis the circadian oscillator at the core of this system is composed of the interlocked feedback loop formed by the major transcriptional factors CCA1 (circadian clock associated), LHY (late elongated hypocotyl) and TOC1 (timing of cab), a pseudo response regulator (PRR). The morning-expressed CCA1/LHY Myb transcription factors suppress TOC1 expression by binding to its promoter. Moreover, CCA1/LHY activates the expression of PRR7/9 in the morning and then PRR7/9 repress the transcription of CCA1/LHY during the rest of the day. By contrast, the evening-expressed TOC1 activates the expression of CCA1/LHY.', 'Organismal Systems; Environmental adaptation', 'Circadian rhythm - plant', 'GO: 0007623', 'ko04712', 'list(REFERENCE = \"PMID:11710980\", AUTHORS = \"McWatters HG, Roden LC, Staiger D.\", TITLE = \"Picking out parallels: plant circadian clocks in context.\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 356:1735-43 (2001)\", \"DOI:10.1098/rstb.2001.0936\")), list(REFERENCE = \"PMID:11597501\", AUTHORS = \"Yanovsky MJ, Kay SA.\", TITLE = \"Signaling networks in the plant circadian system.\", JOURNAL = c(\"Curr Opin Plant Biol 4:429-35 (2001)\", \"DOI:10.1016/S1369-5266(00)00196-5\")), list(REFERENCE = \"PMID:10792828\", AUTHORS = \"Kim L, Kircher S, Toth R, Adam E, Schafer E, Nagy F.\", TITLE = \"Light-induced nuclear import of phytochrome-A:GFP fusion proteins is differentially regulated in transgenic tobacco and Arabidopsis.\", JOURNAL = c(\"Plant J 22:125-33 (2000)\", \"DOI:10.1046/j.1365-313x.2000.00729.x\")), list(REFERENCE = \"PMID:8953247\", AUTHORS = \"Sakamoto K, Nagatani A.\", TITLE = \"Nuclear localization activity of phytochrome B.\", JOURNAL = c(\"Plant J 10:859-68 (1996)\", \"DOI:10.1046/j.1365-313X.1996.10050859.x\")), list(REFERENCE = \"PMID:11402161\", AUTHORS = \"Liu XL, Covington MF, Fankhauser C, Chory J, Wagner DR.\", TITLE = \"ELF3 encodes a circadian clock-regulated nuclear protein that functions in an Arabidopsis PHYB signal transduction pathway.\", JOURNAL = c(\"Plant Cell 13:1293-304 (2001)\", \"DOI:10.1105/TPC.000475\")), list(REFERENCE = \"PMID:11069292\", AUTHORS = \"Zhu Y, Tepperman JM, Fairchild CD, Quail PH.\", TITLE = \"Phytochrome B binds with greater apparent affinity than phytochrome A to the basic helix-loop-helix factor PIF3 in a reaction requiring the PAS domain of PIF3.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 97:13419-24 (2000)\", \"DOI:10.1073/pnas.230433797\")), list(REFERENCE = \"PMID:9845368\", AUTHORS = \"Ni M, Tepperman JM, Quail PH.\", TITLE = \"PIF3, a phytochrome-interacting factor necessary for normal photoinduced signal transduction, is a novel basic helix-loop-helix protein.\", JOURNAL = c(\"Cell 95:657-67 (1998)\", \"DOI:10.1016/S0092-8674(00)81636-0\")), list(REFERENCE = \"PMID:11743105\", AUTHORS = \"Toth R, Kevei E, Hall A, Millar AJ, Nagy F, Kozma-Bognar L.\", TITLE = \"Circadian clock-regulated expression of phytochrome and cryptochrome genes in Arabidopsis.\", JOURNAL = c(\"Plant Physiol 127:1607-16 (2001)\", \"DOI:10.1104/pp.900010\")), list(REFERENCE = \"PMID:11752379\", AUTHORS = \"Schultz TF, Kiyosue T, Yanovsky M, Wada M, Kay SA.\", TITLE = \"A role for LKP2 in the circadian clock of Arabidopsis.\", JOURNAL = c(\"Plant Cell 13:2659-70 (2001)\", \"DOI:10.1105/tpc.010332\")), list(REFERENCE = \"PMID:11260718\", AUTHORS = \"Jarillo JA, Capel J, Tang RH, Yang HQ, Alonso JM, Ecker JR, Cashmore AR.\", TITLE = \"An Arabidopsis circadian clock component interacts with both CRY1 and phyB.\", JOURNAL = c(\"Nature 410:487-90 (2001)\", \"DOI:10.1038/35068589\")), list(REFERENCE = \"PMID:11828029\", AUTHORS = \"Matsushika A, Makino S, Kojima M, Yamashino T, Mizuno T.\", TITLE = \"The APRR1/TOC1 quintet implicated in circadian rhythms of Arabidopsis thaliana: II. Characterization with CCA1-overexpressing plants.\", JOURNAL = c(\"Plant Cell Physiol 43:118-22 (2002)\", \"DOI:10.1093/pcp/pcf006\")), list(REFERENCE = \"PMID:10535927\", AUTHORS = \"Sugano S, Andronis C, Ong MS, Green RM, Tobin EM.\", TITLE = \"The protein kinase CK2 is involved in regulation of circadian rhythms in Arabidopsis.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 96:12362-6 (1999)\", \"DOI:10.1073/pnas.96.22.12362\")), list(REFERENCE = \"PMID:11089975\", AUTHORS = \"Mas P, Devlin PF, Panda S, Kay SA.\", TITLE = \"Functional interaction of phytochrome B and cryptochrome 2.\", JOURNAL = c(\"Nature 408:207-11 (2000)\", \"DOI:10.1038/35041583\")), list(REFERENCE = \"PMID:9651577\", AUTHORS = \"Ahmad M, Jarillo JA, Smirnova O, Cashmore AR.\", TITLE = \"The CRY1 blue light photoreceptor of Arabidopsis interacts with phytochrome A in vitro.\", JOURNAL = c(\"Mol Cell 1:939-48 (1998)\", \"DOI:10.1016/S1097-2765(00)80094-5\")), list(REFERENCE = \"PMID:11486091\", AUTHORS = \"Alabadi D, Oyama T, Yanovsky MJ, Harmon FG, Mas P, Kay SA.\", TITLE = \"Reciprocal regulation between TOC1 and LHY/CCA1 within the Arabidopsis circadian clock.\", JOURNAL = c(\"Science 293:880-3 (2001)\", \"DOI:10.1126/science.1061320\")), list(REFERENCE = \"PMID:11148285\", AUTHORS = \"Borevitz JO, Xia Y, Blount J, Dixon RA, Lamb C.\", TITLE = \"Activation tagging identifies a conserved MYB regulator of phenylpropanoid biosynthesis.\", JOURNAL = c(\"Plant Cell 12:2383-2394 (2000)\", \"DOI:10.1105/tpc.12.12.2383\")), list(REFERENCE = \"PMID:12091722\", AUTHORS = \"Murakami-Kojima M, Nakamichi N, Yamashino T, Mizuno T.\", TITLE = \"The APRR3 component of the clock-associated APRR1/TOC1 quintet is phosphorylated by a novel protein kinase belonging to the WNK family, the gene for which is also transcribed rhythmically in Arabidopsis thaliana.\", JOURNAL = c(\"Plant Cell Physiol 43:675-83 (2002)\", \"DOI:10.1093/pcp/pcf084\")), list(REFERENCE = \"PMID:19386812\", AUTHORS = \"Pan Y, Michael TP, Hudson ME, Kay SA, Chory J, Schuler MA\", TITLE = \"Cytochrome P450 monooxygenases as reporters for circadian-regulated pathways.\", JOURNAL = c(\"Plant Physiol 150:858-78 (2009)\", \"DOI:10.1104/pp.108.130757\")), list(REFERENCE = \"PMID:11118138\", AUTHORS = \"Harmer SL, Hogenesch JB, Straume M, Chang HS, Han B, Zhu T, Wang X, Kreps JA, Kay SA\", TITLE = \"Orchestrated transcription of key pathways in Arabidopsis by the circadian clock.\", JOURNAL = c(\"Science 290:2110-3 (2000)\", \"DOI:10.1126/science.290.5499.2110\")), list(REFERENCE = \"PMID:12045273\", AUTHORS = \"Mouradov A, Cremer F, Coupland G\", TITLE = \"Control of flowering time: interacting pathways as a basis for diversity.\", JOURNAL = c(\"Plant Cell 14 Suppl:S111-30 (2002)\", \"DOI:10.1105/tpc.001362\")), list(REFERENCE = \"PMID:15568973\", AUTHORS = \"Chen M, Chory J, Fankhauser C\", TITLE = \"Light signal transduction in higher plants.\", JOURNAL = c(\"Annu Rev Genet 38:87-117 (2004)\", \"DOI:10.1146/annurev.genet.38.072902.092259\")), list(REFERENCE = \"PMID:16096959\", AUTHORS = \"Mas P\", TITLE = \"Circadian clock signaling in Arabidopsis thaliana: from gene expression to physiology and development.\", JOURNAL = c(\"Int J Dev Biol 49:491-500 (2005)\", \"DOI:10.1387/ijdb.041968pm\")), list(REFERENCE = \"PMID:17304247\", AUTHORS = \"Jiao Y, Lau OS, Deng XW\", TITLE = \"Light-regulated transcriptional networks in higher plants.\", JOURNAL = c(\"Nat Rev Genet 8:217-30 (2007)\", \"DOI:10.1038/nrg2049\")), list(REFERENCE = \"PMID:18444908\", AUTHORS = \"Turck F, Fornara F, Coupland G\", TITLE = \"Regulation and identity of florigen: FLOWERING LOCUS T moves center stage.\", JOURNAL = c(\"Annu Rev Plant Biol 59:573-94 (2008)\", \"DOI:10.1146/annurev.arplant.59.032607.092755\")), list(REFERENCE = \"PMID:19836294\", AUTHORS = \"Imaizumi T\", TITLE = \"Arabidopsis circadian clock and photoperiodism: time to think about location.\", JOURNAL = c(\"Curr Opin Plant Biol 13:83-9 (2010)\", \"DOI:10.1016/j.pbi.2009.09.007\")), list(REFERENCE = \"PMID:20459860\", AUTHORS = \"McClung CR\", TITLE = \"A modern circadian clock in the common angiosperm ancestor of monocots and eudicots.\", JOURNAL = c(\"BMC Biol 8:55 (2010)\", \"DOI:10.1186/1741-7007-8-55\")), list(REFERENCE = \"PMID:20809800\", AUTHORS = \"Doherty CJ, Kay SA\", TITLE = \"Circadian control of global gene expression patterns.\", JOURNAL = c(\"Annu Rev Genet 44:419-44 (2010)\", \"DOI:10.1146/annurev-genet-102209-163432\")), list(REFERENCE = \"PMID:20889330\", AUTHORS = \"McClung CR, Gutierrez RA\", TITLE = \"Network news: prime time for systems biology of the plant circadian clock.\", JOURNAL = c(\"Curr Opin Genet Dev 20:588-98 (2010)\", \"DOI:10.1016/j.gde.2010.08.010\")), list(REFERENCE = \"PMID:22190341\", AUTHORS = \"Lu SX, Webb CJ, Knowles SM, Kim SH, Wang Z, Tobin EM\", TITLE = \"CCA1 and ELF3 Interact in the control of hypocotyl length and flowering time in Arabidopsis.\", JOURNAL = c(\"Plant Physiol 158:1079-88 (2012)\", \"DOI:10.1104/pp.111.189670\")), list(REFERENCE = \"PMID:22705257\", AUTHORS = \"Lau OS, Deng XW\", TITLE = \"The photomorphogenic repressors COP1 and DET1: 20 years later.\", JOURNAL = c(\"Trends Plant Sci 17:584-93 (2012)\", \"DOI:10.1016/j.tplants.2012.05.004\"))', 'map04712', 'Circadian rhythm - plant', 105, 0, 0, 105, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (324, '04713', 'Circadian entrainment', 'Circadian entrainment is a fundamental property by which the period of the internal biological clock is entrained by recurring exogenous signals, such that the organism\'s endocrine and behavioral rhythms are synchronized to environmental cues. In mammals, a master clock is located in the suprachiasmatic nuclei (SCN) of the hypothalamus and may synchronize circadian oscillators in peripheral tissues. Light signal is the dominant synchronizer for master SCN clock. Downstream from the retina, glutamate and PACAP are released and trigger the activation of signal transduction cascades, including CamKII and nNOS activity, cAMP- and cGMP-dependent protein kinases, and mitogen-activated protein kinase (MAPK). Of non-photic entrainment, important phase shifting capabilities have been found for melatonin, which inhibits light-induced phase shifts through inhibition of adenylate cyclase (AC). Multiple entrainment pathways converge into CREB regulation. In turn, phosphorylated CREB activates clock gene expression.', 'Organismal Systems; Environmental adaptation', 'Circadian entrainment', 'GO: 0009649', 'ko04713', 'list(REFERENCE = \"PMID:17646042\", AUTHORS = \"Brown TM, Piggins HD\", TITLE = \"Electrophysiology of the suprachiasmatic circadian clock.\", JOURNAL = c(\"Prog Neurobiol 82:229-55 (2007)\", \"DOI:10.1016/j.pneurobio.2007.05.002\")), list(REFERENCE = \"PMID:19109992\", AUTHORS = \"Dickson L, Finlayson K\", TITLE = \"VPAC and PAC receptors: From ligands to function.\", JOURNAL = c(\"Pharmacol Ther 121:294-316 (2009)\", \"DOI:10.1016/j.pharmthera.2008.11.006\")), list(REFERENCE = \"PMID:20664079\", AUTHORS = \"Golombek DA, Rosenstein RE\", TITLE = \"Physiology of circadian entrainment.\", JOURNAL = c(\"Physiol Rev 90:1063-102 (2010)\", \"DOI:10.1152/physrev.00009.2009\")), list(REFERENCE = \"PMID:16217123\", AUTHORS = \"Dubocovich ML, Markowska M\", TITLE = \"Functional MT1 and MT2 melatonin receptors in mammals.\", JOURNAL = c(\"Endocrine 27:101-10 (2005)\", \"DOI:10.1385/ENDO:27:2:101\")), list(REFERENCE = \"PMID:20605968\", AUTHORS = \"Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J\", TITLE = \"International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.\", JOURNAL = c(\"Pharmacol Rev 62:343-80 (2010)\", \"DOI:10.1124/pr.110.002832\")), list(REFERENCE = \"PMID:19449447\", AUTHORS = \"Hardeland R\", TITLE = \"Melatonin: signaling mechanisms of a pleiotropic agent.\", JOURNAL = c(\"Biofactors 35:183-92 (2009)\", \"DOI:10.1002/biof.23\")), list(REFERENCE = \"PMID:12700026\", AUTHORS = \"Golombek DA, Ferreyra GA, Agostino PV, Murad AD, Rubio MF, Pizzio GA, Katz ME, Marpegan L, Bekinschtein TA\", TITLE = \"From light to genes: moving the hands of the circadian clock.\", JOURNAL = \"Front Biosci 8:s285-93 (2003)\"), list(REFERENCE = \"PMID:17586087\", AUTHORS = \"Mertens I, Husson SJ, Janssen T, Lindemans M, Schoofs L\", TITLE = \"PACAP and PDF signaling in the regulation of mammalian and insect circadian rhythms.\", JOURNAL = c(\"Peptides 28:1775-83 (2007)\", \"DOI:10.1016/j.peptides.2007.05.005\")), list(REFERENCE = \"PMID:15813931\", AUTHORS = \"Kim DY, Choi HJ, Kim JS, Kim YS, Jeong DU, Shin HC, Kim MJ, Han HC, Hong SK, Kim YI\", TITLE = \"Voltage-gated calcium channels play crucial roles in the glutamate-induced phase shifts of the rat suprachiasmatic circadian clock.\", JOURNAL = c(\"Eur J Neurosci 21:1215-22 (2005)\", \"DOI:10.1111/j.1460-9568.2005.03950.x\")), list(REFERENCE = \"PMID:15016477\", AUTHORS = \"Agostino PV, Ferreyra GA, Murad AD, Watanabe Y, Golombek DA\", TITLE = \"Diurnal, circadian and photic regulation of calcium/calmodulin-dependent kinase II and neuronal nitric oxide synthase in the hamster suprachiasmatic nuclei.\", JOURNAL = c(\"Neurochem Int 44:617-25 (2004)\", \"DOI:10.1016/j.neuint.2003.09.005\")), list(REFERENCE = \"PMID:11294753\", AUTHORS = \"Ferreyra GA, Golombek DA\", TITLE = \"Rhythmicity of the cGMP-related signal transduction pathway in the mammalian circadian system.\", JOURNAL = c(\"Am J Physiol Regul Integr Comp Physiol 280:R1348-55 (2001)\", \"DOI:10.1152/ajpregu.2001.280.5.R1348\")), list(REFERENCE = \"PMID:15930378\", AUTHORS = \"Butcher GQ, Lee B, Cheng HY, Obrietan K\", TITLE = \"Light stimulates MSK1 activation in the suprachiasmatic nucleus via a PACAP-ERK/MAP kinase-dependent mechanism.\", JOURNAL = c(\"J Neurosci 25:5305-13 (2005)\", \"DOI:10.1523/JNEUROSCI.4361-04.2005\")), list(REFERENCE = \"PMID:10446325\", AUTHORS = \"Hamada T, Niki T, Ziging P, Sugiyama T, Watanabe S, Mikoshiba K, Ishida N\", TITLE = \"Differential expression patterns of inositol trisphosphate receptor types 1 and 3 in the rat suprachiasmatic nucleus.\", JOURNAL = c(\"Brain Res 838:131-5 (1999)\", \"DOI:10.1016/S0006-8993(99)01719-9\")), list(REFERENCE = \"PMID:10208575\", AUTHORS = \"Diaz-Munoz M, Dent MA, Granados-Fuentes D, Hall AC, Hernandez-Cruz A, Harrington ME, Aguilar-Roblero R\", TITLE = \"Circadian modulation of the ryanodine receptor type 2 in the SCN of rodents.\", JOURNAL = \"Neuroreport 10:481-6 (1999)\"), list(REFERENCE = \"PMID:11086993\", AUTHORS = \"Fang M, Jaffrey SR, Sawa A, Ye K, Luo X, Snyder SH\", TITLE = \"Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON.\", JOURNAL = c(\"Neuron 28:183-93 (2000)\", \"DOI:10.1016/S0896-6273(00)00095-7\")), list(REFERENCE = \"PMID:12573527\", AUTHORS = \"Takahashi H, Umeda N, Tsutsumi Y, Fukumura R, Ohkaze H, Sujino M, van der Horst G, Yasui A, Inouye ST, Fujimori A, Ohhata T, Araki R, Abe M\", TITLE = \"Mouse dexamethasone-induced RAS protein 1 gene is expressed in a circadian rhythmic manner in the suprachiasmatic nucleus.\", JOURNAL = c(\"Brain Res Mol Brain Res 110:1-6 (2003)\", \"DOI:10.1016/S0169-328X(02)00543-0\")), list(REFERENCE = \"PMID:17167088\", AUTHORS = \"Cheng HY, Dziema H, Papp J, Mathur DP, Koletar M, Ralph MR, Penninger JM, Obrietan K\", TITLE = \"The molecular gatekeeper Dexras1 sculpts the photic responsiveness of the mammalian circadian clock.\", JOURNAL = c(\"J Neurosci 26:12984-95 (2006)\", \"DOI:10.1523/JNEUROSCI.4253-06.2006\"))', 'map04713', 'Circadian entrainment', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (325, '04714', 'Thermogenesis', 'Thermogenesis is essential for warm-blooded animals, ensuring normal cellular and physiological function under conditions of environmental challenge. Thermogenesis in brown and beige adipose tissue is mainly controlled by norepinephrine, which is released from sympathetic nervous system in response to cold or dietary stimuli. The mitochondrial uncoupling protein 1 (UCP1) is responsible for the process whereby chemical energy is converted into heat in these adipocytes. Activation of these adipocytes leads to an increase in calorie consumption and is expected to improve overweight conditions, providing a potential strategy for treating obesity and its related metabolic disorders.', 'Organismal Systems; Environmental adaptation', 'Thermogenesis', 'Coffin-Siris syndrome, Genetic obesity', 'GO: 1990845', 'ko04714', 'list(REFERENCE = \"PMID:27251423\", AUTHORS = \"Inagaki T, Sakai J, Kajimura S\", TITLE = \"Transcriptional and epigenetic control of brown and beige adipose cell fate and function.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 17:480-95 (2016)\", \"DOI:10.1038/nrm.2016.62\")), list(REFERENCE = \"PMID:24100998\", AUTHORS = \"Harms M, Seale P\", TITLE = \"Brown and beige fat: development, function and therapeutic potential.\", JOURNAL = c(\"Nat Med 19:1252-63 (2013)\", \"DOI:10.1038/nm.3361\")), list(REFERENCE = \"PMID:25154875\", AUTHORS = \"Boon MR, Kooijman S, van Dam AD, Pelgrom LR, Berbee JF, Visseren CA, van Aggele RC, van den Hoek AM, Sips HC, Lombes M, Havekes LM, Tamsma JT, Guigas B, Meijer OC, Jukema JW, Rensen PC\", TITLE = \"Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity.\", JOURNAL = c(\"FASEB J 28:5361-75 (2014)\", \"DOI:10.1096/fj.13-247643\")), list(REFERENCE = \"PMID:26201764\", AUTHORS = \"Merlin J, Evans BA, Dehvari N, Sato M, Bengtsson T, Hutchinson DS\", TITLE = \"Could burning fat start with a brite spark? Pharmacological and nutritional ways to promote thermogenesis.\", JOURNAL = c(\"Mol Nutr Food Res 60:18-42 (2016)\", \"DOI:10.1002/mnfr.201500251\")), list(REFERENCE = \"PMID:26271143\", AUTHORS = \"van Dam AD, Kooijman S, Schilperoort M, Rensen PC, Boon MR\", TITLE = \"Regulation of brown fat by AMP-activated protein kinase.\", JOURNAL = c(\"Trends Mol Med 21:571-9 (2015)\", \"DOI:10.1016/j.molmed.2015.07.003\")), list(REFERENCE = \"PMID:26482876\", AUTHORS = \"Kooijman S, van den Heuvel JK, Rensen PC\", TITLE = \"Neuronal Control of Brown Fat Activity.\", JOURNAL = c(\"Trends Endocrinol Metab 26:657-68 (2015)\", \"DOI:10.1016/j.tem.2015.09.008\")), list(REFERENCE = \"PMID:28448947\", AUTHORS = \"Contreras C, Nogueiras R, Dieguez C, Rahmouni K, Lopez M\", TITLE = \"Traveling from the hypothalamus to the adipose tissue: The thermogenic pathway.\", JOURNAL = c(\"Redox Biol 12:854-863 (2017)\", \"DOI:10.1016/j.redox.2017.04.019\")), list(REFERENCE = \"PMID:24872083\", AUTHORS = \"Fruhbeck G, Mendez-Gimenez L, Fernandez-Formoso JA, Fernandez S, Rodriguez A\", TITLE = \"Regulation of adipocyte lipolysis.\", JOURNAL = c(\"Nutr Res Rev 27:63-93 (2014)\", \"DOI:10.1017/S095442241400002X\")), list(REFERENCE = \"PMID:15545214\", AUTHORS = \"Tansey JT, Sztalryd C, Hlavin EM, Kimmel AR, Londos C\", TITLE = \"The central role of perilipin a in lipid metabolism and adipocyte lipolysis.\", JOURNAL = c(\"IUBMB Life 56:379-85 (2004)\", \"DOI:10.1080/15216540400009968\")), list(REFERENCE = \"PMID:20935662\", AUTHORS = \"Collins S, Yehuda-Shnaidman E, Wang H\", TITLE = \"Positive and negative control of Ucp1 gene transcription and the role of beta-adrenergic signaling networks.\", JOURNAL = c(\"Int J Obes (Lond) 34 Suppl 1:S28-33 (2010)\", \"DOI:10.1038/ijo.2010.180\")), list(REFERENCE = \"PMID:15964803\", AUTHORS = \"Robidoux J, Cao W, Quan H, Daniel KW, Moukdar F, Bai X, Floering LM, Collins S\", TITLE = \"Selective activation of mitogen-activated protein (MAP) kinase kinase 3 and p38alpha MAP kinase is essential for cyclic AMP-dependent UCP1 expression in adipocytes.\", JOURNAL = c(\"Mol Cell Biol 25:5466-79 (2005)\", \"DOI:10.1128/MCB.25.13.5466-5479.2005\")), list(REFERENCE = \"PMID:27045525\", AUTHORS = \"Hattori K, Naguro I, Okabe K, Funatsu T, Furutani S, Takeda K, Ichijo H\", TITLE = \"ASK1 signalling regulates brown and beige adipocyte function.\", JOURNAL = c(\"Nat Commun 7:11158 (2016)\", \"DOI:10.1038/ncomms11158\")), list(REFERENCE = \"PMID:25948511\", AUTHORS = \"Abe Y, Rozqie R, Matsumura Y, Kawamura T, Nakaki R, Tsurutani Y, Tanimura-Inagaki K, Shiono A, Magoori K, Nakamura K, Ogi S, Kajimura S, Kimura H, Tanaka T, Fukami K, Osborne TF, Kodama T, Aburatani H, Inagaki T, Sakai J\", TITLE = \"JMJD1A is a signal-sensing scaffold that regulates acute chromatin dynamics via SWI/SNF association for thermogenesis.\", JOURNAL = c(\"Nat Commun 6:7052 (2015)\", \"DOI:10.1038/ncomms8052\")), list(REFERENCE = \"PMID:25578880\", AUTHORS = \"Dempersmier J, Sambeat A, Gulyaeva O, Paul SM, Hudak CS, Raposo HF, Kwan HY, Kang C, Wong RH, Sul HS\", TITLE = \"Cold-inducible Zfp516 activates UCP1 transcription to promote browning of white fat and development of brown fat.\", JOURNAL = c(\"Mol Cell 57:235-46 (2015)\", \"DOI:10.1016/j.molcel.2014.12.005\")), list(REFERENCE = \"PMID:27264172\", AUTHORS = \"Sambeat A, Gulyaeva O, Dempersmier J, Tharp KM, Stahl A, Paul SM, Sul HS\", TITLE = \"LSD1 Interacts with Zfp516 to Promote UCP1 Transcription and Brown Fat Program.\", JOURNAL = c(\"Cell Rep 15:2536-49 (2016)\", \"DOI:10.1016/j.celrep.2016.05.019\")), list(REFERENCE = \"PMID:27693079\", AUTHORS = \"Villarroya F, Peyrou M, Giralt M\", TITLE = \"Transcriptional regulation of the uncoupling protein-1 gene.\", JOURNAL = c(\"Biochimie 134:86-92 (2017)\", \"DOI:10.1016/j.biochi.2016.09.017\")), list(REFERENCE = \"PMID:15024092\", AUTHORS = \"Cao W, Daniel KW, Robidoux J, Puigserver P, Medvedev AV, Bai X, Floering LM, Spiegelman BM, Collins S\", TITLE = \"p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene.\", JOURNAL = c(\"Mol Cell Biol 24:3057-67 (2004)\", \"DOI:10.1128/MCB.24.7.3057-3067.2004\")), list(REFERENCE = \"PMID:21317437\", AUTHORS = \"Hondares E, Iglesias R, Giralt A, Gonzalez FJ, Giralt M, Mampel T, Villarroya F\", TITLE = \"Thermogenic activation induces FGF21 expression and release in brown adipose tissue.\", JOURNAL = c(\"J Biol Chem 286:12983-90 (2011)\", \"DOI:10.1074/jbc.M110.215889\")), list(REFERENCE = \"PMID:28723567\", AUTHORS = \"Yao L, Cui X, Chen Q, Yang X, Fang F, Zhang J, Liu G, Jin W, Chang Y\", TITLE = \"Cold-Inducible SIRT6 Regulates Thermogenesis of Brown and Beige Fat.\", JOURNAL = c(\"Cell Rep 20:641-654 (2017)\", \"DOI:10.1016/j.celrep.2017.06.069\")), list(REFERENCE = \"PMID:27794497\", AUTHORS = \"Klingenberg M\", TITLE = \"UCP1 - A sophisticated energy valve.\", JOURNAL = c(\"Biochimie 134:19-27 (2017)\", \"DOI:10.1016/j.biochi.2016.10.012\")), list(REFERENCE = \"PMID:27984203\", AUTHORS = \"Bertholet AM, Kirichok Y\", TITLE = \"UCP1: A transporter for H(+) and fatty acid anions.\", JOURNAL = c(\"Biochimie 134:28-34 (2017)\", \"DOI:10.1016/j.biochi.2016.10.013\")), list(REFERENCE = \"PMID:29052591\", AUTHORS = \"Betz MJ, Enerback S\", TITLE = \"Targeting thermogenesis in brown fat and muscle to treat obesity and metabolic disease.\", JOURNAL = c(\"Nat Rev Endocrinol 14:77-87 (2018)\", \"DOI:10.1038/nrendo.2017.132\")), list(REFERENCE = \"PMID:20514071\", AUTHORS = \"Tseng YH, Cypess AM, Kahn CR\", TITLE = \"Cellular bioenergetics as a target for obesity therapy.\", JOURNAL = c(\"Nat Rev Drug Discov 9:465-82 (2010)\", \"DOI:10.1038/nrd3138\")), list(REFERENCE = \"PMID:25390014\", AUTHORS = \"Fenzl A, Kiefer FW\", TITLE = \"Brown adipose tissue and thermogenesis.\", JOURNAL = c(\"Horm Mol Biol Clin Investig 19:25-37 (2014)\", \"DOI:10.1515/hmbci-2014-0022\")), list(REFERENCE = \"PMID:27681418\", AUTHORS = \"Minard AY, Tan SX, Yang P, Fazakerley DJ, Domanova W, Parker BL, Humphrey SJ, Jothi R, Stockli J, James DE\", TITLE = \"mTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes.\", JOURNAL = c(\"Cell Rep 17:29-36 (2016)\", \"DOI:10.1016/j.celrep.2016.08.086\")), list(REFERENCE = \"PMID:22302939\", AUTHORS = \"Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, Wu J, Kharitonenkov A, Flier JS, Maratos-Flier E, Spiegelman BM\", TITLE = \"FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis.\", JOURNAL = c(\"Genes Dev 26:271-81 (2012)\", \"DOI:10.1101/gad.177857.111\")), list(REFERENCE = \"PMID:24820868\", AUTHORS = \"Zois NE, Bartels ED, Hunter I, Kousholt BS, Olsen LH, Goetze JP\", TITLE = \"Natriuretic peptides in cardiometabolic regulation and disease.\", JOURNAL = c(\"Nat Rev Cardiol 11:403-12 (2014)\", \"DOI:10.1038/nrcardio.2014.64\")), list(REFERENCE = \"PMID:22020112\", AUTHORS = \"Indiveri C, Iacobazzi V, Tonazzi A, Giangregorio N, Infantino V, Convertini P, Console L, Palmieri F\", TITLE = \"The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology.\", JOURNAL = c(\"Mol Aspects Med 32:223-33 (2011)\", \"DOI:10.1016/j.mam.2011.10.008\")), list(REFERENCE = \"PMID:26303601\", AUTHORS = \"McCoin CS, Knotts TA, Adams SH\", TITLE = \"Acylcarnitines--old actors auditioning for new roles in metabolic physiology.\", JOURNAL = c(\"Nat Rev Endocrinol 11:617-25 (2015)\", \"DOI:10.1038/nrendo.2015.129\")), list(REFERENCE = \"PMID:28955734\", AUTHORS = \"Ohtomo T, Ino K, Miyashita R, Chigira M, Nakamura M, Someya K, Inaba N, Fujita M, Takagi M, Yamada J\", TITLE = \"Chronic high-fat feeding impairs adaptive induction of mitochondrial fatty acid combustion-associated proteins in brown adipose tissue of mice.\", JOURNAL = c(\"Biochem Biophys Rep 10:32-38 (2017)\", \"DOI:10.1016/j.bbrep.2017.02.002\"))', 'map04714', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (326, '04720', 'Long-term potentiation', 'Hippocampal long-term potentiation (LTP), a long-lasting increase in synaptic efficacy, is the molecular basis for learning and memory. Tetanic stimulation of afferents in the CA1 region of the hippocampus induces glutamate release and activation of glutamate receptors in dendritic spines. A large increase in [Ca2+]i resulting from influx through NMDA receptors leads to constitutive activation of CaM kinase II (CaM KII) . Constitutively active CaM kinase II phosphorylates AMPA receptors, resulting in potentiation of the ionic conductance of AMPA receptors. Early-phase LTP (E-LTP) expression is due, in part, to this phosphorylation of the AMPA receptor. It is hypothesized that postsynaptic Ca2+ increases generated through NMDA receptors activate several signal transduction pathways including the Erk/MAP kinase and cAMP regulatory pathways. The convergence of these pathways at the level of the CREB/CRE transcriptional pathway may increase expression of a family of genes required for late-phase LTP (L-LTP).', 'Organismal Systems; Nervous system', 'Long-term potentiation', 'GO: 0048169', 'ko04720', 'list(REFERENCE = \"PMID:15652868\", AUTHORS = \"Blitzer RD, Iyengar R, Landau EM.\", TITLE = \"Postsynaptic signaling networks: cellular cogwheels underlying long-term plasticity.\", JOURNAL = c(\"Biol Psychiatry 57:113-9 (2005)\", \"DOI:10.1016/j.biopsych.2004.02.031\")), list(REFERENCE = \"PMID:10652548\", AUTHORS = \"Soderling TR, Derkach VA.\", TITLE = \"Postsynaptic protein phosphorylation and LTP.\", JOURNAL = c(\"Trends Neurosci 23:75-80 (2000)\", \"DOI:10.1016/S0166-2236(99)01490-3\")), list(REFERENCE = \"PMID:11378299\", AUTHORS = \"Poser S, Storm DR.\", TITLE = \"Role of Ca2+-stimulated adenylyl cyclases in LTP and memory formation.\", JOURNAL = c(\"Int J Dev Neurosci 19:387-94 (2001)\", \"DOI:10.1016/S0736-5748(00)00094-0\")), list(REFERENCE = \"PMID:15803158\", AUTHORS = \"Xia Z, Storm DR.\", TITLE = \"The role of calmodulin as a signal integrator for synaptic plasticity.\", JOURNAL = c(\"Nat Rev Neurosci 6:267-76 (2005)\", \"DOI:10.1038/nrn1647\")), list(REFERENCE = \"\", AUTHORS = \"Purves D, Augustine GJ (ed).\", TITLE = \"Neuroscience\", JOURNAL = \"Sunderland, Mass.:Sinauer Associates (2004)\"), list(REFERENCE = \"PMID:14715912\", AUTHORS = \"Lynch MA.\", TITLE = \"Long-term potentiation and memory.\", JOURNAL = c(\"Physiol Rev 84:87-136 (2004)\", \"DOI:10.1152/physrev.00014.2003\")), list(REFERENCE = \"PMID:15857686\", AUTHORS = \"Kelly PT, Mackinnon RL 2nd, Dietz RV, Maher BJ, Wang J.\", TITLE = \"Postsynaptic IP3 receptor-mediated Ca2+ release modulates synaptic transmission in hippocampal neurons.\", JOURNAL = c(\"Brain Res Mol Brain Res 135:232-48 (2005)\", \"DOI:10.1016/j.molbrainres.2004.12.018\")), list(REFERENCE = \"PMID:9697848\", AUTHORS = \"Berridge MJ.\", TITLE = \"Neuronal calcium signaling.\", JOURNAL = c(\"Neuron 21:13-26 (1998)\", \"DOI:10.1016/S0896-6273(00)80510-3\"))', 'map04720', 'Long-term potentiation', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (327, '04721', 'Synaptic vesicle cycle', 'Communication between neurons is mediated by the release of neurotransmitter from synaptic vesicles (SVs). At the nerve terminal, SVs cycle through repetitive episodes of exocytosis and endocytosis. SVs are filled with neurotransmitters by active transport. The loaded SVs are then docked at a specialized region of the presynaptic plasma membrane known as the active zone, where they undergo a priming reaction. Upon arrival of an action potential, Ca2+ enters through voltage-gated channels and neurotransmitter is released by exocytosis, usually in less than a millisecond. After fusion, the vesicle is retrieved by endocytosis and reloaded for another round of exocytosis.', 'Organismal Systems; Nervous system', 'Synaptic vesicle cycle', 'Centronuclear myopathy, Episodic ataxias, Hemiplegic migraine, DDOD syndrome', 'GO: 0016079 0048488', 'ko04721', 'list(REFERENCE = \"PMID:12827282\", AUTHORS = \"Li L, Chin LS\", TITLE = \"The molecular machinery of synaptic vesicle exocytosis.\", JOURNAL = c(\"Cell Mol Life Sci 60:942-60 (2003)\", \"DOI:10.1007/s00018-003-2240-7\")), list(REFERENCE = \"\", AUTHORS = \"Nestler EJ, Hyman SE, Malenka RC.\", TITLE = \"Molecular neuropharmacology: A foundation for clinical neuroscience\", JOURNAL = \"The McGraw-Hill Companies, Inc. (2001)\"), list(REFERENCE = \"PMID:18275379\", AUTHORS = \"Chapman ER\", TITLE = \"How does synaptotagmin trigger neurotransmitter release?\", JOURNAL = c(\"Annu Rev Biochem 77:615-41 (2008)\", \"DOI:10.1146/annurev.biochem.77.062005.101135\")), list(REFERENCE = \"PMID:10212473\", AUTHORS = \"Benfenati F, Onofri F, Giovedi S\", TITLE = \"Protein-protein interactions and protein modules in the control of neurotransmitter release.\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 354:243-57 (1999)\", \"DOI:10.1098/rstb.1999.0376\")), list(REFERENCE = \"PMID:20634814\", AUTHORS = \"de Saint Basile G, Menasche G, Fischer A\", TITLE = \"Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules.\", JOURNAL = c(\"Nat Rev Immunol 10:568-79 (2010)\", \"DOI:10.1038/nri2803\")), list(REFERENCE = \"PMID:17767192\", AUTHORS = \"Carr CM, Munson M\", TITLE = \"Tag team action at the synapse.\", JOURNAL = c(\"EMBO Rep 8:834-8 (2007)\", \"DOI:10.1038/sj.embor.7401051\")), list(REFERENCE = \"PMID:15217342\", AUTHORS = \"Sudhof TC\", TITLE = \"The synaptic vesicle cycle.\", JOURNAL = c(\"Annu Rev Neurosci 27:509-47 (2004)\", \"DOI:10.1146/annurev.neuro.26.041002.131412\")), list(REFERENCE = \"PMID:12563290\", AUTHORS = \"Gundelfinger ED, Kessels MM, Qualmann B\", TITLE = \"Temporal and spatial coordination of exocytosis and endocytosis.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 4:127-39 (2003)\", \"DOI:10.1038/nrm1016\")), list(REFERENCE = \"PMID:16990140\", AUTHORS = \"Tang J, Maximov A, Shin OH, Dai H, Rizo J, Sudhof TC\", TITLE = \"A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis.\", JOURNAL = c(\"Cell 126:1175-87 (2006)\", \"DOI:10.1016/j.cell.2006.08.030\")), list(REFERENCE = \"PMID:12094216\", AUTHORS = \"Chapman ER\", TITLE = \"Synaptotagmin: a Ca(2+) sensor that triggers exocytosis?\", JOURNAL = c(\"Nat Rev Mol Cell Biol 3:498-508 (2002)\", \"DOI:10.1038/nrm855\")), list(REFERENCE = \"PMID:7791897\", AUTHORS = \"Sudhof TC\", TITLE = \"The synaptic vesicle cycle: a cascade of protein-protein interactions.\", JOURNAL = c(\"Nature 375:645-53 (1995)\", \"DOI:10.1038/375645a0\")), list(REFERENCE = \"PMID:12154365\", AUTHORS = \"Rizo J, Sudhof TC\", TITLE = \"Snares and Munc18 in synaptic vesicle fusion.\", JOURNAL = c(\"Nat Rev Neurosci 3:641-53 (2002)\", \"DOI:10.1038/nrn898\")), list(REFERENCE = \"PMID:18726177\", AUTHORS = \"Malsam J, Kreye S, Sollner TH\", TITLE = \"Membrane fusion: SNAREs and regulation.\", JOURNAL = c(\"Cell Mol Life Sci 65:2814-32 (2008)\", \"DOI:10.1007/s00018-008-8352-3\"))', 'map04721', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (328, '04722', 'Neurotrophin signaling pathway', 'Neurotrophins are a family of trophic factors involved in differentiation and survival of neural cells. The neurotrophin family consists of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin 4 (NT-4). Neurotrophins exert their functions through engagement of Trk tyrosine kinase receptors or p75 neurotrophin receptor (p75NTR). Neurotrophin/Trk signaling is regulated by connecting a variety of intracellular signaling cascades, which include MAPK pathway, PI-3 kinase pathway, and PLC pathway, transmitting positive signals like enhanced survival and growth. On the other hand, p75NTR transmits both positive and nagative signals. These signals play an important role for neural development and additional higher-order activities such as learning and memory.', 'Organismal Systems; Nervous system', 'Neurotrophin signaling pathway', 'Frontotemporal lobar degeneration, Hereditary sensory and autonomic neuropathy, Type 1 diabetes mellitus, Acne inversa, Congenital central hypoventilation syndrome, Choroid plexus papilloma, Metachondromatosis, Congenital pain insensitivity with anhidrosis, Leopard syndrome', 'ko04722', 'list(REFERENCE = \"PMID:12676795\", AUTHORS = \"Huang EJ, Reichardt LF.\", TITLE = \"Trk receptors: roles in neuronal signal transduction.\", JOURNAL = c(\"Annu Rev Biochem 72:609-42 (2003)\", \"DOI:10.1146/annurev.biochem.72.121801.161629\")), list(REFERENCE = \"PMID:11399424\", AUTHORS = \"Patapoutian A, Reichardt LF\", TITLE = \"Trk receptors: mediators of neurotrophin action.\", JOURNAL = c(\"Curr Opin Neurobiol 11:272-80 (2001)\", \"DOI:10.1016/S0959-4388(00)00208-7\")), list(REFERENCE = \"PMID:16699811\", AUTHORS = \"Arevalo JC, Wu SH\", TITLE = \"Neurotrophin signaling: many exciting surprises!\", JOURNAL = c(\"Cell Mol Life Sci 63:1523-37 (2006)\", \"DOI:10.1007/s00018-006-6010-1\")), list(REFERENCE = \"PMID:14704852\", AUTHORS = \"Teng KK, Hempstead BL\", TITLE = \"Neurotrophins and their receptors: signaling trios in complex biological systems.\", JOURNAL = c(\"Cell Mol Life Sci 61:35-48 (2004)\", \"DOI:10.1007/s00018-003-3099-3\")), list(REFERENCE = \"PMID:11529497\", AUTHORS = \"Miller FD, Kaplan DR\", TITLE = \"Neurotrophin signalling pathways regulating neuronal apoptosis.\", JOURNAL = c(\"Cell Mol Life Sci 58:1045-53 (2001)\", \"DOI:10.1007/PL00000919\")), list(REFERENCE = \"PMID:10851172\", AUTHORS = \"Kaplan DR, Miller FD\", TITLE = \"Neurotrophin signal transduction in the nervous system.\", JOURNAL = c(\"Curr Opin Neurobiol 10:381-91 (2000)\", \"DOI:10.1016/S0959-4388(00)00092-1\")), list(REFERENCE = \"PMID:16939974\", AUTHORS = \"Reichardt LF\", TITLE = \"Neurotrophin-regulated signalling pathways.\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 361:1545-64 (2006)\", \"DOI:10.1098/rstb.2006.1894\")), list(REFERENCE = \"PMID:16856873\", AUTHORS = \"Zampieri N, Chao MV\", TITLE = \"Mechanisms of neurotrophin receptor signalling.\", JOURNAL = c(\"Biochem Soc Trans 34:607-11 (2006)\", \"DOI:10.1042/BST0340607\")), list(REFERENCE = \"PMID:15499580\", AUTHORS = \"Rose CR, Blum R, Kafitz KW, Kovalchuk Y, Konnerth A\", TITLE = \"From modulator to mediator: rapid effects of BDNF on ion channels.\", JOURNAL = c(\"Bioessays 26:1185-94 (2004)\", \"DOI:10.1002/bies.20118\")), list(REFERENCE = \"PMID:10812966\", AUTHORS = \"Yano H, Chao MV\", TITLE = \"Neurotrophin receptor structure and interactions.\", JOURNAL = \"Pharm Acta Helv 74:253-60 (2000)\"), list(REFERENCE = \"PMID:10764727\", AUTHORS = \"Mukai J, Hachiya T, Shoji-Hoshino S, Kimura MT, Nadano D, Suvanto P, Hanaoka T, Li Y, Irie S, Greene LA, Sato TA\", TITLE = \"NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR.\", JOURNAL = c(\"J Biol Chem 275:17566-70 (2000)\", \"DOI:10.1074/jbc.C000140200\")), list(REFERENCE = \"PMID:10985348\", AUTHORS = \"Salehi AH, Roux PP, Kubu CJ, Zeindler C, Bhakar A, Tannis LL, Verdi JM, Barker PA\", TITLE = \"NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis.\", JOURNAL = c(\"Neuron 27:279-88 (2000)\", \"DOI:10.1016/S0896-6273(00)00036-2\"))', 'map04722', 'Neurotrophin signaling pathway', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (329, '04723', 'Retrograde endocannabinoid signaling', 'Endogenous cannabinoids (endocannabinoids) serve as retrograde messengers at synapses in various regions of the brain. The family of endocannabinoids includes at least five derivatives of arachidonic acid; the two best characterized are arachydonoyl ethanolamide (anandamide, AEA) and 2-arachydonoil glycerol (2AG). They are released from postsynaptic neurons upon postsynaptic depolarization and/or receptor activation. The released endocannabinoids then activate the CB1 receptors (CB1R) at presynaptic terminals and suppress the release of inhibitory transmitter GABA (depolarization-induced suppression of inhibition, DSI) or excitatory transmitter glutamate (depolarization-induced suppression of excitation, DSE) by inhibiting Ca2+ channels. Besides the well-known expression of the CB1R in the plasma membrane, this receptor is also present in mitochondrial membranes, where it reduces the mitochondrial respiration and contributes to DSI. Whereas DSI and DSE result in short-term synaptic plasticity, endocannabinoids also mediate long-term synaptic changes (eCB-LTD). Persistent activation of CB1 receptors over a period of minutes triggers eCB-LTD by a RIM1alpha-dependent mechanism.', 'Organismal Systems; Nervous system', 'Retrograde endocannabinoid signaling', 'Early infantile epileptic encephalopathy', 'GO: 0071926', 'ko04723', 'list(REFERENCE = \"PMID:17419048\", AUTHORS = \"Hashimotodani Y, Ohno-Shosaku T, Kano M\", TITLE = \"Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities.\", JOURNAL = c(\"Curr Opin Neurobiol 17:360-5 (2007)\", \"DOI:10.1016/j.conb.2007.03.012\")), list(REFERENCE = \"PMID:21531987\", AUTHORS = \"Ohno-Shosaku T, Tanimura A, Hashimotodani Y, Kano M\", TITLE = \"Endocannabinoids and retrograde modulation of synaptic transmission.\", JOURNAL = c(\"Neuroscientist 18:119-32 (2012)\", \"DOI:10.1177/1073858410397377\")), list(REFERENCE = \"PMID:18084639\", AUTHORS = \"Basavarajappa BS\", TITLE = \"Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.\", JOURNAL = \"Curr Neuropharmacol 5:81-97 (2007)\"), list(REFERENCE = \"PMID:16968947\", AUTHORS = \"Pacher P, Batkai S, Kunos G\", TITLE = \"The endocannabinoid system as an emerging target of pharmacotherapy.\", JOURNAL = c(\"Pharmacol Rev 58:389-462 (2006)\", \"DOI:10.1124/pr.58.3.2\")), list(REFERENCE = \"PMID:15340387\", AUTHORS = \"Di Marzo V, Bifulco M, De Petrocellis L\", TITLE = \"The endocannabinoid system and its therapeutic exploitation.\", JOURNAL = c(\"Nat Rev Drug Discov 3:771-84 (2004)\", \"DOI:10.1038/nrd1495\")), list(REFERENCE = \"PMID:17404373\", AUTHORS = \"Hashimotodani Y, Ohno-Shosaku T, Kano M\", TITLE = \"Endocannabinoids and synaptic function in the CNS.\", JOURNAL = c(\"Neuroscientist 13:127-37 (2007)\", \"DOI:10.1177/1073858406296716\")), list(REFERENCE = \"PMID:19126760\", AUTHORS = \"Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M\", TITLE = \"Endocannabinoid-mediated control of synaptic transmission.\", JOURNAL = c(\"Physiol Rev 89:309-80 (2009)\", \"DOI:10.1152/physrev.00019.2008\")), list(REFERENCE = \"PMID:19640475\", AUTHORS = \"Regehr WG, Carey MR, Best AR\", TITLE = \"Activity-dependent regulation of synapses by retrograde messengers.\", JOURNAL = c(\"Neuron 63:154-70 (2009)\", \"DOI:10.1016/j.neuron.2009.06.021\")), list(REFERENCE = \"PMID:17636069\", AUTHORS = \"Benarroch E\", TITLE = \"Endocannabinoids in basal ganglia circuits: implications for Parkinson disease.\", JOURNAL = c(\"Neurology 69:306-9 (2007)\", \"DOI:10.1212/01.wnl.0000267407.79757.75\")), list(REFERENCE = \"PMID:16085309\", AUTHORS = \"Ohno-Shosaku T, Hashimotodani Y, Maejima T, Kano M\", TITLE = \"Calcium signaling and synaptic modulation: regulation of endocannabinoid-mediated synaptic modulation by calcium.\", JOURNAL = c(\"Cell Calcium 38:369-74 (2005)\", \"DOI:10.1016/j.ceca.2005.06.014\")), list(REFERENCE = \"PMID:18801434\", AUTHORS = \"Harkany T, Mackie K, Doherty P\", TITLE = \"Wiring and firing neuronal networks: endocannabinoids take center stage.\", JOURNAL = c(\"Curr Opin Neurobiol 18:338-45 (2008)\", \"DOI:10.1016/j.conb.2008.08.007\")), list(REFERENCE = \"PMID:18515270\", AUTHORS = \"Hosking RD, Zajicek JP\", TITLE = \"Therapeutic potential of cannabis in pain medicine.\", JOURNAL = c(\"Br J Anaesth 101:59-68 (2008)\", \"DOI:10.1093/bja/aen119\")), list(REFERENCE = \"PMID:21187849\", AUTHORS = \"Di Marzo V\", TITLE = \"Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.\", JOURNAL = c(\"Nat Neurosci 14:9-15 (2011)\", \"DOI:10.1038/nn.2720\")), list(REFERENCE = \"PMID:18948642\", AUTHORS = \"McPartland JM\", TITLE = \"The endocannabinoid system: an osteopathic perspective.\", JOURNAL = \"J Am Osteopath Assoc 108:586-600 (2008)\"), list(REFERENCE = \"PMID:17553427\", AUTHORS = \"Chevaleyre V, Heifets BD, Kaeser PS, Sudhof TC, Castillo PE\", TITLE = \"Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha.\", JOURNAL = c(\"Neuron 54:801-12 (2007)\", \"DOI:10.1016/j.neuron.2007.05.020\")), list(REFERENCE = \"PMID:19553483\", AUTHORS = \"Lafourcade CA\", TITLE = \"Presynaptic mechanisms of endocannabinoid-mediated long-term depression in the hippocampus.\", JOURNAL = c(\"J Neurophysiol 102:2009-12 (2009)\", \"DOI:10.1152/jn.00441.2009\")), list(REFERENCE = \"PMID:21328621\", AUTHORS = \"Ueda N, Tsuboi K, Uyama T, Ohnishi T\", TITLE = \"Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.\", JOURNAL = c(\"Biofactors 37:1-7 (2011)\", \"DOI:10.1002/biof.131\")), list(REFERENCE = \"PMID:14978245\", AUTHORS = \"Guo J, Ikeda SR\", TITLE = \"Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons.\", JOURNAL = c(\"Mol Pharmacol 65:665-74 (2004)\", \"DOI:10.1124/mol.65.3.665\")), list(REFERENCE = \"PMID:22388959\", AUTHORS = \"Benard G, Massa F, Puente N, Lourenco J, Bellocchio L, Soria-Gomez E, Matias I, Delamarre A, Metna-Laurent M, Cannich A, Hebert-Chatelain E, Mulle C, Ortega-Gutierrez S, Martin-Fontecha M, Klugmann M, Guggenhuber S, Lutz B, Gertsch J, Chaouloff F, Lopez-Rodriguez ML, Grandes P, Rossignol R, Marsicano G\", TITLE = \"Mitochondrial CB(1) receptors regulate neuronal energy metabolism.\", JOURNAL = c(\"Nat Neurosci 15:558-64 (2012)\", \"DOI:10.1038/nn.3053\")), list(REFERENCE = \"PMID:26260530\", AUTHORS = \"Busquets-Garcia A, Desprez T, Metna-Laurent M, Bellocchio L, Marsicano G, Soria-Gomez E\", TITLE = \"Dissecting the cannabinergic control of behavior: The where matters.\", JOURNAL = c(\"Bioessays 37:1215-25 (2015)\", \"DOI:10.1002/bies.201500046\")), list(REFERENCE = \"PMID:28076767\", AUTHORS = \"Harkany T, Horvath TL\", TITLE = \"(S)Pot on Mitochondria: Cannabinoids Disrupt Cellular Respiration to Limit Neuronal Activity.\", JOURNAL = c(\"Cell Metab 25:8-10 (2017)\", \"DOI:10.1016/j.cmet.2016.12.020\")), list(REFERENCE = \"PMID:22449955\", AUTHORS = \"Alger BE, Tang AH\", TITLE = \"Do cannabinoids reduce brain power?\", JOURNAL = c(\"Nat Neurosci 15:499-501 (2012)\", \"DOI:10.1038/nn.3072\"))', 'map04723', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (330, '04724', 'Glutamatergic synapse', 'Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system(CNS). Glutamate is packaged into synaptic vesicles in the presynaptic terminal. Once released into the synaptic cleft, glutamate acts on postsynaptic ionotropic glutamate receptors (iGluRs) to mediate fast excitatory synaptic transmission. Glutamate can also act on metabotropic glutamate receptors (mGluRs) and exert a variety of modulatory effects through their coupling to G proteins and the subsequent recruitment of second messenger systems. Presynaptically localized Group II and Group III mGluRs are thought to represent the classical inhibitory autoreceptor mechanism that suppresses excess glutamate release. After its action on these receptors, glutamate can be removed from the synaptic cleft by EAATs located either on the presynaptic terminal, neighboring glial cells, or the postsynaptic neuron. In glia, glutamate is converted to glutamine, which is then transported back to the presynaptic terminal and converted back to glutamate.', 'Organismal Systems; Nervous system', 'Glutamatergic synapse', 'Early infantile epileptic encephalopathy, Episodic ataxias, Hemiplegic migraine, Congenital stationary night blindness, Dicarboxylic aminoaciduria, Congenital systemic glutamine deficiency, Phelan-McDermid syndrome, Obsessive-compulsive disorder, Rolandic epilepsy, mental retardation, and speech dyspraxia, Autism', 'GO: 0051966', 'ko04724', 'list(REFERENCE = \"PMID:20055706\", AUTHORS = \"Niswender CM, Conn PJ\", TITLE = \"Metabotropic glutamate receptors: physiology, pharmacology, and disease.\", JOURNAL = c(\"Annu Rev Pharmacol Toxicol 50:295-322 (2010)\", \"DOI:10.1146/annurev.pharmtox.011008.145533\")), list(REFERENCE = \"PMID:19112153\", AUTHORS = \"Ferraguti F, Crepaldi L, Nicoletti F\", TITLE = \"Metabotropic glutamate 1 receptor: current concepts and perspectives.\", JOURNAL = c(\"Pharmacol Rev 60:536-81 (2008)\", \"DOI:10.1124/pr.108.000166\")), list(REFERENCE = \"PMID:11672421\", AUTHORS = \"Hermans E, Challiss RA\", TITLE = \"Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors.\", JOURNAL = c(\"Biochem J 359:465-84 (2001)\", \"DOI:10.1042/bj3590465\")), list(REFERENCE = \"PMID:17663464\", AUTHORS = \"Kim CH, Lee J, Lee JY, Roche KW\", TITLE = \"Metabotropic glutamate receptors: phosphorylation and receptor signaling.\", JOURNAL = c(\"J Neurosci Res 86:1-10 (2008)\", \"DOI:10.1002/jnr.21437\")), list(REFERENCE = \"PMID:14684436\", AUTHORS = \"Meador-Woodruff JH, Clinton SM, Beneyto M, McCullumsmith RE\", TITLE = \"Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia.\", JOURNAL = c(\"Ann N Y Acad Sci 1003:75-93 (2003)\", \"DOI:10.1196/annals.1300.005\")), list(REFERENCE = \"PMID:18425072\", AUTHORS = \"Sanacora G, Zarate CA, Krystal JH, Manji HK\", TITLE = \"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.\", JOURNAL = c(\"Nat Rev Drug Discov 7:426-37 (2008)\", \"DOI:10.1038/nrd2462\")), list(REFERENCE = \"PMID:17706608\", AUTHORS = \"Gass JT, Olive MF\", TITLE = \"Glutamatergic substrates of drug addiction and alcoholism.\", JOURNAL = c(\"Biochem Pharmacol 75:218-65 (2008)\", \"DOI:10.1016/j.bcp.2007.06.039\")), list(REFERENCE = \"PMID:9665875\", AUTHORS = \"Palmada M, Centelles JJ\", TITLE = \"Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain.\", JOURNAL = \"Front Biosci 3:d701-18 (1998)\"), list(REFERENCE = \"PMID:11561058\", AUTHORS = \"Schoepp DD\", TITLE = \"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.\", JOURNAL = \"J Pharmacol Exp Ther 299:12-20 (2001)\"), list(REFERENCE = \"PMID:19559598\", AUTHORS = \"de Jong AP, Verhage M\", TITLE = \"Presynaptic signal transduction pathways that modulate synaptic transmission.\", JOURNAL = c(\"Curr Opin Neurobiol 19:245-53 (2009)\", \"DOI:10.1016/j.conb.2009.06.005\")), list(REFERENCE = \"PMID:18464791\", AUTHORS = \"Pinheiro PS, Mulle C\", TITLE = \"Presynaptic glutamate receptors: physiological functions and mechanisms of action.\", JOURNAL = c(\"Nat Rev Neurosci 9:423-36 (2008)\", \"DOI:10.1038/nrn2379\")), list(REFERENCE = \"PMID:19110202\", AUTHORS = \"Byrnes KR, Loane DJ, Faden AI\", TITLE = \"Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders.\", JOURNAL = c(\"Neurotherapeutics 6:94-107 (2009)\", \"DOI:10.1016/j.nurt.2008.10.038\")), list(REFERENCE = \"PMID:10481192\", AUTHORS = \"Conti F, Weinberg RJ\", TITLE = \"Shaping excitation at glutamatergic synapses.\", JOURNAL = c(\"Trends Neurosci 22:451-8 (1999)\", \"DOI:10.1016/S0166-2236(99)01445-9\")), list(REFERENCE = \"PMID:12399578\", AUTHORS = \"Sheng M, Kim MJ\", TITLE = \"Postsynaptic signaling and plasticity mechanisms.\", JOURNAL = c(\"Science 298:776-80 (2002)\", \"DOI:10.1126/science.1075333\"))', 'map04724', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (331, '04725', 'Cholinergic synapse', 'Acetylcholine (ACh) is a neurotransmitter widely distributed in the central (and also peripheral, autonomic and enteric) nervous system (CNS). In the CNS, ACh facilitates many functions, such as learning, memory, attention and motor control. When released in the synaptic cleft, ACh binds to two distinct types of receptors: Ionotropic nicotinic acetylcholine receptors (nAChR) and metabotropic muscarinic acetylcholine receptors (mAChRs). The activation of nAChR by ACh leads to the rapid influx of Na+ and Ca2+ and subsequent cellular depolarization. Activation of mAChRs is relatively slow (milliseconds to seconds) and, depending on the subtypes present (M1-M5), they directly alter cellular homeostasis of phospholipase C, inositol trisphosphate, cAMP, and free calcium. In the cleft, ACh may also be hydrolyzed by acetylcholinesterase (AChE) into choline and acetate. The choline derived from ACh hydrolysis is recovered by a presynaptic high-affinity choline transporter (CHT).', 'Organismal Systems; Nervous system', 'Cholinergic synapse', 'Periodic paralysis, Hypokalemic periodic paralysis (HypoPP), Andersen-Tawil syndrome, Episodic ataxias, Congenital myasthenic syndrome, Hemiplegic migraine, Benign familial neonatal and infantile epilepsies, Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)', 'GO: 0032222', 'ko04725', 'list(REFERENCE = \"\", AUTHORS = \"Nestler EJ, Hyman SE, Malenka RC.\", TITLE = \"Molecular neuropharmacology: A foundation for clinical neuroscience\", JOURNAL = \"The McGraw-Hill Companies, Inc. (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Nicholls JG, Martin AR, Wallace BG, Fuchs PA.\", TITLE = \"From neuron to brain, 4th ed.\", JOURNAL = \"Sunderland, MA: Sinauer associates (2001)\"), list(REFERENCE = \"PMID:15165747\", AUTHORS = \"Dajas-Bailador F, Wonnacott S\", TITLE = \"Nicotinic acetylcholine receptors and the regulation of neuronal signalling.\", JOURNAL = c(\"Trends Pharmacol Sci 25:317-24 (2004)\", \"DOI:10.1016/j.tips.2004.04.006\")), list(REFERENCE = \"PMID:19712465\", AUTHORS = \"Resende RR, Adhikari A\", TITLE = \"Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.\", JOURNAL = c(\"Cell Commun Signal 7:20 (2009)\", \"DOI:10.1186/1478-811X-7-20\")), list(REFERENCE = \"PMID:19378880\", AUTHORS = \"Origlia N, Kuczewski N, Pesavento E, Aztiria E, Domenici L\", TITLE = \"The role of cholinergic system in neuronal plasticity: focus on visual cortex and muscarinic receptors.\", JOURNAL = \"Arch Ital Biol 146:165-88 (2008)\"), list(REFERENCE = \"PMID:21550798\", AUTHORS = \"Oldenburg IA, Ding JB\", TITLE = \"Cholinergic modulation of synaptic integration and dendritic excitability in the striatum.\", JOURNAL = c(\"Curr Opin Neurobiol 21:425-32 (2011)\", \"DOI:10.1016/j.conb.2011.04.004\")), list(REFERENCE = \"PMID:12893537\", AUTHORS = \"Lanzafame AA, Christopoulos A, Mitchelson F\", TITLE = \"Cellular signaling mechanisms for muscarinic acetylcholine receptors.\", JOURNAL = c(\"Receptors Channels 9:241-60 (2003)\", \"DOI:10.3109/10606820308263\")), list(REFERENCE = \"PMID:20446119\", AUTHORS = \"Brown DA\", TITLE = \"Muscarinic acetylcholine receptors (mAChRs) in the nervous system: some functions and mechanisms.\", JOURNAL = c(\"J Mol Neurosci 41:340-6 (2010)\", \"DOI:10.1007/s12031-010-9377-2\")), list(REFERENCE = \"PMID:11738031\", AUTHORS = \"Chang KT, Berg DK\", TITLE = \"Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons.\", JOURNAL = c(\"Neuron 32:855-65 (2001)\", \"DOI:10.1016/S0896-6273(01)00516-5\")), list(REFERENCE = \"PMID:11283752\", AUTHORS = \"Soreq H, Seidman S\", TITLE = \"Acetylcholinesterase--new roles for an old actor.\", JOURNAL = c(\"Nat Rev Neurosci 2:294-302 (2001)\", \"DOI:10.1038/35067589\")), list(REFERENCE = \"PMID:12436417\", AUTHORS = \"Sharma G, Vijayaraghavan S\", TITLE = \"Nicotinic receptor signaling in nonexcitable cells.\", JOURNAL = c(\"J Neurobiol 53:524-34 (2002)\", \"DOI:10.1002/neu.10114\")), list(REFERENCE = \"PMID:11923408\", AUTHORS = \"Araque A, Martin ED, Perea G, Arellano JI, Buno W\", TITLE = \"Synaptically released acetylcholine evokes Ca2+ elevations in astrocytes in hippocampal slices.\", JOURNAL = c(\"J Neurosci 22:2443-50 (2002)\", \"DOI:10.1523/JNEUROSCI.22-07-02443.2002\")), list(REFERENCE = \"PMID:12690458\", AUTHORS = \"Lucas-Meunier E, Fossier P, Baux G, Amar M\", TITLE = \"Cholinergic modulation of the cortical neuronal network.\", JOURNAL = c(\"Pflugers Arch 446:17-29 (2003)\", \"DOI:10.1007/s00424-002-0999-2\")), list(REFERENCE = \"PMID:20060019\", AUTHORS = \"Abreu-Villaca Y, Filgueiras CC, Manhaes AC\", TITLE = \"Developmental aspects of the cholinergic system.\", JOURNAL = c(\"Behav Brain Res 221:367-78 (2011)\", \"DOI:10.1016/j.bbr.2009.12.049\"))', 'map04725', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (332, '04726', 'Serotonergic synapse', 'Serotonin (5-Hydroxytryptamine, 5-HT) is a monoamine neurotransmitter that plays important roles in physiological functions such as learning and memory, emotion, sleep, pain, motor function and endocrine secretion, as well as in pathological states including abnormal mood and cognition. Once released from presynaptic axonal terminals, 5-HT binds to receptors, which have been divided into 7 subfamilies on the basis of conserved structures and signaling mechanisms. These families include the ionotropic 5-HT3 receptors and G-protein-coupled 5-HT receptors, the 5-HT1 (Gi /Go -coupled), 5-HT2(Gq-coupled), 5-HT4/6/7 (Gs-coupled) and 5-HT5 receptors. Presynaptically localized 5-HT1B receptors are thought to be the autoreceptors that suppress excess 5-HT release. 5-HT\'s actions are terminated by transporter- mediated reuptake into neurons, leading to catabolism by monoamine oxidase.', 'Organismal Systems; Nervous system', 'Serotonergic synapse', 'Early infantile epileptic encephalopathy, Aromatic L-amino acid decarboxylase deficiency, Cerebral amyloid angiopathy, Body dysmorphic disorder, Obsessive-compulsive disorder, Major depressive disorder, Attention deficit hyperactivity disorder (ADHD)', 'GO: 0007210', 'ko04726', 'list(REFERENCE = \"PMID:18676031\", AUTHORS = \"Millan MJ, Marin P, Bockaert J, Mannoury la Cour C\", TITLE = \"Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions.\", JOURNAL = c(\"Trends Pharmacol Sci 29:454-64 (2008)\", \"DOI:10.1016/j.tips.2008.06.007\")), list(REFERENCE = \"PMID:16896947\", AUTHORS = \"Bockaert J, Claeysen S, Becamel C, Dumuis A, Marin P\", TITLE = \"Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation.\", JOURNAL = c(\"Cell Tissue Res 326:553-72 (2006)\", \"DOI:10.1007/s00441-006-0286-1\")), list(REFERENCE = \"PMID:11916537\", AUTHORS = \"Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN\", TITLE = \"Multiplicity of mechanisms of serotonin receptor signal transduction.\", JOURNAL = c(\"Pharmacol Ther 92:179-212 (2001)\", \"DOI:10.1016/S0163-7258(01)00169-3\")), list(REFERENCE = \"PMID:15034221\", AUTHORS = \"Noda M, Higashida H, Aoki S, Wada K\", TITLE = \"Multiple signal transduction pathways mediated by 5-HT receptors.\", JOURNAL = c(\"Mol Neurobiol 29:31-9 (2004)\", \"DOI:10.1385/MN:29:1:31\")), list(REFERENCE = \"PMID:20561690\", AUTHORS = \"Daubert EA, Condron BG\", TITLE = \"Serotonin: a regulator of neuronal morphology and circuitry.\", JOURNAL = c(\"Trends Neurosci 33:424-34 (2010)\", \"DOI:10.1016/j.tins.2010.05.005\")), list(REFERENCE = \"PMID:16826372\", AUTHORS = \"Chameau P, van Hooft JA\", TITLE = \"Serotonin 5-HT(3) receptors in the central nervous system.\", JOURNAL = c(\"Cell Tissue Res 326:573-81 (2006)\", \"DOI:10.1007/s00441-006-0255-8\")), list(REFERENCE = \"PMID:9651340\", AUTHORS = \"Tournois C, Mutel V, Manivet P, Launay JM, Kellermann O\", TITLE = \"Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolism.\", JOURNAL = c(\"J Biol Chem 273:17498-503 (1998)\", \"DOI:10.1074/jbc.273.28.17498\")), list(REFERENCE = \"PMID:19545642\", AUTHORS = \"Iliff JJ, Jia J, Nelson J, Goyagi T, Klaus J, Alkayed NJ\", TITLE = \"Epoxyeicosanoid signaling in CNS function and disease.\", JOURNAL = c(\"Prostaglandins Other Lipid Mediat 91:68-84 (2010)\", \"DOI:10.1016/j.prostaglandins.2009.06.004\")), list(REFERENCE = \"PMID:12676358\", AUTHORS = \"Adayev T, Ray I, Sondhi R, Sobocki T, Banerjee P\", TITLE = \"The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Calpha.\", JOURNAL = c(\"Biochim Biophys Acta 1640:85-96 (2003)\", \"DOI:10.1016/S0167-4889(03)00023-5\")), list(REFERENCE = \"PMID:11701344\", AUTHORS = \"Albert PR, Tiberi M\", TITLE = \"Receptor signaling and structure: insights from serotonin-1 receptors.\", JOURNAL = c(\"Trends Endocrinol Metab 12:453-60 (2001)\", \"DOI:10.1016/S1043-2760(01)00498-2\")), list(REFERENCE = \"PMID:9658404\", AUTHORS = \"Durham PL, Russo AF\", TITLE = \"Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.\", JOURNAL = c(\"Mol Endocrinol 12:1002-9 (1998)\", \"DOI:10.1210/mend.12.7.0135\")), list(REFERENCE = \"PMID:15710402\", AUTHORS = \"Robert S, Maillet M, Morel E, Launay JM, Fischmeister R, Mercken L, Lezoualc\'h F\", TITLE = \"Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and Epac.\", JOURNAL = c(\"FEBS Lett 579:1136-42 (2005)\", \"DOI:10.1016/j.febslet.2005.01.010\")), list(REFERENCE = \"PMID:12543273\", AUTHORS = \"Lezoualc\'h F, Robert SJ\", TITLE = \"The serotonin 5-HT4 receptor and the amyloid precursor protein processing.\", JOURNAL = c(\"Exp Gerontol 38:159-66 (2003)\", \"DOI:10.1016/S0531-5565(02)00157-2\")), list(REFERENCE = \"PMID:11043573\", AUTHORS = \"Durham PL, Russo AF\", TITLE = \"Differential regulation of mitogen-activated protein kinase-responsive genes by the duration of a calcium signal.\", JOURNAL = c(\"Mol Endocrinol 14:1570-82 (2000)\", \"DOI:10.1210/mend.14.10.0529\")), list(REFERENCE = \"PMID:9542727\", AUTHORS = \"Hagberg GB, Blomstrand F, Nilsson M, Tamir H, Hansson E\", TITLE = \"Stimulation of 5-HT2A receptors on astrocytes in primary culture opens voltage-independent Ca2+ channels.\", JOURNAL = c(\"Neurochem Int 32:153-62 (1998)\", \"DOI:10.1016/S0197-0186(97)00087-9\")), list(REFERENCE = \"\", AUTHORS = \"Nestler EJ, Hyman SE, Malenka RC.\", TITLE = \"Molecular neuropharmacology: A foundation for clinical neuroscience\", JOURNAL = \"The McGraw-Hill Companies, Inc. (2001)\")', 'map04726', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (333, '04727', 'GABAergic synapse', 'Gamma aminobutyric acid (GABA) is the most abundant inhibitory neurotransmitter in the mammalian central nervous system (CNS). When released in the synaptic cleft, GABA binds to three major classes of receptors: GABAA, GABAB, and GABAC receptors. GABAA and GABAC receptors are ionotropic and mediate fast GABA responses by triggering chloride channel openings, while GABAB receptors are metabotropic and mediate slower GABA responses by activating G-proteins and influencing second messenger systems. GABAA receptors, the major sites for fast inhibitory neurotransmission in the CNS, are regulated by phosphorylation mechanisms, affecting both their functional properties and their cell surface mobility and trafficking. GABA release by the presynaptic terminal is negatively regulated by GABAB autoreceptors, and is cleared from the extracellular space by GABA transporters (GATs) located either on the presynaptic terminal or neighboring glial cells.', 'Organismal Systems; Nervous system', 'GABAergic synapse', 'Early infantile epileptic encephalopathy, Hypokalemic periodic paralysis (HypoPP), Episodic ataxias, Hemiplegic migraine, Febrile seizures, Idiopathic generalized epilepsies, Congenital systemic glutamine deficiency, Spastic quadriplegic cerebral palsy, Childhood absence epilepsy', 'GO: 0051932', 'ko04727', 'list(REFERENCE = \"\", AUTHORS = \"Davis KL, Charney D, Coyle JT, Nemeroff C (ed).\", TITLE = \"Neuropsychopharmacology: The fifth generation of progress\", JOURNAL = c(\"Lippincott Williams & Wikins (2002)\", \"DOI:10.1002/hup.431\")), list(REFERENCE = \"PMID:17499109\", AUTHORS = \"Farrant M, Kaila K\", TITLE = \"The cellular, molecular and ionic basis of GABA(A) receptor signalling.\", JOURNAL = c(\"Prog Brain Res 160:59-87 (2007)\", \"DOI:10.1016/S0079-6123(06)60005-8\")), list(REFERENCE = \"PMID:9364667\", AUTHORS = \"Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa JL\", TITLE = \"GABAA, NMDA and AMPA receptors: a developmentally regulated \'menage a trois\'.\", JOURNAL = c(\"Trends Neurosci 20:523-9 (1997)\", \"DOI:10.1016/S0166-2236(97)01147-8\")), list(REFERENCE = \"PMID:20655485\", AUTHORS = \"Pinard A, Seddik R, Bettler B\", TITLE = \"GABAB receptors: physiological functions and mechanisms of diversity.\", JOURNAL = c(\"Adv Pharmacol 58:231-55 (2010)\", \"DOI:10.1016/S1054-3589(10)58010-4\")), list(REFERENCE = \"PMID:21376567\", AUTHORS = \"Chalifoux JR, Carter AG\", TITLE = \"GABAB receptor modulation of synaptic function.\", JOURNAL = c(\"Curr Opin Neurobiol 21:339-44 (2011)\", \"DOI:10.1016/j.conb.2011.02.004\")), list(REFERENCE = \"PMID:20655481\", AUTHORS = \"Padgett CL, Slesinger PA\", TITLE = \"GABAB receptor coupling to G-proteins and ion channels.\", JOURNAL = c(\"Adv Pharmacol 58:123-47 (2010)\", \"DOI:10.1016/S1054-3589(10)58006-2\")), list(REFERENCE = \"PMID:17499108\", AUTHORS = \"Emson PC\", TITLE = \"GABA(B) receptors: structure and function.\", JOURNAL = c(\"Prog Brain Res 160:43-57 (2007)\", \"DOI:10.1016/S0079-6123(06)60004-6\")), list(REFERENCE = \"PMID:16932937\", AUTHORS = \"Kornau HC\", TITLE = \"GABA(B) receptors and synaptic modulation.\", JOURNAL = c(\"Cell Tissue Res 326:517-33 (2006)\", \"DOI:10.1007/s00441-006-0264-7\")), list(REFERENCE = \"PMID:18382465\", AUTHORS = \"Jacob TC, Moss SJ, Jurd R\", TITLE = \"GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition.\", JOURNAL = c(\"Nat Rev Neurosci 9:331-43 (2008)\", \"DOI:10.1038/nrn2370\")), list(REFERENCE = \"PMID:12086709\", AUTHORS = \"Kneussel M\", TITLE = \"Dynamic regulation of GABA(A) receptors at synaptic sites.\", JOURNAL = c(\"Brain Res Brain Res Rev 39:74-83 (2002)\", \"DOI:10.1016/S0165-0173(02)00159-5\")), list(REFERENCE = \"PMID:21555068\", AUTHORS = \"Luscher B, Fuchs T, Kilpatrick CL\", TITLE = \"GABAA receptor trafficking-mediated plasticity of inhibitory synapses.\", JOURNAL = c(\"Neuron 70:385-409 (2011)\", \"DOI:10.1016/j.neuron.2011.03.024\")), list(REFERENCE = \"PMID:19374920\", AUTHORS = \"Arancibia-Carcamo IL, Kittler JT\", TITLE = \"Regulation of GABA(A) receptor membrane trafficking and synaptic localization.\", JOURNAL = c(\"Pharmacol Ther 123:17-31 (2009)\", \"DOI:10.1016/j.pharmthera.2009.03.012\")), list(REFERENCE = \"PMID:16787421\", AUTHORS = \"Bak LK, Schousboe A, Waagepetersen HS\", TITLE = \"The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer.\", JOURNAL = c(\"J Neurochem 98:641-53 (2006)\", \"DOI:10.1111/j.1471-4159.2006.03913.x\")), list(REFERENCE = \"PMID:15210304\", AUTHORS = \"Conti F, Minelli A, Melone M\", TITLE = \"GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications.\", JOURNAL = c(\"Brain Res Brain Res Rev 45:196-212 (2004)\", \"DOI:10.1016/j.brainresrev.2004.03.003\")), list(REFERENCE = \"PMID:12888801\", AUTHORS = \"Brambilla P, Perez J, Barale F, Schettini G, Soares JC\", TITLE = \"GABAergic dysfunction in mood disorders.\", JOURNAL = c(\"Mol Psychiatry 8:721-37, 715 (2003)\", \"DOI:10.1038/sj.mp.4001362\")), list(REFERENCE = \"PMID:10780899\", AUTHORS = \"Chebib M, Johnston GA\", TITLE = \"GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.\", JOURNAL = c(\"J Med Chem 43:1427-47 (2000)\", \"DOI:10.1021/jm9904349\"))', 'map04727', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (334, '04728', 'Dopaminergic synapse', 'Dopamine (DA) is an important and prototypical slow neurotransmitter in the mammalian brain, where it controls a variety of functions including locomotor activity, motivation and reward, learning and memory, and endocrine regulation. Once released from presynaptic axonal terminals, DA interacts with at least five receptor subtypes in the central nervous system (CNS), which have been divided into two groups: the D1-like receptors (D1Rs), comprising D1 and D5 receptors, both positively coupled to adenylyl cyclase and cAMP production, and the D2-like receptors (D2Rs), comprising D2, D3, and D4 receptors, whose activation results in inhibition of adenylyl cyclase and suppression of cAMP production. In addition, D1Rs and D2Rs modulate intracellular Ca2+ levels and a number of Ca2+ -dependent intracellular signaling processes. Through diverse cAMP- and Ca2+-dependent and - independent mechanisms, DA influences neuronal activity, synaptic plasticity, and behavior. Presynaptically localized D2Rs regulate synthesis and release of DA as the main autoreceptor of the dopaminergic system.', 'Organismal Systems; Nervous system', 'Dopaminergic synapse', 'Brunner syndrome, Early infantile epileptic encephalopathy, Episodic ataxias, Autosomal dominant mental retardation, Hemiplegic migraine, Febrile seizures, Primary dystonia, Aromatic L-amino acid decarboxylase deficiency, Obsessive-compulsive disorder, Schizophrenia, Neurosis, Dravet syndrome, Attention deficit hyperactivity disorder (ADHD)', 'GO: 0001963', 'ko04728', 'list(REFERENCE = \"PMID:21303898\", AUTHORS = \"Beaulieu JM, Gainetdinov RR\", TITLE = \"The physiology, signaling, and pharmacology of dopamine receptors.\", JOURNAL = c(\"Pharmacol Rev 63:182-217 (2011)\", \"DOI:10.1124/pr.110.002642\")), list(REFERENCE = \"PMID:15521361\", AUTHORS = \"Neve KA, Seamans JK, Trantham-Davidson H\", TITLE = \"Dopamine receptor signaling.\", JOURNAL = c(\"J Recept Signal Transduct Res 24:165-205 (2004)\", \"DOI:10.1081/RRS-200029981\")), list(REFERENCE = \"PMID:17408758\", AUTHORS = \"Surmeier DJ, Ding J, Day M, Wang Z, Shen W\", TITLE = \"D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.\", JOURNAL = c(\"Trends Neurosci 30:228-35 (2007)\", \"DOI:10.1016/j.tins.2007.03.008\")), list(REFERENCE = \"PMID:20224735\", AUTHORS = \"Knab AM, Lightfoot JT\", TITLE = \"Does the difference between physically active and couch potato lie in the dopamine system?\", JOURNAL = c(\"Int J Biol Sci 6:133-50 (2010)\", \"DOI:10.7150/ijbs.6.133\")), list(REFERENCE = \"PMID:10433257\", AUTHORS = \"Greengard P, Allen PB, Nairn AC\", TITLE = \"Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.\", JOURNAL = c(\"Neuron 23:435-47 (1999)\", \"DOI:10.1016/S0896-6273(00)80798-9\")), list(REFERENCE = \"PMID:15590733\", AUTHORS = \"Hu XT, Dong Y, Zhang XF, White FJ\", TITLE = \"Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons.\", JOURNAL = c(\"J Neurophysiol 93:1406-17 (2005)\", \"DOI:10.1152/jn.00771.2004\")), list(REFERENCE = \"PMID:17349698\", AUTHORS = \"Beaulieu JM, Gainetdinov RR, Caron MG\", TITLE = \"The Akt-GSK-3 signaling cascade in the actions of dopamine.\", JOURNAL = c(\"Trends Pharmacol Sci 28:166-72 (2007)\", \"DOI:10.1016/j.tips.2007.02.006\")), list(REFERENCE = \"PMID:19138563\", AUTHORS = \"De Mei C, Ramos M, Iitaka C, Borrelli E\", TITLE = \"Getting specialized: presynaptic and postsynaptic dopamine D2 receptors.\", JOURNAL = c(\"Curr Opin Pharmacol 9:53-8 (2009)\", \"DOI:10.1016/j.coph.2008.12.002\")), list(REFERENCE = \"PMID:15381316\", AUTHORS = \"Seamans JK, Yang CR\", TITLE = \"The principal features and mechanisms of dopamine modulation in the prefrontal cortex.\", JOURNAL = c(\"Prog Neurobiol 74:1-58 (2004)\", \"DOI:10.1016/j.pneurobio.2004.05.006\")), list(REFERENCE = \"PMID:18353279\", AUTHORS = \"Yao WD, Spealman RD, Zhang J\", TITLE = \"Dopaminergic signaling in dendritic spines.\", JOURNAL = c(\"Biochem Pharmacol 75:2055-69 (2008)\", \"DOI:10.1016/j.bcp.2008.01.018\")), list(REFERENCE = \"PMID:20727368\", AUTHORS = \"Li YC, Gao WJ\", TITLE = \"GSK-3beta activity and hyperdopamine-dependent behaviors.\", JOURNAL = c(\"Neurosci Biobehav Rev 35:645-54 (2011)\", \"DOI:10.1016/j.neubiorev.2010.08.001\")), list(REFERENCE = \"PMID:15292232\", AUTHORS = \"Tang TS, Bezprozvanny I\", TITLE = \"Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons.\", JOURNAL = c(\"J Biol Chem 279:42082-94 (2004)\", \"DOI:10.1074/jbc.M407389200\")), list(REFERENCE = \"PMID:12967774\", AUTHORS = \"Bergson C, Levenson R, Goldman-Rakic PS, Lidow MS\", TITLE = \"Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling.\", JOURNAL = c(\"Trends Pharmacol Sci 24:486-92 (2003)\", \"DOI:10.1016/S0165-6147(03)00232-3\")), list(REFERENCE = \"PMID:9457173\", AUTHORS = \"Missale C, Nash SR, Robinson SW, Jaber M, Caron MG\", TITLE = \"Dopamine receptors: from structure to function.\", JOURNAL = c(\"Physiol Rev 78:189-225 (1998)\", \"DOI:10.1152/physrev.1998.78.1.189\")), list(REFERENCE = \"PMID:19251795\", AUTHORS = \"Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ\", TITLE = \"Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?\", JOURNAL = c(\"Eur Respir J 33:468-80 (2009)\", \"DOI:10.1183/09031936.00056908\"))', 'map04728', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (335, '04730', 'Long-term depression', 'Cerebellar long-term depression (LTD), thought to be a molecular and cellular basis for cerebellar learning, is a process involving a decrease in the synaptic strength between parallel fiber (PF) and Purkinje cells (PCs) induced by the conjunctive activation of PFs and climbing fiber (CF). Multiple signal transduction pathways have been shown to be involved in this process. Activation of PFs terminating on spines in dendritic branchlets leads to glutamate release and activation of both AMPA and mGluRs. Activation of CFs, which make multiple synaptic contacts on proximal dendrites, also via AMPA receptors, opens voltage-gated calcium channels (VGCCs) and causes a generalized influx of calcium. These cellular signals, generated from two different synaptic origins, trigger a cascade of events culminating in a phosphorylation-dependent, long-term reduction in AMPA receptor sensitivity at the PF-PC synapse. This may take place either through receptor internalization and/or through receptor desensitization.', 'Organismal Systems; Nervous system', 'Long-term depression', 'Spinocerebellar ataxia (SCA), Central core disease, Episodic ataxias, Hemiplegic migraine, Growth delay due to insulin-like growth factor I resistance, Multi-minicore disease', 'GO: 0048169', 'ko04730', 'list(REFERENCE = \"PMID:12415297\", AUTHORS = \"Ito M.\", TITLE = \"The molecular organization of cerebellar long-term depression.\", JOURNAL = c(\"Nat Rev Neurosci 3:896-902 (2002)\", \"DOI:10.1038/nrn962\")), list(REFERENCE = \"PMID:11427694\", AUTHORS = \"Ito M.\", TITLE = \"Cerebellar long-term depression: characterization, signal transduction, and functional roles.\", JOURNAL = c(\"Physiol Rev 81:1143-95 (2001)\", \"DOI:10.1152/physrev.2001.81.3.1143\")), list(REFERENCE = \"\", AUTHORS = \"Purves D, Augustine GJ (ed).\", TITLE = \"Neuroscience\", JOURNAL = \"Sunderland, Mass.:Sinauer Associates (2004)\"), list(REFERENCE = \"PMID:9735948\", AUTHORS = \"Daniel H, Levenes C, Crepel F.\", TITLE = \"Cellular mechanisms of cerebellar LTD.\", JOURNAL = c(\"Trends Neurosci 21:401-7 (1998)\", \"DOI:10.1016/S0166-2236(98)01304-6\")), list(REFERENCE = \"PMID:9602501\", AUTHORS = \"Levenes C, Daniel H, Crepel F.\", TITLE = \"Long-term depression of synaptic transmission in the cerebellum: cellular and molecular mechanisms revisited.\", JOURNAL = c(\"Prog Neurobiol 55:79-91 (1998)\", \"DOI:10.1016/S0301-0082(97)00096-8\")), list(REFERENCE = \"PMID:14509570\", AUTHORS = \"Metzger F, Kapfhammer JP.\", TITLE = \"Protein kinase C: its role in activity-dependent Purkinje cell dendritic development and plasticity.\", JOURNAL = c(\"Cerebellum 2:206-14 (2003)\", \"DOI:10.1080/14734220310016150\"))', 'map04730', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (336, '04740', 'Olfactory transduction', 'Within the compact cilia of the olfactory receptor neurons (ORNs) a cascade of enzymatic activity transduces the binding of an odorant molecule to a receptor into an electrical signal that can be transmitted to the brain. Odorant molecules bind to a receptor protein (R) coupled to an olfactory specific Gs-protein (G) and activate a type III adenylyl cyclase (AC), increasing intracellular cAMP levels. cAMP targets an olfactory-specific cyclic-nucleotide gated ion channel (CNG), allowing cations, particularly Na and Ca, to flow down their electrochemical gradients into the cell, depolarizing the ORN. Furthermore, the Ca entering the cell is able to activate a Ca-activated Cl channel, which would allow Cl to flow out of the cell, thus further increasing the depolarization. Elevated intracellular Ca causes adaptation by at least two different molecular steps: inhibition of the activity of adenylyl cyclase via CAMKII-dependent phosphorylation and down-regulation of the affinity of the CNG channel to cAMP.', 'Organismal Systems; Sensory system', 'Olfactory transduction', 'GO: 0007608', 'ko04740', 'list(REFERENCE = \"PMID:20145624\", AUTHORS = \"Kaupp UB\", TITLE = \"Olfactory signalling in vertebrates and insects: differences and commonalities.\", JOURNAL = c(\"Nat Rev Neurosci 11:188-200 (2010)\", \"DOI:10.1038/nrn2789\")), list(REFERENCE = \"PMID:24733839\", AUTHORS = \"Peterlin Z, Firestein S, Rogers ME\", TITLE = \"The state of the art of odorant receptor deorphanization: a report from the orphanage.\", JOURNAL = c(\"J Gen Physiol 143:527-42 (2014)\", \"DOI:10.1085/jgp.201311151\")), list(REFERENCE = \"PMID:19652915\", AUTHORS = \"Kato A, Touhara K\", TITLE = \"Mammalian olfactory receptors: pharmacology, G protein coupling and desensitization.\", JOURNAL = c(\"Cell Mol Life Sci 66:3743-53 (2009)\", \"DOI:10.1007/s00018-009-0111-6\")), list(REFERENCE = \"PMID:11557990\", AUTHORS = \"Firestein S.\", TITLE = \"How the olfactory system makes sense of scents.\", JOURNAL = c(\"Nature 413:211-8 (2001)\", \"DOI:10.1038/35093026\")), list(REFERENCE = \"PMID:16269360\", AUTHORS = \"Ache BW, Young JM.\", TITLE = \"Olfaction: diverse species, conserved principles.\", JOURNAL = c(\"Neuron 48:417-30 (2005)\", \"DOI:10.1016/j.neuron.2005.10.022\")), list(REFERENCE = \"PMID:10944513\", AUTHORS = \"Zufall F, Leinders-Zufall T.\", TITLE = \"The cellular and molecular basis of odor adaptation.\", JOURNAL = c(\"Chem Senses 25:473-81 (2000)\", \"DOI:10.1093/chemse/25.4.473\")), list(REFERENCE = \"PMID:22875451\", AUTHORS = \"Lodovichi C, Belluscio L\", TITLE = \"Odorant receptors in the formation of the olfactory bulb circuitry.\", JOURNAL = c(\"Physiology (Bethesda) 27:200-12 (2012)\", \"DOI:10.1152/physiol.00015.2012\")), list(REFERENCE = \"PMID:12488531\", AUTHORS = \"Kohout TA, Lefkowitz RJ.\", TITLE = \"Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization.\", JOURNAL = c(\"Mol Pharmacol 63:9-18 (2003)\", \"DOI:10.1124/mol.63.1.9\")), list(REFERENCE = \"PMID:22735517\", AUTHORS = \"De Palo G, Boccaccio A, Miri A, Menini A, Altafini C\", TITLE = \"A dynamical feedback model for adaptation in the olfactory transduction pathway.\", JOURNAL = c(\"Biophys J 102:2677-86 (2012)\", \"DOI:10.1016/j.bpj.2012.04.040\")), list(REFERENCE = \"PMID:19941039\", AUTHORS = \"Zufall F, Munger SD\", TITLE = \"Receptor guanylyl cyclases in mammalian olfactory function.\", JOURNAL = c(\"Mol Cell Biochem 334:191-7 (2010)\", \"DOI:10.1007/s11010-009-0325-9\")), list(REFERENCE = \"PMID:19306880\", AUTHORS = \"Duda T, Sharma RK\", TITLE = \"Ca2+-modulated ONE-GC odorant signal transduction.\", JOURNAL = c(\"FEBS Lett 583:1327-30 (2009)\", \"DOI:10.1016/j.febslet.2009.03.036\"))', 'map04740', 'Olfactory transduction', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (337, '04742', 'Taste transduction', 'Five basic tastes are recognized by humans and most other animals - bitter, sweet, sour, salty and umami. In vertebrates, taste stimuli are detected by taste receptor cells (TRCs). At least three distinct cell types are found in mammalian taste buds : type I cells, type II cells, and type III cells. Type I cells express epithelial sodium channel (ENaC) and are considered to be the major mediator of perception of low salt. In type II cells, transduction of bitter, sweet and umami is mediated by a canonical PLC-beta/IP3-signaling cascade, which culminates in the opening of the TRPM5 ion channel. This produces a depolarization that may allow CALMH1 channels to open and release ATP, which serves as a neurotransmitter to activate closely associated nerve afferents expressing P2X2, P2X3 receptors and adjacent type III cells expressing P2Y4 receptors. Type II taste cells also secrete acetylcholine (ACh) that appears to stimulate muscarinic receptors, specifically M3, on the same or neighboring Type II cells. This muscarinic feedback augments taste-evoked release of ATP. In type III cells, sour taste is initiated when protons enter through apically located proton-selective ion channels: polycystic kidney disease 2-like 1 protein (PKD2L1) and polycystic kidney disease 1-like 3 protein (PKD1L3) channels. Weak acids may also activate sour cells by penetrating the cell membrane and leading to closure of resting K+ channels and membrane depolarization. Further, voltage-gated Ca2+ channels are activated and release vesicular serotonin (5-HT), norepinephrine (NE) and gamma-aminobutyric acid (GABA). 5-HT and GABA provide negative paracrine feedback onto receptor cells by activating 5-HT1A and GABAA, GABAB receptors, respectively. 5-HT also functions as a transmitter between presynaptic cells and the sensory afferent.', 'Organismal Systems; Sensory system', 'Taste transduction', 'GO: 0050909', 'ko04742', 'list(REFERENCE = \"PMID:24607224\", AUTHORS = \"Liman ER, Zhang YV, Montell C\", TITLE = \"Peripheral coding of taste.\", JOURNAL = c(\"Neuron 81:984-1000 (2014)\", \"DOI:10.1016/j.neuron.2014.02.022\")), list(REFERENCE = \"PMID:24385952\", AUTHORS = \"Kinnamon SC, Finger TE\", TITLE = \"A taste for ATP: neurotransmission in taste buds.\", JOURNAL = c(\"Front Cell Neurosci 7:264 (2013)\", \"DOI:10.3389/fncel.2013.00264\")), list(REFERENCE = \"PMID:23261954\", AUTHORS = \"Roper SD\", TITLE = \"Taste buds as peripheral chemosensory processors.\", JOURNAL = c(\"Semin Cell Dev Biol 24:71-9 (2013)\", \"DOI:10.1016/j.semcdb.2012.12.002\")), list(REFERENCE = \"PMID:21481196\", AUTHORS = \"Kinnamon SC\", TITLE = \"Taste receptor signalling - from tongues to lungs.\", JOURNAL = c(\"Acta Physiol (Oxf) 204:158-68 (2012)\", \"DOI:10.1111/j.1748-1716.2011.02308.x\")), list(REFERENCE = \"PMID:23587289\", AUTHORS = \"Kinnamon SC\", TITLE = \"Neurosensory transmission without a synapse: new perspectives on taste signaling.\", JOURNAL = c(\"BMC Biol 11:42 (2013)\", \"DOI:10.1186/1741-7007-11-42\")), list(REFERENCE = \"PMID:20696704\", AUTHORS = \"Chaudhari N, Roper SD\", TITLE = \"The cell biology of taste.\", JOURNAL = c(\"J Cell Biol 190:285-96 (2010)\", \"DOI:10.1083/jcb.201003144\")), list(REFERENCE = \"PMID:19439032\", AUTHORS = \"Vandenbeuch A, Kinnamon SC\", TITLE = \"Why do taste cells generate action potentials?\", JOURNAL = c(\"J Biol 8:42 (2009)\", \"DOI:10.1186/jbiol138\")), list(REFERENCE = \"PMID:17108952\", AUTHORS = \"Chandrashekar J, Hoon MA, Ryba NJ, Zuker CS\", TITLE = \"The receptors and cells for mammalian taste.\", JOURNAL = c(\"Nature 444:288-94 (2006)\", \"DOI:10.1038/nature05401\")), list(REFERENCE = \"PMID:23959882\", AUTHORS = \"Vandenbeuch A, Anderson CB, Parnes J, Enjyoji K, Robson SC, Finger TE, Kinnamon SC\", TITLE = \"Role of the ectonucleotidase NTPDase2 in taste bud function.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 110:14789-94 (2013)\", \"DOI:10.1073/pnas.1309468110\")), list(REFERENCE = \"PMID:23467090\", AUTHORS = \"Taruno A, Vingtdeux V, Ohmoto M, Ma Z, Dvoryanchikov G, Li A, Adrien L, Zhao H, Leung S, Abernethy M, Koppel J, Davies P, Civan MM, Chaudhari N, Matsumoto I, Hellekant G, Tordoff MG, Marambaud P, Foskett JK\", TITLE = \"CALHM1 ion channel mediates purinergic neurotransmission of sweet, bitter and umami tastes.\", JOURNAL = c(\"Nature 495:223-6 (2013)\", \"DOI:10.1038/nature11906\")), list(REFERENCE = \"PMID:19284629\", AUTHORS = \"Gao N, Lu M, Echeverri F, Laita B, Kalabat D, Williams ME, Hevezi P, Zlotnik A, Moyer BD\", TITLE = \"Voltage-gated sodium channels in taste bud cells.\", JOURNAL = c(\"BMC Neurosci 10:20 (2009)\", \"DOI:10.1186/1471-2202-10-20\")), list(REFERENCE = \"PMID:25820328\", AUTHORS = \"Zheng W, Hussein S, Yang J, Huang J, Zhang F, Hernandez-Anzaldo S, Fernandez-Patron C, Cao Y, Zeng H, Tang J, Chen XZ\", TITLE = \"A novel PKD2L1 C-terminal domain critical for trimerization and channel function.\", JOURNAL = c(\"Sci Rep 5:9460 (2015)\", \"DOI:10.1038/srep09460\")), list(REFERENCE = \"PMID:17287577\", AUTHORS = \"Shimada S, Ueda T, Ishida Y, Yamamoto T, Ugawa S\", TITLE = \"Acid-sensing ion channels in taste buds.\", JOURNAL = c(\"Arch Histol Cytol 69:227-31 (2006)\", \"DOI:10.1679/aohc.69.227\")), list(REFERENCE = \"PMID:22570381\", AUTHORS = \"Dando R, Roper SD\", TITLE = \"Acetylcholine is released from taste cells, enhancing taste signalling.\", JOURNAL = c(\"J Physiol 590:3009-17 (2012)\", \"DOI:10.1113/jphysiol.2012.232009\")), list(REFERENCE = \"PMID:14715493\", AUTHORS = \"Kaya N, Shen T, Lu SG, Zhao FL, Herness S\", TITLE = \"A paracrine signaling role for serotonin in rat taste buds: expression and localization of serotonin receptor subtypes.\", JOURNAL = c(\"Am J Physiol Regul Integr Comp Physiol 286:R649-58 (2004)\", \"DOI:10.1152/ajpregu.00572.2003\"))', 'map04742', 'Taste transduction', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (338, '04744', 'Phototransduction', 'Phototransduction is a biochemical process by which the photoreceptor cells generate electrical signals in response to captured photons. The vertebrate cascade starts with the absorption of photons by the photoreceptive pigments, the rhodopsins, which consist of a membrane embedded chromophore, 11-cis-retinal, and a G-protein-coupled receptor, opsin. The photon isomerizes 11-cis-retinal to all-trans-retinal which induces a structural change that activates the opsin. This triggers hydrolysis of cGMP by activating a transducinphosphodiesterase 6 (PDE6) cascade, which results in closure of the cGMP-gated cation channels (CNG) in the plasma membrane and membrane hyperpolarization. The hyperpolarization of the membrane potential of the photoreceptor cell modulates the release of neurotransmitters to downstream cells. Recovery from light involves the deactivation of the light- activated intermediates: photolyzed rhodopsin is phosphorylated by rhodopsin kinase (RK) and subsequently capped off by arrestin; GTP-binding transducin alpha subunit deactivates through a process that is stimulated by RGS9.', 'Organismal Systems; Sensory system', 'Phototransduction', 'Cone-rod dystrophy and cone dystrophy, Retinitis pigmentosa, Congenital stationary night blindness, Familial flecked retina syndrome, Leber congenital amaurosis, Achromatopsia, Bradyopsia', 'GO: 0009586', 'ko04744', 'list(REFERENCE = \"PMID:19837030\", AUTHORS = \"Yau KW, Hardie RC\", TITLE = \"Phototransduction motifs and variations.\", JOURNAL = c(\"Cell 139:246-64 (2009)\", \"DOI:10.1016/j.cell.2009.09.029\")), list(REFERENCE = \"PMID:11952100\", AUTHORS = \"Koch KW, Duda T, Sharma RK\", TITLE = \"Photoreceptor specific guanylate cyclases in vertebrate phototransduction.\", JOURNAL = \"Mol Cell Biochem 230:97-106 (2002)\"), list(REFERENCE = \"PMID:9803480\", AUTHORS = \"Jindrova H\", TITLE = \"Vertebrate phototransduction: activation, recovery, and adaptation.\", JOURNAL = \"Physiol Res 47:155-68 (1998)\"), list(REFERENCE = \"PMID:11070368\", AUTHORS = \"Ebrey T, Koutalos Y\", TITLE = \"Vertebrate photoreceptors.\", JOURNAL = c(\"Prog Retin Eye Res 20:49-94 (2001)\", \"DOI:10.1016/S1350-9462(00)00014-8\")), list(REFERENCE = \"PMID:11587916\", AUTHORS = \"Pepe IM\", TITLE = \"Recent advances in our understanding of rhodopsin and phototransduction.\", JOURNAL = c(\"Prog Retin Eye Res 20:733-59 (2001)\", \"DOI:10.1016/S1350-9462(01)00013-1\")), list(REFERENCE = \"PMID:11551982\", AUTHORS = \"Kramer RH, Molokanova E\", TITLE = \"Modulation of cyclic-nucleotide-gated channels and regulation of vertebrate phototransduction.\", JOURNAL = \"J Exp Biol 204:2921-31 (2001)\"), list(REFERENCE = \"PMID:19720650\", AUTHORS = \"Larhammar D, Nordstrom K, Larsson TA\", TITLE = \"Evolution of vertebrate rod and cone phototransduction genes.\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 364:2867-80 (2009)\", \"DOI:10.1098/rstb.2009.0077\")), list(REFERENCE = \"PMID:19953307\", AUTHORS = \"Dizhoor AM, Olshevskaya EV, Peshenko IV\", TITLE = \"Mg2+/Ca2+ cation binding cycle of guanylyl cyclase activating proteins (GCAPs): role in regulation of photoreceptor guanylyl cyclase.\", JOURNAL = c(\"Mol Cell Biochem 334:117-24 (2010)\", \"DOI:10.1007/s11010-009-0328-6\")), list(REFERENCE = \"PMID:12161344\", AUTHORS = \"Krizaj D, Copenhagen DR\", TITLE = \"Calcium regulation in photoreceptors.\", JOURNAL = \"Front Biosci 7:d2023-44 (2002)\"), list(REFERENCE = \"PMID:9893707\", AUTHORS = \"Shichida Y, Imai H\", TITLE = \"Visual pigment: G-protein-coupled receptor for light signals.\", JOURNAL = c(\"Cell Mol Life Sci 54:1299-315 (1998)\", \"DOI:10.1007/s000180050256\")), list(REFERENCE = \"PMID:9419388\", AUTHORS = \"Pugh EN Jr, Duda T, Sitaramayya A, Sharma RK\", TITLE = \"Photoreceptor guanylate cyclases: a review.\", JOURNAL = c(\"Biosci Rep 17:429-73 (1997)\", \"DOI:10.1023/A:1027365520442\")), list(REFERENCE = \"PMID:18632568\", AUTHORS = \"Luo DG, Xue T, Yau KW\", TITLE = \"How vision begins: an odyssey.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:9855-62 (2008)\", \"DOI:10.1073/pnas.0708405105\")), list(REFERENCE = \"PMID:17545152\", AUTHORS = \"Peshenko IV, Dizhoor AM\", TITLE = \"Activation and inhibition of photoreceptor guanylyl cyclase by guanylyl cyclase activating protein 1 (GCAP-1): the functional role of Mg2+/Ca2+ exchange in EF-hand domains.\", JOURNAL = c(\"J Biol Chem 282:21645-52 (2007)\", \"DOI:10.1074/jbc.M702368200\")), list(REFERENCE = \"PMID:13678959\", AUTHORS = \"Ridge KD, Abdulaev NG, Sousa M, Palczewski K\", TITLE = \"Phototransduction: crystal clear.\", JOURNAL = c(\"Trends Biochem Sci 28:479-87 (2003)\", \"DOI:10.1016/S0968-0004(03)00172-5\"))', 'map04744', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (339, '04745', 'Phototransduction - fly', 'Phototransduction is the process that converts the signal of light (photons) into a change of membrane potential in photoreceptor cells. Drosophila visual signaling is initiated with the activation of rhodopsin by light. Rhodopsin is composed of a protein, opsin, covalently linked to a chromophore, 3-hydroxy-11-cis-retinal. Upon absorption of a light photon the chromophore is isomerized from the 11-cis to the all-trans configuration which induces a structural change that activates the opsin. This photoconversion activates heterotrimeric Gq protein via GTP-GDP exchange, releasing the G(alpha)q subunit. G(alpha)q activates PLC, generating InsP3 and DAG from PIP2. DAG may further release polyunsaturated fatty acids (PUFAs) via action of DAG lipase. This reaction leads to the opening of cation-selective channels (trp and trpl genes) and causes the depolarization of the photoreceptor cells. The transduction proteins rhodopsin, G(alpha)q, PLC, PKC, TRP, and TRPL are coordinated by a polymer of INAD scaffold proteins.', 'Organismal Systems; Sensory system', 'Phototransduction - fly', 'ko04745', 'list(REFERENCE = \"PMID:19623243\", AUTHORS = \"Katz B, Minke B\", TITLE = \"Drosophila photoreceptors and signaling mechanisms.\", JOURNAL = c(\"Front Cell Neurosci 3:2 (2009)\", \"DOI:10.3389/neuro.03.002.2009\")), list(REFERENCE = \"PMID:19138592\", AUTHORS = \"Borst A\", TITLE = \"Drosophila\'s view on insect vision.\", JOURNAL = c(\"Curr Biol 19:R36-47 (2009)\", \"DOI:10.1016/j.cub.2008.11.001\")), list(REFERENCE = \"PMID:19837030\", AUTHORS = \"Yau KW, Hardie RC\", TITLE = \"Phototransduction motifs and variations.\", JOURNAL = c(\"Cell 139:246-64 (2009)\", \"DOI:10.1016/j.cell.2009.09.029\")), list(REFERENCE = \"PMID:19011871\", AUTHORS = \"Frings S\", TITLE = \"Primary processes in sensory cells: current advances.\", JOURNAL = c(\"J Comp Physiol A Neuroethol Sens Neural Behav Physiol 195:1-19 (2009)\", \"DOI:10.1007/s00359-008-0389-0\")), list(REFERENCE = \"PMID:17487503\", AUTHORS = \"Wang T, Montell C\", TITLE = \"Phototransduction and retinal degeneration in Drosophila.\", JOURNAL = c(\"Pflugers Arch 454:821-47 (2007)\", \"DOI:10.1007/s00424-007-0251-1\")), list(REFERENCE = \"PMID:12765684\", AUTHORS = \"Hardie RC\", TITLE = \"TRP channels in Drosophila photoreceptors: the lipid connection.\", JOURNAL = c(\"Cell Calcium 33:385-93 (2003)\", \"DOI:10.1016/S0143-4160(03)00051-4\")), list(REFERENCE = \"PMID:16460287\", AUTHORS = \"Minke B, Parnas M\", TITLE = \"Insights on TRP channels from in vivo studies in Drosophila.\", JOURNAL = c(\"Annu Rev Physiol 68:649-84 (2006)\", \"DOI:10.1146/annurev.physiol.68.040204.100939\")), list(REFERENCE = \"PMID:10611962\", AUTHORS = \"Montell C\", TITLE = \"Visual transduction in Drosophila.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 15:231-68 (1999)\", \"DOI:10.1146/annurev.cellbio.15.1.231\")), list(REFERENCE = \"PMID:20144772\", AUTHORS = \"Fain GL, Hardie R, Laughlin SB\", TITLE = \"Phototransduction and the evolution of photoreceptors.\", JOURNAL = c(\"Curr Biol 20:R114-24 (2010)\", \"DOI:10.1016/j.cub.2009.12.006\")), list(REFERENCE = \"PMID:14761309\", AUTHORS = \"Kim C\", TITLE = \"Transient receptor potential ion channels and animal sensation: lessons from Drosophila functional research.\", JOURNAL = \"J Biochem Mol Biol 37:114-21 (2004)\"), list(REFERENCE = \"PMID:18579072\", AUTHORS = \"Montell C\", TITLE = \"In search of the holy grail for Drosophila TRP.\", JOURNAL = c(\"Neuron 58:825-7 (2008)\", \"DOI:10.1016/j.neuron.2008.06.006\")), list(REFERENCE = \"PMID:15620638\", AUTHORS = \"Osorio D, Nilsson DE\", TITLE = \"Visual pigments: trading noise for fast recovery.\", JOURNAL = c(\"Curr Biol 14:R1051-3 (2004)\", \"DOI:10.1016/j.cub.2004.11.044\")), list(REFERENCE = \"PMID:20045325\", AUTHORS = \"Wang X, Wang T, Jiao Y, von Lintig J, Montell C\", TITLE = \"Requirement for an enzymatic visual cycle in Drosophila.\", JOURNAL = c(\"Curr Biol 20:93-102 (2010)\", \"DOI:10.1016/j.cub.2009.12.022\")), list(REFERENCE = \"PMID:18786361\", AUTHORS = \"Liu CH, Satoh AK, Postma M, Huang J, Ready DF, Hardie RC\", TITLE = \"Ca2+-dependent metarhodopsin inactivation mediated by calmodulin and NINAC myosin III.\", JOURNAL = c(\"Neuron 59:778-89 (2008)\", \"DOI:10.1016/j.neuron.2008.07.007\")), list(REFERENCE = \"PMID:18579079\", AUTHORS = \"Leung HT, Tseng-Crank J, Kim E, Mahapatra C, Shino S, Zhou Y, An L, Doerge RW, Pak WL\", TITLE = \"DAG lipase activity is necessary for TRP channel regulation in Drosophila photoreceptors.\", JOURNAL = c(\"Neuron 58:884-96 (2008)\", \"DOI:10.1016/j.neuron.2008.05.001\")), list(REFERENCE = \"PMID:16914683\", AUTHORS = \"Popescu DC, Ham AJ, Shieh BH\", TITLE = \"Scaffolding protein INAD regulates deactivation of vision by promoting phosphorylation of transient receptor potential by eye protein kinase C in Drosophila.\", JOURNAL = c(\"J Neurosci 26:8570-7 (2006)\", \"DOI:10.1523/JNEUROSCI.1478-06.2006\"))', 'map04745', 'Phototransduction - fly', 'Phototransduction is the process that converts the signal of light (photons) into a change of membrane potential in photoreceptor cells. Drosophila visual signaling is initiated with the activation of rhodopsin by light. Rhodopsin is composed of a protein, opsin, covalently linked to a chromophore, 3-hydroxy-11-cis-retinal. Upon absorption of a light photon the chromophore is isomerized from the 11-cis to the all-trans configuration which induces a structural change that activates the opsin. This photoconversion activates heterotrimeric Gq protein via GTP-GDP exchange, releasing the G(alpha)q subunit. G(alpha)q activates PLC, generating InsP3 and DAG from PIP2. DAG may further release polyunsaturated fatty acids (PUFAs) via action of DAG lipase. This reaction leads to the opening of cation-selective channels (trp and trpl genes) and causes the depolarization of the photoreceptor cells. The transduction proteins rhodopsin, G(alpha)q, PLC, PKC, TRP, and TRPL are coordinated by a polymer of INAD scaffold proteins.', 64, 0, 64, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (340, '04750', 'Inflammatory mediator regulation of TRP channels', 'The TRP channels that exhibit a unique response to temperature have been given the name thermo-TRPs. Among all thermo- TRP channels, TRPV1-4, TRPM8, and TRPA1 are expressed in subsets of nociceptive dorsal root ganglion (DRG) neuron cell bodies including their peripheral and central projections. These channels can be modulated indirectly by inflammatory mediators such as PGE2, bradykinin, ATP, NGF, and proinflammatory cytokines that are generated during tissue injury. While the noxious heat receptor TRPV1 is sensitized (that is, their excitability can be increased) by post-translational modifications upon activation of G-protein coupled receptors (GPCRs) or tyrosine kinase receptors, the receptors for inflammatory mediators, the same action appears to mainly desensitize TRPM8, the main somatic innocuous cold sensor. This aforementioned sensitization could allow the receptor to become active at body temperature, so it not only contributes toward thermal hypersensitivity but also is possibly a substrate for ongoing persistent pain.', 'Organismal Systems; Sensory system', 'Inflammatory mediator regulation of TRP channels', 'Familial episodic pain syndrome', 'GO: 0019233', 'ko04750', 'list(REFERENCE = \"PMID:15820689\", AUTHORS = \"Wang H, Woolf CJ\", TITLE = \"Pain TRPs.\", JOURNAL = c(\"Neuron 46:9-12 (2005)\", \"DOI:10.1016/j.neuron.2005.03.011\")), list(REFERENCE = \"PMID:17321113\", AUTHORS = \"Levine JD, Alessandri-Haber N\", TITLE = \"TRP channels: targets for the relief of pain.\", JOURNAL = c(\"Biochim Biophys Acta 1772:989-1003 (2007)\", \"DOI:10.1016/j.bbadis.2007.01.008\")), list(REFERENCE = \"PMID:18427980\", AUTHORS = \"Cheng JK, Ji RR\", TITLE = \"Intracellular signaling in primary sensory neurons and persistent pain.\", JOURNAL = c(\"Neurochem Res 33:1970-8 (2008)\", \"DOI:10.1007/s11064-008-9711-z\")), list(REFERENCE = \"PMID:24099085\", AUTHORS = \"Julius D\", TITLE = \"TRP channels and pain.\", JOURNAL = c(\"Annu Rev Cell Dev Biol 29:355-84 (2013)\", \"DOI:10.1146/annurev-cellbio-101011-155833\")), list(REFERENCE = \"PMID:12838328\", AUTHORS = \"Patapoutian A, Peier AM, Story GM, Viswanath V\", TITLE = \"ThermoTRP channels and beyond: mechanisms of temperature sensation.\", JOURNAL = c(\"Nat Rev Neurosci 4:529-39 (2003)\", \"DOI:10.1038/nrn1141\")), list(REFERENCE = \"PMID:16776582\", AUTHORS = \"Dhaka A, Viswanath V, Patapoutian A\", TITLE = \"Trp ion channels and temperature sensation.\", JOURNAL = c(\"Annu Rev Neurosci 29:135-61 (2006)\", \"DOI:10.1146/annurev.neuro.29.051605.112958\")), list(REFERENCE = \"PMID:18615141\", AUTHORS = \"Story GM\", TITLE = \"The emerging role of TRP channels in mechanisms of temperature and pain sensation.\", JOURNAL = \"Curr Neuropharmacol 4:183-96 (2006)\"), list(REFERENCE = \"PMID:17548207\", AUTHORS = \"Velazquez KT, Mohammad H, Sweitzer SM\", TITLE = \"Protein kinase C in pain: involvement of multiple isoforms.\", JOURNAL = c(\"Pharmacol Res 55:578-89 (2007)\", \"DOI:10.1016/j.phrs.2007.04.006\")), list(REFERENCE = \"PMID:16319926\", AUTHORS = \"Zhang X, Huang J, McNaughton PA\", TITLE = \"NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels.\", JOURNAL = c(\"EMBO J 24:4211-23 (2005)\", \"DOI:10.1038/sj.emboj.7600893\")), list(REFERENCE = \"PMID:19074743\", AUTHORS = \"Bessac BF, Jordt SE\", TITLE = \"Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control.\", JOURNAL = c(\"Physiology (Bethesda) 23:360-70 (2008)\", \"DOI:10.1152/physiol.00026.2008\")), list(REFERENCE = \"PMID:17684094\", AUTHORS = \"Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, Imamachi N, Andre E, Patacchini R, Cottrell GS, Gatti R, Basbaum AI, Bunnett NW, Julius D, Geppetti P\", TITLE = \"4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 104:13519-24 (2007)\", \"DOI:10.1073/pnas.0705923104\")), list(REFERENCE = \"PMID:21841075\", AUTHORS = \"Latorre R, Brauchi S, Madrid R, Orio P\", TITLE = \"A cool channel in cold transduction.\", JOURNAL = c(\"Physiology (Bethesda) 26:273-85 (2011)\", \"DOI:10.1152/physiol.00004.2011\")), list(REFERENCE = \"PMID:20932256\", AUTHORS = \"Babes A, Ciobanu AC, Neacsu C, Babes RM\", TITLE = \"TRPM8, a sensor for mild cooling in mammalian sensory nerve endings.\", JOURNAL = c(\"Curr Pharm Biotechnol 12:78-88 (2011)\", \"DOI:10.2174/138920111793937835\")), list(REFERENCE = \"PMID:23000387\", AUTHORS = \"Loyd DR, Henry MA, Hargreaves KM\", TITLE = \"Serotonergic neuromodulation of peripheral nociceptors.\", JOURNAL = c(\"Semin Cell Dev Biol 24:51-7 (2013)\", \"DOI:10.1016/j.semcdb.2012.09.002\")), list(REFERENCE = \"PMID:17124270\", AUTHORS = \"Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, Altier C, Cenac N, Zamponi GW, Bautista-Cruz F, Lopez CB, Joseph EK, Levine JD, Liedtke W, Vanner S, Vergnolle N, Geppetti P, Bunnett NW\", TITLE = \"Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice.\", JOURNAL = c(\"J Physiol 578:715-33 (2007)\", \"DOI:10.1113/jphysiol.2006.121111\")), list(REFERENCE = \"PMID:22470230\", AUTHORS = \"Mandadi S, Armati PJ, Roufogalis BD\", TITLE = \"Protein kinase C modulation of thermo-sensitive transient receptor potential channels: Implications for pain signaling.\", JOURNAL = c(\"J Nat Sci Biol Med 2:13-25 (2011)\", \"DOI:10.4103/0976-9668.82311\"))', 'map04750', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (341, '04810', 'Regulation of actin cytoskeleton', 'Cellular Processes; Cell motility', 'Regulation of actin cytoskeleton', 'MYH9-related disease, Hypogonadotropic hypogonadism, X-linked mental retardation, Multiple synostosis syndrome, FGFR3-related short limb skeletal dysplasia, Aarskog-Scott syndrome, Epstein syndrome, Epidermolysis bullosa, junctional, Congenital muscular dystrophies (CMD/MDC), Lacrimo-auriculo-dento-digital syndrome, Nemaline myopathy, Familial thoracic aortic aneurysm and dissection, Fleck corneal dystrophy, CATSHL syndrome, Familial adenomatous polyposis, Familial tumoral calcinosis, Trigonocephaly, Juvenile-onset dystonia, Glomerulopathy with fibronectin deposits, Wiskott-Aldrich syndrome, Macrothrombocytopenia, Baraitser-Winter syndrome, May-Hegglin anomaly, Fechtner syndrome, Hypochondroplasia, SADDAN', 'GO: 0030036', 'ko04810', 'list(REFERENCE = \"PMID:14744429\", AUTHORS = \"Burridge K, Wennerberg K.\", TITLE = \"Rho and Rac take center stage.\", JOURNAL = c(\"Cell 116:167-79 (2004)\", \"DOI:10.1016/S0092-8674(04)00003-0\")), list(REFERENCE = \"PMID:11082269\", AUTHORS = \"Schmitz AA, Govek EE, Bottner B, Van Aelst L.\", TITLE = \"Rho GTPases: signaling, migration, and invasion.\", JOURNAL = c(\"Exp Cell Res 261:1-12 (2000)\", \"DOI:10.1006/excr.2000.5049\")), list(REFERENCE = \"PMID:11152757\", AUTHORS = \"Takai Y, Sasaki T, Matozaki T.\", TITLE = \"Small GTP-binding proteins.\", JOURNAL = c(\"Physiol Rev 81:153-208 (2001)\", \"DOI:10.1152/physrev.2001.81.1.153\")), list(REFERENCE = \"PMID:12700767\", AUTHORS = \"Pollard TD.\", TITLE = \"The cytoskeleton, cellular motility and the reductionist agenda.\", JOURNAL = c(\"Nature 422:741-5 (2003)\", \"DOI:10.1038/nature01598\")), list(REFERENCE = \"PMID:14657486\", AUTHORS = \"Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR.\", TITLE = \"Cell migration: integrating signals from front to back.\", JOURNAL = c(\"Science 302:1704-9 (2003)\", \"DOI:10.1126/science.1092053\")), list(REFERENCE = \"PMID:11082272\", AUTHORS = \"Sastry SK, Burridge K.\", TITLE = \"Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics.\", JOURNAL = c(\"Exp Cell Res 261:25-36 (2000)\", \"DOI:10.1006/excr.2000.5043\")), list(REFERENCE = \"PMID:10574699\", AUTHORS = \"Fukata M, Nakagawa M, Kuroda S, Kaibuchi K.\", TITLE = \"Cell adhesion and Rho small GTPases.\", JOURNAL = \"J Cell Sci 112 ( Pt 24):4491-500 (1999)\")', 'map04810', 'Regulation of actin cytoskeleton', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (342, '04910', 'Insulin signaling pathway', 'c(\"Insulin binding to its receptor results in the tyrosine phosphorylation of insulin receptor substrates (IRS) by the insulin receptor tyrosine kinase (INSR). This allows association of IRSs with the regulatory subunit of phosphoinositide 3-kinase (PI3K). PI3K activates 3-phosphoinositide-dependent protein kinase 1 (PDK1), which activates Akt, a serine kinase. Akt in turn deactivates glycogen synthase kinase 3 (GSK-3), leading to activation of glycogen synthase (GYS) and thus glycogen synthesis. Activation of Akt also results in the translocation of GLUT4 vesicles from their intracellular pool to the plasma membrane, where they allow uptake of glucose into the cell. Akt also leads to mTOR-mediated activation of protein synthesis by eIF4 and p70S6K. The translocation of GLUT4 protein is also elicited through the CAP/Cbl/TC10 pathway, once Cbl is phosphorylated by INSR.\", \n\"Other signal transduction proteins interact with IRS including GRB2. GRB2 is part of the cascade including SOS, RAS, RAF and MEK that leads to activation of mitogen-activated protein kinase (MAPK) and mitogenic responses in the form of gene transcription. SHC is another substrate of INSR. When tyrosine phosphorylated, SHC associates with GRB2 and can thus activate the RAS/MAPK pathway independently of IRS-1.\")', 'Organismal Systems; Endocrine system', 'Insulin signaling pathway', 'Glycogen storage disease, Maturity onset diabetes of the young (MODY), Familial partial lipodystrophy, Permanent neonatal diabetes mellitus, Leprechaunism, Lymphangioleiomyomatosis, Tuberous sclerosis complex, Rabson-Mendenhall syndrome, Pituitary adenomas, Wolff-Parkinson-White (WPW) syndrome, Insulin-resistant diabetes mellitus with acanthosis nigricans, Focal cortical dysplasia of Taylor, Familial hyperinsulinemic hypoglycemia, Hepatic glycogen storage disease, Muscle glycogen storage disease, Glycogen storage disease type V, Glycogen storage disease type VI, Glycogen storage disease type IX, Glycogen storage disease type 0b, Glycogen storage disease type 0a, Glycogen storage disease of heart', 'ko04910', 'list(REFERENCE = \"PMID:14635525\", AUTHORS = \"Ogawa W, Kasuga M.\", TITLE = \"[Mechanism of insulin action and diabetes mellitus]\", JOURNAL = \"Seikagaku 75:1332-44 (2003)\"), list(REFERENCE = \"PMID:11282018\", AUTHORS = \"Bevan P.\", TITLE = \"Insulin signalling.\", JOURNAL = \"J Cell Sci 114:1429-30 (2001)\"), list(REFERENCE = \"PMID:12867054\", AUTHORS = \"Kanzaki M, Pessin JE.\", TITLE = \"Insulin signaling: GLUT4 vesicles exit via the exocyst.\", JOURNAL = c(\"Curr Biol 13:R574-6 (2003)\", \"DOI:10.1016/S0960-9822(03)00478-0\")), list(REFERENCE = \"PMID:10196204\", AUTHORS = \"Moodie SA, Alleman-Sposeto J, Gustafson TA.\", TITLE = \"Identification of the APS protein as a novel insulin receptor substrate.\", JOURNAL = c(\"J Biol Chem 274:11186-93 (1999)\", \"DOI:10.1074/jbc.274.16.11186\")), list(REFERENCE = \"PMID:15733744\", AUTHORS = \"Gual P, Le Marchand-Brustel Y, Tanti JF.\", TITLE = \"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.\", JOURNAL = c(\"Biochimie 87:99-109 (2005)\", \"DOI:10.1016/j.biochi.2004.10.019\")), list(REFERENCE = \"PMID:9748166\", AUTHORS = \"Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ.\", TITLE = \"Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1.\", JOURNAL = c(\"Science 281:2042-5 (1998)\", \"DOI:10.1126/science.281.5385.2042\")), list(REFERENCE = \"PMID:11742412\", AUTHORS = \"Saltiel AR, Kahn CR.\", TITLE = \"Insulin signalling and the regulation of glucose and lipid metabolism.\", JOURNAL = c(\"Nature 414:799-806 (2001)\", \"DOI:10.1038/414799a\")), list(REFERENCE = \"PMID:15624019\", AUTHORS = \"Inoki K, Corradetti MN, Guan KL.\", TITLE = \"Dysregulation of the TSC-mTOR pathway in human disease.\", JOURNAL = c(\"Nat Genet 37:19-24 (2005)\", \"DOI:10.1038/ng1494\")), list(REFERENCE = \"PMID:16288289\", AUTHORS = \"Ruggero D, Sonenberg N.\", TITLE = \"The Akt of translational control.\", JOURNAL = c(\"Oncogene 24:7426-34 (2005)\", \"DOI:10.1038/sj.onc.1209098\")), list(REFERENCE = \"PMID:10567225\", AUTHORS = \"Nave BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR.\", TITLE = \"Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.\", JOURNAL = c(\"Biochem J 344 Pt 2:427-31 (1999)\", \"DOI:10.1042/bj3440427\")), list(REFERENCE = \"PMID:9445476\", AUTHORS = \"Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G.\", TITLE = \"Phosphorylation and activation of p70s6k by PDK1.\", JOURNAL = c(\"Science 279:707-10 (1998)\", \"DOI:10.1126/science.279.5351.707\")), list(REFERENCE = \"PMID:9609110\", AUTHORS = \"Ogawa W, Matozaki T, Kasuga M.\", TITLE = \"Role of binding proteins to IRS-1 in insulin signalling.\", JOURNAL = \"Mol Cell Biochem 182:13-22 (1998)\"), list(REFERENCE = \"PMID:9609111\", AUTHORS = \"Ceresa BP, Pessin JE.\", TITLE = \"Insulin regulation of the Ras activation/inactivation cycle.\", JOURNAL = \"Mol Cell Biochem 182:23-9 (1998)\"), list(REFERENCE = \"PMID:15229476\", AUTHORS = \"Pollak MN, Schernhammer ES, Hankinson SE.\", TITLE = \"Insulin-like growth factors and neoplasia.\", JOURNAL = c(\"Nat Rev Cancer 4:505-18 (2004)\", \"DOI:10.1038/nrc1387\")), list(REFERENCE = \"PMID:9346240\", AUTHORS = \"Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME.\", TITLE = \"Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.\", JOURNAL = c(\"Cell 91:231-41 (1997)\", \"DOI:10.1016/S0092-8674(00)80405-5\")), list(REFERENCE = \"PMID:17344645\", AUTHORS = \"Ferre P, Foufelle F\", TITLE = \"SREBP-1c transcription factor and lipid homeostasis: clinical perspective.\", JOURNAL = c(\"Horm Res 68:72-82 (2007)\", \"DOI:10.1159/000100426\")), list(REFERENCE = \"PMID:18291668\", AUTHORS = \"Raghow R, Yellaturu C, Deng X, Park EA, Elam MB\", TITLE = \"SREBPs: the crossroads of physiological and pathological lipid homeostasis.\", JOURNAL = c(\"Trends Endocrinol Metab 19:65-73 (2008)\", \"DOI:10.1016/j.tem.2007.10.009\")), list(REFERENCE = \"PMID:11343120\", AUTHORS = \"Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Le Marchand-Brustel Y, Erneux C, Hue L, Schurmans S\", TITLE = \"The lipid phosphatase SHIP2 controls insulin sensitivity.\", JOURNAL = c(\"Nature 409:92-7 (2001)\", \"DOI:10.1038/35051094\")), list(REFERENCE = \"PMID:12791379\", AUTHORS = \"Backers K, Blero D, Paternotte N, Zhang J, Erneux C\", TITLE = \"The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.\", JOURNAL = c(\"Adv Enzyme Regul 43:15-28 (2003)\", \"DOI:10.1016/S0065-2571(02)00043-2\"))', 'map04910', 'Insulin signaling pathway', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (343, '04911', 'Insulin secretion', 'Pancreatic beta cells are specialised endocrine cells that continuously sense the levels of blood sugar and other fuels and, in response, secrete insulin to maintain normal fuel homeostasis. Glucose-induced insulin secretion and its potentiation constitute the principal mechanism of insulin release. Glucose is transported by the glucose transporter (GLUT) into the pancreatic beta-cell. Metabolism of glucose generates ATP, which inhibits ATP-sensitive K+ channels and causes voltage-dependent Ca2+ influx. Elevation of [Ca2+]i triggers exocytotic release of insulin granules. Insulin secretion is further regulated by several hormones and neurotransmitters. Peptide hormones, such as glucagon-like peptide 1 (GLP-1), increase cAMP levels and thereby potentiate insulin secretion via the combined action of PKA and Epac2. Achetylcholine (ACh), a major parasympathetic neurotransmitter, binds to Gq-coupled receptors and activates phospholipase C- (PLC-), and the stimulatory effects involve activation of protein kinase C (PKC), which stimulates exocytosis. In addition, ACh mobilizes intracellular Ca2+ by activation of IP3 receptors.', 'Organismal Systems; Endocrine system', 'Insulin secretion', 'Type 2 diabetes mellitus, Fanconi-Bickel syndrome', 'GO: 0030073', 'ko04911', 'list(REFERENCE = \"PMID:20551594\", AUTHORS = \"Seino S, Shibasaki T, Minami K\", TITLE = \"Pancreatic beta-cell signaling: toward better understanding of diabetes and its treatment.\", JOURNAL = c(\"Proc Jpn Acad Ser B Phys Biol Sci 86:563-77 (2010)\", \"DOI:10.2183/pjab.86.563\")), list(REFERENCE = \"PMID:20225132\", AUTHORS = \"Jitrapakdee S, Wutthisathapornchai A, Wallace JC, MacDonald MJ\", TITLE = \"Regulation of insulin secretion: role of mitochondrial signalling.\", JOURNAL = c(\"Diabetologia 53:1019-32 (2010)\", \"DOI:10.1007/s00125-010-1685-0\")), list(REFERENCE = \"PMID:22974438\", AUTHORS = \"Rorsman P, Braun M\", TITLE = \"Regulation of insulin secretion in human pancreatic islets.\", JOURNAL = c(\"Annu Rev Physiol 75:155-79 (2013)\", \"DOI:10.1146/annurev-physiol-030212-183754\")), list(REFERENCE = \"PMID:9715374\", AUTHORS = \"Jones PM, Persaud SJ\", TITLE = \"Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic beta-cells.\", JOURNAL = c(\"Endocr Rev 19:429-61 (1998)\", \"DOI:10.1210/edrv.19.4.0339\")), list(REFERENCE = \"PMID:21934040\", AUTHORS = \"MacDonald PE\", TITLE = \"Signal integration at the level of ion channel and exocytotic function in pancreatic beta-cells.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 301:E1065-9 (2011)\", \"DOI:10.1152/ajpendo.00426.2011\")), list(REFERENCE = \"PMID:9914469\", AUTHORS = \"Lang J\", TITLE = \"Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion.\", JOURNAL = c(\"Eur J Biochem 259:3-17 (1999)\", \"DOI:10.1046/j.1432-1327.1999.00043.x\")), list(REFERENCE = \"PMID:10605628\", AUTHORS = \"Kieffer TJ, Habener JF\", TITLE = \"The glucagon-like peptides.\", JOURNAL = c(\"Endocr Rev 20:876-913 (1999)\", \"DOI:10.1210/edrv.20.6.0385\")), list(REFERENCE = \"PMID:19036624\", AUTHORS = \"Girard J\", TITLE = \"The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions.\", JOURNAL = c(\"Diabetes Metab 34:550-9 (2008)\", \"DOI:10.1016/j.diabet.2008.09.001\")), list(REFERENCE = \"PMID:15655710\", AUTHORS = \"Holz GG\", TITLE = \"New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.\", JOURNAL = c(\"Horm Metab Res 36:787-94 (2004)\", \"DOI:10.1055/s-2004-826165\")), list(REFERENCE = \"PMID:15271645\", AUTHORS = \"Holst JJ, Gromada J\", TITLE = \"Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 287:E199-206 (2004)\", \"DOI:10.1152/ajpendo.00545.2003\")), list(REFERENCE = \"PMID:17306374\", AUTHORS = \"Doyle ME, Egan JM\", TITLE = \"Mechanisms of action of glucagon-like peptide 1 in the pancreas.\", JOURNAL = c(\"Pharmacol Ther 113:546-93 (2007)\", \"DOI:10.1016/j.pharmthera.2006.11.007\")), list(REFERENCE = \"PMID:19074620\", AUTHORS = \"Kim W, Egan JM\", TITLE = \"The role of incretins in glucose homeostasis and diabetes treatment.\", JOURNAL = c(\"Pharmacol Rev 60:470-512 (2008)\", \"DOI:10.1124/pr.108.000604\")), list(REFERENCE = \"PMID:19817800\", AUTHORS = \"Seino S, Takahashi H, Fujimoto W, Shibasaki T\", TITLE = \"Roles of cAMP signalling in insulin granule exocytosis.\", JOURNAL = c(\"Diabetes Obes Metab 11 Suppl 4:180-8 (2009)\", \"DOI:10.1111/j.1463-1326.2009.01108.x\")), list(REFERENCE = \"PMID:22970724\", AUTHORS = \"Tengholm A\", TITLE = \"Cyclic AMP dynamics in the pancreatic beta-cell.\", JOURNAL = c(\"Ups J Med Sci 117:355-69 (2012)\", \"DOI:10.3109/03009734.2012.724732\")), list(REFERENCE = \"PMID:14693691\", AUTHORS = \"Holz GG\", TITLE = \"Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell.\", JOURNAL = c(\"Diabetes 53:5-13 (2004)\", \"DOI:10.2337/diabetes.53.1.5\")), list(REFERENCE = \"PMID:20055708\", AUTHORS = \"Gloerich M, Bos JL\", TITLE = \"Epac: defining a new mechanism for cAMP action.\", JOURNAL = c(\"Annu Rev Pharmacol Toxicol 50:355-75 (2010)\", \"DOI:10.1146/annurev.pharmtox.010909.105714\")), list(REFERENCE = \"PMID:17084085\", AUTHORS = \"Bos JL\", TITLE = \"Epac proteins: multi-purpose cAMP targets.\", JOURNAL = c(\"Trends Biochem Sci 31:680-6 (2006)\", \"DOI:10.1016/j.tibs.2006.10.002\")), list(REFERENCE = \"PMID:11522660\", AUTHORS = \"Filipsson K, Kvist-Reimer M, Ahren B\", TITLE = \"The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function.\", JOURNAL = c(\"Diabetes 50:1959-69 (2001)\", \"DOI:10.2337/diabetes.50.9.1959\")), list(REFERENCE = \"PMID:19817784\", AUTHORS = \"Kebede MA, Alquier T, Latour MG, Poitout V\", TITLE = \"Lipid receptors and islet function: therapeutic implications?\", JOURNAL = c(\"Diabetes Obes Metab 11 Suppl 4:10-20 (2009)\", \"DOI:10.1111/j.1463-1326.2009.01114.x\")), list(REFERENCE = \"PMID:19660440\", AUTHORS = \"Morgan NG, Dhayal S\", TITLE = \"G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell.\", JOURNAL = c(\"Biochem Pharmacol 78:1419-27 (2009)\", \"DOI:10.1016/j.bcp.2009.07.020\"))', 'map04911', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (344, '04912', 'GnRH signaling pathway', 'Gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus acts upon its receptor in the anterior pituitary to regulate the production and release of the gonadotropins, LH and FSH. The GnRHR is coupled to Gq/11 proteins to activate phospholipase C which transmits its signal to diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG activates the intracellular protein kinase C (PKC) pathway and IP3 stimulates release of intracellular calcium. In addition to the classical Gq/11, coupling of Gs is occasionally observed in a cell-specific fashion. Signaling downstream of protein kinase C (PKC) leads to transactivation of the epidermal growth factor (EGF) receptor and activation of mitogen-activated protein kinases (MAPKs), including extracellular-signal-regulated kinase (ERK), Jun N-terminal kinase (JNK) and p38 MAPK. Active MAPKs translocate to the nucleus, resulting in activation of transcription factors and rapid induction of early genes.', 'Organismal Systems; Endocrine system', 'GnRH signaling pathway', 'Hypogonadotropic hypogonadism, Hypokalemic periodic paralysis (HypoPP), Precocious puberty, Isolated follicle-stimulating hormone deficiency, Abnormal pituitary gonadotropin secretion', 'ko04912', 'list(REFERENCE = \"PMID:15350605\", AUTHORS = \"Ruf F, Sealfon SC.\", TITLE = \"Genomics view of gonadotrope signaling circuits.\", JOURNAL = c(\"Trends Endocrinol Metab 15:331-8 (2004)\", \"DOI:10.1016/j.tem.2004.07.008\")), list(REFERENCE = \"PMID:15613448\", AUTHORS = \"Harrison GS, Wierman ME, Nett TM, Glode LM.\", TITLE = \"Gonadotropin-releasing hormone and its receptor in normal and malignant cells.\", JOURNAL = c(\"Endocr Relat Cancer 11:725-48 (2004)\", \"DOI:10.1677/erc.1.00777\")), list(REFERENCE = \"PMID:15982836\", AUTHORS = \"Pawson AJ, McNeilly AS.\", TITLE = \"The pituitary effects of GnRH.\", JOURNAL = c(\"Anim Reprod Sci 88:75-94 (2005)\", \"DOI:10.1016/j.anireprosci.2005.05.010\")), list(REFERENCE = \"\", AUTHORS = \"DeGroot LJ, Jameson JL (ed).\", TITLE = \"Endocrinology (Fifth edition)\", JOURNAL = \"Elsevier Saunders (2006)\"), list(REFERENCE = \"PMID:10707049\", AUTHORS = \"Naor Z, Benard O, Seger R.\", TITLE = \"Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor.\", JOURNAL = c(\"Trends Endocrinol Metab 11:91-9 (2000)\", \"DOI:10.1016/S1043-2760(99)00232-5\")), list(REFERENCE = \"PMID:14596811\", AUTHORS = \"Ruf F, Fink MY, Sealfon SC.\", TITLE = \"Structure of the GnRH receptor-stimulated signaling network: insights from genomics.\", JOURNAL = c(\"Front Neuroendocrinol 24:181-99 (2003)\", \"DOI:10.1016/S0091-3022(03)00027-X\")), list(REFERENCE = \"PMID:12943720\", AUTHORS = \"Farshori PQ, Shah BH, Arora KK, Martinez-Fuentes A, Catt KJ.\", TITLE = \"Activation and nuclear translocation of PKCdelta, Pyk2 and ERK1/2 by gonadotropin releasing hormone in HEK293 cells.\", JOURNAL = c(\"J Steroid Biochem Mol Biol 85:337-47 (2003)\", \"DOI:10.1016/S0960-0760(03)00226-7\")), list(REFERENCE = \"PMID:15080147\", AUTHORS = \"Shah BH, Catt KJ.\", TITLE = \"Matrix metalloproteinases in reproductive endocrinology.\", JOURNAL = c(\"Trends Endocrinol Metab 15:47-9 (2004)\", \"DOI:10.1016/j.tem.2004.01.004\")), list(REFERENCE = \"PMID:12963732\", AUTHORS = \"Roelle S, Grosse R, Aigner A, Krell HW, Czubayko F, Gudermann T.\", TITLE = \"Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone.\", JOURNAL = c(\"J Biol Chem 278:47307-18 (2003)\", \"DOI:10.1074/jbc.M304377200\")), list(REFERENCE = \"PMID:18708085\", AUTHORS = \"Naor Z\", TITLE = \"Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.\", JOURNAL = c(\"Front Neuroendocrinol 30:10-29 (2009)\", \"DOI:10.1016/j.yfrne.2008.07.001\"))', 'map04912', 'GnRH signaling pathway', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (345, '04913', 'Ovarian steroidogenesis', 'The ovarian steroids, 17-beta estradiol (E2) and progesterone (P4), are critical for normal uterine function, establishment and maintenance of pregnancy, and mammary gland development. Furthermore, the local effects that are essential for normal ovarian physiology are dependent on the endocrine, paracrine, and autocrine actions of E2, P4, and androgens. In most mammals (including humans and mice), ovarian steroidogenesis occurs according to the two-cell/two-gonadotropin theory. This theory describes how granulosa and theca cells work together to make the ovarian steroids. Theca cells respond to LH signaling by increasing the expression of enzymes necessary for the conversion of cholesterol to androgens, such as androstenedione (A) and testosterone (T). Granulosa cells respond to FSH signaling by increasing the expression of enzymes necessary for the conversion of theca-derived androgens into estrogens (E2 and estrone).', 'Organismal Systems; Endocrine system', 'Ovarian steroidogenesis', '46,XX gonadal dysgenesis, Premature ovarian failure, Hyperlipoproteinemia type IIa, Fertile eunuch syndrome, Aromatase deficiency', 'GO: 0050810', 'ko04913', 'list(REFERENCE = \"PMID:15541573\", AUTHORS = \"Havelock JC, Rainey WE, Carr BR\", TITLE = \"Ovarian granulosa cell lines.\", JOURNAL = c(\"Mol Cell Endocrinol 228:67-78 (2004)\", \"DOI:10.1016/j.mce.2004.04.018\")), list(REFERENCE = \"PMID:15831519\", AUTHORS = \"Stocco DM, Wang X, Jo Y, Manna PR\", TITLE = \"Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought.\", JOURNAL = c(\"Mol Endocrinol 19:2647-59 (2005)\", \"DOI:10.1210/me.2004-0532\")), list(REFERENCE = \"PMID:20937107\", AUTHORS = \"Wen X, Li D, Tozer AJ, Docherty SM, Iles RK\", TITLE = \"Estradiol, progesterone, testosterone profiles in human follicular fluid and cultured granulosa cells from luteinized pre-ovulatory follicles.\", JOURNAL = c(\"Reprod Biol Endocrinol 8:117 (2010)\", \"DOI:10.1186/1477-7827-8-117\")), list(REFERENCE = \"PMID:11704115\", AUTHORS = \"Erickson GF, Shimasaki S\", TITLE = \"The physiology of folliculogenesis: the role of novel growth factors.\", JOURNAL = c(\"Fertil Steril 76:943-9 (2001)\", \"DOI:10.1016/S0015-0282(01)02859-X\")), list(REFERENCE = \"PMID:11883103\", AUTHORS = \"Wood JR, Strauss JF 3rd\", TITLE = \"Multiple signal transduction pathways regulate ovarian steroidogenesis.\", JOURNAL = c(\"Rev Endocr Metab Disord 3:33-46 (2002)\", \"DOI:10.1023/A:1012748718150\")), list(REFERENCE = \"PMID:16603089\", AUTHORS = \"Drummond AE\", TITLE = \"The role of steroids in follicular growth.\", JOURNAL = c(\"Reprod Biol Endocrinol 4:16 (2006)\", \"DOI:10.1186/1477-7827-4-16\")), list(REFERENCE = \"PMID:21862696\", AUTHORS = \"Craig ZR, Wang W, Flaws JA\", TITLE = \"Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling.\", JOURNAL = c(\"Reproduction 142:633-46 (2011)\", \"DOI:10.1530/REP-11-0136\")), list(REFERENCE = \"PMID:20628033\", AUTHORS = \"Young JM, McNeilly AS\", TITLE = \"Theca: the forgotten cell of the ovarian follicle.\", JOURNAL = c(\"Reproduction 140:489-504 (2010)\", \"DOI:10.1530/REP-10-0094\")), list(REFERENCE = \"PMID:18440223\", AUTHORS = \"Diamanti-Kandarakis E, Argyrakopoulou G, Economou F, Kandaraki E, Koutsilieris M\", TITLE = \"Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS).\", JOURNAL = c(\"J Steroid Biochem Mol Biol 109:242-6 (2008)\", \"DOI:10.1016/j.jsbmb.2008.03.014\")), list(REFERENCE = \"PMID:11408113\", AUTHORS = \"Spicer LJ\", TITLE = \"Receptors for insulin-like growth factor-I and tumor necrosis factor-alpha are hormonally regulated in bovine granulosa and thecal cells.\", JOURNAL = c(\"Anim Reprod Sci 67:45-58 (2001)\", \"DOI:10.1016/S0378-4320(01)00114-2\")), list(REFERENCE = \"PMID:10630400\", AUTHORS = \"Wang X, Stocco DM\", TITLE = \"Cyclic AMP and arachidonic acid: a tale of two pathways.\", JOURNAL = c(\"Mol Cell Endocrinol 158:7-12 (1999)\", \"DOI:10.1016/S0303-7207(99)00130-6\")), list(REFERENCE = \"PMID:17003287\", AUTHORS = \"Wang X, Shen CL, Dyson MT, Yin X, Schiffer RB, Grammas P, Stocco DM\", TITLE = \"The involvement of epoxygenase metabolites of arachidonic acid in cAMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression.\", JOURNAL = c(\"J Endocrinol 190:871-8 (2006)\", \"DOI:10.1677/joe.1.06933\")), list(REFERENCE = \"PMID:17008391\", AUTHORS = \"Miyoshi T, Otsuka F, Inagaki K, Otani H, Takeda M, Suzuki J, Goto J, Ogura T, Makino H\", TITLE = \"Differential regulation of steroidogenesis by bone morphogenetic proteins in granulosa cells: involvement of extracellularly regulated kinase signaling and oocyte actions in follicle-stimulating hormone-induced estrogen production.\", JOURNAL = c(\"Endocrinology 148:337-45 (2007)\", \"DOI:10.1210/en.2006-0966\")), list(REFERENCE = \"PMID:11447221\", AUTHORS = \"Otsuka F, Moore RK, Shimasaki S\", TITLE = \"Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary.\", JOURNAL = c(\"J Biol Chem 276:32889-95 (2001)\", \"DOI:10.1074/jbc.M103212200\")), list(REFERENCE = \"PMID:14769828\", AUTHORS = \"Shimasaki S, Moore RK, Otsuka F, Erickson GF.\", TITLE = \"The bone morphogenetic protein system in mammalian reproduction.\", JOURNAL = c(\"Endocr Rev 25:72-101 (2004)\", \"DOI:10.1210/er.2003-0007\")), list(REFERENCE = \"PMID:16414178\", AUTHORS = \"Lukacik P, Kavanagh KL, Oppermann U\", TITLE = \"Structure and function of human 17beta-hydroxysteroid dehydrogenases.\", JOURNAL = c(\"Mol Cell Endocrinol 248:61-71 (2006)\", \"DOI:10.1016/j.mce.2005.12.007\"))', 'map04913', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (346, '04914', 'Progesterone-mediated oocyte maturation', 'Xenopus oocytes are naturally arrested at G2 of meiosis I. Exposure to either insulin/IGF-1 or the steroid hormone progesterone breaks this arrest and induces resumption of the two meiotic division cycles and maturation of the oocyte into a mature, fertilizable egg. This process is termed oocyte maturation. The transition is accompanied by an increase in maturation promoting factor (MPF or Cdc2/cyclin B) which precedes germinal vesicle breakdown (GVBD). Most reports point towards the Mos-MEK1-ERK2 pathway [where ERK is an extracellular signal-related protein kinase, MEK is a MAPK/ERK kinase and Mos is a p42(MAPK) activator] and the polo-like kinase/CDC25 pathway as responsible for the activation of MPF in meiosis, most likely triggered by a decrease in cAMP.', 'Organismal Systems; Endocrine system', 'Progesterone-mediated oocyte maturation', 'Growth delay due to insulin-like growth factor I resistance', 'GO: 0001556', 'ko04914', 'list(REFERENCE = \"PMID:12045215\", AUTHORS = \"Schmitt A, Nebreda AR.\", TITLE = \"Signalling pathways in oocyte meiotic maturation.\", JOURNAL = \"J Cell Sci 115:2457-9 (2002)\"), list(REFERENCE = \"PMID:12084906\", AUTHORS = \"Cato AC, Nestl A, Mink S.\", TITLE = \"Rapid actions of steroid receptors in cellular signaling pathways.\", JOURNAL = c(\"Sci STKE 2002:RE9 (2002)\", \"DOI:10.1126/stke.2002.138.re9\")), list(REFERENCE = \"PMID:11730319\", AUTHORS = \"Maller JL, Schwab MS, Roberts BT, Gross SD, Taieb FE, Tunquist BJ.\", TITLE = \"The pathway of MAP kinase mediation of CSF arrest in Xenopus oocytes.\", JOURNAL = c(\"Biol Cell 93:27-33 (2001)\", \"DOI:10.1016/S0248-4900(01)01127-3\")), list(REFERENCE = \"PMID:11063930\", AUTHORS = \"Nebreda AR, Ferby I.\", TITLE = \"Regulation of the meiotic cell cycle in oocytes.\", JOURNAL = c(\"Curr Opin Cell Biol 12:666-75 (2000)\", \"DOI:10.1016/S0955-0674(00)00150-2\")), list(REFERENCE = \"PMID:10497333\", AUTHORS = \"Ferrell JE Jr.\", TITLE = \"Xenopus oocyte maturation: new lessons from a good egg.\", JOURNAL = c(\"Bioessays 21:833-42 (1999)\", \"DOI:10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P\")), list(REFERENCE = \"PMID:12374568\", AUTHORS = \"Andersen CB, Sakaue H, Nedachi T, Kovacina KS, Clayberger C, Conti M, Roth RA.\", TITLE = \"Protein kinase B/Akt is essential for the insulin- but not progesterone-stimulated resumption of meiosis in Xenopus oocytes.\", JOURNAL = c(\"Biochem J 369:227-38 (2003)\", \"DOI:10.1042/BJ20021243\")), list(REFERENCE = \"PMID:12477927\", AUTHORS = \"Duckworth BC, Weaver JS, Ruderman JV.\", TITLE = \"G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 99:16794-9 (2002)\", \"DOI:10.1073/pnas.222661299\")), list(REFERENCE = \"PMID:11148128\", AUTHORS = \"Abrieu A, Doree M, Fisher D.\", TITLE = \"The interplay between cyclin-B-Cdc2 kinase (MPF) and MAP kinase during maturation of oocytes.\", JOURNAL = \"J Cell Sci 114:257-67 (2001)\")', 'map04914', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (347, '04915', 'Estrogen signaling pathway', 'Estrogens are steroid hormones that regulate a plethora of physiological processes in mammals, including reproduction, cardiovascular protection, bone integrity, cellular homeostasis, and behavior. Estrogen mediates its cellular actions through two signaling pathways classified as \"nuclear-initiated steroid signaling\" and \"membrane-initiated steroid signaling\". In the \"nuclear\" pathway, estrogen binds either ERalpha or ERbeta, which in turn translocates to the nucleus, binds DNA at ERE elements and activates the expression of ERE-dependent genes. In \"membrane\" pathway, Estrogen can exert its actions through a subpopulation of ER at the plasma membrane (mER) or novel G-protein coupled E2 receptors (GPER). Upon activation of these receptors various signaling pathways (i.e. Ca2+, cAMP, protein kinase cascades) are rapidly activated and ultimately influence downstream transcription factors.', 'Organismal Systems; Endocrine system', 'Estrogen signaling pathway', 'Pachyonychia congenita, Naegeli-Franceschetti-Jadassohn syndrome, Estrogen resistance syndrome', 'GO: 0030520', 'ko04915', 'list(REFERENCE = \"PMID:16516516\", AUTHORS = \"Zhang D, Trudeau VL\", TITLE = \"Integration of membrane and nuclear estrogen receptor signaling.\", JOURNAL = c(\"Comp Biochem Physiol A Mol Integr Physiol 144:306-15 (2006)\", \"DOI:10.1016/j.cbpa.2006.01.025\")), list(REFERENCE = \"PMID:19187465\", AUTHORS = \"Roepke TA, Qiu J, Bosch MA, Ronnekleiv OK, Kelly MJ\", TITLE = \"Cross-talk between membrane-initiated and nuclear-initiated oestrogen signalling in the hypothalamus.\", JOURNAL = c(\"J Neuroendocrinol 21:263-70 (2009)\", \"DOI:10.1111/j.1365-2826.2009.01846.x\")), list(REFERENCE = \"PMID:19700741\", AUTHORS = \"McCarthy MM\", TITLE = \"The two faces of estradiol: effects on the developing brain.\", JOURNAL = c(\"Neuroscientist 15:599-610 (2009)\", \"DOI:10.1177/1073858409340924\")), list(REFERENCE = \"PMID:18538919\", AUTHORS = \"Kelly MJ, Ronnekleiv OK\", TITLE = \"Membrane-initiated estrogen signaling in hypothalamic neurons.\", JOURNAL = c(\"Mol Cell Endocrinol 290:14-23 (2008)\", \"DOI:10.1016/j.mce.2008.04.014\")), list(REFERENCE = \"PMID:16112267\", AUTHORS = \"Kelly MJ, Qiu J, Ronnekleiv OK\", TITLE = \"Estrogen signaling in the hypothalamus.\", JOURNAL = c(\"Vitam Horm 71:123-45 (2005)\", \"DOI:10.1016/S0083-6729(05)71005-0\")), list(REFERENCE = \"PMID:18253054\", AUTHORS = \"Raz L, Khan MM, Mahesh VB, Vadlamudi RK, Brann DW\", TITLE = \"Rapid estrogen signaling in the brain.\", JOURNAL = c(\"Neurosignals 16:140-53 (2008)\", \"DOI:10.1159/000111559\")), list(REFERENCE = \"PMID:15862823\", AUTHORS = \"Malyala A, Kelly MJ, Ronnekleiv OK\", TITLE = \"Estrogen modulation of hypothalamic neurons: activation of multiple signaling pathways and gene expression changes.\", JOURNAL = c(\"Steroids 70:397-406 (2005)\", \"DOI:10.1016/j.steroids.2005.03.004\")), list(REFERENCE = \"PMID:14573532\", AUTHORS = \"Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK, Kelly MJ\", TITLE = \"Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C.\", JOURNAL = c(\"J Neurosci 23:9529-40 (2003)\", \"DOI:10.1523/JNEUROSCI.23-29-09529.2003\")), list(REFERENCE = \"PMID:14993035\", AUTHORS = \"Kelly MJ, Qiu J, Ronnekleiv OK\", TITLE = \"Estrogen modulation of G-protein-coupled receptor activation of potassium channels in the central nervous system.\", JOURNAL = c(\"Ann N Y Acad Sci 1007:6-16 (2003)\", \"DOI:10.1196/annals.1286.001\")), list(REFERENCE = \"PMID:19549587\", AUTHORS = \"Meyer MR, Haas E, Prossnitz ER, Barton M\", TITLE = \"Non-genomic regulation of vascular cell function and growth by estrogen.\", JOURNAL = c(\"Mol Cell Endocrinol 308:9-16 (2009)\", \"DOI:10.1016/j.mce.2009.03.009\")), list(REFERENCE = \"PMID:20694192\", AUTHORS = \"do Nascimento GR, Barros YV, Wells AK, Khalil RA\", TITLE = \"Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.\", JOURNAL = c(\"Curr Hypertens Rev 5:283-306 (2009)\", \"DOI:10.2174/157340209789587717\")), list(REFERENCE = \"PMID:15695368\", AUTHORS = \"Bjornstrom L, Sjoberg M\", TITLE = \"Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes.\", JOURNAL = c(\"Mol Endocrinol 19:833-42 (2005)\", \"DOI:10.1210/me.2004-0486\")), list(REFERENCE = \"PMID:16270355\", AUTHORS = \"Manavathi B, Kumar R\", TITLE = \"Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.\", JOURNAL = c(\"J Cell Physiol 207:594-604 (2006)\", \"DOI:10.1002/jcp.20551\")), list(REFERENCE = \"PMID:21844907\", AUTHORS = \"Prossnitz ER, Barton M\", TITLE = \"The G-protein-coupled estrogen receptor GPER in health and disease.\", JOURNAL = c(\"Nat Rev Endocrinol 7:715-26 (2011)\", \"DOI:10.1038/nrendo.2011.122\")), list(REFERENCE = \"PMID:21742056\", AUTHORS = \"Meyer MR, Prossnitz ER, Barton M\", TITLE = \"The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.\", JOURNAL = c(\"Vascul Pharmacol 55:17-25 (2011)\", \"DOI:10.1016/j.vph.2011.06.003\")), list(REFERENCE = \"PMID:19767412\", AUTHORS = \"Maggiolini M, Picard D\", TITLE = \"The unfolding stories of GPR30, a new membrane-bound estrogen receptor.\", JOURNAL = c(\"J Endocrinol 204:105-14 (2010)\", \"DOI:10.1677/JOE-09-0242\")), list(REFERENCE = \"PMID:19464786\", AUTHORS = \"Prossnitz ER, Maggiolini M\", TITLE = \"Mechanisms of estrogen signaling and gene expression via GPR30.\", JOURNAL = c(\"Mol Cell Endocrinol 308:32-8 (2009)\", \"DOI:10.1016/j.mce.2009.03.026\")), list(REFERENCE = \"PMID:12650715\", AUTHORS = \"Kelly MJ, Qiu J, Wagner EJ, Ronnekleiv OK\", TITLE = \"Rapid effects of estrogen on G protein-coupled receptor activation of potassium channels in the central nervous system (CNS).\", JOURNAL = c(\"J Steroid Biochem Mol Biol 83:187-93 (2002)\", \"DOI:10.1016/S0960-0760(02)00249-2\")), list(REFERENCE = \"PMID:9278514\", AUTHORS = \"Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS\", TITLE = \"Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.\", JOURNAL = c(\"Science 277:1508-10 (1997)\", \"DOI:10.1126/science.277.5331.1508\")), list(REFERENCE = \"PMID:12421825\", AUTHORS = \"Razandi M, Pedram A, Park ST, Levin ER\", TITLE = \"Proximal events in signaling by plasma membrane estrogen receptors.\", JOURNAL = c(\"J Biol Chem 278:2701-12 (2003)\", \"DOI:10.1074/jbc.M205692200\")), list(REFERENCE = \"PMID:18755790\", AUTHORS = \"Roepke TA, Xue C, Bosch MA, Scanlan TS, Kelly MJ, Ronnekleiv OK\", TITLE = \"Genes associated with membrane-initiated signaling of estrogen and energy homeostasis.\", JOURNAL = c(\"Endocrinology 149:6113-24 (2008)\", \"DOI:10.1210/en.2008-0769\")), list(REFERENCE = \"PMID:21779010\", AUTHORS = \"Thomas C, Gustafsson JA\", TITLE = \"The different roles of ER subtypes in cancer biology and therapy.\", JOURNAL = c(\"Nat Rev Cancer 11:597-608 (2011)\", \"DOI:10.1038/nrc3093\"))', 'map04915', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (348, '04916', 'Melanogenesis', 'Cutaneous melanin pigment plays a critical role in camouflage, mimicry, social communication, and protection against harmful effects of solar radiation. Melanogenesis is under complex regulatory control by multiple agents. The most important positive regulator of melanogenesis is the MC1 receptor with its ligands melanocortic peptides. MC1R activates the cyclic AMP (cAMP) response-element binding protein (CREB). Increased expression of MITF and its activation by phosphorylation (P) stimulate the transcription of tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), and dopachrome tautomerase (DCT), which produce melanin. Melanin synthesis takes place within specialized intracellular organelles named melanosomes. Melanin-containing melanosomes then move from the perinuclear region to the dendrite tips and are transferred to keratinocytes by a still not well-characterized mechanism.', 'Organismal Systems; Endocrine system', 'Melanogenesis', 'Oculocutaneous albinism, Ocular albinism, Piebaldism, Odontoonychodermal dysplasia, Waardenburg syndrome, Waardenburg syndrome, ABCD syndrome, Familial progressive hyperpigmentation, Pilomatricoma, Tietz syndrome', 'ko04916', 'list(REFERENCE = \"PMID:15383650\", AUTHORS = \"Slominski A, Tobin DJ, Shibahara S, Wortsman J.\", TITLE = \"Melanin pigmentation in mammalian skin and its hormonal regulation.\", JOURNAL = c(\"Physiol Rev 84:1155-228 (2004)\", \"DOI:10.1152/physrev.00044.2003\")), list(REFERENCE = \"PMID:10841026\", AUTHORS = \"Busca R, Ballotti R.\", TITLE = \"Cyclic AMP a key messenger in the regulation of skin pigmentation.\", JOURNAL = c(\"Pigment Cell Res 13:60-9 (2000)\", \"DOI:10.1034/j.1600-0749.2000.130203.x\")), list(REFERENCE = \"PMID:15016298\", AUTHORS = \"Imokawa G.\", TITLE = \"Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders.\", JOURNAL = c(\"Pigment Cell Res 17:96-110 (2004)\", \"DOI:10.1111/j.1600-0749.2003.00126.x\")), list(REFERENCE = \"PMID:11023702\", AUTHORS = \"Wikberg JE, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A.\", TITLE = \"New aspects on the melanocortins and their receptors.\", JOURNAL = c(\"Pharmacol Res 42:393-420 (2000)\", \"DOI:10.1006/phrs.2000.0725\")), list(REFERENCE = \"PMID:12894244\", AUTHORS = \"Chin L.\", TITLE = \"The genetics of malignant melanoma: lessons from mouse and man.\", JOURNAL = c(\"Nat Rev Cancer 3:559-70 (2003)\", \"DOI:10.1038/nrc1145\")), list(REFERENCE = \"PMID:16822996\", AUTHORS = \"Miller AJ, Mihm MC Jr.\", TITLE = \"Melanoma.\", JOURNAL = c(\"N Engl J Med 355:51-65 (2006)\", \"DOI:10.1056/NEJMra052166\")), list(REFERENCE = \"PMID:12753399\", AUTHORS = \"Saito H, Yasumoto K, Takeda K, Takahashi K, Yamamoto H, Shibahara S.\", TITLE = \"Microphthalmia-associated transcription factor in the Wnt signaling pathway.\", JOURNAL = c(\"Pigment Cell Res 16:261-5 (2003)\", \"DOI:10.1034/j.1600-0749.2003.00039.x\")), list(REFERENCE = \"PMID:9263329\", AUTHORS = \"Imokawa G, Kobayashi T, Miyagishi M, Higashi K, Yada Y.\", TITLE = \"The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis.\", JOURNAL = c(\"Pigment Cell Res 10:218-28 (1997)\", \"DOI:10.1111/j.1600-0749.1997.tb00488.x\")), list(REFERENCE = \"PMID:10643996\", AUTHORS = \"Park HY, Gilchrest BA.\", TITLE = \"Signaling pathways mediating melanogenesis.\", JOURNAL = \"Cell Mol Biol (Noisy-le-grand) 45:919-30 (1999)\"), list(REFERENCE = \"PMID:10347209\", AUTHORS = \"Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA.\", TITLE = \"Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain.\", JOURNAL = c(\"J Biol Chem 274:16470-8 (1999)\", \"DOI:10.1074/jbc.274.23.16470\")), list(REFERENCE = \"PMID:11602344\", AUTHORS = \"Sturm RA, Teasdale RD, Box NF.\", TITLE = \"Human pigmentation genes: identification, structure and consequences of polymorphic variation.\", JOURNAL = c(\"Gene 277:49-62 (2001)\", \"DOI:10.1016/S0378-1119(01)00694-1\")), list(REFERENCE = \"PMID:11041354\", AUTHORS = \"Hearing VJ.\", TITLE = \"The melanosome: the perfect model for cellular responses to the environment.\", JOURNAL = c(\"Pigment Cell Res 13 Suppl 8:23-34 (2000)\", \"DOI:10.1034/j.1600-0749.13.s8.7.x\")), list(REFERENCE = \"PMID:16246839\", AUTHORS = \"Molina DM, Grewal S, Bardwell L.\", TITLE = \"Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation.\", JOURNAL = c(\"J Biol Chem 280:42051-60 (2005)\", \"DOI:10.1074/jbc.M510590200\"))', 'map04916', 'Melanogenesis', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (349, '04917', 'Prolactin signaling pathway', 'Prolactin (PRL) is a polypeptide hormone known to be involved in a wide range of biological functions including osmoregulation, lactation, reproduction, growth and development, endocrinology and metabolism, brain and behavior, and immunomodulation. PRL mediates its action through PRLR, a transmembrane protein of the hematopoietin cytokine receptor superfamily. At the protein level, the long PRLR isoform (long-R) and several short PRLR isoforms (short-R) have been detected. Acting through the long-R, PRL activates many signaling cascades including Jak2/Stat, the major cascade, Src kinase, phosphatidylinositol-3-kinase (PI3K)/AKT, and mitogen-activated protein kinase (MAPK) pathways. PRL cannot activate Jak2/Stat5 through the short-R, but can activate pathways including MAPK and PI3K pathways.', 'Organismal Systems; Endocrine system', 'Prolactin signaling pathway', 'Hyperprolactinemia, Fertile eunuch syndrome, Familial male-limited precocious puberty, Estrogen resistance syndrome', 'GO: 0038161', 'ko04917', 'list(REFERENCE = \"PMID:20149678\", AUTHORS = \"Binart N, Bachelot A, Bouilly J\", TITLE = \"Impact of prolactin receptor isoforms on reproduction.\", JOURNAL = c(\"Trends Endocrinol Metab 21:362-8 (2010)\", \"DOI:10.1016/j.tem.2010.01.008\")), list(REFERENCE = \"PMID:17307904\", AUTHORS = \"Bachelot A, Binart N\", TITLE = \"Reproductive role of prolactin.\", JOURNAL = c(\"Reproduction 133:361-9 (2007)\", \"DOI:10.1530/REP-06-0299\")), list(REFERENCE = \"PMID:16231422\", AUTHORS = \"Hennighausen L, Robinson GW\", TITLE = \"Information networks in the mammary gland.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 6:715-25 (2005)\", \"DOI:10.1038/nrm1714\")), list(REFERENCE = \"PMID:21664429\", AUTHORS = \"Bouilly J, Sonigo C, Auffret J, Gibori G, Binart N\", TITLE = \"Prolactin signaling mechanisms in ovary.\", JOURNAL = c(\"Mol Cell Endocrinol 356:80-7 (2012)\", \"DOI:10.1016/j.mce.2011.05.004\")), list(REFERENCE = \"PMID:18219564\", AUTHORS = \"Oakes SR, Rogers RL, Naylor MJ, Ormandy CJ\", TITLE = \"Prolactin regulation of mammary gland development.\", JOURNAL = c(\"J Mammary Gland Biol Neoplasia 13:13-28 (2008)\", \"DOI:10.1007/s10911-008-9069-5\")), list(REFERENCE = \"PMID:12670737\", AUTHORS = \"Frasor J, Gibori G\", TITLE = \"Prolactin regulation of estrogen receptor expression.\", JOURNAL = c(\"Trends Endocrinol Metab 14:118-23 (2003)\", \"DOI:10.1016/S1043-2760(03)00030-4\")), list(REFERENCE = \"PMID:9626554\", AUTHORS = \"Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA\", TITLE = \"Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.\", JOURNAL = c(\"Endocr Rev 19:225-68 (1998)\", \"DOI:10.1210/edrv.19.3.0334\")), list(REFERENCE = \"PMID:17535875\", AUTHORS = \"Weinhaus AJ, Stout LE, Bhagroo NV, Brelje TC, Sorenson RL\", TITLE = \"Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy.\", JOURNAL = c(\"J Endocrinol 193:367-81 (2007)\", \"DOI:10.1677/JOE-07-0043\")), list(REFERENCE = \"PMID:18601698\", AUTHORS = \"Grattan DR, Kokay IC\", TITLE = \"Prolactin: a pleiotropic neuroendocrine hormone.\", JOURNAL = c(\"J Neuroendocrinol 20:752-63 (2008)\", \"DOI:10.1111/j.1365-2826.2008.01736.x\")), list(REFERENCE = \"PMID:9475379\", AUTHORS = \"Yu-Lee LY, Luo G, Book ML, Morris SM\", TITLE = \"Lactogenic hormone signal transduction.\", JOURNAL = c(\"Biol Reprod 58:295-301 (1998)\", \"DOI:10.1095/biolreprod58.2.295\")), list(REFERENCE = \"PMID:11606470\", AUTHORS = \"Tam SP, Lau P, Djiane J, Hilton DJ, Waters MJ\", TITLE = \"Tissue-specific induction of SOCS gene expression by PRL.\", JOURNAL = c(\"Endocrinology 142:5015-26 (2001)\", \"DOI:10.1210/endo.142.11.8466\")), list(REFERENCE = \"PMID:17975019\", AUTHORS = \"Halperin J, Devi SY, Elizur S, Stocco C, Shehu A, Rebourcet D, Unterman TG, Leslie ND, Le J, Binart N, Gibori G\", TITLE = \"Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect.\", JOURNAL = c(\"Mol Endocrinol 22:513-22 (2008)\", \"DOI:10.1210/me.2007-0399\")), list(REFERENCE = \"PMID:17519353\", AUTHORS = \"Sakamoto K, Creamer BA, Triplett AA, Wagner KU\", TITLE = \"The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells.\", JOURNAL = c(\"Mol Endocrinol 21:1877-92 (2007)\", \"DOI:10.1210/me.2006-0316\")), list(REFERENCE = \"PMID:16677418\", AUTHORS = \"Oakes SR, Hilton HN, Ormandy CJ\", TITLE = \"The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium.\", JOURNAL = c(\"Breast Cancer Res 8:207 (2006)\", \"DOI:10.1186/bcr1411\"))', 'map04917', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (350, '04918', 'Thyroid hormone synthesis', 'Thyroid hormones triiodothyronine (T3) and thyroxine (T4) are essential for normal development, growth and metabolic homeostasis in all vertebrates, and synthesized in the thyroid gland. The functional unit of the thyroid gland is the follicle, delimited by a monolayer of thyrocytes. Polarized thyrocytes surround the follicular lumen; with their basal and apical surfaces facing the bloodstream and the lumen, respectively. To synthesize thyroid hormones, thyrocytes take up iodide at their basal side and concentrate it into the lumen. They also secrete in this lumen the specialized protein thyroglobulin (TG) which serves as a store for the hormones. In the follicular lumen oxidation of iodine, iodination of tyrosines (MIT, 3-monoiodotyrosine; DIT, 3,5-diiodotyrosine) and coupling of iodotyrosines takes place on tyrosine residues in TG, resulting in T3 and T4 synthesis. Iodinated TG is resorbed through the apical membrane and degraded to form T3/T4 in lysosomes; the T3/T4 is then secreted through the basal membrane.', 'Organismal Systems; Endocrine system', 'Thyroid hormone synthesis', 'Congenital nongoitrous hypothyroidism (CHNG), Thyroid dyshormonogenesis, Isolated TSH deficiency', 'GO: 0006590', 'ko04918', 'list(REFERENCE = \"PMID:21448409\", AUTHORS = \"Ahad F, Ganie SA\", TITLE = \"Iodine, Iodine metabolism and Iodine deficiency disorders revisited.\", JOURNAL = \"Indian J Endocrinol Metab 14:13-7 (2010)\"), list(REFERENCE = \"PMID:11717564\", AUTHORS = \"Gillam MP, Kopp P\", TITLE = \"Genetic defects in thyroid hormone synthesis.\", JOURNAL = \"Curr Opin Pediatr 13:364-72 (2001)\"), list(REFERENCE = \"PMID:20167242\", AUTHORS = \"Rokita SE, Adler JM, McTamney PM, Watson JA Jr\", TITLE = \"Efficient use and recycling of the micronutrient iodide in mammals.\", JOURNAL = c(\"Biochimie 92:1227-35 (2010)\", \"DOI:10.1016/j.biochi.2010.02.013\")), list(REFERENCE = \"PMID:21683758\", AUTHORS = \"Massart C, Hoste C, Virion A, Ruf J, Dumont JE, Van Sande J\", TITLE = \"Cell biology of H2O2 generation in the thyroid: investigation of the control of dual oxidases (DUOX) activity in intact ex vivo thyroid tissue and cell lines.\", JOURNAL = c(\"Mol Cell Endocrinol 343:32-44 (2011)\", \"DOI:10.1016/j.mce.2011.05.047\")), list(REFERENCE = \"PMID:19196800\", AUTHORS = \"Bizhanova A, Kopp P\", TITLE = \"Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.\", JOURNAL = c(\"Endocrinology 150:1084-90 (2009)\", \"DOI:10.1210/en.2008-1437\")), list(REFERENCE = \"PMID:21986207\", AUTHORS = \"Fong P\", TITLE = \"Thyroid iodide efflux: a team effort?\", JOURNAL = c(\"J Physiol 589:5929-39 (2011)\", \"DOI:10.1113/jphysiol.2011.218594\")), list(REFERENCE = \"PMID:17666482\", AUTHORS = \"Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, Maenhaut C, Miot F, Van Sande J, Many MC, Dumont JE\", TITLE = \"Roles of hydrogen peroxide in thyroid physiology and disease.\", JOURNAL = c(\"J Clin Endocrinol Metab 92:3764-73 (2007)\", \"DOI:10.1210/jc.2007-0660\")), list(REFERENCE = \"PMID:11137035\", AUTHORS = \"Kohn LD, Suzuki K, Nakazato M, Royaux I, Green ED\", TITLE = \"Effects of thyroglobulin and pendrin on iodide flux through the thyrocyte.\", JOURNAL = c(\"Trends Endocrinol Metab 12:10-6 (2001)\", \"DOI:10.1016/S1043-2760(00)00337-4\")), list(REFERENCE = \"PMID:11029276\", AUTHORS = \"Marino M, McCluskey RT\", TITLE = \"Role of thyroglobulin endocytic pathways in the control of thyroid hormone release.\", JOURNAL = c(\"Am J Physiol Cell Physiol 279:C1295-306 (2000)\", \"DOI:10.1152/ajpcell.2000.279.5.C1295\")), list(REFERENCE = \"PMID:16870170\", AUTHORS = \"Rivolta CM, Targovnik HM\", TITLE = \"Molecular advances in thyroglobulin disorders.\", JOURNAL = c(\"Clin Chim Acta 374:8-24 (2006)\", \"DOI:10.1016/j.cca.2006.05.043\")), list(REFERENCE = \"PMID:10893432\", AUTHORS = \"De La Vieja A, Dohan O, Levy O, Carrasco N\", TITLE = \"Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.\", JOURNAL = c(\"Physiol Rev 80:1083-105 (2000)\", \"DOI:10.1152/physrev.2000.80.3.1083\")), list(REFERENCE = \"PMID:20407074\", AUTHORS = \"Ohye H, Sugawara M\", TITLE = \"Dual oxidase, hydrogen peroxide and thyroid diseases.\", JOURNAL = c(\"Exp Biol Med (Maywood) 235:424-33 (2010)\", \"DOI:10.1258/ebm.2009.009241\")), list(REFERENCE = \"PMID:20093166\", AUTHORS = \"Targovnik HM, Esperante SA, Rivolta CM\", TITLE = \"Genetics and phenomics of hypothyroidism and goiter due to thyroglobulin mutations.\", JOURNAL = c(\"Mol Cell Endocrinol 322:44-55 (2010)\", \"DOI:10.1016/j.mce.2010.01.009\")), list(REFERENCE = \"PMID:20122987\", AUTHORS = \"Grasberger H\", TITLE = \"Defects of thyroidal hydrogen peroxide generation in congenital hypothyroidism.\", JOURNAL = c(\"Mol Cell Endocrinol 322:99-106 (2010)\", \"DOI:10.1016/j.mce.2010.01.029\")), list(REFERENCE = \"PMID:9086577\", AUTHORS = \"Arvan P, Kim PS, Kuliawat R, Prabakaran D, Muresan Z, Yoo SE, Abu Hossain S\", TITLE = \"Intracellular protein transport to the thyrocyte plasma membrane: potential implications for thyroid physiology.\", JOURNAL = c(\"Thyroid 7:89-105 (1997)\", \"DOI:10.1089/thy.1997.7.89\")), list(REFERENCE = \"PMID:15611820\", AUTHORS = \"Vono-Toniolo J, Kopp P\", TITLE = \"Thyroglobulin gene mutations and other genetic defects associated with congenital hypothyroidism.\", JOURNAL = c(\"Arq Bras Endocrinol Metabol 48:70-82 (2004)\", \"DOI:10.1590/S0004-27302004000100009\")), list(REFERENCE = \"PMID:23438835\", AUTHORS = \"Vitale G, Salvioli S, Franceschi C\", TITLE = \"Oxidative stress and the ageing endocrine system.\", JOURNAL = c(\"Nat Rev Endocrinol 9:228-40 (2013)\", \"DOI:10.1038/nrendo.2013.29\")), list(REFERENCE = \"PMID:20378719\", AUTHORS = \"Calebiro D, Nikolaev VO, Lohse MJ\", TITLE = \"Imaging of persistent cAMP signaling by internalized G protein-coupled receptors.\", JOURNAL = c(\"J Mol Endocrinol 45:1-8 (2010)\", \"DOI:10.1677/JME-10-0014\")), list(REFERENCE = \"PMID:9538302\", AUTHORS = \"Newman CM, Price A, Davies DW, Gray TA, Weetman AP\", TITLE = \"Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.\", JOURNAL = c(\"Heart 79:121-7 (1998)\", \"DOI:10.1136/hrt.79.2.121\"))', 'map04918', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (351, '04919', 'Thyroid hormone signaling pathway', 'The thyroid hormones (THs) are important regulators of growth, development and metabolism. The action of TH is mainly mediated by T3 (3,5,3\'-triiodo-L-thyronine). Thyroid hormones, L-thyroxine (T4) and T3 enter the cell through transporter proteins. Although the major form of TH in the blood is T4, it is converted to the more active hormone T3 within cells. T3 binds to nuclear thyroid hormone receptors (TRs), which functions as a ligand-dependent transcription factor and controls the expression of target genes (genomic action). Nongenomic mechanisms of action is initiated at the integrin receptor. The plasma membrane alpha(v)beta(3)-integrin has distinct binding sites for T3 and T4. One binding site binds only T3 and activates the phosphatidylinositol 3-kinase (PI3K) pathway. The other binding site binds both T3 and T4 and activates the ERK1/2 MAP kinase pathway.', 'Organismal Systems; Endocrine system', 'Thyroid hormone signaling pathway', 'Thyroid hormone resistance syndrome, Congenital nongoitrous hypothyroidism (CHNG), Lujan-Fryns syndrome', 'GO: 0002154', 'ko04919', 'list(REFERENCE = \"PMID:20051527\", AUTHORS = \"Cheng SY, Leonard JL, Davis PJ\", TITLE = \"Molecular aspects of thyroid hormone actions.\", JOURNAL = c(\"Endocr Rev 31:139-70 (2010)\", \"DOI:10.1210/er.2009-0007\")), list(REFERENCE = \"PMID:16214361\", AUTHORS = \"Davis PJ, Davis FB, Cody V\", TITLE = \"Membrane receptors mediating thyroid hormone action.\", JOURNAL = c(\"Trends Endocrinol Metab 16:429-35 (2005)\", \"DOI:10.1016/j.tem.2005.09.007\")), list(REFERENCE = \"PMID:18329679\", AUTHORS = \"Davis PJ, Davis FB, Lin HY\", TITLE = \"Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors.\", JOURNAL = c(\"Steroids 73:1013-7 (2008)\", \"DOI:10.1016/j.steroids.2007.12.030\")), list(REFERENCE = \"PMID:22484490\", AUTHORS = \"Pascual A, Aranda A\", TITLE = \"Thyroid hormone receptors, cell growth and differentiation.\", JOURNAL = c(\"Biochim Biophys Acta 1830:3908-16 (2013)\", \"DOI:10.1016/j.bbagen.2012.03.012\")), list(REFERENCE = \"PMID:17983645\", AUTHORS = \"Davis PJ, Leonard JL, Davis FB\", TITLE = \"Mechanisms of nongenomic actions of thyroid hormone.\", JOURNAL = c(\"Front Neuroendocrinol 29:211-8 (2008)\", \"DOI:10.1016/j.yfrne.2007.09.003\")), list(REFERENCE = \"PMID:19755667\", AUTHORS = \"Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK\", TITLE = \"Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 297:E1238-46 (2009)\", \"DOI:10.1152/ajpendo.00480.2009\")), list(REFERENCE = \"PMID:20868274\", AUTHORS = \"Davis PJ, Davis FB, Mousa SA, Luidens MK, Lin HY\", TITLE = \"Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.\", JOURNAL = c(\"Annu Rev Pharmacol Toxicol 51:99-115 (2011)\", \"DOI:10.1146/annurev-pharmtox-010510-100512\")), list(REFERENCE = \"PMID:23021374\", AUTHORS = \"Lin HY, Tang HY, Davis FB, Mousa SA, Incerpi S, Luidens MK, Meng R, Davis PJ\", TITLE = \"Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps.\", JOURNAL = \"Discov Med 14:199-206 (2012)\"), list(REFERENCE = \"PMID:21835053\", AUTHORS = \"Moeller LC, Broecker-Preuss M\", TITLE = \"Transcriptional regulation by nonclassical action of thyroid hormone.\", JOURNAL = c(\"Thyroid Res 4 Suppl 1:S6 (2011)\", \"DOI:10.1186/1756-6614-4-S1-S6\")), list(REFERENCE = \"PMID:19295177\", AUTHORS = \"Bhargava M, Lei J, Ingbar DH\", TITLE = \"Nongenomic actions of L-thyroxine and 3,5,3\'-triiodo-L-thyronine. Focus on \\\"L-Thyroxine vs. 3,5,3\'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase\\\".\", JOURNAL = c(\"Am J Physiol Cell Physiol 296:C977-9 (2009)\", \"DOI:10.1152/ajpcell.00116.2009\")), list(REFERENCE = \"PMID:17574003\", AUTHORS = \"Oetting A, Yen PM\", TITLE = \"New insights into thyroid hormone action.\", JOURNAL = c(\"Best Pract Res Clin Endocrinol Metab 21:193-208 (2007)\", \"DOI:10.1016/j.beem.2007.04.004\")), list(REFERENCE = \"PMID:20005976\", AUTHORS = \"Ojamaa K\", TITLE = \"Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.\", JOURNAL = c(\"Vascul Pharmacol 52:113-9 (2010)\", \"DOI:10.1016/j.vph.2009.11.008\")), list(REFERENCE = \"PMID:19716314\", AUTHORS = \"Aranda A, Martinez-Iglesias O, Ruiz-Llorente L, Garcia-Carpizo V, Zambrano A\", TITLE = \"Thyroid receptor: roles in cancer.\", JOURNAL = c(\"Trends Endocrinol Metab 20:318-24 (2009)\", \"DOI:10.1016/j.tem.2009.03.011\")), list(REFERENCE = \"PMID:16951130\", AUTHORS = \"Otulakowski G, O\'Brodovich H\", TITLE = \"Thyroid hormone and Na+-K+-ATPase: more than simple transcription.\", JOURNAL = c(\"Am J Physiol Lung Cell Mol Physiol 292:L4-5 (2007)\", \"DOI:10.1152/ajplung.00332.2006\")), list(REFERENCE = \"PMID:16051672\", AUTHORS = \"Moeller LC, Dumitrescu AM, Refetoff S\", TITLE = \"Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes.\", JOURNAL = c(\"Mol Endocrinol 19:2955-63 (2005)\", \"DOI:10.1210/me.2004-0542\")), list(REFERENCE = \"PMID:15345678\", AUTHORS = \"D\'Arezzo S, Incerpi S, Davis FB, Acconcia F, Marino M, Farias RN, Davis PJ\", TITLE = \"Rapid nongenomic effects of 3,5,3\'-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways.\", JOURNAL = c(\"Endocrinology 145:5694-703 (2004)\", \"DOI:10.1210/en.2004-0890\"))', 'map04919', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (352, '04920', 'Adipocytokine signaling pathway', 'c(\"Increased adipocyte volume and number are positively correlated with leptin production, and negatively correlated with production of adiponectin.\", \"Leptin is an important regulator of energy intake and metabolic rate primarily by acting at hypothalamic nuclei. Leptin exerts its anorectic effects by modulating the levels of neuropeptides such as NPY, AGRP, and alpha-MSH. This leptin action is through the JAK kinase, STAT3 phosphorylation, and nuclear transcriptional effect.\", \"Adiponectin lowers plasma glucose and FFAs. These effects are partly accounted for by adiponectin-induced AMPK activation, which in turn stimulates skeletal muscle fatty acid oxidation and glucose uptake. Furthermore, activation of AMPK by adiponectin suppresses endogenous glucose production, concomitantly with inhibition of PEPCK and G6Pase expression.\", \n\"The proinflammatory cytokine TNFalpha has been implicated as a link between obesity and insulin resistance. TNFalpha interferes with early steps of insulin signaling. Several data have shown that TNFalpha inhibits IRS1 tyrosine phosphorylation by promoting its serine phosphorylation. Among the serine/threonine kinases activated by TNFalpha, JNK, mTOR and IKK have been shown to be involved in this phosphorylation.\")', 'Organismal Systems; Endocrine system', 'Adipocytokine signaling pathway', 'Incontinentia pigmenti, Peutz-Jeghers syndrome, Primary dystonia, GLUT1 deficiency syndrome, Cocoon syndrome, Adiponectin deficiency, Metachondromatosis, CD36 deficiency, Wolff-Parkinson-White (WPW) syndrome, Eating Disorders, Leptin deficiency, Leptin receptor deficiency', 'ko04920', 'list(REFERENCE = \"PMID:15733744\", AUTHORS = \"Gual P, Le Marchand-Brustel Y, Tanti JF.\", TITLE = \"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.\", JOURNAL = c(\"Biochimie 87:99-109 (2005)\", \"DOI:10.1016/j.biochi.2004.10.019\")), list(REFERENCE = \"PMID:12829246\", AUTHORS = \"Hardie DG, Scott JW, Pan DA, Hudson ER.\", TITLE = \"Management of cellular energy by the AMP-activated protein kinase system.\", JOURNAL = c(\"FEBS Lett 546:113-20 (2003)\", \"DOI:10.1016/S0014-5793(03)00560-X\")), list(REFERENCE = \"PMID:15980064\", AUTHORS = \"Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA.\", TITLE = \"The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases.\", JOURNAL = c(\"J Biol Chem 280:29060-6 (2005)\", \"DOI:10.1074/jbc.M503824200\")), list(REFERENCE = \"PMID:10766253\", AUTHORS = \"Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG.\", TITLE = \"Central nervous system control of food intake.\", JOURNAL = c(\"Nature 404:661-71 (2000)\", \"DOI:10.1038/35007534\")), list(REFERENCE = \"PMID:15856064\", AUTHORS = \"Munzberg H, Myers MG Jr.\", TITLE = \"Molecular and anatomical determinants of central leptin resistance.\", JOURNAL = c(\"Nat Neurosci 8:566-70 (2005)\", \"DOI:10.1038/nn1454\")), list(REFERENCE = \"PMID:12754525\", AUTHORS = \"Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM.\", TITLE = \"Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.\", JOURNAL = c(\"Nature 423:550-5 (2003)\", \"DOI:10.1038/nature01667\")), list(REFERENCE = \"PMID:11557972\", AUTHORS = \"Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM.\", TITLE = \"Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.\", JOURNAL = c(\"Nature 413:131-8 (2001)\", \"DOI:10.1038/35093050\")), list(REFERENCE = \"PMID:14716305\", AUTHORS = \"Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M.\", TITLE = \"Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.\", JOURNAL = c(\"Nat Med 10:168-74 (2004)\", \"DOI:10.1038/nm980\")), list(REFERENCE = \"PMID:9671776\", AUTHORS = \"Zhou YT, Shimabukuro M, Wang MY, Lee Y, Higa M, Milburn JL, Newgard CB, Unger RH.\", TITLE = \"Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 95:8898-903 (1998)\", \"DOI:10.1073/pnas.95.15.8898\")), list(REFERENCE = \"PMID:10905472\", AUTHORS = \"Kelley DE, Mandarino LJ.\", TITLE = \"Fuel selection in human skeletal muscle in insulin resistance: a reexamination.\", JOURNAL = c(\"Diabetes 49:677-83 (2000)\", \"DOI:10.2337/diabetes.49.5.677\")), list(REFERENCE = \"PMID:12368907\", AUTHORS = \"Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T.\", TITLE = \"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.\", JOURNAL = c(\"Nat Med 8:1288-95 (2002)\", \"DOI:10.1038/nm788\")), list(REFERENCE = \"PMID:11479627\", AUTHORS = \"Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T.\", TITLE = \"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.\", JOURNAL = c(\"Nat Med 7:941-6 (2001)\", \"DOI:10.1038/90984\")), list(REFERENCE = \"PMID:15058305\", AUTHORS = \"Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB.\", TITLE = \"AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.\", JOURNAL = c(\"Nature 428:569-74 (2004)\", \"DOI:10.1038/nature02440\")), list(REFERENCE = \"PMID:14679176\", AUTHORS = \"Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr.\", TITLE = \"Obesity is associated with macrophage accumulation in adipose tissue.\", JOURNAL = c(\"J Clin Invest 112:1796-808 (2003)\", \"DOI:10.1172/JCI19246\"))', 'map04920', 'Adipocytokine signaling pathway', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (353, '04921', 'Oxytocin signaling pathway', 'Oxytocin (OT) is a nonapeptide synthesized by the magno-cellular neurons located in the supraoptic (SON) and paraventricular (PVN) nuclei of the hypothalamus. It exerts a wide variety of central and peripheral effects. However, its best-known and most well-established roles are stimulation of uterine contractions during parturition and milk release during lactation. Oxytocin also influences cardiovascular regulation and various social behaviors. The actions of OT are all mediated by one type of OT receptor (OTR). This is a transmembrane receptor belonging to the G-protein-coupled receptor superfamily. The main signaling pathway is the Gq/PLC/Ins3 pathway, but the MAPK and the RhoA/Rho kinase pathways are also activated, contributing to increased prostaglandin production and direct contractile effect on myometrial cells. In the cardiovascular system, OTR is associated with the ANP-cGMP and NO-cGMP pathways, which reduce the force and rate of contraction and increase vasodilatation.', 'Organismal Systems; Endocrine system', 'Oxytocin signaling pathway', 'Long QT syndrome', 'ko04921', 'list(REFERENCE = \"PMID:18655881\", AUTHORS = \"Devost D, Wrzal P, Zingg HH\", TITLE = \"Oxytocin receptor signalling.\", JOURNAL = c(\"Prog Brain Res 170:167-76 (2008)\", \"DOI:10.1016/S0079-6123(08)00415-9\")), list(REFERENCE = \"PMID:20626426\", AUTHORS = \"Viero C, Shibuya I, Kitamura N, Verkhratsky A, Fujihara H, Katoh A, Ueta Y, Zingg HH, Chvatal A, Sykova E, Dayanithi G\", TITLE = \"REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy.\", JOURNAL = c(\"CNS Neurosci Ther 16:e138-56 (2010)\", \"DOI:10.1111/j.1755-5949.2010.00185.x\")), list(REFERENCE = \"PMID:21981277\", AUTHORS = \"Gutkowska J, Jankowski M\", TITLE = \"Oxytocin revisited: its role in cardiovascular regulation.\", JOURNAL = c(\"J Neuroendocrinol 24:599-608 (2012)\", \"DOI:10.1111/j.1365-2826.2011.02235.x\")), list(REFERENCE = \"PMID:22190926\", AUTHORS = \"Vrachnis N, Malamas FM, Sifakis S, Deligeoroglou E, Iliodromiti Z\", TITLE = \"The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents.\", JOURNAL = c(\"Int J Endocrinol 2011:350546 (2011)\", \"DOI:10.1155/2011/350546\")), list(REFERENCE = \"PMID:19840865\", AUTHORS = \"Tom N, Assinder SJ\", TITLE = \"Oxytocin in health and disease.\", JOURNAL = c(\"Int J Biochem Cell Biol 42:202-5 (2010)\", \"DOI:10.1016/j.biocel.2009.10.008\")), list(REFERENCE = \"PMID:9575824\", AUTHORS = \"Strakova Z, Copland JA, Lolait SJ, Soloff MS\", TITLE = \"ERK2 mediates oxytocin-stimulated PGE2 synthesis.\", JOURNAL = c(\"Am J Physiol 274:E634-41 (1998)\", \"DOI:10.1152/ajpendo.1998.274.4.E634\")), list(REFERENCE = \"PMID:12009385\", AUTHORS = \"Slater DM, Zervou S, Thornton S\", TITLE = \"Prostaglandins and prostanoid receptors in human pregnancy and parturition.\", JOURNAL = \"J Soc Gynecol Investig 9:118-24 (2002)\"), list(REFERENCE = \"PMID:16787565\", AUTHORS = \"Shmygol A, Gullam J, Blanks A, Thornton S\", TITLE = \"Multiple mechanisms involved in oxytocin-induced modulation of myometrial contractility.\", JOURNAL = c(\"Acta Pharmacol Sin 27:827-32 (2006)\", \"DOI:10.1111/j.1745-7254.2006.00393.x\")), list(REFERENCE = \"PMID:11861513\", AUTHORS = \"Tahara M, Morishige K, Sawada K, Ikebuchi Y, Kawagishi R, Tasaka K, Murata Y\", TITLE = \"RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction.\", JOURNAL = c(\"Endocrinology 143:920-9 (2002)\", \"DOI:10.1210/endo.143.3.8696\")), list(REFERENCE = \"PMID:12433531\", AUTHORS = \"Slattery MM, Morrison JJ\", TITLE = \"Preterm delivery.\", JOURNAL = c(\"Lancet 360:1489-97 (2002)\", \"DOI:10.1016/S0140-6736(02)11476-0\")), list(REFERENCE = \"PMID:22902539\", AUTHORS = \"Pont JN, McArdle CA, Lopez Bernal A\", TITLE = \"Oxytocin-stimulated NFAT transcriptional activation in human myometrial cells.\", JOURNAL = c(\"Mol Endocrinol 26:1743-56 (2012)\", \"DOI:10.1210/me.2012-1057\")), list(REFERENCE = \"PMID:9326674\", AUTHORS = \"Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM\", TITLE = \"Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 94:11704-9 (1997)\", \"DOI:10.1073/pnas.94.21.11704\")), list(REFERENCE = \"PMID:14715914\", AUTHORS = \"Antunes-Rodrigues J, de Castro M, Elias LL, Valenca MM, McCann SM\", TITLE = \"Neuroendocrine control of body fluid metabolism.\", JOURNAL = c(\"Physiol Rev 84:169-208 (2004)\", \"DOI:10.1152/physrev.00017.2003\")), list(REFERENCE = \"PMID:18555543\", AUTHORS = \"Lee ES, Uhm KO, Lee YM, Kwon J, Park SH, Soo KH\", TITLE = \"Oxytocin stimulates glucose uptake in skeletal muscle cells through the calcium-CaMKK-AMPK pathway.\", JOURNAL = c(\"Regul Pept 151:71-4 (2008)\", \"DOI:10.1016/j.regpep.2008.05.001\")), list(REFERENCE = \"PMID:9219843\", AUTHORS = \"Cassoni P, Sapino A, Fortunati N, Munaron L, Chini B, Bussolati G\", TITLE = \"Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A.\", JOURNAL = c(\"Int J Cancer 72:340-4 (1997)\", \"DOI:10.1002/(SICI)1097-0215(19970717)72:2<340::AID-IJC23>3.0.CO;2-I\")), list(REFERENCE = \"PMID:23356278\", AUTHORS = \"Busnelli M, Peverelli E, Mantovani G, Spada A, Chini B\", TITLE = \"Deciphering the specific role of G(alphai/o) isoforms: functional selective oxytocin ligands and somatostatin SST5 receptor mutants.\", JOURNAL = c(\"Biochem Soc Trans 41:166-71 (2013)\", \"DOI:10.1042/BST20120306\")), list(REFERENCE = \"PMID:16966388\", AUTHORS = \"Reversi A, Rimoldi V, Brambillasca S, Chini B\", TITLE = \"Effects of cholesterol manipulation on the signaling of the human oxytocin receptor.\", JOURNAL = c(\"Am J Physiol Regul Integr Comp Physiol 291:R861-9 (2006)\", \"DOI:10.1152/ajpregu.00333.2006\")), list(REFERENCE = \"PMID:20141572\", AUTHORS = \"Salmina AB, Lopatina O, Ekimova MV, Mikhutkina SV, Higashida H\", TITLE = \"CD38/cyclic ADP-ribose system: a new player for oxytocin secretion and regulation of social behaviour.\", JOURNAL = c(\"J Neuroendocrinol 22:380-92 (2010)\", \"DOI:10.1111/j.1365-2826.2010.01970.x\")), list(REFERENCE = \"PMID:22227279\", AUTHORS = \"Higashida H, Yokoyama S, Kikuchi M, Munesue T\", TITLE = \"CD38 and its role in oxytocin secretion and social behavior.\", JOURNAL = c(\"Horm Behav 61:351-8 (2012)\", \"DOI:10.1016/j.yhbeh.2011.12.011\")), list(REFERENCE = \"PMID:23335873\", AUTHORS = \"Lopatina O, Inzhutova A, Salmina AB, Higashida H\", TITLE = \"The roles of oxytocin and CD38 in social or parental behaviors.\", JOURNAL = c(\"Front Neurosci 6:182 (2012)\", \"DOI:10.3389/fnins.2012.00182\")), list(REFERENCE = \"PMID:16156781\", AUTHORS = \"Guse AH\", TITLE = \"Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR).\", JOURNAL = c(\"FEBS J 272:4590-7 (2005)\", \"DOI:10.1111/j.1742-4658.2005.04863.x\"))', 'map04921', 'Oxytocin signaling pathway', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (354, '04922', 'Glucagon signaling pathway', 'Glucagon is conventionally regarded as a counterregulatory hormone for insulin and plays a critical anti-hypoglycemic role by maintaining glucose homeostasis in both animals and humans. To increase blood glucose, glucagon promotes hepatic glucose output by increasing glycogenolysis and gluconeogenesis and by decreasing glycogenesis and glycolysis in a concerted fashion via multiple mechanisms. Glucagon also stimulates hepatic mitochondrial beta-oxidation to supply energy for glucose production. Glucagon performs its main effect via activation of adenylate cyclase. The adenylate-cyclase-derived cAMP activates protein kinase A (PKA), which then phosphorylates downstream targets, such as cAMP response element binding protein (CREB) and the bifunctional enzyme 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase (one of the isoforms being PFK/FBPase 1, encoded by PFKFB1).', 'Organismal Systems; Endocrine system', 'Glucagon signaling pathway', 'Muscle glycogen storage disease, Glycogen storage disease type VI, Glycogen storage disease type IX, Glycogen storage disease type X, Glycogen storage disease of heart', 'ko04922', 'list(REFERENCE = \"PMID:12626323\", AUTHORS = \"Jiang G, Zhang BB\", TITLE = \"Glucagon and regulation of glucose metabolism.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 284:E671-8 (2003)\", \"DOI:10.1152/ajpendo.00492.2002\")), list(REFERENCE = \"PMID:24692138\", AUTHORS = \"Rui L\", TITLE = \"Energy metabolism in the liver.\", JOURNAL = c(\"Compr Physiol 4:177-97 (2014)\", \"DOI:10.1002/cphy.c130024\")), list(REFERENCE = \"PMID:22004992\", AUTHORS = \"Jitrapakdee S\", TITLE = \"Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis.\", JOURNAL = c(\"Int J Biochem Cell Biol 44:33-45 (2012)\", \"DOI:10.1016/j.biocel.2011.10.001\")), list(REFERENCE = \"PMID:16601267\", AUTHORS = \"Desvergne B, Michalik L, Wahli W.\", TITLE = \"Transcriptional regulation of metabolism.\", JOURNAL = c(\"Physiol Rev 86:465-514 (2006)\", \"DOI:10.1152/physrev.00025.2005\")), list(REFERENCE = \"PMID:22550228\", AUTHORS = \"Hardie DG\", TITLE = \"Organismal carbohydrate and lipid homeostasis.\", JOURNAL = c(\"Cold Spring Harb Perspect Biol 4:a006031 (2012)\", \"DOI:10.1101/cshperspect.a006031\")), list(REFERENCE = \"PMID:22796337\", AUTHORS = \"Hasenour CM, Berglund ED, Wasserman DH\", TITLE = \"Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver.\", JOURNAL = c(\"Mol Cell Endocrinol 366:152-62 (2013)\", \"DOI:10.1016/j.mce.2012.06.018\")), list(REFERENCE = \"PMID:18669612\", AUTHORS = \"Quesada I, Tuduri E, Ripoll C, Nadal A\", TITLE = \"Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes.\", JOURNAL = c(\"J Endocrinol 199:5-19 (2008)\", \"DOI:10.1677/JOE-08-0290\")), list(REFERENCE = \"PMID:24238363\", AUTHORS = \"Oh KJ, Han HS, Kim MJ, Koo SH\", TITLE = \"CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis.\", JOURNAL = c(\"BMB Rep 46:567-74 (2013)\", \"DOI:10.5483/BMBRep.2013.46.12.248\")), list(REFERENCE = \"PMID:16479585\", AUTHORS = \"Cheng A, Saltiel AR\", TITLE = \"More TORC for the gluconeogenic engine.\", JOURNAL = c(\"Bioessays 28:231-4 (2006)\", \"DOI:10.1002/bies.20375\")), list(REFERENCE = \"PMID:21346730\", AUTHORS = \"Altarejos JY, Montminy M\", TITLE = \"CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 12:141-51 (2011)\", \"DOI:10.1038/nrm3072\")), list(REFERENCE = \"PMID:24393785\", AUTHORS = \"Pernicova I, Korbonits M\", TITLE = \"Metformin--mode of action and clinical implications for diabetes and cancer.\", JOURNAL = c(\"Nat Rev Endocrinol 10:143-56 (2014)\", \"DOI:10.1038/nrendo.2013.256\")), list(REFERENCE = \"PMID:20735177\", AUTHORS = \"Hirota K, Fukamizu A\", TITLE = \"Transcriptional regulation of energy metabolism in the liver.\", JOURNAL = c(\"J Recept Signal Transduct Res 30:403-9 (2010)\", \"DOI:10.3109/10799893.2010.509730\")), list(REFERENCE = \"PMID:21941300\", AUTHORS = \"Chalkiadaki A, Guarente L\", TITLE = \"Metabolic signals regulate SIRT1 expression.\", JOURNAL = c(\"EMBO Rep 12:985-6 (2011)\", \"DOI:10.1038/embor.2011.179\")), list(REFERENCE = \"PMID:22249520\", AUTHORS = \"Chalkiadaki A, Guarente L\", TITLE = \"Sirtuins mediate mammalian metabolic responses to nutrient availability.\", JOURNAL = c(\"Nat Rev Endocrinol 8:287-96 (2012)\", \"DOI:10.1038/nrendo.2011.225\")), list(REFERENCE = \"PMID:19912989\", AUTHORS = \"Tang BL, Chua CE\", TITLE = \"Is systemic activation of Sirt1 beneficial for ageing-associated metabolic disorders?\", JOURNAL = c(\"Biochem Biophys Res Commun 391:6-10 (2010)\", \"DOI:10.1016/j.bbrc.2009.11.016\")), list(REFERENCE = \"PMID:22503562\", AUTHORS = \"Ozcan L, Wong CC, Li G, Xu T, Pajvani U, Park SK, Wronska A, Chen BX, Marks AR, Fukamizu A, Backs J, Singer HA, Yates JR 3rd, Accili D, Tabas I\", TITLE = \"Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity.\", JOURNAL = c(\"Cell Metab 15:739-51 (2012)\", \"DOI:10.1016/j.cmet.2012.03.002\")), list(REFERENCE = \"PMID:22495310\", AUTHORS = \"Wang Y, Li G, Goode J, Paz JC, Ouyang K, Screaton R, Fischer WH, Chen J, Tabas I, Montminy M\", TITLE = \"Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes.\", JOURNAL = c(\"Nature 485:128-32 (2012)\", \"DOI:10.1038/nature10988\"))', 'map04922', 'Glucagon signaling pathway', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (355, '04923', 'Regulation of lipolysis in adipocytes', 'Lipolysis in adipocytes, the hydrolysis of triacylglycerol (TAG) to release fatty acids (FAs) and glycerol for use by other organs as energy substrates, is a unique function of white adipose tissue. Lipolysis is under tight hormonal control. During fasting, catecholamines, by binding to Gs-coupled-adrenergic receptors (-AR), activate adenylate cyclase (AC) to increase cAMP and activate protein kinase A (PKA). PKA phosphorylates target protein such as hormone-sensitive lipase (HSL) and perilipin 1 (PLIN). PLIN phosphorylation is a key event in the sequential activation of TAG hydrolysis involving adipose triglyceride lipase (ATGL), HSL, and monoglyceride lipase (MGL). During the fed state, insulin, through activation of phosphodiesterase-3B (PDE-3B), inhibits catecholamine-induced lipolysis via the degradation of cAMP.', 'Organismal Systems; Endocrine system', 'Regulation of lipolysis in adipocytes', 'Familial partial lipodystrophy, Dorfman-Chanarin syndrome, Neutral lipid storage disease with myopathy, Genetic obesity', 'GO: 0016042', 'ko04923', 'list(REFERENCE = \"PMID:20025992\", AUTHORS = \"Ahmadian M, Wang Y, Sul HS\", TITLE = \"Lipolysis in adipocytes.\", JOURNAL = c(\"Int J Biochem Cell Biol 42:555-9 (2010)\", \"DOI:10.1016/j.biocel.2009.12.009\")), list(REFERENCE = \"PMID:19796963\", AUTHORS = \"Ahmadian M, Duncan RE, Sul HS\", TITLE = \"The skinny on fat: lipolysis and fatty acid utilization in adipocytes.\", JOURNAL = c(\"Trends Endocrinol Metab 20:424-8 (2009)\", \"DOI:10.1016/j.tem.2009.06.002\")), list(REFERENCE = \"PMID:18762440\", AUTHORS = \"Wang S, Soni KG, Semache M, Casavant S, Fortier M, Pan L, Mitchell GA\", TITLE = \"Lipolysis and the integrated physiology of lipid energy metabolism.\", JOURNAL = c(\"Mol Genet Metab 95:117-26 (2008)\", \"DOI:10.1016/j.ymgme.2008.06.012\")), list(REFERENCE = \"PMID:21900692\", AUTHORS = \"Lafontan M\", TITLE = \"Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways.\", JOURNAL = c(\"Am J Physiol Cell Physiol 302:C327-59 (2012)\", \"DOI:10.1152/ajpcell.00168.2011\")), list(REFERENCE = \"PMID:24872083\", AUTHORS = \"Fruhbeck G, Mendez-Gimenez L, Fernandez-Formoso JA, Fernandez S, Rodriguez A\", TITLE = \"Regulation of adipocyte lipolysis.\", JOURNAL = c(\"Nutr Res Rev 27:63-93 (2014)\", \"DOI:10.1017/S095442241400002X\")), list(REFERENCE = \"PMID:24676492\", AUTHORS = \"Proenca AR, Sertie RA, Oliveira AC, Campana AB, Caminhotto RO, Chimin P, Lima FB\", TITLE = \"New concepts in white adipose tissue physiology.\", JOURNAL = c(\"Braz J Med Biol Res 47:192-205 (2014)\", \"DOI:10.1590/1414-431X20132911\")), list(REFERENCE = \"PMID:17313320\", AUTHORS = \"Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS\", TITLE = \"Regulation of lipolysis in adipocytes.\", JOURNAL = c(\"Annu Rev Nutr 27:79-101 (2007)\", \"DOI:10.1146/annurev.nutr.27.061406.093734\")), list(REFERENCE = \"PMID:19136990\", AUTHORS = \"Lafontan M\", TITLE = \"Advances in adipose tissue metabolism.\", JOURNAL = c(\"Int J Obes (Lond) 32 Suppl 7:S39-51 (2008)\", \"DOI:10.1038/ijo.2008.237\")), list(REFERENCE = \"PMID:17218471\", AUTHORS = \"Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS\", TITLE = \"Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue.\", JOURNAL = c(\"Am J Physiol Gastrointest Liver Physiol 293:G1-4 (2007)\", \"DOI:10.1152/ajpgi.00554.2006\")), list(REFERENCE = \"PMID:22298655\", AUTHORS = \"Thompson D, Karpe F, Lafontan M, Frayn K\", TITLE = \"Physical activity and exercise in the regulation of human adipose tissue physiology.\", JOURNAL = c(\"Physiol Rev 92:157-91 (2012)\", \"DOI:10.1152/physrev.00012.2011\")), list(REFERENCE = \"PMID:19464318\", AUTHORS = \"Lafontan M, Langin D\", TITLE = \"Lipolysis and lipid mobilization in human adipose tissue.\", JOURNAL = c(\"Prog Lipid Res 48:275-97 (2009)\", \"DOI:10.1016/j.plipres.2009.05.001\")), list(REFERENCE = \"PMID:24731595\", AUTHORS = \"Arner P, Langin D\", TITLE = \"Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance.\", JOURNAL = c(\"Trends Endocrinol Metab 25:255-62 (2014)\", \"DOI:10.1016/j.tem.2014.03.002\")), list(REFERENCE = \"PMID:17878492\", AUTHORS = \"Brasaemle DL\", TITLE = \"Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis.\", JOURNAL = c(\"J Lipid Res 48:2547-59 (2007)\", \"DOI:10.1194/jlr.R700014-JLR200\")), list(REFERENCE = \"PMID:21241784\", AUTHORS = \"Lampidonis AD, Rogdakis E, Voutsinas GE, Stravopodis DJ\", TITLE = \"The resurgence of Hormone-Sensitive Lipase (HSL) in mammalian lipolysis.\", JOURNAL = c(\"Gene 477:1-11 (2011)\", \"DOI:10.1016/j.gene.2011.01.007\")), list(REFERENCE = \"PMID:19375517\", AUTHORS = \"Bickel PE, Tansey JT, Welte MA\", TITLE = \"PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores.\", JOURNAL = c(\"Biochim Biophys Acta 1791:419-40 (2009)\", \"DOI:10.1016/j.bbalip.2009.04.002\"))', 'map04923', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (356, '04924', 'Renin secretion', 'The aspartyl-protease renin is the key regulator of the renin-angiotensin-aldosterone system, which is critically involved in extracellular fluid volume and blood pressure homeostasis of the body. Renin is synthesized, stored in, and released into circulation by the juxtaglomerular (JG) cells of the kidney. Secretion of renin from JG cells at the organ level is controlled by the four main mechanisms: the sympathetic nervous system, the local JG apparatus baroreflex, the macula densa mechanism, and several hormones acting locally within the JG apparatus. Renin secretion at the level of renal JG cells appears to be controlled mainly by classic second messengers, namely cAMP, cGMP, and free cytosolic calcium concentration. While cAMP generally stimulates renin release and the intracellular calcium concentration suppresses the exocytosis of renin, the effects of cGMP in the regulation of the renin system are more complex as it both may stimulate or inhibit renin release.', 'Organismal Systems; Endocrine system', 'Renin secretion', 'GO: 0002001', 'ko04924', 'list(REFERENCE = \"PMID:20936939\", AUTHORS = \"Kurtz A\", TITLE = \"Renin release: sites, mechanisms, and control.\", JOURNAL = c(\"Annu Rev Physiol 73:377-99 (2011)\", \"DOI:10.1146/annurev-physiol-012110-142238\")), list(REFERENCE = \"PMID:17928544\", AUTHORS = \"Schweda F, Friis U, Wagner C, Skott O, Kurtz A\", TITLE = \"Renin release.\", JOURNAL = c(\"Physiology (Bethesda) 22:310-9 (2007)\", \"DOI:10.1152/physiol.00024.2007\")), list(REFERENCE = \"PMID:20393195\", AUTHORS = \"Castrop H, Hocherl K, Kurtz A, Schweda F, Todorov V, Wagner C\", TITLE = \"Physiology of kidney renin.\", JOURNAL = c(\"Physiol Rev 90:607-73 (2010)\", \"DOI:10.1152/physrev.00011.2009\")), list(REFERENCE = \"PMID:22733355\", AUTHORS = \"Friis UG, Madsen K, Stubbe J, Hansen PB, Svenningsen P, Bie P, Skott O, Jensen BL\", TITLE = \"Regulation of renin secretion by renal juxtaglomerular cells.\", JOURNAL = c(\"Pflugers Arch 465:25-37 (2013)\", \"DOI:10.1007/s00424-012-1126-7\")), list(REFERENCE = \"PMID:22124804\", AUTHORS = \"Kim SM, Briggs JP, Schnermann J\", TITLE = \"Convergence of major physiological stimuli for renin release on the Gs-alpha/cyclic adenosine monophosphate signaling pathway.\", JOURNAL = c(\"Clin Exp Nephrol 16:17-24 (2012)\", \"DOI:10.1007/s10157-011-0494-1\")), list(REFERENCE = \"PMID:22237158\", AUTHORS = \"Kurtz A\", TITLE = \"Control of renin synthesis and secretion.\", JOURNAL = c(\"Am J Hypertens 25:839-47 (2012)\", \"DOI:10.1038/ajh.2011.246\")), list(REFERENCE = \"PMID:9882634\", AUTHORS = \"Kurtz A, Wagner C\", TITLE = \"Cellular control of renin secretion.\", JOURNAL = \"J Exp Biol 202:219-25 (1999)\"), list(REFERENCE = \"PMID:12949225\", AUTHORS = \"Persson PB\", TITLE = \"Renin: origin, secretion and synthesis.\", JOURNAL = c(\"J Physiol 552:667-71 (2003)\", \"DOI:10.1113/jphysiol.2003.049890\")), list(REFERENCE = \"PMID:15283749\", AUTHORS = \"Schweda F, Kurtz A\", TITLE = \"Cellular mechanism of renin release.\", JOURNAL = c(\"Acta Physiol Scand 181:383-90 (2004)\", \"DOI:10.1111/j.1365-201X.2004.01309.x\")), list(REFERENCE = \"PMID:24944035\", AUTHORS = \"Sparks MA, Crowley SD, Gurley SB, Mirotsou M, Coffman TM\", TITLE = \"Classical Renin-Angiotensin system in kidney physiology.\", JOURNAL = c(\"Compr Physiol 4:1201-28 (2014)\", \"DOI:10.1002/cphy.c130040\")), list(REFERENCE = \"PMID:19948673\", AUTHORS = \"Harrison-Bernard LM\", TITLE = \"The renal renin-angiotensin system.\", JOURNAL = c(\"Adv Physiol Educ 33:270-4 (2009)\", \"DOI:10.1152/advan.00049.2009\")), list(REFERENCE = \"PMID:22258323\", AUTHORS = \"Schnermann J, Briggs JP\", TITLE = \"Synthesis and secretion of renin in mice with induced genetic mutations.\", JOURNAL = c(\"Kidney Int 81:529-38 (2012)\", \"DOI:10.1038/ki.2011.451\")), list(REFERENCE = \"PMID:12388321\", AUTHORS = \"Ryan MJ, Black TA, Millard SL, Gross KW, Hajduczok G\", TITLE = \"Endothelin-1 increases calcium and attenuates renin gene expression in As4.1 cells.\", JOURNAL = c(\"Am J Physiol Heart Circ Physiol 283:H2458-65 (2002)\", \"DOI:10.1152/ajpheart.00295.2002\")), list(REFERENCE = \"PMID:17360952\", AUTHORS = \"Hautmann M, Friis UG, Desch M, Todorov V, Castrop H, Segerer F, Otto C, Schutz G, Schweda F\", TITLE = \"Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors.\", JOURNAL = c(\"J Am Soc Nephrol 18:1150-6 (2007)\", \"DOI:10.1681/ASN.2006060633\"))', 'map04924', 'Renin secretion', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (357, '04925', 'Aldosterone synthesis and secretion', 'Aldosterone is a steroid hormone synthesized in and secreted from the outer layer of the adrenal cortex, the zona glomerulosa. Aldosterone plays an important role in the regulation of systemic blood pressure through the absorption of sodium and water. Angiotensin II (Ang II), potassium (K+) and adrenocorticotropin (ACTH) are the main extracellular stimuli which regulate aldosterone secretion. These physiological agonists all converge on two major intracellular signaling pathways: calcium (Ca2+) mobilization and an increase in cAMP production. The increase in cytosolic calcium levels activates calcium/calmodulin- dependent protein kinases (CaMK), and the increased cAMP levels stimulate the activity of cAMP-dependent protein kinase, or protein kinase A (PKA). The activated CaMK, and possibly PKA, activates transcription factors (NURR1 and NGF1B, CREB) to induce StAR and CYP11B2 expression, the early and late rate- limiting steps in aldosterone biosynthesis, respectively, thereby stimulating aldosterone secretion.', 'Organismal Systems; Endocrine system', 'Aldosterone synthesis and secretion', 'GO: 0035932', 'ko04925', 'list(REFERENCE = \"PMID:21839803\", AUTHORS = \"Hattangady NG, Olala LO, Bollag WB, Rainey WE\", TITLE = \"Acute and chronic regulation of aldosterone production.\", JOURNAL = c(\"Mol Cell Endocrinol 350:151-62 (2012)\", \"DOI:10.1016/j.mce.2011.07.034\")), list(REFERENCE = \"PMID:24944029\", AUTHORS = \"Bollag WB\", TITLE = \"Regulation of aldosterone synthesis and secretion.\", JOURNAL = c(\"Compr Physiol 4:1017-55 (2014)\", \"DOI:10.1002/cphy.c130037\")), list(REFERENCE = \"PMID:15044681\", AUTHORS = \"Spat A, Hunyady L\", TITLE = \"Control of aldosterone secretion: a model for convergence in cellular signaling pathways.\", JOURNAL = c(\"Physiol Rev 84:489-539 (2004)\", \"DOI:10.1152/physrev.00030.2003\")), list(REFERENCE = \"PMID:18406824\", AUTHORS = \"Boon WC, Coghlan JP, Curnow KM, McDougall JG\", TITLE = \"Aldosterone secretion: a molecular perspective.\", JOURNAL = c(\"Trends Endocrinol Metab 8:346-54 (1997)\", \"DOI:10.1016/S1043-2760(97)00136-7\")), list(REFERENCE = \"PMID:14645496\", AUTHORS = \"Bassett MH, Suzuki T, Sasano H, White PC, Rainey WE\", TITLE = \"The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production.\", JOURNAL = c(\"Mol Endocrinol 18:279-90 (2004)\", \"DOI:10.1210/me.2003-0005\")), list(REFERENCE = \"PMID:22689262\", AUTHORS = \"Guagliardo NA, Yao J, Hu C, Barrett PQ\", TITLE = \"Minireview: aldosterone biosynthesis: electrically gated for our protection.\", JOURNAL = c(\"Endocrinology 153:3579-86 (2012)\", \"DOI:10.1210/en.2012-1339\")), list(REFERENCE = \"PMID:22364774\", AUTHORS = \"Spat A, Fulop L, Szanda G\", TITLE = \"The role of mitochondrial Ca(2+) and NAD(P)H in the control of aldosterone secretion.\", JOURNAL = c(\"Cell Calcium 52:64-72 (2012)\", \"DOI:10.1016/j.ceca.2012.01.009\")), list(REFERENCE = \"PMID:22395411\", AUTHORS = \"Spat A, Szanda G\", TITLE = \"Special features of mitochondrial Ca(2)(+) signalling in adrenal glomerulosa cells.\", JOURNAL = c(\"Pflugers Arch 464:43-50 (2012)\", \"DOI:10.1007/s00424-012-1086-y\")), list(REFERENCE = \"PMID:21962440\", AUTHORS = \"Tsai LC, Beavo JA\", TITLE = \"The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.\", JOURNAL = c(\"Curr Opin Pharmacol 11:670-5 (2011)\", \"DOI:10.1016/j.coph.2011.09.003\")), list(REFERENCE = \"PMID:10536682\", AUTHORS = \"Delcayre C, Silvestre JS\", TITLE = \"Aldosterone and the heart: towards a physiological function?\", JOURNAL = c(\"Cardiovasc Res 43:7-12 (1999)\", \"DOI:10.1016/S0008-6363(99)00088-7\")), list(REFERENCE = \"PMID:15026188\", AUTHORS = \"Lisurek M, Bernhardt R\", TITLE = \"Modulation of aldosterone and cortisol synthesis on the molecular level.\", JOURNAL = c(\"Mol Cell Endocrinol 215:149-59 (2004)\", \"DOI:10.1016/j.mce.2003.11.008\")), list(REFERENCE = \"PMID:23628605\", AUTHORS = \"Miller WL\", TITLE = \"Steroid hormone synthesis in mitochondria.\", JOURNAL = c(\"Mol Cell Endocrinol 379:62-73 (2013)\", \"DOI:10.1016/j.mce.2013.04.014\")), list(REFERENCE = \"PMID:25788893\", AUTHORS = \"Martinez-Arguelles DB, Papadopoulos V\", TITLE = \"Mechanisms mediating environmental chemical-induced endocrine disruption in the adrenal gland.\", JOURNAL = c(\"Front Endocrinol (Lausanne) 6:29 (2015)\", \"DOI:10.3389/fendo.2015.00029\"))', 'map04925', 'Aldosterone synthesis and secretion', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (358, '04926', 'Relaxin signaling pathway', 'Human relaxin-2 (\"relaxin\"), originally identified as a peptidic hormone of pregnancy, is now known to exert a range of pleiotropic effects including vasodilatory, anti-fibrotic and angiogenic effects in both males and females. It belongs to the so-called relaxin peptide family which includes the insulin-like peptides INSL3 and INSL5, and relaxin-3 (H3) as well as relaxin. INSL3 has clearly defined specialist roles in male and female reproduction, relaxin-3 is primarily a neuropeptide involved in stress and metabolic control, and INSL5 is widely distributed particularly in the gastrointestinal tract. These members of relaxin peptide family exert such effects binding to different kinds of receptors, classified as relaxin family peptide (RXFP) receptors: RXFP1, RXFP2, RXFP3, and RXFP4. These G protein-coupled receptors predominantly bind relaxin, INSL3, relaxin-3, and INSL-5, respectively. RXFP1 activates a wide spectrum of signaling pathways to generate second messengers that include cAMP and nitric oxide, whereas RXFP2 activates a subset of these pathways. Both RXFP3 and RXFP4 inhibit cAMP production, and RXFP3 activate MAP kinases.', 'Organismal Systems; Endocrine system', 'Relaxin signaling pathway', 'Ehlers-Danlos syndrome cardiac valvular type, Ehlers-Danlos syndrome vascular type, Ehlers-Danlos syndrome arthrochalasia type', 'ko04926', 'list(REFERENCE = \"PMID:23303914\", AUTHORS = \"Bathgate RA, Halls ML, van der Westhuizen ET, Callander GE, Kocan M, Summers RJ\", TITLE = \"Relaxin family peptides and their receptors.\", JOURNAL = c(\"Physiol Rev 93:405-80 (2013)\", \"DOI:10.1152/physrev.00001.2012\")), list(REFERENCE = \"PMID:23401142\", AUTHORS = \"Cernaro V, Lacquaniti A, Lupica R, Buemi A, Trimboli D, Giorgianni G, Bolignano D, Buemi M\", TITLE = \"Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.\", JOURNAL = c(\"Med Res Rev 34:77-105 (2014)\", \"DOI:10.1002/med.21277\")), list(REFERENCE = \"PMID:18675759\", AUTHORS = \"van der Westhuizen ET, Halls ML, Samuel CS, Bathgate RA, Unemori EN, Sutton SW, Summers RJ\", TITLE = \"Relaxin family peptide receptors--from orphans to therapeutic targets.\", JOURNAL = c(\"Drug Discov Today 13:640-51 (2008)\", \"DOI:10.1016/j.drudis.2008.04.002\")), list(REFERENCE = \"PMID:17293890\", AUTHORS = \"Halls ML, van der Westhuizen ET, Bathgate RA, Summers RJ\", TITLE = \"Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.\", JOURNAL = c(\"Br J Pharmacol 150:677-91 (2007)\", \"DOI:10.1038/sj.bjp.0707140\")), list(REFERENCE = \"PMID:16507880\", AUTHORS = \"Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ\", TITLE = \"International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.\", JOURNAL = c(\"Pharmacol Rev 58:7-31 (2006)\", \"DOI:10.1124/pr.58.1.9\")), list(REFERENCE = \"PMID:19935741\", AUTHORS = \"Du XJ, Bathgate RA, Samuel CS, Dart AM, Summers RJ\", TITLE = \"Cardiovascular effects of relaxin: from basic science to clinical therapy.\", JOURNAL = c(\"Nat Rev Cardiol 7:48-58 (2010)\", \"DOI:10.1038/nrcardio.2009.198\")), list(REFERENCE = \"PMID:12646076\", AUTHORS = \"Nistri S, Bani D\", TITLE = \"Relaxin receptors and nitric oxide synthases: search for the missing link.\", JOURNAL = \"Reprod Biol Endocrinol 1:5 (2003)\"), list(REFERENCE = \"PMID:17458501\", AUTHORS = \"Samuel CS, Hewitson TD, Unemori EN, Tang ML\", TITLE = \"Drugs of the future: the hormone relaxin.\", JOURNAL = c(\"Cell Mol Life Sci 64:1539-57 (2007)\", \"DOI:10.1007/s00018-007-6543-y\")), list(REFERENCE = \"PMID:23883673\", AUTHORS = \"Sasser JM\", TITLE = \"The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.\", JOURNAL = c(\"Am J Physiol Regul Integr Comp Physiol 305:R559-65 (2013)\", \"DOI:10.1152/ajpregu.00528.2012\")), list(REFERENCE = \"PMID:27239943\", AUTHORS = \"Sarwar M, Du XJ, Dschietzig TB, Summers RJ\", TITLE = \"The actions of relaxin on the human cardiovascular system.\", JOURNAL = c(\"Br J Pharmacol 174:933-949 (2017)\", \"DOI:10.1111/bph.13523\")), list(REFERENCE = \"PMID:15956688\", AUTHORS = \"Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ\", TITLE = \"Receptors for relaxin family peptides.\", JOURNAL = c(\"Ann N Y Acad Sci 1041:61-76 (2005)\", \"DOI:10.1196/annals.1282.010\")), list(REFERENCE = \"PMID:22936987\", AUTHORS = \"Chow BS, Chew EG, Zhao C, Bathgate RA, Hewitson TD, Samuel CS\", TITLE = \"Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.\", JOURNAL = c(\"PLoS One 7:e42714 (2012)\", \"DOI:10.1371/journal.pone.0042714\")), list(REFERENCE = \"PMID:16814863\", AUTHORS = \"Samuel CS, Du XJ, Bathgate RA, Summers RJ\", TITLE = \"\'Relaxin\' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease.\", JOURNAL = c(\"Pharmacol Ther 112:529-52 (2006)\", \"DOI:10.1016/j.pharmthera.2005.05.012\")), list(REFERENCE = \"PMID:25759289\", AUTHORS = \"Wilson SS, Ayaz SI, Levy PD\", TITLE = \"Relaxin: a novel agent for the treatment of acute heart failure.\", JOURNAL = c(\"Pharmacotherapy 35:315-27 (2015)\", \"DOI:10.1002/phar.1548\")), list(REFERENCE = \"PMID:16569707\", AUTHORS = \"Halls ML, Bathgate RA, Summers RJ\", TITLE = \"Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.\", JOURNAL = c(\"Mol Pharmacol 70:214-26 (2006)\", \"DOI:10.1124/mol.105.021691\")), list(REFERENCE = \"PMID:26294284\", AUTHORS = \"Kocan M, Ang SY, Summers RJ\", TITLE = \"Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3.\", JOURNAL = c(\"Neurochem Res 41:610-9 (2016)\", \"DOI:10.1007/s11064-015-1701-3\")), list(REFERENCE = \"PMID:17351017\", AUTHORS = \"van der Westhuizen ET, Werry TD, Sexton PM, Summers RJ\", TITLE = \"The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.\", JOURNAL = c(\"Mol Pharmacol 71:1618-29 (2007)\", \"DOI:10.1124/mol.106.032763\"))', 'map04926', 'Relaxin signaling pathway', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (359, '04927', 'Cortisol synthesis and secretion', 'Cortisol is the main endogenous glucocorticoid, which affects a plethora of physiological functions, e.g., lipid and glucose metabolism, metabolic homeostasis and adaptation to stress. Cortisol production is primarily regulated by corticotropin (ACTH) in zona fasciculata. The stimulatory effect of ACTH on cortisol synthesis depends on cAMP dependent signaling, but also involves membrane depolarization and increased cytosolic Ca2+. Each of cAMP and Ca2+ induces the expression of StAR, stimulating intramitochondrial cholesterol transfer, as well as the steroidogenic enzymes in the pathway from cholesterol to cortisol (e.g., CHE, CYP17A1, CYP11B1).', 'Organismal Systems; Endocrine system', 'Cortisol synthesis and secretion', 'Adrenal insufficiency, NR5A1 related', 'GO: 0043400', 'ko04927', 'list(REFERENCE = \"PMID:24944026\", AUTHORS = \"Gallo-Payet N, Battista MC\", TITLE = \"Steroidogenesis-adrenal cell signal transduction.\", JOURNAL = c(\"Compr Physiol 4:889-964 (2014)\", \"DOI:10.1002/cphy.c130050\")), list(REFERENCE = \"PMID:15727807\", AUTHORS = \"Enyeart JJ\", TITLE = \"Biochemical and Ionic signaling mechanisms for ACTH-stimulated cortisol production.\", JOURNAL = c(\"Vitam Horm 70:265-79 (2005)\", \"DOI:10.1016/S0083-6729(05)70008-X\")), list(REFERENCE = \"PMID:25339223\", AUTHORS = \"Bandulik S, Tauber P, Lalli E, Barhanin J, Warth R\", TITLE = \"Two-pore domain potassium channels in the adrenal cortex.\", JOURNAL = c(\"Pflugers Arch 467:1027-42 (2015)\", \"DOI:10.1007/s00424-014-1628-6\")), list(REFERENCE = \"PMID:17494631\", AUTHORS = \"Liu H, Enyeart JA, Enyeart JJ\", TITLE = \"Angiotensin II inhibits native bTREK-1 K+ channels through a PLC-, kinase C-, and PIP2-independent pathway requiring ATP hydrolysis.\", JOURNAL = c(\"Am J Physiol Cell Physiol 293:C682-95 (2007)\", \"DOI:10.1152/ajpcell.00087.2007\")), list(REFERENCE = \"PMID:15994319\", AUTHORS = \"Enyeart JJ, Danthi SJ, Liu H, Enyeart JA\", TITLE = \"Angiotensin II inhibits bTREK-1 K+ channels in adrenocortical cells by separate Ca2+- and ATP hydrolysis-dependent mechanisms.\", JOURNAL = c(\"J Biol Chem 280:30814-28 (2005)\", \"DOI:10.1074/jbc.M504283200\")), list(REFERENCE = \"PMID:27242666\", AUTHORS = \"Shen WJ, Azhar S, Kraemer FB\", TITLE = \"ACTH Regulation of Adrenal SR-B1.\", JOURNAL = c(\"Front Endocrinol (Lausanne) 7:42 (2016)\", \"DOI:10.3389/fendo.2016.00042\")), list(REFERENCE = \"PMID:27065945\", AUTHORS = \"Ruggiero C, Lalli E\", TITLE = \"Impact of ACTH Signaling on Transcriptional Regulation of Steroidogenic Genes.\", JOURNAL = c(\"Front Endocrinol (Lausanne) 7:24 (2016)\", \"DOI:10.3389/fendo.2016.00024\")), list(REFERENCE = \"PMID:25905342\", AUTHORS = \"Margioris AN, Tsatsanis C\", TITLE = \"ACTH Action on the Adrenals\", JOURNAL = \"(2000)\"), list(REFERENCE = \"PMID:25662280\", AUTHORS = \"Spiga F, Lightman SL\", TITLE = \"Dynamics of adrenal glucocorticoid steroidogenesis in health and disease.\", JOURNAL = c(\"Mol Cell Endocrinol 408:227-34 (2015)\", \"DOI:10.1016/j.mce.2015.02.005\")), list(REFERENCE = \"PMID:21962440\", AUTHORS = \"Tsai LC, Beavo JA\", TITLE = \"The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.\", JOURNAL = c(\"Curr Opin Pharmacol 11:670-5 (2011)\", \"DOI:10.1016/j.coph.2011.09.003\")), list(REFERENCE = \"PMID:26807866\", AUTHORS = \"Odermatt A, Strajhar P, Engeli RT\", TITLE = \"Disruption of steroidogenesis: Cell models for mechanistic investigations and as screening tools.\", JOURNAL = c(\"J Steroid Biochem Mol Biol 158:9-21 (2016)\", \"DOI:10.1016/j.jsbmb.2016.01.009\")), list(REFERENCE = \"PMID:26271515\", AUTHORS = \"Manna PR, Stetson CL, Slominski AT, Pruitt K\", TITLE = \"Role of the steroidogenic acute regulatory protein in health and disease.\", JOURNAL = c(\"Endocrine 51:7-21 (2016)\", \"DOI:10.1007/s12020-015-0715-6\")), list(REFERENCE = \"PMID:26113808\", AUTHORS = \"Jackson DS, Ramachandrappa S, Clark AJ, Chan LF\", TITLE = \"Melanocortin receptor accessory proteins in adrenal disease and obesity.\", JOURNAL = c(\"Front Neurosci 9:213 (2015)\", \"DOI:10.3389/fnins.2015.00213\")), list(REFERENCE = \"PMID:23410915\", AUTHORS = \"Cerda-Reverter JM, Agulleiro MJ, Cortes R, Sanchez E, Guillot R, Leal E, Fernandez-Duran B, Puchol S, Eley M\", TITLE = \"Involvement of melanocortin receptor accessory proteins (MRAPs) in the function of melanocortin receptors.\", JOURNAL = c(\"Gen Comp Endocrinol 188:133-6 (2013)\", \"DOI:10.1016/j.ygcen.2013.01.017\")), list(REFERENCE = \"PMID:23858003\", AUTHORS = \"Enyeart JJ, Enyeart JA\", TITLE = \"Ca2+ and K+ channels of normal human adrenal zona fasciculata cells: properties and modulation by ACTH and AngII.\", JOURNAL = c(\"J Gen Physiol 142:137-55 (2013)\", \"DOI:10.1085/jgp.201310964\")), list(REFERENCE = \"PMID:27524977\", AUTHORS = \"Midzak A, Papadopoulos V\", TITLE = \"Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies.\", JOURNAL = c(\"Front Endocrinol (Lausanne) 7:106 (2016)\", \"DOI:10.3389/fendo.2016.00106\")), list(REFERENCE = \"PMID:26139209\", AUTHORS = \"Calebiro D, Di Dalmazi G, Bathon K, Ronchi CL, Beuschlein F\", TITLE = \"cAMP signaling in cortisol-producing adrenal adenoma.\", JOURNAL = c(\"Eur J Endocrinol 173:M99-106 (2015)\", \"DOI:10.1530/EJE-15-0353\")), list(REFERENCE = \"PMID:26038201\", AUTHORS = \"Turcu AF, Auchus RJ\", TITLE = \"Adrenal steroidogenesis and congenital adrenal hyperplasia.\", JOURNAL = c(\"Endocrinol Metab Clin North Am 44:275-96 (2015)\", \"DOI:10.1016/j.ecl.2015.02.002\"))', 'map04927', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (360, '04928', 'Parathyroid hormone synthesis, secretion and action', 'Parathyroid hormone (PTH) is a key regulator of calcium and phosphorus homeostasis. The principal regulators of PTH secretion are extracellular ionized calcium (Ca2+) and 1,25-dihydroxyvitamin D (1,25(OH)2D3). Under conditions of dietary Ca restriction, a decrement in serum Ca concentration induces release of PTH from the parathyroid gland. PTH acts on bone and kidney to stimulate bone turnover, increase the circulating levels of 1,25(OH)2D3 and calcium and inhibit the reabsorption of phosphate from the glomerular filtrate. This hormone exerts its actions via binding to the PTH/PTH-related peptide receptor (PTH1R). PTH1R primarily activates two sub-types of heterotrimeric Gproteins: Gs and Gq , which in turn regulate the activity of adenylyl cyclases and phospholipase C (PLC) that control the flow of cAMP/PKA and IP/PKC signaling cascades, respectively.', 'Organismal Systems; Endocrine system', 'Parathyroid hormone synthesis, secretion and action', 'Hereditary hypophophatemic rickets with hypercalciuria, Acrodysostosis', 'ko04928', 'list(REFERENCE = \"PMID:27065162\", AUTHORS = \"Khundmiri SJ, Murray RD, Lederer E\", TITLE = \"PTH and Vitamin D.\", JOURNAL = c(\"Compr Physiol 6:561-601 (2016)\", \"DOI:10.1002/cphy.c140071\")), list(REFERENCE = \"PMID:28363951\", AUTHORS = \"Bastepe M, Turan S, He Q\", TITLE = \"Heterotrimeric G proteins in the control of parathyroid hormone actions.\", JOURNAL = c(\"J Mol Endocrinol 58:R203-R224 (2017)\", \"DOI:10.1530/JME-16-0221\")), list(REFERENCE = \"PMID:20703892\", AUTHORS = \"Vilardaga JP, Romero G, Friedman PA, Gardella TJ\", TITLE = \"Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.\", JOURNAL = c(\"Cell Mol Life Sci 68:1-13 (2011)\", \"DOI:10.1007/s00018-010-0465-9\")), list(REFERENCE = \"PMID:29291826\", AUTHORS = \"Naveh-Many T, Silver J\", TITLE = \"Transcription factors that determine parathyroid development power PTH expression.\", JOURNAL = c(\"Kidney Int 93:7-9 (2018)\", \"DOI:10.1016/j.kint.2017.08.026\")), list(REFERENCE = \"PMID:25917456\", AUTHORS = \"Han SI, Tsunekage Y, Kataoka K\", TITLE = \"Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1.\", JOURNAL = c(\"Mol Cell Endocrinol 411:113-20 (2015)\", \"DOI:10.1016/j.mce.2015.04.018\")), list(REFERENCE = \"PMID:22622503\", AUTHORS = \"Ferre S, Hoenderop JG, Bindels RJ\", TITLE = \"Sensing mechanisms involved in Ca2+ and Mg2+ homeostasis.\", JOURNAL = c(\"Kidney Int 82:1157-66 (2012)\", \"DOI:10.1038/ki.2012.179\")), list(REFERENCE = \"PMID:20010546\", AUTHORS = \"Komaba H, Fukagawa M\", TITLE = \"FGF23-parathyroid interaction: implications in chronic kidney disease.\", JOURNAL = c(\"Kidney Int 77:292-8 (2010)\", \"DOI:10.1038/ki.2009.466\")), list(REFERENCE = \"PMID:27194212\", AUTHORS = \"Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F\", TITLE = \"Primary hyperparathyroidism.\", JOURNAL = c(\"Nat Rev Dis Primers 2:16033 (2016)\", \"DOI:10.1038/nrdp.2016.33\")), list(REFERENCE = \"PMID:21576356\", AUTHORS = \"de Groot T, Kovalevskaya NV, Verkaart S, Schilderink N, Felici M, van der Hagen EA, Bindels RJ, Vuister GW, Hoenderop JG\", TITLE = \"Molecular mechanisms of calmodulin action on TRPV5 and modulation by parathyroid hormone.\", JOURNAL = c(\"Mol Cell Biol 31:2845-53 (2011)\", \"DOI:10.1128/MCB.01319-10\")), list(REFERENCE = \"PMID:17975663\", AUTHORS = \"Hernando N, Wagner C, Biber J, Murer H\", TITLE = \"Kidney kinase network regulates renal ion cotransport.\", JOURNAL = c(\"J Clin Invest 117:3179-82 (2007)\", \"DOI:10.1172/JCI33859\")), list(REFERENCE = \"PMID:22628548\", AUTHORS = \"Wang B, Means CK, Yang Y, Mamonova T, Bisello A, Altschuler DL, Scott JD, Friedman PA\", TITLE = \"Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport.\", JOURNAL = c(\"J Biol Chem 287:24148-63 (2012)\", \"DOI:10.1074/jbc.M112.369405\")), list(REFERENCE = \"PMID:21097685\", AUTHORS = \"Crenshaw TD, Rortvedt LA, Hassen Z\", TITLE = \"Triennial Growth Symposium: a novel pathway for vitamin D-mediated phosphate homeostasis: implications for skeleton growth and mineralization.\", JOURNAL = c(\"J Anim Sci 89:1957-64 (2011)\", \"DOI:10.2527/jas.2010-3411\")), list(REFERENCE = \"PMID:11698670\", AUTHORS = \"Zierold C, Mings JA, DeLuca HF\", TITLE = \"Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 98:13572-6 (2001)\", \"DOI:10.1073/pnas.241516798\")), list(REFERENCE = \"PMID:20074973\", AUTHORS = \"Kramer I, Keller H, Leupin O, Kneissel M\", TITLE = \"Does osteocytic SOST suppression mediate PTH bone anabolism?\", JOURNAL = c(\"Trends Endocrinol Metab 21:237-44 (2010)\", \"DOI:10.1016/j.tem.2009.12.002\")), list(REFERENCE = \"PMID:17696759\", AUTHORS = \"Leupin O, Kramer I, Collette NM, Loots GG, Natt F, Kneissel M, Keller H\", TITLE = \"Control of the SOST bone enhancer by PTH using MEF2 transcription factors.\", JOURNAL = c(\"J Bone Miner Res 22:1957-67 (2007)\", \"DOI:10.1359/jbmr.070804\")), list(REFERENCE = \"PMID:24940803\", AUTHORS = \"Meir T, Durlacher K, Pan Z, Amir G, Richards WG, Silver J, Naveh-Many T\", TITLE = \"Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.\", JOURNAL = c(\"Kidney Int 86:1106-15 (2014)\", \"DOI:10.1038/ki.2014.215\")), list(REFERENCE = \"PMID:29413898\", AUTHORS = \"Pellicelli M, Hariri H, Miller JA, St-Arnaud R\", TITLE = \"Lrp6 is a target of the PTH-activated alphaNAC transcriptional coregulator.\", JOURNAL = c(\"Biochim Biophys Acta 1861:61-71 (2018)\", \"DOI:10.1016/j.bbagrm.2018.01.008\")), list(REFERENCE = \"PMID:12364326\", AUTHORS = \"Fu Q, Jilka RL, Manolagas SC, O\'Brien CA\", TITLE = \"Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.\", JOURNAL = c(\"J Biol Chem 277:48868-75 (2002)\", \"DOI:10.1074/jbc.M208494200\")), list(REFERENCE = \"PMID:19716455\", AUTHORS = \"O\'Brien CA\", TITLE = \"Control of RANKL gene expression.\", JOURNAL = c(\"Bone 46:911-9 (2010)\", \"DOI:10.1016/j.bone.2009.08.050\")), list(REFERENCE = \"PMID:17517365\", AUTHORS = \"Jilka RL\", TITLE = \"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.\", JOURNAL = c(\"Bone 40:1434-46 (2007)\", \"DOI:10.1016/j.bone.2007.03.017\")), list(REFERENCE = \"PMID:8810350\", AUTHORS = \"Pearman AT, Chou WY, Bergman KD, Pulumati MR, Partridge NC\", TITLE = \"Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE.\", JOURNAL = c(\"J Biol Chem 271:25715-21 (1996)\", \"DOI:10.1074/jbc.271.41.25715\")), list(REFERENCE = \"PMID:16164977\", AUTHORS = \"Boumah CE, Selvamurugan N, Partridge NC\", TITLE = \"Transcription in the osteoblast: regulatory mechanisms utilized by parathyroid hormone and transforming growth factor-beta.\", JOURNAL = c(\"Prog Nucleic Acid Res Mol Biol 80:287-321 (2005)\", \"DOI:10.1016/S0079-6603(05)80007-8\")), list(REFERENCE = \"PMID:11274169\", AUTHORS = \"Hess J, Porte D, Munz C, Angel P\", TITLE = \"AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1  composite element.\", JOURNAL = c(\"J Biol Chem 276:20029-38 (2001)\", \"DOI:10.1074/jbc.M010601200\")), list(REFERENCE = \"PMID:15705779\", AUTHORS = \"Singh AT, Gilchrist A, Voyno-Yasenetskaya T, Radeff-Huang JM, Stern PH\", TITLE = \"G alpha12/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells.\", JOURNAL = c(\"Endocrinology 146:2171-5 (2005)\", \"DOI:10.1210/en.2004-1283\")), list(REFERENCE = \"PMID:12738761\", AUTHORS = \"Ahmed I, Gesty-Palmer D, Drezner MK, Luttrell LM\", TITLE = \"Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.\", JOURNAL = c(\"Mol Endocrinol 17:1607-21 (2003)\", \"DOI:10.1210/me.2002-0040\")), list(REFERENCE = \"PMID:17107942\", AUTHORS = \"Sneddon WB, Yang Y, Ba J, Harinstein LM, Friedman PA\", TITLE = \"Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells.\", JOURNAL = c(\"Am J Physiol Renal Physiol 292:F1028-34 (2007)\", \"DOI:10.1152/ajprenal.00288.2006\"))', 'map04928', 'Parathyroid hormone synthesis, secretion and action', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (361, '04929', 'GnRH secretion', 'Hypothalamic gonadotropin-releasing hormone (GnRH) neurons are key regulators of reproduction. They release GnRH into the portal circulation. In turn, GnRH stimulates the pituitary gland to secrete follicle-stimulating hormone and luteinizing hormone (LH) to regulate gonadal functions. Gonadal steroids provide feedback to regulate GnRH release. GnRH neurons express the kisspeptin receptor, GPR 54, and kisspeptins potently stimulate the release of GnRH by depolarising and inducing sustained action potential firing in GnRH neurons. It is also demonstrated that Kisspeptin-GPR54 system positively regulates the GnRH expression  with a time course consistent with activation of Akt and MAP kinase signaling pathways.', 'Organismal Systems; Endocrine system', 'GnRH secretion', 'ko04929', 'list(REFERENCE = \"PMID:23550004\", AUTHORS = \"Ronnekleiv OK, Kelly MJ\", TITLE = \"Kisspeptin excitation of GnRH neurons.\", JOURNAL = c(\"Adv Exp Med Biol 784:113-31 (2013)\", \"DOI:10.1007/978-1-4614-6199-9_6\")), list(REFERENCE = \"PMID:24145132\", AUTHORS = \"Beltramo M, Dardente H, Cayla X, Caraty A\", TITLE = \"Cellular mechanisms and integrative timing of neuroendocrine control of GnRH secretion by kisspeptin.\", JOURNAL = c(\"Mol Cell Endocrinol 382:387-399 (2014)\", \"DOI:10.1016/j.mce.2013.10.015\")), list(REFERENCE = \"PMID:19770291\", AUTHORS = \"Oakley AE, Clifton DK, Steiner RA\", TITLE = \"Kisspeptin signaling in the brain.\", JOURNAL = c(\"Endocr Rev 30:713-43 (2009)\", \"DOI:10.1210/er.2009-0005\")), list(REFERENCE = \"PMID:22811428\", AUTHORS = \"Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M\", TITLE = \"Kisspeptins and reproduction: physiological roles and regulatory mechanisms.\", JOURNAL = c(\"Physiol Rev 92:1235-316 (2012)\", \"DOI:10.1152/physrev.00037.2010\")), list(REFERENCE = \"PMID:20699467\", AUTHORS = \"d\'Anglemont de Tassigny X, Colledge WH\", TITLE = \"The role of kisspeptin signaling in reproduction.\", JOURNAL = c(\"Physiology (Bethesda) 25:207-17 (2010)\", \"DOI:10.1152/physiol.00009.2010\")), list(REFERENCE = \"PMID:19464345\", AUTHORS = \"Tena-Sempere M\", TITLE = \"Kisspeptin signaling in the brain: recent developments and future challenges.\", JOURNAL = c(\"Mol Cell Endocrinol 314:164-9 (2010)\", \"DOI:10.1016/j.mce.2009.05.004\")), list(REFERENCE = \"PMID:19097915\", AUTHORS = \"Colledge WH\", TITLE = \"Kisspeptins and GnRH neuronal signalling.\", JOURNAL = c(\"Trends Endocrinol Metab 20:115-21 (2009)\", \"DOI:10.1016/j.tem.2008.10.005\")), list(REFERENCE = \"PMID:18793689\", AUTHORS = \"Roa J, Castellano JM, Navarro VM, Handelsman DJ, Pinilla L, Tena-Sempere M\", TITLE = \"Kisspeptins and the control of gonadotropin secretion in male and female rodents.\", JOURNAL = c(\"Peptides 30:57-66 (2009)\", \"DOI:10.1016/j.peptides.2008.08.009\")), list(REFERENCE = \"PMID:24907402\", AUTHORS = \"Piet R, de Croft S, Liu X, Herbison AE\", TITLE = \"Electrical properties of kisspeptin neurons and their regulation of GnRH neurons.\", JOURNAL = c(\"Front Neuroendocrinol 36:15-27 (2015)\", \"DOI:10.1016/j.yfrne.2014.05.006\")), list(REFERENCE = \"PMID:23744639\", AUTHORS = \"Zhang C, Bosch MA, Ronnekleiv OK, Kelly MJ\", TITLE = \"Kisspeptin activation of TRPC4 channels in female GnRH neurons requires PIP2 depletion and cSrc kinase activation.\", JOURNAL = c(\"Endocrinology 154:2772-83 (2013)\", \"DOI:10.1210/en.2013-1180\")), list(REFERENCE = \"PMID:20816765\", AUTHORS = \"Ronnekleiv OK, Bosch MA, Zhang C\", TITLE = \"Regulation of endogenous conductances in GnRH neurons by estrogens.\", JOURNAL = c(\"Brain Res 1364:25-34 (2010)\", \"DOI:10.1016/j.brainres.2010.08.096\")), list(REFERENCE = \"PMID:25612870\", AUTHORS = \"Ronnekleiv OK, Zhang C, Bosch MA, Kelly MJ\", TITLE = \"Kisspeptin and Gonadotropin-Releasing Hormone Neuronal Excitability: Molecular Mechanisms Driven by 17beta-Estradiol.\", JOURNAL = c(\"Neuroendocrinology 102:184-93 (2015)\", \"DOI:10.1159/000370311\")), list(REFERENCE = \"PMID:22343183\", AUTHORS = \"Zhang XB, Spergel DJ\", TITLE = \"Kisspeptin inhibits high-voltage activated Ca2+ channels in GnRH neurons via multiple Ca2+ influx and release pathways.\", JOURNAL = c(\"Neuroendocrinology 96:68-80 (2012)\", \"DOI:10.1159/000335985\")), list(REFERENCE = \"PMID:19576263\", AUTHORS = \"Novaira HJ, Ng Y, Wolfe A, Radovick S\", TITLE = \"Kisspeptin increases GnRH mRNA expression and secretion in GnRH secreting neuronal cell lines.\", JOURNAL = c(\"Mol Cell Endocrinol 311:126-34 (2009)\", \"DOI:10.1016/j.mce.2009.06.011\")), list(REFERENCE = \"PMID:25314270\", AUTHORS = \"Glanowska KM, Moenter SM\", TITLE = \"Differential regulation of GnRH secretion in the preoptic area (POA) and the median eminence (ME) in male mice.\", JOURNAL = c(\"Endocrinology 156:231-41 (2015)\", \"DOI:10.1210/en.2014-1458\")), list(REFERENCE = \"PMID:20886089\", AUTHORS = \"Szereszewski JM, Pampillo M, Ahow MR, Offermanns S, Bhattacharya M, Babwah AV\", TITLE = \"GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Galpha(q/11) and beta-arrestin-dependent manner.\", JOURNAL = c(\"PLoS One 5:e12964 (2010)\", \"DOI:10.1371/journal.pone.0012964\")), list(REFERENCE = \"PMID:19710308\", AUTHORS = \"Zhang C, Bosch MA, Rick EA, Kelly MJ, Ronnekleiv OK\", TITLE = \"17Beta-estradiol regulation of T-type calcium channels in gonadotropin-releasing hormone neurons.\", JOURNAL = c(\"J Neurosci 29:10552-62 (2009)\", \"DOI:10.1523/JNEUROSCI.2962-09.2009\")), list(REFERENCE = \"PMID:23880664\", AUTHORS = \"Terasaka T, Otsuka F, Tsukamoto N, Nakamura E, Inagaki K, Toma K, Ogura-Ochi K, Glidewell-Kenney C, Lawson MA, Makino H\", TITLE = \"Mutual interaction of kisspeptin, estrogen and bone morphogenetic protein-4 activity in GnRH regulation by GT1-7 cells.\", JOURNAL = c(\"Mol Cell Endocrinol 381:8-15 (2013)\", \"DOI:10.1016/j.mce.2013.07.009\")), list(REFERENCE = \"PMID:22654870\", AUTHORS = \"Radovick S, Levine JE, Wolfe A\", TITLE = \"Estrogenic regulation of the GnRH neuron.\", JOURNAL = c(\"Front Endocrinol (Lausanne) 3:52 (2012)\", \"DOI:10.3389/fendo.2012.00052\")), list(REFERENCE = \"PMID:16373418\", AUTHORS = \"Dungan HM, Clifton DK, Steiner RA\", TITLE = \"Minireview: kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion.\", JOURNAL = c(\"Endocrinology 147:1154-8 (2006)\", \"DOI:10.1210/en.2005-1282\")), list(REFERENCE = \"PMID:16627563\", AUTHORS = \"Kato M, Tanaka N, Usui S, Sakuma Y\", TITLE = \"The SK channel blocker apamin inhibits slow afterhyperpolarization currents in rat gonadotropin-releasing hormone neurones.\", JOURNAL = c(\"J Physiol 574:431-42 (2006)\", \"DOI:10.1113/jphysiol.2006.110155\")), list(REFERENCE = \"PMID:23548613\", AUTHORS = \"Zhang C, Ronnekleiv OK, Kelly MJ\", TITLE = \"Kisspeptin inhibits a slow afterhyperpolarization current via protein kinase C and reduces spike frequency adaptation in GnRH neurons.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 304:E1237-44 (2013)\", \"DOI:10.1152/ajpendo.00058.2013\"))', 'map04929', 'GnRH secretion', 'Hypothalamic gonadotropin-releasing hormone (GnRH) neurons are key regulators of reproduction. They release GnRH into the portal circulation. In turn, GnRH stimulates the pituitary gland to secrete follicle-stimulating hormone and luteinizing hormone (LH) to regulate gonadal functions. Gonadal steroids provide feedback to regulate GnRH release. GnRH neurons express the kisspeptin receptor, GPR 54, and kisspeptins potently stimulate the release of GnRH by depolarising and inducing sustained action potential firing in GnRH neurons. It is also demonstrated that Kisspeptin-GPR54 system positively regulates the GnRH expression  with a time course consistent with activation of Akt and MAP kinase signaling pathways.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (362, '04930', 'Type II diabetes mellitus', 'c(\"Insulin resistance is strongly associated with type II diabetes. \\\"Diabetogenic\\\" factors including FFA, TNFalpha and cellular stress induce insulin resistance through inhibition of IRS1 functions. Serine/threonine phosphorylation, interaction with SOCS, regulation of the expression, modification of the cellular localization, and degradation represent the molecular mechanisms stimulated by them. Various kinases (ERK, JNK, IKKbeta, PKCzeta, PKCtheta and mTOR) are involved in this process.\", \"The development of type II diabetes requires impaired beta-cell function. Chronic hyperglycemia has been shown to induce multiple defects in beta-cells. Hyperglycemia has been proposed to lead to large amounts of reactive oxygen species (ROS) in beta-cells, with subsequent damage to cellular components including PDX-1. Loss of PDX-1, a critical regulator of insulin promoter activity, has also been proposed as an important mechanism leading to beta-cell dysfunction.\", \n\"Although there is little doubt as to the importance of genetic factors in type II diabetes, genetic analysis is difficult due to complex interaction among multiple susceptibility genes and between genetic and environmental factors. Genetic studies have therefore given very diverse results. Kir6.2 and IRS are two of the candidate genes. It is known that Kir6.2 and IRS play central roles in insulin secretion and insulin signal transmission, respectively.\")', 'Human Diseases; Endocrine and metabolic disease', 'Type II diabetes mellitus', 'Type 2 diabetes mellitus, Maturity onset diabetes of the young (MODY), Adiponectin deficiency, Insulin-resistant diabetes mellitus with acanthosis nigricans, Familial hyperinsulinemic hypoglycemia', 'ko04930', 'list(REFERENCE = \"PMID:15823385\", AUTHORS = \"Stumvoll M, Goldstein BJ, van Haeften TW.\", TITLE = \"Type 2 diabetes: principles of pathogenesis and therapy.\", JOURNAL = c(\"Lancet 365:1333-46 (2005)\", \"DOI:10.1016/S0140-6736(05)61032-X\")), list(REFERENCE = \"PMID:15733744\", AUTHORS = \"Gual P, Le Marchand-Brustel Y, Tanti JF.\", TITLE = \"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.\", JOURNAL = c(\"Biochimie 87:99-109 (2005)\", \"DOI:10.1016/j.biochi.2004.10.019\")), list(REFERENCE = \"PMID:11078440\", AUTHORS = \"Henquin JC.\", TITLE = \"Triggering and amplifying pathways of regulation of insulin secretion by glucose.\", JOURNAL = c(\"Diabetes 49:1751-60 (2000)\", \"DOI:10.2337/diabetes.49.11.1751\")), list(REFERENCE = \"PMID:11272200\", AUTHORS = \"Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S.\", TITLE = \"Role of apoptosis in pancreatic beta-cell death in diabetes.\", JOURNAL = c(\"Diabetes 50 Suppl 1:S44-7 (2001)\", \"DOI:10.2337/diabetes.50.2007.S44\")), list(REFERENCE = \"PMID:15759102\", AUTHORS = \"Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Miyatsuka T, Matsuhisa M, Yamasaki Y.\", TITLE = \"Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.\", JOURNAL = c(\"J Mol Med 83:429-39 (2005)\", \"DOI:10.1007/s00109-005-0640-x\")), list(REFERENCE = \"PMID:12480546\", AUTHORS = \"Sakai K, Matsumoto K, Nishikawa T, Suefuji M, Nakamaru K, Hirashima Y, Kawashima J, Shirotani T, Ichinose K, Brownlee M, Araki E.\", TITLE = \"Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells.\", JOURNAL = c(\"Biochem Biophys Res Commun 300:216-22 (2003)\", \"DOI:10.1016/S0006-291X(02)02832-2\")), list(REFERENCE = \"PMID:11390407\", AUTHORS = \"Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A, Weir GC.\", TITLE = \"Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress.\", JOURNAL = c(\"J Biol Chem 276:31099-104 (2001)\", \"DOI:10.1074/jbc.M104115200\")), list(REFERENCE = \"PMID:9011569\", AUTHORS = \"Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y.\", TITLE = \"Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.\", JOURNAL = c(\"J Clin Invest 99:144-50 (1997)\", \"DOI:10.1172/JCI119126\")), list(REFERENCE = \"PMID:7491105\", AUTHORS = \"Sharma A, Olson LK, Robertson RP, Stein R.\", TITLE = \"The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression.\", JOURNAL = c(\"Mol Endocrinol 9:1127-34 (1995)\", \"DOI:10.1210/mend.9.9.7491105\")), list(REFERENCE = \"PMID:15258147\", AUTHORS = \"Robertson RP.\", TITLE = \"Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes.\", JOURNAL = c(\"J Biol Chem 279:42351-4 (2004)\", \"DOI:10.1074/jbc.R400019200\")), list(REFERENCE = \"PMID:9974390\", AUTHORS = \"Eto K, Tsubamoto Y, Terauchi Y, Sugiyama T, Kishimoto T, Takahashi N, Yamauchi N, Kubota N, Murayama S, Aizawa T, Akanuma Y, Aizawa S, Kasai H, Yazaki Y, Kadowaki T.\", TITLE = \"Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion.\", JOURNAL = c(\"Science 283:981-5 (1999)\", \"DOI:10.1126/science.283.5404.981\")), list(REFERENCE = \"PMID:11325516\", AUTHORS = \"Novelli M, Fabregat ME, Fernandez-Alvarez J, Gomis R, Masiello P.\", TITLE = \"Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes.\", JOURNAL = c(\"Mol Cell Endocrinol 175:57-66 (2001)\", \"DOI:10.1016/S0303-7207(01)00400-2\")), list(REFERENCE = \"PMID:15585596\", AUTHORS = \"Yang SN, Berggren PO.\", TITLE = \"Beta-cell CaV channel regulation in physiology and pathophysiology.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 288:E16-28 (2005)\", \"DOI:10.1152/ajpendo.00042.2004\"))', 'map04930', 'Type II diabetes mellitus', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (363, '04931', 'Insulin resistance', 'Insulin resistance is a condition where cells become resistant to the effects of insulin. It is often found in people with health disorders, including obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular diseases. In this diagram multiple mechanisms underlying insulin resistance are shown: (a) increased phosphorylation of IRS (insulin receptor substrate) protein through serine/threonine kinases, such as JNK1 and IKKB, and protein kinase C, (b) increased IRS-1 proteasome degradation via mTOR signaling pathway, (c) decreased activation of signaling molecules including PI3K and AKT, (d) increase in activity of phosphatases including PTPs, PTEN, and PP2A. Regulatory actions such as oxidative stress, mitochondrial dysfunction, accumulation of intracellular lipid derivatives (diacylglycrol and ceramides), and inflammation (via IL-6 and TNFA) contribute to these mechanisms. Consequently, insulin resistance causes reduced GLUT4 translocation, resulting in glucose takeup and glycogen synthesis in skeletal muscle as well as increased hepatic gluconeogenesis and decreased glycogen synthesis in liver. At the bottom of the diagram, interplay between O-GlcNAcylation and serine/threonine phosphorylation is shown. Studies suggested that elevated O-GlcNAc level was correlated to high glucose-induced insulin resistance. Donor UDP-GlcNAc is induced through hexosamine biosynthesis pathway and added to proteins by O-GlcNAc transferase. Elevation of O-GlcNAc modification alters phosphorylation and function of key insulin signaling proteins including IRS-1, PI3K, PDK1, Akt and other transcription factor and cofactors, resulting in the attenuation of insulin signaling cascade.', 'Human Diseases; Endocrine and metabolic disease', 'Insulin resistance', 'ko04931', 'list(REFERENCE = \"PMID:22360800\", AUTHORS = \"Martins AR, Nachbar RT, Gorjao R, Vinolo MA, Festuccia WT, Lambertucci RH, Cury-Boaventura MF, Silveira LR, Curi R, Hirabara SM\", TITLE = \"Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function.\", JOURNAL = c(\"Lipids Health Dis 11:30 (2012)\", \"DOI:10.1186/1476-511X-11-30\")), list(REFERENCE = \"PMID:12765939\", AUTHORS = \"Bouzakri K, Roques M, Gual P, Espinosa S, Guebre-Egziabher F, Riou JP, Laville M, Le Marchand-Brustel Y, Tanti JF, Vidal H\", TITLE = \"Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.\", JOURNAL = c(\"Diabetes 52:1319-25 (2003)\", \"DOI:10.2337/diabetes.52.6.1319\")), list(REFERENCE = \"PMID:20526383\", AUTHORS = \"Choi K, Kim YB\", TITLE = \"Molecular mechanism of insulin resistance in obesity and type 2 diabetes.\", JOURNAL = c(\"Korean J Intern Med 25:119-29 (2010)\", \"DOI:10.3904/kjim.2010.25.2.119\")), list(REFERENCE = \"PMID:7666792\", AUTHORS = \"Ahmad F, Goldstein BJ\", TITLE = \"Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.\", JOURNAL = c(\"Metabolism 44:1175-84 (1995)\", \"DOI:10.1016/0026-0495(95)90012-8\")), list(REFERENCE = \"PMID:15166380\", AUTHORS = \"George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL, Dunger DB, Barford D, Umpleby AM, Wareham NJ, Davies HA, Schafer AJ, Stoffel M, O\'Rahilly S, Barroso I\", TITLE = \"A family with severe insulin resistance and diabetes due to a mutation in AKT2.\", JOURNAL = c(\"Science 304:1325-8 (2004)\", \"DOI:10.1126/science.1096706\")), list(REFERENCE = \"PMID:22675355\", AUTHORS = \"Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JW, Meinders AE, Jazet IM\", TITLE = \"Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions.\", JOURNAL = c(\"Int J Endocrinol 2012:983814 (2012)\", \"DOI:10.1155/2012/983814\")), list(REFERENCE = \"PMID:17130651\", AUTHORS = \"Morino K, Petersen KF, Shulman GI\", TITLE = \"Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.\", JOURNAL = c(\"Diabetes 55 Suppl 2:S9-S15 (2006)\", \"DOI:10.2337/db06-S002\")), list(REFERENCE = \"PMID:16186396\", AUTHORS = \"Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK\", TITLE = \"Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.\", JOURNAL = c(\"Diabetes 54:2939-45 (2005)\", \"DOI:10.2337/diabetes.54.10.2939\")), list(REFERENCE = \"PMID:18309108\", AUTHORS = \"Kim JA, Wei Y, Sowers JR\", TITLE = \"Role of mitochondrial dysfunction in insulin resistance.\", JOURNAL = c(\"Circ Res 102:401-14 (2008)\", \"DOI:10.1161/CIRCRESAHA.107.165472\")), list(REFERENCE = \"PMID:17141630\", AUTHORS = \"Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Gorgun CZ, Carling D, Hotamisligil GS, Febbraio MA, Kay TW, Kemp BE\", TITLE = \"Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling.\", JOURNAL = c(\"Cell Metab 4:465-74 (2006)\", \"DOI:10.1016/j.cmet.2006.11.005\")), list(REFERENCE = \"PMID:9886945\", AUTHORS = \"Ruderman NB, Saha AK, Vavvas D, Witters LA\", TITLE = \"Malonyl-CoA, fuel sensing, and insulin resistance.\", JOURNAL = c(\"Am J Physiol 276:E1-E18 (1999)\", \"DOI:10.1152/ajpendo.1999.276.1.E1\")), list(REFERENCE = \"PMID:8048519\", AUTHORS = \"Saha AK, Kurowski TG, Colca JR, Ruderman NB\", TITLE = \"Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol.\", JOURNAL = c(\"Am J Physiol 267:E95-101 (1994)\", \"DOI:10.1152/ajpendo.1994.267.1.E95\")), list(REFERENCE = \"PMID:22677645\", AUTHORS = \"Blachnio-Zabielska AU, Koutsari C, Tchkonia T, Jensen MD\", TITLE = \"Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance.\", JOURNAL = c(\"Obesity (Silver Spring) 20:2341-7 (2012)\", \"DOI:10.1038/oby.2012.126\")), list(REFERENCE = \"PMID:16364488\", AUTHORS = \"Larter CZ, Farrell GC\", TITLE = \"Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?\", JOURNAL = c(\"J Hepatol 44:253-61 (2006)\", \"DOI:10.1016/j.jhep.2005.11.030\")), list(REFERENCE = \"PMID:15107844\", AUTHORS = \"Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M\", TITLE = \"PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.\", JOURNAL = c(\"Nat Med 10:530-4 (2004)\", \"DOI:10.1038/nm1044\")), list(REFERENCE = \"PMID:20466550\", AUTHORS = \"Slawson C, Copeland RJ, Hart GW\", TITLE = \"O-GlcNAc signaling: a metabolic link between diabetes and cancer?\", JOURNAL = c(\"Trends Biochem Sci 35:547-55 (2010)\", \"DOI:10.1016/j.tibs.2010.04.005\")), list(REFERENCE = \"PMID:23647930\", AUTHORS = \"Ruan HB, Singh JP, Li MD, Wu J, Yang X\", TITLE = \"Cracking the O-GlcNAc code in metabolism.\", JOURNAL = c(\"Trends Endocrinol Metab 24:301-9 (2013)\", \"DOI:10.1016/j.tem.2013.02.002\")), list(REFERENCE = \"PMID:16756496\", AUTHORS = \"Muoio DM, Newgard CB\", TITLE = \"Obesity-related derangements in metabolic regulation.\", JOURNAL = c(\"Annu Rev Biochem 75:367-401 (2006)\", \"DOI:10.1146/annurev.biochem.75.103004.142512\")), list(REFERENCE = \"PMID:10923637\", AUTHORS = \"Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL\", TITLE = \"Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.\", JOURNAL = c(\"Diabetes 49:1353-8 (2000)\", \"DOI:10.2337/diabetes.49.8.1353\"))', 'map04931', 'Insulin resistance', 'Insulin resistance is a condition where cells become resistant to the effects of insulin. It is often found in people with health disorders, including obesity, type 2 diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular diseases. In this diagram multiple mechanisms underlying insulin resistance are shown: (a) increased phosphorylation of IRS (insulin receptor substrate) protein through serine/threonine kinases, such as JNK1 and IKKB, and protein kinase C, (b) increased IRS-1 proteasome degradation via mTOR signaling pathway, (c) decreased activation of signaling molecules including PI3K and AKT, (d) increase in activity of phosphatases including PTPs, PTEN, and PP2A. Regulatory actions such as oxidative stress, mitochondrial dysfunction, accumulation of intracellular lipid derivatives (diacylglycrol and ceramides), and inflammation (via IL-6 and TNFA) contribute to these mechanisms. Consequently, insulin resistance causes reduced GLUT4 translocation, resulting in glucose takeup and glycogen synthesis in skeletal muscle as well as increased hepatic gluconeogenesis and decreased glycogen synthesis in liver. At the bottom of the diagram, interplay between O-GlcNAcylation and serine/threonine phosphorylation is shown. Studies suggested that elevated O-GlcNAc level was correlated to high glucose-induced insulin resistance. Donor UDP-GlcNAc is induced through hexosamine biosynthesis pathway and added to proteins by O-GlcNAc transferase. Elevation of O-GlcNAc modification alters phosphorylation and function of key insulin signaling proteins including IRS-1, PI3K, PDK1, Akt and other transcription factor and cofactors, resulting in the attenuation of insulin signaling cascade.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (364, '04932', 'Non-alcoholic fatty liver disease (NAFLD)', 'Non-alcoholic fatty liver disease (NAFLD) represents a spectrum ranging from simple steatosis to more severe steatohepatitis with hepatic inflammation and fibrosis, known as nonalcoholic steatohepatitis (NASH). NASH may further lead to cirrhosis and hepatocellular carcinoma (HCC). This map shows a stage-dependent progression of NAFLD. In the first stage of NAFLD, excess lipid accumulation has been demonstrated. The main cause is the induction of insulin resistance, which leads to a defect in insulin suppression of free fatty acids (FAAs) disposal. In addition, two transcription factors, SREBP-1c and PPAR-alpha, activate key enzymes of lipogenesis and increase the synthesis of FAAs in liver. In the second stage, as a consequence of the progression to NASH, the production of reactive oxygen species (ROS) is enhanced due to oxidation stress through mitochondrial beta-oxidation of fatty acids and endoplamic reticulum (ER) stress, leading to lipid peroxidation. The lipid peroxidation can further cause the production of cytokines (Fas ligand, TNF-alpha, IL-8 and TGF), promoting cell death, inflammation and fibrosis. The activation of JNK, which is induced by ER stress, TNF-alpha and FAAs, is also associated with NAFLD progression. Increased JNK promotes cytokine production and initiation of HCC.', 'Human Diseases; Endocrine and metabolic disease', 'Non-alcoholic fatty liver disease (NAFLD)', 'Cowden syndrome, Nonalcoholic fatty liver disease', 'ko04932', 'list(REFERENCE = \"PMID:23545492\", AUTHORS = \"Naik A, Kosir R, Rozman D\", TITLE = \"Genomic aspects of NAFLD pathogenesis.\", JOURNAL = c(\"Genomics 102:84-95 (2013)\", \"DOI:10.1016/j.ygeno.2013.03.007\")), list(REFERENCE = \"PMID:19352614\", AUTHORS = \"Malaguarnera M, Di Rosa M, Nicoletti F, Malaguarnera L\", TITLE = \"Molecular mechanisms involved in NAFLD progression.\", JOURNAL = c(\"J Mol Med (Berl) 87:679-95 (2009)\", \"DOI:10.1007/s00109-009-0464-1\")), list(REFERENCE = \"PMID:22705006\", AUTHORS = \"Seki E, Brenner DA, Karin M\", TITLE = \"A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches.\", JOURNAL = c(\"Gastroenterology 143:307-20 (2012)\", \"DOI:10.1053/j.gastro.2012.06.004\")), list(REFERENCE = \"PMID:21038418\", AUTHORS = \"Tilg H, Moschen AR\", TITLE = \"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.\", JOURNAL = c(\"Hepatology 52:1836-46 (2010)\", \"DOI:10.1002/hep.24001\")), list(REFERENCE = \"PMID:16364488\", AUTHORS = \"Larter CZ, Farrell GC\", TITLE = \"Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?\", JOURNAL = c(\"J Hepatol 44:253-61 (2006)\", \"DOI:10.1016/j.jhep.2005.11.030\")), list(REFERENCE = \"PMID:22570745\", AUTHORS = \"Farrell GC, van Rooyen D, Gan L, Chitturi S\", TITLE = \"NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.\", JOURNAL = c(\"Gut Liver 6:149-71 (2012)\", \"DOI:10.5009/gnl.2012.6.2.149\")), list(REFERENCE = \"PMID:20619513\", AUTHORS = \"Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P\", TITLE = \"The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease.\", JOURNAL = c(\"Clin Nutr 30:6-19 (2011)\", \"DOI:10.1016/j.clnu.2010.06.001\")), list(REFERENCE = \"PMID:20303879\", AUTHORS = \"Hotamisligil GS\", TITLE = \"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.\", JOURNAL = c(\"Cell 140:900-17 (2010)\", \"DOI:10.1016/j.cell.2010.02.034\")), list(REFERENCE = \"PMID:17498512\", AUTHORS = \"Parekh S, Anania FA\", TITLE = \"Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.\", JOURNAL = c(\"Gastroenterology 132:2191-207 (2007)\", \"DOI:10.1053/j.gastro.2007.03.055\")), list(REFERENCE = \"PMID:16374858\", AUTHORS = \"Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ\", TITLE = \"JNK1 but not JNK2 promotes the development of steatohepatitis in mice.\", JOURNAL = c(\"Hepatology 43:163-72 (2006)\", \"DOI:10.1002/hep.20999\")), list(REFERENCE = \"PMID:22940046\", AUTHORS = \"Leung TM, Nieto N\", TITLE = \"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.\", JOURNAL = c(\"J Hepatol 58:395-8 (2013)\", \"DOI:10.1016/j.jhep.2012.08.018\")), list(REFERENCE = \"PMID:14685853\", AUTHORS = \"Zafrani ES\", TITLE = \"Non-alcoholic fatty liver disease: an emerging pathological spectrum.\", JOURNAL = c(\"Virchows Arch 444:3-12 (2004)\", \"DOI:10.1007/s00428-003-0943-7\")), list(REFERENCE = \"PMID:12891546\", AUTHORS = \"Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ\", TITLE = \"Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.\", JOURNAL = c(\"Gastroenterology 125:437-43 (2003)\", \"DOI:10.1016/S0016-5085(03)00907-7\")), list(REFERENCE = \"PMID:16406828\", AUTHORS = \"Begriche K, Igoudjil A, Pessayre D, Fromenty B\", TITLE = \"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.\", JOURNAL = c(\"Mitochondrion 6:1-28 (2006)\", \"DOI:10.1016/j.mito.2005.10.004\")), list(REFERENCE = \"PMID:9285483\", AUTHORS = \"Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G\", TITLE = \"The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis.\", JOURNAL = c(\"FASEB J 11:851-7 (1997)\", \"DOI:10.1096/fasebj.11.11.9285483\")), list(REFERENCE = \"PMID:21145844\", AUTHORS = \"Malhi H, Kaufman RJ\", TITLE = \"Endoplasmic reticulum stress in liver disease.\", JOURNAL = c(\"J Hepatol 54:795-809 (2011)\", \"DOI:10.1016/j.jhep.2010.11.005\")), list(REFERENCE = \"PMID:18242193\", AUTHORS = \"Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM\", TITLE = \"Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.\", JOURNAL = c(\"Free Radic Biol Med 44:1259-72 (2008)\", \"DOI:10.1016/j.freeradbiomed.2007.12.029\")), list(REFERENCE = \"PMID:18061659\", AUTHORS = \"Serviddio G, Sastre J, Bellanti F, Vina J, Vendemiale G, Altomare E\", TITLE = \"Mitochondrial involvement in non-alcoholic steatohepatitis.\", JOURNAL = c(\"Mol Aspects Med 29:22-35 (2008)\", \"DOI:10.1016/j.mam.2007.09.014\")), list(REFERENCE = \"PMID:23299992\", AUTHORS = \"Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B\", TITLE = \"Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.\", JOURNAL = c(\"Hepatology 58:1497-507 (2013)\", \"DOI:10.1002/hep.26226\"))', 'map04932', 'Non-alcoholic fatty liver disease (NAFLD)', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (365, '04933', 'AGE-RAGE signaling pathway in diabetic complications', 'Advanced glycation end products (AGEs) are a complex group of compounds produced through the non-enzymatic glycation and oxidation of proteins, lipids and nucleic acids, primarily due to aging and under certain pathologic condition such as huperglycemia. Some of the best chemically characterized AGEs include N-epsilon-carboxy-methyl-lysine (CML), N-epsilon-carboxy-ethyl-lysine (CEL), and Imidazolone. The major receptor for AGEs, known as receptor for advanced glycation end products (RAGE or AGER), belongs to the immunoglobulin superfamily and has been described as a pattern recognition receptor. AGE/RAGE signaling elicits activation of multiple intracellular signal pathways involving NADPH oxidase, protein kinase C, and MAPKs, then resulting in NF-kappaB activity. NF-kappa B promotes the expression of pro-inflammatory cytokines such as IL-1, IL-6 and TNF-alpha and a variety of atherosclerosis-related genes, including VCAM-1, tissue factor, VEGF, and RAGE. In addition, JAK-STAT-mediated and PI3K-Akt-dependent pathways are induced via RAGE, which in turn participate in cell proliferation and apoptosis respectively. Hypoxia-mediated induction of Egr-1 was also shown to require the AGE-RAGE interaction. The results of these signal transductions have been reported to be the possible mechanism that initates diabetic complications.', 'Human Diseases; Endocrine and metabolic disease', 'AGE-RAGE signaling pathway in diabetic complications', 'Diabetic nephropathy, Diabetic retinopathy, Diabetic neuropathy, Osteoporosis', 'GO: 1904603', 'ko04933', 'list(REFERENCE = \"PMID:21261520\", AUTHORS = \"Kanwar YS, Sun L, Xie P, Liu FY, Chen S\", TITLE = \"A glimpse of various pathogenetic mechanisms of diabetic nephropathy.\", JOURNAL = c(\"Annu Rev Pathol 6:395-423 (2011)\", \"DOI:10.1146/annurev.pathol.4.110807.092150\")), list(REFERENCE = \"PMID:21111800\", AUTHORS = \"Yamagishi S\", TITLE = \"Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.\", JOURNAL = c(\"Exp Gerontol 46:217-24 (2011)\", \"DOI:10.1016/j.exger.2010.11.007\")), list(REFERENCE = \"PMID:23961320\", AUTHORS = \"Roy B\", TITLE = \"Biomolecular basis of the role of diabetes mellitus in osteoporosis and bone fractures.\", JOURNAL = c(\"World J Diabetes 4:101-13 (2013)\", \"DOI:10.4239/wjd.v4.i4.101\")), list(REFERENCE = \"PMID:22558488\", AUTHORS = \"Hegab Z, Gibbons S, Neyses L, Mamas MA\", TITLE = \"Role of advanced glycation end products in cardiovascular disease.\", JOURNAL = c(\"World J Cardiol 4:90-102 (2012)\", \"DOI:10.4330/wjc.v4.i4.90\")), list(REFERENCE = \"PMID:19404313\", AUTHORS = \"Calcutt NA, Cooper ME, Kern TS, Schmidt AM\", TITLE = \"Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials.\", JOURNAL = c(\"Nat Rev Drug Discov 8:417-29 (2009)\", \"DOI:10.1038/nrd2476\")), list(REFERENCE = \"PMID:11180401\", AUTHORS = \"Huang JS, Guh JY, Chen HC, Hung WC, Lai YH, Chuang LY\", TITLE = \"Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells.\", JOURNAL = c(\"J Cell Biochem 81:102-13 (2001)\", \"DOI:10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y\")), list(REFERENCE = \"PMID:21680901\", AUTHORS = \"Meloche J, Paulin R, Courboulin A, Lambert C, Barrier M, Bonnet P, Bisserier M, Roy M, Sussman MA, Agharazii M, Bonnet S\", TITLE = \"RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes.\", JOURNAL = c(\"Arterioscler Thromb Vasc Biol 31:2114-24 (2011)\", \"DOI:10.1161/ATVBAHA.111.230573\")), list(REFERENCE = \"PMID:11684565\", AUTHORS = \"Guh JY, Huang JS, Chen HC, Hung WC, Lai YH, Chuang LY\", TITLE = \"Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1.\", JOURNAL = c(\"Am J Kidney Dis 38:1096-104 (2001)\", \"DOI:10.1053/ajkd.2001.28616\")), list(REFERENCE = \"PMID:16894049\", AUTHORS = \"Goldin A, Beckman JA, Schmidt AM, Creager MA\", TITLE = \"Advanced glycation end products: sparking the development of diabetic vascular injury.\", JOURNAL = c(\"Circulation 114:597-605 (2006)\", \"DOI:10.1161/CIRCULATIONAHA.106.621854\")), list(REFERENCE = \"PMID:21590515\", AUTHORS = \"Zong H, Ward M, Stitt AW\", TITLE = \"AGEs, RAGE, and diabetic retinopathy.\", JOURNAL = c(\"Curr Diab Rep 11:244-52 (2011)\", \"DOI:10.1007/s11892-011-0198-7\")), list(REFERENCE = \"PMID:21440603\", AUTHORS = \"Yamagishi S, Maeda S, Matsui T, Ueda S, Fukami K, Okuda S\", TITLE = \"Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes.\", JOURNAL = c(\"Biochim Biophys Acta 1820:663-71 (2012)\", \"DOI:10.1016/j.bbagen.2011.03.014\")), list(REFERENCE = \"PMID:23776698\", AUTHORS = \"Shi L, Yu X, Yang H, Wu X\", TITLE = \"Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways.\", JOURNAL = c(\"PLoS One 8:e66781 (2013)\", \"DOI:10.1371/journal.pone.0066781\")), list(REFERENCE = \"PMID:17005604\", AUTHORS = \"Alikhani M, Maclellan CM, Raptis M, Vora S, Trackman PC, Graves DT\", TITLE = \"Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor.\", JOURNAL = c(\"Am J Physiol Cell Physiol 292:C850-6 (2007)\", \"DOI:10.1152/ajpcell.00356.2006\")), list(REFERENCE = \"PMID:20300563\", AUTHORS = \"Alikhani M, Roy S, Graves DT\", TITLE = \"FOXO1 plays an essential role in apoptosis of retinal pericytes.\", JOURNAL = \"Mol Vis 16:408-15 (2010)\"), list(REFERENCE = \"PMID:20470857\", AUTHORS = \"Sheikpranbabu S, Haribalaganesh R, Lee KJ, Gurunathan S\", TITLE = \"Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.\", JOURNAL = c(\"Biochimie 92:1040-51 (2010)\", \"DOI:10.1016/j.biochi.2010.05.004\")), list(REFERENCE = \"PMID:18922799\", AUTHORS = \"Hudson BI, Kalea AZ, Del Mar Arriero M, Harja E, Boulanger E, D\'Agati V, Schmidt AM\", TITLE = \"Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42.\", JOURNAL = c(\"J Biol Chem 283:34457-68 (2008)\", \"DOI:10.1074/jbc.M801465200\")), list(REFERENCE = \"PMID:11375353\", AUTHORS = \"Yeh CH, Sturgis L, Haidacher J, Zhang XN, Sherwood SJ, Bjercke RJ, Juhasz O, Crow MT, Tilton RG, Denner L\", TITLE = \"Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion.\", JOURNAL = c(\"Diabetes 50:1495-504 (2001)\", \"DOI:10.2337/diabetes.50.6.1495\")), list(REFERENCE = \"PMID:12709399\", AUTHORS = \"Li JH, Huang XR, Zhu HJ, Oldfield M, Cooper M, Truong LD, Johnson RJ, Lan HY\", TITLE = \"Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.\", JOURNAL = c(\"FASEB J 18:176-8 (2004)\", \"DOI:10.1096/fj.02-1117fje\")), list(REFERENCE = \"PMID:18323529\", AUTHORS = \"Chang JS, Wendt T, Qu W, Kong L, Zou YS, Schmidt AM, Yan SF\", TITLE = \"Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products.\", JOURNAL = c(\"Circ Res 102:905-13 (2008)\", \"DOI:10.1161/CIRCRESAHA.107.165308\")), list(REFERENCE = \"PMID:15569303\", AUTHORS = \"Fukami K, Ueda S, Yamagishi S, Kato S, Inagaki Y, Takeuchi M, Motomiya Y, Bucala R, Iida S, Tamaki K, Imaizumi T, Cooper ME, Okuda S\", TITLE = \"AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.\", JOURNAL = c(\"Kidney Int 66:2137-47 (2004)\", \"DOI:10.1111/j.1523-1755.2004.66004.x\"))', 'map04933', 517, 16, 248, 105, 124, 40, 16, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (366, '04934', 'Cushing syndrome', 'Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing\'s disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).', 'Human Diseases; Endocrine and metabolic disease', 'Cushing syndrome', 'Cushing syndrome, Bilateral macronodular adrenal hyperplasia', 'ko04934', 'list(REFERENCE = \"PMID:26004339\", AUTHORS = \"Lacroix A, Feelders RA, Stratakis CA, Nieman LK\", TITLE = \"Cushing\'s syndrome.\", JOURNAL = c(\"Lancet 386:913-27 (2015)\", \"DOI:10.1016/S0140-6736(14)61375-1\")), list(REFERENCE = \"PMID:27588171\", AUTHORS = \"Xiong Q, Ge W\", TITLE = \"Gene mutations in Cushing\'s disease.\", JOURNAL = c(\"Biomed Rep 5:277-282 (2016)\", \"DOI:10.3892/br.2016.729\")), list(REFERENCE = \"PMID:25877147\", AUTHORS = \"Fukuoka H, Takahashi Y\", TITLE = \"The role of genetic and epigenetic changes in pituitary tumorigenesis.\", JOURNAL = c(\"Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)\", \"DOI:10.2176/nmc.suppl.2014-3\")), list(REFERENCE = \"PMID:18987159\", AUTHORS = \"Quereda V, Malumbres M\", TITLE = \"Cell cycle control of pituitary development and disease.\", JOURNAL = c(\"J Mol Endocrinol 42:75-86 (2009)\", \"DOI:10.1677/JME-08-0146\")), list(REFERENCE = \"PMID:27742789\", AUTHORS = \"Caimari F, Korbonits M\", TITLE = \"Novel Genetic Causes of Pituitary Adenomas.\", JOURNAL = c(\"Clin Cancer Res 22:5030-5042 (2016)\", \"DOI:10.1158/1078-0432.CCR-16-0452\")), list(REFERENCE = \"PMID:25350067\", AUTHORS = \"Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P\", TITLE = \"Genetic mutations in sporadic pituitary adenomas--what to screen for?\", JOURNAL = c(\"Nat Rev Endocrinol 11:43-54 (2015)\", \"DOI:10.1038/nrendo.2014.181\")), list(REFERENCE = \"PMID:27625633\", AUTHORS = \"Hannah-Shmouni F, Faucz FR, Stratakis CA\", TITLE = \"Alterations of Phosphodiesterases in Adrenocortical Tumors.\", JOURNAL = c(\"Front Endocrinol (Lausanne) 7:111 (2016)\", \"DOI:10.3389/fendo.2016.00111\")), list(REFERENCE = \"PMID:21423242\", AUTHORS = \"Melmed S\", TITLE = \"Pathogenesis of pituitary tumors.\", JOURNAL = c(\"Nat Rev Endocrinol 7:257-66 (2011)\", \"DOI:10.1038/nrendo.2011.40\")), list(REFERENCE = \"PMID:19407507\", AUTHORS = \"Daly AF, Tichomirowa MA, Beckers A\", TITLE = \"Genetic, molecular and clinical features of familial isolated pituitary adenomas.\", JOURNAL = c(\"Horm Res 71 Suppl 2:116-22 (2009)\", \"DOI:10.1159/000192448\")), list(REFERENCE = \"PMID:28850717\", AUTHORS = \"Albani A, Theodoropoulou M, Reincke M\", TITLE = \"Genetics of Cushing\'s disease.\", JOURNAL = c(\"Clin Endocrinol (Oxf) 88:3-12 (2018)\", \"DOI:10.1111/cen.13457\")), list(REFERENCE = \"PMID:26045561\", AUTHORS = \"Duan K, Hernandez KG, Mete O\", TITLE = \"Clinicopathological correlates of adrenal Cushing\'s syndrome.\", JOURNAL = c(\"Postgrad Med J 91:331-42 (2015)\", \"DOI:10.1136/postgradmedj-2014-202612rep\")), list(REFERENCE = \"PMID:26264719\", AUTHORS = \"Drougat L, Espiard S, Bertherat J\", TITLE = \"Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing\'s syndrome?\", JOURNAL = c(\"Eur J Endocrinol 173:M121-31 (2015)\", \"DOI:10.1530/EJE-15-0532\")), list(REFERENCE = \"PMID:17955016\", AUTHORS = \"Stratakis CA, Boikos SA\", TITLE = \"Genetics of adrenal tumors associated with Cushing\'s syndrome: a new classification for bilateral adrenocortical hyperplasias.\", JOURNAL = c(\"Nat Clin Pract Endocrinol Metab 3:748-57 (2007)\", \"DOI:10.1038/ncpendmet0648\")), list(REFERENCE = \"PMID:19906235\", AUTHORS = \"Refojo D, Holsboer F\", TITLE = \"CRH signaling. Molecular specificity for drug targeting in the CNS.\", JOURNAL = c(\"Ann N Y Acad Sci 1179:106-19 (2009)\", \"DOI:10.1111/j.1749-6632.2009.04983.x\")), list(REFERENCE = \"PMID:12089357\", AUTHORS = \"Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E\", TITLE = \"Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.\", JOURNAL = c(\"Mol Endocrinol 16:1638-51 (2002)\", \"DOI:10.1210/mend.16.7.0863\")), list(REFERENCE = \"PMID:15380809\", AUTHORS = \"Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J\", TITLE = \"Cushing\'s syndrome variants secondary to aberrant hormone receptors.\", JOURNAL = c(\"Trends Endocrinol Metab 15:375-82 (2004)\", \"DOI:10.1016/j.tem.2004.08.007\")), list(REFERENCE = \"PMID:25485838\", AUTHORS = \"Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M\", TITLE = \"Mutations in the deubiquitinase gene USP8 cause Cushing\'s disease.\", JOURNAL = c(\"Nat Genet 47:31-8 (2015)\", \"DOI:10.1038/ng.3166\")), list(REFERENCE = \"PMID:25930709\", AUTHORS = \"Kaiser UB\", TITLE = \"Cushing\'s disease: towards precision medicine.\", JOURNAL = c(\"Cell Res 25:649-50 (2015)\", \"DOI:10.1038/cr.2015.53\")), list(REFERENCE = \"PMID:28487882\", AUTHORS = \"Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB\", TITLE = \"Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.\", JOURNAL = c(\"Cold Spring Harb Mol Case Stud 3:a001602 (2017)\", \"DOI:10.1101/mcs.a001602\")), list(REFERENCE = \"PMID:26285834\", AUTHORS = \"Huang C, Shi Y, Zhao Y\", TITLE = \"USP8 mutation in Cushing\'s disease.\", JOURNAL = c(\"Oncotarget 6:18240-1 (2015)\", \"DOI:10.18632/oncotarget.4856\")), list(REFERENCE = \"PMID:26012588\", AUTHORS = \"Theodoropoulou M, Reincke M, Fassnacht M, Komada M\", TITLE = \"Decoding the genetic basis of Cushing\'s disease: USP8 in the spotlight.\", JOURNAL = c(\"Eur J Endocrinol 173:M73-83 (2015)\", \"DOI:10.1530/EJE-15-0320\")), list(REFERENCE = \"PMID:29370219\", AUTHORS = \"Yu L, Zhang J, Guo X, Chen X, He Z, He Q\", TITLE = \"ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.\", JOURNAL = c(\"PLoS One 13:e0191602 (2018)\", \"DOI:10.1371/journal.pone.0191602\")), list(REFERENCE = \"PMID:19075677\", AUTHORS = \"Wu X, Hua X\", TITLE = \"Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.\", JOURNAL = c(\"Curr Mol Med 8:805-15 (2008)\", \"DOI:10.2174/156652408786733702\")), list(REFERENCE = \"PMID:20457215\", AUTHORS = \"Ozfirat Z, Korbonits M\", TITLE = \"AIP gene and familial isolated pituitary adenomas.\", JOURNAL = c(\"Mol Cell Endocrinol 326:71-9 (2010)\", \"DOI:10.1016/j.mce.2010.05.001\"))', 'map04934', 'Cushing syndrome', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (367, '04935', 'Growth hormone synthesis, secretion and action', 'Growth hormone (GH) is a peptide hormone secreted from the anterior pituitary and plays a critical role in cell growth, development, and metabolism throughout the body. GH secretion occurs episodically and is primarily under the control of two hypothalamic neuroendocrine hormones: GH-releasing hormone (GHRH), which stimulates GH secretion, and somatostatin, which inhibits GH secretion. GHRH interacts with a G protein-coupled receptor (GHRHR) in somatotroph cells to activate the cAMP signaling pathway, which leads to increased GH mRNA transcription and release. Once released into the circulation, GH binds to cell-surface GHR in target tissues such as liver, muscle, bone, and adipose tissue. Binding leads to activation of JAK2 that in turn triggers an array of signaling cascade including Raf-MEK-ERK, PI3K-Akt, and STAT5. ERK, Akt, and STAT5 all promote growth via the synthesis and secretion of IGF-1.', 'Organismal Systems; Endocrine system', 'Growth hormone synthesis, secretion and action', 'ko04935', 'list(REFERENCE = \"\", AUTHORS = \"Nishad R, Mukhi D, Menon R K, Pasupulati A.\", TITLE = \"Growth Hormone and Metabolic Homeostasis\", JOURNAL = \"European Medical Journal 6(1):78-87 (2018)\"), list(REFERENCE = \"PMID:30775002\", AUTHORS = \"Lu M, Flanagan JU, Langley RJ, Hay MP, Perry JK\", TITLE = \"Targeting growth hormone function: strategies and therapeutic applications.\", JOURNAL = c(\"Signal Transduct Target Ther 4:3 (2019)\", \"DOI:10.1038/s41392-019-0036-y\")), list(REFERENCE = \"PMID:8874495\", AUTHORS = \"Argetsinger LS, Carter-Su C\", TITLE = \"Mechanism of signaling by growth hormone receptor.\", JOURNAL = c(\"Physiol Rev 76:1089-107 (1996)\", \"DOI:10.1152/physrev.1996.76.4.1089\")), list(REFERENCE = \"PMID:8815791\", AUTHORS = \"Carter-Su C, Schwartz J, Smit LS\", TITLE = \"Molecular mechanism of growth hormone action.\", JOURNAL = c(\"Annu Rev Physiol 58:187-207 (1996)\", \"DOI:10.1146/annurev.ph.58.030196.001155\")), list(REFERENCE = \"PMID:10912517\", AUTHORS = \"Carter-Su C, Rui L, Herrington J\", TITLE = \"Role of the tyrosine kinase JAK2 in signal transduction by growth hormone.\", JOURNAL = c(\"Pediatr Nephrol 14:550-7 (2000)\", \"DOI:10.1007/s004670000366\")), list(REFERENCE = \"PMID:29487568\", AUTHORS = \"Dehkhoda F, Lee CMM, Medina J, Brooks AJ\", TITLE = \"The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.\", JOURNAL = c(\"Front Endocrinol (Lausanne) 9:35 (2018)\", \"DOI:10.3389/fendo.2018.00035\")), list(REFERENCE = \"PMID:26421979\", AUTHORS = \"Carter-Su C, Schwartz J, Argetsinger LS\", TITLE = \"Growth hormone signaling pathways.\", JOURNAL = c(\"Growth Horm IGF Res 28:11-5 (2016)\", \"DOI:10.1016/j.ghir.2015.09.002\")), list(REFERENCE = \"PMID:28435436\", AUTHORS = \"Berryman DE, Henry B, Hjortebjerg R, List EO, Kopchick JJ\", TITLE = \"Developments in our understanding of the effects of growth hormone on white adipose tissue from mice: implications to the clinic.\", JOURNAL = c(\"Expert Rev Endocrinol Metab 11:197-207 (2016)\", \"DOI:10.1586/17446651.2016.1147950\")), list(REFERENCE = \"PMID:9837978\", AUTHORS = \"Zhu T, Goh EL, LeRoith D, Lobie PE\", TITLE = \"Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK).\", JOURNAL = c(\"J Biol Chem 273:33864-75 (1998)\", \"DOI:10.1074/jbc.273.50.33864\")), list(REFERENCE = \"\", AUTHORS = \"Choi S (ed).\", TITLE = \"Encyclopedia of Signaling Molecules\", JOURNAL = c(\"Springer International Publishing\", \"DOI:10.1007/978-1-4614-6438-9_101674-1\")), list(REFERENCE = \"PMID:11997217\", AUTHORS = \"Gracia-Navarro F, Castano JP, Malagon MM, Sanchez-Hormigo A, Luque RM, Hickey GJ, Peinado JR, Delgado E, Martinez-Fuentes AJ\", TITLE = \"Research progress in the stimulatory inputs regulating growth hormone (GH) secretion.\", JOURNAL = c(\"Comp Biochem Physiol B Biochem Mol Biol 132:141-50 (2002)\", \"DOI:10.1016/s1096-4959(01)00544-9\")), list(REFERENCE = \"PMID:9167959\", AUTHORS = \"Bertherat J\", TITLE = \"Nuclear effects of the cAMP pathway activation in somatotrophs.\", JOURNAL = c(\"Horm Res 47:245-50 (1997)\", \"DOI:10.1159/000185471\")), list(REFERENCE = \"PMID:8625613\", AUTHORS = \"Tuggle CK, Trenkle A\", TITLE = \"Control of growth hormone synthesis.\", JOURNAL = \"Domest Anim Endocrinol 13:1-33 (1996)\"), list(REFERENCE = \"PMID:10525051\", AUTHORS = \"Cohen LE, Hashimoto Y, Zanger K, Wondisford F, Radovick S\", TITLE = \"CREB-independent regulation by CBP is a novel mechanism of human growth hormone gene expression.\", JOURNAL = c(\"J Clin Invest 104:1123-30 (1999)\", \"DOI:10.1172/JCI7308\")), list(REFERENCE = \"PMID:25302229\", AUTHORS = \"Khatib N, Gaidhane S, Gaidhane AM, Khatib M, Simkhada P, Gode D, Zahiruddin QS\", TITLE = \"Ghrelin: ghrelin as a regulatory Peptide in growth hormone secretion.\", JOURNAL = c(\"J Clin Diagn Res 8:MC13-7 (2014)\", \"DOI:10.7860/JCDR/2014/9863.4767\")), list(REFERENCE = \"PMID:16628271\", AUTHORS = \"Lengyel AM\", TITLE = \"From growth hormone-releasing peptides to ghrelin: discovery of new modulators of GH secretion.\", JOURNAL = c(\"Arq Bras Endocrinol Metabol 50:17-24 (2006)\", \"DOI:10.1590/s0004-27302006000100004\")), list(REFERENCE = \"PMID:15927771\", AUTHORS = \"Anderson LL, Jeftinija S, Scanes CG, Stromer MH, Lee JS, Jeftinija K, Glavaski-Joksimovic A\", TITLE = \"Physiology of ghrelin and related peptides.\", JOURNAL = c(\"Domest Anim Endocrinol 29:111-44 (2005)\", \"DOI:10.1016/j.domaniend.2005.02.033\")), list(REFERENCE = \"PMID:14610293\", AUTHORS = \"Camina JP, Carreira MC, Micic D, Pombo M, Kelestimur F, Dieguez C, Casanueva FF\", TITLE = \"Regulation of ghrelin secretion and action.\", JOURNAL = c(\"Endocrine 22:5-12 (2003)\", \"DOI:10.1385/ENDO:22:1:5\")), list(REFERENCE = \"PMID:22243899\", AUTHORS = \"Yang SK, Steyn F, Chen C\", TITLE = \"Influence of membrane ion channel in pituitary somatotrophs by hypothalamic regulators.\", JOURNAL = c(\"Cell Calcium 51:231-9 (2012)\", \"DOI:10.1016/j.ceca.2011.12.005\")), list(REFERENCE = \"PMID:19884662\", AUTHORS = \"Melmed S\", TITLE = \"Acromegaly pathogenesis and treatment.\", JOURNAL = c(\"J Clin Invest 119:3189-202 (2009)\", \"DOI:10.1172/JCI39375\"))', 'map04935', 'Growth hormone synthesis, secretion and action', 'Growth hormone (GH) is a peptide hormone secreted from the anterior pituitary and plays a critical role in cell growth, development, and metabolism throughout the body. GH secretion occurs episodically and is primarily under the control of two hypothalamic neuroendocrine hormones: GH-releasing hormone (GHRH), which stimulates GH secretion, and somatostatin, which inhibits GH secretion. GHRH interacts with a G protein-coupled receptor (GHRHR) in somatotroph cells to activate the cAMP signaling pathway, which leads to increased GH mRNA transcription and release. Once released into the circulation, GH binds to cell-surface GHR in target tissues such as liver, muscle, bone, and adipose tissue. Binding leads to activation of JAK2 that in turn triggers an array of signaling cascade including Raf-MEK-ERK, PI3K-Akt, and STAT5. ERK, Akt, and STAT5 all promote growth via the synthesis and secretion of IGF-1.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (368, '04940', 'Type I diabetes mellitus', 'c(\"Type I diabetes mellitus is a disease that results from autoimmune destruction of the insulin-producing beta-cells. Certain beta-cell proteins act as autoantigens after being processed by antigen-presenting cell (APC), such as macrophages and dendritic cells, and presented in a complex with MHC-II molecules on the surface of the APC. Then immunogenic signals from APC activate CD4+ T cells, predominantly of the Th1 subset. Antigen-activated Th1 cells produce IL-2 and IFNgamma. They activate macrophages and cytotoxic CD8+ T cells, and these effector cells may kill islet beta-cells by one or both of two types of mechanisms: (1) direct interactions of antigen-specific cytotoxic T cells with a beta-cell autoantigen-MHC-I complex on the beta-cell, and (2) non-specific inflammatory mediators, such as free radicals/oxidants and cytokines (IL-1, TNFalpha, TNFbeta, IFNgamma).\", \n\"Type I diabetes is a polygenic disease. One of the principle determining genetic factors in diabetes incidence is the inheritance of mutant MHC-II alleles. Another plausible candidate gene is the insulin gene.\")', 'Human Diseases; Endocrine and metabolic disease', 'Type I diabetes mellitus', 'Type 1 diabetes mellitus', 'ko04940', 'list(REFERENCE = \"PMID:9719467\", AUTHORS = \"Rabinovitch A, Suarez-Pinzon WL.\", TITLE = \"Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.\", JOURNAL = c(\"Biochem Pharmacol 55:1139-49 (1998)\", \"DOI:10.1016/S0006-2952(97)00492-9\")), list(REFERENCE = \"PMID:11507694\", AUTHORS = \"Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, Concannon P\", TITLE = \"Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.\", JOURNAL = c(\"Am J Hum Genet 69:820-30 (2001)\", \"DOI:10.1086/323501\")), list(REFERENCE = \"PMID:8072542\", AUTHORS = \"Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, et al.\", TITLE = \"A genome-wide search for human type 1 diabetes susceptibility genes.\", JOURNAL = c(\"Nature 371:130-6 (1994)\", \"DOI:10.1038/371130a0\")), list(REFERENCE = \"PMID:8786033\", AUTHORS = \"Fujisawa T, Ikegami H, Kawaguchi Y, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Shima K, Ogihara T.\", TITLE = \"Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.\", JOURNAL = c(\"Diabetologia 38:1493-5 (1995)\", \"DOI:10.1007/BF00400620\")), list(REFERENCE = \"PMID:12796471\", AUTHORS = \"Jaeckel E, Klein L, Martin-Orozco N, von Boehmer H.\", TITLE = \"Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.\", JOURNAL = c(\"J Exp Med 197:1635-44 (2003)\", \"DOI:10.1084/jem.20030215\")), list(REFERENCE = \"PMID:15889095\", AUTHORS = \"Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS.\", TITLE = \"Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.\", JOURNAL = c(\"Nature 435:220-3 (2005)\", \"DOI:10.1038/nature03523\")), list(REFERENCE = \"PMID:15889096\", AUTHORS = \"Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA.\", TITLE = \"Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.\", JOURNAL = c(\"Nature 435:224-8 (2005)\", \"DOI:10.1038/nature03625\")), list(REFERENCE = \"PMID:14617043\", AUTHORS = \"Lieberman SM, DiLorenzo TP.\", TITLE = \"A comprehensive guide to antibody and T-cell responses in type 1 diabetes.\", JOURNAL = c(\"Tissue Antigens 62:359-77 (2003)\", \"DOI:10.1034/j.1399-0039.2003.00152.x\")), list(REFERENCE = \"PMID:12752668\", AUTHORS = \"Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.\", TITLE = \"Granzyme B: a natural born killer.\", JOURNAL = c(\"Immunol Rev 193:31-8 (2003)\", \"DOI:10.1034/j.1600-065X.2003.00044.x\"))', 'map04940', 'Type I diabetes mellitus', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (369, '04950', 'Maturity onset diabetes of the young', 'c(\"About 2-5% of type II diabetic patients suffer from a monogenic disease with autosomal dominant inheritance. This monogenic form of type II diabetes is called maturity onset diabetes of the young (MODY).\", \"We now know that MODY is caused by heterozygous mutations in at least five genes encoding transcription factors: HNF4alpha (MODY1), HNF1alpha (MODY3), PDX1 (MODY4), HNF1beta (MODY5) and NEUROD1 (MODY6). MODY2, which is so far the only subtype not related to a transcription factor, is caused by mutations in the glucokinase gene. Mutations of MODY transcription factor genes lead to abnormal expression of genes involved in pancreatic islet development and metabolism.\"\n)', 'Human Diseases; Endocrine and metabolic disease', 'Maturity onset diabetes of the young', 'ko04950', 'list(REFERENCE = \"PMID:15298336\", AUTHORS = \"Servitja JM, Ferrer J.\", TITLE = \"Transcriptional networks controlling pancreatic development and beta cell function.\", JOURNAL = c(\"Diabetologia 47:597-613 (2004)\", \"DOI:10.1007/s00125-004-1368-9\")), list(REFERENCE = \"PMID:15604203\", AUTHORS = \"Habener JF, Kemp DM, Thomas MK.\", TITLE = \"Minireview: transcriptional regulation in pancreatic development.\", JOURNAL = c(\"Endocrinology 146:1025-34 (2005)\", \"DOI:10.1210/en.2004-1576\")), list(REFERENCE = \"PMID:15028942\", AUTHORS = \"Ashizawa S, Brunicardi FC, Wang XP.\", TITLE = \"PDX-1 and the pancreas.\", JOURNAL = \"Pancreas 28:109-20 (2004)\"), list(REFERENCE = \"PMID:14614204\", AUTHORS = \"Yamagata K.\", TITLE = \"Regulation of pancreatic beta-cell function by the HNF transcription network: lessons from maturity-onset diabetes of the young (MODY).\", JOURNAL = c(\"Endocr J 50:491-9 (2003)\", \"DOI:10.1507/endocrj.50.491\"))', 'map04950', 'Maturity onset diabetes of the young', 'About 2-5% of type II diabetic patients suffer from a monogenic disease with autosomal dominant inheritance. This monogenic form of type II diabetes is called maturity onset diabetes of the young (MODY)., We now know that MODY is caused by heterozygous mutations in at least five genes encoding transcription factors: HNF4alpha (MODY1), HNF1alpha (MODY3), PDX1 (MODY4), HNF1beta (MODY5) and NEUROD1 (MODY6). MODY2, which is so far the only subtype not related to a transcription factor, is caused by mutations in the glucokinase gene. Mutations of MODY transcription factor genes lead to abnormal expression of genes involved in pancreatic islet development and metabolism.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (370, '04960', 'Aldosterone-regulated sodium reabsorption', 'Sodium transport across the tight epithelia of Na+ reabsorbing tissues such as the distal part of the kidney nephron and colon is the major factor determining total-body Na+ levels, and thus, long-term blood pressure. Aldosterone plays a major role in sodium and potassium metabolism by binding to epithelial mineralocorticoid receptors (MR) in the renal collecting duct cells localized in the distal nephron, promoting sodium resorption and potassium excretion. Aldosterone enters a target cell and binds MR, which translocates into the nucleus and regulates gene transcription. Activation of MR leads to increased expression of Sgk-1, which phosphorylates Nedd4-2, an ubiquitin-ligase which targets ENAC to proteosomal degradation. Phosphorylated Nedd4-2 dissociates from ENAC, increasing its apical membrane abundance. Activation of MR also leads to increased expression of Na+/K+-ATPase, thus causing a net increase in sodium uptake from the renal filtrate. The specificity of MR for aldosterone is provided by 11beta-HSD2 by the rapid conversion of cortisol to cortisone in renal cortical collecting duct cells. Recently, besides genomic effects mediated by activated MR, rapid aldosterone actions that are independent of translation and transcription have been documented.', 'Organismal Systems; Excretory system', 'Aldosterone-regulated sodium reabsorption', 'Bartter syndrome, Liddle syndrome, Hyperkalemic distal renal tubular acidosis (RTA type 4), Hypertension exacerbated in pregnancy, Leprechaunism, Bronchiectasis with or without elevated sweat chloride, Rabson-Mendenhall syndrome, Alternating hemiplegia of childhood, Insulin-resistant diabetes mellitus with acanthosis nigricans, Renal tubular acidosis', 'ko04960', 'list(REFERENCE = \"PMID:16002531\", AUTHORS = \"Connell JM, Davies E\", TITLE = \"The new biology of aldosterone.\", JOURNAL = c(\"J Endocrinol 186:1-20 (2005)\", \"DOI:10.1677/joe.1.06017\")), list(REFERENCE = \"PMID:11850323\", AUTHORS = \"Booth RE, Johnson JP, Stockand JD\", TITLE = \"Aldosterone.\", JOURNAL = c(\"Adv Physiol Educ 26:8-20 (2002)\", \"DOI:10.1152/advan.00123.2015\")), list(REFERENCE = \"PMID:18197893\", AUTHORS = \"Lee IH, Campbell CR, Cook DI, Dinudom A\", TITLE = \"Regulation of epithelial Na+ channels by aldosterone: role of Sgk1.\", JOURNAL = c(\"Clin Exp Pharmacol Physiol 35:235-41 (2008)\", \"DOI:10.1111/j.1440-1681.2007.04844.x\")), list(REFERENCE = \"PMID:18174920\", AUTHORS = \"Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombes M\", TITLE = \"The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology.\", JOURNAL = c(\"Nucl Recept Signal 5:e012 (2007)\", \"DOI:10.1621/nrs.05012\")), list(REFERENCE = \"PMID:16286565\", AUTHORS = \"Fuller PJ, Young MJ\", TITLE = \"Mechanisms of mineralocorticoid action.\", JOURNAL = c(\"Hypertension 46:1227-35 (2005)\", \"DOI:10.1161/01.HYP.0000193502.77417.17\")), list(REFERENCE = \"PMID:12649599\", AUTHORS = \"Verrey F, Loffing J, Zecevic M, Heitzmann D, Staub O\", TITLE = \"SGK1: aldosterone-induced relay of Na+ transport regulation in distal kidney nephron cells.\", JOURNAL = c(\"Cell Physiol Biochem 13:21-8 (2003)\", \"DOI:10.1159/000070246\")), list(REFERENCE = \"PMID:17332888\", AUTHORS = \"Pearce D, Kleyman TR\", TITLE = \"Salt, sodium channels, and SGK1.\", JOURNAL = c(\"J Clin Invest 117:592-5 (2007)\", \"DOI:10.1172/JCI31538\")), list(REFERENCE = \"PMID:19549592\", AUTHORS = \"Grossmann C, Gekle M\", TITLE = \"New aspects of rapid aldosterone signaling.\", JOURNAL = c(\"Mol Cell Endocrinol 308:53-62 (2009)\", \"DOI:10.1016/j.mce.2009.02.005\")), list(REFERENCE = \"PMID:15590995\", AUTHORS = \"Vallon V, Wulff P, Huang DY, Loffing J, Volkl H, Kuhl D, Lang F\", TITLE = \"Role of Sgk1 in salt and potassium homeostasis.\", JOURNAL = c(\"Am J Physiol Regul Integr Comp Physiol 288:R4-10 (2005)\", \"DOI:10.1152/ajpregu.00369.2004\")), list(REFERENCE = \"PMID:12943727\", AUTHORS = \"Rogerson FM, Brennan FE, Fuller PJ\", TITLE = \"Dissecting mineralocorticoid receptor structure and function.\", JOURNAL = c(\"J Steroid Biochem Mol Biol 85:389-96 (2003)\", \"DOI:10.1016/S0960-0760(03)00200-0\")), list(REFERENCE = \"PMID:11208606\", AUTHORS = \"Wang J, Barbry P, Maiyar AC, Rozansky DJ, Bhargava A, Leong M, Firestone GL, Pearce D\", TITLE = \"SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport.\", JOURNAL = c(\"Am J Physiol Renal Physiol 280:F303-13 (2001)\", \"DOI:10.1152/ajprenal.2001.280.2.F303\")), list(REFERENCE = \"PMID:17309947\", AUTHORS = \"Good DW\", TITLE = \"Nongenomic actions of aldosterone on the renal tubule.\", JOURNAL = c(\"Hypertension 49:728-39 (2007)\", \"DOI:10.1161/01.HYP.0000259797.48382.b2\"))', 'map04960', 'Aldosterone-regulated sodium reabsorption', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (371, '04961', 'Endocrine and other factor-regulated calcium reabsorption', 'Calcium (Ca2+) is essential for numerous physiological functions including intracellular signalling processes, neuronal excitability, muscle contraction and bone formation. Therefore, its homeostasis is finely maintained through the coordination of intestinal absorption, renal reabsorption, and bone resorption. In kidney, the late part of the distal convoluted tubule (DCT) and the connecting tubule (CNT) are the site of active Ca2+ transport and precisely regulate Ca2+ reabsorption. Following Ca2+ entry through TRPV5, Ca2+ bound to calbindin-D28K diffuses to the basolateral side, where it is extruded into the blood compartment through NCX1 and to a lesser extent PMCA1b. In the urinary compartment, both klotho and tissue kallikrein (TK) increase the apical abundance of TRPV5. In the blood compartment, PTH, 1,25(OH)2D3 and estrogen increase the transcription and protein expression of the luminal Ca2+ channels, calbindins, and the extrusion systems.', 'Organismal Systems; Excretory system', 'Endocrine and other factor-regulated calcium reabsorption', 'Primary failure of tooth eruption, Centronuclear myopathy, Localized autosomal recessive hypotrichosis, Alternating hemiplegia of childhood, Vitamin D-dependent rickets, Familial tumoral calcinosis, Osteoporosis, Familial hypocalciuric hypercalcemia', 'ko04961', 'list(REFERENCE = \"PMID:18989697\", AUTHORS = \"Boros S, Bindels RJ, Hoenderop JG\", TITLE = \"Active Ca(2+) reabsorption in the connecting tubule.\", JOURNAL = c(\"Pflugers Arch 458:99-109 (2009)\", \"DOI:10.1007/s00424-008-0602-6\")), list(REFERENCE = \"PMID:16518325\", AUTHORS = \"Lambers TT, Bindels RJ, Hoenderop JG\", TITLE = \"Coordinated control of renal Ca2+ handling.\", JOURNAL = c(\"Kidney Int 69:650-4 (2006)\", \"DOI:10.1038/sj.ki.5000169\")), list(REFERENCE = \"PMID:18596722\", AUTHORS = \"de Groot T, Bindels RJ, Hoenderop JG\", TITLE = \"TRPV5: an ingeniously controlled calcium channel.\", JOURNAL = c(\"Kidney Int 74:1241-6 (2008)\", \"DOI:10.1038/ki.2008.320\")), list(REFERENCE = \"PMID:20969972\", AUTHORS = \"Markadieu N, Bindels RJ, Hoenderop JG\", TITLE = \"The renal connecting tubule: Resolved and unresolved issues in Ca(2+) transport.\", JOURNAL = c(\"Int J Biochem Cell Biol 43:1-4 (2011)\", \"DOI:10.1016/j.biocel.2010.10.006\")), list(REFERENCE = \"PMID:15618484\", AUTHORS = \"Hoenderop JG, Nilius B, Bindels RJ\", TITLE = \"Calcium absorption across epithelia.\", JOURNAL = c(\"Physiol Rev 85:373-422 (2005)\", \"DOI:10.1152/physrev.00003.2004\")), list(REFERENCE = \"PMID:15747113\", AUTHORS = \"van Abel M, Hoenderop JG, Bindels RJ\", TITLE = \"The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease.\", JOURNAL = c(\"Naunyn Schmiedebergs Arch Pharmacol 371:295-306 (2005)\", \"DOI:10.1007/s00210-005-1021-2\")), list(REFERENCE = \"PMID:16044309\", AUTHORS = \"Nijenhuis T, Hoenderop JG, Bindels RJ\", TITLE = \"TRPV5 and TRPV6 in Ca(2+) (re)absorption: regulating Ca(2+) entry at the gate.\", JOURNAL = c(\"Pflugers Arch 451:181-92 (2005)\", \"DOI:10.1007/s00424-005-1430-6\")), list(REFERENCE = \"PMID:12684797\", AUTHORS = \"Hoenderop JG, Nilius B, Bindels RJ\", TITLE = \"Epithelial calcium channels: from identification to function and regulation.\", JOURNAL = c(\"Pflugers Arch 446:304-8 (2003)\", \"DOI:10.1007/s00424-003-1045-8\")), list(REFERENCE = \"PMID:17006539\", AUTHORS = \"Gkika D, Topala CN, Chang Q, Picard N, Thebault S, Houillier P, Hoenderop JG, Bindels RJ\", TITLE = \"Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5.\", JOURNAL = c(\"EMBO J 25:4707-16 (2006)\", \"DOI:10.1038/sj.emboj.7601357\")), list(REFERENCE = \"PMID:17233615\", AUTHORS = \"Schoeber JP, Hoenderop JG, Bindels RJ\", TITLE = \"Concerted action of associated proteins in the regulation of TRPV5 and TRPV6.\", JOURNAL = c(\"Biochem Soc Trans 35:115-9 (2007)\", \"DOI:10.1042/BST0350115\")), list(REFERENCE = \"PMID:18293139\", AUTHORS = \"Renkema KY, Alexander RT, Bindels RJ, Hoenderop JG\", TITLE = \"Calcium and phosphate homeostasis: concerted interplay of new regulators.\", JOURNAL = c(\"Ann Med 40:82-91 (2008)\", \"DOI:10.1080/07853890701689645\")), list(REFERENCE = \"PMID:19423690\", AUTHORS = \"de Groot T, Lee K, Langeslag M, Xi Q, Jalink K, Bindels RJ, Hoenderop JG\", TITLE = \"Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation.\", JOURNAL = c(\"J Am Soc Nephrol 20:1693-704 (2009)\", \"DOI:10.1681/ASN.2008080873\"))', 'map04961', 'Endocrine and other factor-regulated calcium reabsorption', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (372, '04962', 'Vasopressin-regulated water reabsorption', 'In the kidney, the antidiuretic hormone vasopressin (AVP) is a critical regulator of water homeostasis by controlling the water movement from lumen to the interstitium for water reabsorption and adjusting the urinary water excretion. In normal physiology, AVP is secreted into the circulation by the posterior pituitary gland, in response to an increase in serum osmolality or a decrease in effective circulating volume. When reaching the kidney, AVP binds to V2 receptors on the basolateral surface of the collecting duct epithelium, triggering a G-protein-linked signaling cascade, which leads to water channel aquaporin-2 (AQP2) vesicle insertion into the apical plasma membrane. This results in higher water permeability in the collecting duct and, driven by an osmotic gradient, pro-urinary water then passes the membrane through AQP2 and leaves the cell on the basolateral side via AQP3 and AQP4 water channels, which are constitutively expressed on the basolateral side of these cells. When isotonicity is restored, reduced blood AVP levels results in AQP2 internalization, leaving the apical membrane watertight again.', 'Organismal Systems; Excretory system', 'Vasopressin-regulated water reabsorption', 'Congenital nephrogenic diabetes insipidus, Asphyxiating thoracic dystrophy, Nephrogenic syndrome of inappropriate antidiuresis, Syndrome of inappropriate secretion of antidiuretic hormone, Disorders of antidiuretic hormone (ADH) secretion', 'ko04962', 'list(REFERENCE = \"PMID:18431594\", AUTHORS = \"Boone M, Deen PM\", TITLE = \"Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption.\", JOURNAL = c(\"Pflugers Arch 456:1005-24 (2008)\", \"DOI:10.1007/s00424-008-0498-1\")), list(REFERENCE = \"PMID:18566824\", AUTHORS = \"Takata K, Matsuzaki T, Tajika Y, Ablimit A, Hasegawa T\", TITLE = \"Localization and trafficking of aquaporin 2 in the kidney.\", JOURNAL = c(\"Histochem Cell Biol 130:197-209 (2008)\", \"DOI:10.1007/s00418-008-0457-0\")), list(REFERENCE = \"PMID:10073616\", AUTHORS = \"Nielsen S, Kwon TH, Christensen BM, Promeneur D, Frokiaer J, Marples D\", TITLE = \"Physiology and pathophysiology of renal aquaporins.\", JOURNAL = \"J Am Soc Nephrol 10:647-63 (1999)\"), list(REFERENCE = \"PMID:10070156\", AUTHORS = \"Marples D, Frokiaer J, Nielsen S\", TITLE = \"Long-term regulation of aquaporins in the kidney.\", JOURNAL = c(\"Am J Physiol 276:F331-9 (1999)\", \"DOI:10.1152/ajprenal.1999.276.3.F331\")), list(REFERENCE = \"PMID:10099706\", AUTHORS = \"Ward DT, Hammond TG, Harris HW\", TITLE = \"Modulation of vasopressin-elicited water transport by trafficking of aquaporin2-containing vesicles.\", JOURNAL = c(\"Annu Rev Physiol 61:683-97 (1999)\", \"DOI:10.1146/annurev.physiol.61.1.683\")), list(REFERENCE = \"PMID:18655910\", AUTHORS = \"Fenton RA, Moeller HB\", TITLE = \"Recent discoveries in vasopressin-regulated aquaporin-2 trafficking.\", JOURNAL = c(\"Prog Brain Res 170:571-9 (2008)\", \"DOI:10.1016/S0079-6123(08)00444-5\")), list(REFERENCE = \"PMID:11773613\", AUTHORS = \"Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA\", TITLE = \"Aquaporins in the kidney: from molecules to medicine.\", JOURNAL = c(\"Physiol Rev 82:205-44 (2002)\", \"DOI:10.1152/physrev.00024.2001\")), list(REFERENCE = \"PMID:11001488\", AUTHORS = \"Deen PM, van Balkom BW, Kamsteeg EJ\", TITLE = \"Routing of the aquaporin-2 water channel in health and disease.\", JOURNAL = c(\"Eur J Cell Biol 79:523-30 (2000)\", \"DOI:10.1078/0171-9335-00075\")), list(REFERENCE = \"PMID:15522987\", AUTHORS = \"Bonilla-Felix M\", TITLE = \"Development of water transport in the collecting duct.\", JOURNAL = c(\"Am J Physiol Renal Physiol 287:F1093-101 (2004)\", \"DOI:10.1152/ajprenal.00119.2004\")), list(REFERENCE = \"PMID:17956998\", AUTHORS = \"Uawithya P, Pisitkun T, Ruttenberg BE, Knepper MA\", TITLE = \"Transcriptional profiling of native inner medullary collecting duct cells from rat kidney.\", JOURNAL = c(\"Physiol Genomics 32:229-53 (2008)\", \"DOI:10.1152/physiolgenomics.00201.2007\")), list(REFERENCE = \"PMID:14586738\", AUTHORS = \"Nguyen MK, Nielsen S, Kurtz I\", TITLE = \"Molecular pathogenesis of nephrogenic diabetes insipidus.\", JOURNAL = c(\"Clin Exp Nephrol 7:9-17 (2003)\", \"DOI:10.1007/s101570300001\"))', 'map04962', 'Vasopressin-regulated water reabsorption', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (373, '04964', 'Proximal tubule bicarbonate reclamation', 'One of the major tasks of the renal proximal tubule (PT) is to secrete acid into the tubule lumen, thereby reabsorbing approximately 80% of the filtered bicarbonate (HCO3(-)), as well as generating \"new HCO3(-)\" for regulating blood pH. In the tubular lumen, filtered HCO3(-) combines with H(+) in a reaction catalyzed by CA IV. The CO2 thus produced rapidly diffuses into the tubular cells and is combined with water to produce intracellular H(+) and HCO3(-), catalyzed by soluble cytoplasmic CA II. HCO3(-) is then cotransported with Na(+) into blood via the NBC-1. The intracellular H(+) produced by CA II is secreted into the tubular lumen predominantly via the NHE-3. The PT creates the \"new HCO3(-)\" by taking glutamine and metabolizing it to two molecules each of NH4(+) and HCO3(-). The NH4(+) is excreted into the tubular lumen, and the HCO3(-) , which is \"new HCO3(-) ,\" is returned to the blood, where it replaces the HCO3(-) lost earlier in the titration of nonvolatile acids.', 'Organismal Systems; Excretory system', 'Proximal tubule bicarbonate reclamation', 'Combined proximal and distal renal tubular acidosis, Proximal renal tubular acidosis (RTA type 2), Alternating hemiplegia of childhood, Renal tubular acidosis', 'ko04964', 'list(REFERENCE = \"PMID:19948674\", AUTHORS = \"Koeppen BM\", TITLE = \"The kidney and acid-base regulation.\", JOURNAL = c(\"Adv Physiol Educ 33:275-81 (2009)\", \"DOI:10.1152/advan.00054.2009\")), list(REFERENCE = \"PMID:16914536\", AUTHORS = \"Boron WF\", TITLE = \"Acid-base transport by the renal proximal tubule.\", JOURNAL = c(\"J Am Soc Nephrol 17:2368-82 (2006)\", \"DOI:10.1681/ASN.2006060620\")), list(REFERENCE = \"PMID:9550618\", AUTHORS = \"Hayashi M\", TITLE = \"Physiology and pathophysiology of acid-base homeostasis in the kidney.\", JOURNAL = c(\"Intern Med 37:221-5 (1998)\", \"DOI:10.2169/internalmedicine.37.221\")), list(REFERENCE = \"PMID:16352913\", AUTHORS = \"Wagner CA, Kovacikova J, Stehberger PA, Winter C, Benabbas C, Mohebbi N\", TITLE = \"Renal acid-base transport: old and new players.\", JOURNAL = c(\"Nephron Physiol 103:p1-6 (2006)\", \"DOI:10.1159/000090217\")), list(REFERENCE = \"PMID:17557941\", AUTHORS = \"Fry AC, Karet FE\", TITLE = \"Inherited renal acidoses.\", JOURNAL = c(\"Physiology (Bethesda) 22:202-11 (2007)\", \"DOI:10.1152/physiol.00044.2006\")), list(REFERENCE = \"PMID:19721811\", AUTHORS = \"Pereira PC, Miranda DM, Oliveira EA, Silva AC\", TITLE = \"Molecular pathophysiology of renal tubular acidosis.\", JOURNAL = c(\"Curr Genomics 10:51-9 (2009)\", \"DOI:10.2174/138920209787581262\")), list(REFERENCE = \"PMID:12138151\", AUTHORS = \"Igarashi T, Sekine T, Inatomi J, Seki G\", TITLE = \"Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis.\", JOURNAL = c(\"J Am Soc Nephrol 13:2171-7 (2002)\", \"DOI:10.1097/01.ASN.0000025281.70901.30\")), list(REFERENCE = \"PMID:11826292\", AUTHORS = \"Alper SL\", TITLE = \"Genetic diseases of acid-base transporters.\", JOURNAL = c(\"Annu Rev Physiol 64:899-923 (2002)\", \"DOI:10.1146/annurev.physiol.64.092801.141759\")), list(REFERENCE = \"PMID:11385088\", AUTHORS = \"Unwin RJ, Capasso G\", TITLE = \"The renal tubular acidoses.\", JOURNAL = \"J R Soc Med 94:221-5 (2001)\"), list(REFERENCE = \"PMID:11045400\", AUTHORS = \"Rodriguez-Soriano J\", TITLE = \"New insights into the pathogenesis of renal tubular acidosis--from functional to molecular studies.\", JOURNAL = \"Pediatr Nephrol 14:1121-36 (2000)\"), list(REFERENCE = \"PMID:18056784\", AUTHORS = \"Nowik M, Lecca MR, Velic A, Rehrauer H, Brandli AW, Wagner CA\", TITLE = \"Genome-wide gene expression profiling reveals renal genes regulated during metabolic acidosis.\", JOURNAL = c(\"Physiol Genomics 32:322-34 (2008)\", \"DOI:10.1152/physiolgenomics.00160.2007\")), list(REFERENCE = \"PMID:11533299\", AUTHORS = \"Curthoys NP\", TITLE = \"Role of mitochondrial glutaminase in rat renal glutamine metabolism.\", JOURNAL = c(\"J Nutr 131:2491S-5S; discussion 2496S-7S (2001)\", \"DOI:10.1093/jn/131.9.2491S\"))', 'map04964', 'Proximal tubule bicarbonate reclamation', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (374, '04966', 'Collecting duct acid secretion', 'One of the important roles of the collecting duct segment of the kidney nephron is acid secretion. As daily food intake loads acid into the body, urinary acid excretion is essential, and urine pH can drop as low as 4.5. The alpha-intercalated cell of collecting duct is the main responsible for hydrogen secretion into the urine. The carbon dioxide, which is generated in the cells and enters from the blood, is changed to carbonic acid. This carbonic acid is divided into hydrogen ion and bicarbonate ion. Intracellular CA II catalyses the formation of these ions. The hydrogen ion is secreted into the lumen by the luminal H(+)-ATPase. The bicarbonate ion is transported to the blood side by the anion exchanger type 1. Hydrogen ion in the lumen is trapped by urinary buffers. These include ammonium and phosphate.', 'Organismal Systems; Excretory system', 'Collecting duct acid secretion', 'Combined proximal and distal renal tubular acidosis, Distal renal tubular acidosis (RTA type 1), Renal tubular acidosis', 'ko04966', 'list(REFERENCE = \"PMID:16352913\", AUTHORS = \"Wagner CA, Kovacikova J, Stehberger PA, Winter C, Benabbas C, Mohebbi N\", TITLE = \"Renal acid-base transport: old and new players.\", JOURNAL = c(\"Nephron Physiol 103:p1-6 (2006)\", \"DOI:10.1159/000090217\")), list(REFERENCE = \"PMID:19277700\", AUTHORS = \"Wagner CA, Devuyst O, Bourgeois S, Mohebbi N\", TITLE = \"Regulated acid-base transport in the collecting duct.\", JOURNAL = c(\"Pflugers Arch 458:137-56 (2009)\", \"DOI:10.1007/s00424-009-0657-z\")), list(REFERENCE = \"PMID:19948674\", AUTHORS = \"Koeppen BM\", TITLE = \"The kidney and acid-base regulation.\", JOURNAL = c(\"Adv Physiol Educ 33:275-81 (2009)\", \"DOI:10.1152/advan.00054.2009\")), list(REFERENCE = \"PMID:9550618\", AUTHORS = \"Hayashi M\", TITLE = \"Physiology and pathophysiology of acid-base homeostasis in the kidney.\", JOURNAL = c(\"Intern Med 37:221-5 (1998)\", \"DOI:10.2169/internalmedicine.37.221\")), list(REFERENCE = \"PMID:17557941\", AUTHORS = \"Fry AC, Karet FE\", TITLE = \"Inherited renal acidoses.\", JOURNAL = c(\"Physiology (Bethesda) 22:202-11 (2007)\", \"DOI:10.1152/physiol.00044.2006\")), list(REFERENCE = \"PMID:19721811\", AUTHORS = \"Pereira PC, Miranda DM, Oliveira EA, Silva AC\", TITLE = \"Molecular pathophysiology of renal tubular acidosis.\", JOURNAL = c(\"Curr Genomics 10:51-9 (2009)\", \"DOI:10.2174/138920209787581262\")), list(REFERENCE = \"PMID:11045400\", AUTHORS = \"Rodriguez-Soriano J\", TITLE = \"New insights into the pathogenesis of renal tubular acidosis--from functional to molecular studies.\", JOURNAL = \"Pediatr Nephrol 14:1121-36 (2000)\"), list(REFERENCE = \"PMID:11826292\", AUTHORS = \"Alper SL\", TITLE = \"Genetic diseases of acid-base transporters.\", JOURNAL = c(\"Annu Rev Physiol 64:899-923 (2002)\", \"DOI:10.1146/annurev.physiol.64.092801.141759\"))', 'map04966', 'Collecting duct acid secretion', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (375, '04970', 'Salivary secretion', 'Saliva has manifold functions in maintaining the integrity of the oral tissues, in protecting teeth from caries, in the tasting and ingestion of food, in speech and in the tolerance of tenures, for example. Salivary secretion occurs in response to stimulation by neurotransmitters released from autonomic nerve endings. There are two secretory pathways: protein exocytosis and fluid secretion. Sympathetic stimulation leads to the activation of adenylate cyclase and accumulation of intracellular cAMP. The elevation of cAMP causes the secretion of proteins such as amylase and mucin. In contrast, parasympathetic stimulation activates phospholipase C and causes the elevation of intracellular Ca2+, which leads to fluid secretion; that is, water and ion transport. Ca2+ also induces amylase secretion, but the amount is smaller than that induced by cAMP.', 'Organismal Systems; Digestive system', 'Salivary secretion', 'GO: 0046541', 'ko04970', 'list(REFERENCE = \"PMID:16799262\", AUTHORS = \"Ishikawa Y, Cho G, Yuan Z, Skowronski MT, Pan Y, Ishida H\", TITLE = \"Water channels and zymogen granules in salivary glands.\", JOURNAL = c(\"J Pharmacol Sci 100:495-512 (2006)\", \"DOI:10.1254/jphs.CRJ06007X\")), list(REFERENCE = \"PMID:16712780\", AUTHORS = \"Ishikawa Y, Cho G, Yuan Z, Inoue N, Nakae Y\", TITLE = \"Aquaporin-5 water channel in lipid rafts of rat parotid glands.\", JOURNAL = c(\"Biochim Biophys Acta 1758:1053-60 (2006)\", \"DOI:10.1016/j.bbamem.2006.03.026\")), list(REFERENCE = \"PMID:10682899\", AUTHORS = \"Ambudkar IS\", TITLE = \"Regulation of calcium in salivary gland secretion.\", JOURNAL = c(\"Crit Rev Oral Biol Med 11:4-25 (2000)\", \"DOI:10.1177/10454411000110010301\")), list(REFERENCE = \"PMID:10928320\", AUTHORS = \"Ishikawa Y, Ishida H\", TITLE = \"Aquaporin water channel in salivary glands.\", JOURNAL = c(\"Jpn J Pharmacol 83:95-101 (2000)\", \"DOI:10.1254/jjp.83.95\")), list(REFERENCE = \"PMID:8105741\", AUTHORS = \"Baum BJ\", TITLE = \"Principles of saliva secretion.\", JOURNAL = c(\"Ann N Y Acad Sci 694:17-23 (1993)\", \"DOI:10.1111/j.1749-6632.1993.tb18338.x\")), list(REFERENCE = \"PMID:9720759\", AUTHORS = \"Fujita-Yoshigaki J\", TITLE = \"Divergence and convergence in regulated exocytosis: the characteristics of cAMP-dependent enzyme secretion of parotid salivary acinar cells.\", JOURNAL = c(\"Cell Signal 10:371-5 (1998)\", \"DOI:10.1016/S0898-6568(97)00178-2\")), list(REFERENCE = \"PMID:18626068\", AUTHORS = \"Heitzmann D, Warth R\", TITLE = \"Physiology and pathophysiology of potassium channels in gastrointestinal epithelia.\", JOURNAL = c(\"Physiol Rev 88:1119-82 (2008)\", \"DOI:10.1152/physrev.00020.2007\")), list(REFERENCE = \"PMID:17157080\", AUTHORS = \"Proctor GB, Carpenter GH\", TITLE = \"Regulation of salivary gland function by autonomic nerves.\", JOURNAL = c(\"Auton Neurosci 133:3-18 (2007)\", \"DOI:10.1016/j.autneu.2006.10.006\")), list(REFERENCE = \"PMID:11936453\", AUTHORS = \"Turner RJ, Sugiya H\", TITLE = \"Understanding salivary fluid and protein secretion.\", JOURNAL = c(\"Oral Dis 8:3-11 (2002)\", \"DOI:10.1034/j.1601-0825.2002.10815.x\")), list(REFERENCE = \"PMID:15153696\", AUTHORS = \"Van Nieuw Amerongen A, Bolscher JG, Veerman EC\", TITLE = \"Salivary proteins: protective and diagnostic value in cariology?\", JOURNAL = c(\"Caries Res 38:247-53 (2004)\", \"DOI:10.1159/000077762\")), list(REFERENCE = \"PMID:17347411\", AUTHORS = \"Nakamoto T, Srivastava A, Romanenko VG, Ovitt CE, Perez-Cornejo P, Arreola J, Begenisich T, Melvin JE\", TITLE = \"Functional and molecular characterization of the fluid secretion mechanism in human parotid acinar cells.\", JOURNAL = c(\"Am J Physiol Regul Integr Comp Physiol 292:R2380-90 (2007)\", \"DOI:10.1152/ajpregu.00591.2006\")), list(REFERENCE = \"PMID:15709965\", AUTHORS = \"Melvin JE, Yule D, Shuttleworth T, Begenisich T\", TITLE = \"Regulation of fluid and electrolyte secretion in salivary gland acinar cells.\", JOURNAL = c(\"Annu Rev Physiol 67:445-69 (2005)\", \"DOI:10.1146/annurev.physiol.67.041703.084745\")), list(REFERENCE = \"PMID:20224180\", AUTHORS = \"Catalan MA, Nakamoto T, Melvin JE\", TITLE = \"The salivary gland fluid secretion mechanism.\", JOURNAL = c(\"J Med Invest 56 Suppl:192-6 (2009)\", \"DOI:10.2152/jmi.56.192\"))', 'map04970', 'Salivary secretion', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (376, '04971', 'Gastric acid secretion', 'Gastric acid is a key factor in normal upper gastrointestinal functions, including protein digestion and calcium and iron absorption, as well as providing some protection against bacterial infections. The principal stimulants of acid secretion at the level of the parietal cell are histamine (paracrine), gastrin (hormonal), and acetycholine (ACh; neurocrine). Stimulation of acid secretion typically involves an initial elevation of intracellular calcium and cAMP, followed by activation of protein kinase cascades, which trigger the translocation of the proton pump, H+,K+-ATPase, from cytoplasmic tubulovesicles to the apical plasma membrane and thereby H+ secretion into the stomach lumen.', 'Organismal Systems; Digestive system', 'Gastric acid secretion', 'Hereditary pancreatitis, Zollinger-Ellison syndrome', 'GO: 0001696', 'ko04971', 'list(REFERENCE = \"PMID:18474247\", AUTHORS = \"Schubert ML, Peura DA\", TITLE = \"Control of gastric acid secretion in health and disease.\", JOURNAL = c(\"Gastroenterology 134:1842-60 (2008)\", \"DOI:10.1053/j.gastro.2008.05.021\")), list(REFERENCE = \"PMID:9307437\", AUTHORS = \"Urushidani T, Forte JG\", TITLE = \"Signal transduction and activation of acid secretion in the parietal cell.\", JOURNAL = c(\"J Membr Biol 159:99-111 (1997)\", \"DOI:10.1007/s002329900274\")), list(REFERENCE = \"PMID:12500969\", AUTHORS = \"Yao X, Forte JG\", TITLE = \"Cell biology of acid secretion by the parietal cell.\", JOURNAL = c(\"Annu Rev Physiol 65:103-31 (2003)\", \"DOI:10.1146/annurev.physiol.65.072302.114200\")), list(REFERENCE = \"PMID:17928547\", AUTHORS = \"Heitzmann D, Warth R\", TITLE = \"No potassium, no acid: K+ channels and gastric acid secretion.\", JOURNAL = c(\"Physiology (Bethesda) 22:335-41 (2007)\", \"DOI:10.1152/physiol.00016.2007\")), list(REFERENCE = \"PMID:19889964\", AUTHORS = \"Kopic S, Murek M, Geibel JP\", TITLE = \"Revisiting the parietal cell.\", JOURNAL = c(\"Am J Physiol Cell Physiol 298:C1-C10 (2010)\", \"DOI:10.1152/ajpcell.00478.2009\")), list(REFERENCE = \"PMID:15703676\", AUTHORS = \"Schubert ML\", TITLE = \"Gastric secretion.\", JOURNAL = \"Curr Opin Gastroenterol 20:519-25 (2004)\"), list(REFERENCE = \"PMID:16391411\", AUTHORS = \"Konturek SJ, Konturek PC, Brzozowski T, Konturek JW, Pawlik WW\", TITLE = \"From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century.\", JOURNAL = \"J Physiol Pharmacol 56:507-30 (2005)\"), list(REFERENCE = \"PMID:20148676\", AUTHORS = \"Forte JG, Zhu L\", TITLE = \"Apical recycling of the gastric parietal cell H,K-ATPase.\", JOURNAL = c(\"Annu Rev Physiol 72:273-96 (2010)\", \"DOI:10.1146/annurev-physiol-021909-135744\")), list(REFERENCE = \"PMID:18061403\", AUTHORS = \"Szaszak M, Christian F, Rosenthal W, Klussmann E\", TITLE = \"Compartmentalized cAMP signalling in regulated exocytic processes in non-neuronal cells.\", JOURNAL = c(\"Cell Signal 20:590-601 (2008)\", \"DOI:10.1016/j.cellsig.2007.10.020\")), list(REFERENCE = \"PMID:18626068\", AUTHORS = \"Heitzmann D, Warth R\", TITLE = \"Physiology and pathophysiology of potassium channels in gastrointestinal epithelia.\", JOURNAL = c(\"Physiol Rev 88:1119-82 (2008)\", \"DOI:10.1152/physrev.00020.2007\")), list(REFERENCE = \"PMID:15579540\", AUTHORS = \"Heitzmann D, Grahammer F, von Hahn T, Schmitt-Graff A, Romeo E, Nitschke R, Gerlach U, Lang HJ, Verrey F, Barhanin J, Warth R\", TITLE = \"Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells.\", JOURNAL = c(\"J Physiol 561:547-57 (2004)\", \"DOI:10.1113/jphysiol.2004.075168\")), list(REFERENCE = \"PMID:20331540\", AUTHORS = \"Seidler U, Song P, Xiao F, Riederer B, Bachmann O, Chen M\", TITLE = \"Recent advances in the molecular and functional characterization of acid/base and electrolyte transporters in the basolateral membranes of gastric and duodenal epithelial cells.\", JOURNAL = c(\"Acta Physiol (Oxf) 201:3-20 (2011)\", \"DOI:10.1111/j.1748-1716.2010.02107.x\"))', 'map04971', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (377, '04972', 'Pancreatic secretion', 'The pancreas performs both exocrine and endocrine functions. The exocrine pancreas consists of two parts, the acinar and duct cells. The primary functions of pancreatic acinar cells are to synthesize and secrete digestive enzymes. Stimulation of the cell by secretagogues such as acetylcholine (ACh) and cholecystokinin (CCK) causes the generation of an intracellular Ca2+ signal. This signal, in turn, triggers the fusion of the zymogen granules with the apical plasma membrane, leading to the polarised secretion of the enzymes. The major task of pancreatic duct cells is the secretion of fluid and bicarbonate ions (HCO3-), which neutralize the acidity of gastric contents that enter the duodenum. An increase in intracellular cAMP by secretin is one of the major signals of pancreatic HCO3- secretion. Activation of the CFTR Cl- channel and the CFTR-dependent Cl-/HCO3- exchange activities is responsible for cAMP-induced HCO3- secretion.', 'Organismal Systems; Digestive system', 'Pancreatic secretion', 'Type 2 diabetes mellitus, Hereditary pancreatitis, Pancreatic lipase deficiency', 'GO: 0030157', 'ko04972', 'list(REFERENCE = \"PMID:17850212\", AUTHORS = \"Petersen OH, Tepikin AV\", TITLE = \"Polarized calcium signaling in exocrine gland cells.\", JOURNAL = c(\"Annu Rev Physiol 70:273-99 (2008)\", \"DOI:10.1146/annurev.physiol.70.113006.100618\")), list(REFERENCE = \"PMID:20625287\", AUTHORS = \"Williams JA\", TITLE = \"Regulation of acinar cell function in the pancreas.\", JOURNAL = c(\"Curr Opin Gastroenterol 26:478-83 (2010)\", \"DOI:10.1097/MOG.0b013e32833d11c6\")), list(REFERENCE = \"PMID:16891880\", AUTHORS = \"Williams JA\", TITLE = \"Regulation of pancreatic acinar cell function.\", JOURNAL = c(\"Curr Opin Gastroenterol 22:498-504 (2006)\", \"DOI:10.1097/01.mog.0000239863.96833.c0\")), list(REFERENCE = \"PMID:15689674\", AUTHORS = \"Bi Y, Williams JA\", TITLE = \"Receptor biology and signal transduction in pancreatic acinar cells.\", JOURNAL = \"Curr Opin Gastroenterol 20:427-34 (2004)\"), list(REFERENCE = \"PMID:14660554\", AUTHORS = \"Yamasaki M, Masgrau R, Morgan AJ, Churchill GC, Patel S, Ashcroft SJ, Galione A\", TITLE = \"Organelle selection determines agonist-specific Ca2+ signals in pancreatic acinar and beta cells.\", JOURNAL = c(\"J Biol Chem 279:7234-40 (2004)\", \"DOI:10.1074/jbc.M311088200\")), list(REFERENCE = \"PMID:9548666\", AUTHORS = \"Kanno T\", TITLE = \"Ca2+ signaling in the pancreatic acinus.\", JOURNAL = \"Pancreas 16:273-6 (1998)\"), list(REFERENCE = \"PMID:18626068\", AUTHORS = \"Heitzmann D, Warth R\", TITLE = \"Physiology and pathophysiology of potassium channels in gastrointestinal epithelia.\", JOURNAL = c(\"Physiol Rev 88:1119-82 (2008)\", \"DOI:10.1152/physrev.00020.2007\")), list(REFERENCE = \"PMID:14637169\", AUTHORS = \"Konturek SJ, Zabielski R, Konturek JW, Czarnecki J\", TITLE = \"Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion.\", JOURNAL = c(\"Eur J Pharmacol 481:1-14 (2003)\", \"DOI:10.1016/j.ejphar.2003.08.042\")), list(REFERENCE = \"PMID:16888148\", AUTHORS = \"Chu JY, Yung WH, Chow BK\", TITLE = \"Secretin: a pleiotrophic hormone.\", JOURNAL = c(\"Ann N Y Acad Sci 1070:27-50 (2006)\", \"DOI:10.1196/annals.1317.013\")), list(REFERENCE = \"PMID:16930743\", AUTHORS = \"Siu FK, Lam IP, Chu JY, Chow BK\", TITLE = \"Signaling mechanisms of secretin receptor.\", JOURNAL = c(\"Regul Pept 137:95-104 (2006)\", \"DOI:10.1016/j.regpep.2006.02.011\")), list(REFERENCE = \"PMID:15709963\", AUTHORS = \"Steward MC, Ishiguro H, Case RM\", TITLE = \"Mechanisms of bicarbonate secretion in the pancreatic duct.\", JOURNAL = c(\"Annu Rev Physiol 67:377-409 (2005)\", \"DOI:10.1146/annurev.physiol.67.031103.153247\")), list(REFERENCE = \"PMID:20224219\", AUTHORS = \"Kim D, Steward MC\", TITLE = \"The role of CFTR in bicarbonate secretion by pancreatic duct and airway epithelia.\", JOURNAL = c(\"J Med Invest 56 Suppl:336-42 (2009)\", \"DOI:10.2152/jmi.56.336\")), list(REFERENCE = \"PMID:17205399\", AUTHORS = \"Whitcomb DC, Lowe ME\", TITLE = \"Human pancreatic digestive enzymes.\", JOURNAL = c(\"Dig Dis Sci 52:1-17 (2007)\", \"DOI:10.1007/s10620-006-9589-z\")), list(REFERENCE = \"PMID:10835353\", AUTHORS = \"Cancela JM, Gerasimenko OV, Gerasimenko JV, Tepikin AV, Petersen OH\", TITLE = \"Two different but converging messenger pathways to intracellular Ca(2+) release: the roles of nicotinic acid adenine dinucleotide phosphate, cyclic ADP-ribose and inositol trisphosphate.\", JOURNAL = c(\"EMBO J 19:2549-57 (2000)\", \"DOI:10.1093/emboj/19.11.2549\")), list(REFERENCE = \"PMID:10078532\", AUTHORS = \"Cancela JM, Churchill GC, Galione A\", TITLE = \"Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells.\", JOURNAL = c(\"Nature 398:74-6 (1999)\", \"DOI:10.1038/18032\")), list(REFERENCE = \"PMID:11087843\", AUTHORS = \"Parekh AB\", TITLE = \"Calcium signaling and acute pancreatitis: specific response to a promiscuous messenger.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 97:12933-4 (2000)\", \"DOI:10.1073/pnas.97.24.12933\")), list(REFERENCE = \"PMID:19088252\", AUTHORS = \"Williams JA, Chen X, Sabbatini ME\", TITLE = \"Small G proteins as key regulators of pancreatic digestive enzyme secretion.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 296:E405-14 (2009)\", \"DOI:10.1152/ajpendo.90874.2008\"))', 'map04972', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (378, '04973', 'Carbohydrate digestion and absorption', 'Dietary carbohydrate in humans and omnivorous animals is a major nutrient. The carbohydrates that we ingest vary from the lactose in milk to complex carbohydrates. These carbohydrates are digested to monosaccharides, mostly glucose, galactose and fructose, prior to absorption in the small intestine. Glucose and galactose are initially transported into the enterocyte by SGLT1 located in the apical brush border membrane and then exit through the basolateral membrane by either GLUT2 or exocytosis. In a new model of intestinal glucose absorption, transport by SGLT1 induces rapid insertion and activation of GLUT2 in the brush border membrane by a PKC betaII-dependent mechanism. Moreover, trafficking of apical GLUT2 is rapidly up-regulated by glucose and artificial sweeteners, which act through T1R2 + T1R3/alpha-gustducin to activate PLC-beta2 and PKC-beta II. Fructose is transported separately by the brush border GLUT5 and then released out of the enterocyte into the blood by GLUT2.', 'Organismal Systems; Digestive system', 'Carbohydrate digestion and absorption', 'Congenital glucose-galactose malabsorption, Glycogen storage disease type I, Fanconi-Bickel syndrome', 'GO: 0044245 0001951', 'ko04973', 'list(REFERENCE = \"PMID:16586532\", AUTHORS = \"Drozdowski LA, Thomson AB\", TITLE = \"Intestinal sugar transport.\", JOURNAL = c(\"World J Gastroenterol 12:1657-70 (2006)\", \"DOI:10.3748/wjg.v12.i11.1657\")), list(REFERENCE = \"PMID:14642859\", AUTHORS = \"Wright EM, Martin MG, Turk E\", TITLE = \"Intestinal absorption in health and disease--sugars.\", JOURNAL = c(\"Best Pract Res Clin Gastroenterol 17:943-56 (2003)\", \"DOI:10.1016/S1521-6918(03)00107-0\")), list(REFERENCE = \"PMID:18393659\", AUTHORS = \"Kellett GL, Brot-Laroche E, Mace OJ, Leturque A\", TITLE = \"Sugar absorption in the intestine: the role of GLUT2.\", JOURNAL = c(\"Annu Rev Nutr 28:35-54 (2008)\", \"DOI:10.1146/annurev.nutr.28.061807.155518\")), list(REFERENCE = \"PMID:19001049\", AUTHORS = \"Mace OJ, Lister N, Morgan E, Shepherd E, Affleck J, Helliwell P, Bronk JR, Kellett GL, Meredith D, Boyd R, Pieri M, Bailey PD, Pettcrew R, Foley D\", TITLE = \"An energy supply network of nutrient absorption coordinated by calcium and T1R taste receptors in rat small intestine.\", JOURNAL = c(\"J Physiol 587:195-210 (2009)\", \"DOI:10.1113/jphysiol.2008.159616\")), list(REFERENCE = \"PMID:16186415\", AUTHORS = \"Kellett GL, Brot-Laroche E\", TITLE = \"Apical GLUT2: a major pathway of intestinal sugar absorption.\", JOURNAL = c(\"Diabetes 54:3056-62 (2005)\", \"DOI:10.2337/diabetes.54.10.3056\")), list(REFERENCE = \"PMID:20522896\", AUTHORS = \"Goodman BE\", TITLE = \"Insights into digestion and absorption of major nutrients in humans.\", JOURNAL = c(\"Adv Physiol Educ 34:44-53 (2010)\", \"DOI:10.1152/advan.00094.2009\")), list(REFERENCE = \"PMID:17222166\", AUTHORS = \"Wright EM, Hirayama BA, Loo DF\", TITLE = \"Active sugar transport in health and disease.\", JOURNAL = c(\"J Intern Med 261:32-43 (2007)\", \"DOI:10.1111/j.1365-2796.2006.01746.x\")), list(REFERENCE = \"PMID:12512027\", AUTHORS = \"Santer R, Hillebrand G, Steinmann B, Schaub J\", TITLE = \"Intestinal glucose transport: evidence for a membrane traffic-based pathway in humans.\", JOURNAL = c(\"Gastroenterology 124:34-9 (2003)\", \"DOI:10.1053/gast.2003.50009\")), list(REFERENCE = \"PMID:11562503\", AUTHORS = \"Stumpel F, Burcelin R, Jungermann K, Thorens B\", TITLE = \"Normal kinetics of intestinal glucose absorption in the absence of GLUT2: evidence for a transport pathway requiring glucose phosphorylation and transfer into the endoplasmic reticulum.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 98:11330-5 (2001)\", \"DOI:10.1073/pnas.211357698\")), list(REFERENCE = \"PMID:15546855\", AUTHORS = \"Wright EM, Loo DD, Hirayama BA, Turk E\", TITLE = \"Surprising versatility of Na+-glucose cotransporters: SLC5.\", JOURNAL = c(\"Physiology (Bethesda) 19:370-6 (2004)\", \"DOI:10.1152/physiol.00026.2004\")), list(REFERENCE = \"PMID:12750891\", AUTHORS = \"Uldry M, Thorens B\", TITLE = \"The SLC2 family of facilitated hexose and polyol transporters.\", JOURNAL = c(\"Pflugers Arch 447:480-9 (2004)\", \"DOI:10.1007/s00424-003-1085-0\")), list(REFERENCE = \"PMID:7555019\", AUTHORS = \"Van Beers EH, Buller HA, Grand RJ, Einerhand AW, Dekker J\", TITLE = \"Intestinal brush border glycohydrolases: structure, function, and development.\", JOURNAL = c(\"Crit Rev Biochem Mol Biol 30:197-262 (1995)\", \"DOI:10.3109/10409239509085143\")), list(REFERENCE = \"PMID:5089892\", AUTHORS = \"Marsh MN\", TITLE = \"Digestive-absorptive functions of the enterocyte.\", JOURNAL = \"Ann R Coll Surg Engl 48:356-68 (1971)\"), list(REFERENCE = \"PMID:12583961\", AUTHORS = \"Guarner F, Malagelada JR\", TITLE = \"Gut flora in health and disease.\", JOURNAL = c(\"Lancet 361:512-9 (2003)\", \"DOI:10.1016/S0140-6736(03)12489-0\")), list(REFERENCE = \"PMID:11427691\", AUTHORS = \"Topping DL, Clifton PM\", TITLE = \"Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides.\", JOURNAL = c(\"Physiol Rev 81:1031-64 (2001)\", \"DOI:10.1152/physrev.2001.81.3.1031\"))', 'map04973', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (379, '04974', 'Protein digestion and absorption', 'Protein is a dietary component essential for nutritional homeostasis in humans. Normally, ingested protein undergoes a complex series of degradative processes following the action of gastric, pancreatic and small intestinal enzymes. The result of this proteolytic activity is a mixture of amino acids and small peptides. Amino acids (AAs) are transported into the enterocyte (intestinal epithelial cell) by a variety of AA transporters that are specific for cationic (basic) AA, neutral AA, and anionic (acidic) AA. Small peptides are absorbed into enterocytes by the PEPT1 transporter. Inside enterocytes peptides are hydrolyzed, and the resulting amino acids are released together with those absorbed by AA transporters into blood via multiple, basolateral, AA transporters. Hydrolysis-resistant peptides, however, are transported out of the cells by a basolateral peptide transporter that has not been identified molecularly.', 'Organismal Systems; Digestive system', 'Protein digestion and absorption', 'Hartnup disorder, Lysinuric protein intolerance, Cystinuria, Iminoglycinuria, Dicarboxylic aminoaciduria, Hereditary pancreatitis, Hyperglycinuria', 'GO: 0044256 0050892', 'ko04974', 'list(REFERENCE = \"PMID:18195088\", AUTHORS = \"Broer S\", TITLE = \"Amino acid transport across mammalian intestinal and renal epithelia.\", JOURNAL = c(\"Physiol Rev 88:249-86 (2008)\", \"DOI:10.1152/physrev.00018.2006\")), list(REFERENCE = \"PMID:15772300\", AUTHORS = \"Palacin M, Nunes V, Font-Llitjos M, Jimenez-Vidal M, Fort J, Gasol E, Pineda M, Feliubadalo L, Chillaron J, Zorzano A\", TITLE = \"The genetics of heteromeric amino acid transporters.\", JOURNAL = c(\"Physiology (Bethesda) 20:112-24 (2005)\", \"DOI:10.1152/physiol.00051.2004\")), list(REFERENCE = \"PMID:20522896\", AUTHORS = \"Goodman BE\", TITLE = \"Insights into digestion and absorption of major nutrients in humans.\", JOURNAL = c(\"Adv Physiol Educ 34:44-53 (2010)\", \"DOI:10.1152/advan.00094.2009\")), list(REFERENCE = \"PMID:11546643\", AUTHORS = \"Wagner CA, Lang F, Broer S\", TITLE = \"Function and structure of heterodimeric amino acid transporters.\", JOURNAL = c(\"Am J Physiol Cell Physiol 281:C1077-93 (2001)\", \"DOI:10.1152/ajpcell.2001.281.4.C1077\")), list(REFERENCE = \"PMID:18400692\", AUTHORS = \"Broer S\", TITLE = \"Apical transporters for neutral amino acids: physiology and pathophysiology.\", JOURNAL = c(\"Physiology (Bethesda) 23:95-103 (2008)\", \"DOI:10.1152/physiol.00045.2007\")), list(REFERENCE = \"PMID:9687539\", AUTHORS = \"Wu G\", TITLE = \"Intestinal mucosal amino acid catabolism.\", JOURNAL = c(\"J Nutr 128:1249-52 (1998)\", \"DOI:10.1093/jn/128.8.1249\")), list(REFERENCE = \"PMID:14977407\", AUTHORS = \"Daniel H\", TITLE = \"Molecular and integrative physiology of intestinal peptide transport.\", JOURNAL = c(\"Annu Rev Physiol 66:361-84 (2004)\", \"DOI:10.1146/annurev.physiol.66.032102.144149\")), list(REFERENCE = \"PMID:12237156\", AUTHORS = \"Rubio-Aliaga I, Daniel H\", TITLE = \"Mammalian peptide transporters as targets for drug delivery.\", JOURNAL = c(\"Trends Pharmacol Sci 23:434-40 (2002)\", \"DOI:10.1016/S0165-6147(02)02072-2\")), list(REFERENCE = \"PMID:7937532\", AUTHORS = \"Bai JP\", TITLE = \"Distribution of brush-border membrane peptidases along the rat intestine.\", JOURNAL = \"Pharm Res 11:897-900 (1994)\"), list(REFERENCE = \"PMID:12583961\", AUTHORS = \"Guarner F, Malagelada JR\", TITLE = \"Gut flora in health and disease.\", JOURNAL = c(\"Lancet 361:512-9 (2003)\", \"DOI:10.1016/S0140-6736(03)12489-0\")), list(REFERENCE = \"PMID:16887608\", AUTHORS = \"Smith EA, Macfarlane GT\", TITLE = \"Dissimilatory amino Acid metabolism in human colonic bacteria.\", JOURNAL = c(\"Anaerobe 3:327-37 (1997)\", \"DOI:10.1006/anae.1997.0121\")), list(REFERENCE = \"PMID:20093818\", AUTHORS = \"Schepers E, Glorieux G, Vanholder R\", TITLE = \"The gut: the forgotten organ in uremia?\", JOURNAL = c(\"Blood Purif 29:130-6 (2010)\", \"DOI:10.1159/000245639\")), list(REFERENCE = \"\", AUTHORS = \"John H.Cummings\", TITLE = \"The large intestine in nutrition and disease\", JOURNAL = \"Institut Danone\"), list(REFERENCE = \"PMID:18626068\", AUTHORS = \"Heitzmann D, Warth R\", TITLE = \"Physiology and pathophysiology of potassium channels in gastrointestinal epithelia.\", JOURNAL = c(\"Physiol Rev 88:1119-82 (2008)\", \"DOI:10.1152/physrev.00020.2007\"))', 'map04974', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (380, '04975', 'Fat digestion and absorption', 'Fat is an important energy source from food. More than 95% of dietary fat is long-chain triacylglycerols (TAG), the remaining being phospholipids (4.5%) and sterols. In the small intestine lumen, dietary TAG is hydrolyzed to fatty acids (FA) and monoacylglycerols (MAG) by pancreatic lipase. These products are then emulsified with the help of phospholipids (PL) and bile acids (BA) present in bile to form micelles. Free FAs and MAGs are taken up by the enterocyte where they are rapidly resynthesized in endoplasmic reticulum (ER) to form TAG. PLs from the diet as well as bile - mainly LPA - too are absorbed by the enterocyte and are acylated to form phosphatidic acid (PA), which is also converted into TAG. Absorbed cholesterol (CL) is acylated to cholesterol esters (CE). Within the ER, TAG joins CE and apolipoprotein B (ApoB) to form chylomicrons that enter circulation through the lymph.', 'Organismal Systems; Digestive system', 'Fat digestion and absorption', 'Hypoalphalipoproteinemia, CD36 deficiency, Gallbladder disease, Familial hypobetalipoproteinemia, Pancreatic lipase deficiency', 'GO: 0044241 0030299', 'ko04975', 'list(REFERENCE = \"PMID:19158321\", AUTHORS = \"Iqbal J, Hussain MM\", TITLE = \"Intestinal lipid absorption.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 296:E1183-94 (2009)\", \"DOI:10.1152/ajpendo.90899.2008\")), list(REFERENCE = \"PMID:20522896\", AUTHORS = \"Goodman BE\", TITLE = \"Insights into digestion and absorption of major nutrients in humans.\", JOURNAL = c(\"Adv Physiol Educ 34:44-53 (2010)\", \"DOI:10.1152/advan.00094.2009\")), list(REFERENCE = \"PMID:19280719\", AUTHORS = \"Niot I, Poirier H, Tran TT, Besnard P\", TITLE = \"Intestinal absorption of long-chain fatty acids: evidence and uncertainties.\", JOURNAL = c(\"Prog Lipid Res 48:101-15 (2009)\", \"DOI:10.1016/j.plipres.2009.01.001\")), list(REFERENCE = \"PMID:15286736\", AUTHORS = \"Shi Y, Burn P\", TITLE = \"Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.\", JOURNAL = c(\"Nat Rev Drug Discov 3:695-710 (2004)\", \"DOI:10.1038/nrd1469\")), list(REFERENCE = \"PMID:20148678\", AUTHORS = \"Mansbach CM, Siddiqi SA\", TITLE = \"The biogenesis of chylomicrons.\", JOURNAL = c(\"Annu Rev Physiol 72:315-33 (2010)\", \"DOI:10.1146/annurev-physiol-021909-135801\")), list(REFERENCE = \"PMID:19116371\", AUTHORS = \"Shi Y, Cheng D\", TITLE = \"Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism.\", JOURNAL = c(\"Am J Physiol Endocrinol Metab 297:E10-8 (2009)\", \"DOI:10.1152/ajpendo.90949.2008\")), list(REFERENCE = \"PMID:10924713\", AUTHORS = \"Ros E\", TITLE = \"Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk.\", JOURNAL = c(\"Atherosclerosis 151:357-79 (2000)\", \"DOI:10.1016/S0021-9150(00)00456-1\")), list(REFERENCE = \"PMID:12621063\", AUTHORS = \"Yen CL, Farese RV Jr\", TITLE = \"MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine.\", JOURNAL = c(\"J Biol Chem 278:18532-7 (2003)\", \"DOI:10.1074/jbc.M301633200\")), list(REFERENCE = \"PMID:17495606\", AUTHORS = \"Levy E, Spahis S, Sinnett D, Peretti N, Maupas-Schwalm F, Delvin E, Lambert M, Lavoie MA\", TITLE = \"Intestinal cholesterol transport proteins: an update and beyond.\", JOURNAL = c(\"Curr Opin Lipidol 18:310-8 (2007)\", \"DOI:10.1097/MOL.0b013e32813fa2e2\")), list(REFERENCE = \"PMID:18830418\", AUTHORS = \"Williams KJ\", TITLE = \"Molecular processes that handle -- and mishandle -- dietary lipids.\", JOURNAL = c(\"J Clin Invest 118:3247-59 (2008)\", \"DOI:10.1172/JCI35206\")), list(REFERENCE = \"PMID:11504671\", AUTHORS = \"Lu K, Lee MH, Patel SB\", TITLE = \"Dietary cholesterol absorption; more than just bile.\", JOURNAL = c(\"Trends Endocrinol Metab 12:314-20 (2001)\", \"DOI:10.1016/S1043-2760(01)00433-7\")), list(REFERENCE = \"PMID:14976303\", AUTHORS = \"Klett EL, Patel SB\", TITLE = \"Biomedicine. Will the real cholesterol transporter please stand up.\", JOURNAL = c(\"Science 303:1149-50 (2004)\", \"DOI:10.1126/science.1095519\")), list(REFERENCE = \"PMID:17002594\", AUTHORS = \"Wang DQ\", TITLE = \"Regulation of intestinal cholesterol absorption.\", JOURNAL = c(\"Annu Rev Physiol 69:221-48 (2007)\", \"DOI:10.1146/annurev.physiol.69.031905.160725\")), list(REFERENCE = \"PMID:19663632\", AUTHORS = \"Patel JP, Brocks DR\", TITLE = \"The effect of oral lipids and circulating lipoproteins on the metabolism of drugs.\", JOURNAL = c(\"Expert Opin Drug Metab Toxicol 5:1385-98 (2009)\", \"DOI:10.1517/17425250903176439\")), list(REFERENCE = \"PMID:15891388\", AUTHORS = \"Hussain MM, Fatma S, Pan X, Iqbal J\", TITLE = \"Intestinal lipoprotein assembly.\", JOURNAL = \"Curr Opin Lipidol 16:281-5 (2005)\"), list(REFERENCE = \"PMID:20493784\", AUTHORS = \"Kindel T, Lee DM, Tso P\", TITLE = \"The mechanism of the formation and secretion of chylomicrons.\", JOURNAL = c(\"Atheroscler Suppl 11:11-6 (2010)\", \"DOI:10.1016/j.atherosclerosissup.2010.03.003\"))', 'map04975', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (381, '04976', 'Bile secretion', 'Bile is a vital secretion, essential for digestion and absorption of fats and fat-soluble vitamins in the small intestine. Moreover, bile is an important route of elimination for excess cholesterol and many waste product, bilirubin, drugs and toxic compounds. Bile secretion depends on the function of membrane transport systems in hepatocytes and cholangiocytes and on the structural and functional integrity of the biliary tree. The hepatocytes generate the so-called primary bile in their canaliculi. Cholangiocytes modify the canalicular bile by secretory and reabsorptive processes as bile passes through the bile ducts. The main solutes in bile are bile acids, which stimulate bile secretion osmotically, as well as facilitate the intestinal absorption of dietary lipids by their detergent properties. Bile acids are also important signalling molecules. Through the activation of nuclear receptors, they regulate their own synthesis and transport rates.', 'Organismal Systems; Digestive system', 'Bile secretion', 'Familial hypercholesterolemia, Hyperbilirubinemia, Progressive familial intrahepatic cholestasis, Primary dystonia, GLUT1 deficiency syndrome, Hereditary pancreatitis, Primary bile acid malabsorption, Gallbladder disease, Hyperlipoproteinemia type IIa, Familial hypercholanemia, Dubin-Johnson syndrome, Rotor syndrome, Benign recurrent intrahepatic cholestasis, Intrahepatic cholestasis of pregnancy', 'GO: 0032782', 'ko04976', 'list(REFERENCE = \"PMID:11826283\", AUTHORS = \"Meier PJ, Stieger B\", TITLE = \"Bile salt transporters.\", JOURNAL = c(\"Annu Rev Physiol 64:635-61 (2002)\", \"DOI:10.1146/annurev.physiol.64.082201.100300\")), list(REFERENCE = \"PMID:10728790\", AUTHORS = \"Kullak-Ublick GA, Beuers U, Paumgartner G\", TITLE = \"Hepatobiliary transport.\", JOURNAL = c(\"J Hepatol 32:3-18 (2000)\", \"DOI:10.1016/S0168-8278(00)80411-0\")), list(REFERENCE = \"PMID:18668439\", AUTHORS = \"Kosters A, Karpen SJ\", TITLE = \"Bile acid transporters in health and disease.\", JOURNAL = c(\"Xenobiotica 38:1043-71 (2008)\", \"DOI:10.1080/00498250802040584\")), list(REFERENCE = \"PMID:14999673\", AUTHORS = \"Anwer MS\", TITLE = \"Cellular regulation of hepatic bile acid transport in health and cholestasis.\", JOURNAL = c(\"Hepatology 39:581-90 (2004)\", \"DOI:10.1002/hep.20090\")), list(REFERENCE = \"PMID:17404808\", AUTHORS = \"Alrefai WA, Gill RK\", TITLE = \"Bile acid transporters: structure, function, regulation and pathophysiological implications.\", JOURNAL = c(\"Pharm Res 24:1803-23 (2007)\", \"DOI:10.1007/s11095-007-9289-1\")), list(REFERENCE = \"PMID:12663868\", AUTHORS = \"Trauner M, Boyer JL\", TITLE = \"Bile salt transporters: molecular characterization, function, and regulation.\", JOURNAL = c(\"Physiol Rev 83:633-71 (2003)\", \"DOI:10.1152/physrev.00027.2002\")), list(REFERENCE = \"PMID:20103563\", AUTHORS = \"Klaassen CD, Aleksunes LM\", TITLE = \"Xenobiotic, bile acid, and cholesterol transporters: function and regulation.\", JOURNAL = c(\"Pharmacol Rev 62:1-96 (2010)\", \"DOI:10.1124/pr.109.002014\")), list(REFERENCE = \"PMID:15758646\", AUTHORS = \"Trauner M, Wagner M, Fickert P, Zollner G\", TITLE = \"Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.\", JOURNAL = c(\"J Clin Gastroenterol 39:S111-24 (2005)\", \"DOI:10.1097/01.mcg.0000155551.37266.26\")), list(REFERENCE = \"PMID:14659471\", AUTHORS = \"Arrese M, Trauner M\", TITLE = \"Molecular aspects of bile formation and cholestasis.\", JOURNAL = c(\"Trends Mol Med 9:558-64 (2003)\", \"DOI:10.1016/j.molmed.2003.10.002\")), list(REFERENCE = \"PMID:18837079\", AUTHORS = \"Esteller A\", TITLE = \"Physiology of bile secretion.\", JOURNAL = c(\"World J Gastroenterol 14:5641-9 (2008)\", \"DOI:10.3748/wjg.14.5641\")), list(REFERENCE = \"PMID:12483266\", AUTHORS = \"Takikawa H\", TITLE = \"Hepatobiliary transport of bile acids and organic anions.\", JOURNAL = c(\"J Hepatobiliary Pancreat Surg 9:443-7 (2002)\", \"DOI:10.1007/s005340200055\")), list(REFERENCE = \"PMID:11316487\", AUTHORS = \"St-Pierre MV, Kullak-Ublick GA, Hagenbuch B, Meier PJ\", TITLE = \"Transport of bile acids in hepatic and non-hepatic tissues.\", JOURNAL = \"J Exp Biol 204:1673-86 (2001)\"), list(REFERENCE = \"PMID:18670431\", AUTHORS = \"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K\", TITLE = \"Targeting bile-acid signalling for metabolic diseases.\", JOURNAL = c(\"Nat Rev Drug Discov 7:678-93 (2008)\", \"DOI:10.1038/nrd2619\")), list(REFERENCE = \"PMID:15975683\", AUTHORS = \"Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ\", TITLE = \"Enterohepatic transport of bile salts and genetics of cholestasis.\", JOURNAL = c(\"J Hepatol 43:342-57 (2005)\", \"DOI:10.1016/j.jhep.2005.03.017\")), list(REFERENCE = \"PMID:18081658\", AUTHORS = \"Pellicoro A, Faber KN\", TITLE = \"Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport.\", JOURNAL = c(\"Aliment Pharmacol Ther 26 Suppl 2:149-60 (2007)\", \"DOI:10.1111/j.1365-2036.2007.03522.x\")), list(REFERENCE = \"PMID:19482594\", AUTHORS = \"Jonker JW, Stedman CA, Liddle C, Downes M\", TITLE = \"Hepatobiliary ABC transporters: physiology, regulation and implications for disease.\", JOURNAL = c(\"Front Biosci 14:4904-20 (2009)\", \"DOI:10.2741/3576\")), list(REFERENCE = \"PMID:19273385\", AUTHORS = \"Modica S, Bellafante E, Moschetta A\", TITLE = \"Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio.\", JOURNAL = c(\"Front Biosci 14:4719-45 (2009)\", \"DOI:10.2741/3563\")), list(REFERENCE = \"PMID:16706681\", AUTHORS = \"Cai SY, Boyer JL\", TITLE = \"FXR: a target for cholestatic syndromes?\", JOURNAL = c(\"Expert Opin Ther Targets 10:409-21 (2006)\", \"DOI:10.1517/14728222.10.3.409\")), list(REFERENCE = \"PMID:19273238\", AUTHORS = \"Ballatori N, Li N, Fang F, Boyer JL, Christian WV, Hammond CL\", TITLE = \"OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids.\", JOURNAL = c(\"Front Biosci 14:2829-44 (2009)\", \"DOI:10.2741/3416\")), list(REFERENCE = \"PMID:18377365\", AUTHORS = \"Roma MG, Crocenzi FA, Sanchez Pozzi EA\", TITLE = \"Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects.\", JOURNAL = c(\"Clin Sci (Lond) 114:567-88 (2008)\", \"DOI:10.1042/CS20070227\")), list(REFERENCE = \"PMID:18371245\", AUTHORS = \"Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ\", TITLE = \"Molecular pathogenesis of intrahepatic cholestasis of pregnancy.\", JOURNAL = c(\"Expert Rev Mol Med 10:e9 (2008)\", \"DOI:10.1017/S1462399408000628\"))', 'map04976', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (382, '04977', 'Vitamin digestion and absorption', 'Vitamins are a diverse and chemically unrelated group of organic substances that share a common feature of being essential for normal health and well-being. They catalyze numerous biochemical reactions. Because humans and other mammals cannot synthesize these compounds (except for some synthesis of niacin), they must obtain them from exogenous sources via intestinal absorption. Vitamins are classified based on their solubility in water or fat. Most of the water-soluble vitamins are transported across the small intestinal membrane by carrier-mediated mechanisms, but vitamin B12, cobalamin, is transported by a receptor-mediated mechanism. Intestinal absorption of fat-soluble vitamins requires all of the processes needed for fat absorption. After digestion, these vitamins and the products of pancreatic hydrolysis of triglycerides (TG) are emulsified by bile salts to form mixed micelles which are taken up by intestinal enterocytes and incorporated into chylomicrons (CM). CM are then secreted into the lymphatic system, and finally moves into the plasma.', 'Organismal Systems; Digestive system', 'Vitamin digestion and absorption', 'Hypoalphalipoproteinemia, Biotinidase deficiency, Transcobalamin II deficiency, Biotin-responsive basal ganglia disease, Hereditary folate malabsorption, Familial hypobetalipoproteinemia, Vitamin B12 deficiency anaemia, Wernicke encephalopathy, Brown-Vialetto-Van Laere syndrome, Methylmalonic aciduria and homocystinuria, Pancreatic lipase deficiency', 'GO: 0051180', 'ko04977', 'list(REFERENCE = \"PMID:16462170\", AUTHORS = \"Said HM, Mohammed ZM\", TITLE = \"Intestinal absorption of water-soluble vitamins: an update.\", JOURNAL = c(\"Curr Opin Gastroenterol 22:140-6 (2006)\", \"DOI:10.1097/01.mog.0000203870.22706.52\")), list(REFERENCE = \"PMID:14642860\", AUTHORS = \"Basu TK, Donaldson D\", TITLE = \"Intestinal absorption in health and disease: micronutrients.\", JOURNAL = c(\"Best Pract Res Clin Gastroenterol 17:957-79 (2003)\", \"DOI:10.1016/S1521-6918(03)00084-2\")), list(REFERENCE = \"PMID:14977409\", AUTHORS = \"Said HM\", TITLE = \"Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins.\", JOURNAL = c(\"Annu Rev Physiol 66:419-46 (2004)\", \"DOI:10.1146/annurev.physiol.66.032102.144611\")), list(REFERENCE = \"PMID:16206251\", AUTHORS = \"Reidling JC, Nabokina SM, Balamurugan K, Said HM\", TITLE = \"Developmental maturation of intestinal and renal thiamin uptake: studies in wild-type and transgenic mice carrying human THTR-1 and 2 promoters.\", JOURNAL = c(\"J Cell Physiol 206:371-7 (2006)\", \"DOI:10.1002/jcp.20492\")), list(REFERENCE = \"PMID:20724488\", AUTHORS = \"Fujimura M, Yamamoto S, Murata T, Yasujima T, Inoue K, Ohta KY, Yuasa H\", TITLE = \"Functional characteristics of the human ortholog of riboflavin transporter 2 and riboflavin-responsive expression of its rat ortholog in the small intestine indicate its involvement in riboflavin absorption.\", JOURNAL = c(\"J Nutr 140:1722-7 (2010)\", \"DOI:10.3945/jn.110.128330\")), list(REFERENCE = \"PMID:19056639\", AUTHORS = \"Said HM\", TITLE = \"Cell and molecular aspects of human intestinal biotin absorption.\", JOURNAL = c(\"J Nutr 139:158-62 (2009)\", \"DOI:10.3945/jn.108.092023\")), list(REFERENCE = \"PMID:20185591\", AUTHORS = \"Green R\", TITLE = \"Ins and outs of cellular cobalamin transport.\", JOURNAL = c(\"Blood 115:1476-7 (2010)\", \"DOI:10.1182/blood-2009-12-254037\")), list(REFERENCE = \"PMID:19173758\", AUTHORS = \"Zhao R, Matherly LH, Goldman ID\", TITLE = \"Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.\", JOURNAL = c(\"Expert Rev Mol Med 11:e4 (2009)\", \"DOI:10.1017/S1462399409000969\")), list(REFERENCE = \"PMID:11984580\", AUTHORS = \"Hediger MA\", TITLE = \"New view at C.\", JOURNAL = c(\"Nat Med 8:445-6 (2002)\", \"DOI:10.1038/nm0502-445\")), list(REFERENCE = \"PMID:11340090\", AUTHORS = \"Harrison EH, Hussain MM\", TITLE = \"Mechanisms involved in the intestinal digestion and absorption of dietary vitamin A.\", JOURNAL = c(\"J Nutr 131:1405-8 (2001)\", \"DOI:10.1093/jn/131.5.1405\")), list(REFERENCE = \"PMID:16688755\", AUTHORS = \"Blomhoff R, Blomhoff HK.\", TITLE = \"Overview of retinoid metabolism and function.\", JOURNAL = c(\"J Neurobiol 66:606-30 (2006)\", \"DOI:10.1002/neu.20242\")), list(REFERENCE = \"PMID:20166147\", AUTHORS = \"Lemaire-Ewing S, Desrumaux C, Neel D, Lagrost L\", TITLE = \"Vitamin E transport, membrane incorporation and cell metabolism: Is alpha-tocopherol in lipid rafts an oar in the lifeboat?\", JOURNAL = c(\"Mol Nutr Food Res 54:631-40 (2010)\", \"DOI:10.1002/mnfr.200900445\")), list(REFERENCE = \"PMID:18841274\", AUTHORS = \"Shearer MJ, Newman P\", TITLE = \"Metabolism and cell biology of vitamin K.\", JOURNAL = c(\"Thromb Haemost 100:530-47 (2008)\", \"DOI:10.1160/TH08-03-0147\"))', 'map04977', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (383, '04978', 'Mineral absorption', 'Minerals are one of the five fundamental groups of nutrients needed to sustain life. Of the minerals, calcium plays innumerable roles in our bodies, serving as a main component of bone as well as an intracellular messenger in muscle contraction/relaxation, neural networks, the immune system, and endocrine/exocrine cells. Iron, copper, and other metals are required for redox reactions (as cofactors) and for oxygen transport and binding (in hemoglobin and myoglobin). Many enzymes require specific metal atoms to complete their catalytic functions. Animal tissues need moderate quantities of some elements (Ca, P, K, Na, Mg, S, and Cl) and trace amounts of others (Mn, Fe, I, Co, Cr, Cu, Zn, and Se). The minerals are absorbed by either passive or active transport systems through the intestinal mucosa, often using specialized transport proteins, such as ferritin for Fe3+ and vitamin D-induced protein for calcium.', 'Organismal Systems; Digestive system', 'Mineral absorption', 'Localized autosomal recessive hypotrichosis, Hartnup disorder, Iminoglycinuria, Vitamin D-dependent rickets, Atransferrinemia, Congenital diarrhea, Hypochromic microcytic anemia, Hypomagnesemia, Hereditary folate malabsorption, Hyperglycinuria, Osteoporosis', 'ko04978', 'list(REFERENCE = \"PMID:18277073\", AUTHORS = \"Perez AV, Picotto G, Carpentieri AR, Rivoira MA, Peralta Lopez ME, Tolosa de Talamoni NG\", TITLE = \"Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway.\", JOURNAL = c(\"Digestion 77:22-34 (2008)\", \"DOI:10.1159/000116623\")), list(REFERENCE = \"PMID:18598134\", AUTHORS = \"Khanal RC, Nemere I\", TITLE = \"Regulation of intestinal calcium transport.\", JOURNAL = c(\"Annu Rev Nutr 28:179-96 (2008)\", \"DOI:10.1146/annurev.nutr.010308.161202\")), list(REFERENCE = \"PMID:15618484\", AUTHORS = \"Hoenderop JG, Nilius B, Bindels RJ\", TITLE = \"Calcium absorption across epithelia.\", JOURNAL = c(\"Physiol Rev 85:373-422 (2005)\", \"DOI:10.1152/physrev.00003.2004\")), list(REFERENCE = \"PMID:12520535\", AUTHORS = \"Bouillon R, Van Cromphaut S, Carmeliet G\", TITLE = \"Intestinal calcium absorption: Molecular vitamin D mediated mechanisms.\", JOURNAL = c(\"J Cell Biochem 88:332-9 (2003)\", \"DOI:10.1002/jcb.10360\")), list(REFERENCE = \"PMID:17943492\", AUTHORS = \"Chua AC, Graham RM, Trinder D, Olynyk JK\", TITLE = \"The regulation of cellular iron metabolism.\", JOURNAL = c(\"Crit Rev Clin Lab Sci 44:413-59 (2007)\", \"DOI:10.1080/10408360701428257\")), list(REFERENCE = \"PMID:18636652\", AUTHORS = \"West AR, Oates PS\", TITLE = \"Mechanisms of heme iron absorption: current questions and controversies.\", JOURNAL = c(\"World J Gastroenterol 14:4101-10 (2008)\", \"DOI:10.3748/wjg.14.4101\")), list(REFERENCE = \"PMID:17194590\", AUTHORS = \"Dunn LL, Rahmanto YS, Richardson DR\", TITLE = \"Iron uptake and metabolism in the new millennium.\", JOURNAL = c(\"Trends Cell Biol 17:93-100 (2007)\", \"DOI:10.1016/j.tcb.2006.12.003\")), list(REFERENCE = \"PMID:16565477\", AUTHORS = \"Donovan A, Roy CN, Andrews NC\", TITLE = \"The ins and outs of iron homeostasis.\", JOURNAL = c(\"Physiology (Bethesda) 21:115-23 (2006)\", \"DOI:10.1152/physiol.00052.2005\")), list(REFERENCE = \"PMID:18779306\", AUTHORS = \"Lonnerdal B\", TITLE = \"Intestinal regulation of copper homeostasis: a developmental perspective.\", JOURNAL = c(\"Am J Clin Nutr 88:846S-50S (2008)\", \"DOI:10.1093/ajcn/88.3.846S\")), list(REFERENCE = \"PMID:18779302\", AUTHORS = \"Prohaska JR\", TITLE = \"Role of copper transporters in copper homeostasis.\", JOURNAL = c(\"Am J Clin Nutr 88:826S-9S (2008)\", \"DOI:10.1093/ajcn/88.3.826S\")), list(REFERENCE = \"PMID:20120011\", AUTHORS = \"Wang X, Zhou B\", TITLE = \"Dietary zinc absorption: A play of Zips and ZnTs in the gut.\", JOURNAL = c(\"IUBMB Life 62:176-82 (2010)\", \"DOI:10.1002/iub.291\")), list(REFERENCE = \"PMID:19400752\", AUTHORS = \"Lichten LA, Cousins RJ\", TITLE = \"Mammalian zinc transporters: nutritional and physiologic regulation.\", JOURNAL = c(\"Annu Rev Nutr 29:153-76 (2009)\", \"DOI:10.1146/annurev-nutr-033009-083312\")), list(REFERENCE = \"PMID:18301276\", AUTHORS = \"Quamme GA\", TITLE = \"Recent developments in intestinal magnesium absorption.\", JOURNAL = c(\"Curr Opin Gastroenterol 24:230-5 (2008)\", \"DOI:10.1097/MOG.0b013e3282f37b59\")), list(REFERENCE = \"PMID:19448074\", AUTHORS = \"Donowitz M, Mohan S, Zhu CX, Chen TE, Lin R, Cha B, Zachos NC, Murtazina R, Sarker R, Li X\", TITLE = \"NHE3 regulatory complexes.\", JOURNAL = c(\"J Exp Biol 212:1638-46 (2009)\", \"DOI:10.1242/jeb.028605\")), list(REFERENCE = \"PMID:21054167\", AUTHORS = \"Kato A, Romero MF\", TITLE = \"Regulation of Electroneutral NaCl Absorption by the Small Intestine.\", JOURNAL = c(\"Annu Rev Physiol 73:261-81 (2011)\", \"DOI:10.1146/annurev-physiol-012110-142244\")), list(REFERENCE = \"PMID:19729436\", AUTHORS = \"Sabbagh Y, O\'Brien SP, Song W, Boulanger JH, Stockmann A, Arbeeny C, Schiavi SC\", TITLE = \"Intestinal npt2b plays a major role in phosphate absorption and homeostasis.\", JOURNAL = c(\"J Am Soc Nephrol 20:2348-58 (2009)\", \"DOI:10.1681/ASN.2009050559\")), list(REFERENCE = \"PMID:16431934\", AUTHORS = \"Marks J, Srai SK, Biber J, Murer H, Unwin RJ, Debnam ES\", TITLE = \"Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice.\", JOURNAL = c(\"Exp Physiol 91:531-7 (2006)\", \"DOI:10.1113/expphysiol.2005.032516\"))', 'map04978', 'Mineral absorption', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (384, '04979', 'Cholesterol metabolism', 'Cholesterol is an essential component of mammalian cell membranes as well as a precursor of bile acids, vitamin D and steroid hormones. Cholesterol homeostasis in humans is regulated by well-balanced mechanisms of intestinal uptake, endogenous synthesis, transport in lipoprotein particles, and biliary excretion. Its abnormal metabolism can lead to increased risk for various endocrine disorders and cardiovascular diseases.', 'Organismal Systems; Digestive system', 'Cholesterol metabolism', 'Progressive familial intrahepatic cholestasis, Benign recurrent intrahepatic cholestasis, Hepatic lipase deficiency', 'GO: 0008203', 'ko04979', 'list(REFERENCE = \"PMID:28577571\", AUTHORS = \"Paththinige CS, Sirisena ND, Dissanayake V\", TITLE = \"Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review.\", JOURNAL = c(\"Lipids Health Dis 16:103 (2017)\", \"DOI:10.1186/s12944-017-0488-4\")), list(REFERENCE = \"PMID:24385507\", AUTHORS = \"Oldoni F, Sinke RJ, Kuivenhoven JA\", TITLE = \"Mendelian disorders of high-density lipoprotein metabolism.\", JOURNAL = c(\"Circ Res 114:124-42 (2014)\", \"DOI:10.1161/CIRCRESAHA.113.300634\")), list(REFERENCE = \"PMID:15451808\", AUTHORS = \"Lusis AJ, Fogelman AM, Fonarow GC\", TITLE = \"Genetic basis of atherosclerosis: part I: new genes and pathways.\", JOURNAL = c(\"Circulation 110:1868-73 (2004)\", \"DOI:10.1161/01.CIR.0000143041.58692.CC\")), list(REFERENCE = \"PMID:18079757\", AUTHORS = \"Wasan KM, Brocks DR, Lee SD, Sachs-Barrable K, Thornton SJ\", TITLE = \"Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery.\", JOURNAL = c(\"Nat Rev Drug Discov 7:84-99 (2008)\", \"DOI:10.1038/nrd2353\")), list(REFERENCE = \"PMID:18216769\", AUTHORS = \"Ikonen E\", TITLE = \"Cellular cholesterol trafficking and compartmentalization.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 9:125-38 (2008)\", \"DOI:10.1038/nrm2336\")), list(REFERENCE = \"PMID:26568191\", AUTHORS = \"Vaziri ND\", TITLE = \"HDL abnormalities in nephrotic syndrome and chronic kidney disease.\", JOURNAL = c(\"Nat Rev Nephrol 12:37-47 (2016)\", \"DOI:10.1038/nrneph.2015.180\")), list(REFERENCE = \"PMID:24854407\", AUTHORS = \"Kingwell BA, Chapman MJ, Kontush A, Miller NE\", TITLE = \"HDL-targeted therapies: progress, failures and future.\", JOURNAL = c(\"Nat Rev Drug Discov 13:445-64 (2014)\", \"DOI:10.1038/nrd4279\")), list(REFERENCE = \"PMID:25172365\", AUTHORS = \"Do RQ, Nicholls SJ, Schwartz GG\", TITLE = \"Evolving targets for lipid-modifying therapy.\", JOURNAL = c(\"EMBO Mol Med 6:1215-30 (2014)\", \"DOI:10.15252/emmm.201404000\")), list(REFERENCE = \"PMID:26247089\", AUTHORS = \"Feingold KR, Grunfeld C\", TITLE = \"Introduction to Lipids and Lipoproteins\", JOURNAL = \"Endotext (2000)\"), list(REFERENCE = \"PMID:25551803\", AUTHORS = \"Sacks FM\", TITLE = \"The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia.\", JOURNAL = c(\"Curr Opin Lipidol 26:56-63 (2015)\", \"DOI:10.1097/MOL.0000000000000146\")), list(REFERENCE = \"PMID:20962428\", AUTHORS = \"Yasuda T, Ishida T, Rader DJ\", TITLE = \"Update on the role of endothelial lipase in high-density lipoprotein metabolism, reverse cholesterol transport, and atherosclerosis.\", JOURNAL = c(\"Circ J 74:2263-70 (2010)\", \"DOI:10.1253/circj.CJ-10-0934\")), list(REFERENCE = \"PMID:25359426\", AUTHORS = \"Wang S, Smith JD\", TITLE = \"ABCA1 and nascent HDL biogenesis.\", JOURNAL = c(\"Biofactors 40:547-54 (2014)\", \"DOI:10.1002/biof.1187\")), list(REFERENCE = \"PMID:28971105\", AUTHORS = \"Hassan M\", TITLE = \"ANGPLT3: A novel modulator of lipid metabolism.\", JOURNAL = c(\"Glob Cardiol Sci Pract 2017:e201706 (2017)\", \"DOI:10.21542/gcsp.2017.6\")), list(REFERENCE = \"PMID:24397894\", AUTHORS = \"Dijk W, Kersten S\", TITLE = \"Regulation of lipoprotein lipase by Angptl4.\", JOURNAL = c(\"Trends Endocrinol Metab 25:146-55 (2014)\", \"DOI:10.1016/j.tem.2013.12.005\")), list(REFERENCE = \"PMID:11254896\", AUTHORS = \"Huuskonen J, Olkkonen VM, Jauhiainen M, Ehnholm C\", TITLE = \"The impact of phospholipid transfer protein (PLTP) on HDL metabolism.\", JOURNAL = c(\"Atherosclerosis 155:269-81 (2001)\", \"DOI:10.1016/S0021-9150(01)00447-6\")), list(REFERENCE = \"PMID:22661899\", AUTHORS = \"Shinkai H\", TITLE = \"Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases.\", JOURNAL = c(\"Vasc Health Risk Manag 8:323-31 (2012)\", \"DOI:10.2147/VHRM.S25238\")), list(REFERENCE = \"PMID:26435212\", AUTHORS = \"Norata GD, Tsimikas S, Pirillo A, Catapano AL\", TITLE = \"Apolipoprotein C-III: From Pathophysiology to Pharmacology.\", JOURNAL = c(\"Trends Pharmacol Sci 36:675-87 (2015)\", \"DOI:10.1016/j.tips.2015.07.001\")), list(REFERENCE = \"PMID:27312323\", AUTHORS = \"Zhong LY, Cayabyab FS, Tang CK, Zheng XL, Peng TH, Lv YC\", TITLE = \"Sortilin: A novel regulator in lipid metabolism and atherogenesis.\", JOURNAL = c(\"Clin Chim Acta 460:11-7 (2016)\", \"DOI:10.1016/j.cca.2016.06.013\")), list(REFERENCE = \"PMID:22510808\", AUTHORS = \"Sorrentino V, Zelcer N\", TITLE = \"Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.\", JOURNAL = c(\"Curr Opin Lipidol 23:213-9 (2012)\", \"DOI:10.1097/MOL.0b013e3283532947\")), list(REFERENCE = \"PMID:25003069\", AUTHORS = \"Jiang W, Song BL\", TITLE = \"Ubiquitin ligases in cholesterol metabolism.\", JOURNAL = c(\"Diabetes Metab J 38:171-80 (2014)\", \"DOI:10.4093/dmj.2014.38.3.171\")), list(REFERENCE = \"PMID:22811413\", AUTHORS = \"Lambert G, Sjouke B, Choque B, Kastelein JJ, Hovingh GK\", TITLE = \"The PCSK9 decade.\", JOURNAL = c(\"J Lipid Res 53:2515-24 (2012)\", \"DOI:10.1194/jlr.R026658\")), list(REFERENCE = \"PMID:26015858\", AUTHORS = \"Graham A, Allen AM\", TITLE = \"Mitochondrial function and regulation of macrophage sterol metabolism and inflammatory responses.\", JOURNAL = c(\"World J Cardiol 7:277-86 (2015)\", \"DOI:10.4330/wjc.v7.i5.277\")), list(REFERENCE = \"PMID:27565112\", AUTHORS = \"Elustondo P, Martin LA, Karten B\", TITLE = \"Mitochondrial cholesterol import.\", JOURNAL = c(\"Biochim Biophys Acta 1862:90-101 (2017)\", \"DOI:10.1016/j.bbalip.2016.08.012\")), list(REFERENCE = \"PMID:26041457\", AUTHORS = \"Raiborg C, Wenzel EM, Stenmark H\", TITLE = \"ER-endosome contact sites: molecular compositions and functions.\", JOURNAL = c(\"EMBO J 34:1848-58 (2015)\", \"DOI:10.15252/embj.201591481\")), list(REFERENCE = \"PMID:24554437\", AUTHORS = \"van der Kant R, Neefjes J\", TITLE = \"Small regulators, major consequences - Ca(2)(+) and cholesterol at the endosome-ER interface.\", JOURNAL = c(\"J Cell Sci 127:929-38 (2014)\", \"DOI:10.1242/jcs.137539\")), list(REFERENCE = \"PMID:20816088\", AUTHORS = \"Kjolby M, Andersen OM, Breiderhoff T, Fjorback AW, Pedersen KM, Madsen P, Jansen P, Heeren J, Willnow TE, Nykjaer A\", TITLE = \"Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export.\", JOURNAL = c(\"Cell Metab 12:213-23 (2010)\", \"DOI:10.1016/j.cmet.2010.08.006\"))', 'map04979', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (385, '05010', 'Alzheimer disease', 'Alzheimer disease (AD) is a chronic disorder that slowly destroys neurons and causes serious cognitive disability. AD is associated with senile plaques and neurofibrillary tangles (NFTs). Amyloid-beta (Abeta), a major component of senile plaques, has various pathological effects on cell and organelle function. The extracellular Abeta oligomers may activate caspases through activation of cell surface death receptors. Alternatively, intracellular Abeta may contribute to pathology by facilitating tau hyper-phosphorylation, disrupting mitochondria function, and triggering calcium dysfunction. To date genetic studies have revealed four genes that may be linked to autosomal dominant or familial early onset AD (FAD). These four genes include: amyloid precursor protein (APP), presenilin 1 (PS1), presenilin 2 (PS2) and apolipoprotein E (ApoE). All mutations associated with APP and PS proteins can lead to an increase in the production of Abeta peptides, specfically the more amyloidogenic form, Abeta42. FAD-linked PS1 mutation downregulates the unfolded protein response and leads to vulnerability to ER stress.', 'Human Diseases; Neurodegenerative disease', 'Alzheimer disease', 'Alzheimer disease', 'ko05010', 'list(REFERENCE = \"PMID:15232608\", AUTHORS = \"Dickson DW\", TITLE = \"Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?\", JOURNAL = c(\"J Clin Invest 114:23-7 (2004)\", \"DOI:10.1172/JCI22317\")), list(REFERENCE = \"PMID:15750290\", AUTHORS = \"Takuma K, Yan SS, Stern DM, Yamada K\", TITLE = \"Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer\'s disease.\", JOURNAL = c(\"J Pharmacol Sci 97:312-6 (2005)\", \"DOI:10.1254/jphs.CPJ04006X\")), list(REFERENCE = \"PMID:18675468\", AUTHORS = \"Bezprozvanny I, Mattson MP\", TITLE = \"Neuronal calcium mishandling and the pathogenesis of Alzheimer\'s disease.\", JOURNAL = c(\"Trends Neurosci 31:454-63 (2008)\", \"DOI:10.1016/j.tins.2008.06.005\")), list(REFERENCE = \"PMID:9848086\", AUTHORS = \"Holscher C\", TITLE = \"Possible causes of Alzheimer\'s disease: amyloid fragments, free radicals, and calcium homeostasis.\", JOURNAL = c(\"Neurobiol Dis 5:129-41 (1998)\", \"DOI:10.1006/nbdi.1998.0193\")), list(REFERENCE = \"PMID:18035450\", AUTHORS = \"Bojarski L, Herms J, Kuznicki J\", TITLE = \"Calcium dysregulation in Alzheimer\'s disease.\", JOURNAL = c(\"Neurochem Int 52:621-33 (2008)\", \"DOI:10.1016/j.neuint.2007.10.002\")), list(REFERENCE = \"PMID:15363492\", AUTHORS = \"Katayama T, Imaizumi K, Manabe T, Hitomi J, Kudo T, Tohyama M\", TITLE = \"Induction of neuronal death by ER stress in Alzheimer\'s disease.\", JOURNAL = c(\"J Chem Neuroanat 28:67-78 (2004)\", \"DOI:10.1016/j.jchemneu.2003.12.004\")), list(REFERENCE = \"PMID:11484003\", AUTHORS = \"Small DH, Mok SS, Bornstein JC\", TITLE = \"Alzheimer\'s disease and Abeta toxicity: from top to bottom.\", JOURNAL = c(\"Nat Rev Neurosci 2:595-8 (2001)\", \"DOI:10.1038/35086072\")), list(REFERENCE = \"PMID:15295589\", AUTHORS = \"Mattson MP\", TITLE = \"Pathways towards and away from Alzheimer\'s disease.\", JOURNAL = c(\"Nature 430:631-9 (2004)\", \"DOI:10.1038/nature02621\")), list(REFERENCE = \"PMID:15177383\", AUTHORS = \"Parihar MS, Hemnani T\", TITLE = \"Alzheimer\'s disease pathogenesis and therapeutic interventions.\", JOURNAL = c(\"J Clin Neurosci 11:456-67 (2004)\", \"DOI:10.1016/j.jocn.2003.12.007\")), list(REFERENCE = \"PMID:17568632\", AUTHORS = \"Cowburn RF, Popescu BO, Ankarcrona M, Dehvari N, Cedazo-Minguez A\", TITLE = \"Presenilin-mediated signal transduction.\", JOURNAL = c(\"Physiol Behav 92:93-7 (2007)\", \"DOI:10.1016/j.physbeh.2007.05.053\")), list(REFERENCE = \"PMID:17055782\", AUTHORS = \"Shen Y, He P, Zhong Z, McAllister C, Lindholm K\", TITLE = \"Distinct destructive signal pathways of neuronal death in Alzheimer\'s disease.\", JOURNAL = c(\"Trends Mol Med 12:574-9 (2006)\", \"DOI:10.1016/j.molmed.2006.10.002\")), list(REFERENCE = \"PMID:18782350\", AUTHORS = \"Reese LC, Zhang W, Dineley KT, Kayed R, Taglialatela G\", TITLE = \"Selective induction of calcineurin activity and signaling by oligomeric amyloid beta.\", JOURNAL = c(\"Aging Cell 7:824-35 (2008)\", \"DOI:10.1111/j.1474-9726.2008.00434.x\")), list(REFERENCE = \"PMID:10830966\", AUTHORS = \"Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH\", TITLE = \"Neurotoxicity induces cleavage of p35 to p25 by calpain.\", JOURNAL = c(\"Nature 405:360-4 (2000)\", \"DOI:10.1038/35012636\")), list(REFERENCE = \"PMID:16677790\", AUTHORS = \"Hauptmann S, Keil U, Scherping I, Bonert A, Eckert A, Muller WE\", TITLE = \"Mitochondrial dysfunction in sporadic and genetic Alzheimer\'s disease.\", JOURNAL = c(\"Exp Gerontol 41:668-73 (2006)\", \"DOI:10.1016/j.exger.2006.03.012\")), list(REFERENCE = \"PMID:16529745\", AUTHORS = \"Avila J\", TITLE = \"Tau phosphorylation and aggregation in Alzheimer\'s disease pathology.\", JOURNAL = c(\"FEBS Lett 580:2922-7 (2006)\", \"DOI:10.1016/j.febslet.2006.02.067\")), list(REFERENCE = \"PMID:10527810\", AUTHORS = \"Ivins KJ, Thornton PL, Rohn TT, Cotman CW\", TITLE = \"Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8.\", JOURNAL = c(\"Neurobiol Dis 6:440-9 (1999)\", \"DOI:10.1006/nbdi.1999.0268\")), list(REFERENCE = \"PMID:15864339\", AUTHORS = \"Gandy S\", TITLE = \"The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease.\", JOURNAL = c(\"J Clin Invest 115:1121-9 (2005)\", \"DOI:10.1172/JCI25100\"))', 'map05010', 'Alzheimer disease', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (386, '05012', 'Parkinson disease', 'Parkinson disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc). Mutations in alpha-synuclein, UCHL1 (a ubiquitin carboxy-terminal hydrolase L1), parkin, DJ1 (a parkin-associated protein involved with oxidative stress), and PINK1 (a putative serine threonine kinase) are known to cause early-onset PD. Mutations or altered expression of these proteins contributes to the damage and subsequent loss of DA neurons through common mechanisms that result in proteasome dysfunction, mitochondrial impairment, and oxidative stress. The demise of DA neurons located in the SNc leads to a drop in the dopaminergic input to the striatum. This results in a reduced activation of the direct pathway and in a disinhibition of the indirect pathway, which is associated with the elevation of adenosine A2A receptor transmission. Such unbalanced activity of the striatal output pathway is at the basis of the motor impairment observed in PD.', 'Human Diseases; Neurodegenerative disease', 'Parkinson disease', 'Parkinson disease', 'ko05012', 'list(REFERENCE = \"PMID:17911161\", AUTHORS = \"Thomas B, Beal MF\", TITLE = \"Parkinson\'s disease.\", JOURNAL = c(\"Hum Mol Genet 16 Spec No. 2:R183-94 (2007)\", \"DOI:10.1093/hmg/ddm159\")), list(REFERENCE = \"PMID:12938733\", AUTHORS = \"Lim KL, Lim TM\", TITLE = \"Molecular mechanisms of neurodegeneration in Parkinson\'s disease: clues from Mendelian syndromes.\", JOURNAL = c(\"IUBMB Life 55:315-22 (2003)\", \"DOI:10.1080/1521654031000153030\")), list(REFERENCE = \"PMID:16022590\", AUTHORS = \"Moore DJ, West AB, Dawson VL, Dawson TM\", TITLE = \"Molecular pathophysiology of Parkinson\'s disease.\", JOURNAL = c(\"Annu Rev Neurosci 28:57-87 (2005)\", \"DOI:10.1146/annurev.neuro.28.061604.135718\")), list(REFERENCE = \"PMID:16495942\", AUTHORS = \"Abou-Sleiman PM, Muqit MM, Wood NW\", TITLE = \"Expanding insights of mitochondrial dysfunction in Parkinson\'s disease.\", JOURNAL = c(\"Nat Rev Neurosci 7:207-19 (2006)\", \"DOI:10.1038/nrn1868\")), list(REFERENCE = \"PMID:18426756\", AUTHORS = \"Mizuno Y, Hattori N, Kubo S, Sato S, Nishioka K, Hatano T, Tomiyama H, Funayama M, Machida Y, Mochizuki H\", TITLE = \"Progress in the pathogenesis and genetics of Parkinson\'s disease.\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 363:2215-27 (2008)\", \"DOI:10.1098/rstb.2008.2273\")), list(REFERENCE = \"PMID:16278972\", AUTHORS = \"Gandhi S, Wood NW\", TITLE = \"Molecular pathogenesis of Parkinson\'s disease.\", JOURNAL = c(\"Hum Mol Genet 14 Spec No. 2:2749-2755 (2005)\", \"DOI:10.1093/hmg/ddi308\")), list(REFERENCE = \"PMID:12461550\", AUTHORS = \"Lotharius J, Brundin P\", TITLE = \"Pathogenesis of Parkinson\'s disease: dopamine, vesicles and alpha-synuclein.\", JOURNAL = c(\"Nat Rev Neurosci 3:932-42 (2002)\", \"DOI:10.1038/nrn983\")), list(REFERENCE = \"PMID:15767499\", AUTHORS = \"Eriksen JL, Wszolek Z, Petrucelli L\", TITLE = \"Molecular pathogenesis of Parkinson disease.\", JOURNAL = c(\"Arch Neurol 62:353-7 (2005)\", \"DOI:10.1001/archneur.62.3.353\")), list(REFERENCE = \"PMID:15054086\", AUTHORS = \"Sidhu A, Wersinger C, Vernier P\", TITLE = \"Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?\", JOURNAL = c(\"FASEB J 18:637-47 (2004)\", \"DOI:10.1096/fj.03-1112rev\")), list(REFERENCE = \"PMID:15681812\", AUTHORS = \"Sidhu A, Wersinger C, Moussa CE, Vernier P\", TITLE = \"The role of alpha-synuclein in both neuroprotection and neurodegeneration.\", JOURNAL = c(\"Ann N Y Acad Sci 1035:250-70 (2004)\", \"DOI:10.1196/annals.1332.016\")), list(REFERENCE = \"PMID:12971891\", AUTHORS = \"Dauer W, Przedborski S\", TITLE = \"Parkinson\'s disease: mechanisms and models.\", JOURNAL = c(\"Neuron 39:889-909 (2003)\", \"DOI:10.1016/S0896-6273(03)00568-3\")), list(REFERENCE = \"PMID:15525720\", AUTHORS = \"Feany MB\", TITLE = \"New genetic insights into Parkinson\'s disease.\", JOURNAL = c(\"N Engl J Med 351:1937-40 (2004)\", \"DOI:10.1056/NEJMp048263\")), list(REFERENCE = \"PMID:11331916\", AUTHORS = \"Beal MF\", TITLE = \"Experimental models of Parkinson\'s disease.\", JOURNAL = c(\"Nat Rev Neurosci 2:325-34 (2001)\", \"DOI:10.1038/35072550\")), list(REFERENCE = \"PMID:15770999\", AUTHORS = \"Corti O, Hampe C, Darios F, Ibanez P, Ruberg M, Brice A\", TITLE = \"Parkinson\'s disease: from causes to mechanisms.\", JOURNAL = c(\"C R Biol 328:131-42 (2005)\", \"DOI:10.1016/j.crvi.2004.10.009\")), list(REFERENCE = \"PMID:18680555\", AUTHORS = \"Vila M, Ramonet D, Perier C\", TITLE = \"Mitochondrial alterations in Parkinson\'s disease: new clues.\", JOURNAL = c(\"J Neurochem 107:317-28 (2008)\", \"DOI:10.1111/j.1471-4159.2008.05604.x\")), list(REFERENCE = \"PMID:12728264\", AUTHORS = \"Vila M, Przedborski S\", TITLE = \"Targeting programmed cell death in neurodegenerative diseases.\", JOURNAL = c(\"Nat Rev Neurosci 4:365-75 (2003)\", \"DOI:10.1038/nrn1100\")), list(REFERENCE = \"PMID:22927178\", AUTHORS = \"Calabresi P, Di Filippo M, Gallina A, Wang Y, Stankowski JN, Picconi B, Dawson VL, Dawson TM\", TITLE = \"New synaptic and molecular targets for neuroprotection in Parkinson\'s disease.\", JOURNAL = c(\"Mov Disord 28:51-60 (2013)\", \"DOI:10.1002/mds.25096\")), list(REFERENCE = \"PMID:21811441\", AUTHORS = \"Nishi A, Kuroiwa M, Shuto T\", TITLE = \"Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons.\", JOURNAL = c(\"Front Neuroanat 5:43 (2011)\", \"DOI:10.3389/fnana.2011.00043\")), list(REFERENCE = \"PMID:20236221\", AUTHORS = \"Hara M, Fukui R, Hieda E, Kuroiwa M, Bateup HS, Kano T, Greengard P, Nishi A\", TITLE = \"Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.\", JOURNAL = c(\"J Neurochem 113:1046-59 (2010)\", \"DOI:10.1111/j.1471-4159.2010.06668.x\"))', 'map05012', 'Parkinson disease', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (387, '05014', 'Amyotrophic lateral sclerosis (ALS)', 'Amyotrophic lateral sclerosis (ALS) is a progressive, lethal, degenerative disorder of motor neurons. The hallmark of this disease is the selective death of motor neurons in the brain and spinal cord, leading to paralysis of voluntary muscles. Mutant superoxide dismutase 1 (SOD1), as seen in some familial ALS (FALS) cases, is unstable, forming aggregates in the motor neuron cytoplasm, axoplasm and mitochondria. Within mitochondria, mutant SOD1 may interfere with the anti-apoptotic function of Bcl-2, affect mitochondrial import by interfering with the translocation machinery (TOM/TIM), and generate toxic free radicals (ROS). Reactive oxygen species (ROS), produced within mitochondria, inhibit the function of EAAT2, the main glial glutamate transporter protein, responsible for most of the reuptake of synaptically released glutamate. Glutamate excess increases intracellular calcium, which enhances oxidative stress and mitochondrial damage. Mutant SOD1 can also trigger oxidative reactions , which can then cause damage through the formation of hydroxyl radicals or via nitration of tyrosine residues on proteins. Nitration may target neurofilament proteins, affecting axonal transport. Collectively, these mechanisms are predicted to disturb cellular homeostasis, ultimately triggering motor neuron death.', 'Human Diseases; Neurodegenerative disease', 'Amyotrophic lateral sclerosis (ALS)', 'Amyotrophic lateral sclerosis (ALS)', 'ko05014', 'list(REFERENCE = \"PMID:16924260\", AUTHORS = \"Pasinelli P, Brown RH\", TITLE = \"Molecular biology of amyotrophic lateral sclerosis: insights from genetics.\", JOURNAL = c(\"Nat Rev Neurosci 7:710-23 (2006)\", \"DOI:10.1038/nrn1971\")), list(REFERENCE = \"PMID:16723044\", AUTHORS = \"Goodall EF, Morrison KE\", TITLE = \"Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment.\", JOURNAL = c(\"Expert Rev Mol Med 8:1-22 (2006)\", \"DOI:10.1017/S1462399406010854\")), list(REFERENCE = \"PMID:17015226\", AUTHORS = \"Boillee S, Vande Velde C, Cleveland DW\", TITLE = \"ALS: a disease of motor neurons and their nonneuronal neighbors.\", JOURNAL = c(\"Neuron 52:39-59 (2006)\", \"DOI:10.1016/j.neuron.2006.09.018\")), list(REFERENCE = \"PMID:11239414\", AUTHORS = \"Julien JP.\", TITLE = \"Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded.\", JOURNAL = c(\"Cell 104:581-91 (2001)\", \"DOI:10.1016/S0092-8674(01)00244-6\")), list(REFERENCE = \"PMID:16050975\", AUTHORS = \"Manfredi G, Xu Z\", TITLE = \"Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.\", JOURNAL = c(\"Mitochondrion 5:77-87 (2005)\", \"DOI:10.1016/j.mito.2005.01.002\")), list(REFERENCE = \"PMID:11870681\", AUTHORS = \"Hand CK, Rouleau GA\", TITLE = \"Familial amyotrophic lateral sclerosis.\", JOURNAL = c(\"Muscle Nerve 25:135-59 (2002)\", \"DOI:10.1002/mus.10000\")), list(REFERENCE = \"PMID:16713195\", AUTHORS = \"Barber SC, Mead RJ, Shaw PJ\", TITLE = \"Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.\", JOURNAL = c(\"Biochim Biophys Acta 1762:1051-67 (2006)\", \"DOI:10.1016/j.bbadis.2006.03.008\")), list(REFERENCE = \"PMID:16026864\", AUTHORS = \"von Lewinski F, Keller BU\", TITLE = \"Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS.\", JOURNAL = c(\"Trends Neurosci 28:494-500 (2005)\", \"DOI:10.1016/j.tins.2005.07.001\")), list(REFERENCE = \"PMID:10970056\", AUTHORS = \"Al-Chalabi A, Leigh PN\", TITLE = \"Recent advances in amyotrophic lateral sclerosis.\", JOURNAL = \"Curr Opin Neurol 13:397-405 (2000)\"), list(REFERENCE = \"PMID:12531867\", AUTHORS = \"Guegan C, Przedborski S\", TITLE = \"Programmed cell death in amyotrophic lateral sclerosis.\", JOURNAL = c(\"J Clin Invest 111:153-61 (2003)\", \"DOI:10.1172/JCI17610\")), list(REFERENCE = \"PMID:16909017\", AUTHORS = \"Bendotti C, Bao Cutrona M, Cheroni C, Grignaschi G, Lo Coco D, Peviani M, Tortarolo M, Veglianese P, Zennaro E\", TITLE = \"Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase.\", JOURNAL = c(\"Neurodegener Dis 2:128-34 (2005)\", \"DOI:10.1159/000089617\")), list(REFERENCE = \"PMID:14739060\", AUTHORS = \"Emerit J, Edeas M, Bricaire F\", TITLE = \"Neurodegenerative diseases and oxidative stress.\", JOURNAL = c(\"Biomed Pharmacother 58:39-46 (2004)\", \"DOI:10.1016/j.biopha.2003.11.004\")), list(REFERENCE = \"PMID:11715057\", AUTHORS = \"Cleveland DW, Rothstein JD\", TITLE = \"From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS.\", JOURNAL = c(\"Nat Rev Neurosci 2:806-19 (2001)\", \"DOI:10.1038/35097565\")), list(REFERENCE = \"PMID:15310460\", AUTHORS = \"Bendotti C, Carri MT\", TITLE = \"Lessons from models of SOD1-linked familial ALS.\", JOURNAL = c(\"Trends Mol Med 10:393-400 (2004)\", \"DOI:10.1016/j.molmed.2004.06.009\")), list(REFERENCE = \"PMID:12595144\", AUTHORS = \"Robertson J, Kriz J, Nguyen MD, Julien JP\", TITLE = \"Pathways to motor neuron degeneration in transgenic mouse models.\", JOURNAL = c(\"Biochimie 84:1151-60 (2002)\", \"DOI:10.1016/S0300-9084(02)00025-1\")), list(REFERENCE = \"PMID:16603792\", AUTHORS = \"Bacman SR, Bradley WG, Moraes CT\", TITLE = \"Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?\", JOURNAL = c(\"Mol Neurobiol 33:113-31 (2006)\", \"DOI:10.1385/MN:33:2:113\")), list(REFERENCE = \"PMID:18519638\", AUTHORS = \"Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H, Noguchi T, Matsuzawa A, Takeda K, Ichijo H\", TITLE = \"ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.\", JOURNAL = c(\"Genes Dev 22:1451-64 (2008)\", \"DOI:10.1101/gad.1640108\")), list(REFERENCE = \"PMID:14569202\", AUTHORS = \"Simpson EP, Yen AA, Appel SH\", TITLE = \"Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.\", JOURNAL = \"Curr Opin Rheumatol 15:730-6 (2003)\"), list(REFERENCE = \"PMID:12728264\", AUTHORS = \"Vila M, Przedborski S\", TITLE = \"Targeting programmed cell death in neurodegenerative diseases.\", JOURNAL = c(\"Nat Rev Neurosci 4:365-75 (2003)\", \"DOI:10.1038/nrn1100\")), list(REFERENCE = \"PMID:11513882\", AUTHORS = \"Volkel H, Scholz M, Link J, Selzle M, Werner P, Tunnemann R, Jung G, Ludolph AC, Reuter A\", TITLE = \"Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin.\", JOURNAL = c(\"FEBS Lett 503:201-5 (2001)\", \"DOI:10.1016/S0014-5793(01)02730-2\")), list(REFERENCE = \"PMID:17434459\", AUTHORS = \"Eve DJ, Dennis JS, Citron BA\", TITLE = \"Transcription factor p53 in degenerating spinal cords.\", JOURNAL = c(\"Brain Res 1150:174-81 (2007)\", \"DOI:10.1016/j.brainres.2007.02.088\")), list(REFERENCE = \"PMID:16909020\", AUTHORS = \"Van Damme P, Dewil M, Robberecht W, Van Den Bosch L\", TITLE = \"Excitotoxicity and amyotrophic lateral sclerosis.\", JOURNAL = c(\"Neurodegener Dis 2:147-59 (2005)\", \"DOI:10.1159/000089620\")), list(REFERENCE = \"PMID:17566607\", AUTHORS = \"Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE\", TITLE = \"Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.\", JOURNAL = c(\"Neurochem Int 51:74-84 (2007)\", \"DOI:10.1016/j.neuint.2007.04.010\")), list(REFERENCE = \"PMID:17409386\", AUTHORS = \"Kunita R, Otomo A, Mizumura H, Suzuki-Utsunomiya K, Hadano S, Ikeda JE\", TITLE = \"The Rab5 activator ALS2/alsin acts as a novel Rac1 effector through Rac1-activated endocytosis.\", JOURNAL = c(\"J Biol Chem 282:16599-611 (2007)\", \"DOI:10.1074/jbc.M610682200\"))', 'map05014', 'Amyotrophic lateral sclerosis (ALS)', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (388, '05016', 'Huntington disease', 'Huntington disease (HD) is an autosomal-dominant neurodegenerative disorder that primarily affects medium spiny striatal neurons (MSN). The symptoms are choreiform, involuntary movements, personality changes and dementia. HD is caused by a CAG repeat expansion in the IT15gene, which results in a long stretch of polyglutamine close to the amino-terminus of the HD protein huntingtin (Htt). Mutant Htt (mHtt) has effects both in the cytoplasm and in the nucleus. In the cytoplasm, full-length mHtt can interfere with BDNF vesicular transport on microtubules. This mutant protein also may lead to abnormal endocytosis and secretion in neurons, because normal Htt form a complex with the proteins Hip1, clathrin and AP2 that are involved in endocytosis. In addition, mHtt affects Ca2+ signaling by sensitizing InsP3R1 to activation by InsP3, stimulating NMDAR activity, and destabilizing mitochondrial Ca2+ handling. The mHtt translocates to the nucleus, where it forms intranuclear inclusions. Nuclear toxicity is believed to be caused by interference with gene transcription, leading to loss of transcription of neuroprotective molecules such as BDNF. While mHtt binds to p53 and upregulates levels of nuclear p53 as well as p53 transcriptional activity. Augmented p53 mediates mitochondrial dysfunction.', 'Human Diseases; Neurodegenerative disease', 'Huntington disease', 'Huntington disease', 'ko05016', 'list(REFERENCE = \"PMID:15459747\", AUTHORS = \"Landles C, Bates GP\", TITLE = \"Huntingtin and the molecular pathogenesis of Huntington\'s disease. Fourth in molecular medicine review series.\", JOURNAL = c(\"EMBO Rep 5:958-63 (2004)\", \"DOI:10.1038/sj.embor.7400250\")), list(REFERENCE = \"PMID:17041811\", AUTHORS = \"Borrell-Pages M, Zala D, Humbert S, Saudou F\", TITLE = \"Huntington\'s disease: from huntingtin function and dysfunction to therapeutic strategies.\", JOURNAL = c(\"Cell Mol Life Sci 63:2642-60 (2006)\", \"DOI:10.1007/s00018-006-6242-0\")), list(REFERENCE = \"PMID:18951640\", AUTHORS = \"Bossy-Wetzel E, Petrilli A, Knott AB\", TITLE = \"Mutant huntingtin and mitochondrial dysfunction.\", JOURNAL = c(\"Trends Neurosci 31:609-16 (2008)\", \"DOI:10.1016/j.tins.2008.09.004\")), list(REFERENCE = \"PMID:16288298\", AUTHORS = \"Cattaneo E, Zuccato C, Tartari M\", TITLE = \"Normal huntingtin function: an alternative approach to Huntington\'s disease.\", JOURNAL = c(\"Nat Rev Neurosci 6:919-30 (2005)\", \"DOI:10.1038/nrn1806\")), list(REFERENCE = \"PMID:15336977\", AUTHORS = \"Bezprozvanny I, Hayden MR\", TITLE = \"Deranged neuronal calcium signaling and Huntington disease.\", JOURNAL = c(\"Biochem Biophys Res Commun 322:1310-7 (2004)\", \"DOI:10.1016/j.bbrc.2004.08.035\")), list(REFERENCE = \"PMID:14526190\", AUTHORS = \"Sawa A, Tomoda T, Bae BI\", TITLE = \"Mechanisms of neuronal cell death in Huntington\'s disease.\", JOURNAL = c(\"Cytogenet Genome Res 100:287-95 (2003)\", \"DOI:10.1159/000072864\")), list(REFERENCE = \"PMID:12372277\", AUTHORS = \"Ross CA.\", TITLE = \"Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington\'s disease and related disorders.\", JOURNAL = c(\"Neuron 35:819-22 (2002)\", \"DOI:10.1016/S0896-6273(02)00872-3\")), list(REFERENCE = \"PMID:15242639\", AUTHORS = \"Ross CA\", TITLE = \"Huntington\'s disease: new paths to pathogenesis.\", JOURNAL = c(\"Cell 118:4-7 (2004)\", \"DOI:10.1016/j.cell.2004.06.022\")), list(REFERENCE = \"PMID:15695335\", AUTHORS = \"Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinas R, Kristal BS, Hayden MR, Bezprozvanny I\", TITLE = \"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington\'s disease.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 102:2602-7 (2005)\", \"DOI:10.1073/pnas.0409402102\")), list(REFERENCE = \"PMID:11807533\", AUTHORS = \"Mattson MP.\", TITLE = \"Accomplices to neuronal death.\", JOURNAL = c(\"Nature 415:377-9 (2002)\", \"DOI:10.1038/415377a\")), list(REFERENCE = \"PMID:17081970\", AUTHORS = \"McGill JK, Beal MF\", TITLE = \"PGC-1alpha, a new therapeutic target in Huntington\'s disease?\", JOURNAL = c(\"Cell 127:465-8 (2006)\", \"DOI:10.1016/j.cell.2006.10.023\")), list(REFERENCE = \"PMID:15996541\", AUTHORS = \"La Spada AR, Morrison RS\", TITLE = \"The power of the dark side: Huntington\'s disease protein and p53 form a deadly alliance.\", JOURNAL = c(\"Neuron 47:1-3 (2005)\", \"DOI:10.1016/j.neuron.2005.06.023\")), list(REFERENCE = \"PMID:11738471\", AUTHORS = \"Lesort M, Chun W, Tucholski J, Johnson GV\", TITLE = \"Does tissue transglutaminase play a role in Huntington\'s disease?\", JOURNAL = c(\"Neurochem Int 40:37-52 (2002)\", \"DOI:10.1016/S0197-0186(01)00059-6\")), list(REFERENCE = \"PMID:15996546\", AUTHORS = \"Bae BI, Xu H, Igarashi S, Fujimuro M, Agrawal N, Taya Y, Hayward SD, Moran TH, Montell C, Ross CA, Snyder SH, Sawa A\", TITLE = \"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\'s disease.\", JOURNAL = c(\"Neuron 47:29-41 (2005)\", \"DOI:10.1016/j.neuron.2005.06.005\")), list(REFERENCE = \"PMID:11839795\", AUTHORS = \"Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ\", TITLE = \"Interaction of Huntington disease protein with transcriptional activator Sp1.\", JOURNAL = c(\"Mol Cell Biol 22:1277-87 (2002)\", \"DOI:10.1128/MCB.22.5.1277-1287.2002\"))', 'map05016', 'Huntington disease', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (389, '05020', 'Prion diseases', 'Prion diseases, also termed transmissible spongiform encephalopathies (TSEs), are a group of fatal neurodegenerative diseases that affect humans and a number of other animal species. The etiology of these diseases is thought to be associated with the conversion of a normal protein, PrPC, into an infectious, pathogenic form, PrPSc. The conversion is induced by prion infections (for example, variant Creutzfeldt-Jakob disease (vCJD), iatrogenic CJD, Kuru), mutations (familial CJD, Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia (FFI)) or unknown factors (sporadic CJD (sCJD)), and is thought to occur after PrPC has reached the plasma membrane or is re-internalized for degradation. The PrPSc form shows greater protease resistance than PrPC and accumulates in affected individuals, often in the form of extracellular plaques. Pathways that may lead to neuronal death comprise oxidative stress, regulated activation of complement, ubiquitin-proteasome and endosomal-lysosomal systems, synaptic alterations and dendritic atrophy, corticosteroid response, and endoplasmic reticulum stress. In addition, the conformational transition could lead to the lost of a beneficial activity of the natively folded protein, PrPC.', 'Human Diseases; Neurodegenerative disease', 'Prion diseases', 'Prion disease', 'ko05020', 'list(REFERENCE = \"PMID:18245809\", AUTHORS = \"Kovacs GG, Budka H\", TITLE = \"Prion diseases: from protein to cell pathology.\", JOURNAL = c(\"Am J Pathol 172:555-65 (2008)\", \"DOI:10.2353/ajpath.2008.070442\")), list(REFERENCE = \"PMID:15695097\", AUTHORS = \"Campana V, Sarnataro D, Zurzolo C\", TITLE = \"The highways and byways of prion protein trafficking.\", JOURNAL = c(\"Trends Cell Biol 15:102-11 (2005)\", \"DOI:10.1016/j.tcb.2004.12.002\")), list(REFERENCE = \"PMID:14661267\", AUTHORS = \"Nunziante M, Gilch S, Schatzl HM\", TITLE = \"Prion diseases: from molecular biology to intervention strategies.\", JOURNAL = c(\"Chembiochem 4:1268-84 (2003)\", \"DOI:10.1002/cbic.200300704\")), list(REFERENCE = \"PMID:17051207\", AUTHORS = \"Caughey B, Baron GS\", TITLE = \"Prions and their partners in crime.\", JOURNAL = c(\"Nature 443:803-10 (2006)\", \"DOI:10.1038/nature05294\")), list(REFERENCE = \"PMID:18391177\", AUTHORS = \"Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR\", TITLE = \"Physiology of the prion protein.\", JOURNAL = c(\"Physiol Rev 88:673-728 (2008)\", \"DOI:10.1152/physrev.00007.2007\")), list(REFERENCE = \"PMID:11592845\", AUTHORS = \"Chiesa R, Harris DA\", TITLE = \"Prion diseases: what is the neurotoxic molecule?\", JOURNAL = c(\"Neurobiol Dis 8:743-63 (2001)\", \"DOI:10.1006/nbdi.2001.0433\")), list(REFERENCE = \"PMID:10398674\", AUTHORS = \"Harris DA\", TITLE = \"Cellular biology of prion diseases.\", JOURNAL = \"Clin Microbiol Rev 12:429-44 (1999)\"), list(REFERENCE = \"PMID:15528202\", AUTHORS = \"Marella M, Gaggioli C, Batoz M, Deckert M, Tartare-Deckert S, Chabry J\", TITLE = \"Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment.\", JOURNAL = c(\"J Biol Chem 280:1529-34 (2005)\", \"DOI:10.1074/jbc.M410966200\")), list(REFERENCE = \"PMID:15611724\", AUTHORS = \"Mallucci G, Collinge J\", TITLE = \"Rational targeting for prion therapeutics.\", JOURNAL = c(\"Nat Rev Neurosci 6:23-34 (2005)\", \"DOI:10.1038/nrn1584\")), list(REFERENCE = \"PMID:12850426\", AUTHORS = \"Hegde RS, Rane NS\", TITLE = \"Prion protein trafficking and the development of neurodegeneration.\", JOURNAL = c(\"Trends Neurosci 26:337-9 (2003)\", \"DOI:10.1016/S0166-2236(03)00143-7\")), list(REFERENCE = \"PMID:17085779\", AUTHORS = \"Fasano C, Campana V, Zurzolo C\", TITLE = \"Prions: protein only or something more? Overview of potential prion cofactors.\", JOURNAL = c(\"J Mol Neurosci 29:195-214 (2006)\", \"DOI:10.1385/JMN:29:3:195\")), list(REFERENCE = \"PMID:14705136\", AUTHORS = \"Roucou X, Gains M, LeBlanc AC\", TITLE = \"Neuroprotective functions of prion protein.\", JOURNAL = c(\"J Neurosci Res 75:153-61 (2004)\", \"DOI:10.1002/jnr.10864\")), list(REFERENCE = \"PMID:15890824\", AUTHORS = \"Novakofski J, Brewer MS, Mateus-Pinilla N, Killefer J, McCusker RH\", TITLE = \"Prion biology relevant to bovine spongiform encephalopathy.\", JOURNAL = c(\"J Anim Sci 83:1455-76 (2005)\", \"DOI:10.2527/2005.8361455x\")), list(REFERENCE = \"PMID:18558863\", AUTHORS = \"Aguzzi A, Baumann F, Bremer J\", TITLE = \"The prion\'s elusive reason for being.\", JOURNAL = c(\"Annu Rev Neurosci 31:439-77 (2008)\", \"DOI:10.1146/annurev.neuro.31.060407.125620\")), list(REFERENCE = \"PMID:15342004\", AUTHORS = \"Mabbott NA\", TITLE = \"The complement system in prion diseases.\", JOURNAL = c(\"Curr Opin Immunol 16:587-93 (2004)\", \"DOI:10.1016/j.coi.2004.07.002\"))', 'map05020', 'Prion diseases', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (390, '05030', 'Cocaine addiction', 'Drug addiction is a chronic, relapsing disorder in which compulsive drug-seeking and drug-taking behavior persists despite serious negative consequences.There is strong evidence that the dopaminergic system that projects from the ventral tegmental area (VTA) of the midbrain to the nucleus accumbens (NAc), and to other forebrain sites, is the major substrate of reward and reinforcement for both natural rewards and addictive drugs. Cocaine binds strongly to the dopamine-reuptake transporter, preventing the reuptake of dopamine into the nerve terminal. Because of this blocking effect, dopamine remains at high concentrations in the synapse and continues to affect adjacent neurons, producing the characteristic cocaine \"high.\" Activated D1 receptor activates the PKA signaling pathway, and this pathway plays a critical role in mediating the behavioral responses to cocaine administration. Cocaine-induced neuroadaptations, including dopamine depletion, may underlie craving and hedonic dysregulation.', 'Human Diseases; Substance dependence', 'Cocaine addiction', 'GO: 0042220', 'ko05030', 'list(REFERENCE = \"PMID:16278489\", AUTHORS = \"Ron D, Jurd R\", TITLE = \"The \\\"ups and downs\\\" of signaling cascades in addiction.\", JOURNAL = c(\"Sci STKE 2005:re14 (2005)\", \"DOI:10.1126/stke.3092005re14\")), list(REFERENCE = \"PMID:18440072\", AUTHORS = \"Cunha-Oliveira T, Rego AC, Oliveira CR\", TITLE = \"Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.\", JOURNAL = c(\"Brain Res Rev 58:192-208 (2008)\", \"DOI:10.1016/j.brainresrev.2008.03.002\")), list(REFERENCE = \"PMID:19403004\", AUTHORS = \"Chen JC, Chen PC, Chiang YC\", TITLE = \"Molecular mechanisms of psychostimulant addiction.\", JOURNAL = \"Chang Gung Med J 32:148-54 (2009)\"), list(REFERENCE = \"PMID:16251986\", AUTHORS = \"Nestler EJ\", TITLE = \"Is there a common molecular pathway for addiction?\", JOURNAL = c(\"Nat Neurosci 8:1445-9 (2005)\", \"DOI:10.1038/nn1578\")), list(REFERENCE = \"PMID:15091342\", AUTHORS = \"Bowers MS, McFarland K, Lake RW, Peterson YK, Lapish CC, Gregory ML, Lanier SM, Kalivas PW\", TITLE = \"Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking.\", JOURNAL = c(\"Neuron 42:269-81 (2004)\", \"DOI:10.1016/S0896-6273(04)00159-X\")), list(REFERENCE = \"PMID:12818179\", AUTHORS = \"Rahman Z, Schwarz J, Gold SJ, Zachariou V, Wein MN, Choi KH, Kovoor A, Chen CK, DiLeone RJ, Schwarz SC, Selley DE, Sim-Selley LJ, Barrot M, Luedtke RR, Self D, Neve RL, Lester HA, Simon MI, Nestler EJ\", TITLE = \"RGS9 modulates dopamine signaling in the basal ganglia.\", JOURNAL = c(\"Neuron 38:941-52 (2003)\", \"DOI:10.1016/S0896-6273(03)00321-0\")), list(REFERENCE = \"PMID:10234039\", AUTHORS = \"Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR\", TITLE = \"Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor.\", JOURNAL = c(\"J Neurosci 19:4110-22 (1999)\", \"DOI:10.1523/JNEUROSCI.19-10-04110.1999\")), list(REFERENCE = \"PMID:12064476\", AUTHORS = \"Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S\", TITLE = \"Dopamine transport function is elevated in cocaine users.\", JOURNAL = c(\"J Neurochem 81:292-300 (2002)\", \"DOI:10.1046/j.1471-4159.2002.00820.x\")), list(REFERENCE = \"PMID:14566342\", AUTHORS = \"McClung CA, Nestler EJ\", TITLE = \"Regulation of gene expression and cocaine reward by CREB and DeltaFosB.\", JOURNAL = c(\"Nat Neurosci 6:1208-15 (2003)\", \"DOI:10.1038/nn1143\")), list(REFERENCE = \"PMID:15582154\", AUTHORS = \"McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ\", TITLE = \"DeltaFosB: a molecular switch for long-term adaptation in the brain.\", JOURNAL = c(\"Brain Res Mol Brain Res 132:146-54 (2004)\", \"DOI:10.1016/j.molbrainres.2004.05.014\")), list(REFERENCE = \"PMID:11595774\", AUTHORS = \"Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E, Nestler EJ\", TITLE = \"Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration.\", JOURNAL = c(\"J Neurochem 79:221-4 (2001)\", \"DOI:10.1046/j.1471-4159.2001.00563.x\")), list(REFERENCE = \"PMID:11268215\", AUTHORS = \"Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P\", TITLE = \"Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.\", JOURNAL = c(\"Nature 410:376-80 (2001)\", \"DOI:10.1038/35066591\")), list(REFERENCE = \"PMID:14746512\", AUTHORS = \"Chao J, Nestler EJ\", TITLE = \"Molecular neurobiology of drug addiction.\", JOURNAL = c(\"Annu Rev Med 55:113-32 (2004)\", \"DOI:10.1146/annurev.med.55.091902.103730\"))', 'map05030', 'Cocaine addiction', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (391, '05031', 'Amphetamine addiction', 'Amphetamine is a psychostimulant drug that exerts persistent addictive effects. Most addictive drugs increase extracellular concentrations of dopamine (DA) in nucleus accumbens (NAc) and medial prefrontal cortex (mPFC), projection areas of mesocorticolimbic DA neurons and key components of the \"brain reward circuit\". Amphetamine achieves this elevation in extracellular levels of DA by promoting efflux from synaptic terminals. Acute administration of amphetamine induces phosphorylation of cAMP response element-binding protein (CREB) and expression of a number of immediate early genes (IEGs), such as c-fos. The IEGs is likely to initiate downstream molecular events, which may have important roles in the induction and maintenance of addictive states. Chronic exposure to amphetamine induces a unique transcription factor delta FosB, which plays an essential role in long-term adaptive changes in the brain.', 'Human Diseases; Substance dependence', 'Amphetamine addiction', 'GO: 0001975', 'ko05031', 'list(REFERENCE = \"PMID:16724157\", AUTHORS = \"Rajadhyaksha AM, Kosofsky BE\", TITLE = \"Psychostimulants, Protein phosphorylation and Gene expression: a growing role of L-type calcium channels.\", JOURNAL = c(\"Cellscience 2:127-144 (2005)\", \"DOI:10.1901/jaba.2005.2-127\")), list(REFERENCE = \"PMID:18440072\", AUTHORS = \"Cunha-Oliveira T, Rego AC, Oliveira CR\", TITLE = \"Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.\", JOURNAL = c(\"Brain Res Rev 58:192-208 (2008)\", \"DOI:10.1016/j.brainresrev.2008.03.002\")), list(REFERENCE = \"PMID:16776597\", AUTHORS = \"Hyman SE, Malenka RC, Nestler EJ\", TITLE = \"Neural mechanisms of addiction: the role of reward-related learning and memory.\", JOURNAL = c(\"Annu Rev Neurosci 29:565-98 (2006)\", \"DOI:10.1146/annurev.neuro.29.051605.113009\")), list(REFERENCE = \"PMID:16151049\", AUTHORS = \"Rajadhyaksha AM, Kosofsky BE\", TITLE = \"Psychostimulants, L-type calcium channels, kinases, and phosphatases.\", JOURNAL = c(\"Neuroscientist 11:494-502 (2005)\", \"DOI:10.1177/1073858405278236\")), list(REFERENCE = \"PMID:14622123\", AUTHORS = \"Dudman JT, Eaton ME, Rajadhyaksha A, Macias W, Taher M, Barczak A, Kameyama K, Huganir R, Konradi C\", TITLE = \"Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1.\", JOURNAL = c(\"J Neurochem 87:922-34 (2003)\", \"DOI:10.1046/j.1471-4159.2003.02067.x\")), list(REFERENCE = \"PMID:10414964\", AUTHORS = \"Rajadhyaksha A, Barczak A, Macias W, Leveque JC, Lewis SE, Konradi C\", TITLE = \"L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons.\", JOURNAL = c(\"J Neurosci 19:6348-59 (1999)\", \"DOI:10.1523/JNEUROSCI.19-15-06348.1999\")), list(REFERENCE = \"PMID:8753884\", AUTHORS = \"Konradi C, Leveque JC, Hyman SE\", TITLE = \"Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.\", JOURNAL = c(\"J Neurosci 16:4231-9 (1996)\", \"DOI:10.1523/JNEUROSCI.16-13-04231.1996\")), list(REFERENCE = \"PMID:10774721\", AUTHORS = \"Berke JD, Hyman SE\", TITLE = \"Addiction, dopamine, and the molecular mechanisms of memory.\", JOURNAL = c(\"Neuron 25:515-32 (2000)\", \"DOI:10.1016/S0896-6273(00)81056-9\")), list(REFERENCE = \"PMID:17728700\", AUTHORS = \"McClung CA, Nestler EJ\", TITLE = \"Neuroplasticity mediated by altered gene expression.\", JOURNAL = c(\"Neuropsychopharmacology 33:3-17 (2008)\", \"DOI:10.1038/sj.npp.1301544\")), list(REFERENCE = \"PMID:14746512\", AUTHORS = \"Chao J, Nestler EJ\", TITLE = \"Molecular neurobiology of drug addiction.\", JOURNAL = c(\"Annu Rev Med 55:113-32 (2004)\", \"DOI:10.1146/annurev.med.55.091902.103730\")), list(REFERENCE = \"PMID:19199083\", AUTHORS = \"Robertson SD, Matthies HJ, Galli A\", TITLE = \"A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.\", JOURNAL = c(\"Mol Neurobiol 39:73-80 (2009)\", \"DOI:10.1007/s12035-009-8053-4\")), list(REFERENCE = \"PMID:18617632\", AUTHORS = \"Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, Fog JU, Zhang M, Sen N, Colbran RJ, Gnegy ME, Gether U, Javitch JA, Erreger K, Galli A\", TITLE = \"Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.\", JOURNAL = c(\"Mol Pharmacol 74:1101-8 (2008)\", \"DOI:10.1124/mol.108.048447\")), list(REFERENCE = \"PMID:21338876\", AUTHORS = \"Sulzer D\", TITLE = \"How addictive drugs disrupt presynaptic dopamine neurotransmission.\", JOURNAL = c(\"Neuron 69:628-49 (2011)\", \"DOI:10.1016/j.neuron.2011.02.010\")), list(REFERENCE = \"PMID:8630246\", AUTHORS = \"Hyman SE\", TITLE = \"Addiction to cocaine and amphetamine.\", JOURNAL = c(\"Neuron 16:901-4 (1996)\", \"DOI:10.1016/S0896-6273(00)80111-7\")), list(REFERENCE = \"PMID:18632938\", AUTHORS = \"Renthal W, Carle TL, Maze I, Covington HE 3rd, Truong HT, Alibhai I, Kumar A, Montgomery RL, Olson EN, Nestler EJ\", TITLE = \"Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure.\", JOURNAL = c(\"J Neurosci 28:7344-9 (2008)\", \"DOI:10.1523/JNEUROSCI.1043-08.2008\")), list(REFERENCE = \"PMID:21989194\", AUTHORS = \"Robison AJ, Nestler EJ\", TITLE = \"Transcriptional and epigenetic mechanisms of addiction.\", JOURNAL = c(\"Nat Rev Neurosci 12:623-37 (2011)\", \"DOI:10.1038/nrn3111\")), list(REFERENCE = \"PMID:14529709\", AUTHORS = \"Snyder GL, Galdi S, Fienberg AA, Allen P, Nairn AC, Greengard P\", TITLE = \"Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists.\", JOURNAL = c(\"Neuropharmacology 45:703-13 (2003)\", \"DOI:10.1016/S0028-3908(03)00319-8\")), list(REFERENCE = \"PMID:19222557\", AUTHORS = \"Banerjee PS, Aston J, Khundakar AA, Zetterstrom TS\", TITLE = \"Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and adult brain.\", JOURNAL = c(\"Eur J Neurosci 29:465-76 (2009)\", \"DOI:10.1111/j.1460-9568.2008.06601.x\"))', 'map05031', 'Amphetamine addiction', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (392, '05032', 'Morphine addiction', 'Morphine is an alkaloid from the plant extracts of opium poppy. Although morphine is highly effective for the treatment of pain, it is also known to be intensely addictive. We now know that the most important brain-reward circuit involves dopamine (DA) -containing neurons in the ventral tegmental area (VTA) of the midbrain and their target areas in the limbic forebrain, in particular, the nucleus accumbens (NAc) and frontal regions of cerebral cortex. Morphine can cause indirect excitation of VTA dopamine neurons by reducing inhibitory synaptic transmission mediated by GABAergic neurons. The chronic use of morphine is characterized by adaptive changes in neurons and neuronal communication; such adaptations (e.g., \'superactivation\' of adenylyl cyclase) must underlie altered behaviour associated with morphine dependence and withdrawal syndrome, as well as drug-induced craving and relapse to drug use.', 'Human Diseases; Substance dependence', 'Morphine addiction', 'GO: 0043278', 'ko05032', 'list(REFERENCE = \"PMID:15661627\", AUTHORS = \"Bailey CP, Connor M\", TITLE = \"Opioids: cellular mechanisms of tolerance and physical dependence.\", JOURNAL = c(\"Curr Opin Pharmacol 5:60-8 (2005)\", \"DOI:10.1016/j.coph.2004.08.012\")), list(REFERENCE = \"PMID:11152760\", AUTHORS = \"Williams JT, Christie MJ, Manzoni O\", TITLE = \"Cellular and synaptic adaptations mediating opioid dependence.\", JOURNAL = c(\"Physiol Rev 81:299-343 (2001)\", \"DOI:10.1152/physrev.2001.81.1.299\")), list(REFERENCE = \"PMID:16581089\", AUTHORS = \"Gintzler AR, Chakrabarti S\", TITLE = \"Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules.\", JOURNAL = c(\"Life Sci 79:717-22 (2006)\", \"DOI:10.1016/j.lfs.2006.02.016\")), list(REFERENCE = \"PMID:8785060\", AUTHORS = \"Bonci A, Williams JT\", TITLE = \"A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine.\", JOURNAL = c(\"Neuron 16:631-9 (1996)\", \"DOI:10.1016/S0896-6273(00)80082-3\")), list(REFERENCE = \"PMID:11750924\", AUTHORS = \"Liu JG, Anand KJ\", TITLE = \"Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence.\", JOURNAL = c(\"Brain Res Brain Res Rev 38:1-19 (2001)\", \"DOI:10.1016/S0165-0173(01)00057-1\")), list(REFERENCE = \"PMID:10066284\", AUTHORS = \"Shoji Y, Delfs J, Williams JT\", TITLE = \"Presynaptic inhibition of GABA(B)-mediated synaptic potentials in the ventral tegmental area during morphine withdrawal.\", JOURNAL = c(\"J Neurosci 19:2347-55 (1999)\", \"DOI:10.1523/JNEUROSCI.19-06-02347.1999\")), list(REFERENCE = \"PMID:18349442\", AUTHORS = \"Zhang Y, Chen Q, Yu LC\", TITLE = \"Morphine: a protective or destructive role in neurons?\", JOURNAL = c(\"Neuroscientist 14:561-70 (2008)\", \"DOI:10.1177/1073858408314434\")), list(REFERENCE = \"PMID:12859419\", AUTHORS = \"Tso PH, Wong YH\", TITLE = \"Molecular basis of opioid dependence: role of signal regulation by G-proteins.\", JOURNAL = c(\"Clin Exp Pharmacol Physiol 30:307-16 (2003)\", \"DOI:10.1046/j.1440-1681.2003.03835.x\")), list(REFERENCE = \"PMID:1346804\", AUTHORS = \"Johnson SW, North RA\", TITLE = \"Opioids excite dopamine neurons by hyperpolarization of local interneurons.\", JOURNAL = c(\"J Neurosci 12:483-8 (1992)\", \"DOI:10.1523/JNEUROSCI.12-02-00483.1992\")), list(REFERENCE = \"PMID:20962224\", AUTHORS = \"Madhavan A, Bonci A, Whistler JL\", TITLE = \"Opioid-Induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area.\", JOURNAL = c(\"J Neurosci 30:14029-35 (2010)\", \"DOI:10.1523/JNEUROSCI.3366-10.2010\")), list(REFERENCE = \"PMID:8987801\", AUTHORS = \"Bonci A, Williams JT\", TITLE = \"Increased probability of GABA release during withdrawal from morphine.\", JOURNAL = c(\"J Neurosci 17:796-803 (1997)\", \"DOI:10.1523/JNEUROSCI.17-02-00796.1997\")), list(REFERENCE = \"PMID:21872647\", AUTHORS = \"Morikawa H, Paladini CA\", TITLE = \"Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms.\", JOURNAL = c(\"Neuroscience 198:95-111 (2011)\", \"DOI:10.1016/j.neuroscience.2011.08.023\")), list(REFERENCE = \"PMID:12217944\", AUTHORS = \"Xi ZX, Stein EA\", TITLE = \"GABAergic mechanisms of opiate reinforcement .\", JOURNAL = c(\"Alcohol Alcohol 37:485-94 (2002)\", \"DOI:10.1093/alcalc/37.5.485\")), list(REFERENCE = \"PMID:8096779\", AUTHORS = \"Kalivas PW\", TITLE = \"Neurotransmitter regulation of dopamine neurons in the ventral tegmental area.\", JOURNAL = c(\"Brain Res Brain Res Rev 18:75-113 (1993)\", \"DOI:10.1016/0165-0173(93)90008-N\")), list(REFERENCE = \"PMID:21930931\", AUTHORS = \"Jalabert M, Bourdy R, Courtin J, Veinante P, Manzoni OJ, Barrot M, Georges F\", TITLE = \"Neuronal circuits underlying acute morphine action on dopamine neurons.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 108:16446-50 (2011)\", \"DOI:10.1073/pnas.1105418108\")), list(REFERENCE = \"PMID:14625081\", AUTHORS = \"Chakrabarti S, Gintzler AR\", TITLE = \"Phosphorylation of Gbeta is augmented by chronic morphine and enhances Gbetagamma stimulation of adenylyl cyclase activity.\", JOURNAL = c(\"Brain Res Mol Brain Res 119:144-51 (2003)\", \"DOI:10.1016/j.molbrainres.2003.09.002\")), list(REFERENCE = \"PMID:14969742\", AUTHORS = \"Ferrer-Alcon M, La Harpe R, Garcia-Sevilla JA\", TITLE = \"Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts.\", JOURNAL = c(\"Brain Res Mol Brain Res 121:114-22 (2004)\", \"DOI:10.1016/j.molbrainres.2003.11.009\"))', 'map05032', 'Morphine addiction', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (393, '05033', 'Nicotine addiction', 'Nicotine is one of the main psychoactive ingredients in tobacco that contributes to the harmful tobacco smoking habit. A common feature of addictive drugs, including nicotine, is that they increase dopamine (DA) release in the nucleus accumbens (NAc). The principal dopaminergic projections to NAc arise from neurons in the ventral tegmental area (VTA). In the VTA, alpha6- and alpha4beta2-containing nAChRs (alpha6*-AChRs and alpha4beta2*-AChRs, respectively) are located on GABAergic terminals and provide inhibitory inputs onto DAergic neuons, while alpha7*-nAChRs are located on glutamatergic terminals and activation of these receptors enhances glutamate release and increases excitability of DAergic neurons. Nicotine acts as an agonist to activate and desensitize these nicotinic acetylcholine receptors (nAChRs). After a short exposure to nicotine, alpha6*- and alpha4beta2*- nAChRs on GABAergic afferents are desensitized, decreasing GABA release and decreasing local inhibition of DA neurons. But the alpha7*-nAChRs on glutamatergic afferents remain active and enhance glutamate excitation of the DA neurons, leading to increased DA release in the NAc -and so facilitate the reinforcing effects of nicotine.', 'Human Diseases; Substance dependence', 'Nicotine addiction', 'GO: 0035094', 'ko05033', 'list(REFERENCE = \"PMID:12436424\", AUTHORS = \"Mansvelder HD, McGehee DS\", TITLE = \"Cellular and synaptic mechanisms of nicotine addiction.\", JOURNAL = c(\"J Neurobiol 53:606-17 (2002)\", \"DOI:10.1002/neu.10148\")), list(REFERENCE = \"PMID:15661626\", AUTHORS = \"Wonnacott S, Sidhpura N, Balfour DJ\", TITLE = \"Nicotine: from molecular mechanisms to behaviour.\", JOURNAL = c(\"Curr Opin Pharmacol 5:53-9 (2005)\", \"DOI:10.1016/j.coph.2004.12.002\")), list(REFERENCE = \"PMID:19669944\", AUTHORS = \"Mao D, McGehee DS\", TITLE = \"Nicotine and behavioral sensitization.\", JOURNAL = c(\"J Mol Neurosci 40:154-63 (2010)\", \"DOI:10.1007/s12031-009-9230-7\")), list(REFERENCE = \"PMID:19184650\", AUTHORS = \"Barik J, Wonnacott S\", TITLE = \"Molecular and cellular mechanisms of action of nicotine in the CNS.\", JOURNAL = c(\"Handb Exp Pharmacol 173-207 (2009)\", \"DOI:10.1007/978-3-540-69248-5_7\")), list(REFERENCE = \"PMID:19498417\", AUTHORS = \"Yang KC, Jin GZ, Wu J\", TITLE = \"Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.\", JOURNAL = c(\"Acta Pharmacol Sin 30:740-51 (2009)\", \"DOI:10.1038/aps.2009.63\")), list(REFERENCE = \"PMID:14747518\", AUTHORS = \"Pidoplichko VI, Noguchi J, Areola OO, Liang Y, Peterson J, Zhang T, Dani JA\", TITLE = \"Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction.\", JOURNAL = c(\"Learn Mem 11:60-9 (2004)\", \"DOI:10.1101/lm.70004\")), list(REFERENCE = \"PMID:12716925\", AUTHORS = \"Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA\", TITLE = \"Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas.\", JOURNAL = c(\"J Neurosci 23:3176-85 (2003)\", \"DOI:10.1523/JNEUROSCI.23-08-03176.2003\")), list(REFERENCE = \"PMID:19434058\", AUTHORS = \"Xi ZX, Spiller K, Gardner EL\", TITLE = \"Mechanism-based medication development for the treatment of nicotine dependence.\", JOURNAL = c(\"Acta Pharmacol Sin 30:723-39 (2009)\", \"DOI:10.1038/aps.2009.46\")), list(REFERENCE = \"PMID:14708004\", AUTHORS = \"Laviolette SR, van der Kooy D\", TITLE = \"The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour.\", JOURNAL = c(\"Nat Rev Neurosci 5:55-65 (2004)\", \"DOI:10.1038/nrn1298\")), list(REFERENCE = \"PMID:20485364\", AUTHORS = \"Changeux JP\", TITLE = \"Nicotine addiction and nicotinic receptors: lessons from genetically modified mice.\", JOURNAL = c(\"Nat Rev Neurosci 11:389-401 (2010)\", \"DOI:10.1038/nrn2849\")), list(REFERENCE = \"PMID:17009926\", AUTHORS = \"Dani JA, Bertrand D\", TITLE = \"Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.\", JOURNAL = c(\"Annu Rev Pharmacol Toxicol 47:699-729 (2007)\", \"DOI:10.1146/annurev.pharmtox.47.120505.105214\")), list(REFERENCE = \"PMID:11906697\", AUTHORS = \"Mansvelder HD, Keath JR, McGehee DS\", TITLE = \"Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas.\", JOURNAL = c(\"Neuron 33:905-19 (2002)\", \"DOI:10.1016/S0896-6273(02)00625-6\")), list(REFERENCE = \"PMID:18723034\", AUTHORS = \"O\'Dell LE\", TITLE = \"A psychobiological framework of the substrates that mediate nicotine use during adolescence.\", JOURNAL = c(\"Neuropharmacology 56 Suppl 1:263-78 (2009)\", \"DOI:10.1016/j.neuropharm.2008.07.039\")), list(REFERENCE = \"PMID:20833261\", AUTHORS = \"Ortells MO, Arias HR\", TITLE = \"Neuronal networks of nicotine addiction.\", JOURNAL = c(\"Int J Biochem Cell Biol 42:1931-5 (2010)\", \"DOI:10.1016/j.biocel.2010.08.019\")), list(REFERENCE = \"PMID:16251989\", AUTHORS = \"Dani JA, Harris RA\", TITLE = \"Nicotine addiction and comorbidity with alcohol abuse and mental illness.\", JOURNAL = c(\"Nat Neurosci 8:1465-70 (2005)\", \"DOI:10.1038/nn1580\")), list(REFERENCE = \"PMID:18640919\", AUTHORS = \"Markou A\", TITLE = \"Review. Neurobiology of nicotine dependence.\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 363:3159-68 (2008)\", \"DOI:10.1098/rstb.2008.0095\")), list(REFERENCE = \"PMID:15165747\", AUTHORS = \"Dajas-Bailador F, Wonnacott S\", TITLE = \"Nicotinic acetylcholine receptors and the regulation of neuronal signalling.\", JOURNAL = c(\"Trends Pharmacol Sci 25:317-24 (2004)\", \"DOI:10.1016/j.tips.2004.04.006\"))', 'map05033', 'Nicotine addiction', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (394, '05034', 'Alcoholism', 'Alcoholism, also called dependence on alcohol (ethanol), is a chronic relapsing disorder that is progressive and has serious detrimental health outcomes. As one of the primary mediators of the rewarding effects of alcohol, dopaminergic ventral tegmental area (VTA) projections to the nucleus accumbens (NAc) have been identified. Acute exposure to alcohol stimulates dopamine release into the NAc, which activates D1 receptors, stimulating PKA signaling and subsequent CREB-mediated gene expression, whereas chronic alcohol exposure leads to an adaptive downregulation of this pathway, in particular of CREB function. The decreased CREB function in the NAc may promote the intake of drugs of abuse to achieve an increase in reward and thus may be involved in the regulation of positive affective states of addiction. PKA signaling also affects NMDA receptor activity and may play an important role in neuroadaptation in response to chronic alcohol exposure.', 'Human Diseases; Substance dependence', 'Alcoholism', 'Alcohol dependence', 'GO: 0045471', 'ko05034', 'list(REFERENCE = \"PMID:19342616\", AUTHORS = \"Spanagel R\", TITLE = \"Alcoholism: a systems approach from molecular physiology to addictive behavior.\", JOURNAL = c(\"Physiol Rev 89:649-705 (2009)\", \"DOI:10.1152/physrev.00013.2008\")), list(REFERENCE = \"PMID:16102840\", AUTHORS = \"Newton PM, Messing RO\", TITLE = \"Intracellular signaling pathways that regulate behavioral responses to ethanol.\", JOURNAL = c(\"Pharmacol Ther 109:227-37 (2006)\", \"DOI:10.1016/j.pharmthera.2005.07.004\")), list(REFERENCE = \"PMID:14729391\", AUTHORS = \"Mailliard WS, Diamond I\", TITLE = \"Recent advances in the neurobiology of alcoholism: the role of adenosine.\", JOURNAL = c(\"Pharmacol Ther 101:39-46 (2004)\", \"DOI:10.1016/j.pharmthera.2003.10.002\")), list(REFERENCE = \"PMID:16278489\", AUTHORS = \"Ron D, Jurd R\", TITLE = \"The \\\"ups and downs\\\" of signaling cascades in addiction.\", JOURNAL = c(\"Sci STKE 2005:re14 (2005)\", \"DOI:10.1126/stke.3092005re14\")), list(REFERENCE = \"PMID:12605085\", AUTHORS = \"Diana M, Brodie M, Muntoni A, Puddu MC, Pillolla G, Steffensen S, Spiga S, Little HJ\", TITLE = \"Enduring effects of chronic ethanol in the CNS: basis for alcoholism.\", JOURNAL = c(\"Alcohol Clin Exp Res 27:354-61 (2003)\", \"DOI:10.1097/01.ALC.0000057121.36127.19\")), list(REFERENCE = \"PMID:19756388\", AUTHORS = \"Moonat S, Starkman BG, Sakharkar A, Pandey SC\", TITLE = \"Neuroscience of alcoholism: molecular and cellular mechanisms.\", JOURNAL = c(\"Cell Mol Life Sci 67:73-88 (2010)\", \"DOI:10.1007/s00018-009-0135-y\")), list(REFERENCE = \"PMID:15500908\", AUTHORS = \"Pandey SC\", TITLE = \"The gene transcription factor cyclic AMP-responsive element binding protein: role in positive and negative affective states of alcohol addiction.\", JOURNAL = c(\"Pharmacol Ther 104:47-58 (2004)\", \"DOI:10.1016/j.pharmthera.2004.08.002\")), list(REFERENCE = \"PMID:16764827\", AUTHORS = \"Zhang TA, Maldve RE, Morrisett RA\", TITLE = \"Coincident signaling in mesolimbic structures underlying alcohol reinforcement.\", JOURNAL = c(\"Biochem Pharmacol 72:919-27 (2006)\", \"DOI:10.1016/j.bcp.2006.04.022\")), list(REFERENCE = \"PMID:12068305\", AUTHORS = \"Maldve RE, Zhang TA, Ferrani-Kile K, Schreiber SS, Lippmann MJ, Snyder GL, Fienberg AA, Leslie SW, Gonzales RA, Morrisett RA\", TITLE = \"DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens.\", JOURNAL = c(\"Nat Neurosci 5:641-8 (2002)\", \"DOI:10.1038/nn877\")), list(REFERENCE = \"PMID:12085089\", AUTHORS = \"Lovinger DM\", TITLE = \"NMDA receptors lose their inhibitions.\", JOURNAL = c(\"Nat Neurosci 5:614-6 (2002)\", \"DOI:10.1038/nn0702-614\")), list(REFERENCE = \"PMID:16776597\", AUTHORS = \"Hyman SE, Malenka RC, Nestler EJ\", TITLE = \"Neural mechanisms of addiction: the role of reward-related learning and memory.\", JOURNAL = c(\"Annu Rev Neurosci 29:565-98 (2006)\", \"DOI:10.1146/annurev.neuro.29.051605.113009\")), list(REFERENCE = \"PMID:10774721\", AUTHORS = \"Berke JD, Hyman SE\", TITLE = \"Addiction, dopamine, and the molecular mechanisms of memory.\", JOURNAL = c(\"Neuron 25:515-32 (2000)\", \"DOI:10.1016/S0896-6273(00)81056-9\")), list(REFERENCE = \"PMID:20729980\", AUTHORS = \"Clapp P, Bhave SV, Hoffman PL\", TITLE = \"How Adaptation of the Brain to Alcohol Leads to Dependence: A Pharmacological Perspective.\", JOURNAL = \"Alcohol Res Health 31:310-339 (2008)\"), list(REFERENCE = \"PMID:20947635\", AUTHORS = \"Jeanes ZM, Buske TR, Morrisett RA\", TITLE = \"In vivo chronic intermittent ethanol exposure reverses the polarity of synaptic plasticity in the nucleus accumbens shell.\", JOURNAL = c(\"J Pharmacol Exp Ther 336:155-64 (2011)\", \"DOI:10.1124/jpet.110.171009\")), list(REFERENCE = \"PMID:18991950\", AUTHORS = \"Lee AM, Messing RO\", TITLE = \"Protein kinases and addiction.\", JOURNAL = c(\"Ann N Y Acad Sci 1141:22-57 (2008)\", \"DOI:10.1196/annals.1441.022\")), list(REFERENCE = \"PMID:17270154\", AUTHORS = \"Repunte-Canonigo V, Lutjens R, van der Stap LD, Sanna PP\", TITLE = \"Increased expression of protein kinase A inhibitor alpha (PKI-alpha) and decreased PKA-regulated genes in chronic intermittent alcohol exposure.\", JOURNAL = c(\"Brain Res 1138:48-56 (2007)\", \"DOI:10.1016/j.brainres.2006.09.115\")), list(REFERENCE = \"PMID:18310464\", AUTHORS = \"Logrip ML, Janak PH, Ron D\", TITLE = \"Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake.\", JOURNAL = c(\"FASEB J 22:2393-404 (2008)\", \"DOI:10.1096/fj.07-099135\")), list(REFERENCE = \"PMID:18616668\", AUTHORS = \"Shukla SD, Velazquez J, French SW, Lu SC, Ticku MK, Zakhari S\", TITLE = \"Emerging role of epigenetics in the actions of alcohol.\", JOURNAL = c(\"Alcohol Clin Exp Res 32:1525-34 (2008)\", \"DOI:10.1111/j.1530-0277.2008.00729.x\")), list(REFERENCE = \"PMID:19077056\", AUTHORS = \"Pascual M, Boix J, Felipo V, Guerri C\", TITLE = \"Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat.\", JOURNAL = c(\"J Neurochem 108:920-31 (2009)\", \"DOI:10.1111/j.1471-4159.2008.05835.x\")), list(REFERENCE = \"PMID:20626732\", AUTHORS = \"Li J, Cheng Y, Bian W, Liu X, Zhang C, Ye JH\", TITLE = \"Region-specific induction of FosB/DeltaFosB by voluntary alcohol intake: effects of naltrexone.\", JOURNAL = c(\"Alcohol Clin Exp Res 34:1742-50 (2010)\", \"DOI:10.1111/j.1530-0277.2010.01261.x\"))', 'map05034', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (395, '05100', 'Bacterial invasion of epithelial cells', 'Many pathogenic bacteria can invade phagocytic and non-phagocytic cells and colonize them intracellularly, then become disseminated to other cells. Invasive bacteria induce their own uptake by non-phagocytic host cells (e.g. epithelial cells) using two mechanisms referred to as zipper model and trigger model. Listeria, Staphylococcus, Streptococcus, and Yersinia are examples of bacteria that enter using the zipper model. These bacteria express proteins on their surfaces that interact with cellular receptors, initiating signalling cascades that result in close apposition of the cellular membrane around the entering bacteria. Shigella and Salmonella are the examples of bacteria entering cells using the trigger model. These bacteria use type III secretion systems to inject protein effectors that interact with the actin cytoskeleton.', 'Human Diseases; Infectious disease: bacterial', 'Bacterial invasion of epithelial cells', 'ko05100', 'list(REFERENCE = \"PMID:19296488\", AUTHORS = \"Mostowy S, Cossart P\", TITLE = \"Cytoskeleton rearrangements during Listeria infection: clathrin and septins as new players in the game.\", JOURNAL = c(\"Cell Motil Cytoskeleton 66:816-23 (2009)\", \"DOI:10.1002/cm.20353\")), list(REFERENCE = \"PMID:16406780\", AUTHORS = \"Hauck CR, Ohlsen K\", TITLE = \"Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus.\", JOURNAL = c(\"Curr Opin Microbiol 9:5-11 (2006)\", \"DOI:10.1016/j.mib.2005.12.002\")), list(REFERENCE = \"PMID:17298394\", AUTHORS = \"Wang B, Li S, Dedhar S, Cleary PP\", TITLE = \"Paxillin phosphorylation: bifurcation point downstream of integrin-linked kinase (ILK) in streptococcal invasion.\", JOURNAL = c(\"Cell Microbiol 9:1519-28 (2007)\", \"DOI:10.1111/j.1462-5822.2007.00889.x\")), list(REFERENCE = \"PMID:19185531\", AUTHORS = \"Matsumoto H, Young GM\", TITLE = \"Translocated effectors of Yersinia.\", JOURNAL = c(\"Curr Opin Microbiol 12:94-100 (2009)\", \"DOI:10.1016/j.mib.2008.12.005\")), list(REFERENCE = \"PMID:19157959\", AUTHORS = \"McGhie EJ, Brawn LC, Hume PJ, Humphreys D, Koronakis V\", TITLE = \"Salmonella takes control: effector-driven manipulation of the host.\", JOURNAL = c(\"Curr Opin Microbiol 12:117-24 (2009)\", \"DOI:10.1016/j.mib.2008.12.001\")), list(REFERENCE = \"PMID:17719540\", AUTHORS = \"Iwai H, Kim M, Yoshikawa Y, Ashida H, Ogawa M, Fujita Y, Muller D, Kirikae T, Jackson PK, Kotani S, Sasakawa C\", TITLE = \"A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling.\", JOURNAL = c(\"Cell 130:611-23 (2007)\", \"DOI:10.1016/j.cell.2007.06.043\"))', 'map05100', 'Bacterial invasion of epithelial cells', 'Many pathogenic bacteria can invade phagocytic and non-phagocytic cells and colonize them intracellularly, then become disseminated to other cells. Invasive bacteria induce their own uptake by non-phagocytic host cells (e.g. epithelial cells) using two mechanisms referred to as zipper model and trigger model. Listeria, Staphylococcus, Streptococcus, and Yersinia are examples of bacteria that enter using the zipper model. These bacteria express proteins on their surfaces that interact with cellular receptors, initiating signalling cascades that result in close apposition of the cellular membrane around the entering bacteria. Shigella and Salmonella are the examples of bacteria entering cells using the trigger model. These bacteria use type III secretion systems to inject protein effectors that interact with the actin cytoskeleton.', 65, 156, 65, 0, 0, 0, 156, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (396, '05110', 'Vibrio cholerae infection', 'c(\"Cholera toxin (CTX) is one of the main virulence factors of Vibrio cholerae. Once secreted, CTX B-chain (CTXB) binds to ganglioside GM1 on the surface of the host\'s cells. After binding takes place, the entire CTX complex is carried from plasma membrane (PM) to endoplasmic reticulum (ER). In the ER, the A-chain (CTXA) is recognized by protein disulfide isomerase (PDI), unfolded, and delivered to the membrane where the membrane-associated ER-oxidase, Ero1, oxidizes PDI to release the CTXA into the protein-conducting channel, Sec61. CTXA is then retro-translocated to the cytosol and induces water and electrolyte secretion by increasing cAMP levels via adenylate cyclase (AC) to exert toxicity.\", \n\"Other than CTX, Vibrio cholerae generates several toxins that are perilous to eukaryotic cells. Zonula occludens toxin (ZOT) causes tight junction disruption through protein kinase C-dependent actin polymerization. RTX toxin (RtxA) causes actin depolymerization by covalently cross-linking actin monomers into dimers, trimers, and higher multimers. Vibrio cholerae cytolysin (VCC) is an important pore-forming toxin. The assembly of VCC anion channels in cells cause vacuolization and lysis.\")', 'Human Diseases; Infectious disease: bacterial', 'Vibrio cholerae infection', 'Vibrio cholerae pathogenicity signature, cholera toxins [PATH:map05110], Vibrio cholerae pathogenicity signature, toxin coregulated pilus [PATH:map05110]', 'Cholera', 'ko05110', 'list(REFERENCE = \"PMID:10942706\", AUTHORS = \"Trucksis M, Conn TL, Wasserman SS, Sears CL.\", TITLE = \"Vibrio cholerae ACE stimulates Ca(2+)-dependent Cl(-)/HCO(3)(-) secretion in T84 cells in vitro.\", JOURNAL = c(\"Am J Physiol Cell Physiol 279:C567-77 (2000)\", \"DOI:10.1152/ajpcell.2000.279.3.C567\")), list(REFERENCE = \"PMID:11032799\", AUTHORS = \"Fullner KJ, Mekalanos JJ.\", TITLE = \"In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin.\", JOURNAL = c(\"EMBO J 19:5315-23 (2000)\", \"DOI:10.1093/emboj/19.20.5315\")), list(REFERENCE = \"PMID:11292584\", AUTHORS = \"Lencer WI.\", TITLE = \"Microbes and microbial Toxins: paradigms for microbial-mucosal toxins. V. Cholera: invasion of the intestinal epithelial barrier by a stably folded protein toxin.\", JOURNAL = c(\"Am J Physiol Gastrointest Liver Physiol 280:G781-6 (2001)\", \"DOI:10.1152/ajpgi.2001.280.5.G781\")), list(REFERENCE = \"PMID:12102686\", AUTHORS = \"Moschioni M, Tombola F, de Bernard M, Coelho A, Zitzer A, Zoratti M, Montecucco C.\", TITLE = \"The Vibrio cholerae haemolysin anion channel is required for cell vacuolation and death.\", JOURNAL = c(\"Cell Microbiol 4:397-409 (2002)\", \"DOI:10.1046/j.1462-5822.2002.00199.x\")), list(REFERENCE = \"PMID:12403808\", AUTHORS = \"Tsai B, Rapoport TA.\", TITLE = \"Unfolded cholera toxin is transferred to the ER membrane and released from protein disulfide isomerase upon oxidation by Ero1.\", JOURNAL = c(\"J Cell Biol 159:207-16 (2002)\", \"DOI:10.1083/jcb.200207120\")), list(REFERENCE = \"PMID:13679513\", AUTHORS = \"Fujinaga Y, Wolf AA, Rodighiero C, Wheeler H, Tsai B, Allen L, Jobling MG, Rapoport T, Holmes RK, Lencer WI.\", TITLE = \"Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulm.\", JOURNAL = c(\"Mol Biol Cell 14:4783-93 (2003)\", \"DOI:10.1091/mbc.E03-06-0354\")), list(REFERENCE = \"PMID:11953326\", AUTHORS = \"Fasano A.\", TITLE = \"Toxins and the gut: role in human disease.\", JOURNAL = c(\"Gut 50 Suppl 3:III9-14 (2002)\", \"DOI:10.1136/gut.50.suppl_3.iii9\")), list(REFERENCE = \"PMID:11207565\", AUTHORS = \"Uzzau S, Fasano A.\", TITLE = \"Cross-talk between enteric pathogens and the intestine.\", JOURNAL = c(\"Cell Microbiol 2:83-9 (2000)\", \"DOI:10.1046/j.1462-5822.2000.00041.x\")), list(REFERENCE = \"PMID:11349009\", AUTHORS = \"Sandkvist M.\", TITLE = \"Type II secretion and pathogenesis.\", JOURNAL = c(\"Infect Immun 69:3523-35 (2001)\", \"DOI:10.1128/IAI.69.6.3523-3535.2001\")), list(REFERENCE = \"PMID:12671039\", AUTHORS = \"Field M.\", TITLE = \"Intestinal ion transport and the pathophysiology of diarrhea.\", JOURNAL = c(\"J Clin Invest 111:931-43 (2003)\", \"DOI:10.1172/JCI18326\")), list(REFERENCE = \"PMID:14659695\", AUTHORS = \"Lencer WI, Tsai B.\", TITLE = \"The intracellular voyage of cholera toxin: going retro.\", JOURNAL = c(\"Trends Biochem Sci 28:639-45 (2003)\", \"DOI:10.1016/j.tibs.2003.10.002\")), list(REFERENCE = \"PMID:15204437\", AUTHORS = \"De Haan L, Hirst TR.\", TITLE = \"Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review).\", JOURNAL = c(\"Mol Membr Biol 21:77-92 (2004)\", \"DOI:10.1080/09687680410001663267\")), list(REFERENCE = \"PMID:17156122\", AUTHORS = \"Chinnapen DJ, Chinnapen H, Saslowsky D, Lencer WI.\", TITLE = \"Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER.\", JOURNAL = c(\"FEMS Microbiol Lett 266:129-37 (2007)\", \"DOI:10.1111/j.1574-6968.2006.00545.x\")), list(REFERENCE = \"PMID:17464284\", AUTHORS = \"Sheahan KL, Cordero CL, Satchell KJ.\", TITLE = \"Autoprocessing of the Vibrio cholerae RTX toxin by the cysteine protease domain.\", JOURNAL = c(\"EMBO J 26:2552-61 (2007)\", \"DOI:10.1038/sj.emboj.7601700\")), list(REFERENCE = \"PMID:11454785\", AUTHORS = \"Fasano A.\", TITLE = \"Intestinal zonulin: open sesame!\", JOURNAL = c(\"Gut 49:159-62 (2001)\", \"DOI:10.1136/gut.49.2.159\"))', 'map05110', 1, 10, 1, 0, 0, 0, 10, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (397, '05111', 'Biofilm formation - Vibrio cholerae', 'Surface colonization and subsequent biofilm formation and development provide numerous advantages to microorganisms. On the other hand, biofilm formation is an energetically costly process and therefore must be tightly regulated and plastic, enabling biofilm bacteria to be responsive to the various environmental cues. The quorum sensing (QS) pathway of Vibrio cholerae activates the expression of VpsR, VpsT and AphA (the main activators of biofilm formation) at low cell density and HapR (the main repressor) at high cell density. At low cell density, biofilm genes, including Vibrio polysaccharide (VPS) biosynthesis genes and the major extracellular matrix genes RbmA, RbmC, and Bap1, are expressed. The QS pathway also leads to induction of virulence factors such as toxin coregulated pilus (TCP) and cholera toxin (CTX), essential for colonization of the host and enterotoxicity, respectively. The VarS/VarA signaling system responds to an unknown environmental cue and represses biofilm production by process which involves the regulatory sRNAs CsrB, CsrC and CsrD and the RNA-binding protein CsrA, interfering with LuxO of the QS pathway. The second messenger cAMP acts as a repressor of biofilm formation. cAMP is generated by adenylate cyclase CyaA, and in complex with cAMP receptor protein (CRP), this nucleotide has been shown to upregulate HapR production through the positive regulation of the CAI-I synthase CqsA and the negative regulation of Fis. The second messenger c-di-GMP is a key signalling molecule controlling motility and biofilm matrix production. High cellular levels of c-di-GMP promote enhanced transcription of genes involved in biofilm formation, possibly by promoting VpsT-mediated transcriptional activation of vps genes.', 'Cellular Processes; Cellular community - prokaryotes', 'Biofilm formation - Vibrio cholerae', 'Vibrio cholerae pathogenicity signature, toxin coregulated pilus [PATH:map05111]', 'ko05111', 'list(REFERENCE = \"PMID:25895940\", AUTHORS = \"Teschler JK, Zamorano-Sanchez D, Utada AS, Warner CJ, Wong GC, Linington RG, Yildiz FH\", TITLE = \"Living in the matrix: assembly and control of Vibrio cholerae biofilms.\", JOURNAL = c(\"Nat Rev Microbiol 13:255-68 (2015)\", \"DOI:10.1038/nrmicro3433\")), list(REFERENCE = \"PMID:26700108\", AUTHORS = \"Dang H, Lovell CR\", TITLE = \"Microbial Surface Colonization and Biofilm Development in Marine Environments.\", JOURNAL = c(\"Microbiol Mol Biol Rev 80:91-138 (2016)\", \"DOI:10.1128/MMBR.00037-15\")), list(REFERENCE = \"PMID:19287449\", AUTHORS = \"Hengge R\", TITLE = \"Principles of c-di-GMP signalling in bacteria.\", JOURNAL = c(\"Nat Rev Microbiol 7:263-73 (2009)\", \"DOI:10.1038/nrmicro2109\")), list(REFERENCE = \"PMID:25666534\", AUTHORS = \"Liang ZX\", TITLE = \"The expanding roles of c-di-GMP in the biosynthesis of exopolysaccharides and secondary metabolites.\", JOURNAL = c(\"Nat Prod Rep 32:663-83 (2015)\", \"DOI:10.1039/c4np00086b\")), list(REFERENCE = \"PMID:9371445\", AUTHORS = \"Sandkvist M, Michel LO, Hough LP, Morales VM, Bagdasarian M, Koomey M, DiRita VJ, Bagdasarian M\", TITLE = \"General secretion pathway (eps) genes required for toxin secretion and outer membrane biogenesis in Vibrio cholerae.\", JOURNAL = c(\"J Bacteriol 179:6994-7003 (1997)\", \"DOI:10.1128/JB.179.22.6994-7003.1997\")), list(REFERENCE = \"PMID:16262799\", AUTHORS = \"Lenz DH, Miller MB, Zhu J, Kulkarni RV, Bassler BL\", TITLE = \"CsrA and three redundant small RNAs regulate quorum sensing in Vibrio cholerae.\", JOURNAL = c(\"Mol Microbiol 58:1186-202 (2005)\", \"DOI:10.1111/j.1365-2958.2005.04902.x\")), list(REFERENCE = \"PMID:17981973\", AUTHORS = \"Houot L, Watnick PI\", TITLE = \"A novel role for enzyme I of the Vibrio cholerae phosphoenolpyruvate phosphotransferase system in regulation of growth in a biofilm.\", JOURNAL = c(\"J Bacteriol 190:311-20 (2008)\", \"DOI:10.1128/JB.01410-07\")), list(REFERENCE = \"PMID:17921282\", AUTHORS = \"Liang W, Silva AJ, Benitez JA\", TITLE = \"The cyclic AMP receptor protein modulates colonial morphology in Vibrio cholerae.\", JOURNAL = c(\"Appl Environ Microbiol 73:7482-7 (2007)\", \"DOI:10.1128/AEM.01564-07\")), list(REFERENCE = \"PMID:17181781\", AUTHORS = \"Lenz DH, Bassler BL\", TITLE = \"The small nucleoid protein Fis is involved in Vibrio cholerae quorum sensing.\", JOURNAL = c(\"Mol Microbiol 63:859-71 (2007)\", \"DOI:10.1111/j.1365-2958.2006.05545.x\"))', 'map05111', 'Biofilm formation - Vibrio cholerae', 0, 50, 0, 0, 0, 0, 50, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (398, '05120', 'Epithelial cell signaling in Helicobacter pylori infection', 'c(\"Two major virulence factors of H. pylori are the vacuolating cytotoxin (VacA) and the cag type-IV secretion system (T4SS) and its translocated effector protein, cytotoxin-associated antigen A (CagA).\", \"VacA binds to lipid rafts and glycosylphosphatidylinositol-anchored proteins (GPI-APs) of the target cell membrane. After insertion into the plasma membrane, VacA channels are endocytosed and eventually reach late endosomal compartments, increasing their permeability to anions with enhancement of the electrogenic vacuolar ATPase (v-ATPase) proton pump. In the presence of weak bases, osmotically active acidotropic ions will accumulate in the endosomes. This leads to water influx and vesicle swelling, an essential step in vacuole formation. In addition, it is reported that the VacA cleavage product binds to the tyrosine phosphatase receptor zeta (Ptprz) on epithelial cells and the induced signaling leads to the phosphorylation of the G protein-coupled receptor kinase-interactor 1 (Git1) and induces ulcerogenesis in mice.\", \n\"The other virulence factor cag T4SS mediates the translocation of the effector protein CagA, which is subsequently phosphorylated by a Src kinase. Phosphorylated CagA interacts with the protein tyrosine phosphatase SHP-2, thus stimulating its phosphatase activity. Activated SHP-2 is able to induce MAPK signalling through Ras/Raf-dependent and -independent mechanisms. Deregulation of this pathway by CagA may lead to abnormal proliferation and movement of gastric epithelial cells.\")', 'Human Diseases; Infectious disease: bacterial', 'Epithelial cell signaling in Helicobacter pylori infection', 'Helicobacter pylori pathogenicity signature, cagA pathogenicity island [PATH:map05120]', 'Helicobacter pylori infection', 'ko05120', 'list(REFERENCE = \"PMID:14700549\", AUTHORS = \"Naumann M, Crabtree JE.\", TITLE = \"Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis.\", JOURNAL = c(\"Trends Microbiol 12:29-36 (2004)\", \"DOI:10.1016/j.tim.2003.11.005\")), list(REFERENCE = \"PMID:15694859\", AUTHORS = \"Rieder G, Fischer W, Haas R.\", TITLE = \"Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules.\", JOURNAL = c(\"Curr Opin Microbiol 8:67-73 (2005)\", \"DOI:10.1016/j.mib.2004.12.004\")), list(REFERENCE = \"PMID:11389469\", AUTHORS = \"Montecucco C, Rappuoli R.\", TITLE = \"Living dangerously: how Helicobacter pylori survives in the human stomach.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 2:457-66 (2001)\", \"DOI:10.1038/35073084\")), list(REFERENCE = \"PMID:12197905\", AUTHORS = \"Gerhard M, Rad R, Prinz C, Naumann M.\", TITLE = \"Pathogenesis of Helicobacter pylori infection.\", JOURNAL = c(\"Helicobacter 7 Suppl 1:17-23 (2002)\", \"DOI:10.1046/j.1523-5378.7.s1.3.x\"))', 'map05120', 1, 8, 1, 0, 0, 0, 8, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (399, '05130', 'Pathogenic Escherichia coli infection', 'Enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli (EHEC) are closely related pathogenic strains of Escherichia coli. The hallmark of EPEC/EHEC infections [DS:H00278 H00277] is induction of attaching and effacing (A/E) lesions that damage intestinal epithelial cells. The capacity to form A/E lesions is encoded mainly by the locus of enterocyte effacement (LEE) pathogenicity island. Tir, Map, EspF, EspG are known LEE-encoded effector proteins secreted via the type III secretion system, which is also LEE-encoded, into the host cell. EPEC and EHEC Tir\'s link the extracellular bacterium to the cell cytoskeleton. Map and EspF are involved in mitochondrion membrane permeabilization. EspG interacts with tubulins and stimulates microtubule destabilization. LEE-encoded adhesin or intimin (Eae) is exported via the general secretory pathway to the periplasm, where it is inserted into the outer membrane. In addition to Tir, two potential host cell-carried intimin receptors, beta1 integrin (ITGB1) and nucleolin (NCL), have so far been identified. The distinguishing feature of EHEC is the elaboration of Shiga-like toxin (Stx). Stx cleaves ribosomal RNA, thereby disrupting protein synthesis and killing the intoxicated epithelial or endothelial cells.', 'Human Diseases; Infectious disease: bacterial', 'Pathogenic Escherichia coli infection', 'EHEC pathogenicity signature, Shiga toxin [PATH:map05130], EHEC/EPEC pathogenicity signature, T3SS and effectors [PATH:map05130]', 'Enterohemorrhagic Escherichia coli (EHEC) infection, Enteropathogenic Escherichia coli (EPEC) infection', 'ko05130', 'list(REFERENCE = \"PMID:29477730\", AUTHORS = \"Pinaud L, Sansonetti PJ, Phalipon A\", TITLE = \"Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.\", JOURNAL = c(\"Trends Microbiol 26:266-283 (2018)\", \"DOI:10.1016/j.tim.2018.01.010\")), list(REFERENCE = \"PMID:25588886\", AUTHORS = \"Santos AS, Finlay BB\", TITLE = \"Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.\", JOURNAL = c(\"Cell Microbiol 17:318-32 (2015)\", \"DOI:10.1111/cmi.12412\")), list(REFERENCE = \"PMID:26104206\", AUTHORS = \"Pearson JS, Hartland EL\", TITLE = \"The Inflammatory Response during Enterohemorrhagic Escherichia coli Infection.\", JOURNAL = c(\"Microbiol Spectr 2:EHEC-0012-2013 (2014)\", \"DOI:10.1128/microbiolspec.EHEC-0012-2013\")), list(REFERENCE = \"PMID:21488979\", AUTHORS = \"Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, Frankel G, Hartland EL\", TITLE = \"Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.\", JOURNAL = c(\"Mol Microbiol 80:1420-38 (2011)\", \"DOI:10.1111/j.1365-2958.2011.07661.x\")), list(REFERENCE = \"PMID:23927593\", AUTHORS = \"Lai Y, Rosenshine I, Leong JM, Frankel G\", TITLE = \"Intimate host attachment: enteropathogenic and enterohaemorrhagic Escherichia coli.\", JOURNAL = c(\"Cell Microbiol 15:1796-808 (2013)\", \"DOI:10.1111/cmi.12179\")), list(REFERENCE = \"PMID:27606286\", AUTHORS = \"Ugalde-Silva P, Gonzalez-Lugo O, Navarro-Garcia F\", TITLE = \"Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.\", JOURNAL = c(\"Front Cell Infect Microbiol 6:87 (2016)\", \"DOI:10.3389/fcimb.2016.00087\")), list(REFERENCE = \"PMID:27617233\", AUTHORS = \"Yen H, Karino M, Tobe T\", TITLE = \"Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.\", JOURNAL = c(\"Front Cell Infect Microbiol 6:89 (2016)\", \"DOI:10.3389/fcimb.2016.00089\")), list(REFERENCE = \"PMID:27732847\", AUTHORS = \"Humphreys D, Singh V, Koronakis V\", TITLE = \"Inhibition of WAVE Regulatory Complex Activation by a Bacterial Virulence Effector Counteracts Pathogen Phagocytosis.\", JOURNAL = c(\"Cell Rep 17:697-707 (2016)\", \"DOI:10.1016/j.celrep.2016.09.039\")), list(REFERENCE = \"PMID:20300064\", AUTHORS = \"Dong N, Liu L, Shao F\", TITLE = \"A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis.\", JOURNAL = c(\"EMBO J 29:1363-76 (2010)\", \"DOI:10.1038/emboj.2010.33\")), list(REFERENCE = \"PMID:15318166\", AUTHORS = \"Matsuzawa T, Kuwae A, Yoshida S, Sasakawa C, Abe A.\", TITLE = \"Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1.\", JOURNAL = c(\"EMBO J 23:3570-82 (2004)\", \"DOI:10.1038/sj.emboj.7600359\"))', 'map05130', 1, 13, 1, 0, 0, 0, 13, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (400, '05131', 'Shigellosis', 'Shigellosis, or bacillary dysentery, is an intestinal infection caused by Shigella, a genus of enterobacteria. Shigella are potential food-borne pathogens that are capable of colonizing the intestinal epithelium by exploiting epithelial-cell functions and circumventing the host innate immune response. During basolateral entry into the host-cell cytoplasm, Shigella deliver a subset of effectors into the host cells through the type III secretion system. The effectors induce membrane ruffling through the stimulation of the Rac1-WAVE-Arp2/3 pathway, enabling bacterial entry into the epithelial cells. During multiplication within the cells, Shigella secrete another subset of effectors. VirG induces actin polymerization at one pole of the bacteria, allowing the bacteria to spread intracellularly and to infect adjacent cells. OspF, OspG and IpaH(9.8) downregulate the production of proinflammatory cytokines such as IL-8, helping bacteria circumvent the innate immune response.', 'Human Diseases; Infectious disease: bacterial', 'Shigellosis', 'EHEC pathogenicity signature, Shiga toxin [PATH:map05131]', 'Shigellosis', 'ko05131', 'list(REFERENCE = \"PMID:30953429\", AUTHORS = \"Schnupf P, Sansonetti PJ\", TITLE = \"Shigella Pathogenesis: New Insights through Advanced Methodologies.\", JOURNAL = c(\"Microbiol Spectr 7 (2019)\", \"DOI:10.1128/microbiolspec.BAI-0023-2019\")), list(REFERENCE = \"PMID:28393050\", AUTHORS = \"Mattock E, Blocker AJ\", TITLE = \"How Do the Virulence Factors of Shigella Work Together to Cause Disease?\", JOURNAL = c(\"Front Cell Infect Microbiol 7:64 (2017)\", \"DOI:10.3389/fcimb.2017.00064\")), list(REFERENCE = \"PMID:25999954\", AUTHORS = \"Ashida H, Mimuro H, Sasakawa C\", TITLE = \"Shigella manipulates host immune responses by delivering effector proteins with specific roles.\", JOURNAL = c(\"Front Immunol 6:219 (2015)\", \"DOI:10.3389/fimmu.2015.00219\")), list(REFERENCE = \"PMID:20228623\", AUTHORS = \"Sasakawa C\", TITLE = \"A new paradigm of bacteria-gut interplay brought through the study of Shigella.\", JOURNAL = c(\"Proc Jpn Acad Ser B Phys Biol Sci 86:229-43 (2010)\", \"DOI:10.2183/pjab.86.229\")), list(REFERENCE = \"PMID:25264025\", AUTHORS = \"Ashida H, Kim M, Sasakawa C\", TITLE = \"Manipulation of the host cell death pathway by Shigella.\", JOURNAL = c(\"Cell Microbiol 16:1757-66 (2014)\", \"DOI:10.1111/cmi.12367\")), list(REFERENCE = \"PMID:29875765\", AUTHORS = \"Siqueira MDS, Ribeiro RM, Travassos LH\", TITLE = \"Autophagy and Its Interaction With Intracellular Bacterial Pathogens.\", JOURNAL = c(\"Front Immunol 9:935 (2018)\", \"DOI:10.3389/fimmu.2018.00935\")), list(REFERENCE = \"PMID:29477730\", AUTHORS = \"Pinaud L, Sansonetti PJ, Phalipon A\", TITLE = \"Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.\", JOURNAL = c(\"Trends Microbiol 26:266-283 (2018)\", \"DOI:10.1016/j.tim.2018.01.010\"))', 'map05131', 1, 7, 1, 0, 0, 0, 7, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (401, '05132', 'Salmonella infection', 'c(\"Salmonella infection usually presents as a self-limiting gastroenteritis or the more severe typhoid fever and bacteremia. The common disease-causing Salmonella species in human is a single species, Salmonella enterica, which has numerous serovars.\", \"Following intestinal colonization Salmonella inject effector proteins into the host cells using a type III secretion system (T3SS), T3SS1. Then a small group of effector proteins induce rearrangement of the actin cytoskeleton resulting in membrane ruffles and rapid internalization of the bacteria.The T3SS2 is responsible for translocating effector proteins that direct Salmonella-containing vacuole (SCV) maturation. The majority of the bacteria are known to survive and replicate in SCV.\"\n)', 'Human Diseases; Infectious disease: bacterial', 'Salmonella infection', 'Typhoid fever', 'ko05132', 'list(REFERENCE = \"PMID:20526845\", AUTHORS = \"Trebichavsky I, Splichal I, Splichalova A\", TITLE = \"Innate immune response in the gut against Salmonella - review.\", JOURNAL = c(\"Folia Microbiol (Praha) 55:295-300 (2010)\", \"DOI:10.1007/s12223-010-0044-3\")), list(REFERENCE = \"PMID:19930040\", AUTHORS = \"Talbot S, Totemeyer S, Yamamoto M, Akira S, Hughes K, Gray D, Barr T, Mastroeni P, Maskell DJ, Bryant CE\", TITLE = \"Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearance.\", JOURNAL = c(\"Immunology 128:472-83 (2009)\", \"DOI:10.1111/j.1365-2567.2009.03146.x\")), list(REFERENCE = \"PMID:19775254\", AUTHORS = \"Ibarra JA, Steele-Mortimer O\", TITLE = \"Salmonella--the ultimate insider. Salmonella virulence factors that modulate intracellular survival.\", JOURNAL = c(\"Cell Microbiol 11:1579-86 (2009)\", \"DOI:10.1111/j.1462-5822.2009.01368.x\")), list(REFERENCE = \"PMID:11489966\", AUTHORS = \"Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL\", TITLE = \"Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression.\", JOURNAL = c(\"J Immunol 167:1882-5 (2001)\", \"DOI:10.4049/jimmunol.167.4.1882\")), list(REFERENCE = \"PMID:17071592\", AUTHORS = \"Vijay-Kumar M, Wu H, Jones R, Grant G, Babbin B, King TP, Kelly D, Gewirtz AT, Neish AS\", TITLE = \"Flagellin suppresses epithelial apoptosis and limits disease during enteric infection.\", JOURNAL = c(\"Am J Pathol 169:1686-700 (2006)\", \"DOI:10.2353/ajpath.2006.060345\")), list(REFERENCE = \"PMID:17690885\", AUTHORS = \"Miao EA, Andersen-Nissen E, Warren SE, Aderem A\", TITLE = \"TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system.\", JOURNAL = c(\"Semin Immunopathol 29:275-88 (2007)\", \"DOI:10.1007/s00281-007-0078-z\")), list(REFERENCE = \"PMID:20158475\", AUTHORS = \"Bueno SM, Riedel CA, Carreno LJ, Kalergis AM\", TITLE = \"Virulence mechanisms displayed by Salmonella to impair dendritic cell function.\", JOURNAL = c(\"Curr Med Chem 17:1156-66 (2010)\", \"DOI:10.2174/092986710790827825\")), list(REFERENCE = \"PMID:18026123\", AUTHORS = \"Haraga A, Ohlson MB, Miller SI\", TITLE = \"Salmonellae interplay with host cells.\", JOURNAL = c(\"Nat Rev Microbiol 6:53-66 (2008)\", \"DOI:10.1038/nrmicro1788\")), list(REFERENCE = \"PMID:11825778\", AUTHORS = \"Kimbrough TG, Miller SI\", TITLE = \"Assembly of the type III secretion needle complex of Salmonella typhimurium.\", JOURNAL = c(\"Microbes Infect 4:75-82 (2002)\", \"DOI:10.1016/S1286-4579(01)01512-X\")), list(REFERENCE = \"PMID:17074883\", AUTHORS = \"Patel JC, Galan JE\", TITLE = \"Differential activation and function of Rho GTPases during Salmonella-host cell interactions.\", JOURNAL = c(\"J Cell Biol 175:453-63 (2006)\", \"DOI:10.1083/jcb.200605144\")), list(REFERENCE = \"PMID:20123714\", AUTHORS = \"Bulgin R, Raymond B, Garnett JA, Frankel G, Crepin VF, Berger CN, Arbeloa A\", TITLE = \"Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors.\", JOURNAL = c(\"Infect Immun 78:1417-25 (2010)\", \"DOI:10.1128/IAI.01250-09\")), list(REFERENCE = \"PMID:18778407\", AUTHORS = \"Bakowski MA, Braun V, Brumell JH\", TITLE = \"Salmonella-containing vacuoles: directing traffic and nesting to grow.\", JOURNAL = c(\"Traffic 9:2022-31 (2008)\", \"DOI:10.1111/j.1600-0854.2008.00827.x\")), list(REFERENCE = \"PMID:18411289\", AUTHORS = \"Wasylnka JA, Bakowski MA, Szeto J, Ohlson MB, Trimble WS, Miller SI, Brumell JH\", TITLE = \"Role for myosin II in regulating positioning of Salmonella-containing vacuoles and intracellular replication.\", JOURNAL = c(\"Infect Immun 76:2722-35 (2008)\", \"DOI:10.1128/IAI.00152-08\")), list(REFERENCE = \"PMID:11567004\", AUTHORS = \"Nikolaus T, Deiwick J, Rappl C, Freeman JA, Schroder W, Miller SI, Hensel M\", TITLE = \"SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon.\", JOURNAL = c(\"J Bacteriol 183:6036-45 (2001)\", \"DOI:10.1128/JB.183.20.6036-6045.2001\")), list(REFERENCE = \"PMID:11755407\", AUTHORS = \"Eckmann L, Kagnoff MF\", TITLE = \"Cytokines in host defense against Salmonella.\", JOURNAL = c(\"Microbes Infect 3:1191-200 (2001)\", \"DOI:10.1016/S1286-4579(01)01479-4\")), list(REFERENCE = \"PMID:10499590\", AUTHORS = \"Fu Y, Galan JE\", TITLE = \"A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion.\", JOURNAL = c(\"Nature 401:293-7 (1999)\", \"DOI:10.1038/45829\")), list(REFERENCE = \"PMID:19779561\", AUTHORS = \"Du F, Galan JE\", TITLE = \"Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA.\", JOURNAL = c(\"PLoS Pathog 5:e1000595 (2009)\", \"DOI:10.1371/journal.ppat.1000595\")), list(REFERENCE = \"PMID:18407067\", AUTHORS = \"Jones RM, Wu H, Wentworth C, Luo L, Collier-Hyams L, Neish AS\", TITLE = \"Salmonella AvrA Coordinates Suppression of Host Immune and Apoptotic Defenses via JNK Pathway Blockade.\", JOURNAL = c(\"Cell Host Microbe 3:233-44 (2008)\", \"DOI:10.1016/j.chom.2008.02.016\")), list(REFERENCE = \"PMID:16611232\", AUTHORS = \"Haraga A, Miller SI\", TITLE = \"A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1.\", JOURNAL = c(\"Cell Microbiol 8:837-46 (2006)\", \"DOI:10.1111/j.1462-5822.2005.00670.x\")), list(REFERENCE = \"PMID:16800847\", AUTHORS = \"Abrahams GL, Muller P, Hensel M\", TITLE = \"Functional dissection of SseF, a type III effector protein involved in positioning the salmonella-containing vacuole.\", JOURNAL = c(\"Traffic 7:950-65 (2006)\", \"DOI:10.1111/j.1600-0854.2006.00454.x\")), list(REFERENCE = \"PMID:16938850\", AUTHORS = \"Henry T, Couillault C, Rockenfeller P, Boucrot E, Dumont A, Schroeder N, Hermant A, Knodler LA, Lecine P, Steele-Mortimer O, Borg JP, Gorvel JP, Meresse S\", TITLE = \"The Salmonella effector protein PipB2 is a linker for kinesin-1.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 103:13497-502 (2006)\", \"DOI:10.1073/pnas.0605443103\")), list(REFERENCE = \"PMID:12675800\", AUTHORS = \"Miao EA, Brittnacher M, Haraga A, Jeng RL, Welch MD, Miller SI\", TITLE = \"Salmonella effectors translocated across the vacuolar membrane interact with the actin cytoskeleton.\", JOURNAL = c(\"Mol Microbiol 48:401-15 (2003)\", \"DOI:10.1046/j.1365-2958.2003.t01-1-03456.x\")), list(REFERENCE = \"PMID:20943123\", AUTHORS = \"Prior K, Hautefort I, Hinton JC, Richardson DJ, Rowley G\", TITLE = \"All stressed out. Salmonella pathogenesis and reactive nitrogen species.\", JOURNAL = c(\"Adv Microb Physiol 56:1-28 (2009)\", \"DOI:10.1016/S0065-2911(09)05601-X\"))', 'map05132', 'Salmonella infection', 145, 53, 145, 0, 0, 0, 53, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (402, '05133', 'Pertussis', 'c(\"Pertussis, also known as whooping cough, is an acute respiratory infectious disease caused by a bacteria called Bordetella Pertussis. The characteristic symptoms are paroxysmal cough, inspiratory wheezing and post-tussive vomiting.\", \"Following the inhalation of respiratory secretions from an infected individual, bacteria enter the upper respiratory tract and adhere to epithelial cells. Several adhesion factors have been implicated: the filamentous hemagglutinin (FHA), fimbriae, and pertactin (Prn).\", \n\"Pertussis toxin (Ptx) and adenylate cyclase toxin (ACT) have been identified so far as major protein toxins of B. pertussis. PTX is a hexameric AB5-type exotoxin. Catalytic A subunit catalyzes the ADP-ribosylation of the Gi subunits of the heterotrimeric G protein, then inhibits multiple downstream pathways. ACT is able to penetrate the cytoplasmic membrane of host cells and becomes activated through the cleavage and the binding of calmodulin (CaM). Activated ACT converts ATP to cyclic AMP and subverts cellular signaling pathways.\"\n)', 'Human Diseases; Infectious disease: bacterial', 'Pertussis', 'Pertussis pathogenicity signature, pertussis toxin [PATH:map05133], Pertussis pathogenicity signature, T1SS [PATH:map05133]', 'Pertussis', 'ko05133', 'list(REFERENCE = \"PMID:21204863\", AUTHORS = \"de Gouw D, Diavatopoulos DA, Bootsma HJ, Hermans PW, Mooi FR\", TITLE = \"Pertussis: a matter of immune modulation.\", JOURNAL = c(\"FEMS Microbiol Rev 35:441-74 (2011)\", \"DOI:10.1111/j.1574-6976.2010.00257.x\")), list(REFERENCE = \"PMID:20210554\", AUTHORS = \"Carbonetti NH\", TITLE = \"Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.\", JOURNAL = c(\"Future Microbiol 5:455-69 (2010)\", \"DOI:10.2217/fmb.09.133\")), list(REFERENCE = \"PMID:10540218\", AUTHORS = \"van den Berg BM, van Furth R, Hazenbos WL\", TITLE = \"Activation of complement receptor 3 on human monocytes by cross-linking of very-late antigen-5 is mediated via protein tyrosine kinases.\", JOURNAL = c(\"Immunology 98:197-202 (1999)\", \"DOI:10.1046/j.1365-2567.1999.00871.x\")), list(REFERENCE = \"PMID:16999837\", AUTHORS = \"Mazar J, Cotter PA\", TITLE = \"Topology and maturation of filamentous haemagglutinin suggest a new model for two-partner secretion.\", JOURNAL = c(\"Mol Microbiol 62:641-54 (2006)\", \"DOI:10.1111/j.1365-2958.2006.05392.x\")), list(REFERENCE = \"PMID:16390441\", AUTHORS = \"Hewlett EL, Donato GM, Gray MC\", TITLE = \"Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP!\", JOURNAL = c(\"Mol Microbiol 59:447-59 (2006)\", \"DOI:10.1111/j.1365-2958.2005.04958.x\")), list(REFERENCE = \"PMID:20610650\", AUTHORS = \"Dunne A, Ross PJ, Pospisilova E, Masin J, Meaney A, Sutton CE, Iwakura Y, Tschopp J, Sebo P, Mills KH\", TITLE = \"Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis.\", JOURNAL = c(\"J Immunol 185:1711-9 (2010)\", \"DOI:10.4049/jimmunol.1000105\")), list(REFERENCE = \"PMID:18401006\", AUTHORS = \"Hickey FB, Brereton CF, Mills KH\", TITLE = \"Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.\", JOURNAL = c(\"J Leukoc Biol 84:234-43 (2008)\", \"DOI:10.1189/jlb.0208113\")), list(REFERENCE = \"PMID:16622221\", AUTHORS = \"Spensieri F, Fedele G, Fazio C, Nasso M, Stefanelli P, Mastrantonio P, Ausiello CM\", TITLE = \"Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction.\", JOURNAL = c(\"Infect Immun 74:2831-8 (2006)\", \"DOI:10.1128/IAI.74.5.2831-2838.2006\")), list(REFERENCE = \"PMID:17148436\", AUTHORS = \"Fiser R, Masin J, Basler M, Krusek J, Spulakova V, Konopasek I, Sebo P\", TITLE = \"Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b+ monocytes independently of the catalytic and hemolytic activities.\", JOURNAL = c(\"J Biol Chem 282:2808-20 (2007)\", \"DOI:10.1074/jbc.M609979200\")), list(REFERENCE = \"PMID:16863919\", AUTHORS = \"Wang ZY, Yang D, Chen Q, Leifer CA, Segal DM, Su SB, Caspi RR, Howard ZO, Oppenheim JJ\", TITLE = \"Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways.\", JOURNAL = c(\"Exp Hematol 34:1115-24 (2006)\", \"DOI:10.1016/j.exphem.2006.04.025\")), list(REFERENCE = \"PMID:15201703\", AUTHORS = \"Fan H, Peck OM, Tempel GE, Halushka PV, Cook JA\", TITLE = \"Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation.\", JOURNAL = \"Shock 22:57-62 (2004)\"), list(REFERENCE = \"PMID:17328678\", AUTHORS = \"Lee MS, Kim YJ\", TITLE = \"Signaling pathways downstream of pattern-recognition receptors and their cross talk.\", JOURNAL = c(\"Annu Rev Biochem 76:447-80 (2007)\", \"DOI:10.1146/annurev.biochem.76.060605.122847\")), list(REFERENCE = \"PMID:20404851\", AUTHORS = \"Kawai T, Akira S\", TITLE = \"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.\", JOURNAL = c(\"Nat Immunol 11:373-84 (2010)\", \"DOI:10.1038/ni.1863\")), list(REFERENCE = \"PMID:12701623\", AUTHORS = \"Ferlito M, Romanenko OG, Guyton K, Ashton S, Squadrito F, Halushka PV, Cook JA\", TITLE = \"Implication of Galpha i proteins and Src tyrosine kinases in endotoxin-induced signal transduction events and mediator production.\", JOURNAL = \"J Endotoxin Res 8:427-35 (2002)\"), list(REFERENCE = \"PMID:21423776\", AUTHORS = \"Han HJ, Kuwae A, Abe A, Arakawa Y, Kamachi K\", TITLE = \"Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis.\", JOURNAL = c(\"PLoS One 6:e17797 (2011)\", \"DOI:10.1371/journal.pone.0017797\")), list(REFERENCE = \"PMID:16481212\", AUTHORS = \"Beier D, Gross R\", TITLE = \"Regulation of bacterial virulence by two-component systems.\", JOURNAL = c(\"Curr Opin Microbiol 9:143-52 (2006)\", \"DOI:10.1016/j.mib.2006.01.005\")), list(REFERENCE = \"PMID:12915094\", AUTHORS = \"Cotter PA, Jones AM\", TITLE = \"Phosphorelay control of virulence gene expression in Bordetella.\", JOURNAL = c(\"Trends Microbiol 11:367-73 (2003)\", \"DOI:10.1016/S0966-842X(03)00156-2\"))', 'map05133', 65, 21, 65, 0, 0, 0, 21, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (403, '05134', 'Legionellosis', 'c(\"Legionellosis is a potentially fatal infectious disease caused by the bacterium Legionella pneumophila and other legionella species. Two distinct clinical and epidemiological syndromes are associated with Legionella species: Legionnaires\' disease is the more severe form of the infection, which may involve pneumonia, and Pontiac fever is a milder respiratory illness.\", \"The pathogenesis of L. pneumophila is derived from its growth within lung macrophages. One of the L. pneumophila\'s type IV secretion systems, the Dot/Icm secretion system, is of critical importance for its ability to replicate and to cause disease. The Dot/Icm substrates modulate multiple host cell processes and in particular, redirect trafficking of the L. pneumophila phagosome and mediate its conversion into an ER-derived organelle competent for intracellular bacterial replication. L. pneumophila also manipulates host cell death and survival pathways in a way that allows continued intracellular replication.\"\n)', 'Human Diseases; Infectious disease: bacterial', 'Legionellosis', 'Legionellosis', 'ko05134', 'list(REFERENCE = \"PMID:20375353\", AUTHORS = \"Newton HJ, Ang DK, van Driel IR, Hartland EL\", TITLE = \"Molecular pathogenesis of infections caused by Legionella pneumophila.\", JOURNAL = c(\"Clin Microbiol Rev 23:274-98 (2010)\", \"DOI:10.1128/CMR.00052-09\")), list(REFERENCE = \"PMID:18363881\", AUTHORS = \"Shin S, Roy CR\", TITLE = \"Host cell processes that influence the intracellular survival of Legionella pneumophila.\", JOURNAL = c(\"Cell Microbiol 10:1209-20 (2008)\", \"DOI:10.1111/j.1462-5822.2008.01145.x\")), list(REFERENCE = \"PMID:19157961\", AUTHORS = \"Ensminger AW, Isberg RR\", TITLE = \"Legionella pneumophila Dot/Icm translocated substrates: a sum of parts.\", JOURNAL = c(\"Curr Opin Microbiol 12:67-73 (2009)\", \"DOI:10.1016/j.mib.2008.12.004\")), list(REFERENCE = \"PMID:15972519\", AUTHORS = \"Chang B, Kura F, Amemura-Maekawa J, Koizumi N, Watanabe H\", TITLE = \"Identification of a novel adhesion molecule involved in the virulence of Legionella pneumophila.\", JOURNAL = c(\"Infect Immun 73:4272-80 (2005)\", \"DOI:10.1128/IAI.73.7.4272-4280.2005\")), list(REFERENCE = \"PMID:18549456\", AUTHORS = \"Liu M, Conover GM, Isberg RR\", TITLE = \"Legionella pneumophila EnhC is required for efficient replication in tumour necrosis factor alpha-stimulated macrophages.\", JOURNAL = c(\"Cell Microbiol 10:1906-23 (2008)\", \"DOI:10.1111/j.1462-5822.2008.01180.x\")), list(REFERENCE = \"PMID:19021631\", AUTHORS = \"Weber SS, Ragaz C, Hilbi H\", TITLE = \"The inositol polyphosphate 5-phosphatase OCRL1 restricts intracellular growth of Legionella, localizes to the replicative vacuole and binds to the bacterial effector LpnE.\", JOURNAL = c(\"Cell Microbiol 11:442-60 (2009)\", \"DOI:10.1111/j.1462-5822.2008.01266.x\")), list(REFERENCE = \"PMID:16495539\", AUTHORS = \"Newton HJ, Sansom FM, Bennett-Wood V, Hartland EL\", TITLE = \"Identification of Legionella pneumophila-specific genes by genomic subtractive hybridization with Legionella micdadei and identification of lpnE, a gene required for efficient host cell entry.\", JOURNAL = c(\"Infect Immun 74:1683-91 (2006)\", \"DOI:10.1128/IAI.74.3.1683-1691.2006\")), list(REFERENCE = \"PMID:18048909\", AUTHORS = \"De Buck E, Anne J, Lammertyn E\", TITLE = \"The role of protein secretion systems in the virulence of the intracellular pathogen Legionella pneumophila.\", JOURNAL = c(\"Microbiology 153:3948-53 (2007)\", \"DOI:10.1099/mic.0.2007/012039-0\")), list(REFERENCE = \"PMID:19687203\", AUTHORS = \"Chong A, Lima CA, Allan DS, Nasrallah GK, Garduno RA\", TITLE = \"The purified and recombinant Legionella pneumophila chaperonin alters mitochondrial trafficking and microfilament organization.\", JOURNAL = c(\"Infect Immun 77:4724-39 (2009)\", \"DOI:10.1128/IAI.00150-09\")), list(REFERENCE = \"PMID:1721820\", AUTHORS = \"Cooper NR\", TITLE = \"Complement evasion strategies of microorganisms.\", JOURNAL = c(\"Immunol Today 12:327-31 (1991)\", \"DOI:10.1016/0167-5699(91)90010-Q\")), list(REFERENCE = \"PMID:16824952\", AUTHORS = \"Machner MP, Isberg RR\", TITLE = \"Targeting of host Rab GTPase function by the intravacuolar pathogen Legionella pneumophila.\", JOURNAL = c(\"Dev Cell 11:47-56 (2006)\", \"DOI:10.1016/j.devcel.2006.05.013\")), list(REFERENCE = \"PMID:12427954\", AUTHORS = \"Neumeister B, Faigle M, Lauber K, Northoff H, Wesselborg S\", TITLE = \"Legionella pneumophila induces apoptosis via the mitochondrial death pathway.\", JOURNAL = c(\"Microbiology 148:3639-50 (2002)\", \"DOI:10.1099/00221287-148-11-3639\")), list(REFERENCE = \"PMID:17124169\", AUTHORS = \"Laguna RK, Creasey EA, Li Z, Valtz N, Isberg RR\", TITLE = \"A Legionella pneumophila-translocated substrate that is required for growth within macrophages and protection from host cell death.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 103:18745-50 (2006)\", \"DOI:10.1073/pnas.0609012103\")), list(REFERENCE = \"PMID:19666608\", AUTHORS = \"Ge J, Xu H, Li T, Zhou Y, Zhang Z, Li S, Liu L, Shao F\", TITLE = \"A Legionella type IV effector activates the NF-kappaB pathway by phosphorylating the IkappaB family of inhibitors.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 106:13725-30 (2009)\", \"DOI:10.1073/pnas.0907200106\")), list(REFERENCE = \"PMID:18284575\", AUTHORS = \"Kubori T, Hyakutake A, Nagai H\", TITLE = \"Legionella translocates an E3 ubiquitin ligase that has multiple U-boxes with distinct functions.\", JOURNAL = c(\"Mol Microbiol 67:1307-19 (2008)\", \"DOI:10.1111/j.1365-2958.2008.06124.x\")), list(REFERENCE = \"PMID:19386084\", AUTHORS = \"Shen X, Banga S, Liu Y, Xu L, Gao P, Shamovsky I, Nudler E, Luo ZQ\", TITLE = \"Targeting eEF1A by a Legionella pneumophila effector leads to inhibition of protein synthesis and induction of host stress response.\", JOURNAL = c(\"Cell Microbiol 11:911-26 (2009)\", \"DOI:10.1111/j.1462-5822.2009.01301.x\")), list(REFERENCE = \"PMID:19478083\", AUTHORS = \"Belyi Y, Stahl M, Sovkova I, Kaden P, Luy B, Aktories K\", TITLE = \"Region of elongation factor 1A1 involved in substrate recognition by Legionella pneumophila glucosyltransferase Lgt1: identification of Lgt1 as a retaining glucosyltransferase.\", JOURNAL = c(\"J Biol Chem 284:20167-74 (2009)\", \"DOI:10.1074/jbc.M109.008441\")), list(REFERENCE = \"PMID:18281405\", AUTHORS = \"Belyi Y, Tabakova I, Stahl M, Aktories K\", TITLE = \"Lgt: a family of cytotoxic glucosyltransferases produced by Legionella pneumophila.\", JOURNAL = c(\"J Bacteriol 190:3026-35 (2008)\", \"DOI:10.1128/JB.01798-07\")), list(REFERENCE = \"PMID:19343209\", AUTHORS = \"Akhter A, Gavrilin MA, Frantz L, Washington S, Ditty C, Limoli D, Day C, Sarkar A, Newland C, Butchar J, Marsh CB, Wewers MD, Tridandapani S, Kanneganti TD, Amer AO\", TITLE = \"Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection.\", JOURNAL = c(\"PLoS Pathog 5:e1000361 (2009)\", \"DOI:10.1371/journal.ppat.1000361\")), list(REFERENCE = \"PMID:20941588\", AUTHORS = \"Palusinska-Szysz M, Janczarek M\", TITLE = \"Innate immunity to Legionella and toll-like receptors - review.\", JOURNAL = c(\"Folia Microbiol (Praha) 55:508-14 (2010)\", \"DOI:10.1007/s12223-010-0084-8\"))', 'map05134', 'Legionellosis', 65, 19, 65, 0, 0, 0, 19, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (404, '05135', 'Yersinia infection', 'Pathogenic Yersinia injects virulent Yersinia outer proteins (Yops) into the host cell through a type three secretion system (T3SS) to express its pathogenicity. Through inactivation of small GTPases by YopT protease, YopE GTPase-activating protein, and YpkA/YopO sequestration of GDP-bound small GTPases, Yersinia prevents its uptake by phagocytic cells and disrupts the actin cytoskeleton. YopH phosphatase shuts down phagocytosis by dephosphorylating key host proteins as well as suppresses T cell activation. Yersinia induces macrophage pyroptosis via YopB/YopD activation of canonical and noncanonical inflammasomes and YopT/YopE-mediated activation of pyrin. These effects are counteracted by YopK and YopM. YopP/J is a member of an ubiquitin-like protein cysteine protease family and simultaneously targets signaling components of the MAPK and NF-kappaB signaling pathways following activation of Toll-like receptor4 to inhibit production of proinflammatory cytokines.', 'Human Diseases; Infectious disease: bacterial', 'Yersinia infection', 'Yersiniosis', 'ko05135', 'list(REFERENCE = \"PMID:26981193\", AUTHORS = \"Pha K, Navarro L\", TITLE = \"Yersinia type III effectors perturb host innate immune responses.\", JOURNAL = c(\"World J Biol Chem 7:1-13 (2016)\", \"DOI:10.4331/wjbc.v7.i1.1\")), list(REFERENCE = \"PMID:29477730\", AUTHORS = \"Pinaud L, Sansonetti PJ, Phalipon A\", TITLE = \"Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.\", JOURNAL = c(\"Trends Microbiol 26:266-283 (2018)\", \"DOI:10.1016/j.tim.2018.01.010\")), list(REFERENCE = \"PMID:19339545\", AUTHORS = \"Huveneers S, Danen EH\", TITLE = \"Adhesion signaling - crosstalk between integrins, Src and Rho.\", JOURNAL = c(\"J Cell Sci 122:1059-69 (2009)\", \"DOI:10.1242/jcs.039446\")), list(REFERENCE = \"PMID:17257058\", AUTHORS = \"Angot A, Vergunst A, Genin S, Peeters N\", TITLE = \"Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems.\", JOURNAL = c(\"PLoS Pathog 3:e3 (2007)\", \"DOI:10.1371/journal.ppat.0030003\")), list(REFERENCE = \"PMID:10785635\", AUTHORS = \"Bliska JB\", TITLE = \"Yop effectors of Yersinia spp. and actin rearrangements.\", JOURNAL = c(\"Trends Microbiol 8:205-8 (2000)\", \"DOI:10.1016/S0966-842X(00)01738-8\")), list(REFERENCE = \"PMID:15044442\", AUTHORS = \"Gustavsson A, Yuan M, Fallman M\", TITLE = \"Temporal dissection of beta1-integrin signaling indicates a role for p130Cas-Crk in filopodia formation.\", JOURNAL = c(\"J Biol Chem 279:22893-901 (2004)\", \"DOI:10.1074/jbc.M309693200\")), list(REFERENCE = \"PMID:12077360\", AUTHORS = \"Bruce-Staskal PJ, Weidow CL, Gibson JJ, Bouton AH\", TITLE = \"Cas, Fak and Pyk2 function in diverse signaling cascades to promote Yersinia uptake.\", JOURNAL = \"J Cell Sci 115:2689-700 (2002)\"), list(REFERENCE = \"PMID:11734206\", AUTHORS = \"McGee K, Zettl M, Way M, Fallman M\", TITLE = \"A role for N-WASP in invasin-promoted internalisation.\", JOURNAL = c(\"FEBS Lett 509:59-65 (2001)\", \"DOI:10.1016/S0014-5793(01)03139-8\")), list(REFERENCE = \"PMID:15516995\", AUTHORS = \"Pizarro-Cerda J, Cossart P\", TITLE = \"Subversion of phosphoinositide metabolism by intracellular bacterial pathogens.\", JOURNAL = c(\"Nat Cell Biol 6:1026-33 (2004)\", \"DOI:10.1038/ncb1104-1026\")), list(REFERENCE = \"PMID:27569559\", AUTHORS = \"Chung LK, Park YH, Zheng Y, Brodsky IE, Hearing P, Kastner DL, Chae JJ, Bliska JB\", TITLE = \"The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.\", JOURNAL = c(\"Cell Host Microbe 20:296-306 (2016)\", \"DOI:10.1016/j.chom.2016.07.018\")), list(REFERENCE = \"PMID:15060067\", AUTHORS = \"Schotte P, Denecker G, Van Den Broeke A, Vandenabeele P, Cornelis GR, Beyaert R\", TITLE = \"Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1beta.\", JOURNAL = c(\"J Biol Chem 279:25134-42 (2004)\", \"DOI:10.1074/jbc.M401245200\")), list(REFERENCE = \"PMID:10489373\", AUTHORS = \"Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE\", TITLE = \"Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector.\", JOURNAL = c(\"Science 285:1920-3 (1999)\", \"DOI:10.1126/science.285.5435.1920\")), list(REFERENCE = \"PMID:16301742\", AUTHORS = \"Zhou H, Monack DM, Kayagaki N, Wertz I, Yin J, Wolf B, Dixit VM\", TITLE = \"Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation.\", JOURNAL = c(\"J Exp Med 202:1327-32 (2005)\", \"DOI:10.1084/jem.20051194\")), list(REFERENCE = \"PMID:16339560\", AUTHORS = \"Haase R, Richter K, Pfaffinger G, Courtois G, Ruckdeschel K\", TITLE = \"Yersinia outer protein P suppresses TGF-beta-activated kinase-1 activity to impair innate immune signaling in Yersinia enterocolitica-infected cells.\", JOURNAL = c(\"J Immunol 175:8209-17 (2005)\", \"DOI:10.4049/jimmunol.175.12.8209\")), list(REFERENCE = \"PMID:16845370\", AUTHORS = \"Thiefes A, Wolf A, Doerrie A, Grassl GA, Matsumoto K, Autenrieth I, Bohn E, Sakurai H, Niedenthal R, Resch K, Kracht M\", TITLE = \"The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway.\", JOURNAL = c(\"EMBO Rep 7:838-44 (2006)\", \"DOI:10.1038/sj.embor.7400754\")), list(REFERENCE = \"PMID:26651944\", AUTHORS = \"Rosadini CV, Zanoni I, Odendall C, Green ER, Paczosa MK, Philip NH, Brodsky IE, Mecsas J, Kagan JC\", TITLE = \"A Single Bacterial Immune Evasion Strategy Dismantles Both MyD88 and TRIF Signaling Pathways Downstream of TLR4.\", JOURNAL = c(\"Cell Host Microbe 18:682-93 (2015)\", \"DOI:10.1016/j.chom.2015.11.006\")), list(REFERENCE = \"PMID:24034616\", AUTHORS = \"Rolan HG, Durand EA, Mecsas J\", TITLE = \"Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection.\", JOURNAL = c(\"Cell Host Microbe 14:306-17 (2013)\", \"DOI:10.1016/j.chom.2013.08.013\")), list(REFERENCE = \"PMID:14623872\", AUTHORS = \"Alonso A, Bottini N, Bruckner S, Rahmouni S, Williams S, Schoenberger SP, Mustelin T\", TITLE = \"Lck dephosphorylation at Tyr-394 and inhibition of T cell antigen receptor signaling by Yersinia phosphatase YopH.\", JOURNAL = c(\"J Biol Chem 279:4922-8 (2004)\", \"DOI:10.1074/jbc.M308978200\"))', 'map05135', 'Yersinia infection', 65, 24, 65, 0, 0, 0, 24, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (405, '05140', 'Leishmaniasis', 'Leishmania is an intracellular protozoan parasite of macrophages that causes visceral, mucosal, and cutaneous diseases. The parasite is transmitted to humans by sandflies, where they survive and proliferate intracellularly by deactivating the macrophage. Successful infection of Leishmania is achieved by alteration of signaling events in the host cell, leading to enhanced production of the autoinhibitory molecules like TGF-beta and decreased induction of cytokines such as IL12 for protective immunity. Nitric oxide production is also inhibited. In addition, defective expression of major histocompatibility complex (MHC) genes silences subsequent T cell activation mediated by macrophages, resulting in abnormal immune responses.', 'Human Diseases; Infectious disease: parasitic', 'Leishmaniasis', 'Leishmaniasis', 'ko05140', 'list(REFERENCE = \"PMID:11890722\", AUTHORS = \"Cunningham AC\", TITLE = \"Parasitic adaptive mechanisms in infection by leishmania.\", JOURNAL = c(\"Exp Mol Pathol 72:132-41 (2002)\", \"DOI:10.1006/exmp.2002.2418\")), list(REFERENCE = \"PMID:10770277\", AUTHORS = \"Nandan D, Knutson KL, Lo R, Reiner NE\", TITLE = \"Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis.\", JOURNAL = c(\"J Leukoc Biol 67:464-70 (2000)\", \"DOI:10.1002/jlb.67.4.464\")), list(REFERENCE = \"PMID:7591091\", AUTHORS = \"Nandan D, Reiner NE\", TITLE = \"Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1.\", JOURNAL = \"Infect Immun 63:4495-500 (1995)\"), list(REFERENCE = \"PMID:10417174\", AUTHORS = \"Nandan D, Lo R, Reiner NE\", TITLE = \"Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani.\", JOURNAL = \"Infect Immun 67:4055-63 (1999)\"), list(REFERENCE = \"PMID:7916951\", AUTHORS = \"Reiner NE\", TITLE = \"Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection.\", JOURNAL = c(\"Immunol Today 15:374-81 (1994)\", \"DOI:10.1016/0167-5699(94)90176-7\")), list(REFERENCE = \"PMID:15721837\", AUTHORS = \"Nandan D, Reiner NE\", TITLE = \"Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1.\", JOURNAL = c(\"Clin Immunol 114:266-77 (2005)\", \"DOI:10.1016/j.clim.2004.07.017\")), list(REFERENCE = \"PMID:17543969\", AUTHORS = \"Kima PE\", TITLE = \"The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist.\", JOURNAL = c(\"Int J Parasitol 37:1087-96 (2007)\", \"DOI:10.1016/j.ijpara.2007.04.007\")), list(REFERENCE = \"PMID:15983048\", AUTHORS = \"Forget G, Gregory DJ, Olivier M\", TITLE = \"Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani.\", JOURNAL = c(\"J Biol Chem 280:30542-9 (2005)\", \"DOI:10.1074/jbc.M414126200\")), list(REFERENCE = \"PMID:15322192\", AUTHORS = \"Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, Alexander J, Plevin R\", TITLE = \"Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway.\", JOURNAL = c(\"J Immunol 173:3297-304 (2004)\", \"DOI:10.4049/jimmunol.173.5.3297\")), list(REFERENCE = \"PMID:18070909\", AUTHORS = \"Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V\", TITLE = \"Toll-like receptors and leishmaniasis.\", JOURNAL = c(\"Infect Immun 76:866-72 (2008)\", \"DOI:10.1128/IAI.01090-07\")), list(REFERENCE = \"PMID:15039466\", AUTHORS = \"Kropf P, Freudenberg N, Kalis C, Modolell M, Herath S, Galanos C, Freudenberg M, Muller I\", TITLE = \"Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication.\", JOURNAL = c(\"J Leukoc Biol 76:48-57 (2004)\", \"DOI:10.1189/jlb.1003484\")), list(REFERENCE = \"PMID:10586030\", AUTHORS = \"Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY\", TITLE = \"Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase.\", JOURNAL = \"J Immunol 163:6403-12 (1999)\"), list(REFERENCE = \"PMID:15831826\", AUTHORS = \"Olivier M, Gregory DJ, Forget G\", TITLE = \"Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.\", JOURNAL = c(\"Clin Microbiol Rev 18:293-305 (2005)\", \"DOI:10.1128/CMR.18.2.293-305.2005\")), list(REFERENCE = \"PMID:11298294\", AUTHORS = \"Matte C, Maion G, Mourad W, Olivier M\", TITLE = \"Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis.\", JOURNAL = c(\"Parasite Immunol 23:177-84 (2001)\", \"DOI:10.1046/j.1365-3024.2001.00372.x\")), list(REFERENCE = \"PMID:12438359\", AUTHORS = \"Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, Roy S, Majumdar S\", TITLE = \"Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase.\", JOURNAL = c(\"Infect Immun 70:6828-38 (2002)\", \"DOI:10.1128/IAI.70.12.6828-6838.2002\")), list(REFERENCE = \"PMID:9504340\", AUTHORS = \"Bogdan C, Rollinghoff M\", TITLE = \"The immune response to Leishmania: mechanisms of parasite control and evasion.\", JOURNAL = c(\"Int J Parasitol 28:121-34 (1998)\", \"DOI:10.1016/S0020-7519(97)00169-0\")), list(REFERENCE = \"PMID:18793215\", AUTHORS = \"Blanchette J, Abu-Dayyeh I, Hassani K, Whitcombe L, Olivier M\", TITLE = \"Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1).\", JOURNAL = c(\"Immunology 127:123-33 (2009)\", \"DOI:10.1111/j.1365-2567.2008.02929.x\")), list(REFERENCE = \"PMID:10462516\", AUTHORS = \"Alexander J, Satoskar AR, Russell DG\", TITLE = \"Leishmania species: models of intracellular parasitism.\", JOURNAL = \"J Cell Sci 112 Pt 18:2993-3002 (1999)\"), list(REFERENCE = \"PMID:15639739\", AUTHORS = \"Denkers EY, Butcher BA\", TITLE = \"Sabotage and exploitation in macrophages parasitized by intracellular protozoans.\", JOURNAL = c(\"Trends Parasitol 21:35-41 (2005)\", \"DOI:10.1016/j.pt.2004.10.004\")), list(REFERENCE = \"PMID:16848789\", AUTHORS = \"Lodge R, Diallo TO, Descoteaux A\", TITLE = \"Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane.\", JOURNAL = c(\"Cell Microbiol 8:1922-31 (2006)\", \"DOI:10.1111/j.1462-5822.2006.00758.x\")), list(REFERENCE = \"PMID:11728310\", AUTHORS = \"de Freitas Balanco JM, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C, Barcinski MA\", TITLE = \"Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity.\", JOURNAL = c(\"Curr Biol 11:1870-3 (2001)\", \"DOI:10.1016/S0960-9822(01)00563-2\")), list(REFERENCE = \"PMID:10608501\", AUTHORS = \"Kane MM, Mosser DM\", TITLE = \"Leishmania parasites and their ploys to disrupt macrophage activation.\", JOURNAL = \"Curr Opin Hematol 7:26-31 (2000)\"), list(REFERENCE = \"PMID:14762510\", AUTHORS = \"de Almeida MC, Vilhena V, Barral A, Barral-Netto M\", TITLE = \"Leishmanial infection: analysis of its first steps. A review.\", JOURNAL = c(\"Mem Inst Oswaldo Cruz 98:861-70 (2003)\", \"DOI:10.1590/S0074-02762003000700001\"))', 'map05140', 'Leishmaniasis', 68, 0, 65, 0, 0, 3, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (406, '05142', 'Chagas disease (American trypanosomiasis)', 'Trypanosoma cruzi is an intracellular protozoan parasite that causes Chagas disease. The parasite life cycle involves hematophagous reduviid bugs as vectors. Once parasites enter the host body, they invade diverse host cells including cardiomyocytes. Establishment of infection depends on various parasite molecules such as cruzipain, oligopeptidase B, and trans-sialidase that activate Ca2+ signaling. Internalized parasites escape from the parasitophorous vacuole using secreted pore-forming TcTOX molecule and replicate in the cytosol. Multiplied parasites eventually lyse infected host cells and are released in the circulation. During these events, the parasites manipulate host innate immunity and elicit cardiomyocyte hypertrophy. T lymphocyte responses are also disturbed.', 'Human Diseases; Infectious disease: parasitic', 'Chagas disease (American trypanosomiasis)', 'Chagas disease', 'ko05142', 'list(REFERENCE = \"PMID:10234174\", AUTHORS = \"Bogdan C, Rollinghoff M\", TITLE = \"How do protozoan parasites survive inside macrophages?\", JOURNAL = c(\"Parasitol Today 15:22-8 (1999)\", \"DOI:10.1016/S0169-4758(98)01362-3\")), list(REFERENCE = \"PMID:17110955\", AUTHORS = \"Gazzinelli RT, Denkers EY\", TITLE = \"Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism.\", JOURNAL = c(\"Nat Rev Immunol 6:895-906 (2006)\", \"DOI:10.1038/nri1978\")), list(REFERENCE = \"PMID:1717552\", AUTHORS = \"Norris KA, Bradt B, Cooper NR, So M\", TITLE = \"Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.\", JOURNAL = \"J Immunol 147:2240-7 (1991)\"), list(REFERENCE = \"PMID:16238097\", AUTHORS = \"Aguilar L, Ramirez G, Valck C, Molina MC, Rojas A, Schwaeble W, Ferreira V, Ferreira A\", TITLE = \"F(ab\')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement.\", JOURNAL = c(\"Biol Res 38:187-95 (2005)\", \"DOI:10.4067/S0716-97602005000200008\")), list(REFERENCE = \"PMID:15223603\", AUTHORS = \"Campos MA, Gazzinelli RT\", TITLE = \"Trypanosoma cruzi and its components as exogenous mediators of inflammation recognized through Toll-like receptors.\", JOURNAL = c(\"Mediators Inflamm 13:139-43 (2004)\", \"DOI:10.1080/09511920410001713565\")), list(REFERENCE = \"PMID:12427093\", AUTHORS = \"Burleigh BA, Woolsey AM\", TITLE = \"Cell signalling and Trypanosoma cruzi invasion.\", JOURNAL = c(\"Cell Microbiol 4:701-11 (2002)\", \"DOI:10.1046/j.1462-5822.2002.00226.x\")), list(REFERENCE = \"PMID:17651955\", AUTHORS = \"Tarleton RL\", TITLE = \"Immune system recognition of Trypanosoma cruzi.\", JOURNAL = c(\"Curr Opin Immunol 19:430-4 (2007)\", \"DOI:10.1016/j.coi.2007.06.003\")), list(REFERENCE = \"PMID:16175174\", AUTHORS = \"Andrade LO, Andrews NW\", TITLE = \"The Trypanosoma cruzi-host-cell interplay: location, invasion, retention.\", JOURNAL = c(\"Nat Rev Microbiol 3:819-23 (2005)\", \"DOI:10.1038/nrmicro1249\")), list(REFERENCE = \"PMID:12377585\", AUTHORS = \"Tan H, Andrews NW\", TITLE = \"Don\'t bother to knock--the cell invasion strategy of Trypanosoma cruzi.\", JOURNAL = c(\"Trends Parasitol 18:427-8 (2002)\", \"DOI:10.1016/S1471-4922(02)02368-1\")), list(REFERENCE = \"PMID:10066513\", AUTHORS = \"Burleigh BA, Andrews NW\", TITLE = \"Signaling and host cell invasion by Trypanosoma cruzi.\", JOURNAL = c(\"Curr Opin Microbiol 1:461-5 (1998)\", \"DOI:10.1016/S1369-5274(98)80066-0\")), list(REFERENCE = \"PMID:12377942\", AUTHORS = \"Stempin C, Giordanengo L, Gea S, Cerban F\", TITLE = \"Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen.\", JOURNAL = c(\"J Leukoc Biol 72:727-34 (2002)\", \"DOI:10.1189/jlb.72.4.727\")), list(REFERENCE = \"PMID:16030288\", AUTHORS = \"Burleigh BA\", TITLE = \"Host cell signaling and Trypanosoma cruzi invasion: do all roads lead to lysosomes?\", JOURNAL = c(\"Sci STKE 2005:pe36 (2005)\", \"DOI:10.1126/stke.2932005pe36\")), list(REFERENCE = \"PMID:1396957\", AUTHORS = \"Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A\", TITLE = \"The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.\", JOURNAL = c(\"Eur J Immunol 22:2501-6 (1992)\", \"DOI:10.1002/eji.1830221006\")), list(REFERENCE = \"PMID:2194668\", AUTHORS = \"Andrews NW, Abrams CK, Slatin SL, Griffiths G\", TITLE = \"A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH.\", JOURNAL = c(\"Cell 61:1277-87 (1990)\", \"DOI:10.1016/0092-8674(90)90692-8\")), list(REFERENCE = \"PMID:9794425\", AUTHORS = \"Freire-de-Lima CG, Nunes MP, Corte-Real S, Soares MP, Previato JO, Mendonca-Previato L, DosReis GA\", TITLE = \"Proapoptotic activity of a Trypanosoma cruzi ceramide-containing glycolipid turned on in host macrophages by IFN-gamma.\", JOURNAL = \"J Immunol 161:4909-16 (1998)\"), list(REFERENCE = \"PMID:15917295\", AUTHORS = \"Hashimoto M, Nakajima-Shimada J, Aoki T\", TITLE = \"Trypanosoma cruzi posttranscriptionally up-regulates and exploits cellular FLIP for inhibition of death-inducing signal.\", JOURNAL = c(\"Mol Biol Cell 16:3521-8 (2005)\", \"DOI:10.1091/mbc.E04-12-1051\")), list(REFERENCE = \"PMID:12874238\", AUTHORS = \"Ropert C, Closel M, Chaves AC, Gazzinelli RT\", TITLE = \"Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages.\", JOURNAL = c(\"J Immunol 171:1456-65 (2003)\", \"DOI:10.4049/jimmunol.171.3.1456\")), list(REFERENCE = \"PMID:12055254\", AUTHORS = \"Ouaissi A, Guilvard E, Delneste Y, Caron G, Magistrelli G, Herbault N, Thieblemont N, Jeannin P\", TITLE = \"The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.\", JOURNAL = c(\"J Immunol 168:6366-74 (2002)\", \"DOI:10.4049/jimmunol.168.12.6366\")), list(REFERENCE = \"PMID:12036740\", AUTHORS = \"Teixeira MM, Gazzinelli RT, Silva JS\", TITLE = \"Chemokines, inflammation and Trypanosoma cruzi infection.\", JOURNAL = c(\"Trends Parasitol 18:262-5 (2002)\", \"DOI:10.1016/S1471-4922(02)02283-3\")), list(REFERENCE = \"PMID:9190942\", AUTHORS = \"Camargo MM, Almeida IC, Pereira ME, Ferguson MA, Travassos LR, Gazzinelli RT\", TITLE = \"Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages.\", JOURNAL = \"J Immunol 158:5890-901 (1997)\")', 'map05142', 'Chagas disease (American trypanosomiasis)', 66, 0, 65, 0, 0, 1, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (407, '05143', 'African trypanosomiasis', 'Trypanosoma brucei, the parasite responsible for African trypanosomiasis (sleeping sickness), are spread by the tsetse fly in sub-Saharan Africa. The parasites are able to pass through the blood-brain barrier and cause neurological damage by inducing cytokines like TNF alpha, IFN gamma, and IL1. These cytokines and other metabolites such as nitric oxide and somnogenic prostaglandin D2 disturb circadian rhythms in patients with African trypanosomiasis.', 'Human Diseases; Infectious disease: parasitic', 'African trypanosomiasis', 'African trypanosomiasis', 'ko05143', 'list(REFERENCE = \"PMID:19168735\", AUTHORS = \"Antoine-Moussiaux N, Buscher P, Desmecht D\", TITLE = \"Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.\", JOURNAL = c(\"Infect Immun 77:1276-84 (2009)\", \"DOI:10.1128/IAI.01185-08\")), list(REFERENCE = \"PMID:12088284\", AUTHORS = \"Enanga B, Burchmore RJ, Stewart ML, Barrett MP\", TITLE = \"Sleeping sickness and the brain.\", JOURNAL = c(\"Cell Mol Life Sci 59:845-58 (2002)\", \"DOI:10.1007/s00018-002-8472-0\")), list(REFERENCE = \"PMID:16600243\", AUTHORS = \"Bisser S, Ouwe-Missi-Oukem-Boyer ON, Toure FS, Taoufiq Z, Bouteille B, Buguet A, Mazier D\", TITLE = \"Harbouring in the brain: A focus on immune evasion mechanisms and their deleterious effects in malaria and human African trypanosomiasis.\", JOURNAL = c(\"Int J Parasitol 36:529-40 (2006)\", \"DOI:10.1016/j.ijpara.2006.02.001\")), list(REFERENCE = \"PMID:17582444\", AUTHORS = \"Masocha W, Rottenberg ME, Kristensson K\", TITLE = \"Migration of African trypanosomes across the blood-brain barrier.\", JOURNAL = c(\"Physiol Behav 92:110-4 (2007)\", \"DOI:10.1016/j.physbeh.2007.05.045\")), list(REFERENCE = \"PMID:11850009\", AUTHORS = \"Lonsdale-Eccles JD, Grab DJ\", TITLE = \"Trypanosome hydrolases and the blood-brain barrier.\", JOURNAL = c(\"Trends Parasitol 18:17-9 (2002)\", \"DOI:10.1016/S1471-4922(01)02120-1\")), list(REFERENCE = \"PMID:19016378\", AUTHORS = \"Grab DJ, Kennedy PG\", TITLE = \"Traversal of human and animal trypanosomes across the blood-brain barrier.\", JOURNAL = c(\"J Neurovirol 14:344-51 (2008)\", \"DOI:10.1080/13550280802282934\")), list(REFERENCE = \"PMID:19995590\", AUTHORS = \"Kristensson K, Nygard M, Bertini G, Bentivoglio M\", TITLE = \"African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions.\", JOURNAL = c(\"Prog Neurobiol 91:152-71 (2010)\", \"DOI:10.1016/j.pneurobio.2009.12.001\")), list(REFERENCE = \"PMID:19559585\", AUTHORS = \"Pays E, Vanhollebeke B\", TITLE = \"Human innate immunity against African trypanosomes.\", JOURNAL = c(\"Curr Opin Immunol 21:493-8 (2009)\", \"DOI:10.1016/j.coi.2009.05.024\")), list(REFERENCE = \"PMID:9574925\", AUTHORS = \"Donelson JE, Hill KL, El-Sayed NM\", TITLE = \"Multiple mechanisms of immune evasion by African trypanosomes.\", JOURNAL = c(\"Mol Biochem Parasitol 91:51-66 (1998)\", \"DOI:10.1016/S0166-6851(97)00209-0\")), list(REFERENCE = \"PMID:19621073\", AUTHORS = \"Grab DJ, Garcia-Garcia JC, Nikolskaia OV, Kim YV, Brown A, Pardo CA, Zhang Y, Becker KG, Wilson BA, de A Lima AP, Scharfstein J, Dumler JS\", TITLE = \"Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells.\", JOURNAL = c(\"PLoS Negl Trop Dis 3:e479 (2009)\", \"DOI:10.1371/journal.pntd.0000479\")), list(REFERENCE = \"PMID:20398209\", AUTHORS = \"Vanhollebeke B, Pays E\", TITLE = \"The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill.\", JOURNAL = c(\"Mol Microbiol 76:806-14 (2010)\", \"DOI:10.1111/j.1365-2958.2010.07156.x\"))', 'map05143', 'African trypanosomiasis', 66, 0, 65, 0, 0, 1, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (408, '05144', 'Malaria', 'c(\"Plasmodium protozoa are parasites that account for malaria infection. Sporozoite forms of the parasite are injected by mosquito bites under the skin and are carried to the liver where they develop into the merozoite form.\", \"Sporozoite invasion of hepatocytes is mediated by parasite surface protein like CSP. Subsequent infection into red blood cells (RBCs) by merozoites causes malaria disease via aberrant cytokine production and sequestration of parasite-infected red blood cells (pRBCs) to host endothelium. Microvasculature sequestration in the brain brings about cerebral malaria that can results in death or persisting neurological impairment. PfEMP1 has been suggested as the key adhesive molecule of pRBCs.\"\n)', 'Human Diseases; Infectious disease: parasitic', 'Malaria', 'Malaria', 'ko05144', 'list(REFERENCE = \"PMID:19101208\", AUTHORS = \"Morahan BJ, Wang L, Coppel RL\", TITLE = \"No TRAP, no invasion.\", JOURNAL = c(\"Trends Parasitol 25:77-84 (2009)\", \"DOI:10.1016/j.pt.2008.11.004\")), list(REFERENCE = \"PMID:8920859\", AUTHORS = \"Shakibaei M, Frevert U\", TITLE = \"Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans.\", JOURNAL = c(\"J Exp Med 184:1699-711 (1996)\", \"DOI:10.1084/jem.184.5.1699\")), list(REFERENCE = \"PMID:15106591\", AUTHORS = \"Silvie O, Franetich JF, Renia L, Mazier D\", TITLE = \"Malaria sporozoite: migrating for a living.\", JOURNAL = c(\"Trends Mol Med 10:97-100; discussion 100-1 (2004)\", \"DOI:10.1016/j.molmed.2004.01.004\")), list(REFERENCE = \"PMID:15464448\", AUTHORS = \"Mota MM, Giordano S, Rodriguez A\", TITLE = \"Targeting Plasmodium host cells: survival within hepatocytes.\", JOURNAL = c(\"Trends Mol Med 10:487-92 (2004)\", \"DOI:10.1016/j.molmed.2004.08.003\")), list(REFERENCE = \"PMID:12364790\", AUTHORS = \"Cowman AF, Crabb BS\", TITLE = \"The Plasmodium falciparum genome--a blueprint for erythrocyte invasion.\", JOURNAL = c(\"Science 298:126-8 (2002)\", \"DOI:10.1126/science.1078169\")), list(REFERENCE = \"PMID:16019257\", AUTHORS = \"O\'Donnell RA, Blackman MJ\", TITLE = \"The role of malaria merozoite proteases in red blood cell invasion.\", JOURNAL = c(\"Curr Opin Microbiol 8:422-7 (2005)\", \"DOI:10.1016/j.mib.2005.06.018\")), list(REFERENCE = \"PMID:17630968\", AUTHORS = \"Iyer J, Gruner AC, Renia L, Snounou G, Preiser PR\", TITLE = \"Invasion of host cells by malaria parasites: a tale of two protein families.\", JOURNAL = c(\"Mol Microbiol 65:231-49 (2007)\", \"DOI:10.1111/j.1365-2958.2007.05791.x\")), list(REFERENCE = \"PMID:11224682\", AUTHORS = \"Chitnis CE\", TITLE = \"Molecular insights into receptors used by malaria parasites for erythrocyte invasion.\", JOURNAL = \"Curr Opin Hematol 8:85-91 (2001)\"), list(REFERENCE = \"PMID:15094163\", AUTHORS = \"Rasti N, Wahlgren M, Chen Q\", TITLE = \"Molecular aspects of malaria pathogenesis.\", JOURNAL = c(\"FEMS Immunol Med Microbiol 41:9-26 (2004)\", \"DOI:10.1016/j.femsim.2004.01.010\")), list(REFERENCE = \"PMID:15463497\", AUTHORS = \"Clark IA, Rockett KA, Cowden WB\", TITLE = \"Proposed link between cytokines, nitric oxide and human cerebral malaria.\", JOURNAL = c(\"Parasitol Today 7:205-7 (1991)\", \"DOI:10.1016/0169-4758(91)90142-B\")), list(REFERENCE = \"PMID:18250459\", AUTHORS = \"Hisaeda H, Tetsutani K, Imai T, Moriya C, Tu L, Hamano S, Duan X, Chou B, Ishida H, Aramaki A, Shen J, Ishii KJ, Coban C, Akira S, Takeda K, Yasutomo K, Torii M, Himeno K\", TITLE = \"Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells.\", JOURNAL = c(\"J Immunol 180:2496-503 (2008)\", \"DOI:10.4049/jimmunol.180.4.2496\")), list(REFERENCE = \"PMID:10885986\", AUTHORS = \"Chen Q, Schlichtherle M, Wahlgren M\", TITLE = \"Molecular aspects of severe malaria.\", JOURNAL = c(\"Clin Microbiol Rev 13:439-50 (2000)\", \"DOI:10.1128/CMR.13.3.439-450.2000\")), list(REFERENCE = \"PMID:11832955\", AUTHORS = \"Miller LH, Baruch DI, Marsh K, Doumbo OK\", TITLE = \"The pathogenic basis of malaria.\", JOURNAL = c(\"Nature 415:673-9 (2002)\", \"DOI:10.1038/415673a\")), list(REFERENCE = \"PMID:19967139\", AUTHORS = \"Faille D, El-Assaad F, Alessi MC, Fusai T, Combes V, Grau GE\", TITLE = \"Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding.\", JOURNAL = c(\"Thromb Haemost 102:1093-102 (2009)\", \"DOI:10.1160/TH09-05-0337\")), list(REFERENCE = \"PMID:16138104\", AUTHORS = \"Schofield L, Grau GE\", TITLE = \"Immunological processes in malaria pathogenesis.\", JOURNAL = c(\"Nat Rev Immunol 5:722-35 (2005)\", \"DOI:10.1038/nri1686\")), list(REFERENCE = \"PMID:14737184\", AUTHORS = \"Ishino T, Yano K, Chinzei Y, Yuda M\", TITLE = \"Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer.\", JOURNAL = c(\"PLoS Biol 2:E4 (2004)\", \"DOI:10.1371/journal.pbio.0020004\")), list(REFERENCE = \"PMID:16468982\", AUTHORS = \"Kariu T, Ishino T, Yano K, Chinzei Y, Yuda M\", TITLE = \"CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts.\", JOURNAL = c(\"Mol Microbiol 59:1369-79 (2006)\", \"DOI:10.1111/j.1365-2958.2005.05024.x\")), list(REFERENCE = \"PMID:20091081\", AUTHORS = \"Cox D, McConkey S\", TITLE = \"The role of platelets in the pathogenesis of cerebral malaria.\", JOURNAL = c(\"Cell Mol Life Sci 67:557-68 (2010)\", \"DOI:10.1007/s00018-009-0211-3\"))', 'map05144', 'Malaria', 73, 0, 65, 0, 0, 8, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (409, '05145', 'Toxoplasmosis', 'Toxoplasma gondii is an obligate intracellular parasite that is prevalent worldwide. The tachyzoite form acquired by oral ingestion downmodulates proinflammatory signaling pathways via various mechanisms. During early infection, nuclear translocation of NFkB is temporally blocked and p38 MAPK phosphorylation is prevented, suppressing IL-12 production. Another pathway for IL-12 induction occurs through CCR5 dependent pathway, but parasitic induction of an eicosanoid LXA4 contributes to the downregulation of IL-12. Direct activation of STAT3 by the parasite enhance anti-inflammatory function of IL-10 and TGF beta. T. gondii can cause lifelong chronic infection by establishing an anti-apoptotic environment through induction of bcl-2 or IAPs and by redirecting LDL-mediated cholesterol transport to scavenge nutrients from the host.', 'Human Diseases; Infectious disease: parasitic', 'Toxoplasmosis', 'Toxoplasmosis', 'ko05145', 'list(REFERENCE = \"PMID:15639739\", AUTHORS = \"Denkers EY, Butcher BA\", TITLE = \"Sabotage and exploitation in macrophages parasitized by intracellular protozoans.\", JOURNAL = c(\"Trends Parasitol 21:35-41 (2005)\", \"DOI:10.1016/j.pt.2004.10.004\")), list(REFERENCE = \"PMID:14642303\", AUTHORS = \"Denkers EY\", TITLE = \"From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.\", JOURNAL = c(\"FEMS Immunol Med Microbiol 39:193-203 (2003)\", \"DOI:10.1016/S0928-8244(03)00279-7\")), list(REFERENCE = \"PMID:19744886\", AUTHORS = \"Pollard AM, Knoll LJ, Mordue DG\", TITLE = \"The role of specific Toxoplasma gondii molecules in manipulation of innate immunity.\", JOURNAL = c(\"Trends Parasitol 25:491-4 (2009)\", \"DOI:10.1016/j.pt.2009.07.009\")), list(REFERENCE = \"PMID:19891610\", AUTHORS = \"Leng J, Butcher BA, Denkers EY\", TITLE = \"Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances.\", JOURNAL = c(\"Parasite Immunol 31:717-28 (2009)\", \"DOI:10.1111/j.1365-3024.2009.01122.x\")), list(REFERENCE = \"PMID:18775432\", AUTHORS = \"Miller CM, Boulter NR, Ikin RJ, Smith NC\", TITLE = \"The immunobiology of the innate response to Toxoplasma gondii.\", JOURNAL = c(\"Int J Parasitol 39:23-39 (2009)\", \"DOI:10.1016/j.ijpara.2008.08.002\")), list(REFERENCE = \"PMID:12580944\", AUTHORS = \"Denkers EY, Kim L, Butcher BA\", TITLE = \"In the belly of the beast: subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection.\", JOURNAL = c(\"Cell Microbiol 5:75-83 (2003)\", \"DOI:10.1046/j.1462-5822.2003.00258.x\")), list(REFERENCE = \"PMID:17110955\", AUTHORS = \"Gazzinelli RT, Denkers EY\", TITLE = \"Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism.\", JOURNAL = c(\"Nat Rev Immunol 6:895-906 (2006)\", \"DOI:10.1038/nri1978\")), list(REFERENCE = \"PMID:17024357\", AUTHORS = \"Lang C, Gross U, Luder CG\", TITLE = \"Subversion of innate and adaptive immune responses by Toxoplasma gondii.\", JOURNAL = c(\"Parasitol Res 100:191-203 (2007)\", \"DOI:10.1007/s00436-006-0306-9\")), list(REFERENCE = \"PMID:19400868\", AUTHORS = \"Blader IJ, Saeij JP\", TITLE = \"Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.\", JOURNAL = c(\"APMIS 117:458-76 (2009)\", \"DOI:10.1111/j.1600-0463.2009.02453.x\")), list(REFERENCE = \"PMID:18059289\", AUTHORS = \"Boothroyd JC, Dubremetz JF\", TITLE = \"Kiss and spit: the dual roles of Toxoplasma rhoptries.\", JOURNAL = c(\"Nat Rev Microbiol 6:79-88 (2008)\", \"DOI:10.1038/nrmicro1800\")), list(REFERENCE = \"PMID:15361242\", AUTHORS = \"Denkers EY, Butcher BA, Del Rio L, Kim L\", TITLE = \"Manipulation of mitogen-activated protein kinase/nuclear factor-kappaB-signaling cascades during intracellular Toxoplasma gondii infection.\", JOURNAL = c(\"Immunol Rev 201:191-205 (2004)\", \"DOI:10.1111/j.0105-2896.2004.00180.x\")), list(REFERENCE = \"PMID:18617274\", AUTHORS = \"Yarovinsky F\", TITLE = \"Toll-like receptors and their role in host resistance to Toxoplasma gondii.\", JOURNAL = c(\"Immunol Lett 119:17-21 (2008)\", \"DOI:10.1016/j.imlet.2008.05.007\")), list(REFERENCE = \"PMID:14987366\", AUTHORS = \"Coppens I, Joiner KA\", TITLE = \"Parasitehost cell interactions in toxoplasmosis: new avenues for intervention?\", JOURNAL = c(\"Expert Rev Mol Med 2001:1-20 (2001)\", \"DOI:10.1017/S1462399401002277\")), list(REFERENCE = \"PMID:12106793\", AUTHORS = \"Aliberti J, Sher A\", TITLE = \"Role of G-protein-coupled signaling in the induction and regulation of dendritic cell function by Toxoplasma gondii.\", JOURNAL = c(\"Microbes Infect 4:991-7 (2002)\", \"DOI:10.1016/S1286-4579(02)01618-0\")), list(REFERENCE = \"PMID:12857995\", AUTHORS = \"Sher A, Collazzo C, Scanga C, Jankovic D, Yap G, Aliberti J\", TITLE = \"Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii.\", JOURNAL = c(\"Immunol Res 27:521-8 (2003)\", \"DOI:10.1385/IR:27:2-3:521\")), list(REFERENCE = \"PMID:10525166\", AUTHORS = \"Bonhomme A, Bouchot A, Pezzella N, Gomez J, Le Moal H, Pinon JM\", TITLE = \"Signaling during the invasion of host cells by Toxoplasma gondii.\", JOURNAL = c(\"FEMS Microbiol Rev 23:551-61 (1999)\", \"DOI:10.1111/j.1574-6976.1999.tb00413.x\")), list(REFERENCE = \"PMID:18327664\", AUTHORS = \"Laliberte J, Carruthers VB\", TITLE = \"Host cell manipulation by the human pathogen Toxoplasma gondii.\", JOURNAL = c(\"Cell Mol Life Sci 65:1900-15 (2008)\", \"DOI:10.1007/s00018-008-7556-x\")), list(REFERENCE = \"PMID:10234174\", AUTHORS = \"Bogdan C, Rollinghoff M\", TITLE = \"How do protozoan parasites survive inside macrophages?\", JOURNAL = c(\"Parasitol Today 15:22-8 (1999)\", \"DOI:10.1016/S0169-4758(98)01362-3\")), list(REFERENCE = \"PMID:16339966\", AUTHORS = \"Molestina RE, Sinai AP\", TITLE = \"Host and parasite-derived IKK activities direct distinct temporal phases of NF-kappaB activation and target gene expression following Toxoplasma gondii infection.\", JOURNAL = c(\"J Cell Sci 118:5785-96 (2005)\", \"DOI:10.1242/jcs.02709\"))', 'map05145', 'Toxoplasmosis', 66, 0, 65, 0, 0, 1, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (410, '05146', 'Amoebiasis', 'Entamoeba histolytica, an extracellular protozoan parasite is a human pathogen that invades the intestinal epithelium. Infection occurs on ingestion of contaminated water and food. The pathogenesis of amoebiasis begins with parasite attachment and disruption of the intestinal mucus layer, followed by apoptosis of host epithelial cells. Intestinal tissue destruction causes severe dysentery and ulcerations in amoebic colitis. Several amoebic proteins such as lectins, cysteine proteineases, and amoebapores are associated with the invasion process. The parasite can cause extraintestinal infection like amoebic liver abscess by evading immune response.', 'Human Diseases; Infectious disease: parasitic', 'Amoebiasis', 'Amoebiasis', 'ko05146', 'list(REFERENCE = \"PMID:11378035\", AUTHORS = \"Stanley SL\", TITLE = \"Pathophysiology of amoebiasis.\", JOURNAL = c(\"Trends Parasitol 17:280-5 (2001)\", \"DOI:10.1016/S1471-4922(01)01903-1\")), list(REFERENCE = \"PMID:10756002\", AUTHORS = \"Espinosa-Cantellano M, Martinez-Palomo A\", TITLE = \"Pathogenesis of intestinal amebiasis: from molecules to disease.\", JOURNAL = c(\"Clin Microbiol Rev 13:318-31 (2000)\", \"DOI:10.1128/CMR.13.2.318-331.2000\")), list(REFERENCE = \"PMID:9832261\", AUTHORS = \"Huston CD, Petri WA Jr\", TITLE = \"Host-pathogen interaction in amebiasis and progress in vaccine development.\", JOURNAL = c(\"Eur J Clin Microbiol Infect Dis 17:601-14 (1998)\", \"DOI:10.1007/BF01708342\")), list(REFERENCE = \"PMID:14700586\", AUTHORS = \"Huston CD\", TITLE = \"Parasite and host contributions to the pathogenesis of amebic colitis.\", JOURNAL = c(\"Trends Parasitol 20:23-6 (2004)\", \"DOI:10.1016/j.pt.2003.10.013\")), list(REFERENCE = \"PMID:15813717\", AUTHORS = \"Campos-Rodriguezp R, Jarillo-Luna A\", TITLE = \"The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity.\", JOURNAL = c(\"Parasite Immunol 27:1-8 (2005)\", \"DOI:10.1111/j.1365-3024.2005.00743.x\")), list(REFERENCE = \"PMID:19207103\", AUTHORS = \"Lejeune M, Rybicka JM, Chadee K\", TITLE = \"Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica.\", JOURNAL = c(\"Future Microbiol 4:105-18 (2009)\", \"DOI:10.2217/17460913.4.1.105\")), list(REFERENCE = \"PMID:17576362\", AUTHORS = \"Carrero JC, Cervantes-Rebolledo C, Aguilar-Diaz H, Diaz-Gallardo MY, Laclette JP, Morales-Montor J\", TITLE = \"The role of the secretory immune response in the infection by Entamoeba histolytica.\", JOURNAL = c(\"Parasite Immunol 29:331-8 (2007)\", \"DOI:10.1111/j.1365-3024.2007.00955.x\")), list(REFERENCE = \"PMID:12660071\", AUTHORS = \"Stanley SL Jr\", TITLE = \"Amoebiasis.\", JOURNAL = c(\"Lancet 361:1025-34 (2003)\", \"DOI:10.1016/S0140-6736(03)12830-9\")), list(REFERENCE = \"PMID:14502002\", AUTHORS = \"Stauffer W, Ravdin JI\", TITLE = \"Entamoeba histolytica: an update.\", JOURNAL = c(\"Curr Opin Infect Dis 16:479-85 (2003)\", \"DOI:10.1097/01.qco.0000092821.42392.ca\")), list(REFERENCE = \"PMID:12142490\", AUTHORS = \"Petri WA Jr, Haque R, Mann BJ\", TITLE = \"The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica.\", JOURNAL = c(\"Annu Rev Microbiol 56:39-64 (2002)\", \"DOI:10.1146/annurev.micro.56.012302.160959\")), list(REFERENCE = \"PMID:18725798\", AUTHORS = \"Baxt LA, Singh U\", TITLE = \"New insights into Entamoeba histolytica pathogenesis.\", JOURNAL = c(\"Curr Opin Infect Dis 21:489-94 (2008)\", \"DOI:10.1097/QCO.0b013e32830ce75f\")), list(REFERENCE = \"PMID:12160867\", AUTHORS = \"Petri WA Jr\", TITLE = \"Pathogenesis of amebiasis.\", JOURNAL = c(\"Curr Opin Microbiol 5:443-7 (2002)\", \"DOI:10.1016/S1369-5274(02)00335-1\")), list(REFERENCE = \"PMID:17702556\", AUTHORS = \"Guo X, Houpt E, Petri WA Jr\", TITLE = \"Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies.\", JOURNAL = c(\"Curr Opin Immunol 19:376-84 (2007)\", \"DOI:10.1016/j.coi.2007.07.005\")), list(REFERENCE = \"PMID:20303955\", AUTHORS = \"Mortimer L, Chadee K\", TITLE = \"The immunopathogenesis of Entamoeba histolytica.\", JOURNAL = c(\"Exp Parasitol 126:366-80 (2010)\", \"DOI:10.1016/j.exppara.2010.03.005\")), list(REFERENCE = \"PMID:16380324\", AUTHORS = \"Meza I, Talamas-Rohana P, Vargas MA\", TITLE = \"The cytoskeleton of Entamoeba histolytica: structure, function, and regulation by signaling pathways.\", JOURNAL = c(\"Arch Med Res 37:234-43 (2006)\", \"DOI:10.1016/j.arcmed.2005.09.008\")), list(REFERENCE = \"PMID:10637584\", AUTHORS = \"Meza I\", TITLE = \"Extracellular matrix-induced signaling in Entamoeba histolytica: its role in invasiveness.\", JOURNAL = c(\"Parasitol Today 16:23-8 (2000)\", \"DOI:10.1016/S0169-4758(99)01586-0\")), list(REFERENCE = \"PMID:11352795\", AUTHORS = \"Stanley SL Jr, Reed SL\", TITLE = \"Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VI. Entamoeba histolytica: parasite-host interactions.\", JOURNAL = c(\"Am J Physiol Gastrointest Liver Physiol 280:G1049-54 (2001)\", \"DOI:10.1152/ajpgi.2001.280.6.G1049\")), list(REFERENCE = \"PMID:20145703\", AUTHORS = \"Wong-Baeza I, Alcantara-Hernandez M, Mancilla-Herrera I, Ramirez-Saldivar I, Arriaga-Pizano L, Ferat-Osorio E, Lopez-Macias C, Isibasi A\", TITLE = \"The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.\", JOURNAL = c(\"J Biomed Biotechnol 2010:254521 (2010)\", \"DOI:10.1155/2010/254521\"))', 'map05146', 'Amoebiasis', 68, 0, 65, 0, 0, 3, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (411, '05150', 'Staphylococcus aureus infection', 'Staphylococcus aureus can cause multiple forms of infections ranging from superficial skin infections to food poisoning and life-threatening infections. The organism has several ways to divert the effectiveness of the immune system: secreting immune modulating proteins that inhibit complement activation and neutrophil chemotaxis or lysis, modulating the sensitivity to cationic antimicrobial peptides (such as defensin) by increasing the positive net charge of its cytoplasmic membrane, and expression of superantigens that prevent development of a normal immune response or cause an emetic response when ingested.', 'Human Diseases; Infectious disease: bacterial', 'Staphylococcus aureus infection', 'Methicillin-resistant Staphylococcal aureus (MRSA) infection, Vancomycin-resistant Staphylococcal aureus (VRSA) infection, Methicillin-sensitive Staphylococcus aureus (MSSA) infection', 'ko05150', 'list(REFERENCE = \"PMID:20178484\", AUTHORS = \"Foster TJ\", TITLE = \"Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion.\", JOURNAL = c(\"Vet Dermatol 20:456-70 (2009)\", \"DOI:10.1111/j.1365-3164.2009.00825.x\")), list(REFERENCE = \"PMID:16322743\", AUTHORS = \"Foster TJ\", TITLE = \"Immune evasion by staphylococci.\", JOURNAL = c(\"Nat Rev Microbiol 3:948-58 (2005)\", \"DOI:10.1038/nrmicro1289\")), list(REFERENCE = \"PMID:20062962\", AUTHORS = \"Laarman A, Milder F, van Strijp J, Rooijakkers S\", TITLE = \"Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.\", JOURNAL = c(\"J Mol Med 88:115-20 (2010)\", \"DOI:10.1007/s00109-009-0572-y\")), list(REFERENCE = \"PMID:16242332\", AUTHORS = \"Rooijakkers SH, van Kessel KP, van Strijp JA\", TITLE = \"Staphylococcal innate immune evasion.\", JOURNAL = c(\"Trends Microbiol 13:596-601 (2005)\", \"DOI:10.1016/j.tim.2005.10.002\")), list(REFERENCE = \"PMID:16679003\", AUTHORS = \"Iwatsuki K, Yamasaki O, Morizane S, Oono T\", TITLE = \"Staphylococcal cutaneous infections: invasion, evasion and aggression.\", JOURNAL = c(\"J Dermatol Sci 42:203-14 (2006)\", \"DOI:10.1016/j.jdermsci.2006.03.011\")), list(REFERENCE = \"PMID:11361034\", AUTHORS = \"Torres BA, Kominsky S, Perrin GQ, Hobeika AC, Johnson HM\", TITLE = \"Superantigens: the good, the bad, and the ugly.\", JOURNAL = c(\"Exp Biol Med (Maywood) 226:164-76 (2001)\", \"DOI:10.1177/153537020122600303\")), list(REFERENCE = \"PMID:18061675\", AUTHORS = \"Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins AT, Feil EJ, van den Elsen JM\", TITLE = \"S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.\", JOURNAL = c(\"Mol Immunol 45:1600-11 (2008)\", \"DOI:10.1016/j.molimm.2007.10.021\")), list(REFERENCE = \"PMID:16724100\", AUTHORS = \"Silverman GJ, Goodyear CS\", TITLE = \"Confounding B-cell defences: lessons from a staphylococcal superantigen.\", JOURNAL = c(\"Nat Rev Immunol 6:465-75 (2006)\", \"DOI:10.1038/nri1853\")), list(REFERENCE = \"PMID:15273292\", AUTHORS = \"Goodyear CS, Silverman GJ\", TITLE = \"Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 101:11392-7 (2004)\", \"DOI:10.1073/pnas.0404382101\")), list(REFERENCE = \"PMID:19112495\", AUTHORS = \"Haupt K, Reuter M, van den Elsen J, Burman J, Halbich S, Richter J, Skerka C, Zipfel PF\", TITLE = \"The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.\", JOURNAL = c(\"PLoS Pathog 4:e1000250 (2008)\", \"DOI:10.1371/journal.ppat.1000250\")), list(REFERENCE = \"PMID:16111912\", AUTHORS = \"Bokarewa MI, Jin T, Tarkowski A\", TITLE = \"Staphylococcus aureus: Staphylokinase.\", JOURNAL = c(\"Int J Biochem Cell Biol 38:504-9 (2006)\", \"DOI:10.1016/j.biocel.2005.07.005\")), list(REFERENCE = \"PMID:16086019\", AUTHORS = \"Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA\", TITLE = \"Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.\", JOURNAL = c(\"Nat Immunol 6:920-7 (2005)\", \"DOI:10.1038/ni1235\")), list(REFERENCE = \"PMID:19503103\", AUTHORS = \"Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P\", TITLE = \"Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.\", JOURNAL = c(\"Nat Immunol 10:721-7 (2009)\", \"DOI:10.1038/ni.1756\")), list(REFERENCE = \"PMID:17893203\", AUTHORS = \"Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH\", TITLE = \"Staphylococcal complement evasion by various convertase-blocking molecules.\", JOURNAL = c(\"J Exp Med 204:2461-71 (2007)\", \"DOI:10.1084/jem.20070818\")), list(REFERENCE = \"PMID:18544012\", AUTHORS = \"Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM\", TITLE = \"Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.\", JOURNAL = c(\"J Infect Dis 198:125-33 (2008)\", \"DOI:10.1086/588825\")), list(REFERENCE = \"PMID:16640587\", AUTHORS = \"Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ\", TITLE = \"Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.\", JOURNAL = c(\"FEMS Microbiol Lett 258:290-6 (2006)\", \"DOI:10.1111/j.1574-6968.2006.00229.x\")), list(REFERENCE = \"PMID:20133685\", AUTHORS = \"Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B, Spillner E, Christensen JB, Jensen M, Fredslund F, Bjerre M, Sottrup-Jensen L, Fraser JD, Andersen GR\", TITLE = \"Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 107:3681-6 (2010)\", \"DOI:10.1073/pnas.0910565107\")), list(REFERENCE = \"PMID:17848512\", AUTHORS = \"Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD\", TITLE = \"Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 104:15051-6 (2007)\", \"DOI:10.1073/pnas.0706028104\")), list(REFERENCE = \"PMID:14993252\", AUTHORS = \"de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA\", TITLE = \"Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.\", JOURNAL = c(\"J Exp Med 199:687-95 (2004)\", \"DOI:10.1084/jem.20031636\")), list(REFERENCE = \"PMID:17114475\", AUTHORS = \"Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP\", TITLE = \"A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.\", JOURNAL = c(\"J Immunol 177:8017-26 (2006)\", \"DOI:10.4049/jimmunol.177.11.8017\")), list(REFERENCE = \"PMID:17132726\", AUTHORS = \"Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ\", TITLE = \"Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling.\", JOURNAL = c(\"Blood 109:2936-43 (2007)\", \"DOI:10.1182/blood-2006-06-015461\")), list(REFERENCE = \"PMID:18045383\", AUTHORS = \"Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD\", TITLE = \"The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.\", JOURNAL = c(\"Mol Microbiol 66:1342-55 (2007)\", \"DOI:10.1111/j.1365-2958.2007.05989.x\")), list(REFERENCE = \"PMID:12091905\", AUTHORS = \"Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT\", TITLE = \"Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes.\", JOURNAL = c(\"Nat Med 8:687-93 (2002)\", \"DOI:10.1038/nm728\")), list(REFERENCE = \"PMID:17517597\", AUTHORS = \"Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M\", TITLE = \"Gram-positive three-component antimicrobial peptide-sensing system.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 104:9469-74 (2007)\", \"DOI:10.1073/pnas.0702159104\")), list(REFERENCE = \"PMID:15561843\", AUTHORS = \"Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J\", TITLE = \"Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.\", JOURNAL = c(\"Antimicrob Agents Chemother 48:4673-9 (2004)\", \"DOI:10.1128/AAC.48.12.4673-4679.2004\")), list(REFERENCE = \"PMID:18837785\", AUTHORS = \"Fraser JD, Proft T\", TITLE = \"The bacterial superantigen and superantigen-like proteins.\", JOURNAL = c(\"Immunol Rev 225:226-43 (2008)\", \"DOI:10.1111/j.1600-065X.2008.00681.x\")), list(REFERENCE = \"PMID:12228315\", AUTHORS = \"Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, Takata T, Ohara M, Komatsuzawa H, Amagai M, Sugai M\", TITLE = \"Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.\", JOURNAL = c(\"Infect Immun 70:5835-45 (2002)\", \"DOI:10.1128/IAI.70.10.5835-5845.2002\")), list(REFERENCE = \"PMID:16710608\", AUTHORS = \"Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J\", TITLE = \"Human beta-defensins.\", JOURNAL = c(\"Cell Mol Life Sci 63:1294-313 (2006)\", \"DOI:10.1007/s00018-005-5540-2\")), list(REFERENCE = \"PMID:16184199\", AUTHORS = \"Zhang Q, Mousdicas N, Yi Q, Al-Hassani M, Billings SD, Perkins SM, Howard KM, Ishii S, Shimizu T, Travers JB\", TITLE = \"Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.\", JOURNAL = c(\"J Clin Invest 115:2855-61 (2005)\", \"DOI:10.1172/JCI25429\")), list(REFERENCE = \"PMID:15372083\", AUTHORS = \"Lehrer RI\", TITLE = \"Primate defensins.\", JOURNAL = c(\"Nat Rev Microbiol 2:727-38 (2004)\", \"DOI:10.1038/nrmicro976\"))', 'map05150', 'Staphylococcus aureus infection', 65, 53, 65, 0, 0, 0, 53, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (412, '05152', 'Tuberculosis', 'Tuberculosis, or TB, is an infectious disease caused by Mycobacterium tuberculosis. One third of the world\'s population is thought to be infected with TB. About 90% of those infected result in latent infections, and about 10% of latent infections develop active diseases when their immune system is impaired due to the age, other diseases such as AIDS or exposure to immunosuppressive drugs. TB is transmitted through the air and primarily attacks the lungs, then it can spread by the circulatory system to other parts of body. Once TB bacilli have entered the host by the respiratory route and infected macrophages in the lungs, they interfere with phagosomal maturation, antigen presentation, apoptosis and host immune system to establish persistent or latent infection.', 'Human Diseases; Infectious disease: bacterial', 'Tuberculosis', 'Tuberculosis', 'ko05152', 'list(REFERENCE = \"PMID:21274449\", AUTHORS = \"Saiga H, Shimada Y, Takeda K\", TITLE = \"Innate immune effectors in mycobacterial infection.\", JOURNAL = c(\"Clin Dev Immunol 2011:347594 (2011)\", \"DOI:10.1155/2011/347594\")), list(REFERENCE = \"PMID:20415982\", AUTHORS = \"Dheda K, Schwander SK, Zhu B, van Zyl-Smit RN, Zhang Y\", TITLE = \"The immunology of tuberculosis: from bench to bedside.\", JOURNAL = c(\"Respirology 15:433-50 (2010)\", \"DOI:10.1111/j.1440-1843.2010.01739.x\")), list(REFERENCE = \"PMID:11932234\", AUTHORS = \"van Crevel R, Ottenhoff TH, van der Meer JW\", TITLE = \"Innate immunity to Mycobacterium tuberculosis.\", JOURNAL = c(\"Clin Microbiol Rev 15:294-309 (2002)\", \"DOI:10.1128/CMR.15.2.294-309.2002\")), list(REFERENCE = \"PMID:18288961\", AUTHORS = \"Torrelles JB, Azad AK, Henning LN, Carlson TK, Schlesinger LS\", TITLE = \"Role of C-type lectins in mycobacterial infections.\", JOURNAL = c(\"Curr Drug Targets 9:102-12 (2008)\", \"DOI:10.2174/138945008783502467\")), list(REFERENCE = \"PMID:17359235\", AUTHORS = \"Jo EK, Yang CS, Choi CH, Harding CV\", TITLE = \"Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors.\", JOURNAL = c(\"Cell Microbiol 9:1087-98 (2007)\", \"DOI:10.1111/j.1462-5822.2007.00914.x\")), list(REFERENCE = \"PMID:21274433\", AUTHORS = \"Marakalala MJ, Graham LM, Brown GD\", TITLE = \"The role of Syk/CARD9-coupled C-type lectin receptors in immunity to Mycobacterium tuberculosis infections.\", JOURNAL = c(\"Clin Dev Immunol 2010:567571 (2010)\", \"DOI:10.1155/2010/567571\")), list(REFERENCE = \"PMID:15083155\", AUTHORS = \"Koul A, Herget T, Klebl B, Ullrich A\", TITLE = \"Interplay between mycobacteria and host signalling pathways.\", JOURNAL = c(\"Nat Rev Microbiol 2:189-202 (2004)\", \"DOI:10.1038/nrmicro840\")), list(REFERENCE = \"PMID:20199890\", AUTHORS = \"Torrelles JB, Schlesinger LS\", TITLE = \"Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host.\", JOURNAL = c(\"Tuberculosis (Edinb) 90:84-93 (2010)\", \"DOI:10.1016/j.tube.2010.02.003\")), list(REFERENCE = \"PMID:15228522\", AUTHORS = \"Briken V, Porcelli SA, Besra GS, Kremer L\", TITLE = \"Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.\", JOURNAL = c(\"Mol Microbiol 53:391-403 (2004)\", \"DOI:10.1111/j.1365-2958.2004.04183.x\")), list(REFERENCE = \"PMID:19563525\", AUTHORS = \"Baena A, Porcelli SA\", TITLE = \"Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.\", JOURNAL = c(\"Tissue Antigens 74:189-204 (2009)\", \"DOI:10.1111/j.1399-0039.2009.01301.x\")), list(REFERENCE = \"PMID:19369951\", AUTHORS = \"Flannagan RS, Cosio G, Grinstein S\", TITLE = \"Antimicrobial mechanisms of phagocytes and bacterial evasion strategies.\", JOURNAL = c(\"Nat Rev Microbiol 7:355-66 (2009)\", \"DOI:10.1038/nrmicro2128\")), list(REFERENCE = \"PMID:18541216\", AUTHORS = \"Pieters J\", TITLE = \"Mycobacterium tuberculosis and the macrophage: maintaining a balance.\", JOURNAL = c(\"Cell Host Microbe 3:399-407 (2008)\", \"DOI:10.1016/j.chom.2008.05.006\")), list(REFERENCE = \"PMID:19634703\", AUTHORS = \"Scherr N, Jayachandran R, Mueller P, Pieters J\", TITLE = \"Interference of Mycobacterium tuberculosis with macrophage responses.\", JOURNAL = \"Indian J Exp Biol 47:401-6 (2009)\"), list(REFERENCE = \"PMID:16200082\", AUTHORS = \"Reith W, LeibundGut-Landmann S, Waldburger JM.\", TITLE = \"Regulation of MHC class II gene expression by the class II transactivator.\", JOURNAL = c(\"Nat Rev Immunol 5:793-806 (2005)\", \"DOI:10.1038/nri1708\")), list(REFERENCE = \"PMID:17785780\", AUTHORS = \"Rothfuchs AG, Bafica A, Feng CG, Egen JG, Williams DL, Brown GD, Sher A\", TITLE = \"Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells.\", JOURNAL = c(\"J Immunol 179:3463-71 (2007)\", \"DOI:10.4049/jimmunol.179.6.3463\")), list(REFERENCE = \"PMID:18407066\", AUTHORS = \"Master SS, Rampini SK, Davis AS, Keller C, Ehlers S, Springer B, Timmins GS, Sander P, Deretic V\", TITLE = \"Mycobacterium tuberculosis prevents inflammasome activation.\", JOURNAL = c(\"Cell Host Microbe 3:224-32 (2008)\", \"DOI:10.1016/j.chom.2008.03.003\")), list(REFERENCE = \"PMID:11378475\", AUTHORS = \"Shtrichman R, Samuel CE\", TITLE = \"The role of gamma interferon in antimicrobial immunity.\", JOURNAL = c(\"Curr Opin Microbiol 4:251-9 (2001)\", \"DOI:10.1016/S1369-5274(00)00199-5\"))', 'map05152', 'Tuberculosis', 65, 70, 65, 0, 0, 0, 70, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (413, '05160', 'Hepatitis C', 'Hepatitis C virus (HCV) is a major cause of chronic liver disease. The HCV employ several strategies to perturb host cell immunity. After invasion, HCV RNA genome functions directly as an mRNA in the cytoplasm of the host cell and forms membrane-associated replication complexes along with non-structural proteins. Viral RNA can trigger the RIG-I pathway and interferon production during this process. Translated HCV protein products regulate immune response to inhibit the action of interferon. HCV core and NS5A proteins appear to be the most important molecules with regulatory functions that modulate transcription, cellular proliferation, and apoptosis.', 'Human Diseases; Infectious disease: viral', 'Hepatitis C', 'Hepatocellular carcinoma, Hepatitis C', 'ko05160', 'list(REFERENCE = \"PMID:24520529\", AUTHORS = \"Hassan M, Selimovic D, El-Khattouti A, Ghozlan H, Haikel Y, Abdelkader O\", TITLE = \"Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.\", JOURNAL = c(\"World J Exp Med 2:7-25 (2012)\", \"DOI:10.5493/wjem.v2.i2.7\")), list(REFERENCE = \"PMID:23641066\", AUTHORS = \"Yamauchi Y, Helenius A\", TITLE = \"Virus entry at a glance.\", JOURNAL = c(\"J Cell Sci 126:1289-95 (2013)\", \"DOI:10.1242/jcs.119685\")), list(REFERENCE = \"PMID:24509809\", AUTHORS = \"Feneant L, Levy S, Cocquerel L\", TITLE = \"CD81 and hepatitis C virus (HCV) infection.\", JOURNAL = c(\"Viruses 6:535-72 (2014)\", \"DOI:10.3390/v6020535\")), list(REFERENCE = \"PMID:18081727\", AUTHORS = \"Dubuisson J, Helle F, Cocquerel L\", TITLE = \"Early steps of the hepatitis C virus life cycle.\", JOURNAL = c(\"Cell Microbiol 10:821-7 (2008)\", \"DOI:10.1111/j.1462-5822.2007.01107.x\")), list(REFERENCE = \"PMID:23675659\", AUTHORS = \"Liang TJ, Ghany MG\", TITLE = \"Current and future therapies for hepatitis C virus infection.\", JOURNAL = c(\"N Engl J Med 368:1907-17 (2013)\", \"DOI:10.1056/NEJMra1213651\")), list(REFERENCE = \"PMID:23836234\", AUTHORS = \"Scheel TK, Rice CM\", TITLE = \"Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.\", JOURNAL = c(\"Nat Med 19:837-49 (2013)\", \"DOI:10.1038/nm.3248\")), list(REFERENCE = \"PMID:26586968\", AUTHORS = \"Holmes JA, Thompson AJ\", TITLE = \"Interferon-free combination therapies for the treatment of hepatitis C: current insights.\", JOURNAL = c(\"Hepat Med 7:51-70 (2015)\", \"DOI:10.2147/HMER.S55864\")), list(REFERENCE = \"PMID:15039538\", AUTHORS = \"Taguchi T, Nagano-Fujii M, Akutsu M, Kadoya H, Ohgimoto S, Ishido S, Hotta H\", TITLE = \"Hepatitis C virus NS5A protein interacts with 2\',5\'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner.\", JOURNAL = c(\"J Gen Virol 85:959-69 (2004)\", \"DOI:10.1099/vir.0.19513-0\")), list(REFERENCE = \"PMID:19708811\", AUTHORS = \"Horner SM, Gale M Jr\", TITLE = \"Intracellular innate immune cascades and interferon defenses that control hepatitis C virus.\", JOURNAL = c(\"J Interferon Cytokine Res 29:489-98 (2009)\", \"DOI:10.1089/jir.2009.0063\")), list(REFERENCE = \"PMID:20457596\", AUTHORS = \"Lemon SM\", TITLE = \"Induction and evasion of innate antiviral responses by hepatitis C virus.\", JOURNAL = c(\"J Biol Chem 285:22741-7 (2010)\", \"DOI:10.1074/jbc.R109.099556\")), list(REFERENCE = \"PMID:23836238\", AUTHORS = \"Horner SM, Gale M Jr\", TITLE = \"Regulation of hepatic innate immunity by hepatitis C virus.\", JOURNAL = c(\"Nat Med 19:879-88 (2013)\", \"DOI:10.1038/nm.3253\")), list(REFERENCE = \"PMID:28862649\", AUTHORS = \"Ortega-Prieto AM, Dorner M\", TITLE = \"Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.\", JOURNAL = c(\"Vaccines (Basel) 5:E24 (2017)\", \"DOI:10.3390/vaccines5030024\")), list(REFERENCE = \"PMID:25852264\", AUTHORS = \"Yang DR, Zhu HZ\", TITLE = \"Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?\", JOURNAL = c(\"World J Gastroenterol 21:3786-800 (2015)\", \"DOI:10.3748/wjg.v21.i13.3786\")), list(REFERENCE = \"PMID:16107833\", AUTHORS = \"Gale M Jr, Foy EM\", TITLE = \"Evasion of intracellular host defence by hepatitis C virus.\", JOURNAL = c(\"Nature 436:939-45 (2005)\", \"DOI:10.1038/nature04078\")), list(REFERENCE = \"PMID:17467654\", AUTHORS = \"Bode JG, Brenndorfer ED, Haussinger D\", TITLE = \"Subversion of innate host antiviral strategies by the hepatitis C virus.\", JOURNAL = c(\"Arch Biochem Biophys 462:254-65 (2007)\", \"DOI:10.1016/j.abb.2007.03.033\")), list(REFERENCE = \"PMID:12686421\", AUTHORS = \"Panteva M, Korkaya H, Jameel S\", TITLE = \"Hepatitis viruses and the MAPK pathway: is this a survival strategy?\", JOURNAL = c(\"Virus Res 92:131-40 (2003)\", \"DOI:10.1016/S0168-1702(02)00356-8\")), list(REFERENCE = \"PMID:16239065\", AUTHORS = \"Pang R, Tse E, Poon RT\", TITLE = \"Molecular pathways in hepatocellular carcinoma.\", JOURNAL = c(\"Cancer Lett 240:157-69 (2006)\", \"DOI:10.1016/j.canlet.2005.08.031\")), list(REFERENCE = \"PMID:15302943\", AUTHORS = \"Macdonald A, Harris M\", TITLE = \"Hepatitis C virus NS5A: tales of a promiscuous protein.\", JOURNAL = c(\"J Gen Virol 85:2485-502 (2004)\", \"DOI:10.1099/vir.0.80204-0\")), list(REFERENCE = \"PMID:21250384\", AUTHORS = \"He Y, Staschke KA, Tan SL\", TITLE = \"HCV NS5A: A Multifunctional Regulator of Cellular Pathways and Virus Replication\", JOURNAL = \"Hepatitis C Viruses: Genomes and Molecular Biology (2006)\"), list(REFERENCE = \"PMID:12101418\", AUTHORS = \"Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD\", TITLE = \"HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.\", JOURNAL = c(\"Oncogene 21:4801-11 (2002)\", \"DOI:10.1038/sj.onc.1205589\")), list(REFERENCE = \"PMID:11886269\", AUTHORS = \"Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, Ray RB\", TITLE = \"Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.\", JOURNAL = c(\"Virology 294:94-105 (2002)\", \"DOI:10.1006/viro.2001.1309\")), list(REFERENCE = \"PMID:15381253\", AUTHORS = \"Hassan M, Ghozlan H, Abdel-Kader O\", TITLE = \"Activation of RB/E2F signaling pathway is required for the modulation of hepatitis C virus core protein-induced cell growth in liver and non-liver cells.\", JOURNAL = c(\"Cell Signal 16:1375-85 (2004)\", \"DOI:10.1016/j.cellsig.2004.04.005\")), list(REFERENCE = \"PMID:11514734\", AUTHORS = \"Kwun HJ, Jung EY, Ahn JY, Lee MN, Jang KL\", TITLE = \"p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3.\", JOURNAL = c(\"J Gen Virol 82:2235-41 (2001)\", \"DOI:10.1099/0022-1317-82-9-2235\")), list(REFERENCE = \"PMID:12056797\", AUTHORS = \"Yamanaka T, Uchida M, Doi T\", TITLE = \"Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein.\", JOURNAL = c(\"Biochem Biophys Res Commun 294:521-7 (2002)\", \"DOI:10.1016/S0006-291X(02)00507-7\")), list(REFERENCE = \"PMID:22611309\", AUTHORS = \"Lim EJ, Chin R, Angus PW, Torresi J\", TITLE = \"Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants.\", JOURNAL = c(\"World J Gastroenterol 18:2172-9 (2012)\", \"DOI:10.3748/wjg.v18.i18.2172\")), list(REFERENCE = \"PMID:17828818\", AUTHORS = \"Fischer R, Baumert T, Blum HE\", TITLE = \"Hepatitis C virus infection and apoptosis.\", JOURNAL = c(\"World J Gastroenterol 13:4865-72 (2007)\", \"DOI:10.3748/wjg.v13.i36.4865\")), list(REFERENCE = \"PMID:16611896\", AUTHORS = \"Saito K, Meyer K, Warner R, Basu A, Ray RB, Ray R\", TITLE = \"Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein.\", JOURNAL = c(\"J Virol 80:4372-9 (2006)\", \"DOI:10.1128/JVI.80.9.4372-4379.2006\")), list(REFERENCE = \"PMID:19148799\", AUTHORS = \"Koike K\", TITLE = \"Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.\", JOURNAL = c(\"J Gastroenterol 44 Suppl 19:82-8 (2009)\", \"DOI:10.1007/s00535-008-2276-4\")), list(REFERENCE = \"PMID:17764115\", AUTHORS = \"Tanaka N, Moriya K, Kiyosawa K, Koike K, Aoyama T\", TITLE = \"Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis.\", JOURNAL = c(\"Int J Cancer 122:124-31 (2008)\", \"DOI:10.1002/ijc.23056\")), list(REFERENCE = \"PMID:18251977\", AUTHORS = \"Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ\", TITLE = \"Viral hepatocarcinogenesis: from infection to cancer.\", JOURNAL = c(\"Liver Int 28:175-88 (2008)\", \"DOI:10.1111/j.1478-3231.2007.01652.x\"))', 'map05160', 'Hepatitis C', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (414, '05161', 'Hepatitis B', 'Hepatitis B virus (HBV) is an enveloped virus and contains a partially double-stranded relaxed circular DNA (RC-DNA) genome. After entry into hepatocytes, HBV RC-DNA is transported to the nucleus and converted into a covalently closed circular molecule cccDNA. The cccDNA is the template for transcription of all viral RNAs including the pregenomic RNA (pgRNA), encoding for 7 viral proteins: large, middle, and small envelope proteins (LHBs, MHBs, and SHBs) that form the surface antigen (HBsAg), the core antigen (HBcAg), the e antigen (HBeAg), the HBV polymerase, and the regulatory protein X (HBx). The pgRNA interacts with the viral polymerase protein to initiate the encapsidation into the core particles. Through endoplasmic reticulum, the core particles finish assembling with the envelope proteins and are released. HBV infection leads to a wide spectrum of liver diseases raging from chronic hepatitis, cirrhosis to hepatocellular carcinoma. The mechanism of liver injury is still not clear. However, HBV proteins target host proteins, involved in a variety of functions, thus regulating transcription, cellular signaling cascades, proliferation, differentiation, and apoptosis.', 'Human Diseases; Infectious disease: viral', 'Hepatitis B', 'Hepatocellular carcinoma, Hepatitis B', 'ko05161', 'list(REFERENCE = \"PMID:30059722\", AUTHORS = \"Caballero A, Tabernero D, Buti M, Rodriguez-Frias F\", TITLE = \"Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategy.\", JOURNAL = c(\"Antiviral Res 158:34-44 (2018)\", \"DOI:10.1016/j.antiviral.2018.07.019\")), list(REFERENCE = \"PMID:22869468\", AUTHORS = \"Walsh R, Locarnini S\", TITLE = \"Hepatitis B precore protein: pathogenic potential and therapeutic promise.\", JOURNAL = c(\"Yonsei Med J 53:875-85 (2012)\", \"DOI:10.3349/ymj.2012.53.5.875\")), list(REFERENCE = \"PMID:26239691\", AUTHORS = \"Liang TJ, Block TM, McMahon BJ, Ghany MG, Urban S, Guo JT, Locarnini S, Zoulim F, Chang KM, Lok AS\", TITLE = \"Present and future therapies of hepatitis B: From discovery to cure.\", JOURNAL = c(\"Hepatology 62:1893-908 (2015)\", \"DOI:10.1002/hep.28025\")), list(REFERENCE = \"PMID:26776362\", AUTHORS = \"Morikawa K, Suda G, Sakamoto N\", TITLE = \"Viral life cycle of hepatitis B virus: Host factors and druggable targets.\", JOURNAL = c(\"Hepatol Res 46:871-7 (2016)\", \"DOI:10.1111/hepr.12650\")), list(REFERENCE = \"PMID:19201080\", AUTHORS = \"Feitelson MA, Reis HM, Tufan NL, Sun B, Pan J, Lian Z\", TITLE = \"Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.\", JOURNAL = c(\"Cancer Lett 286:69-79 (2009)\", \"DOI:10.1016/j.canlet.2008.12.010\")), list(REFERENCE = \"PMID:19263472\", AUTHORS = \"Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K\", TITLE = \"Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.\", JOURNAL = c(\"Hepatology 49:1203-17 (2009)\", \"DOI:10.1002/hep.22765\")), list(REFERENCE = \"PMID:15173177\", AUTHORS = \"Yoo YG, Lee MO\", TITLE = \"Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.\", JOURNAL = c(\"J Biol Chem 279:36242-9 (2004)\", \"DOI:10.1074/jbc.M401290200\")), list(REFERENCE = \"PMID:16459163\", AUTHORS = \"Zhang X, Zhang H, Ye L\", TITLE = \"Effects of hepatitis B virus X protein on the development of liver cancer.\", JOURNAL = c(\"J Lab Clin Med 147:58-66 (2006)\", \"DOI:10.1016/j.lab.2005.10.003\")), list(REFERENCE = \"PMID:19854353\", AUTHORS = \"Benhenda S, Cougot D, Buendia MA, Neuveut C\", TITLE = \"Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis.\", JOURNAL = c(\"Adv Cancer Res 103:75-109 (2009)\", \"DOI:10.1016/S0065-230X(09)03004-8\")), list(REFERENCE = \"PMID:21994562\", AUTHORS = \"Benhenda S, Cougot D, Neuveut C, Buendia MA\", TITLE = \"Liver cell transformation in chronic HBV infection.\", JOURNAL = c(\"Viruses 1:630-46 (2009)\", \"DOI:10.3390/v1030630\")), list(REFERENCE = \"PMID:11099494\", AUTHORS = \"Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD\", TITLE = \"X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway.\", JOURNAL = c(\"J Biol Chem 276:8328-40 (2001)\", \"DOI:10.1074/jbc.M006026200\")), list(REFERENCE = \"PMID:16891440\", AUTHORS = \"Park NH, Song IH, Chung YH\", TITLE = \"Chronic hepatitis B in hepatocarcinogenesis.\", JOURNAL = c(\"Postgrad Med J 82:507-15 (2006)\", \"DOI:10.1136/pgmj.2006.047431\")), list(REFERENCE = \"PMID:28820498\", AUTHORS = \"Lin S, Zhang YJ\", TITLE = \"Interference of Apoptosis by Hepatitis B Virus.\", JOURNAL = c(\"Viruses 9:E230 (2017)\", \"DOI:10.3390/v9080230\")), list(REFERENCE = \"PMID:16173017\", AUTHORS = \"Zhang X, Dong N, Yin L, Cai N, Ma H, You J, Zhang H, Wang H, He R, Ye L\", TITLE = \"Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.\", JOURNAL = c(\"J Med Virol 77:374-81 (2005)\", \"DOI:10.1002/jmv.20466\")), list(REFERENCE = \"PMID:18481805\", AUTHORS = \"Kim HJ, Kim SY, Kim J, Lee H, Choi M, Kim JK, Ahn JK\", TITLE = \"Hepatitis B virus X protein induces apoptosis by enhancing translocation of Bax to mitochondria.\", JOURNAL = c(\"IUBMB Life 60:473-80 (2008)\", \"DOI:10.1002/iub.68\")), list(REFERENCE = \"PMID:21647825\", AUTHORS = \"Ng SA, Lee C\", TITLE = \"Hepatitis B virus X gene and hepatocarcinogenesis.\", JOURNAL = c(\"J Gastroenterol 46:974-90 (2011)\", \"DOI:10.1007/s00535-011-0415-9\")), list(REFERENCE = \"PMID:9195957\", AUTHORS = \"Cong YS, Yao YL, Yang WM, Kuzhandaivelu N, Seto E\", TITLE = \"The hepatitis B virus X-associated protein, XAP3, is a protein kinase C-binding protein.\", JOURNAL = c(\"J Biol Chem 272:16482-9 (1997)\", \"DOI:10.1074/jbc.272.26.16482\")), list(REFERENCE = \"PMID:12686421\", AUTHORS = \"Panteva M, Korkaya H, Jameel S\", TITLE = \"Hepatitis viruses and the MAPK pathway: is this a survival strategy?\", JOURNAL = c(\"Virus Res 92:131-40 (2003)\", \"DOI:10.1016/S0168-1702(02)00356-8\")), list(REFERENCE = \"PMID:9738022\", AUTHORS = \"Lee YH, Yun Y\", TITLE = \"HBx protein of hepatitis B virus activates Jak1-STAT signaling.\", JOURNAL = c(\"J Biol Chem 273:25510-5 (1998)\", \"DOI:10.1074/jbc.273.39.25510\")), list(REFERENCE = \"PMID:18251977\", AUTHORS = \"Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ\", TITLE = \"Viral hepatocarcinogenesis: from infection to cancer.\", JOURNAL = c(\"Liver Int 28:175-88 (2008)\", \"DOI:10.1111/j.1478-3231.2007.01652.x\")), list(REFERENCE = \"PMID:17059849\", AUTHORS = \"Chami M, Oules B, Paterlini-Brechot P\", TITLE = \"Cytobiological consequences of calcium-signaling alterations induced by human viral proteins.\", JOURNAL = c(\"Biochim Biophys Acta 1763:1344-62 (2006)\", \"DOI:10.1016/j.bbamcr.2006.09.025\")), list(REFERENCE = \"PMID:11743185\", AUTHORS = \"Ganem D\", TITLE = \"Virology. The X files--one step closer to closure.\", JOURNAL = c(\"Science 294:2299-300 (2001)\", \"DOI:10.1126/science.1067850\")), list(REFERENCE = \"PMID:15132991\", AUTHORS = \"Chung TW, Lee YC, Kim CH\", TITLE = \"Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.\", JOURNAL = c(\"FASEB J 18:1123-5 (2004)\", \"DOI:10.1096/fj.03-1429fje\")), list(REFERENCE = \"PMID:18605975\", AUTHORS = \"Gurtsevitch VE\", TITLE = \"Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.\", JOURNAL = c(\"Biochemistry (Mosc) 73:504-13 (2008)\", \"DOI:10.1134/S0006297908050039\")), list(REFERENCE = \"PMID:21994545\", AUTHORS = \"Schadler S, Hildt E\", TITLE = \"HBV life cycle: entry and morphogenesis.\", JOURNAL = c(\"Viruses 1:185-209 (2009)\", \"DOI:10.3390/v1020185\")), list(REFERENCE = \"PMID:28862649\", AUTHORS = \"Ortega-Prieto AM, Dorner M\", TITLE = \"Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.\", JOURNAL = c(\"Vaccines (Basel) 5:E24 (2017)\", \"DOI:10.3390/vaccines5030024\")), list(REFERENCE = \"PMID:28704708\", AUTHORS = \"Nosratabadi R, Alavian SM, Zare-Bidaki M, Shahrokhi VM, Arababadi MK\", TITLE = \"Innate immunity related pathogen recognition receptors and chronic hepatitis B infection.\", JOURNAL = c(\"Mol Immunol 90:64-73 (2017)\", \"DOI:10.1016/j.molimm.2017.07.002\")), list(REFERENCE = \"PMID:24530748\", AUTHORS = \"Bagheri V, Askari A, Arababadi MK, Kennedy D\", TITLE = \"Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?\", JOURNAL = c(\"Hum Immunol 75:549-54 (2014)\", \"DOI:10.1016/j.humimm.2014.02.018\")), list(REFERENCE = \"PMID:25550115\", AUTHORS = \"Zhang E, Lu M\", TITLE = \"Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.\", JOURNAL = c(\"Med Microbiol Immunol 204:11-20 (2015)\", \"DOI:10.1007/s00430-014-0370-1\")), list(REFERENCE = \"PMID:20375222\", AUTHORS = \"Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z\", TITLE = \"Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.\", JOURNAL = c(\"J Gen Virol 91:2080-90 (2010)\", \"DOI:10.1099/vir.0.020552-0\")), list(REFERENCE = \"PMID:23363957\", AUTHORS = \"Revill P, Yuan Z\", TITLE = \"New insights into how HBV manipulates the innate immune response to establish acute and persistent infection.\", JOURNAL = c(\"Antivir Ther 18:1-15 (2013)\", \"DOI:10.3851/IMP2542\")), list(REFERENCE = \"PMID:28893934\", AUTHORS = \"Hopcraft SE, Damania B\", TITLE = \"Tumour viruses and innate immunity.\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 372:20160267 (2017)\", \"DOI:10.1098/rstb.2016.0267\")), list(REFERENCE = \"PMID:22504921\", AUTHORS = \"Dandri M, Locarnini S\", TITLE = \"New insight in the pathobiology of hepatitis B virus infection.\", JOURNAL = c(\"Gut 61 Suppl 1:i6-17 (2012)\", \"DOI:10.1136/gutjnl-2012-302056\"))', 'map05161', 'Hepatitis B', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (415, '05162', 'Measles', 'Measles virus (MV) is highly contagious virus that leads infant death worldwide. Humans are the unique natural reservoir for this virus. MV infection is characterized by virus-induced immune suppression that can lead to increased susceptibility to secondary bacterial and viral infections. The P, V and C proteins act as virulence factors to suppress innate immune response in host by inhibiting signaling for both type I IFN induction and JAK/STAT-mediated interferon-stimulated gene (ISG) induction. Moreover,  H protein expressed on viral particles and binding to SLAM or CD46,  as well as N protein liberated from infected cells and interacting with Fc-gamma R, causes an inhibition of IL-12 synthesis in dendritic cells. IL-12 is a key cytokine inducing cellular immune responses to protect host from the harm caused by pathogenic infections.', 'Human Diseases; Infectious disease: viral', 'Measles', 'Measles', 'ko05162', 'list(REFERENCE = \"PMID:19203113\", AUTHORS = \"Schneider-Schaulies S, Schneider-Schaulies J\", TITLE = \"Measles virus-induced immunosuppression.\", JOURNAL = c(\"Curr Top Microbiol Immunol 330:243-69 (2009)\", \"DOI:10.1007/978-3-540-70617-5_12\")), list(REFERENCE = \"PMID:19203114\", AUTHORS = \"Hahm B\", TITLE = \"Hostile communication of measles virus with host innate immunity and dendritic cells.\", JOURNAL = c(\"Curr Top Microbiol Immunol 330:271-87 (2009)\", \"DOI:10.1007/978-3-540-70617-5_13\")), list(REFERENCE = \"PMID:19198566\", AUTHORS = \"Gerlier D, Valentin H\", TITLE = \"Measles virus interaction with host cells and impact on innate immunity.\", JOURNAL = c(\"Curr Top Microbiol Immunol 329:163-91 (2009)\", \"DOI:10.1007/978-3-540-70523-9_8\")), list(REFERENCE = \"PMID:16690907\", AUTHORS = \"Schneider-Schaulies S, Dittmer U\", TITLE = \"Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression.\", JOURNAL = c(\"J Gen Virol 87:1423-38 (2006)\", \"DOI:10.1099/vir.0.81713-0\")), list(REFERENCE = \"PMID:22049305\", AUTHORS = \"Avota E, Gassert E, Schneider-Schaulies S\", TITLE = \"Cytoskeletal dynamics: concepts in measles virus replication and immunomodulation.\", JOURNAL = c(\"Viruses 3:102-17 (2011)\", \"DOI:10.3390/v3020102\")), list(REFERENCE = \"PMID:27854326\", AUTHORS = \"Jiang Y, Qin Y, Chen M\", TITLE = \"Host-Pathogen Interactions in Measles Virus Replication and Anti-Viral Immunity.\", JOURNAL = c(\"Viruses 8:E308 (2016)\", \"DOI:10.3390/v8110308\")), list(REFERENCE = \"PMID:18922877\", AUTHORS = \"Pfaller CK, Conzelmann KK\", TITLE = \"Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction.\", JOURNAL = c(\"J Virol 82:12365-73 (2008)\", \"DOI:10.1128/JVI.01321-08\")), list(REFERENCE = \"PMID:17720800\", AUTHORS = \"Yokota S, Okabayashi T, Yokosawa N, Fujii N\", TITLE = \"Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20.\", JOURNAL = c(\"FASEB J 22:74-83 (2008)\", \"DOI:10.1096/fj.07-8976com\")), list(REFERENCE = \"PMID:23146309\", AUTHORS = \"Delpeut S, Noyce RS, Siu RW, Richardson CD\", TITLE = \"Host factors and measles virus replication.\", JOURNAL = c(\"Curr Opin Virol 2:773-83 (2012)\", \"DOI:10.1016/j.coviro.2012.10.008\")), list(REFERENCE = \"PMID:26878224\", AUTHORS = \"Shah M, Anwar MA, Kim JH, Choi S\", TITLE = \"Advances in Antiviral Therapies Targeting Toll-like Receptors.\", JOURNAL = c(\"Expert Opin Investig Drugs 25:437-53 (2016)\", \"DOI:10.1517/13543784.2016.1154040\")), list(REFERENCE = \"PMID:12620806\", AUTHORS = \"Yokota S, Saito H, Kubota T, Yokosawa N, Amano K, Fujii N\", TITLE = \"Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex.\", JOURNAL = c(\"Virology 306:135-46 (2003)\", \"DOI:10.1016/S0042-6822(02)00026-0\")), list(REFERENCE = \"PMID:12804771\", AUTHORS = \"Takeuchi K, Kadota SI, Takeda M, Miyajima N, Nagata K\", TITLE = \"Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation.\", JOURNAL = c(\"FEBS Lett 545:177-82 (2003)\", \"DOI:10.1016/S0014-5793(03)00528-3\")), list(REFERENCE = \"PMID:12805463\", AUTHORS = \"Palosaari H, Parisien JP, Rodriguez JJ, Ulane CM, Horvath CM\", TITLE = \"STAT protein interference and suppression of cytokine signal transduction by measles virus V protein.\", JOURNAL = c(\"J Virol 77:7635-44 (2003)\", \"DOI:10.1128/JVI.77.13.7635-7644.2003\")), list(REFERENCE = \"PMID:14585342\", AUTHORS = \"Shaffer JA, Bellini WJ, Rota PA\", TITLE = \"The C protein of measles virus inhibits the type I interferon response.\", JOURNAL = c(\"Virology 315:389-97 (2003)\", \"DOI:10.1016/S0042-6822(03)00537-3\")), list(REFERENCE = \"PMID:16971451\", AUTHORS = \"Carsillo T, Traylor Z, Choi C, Niewiesk S, Oglesbee M\", TITLE = \"hsp72, a host determinant of measles virus neurovirulence.\", JOURNAL = c(\"J Virol 80:11031-9 (2006)\", \"DOI:10.1128/JVI.01438-06\")), list(REFERENCE = \"PMID:15914229\", AUTHORS = \"Zhang X, Bourhis JM, Longhi S, Carsillo T, Buccellato M, Morin B, Canard B, Oglesbee M\", TITLE = \"Hsp72 recognizes a P binding motif in the measles virus N protein C-terminus.\", JOURNAL = c(\"Virology 337:162-74 (2005)\", \"DOI:10.1016/j.virol.2005.03.035\")), list(REFERENCE = \"PMID:29712906\", AUTHORS = \"Ke Z, Strauss JD, Hampton CM, Brindley MA, Dillard RS, Leon F, Lamb KM, Plemper RK, Wright ER\", TITLE = \"Promotion of virus assembly and organization by the measles virus matrix protein.\", JOURNAL = c(\"Nat Commun 9:1736 (2018)\", \"DOI:10.1038/s41467-018-04058-2\")), list(REFERENCE = \"PMID:24155404\", AUTHORS = \"Pfaller CK, Radeke MJ, Cattaneo R, Samuel CE\", TITLE = \"Measles virus C protein impairs production of defective copyback double-stranded viral RNA and activation of protein kinase R.\", JOURNAL = c(\"J Virol 88:456-68 (2014)\", \"DOI:10.1128/JVI.02572-13\")), list(REFERENCE = \"PMID:17686838\", AUTHORS = \"Sato H, Masuda M, Kanai M, Tsukiyama-Kohara K, Yoneda M, Kai C\", TITLE = \"Measles virus N protein inhibits host translation by binding to eIF3-p40.\", JOURNAL = c(\"J Virol 81:11569-76 (2007)\", \"DOI:10.1128/JVI.00570-07\")), list(REFERENCE = \"PMID:19895323\", AUTHORS = \"Sion-Vardy N, Lasarov I, Delgado B, Gopas J, Benharroch D, Ariad S\", TITLE = \"Measles virus: evidence for association with lung cancer.\", JOURNAL = c(\"Exp Lung Res 35:701-12 (2009)\", \"DOI:10.3109/01902140902853176\")), list(REFERENCE = \"PMID:16140759\", AUTHORS = \"Chen M, Cortay JC, Logan IR, Sapountzi V, Robson CN, Gerlier D\", TITLE = \"Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein.\", JOURNAL = c(\"J Virol 79:11824-36 (2005)\", \"DOI:10.1128/JVI.79.18.11824-11836.2005\")), list(REFERENCE = \"PMID:16699046\", AUTHORS = \"Cruz CD, Palosaari H, Parisien JP, Devaux P, Cattaneo R, Ouchi T, Horvath CM\", TITLE = \"Measles virus V protein inhibits p53 family member p73.\", JOURNAL = c(\"J Virol 80:5644-50 (2006)\", \"DOI:10.1128/JVI.02400-05\")), list(REFERENCE = \"PMID:10756053\", AUTHORS = \"Servet-Delprat C, Vidalain PO, Azocar O, Le Deist F, Fischer A, Rabourdin-Combe C\", TITLE = \"Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus.\", JOURNAL = c(\"J Virol 74:4387-93 (2000)\", \"DOI:10.1128/JVI.74.9.4387-4393.2000\")), list(REFERENCE = \"PMID:20601611\", AUTHORS = \"Kushwah R, Hu J\", TITLE = \"Dendritic cell apoptosis: regulation of tolerance versus immunity.\", JOURNAL = c(\"J Immunol 185:795-802 (2010)\", \"DOI:10.4049/jimmunol.1000325\")), list(REFERENCE = \"PMID:10590149\", AUTHORS = \"Vidalain PO, Azocar O, Lamouille B, Astier A, Rabourdin-Combe C, Servet-Delprat C\", TITLE = \"Measles virus induces functional TRAIL production by human dendritic cells.\", JOURNAL = c(\"J Virol 74:556-9 (2000)\", \"DOI:10.1128/JVI.74.1.556-559.2000\")), list(REFERENCE = \"PMID:11846228\", AUTHORS = \"Vidalain PO, Azocar O, Rabourdin-Combe C, Servet-Delprat C\", TITLE = \"Measle virus-infected dendritic cells develop immunosuppressive and cytotoxic activities.\", JOURNAL = c(\"Immunobiology 204:629-38 (2001)\", \"DOI:10.1078/0171-2985-00102\")), list(REFERENCE = \"PMID:10423127\", AUTHORS = \"Engelking O, Fedorov LM, Lilischkis R, ter Meulen V, Schneider-Schaulies S\", TITLE = \"Measles virus-induced immunosuppression in vitro is associated with deregulation of G1 cell cycle control proteins.\", JOURNAL = c(\"J Gen Virol 80 ( Pt 7):1599-608 (1999)\", \"DOI:10.1099/0022-1317-80-7-1599\")), list(REFERENCE = \"PMID:30510918\", AUTHORS = \"Fan Y, Sanyal S, Bruzzone R\", TITLE = \"Breaking Bad: How Viruses Subvert the Cell Cycle.\", JOURNAL = c(\"Front Cell Infect Microbiol 8:396 (2018)\", \"DOI:10.3389/fcimb.2018.00396\")), list(REFERENCE = \"PMID:20636817\", AUTHORS = \"Griffin DE\", TITLE = \"Measles virus-induced suppression of immune responses.\", JOURNAL = c(\"Immunol Rev 236:176-89 (2010)\", \"DOI:10.1111/j.1600-065X.2010.00925.x\")), list(REFERENCE = \"PMID:11385511\", AUTHORS = \"Avota E, Avots A, Niewiesk S, Kane LP, Bommhardt U, ter Meulen V, Schneider-Schaulies S\", TITLE = \"Disruption of Akt kinase activation is important for immunosuppression induced by measles virus.\", JOURNAL = c(\"Nat Med 7:725-31 (2001)\", \"DOI:10.1038/89106\")), list(REFERENCE = \"PMID:15308747\", AUTHORS = \"Avota E, Muller N, Klett M, Schneider-Schaulies S\", TITLE = \"Measles virus interacts with and alters signal transduction in T-cell lipid rafts.\", JOURNAL = c(\"J Virol 78:9552-9 (2004)\", \"DOI:10.1128/JVI.78.17.9552-9559.2004\")), list(REFERENCE = \"PMID:16963735\", AUTHORS = \"Yanagi Y, Takeda M, Ohno S\", TITLE = \"Measles virus: cellular receptors, tropism and pathogenesis.\", JOURNAL = c(\"J Gen Virol 87:2767-79 (2006)\", \"DOI:10.1099/vir.0.82221-0\")), list(REFERENCE = \"PMID:16237742\", AUTHORS = \"Kerdiles YM, Sellin CI, Druelle J, Horvat B\", TITLE = \"Immunosuppression caused by measles virus: role of viral proteins.\", JOURNAL = c(\"Rev Med Virol 16:49-63 (2006)\", \"DOI:10.1002/rmv.486\"))', 'map05162', 'Measles', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (416, '05163', 'Human cytomegalovirus infection', 'Human cytomegalovirus (HCMV) is an enveloped, double-stranded DNA virus that is a member of beta-herpesvirus family. HCMV is best known for causing significant morbidity and mortality in immunocompromised populations. As with other herpesviruses, HCMV gB and gH/gL envelope glycoproteins are essential for virus entry. HCMV gB could activate the PDGFRA, and induce activation of the oncogenic PI3-K/AKT pathway. Though it is unlikely that HCMV by itself can act as an oncogenic factor, HCMV may have an oncomodulatory role, to catalyze an oncogenic process that has already been initiated. US28, one of the four HCMV-encoded vGPCRs (US27, US28, UL33 and UL78), also has a specific role in the oncomodulatory properties. In addition, HCMV has developed numerous mechanisms for manipulating the host immune system. The virally encoded US2, US3, US6 and US11 gene products all interfere with major histocompatibility complex (MHC) class I antigen presentation. HCMV encodes several immediate early (IE) antiapoptotic proteins (IE1, IE2, vMIA and vICA). These proteins might avoid immune clearance of infected tumor cells by cytotoxic lymphocytes and NK cells.', 'Human Diseases; Infectious disease: viral', 'Human cytomegalovirus infection', 'Cytomegalovirus infection', 'ko05163', 'list(REFERENCE = \"PMID:19107226\", AUTHORS = \"Michaelis M, Doerr HW, Cinatl J\", TITLE = \"The story of human cytomegalovirus and cancer: increasing evidence and open questions.\", JOURNAL = c(\"Neoplasia 11:1-9 (2009)\", \"DOI:10.1593/neo.81178\")), list(REFERENCE = \"PMID:24839861\", AUTHORS = \"Roy S, Arav-Boger R\", TITLE = \"New cell-signaling pathways for controlling cytomegalovirus replication.\", JOURNAL = c(\"Am J Transplant 14:1249-58 (2014)\", \"DOI:10.1111/ajt.12725\")), list(REFERENCE = \"PMID:14720582\", AUTHORS = \"Cinatl J, Scholz M, Kotchetkov R, Vogel JU, Doerr HW\", TITLE = \"Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology.\", JOURNAL = c(\"Trends Mol Med 10:19-23 (2004)\", \"DOI:10.1016/j.molmed.2003.11.002\")), list(REFERENCE = \"PMID:15380778\", AUTHORS = \"Evers DL, Wang X, Huang ES\", TITLE = \"Cellular stress and signal transduction responses to human cytomegalovirus infection.\", JOURNAL = c(\"Microbes Infect 6:1084-93 (2004)\", \"DOI:10.1016/j.micinf.2004.05.026\")), list(REFERENCE = \"PMID:29547547\", AUTHORS = \"Murray MJ, Peters NE, Reeves MB\", TITLE = \"Navigating the Host Cell Response during Entry into Sites of Latent Cytomegalovirus Infection.\", JOURNAL = c(\"Pathogens 7:E30 (2018)\", \"DOI:10.3390/pathogens7010030\")), list(REFERENCE = \"PMID:27501260\", AUTHORS = \"Campadelli-Fiume G, Collins-McMillen D, Gianni T, Yurochko AD\", TITLE = \"Integrins as Herpesvirus Receptors and Mediators of the Host Signalosome.\", JOURNAL = c(\"Annu Rev Virol 3:215-236 (2016)\", \"DOI:10.1146/annurev-virology-110615-035618\")), list(REFERENCE = \"PMID:28132838\", AUTHORS = \"Fu YZ, Su S, Gao YQ, Wang PP, Huang ZF, Hu MM, Luo WW, Li S, Luo MH, Wang YY, Shu HB\", TITLE = \"Human Cytomegalovirus Tegument Protein UL82 Inhibits STING-Mediated Signaling to Evade Antiviral Immunity.\", JOURNAL = c(\"Cell Host Microbe 21:231-243 (2017)\", \"DOI:10.1016/j.chom.2017.01.001\")), list(REFERENCE = \"PMID:29082387\", AUTHORS = \"Hancock MH, Nelson JA\", TITLE = \"Modulation of the NFkappab Signalling Pathway by Human Cytomegalovirus.\", JOURNAL = \"Virology (Hyderabad) 1:104 (2017)\"), list(REFERENCE = \"PMID:21383764\", AUTHORS = \"Rahman MM, McFadden G\", TITLE = \"Modulation of NF-kappaB signalling by microbial pathogens.\", JOURNAL = c(\"Nat Rev Microbiol 9:291-306 (2011)\", \"DOI:10.1038/nrmicro2539\")), list(REFERENCE = \"PMID:27060663\", AUTHORS = \"Zhang J, Feng H, Xu S, Feng P\", TITLE = \"Hijacking GPCRs by viral pathogens and tumor.\", JOURNAL = c(\"Biochem Pharmacol 114:69-81 (2016)\", \"DOI:10.1016/j.bcp.2016.03.021\")), list(REFERENCE = \"PMID:28035083\", AUTHORS = \"Lee S, Chung YH, Lee C\", TITLE = \"US28, a Virally-Encoded GPCR as an Antiviral Target for Human Cytomegalovirus Infection.\", JOURNAL = c(\"Biomol Ther (Seoul) 25:69-79 (2017)\", \"DOI:10.4062/biomolther.2016.208\")), list(REFERENCE = \"PMID:23145028\", AUTHORS = \"Langemeijer EV, Slinger E, de Munnik S, Schreiber A, Maussang D, Vischer H, Verkaar F, Leurs R, Siderius M, Smit MJ\", TITLE = \"Constitutive beta-catenin signaling by the viral chemokine receptor US28.\", JOURNAL = c(\"PLoS One 7:e48935 (2012)\", \"DOI:10.1371/journal.pone.0048935\")), list(REFERENCE = \"PMID:15990176\", AUTHORS = \"Couty JP, Gershengorn MC\", TITLE = \"G-protein-coupled receptors encoded by human herpesviruses.\", JOURNAL = c(\"Trends Pharmacol Sci 26:405-11 (2005)\", \"DOI:10.1016/j.tips.2005.06.004\")), list(REFERENCE = \"PMID:25549333\", AUTHORS = \"Fiallos E, Judkins J, Matlaf L, Prichard M, Dittmer D, Cobbs C, Soroceanu L\", TITLE = \"Human cytomegalovirus gene expression in long-term infected glioma stem cells.\", JOURNAL = c(\"PLoS One 9:e116178 (2014)\", \"DOI:10.1371/journal.pone.0116178\")), list(REFERENCE = \"PMID:24445563\", AUTHORS = \"Vischer HF, Siderius M, Leurs R, Smit MJ\", TITLE = \"Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?\", JOURNAL = c(\"Nat Rev Drug Discov 13:123-39 (2014)\", \"DOI:10.1038/nrd4189\")), list(REFERENCE = \"PMID:20398729\", AUTHORS = \"Slinger E, Langemeijer E, Siderius M, Vischer HF, Smit MJ\", TITLE = \"Herpesvirus-encoded GPCRs rewire cellular signaling.\", JOURNAL = c(\"Mol Cell Endocrinol 331:179-84 (2011)\", \"DOI:10.1016/j.mce.2010.04.007\")), list(REFERENCE = \"PMID:11175803\", AUTHORS = \"Murphy PM\", TITLE = \"Viral exploitation and subversion of the immune system through chemokine mimicry.\", JOURNAL = c(\"Nat Immunol 2:116-22 (2001)\", \"DOI:10.1038/84214\")), list(REFERENCE = \"PMID:16352349\", AUTHORS = \"Vischer HF, Leurs R, Smit MJ\", TITLE = \"HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networks.\", JOURNAL = c(\"Trends Pharmacol Sci 27:56-63 (2006)\", \"DOI:10.1016/j.tips.2005.11.006\")), list(REFERENCE = \"PMID:25805993\", AUTHORS = \"de Munnik SM, Smit MJ, Leurs R, Vischer HF\", TITLE = \"Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.\", JOURNAL = c(\"Front Pharmacol 6:40 (2015)\", \"DOI:10.3389/fphar.2015.00040\")), list(REFERENCE = \"PMID:15172446\", AUTHORS = \"Michelson S\", TITLE = \"Consequences of human cytomegalovirus mimicry.\", JOURNAL = c(\"Hum Immunol 65:465-75 (2004)\", \"DOI:10.1016/j.humimm.2004.02.002\")), list(REFERENCE = \"PMID:29237840\", AUTHORS = \"Tu CC, Arnolds KL, O\'Connor CM, Spencer JV\", TITLE = \"Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.\", JOURNAL = c(\"J Virol 92:e01981-17 (2018)\", \"DOI:10.1128/JVI.01981-17\")), list(REFERENCE = \"PMID:17169327\", AUTHORS = \"Busillo JM, Benovic JL\", TITLE = \"Regulation of CXCR4 signaling.\", JOURNAL = c(\"Biochim Biophys Acta 1768:952-63 (2007)\", \"DOI:10.1016/j.bbamem.2006.11.002\")), list(REFERENCE = \"PMID:22454101\", AUTHORS = \"Noriega V, Redmann V, Gardner T, Tortorella D\", TITLE = \"Diverse immune evasion strategies by human cytomegalovirus.\", JOURNAL = c(\"Immunol Res 54:140-51 (2012)\", \"DOI:10.1007/s12026-012-8304-8\")), list(REFERENCE = \"PMID:17145306\", AUTHORS = \"Loureiro J, Ploegh HL\", TITLE = \"Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.\", JOURNAL = c(\"Adv Immunol 92:225-305 (2006)\", \"DOI:10.1016/S0065-2776(06)92006-9\")), list(REFERENCE = \"PMID:10707064\", AUTHORS = \"Fortunato EA, McElroy AK, Sanchez I, Spector DH\", TITLE = \"Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus.\", JOURNAL = c(\"Trends Microbiol 8:111-9 (2000)\", \"DOI:10.1016/S0966-842X(00)01699-1\")), list(REFERENCE = \"PMID:15389728\", AUTHORS = \"Cinatl J Jr, Scholz M, Doerr HW\", TITLE = \"Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation.\", JOURNAL = c(\"Med Res Rev 25:167-85 (2005)\", \"DOI:10.1002/med.20018\")), list(REFERENCE = \"PMID:14975530\", AUTHORS = \"Cinatl J Jr, Vogel JU, Kotchetkov R, Wilhelm Doerr H\", TITLE = \"Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression.\", JOURNAL = c(\"FEMS Microbiol Rev 28:59-77 (2004)\", \"DOI:10.1016/j.femsre.2003.07.005\")), list(REFERENCE = \"PMID:12062798\", AUTHORS = \"Castillo JP, Kowalik TF\", TITLE = \"Human cytomegalovirus immediate early proteins and cell growth control.\", JOURNAL = c(\"Gene 290:19-34 (2002)\", \"DOI:10.1016/S0378-1119(02)00566-8\")), list(REFERENCE = \"PMID:15352160\", AUTHORS = \"Kalejta RF\", TITLE = \"Human cytomegalovirus pp71: a new viral tool to probe the mechanisms of cell cycle progression and oncogenesis controlled by the retinoblastoma family of tumor suppressors.\", JOURNAL = c(\"J Cell Biochem 93:37-45 (2004)\", \"DOI:10.1002/jcb.20177\")), list(REFERENCE = \"PMID:20969904\", AUTHORS = \"Brune W\", TITLE = \"Inhibition of programmed cell death by cytomegaloviruses.\", JOURNAL = c(\"Virus Res 157:144-50 (2011)\", \"DOI:10.1016/j.virusres.2010.10.012\")), list(REFERENCE = \"PMID:28869497\", AUTHORS = \"Brune W, Andoniou CE\", TITLE = \"Die Another Day: Inhibition of Cell Death Pathways by Cytomegalovirus.\", JOURNAL = c(\"Viruses 9:E249 (2017)\", \"DOI:10.3390/v9090249\")), list(REFERENCE = \"PMID:27160907\", AUTHORS = \"Yamin R, Lecker LSM, Weisblum Y, Vitenshtein A, Le-Trilling VTK, Wolf DG, Mandelboim O\", TITLE = \"HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2.\", JOURNAL = c(\"Cell Rep 15:1542-1553 (2016)\", \"DOI:10.1016/j.celrep.2016.04.042\")), list(REFERENCE = \"PMID:28488292\", AUTHORS = \"Wang X, Sanchez J, Stone MJ, Payne RJ\", TITLE = \"Sulfation of the Human Cytomegalovirus Protein UL22A Enhances Binding to the Chemokine RANTES.\", JOURNAL = c(\"Angew Chem Int Ed Engl 56:8490-8494 (2017)\", \"DOI:10.1002/anie.201703059\"))', 'map05163', 'Human cytomegalovirus infection', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (417, '05164', 'Influenza A', 'Influenza is a contagious respiratory disease caused by influenza virus infection. Influenza A virus is responsible for both annual seasonal epidemics and periodic worldwide pandemics. Novel strains that cause pandemics arise from avian influenza virus by genetic reassortment among influenza viruses and two surface glycoproteins HA and NA form the basis of serologically distinct virus types. The innate immune system recognizes invaded virus through multiple mechanisms. Viral non-structural NS1 protein is a multifunctional virulence factor that interfere IFN-mediated antiviral response. It inhibits IFN production by blocking activation of transcription factors such as NF-kappa B and IRF3. NS1 further inhibits the activation of IFN-induced antiviral genes. PB1-F2 protein is another virulence factor that induce apoptosis of infected cells, which results in life-threatening bronchiolitis.', 'Human Diseases; Infectious disease: viral', 'Influenza A', 'Influenza, Avian influenza', 'ko05164', 'list(REFERENCE = \"PMID:24225499\", AUTHORS = \"Edinger TO, Pohl MO, Stertz S\", TITLE = \"Entry of influenza A virus: host factors and antiviral targets.\", JOURNAL = c(\"J Gen Virol 95:263-77 (2014)\", \"DOI:10.1099/vir.0.059477-0\")), list(REFERENCE = \"PMID:19565019\", AUTHORS = \"Kido H, Okumura Y, Takahashi E, Pan HY, Wang S, Chida J, Le TQ, Yano M\", TITLE = \"Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.\", JOURNAL = \"J Mol Genet Med 3:167-75 (2008)\"), list(REFERENCE = \"PMID:27751627\", AUTHORS = \"Ramakrishnan B, Viswanathan K, Tharakaraman K, Dancik V, Raman R, Babcock GJ, Shriver Z, Sasisekharan R\", TITLE = \"A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza.\", JOURNAL = c(\"Trends Microbiol 24:933-943 (2016)\", \"DOI:10.1016/j.tim.2016.09.003\")), list(REFERENCE = \"PMID:18588994\", AUTHORS = \"Thanh TT, van Doorn HR, de Jong MD\", TITLE = \"Human H5N1 influenza: current insight into pathogenesis.\", JOURNAL = c(\"Int J Biochem Cell Biol 40:2671-4 (2008)\", \"DOI:10.1016/j.biocel.2008.05.019\")), list(REFERENCE = \"PMID:23977434\", AUTHORS = \"Michael P, Brabant D, Bleiblo F, Ramana CV, Rutherford M, Khurana S, Tai TC, Kumar A, Kumar A\", TITLE = \"Influenza A induced cellular signal transduction pathways.\", JOURNAL = c(\"J Thorac Dis 5 Suppl 2:S132-41 (2013)\", \"DOI:10.3978/j.issn.2072-1439.2013.07.42\")), list(REFERENCE = \"PMID:20020828\", AUTHORS = \"Hale BG, Albrecht RA, Garcia-Sastre A\", TITLE = \"Innate immune evasion strategies of influenza viruses.\", JOURNAL = c(\"Future Microbiol 5:23-41 (2010)\", \"DOI:10.2217/fmb.09.108\")), list(REFERENCE = \"PMID:21698289\", AUTHORS = \"Sharma K, Tripathi S, Ranjan P, Kumar P, Garten R, Deyde V, Katz JM, Cox NJ, Lal RB, Sambhara S, Lal SK\", TITLE = \"Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation.\", JOURNAL = c(\"PLoS One 6:e20215 (2011)\", \"DOI:10.1371/journal.pone.0020215\")), list(REFERENCE = \"PMID:19782761\", AUTHORS = \"Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T, Ludwig S\", TITLE = \"Interplay between influenza A virus and the innate immune signaling.\", JOURNAL = c(\"Microbes Infect 12:81-7 (2010)\", \"DOI:10.1016/j.micinf.2009.09.007\")), list(REFERENCE = \"PMID:23170167\", AUTHORS = \"van de Sandt CE, Kreijtz JH, Rimmelzwaan GF\", TITLE = \"Evasion of influenza A viruses from innate and adaptive immune responses.\", JOURNAL = c(\"Viruses 4:1438-76 (2012)\", \"DOI:10.3390/v4091438\")), list(REFERENCE = \"PMID:30487536\", AUTHORS = \"Long JS, Mistry B, Haslam SM, Barclay WS\", TITLE = \"Host and viral determinants of influenza A virus species specificity.\", JOURNAL = c(\"Nat Rev Microbiol 17:67-81 (2019)\", \"DOI:10.1038/s41579-018-0115-z\")), list(REFERENCE = \"PMID:29556226\", AUTHORS = \"Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen JL\", TITLE = \"Host Immune Response to Influenza A Virus Infection.\", JOURNAL = c(\"Front Immunol 9:320 (2018)\", \"DOI:10.3389/fimmu.2018.00320\")), list(REFERENCE = \"PMID:20130137\", AUTHORS = \"Lu X, Masic A, Li Y, Shin Y, Liu Q, Zhou Y\", TITLE = \"The PI3K/Akt pathway inhibits influenza A virus-induced Bax-mediated apoptosis by negatively regulating the JNK pathway via ASK1.\", JOURNAL = c(\"J Gen Virol 91:1439-49 (2010)\", \"DOI:10.1099/vir.0.018465-0\")), list(REFERENCE = \"PMID:18980544\", AUTHORS = \"Ichinohe T, Iwasaki A, Hasegawa H\", TITLE = \"Innate sensors of influenza virus: clues to developing better intranasal vaccines.\", JOURNAL = c(\"Expert Rev Vaccines 7:1435-45 (2008)\", \"DOI:10.1586/14760584.7.9.1435\")), list(REFERENCE = \"PMID:27231932\", AUTHORS = \"Le Sage V, Cinti A, Amorim R, Mouland AJ\", TITLE = \"Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway.\", JOURNAL = c(\"Viruses 8:E152 (2016)\", \"DOI:10.3390/v8060152\")), list(REFERENCE = \"PMID:30510918\", AUTHORS = \"Fan Y, Sanyal S, Bruzzone R\", TITLE = \"Breaking Bad: How Viruses Subvert the Cell Cycle.\", JOURNAL = c(\"Front Cell Infect Microbiol 8:396 (2018)\", \"DOI:10.3389/fcimb.2018.00396\")), list(REFERENCE = \"PMID:21971186\", AUTHORS = \"Varga ZT, Palese P\", TITLE = \"The influenza A virus protein PB1-F2: killing two birds with one stone?\", JOURNAL = c(\"Virulence 2:542-6 (2011)\", \"DOI:10.4161/viru.2.6.17812\")), list(REFERENCE = \"PMID:30254192\", AUTHORS = \"Atkin-Smith GK, Duan M, Chen W, Poon IKH\", TITLE = \"The induction and consequences of Influenza A virus-induced cell death.\", JOURNAL = c(\"Cell Death Dis 9:1002 (2018)\", \"DOI:10.1038/s41419-018-1035-6\")), list(REFERENCE = \"PMID:30545063\", AUTHORS = \"Nogales A, Martinez-Sobrido L, Topham DJ, DeDiego ML\", TITLE = \"Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.\", JOURNAL = c(\"Viruses 10:E708 (2018)\", \"DOI:10.3390/v10120708\")), list(REFERENCE = \"PMID:21253874\", AUTHORS = \"Dai X, Zhang L, Hong T\", TITLE = \"Host cellular signaling induced by influenza virus.\", JOURNAL = c(\"Sci China Life Sci 54:68-74 (2011)\", \"DOI:10.1007/s11427-010-4116-z\")), list(REFERENCE = \"PMID:26008706\", AUTHORS = \"Li J, Yu M, Zheng W, Liu W\", TITLE = \"Nucleocytoplasmic shuttling of influenza A virus proteins.\", JOURNAL = c(\"Viruses 7:2668-82 (2015)\", \"DOI:10.3390/v7052668\")), list(REFERENCE = \"PMID:30079062\", AUTHORS = \"Dou D, Revol R, Ostbye H, Wang H, Daniels R\", TITLE = \"Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement.\", JOURNAL = c(\"Front Immunol 9:1581 (2018)\", \"DOI:10.3389/fimmu.2018.01581\")), list(REFERENCE = \"PMID:23236273\", AUTHORS = \"Paterson D, Fodor E\", TITLE = \"Emerging roles for the influenza A virus nuclear export protein (NEP).\", JOURNAL = c(\"PLoS Pathog 8:e1003019 (2012)\", \"DOI:10.1371/journal.ppat.1003019\"))', 'map05164', 'Influenza A', 89, 0, 89, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (418, '05165', 'Human papillomavirus infection', 'Human papillomavirus (HPV) is a non-enveloped, double-stranded DNA virus. HPV infect mucoal and cutaneous epithelium resulting in several types of pathologies, most notably, cervical cancer. All types of HPV share a common genomic structure and encode eight proteins: E1, E2, E4, E5, E6, and E7 (early) and L1 and L2 (late). It has been demonstrated that E1 and E2 are involved in viral transcription and replication. The functions of the E4 protein is not yet fully understood. E5, E6, and E7 act as oncoproteins. E5 inhibits the V-ATPase, prolonging EGFR signaling and thereby promoting cell proliferation. The expression of E6 and E7 not only inhibits the tumor suppressors p53 and Rb, but also alters additional signalling pathways. Among these pathways, PI3K/Akt signalling cascade plays a very important role in HPV-induced carcinogenesis. The L1 and L2 proteins form icosahedral capsids for progeny virion generation.', 'Human Diseases; Infectious disease: viral', 'Human papillomavirus infection', 'Cervical cancer', 'ko05165', 'list(REFERENCE = \"PMID:20592731\", AUTHORS = \"Moody CA, Laimins LA\", TITLE = \"Human papillomavirus oncoproteins: pathways to transformation.\", JOURNAL = c(\"Nat Rev Cancer 10:550-60 (2010)\", \"DOI:10.1038/nrc2886\")), list(REFERENCE = \"PMID:25752815\", AUTHORS = \"Chen J\", TITLE = \"Signaling pathways in HPV-associated cancers and therapeutic implications.\", JOURNAL = c(\"Rev Med Virol 25 Suppl 1:24-53 (2015)\", \"DOI:10.1002/rmv.1823\")), list(REFERENCE = \"PMID:26008697\", AUTHORS = \"Tummers B, Burg SH\", TITLE = \"High-risk human papillomavirus targets crossroads in immune signaling.\", JOURNAL = c(\"Viruses 7:2485-506 (2015)\", \"DOI:10.3390/v7052485\")), list(REFERENCE = \"PMID:19684440\", AUTHORS = \"Lehoux M, D\'Abramo CM, Archambault J\", TITLE = \"Molecular mechanisms of human papillomavirus-induced carcinogenesis.\", JOURNAL = c(\"Public Health Genomics 12:268-80 (2009)\", \"DOI:10.1159/000214918\")), list(REFERENCE = \"PMID:23164805\", AUTHORS = \"Pang CL, Thierry F\", TITLE = \"Human papillomavirus proteins as prospective therapeutic targets.\", JOURNAL = c(\"Microb Pathog 58:55-65 (2013)\", \"DOI:10.1016/j.micpath.2012.11.002\")), list(REFERENCE = \"PMID:19156753\", AUTHORS = \"Yugawa T, Kiyono T\", TITLE = \"Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.\", JOURNAL = c(\"Rev Med Virol 19:97-113 (2009)\", \"DOI:10.1002/rmv.605\")), list(REFERENCE = \"PMID:17645777\", AUTHORS = \"Narisawa-Saito M, Kiyono T\", TITLE = \"Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.\", JOURNAL = c(\"Cancer Sci 98:1505-11 (2007)\", \"DOI:10.1111/j.1349-7006.2007.00546.x\")), list(REFERENCE = \"PMID:11486705\", AUTHORS = \"Wolf JK, Ramirez PT.\", TITLE = \"The molecular biology of cervical cancer.\", JOURNAL = c(\"Cancer Invest 19:621-9 (2001)\", \"DOI:10.1081/CNV-100104290\")), list(REFERENCE = \"PMID:10793105\", AUTHORS = \"zur Hausen H\", TITLE = \"Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.\", JOURNAL = c(\"J Natl Cancer Inst 92:690-8 (2000)\", \"DOI:10.1093/jnci/92.9.690\")), list(REFERENCE = \"PMID:16259056\", AUTHORS = \"Kim YT, Zhao M\", TITLE = \"Aberrant cell cycle regulation in cervical carcinoma.\", JOURNAL = c(\"Yonsei Med J 46:597-613 (2005)\", \"DOI:10.3349/ymj.2005.46.5.597\")), list(REFERENCE = \"PMID:15956361\", AUTHORS = \"McCance DJ\", TITLE = \"Human papillomaviruses and cell signaling.\", JOURNAL = c(\"Sci STKE 2005:pe29 (2005)\", \"DOI:10.1126/stke.2882005pe29\")), list(REFERENCE = \"PMID:15342967\", AUTHORS = \"Motoyama S, Ladines-Llave CA, Luis Villanueva S, Maruo T\", TITLE = \"The role of human papilloma virus in the molecular biology of cervical carcinogenesis.\", JOURNAL = \"Kobe J Med Sci 50:9-19 (2004)\"), list(REFERENCE = \"PMID:24316445\", AUTHORS = \"Tommasino M\", TITLE = \"The human papillomavirus family and its role in carcinogenesis.\", JOURNAL = c(\"Semin Cancer Biol 26:13-21 (2014)\", \"DOI:10.1016/j.semcancer.2013.11.002\")), list(REFERENCE = \"PMID:26295406\", AUTHORS = \"Bello JO, Nieva LO, Paredes AC, Gonzalez AM, Zavaleta LR, Lizano M\", TITLE = \"Regulation of the Wnt/beta-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins.\", JOURNAL = c(\"Viruses 7:4734-55 (2015)\", \"DOI:10.3390/v7082842\")), list(REFERENCE = \"PMID:26289783\", AUTHORS = \"Shah M, Anwar MA, Park S, Jafri SS, Choi S\", TITLE = \"In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response.\", JOURNAL = c(\"Sci Rep 5:13446 (2015)\", \"DOI:10.1038/srep13446\")), list(REFERENCE = \"PMID:26797638\", AUTHORS = \"James CD, Roberts S\", TITLE = \"Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?\", JOURNAL = c(\"Pathogens 5:E8 (2016)\", \"DOI:10.3390/pathogens5010008\")), list(REFERENCE = \"PMID:26147797\", AUTHORS = \"Ganti K, Broniarczyk J, Manoubi W, Massimi P, Mittal S, Pim D, Szalmas A, Thatte J, Thomas M, Tomaic V, Banks L\", TITLE = \"The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.\", JOURNAL = c(\"Viruses 7:3530-51 (2015)\", \"DOI:10.3390/v7072785\")), list(REFERENCE = \"PMID:21954943\", AUTHORS = \"Subbaiah VK, Kranjec C, Thomas M, Banks L\", TITLE = \"PDZ domains: the building blocks regulating tumorigenesis.\", JOURNAL = c(\"Biochem J 439:195-205 (2011)\", \"DOI:10.1042/BJ20110903\")), list(REFERENCE = \"PMID:23175122\", AUTHORS = \"Banks L, Pim D, Thomas M\", TITLE = \"Human tumour viruses and the deregulation of cell polarity in cancer.\", JOURNAL = c(\"Nat Rev Cancer 12:877-86 (2012)\", \"DOI:10.1038/nrc3400\")), list(REFERENCE = \"PMID:19029942\", AUTHORS = \"Thomas M, Narayan N, Pim D, Tomaic V, Massimi P, Nagasaka K, Kranjec C, Gammoh N, Banks L\", TITLE = \"Human papillomaviruses, cervical cancer and cell polarity.\", JOURNAL = c(\"Oncogene 27:7018-30 (2008)\", \"DOI:10.1038/onc.2008.351\")), list(REFERENCE = \"PMID:19901438\", AUTHORS = \"Jayshree RS, Sreenivas A, Tessy M, Krishna S\", TITLE = \"Cell intrinsic &amp; extrinsic factors in cervical carcinogenesis.\", JOURNAL = \"Indian J Med Res 130:286-95 (2009)\"), list(REFERENCE = \"PMID:16862386\", AUTHORS = \"Garnett TO, Duerksen-Hughes PJ\", TITLE = \"Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.\", JOURNAL = c(\"Arch Virol 151:2321-35 (2006)\", \"DOI:10.1007/s00705-006-0821-0\")), list(REFERENCE = \"PMID:26022660\", AUTHORS = \"Zhang L, Wu J, Ling MT, Zhao L, Zhao KN\", TITLE = \"The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.\", JOURNAL = c(\"Mol Cancer 14:87 (2015)\", \"DOI:10.1186/s12943-015-0361-x\")), list(REFERENCE = \"PMID:22078316\", AUTHORS = \"Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo MS, Borzacchiello G\", TITLE = \"Papillomavirus E5: the smallest oncoprotein with many functions.\", JOURNAL = c(\"Mol Cancer 10:140 (2011)\", \"DOI:10.1186/1476-4598-10-140\")), list(REFERENCE = \"PMID:11753669\", AUTHORS = \"DiMaio D, Mattoon D\", TITLE = \"Mechanisms of cell transformation by papillomavirus E5 proteins.\", JOURNAL = c(\"Oncogene 20:7866-73 (2001)\", \"DOI:10.1038/sj.onc.1204915\")), list(REFERENCE = \"PMID:22262402\", AUTHORS = \"Ganguly N\", TITLE = \"Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.\", JOURNAL = c(\"Cell Oncol (Dordr) 35:67-76 (2012)\", \"DOI:10.1007/s13402-011-0069-x\")), list(REFERENCE = \"PMID:23731971\", AUTHORS = \"DiMaio D, Petti LM\", TITLE = \"The E5 proteins.\", JOURNAL = c(\"Virology 445:99-114 (2013)\", \"DOI:10.1016/j.virol.2013.05.006\")), list(REFERENCE = \"PMID:23403708\", AUTHORS = \"De Marco F\", TITLE = \"Oxidative stress and HPV carcinogenesis.\", JOURNAL = c(\"Viruses 5:708-31 (2013)\", \"DOI:10.3390/v5020708\")), list(REFERENCE = \"PMID:26643553\", AUTHORS = \"Wieringa HW, van der Zee AG, de Vries EG, van Vugt MA\", TITLE = \"Breaking the DNA damage response to improve cervical cancer treatment.\", JOURNAL = c(\"Cancer Treat Rev 42:30-40 (2016)\", \"DOI:10.1016/j.ctrv.2015.11.008\")), list(REFERENCE = \"PMID:19861444\", AUTHORS = \"Chung CH, Gillison ML\", TITLE = \"Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.\", JOURNAL = c(\"Clin Cancer Res 15:6758-62 (2009)\", \"DOI:10.1158/1078-0432.CCR-09-0784\")), list(REFERENCE = \"PMID:11325599\", AUTHORS = \"Koromilas AE, Li S, Matlashewski G\", TITLE = \"Control of interferon signaling in human papillomavirus infection.\", JOURNAL = c(\"Cytokine Growth Factor Rev 12:157-70 (2001)\", \"DOI:10.1016/S1359-6101(00)00023-X\")), list(REFERENCE = \"PMID:10702232\", AUTHORS = \"Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ\", TITLE = \"Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis.\", JOURNAL = c(\"J Biol Chem 275:6764-9 (2000)\", \"DOI:10.1074/jbc.275.10.6764\")), list(REFERENCE = \"PMID:22499770\", AUTHORS = \"Sandberg A, Lindell G, Kallstrom BN, Branca RM, Danielsson KG, Dahlberg M, Larson B, Forshed J, Lehtio J\", TITLE = \"Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.\", JOURNAL = c(\"Mol Cell Proteomics 11:M112.016998 (2012)\", \"DOI:10.1074/mcp.M112.016998\")), list(REFERENCE = \"PMID:9990017\", AUTHORS = \"Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P\", TITLE = \"Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 96:1291-6 (1999)\", \"DOI:10.1073/pnas.96.4.1291\")), list(REFERENCE = \"PMID:15175323\", AUTHORS = \"Lu Z, Hu X, Li Y, Zheng L, Zhou Y, Jiang H, Ning T, Basang Z, Zhang C, Ke Y\", TITLE = \"Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin.\", JOURNAL = c(\"J Biol Chem 279:35664-70 (2004)\", \"DOI:10.1074/jbc.M403385200\")), list(REFERENCE = \"PMID:18505829\", AUTHORS = \"Xu M, Luo W, Elzi DJ, Grandori C, Galloway DA\", TITLE = \"NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes.\", JOURNAL = c(\"Mol Cell Biol 28:4819-28 (2008)\", \"DOI:10.1128/MCB.01969-07\")), list(REFERENCE = \"PMID:23536685\", AUTHORS = \"Raff AB, Woodham AW, Raff LM, Skeate JG, Yan L, Da Silva DM, Schelhaas M, Kast WM\", TITLE = \"The evolving field of human papillomavirus receptor research: a review of binding and entry.\", JOURNAL = c(\"J Virol 87:6062-72 (2013)\", \"DOI:10.1128/JVI.00330-13\"))', 'map05165', 'Human papillomavirus infection', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (419, '05166', 'Human T-cell leukemia virus 1 infection', 'Human T-cell leukemia virus type 1 (HTLV-1) is a pathogenic retrovirus that is associated with adult T-cell leukemia/lymphoma (ATL). It is also strongly implicated in non-neoplastic chronic inflammatory diseases such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Expression of Tax, a viral regulatory protein is critical to the pathogenesis. Tax is a transcriptional co-factor that interfere several signaling pathways related to anti-apoptosis or cell proliferation. The modulation of the signaling by Tax involve its binding to transcription factors like CREB/ATF, NF-kappa B, and SRF.', 'Human Diseases; Infectious disease: viral', 'Human T-cell leukemia virus 1 infection', 'Adult T-cell leukemia, HTLV1-associated myelopathy', 'ko05166', 'list(REFERENCE = \"PMID:17384582\", AUTHORS = \"Matsuoka M, Jeang KT\", TITLE = \"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.\", JOURNAL = c(\"Nat Rev Cancer 7:270-80 (2007)\", \"DOI:10.1038/nrc2111\")), list(REFERENCE = \"PMID:16155604\", AUTHORS = \"Grassmann R, Aboud M, Jeang KT\", TITLE = \"Molecular mechanisms of cellular transformation by HTLV-1 Tax.\", JOURNAL = c(\"Oncogene 24:5976-85 (2005)\", \"DOI:10.1038/sj.onc.1208978\")), list(REFERENCE = \"PMID:18702816\", AUTHORS = \"Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L\", TITLE = \"The HTLV-1 Tax interactome.\", JOURNAL = c(\"Retrovirology 5:76 (2008)\", \"DOI:10.1186/1742-4690-5-76\")), list(REFERENCE = \"PMID:21994754\", AUTHORS = \"Jones KS, Lambert S, Bouttier M, Benit L, Ruscetti FW, Hermine O, Pique C\", TITLE = \"Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.\", JOURNAL = c(\"Viruses 3:794-810 (2011)\", \"DOI:10.3390/v3060794\")), list(REFERENCE = \"PMID:21114861\", AUTHORS = \"Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O\", TITLE = \"Current concepts regarding the HTLV-1 receptor complex.\", JOURNAL = c(\"Retrovirology 7:99 (2010)\", \"DOI:10.1186/1742-4690-7-99\")), list(REFERENCE = \"\", AUTHORS = \"Sinet F.\", TITLE = \"Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: a number of proteins play a key role in the establishment and maintenance of viral infection.\", JOURNAL = \"BioSciences Master Reviews, July 2013\"), list(REFERENCE = \"PMID:18923409\", AUTHORS = \"Sattentau Q\", TITLE = \"Avoiding the void: cell-to-cell spread of human viruses.\", JOURNAL = c(\"Nat Rev Microbiol 6:815-26 (2008)\", \"DOI:10.1038/nrmicro1972\")), list(REFERENCE = \"PMID:15040584\", AUTHORS = \"Vicente-Manzanares M, Sanchez-Madrid F\", TITLE = \"Role of the cytoskeleton during leukocyte responses.\", JOURNAL = c(\"Nat Rev Immunol 4:110-22 (2004)\", \"DOI:10.1038/nri1268\")), list(REFERENCE = \"PMID:27334587\", AUTHORS = \"Dutartre H, Claviere M, Journo C, Mahieux R\", TITLE = \"Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication.\", JOURNAL = c(\"J Virol 90:7607-17 (2016)\", \"DOI:10.1128/JVI.00407-16\")), list(REFERENCE = \"PMID:15988028\", AUTHORS = \"Awasthi S, Sharma A, Wong K, Zhang J, Matlock EF, Rogers L, Motloch P, Takemoto S, Taguchi H, Cole MD, Luscher B, Dittrich O, Tagami H, Nakatani Y, McGee M, Girard AM, Gaughan L, Robson CN, Monnat RJ Jr, Harrod R\", TITLE = \"A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions.\", JOURNAL = c(\"Mol Cell Biol 25:6178-98 (2005)\", \"DOI:10.1128/MCB.25.14.6178-6198.2005\")), list(REFERENCE = \"PMID:21994758\", AUTHORS = \"Edwards D, Fenizia C, Gold H, de Castro-Amarante MF, Buchmann C, Pise-Masison CA, Franchini G\", TITLE = \"Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.\", JOURNAL = c(\"Viruses 3:861-85 (2011)\", \"DOI:10.3390/v3060861\")), list(REFERENCE = \"PMID:26927155\", AUTHORS = \"Nakano K, Watanabe T\", TITLE = \"HTLV-1 Rex Tunes the Cellular Environment Favorable for Viral Replication.\", JOURNAL = c(\"Viruses 8:58 (2016)\", \"DOI:10.3390/v8030058\")), list(REFERENCE = \"PMID:22783232\", AUTHORS = \"Shida H\", TITLE = \"Role of Nucleocytoplasmic RNA Transport during the Life Cycle of Retroviruses.\", JOURNAL = c(\"Front Microbiol 3:179 (2012)\", \"DOI:10.3389/fmicb.2012.00179\")), list(REFERENCE = \"PMID:23248621\", AUTHORS = \"Bai XT, Nicot C\", TITLE = \"Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis.\", JOURNAL = c(\"Front Microbiol 3:400 (2012)\", \"DOI:10.3389/fmicb.2012.00400\")), list(REFERENCE = \"PMID:18421579\", AUTHORS = \"Taylor JM, Nicot C\", TITLE = \"HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.\", JOURNAL = c(\"Apoptosis 13:733-47 (2008)\", \"DOI:10.1007/s10495-008-0208-7\")), list(REFERENCE = \"PMID:15761473\", AUTHORS = \"D\'Agostino DM, Silic-Benussi M, Hiraragi H, Lairmore MD, Ciminale V\", TITLE = \"The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.\", JOURNAL = c(\"Cell Death Differ 12 Suppl 1:905-15 (2005)\", \"DOI:10.1038/sj.cdd.4401576\")), list(REFERENCE = \"PMID:20332002\", AUTHORS = \"Silic-Benussi M, Biasiotto R, Andresen V, Franchini G, D\'Agostino DM, Ciminale V\", TITLE = \"HTLV-1 p13, a small protein with a busy agenda.\", JOURNAL = c(\"Mol Aspects Med 31:350-8 (2010)\", \"DOI:10.1016/j.mam.2010.03.001\")), list(REFERENCE = \"PMID:23741982\", AUTHORS = \"Fuentes-Gonzalez AM, Contreras-Paredes A, Manzo-Merino J, Lizano M\", TITLE = \"The modulation of apoptosis by oncogenic viruses.\", JOURNAL = c(\"Virol J 10:182 (2013)\", \"DOI:10.1186/1743-422X-10-182\")), list(REFERENCE = \"PMID:21743832\", AUTHORS = \"Qu Z, Xiao G\", TITLE = \"Human T-cell lymphotropic virus: a model of NF-kappaB-associated tumorigenesis.\", JOURNAL = c(\"Viruses 3:714-49 (2011)\", \"DOI:10.3390/v3060714\")), list(REFERENCE = \"PMID:21994767\", AUTHORS = \"Saggioro D\", TITLE = \"Anti-apoptotic effect of Tax: an NF-kappaB path or a CREB way?\", JOURNAL = c(\"Viruses 3:1001-14 (2011)\", \"DOI:10.3390/v3071001\")), list(REFERENCE = \"PMID:16036567\", AUTHORS = \"Harhaj EW, Harhaj NS\", TITLE = \"Mechanisms of persistent NF-kappaB activation by HTLV-I tax.\", JOURNAL = c(\"IUBMB Life 57:83-91 (2005)\", \"DOI:10.1080/15216540500078715\")), list(REFERENCE = \"PMID:16155602\", AUTHORS = \"Sun SC, Yamaoka S\", TITLE = \"Activation of NF-kappaB by HTLV-I and implications for cell transformation.\", JOURNAL = c(\"Oncogene 24:5952-64 (2005)\", \"DOI:10.1038/sj.onc.1208969\")), list(REFERENCE = \"PMID:9710600\", AUTHORS = \"Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham ET Jr, Grant M, Connelly MA, Hambor JE, Marcu KB, Greene WC\", TITLE = \"Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases.\", JOURNAL = c(\"Mol Cell Biol 18:5157-65 (1998)\", \"DOI:10.1128/MCB.18.9.5157\")), list(REFERENCE = \"PMID:21315773\", AUTHORS = \"Nakachi S, Nakazato T, Ishikawa C, Kimura R, Mann DA, Senba M, Masuzaki H, Mori N\", TITLE = \"Human T-cell leukemia virus type 1 tax transactivates the matrix metalloproteinase 7 gene via JunD/AP-1 signaling.\", JOURNAL = c(\"Biochim Biophys Acta 1813:731-41 (2011)\", \"DOI:10.1016/j.bbamcr.2011.02.002\")), list(REFERENCE = \"PMID:26797638\", AUTHORS = \"James CD, Roberts S\", TITLE = \"Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?\", JOURNAL = c(\"Pathogens 5:E8 (2016)\", \"DOI:10.3390/pathogens5010008\")), list(REFERENCE = \"PMID:26324707\", AUTHORS = \"Cherian MA, Baydoun HH, Al-Saleem J, Shkriabai N, Kvaratskhelia M, Green P, Ratner L\", TITLE = \"Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein.\", JOURNAL = c(\"J Biol Chem 290:26270-81 (2015)\", \"DOI:10.1074/jbc.M115.684746\")), list(REFERENCE = \"PMID:11264182\", AUTHORS = \"Mori N, Morishita M, Tsukazaki T, Giam CZ, Kumatori A, Tanaka Y, Yamamoto N\", TITLE = \"Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.\", JOURNAL = \"Blood 97:2137-44 (2001)\"), list(REFERENCE = \"PMID:15310405\", AUTHORS = \"Azran I, Schavinsky-Khrapunsky Y, Aboud M\", TITLE = \"Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity.\", JOURNAL = c(\"Retrovirology 1:20 (2004)\", \"DOI:10.1186/1742-4690-1-20\")), list(REFERENCE = \"PMID:11244044\", AUTHORS = \"Yoshida M\", TITLE = \"Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.\", JOURNAL = c(\"Annu Rev Immunol 19:475-96 (2001)\", \"DOI:10.1146/annurev.immunol.19.1.475\")), list(REFERENCE = \"PMID:12802280\", AUTHORS = \"Gabet AS, Mortreux F, Charneau P, Riou P, Duc-Dodon M, Wu Y, Jeang KT, Wattel E\", TITLE = \"Inactivation of hTERT transcription by Tax.\", JOURNAL = c(\"Oncogene 22:3734-41 (2003)\", \"DOI:10.1038/sj.onc.1206468\"))', 'map05166', 'Human T-cell leukemia virus 1 infection', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (420, '05167', 'Kaposi sarcoma-associated herpesvirus infection', 'Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is the most recently identified human tumor virus, and is associated with the pathogenesis of Kaposi\'s sarcoma (KS), primary effusion lymphoma (PEL), and Multicentric Castleman\'s disease (MCD). Like all other herpesviruses, KSHV displays two modes of life cycle, latency and lytic replication, which are characterized by the patterns of viral gene expression. Genes expressed in latency (LANA, v-cyclin, v-FLIP, Kaposins A, B and C and viral miRNAs) are mainly thought to facilitate the establishment of life long latency in its host and survival against the host innate, and adaptive immune surveillance mechanisms. Among the viral proteins shown to be expressed during lytic replication are potent signaling molecules such as vGPCR, vIL6, vIRFs, vCCLs, K1 and K15, which have been implicated experimentally in the angiogenic and inflammatory phenotype observed in KS lesions. Several of these latent viral and lytic proteins are known to transform host cells, linking KSHV with the development of severe human malignancies.', 'Human Diseases; Infectious disease: viral', 'Kaposi sarcoma-associated herpesvirus infection', 'Kaposi sarcoma', 'ko05167', 'list(REFERENCE = \"PMID:22403573\", AUTHORS = \"Lee HR, Brulois K, Wong L, Jung JU\", TITLE = \"Modulation of Immune System by Kaposi\'s Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies.\", JOURNAL = c(\"Front Microbiol 3:44 (2012)\", \"DOI:10.3389/fmicb.2012.00044\")), list(REFERENCE = \"PMID:18948197\", AUTHORS = \"Liang C, Lee JS, Jung JU\", TITLE = \"Immune evasion in Kaposi\'s sarcoma-associated herpes virus associated oncogenesis.\", JOURNAL = c(\"Semin Cancer Biol 18:423-36 (2008)\", \"DOI:10.1016/j.semcancer.2008.09.003\")), list(REFERENCE = \"PMID:21040832\", AUTHORS = \"Cai Q, Verma SC, Lu J, Robertson ES\", TITLE = \"Molecular biology of Kaposi\'s sarcoma-associated herpesvirus and related oncogenesis.\", JOURNAL = c(\"Adv Virus Res 78:87-142 (2010)\", \"DOI:10.1016/B978-0-12-385032-4.00003-3\")), list(REFERENCE = \"PMID:16760382\", AUTHORS = \"Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ\", TITLE = \"Kaposi\'s sarcoma-associated herpesvirus immune modulation: an overview.\", JOURNAL = c(\"J Gen Virol 87:1781-804 (2006)\", \"DOI:10.1099/vir.0.81919-0\")), list(REFERENCE = \"PMID:19230674\", AUTHORS = \"Areste C, Blackbourn DJ\", TITLE = \"Modulation of the immune system by Kaposi\'s sarcoma-associated herpesvirus.\", JOURNAL = c(\"Trends Microbiol 17:119-29 (2009)\", \"DOI:10.1016/j.tim.2008.12.001\")), list(REFERENCE = \"PMID:16905191\", AUTHORS = \"Mark L, Spiller OB, Villoutreix BO, Blom AM\", TITLE = \"Kaposi\'s sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and more.\", JOURNAL = c(\"Mol Immunol 44:11-22 (2007)\", \"DOI:10.1016/j.molimm.2006.06.018\")), list(REFERENCE = \"PMID:11500830\", AUTHORS = \"Weber KS, Grone HJ, Rocken M, Klier C, Gu S, Wank R, Proudfoot AE, Nelson PJ, Weber C\", TITLE = \"Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II.\", JOURNAL = c(\"Eur J Immunol 31:2458-66 (2001)\", \"DOI:10.1002/1521-4141(200108)31:8<2458::AID-IMMU2458>3.0.CO;2-L\")), list(REFERENCE = \"PMID:10666184\", AUTHORS = \"Stine JT, Wood C, Hill M, Epp A, Raport CJ, Schweickart VL, Endo Y, Sasaki T, Simmons G, Boshoff C, Clapham P, Chang Y, Moore P, Gray PW, Chantry D\", TITLE = \"KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells.\", JOURNAL = \"Blood 95:1151-7 (2000)\"), list(REFERENCE = \"PMID:26431609\", AUTHORS = \"Schulz TF, Cesarman E\", TITLE = \"Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.\", JOURNAL = c(\"Curr Opin Virol 14:116-28 (2015)\", \"DOI:10.1016/j.coviro.2015.08.016\")), list(REFERENCE = \"PMID:10377196\", AUTHORS = \"Endres MJ, Garlisi CG, Xiao H, Shan L, Hedrick JA\", TITLE = \"The Kaposi\'s sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8.\", JOURNAL = c(\"J Exp Med 189:1993-8 (1999)\", \"DOI:10.1084/jem.189.12.1993\")), list(REFERENCE = \"PMID:18434408\", AUTHORS = \"Choi YB, Nicholas J\", TITLE = \"Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines.\", JOURNAL = c(\"J Virol 82:6501-13 (2008)\", \"DOI:10.1128/JVI.02396-07\")), list(REFERENCE = \"PMID:15692053\", AUTHORS = \"McCormick C, Ganem D\", TITLE = \"The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.\", JOURNAL = c(\"Science 307:739-41 (2005)\", \"DOI:10.1126/science.1105779\")), list(REFERENCE = \"PMID:15967719\", AUTHORS = \"Wang HW, Boshoff C\", TITLE = \"Linking Kaposi virus to cancer-associated cytokines.\", JOURNAL = c(\"Trends Mol Med 11:309-12 (2005)\", \"DOI:10.1016/j.molmed.2005.06.002\")), list(REFERENCE = \"PMID:16828973\", AUTHORS = \"Jarviluoma A, Ojala PM\", TITLE = \"Cell signaling pathways engaged by KSHV.\", JOURNAL = c(\"Biochim Biophys Acta 1766:140-58 (2006)\", \"DOI:10.1016/j.bbcan.2006.05.001\")), list(REFERENCE = \"PMID:12032073\", AUTHORS = \"Wang HW, Sharp TV, Koumi A, Koentges G, Boshoff C\", TITLE = \"Characterization of an anti-apoptotic glycoprotein encoded by Kaposi\'s sarcoma-associated herpesvirus which resembles a spliced variant of human survivin.\", JOURNAL = c(\"EMBO J 21:2602-15 (2002)\", \"DOI:10.1093/emboj/21.11.2602\")), list(REFERENCE = \"PMID:10510092\", AUTHORS = \"Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A\", TITLE = \"The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.\", JOURNAL = c(\"J Exp Med 190:1025-32 (1999)\", \"DOI:10.1084/jem.190.7.1025\")), list(REFERENCE = \"PMID:10523854\", AUTHORS = \"Chaudhary PM, Jasmin A, Eby MT, Hood L\", TITLE = \"Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins.\", JOURNAL = c(\"Oncogene 18:5738-46 (1999)\", \"DOI:10.1038/sj.onc.1202976\")), list(REFERENCE = \"PMID:12890756\", AUTHORS = \"Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C, Collins M\", TITLE = \"KSHV vFLIP binds to IKK-gamma to activate IKK.\", JOURNAL = c(\"J Cell Sci 116:3721-8 (2003)\", \"DOI:10.1242/jcs.00691\")), list(REFERENCE = \"PMID:20865011\", AUTHORS = \"Mesri EA, Cesarman E, Boshoff C\", TITLE = \"Kaposi\'s sarcoma and its associated herpesvirus.\", JOURNAL = c(\"Nat Rev Cancer 10:707-19 (2010)\", \"DOI:10.1038/nrc2888\")), list(REFERENCE = \"PMID:10799607\", AUTHORS = \"Ishido S, Wang C, Lee BS, Cohen GB, Jung JU\", TITLE = \"Downregulation of major histocompatibility complex class I molecules by Kaposi\'s sarcoma-associated herpesvirus K3 and K5 proteins.\", JOURNAL = c(\"J Virol 74:5300-9 (2000)\", \"DOI:10.1128/JVI.74.11.5300-5309.2000\")), list(REFERENCE = \"PMID:17166914\", AUTHORS = \"Li Q, Means R, Lang S, Jung JU\", TITLE = \"Downregulation of gamma interferon receptor 1 by Kaposi\'s sarcoma-associated herpesvirus K3 and K5.\", JOURNAL = c(\"J Virol 81:2117-27 (2007)\", \"DOI:10.1128/JVI.01961-06\")), list(REFERENCE = \"PMID:18230726\", AUTHORS = \"Thomas M, Boname JM, Field S, Nejentsev S, Salio M, Cerundolo V, Wills M, Lehner PJ\", TITLE = \"Down-regulation of NKG2D and NKp80 ligands by Kaposi\'s sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:1656-61 (2008)\", \"DOI:10.1073/pnas.0707883105\")), list(REFERENCE = \"PMID:11413168\", AUTHORS = \"Coscoy L, Ganem D\", TITLE = \"A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.\", JOURNAL = c(\"J Clin Invest 107:1599-606 (2001)\", \"DOI:10.1172/JCI12432\")), list(REFERENCE = \"PMID:24710493\", AUTHORS = \"Pratt ZL, Sugden B\", TITLE = \"How human tumor viruses make use of autophagy.\", JOURNAL = c(\"Cells 1:617-30 (2012)\", \"DOI:10.3390/cells1030617\")), list(REFERENCE = \"PMID:10354594\", AUTHORS = \"Schulz TF, Moore PS\", TITLE = \"Kaposi\'s sarcoma-associated herpesvirus: a new human tumor virus, but how?\", JOURNAL = c(\"Trends Microbiol 7:196-200 (1999)\", \"DOI:10.1016/S0966-842X(99)01495-X\")), list(REFERENCE = \"PMID:9594662\", AUTHORS = \"Moore PS, Chang Y\", TITLE = \"Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV.\", JOURNAL = c(\"Trends Genet 14:144-50 (1998)\", \"DOI:10.1016/S0168-9525(98)01408-5\")), list(REFERENCE = \"PMID:12770701\", AUTHORS = \"Verma SC, Robertson ES\", TITLE = \"Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.\", JOURNAL = c(\"FEMS Microbiol Lett 222:155-63 (2003)\", \"DOI:10.1016/S0378-1097(03)00261-1\")), list(REFERENCE = \"PMID:11960692\", AUTHORS = \"Jenner RG, Boshoff C\", TITLE = \"The molecular pathology of Kaposi\'s sarcoma-associated herpesvirus.\", JOURNAL = c(\"Biochim Biophys Acta 1602:1-22 (2002)\", \"DOI:10.1016/S0304-419X(01)00040-3\")), list(REFERENCE = \"PMID:15220441\", AUTHORS = \"Foster-Cuevas M, Wright GJ, Puklavec MJ, Brown MH, Barclay AN\", TITLE = \"Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor.\", JOURNAL = c(\"J Virol 78:7667-76 (2004)\", \"DOI:10.1128/JVI.78.14.7667-7676.2004\")), list(REFERENCE = \"PMID:10987301\", AUTHORS = \"Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, Gutkind JS\", TITLE = \"The Kaposi\'s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.\", JOURNAL = \"Cancer Res 60:4873-80 (2000)\"), list(REFERENCE = \"PMID:27518127\", AUTHORS = \"Abere B, Schulz TF\", TITLE = \"KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi\'s sarcoma.\", JOURNAL = c(\"Curr Opin Virol 20:11-19 (2016)\", \"DOI:10.1016/j.coviro.2016.07.008\")), list(REFERENCE = \"PMID:15573137\", AUTHORS = \"Sodhi A, Montaner S, Gutkind JS\", TITLE = \"Viral hijacking of G-protein-coupled-receptor signalling networks.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 5:998-1012 (2004)\", \"DOI:10.1038/nrm1529\")), list(REFERENCE = \"PMID:17329974\", AUTHORS = \"Montaner S\", TITLE = \"Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi\'s sarcoma.\", JOURNAL = c(\"Cell Cycle 6:438-43 (2007)\", \"DOI:10.4161/cc.6.4.3843\")), list(REFERENCE = \"PMID:23028325\", AUTHORS = \"Bala K, Bosco R, Gramolelli S, Haas DA, Kati S, Pietrek M, Havemeier A, Yakushko Y, Singh VV, Dittrich-Breiholz O, Kracht M, Schulz TF\", TITLE = \"Kaposi\'s sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCgamma1 and activating NFAT1-dependent RCAN1 expression.\", JOURNAL = c(\"PLoS Pathog 8:e1002927 (2012)\", \"DOI:10.1371/journal.ppat.1002927\")), list(REFERENCE = \"PMID:10318948\", AUTHORS = \"Lagunoff M, Majeti R, Weiss A, Ganem D\", TITLE = \"Deregulated signal transduction by the K1 gene product of Kaposi\'s sarcoma-associated herpesvirus.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 96:5704-9 (1999)\", \"DOI:10.1073/pnas.96.10.5704\")), list(REFERENCE = \"PMID:26192396\", AUTHORS = \"Sousa-Squiavinato AC, Silvestre RN, Elgui De Oliveira D\", TITLE = \"Biology and oncogenicity of the Kaposi sarcoma herpesvirus K1 protein.\", JOURNAL = c(\"Rev Med Virol 25:273-85 (2015)\", \"DOI:10.1002/rmv.1843\")), list(REFERENCE = \"PMID:25187543\", AUTHORS = \"Havemeier A, Gramolelli S, Pietrek M, Jochmann R, Sturzl M, Schulz TF\", TITLE = \"Activation of NF-kappaB by the Kaposi\'s sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-kappaB-inducing kinase, IkappaB kinases, and phosphorylation of p65.\", JOURNAL = c(\"J Virol 88:13161-72 (2014)\", \"DOI:10.1128/JVI.01766-14\")), list(REFERENCE = \"PMID:17050609\", AUTHORS = \"Brinkmann MM, Pietrek M, Dittrich-Breiholz O, Kracht M, Schulz TF\", TITLE = \"Modulation of host gene expression by the K15 protein of Kaposi\'s sarcoma-associated herpesvirus.\", JOURNAL = c(\"J Virol 81:42-58 (2007)\", \"DOI:10.1128/JVI.00648-06\")), list(REFERENCE = \"PMID:16585191\", AUTHORS = \"Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B\", TITLE = \"Immortalization of primary endothelial cells by the K1 protein of Kaposi\'s sarcoma-associated herpesvirus.\", JOURNAL = c(\"Cancer Res 66:3658-66 (2006)\", \"DOI:10.1158/0008-5472.CAN-05-3680\")), list(REFERENCE = \"PMID:22521915\", AUTHORS = \"Morris VA, Punjabi AS, Wells RC, Wittkopp CJ, Vart R, Lagunoff M\", TITLE = \"The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation.\", JOURNAL = c(\"Virology 428:112-20 (2012)\", \"DOI:10.1016/j.virol.2012.03.013\")), list(REFERENCE = \"PMID:25594835\", AUTHORS = \"Purushothaman P, Uppal T, Verma SC\", TITLE = \"Molecular biology of KSHV lytic reactivation.\", JOURNAL = c(\"Viruses 7:116-53 (2015)\", \"DOI:10.3390/v7010116\")), list(REFERENCE = \"PMID:14991150\", AUTHORS = \"Fujimuro M, Hayward SD\", TITLE = \"Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers.\", JOURNAL = c(\"J Mol Med (Berl) 82:223-31 (2004)\", \"DOI:10.1007/s00109-003-0519-7\")), list(REFERENCE = \"PMID:26870016\", AUTHORS = \"Purushothaman P, Dabral P, Gupta N, Sarkar R, Verma SC\", TITLE = \"KSHV Genome Replication and Maintenance.\", JOURNAL = c(\"Front Microbiol 7:54 (2016)\", \"DOI:10.3389/fmicb.2016.00054\"))', 'map05167', 'Kaposi sarcoma-associated herpesvirus infection', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (421, '05168', 'Herpes simplex virus 1 infection', 'Herpes simplex virus 1(HSV-1) is a common human pathogen, which initially infects orofacial mucosal surfaces. The virus replicates in epithelial cells at these sites, causing clinically overt disease characterized by vesicular lesions. HSV-1 then penetrates to the nervous system and establishes latency in sensory neurons. Throughout the lifetime of the host, HSV-1 may reactivate from its latent state and reinitiate a lytic infection cycle. HSV-1 has developed various mechanisms to escape its host innate immune responses and increased its capacity to replicate and to persist. ICP34.5, ICP0, ICP27, Us11 and Vhs (UL41) are the proteins involved in viral interference.', 'Human Diseases; Infectious disease: viral', 'Herpes simplex virus 1 infection', 'Herpes simplex virus infection', 'ko05168', 'list(REFERENCE = \"PMID:12787566\", AUTHORS = \"Granger SW, Rickert S\", TITLE = \"LIGHT-HVEM signaling and the regulation of T cell-mediated immunity.\", JOURNAL = c(\"Cytokine Growth Factor Rev 14:289-96 (2003)\", \"DOI:10.1016/S1359-6101(03)00031-5\")), list(REFERENCE = \"PMID:19495760\", AUTHORS = \"Steinberg MW, Shui JW, Ware CF, Kronenberg M\", TITLE = \"Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.\", JOURNAL = c(\"Semin Immunopathol 31:207-21 (2009)\", \"DOI:10.1007/s00281-009-0157-4\")), list(REFERENCE = \"PMID:20221426\", AUTHORS = \"MacLeod IJ, Minson T\", TITLE = \"Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry.\", JOURNAL = c(\"PLoS One 5:e9560 (2010)\", \"DOI:10.1371/journal.pone.0009560\")), list(REFERENCE = \"PMID:23150579\", AUTHORS = \"Gianni T, Leoni V, Chesnokova LS, Hutt-Fletcher LM, Campadelli-Fiume G\", TITLE = \"alphavbeta3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 109:19792-7 (2012)\", \"DOI:10.1073/pnas.1212597109\")), list(REFERENCE = \"PMID:25375272\", AUTHORS = \"Gianni T, Campadelli-Fiume G\", TITLE = \"The epithelial alphavbeta3-integrin boosts the MYD88-dependent TLR2 signaling in response to viral and bacterial components.\", JOURNAL = c(\"PLoS Pathog 10:e1004477 (2014)\", \"DOI:10.1371/journal.ppat.1004477\")), list(REFERENCE = \"PMID:15056211\", AUTHORS = \"Spear PG\", TITLE = \"Herpes simplex virus: receptors and ligands for cell entry.\", JOURNAL = c(\"Cell Microbiol 6:401-10 (2004)\", \"DOI:10.1111/j.1462-5822.2004.00389.x\")), list(REFERENCE = \"PMID:12855695\", AUTHORS = \"Boutell C, Everett RD\", TITLE = \"The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and Ubiquitinates p53.\", JOURNAL = c(\"J Biol Chem 278:36596-602 (2003)\", \"DOI:10.1074/jbc.M300776200\")), list(REFERENCE = \"PMID:24262390\", AUTHORS = \"Ma Y, He B\", TITLE = \"Recognition of herpes simplex viruses: toll-like receptors and beyond.\", JOURNAL = c(\"J Mol Biol 426:1133-47 (2014)\", \"DOI:10.1016/j.jmb.2013.11.012\")), list(REFERENCE = \"PMID:26952111\", AUTHORS = \"Su C, Zhan G, Zheng C\", TITLE = \"Evasion of host antiviral innate immunity by HSV-1, an update.\", JOURNAL = c(\"Virol J 13:38 (2016)\", \"DOI:10.1186/s12985-016-0495-5\")), list(REFERENCE = \"PMID:21994567\", AUTHORS = \"Melchjorsen J, Matikainen S, Paludan SR\", TITLE = \"Activation and evasion of innate antiviral immunity by herpes simplex virus.\", JOURNAL = c(\"Viruses 1:737-59 (2009)\", \"DOI:10.3390/v1030737\")), list(REFERENCE = \"PMID:15276609\", AUTHORS = \"Morrison LA\", TITLE = \"The Toll of herpes simplex virus infection.\", JOURNAL = c(\"Trends Microbiol 12:353-6 (2004)\", \"DOI:10.1016/j.tim.2004.06.001\")), list(REFERENCE = \"PMID:29298887\", AUTHORS = \"Zheng C\", TITLE = \"Evasion of Cytosolic DNA-Stimulated Innate Immune Responses by Herpes Simplex Virus 1.\", JOURNAL = c(\"J Virol 92:e00099-17 (2018)\", \"DOI:10.1128/JVI.00099-17\")), list(REFERENCE = \"PMID:19344302\", AUTHORS = \"Grandi P, Peruzzi P, Reinhart B, Cohen JB, Chiocca EA, Glorioso JC\", TITLE = \"Design and application of oncolytic HSV vectors for glioblastoma therapy.\", JOURNAL = c(\"Expert Rev Neurother 9:505-17 (2009)\", \"DOI:10.1586/ern.09.9\")), list(REFERENCE = \"PMID:23115300\", AUTHORS = \"Lussignol M, Queval C, Bernet-Camard MF, Cotte-Laffitte J, Beau I, Codogno P, Esclatine A\", TITLE = \"The herpes simplex virus 1 Us11 protein inhibits autophagy through its interaction with the protein kinase PKR.\", JOURNAL = c(\"J Virol 87:859-71 (2013)\", \"DOI:10.1128/JVI.01158-12\")), list(REFERENCE = \"PMID:17229694\", AUTHORS = \"Sanchez R, Mohr I\", TITLE = \"Inhibition of cellular 2\'-5\' oligoadenylate synthetase by the herpes simplex virus type 1 Us11 protein.\", JOURNAL = c(\"J Virol 81:3455-64 (2007)\", \"DOI:10.1128/JVI.02520-06\")), list(REFERENCE = \"PMID:12826401\", AUTHORS = \"Wysocka J, Herr W\", TITLE = \"The herpes simplex virus VP16-induced complex: the makings of a regulatory switch.\", JOURNAL = c(\"Trends Biochem Sci 28:294-304 (2003)\", \"DOI:10.1016/S0968-0004(03)00088-4\")), list(REFERENCE = \"PMID:27367734\", AUTHORS = \"Fleming SB\", TITLE = \"Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists.\", JOURNAL = c(\"Vaccines (Basel) 4:E23 (2016)\", \"DOI:10.3390/vaccines4030023\")), list(REFERENCE = \"PMID:15163721\", AUTHORS = \"Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Miura S, Jimbow K, Fujii N\", TITLE = \"Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway.\", JOURNAL = c(\"J Virol 78:6282-6 (2004)\", \"DOI:10.1128/JVI.78.12.6282-6286.2004\")), list(REFERENCE = \"PMID:23864622\", AUTHORS = \"Gu H, Zheng Y, Roizman B\", TITLE = \"Interaction of herpes simplex virus ICP0 with ND10 bodies: a sequential process of adhesion, fusion, and retention.\", JOURNAL = c(\"J Virol 87:10244-54 (2013)\", \"DOI:10.1128/JVI.01487-13\")), list(REFERENCE = \"PMID:21994592\", AUTHORS = \"Tavalai N, Stamminger T\", TITLE = \"Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies.\", JOURNAL = c(\"Viruses 1:1240-64 (2009)\", \"DOI:10.3390/v1031240\")), list(REFERENCE = \"PMID:21146386\", AUTHORS = \"Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ\", TITLE = \"Viral evasion of T cell immunity: ancient mechanisms offering new applications.\", JOURNAL = c(\"Curr Opin Immunol 23:96-103 (2011)\", \"DOI:10.1016/j.coi.2010.11.005\")), list(REFERENCE = \"PMID:12960333\", AUTHORS = \"Neumann J, Eis-Hubinger AM, Koch N\", TITLE = \"Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.\", JOURNAL = c(\"J Immunol 171:3075-83 (2003)\", \"DOI:10.4049/jimmunol.171.6.3075\")), list(REFERENCE = \"PMID:25798530\", AUTHORS = \"Liu X, Cohen JI\", TITLE = \"The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.\", JOURNAL = c(\"Virology 479-480:568-77 (2015)\", \"DOI:10.1016/j.virol.2015.02.040\")), list(REFERENCE = \"PMID:28468873\", AUTHORS = \"Vink EI, Smiley JR, Mohr I\", TITLE = \"Subversion of Host Responses to Energy Insufficiency by Us3 Supports Herpes Simplex Virus 1 Replication during Stress.\", JOURNAL = c(\"J Virol 91:e00295-17 (2017)\", \"DOI:10.1128/JVI.00295-17\")), list(REFERENCE = \"PMID:18508584\", AUTHORS = \"Sandri-Goldin RM\", TITLE = \"The many roles of the regulatory protein ICP27 during herpes simplex virus infection.\", JOURNAL = c(\"Front Biosci 13:5241-56 (2008)\", \"DOI:10.2741/3078\")), list(REFERENCE = \"PMID:15078920\", AUTHORS = \"Sandri-Goldin RM\", TITLE = \"Viral regulation of mRNA export.\", JOURNAL = c(\"J Virol 78:4389-96 (2004)\", \"DOI:10.1128/JVI.78.9.4389-4396.2004\")), list(REFERENCE = \"PMID:27154074\", AUTHORS = \"Yu X, He S\", TITLE = \"The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways.\", JOURNAL = c(\"Virol J 13:77 (2016)\", \"DOI:10.1186/s12985-016-0528-0\"))', 'map05168', 'Herpes simplex virus 1 infection', 145, 0, 145, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (422, '05169', 'Epstein-Barr virus infection', 'Epstein-Barr virus (EBV) is a gamma-herpes virus that widely infects human populations predominantly at an early age but remains mostly asymptomatic. EBV has been linked to a wide spectrum of human malignancies, including nasopharyngeal carcinoma and other hematologic cancers, like Hodgkin\'s lymphoma, Burkitt\'s lymphoma (BL), B-cell immunoblastic lymphoma in HIV patients, and posttransplant-associated lymphoproliferative diseases.  EBV has the unique ability to establish life-long latent infection in primary human B lymphocytes. During latent infection, EBV expresses a small subset of genes, including 6 nuclear antigens (EBNA-1, -2, -3A, -3B, -3C, and -LP), 3 latent membrane proteins (LMP-1, -2A, and -2B), 2 small noncoding RNAs (EBER-1 and 2). On the basis of these latent gene expression, three different latency patterns associated with the types of cancers are recognized.', 'Human Diseases; Infectious disease: viral', 'Epstein-Barr virus infection', 'Hodgkin lymphoma, Burkitt lymphoma, Nasopharyngeal cancer, Infectious mononucleosis', 'ko05169', 'list(REFERENCE = \"PMID:15510157\", AUTHORS = \"Young LS, Rickinson AB.\", TITLE = \"Epstein-Barr virus: 40 years on.\", JOURNAL = c(\"Nat Rev Cancer 4:757-68 (2004)\", \"DOI:10.1038/nrc1452\")), list(REFERENCE = \"PMID:21372216\", AUTHORS = \"Saha A, Robertson ES\", TITLE = \"Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.\", JOURNAL = c(\"Clin Cancer Res 17:3056-63 (2011)\", \"DOI:10.1158/1078-0432.CCR-10-2578\")), list(REFERENCE = \"PMID:21429244\", AUTHORS = \"Ning S\", TITLE = \"Innate immune modulation in EBV infection.\", JOURNAL = c(\"Herpesviridae 2:1 (2011)\", \"DOI:10.1186/2042-4280-2-1\")), list(REFERENCE = \"PMID:28408983\", AUTHORS = \"Stanfield BA, Luftig MA\", TITLE = \"Recent advances in understanding Epstein-Barr virus.\", JOURNAL = c(\"F1000Res 6:386 (2017)\", \"DOI:10.12688/f1000research.10591.1\")), list(REFERENCE = \"PMID:24586164\", AUTHORS = \"van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME\", TITLE = \"Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.\", JOURNAL = c(\"PLoS Pathog 10:e1003960 (2014)\", \"DOI:10.1371/journal.ppat.1003960\")), list(REFERENCE = \"PMID:23850008\", AUTHORS = \"Rajsbaum R, Garcia-Sastre A\", TITLE = \"Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways.\", JOURNAL = c(\"Trends Microbiol 21:421-9 (2013)\", \"DOI:10.1016/j.tim.2013.06.006\")), list(REFERENCE = \"PMID:25704559\", AUTHORS = \"Hoffmann HH, Schneider WM, Rice CM\", TITLE = \"Interferons and viruses: an evolutionary arms race of molecular interactions.\", JOURNAL = c(\"Trends Immunol 36:124-38 (2015)\", \"DOI:10.1016/j.it.2015.01.004\")), list(REFERENCE = \"PMID:22110506\", AUTHORS = \"Spender LC, Inman GJ\", TITLE = \"Inhibition of germinal centre apoptotic programmes by epstein-barr virus.\", JOURNAL = c(\"Adv Hematol 2011:829525 (2011)\", \"DOI:10.1155/2011/829525\")), list(REFERENCE = \"PMID:23303627\", AUTHORS = \"Fu Q, He C, Mao ZR\", TITLE = \"Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.\", JOURNAL = c(\"J Zhejiang Univ Sci B 14:8-24 (2013)\", \"DOI:10.1631/jzus.B1200189\")), list(REFERENCE = \"PMID:29116588\", AUTHORS = \"Wang Y, Banerjee S, Ding L, Cai C, Wei F, Cai Q\", TITLE = \"The regulatory role of protein phosphorylation in human gammaherpesvirus associated cancers.\", JOURNAL = c(\"Virol Sin 32:357-368 (2017)\", \"DOI:10.1007/s12250-017-4081-9\")), list(REFERENCE = \"PMID:23435233\", AUTHORS = \"Melchjorsen J\", TITLE = \"Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.\", JOURNAL = c(\"Viruses 5:470-527 (2013)\", \"DOI:10.3390/v5020470\")), list(REFERENCE = \"PMID:19498380\", AUTHORS = \"Hansen TH, Bouvier M\", TITLE = \"MHC class I antigen presentation: learning from viral evasion strategies.\", JOURNAL = c(\"Nat Rev Immunol 9:503-13 (2009)\", \"DOI:10.1038/nri2575\")), list(REFERENCE = \"PMID:18977445\", AUTHORS = \"Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ\", TITLE = \"Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.\", JOURNAL = c(\"Semin Cancer Biol 18:397-408 (2008)\", \"DOI:10.1016/j.semcancer.2008.10.008\")), list(REFERENCE = \"PMID:21146386\", AUTHORS = \"Horst D, Verweij MC, Davison AJ, Ressing ME, Wiertz EJ\", TITLE = \"Viral evasion of T cell immunity: ancient mechanisms offering new applications.\", JOURNAL = c(\"Curr Opin Immunol 23:96-103 (2011)\", \"DOI:10.1016/j.coi.2010.11.005\")), list(REFERENCE = \"PMID:27886133\", AUTHORS = \"Ghosh Roy S, Robertson ES, Saha A\", TITLE = \"Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis.\", JOURNAL = c(\"Biomolecules 6:E46 (2016)\", \"DOI:10.3390/biom6040046\")), list(REFERENCE = \"PMID:22249143\", AUTHORS = \"Dawson CW, Port RJ, Young LS\", TITLE = \"The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).\", JOURNAL = c(\"Semin Cancer Biol 22:144-53 (2012)\", \"DOI:10.1016/j.semcancer.2012.01.004\")), list(REFERENCE = \"PMID:25613730\", AUTHORS = \"Cai Q, Chen K, Young KH\", TITLE = \"Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.\", JOURNAL = c(\"Exp Mol Med 47:e133 (2015)\", \"DOI:10.1038/emm.2014.105\")), list(REFERENCE = \"PMID:17601372\", AUTHORS = \"Zheng H, Li LL, Hu DS, Deng XY, Cao Y\", TITLE = \"Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.\", JOURNAL = \"Cell Mol Immunol 4:185-96 (2007)\"), list(REFERENCE = \"PMID:23793113\", AUTHORS = \"Ersing I, Bernhardt K, Gewurz BE\", TITLE = \"NF-kappaB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1.\", JOURNAL = c(\"Viruses 5:1587-606 (2013)\", \"DOI:10.3390/v5061587\")), list(REFERENCE = \"PMID:28835489\", AUTHORS = \"Wang LW, Jiang S, Gewurz BE\", TITLE = \"Epstein-Barr Virus LMP1-Mediated Oncogenicity.\", JOURNAL = c(\"J Virol 91:e01718-16 (2017)\", \"DOI:10.1128/JVI.01718-16\")), list(REFERENCE = \"PMID:12740915\", AUTHORS = \"Mori N, Morishita M, Tsukazaki T, Yamamoto N\", TITLE = \"Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.\", JOURNAL = c(\"Int J Cancer 105:661-8 (2003)\", \"DOI:10.1002/ijc.11146\")), list(REFERENCE = \"PMID:25873381\", AUTHORS = \"Edwards RH, Marquitz AR, Raab-Traub N\", TITLE = \"Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.\", JOURNAL = c(\"MBio 6:e00441-15 (2015)\", \"DOI:10.1128/mBio.00441-15\")), list(REFERENCE = \"PMID:11905817\", AUTHORS = \"Thorley-Lawson DA\", TITLE = \"Epstein-Barr virus: exploiting the immune system.\", JOURNAL = c(\"Nat Rev Immunol 1:75-82 (2001)\", \"DOI:10.1038/35095584\")), list(REFERENCE = \"PMID:11669605\", AUTHORS = \"Eliopoulos AG, Young LS\", TITLE = \"LMP1 structure and signal transduction.\", JOURNAL = c(\"Semin Cancer Biol 11:435-44 (2001)\", \"DOI:10.1006/scbi.2001.0410\")), list(REFERENCE = \"PMID:14506283\", AUTHORS = \"Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L\", TITLE = \"Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.\", JOURNAL = c(\"J Biol Chem 278:47753-61 (2003)\", \"DOI:10.1074/jbc.M307200200\")), list(REFERENCE = \"PMID:25403939\", AUTHORS = \"Kang H, Kiess A, Chung CH\", TITLE = \"Emerging biomarkers in head and neck cancer in the era of genomics.\", JOURNAL = c(\"Nat Rev Clin Oncol 12:11-26 (2015)\", \"DOI:10.1038/nrclinonc.2014.192\")), list(REFERENCE = \"PMID:29932446\", AUTHORS = \"Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM\", TITLE = \"Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.\", JOURNAL = c(\"Cancers (Basel) 10:E213 (2018)\", \"DOI:10.3390/cancers10070213\")), list(REFERENCE = \"PMID:19649319\", AUTHORS = \"Sato Y, Kamura T, Shirata N, Murata T, Kudoh A, Iwahori S, Nakayama S, Isomura H, Nishiyama Y, Tsurumi T\", TITLE = \"Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.\", JOURNAL = c(\"PLoS Pathog 5:e1000530 (2009)\", \"DOI:10.1371/journal.ppat.1000530\")), list(REFERENCE = \"PMID:19244339\", AUTHORS = \"Saha A, Murakami M, Kumar P, Bajaj B, Sims K, Robertson ES\", TITLE = \"Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.\", JOURNAL = c(\"J Virol 83:4652-69 (2009)\", \"DOI:10.1128/JVI.02408-08\")), list(REFERENCE = \"PMID:19394062\", AUTHORS = \"Yi F, Saha A, Murakami M, Kumar P, Knight JS, Cai Q, Choudhuri T, Robertson ES\", TITLE = \"Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.\", JOURNAL = c(\"Virology 388:236-47 (2009)\", \"DOI:10.1016/j.virol.2009.03.027\")), list(REFERENCE = \"PMID:25635182\", AUTHORS = \"Kumar P, Murakami M, Kaul R, Saha A, Cai Q, Robertson ES\", TITLE = \"Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.\", JOURNAL = c(\"Future Virol 4:79-91 (2009)\", \"DOI:10.2217/17460794.4.1.79\")), list(REFERENCE = \"PMID:10818681\", AUTHORS = \"Longnecker R\", TITLE = \"Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?\", JOURNAL = \"Adv Cancer Res 79:175-200 (2000)\"), list(REFERENCE = \"PMID:30116721\", AUTHORS = \"El-Sharkawy A, Al Zaidan L, Malki A\", TITLE = \"Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis.\", JOURNAL = c(\"Front Oncol 8:265 (2018)\", \"DOI:10.3389/fonc.2018.00265\")), list(REFERENCE = \"PMID:12811813\", AUTHORS = \"Dolcetti R, Masucci MG\", TITLE = \"Epstein-Barr virus: induction and control of cell transformation.\", JOURNAL = c(\"J Cell Physiol 196:207-18 (2003)\", \"DOI:10.1002/jcp.10263\")), list(REFERENCE = \"PMID:21347341\", AUTHORS = \"Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES\", TITLE = \"Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.\", JOURNAL = c(\"PLoS Pathog 7:e1001275 (2011)\", \"DOI:10.1371/journal.ppat.1001275\"))', 'map05169', 'Epstein-Barr virus infection', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (423, '05170', 'Human immunodeficiency virus 1 infection', 'Human immunodeficiency virus type 1 (HIV-1) , the causative agent of AIDS (acquired immunodeficiency syndrome), is a lentivirus belonging to the Retroviridae family. The primary cell surface receptor for HIV-1, the CD4 protein, and the co-receptor for HIV-1, either CCR5 or CXCR4, are found on macrophages and T lymphocytes. At the earliest step, sequential binding of virus envelope (Env) glycoprotein gp120 to CD4 and the co-receptor CCR5 or CXCR4 facilitates HIV-1 entry and has the potential to trigger critical signaling that may favor viral replication. At advanced stages of the disease, HIV-1 infection results in dramatic induction of T-cell (CD4+ T and CD8+ T cell) apoptosis both in infected and uninfected bystander T cells, a hallmark of HIV-1 pathogenesis. On the contrary, macrophages are resistant to the cytopathic effect of HIV-1 and produce virus for longer periods of time.', 'Human Diseases; Infectious disease: viral', 'Human immunodeficiency virus 1 infection', 'HIV infection', 'ko05170', 'list(REFERENCE = \"PMID:22749173\", AUTHORS = \"Evans VA, Khoury G, Saleh S, Cameron PU, Lewin SR\", TITLE = \"HIV persistence: chemokines and their signalling pathways.\", JOURNAL = c(\"Cytokine Growth Factor Rev 23:151-7 (2012)\", \"DOI:10.1016/j.cytogfr.2012.05.002\")), list(REFERENCE = \"PMID:23806647\", AUTHORS = \"Abbas W, Herbein G\", TITLE = \"Plasma membrane signaling in HIV-1 infection.\", JOURNAL = c(\"Biochim Biophys Acta 1838:1132-42 (2014)\", \"DOI:10.1016/j.bbamem.2013.06.020\")), list(REFERENCE = \"PMID:20041213\", AUTHORS = \"Wu Y, Yoder A\", TITLE = \"Chemokine coreceptor signaling in HIV-1 infection and pathogenesis.\", JOURNAL = c(\"PLoS Pathog 5:e1000520 (2009)\", \"DOI:10.1371/journal.ppat.1000520\")), list(REFERENCE = \"PMID:22085380\", AUTHORS = \"Choi WT, Duggineni S, Xu Y, Huang Z, An J\", TITLE = \"Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).\", JOURNAL = c(\"J Med Chem 55:977-94 (2012)\", \"DOI:10.1021/jm200568c\")), list(REFERENCE = \"PMID:21321123\", AUTHORS = \"Vorster PJ, Guo J, Yoder A, Wang W, Zheng Y, Xu X, Yu D, Spear M, Wu Y\", TITLE = \"LIM kinase 1 modulates cortical actin and CXCR4 cycling and is activated by HIV-1 to initiate viral infection.\", JOURNAL = c(\"J Biol Chem 286:12554-64 (2011)\", \"DOI:10.1074/jbc.M110.182238\")), list(REFERENCE = \"PMID:15817946\", AUTHORS = \"Das SR, Jameel S\", TITLE = \"Biology of the HIV Nef protein.\", JOURNAL = \"Indian J Med Res 121:315-32 (2005)\"), list(REFERENCE = \"PMID:24822052\", AUTHORS = \"Roy N, Pacini G, Berlioz-Torrent C, Janvier K\", TITLE = \"Mechanisms underlying HIV-1 Vpu-mediated viral egress.\", JOURNAL = c(\"Front Microbiol 5:177 (2014)\", \"DOI:10.3389/fmicb.2014.00177\")), list(REFERENCE = \"PMID:22090097\", AUTHORS = \"Magadan JG, Bonifacino JS\", TITLE = \"Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu.\", JOURNAL = c(\"J Virol 86:757-72 (2012)\", \"DOI:10.1128/JVI.05933-11\")), list(REFERENCE = \"PMID:26056579\", AUTHORS = \"Kumar A, Herbein G\", TITLE = \"The macrophage: a therapeutic target in HIV-1 infection.\", JOURNAL = c(\"Mol Cell Ther 2:10 (2014)\", \"DOI:10.1186/2052-8426-2-10\")), list(REFERENCE = \"PMID:20672047\", AUTHORS = \"Yokota S, Okabayashi T, Fujii N\", TITLE = \"The battle between virus and host: modulation of Toll-like receptor signaling pathways by virus infection.\", JOURNAL = c(\"Mediators Inflamm 2010:184328 (2010)\", \"DOI:10.1155/2010/184328\")), list(REFERENCE = \"PMID:26628325\", AUTHORS = \"Sauter D, Kirchhoff F\", TITLE = \"HIV replication: a game of hide and sense.\", JOURNAL = c(\"Curr Opin HIV AIDS 11:173-81 (2016)\", \"DOI:10.1097/COH.0000000000000233\")), list(REFERENCE = \"PMID:25988887\", AUTHORS = \"Altfeld M, Gale M Jr\", TITLE = \"Innate immunity against HIV-1 infection.\", JOURNAL = c(\"Nat Immunol 16:554-62 (2015)\", \"DOI:10.1038/ni.3157\")), list(REFERENCE = \"PMID:28358311\", AUTHORS = \"Pasquereau S, Kumar A, Herbein G\", TITLE = \"Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs.\", JOURNAL = c(\"Viruses 9:E64 (2017)\", \"DOI:10.3390/v9040064\")), list(REFERENCE = \"PMID:18178131\", AUTHORS = \"Herbein G, Khan KA\", TITLE = \"Is HIV infection a TNF receptor signalling-driven disease?\", JOURNAL = c(\"Trends Immunol 29:61-7 (2008)\", \"DOI:10.1016/j.it.2007.10.008\")), list(REFERENCE = \"PMID:24453421\", AUTHORS = \"Kumar A, Abbas W, Herbein G\", TITLE = \"TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?\", JOURNAL = c(\"Mediators Inflamm 2013:484378 (2013)\", \"DOI:10.1155/2013/484378\")), list(REFERENCE = \"PMID:23986795\", AUTHORS = \"Abbas W, Herbein G\", TITLE = \"T-Cell Signaling in HIV-1 Infection.\", JOURNAL = c(\"Open Virol J 7:57-71 (2013)\", \"DOI:10.2174/1874357920130621001\")), list(REFERENCE = \"PMID:21368875\", AUTHORS = \"Cummins NW, Badley AD\", TITLE = \"Mechanisms of HIV-associated lymphocyte apoptosis: 2010.\", JOURNAL = c(\"Cell Death Dis 1:e99 (2010)\", \"DOI:10.1038/cddis.2010.77\")), list(REFERENCE = \"PMID:12766761\", AUTHORS = \"Gougeon ML\", TITLE = \"Apoptosis as an HIV strategy to escape immune attack.\", JOURNAL = c(\"Nat Rev Immunol 3:392-404 (2003)\", \"DOI:10.1038/nri1087\")), list(REFERENCE = \"PMID:21994747\", AUTHORS = \"Fevrier M, Dorgham K, Rebollo A\", TITLE = \"CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis.\", JOURNAL = c(\"Viruses 3:586-612 (2011)\", \"DOI:10.3390/v3050586\")), list(REFERENCE = \"PMID:11237054\", AUTHORS = \"Ross TM\", TITLE = \"Using death to one\'s advantage: HIV modulation of apoptosis.\", JOURNAL = \"Leukemia 15:332-41 (2001)\"), list(REFERENCE = \"PMID:22767237\", AUTHORS = \"Hurley JH, Bonifacino JS\", TITLE = \"Nef-arious goings-on at the Golgi.\", JOURNAL = c(\"Nat Struct Mol Biol 19:661-2 (2012)\", \"DOI:10.1038/nsmb.2304\")), list(REFERENCE = \"PMID:21762823\", AUTHORS = \"Wonderlich ER, Leonard JA, Collins KL\", TITLE = \"HIV immune evasion disruption of antigen presentation by the HIV Nef protein.\", JOURNAL = c(\"Adv Virus Res 80:103-27 (2011)\", \"DOI:10.1016/B978-0-12-385987-7.00005-1\")), list(REFERENCE = \"PMID:20594957\", AUTHORS = \"Laguette N, Bregnard C, Benichou S, Basmaciogullari S\", TITLE = \"Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins.\", JOURNAL = c(\"Mol Aspects Med 31:418-33 (2010)\", \"DOI:10.1016/j.mam.2010.05.003\")), list(REFERENCE = \"PMID:27161574\", AUTHORS = \"Pereira EA, daSilva LL\", TITLE = \"HIV-1 Nef: Taking Control of Protein Trafficking.\", JOURNAL = c(\"Traffic 17:976-96 (2016)\", \"DOI:10.1111/tra.12412\")), list(REFERENCE = \"PMID:26950141\", AUTHORS = \"Sugden SM, Bego MG, Pham TN, Cohen EA\", TITLE = \"Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence.\", JOURNAL = c(\"Viruses 8:67 (2016)\", \"DOI:10.3390/v8030067\")), list(REFERENCE = \"PMID:24906315\", AUTHORS = \"Bagga S, Bouchard MJ\", TITLE = \"Cell cycle regulation during viral infection.\", JOURNAL = c(\"Methods Mol Biol 1170:165-227 (2014)\", \"DOI:10.1007/978-1-4939-0888-2_10\")), list(REFERENCE = \"PMID:15638722\", AUTHORS = \"Andersen JL, Planelles V\", TITLE = \"The role of Vpr in HIV-1 pathogenesis.\", JOURNAL = \"Curr HIV Res 3:43-51 (2005)\"), list(REFERENCE = \"PMID:17140287\", AUTHORS = \"Andersen JL, DeHart JL, Zimmerman ES, Ardon O, Kim B, Jacquot G, Benichou S, Planelles V\", TITLE = \"HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.\", JOURNAL = c(\"PLoS Pathog 2:e127 (2006)\", \"DOI:10.1371/journal.ppat.0020127\")), list(REFERENCE = \"PMID:23430691\", AUTHORS = \"Takaori-Kondo A, Shindo K\", TITLE = \"HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors.\", JOURNAL = c(\"Front Microbiol 4:34 (2013)\", \"DOI:10.3389/fmicb.2013.00034\")), list(REFERENCE = \"PMID:19038776\", AUTHORS = \"Malim MH\", TITLE = \"APOBEC proteins and intrinsic resistance to HIV-1 infection.\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 364:675-87 (2009)\", \"DOI:10.1098/rstb.2008.0185\")), list(REFERENCE = \"PMID:21835787\", AUTHORS = \"Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, Harris RS\", TITLE = \"Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.\", JOURNAL = c(\"J Virol 85:11220-34 (2011)\", \"DOI:10.1128/JVI.05238-11\"))', 'map05170', 'Human immunodeficiency virus 1 infection', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (424, '05200', 'Pathways in cancer', 'Human Diseases; Cancer: overview', 'Pathways in cancer', 'von Hippel-Lindau syndrome, Odontoonychodermal dysplasia, Oligodontia-colorectal cancer syndrome, Li-Fraumeni syndrome, Basal cell nevus syndrome, Pilomatricoma, Choroid plexus papilloma, Juvenile polyposis syndrome, Familial adenomatous polyposis', 'ko05200', 'list(REFERENCE = \"\", AUTHORS = \"Weinberg RA.\", TITLE = \"The biology of cancer\", JOURNAL = \"Garland Science, Taylor & Francis Group, LLC (2007)\"), list(REFERENCE = \"PMID:10647931\", AUTHORS = \"Hanahan D, Weinberg RA\", TITLE = \"The hallmarks of cancer.\", JOURNAL = c(\"Cell 100:57-70 (2000)\", \"DOI:10.1016/S0092-8674(00)81683-9\")), list(REFERENCE = \"PMID:15000146\", AUTHORS = \"Grady WM.\", TITLE = \"Genomic instability and colon cancer.\", JOURNAL = c(\"Cancer Metastasis Rev 23:11-27 (2004)\", \"DOI:10.1023/A:1025861527711\")), list(REFERENCE = \"PMID:16555243\", AUTHORS = \"Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.\", TITLE = \"Microsatellite instability in colorectal cancer.\", JOURNAL = c(\"Br J Surg 93:395-406 (2006)\", \"DOI:10.1002/bjs.5328\")), list(REFERENCE = \"PMID:11078609\", AUTHORS = \"Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.\", TITLE = \"Hereditary non-polyposis colorectal cancer: an updated review.\", JOURNAL = c(\"Eur J Surg Oncol 26:635-45 (2000)\", \"DOI:10.1053/ejso.2000.0974\")), list(REFERENCE = \"PMID:16699851\", AUTHORS = \"Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.\", TITLE = \"Colorectal cancer: genetics of development and metastasis.\", JOURNAL = c(\"J Gastroenterol 41:185-92 (2006)\", \"DOI:10.1007/s00535-006-1801-6\")), list(REFERENCE = \"PMID:12621137\", AUTHORS = \"Lynch HT, de la Chapelle A.\", TITLE = \"Hereditary colorectal cancer.\", JOURNAL = c(\"N Engl J Med 348:919-32 (2003)\", \"DOI:10.1056/NEJMra012242\")), list(REFERENCE = \"PMID:12951588\", AUTHORS = \"Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.\", TITLE = \"The significance of unstable chromosomes in colorectal cancer.\", JOURNAL = c(\"Nat Rev Cancer 3:695-701 (2003)\", \"DOI:10.1038/nrc1165\")), list(REFERENCE = \"PMID:10505543\", AUTHORS = \"Behrens J.\", TITLE = \"Cadherins and catenins: role in signal transduction and tumor progression.\", JOURNAL = c(\"Cancer Metastasis Rev 18:15-30 (1999)\", \"DOI:10.1023/A:1006200102166\")), list(REFERENCE = \"PMID:16042571\", AUTHORS = \"Behrens J.\", TITLE = \"The role of the Wnt signalling pathway in colorectal tumorigenesis.\", JOURNAL = c(\"Biochem Soc Trans 33:672-5 (2005)\", \"DOI:10.1042/BST0330672\")), list(REFERENCE = \"PMID:15349822\", AUTHORS = \"Behrens J, Lustig B.\", TITLE = \"The Wnt connection to tumorigenesis.\", JOURNAL = c(\"Int J Dev Biol 48:477-87 (2004)\", \"DOI:10.1387/ijdb.041815jb\")), list(REFERENCE = \"PMID:9196022\", AUTHORS = \"Polakis P.\", TITLE = \"The adenomatous polyposis coli (APC) tumor suppressor.\", JOURNAL = c(\"Biochim Biophys Acta 1332:F127-47 (1997)\", \"DOI:10.1016/S0304-419X(97)00008-5\")), list(REFERENCE = \"PMID:12737309\", AUTHORS = \"Janssen KP.\", TITLE = \"Murine models of colorectal cancer: studying the role of oncogenic K-ras.\", JOURNAL = c(\"Cell Mol Life Sci 60:495-506 (2003)\", \"DOI:10.1007/s000180300041\")), list(REFERENCE = \"PMID:11459867\", AUTHORS = \"Adjei AA.\", TITLE = \"Blocking oncogenic Ras signaling for cancer therapy.\", JOURNAL = c(\"J Natl Cancer Inst 93:1062-74 (2001)\", \"DOI:10.1093/jnci/93.14.1062\")), list(REFERENCE = \"PMID:15573119\", AUTHORS = \"Arakawa H.\", TITLE = \"Netrin-1 and its receptors in tumorigenesis.\", JOURNAL = c(\"Nat Rev Cancer 4:978-87 (2004)\", \"DOI:10.1038/nrc1504\")), list(REFERENCE = \"PMID:15310786\", AUTHORS = \"Mehlen P, Fearon ER.\", TITLE = \"Role of the dependence receptor DCC in colorectal cancer pathogenesis.\", JOURNAL = c(\"J Clin Oncol 22:3420-8 (2004)\", \"DOI:10.1200/JCO.2004.02.019\")), list(REFERENCE = \"PMID:11223406\", AUTHORS = \"Peltomaki P.\", TITLE = \"DNA mismatch repair and cancer.\", JOURNAL = c(\"Mutat Res 488:77-85 (2001)\", \"DOI:10.1016/S1383-5742(00)00058-2\")), list(REFERENCE = \"PMID:15711891\", AUTHORS = \"Li F, Cao Y, Townsend CM Jr, Ko TC.\", TITLE = \"TGF-beta signaling in colon cancer cells.\", JOURNAL = c(\"World J Surg 29:306-11 (2005)\", \"DOI:10.1007/s00268-004-7813-6\")), list(REFERENCE = \"PMID:11170304\", AUTHORS = \"Roman C, Saha D, Beauchamp R.\", TITLE = \"TGF-beta and colorectal carcinogenesis.\", JOURNAL = c(\"Microsc Res Tech 52:450-7 (2001)\", \"DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O\")), list(REFERENCE = \"PMID:16326109\", AUTHORS = \"Watson AJ.\", TITLE = \"An overview of apoptosis and the prevention of colorectal cancer.\", JOURNAL = c(\"Crit Rev Oncol Hematol 57:107-21 (2006)\", \"DOI:10.1016/j.critrevonc.2005.06.005\")), list(REFERENCE = \"PMID:15479695\", AUTHORS = \"Watson AJ.\", TITLE = \"Apoptosis and colorectal cancer.\", JOURNAL = c(\"Gut 53:1701-9 (2004)\", \"DOI:10.1136/gut.2004.052704\")), list(REFERENCE = \"PMID:11477132\", AUTHORS = \"Houlston RS.\", TITLE = \"What we could do now: molecular pathology of colorectal cancer.\", JOURNAL = c(\"Mol Pathol 54:206-14 (2001)\", \"DOI:10.1136/mp.54.4.206\")), list(REFERENCE = \"\", AUTHORS = \"Von Hoff D, Evans D, Hruban R (ed).\", TITLE = \"Pancreatic cancer\", JOURNAL = \"Jones and Bartlett publishers (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Niitsu Y, Yokota J (ed).\", TITLE = \"[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)\", JOURNAL = \"Nankodo (1999)\"), list(REFERENCE = \"PMID:12459728\", AUTHORS = \"Bardeesy N, DePinho RA.\", TITLE = \"Pancreatic cancer biology and genetics.\", JOURNAL = c(\"Nat Rev Cancer 2:897-909 (2002)\", \"DOI:10.1038/nrc949\")), list(REFERENCE = \"PMID:11407945\", AUTHORS = \"Bardeesy N, Sharpless NE, DePinho RA, Merlino G.\", TITLE = \"The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.\", JOURNAL = c(\"Semin Cancer Biol 11:201-18 (2001)\", \"DOI:10.1006/scbi.2000.0371\")), list(REFERENCE = \"PMID:12946833\", AUTHORS = \"Cowgill SM, Muscarella P.\", TITLE = \"The genetics of pancreatic cancer.\", JOURNAL = c(\"Am J Surg 186:279-86 (2003)\", \"DOI:10.1016/S0002-9610(03)00226-5\")), list(REFERENCE = \"PMID:16702400\", AUTHORS = \"Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.\", TITLE = \"Genetics and biology of pancreatic ductal adenocarcinoma.\", JOURNAL = c(\"Genes Dev 20:1218-49 (2006)\", \"DOI:10.1101/gad.1415606\")), list(REFERENCE = \"PMID:10740269\", AUTHORS = \"Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.\", TITLE = \"Understanding Ras: \'it ain\'t over \'til it\'s over\'.\", JOURNAL = c(\"Trends Cell Biol 10:147-54 (2000)\", \"DOI:10.1016/S0962-8924(00)01740-2\")), list(REFERENCE = \"PMID:12648469\", AUTHORS = \"Holbro T, Civenni G, Hynes NE.\", TITLE = \"The ErbB receptors and their role in cancer progression.\", JOURNAL = c(\"Exp Cell Res 284:99-110 (2003)\", \"DOI:10.1016/S0014-4827(02)00099-X\")), list(REFERENCE = \"PMID:14967450\", AUTHORS = \"Marmor MD, Skaria KB, Yarden Y.\", TITLE = \"Signal transduction and oncogenesis by ErbB/HER receptors.\", JOURNAL = c(\"Int J Radiat Oncol Biol Phys 58:903-13 (2004)\", \"DOI:10.1016/j.ijrobp.2003.06.002\")), list(REFERENCE = \"PMID:14586404\", AUTHORS = \"DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.\", TITLE = \"Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.\", JOURNAL = c(\"Oncogene 22:7781-95 (2003)\", \"DOI:10.1038/sj.onc.1206966\")), list(REFERENCE = \"PMID:12545153\", AUTHORS = \"Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.\", TITLE = \"Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.\", JOURNAL = c(\"Oncogene 22:319-29 (2003)\", \"DOI:10.1038/sj.onc.1206122\")), list(REFERENCE = \"PMID:14580692\", AUTHORS = \"Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.\", TITLE = \"Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.\", JOURNAL = c(\"Cancer Lett 201:107-16 (2003)\", \"DOI:10.1016/S0304-3835(03)00482-8\")), list(REFERENCE = \"PMID:12079267\", AUTHORS = \"Schmid RM.\", TITLE = \"Genetic basis of pancreatic cancer.\", JOURNAL = c(\"Best Pract Res Clin Gastroenterol 16:421-33 (2002)\", \"DOI:10.1053/bega.2002.0316\")), list(REFERENCE = \"PMID:15774796\", AUTHORS = \"Elliott RL, Blobe GC.\", TITLE = \"Role of transforming growth factor Beta in human cancer.\", JOURNAL = c(\"J Clin Oncol 23:2078-93 (2005)\", \"DOI:10.1200/JCO.2005.02.047\")), list(REFERENCE = \"PMID:15823750\", AUTHORS = \"Rudkin TM, Foulkes WD.\", TITLE = \"BRCA2: breaks, mistakes and failed separations.\", JOURNAL = c(\"Trends Mol Med 11:145-8 (2005)\", \"DOI:10.1016/j.molmed.2005.02.003\")), list(REFERENCE = \"PMID:11707511\", AUTHORS = \"Venkitaraman AR.\", TITLE = \"Functions of BRCA1 and BRCA2 in the biological response to DNA damage.\", JOURNAL = \"J Cell Sci 114:3591-8 (2001)\"), list(REFERENCE = \"PMID:15639402\", AUTHORS = \"Soni D, King JA, Kaye AH, Hovens CM.\", TITLE = \"Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.\", JOURNAL = c(\"J Clin Neurosci 12:1-5 (2005)\", \"DOI:10.1016/j.jocn.2004.04.001\")), list(REFERENCE = \"PMID:12154354\", AUTHORS = \"Zhu Y, Parada LF.\", TITLE = \"The molecular and genetic basis of neurological tumours.\", JOURNAL = c(\"Nat Rev Cancer 2:616-26 (2002)\", \"DOI:10.1038/nrc866\")), list(REFERENCE = \"PMID:11253051\", AUTHORS = \"Holland EC.\", TITLE = \"Gliomagenesis: genetic alterations and mouse models.\", JOURNAL = c(\"Nat Rev Genet 2:120-9 (2001)\", \"DOI:10.1038/35052535\")), list(REFERENCE = \"PMID:16700615\", AUTHORS = \"Bansal K, Liang ML, Rutka JT.\", TITLE = \"Molecular biology of human gliomas.\", JOURNAL = c(\"Technol Cancer Res Treat 5:185-94 (2006)\", \"DOI:10.1177/153303460600500302\")), list(REFERENCE = \"\", AUTHORS = \"Tabuchi K (ed).\", TITLE = \"[Gliomas: Research and therapy] (In Japanese)\", JOURNAL = \"Springer-Verlag Tokyo (2006)\"), list(REFERENCE = \"PMID:12762887\", AUTHORS = \"Kapoor GS, O\'Rourke DM.\", TITLE = \"Mitogenic signaling cascades in glial tumors.\", JOURNAL = c(\"Neurosurgery 52:1425-34; discussion 1434-5 (2003)\", \"DOI:10.1227/01.NEU.0000065135.28143.39\")), list(REFERENCE = \"PMID:16095998\", AUTHORS = \"Hulleman E, Helin K.\", TITLE = \"Molecular mechanisms in gliomagenesis.\", JOURNAL = c(\"Adv Cancer Res 94:1-27 (2005)\", \"DOI:10.1016/S0065-230X(05)94001-3\")), list(REFERENCE = \"PMID:11057895\", AUTHORS = \"Schlessinger J.\", TITLE = \"Cell signaling by receptor tyrosine kinases.\", JOURNAL = c(\"Cell 103:211-25 (2000)\", \"DOI:10.1016/S0092-8674(00)00114-8\")), list(REFERENCE = \"PMID:9643506\", AUTHORS = \"Ng HK, Lam PY.\", TITLE = \"The molecular genetics of central nervous system tumors.\", JOURNAL = \"Pathology 30:196-202 (1998)\"), list(REFERENCE = \"PMID:12084351\", AUTHORS = \"Knobbe CB, Merlo A, Reifenberger G.\", TITLE = \"Pten signaling in gliomas.\", JOURNAL = c(\"Neuro-oncol 4:196-211 (2002)\", \"DOI:10.1093/neuonc/4.3.196\")), list(REFERENCE = \"PMID:16557281\", AUTHORS = \"Kondo T, Ezzat S, Asa SL.\", TITLE = \"Pathogenetic mechanisms in thyroid follicular-cell neoplasia.\", JOURNAL = c(\"Nat Rev Cancer 6:292-306 (2006)\", \"DOI:10.1038/nrc1836\")), list(REFERENCE = \"PMID:16551846\", AUTHORS = \"Chiloeches A, Marais R.\", TITLE = \"Is BRAF the Achilles\' Heel of thyroid cancer?\", JOURNAL = c(\"Clin Cancer Res 12:1661-4 (2006)\", \"DOI:10.1158/1078-0432.CCR-06-0051\")), list(REFERENCE = \"PMID:16946003\", AUTHORS = \"Reddi HV, McIver B, Grebe SK, Eberhardt NL\", TITLE = \"The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.\", JOURNAL = c(\"Endocrinology 148:932-5 (2007)\", \"DOI:10.1210/en.2006-0926\")), list(REFERENCE = \"PMID:17062879\", AUTHORS = \"Santoro M, Melillo RM, Fusco A.\", TITLE = \"RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.\", JOURNAL = c(\"Eur J Endocrinol 155:645-653 (2006)\", \"DOI:10.1530/eje.1.02289\")), list(REFERENCE = \"PMID:16242838\", AUTHORS = \"Pierotti MA, Greco A.\", TITLE = \"Oncogenic rearrangements of the NTRK1/NGF receptor.\", JOURNAL = c(\"Cancer Lett 232:90-8 (2006)\", \"DOI:10.1016/j.canlet.2005.07.043\")), list(REFERENCE = \"PMID:16189702\", AUTHORS = \"Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.\", TITLE = \"Molecular pathology of well-differentiated thyroid carcinomas.\", JOURNAL = c(\"Virchows Arch 447:787-93 (2005)\", \"DOI:10.1007/s00428-005-0065-5\")), list(REFERENCE = \"PMID:11165748\", AUTHORS = \"Gimm O.\", TITLE = \"Thyroid cancer.\", JOURNAL = c(\"Cancer Lett 163:143-56 (2001)\", \"DOI:10.1016/S0304-3835(00)00697-2\")), list(REFERENCE = \"PMID:12094241\", AUTHORS = \"Williams D.\", TITLE = \"Cancer after nuclear fallout: lessons from the Chernobyl accident.\", JOURNAL = c(\"Nat Rev Cancer 2:543-9 (2002)\", \"DOI:10.1038/nrc845\")), list(REFERENCE = \"PMID:16236521\", AUTHORS = \"Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.\", TITLE = \"The molecular pathogenesis of acute myeloid leukemia.\", JOURNAL = c(\"Crit Rev Oncol Hematol 56:195-221 (2005)\", \"DOI:10.1016/j.critrevonc.2004.10.012\")), list(REFERENCE = \"PMID:12563308\", AUTHORS = \"Tenen DG.\", TITLE = \"Disruption of differentiation in human cancer: AML shows the way.\", JOURNAL = c(\"Nat Rev Cancer 3:89-101 (2003)\", \"DOI:10.1038/nrc989\")), list(REFERENCE = \"PMID:16146838\", AUTHORS = \"Choudhary C, Muller-Tidow C, Berdel WE, Serve H.\", TITLE = \"Signal transduction of oncogenic Flt3.\", JOURNAL = c(\"Int J Hematol 82:93-9 (2005)\", \"DOI:10.1532/IJH97.05090\")), list(REFERENCE = \"PMID:12951584\", AUTHORS = \"Stirewalt DL, Radich JP.\", TITLE = \"The role of FLT3 in haematopoietic malignancies.\", JOURNAL = c(\"Nat Rev Cancer 3:650-65 (2003)\", \"DOI:10.1038/nrc1169\")), list(REFERENCE = \"PMID:16642045\", AUTHORS = \"Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.\", TITLE = \"Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.\", JOURNAL = c(\"Leukemia 20:911-28 (2006)\", \"DOI:10.1038/sj.leu.2404245\")), list(REFERENCE = \"PMID:15625120\", AUTHORS = \"Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.\", TITLE = \"Normal and oncogenic forms of the receptor tyrosine kinase kit.\", JOURNAL = c(\"Stem Cells 23:16-43 (2005)\", \"DOI:10.1634/stemcells.2004-0117\")), list(REFERENCE = \"PMID:11721960\", AUTHORS = \"Lorsbach RB, Downing JR.\", TITLE = \"The role of the AML1 transcription factor in leukemogenesis.\", JOURNAL = c(\"Int J Hematol 74:258-65 (2001)\", \"DOI:10.1007/BF02982058\")), list(REFERENCE = \"PMID:12468433\", AUTHORS = \"Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.\", TITLE = \"Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.\", JOURNAL = c(\"Blood 101:3164-73 (2003)\", \"DOI:10.1182/blood-2002-06-1677\")), list(REFERENCE = \"PMID:17554387\", AUTHORS = \"Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.\", TITLE = \"The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.\", JOURNAL = c(\"Leukemia 21:1638-47 (2007)\", \"DOI:10.1038/sj.leu.2404732\")), list(REFERENCE = \"PMID:16352814\", AUTHORS = \"Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.\", TITLE = \"ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.\", JOURNAL = c(\"Blood 107:3330-8 (2006)\", \"DOI:10.1182/blood-2005-07-3068\")), list(REFERENCE = \"PMID:15719031\", AUTHORS = \"Ren R.\", TITLE = \"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.\", JOURNAL = c(\"Nat Rev Cancer 5:172-83 (2005)\", \"DOI:10.1038/nrc1567\")), list(REFERENCE = \"PMID:11071626\", AUTHORS = \"Deininger MW, Goldman JM, Melo JV.\", TITLE = \"The molecular biology of chronic myeloid leukemia.\", JOURNAL = \"Blood 96:3343-56 (2000)\"), list(REFERENCE = \"PMID:14982876\", AUTHORS = \"Calabretta B, Perrotti D.\", TITLE = \"The biology of CML blast crisis.\", JOURNAL = c(\"Blood 103:4010-22 (2004)\", \"DOI:10.1182/blood-2003-12-4111\")), list(REFERENCE = \"PMID:10403855\", AUTHORS = \"Faderl S, Talpaz M, Estrov Z, O\'Brien S, Kurzrock R, Kantarjian HM.\", TITLE = \"The biology of chronic myeloid leukemia.\", JOURNAL = c(\"N Engl J Med 341:164-72 (1999)\", \"DOI:10.1056/NEJM199907153410306\")), list(REFERENCE = \"PMID:15156182\", AUTHORS = \"Mitani K.\", TITLE = \"Molecular mechanisms of leukemogenesis by AML1/EVI-1.\", JOURNAL = c(\"Oncogene 23:4263-9 (2004)\", \"DOI:10.1038/sj.onc.1207777\")), list(REFERENCE = \"PMID:16484590\", AUTHORS = \"Dong M, Blobe GC.\", TITLE = \"Role of transforming growth factor-beta in hematologic malignancies.\", JOURNAL = c(\"Blood 107:4589-96 (2006)\", \"DOI:10.1182/blood-2005-10-4169\")), list(REFERENCE = \"PMID:9834202\", AUTHORS = \"Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.\", TITLE = \"The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.\", JOURNAL = \"Blood 92:4003-12 (1998)\"), list(REFERENCE = \"PMID:12801837\", AUTHORS = \"Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.\", TITLE = \"p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.\", JOURNAL = \"Haematologica 88:622-30 (2003)\"), list(REFERENCE = \"PMID:11160144\", AUTHORS = \"Baldwin AS.\", TITLE = \"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.\", JOURNAL = c(\"J Clin Invest 107:241-6 (2001)\", \"DOI:10.1172/JCI11991\")), list(REFERENCE = \"PMID:12244301\", AUTHORS = \"Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.\", TITLE = \"PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.\", JOURNAL = c(\"Nat Med 8:1145-52 (2002)\", \"DOI:10.1038/nm759\")), list(REFERENCE = \"PMID:15948971\", AUTHORS = \"Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.\", TITLE = \"Molecular aetiology and pathogenesis of basal cell carcinoma.\", JOURNAL = c(\"Br J Dermatol 152:1108-24 (2005)\", \"DOI:10.1111/j.1365-2133.2005.06587.x\")), list(REFERENCE = \"PMID:12588368\", AUTHORS = \"Saldanha G, Fletcher A, Slater DN.\", TITLE = \"Basal cell carcinoma: a dermatopathological and molecular biological update.\", JOURNAL = c(\"Br J Dermatol 148:195-202 (2003)\", \"DOI:10.1046/j.1365-2133.2003.05151.x\")), list(REFERENCE = \"PMID:15978322\", AUTHORS = \"Daya-Grosjean L, Couve-Privat S.\", TITLE = \"Sonic hedgehog signaling in basal cell carcinomas.\", JOURNAL = c(\"Cancer Lett 225:181-92 (2005)\", \"DOI:10.1016/j.canlet.2004.10.003\")), list(REFERENCE = \"PMID:15468170\", AUTHORS = \"Tsai KY, Tsao H.\", TITLE = \"The genetics of skin cancer.\", JOURNAL = c(\"Am J Med Genet C Semin Med Genet 131C:82-92 (2004)\", \"DOI:10.1002/ajmg.c.30037\")), list(REFERENCE = \"PMID:16881963\", AUTHORS = \"Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.\", TITLE = \"Hedgehog signalling in skin development and cancer.\", JOURNAL = c(\"Exp Dermatol 15:667-77 (2006)\", \"DOI:10.1111/j.1600-0625.2006.00473.x\")), list(REFERENCE = \"PMID:16306523\", AUTHORS = \"Rubin AI, Chen EH, Ratner D.\", TITLE = \"Basal-cell carcinoma.\", JOURNAL = c(\"N Engl J Med 353:2262-9 (2005)\", \"DOI:10.1056/NEJMra044151\")), list(REFERENCE = \"PMID:11276000\", AUTHORS = \"Saldanha G.\", TITLE = \"The Hedgehog signalling pathway and cancer.\", JOURNAL = c(\"J Pathol 193:427-32 (2001)\", \"DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N\")), list(REFERENCE = \"PMID:15270885\", AUTHORS = \"Saldanha G, Ghura V, Potter L, Fletcher A.\", TITLE = \"Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.\", JOURNAL = c(\"Br J Dermatol 151:157-64 (2004)\", \"DOI:10.1111/j.1365-2133.2004.06048.x\")), list(REFERENCE = \"PMID:14737121\", AUTHORS = \"Pasca di Magliano M, Hebrok M.\", TITLE = \"Hedgehog signalling in cancer formation and maintenance.\", JOURNAL = c(\"Nat Rev Cancer 3:903-11 (2003)\", \"DOI:10.1038/nrc1229\")), list(REFERENCE = \"PMID:15656799\", AUTHORS = \"Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.\", TITLE = \"Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.\", JOURNAL = c(\"Br J Dermatol 152:43-51 (2005)\", \"DOI:10.1111/j.1365-2133.2005.06353.x\")), list(REFERENCE = \"PMID:14556242\", AUTHORS = \"Cohen MM Jr.\", TITLE = \"The hedgehog signaling network.\", JOURNAL = c(\"Am J Med Genet A 123:5-28 (2003)\", \"DOI:10.1002/ajmg.a.20495\")), list(REFERENCE = \"PMID:11736900\", AUTHORS = \"Yamazaki F, Aragane Y, Kawada A, Tezuka T.\", TITLE = \"Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.\", JOURNAL = c(\"Br J Dermatol 145:771-7 (2001)\", \"DOI:10.1046/j.1365-2133.2001.04468.x\")), list(REFERENCE = \"PMID:16054233\", AUTHORS = \"Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.\", TITLE = \"Role of apoptosis in basal cell and squamous cell carcinoma formation.\", JOURNAL = c(\"Immunol Lett 100:68-72 (2005)\", \"DOI:10.1016/j.imlet.2005.06.008\")), list(REFERENCE = \"PMID:11130178\", AUTHORS = \"Toftgard R.\", TITLE = \"Hedgehog signalling in cancer.\", JOURNAL = c(\"Cell Mol Life Sci 57:1720-31 (2000)\", \"DOI:10.1007/PL00000654\")), list(REFERENCE = \"PMID:16822996\", AUTHORS = \"Miller AJ, Mihm MC Jr.\", TITLE = \"Melanoma.\", JOURNAL = c(\"N Engl J Med 355:51-65 (2006)\", \"DOI:10.1056/NEJMra052166\")), list(REFERENCE = \"PMID:12894244\", AUTHORS = \"Chin L.\", TITLE = \"The genetics of malignant melanoma: lessons from mouse and man.\", JOURNAL = c(\"Nat Rev Cancer 3:559-70 (2003)\", \"DOI:10.1038/nrc1145\")), list(REFERENCE = \"PMID:16750612\", AUTHORS = \"Takata M, Saida T.\", TITLE = \"Genetic alterations in melanocytic tumors.\", JOURNAL = c(\"J Dermatol Sci 43:1-10 (2006)\", \"DOI:10.1016/j.jdermsci.2006.05.002\")), list(REFERENCE = \"PMID:15841168\", AUTHORS = \"Chudnovsky Y, Khavari PA, Adams AE.\", TITLE = \"Melanoma genetics and the development of rational therapeutics.\", JOURNAL = c(\"J Clin Invest 115:813-24 (2005)\", \"DOI:10.1172/JCI24808\")), list(REFERENCE = \"PMID:16001050\", AUTHORS = \"Merlino G.\", TITLE = \"Cancer biology: the weakest link?\", JOURNAL = c(\"Nature 436:33-5 (2005)\", \"DOI:10.1038/436033a\")), list(REFERENCE = \"PMID:16001072\", AUTHORS = \"Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.\", TITLE = \"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.\", JOURNAL = c(\"Nature 436:117-22 (2005)\", \"DOI:10.1038/nature03664\")), list(REFERENCE = \"PMID:16899407\", AUTHORS = \"Levy C, Khaled M, Fisher DE.\", TITLE = \"MITF: master regulator of melanocyte development and melanoma oncogene.\", JOURNAL = c(\"Trends Mol Med 12:406-14 (2006)\", \"DOI:10.1016/j.molmed.2006.07.008\")), list(REFERENCE = \"PMID:15009714\", AUTHORS = \"Tsao H, Goel V, Wu H, Yang G, Haluska FG.\", TITLE = \"Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.\", JOURNAL = c(\"J Invest Dermatol 122:337-41 (2004)\", \"DOI:10.1046/j.0022-202X.2004.22243.x\")), list(REFERENCE = \"PMID:11224709\", AUTHORS = \"Gruss C, Herlyn M.\", TITLE = \"Role of cadherins and matrixins in melanoma.\", JOURNAL = \"Curr Opin Oncol 13:117-23 (2001)\"), list(REFERENCE = \"PMID:15721476\", AUTHORS = \"Thompson JF, Scolyer RA, Kefford RF.\", TITLE = \"Cutaneous melanoma.\", JOURNAL = c(\"Lancet 365:687-701 (2005)\", \"DOI:10.1016/S0140-6736(05)17951-3\")), list(REFERENCE = \"PMID:14695152\", AUTHORS = \"Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.\", TITLE = \"NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.\", JOURNAL = \"Clin Cancer Res 9:6483-8 (2003)\"), list(REFERENCE = \"PMID:15557758\", AUTHORS = \"Hussein MR.\", TITLE = \"The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?\", JOURNAL = c(\"Tumour Biol 25:200-7 (2004)\", \"DOI:10.1159/000081103\")), list(REFERENCE = \"PMID:10843728\", AUTHORS = \"Lazar-Molnar E, Hegyesi H, Toth S, Falus A.\", TITLE = \"Autocrine and paracrine regulation by cytokines and growth factors in melanoma.\", JOURNAL = c(\"Cytokine 12:547-54 (2000)\", \"DOI:10.1006/cyto.1999.0614\")), list(REFERENCE = \"PMID:16339096\", AUTHORS = \"Cohen HT, McGovern FJ.\", TITLE = \"Renal-cell carcinoma.\", JOURNAL = c(\"N Engl J Med 353:2477-90 (2005)\", \"DOI:10.1056/NEJMra043172\")), list(REFERENCE = \"PMID:15122209\", AUTHORS = \"Pavlovich CP, Schmidt LS.\", TITLE = \"Searching for the hereditary causes of renal-cell carcinoma.\", JOURNAL = c(\"Nat Rev Cancer 4:381-93 (2004)\", \"DOI:10.1038/nrc1364\")), list(REFERENCE = \"PMID:14634372\", AUTHORS = \"Linehan WM, Walther MM, Zbar B.\", TITLE = \"The genetic basis of cancer of the kidney.\", JOURNAL = c(\"J Urol 170:2163-72 (2003)\", \"DOI:10.1097/01.ju.0000096060.92397.ed\")), list(REFERENCE = \"PMID:14685170\", AUTHORS = \"Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.\", TITLE = \"Met, metastasis, motility and more.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 4:915-25 (2003)\", \"DOI:10.1038/nrm1261\")), list(REFERENCE = \"PMID:15611513\", AUTHORS = \"Kim WY, Kaelin WG.\", TITLE = \"Role of VHL gene mutation in human cancer.\", JOURNAL = c(\"J Clin Oncol 22:4991-5004 (2004)\", \"DOI:10.1200/JCO.2004.05.061\")), list(REFERENCE = \"PMID:17211469\", AUTHORS = \"Sudarshan S, Linehan WM, Neckers L.\", TITLE = \"HIF and fumarate hydratase in renal cancer.\", JOURNAL = c(\"Br J Cancer 96:403-7 (2007)\", \"DOI:10.1038/sj.bjc.6603547\")), list(REFERENCE = \"PMID:17287871\", AUTHORS = \"Sudarshan S, Pinto PA, Neckers L, Linehan WM.\", TITLE = \"Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.\", JOURNAL = c(\"Nat Clin Pract Urol 4:104-10 (2007)\", \"DOI:10.1038/ncpuro0711\")), list(REFERENCE = \"PMID:12351585\", AUTHORS = \"Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.\", TITLE = \"Understanding familial and non-familial renal cell cancer.\", JOURNAL = c(\"Hum Mol Genet 11:2489-98 (2002)\", \"DOI:10.1093/hmg/11.20.2489\")), list(REFERENCE = \"PMID:17158541\", AUTHORS = \"Mitra AP, Datar RH, Cote RJ.\", TITLE = \"Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.\", JOURNAL = c(\"J Clin Oncol 24:5552-64 (2006)\", \"DOI:10.1200/JCO.2006.08.2073\")), list(REFERENCE = \"PMID:16474624\", AUTHORS = \"Wolff EM, Liang G, Jones PA.\", TITLE = \"Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.\", JOURNAL = c(\"Nat Clin Pract Urol 2:502-10 (2005)\", \"DOI:10.1038/ncpuro0318\")), list(REFERENCE = \"PMID:16110317\", AUTHORS = \"Wu XR.\", TITLE = \"Urothelial tumorigenesis: a tale of divergent pathways.\", JOURNAL = c(\"Nat Rev Cancer 5:713-25 (2005)\", \"DOI:10.1038/nrc1697\")), list(REFERENCE = \"PMID:11103787\", AUTHORS = \"Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.\", TITLE = \"Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.\", JOURNAL = \"Cancer Res 60:6298-302 (2000)\"), list(REFERENCE = \"PMID:12850530\", AUTHORS = \"Bellmunt J, Hussain M, Dinney CP.\", TITLE = \"Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.\", JOURNAL = c(\"Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)\", \"DOI:10.1016/S1040-8428(03)00067-2\")), list(REFERENCE = \"PMID:17149381\", AUTHORS = \"Sugano K, Kakizoe T.\", TITLE = \"Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.\", JOURNAL = c(\"Nat Clin Pract Urol 3:642-52 (2006)\", \"DOI:10.1038/ncpuro0649\")), list(REFERENCE = \"PMID:15746962\", AUTHORS = \"Dunn KL, Espino PS, Drobic B, He S, Davie JR.\", TITLE = \"The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.\", JOURNAL = c(\"Biochem Cell Biol 83:1-14 (2005)\", \"DOI:10.1139/o04-121\")), list(REFERENCE = \"PMID:15551095\", AUTHORS = \"Williams SG, Stein JP.\", TITLE = \"Molecular pathways in bladder cancer.\", JOURNAL = c(\"Urol Res 32:373-85 (2004)\", \"DOI:10.1007/s00240-003-0345-y\")), list(REFERENCE = \"PMID:12878745\", AUTHORS = \"Nelson WG, De Marzo AM, Isaacs WB.\", TITLE = \"Prostate cancer.\", JOURNAL = c(\"N Engl J Med 349:366-81 (2003)\", \"DOI:10.1056/NEJMra021562\")), list(REFERENCE = \"PMID:15724144\", AUTHORS = \"Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.\", TITLE = \"The emerging role of the PI3-K-Akt pathway in prostate cancer progression.\", JOURNAL = c(\"Prostate Cancer Prostatic Dis 8:108-18 (2005)\", \"DOI:10.1038/sj.pcan.4500776\")), list(REFERENCE = \"PMID:16551847\", AUTHORS = \"Pienta KJ, Bradley D.\", TITLE = \"Mechanisms underlying the development of androgen-independent prostate cancer.\", JOURNAL = c(\"Clin Cancer Res 12:1665-71 (2006)\", \"DOI:10.1158/1078-0432.CCR-06-0067\")), list(REFERENCE = \"PMID:11900250\", AUTHORS = \"Feldman BJ, Feldman D.\", TITLE = \"The development of androgen-independent prostate cancer.\", JOURNAL = c(\"Nat Rev Cancer 1:34-45 (2001)\", \"DOI:10.1038/35094009\")), list(REFERENCE = \"PMID:15082523\", AUTHORS = \"Heinlein CA, Chang C.\", TITLE = \"Androgen receptor in prostate cancer.\", JOURNAL = c(\"Endocr Rev 25:276-308 (2004)\", \"DOI:10.1210/er.2002-0032\")), list(REFERENCE = \"PMID:9422516\", AUTHORS = \"Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.\", TITLE = \"Androgen receptor gene and hormonal therapy failure of prostate cancer.\", JOURNAL = \"Am J Pathol 152:1-9 (1998)\"), list(REFERENCE = \"PMID:10835690\", AUTHORS = \"Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.\", TITLE = \"Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.\", JOURNAL = c(\"Nat Med 6:703-6 (2000)\", \"DOI:10.1038/76287\")), list(REFERENCE = \"PMID:10453277\", AUTHORS = \"Macri E, Loda M.\", TITLE = \"Role of p27 in prostate carcinogenesis.\", JOURNAL = c(\"Cancer Metastasis Rev 17:337-44 (1998)\", \"DOI:10.1023/A:1006133620914\")), list(REFERENCE = \"PMID:11750244\", AUTHORS = \"Steers WD.\", TITLE = \"5alpha-reductase activity in the prostate.\", JOURNAL = c(\"Urology 58:17-24; discussion 24 (2001)\", \"DOI:10.1016/S0090-4295(01)01299-7\")), list(REFERENCE = \"PMID:8069858\", AUTHORS = \"Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.\", TITLE = \"Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.\", JOURNAL = \"Cancer Res 54:4920-6 (1994)\"), list(REFERENCE = \"PMID:11527574\", AUTHORS = \"Grimes CA, Jope RS.\", TITLE = \"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.\", JOURNAL = c(\"Prog Neurobiol 65:391-426 (2001)\", \"DOI:10.1016/S0301-0082(01)00011-9\")), list(REFERENCE = \"PMID:15947972\", AUTHORS = \"Ryan AJ, Susil B, Jobling TW, Oehler MK.\", TITLE = \"Endometrial cancer.\", JOURNAL = c(\"Cell Tissue Res 322:53-61 (2005)\", \"DOI:10.1007/s00441-005-1109-5\")), list(REFERENCE = \"PMID:14747944\", AUTHORS = \"Lax SF.\", TITLE = \"Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.\", JOURNAL = c(\"Virchows Arch 444:213-23 (2004)\", \"DOI:10.1007/s00428-003-0947-3\")), list(REFERENCE = \"PMID:16508724\", AUTHORS = \"Shiozawa T, Konishi I.\", TITLE = \"Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.\", JOURNAL = c(\"Int J Clin Oncol 11:13-21 (2006)\", \"DOI:10.1007/s10147-005-0546-1\")), list(REFERENCE = \"PMID:17028294\", AUTHORS = \"Hecht JL, Mutter GL.\", TITLE = \"Molecular and pathologic aspects of endometrial carcinogenesis.\", JOURNAL = c(\"J Clin Oncol 24:4783-91 (2006)\", \"DOI:10.1200/JCO.2006.06.7173\")), list(REFERENCE = \"PMID:11431710\", AUTHORS = \"Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.\", TITLE = \"Molecular pathology of endometrial hyperplasia and carcinoma.\", JOURNAL = c(\"Hum Pathol 32:569-77 (2001)\", \"DOI:10.1053/hupa.2001.25929\")), list(REFERENCE = \"PMID:15284264\", AUTHORS = \"Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.\", TITLE = \"Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.\", JOURNAL = c(\"J Clin Oncol 22:3126-32 (2004)\", \"DOI:10.1200/JCO.2004.11.154\")), list(REFERENCE = \"PMID:7585656\", AUTHORS = \"Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.\", TITLE = \"Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.\", JOURNAL = \"Cancer Res 55:5693-8 (1995)\"), list(REFERENCE = \"PMID:16248975\", AUTHORS = \"Kim D, Chung J.\", TITLE = \"Akt: versatile mediator of cell survival and beyond.\", JOURNAL = \"J Biochem Mol Biol 35:106-15 (2002)\"), list(REFERENCE = \"PMID:12711111\", AUTHORS = \"Sanchez-Cespedes M.\", TITLE = \"Dissecting the genetic alterations involved in lung carcinogenesis.\", JOURNAL = c(\"Lung Cancer 40:111-21 (2003)\", \"DOI:10.1016/S0169-5002(03)00033-3\")), list(REFERENCE = \"PMID:11720739\", AUTHORS = \"Kaye FJ.\", TITLE = \"Molecular biology of lung cancer.\", JOURNAL = c(\"Lung Cancer 34 Suppl 2:S35-41 (2001)\", \"DOI:10.1016/S0169-5002(01)00342-7\")), list(REFERENCE = \"PMID:12616528\", AUTHORS = \"Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.\", TITLE = \"Apoptosis and lung cancer: a review.\", JOURNAL = c(\"J Cell Biochem 88:885-98 (2003)\", \"DOI:10.1002/jcb.10440\")), list(REFERENCE = \"PMID:11807782\", AUTHORS = \"Sartorius UA, Krammer PH.\", TITLE = \"Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.\", JOURNAL = c(\"Int J Cancer 97:584-92 (2002)\", \"DOI:10.1002/ijc.10096\")), list(REFERENCE = \"PMID:16064138\", AUTHORS = \"Adhikary S, Eilers M.\", TITLE = \"Transcriptional regulation and transformation by Myc proteins.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 6:635-45 (2005)\", \"DOI:10.1038/nrm1703\")), list(REFERENCE = \"PMID:11463388\", AUTHORS = \"Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.\", TITLE = \"A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.\", JOURNAL = c(\"Mol Cell 7:639-50 (2001)\", \"DOI:10.1016/S1097-2765(01)00210-6\")), list(REFERENCE = \"PMID:15109562\", AUTHORS = \"Buttery RC, Rintoul RC, Sethi T.\", TITLE = \"Small cell lung cancer: the importance of the extracellular matrix.\", JOURNAL = c(\"Int J Biochem Cell Biol 36:1154-60 (2004)\", \"DOI:10.1016/S1357-2725(03)00261-9\")), list(REFERENCE = \"PMID:11559746\", AUTHORS = \"Yamada KM, Araki M.\", TITLE = \"Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.\", JOURNAL = \"J Cell Sci 114:2375-82 (2001)\"), list(REFERENCE = \"PMID:11905738\", AUTHORS = \"Rintoul RC, Sethi T.\", TITLE = \"The role of extracellular matrix in small-cell lung cancer.\", JOURNAL = c(\"Lancet Oncol 2:437-42 (2001)\", \"DOI:10.1016/S1470-2045(00)00421-6\")), list(REFERENCE = \"PMID:12243753\", AUTHORS = \"Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.\", TITLE = \"Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.\", JOURNAL = c(\"Exp Cell Res 279:277-90 (2002)\", \"DOI:10.1006/excr.2002.5608\")), list(REFERENCE = \"PMID:12379883\", AUTHORS = \"Osada H, Takahashi T.\", TITLE = \"Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.\", JOURNAL = c(\"Oncogene 21:7421-34 (2002)\", \"DOI:10.1038/sj.onc.1205802\")), list(REFERENCE = \"PMID:12741677\", AUTHORS = \"Yokota J, Nishioka M, Tani M, Kohno T.\", TITLE = \"Genetic alterations responsible for metastatic phenotypes of lung cancer cells.\", JOURNAL = \"Clin Exp Metastasis 20:189-93 (2003)\"), list(REFERENCE = \"PMID:16870043\", AUTHORS = \"Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.\", TITLE = \"K-ras mutations in non-small-cell lung carcinoma: a review.\", JOURNAL = c(\"Clin Lung Cancer 8:30-8 (2006)\", \"DOI:10.3816/CLC.2006.n.030\")), list(REFERENCE = \"PMID:15948711\", AUTHORS = \"Pfeifer GP, Dammann R.\", TITLE = \"Methylation of the tumor suppressor gene RASSF1A in human tumors.\", JOURNAL = \"Biochemistry (Mosc) 70:576-83 (2005)\"), list(REFERENCE = \"PMID:11902573\", AUTHORS = \"Altucci L, Gronemeyer H.\", TITLE = \"The promise of retinoids to fight against cancer.\", JOURNAL = c(\"Nat Rev Cancer 1:181-93 (2001)\", \"DOI:10.1038/35106036\")), list(REFERENCE = \"PMID:10944551\", AUTHORS = \"Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.\", TITLE = \"Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.\", JOURNAL = c(\"J Natl Cancer Inst 92:1303-7 (2000)\", \"DOI:10.1093/jnci/92.16.1303\")), list(REFERENCE = \"PMID:12867060\", AUTHORS = \"Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.\", TITLE = \"Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.\", JOURNAL = c(\"Lung Cancer 41 Suppl 1:S29-42 (2003)\", \"DOI:10.1016/S0169-5002(03)00137-5\")), list(REFERENCE = \"PMID:16112428\", AUTHORS = \"Panani AD, Roussos C.\", TITLE = \"Cytogenetic and molecular aspects of lung cancer.\", JOURNAL = c(\"Cancer Lett 239:1-9 (2006)\", \"DOI:10.1016/j.canlet.2005.06.030\")), list(REFERENCE = \"PMID:12407699\", AUTHORS = \"Mitsuuchi Y, Testa JR.\", TITLE = \"Cytogenetics and molecular genetics of lung cancer.\", JOURNAL = c(\"Am J Med Genet 115:183-8 (2002)\", \"DOI:10.1002/ajmg.10692\")), list(REFERENCE = \"PMID:15942304\", AUTHORS = \"Breuer RH, Postmus PE, Smit EF.\", TITLE = \"Molecular pathology of non-small-cell lung cancer.\", JOURNAL = c(\"Respiration 72:313-30 (2005)\", \"DOI:10.1159/000085376\")), list(REFERENCE = \"PMID:11895903\", AUTHORS = \"Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.\", TITLE = \"Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.\", JOURNAL = \"Clin Cancer Res 8:734-44 (2002)\"), list(REFERENCE = \"PMID:16189154\", AUTHORS = \"Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.\", TITLE = \"Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.\", JOURNAL = c(\"J Clin Pathol 58:1076-80 (2005)\", \"DOI:10.1136/jcp.2004.025585\")), list(REFERENCE = \"PMID:21193867\", AUTHORS = \"Lappano R, Maggiolini M\", TITLE = \"G protein-coupled receptors: novel targets for drug discovery in cancer.\", JOURNAL = c(\"Nat Rev Drug Discov 10:47-60 (2011)\", \"DOI:10.1038/nrd3320\")), list(REFERENCE = \"PMID:24508914\", AUTHORS = \"O\'Hayre M, Degese MS, Gutkind JS\", TITLE = \"Novel insights into G protein and G protein-coupled receptor signaling in cancer.\", JOURNAL = c(\"Curr Opin Cell Biol 27:126-35 (2014)\", \"DOI:10.1016/j.ceb.2014.01.005\")), list(REFERENCE = \"PMID:17251915\", AUTHORS = \"Dorsam RT, Gutkind JS\", TITLE = \"G-protein-coupled receptors and cancer.\", JOURNAL = c(\"Nat Rev Cancer 7:79-94 (2007)\", \"DOI:10.1038/nrc2069\"))', 'map05200', 'Pathways in cancer', 'Human Diseases; Cancer: overview', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (425, '05202', 'Transcriptional misregulation in cancer', 'In tumor cells, genes encoding transcription factors (TFs) are often amplified, deleted, rearranged via chromosomal translocation and inversion, or subjected to point mutations that result in a gain- or loss-of- function. In hematopoietic cancers and solid tumors, the translocations and inversions increase or deregulate transcription of the oncogene. Recurrent chromosome translocations generate novel fusion oncoproteins, which are common in myeloid cancers and soft-tissue sarcomas. The fusion proteins have aberrant transcriptional function compared to their wild-type counterparts. These fusion transcription factors alter expression of target genes, and thereby result in a variety of altered cellular properties that contribute to the tumourigenic process.', 'Human Diseases; Cancer: overview', 'Transcriptional misregulation in cancer', 'B-cell acute lymphoblastic leukemia, T-cell acute lymphoblastic leukemia, Acute myeloid leukemia, Hairy cell leukemia, Hodgkin lymphoma, Multiple myeloma, Lymphoplasmacytic lymphoma, Renal cell carcinoma, Prostate cancer, Thyroid cancer, Carcinoid, Ewing sarcoma, Rhabdomyosarcoma, Neuroblastoma, Myxoid liposarcoma, Synovial sarcoma, Alveolar soft part sarcoma, Clear cell sarcoma of soft tissue, Extraskeletal myxoid chondrosarcoma, Pituitary adenomas, Desmoplastic small round cell tumor', 'ko05202', 'list(REFERENCE = \"PMID:11607818\", AUTHORS = \"Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M, Pelicci PG\", TITLE = \"Common themes in the pathogenesis of acute myeloid leukemia.\", JOURNAL = c(\"Oncogene 20:5680-94 (2001)\", \"DOI:10.1038/sj.onc.1204642\")), list(REFERENCE = \"PMID:12032780\", AUTHORS = \"Scandura JM, Boccuni P, Cammenga J, Nimer SD\", TITLE = \"Transcription factor fusions in acute leukemia: variations on a theme.\", JOURNAL = c(\"Oncogene 21:3422-44 (2002)\", \"DOI:10.1038/sj.onc.1205315\")), list(REFERENCE = \"PMID:12529654\", AUTHORS = \"Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C\", TITLE = \"New mechanisms of AML1 gene alteration in hematological malignancies.\", JOURNAL = c(\"Leukemia 17:9-16 (2003)\", \"DOI:10.1038/sj.leu.2402766\")), list(REFERENCE = \"PMID:10717473\", AUTHORS = \"Lutterbach B, Hiebert SW\", TITLE = \"Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation.\", JOURNAL = c(\"Gene 245:223-35 (2000)\", \"DOI:10.1016/S0378-1119(00)00014-7\")), list(REFERENCE = \"PMID:19075268\", AUTHORS = \"Koschmieder S, Halmos B, Levantini E, Tenen DG\", TITLE = \"Dysregulation of the C/EBPalpha differentiation pathway in human cancer.\", JOURNAL = c(\"J Clin Oncol 27:619-28 (2009)\", \"DOI:10.1200/JCO.2008.17.9812\")), list(REFERENCE = \"PMID:11340171\", AUTHORS = \"Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR, Tenen DG\", TITLE = \"c-Myc is a critical target for c/EBPalpha in granulopoiesis.\", JOURNAL = c(\"Mol Cell Biol 21:3789-806 (2001)\", \"DOI:10.1128/MCB.21.11.3789-3806.2001\")), list(REFERENCE = \"PMID:15985538\", AUTHORS = \"Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP\", TITLE = \"Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia.\", JOURNAL = c(\"Blood 106:2827-36 (2005)\", \"DOI:10.1182/blood-2005-01-0358\")), list(REFERENCE = \"PMID:12393465\", AUTHORS = \"Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G\", TITLE = \"The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.\", JOURNAL = c(\"Blood 101:270-7 (2003)\", \"DOI:10.1182/blood-2002-04-1288\")), list(REFERENCE = \"PMID:12130514\", AUTHORS = \"Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD, Behre G, Hiddemann W, Ito Y, Tenen DG\", TITLE = \"Heterozygous PU.1 mutations are associated with acute myeloid leukemia.\", JOURNAL = c(\"Blood 100:998-1007 (2002)\", \"DOI:10.1182/blood.V100.3.998\")), list(REFERENCE = \"PMID:15160934\", AUTHORS = \"Jing Y\", TITLE = \"The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.\", JOURNAL = c(\"Leuk Lymphoma 45:639-48 (2004)\", \"DOI:10.1080/10428190310001609933\")), list(REFERENCE = \"PMID:15024077\", AUTHORS = \"Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Kohler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H\", TITLE = \"Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.\", JOURNAL = c(\"Mol Cell Biol 24:2890-904 (2004)\", \"DOI:10.1128/MCB.24.7.2890-2904.2004\")), list(REFERENCE = \"PMID:19855079\", AUTHORS = \"Rice KL, Hormaeche I, Doulatov S, Flatow JM, Grimwade D, Mills KI, Leiva M, Ablain J, Ambardekar C, McConnell MJ, Dick JE, Licht JD\", TITLE = \"Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.\", JOURNAL = c(\"Blood 114:5499-511 (2009)\", \"DOI:10.1182/blood-2009-03-206524\")), list(REFERENCE = \"PMID:10500199\", AUTHORS = \"McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C\", TITLE = \"Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 96:11464-9 (1999)\", \"DOI:10.1073/pnas.96.20.11464\")), list(REFERENCE = \"PMID:15156184\", AUTHORS = \"Zelent A, Greaves M, Enver T\", TITLE = \"Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia.\", JOURNAL = c(\"Oncogene 23:4275-83 (2004)\", \"DOI:10.1038/sj.onc.1207672\")), list(REFERENCE = \"PMID:14630078\", AUTHORS = \"Sawinska M, Ladon D\", TITLE = \"Mechanism, detection and clinical significance of the reciprocal translocation t(12;21)(p12;q22) in the children suffering from acute lymphoblastic leukaemia.\", JOURNAL = c(\"Leuk Res 28:35-42 (2004)\", \"DOI:10.1016/S0145-2126(03)00160-7\")), list(REFERENCE = \"PMID:19141473\", AUTHORS = \"Guenther MG, Lawton LN, Rozovskaia T, Frampton GM, Levine SS, Volkert TL, Croce CM, Nakamura T, Canaani E, Young RA\", TITLE = \"Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia.\", JOURNAL = c(\"Genes Dev 22:3403-8 (2008)\", \"DOI:10.1101/gad.1741408\")), list(REFERENCE = \"PMID:16169901\", AUTHORS = \"Xia ZB, Popovic R, Chen J, Theisler C, Stuart T, Santillan DA, Erfurth F, Diaz MO, Zeleznik-Le NJ\", TITLE = \"The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 102:14028-33 (2005)\", \"DOI:10.1073/pnas.0506464102\")), list(REFERENCE = \"PMID:21518926\", AUTHORS = \"Wang QF, Wu G, Mi S, He F, Wu J, Dong J, Luo RT, Mattison R, Kaberlein JJ, Prabhakar S, Ji H, Thirman MJ\", TITLE = \"MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.\", JOURNAL = c(\"Blood 117:6895-905 (2011)\", \"DOI:10.1182/blood-2010-12-324699\")), list(REFERENCE = \"PMID:14701735\", AUTHORS = \"Zeisig BB, Milne T, Garcia-Cuellar MP, Schreiner S, Martin ME, Fuchs U, Borkhardt A, Chanda SK, Walker J, Soden R, Hess JL, Slany RK\", TITLE = \"Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.\", JOURNAL = c(\"Mol Cell Biol 24:617-28 (2004)\", \"DOI:10.1128/MCB.24.2.617-628.2004\")), list(REFERENCE = \"PMID:19133982\", AUTHORS = \"Riz I, Hawley TS, Johnston H, Hawley RG\", TITLE = \"Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.\", JOURNAL = c(\"Br J Haematol 145:140-3 (2009)\", \"DOI:10.1111/j.1365-2141.2008.07556.x\")), list(REFERENCE = \"PMID:12511414\", AUTHORS = \"Barth TF, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G, Parwaresch RM, Lichter P, Siebert R, Mooller P\", TITLE = \"Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.\", JOURNAL = c(\"Blood 101:3681-6 (2003)\", \"DOI:10.1182/blood-2002-08-2577\")), list(REFERENCE = \"PMID:11313274\", AUTHORS = \"Hinz M, Loser P, Mathas S, Krappmann D, Dorken B, Scheidereit C\", TITLE = \"Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.\", JOURNAL = c(\"Blood 97:2798-807 (2001)\", \"DOI:10.1182/blood.V97.9.2798\")), list(REFERENCE = \"PMID:12670461\", AUTHORS = \"Zuzel M, Cawley JC.\", TITLE = \"The biology of hairy cells.\", JOURNAL = c(\"Best Pract Res Clin Haematol 16:1-13 (2003)\", \"DOI:10.1016/S1521-6926(02)00082-8\")), list(REFERENCE = \"PMID:14998494\", AUTHORS = \"Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM\", TITLE = \"Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma.\", JOURNAL = c(\"Cancer Cell 5:191-9 (2004)\", \"DOI:10.1016/S1535-6108(04)00019-4\")), list(REFERENCE = \"PMID:20974671\", AUTHORS = \"Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, Levens DL, Kelleher NL, Licht JD\", TITLE = \"The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.\", JOURNAL = c(\"Blood 117:211-20 (2011)\", \"DOI:10.1182/blood-2010-07-298349\")), list(REFERENCE = \"PMID:19059936\", AUTHORS = \"Brito JL, Walker B, Jenner M, Dickens NJ, Brown NJ, Ross FM, Avramidou A, Irving JA, Gonzalez D, Davies FE, Morgan GJ\", TITLE = \"MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.\", JOURNAL = c(\"Haematologica 94:78-86 (2009)\", \"DOI:10.3324/haematol.13426\")), list(REFERENCE = \"PMID:10350329\", AUTHORS = \"Iida S, Rao PH, Ueda R, Chaganti RS, Dalla-Favera R\", TITLE = \"Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).\", JOURNAL = c(\"Leuk Lymphoma 34:25-33 (1999)\", \"DOI:10.3109/10428199909083377\")), list(REFERENCE = \"PMID:10784387\", AUTHORS = \"Ohno H, Ueda C, Akasaka T\", TITLE = \"The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin\'s lymphoma.\", JOURNAL = c(\"Leuk Lymphoma 36:435-45 (2000)\", \"DOI:10.3109/10428190009148390\")), list(REFERENCE = \"PMID:19233641\", AUTHORS = \"Prensner JR, Chinnaiyan AM\", TITLE = \"Oncogenic gene fusions in epithelial carcinomas.\", JOURNAL = c(\"Curr Opin Genet Dev 19:82-91 (2009)\", \"DOI:10.1016/j.gde.2008.11.008\")), list(REFERENCE = \"PMID:19406209\", AUTHORS = \"Brenner JC, Chinnaiyan AM\", TITLE = \"Translocations in epithelial cancers.\", JOURNAL = c(\"Biochim Biophys Acta 1796:201-15 (2009)\", \"DOI:10.1016/j.bbcan.2009.04.005\")), list(REFERENCE = \"PMID:16946003\", AUTHORS = \"Reddi HV, McIver B, Grebe SK, Eberhardt NL\", TITLE = \"The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.\", JOURNAL = c(\"Endocrinology 148:932-5 (2007)\", \"DOI:10.1210/en.2006-0926\")), list(REFERENCE = \"PMID:19422821\", AUTHORS = \"Medendorp K, van Groningen JJ, Vreede L, Hetterschijt L, Brugmans L, van den Hurk WH, van Kessel AG\", TITLE = \"The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.\", JOURNAL = c(\"Exp Cell Res 315:2399-409 (2009)\", \"DOI:10.1016/j.yexcr.2009.04.022\")), list(REFERENCE = \"PMID:18563191\", AUTHORS = \"Kumar-Sinha C, Tomlins SA, Chinnaiyan AM\", TITLE = \"Recurrent gene fusions in prostate cancer.\", JOURNAL = c(\"Nat Rev Cancer 8:497-511 (2008)\", \"DOI:10.1038/nrc2402\")), list(REFERENCE = \"PMID:20478527\", AUTHORS = \"Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM\", TITLE = \"An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.\", JOURNAL = c(\"Cancer Cell 17:443-54 (2010)\", \"DOI:10.1016/j.ccr.2010.03.018\")), list(REFERENCE = \"PMID:21747944\", AUTHORS = \"Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R\", TITLE = \"TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.\", JOURNAL = c(\"PLoS One 6:e21650 (2011)\", \"DOI:10.1371/journal.pone.0021650\")), list(REFERENCE = \"PMID:17505060\", AUTHORS = \"Cai C, Hsieh CL, Omwancha J, Zheng Z, Chen SY, Baert JL, Shemshedini L\", TITLE = \"ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.\", JOURNAL = c(\"Mol Endocrinol 21:1835-46 (2007)\", \"DOI:10.1210/me.2006-0480\")), list(REFERENCE = \"PMID:18172298\", AUTHORS = \"Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM\", TITLE = \"Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.\", JOURNAL = c(\"Cancer Res 68:73-80 (2008)\", \"DOI:10.1158/0008-5472.CAN-07-5352\")), list(REFERENCE = \"PMID:21849159\", AUTHORS = \"Westermark UK, Wilhelm M, Frenzel A, Henriksson MA\", TITLE = \"The MYCN oncogene and differentiation in neuroblastoma.\", JOURNAL = c(\"Semin Cancer Biol 21:256-66 (2011)\", \"DOI:10.1016/j.semcancer.2011.08.001\")), list(REFERENCE = \"PMID:20153925\", AUTHORS = \"Bell E, Chen L, Liu T, Marshall GM, Lunec J, Tweddle DA\", TITLE = \"MYCN oncoprotein targets and their therapeutic potential.\", JOURNAL = c(\"Cancer Lett 293:144-57 (2010)\", \"DOI:10.1016/j.canlet.2010.01.015\")), list(REFERENCE = \"PMID:15644444\", AUTHORS = \"Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A, Shohet JM\", TITLE = \"The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 102:731-6 (2005)\", \"DOI:10.1073/pnas.0405495102\")), list(REFERENCE = \"PMID:20190806\", AUTHORS = \"Ochiai H, Takenobu H, Nakagawa A, Yamaguchi Y, Kimura M, Ohira M, Okimoto Y, Fujimura Y, Koseki H, Kohno Y, Nakagawara A, Kamijo T\", TITLE = \"Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.\", JOURNAL = c(\"Oncogene 29:2681-90 (2010)\", \"DOI:10.1038/onc.2010.22\")), list(REFERENCE = \"PMID:20145147\", AUTHORS = \"Chen L, Iraci N, Gherardi S, Gamble LD, Wood KM, Perini G, Lunec J, Tweddle DA\", TITLE = \"p53 is a direct transcriptional target of MYCN in neuroblastoma.\", JOURNAL = c(\"Cancer Res 70:1377-88 (2010)\", \"DOI:10.1158/0008-5472.CAN-09-2598\")), list(REFERENCE = \"PMID:17327229\", AUTHORS = \"Beierle EA, Trujillo A, Nagaram A, Kurenova EV, Finch R, Ma X, Vella J, Cance WG, Golubovskaya VM\", TITLE = \"N-MYC regulates focal adhesion kinase expression in human neuroblastoma.\", JOURNAL = c(\"J Biol Chem 282:12503-16 (2007)\", \"DOI:10.1074/jbc.M701450200\")), list(REFERENCE = \"PMID:21123453\", AUTHORS = \"Iraci N, Diolaiti D, Papa A, Porro A, Valli E, Gherardi S, Herold S, Eilers M, Bernardoni R, Della Valle G, Perini G\", TITLE = \"A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF.\", JOURNAL = c(\"Cancer Res 71:404-12 (2011)\", \"DOI:10.1158/0008-5472.CAN-10-2627\")), list(REFERENCE = \"PMID:17024155\", AUTHORS = \"Dreijerink KM, Hoppener JW, Timmers HM, Lips CJ\", TITLE = \"Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.\", JOURNAL = c(\"Nat Clin Pract Endocrinol Metab 2:562-70 (2006)\", \"DOI:10.1038/ncpendmet0292\")), list(REFERENCE = \"PMID:19075677\", AUTHORS = \"Wu X, Hua X\", TITLE = \"Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.\", JOURNAL = c(\"Curr Mol Med 8:805-15 (2008)\", \"DOI:10.2174/156652408786733702\")), list(REFERENCE = \"PMID:19564705\", AUTHORS = \"Sakurai A, Murakami A, Sano K, Uchino S, Fukushima Y\", TITLE = \"Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1.\", JOURNAL = c(\"Endocr J 56:887-95 (2009)\", \"DOI:10.1507/endocrj.K09E-126\")), list(REFERENCE = \"PMID:17222504\", AUTHORS = \"Yang Y, Hua X\", TITLE = \"In search of tumor suppressing functions of menin.\", JOURNAL = c(\"Mol Cell Endocrinol 265-266:34-41 (2007)\", \"DOI:10.1016/j.mce.2006.12.032\")), list(REFERENCE = \"PMID:15826838\", AUTHORS = \"Aman P\", TITLE = \"Fusion oncogenes in tumor development.\", JOURNAL = c(\"Semin Cancer Biol 15:236-43 (2005)\", \"DOI:10.1016/j.semcancer.2005.01.009\")), list(REFERENCE = \"PMID:12527902\", AUTHORS = \"Fukuma M, Okita H, Hata J, Umezawa A\", TITLE = \"Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.\", JOURNAL = c(\"Oncogene 22:1-9 (2003)\", \"DOI:10.1038/sj.onc.1206055\")), list(REFERENCE = \"PMID:18648544\", AUTHORS = \"Cironi L, Riggi N, Provero P, Wolf N, Suva ML, Suva D, Kindler V, Stamenkovic I\", TITLE = \"IGF1 is a common target gene of Ewing\'s sarcoma fusion proteins in mesenchymal progenitor cells.\", JOURNAL = c(\"PLoS One 3:e2634 (2008)\", \"DOI:10.1371/journal.pone.0002634\")), list(REFERENCE = \"PMID:17250957\", AUTHORS = \"Riggi N, Stamenkovic I.\", TITLE = \"The Biology of Ewing sarcoma.\", JOURNAL = c(\"Cancer Lett 254:1-10 (2007)\", \"DOI:10.1016/j.canlet.2006.12.009\")), list(REFERENCE = \"PMID:20490326\", AUTHORS = \"Jedlicka P\", TITLE = \"Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.\", JOURNAL = \"Int J Clin Exp Pathol 3:338-47 (2010)\"), list(REFERENCE = \"PMID:19738075\", AUTHORS = \"Ordonez JL, Osuna D, Herrero D, de Alava E, Madoz-Gurpide J\", TITLE = \"Advances in Ewing\'s sarcoma research: where are we now and what lies ahead?\", JOURNAL = c(\"Cancer Res 69:7140-50 (2009)\", \"DOI:10.1158/0008-5472.CAN-08-4041\")), list(REFERENCE = \"PMID:12527906\", AUTHORS = \"Jishage M, Fujino T, Yamazaki Y, Kuroda H, Nakamura T\", TITLE = \"Identification of target genes for EWS/ATF-1 chimeric transcription factor.\", JOURNAL = c(\"Oncogene 22:41-9 (2003)\", \"DOI:10.1038/sj.onc.1206074\")), list(REFERENCE = \"PMID:15826834\", AUTHORS = \"Gerald WL, Haber DA\", TITLE = \"The EWS-WT1 gene fusion in desmoplastic small round cell tumor.\", JOURNAL = c(\"Semin Cancer Biol 15:197-205 (2005)\", \"DOI:10.1016/j.semcancer.2005.01.005\")), list(REFERENCE = \"PMID:18855877\", AUTHORS = \"Filion C, Motoi T, Olshen AB, Lae M, Emnett RJ, Gutmann DH, Perry A, Ladanyi M, Labelle Y\", TITLE = \"The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.\", JOURNAL = c(\"J Pathol 217:83-93 (2009)\", \"DOI:10.1002/path.2445\")), list(REFERENCE = \"PMID:18330902\", AUTHORS = \"Kim S, Lee HJ, Jun HJ, Kim J\", TITLE = \"The hTAF II 68-TEC fusion protein functions as a strong transcriptional activator.\", JOURNAL = c(\"Int J Cancer 122:2446-53 (2008)\", \"DOI:10.1002/ijc.23379\")), list(REFERENCE = \"PMID:10537274\", AUTHORS = \"Sjogren H, Meis-Kindblom J, Kindblom LG, Aman P, Stenman G\", TITLE = \"Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.\", JOURNAL = \"Cancer Res 59:5064-7 (1999)\"), list(REFERENCE = \"PMID:15688424\", AUTHORS = \"Goransson M, Elias E, Stahlberg A, Olofsson A, Andersson C, Aman P\", TITLE = \"Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.\", JOURNAL = c(\"Int J Cancer 115:556-60 (2005)\", \"DOI:10.1002/ijc.20893\")), list(REFERENCE = \"PMID:18850010\", AUTHORS = \"Goransson M, Andersson MK, Forni C, Stahlberg A, Andersson C, Olofsson A, Mantovani R, Aman P\", TITLE = \"The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.\", JOURNAL = c(\"Oncogene 28:270-8 (2009)\", \"DOI:10.1038/onc.2008.378\")), list(REFERENCE = \"PMID:20863376\", AUTHORS = \"Willems SM, Schrage YM, Bruijn IH, Szuhai K, Hogendoorn PC, Bovee JV\", TITLE = \"Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.\", JOURNAL = c(\"Mol Cancer 9:257 (2010)\", \"DOI:10.1186/1476-4598-9-257\")), list(REFERENCE = \"PMID:18457914\", AUTHORS = \"Linardic CM\", TITLE = \"PAX3-FOXO1 fusion gene in rhabdomyosarcoma.\", JOURNAL = c(\"Cancer Lett 270:10-8 (2008)\", \"DOI:10.1016/j.canlet.2008.03.035\")), list(REFERENCE = \"PMID:11863357\", AUTHORS = \"Barber TD, Barber MC, Tomescu O, Barr FG, Ruben S, Friedman TB\", TITLE = \"Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma.\", JOURNAL = c(\"Genomics 79:278-84 (2002)\", \"DOI:10.1006/geno.2002.6703\")), list(REFERENCE = \"PMID:17101797\", AUTHORS = \"Ishida M, Miyamoto M, Naitoh S, Tatsuda D, Hasegawa T, Nemoto T, Yokozeki H, Nishioka K, Matsukage A, Ohki M, Ohta T\", TITLE = \"The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma.\", JOURNAL = c(\"Mol Cell Biol 27:1348-55 (2007)\", \"DOI:10.1128/MCB.00658-06\")), list(REFERENCE = \"PMID:19472090\", AUTHORS = \"Jun HJ, Lee J, Lim do H, Park JO, Ahn G, Seo SW, Sung KS, Lim do H, Yoo KH, Choi YL\", TITLE = \"Expression of MET in alveolar soft part sarcoma.\", JOURNAL = c(\"Med Oncol 27:459-65 (2010)\", \"DOI:10.1007/s12032-009-9234-8\")), list(REFERENCE = \"PMID:21779514\", AUTHORS = \"Rivlin N, Brosh R, Oren M, Rotter V\", TITLE = \"Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.\", JOURNAL = c(\"Genes Cancer 2:466-74 (2011)\", \"DOI:10.1177/1947601911408889\")), list(REFERENCE = \"PMID:21765642\", AUTHORS = \"Suzuki K, Matsubara H\", TITLE = \"Recent advances in p53 research and cancer treatment.\", JOURNAL = c(\"J Biomed Biotechnol 2011:978312 (2011)\", \"DOI:10.1155/2011/978312\"))', 'map05202', 'Transcriptional misregulation in cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (426, '05203', 'Viral carcinogenesis', 'There is a strong association between viruses and the development of human malignancies. We now know that at least six human viruses, Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), human papilloma virus (HPV), human T-cell lymphotropic virus (HTLV-1) and Kaposi\'s associated sarcoma virus (KSHV) contribute to 10-15% of the cancers worldwide. Via expression of many potent oncoproteins, these tumor viruses promote an aberrant cell-proliferation via modulating cellular cell-signaling pathways and escape from cellular defense system such as blocking apoptosis. Human tumor virus oncoproteins can also disrupt pathways that are necessary for the maintenance of the integrity of host cellular genome. Viruses that encode such activities can contribute to initiation as well as progression of human cancers.', 'Human Diseases; Cancer: overview', 'Viral carcinogenesis', 'Hodgkin lymphoma, Burkitt lymphoma, Adult T-cell leukemia, Penile cancer, Cervical cancer, Kaposi sarcoma, Cancer of the anal canal, Hepatocellular carcinoma, Nasopharyngeal cancer', 'ko05203', 'list(REFERENCE = \"PMID:18201576\", AUTHORS = \"McLaughlin-Drubin ME, Munger K\", TITLE = \"Viruses associated with human cancer.\", JOURNAL = c(\"Biochim Biophys Acta 1782:127-50 (2008)\", \"DOI:10.1016/j.bbadis.2007.12.005\")), list(REFERENCE = \"PMID:21102637\", AUTHORS = \"Moore PS, Chang Y\", TITLE = \"Why do viruses cause cancer? Highlights of the first century of human tumour virology.\", JOURNAL = c(\"Nat Rev Cancer 10:878-89 (2010)\", \"DOI:10.1038/nrc2961\")), list(REFERENCE = \"PMID:19400863\", AUTHORS = \"Kalland KH, Ke XS, Oyan AM\", TITLE = \"Tumour virology--history, status and future challenges.\", JOURNAL = c(\"APMIS 117:382-99 (2009)\", \"DOI:10.1111/j.1600-0463.2009.02452.x\")), list(REFERENCE = \"PMID:17979705\", AUTHORS = \"Boccardo E, Villa LL\", TITLE = \"Viral origins of human cancer.\", JOURNAL = c(\"Curr Med Chem 14:2526-39 (2007)\", \"DOI:10.2174/092986707782023316\")), list(REFERENCE = \"PMID:21084867\", AUTHORS = \"Saha A, Kaul R, Murakami M, Robertson ES\", TITLE = \"Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.\", JOURNAL = c(\"Cancer Biol Ther 10:961-78 (2010)\", \"DOI:10.4161/cbt.10.10.13923\")), list(REFERENCE = \"PMID:21152115\", AUTHORS = \"Zheng ZM\", TITLE = \"Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.\", JOURNAL = c(\"Int J Biol Sci 6:730-55 (2010)\", \"DOI:10.7150/ijbs.6.730\")), list(REFERENCE = \"PMID:19956178\", AUTHORS = \"Martin D, Gutkind JS\", TITLE = \"Human tumor-associated viruses and new insights into the molecular mechanisms of cancer.\", JOURNAL = c(\"Oncogene 27 Suppl 2:S31-42 (2008)\", \"DOI:10.1038/onc.2009.351\")), list(REFERENCE = \"PMID:16459163\", AUTHORS = \"Zhang X, Zhang H, Ye L\", TITLE = \"Effects of hepatitis B virus X protein on the development of liver cancer.\", JOURNAL = c(\"J Lab Clin Med 147:58-66 (2006)\", \"DOI:10.1016/j.lab.2005.10.003\")), list(REFERENCE = \"PMID:12686421\", AUTHORS = \"Panteva M, Korkaya H, Jameel S\", TITLE = \"Hepatitis viruses and the MAPK pathway: is this a survival strategy?\", JOURNAL = c(\"Virus Res 92:131-40 (2003)\", \"DOI:10.1016/S0168-1702(02)00356-8\")), list(REFERENCE = \"PMID:21647825\", AUTHORS = \"Ng SA, Lee C\", TITLE = \"Hepatitis B virus X gene and hepatocarcinogenesis.\", JOURNAL = c(\"J Gastroenterol 46:974-90 (2011)\", \"DOI:10.1007/s00535-011-0415-9\")), list(REFERENCE = \"PMID:21966251\", AUTHORS = \"Nishida N, Goel A\", TITLE = \"Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.\", JOURNAL = c(\"Curr Genomics 12:130-7 (2011)\", \"DOI:10.2174/138920211795564359\")), list(REFERENCE = \"PMID:19854353\", AUTHORS = \"Benhenda S, Cougot D, Buendia MA, Neuveut C\", TITLE = \"Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis.\", JOURNAL = c(\"Adv Cancer Res 103:75-109 (2009)\", \"DOI:10.1016/S0065-230X(09)03004-8\")), list(REFERENCE = \"PMID:18251977\", AUTHORS = \"Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ\", TITLE = \"Viral hepatocarcinogenesis: from infection to cancer.\", JOURNAL = c(\"Liver Int 28:175-88 (2008)\", \"DOI:10.1111/j.1478-3231.2007.01652.x\")), list(REFERENCE = \"PMID:9343405\", AUTHORS = \"Klein NP, Schneider RJ\", TITLE = \"Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.\", JOURNAL = c(\"Mol Cell Biol 17:6427-36 (1997)\", \"DOI:10.1128/MCB.17.11.6427\")), list(REFERENCE = \"PMID:16039586\", AUTHORS = \"Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC\", TITLE = \"Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.\", JOURNAL = c(\"Mol Cell 19:159-70 (2005)\", \"DOI:10.1016/j.molcel.2005.06.009\")), list(REFERENCE = \"PMID:21994562\", AUTHORS = \"Benhenda S, Cougot D, Neuveut C, Buendia MA\", TITLE = \"Liver cell transformation in chronic HBV infection.\", JOURNAL = c(\"Viruses 1:630-46 (2009)\", \"DOI:10.3390/v1030630\")), list(REFERENCE = \"PMID:11099494\", AUTHORS = \"Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD\", TITLE = \"X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway.\", JOURNAL = c(\"J Biol Chem 276:8328-40 (2001)\", \"DOI:10.1074/jbc.M006026200\")), list(REFERENCE = \"PMID:10824878\", AUTHORS = \"Arbuthnot P, Capovilla A, Kew M\", TITLE = \"Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.\", JOURNAL = c(\"J Gastroenterol Hepatol 15:357-68 (2000)\", \"DOI:10.1046/j.1440-1746.2000.02069.x\")), list(REFERENCE = \"PMID:9837909\", AUTHORS = \"Gottlob K, Fulco M, Levrero M, Graessmann A\", TITLE = \"The hepatitis B virus HBx protein inhibits caspase 3 activity.\", JOURNAL = c(\"J Biol Chem 273:33347-53 (1998)\", \"DOI:10.1074/jbc.273.50.33347\")), list(REFERENCE = \"PMID:15614436\", AUTHORS = \"Zhang JL, Zhao WG, Wu KL, Wang K, Zhang X, Gu CF, Li Y, Zhu Y, Wu JG\", TITLE = \"Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin.\", JOURNAL = c(\"Arch Virol 150:721-41 (2005)\", \"DOI:10.1007/s00705-004-0446-0\")), list(REFERENCE = \"PMID:15105524\", AUTHORS = \"Cooray S\", TITLE = \"The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival.\", JOURNAL = c(\"J Gen Virol 85:1065-76 (2004)\", \"DOI:10.1099/vir.0.19771-0\")), list(REFERENCE = \"PMID:16939421\", AUTHORS = \"Mukherji A, Janbandhu VC, Kumar V\", TITLE = \"HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1.\", JOURNAL = c(\"Biochem J 401:247-56 (2007)\", \"DOI:10.1042/BJ20061091\")), list(REFERENCE = \"PMID:15173177\", AUTHORS = \"Yoo YG, Lee MO\", TITLE = \"Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.\", JOURNAL = c(\"J Biol Chem 279:36242-9 (2004)\", \"DOI:10.1074/jbc.M401290200\")), list(REFERENCE = \"PMID:11604508\", AUTHORS = \"Waris G, Huh KW, Siddiqui A\", TITLE = \"Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress.\", JOURNAL = c(\"Mol Cell Biol 21:7721-30 (2001)\", \"DOI:10.1128/MCB.21.22.7721-7730.2001\")), list(REFERENCE = \"PMID:17894800\", AUTHORS = \"Kasprzak A, Adamek A\", TITLE = \"Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis.\", JOURNAL = c(\"Hepatol Res 38:1-26 (2008)\", \"DOI:10.1111/j.1872-034X.2007.00261.x\")), list(REFERENCE = \"PMID:9882379\", AUTHORS = \"You LR, Chen CM, Lee YH\", TITLE = \"Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha.\", JOURNAL = \"J Virol 73:1672-81 (1999)\"), list(REFERENCE = \"PMID:16581947\", AUTHORS = \"Sato Y, Kato J, Takimoto R, Takada K, Kawano Y, Miyanishi K, Kobune M, Sato Y, Takayama T, Matunaga T, Niitsu Y\", TITLE = \"Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.\", JOURNAL = c(\"Gut 55:1801-8 (2006)\", \"DOI:10.1136/gut.2005.070417\")), list(REFERENCE = \"PMID:14559998\", AUTHORS = \"Watashi K, Hijikata M, Tagawa A, Doi T, Marusawa H, Shimotohno K\", TITLE = \"Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.\", JOURNAL = c(\"Mol Cell Biol 23:7498-509 (2003)\", \"DOI:10.1128/MCB.23.21.7498-7509.2003\")), list(REFERENCE = \"PMID:9651361\", AUTHORS = \"Hsieh TY, Matsumoto M, Chou HC, Schneider R, Hwang SB, Lee AS, Lai MM\", TITLE = \"Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K.\", JOURNAL = c(\"J Biol Chem 273:17651-9 (1998)\", \"DOI:10.1074/jbc.273.28.17651\")), list(REFERENCE = \"PMID:10873631\", AUTHORS = \"Wang F, Yoshida I, Takamatsu M, Ishido S, Fujita T, Oka K, Hotta H\", TITLE = \"Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1.\", JOURNAL = c(\"Biochem Biophys Res Commun 273:479-84 (2000)\", \"DOI:10.1006/bbrc.2000.2970\")), list(REFERENCE = \"PMID:10074132\", AUTHORS = \"You LR, Chen CM, Yeh TS, Tsai TY, Mai RT, Lin CH, Lee YH\", TITLE = \"Hepatitis C virus core protein interacts with cellular putative RNA helicase.\", JOURNAL = \"J Virol 73:2841-53 (1999)\"), list(REFERENCE = \"PMID:10644344\", AUTHORS = \"Aoki H, Hayashi J, Moriyama M, Arakawa Y, Hino O\", TITLE = \"Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1.\", JOURNAL = c(\"J Virol 74:1736-41 (2000)\", \"DOI:10.1128/JVI.74.4.1736-1741.2000\")), list(REFERENCE = \"PMID:17267064\", AUTHORS = \"Yan XB, Battaglia S, Boucreux D, Chen Z, Brechot C, Pavio N\", TITLE = \"Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR.\", JOURNAL = c(\"Virus Res 125:79-87 (2007)\", \"DOI:10.1016/j.virusres.2006.12.010\")), list(REFERENCE = \"PMID:9060639\", AUTHORS = \"Borowski P, Oehlmann K, Heiland M, Laufs R\", TITLE = \"Nonstructural protein 3 of hepatitis C virus blocks the distribution of the free catalytic subunit of cyclic AMP-dependent protein kinase.\", JOURNAL = \"J Virol 71:2838-43 (1997)\"), list(REFERENCE = \"PMID:10405893\", AUTHORS = \"Borowski P, Kuhl R, Laufs R, Schulze zur Wiesch J, Heiland M\", TITLE = \"Identification and characterization of a histone binding site of the non-structural protein 3 of hepatitis C virus.\", JOURNAL = c(\"J Clin Virol 13:61-9 (1999)\", \"DOI:10.1016/S1386-6532(99)00007-4\")), list(REFERENCE = \"PMID:12101418\", AUTHORS = \"Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD\", TITLE = \"HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.\", JOURNAL = c(\"Oncogene 21:4801-11 (2002)\", \"DOI:10.1038/sj.onc.1205589\")), list(REFERENCE = \"PMID:12925958\", AUTHORS = \"Chung YL, Sheu ML, Yen SH\", TITLE = \"Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma.\", JOURNAL = c(\"Int J Cancer 107:65-73 (2003)\", \"DOI:10.1002/ijc.11303\")), list(REFERENCE = \"PMID:10400746\", AUTHORS = \"Gale M Jr, Kwieciszewski B, Dossett M, Nakao H, Katze MG\", TITLE = \"Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.\", JOURNAL = \"J Virol 73:6506-16 (1999)\"), list(REFERENCE = \"PMID:12186904\", AUTHORS = \"He Y, Nakao H, Tan SL, Polyak SJ, Neddermann P, Vijaysri S, Jacobs BL, Katze MG\", TITLE = \"Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase.\", JOURNAL = c(\"J Virol 76:9207-17 (2002)\", \"DOI:10.1128/JVI.76.18.9207-9217.2002\")), list(REFERENCE = \"PMID:15795286\", AUTHORS = \"Street A, Macdonald A, McCormick C, Harris M\", TITLE = \"Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription.\", JOURNAL = c(\"J Virol 79:5006-16 (2005)\", \"DOI:10.1128/JVI.79.8.5006-5016.2005\")), list(REFERENCE = \"PMID:11886269\", AUTHORS = \"Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, Ray RB\", TITLE = \"Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.\", JOURNAL = c(\"Virology 294:94-105 (2002)\", \"DOI:10.1006/viro.2001.1309\")), list(REFERENCE = \"PMID:11278402\", AUTHORS = \"Arima N, Kao CY, Licht T, Padmanabhan R, Sasaguri Y, Padmanabhan R\", TITLE = \"Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A.\", JOURNAL = c(\"J Biol Chem 276:12675-84 (2001)\", \"DOI:10.1074/jbc.M008329200\")), list(REFERENCE = \"PMID:21250384\", AUTHORS = \"He Y, Staschke KA, Tan SL\", TITLE = \"HCV NS5A: A Multifunctional Regulator of Cellular Pathways and Virus Replication\", JOURNAL = \"Hepatitis C Viruses: Genomes and Molecular Biology (2006)\"), list(REFERENCE = \"PMID:12379483\", AUTHORS = \"Qadri I, Iwahashi M, Simon F\", TITLE = \"Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3.\", JOURNAL = c(\"Biochim Biophys Acta 1592:193-204 (2002)\", \"DOI:10.1016/S0167-4889(02)00315-4\")), list(REFERENCE = \"PMID:22110506\", AUTHORS = \"Spender LC, Inman GJ\", TITLE = \"Inhibition of germinal centre apoptotic programmes by epstein-barr virus.\", JOURNAL = c(\"Adv Hematol 2011:829525 (2011)\", \"DOI:10.1155/2011/829525\")), list(REFERENCE = \"PMID:20494113\", AUTHORS = \"Klein G, Klein E, Kashuba E\", TITLE = \"Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.\", JOURNAL = c(\"Biochem Biophys Res Commun 396:67-73 (2010)\", \"DOI:10.1016/j.bbrc.2010.02.146\")), list(REFERENCE = \"PMID:21372216\", AUTHORS = \"Saha A, Robertson ES\", TITLE = \"Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.\", JOURNAL = c(\"Clin Cancer Res 17:3056-63 (2011)\", \"DOI:10.1158/1078-0432.CCR-10-2578\")), list(REFERENCE = \"PMID:15510157\", AUTHORS = \"Young LS, Rickinson AB.\", TITLE = \"Epstein-Barr virus: 40 years on.\", JOURNAL = c(\"Nat Rev Cancer 4:757-68 (2004)\", \"DOI:10.1038/nrc1452\")), list(REFERENCE = \"PMID:14506283\", AUTHORS = \"Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L\", TITLE = \"Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.\", JOURNAL = c(\"J Biol Chem 278:47753-61 (2003)\", \"DOI:10.1074/jbc.M307200200\")), list(REFERENCE = \"PMID:11160754\", AUTHORS = \"Harada S, Yalamanchili R, Kieff E\", TITLE = \"Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association.\", JOURNAL = c(\"J Virol 75:2482-7 (2001)\", \"DOI:10.1128/JVI.75.5.2482-2487.2001\")), list(REFERENCE = \"PMID:15452270\", AUTHORS = \"Peng CW, Zhao B, Kieff E\", TITLE = \"Four EBNA2 domains are important for EBNALP coactivation.\", JOURNAL = c(\"J Virol 78:11439-42 (2004)\", \"DOI:10.1128/JVI.78.20.11439-11442.2004\")), list(REFERENCE = \"PMID:15767449\", AUTHORS = \"Peng R, Moses SC, Tan J, Kremmer E, Ling PD\", TITLE = \"The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.\", JOURNAL = c(\"J Virol 79:4492-505 (2005)\", \"DOI:10.1128/JVI.79.7.4492-4505.2005\")), list(REFERENCE = \"PMID:21177815\", AUTHORS = \"Saha A, Bamidele A, Murakami M, Robertson ES\", TITLE = \"EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.\", JOURNAL = c(\"J Virol 85:2079-88 (2011)\", \"DOI:10.1128/JVI.02279-10\")), list(REFERENCE = \"PMID:21347341\", AUTHORS = \"Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES\", TITLE = \"Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.\", JOURNAL = c(\"PLoS Pathog 7:e1001275 (2011)\", \"DOI:10.1371/journal.ppat.1001275\")), list(REFERENCE = \"PMID:15542638\", AUTHORS = \"Knight JS, Sharma N, Kalman DE, Robertson ES\", TITLE = \"A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.\", JOURNAL = c(\"J Virol 78:12857-67 (2004)\", \"DOI:10.1128/JVI.78.23.12857-12867.2004\")), list(REFERENCE = \"PMID:14747563\", AUTHORS = \"Knight JS, Robertson ES\", TITLE = \"Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity.\", JOURNAL = c(\"J Virol 78:1981-91 (2004)\", \"DOI:10.1128/JVI.78.4.1981-1991.2004\")), list(REFERENCE = \"PMID:16352731\", AUTHORS = \"Knight JS, Sharma N, Robertson ES\", TITLE = \"Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 102:18562-6 (2005)\", \"DOI:10.1073/pnas.0503886102\")), list(REFERENCE = \"PMID:18391203\", AUTHORS = \"Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Isaguliants M, Szekely L, Klein G\", TITLE = \"EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 105:5489-94 (2008)\", \"DOI:10.1073/pnas.0801053105\")), list(REFERENCE = \"PMID:11091847\", AUTHORS = \"Young LS, Dawson CW, Eliopoulos AG\", TITLE = \"The expression and function of Epstein-Barr virus encoded latent genes.\", JOURNAL = c(\"Mol Pathol 53:238-47 (2000)\", \"DOI:10.1136/mp.53.5.238\")), list(REFERENCE = \"PMID:19078975\", AUTHORS = \"Kuppers R\", TITLE = \"The biology of Hodgkin\'s lymphoma.\", JOURNAL = c(\"Nat Rev Cancer 9:15-27 (2009)\", \"DOI:10.1038/nrc2542\")), list(REFERENCE = \"PMID:17049016\", AUTHORS = \"Pattle SB, Farrell PJ\", TITLE = \"The role of Epstein-Barr virus in cancer.\", JOURNAL = c(\"Expert Opin Biol Ther 6:1193-205 (2006)\", \"DOI:10.1517/14712598.6.11.1193\")), list(REFERENCE = \"PMID:11905817\", AUTHORS = \"Thorley-Lawson DA\", TITLE = \"Epstein-Barr virus: exploiting the immune system.\", JOURNAL = c(\"Nat Rev Immunol 1:75-82 (2001)\", \"DOI:10.1038/35095584\")), list(REFERENCE = \"PMID:11669605\", AUTHORS = \"Eliopoulos AG, Young LS\", TITLE = \"LMP1 structure and signal transduction.\", JOURNAL = c(\"Semin Cancer Biol 11:435-44 (2001)\", \"DOI:10.1006/scbi.2001.0410\")), list(REFERENCE = \"PMID:11766888\", AUTHORS = \"Dell G, Gaston K\", TITLE = \"Human papillomaviruses and their role in cervical cancer.\", JOURNAL = c(\"Cell Mol Life Sci 58:1923-42 (2001)\", \"DOI:10.1007/PL00000827\")), list(REFERENCE = \"PMID:10793105\", AUTHORS = \"zur Hausen H\", TITLE = \"Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.\", JOURNAL = c(\"J Natl Cancer Inst 92:690-8 (2000)\", \"DOI:10.1093/jnci/92.9.690\")), list(REFERENCE = \"PMID:19156753\", AUTHORS = \"Yugawa T, Kiyono T\", TITLE = \"Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.\", JOURNAL = c(\"Rev Med Virol 19:97-113 (2009)\", \"DOI:10.1002/rmv.605\")), list(REFERENCE = \"PMID:17645777\", AUTHORS = \"Narisawa-Saito M, Kiyono T\", TITLE = \"Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.\", JOURNAL = c(\"Cancer Sci 98:1505-11 (2007)\", \"DOI:10.1111/j.1349-7006.2007.00546.x\")), list(REFERENCE = \"PMID:15342967\", AUTHORS = \"Motoyama S, Ladines-Llave CA, Luis Villanueva S, Maruo T\", TITLE = \"The role of human papilloma virus in the molecular biology of cervical carcinogenesis.\", JOURNAL = \"Kobe J Med Sci 50:9-19 (2004)\"), list(REFERENCE = \"PMID:20592731\", AUTHORS = \"Moody CA, Laimins LA\", TITLE = \"Human papillomavirus oncoproteins: pathways to transformation.\", JOURNAL = c(\"Nat Rev Cancer 10:550-60 (2010)\", \"DOI:10.1038/nrc2886\")), list(REFERENCE = \"PMID:15956361\", AUTHORS = \"McCance DJ\", TITLE = \"Human papillomaviruses and cell signaling.\", JOURNAL = c(\"Sci STKE 2005:pe29 (2005)\", \"DOI:10.1126/stke.2882005pe29\")), list(REFERENCE = \"PMID:18385245\", AUTHORS = \"Wade R, Brimer N, Vande Pol S\", TITLE = \"Transformation by bovine papillomavirus type 1 E6 requires paxillin.\", JOURNAL = c(\"J Virol 82:5962-6 (2008)\", \"DOI:10.1128/JVI.02747-07\")), list(REFERENCE = \"PMID:9374493\", AUTHORS = \"Berezutskaya E, Bagchi S\", TITLE = \"The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome.\", JOURNAL = c(\"J Biol Chem 272:30135-40 (1997)\", \"DOI:10.1074/jbc.272.48.30135\")), list(REFERENCE = \"PMID:16381817\", AUTHORS = \"Zhang B, Chen W, Roman A\", TITLE = \"The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 103:437-42 (2006)\", \"DOI:10.1073/pnas.0510012103\")), list(REFERENCE = \"PMID:12970441\", AUTHORS = \"He W, Staples D, Smith C, Fisher C\", TITLE = \"Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.\", JOURNAL = c(\"J Virol 77:10566-74 (2003)\", \"DOI:10.1128/JVI.77.19.10566-10574.2003\")), list(REFERENCE = \"PMID:9349482\", AUTHORS = \"Massimi P, Pim D, Banks L\", TITLE = \"Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.\", JOURNAL = c(\"J Gen Virol 78 ( Pt 10):2607-13 (1997)\", \"DOI:10.1099/0022-1317-78-10-2607\")), list(REFERENCE = \"PMID:8617242\", AUTHORS = \"Antinore MJ, Birrer MJ, Patel D, Nader L, McCance DJ\", TITLE = \"The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors.\", JOURNAL = \"EMBO J 15:1950-60 (1996)\"), list(REFERENCE = \"PMID:9990017\", AUTHORS = \"Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P\", TITLE = \"Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 96:1291-6 (1999)\", \"DOI:10.1073/pnas.96.4.1291\")), list(REFERENCE = \"PMID:17384582\", AUTHORS = \"Matsuoka M, Jeang KT\", TITLE = \"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.\", JOURNAL = c(\"Nat Rev Cancer 7:270-80 (2007)\", \"DOI:10.1038/nrc2111\")), list(REFERENCE = \"PMID:15310405\", AUTHORS = \"Azran I, Schavinsky-Khrapunsky Y, Aboud M\", TITLE = \"Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity.\", JOURNAL = c(\"Retrovirology 1:20 (2004)\", \"DOI:10.1186/1742-4690-1-20\")), list(REFERENCE = \"PMID:12910250\", AUTHORS = \"Matsuoka M\", TITLE = \"Human T-cell leukemia virus type I and adult T-cell leukemia.\", JOURNAL = c(\"Oncogene 22:5131-40 (2003)\", \"DOI:10.1038/sj.onc.1206551\")), list(REFERENCE = \"PMID:11244044\", AUTHORS = \"Yoshida M\", TITLE = \"Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.\", JOURNAL = c(\"Annu Rev Immunol 19:475-96 (2001)\", \"DOI:10.1146/annurev.immunol.19.1.475\")), list(REFERENCE = \"PMID:18702816\", AUTHORS = \"Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L\", TITLE = \"The HTLV-1 Tax interactome.\", JOURNAL = c(\"Retrovirology 5:76 (2008)\", \"DOI:10.1186/1742-4690-5-76\")), list(REFERENCE = \"PMID:8223437\", AUTHORS = \"Caron C, Rousset R, Beraud C, Moncollin V, Egly JM, Jalinot P\", TITLE = \"Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP.\", JOURNAL = \"EMBO J 12:4269-78 (1993)\"), list(REFERENCE = \"PMID:8756622\", AUTHORS = \"Clemens KE, Piras G, Radonovich MF, Choi KS, Duvall JF, DeJong J, Roeder R, Brady JN\", TITLE = \"Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA.\", JOURNAL = c(\"Mol Cell Biol 16:4656-64 (1996)\", \"DOI:10.1128/MCB.16.9.4656\")), list(REFERENCE = \"PMID:16036567\", AUTHORS = \"Harhaj EW, Harhaj NS\", TITLE = \"Mechanisms of persistent NF-kappaB activation by HTLV-I tax.\", JOURNAL = c(\"IUBMB Life 57:83-91 (2005)\", \"DOI:10.1080/15216540500078715\")), list(REFERENCE = \"PMID:21743832\", AUTHORS = \"Qu Z, Xiao G\", TITLE = \"Human T-cell lymphotropic virus: a model of NF-kappaB-associated tumorigenesis.\", JOURNAL = c(\"Viruses 3:714-49 (2011)\", \"DOI:10.3390/v3060714\")), list(REFERENCE = \"PMID:16155601\", AUTHORS = \"Kashanchi F, Brady JN\", TITLE = \"Transcriptional and post-transcriptional gene regulation of HTLV-1.\", JOURNAL = c(\"Oncogene 24:5938-51 (2005)\", \"DOI:10.1038/sj.onc.1208973\")), list(REFERENCE = \"PMID:14530271\", AUTHORS = \"Wu K, Bottazzi ME, de la Fuente C, Deng L, Gitlin SD, Maddukuri A, Dadgar S, Li H, Vertes A, Pumfery A, Kashanchi F\", TITLE = \"Protein profile of tax-associated complexes.\", JOURNAL = c(\"J Biol Chem 279:495-508 (2004)\", \"DOI:10.1074/jbc.M310069200\")), list(REFERENCE = \"PMID:16155604\", AUTHORS = \"Grassmann R, Aboud M, Jeang KT\", TITLE = \"Molecular mechanisms of cellular transformation by HTLV-1 Tax.\", JOURNAL = c(\"Oncogene 24:5976-85 (2005)\", \"DOI:10.1038/sj.onc.1208978\")), list(REFERENCE = \"PMID:16308315\", AUTHORS = \"Tabakin-Fix Y, Azran I, Schavinky-Khrapunsky Y, Levy O, Aboud M\", TITLE = \"Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.\", JOURNAL = c(\"Carcinogenesis 27:673-81 (2006)\", \"DOI:10.1093/carcin/bgi274\")), list(REFERENCE = \"PMID:16760382\", AUTHORS = \"Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ\", TITLE = \"Kaposi\'s sarcoma-associated herpesvirus immune modulation: an overview.\", JOURNAL = c(\"J Gen Virol 87:1781-804 (2006)\", \"DOI:10.1099/vir.0.81919-0\")), list(REFERENCE = \"PMID:17457345\", AUTHORS = \"Coscoy L\", TITLE = \"Immune evasion by Kaposi\'s sarcoma-associated herpesvirus.\", JOURNAL = c(\"Nat Rev Immunol 7:391-401 (2007)\", \"DOI:10.1038/nri2076\")), list(REFERENCE = \"PMID:21040832\", AUTHORS = \"Cai Q, Verma SC, Lu J, Robertson ES\", TITLE = \"Molecular biology of Kaposi\'s sarcoma-associated herpesvirus and related oncogenesis.\", JOURNAL = c(\"Adv Virus Res 78:87-142 (2010)\", \"DOI:10.1016/B978-0-12-385032-4.00003-3\")), list(REFERENCE = \"PMID:16828973\", AUTHORS = \"Jarviluoma A, Ojala PM\", TITLE = \"Cell signaling pathways engaged by KSHV.\", JOURNAL = c(\"Biochim Biophys Acta 1766:140-58 (2006)\", \"DOI:10.1016/j.bbcan.2006.05.001\")), list(REFERENCE = \"PMID:18948197\", AUTHORS = \"Liang C, Lee JS, Jung JU\", TITLE = \"Immune evasion in Kaposi\'s sarcoma-associated herpes virus associated oncogenesis.\", JOURNAL = c(\"Semin Cancer Biol 18:423-36 (2008)\", \"DOI:10.1016/j.semcancer.2008.09.003\")), list(REFERENCE = \"PMID:19715458\", AUTHORS = \"Lee HR, Kim MH, Lee JS, Liang C, Jung JU\", TITLE = \"Viral interferon regulatory factors.\", JOURNAL = c(\"J Interferon Cytokine Res 29:621-7 (2009)\", \"DOI:10.1089/jir.2009.0067\")), list(REFERENCE = \"PMID:22566809\", AUTHORS = \"Jacobs SR, Damania B\", TITLE = \"The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?\", JOURNAL = c(\"Front Immunol 2:19 (2011)\", \"DOI:10.3389/fimmu.2011.00019\")), list(REFERENCE = \"PMID:19651473\", AUTHORS = \"Wen KW, Damania B\", TITLE = \"Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.\", JOURNAL = c(\"Cancer Lett 289:140-50 (2010)\", \"DOI:10.1016/j.canlet.2009.07.004\")), list(REFERENCE = \"PMID:15967719\", AUTHORS = \"Wang HW, Boshoff C\", TITLE = \"Linking Kaposi virus to cancer-associated cytokines.\", JOURNAL = c(\"Trends Mol Med 11:309-12 (2005)\", \"DOI:10.1016/j.molmed.2005.06.002\")), list(REFERENCE = \"PMID:15692053\", AUTHORS = \"McCormick C, Ganem D\", TITLE = \"The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.\", JOURNAL = c(\"Science 307:739-41 (2005)\", \"DOI:10.1126/science.1105779\")), list(REFERENCE = \"PMID:12770701\", AUTHORS = \"Verma SC, Robertson ES\", TITLE = \"Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.\", JOURNAL = c(\"FEMS Microbiol Lett 222:155-63 (2003)\", \"DOI:10.1016/S0378-1097(03)00261-1\")), list(REFERENCE = \"PMID:10354594\", AUTHORS = \"Schulz TF, Moore PS\", TITLE = \"Kaposi\'s sarcoma-associated herpesvirus: a new human tumor virus, but how?\", JOURNAL = c(\"Trends Microbiol 7:196-200 (1999)\", \"DOI:10.1016/S0966-842X(99)01495-X\")), list(REFERENCE = \"PMID:10855768\", AUTHORS = \"Schulz TF\", TITLE = \"Kaposi\'s sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis.\", JOURNAL = c(\"J Antimicrob Chemother 45 Suppl T3:15-27 (2000)\", \"DOI:10.1093/jac/45.suppl_4.15\")), list(REFERENCE = \"PMID:9594662\", AUTHORS = \"Moore PS, Chang Y\", TITLE = \"Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV.\", JOURNAL = c(\"Trends Genet 14:144-50 (1998)\", \"DOI:10.1016/S0168-9525(98)01408-5\")), list(REFERENCE = \"PMID:20534855\", AUTHORS = \"Pietrek M, Brinkmann MM, Glowacka I, Enlund A, Havemeier A, Dittrich-Breiholz O, Kracht M, Lewitzky M, Saksela K, Feller SM, Schulz TF\", TITLE = \"Role of the Kaposi\'s sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation.\", JOURNAL = c(\"J Virol 84:8231-40 (2010)\", \"DOI:10.1128/JVI.01696-09\")), list(REFERENCE = \"PMID:21421561\", AUTHORS = \"Bagneris C, Briggs LC, Savva R, Ebrahimi B, Barrett TE\", TITLE = \"Crystal structure of a KSHV-SOX-DNA complex: insights into the molecular mechanisms underlying DNase activity and host shutoff.\", JOURNAL = c(\"Nucleic Acids Res 39:5744-56 (2011)\", \"DOI:10.1093/nar/gkr111\")), list(REFERENCE = \"PMID:15919895\", AUTHORS = \"Glaunsinger B, Chavez L, Ganem D\", TITLE = \"The exonuclease and host shutoff functions of the SOX protein of Kaposi\'s sarcoma-associated herpesvirus are genetically separable.\", JOURNAL = c(\"J Virol 79:7396-401 (2005)\", \"DOI:10.1128/JVI.79.12.7396-7401.2005\"))', 'map05203', 'Viral carcinogenesis', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (427, '05204', 'Chemical carcinogenesis', 'It has been estimated that exposure to environmental chemical carcinogens may contribute significantly to the causation of a sizable fraction, perhaps a majority, of human cancers. Human carcinogens act through a variety of genotoxic and non-genotoxic mechanisms. Genotoxic carcinogens can attack biological macromolecules such as DNA and RNA either directly or indirectly through metabolism, resulting in the formation of adducts with these macromolecules. If DNA adducts escape cellular repair mechanisms and persist, they may lead to miscoding, resulting in permanent mutations. Non-genotoxic carcinogens act by the mechanisms such as induction of inflammation, immunosuppression, formation of reactive oxygen species, activation of receptors, and epigenetic silencing. Together, these genotoxic and non-genotoxic mechanisms can alter signal-transduction pathways that finally result in hypermutability, genomic instability, loss of proliferation control, and resistance to apoptosis - some of the characteristic features of cancer cells.', 'Human Diseases; Cancer: overview', 'Chemical carcinogenesis', 'ko05204', 'list(REFERENCE = \"PMID:15660110\", AUTHORS = \"Luch A.\", TITLE = \"Nature and nurture - lessons from chemical carcinogenesis.\", JOURNAL = c(\"Nat Rev Cancer 5:113-25 (2005)\", \"DOI:10.1038/nrc1546\")), list(REFERENCE = \"PMID:14570033\", AUTHORS = \"Hecht SS\", TITLE = \"Tobacco carcinogens, their biomarkers and tobacco-induced cancer.\", JOURNAL = c(\"Nat Rev Cancer 3:733-44 (2003)\", \"DOI:10.1038/nrc1190\")), list(REFERENCE = \"PMID:18066431\", AUTHORS = \"Oliveira PA, Colaco A, Chaves R, Guedes-Pinto H, De-La-Cruz P LF, Lopes C\", TITLE = \"Chemical carcinogenesis.\", JOURNAL = c(\"An Acad Bras Cienc 79:593-616 (2007)\", \"DOI:10.1590/S0001-37652007000400004\")), list(REFERENCE = \"PMID:15489140\", AUTHORS = \"Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA.\", TITLE = \"Environmental and chemical carcinogenesis.\", JOURNAL = c(\"Semin Cancer Biol 14:473-86 (2004)\", \"DOI:10.1016/j.semcancer.2004.06.010\")), list(REFERENCE = \"PMID:21234336\", AUTHORS = \"Hang B\", TITLE = \"Formation and repair of tobacco carcinogen-derived bulky DNA adducts.\", JOURNAL = c(\"J Nucleic Acids 2010:709521 (2010)\", \"DOI:10.4061/2010/709521\")), list(REFERENCE = \"PMID:12928348\", AUTHORS = \"Tsuneoka Y, Dalton TP, Miller ML, Clay CD, Shertzer HG, Talaska G, Medvedovic M, Nebert DW\", TITLE = \"4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice.\", JOURNAL = c(\"J Natl Cancer Inst 95:1227-37 (2003)\", \"DOI:10.1093/jnci/djg025\")), list(REFERENCE = \"PMID:11978484\", AUTHORS = \"Kawanishi S, Hiraku Y, Murata M, Oikawa S\", TITLE = \"The role of metals in site-specific DNA damage with reference to carcinogenesis.\", JOURNAL = c(\"Free Radic Biol Med 32:822-32 (2002)\", \"DOI:10.1016/S0891-5849(02)00779-7\")), list(REFERENCE = \"PMID:11275476\", AUTHORS = \"Murata M, Tamura A, Tada M, Kawanishi S\", TITLE = \"Mechanism of oxidative DNA damage induced by carcinogenic 4-aminobiphenyl.\", JOURNAL = c(\"Free Radic Biol Med 30:765-73 (2001)\", \"DOI:10.1016/S0891-5849(01)00463-4\")), list(REFERENCE = \"PMID:20232918\", AUTHORS = \"Patterson AD, Gonzalez FJ, Idle JR\", TITLE = \"Xenobiotic metabolism: a view through the metabolometer.\", JOURNAL = c(\"Chem Res Toxicol 23:851-60 (2010)\", \"DOI:10.1021/tx100020p\")), list(REFERENCE = \"PMID:9202760\", AUTHORS = \"Turesky RJ, Box RM, Markovic J, Gremaud E, Snyderwine EG\", TITLE = \"Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline in the rat and nonhuman primates.\", JOURNAL = c(\"Mutat Res 376:235-41 (1997)\", \"DOI:10.1016/S0027-5107(97)00048-1\")), list(REFERENCE = \"PMID:20570348\", AUTHORS = \"Immonen E, Kummu M, Petsalo A, Pihlaja T, Mathiesen L, Nielsen JK, Knudsen LE, Vahakangas K, Myllynen P\", TITLE = \"Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic metabolism.\", JOURNAL = c(\"Placenta 31:641-8 (2010)\", \"DOI:10.1016/j.placenta.2010.05.002\")), list(REFERENCE = \"PMID:8702479\", AUTHORS = \"Solomon MS, Morgenthaler PM, Turesky RJ, Essigmann JM\", TITLE = \"Mutational and DNA binding specificity of the carcinogen 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline.\", JOURNAL = c(\"J Biol Chem 271:18368-74 (1996)\", \"DOI:10.1074/jbc.271.31.18368\")), list(REFERENCE = \"PMID:21456541\", AUTHORS = \"Nauwelaers G, Bessette EE, Gu D, Tang Y, Rageul J, Fessard V, Yuan JM, Yu MC, Langouet S, Turesky RJ\", TITLE = \"DNA adduct formation of 4-aminobiphenyl and heterocyclic aromatic amines in human hepatocytes.\", JOURNAL = c(\"Chem Res Toxicol 24:913-25 (2011)\", \"DOI:10.1021/tx200091y\")), list(REFERENCE = \"PMID:20669524\", AUTHORS = \"\", TITLE = \"The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General.\", JOURNAL = \"The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General (2006)\"), list(REFERENCE = \"PMID:17445838\", AUTHORS = \"Singh R, Sram RJ, Binkova B, Kalina I, Popov TA, Georgieva T, Garte S, Taioli E, Farmer PB\", TITLE = \"The relationship between biomarkers of oxidative DNA damage, polycyclic aromatic hydrocarbon DNA adducts, antioxidant status and genetic susceptibility following exposure to environmental air pollution in humans.\", JOURNAL = c(\"Mutat Res 620:83-92 (2007)\", \"DOI:10.1016/j.mrfmmm.2007.02.025\")), list(REFERENCE = \"PMID:15298956\", AUTHORS = \"Lodovici M, Luceri C, Guglielmi F, Bacci C, Akpan V, Fonnesu ML, Boddi V, Dolara P.\", TITLE = \"Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.\", JOURNAL = \"Cancer Epidemiol Biomarkers Prev 13:1342-8 (2004)\"), list(REFERENCE = \"PMID:19531241\", AUTHORS = \"Androutsopoulos VP, Tsatsakis AM, Spandidos DA\", TITLE = \"Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.\", JOURNAL = c(\"BMC Cancer 9:187 (2009)\", \"DOI:10.1186/1471-2407-9-187\")), list(REFERENCE = \"PMID:11376689\", AUTHORS = \"Gonzalez FJ, Kimura S\", TITLE = \"Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice.\", JOURNAL = c(\"Mutat Res 477:79-87 (2001)\", \"DOI:10.1016/S0027-5107(01)00109-9\")), list(REFERENCE = \"PMID:11467078\", AUTHORS = \"Banoglu E\", TITLE = \"Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens.\", JOURNAL = c(\"Curr Drug Metab 1:1-30 (2000)\", \"DOI:10.2174/1389200003339234\")), list(REFERENCE = \"PMID:15532073\", AUTHORS = \"Lehner AF, Horn J, Flesher JW\", TITLE = \"Mass spectrometric analysis of 7-sulfoxymethyl-12-methylbenz[a]anthracene and related electrophilic polycyclic aromatic hydrocarbon metabolites.\", JOURNAL = c(\"J Mass Spectrom 39:1366-78 (2004)\", \"DOI:10.1002/jms.730\")), list(REFERENCE = \"PMID:21217854\", AUTHORS = \"Stiborova M, Martinek V, Semanska M, Hodek P, Dracinsky M, Cvacka J, Schmeiser HH, Frei E\", TITLE = \"Oxidation of the carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxy-naphthalene (Sudan I) by cytochromes P450 and peroxidases: a comparative study.\", JOURNAL = c(\"Interdiscip Toxicol 2:195-200 (2009)\", \"DOI:10.2478/v10102-009-0017-z\")), list(REFERENCE = \"PMID:10913381\", AUTHORS = \"Maanen MJ, Smeets CJ, Beijnen JH\", TITLE = \"Chemistry, pharmacology and pharmacokinetics of N,N\',N\\\" -triethylenethiophosphoramide (ThioTEPA).\", JOURNAL = c(\"Cancer Treat Rev 26:257-68 (2000)\", \"DOI:10.1053/ctrv.2000.0170\")), list(REFERENCE = \"PMID:11092599\", AUTHORS = \"Hoes I, Van Dongen W, Lemiere F, Esmans EL, Van Bockstaele D, Berneman ZN\", TITLE = \"Comparison between capillary and nano liquid chromatography-electrospray mass spectrometry for the analysis of minor DNA-melphalan adducts.\", JOURNAL = c(\"J Chromatogr B Biomed Sci Appl 748:197-212 (2000)\", \"DOI:10.1016/S0378-4347(00)00400-X\")), list(REFERENCE = \"PMID:22705365\", AUTHORS = \"Lee JC, Son YO, Pratheeshkumar P, Shi X\", TITLE = \"Oxidative stress and metal carcinogenesis.\", JOURNAL = c(\"Free Radic Biol Med 53:742-57 (2012)\", \"DOI:10.1016/j.freeradbiomed.2012.06.002\")), list(REFERENCE = \"PMID:12435844\", AUTHORS = \"Wild CP, Turner PC\", TITLE = \"The toxicology of aflatoxins as a basis for public health decisions.\", JOURNAL = c(\"Mutagenesis 17:471-81 (2002)\", \"DOI:10.1093/mutage/17.6.471\")), list(REFERENCE = \"PMID:9275165\", AUTHORS = \"Kobertz WR, Wang D, Wogan GN, Essigmann JM\", TITLE = \"An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 94:9579-84 (1997)\", \"DOI:10.1073/pnas.94.18.9579\")), list(REFERENCE = \"PMID:8759017\", AUTHORS = \"Bailey EA, Iyer RS, Harris TM, Essigmann JM\", TITLE = \"A viral genome containing an unstable aflatoxin B1-N7-guanine DNA adduct situated at a unique site.\", JOURNAL = c(\"Nucleic Acids Res 24:2821-8 (1996)\", \"DOI:10.1093/nar/24.14.2821\")), list(REFERENCE = \"PMID:21473878\", AUTHORS = \"Chiang HC, Wang CY, Lee HL, Tsou TC\", TITLE = \"Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.\", JOURNAL = c(\"Toxicol Appl Pharmacol 253:145-52 (2011)\", \"DOI:10.1016/j.taap.2011.03.022\")), list(REFERENCE = \"PMID:21154658\", AUTHORS = \"Bhat SH, Gelhaus SL, Mesaros C, Vachani A, Blair IA\", TITLE = \"A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.\", JOURNAL = c(\"Rapid Commun Mass Spectrom 25:115-21 (2011)\", \"DOI:10.1002/rcm.4824\")), list(REFERENCE = \"PMID:20159989\", AUTHORS = \"Maertens LA, Upadhyaya P, Hecht SS, Zimmerman CL\", TITLE = \"Formation and distribution of NNK metabolites in an isolated perfused rat lung.\", JOURNAL = c(\"Drug Metab Dispos 38:752-60 (2010)\", \"DOI:10.1124/dmd.109.031492\")), list(REFERENCE = \"PMID:17459420\", AUTHORS = \"Schuller HM\", TITLE = \"Nitrosamines as nicotinic receptor ligands.\", JOURNAL = c(\"Life Sci 80:2274-80 (2007)\", \"DOI:10.1016/j.lfs.2007.03.006\")), list(REFERENCE = \"PMID:22178655\", AUTHORS = \"Shen J, Xu L, Owonikoko TK, Sun SY, Khuri FR, Curran WJ, Deng X\", TITLE = \"NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCiota/FAK loop.\", JOURNAL = c(\"Cancer Lett 318:106-13 (2012)\", \"DOI:10.1016/j.canlet.2011.12.008\")), list(REFERENCE = \"PMID:8951235\", AUTHORS = \"Lee VM, Keefer LK, Archer MC\", TITLE = \"An evaluation of the roles of metabolic denitrosation and alpha-hydroxylation in the hepatotoxicity of N-Nitrosodimethylamine.\", JOURNAL = c(\"Chem Res Toxicol 9:1319-24 (1996)\", \"DOI:10.1021/tx960077u\")), list(REFERENCE = \"PMID:21163908\", AUTHORS = \"Swenberg JA, Lu K, Moeller BC, Gao L, Upton PB, Nakamura J, Starr TB\", TITLE = \"Endogenous versus exogenous DNA adducts: their role in carcinogenesis, epidemiology, and risk assessment.\", JOURNAL = c(\"Toxicol Sci 120 Suppl 1:S130-45 (2011)\", \"DOI:10.1093/toxsci/kfq371\")), list(REFERENCE = \"PMID:10753215\", AUTHORS = \"Yang Y, Nair J, Barbin A, Bartsch H\", TITLE = \"Immunohistochemical detection of 1,N(6)-ethenodeoxyadenosine, a promutagenic DNA adduct, in liver of rats exposed to vinyl chloride or an iron overload.\", JOURNAL = c(\"Carcinogenesis 21:777-81 (2000)\", \"DOI:10.1093/carcin/21.4.777\")), list(REFERENCE = \"PMID:15582261\", AUTHORS = \"Bartsch H, Nair J\", TITLE = \"Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis.\", JOURNAL = c(\"Cancer Detect Prev 28:385-91 (2004)\", \"DOI:10.1016/j.cdp.2004.07.004\")), list(REFERENCE = \"PMID:19657920\", AUTHORS = \"Tabrez S, Ahmad M\", TITLE = \"Toxicity, biomarkers, genotoxicity, and carcinogenicity of trichloroethylene and its metabolites: a review.\", JOURNAL = c(\"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 27:178-96 (2009)\", \"DOI:10.1080/10590500903091340\")), list(REFERENCE = \"PMID:16421178\", AUTHORS = \"Lock EA, Reed CJ\", TITLE = \"Trichloroethylene: mechanisms of renal toxicity and renal cancer and relevance to risk assessment.\", JOURNAL = c(\"Toxicol Sci 91:313-31 (2006)\", \"DOI:10.1093/toxsci/kfj107\")), list(REFERENCE = \"PMID:16959879\", AUTHORS = \"Kim D, Ghanayem BI\", TITLE = \"Comparative metabolism and disposition of trichloroethylene in Cyp2e1-/-and wild-type mice.\", JOURNAL = c(\"Drug Metab Dispos 34:2020-7 (2006)\", \"DOI:10.1124/dmd.106.010538\")), list(REFERENCE = \"PMID:11222868\", AUTHORS = \"Cummings BS, Parker JC, Lash LH\", TITLE = \"Cytochrome p450-dependent metabolism of trichloroethylene in rat kidney.\", JOURNAL = c(\"Toxicol Sci 60:11-9 (2001)\", \"DOI:10.1093/toxsci/60.1.11\")), list(REFERENCE = \"PMID:9356303\", AUTHORS = \"Abbas R, Fisher JW\", TITLE = \"A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.\", JOURNAL = c(\"Toxicol Appl Pharmacol 147:15-30 (1997)\", \"DOI:10.1006/taap.1997.8190\")), list(REFERENCE = \"PMID:9152590\", AUTHORS = \"Stenner RD, Merdink JL, Stevens DK, Springer DL, Bull RJ\", TITLE = \"Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid. Metabolites of trichloroethylene.\", JOURNAL = \"Drug Metab Dispos 25:529-35 (1997)\"), list(REFERENCE = \"PMID:21255676\", AUTHORS = \"Gwinn MR, Johns DO, Bateson TF, Guyton KZ\", TITLE = \"A review of the genotoxicity of 1,2-dichloroethane (EDC).\", JOURNAL = c(\"Mutat Res 727:42-53 (2011)\", \"DOI:10.1016/j.mrrev.2011.01.001\")), list(REFERENCE = \"PMID:16084004\", AUTHORS = \"Kehe K, Szinicz L\", TITLE = \"Medical aspects of sulphur mustard poisoning.\", JOURNAL = c(\"Toxicology 214:198-209 (2005)\", \"DOI:10.1016/j.tox.2005.06.014\")), list(REFERENCE = \"PMID:17292678\", AUTHORS = \"Matijasevic Z, Volkert MR\", TITLE = \"Base excision repair sensitizes cells to sulfur mustard and chloroethyl ethyl sulfide.\", JOURNAL = c(\"DNA Repair (Amst) 6:733-41 (2007)\", \"DOI:10.1016/j.dnarep.2006.12.014\"))', 'map05204', 'Chemical carcinogenesis', 'It has been estimated that exposure to environmental chemical carcinogens may contribute significantly to the causation of a sizable fraction, perhaps a majority, of human cancers. Human carcinogens act through a variety of genotoxic and non-genotoxic mechanisms. Genotoxic carcinogens can attack biological macromolecules such as DNA and RNA either directly or indirectly through metabolism, resulting in the formation of adducts with these macromolecules. If DNA adducts escape cellular repair mechanisms and persist, they may lead to miscoding, resulting in permanent mutations. Non-genotoxic carcinogens act by the mechanisms such as induction of inflammation, immunosuppression, formation of reactive oxygen species, activation of receptors, and epigenetic silencing. Together, these genotoxic and non-genotoxic mechanisms can alter signal-transduction pathways that finally result in hypermutability, genomic instability, loss of proliferation control, and resistance to apoptosis - some of the characteristic features of cancer cells.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (428, '05205', 'Proteoglycans in cancer', 'Many proteoglycans (PGs) in the tumor microenvironment have been shown to be key macromolecules that contribute to biology of various types of cancer including proliferation, adhesion, angiogenesis and metastasis, affecting tumor progress. The four main types of proteoglycans include hyaluronan (HA), which does not occur as a PG but in free form, heparan sulfate proteoglycans (HSPGs), chondroitin sulfate proteoglycans (CSPGs), dematan sulfate proteoglycans (DSPG) and keratan sulfate proteoglycans (KSPGs) [BR:00535]. Among these proteoglycans such as HA, acting with CD44, promotes tumor cell growth and migration, whereas other proteoglycans such as syndecans (-1~-4), glypican (-1, -3) and perlecan may interact with growth factors, cytokines, morphogens and enzymes through HS chains [BR: 00536], also leading to tumor growth and invasion. In contrast, some of the small leucine-rich proteolgycans, such as decorin and lumican, can function as tumor repressors, and modulate the signaling pathways by the interaction of their core proteins and multiple receptors.', 'Human Diseases; Cancer: overview', 'Proteoglycans in cancer', 'ko05205', 'list(REFERENCE = \"PMID:18450475\", AUTHORS = \"Bourguignon LY\", TITLE = \"Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.\", JOURNAL = c(\"Semin Cancer Biol 18:251-9 (2008)\", \"DOI:10.1016/j.semcancer.2008.03.007\")), list(REFERENCE = \"PMID:12729888\", AUTHORS = \"Briggs MW, Sacks DB\", TITLE = \"IQGAP1 as signal integrator: Ca2+, calmodulin, Cdc42 and the cytoskeleton.\", JOURNAL = c(\"FEBS Lett 542:7-11 (2003)\", \"DOI:10.1016/S0014-5793(03)00333-8\")), list(REFERENCE = \"PMID:12748184\", AUTHORS = \"Bourguignon LY, Singleton PA, Zhu H, Diedrich F\", TITLE = \"Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.\", JOURNAL = c(\"J Biol Chem 278:29420-34 (2003)\", \"DOI:10.1074/jbc.M301885200\")), list(REFERENCE = \"PMID:15655247\", AUTHORS = \"Bourguignon LY, Gilad E, Rothman K, Peyrollier K\", TITLE = \"Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.\", JOURNAL = c(\"J Biol Chem 280:11961-72 (2005)\", \"DOI:10.1074/jbc.M411985200\")), list(REFERENCE = \"PMID:11717317\", AUTHORS = \"Turley EA, Noble PW, Bourguignon LY\", TITLE = \"Signaling properties of hyaluronan receptors.\", JOURNAL = c(\"J Biol Chem 277:4589-92 (2002)\", \"DOI:10.1074/jbc.R100038200\")), list(REFERENCE = \"PMID:9346940\", AUTHORS = \"Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC\", TITLE = \"Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.\", JOURNAL = c(\"J Biol Chem 272:27913-8 (1997)\", \"DOI:10.1074/jbc.272.44.27913\")), list(REFERENCE = \"PMID:22735579\", AUTHORS = \"Neill T, Schaefer L, Iozzo RV\", TITLE = \"Decorin: a guardian from the matrix.\", JOURNAL = c(\"Am J Pathol 181:380-7 (2012)\", \"DOI:10.1016/j.ajpath.2012.04.029\")), list(REFERENCE = \"PMID:22194599\", AUTHORS = \"Neill T, Painter H, Buraschi S, Owens RT, Lisanti MP, Schaefer L, Iozzo RV\", TITLE = \"Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.\", JOURNAL = c(\"J Biol Chem 287:5492-506 (2012)\", \"DOI:10.1074/jbc.M111.283499\")), list(REFERENCE = \"PMID:19433454\", AUTHORS = \"Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ, Ireton K, Iozzo RV\", TITLE = \"Decorin is a novel antagonistic ligand of the Met receptor.\", JOURNAL = c(\"J Cell Biol 185:743-54 (2009)\", \"DOI:10.1083/jcb.200901129\")), list(REFERENCE = \"PMID:15994311\", AUTHORS = \"Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV\", TITLE = \"Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis.\", JOURNAL = c(\"J Biol Chem 280:32468-79 (2005)\", \"DOI:10.1074/jbc.M503833200\")), list(REFERENCE = \"PMID:20974860\", AUTHORS = \"Buraschi S, Pal N, Tyler-Rubinstein N, Owens RT, Neill T, Iozzo RV\", TITLE = \"Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.\", JOURNAL = c(\"J Biol Chem 285:42075-85 (2010)\", \"DOI:10.1074/jbc.M110.172841\")), list(REFERENCE = \"PMID:18798267\", AUTHORS = \"Goldoni S, Iozzo RV\", TITLE = \"Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.\", JOURNAL = c(\"Int J Cancer 123:2473-9 (2008)\", \"DOI:10.1002/ijc.23930\")), list(REFERENCE = \"PMID:23058688\", AUTHORS = \"Sofeu Feugaing DD, Gotte M, Viola M\", TITLE = \"More than matrix: the multifaceted role of decorin in cancer.\", JOURNAL = c(\"Eur J Cell Biol 92:1-11 (2013)\", \"DOI:10.1016/j.ejcb.2012.08.004\")), list(REFERENCE = \"PMID:22087031\", AUTHORS = \"Merline R, Moreth K, Beckmann J, Nastase MV, Zeng-Brouwers J, Tralhao JG, Lemarchand P, Pfeilschifter J, Schaefer RM, Iozzo RV, Schaefer L\", TITLE = \"Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21.\", JOURNAL = c(\"Sci Signal 4:ra75 (2011)\", \"DOI:10.1126/scisignal.2001868\")), list(REFERENCE = \"PMID:22033227\", AUTHORS = \"Teng YH, Aquino RS, Park PW\", TITLE = \"Molecular functions of syndecan-1 in disease.\", JOURNAL = c(\"Matrix Biol 31:3-16 (2012)\", \"DOI:10.1016/j.matbio.2011.10.001\")), list(REFERENCE = \"PMID:11830493\", AUTHORS = \"Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST\", TITLE = \"Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.\", JOURNAL = c(\"Blood 99:1405-10 (2002)\", \"DOI:10.1182/blood.V99.4.1405\")), list(REFERENCE = \"PMID:19733083\", AUTHORS = \"Fux L, Ilan N, Sanderson RD, Vlodavsky I\", TITLE = \"Heparanase: busy at the cell surface.\", JOURNAL = c(\"Trends Biochem Sci 34:511-9 (2009)\", \"DOI:10.1016/j.tibs.2009.06.005\")), list(REFERENCE = \"PMID:18812315\", AUTHORS = \"Purushothaman A, Chen L, Yang Y, Sanderson RD\", TITLE = \"Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.\", JOURNAL = c(\"J Biol Chem 283:32628-36 (2008)\", \"DOI:10.1074/jbc.M806266200\")), list(REFERENCE = \"PMID:19255147\", AUTHORS = \"Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC\", TITLE = \"Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.\", JOURNAL = c(\"J Exp Med 206:691-705 (2009)\", \"DOI:10.1084/jem.20081278\")), list(REFERENCE = \"PMID:20655987\", AUTHORS = \"Mahtouk K, Tjin EP, Spaargaren M, Pals ST\", TITLE = \"The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.\", JOURNAL = c(\"Biochim Biophys Acta 1806:208-19 (2010)\", \"DOI:10.1016/j.bbcan.2010.07.006\")), list(REFERENCE = \"PMID:11931647\", AUTHORS = \"Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M\", TITLE = \"The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones.\", JOURNAL = c(\"Biochem J 363:201-9 (2002)\", \"DOI:10.1042/bj3630201\")), list(REFERENCE = \"PMID:10687947\", AUTHORS = \"Nugent MA, Iozzo RV\", TITLE = \"Fibroblast growth factor-2.\", JOURNAL = c(\"Int J Biochem Cell Biol 32:115-20 (2000)\", \"DOI:10.1016/S1357-2725(99)00123-5\")), list(REFERENCE = \"PMID:10633082\", AUTHORS = \"Baciu PC, Saoncella S, Lee SH, Denhez F, Leuthardt D, Goetinck PF\", TITLE = \"Syndesmos, a protein that interacts with the cytoplasmic domain of syndecan-4, mediates cell spreading and actin cytoskeletal organization.\", JOURNAL = \"J Cell Sci 113 Pt 2:315-24 (2000)\"), list(REFERENCE = \"PMID:12509413\", AUTHORS = \"Thodeti CK, Albrechtsen R, Grauslund M, Asmar M, Larsson C, Takada Y, Mercurio AM, Couchman JR, Wewer UM\", TITLE = \"ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA.\", JOURNAL = c(\"J Biol Chem 278:9576-84 (2003)\", \"DOI:10.1074/jbc.M208937200\")), list(REFERENCE = \"PMID:14711376\", AUTHORS = \"Beauvais DM, Rapraeger AC\", TITLE = \"Syndecans in tumor cell adhesion and signaling.\", JOURNAL = c(\"Reprod Biol Endocrinol 2:3 (2004)\", \"DOI:10.1186/1477-7827-2-3\")), list(REFERENCE = \"PMID:17971838\", AUTHORS = \"Morgan MR, Humphries MJ, Bass MD\", TITLE = \"Synergistic control of cell adhesion by integrins and syndecans.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 8:957-69 (2007)\", \"DOI:10.1038/nrm2289\")), list(REFERENCE = \"PMID:18505598\", AUTHORS = \"Filmus J, Capurro M, Rast J\", TITLE = \"Glypicans.\", JOURNAL = c(\"Genome Biol 9:224 (2008)\", \"DOI:10.1186/gb-2008-9-5-224\")), list(REFERENCE = \"PMID:23305321\", AUTHORS = \"Filmus J, Capurro M\", TITLE = \"Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.\", JOURNAL = c(\"FEBS J 280:2471-6 (2013)\", \"DOI:10.1111/febs.12126\")), list(REFERENCE = \"PMID:22563565\", AUTHORS = \"Gao W, Ho M\", TITLE = \"The role of glypican-3 in regulating Wnt in hepatocellular carcinomas.\", JOURNAL = \"Cancer Rep 1:14-19 (2011)\"), list(REFERENCE = \"PMID:24412155\", AUTHORS = \"Filmus J, Capurro M\", TITLE = \"The role of glypicans in Hedgehog signaling.\", JOURNAL = c(\"Matrix Biol 35:248-52 (2014)\", \"DOI:10.1016/j.matbio.2013.12.007\")), list(REFERENCE = \"PMID:18413366\", AUTHORS = \"Cheng W, Tseng CJ, Lin TT, Cheng I, Pan HW, Hsu HC, Lee YM\", TITLE = \"Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.\", JOURNAL = c(\"Carcinogenesis 29:1319-26 (2008)\", \"DOI:10.1093/carcin/bgn091\")), list(REFERENCE = \"PMID:21155971\", AUTHORS = \"Iozzo RV, Sanderson RD\", TITLE = \"Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.\", JOURNAL = c(\"J Cell Mol Med 15:1013-31 (2011)\", \"DOI:10.1111/j.1582-4934.2010.01236.x\")), list(REFERENCE = \"PMID:18949819\", AUTHORS = \"Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN\", TITLE = \"Lumican, a small leucine-rich proteoglycan.\", JOURNAL = c(\"IUBMB Life 60:818-23 (2008)\", \"DOI:10.1002/iub.131\"))', 'map05205', 'Proteoglycans in cancer', 'Many proteoglycans (PGs) in the tumor microenvironment have been shown to be key macromolecules that contribute to biology of various types of cancer including proliferation, adhesion, angiogenesis and metastasis, affecting tumor progress. The four main types of proteoglycans include hyaluronan (HA), which does not occur as a PG but in free form, heparan sulfate proteoglycans (HSPGs), chondroitin sulfate proteoglycans (CSPGs), dematan sulfate proteoglycans (DSPG) and keratan sulfate proteoglycans (KSPGs) [BR:00535]. Among these proteoglycans such as HA, acting with CD44, promotes tumor cell growth and migration, whereas other proteoglycans such as syndecans (-1~-4), glypican (-1, -3) and perlecan may interact with growth factors, cytokines, morphogens and enzymes through HS chains [BR: 00536], also leading to tumor growth and invasion. In contrast, some of the small leucine-rich proteolgycans, such as decorin and lumican, can function as tumor repressors, and modulate the signaling pathways by the interaction of their core proteins and multiple receptors.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (429, '05206', 'MicroRNAs in cancer', 'MicroRNA (miRNA) is a cluster of small non-encoding RNA molecules of 21 - 23 nucleotides in length, which controls gene expression post-transcriptionally either via the degradation of target mRNAs or the inhibition of protein translation. Using high-throughput profiling, dysregulation of miRNAs has been widely observed in different stages of cancer. The upregulation (overexpression) of specific miRNAs could lead to the repression of tumor suppressor gene expression, and conversely the downregulation of specific miRNAs could result in an increase of oncogene expression; both these situations induce subsequent malignant effects on cell proliferation, differentiation, and apoptosis that lead to tumor growth and progress. The miRNA signatures of cancer observed in various studies differ significantly. These inconsistencies occur due to the differences in the study populations and methodologies used. This pathway map shows the summarized results from various studies in 9 cancers, each of which is presented in a review article.', 'Human Diseases; Cancer: overview', 'MicroRNAs in cancer', 'Small cell lung cancer, Non-small cell lung cancer, Esophageal cancer, Colorectal cancer, Bladder cancer, Prostate cancer, Ovarian cancer, Breast cancer, Glioma, Hepatocellular carcinoma', 'ko05206', 'list(REFERENCE = \"PMID:18817506\", AUTHORS = \"Lee YS, Dutta A\", TITLE = \"MicroRNAs in cancer.\", JOURNAL = c(\"Annu Rev Pathol 4:199-227 (2009)\", \"DOI:10.1146/annurev.pathol.4.110807.092222\")), list(REFERENCE = \"PMID:21402473\", AUTHORS = \"Babashah S, Soleimani M\", TITLE = \"The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.\", JOURNAL = c(\"Eur J Cancer 47:1127-37 (2011)\", \"DOI:10.1016/j.ejca.2011.02.008\")), list(REFERENCE = \"PMID:19630570\", AUTHORS = \"Garzon R, Calin GA, Croce CM\", TITLE = \"MicroRNAs in Cancer.\", JOURNAL = c(\"Annu Rev Med 60:167-79 (2009)\", \"DOI:10.1146/annurev.med.59.053006.104707\")), list(REFERENCE = \"PMID:23075324\", AUTHORS = \"Chen PS, Su JL, Hung MC\", TITLE = \"Dysregulation of microRNAs in cancer.\", JOURNAL = c(\"J Biomed Sci 19:90 (2012)\", \"DOI:10.1186/1423-0127-19-90\")), list(REFERENCE = \"PMID:22035854\", AUTHORS = \"Ling H, Zhang W, Calin GA\", TITLE = \"Principles of microRNA involvement in human cancers.\", JOURNAL = c(\"Chin J Cancer 30:739-48 (2011)\", \"DOI:10.5732/cjc.011.10243\")), list(REFERENCE = \"PMID:22351564\", AUTHORS = \"Iorio MV, Croce CM\", TITLE = \"MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.\", JOURNAL = c(\"EMBO Mol Med 4:143-59 (2012)\", \"DOI:10.1002/emmm.201100209\")), list(REFERENCE = \"PMID:21742789\", AUTHORS = \"Sayed D, Abdellatif M\", TITLE = \"MicroRNAs in development and disease.\", JOURNAL = c(\"Physiol Rev 91:827-87 (2011)\", \"DOI:10.1152/physrev.00006.2010\")), list(REFERENCE = \"PMID:22345301\", AUTHORS = \"Wang Q, Wang S, Wang H, Li P, Ma Z\", TITLE = \"MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.\", JOURNAL = c(\"Exp Biol Med (Maywood) 237:227-35 (2012)\", \"DOI:10.1258/ebm.2011.011192\")), list(REFERENCE = \"PMID:22580099\", AUTHORS = \"Song JH, Meltzer SJ\", TITLE = \"MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers.\", JOURNAL = c(\"Gastroenterology 143:35-47.e2 (2012)\", \"DOI:10.1053/j.gastro.2012.05.003\")), list(REFERENCE = \"PMID:23462054\", AUTHORS = \"Chu Y, Zhu H, Lv L, Zhou Y, Huo J\", TITLE = \"MiRNA s in oesophageal squamous cancer.\", JOURNAL = \"Neth J Med 71:69-75 (2013)\"), list(REFERENCE = \"PMID:19773200\", AUTHORS = \"Kan T, Meltzer SJ\", TITLE = \"MicroRNAs in Barrett\'s esophagus and esophageal adenocarcinoma.\", JOURNAL = c(\"Curr Opin Pharmacol 9:727-32 (2009)\", \"DOI:10.1016/j.coph.2009.08.009\")), list(REFERENCE = \"PMID:20128019\", AUTHORS = \"Smith CM, Watson DI, Michael MZ, Hussey DJ\", TITLE = \"MicroRNAs, development of Barrett\'s esophagus, and progression to esophageal adenocarcinoma.\", JOURNAL = c(\"World J Gastroenterol 16:531-7 (2010)\", \"DOI:10.3748/wjg.v16.i5.531\")), list(REFERENCE = \"PMID:23165235\", AUTHORS = \"Song S, Ajani JA\", TITLE = \"The role of microRNAs in cancers of the upper gastrointestinal tract.\", JOURNAL = c(\"Nat Rev Gastroenterol Hepatol 10:109-18 (2013)\", \"DOI:10.1038/nrgastro.2012.210\")), list(REFERENCE = \"PMID:21565290\", AUTHORS = \"Liu WH, Yeh SH, Chen PJ\", TITLE = \"Role of microRNAs in hepatitis B virus replication and pathogenesis.\", JOURNAL = c(\"Biochim Biophys Acta 1809:678-85 (2011)\", \"DOI:10.1016/j.bbagrm.2011.04.008\")), list(REFERENCE = \"PMID:23091478\", AUTHORS = \"Hrasovec S, Glavac D\", TITLE = \"MicroRNAs as Novel Biomarkers in Colorectal Cancer.\", JOURNAL = c(\"Front Genet 3:180 (2012)\", \"DOI:10.3389/fgene.2012.00180\")), list(REFERENCE = \"PMID:22926415\", AUTHORS = \"Liu H\", TITLE = \"MicroRNAs in breast cancer initiation and progression.\", JOURNAL = c(\"Cell Mol Life Sci 69:3587-99 (2012)\", \"DOI:10.1007/s00018-012-1128-9\")), list(REFERENCE = \"PMID:20345848\", AUTHORS = \"Li SD, Zhang JR, Wang YQ, Wan XP\", TITLE = \"The role of microRNAs in ovarian cancer initiation and progression.\", JOURNAL = c(\"J Cell Mol Med 14:2240-9 (2010)\", \"DOI:10.1111/j.1582-4934.2010.01058.x\")), list(REFERENCE = \"PMID:23316212\", AUTHORS = \"Zabolotneva AA, Zhavoronkov A, Garazha AV, Roumiantsev SA, Buzdin AA\", TITLE = \"Characteristic patterns of microRNA expression in human bladder cancer.\", JOURNAL = c(\"Front Genet 3:310 (2012)\", \"DOI:10.3389/fgene.2012.00310\")), list(REFERENCE = \"PMID:20221895\", AUTHORS = \"Saini S, Majid S, Dahiya R\", TITLE = \"Diet, microRNAs and prostate cancer.\", JOURNAL = c(\"Pharm Res 27:1014-26 (2010)\", \"DOI:10.1007/s11095-010-0086-x\"))', 'map05206', 'MicroRNAs in cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (430, '05210', 'Colorectal cancer', 'Colorectal cancer (CRC) is the second largest cause of cancer-related deaths in Western countries. CRC arises from the colorectal epithelium as a result of the accumulation of genetic alterations in defined oncogenes and tumour suppressor genes (TSG). Two major mechanisms of genomic instability have been identified in sporadic CRC progression. The first, known as chromosomal instability (CIN), results from a series of genetic changes that involve the activation of oncogenes such as K-ras and inactivation of TSG such as p53, DCC/Smad4, and APC. The second, known as microsatellite instability (MSI), results from inactivation of the DNA mismatch repair genes MLH1 and/or MSH2 by hypermethylation of their promoter, and secondary mutation of genes with coding microsatellites, such as transforming growth factor receptor II (TGF-RII) and BAX. Hereditary syndromes have germline mutations in specific genes (mutation in the tumour suppressor gene APC on chromosome 5q in FAP, mutated DNA mismatch repair genes in HNPCC).', 'Human Diseases; Cancer: specific types', 'Colorectal cancer', 'Colorectal cancer, Oligodontia-colorectal cancer syndrome, Mismatch repair deficiency, Juvenile polyposis syndrome, Familial adenomatous polyposis', 'ko05210', 'list(REFERENCE = \"PMID:15000146\", AUTHORS = \"Grady WM.\", TITLE = \"Genomic instability and colon cancer.\", JOURNAL = c(\"Cancer Metastasis Rev 23:11-27 (2004)\", \"DOI:10.1023/A:1025861527711\")), list(REFERENCE = \"PMID:16555243\", AUTHORS = \"Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.\", TITLE = \"Microsatellite instability in colorectal cancer.\", JOURNAL = c(\"Br J Surg 93:395-406 (2006)\", \"DOI:10.1002/bjs.5328\")), list(REFERENCE = \"PMID:11078609\", AUTHORS = \"Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.\", TITLE = \"Hereditary non-polyposis colorectal cancer: an updated review.\", JOURNAL = c(\"Eur J Surg Oncol 26:635-45 (2000)\", \"DOI:10.1053/ejso.2000.0974\")), list(REFERENCE = \"PMID:16699851\", AUTHORS = \"Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.\", TITLE = \"Colorectal cancer: genetics of development and metastasis.\", JOURNAL = c(\"J Gastroenterol 41:185-92 (2006)\", \"DOI:10.1007/s00535-006-1801-6\")), list(REFERENCE = \"PMID:12621137\", AUTHORS = \"Lynch HT, de la Chapelle A.\", TITLE = \"Hereditary colorectal cancer.\", JOURNAL = c(\"N Engl J Med 348:919-32 (2003)\", \"DOI:10.1056/NEJMra012242\")), list(REFERENCE = \"PMID:12951588\", AUTHORS = \"Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.\", TITLE = \"The significance of unstable chromosomes in colorectal cancer.\", JOURNAL = c(\"Nat Rev Cancer 3:695-701 (2003)\", \"DOI:10.1038/nrc1165\")), list(REFERENCE = \"PMID:10505543\", AUTHORS = \"Behrens J.\", TITLE = \"Cadherins and catenins: role in signal transduction and tumor progression.\", JOURNAL = c(\"Cancer Metastasis Rev 18:15-30 (1999)\", \"DOI:10.1023/A:1006200102166\")), list(REFERENCE = \"PMID:16042571\", AUTHORS = \"Behrens J.\", TITLE = \"The role of the Wnt signalling pathway in colorectal tumorigenesis.\", JOURNAL = c(\"Biochem Soc Trans 33:672-5 (2005)\", \"DOI:10.1042/BST0330672\")), list(REFERENCE = \"PMID:15349822\", AUTHORS = \"Behrens J, Lustig B.\", TITLE = \"The Wnt connection to tumorigenesis.\", JOURNAL = c(\"Int J Dev Biol 48:477-87 (2004)\", \"DOI:10.1387/ijdb.041815jb\")), list(REFERENCE = \"PMID:9196022\", AUTHORS = \"Polakis P.\", TITLE = \"The adenomatous polyposis coli (APC) tumor suppressor.\", JOURNAL = c(\"Biochim Biophys Acta 1332:F127-47 (1997)\", \"DOI:10.1016/S0304-419X(97)00008-5\")), list(REFERENCE = \"PMID:12737309\", AUTHORS = \"Janssen KP.\", TITLE = \"Murine models of colorectal cancer: studying the role of oncogenic K-ras.\", JOURNAL = c(\"Cell Mol Life Sci 60:495-506 (2003)\", \"DOI:10.1007/s000180300041\")), list(REFERENCE = \"PMID:11459867\", AUTHORS = \"Adjei AA.\", TITLE = \"Blocking oncogenic Ras signaling for cancer therapy.\", JOURNAL = c(\"J Natl Cancer Inst 93:1062-74 (2001)\", \"DOI:10.1093/jnci/93.14.1062\")), list(REFERENCE = \"PMID:15573119\", AUTHORS = \"Arakawa H.\", TITLE = \"Netrin-1 and its receptors in tumorigenesis.\", JOURNAL = c(\"Nat Rev Cancer 4:978-87 (2004)\", \"DOI:10.1038/nrc1504\")), list(REFERENCE = \"PMID:15310786\", AUTHORS = \"Mehlen P, Fearon ER.\", TITLE = \"Role of the dependence receptor DCC in colorectal cancer pathogenesis.\", JOURNAL = c(\"J Clin Oncol 22:3420-8 (2004)\", \"DOI:10.1200/JCO.2004.02.019\")), list(REFERENCE = \"PMID:11223406\", AUTHORS = \"Peltomaki P.\", TITLE = \"DNA mismatch repair and cancer.\", JOURNAL = c(\"Mutat Res 488:77-85 (2001)\", \"DOI:10.1016/S1383-5742(00)00058-2\")), list(REFERENCE = \"PMID:15711891\", AUTHORS = \"Li F, Cao Y, Townsend CM Jr, Ko TC.\", TITLE = \"TGF-beta signaling in colon cancer cells.\", JOURNAL = c(\"World J Surg 29:306-11 (2005)\", \"DOI:10.1007/s00268-004-7813-6\")), list(REFERENCE = \"PMID:11170304\", AUTHORS = \"Roman C, Saha D, Beauchamp R.\", TITLE = \"TGF-beta and colorectal carcinogenesis.\", JOURNAL = c(\"Microsc Res Tech 52:450-7 (2001)\", \"DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O\")), list(REFERENCE = \"PMID:16326109\", AUTHORS = \"Watson AJ.\", TITLE = \"An overview of apoptosis and the prevention of colorectal cancer.\", JOURNAL = c(\"Crit Rev Oncol Hematol 57:107-21 (2006)\", \"DOI:10.1016/j.critrevonc.2005.06.005\")), list(REFERENCE = \"PMID:15479695\", AUTHORS = \"Watson AJ.\", TITLE = \"Apoptosis and colorectal cancer.\", JOURNAL = c(\"Gut 53:1701-9 (2004)\", \"DOI:10.1136/gut.2004.052704\")), list(REFERENCE = \"PMID:11477132\", AUTHORS = \"Houlston RS.\", TITLE = \"What we could do now: molecular pathology of colorectal cancer.\", JOURNAL = c(\"Mol Pathol 54:206-14 (2001)\", \"DOI:10.1136/mp.54.4.206\")), list(REFERENCE = \"PMID:19167459\", AUTHORS = \"Hector S, Prehn JH\", TITLE = \"Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review.\", JOURNAL = c(\"Biochim Biophys Acta 1795:117-29 (2009)\", \"DOI:10.1016/j.bbcan.2008.12.002\")), list(REFERENCE = \"PMID:18568040\", AUTHORS = \"Karnoub AE, Weinberg RA\", TITLE = \"Ras oncogenes: split personalities.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 9:517-31 (2008)\", \"DOI:10.1038/nrm2438\")), list(REFERENCE = \"PMID:24213116\", AUTHORS = \"Wang D, Xia D, Dubois RN\", TITLE = \"The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer.\", JOURNAL = c(\"Cancers (Basel) 3:3894-908 (2011)\", \"DOI:10.3390/cancers3043894\")), list(REFERENCE = \"PMID:20554751\", AUTHORS = \"Dasari A, Messersmith WA\", TITLE = \"New strategies in colorectal cancer: biomarkers of response to epidermal growth factor receptor monoclonal antibodies and potential therapeutic targets in phosphoinositide 3-kinase and mitogen-activated protein kinase pathways.\", JOURNAL = c(\"Clin Cancer Res 16:3811-8 (2010)\", \"DOI:10.1158/1078-0432.CCR-09-2283\")), list(REFERENCE = \"PMID:26149458\", AUTHORS = \"Hutchinson RA, Adams RA, McArt DG, Salto-Tellez M, Jasani B, Hamilton PW\", TITLE = \"Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer.\", JOURNAL = c(\"J Transl Med 13:217 (2015)\", \"DOI:10.1186/s12967-015-0531-z\"))', 'map05210', 'Colorectal cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (431, '05211', 'Renal cell carcinoma', 'Renal cell cancer (RCC) accounts for ~3% of human malignancies and its incidence appears to be rising. Although most cases of RCC seem to occur sporadically, an inherited predisposition to renal cancer accounts for 1-4% of cases. RCC is not a single disease, it has several morphological subtypes. Conventional RCC (clear cell RCC) accounts for ~80% of cases, followed by papillary RCC (10-15%), chromophobe RCC (5%), and collecting duct RCC (<1%). Genes potentially involved in sporadic neoplasms of each particular type are VHL, MET, BHD, and FH respectively. In the absence of VHL, hypoxia-inducible factor alpha (HIF-alpha) accumulates, leading to production of several growth factors, including vascular endothelial growth factor and platelet-derived growth factor. Activated MET mediates a number of biological effects including motility, invasion of extracellular matrix, cellular transformation, prevention of apoptosis and metastasis formation. Loss of functional FH leads to accumulation of fumarate in the cell, triggering inhibition of HPH and preventing targeted pVHL-mediated degradation of HIF-alpha. BHD mutations cause the Birt-Hogg-Dube syndrome and its associated chromophobe, hybrid oncocytic, and conventional (clear cell) RCC.', 'Human Diseases; Cancer: specific types', 'Renal cell carcinoma', 'Renal cell carcinoma, von Hippel-Lindau syndrome', 'ko05211', 'list(REFERENCE = \"PMID:16339096\", AUTHORS = \"Cohen HT, McGovern FJ.\", TITLE = \"Renal-cell carcinoma.\", JOURNAL = c(\"N Engl J Med 353:2477-90 (2005)\", \"DOI:10.1056/NEJMra043172\")), list(REFERENCE = \"PMID:15122209\", AUTHORS = \"Pavlovich CP, Schmidt LS.\", TITLE = \"Searching for the hereditary causes of renal-cell carcinoma.\", JOURNAL = c(\"Nat Rev Cancer 4:381-93 (2004)\", \"DOI:10.1038/nrc1364\")), list(REFERENCE = \"PMID:14634372\", AUTHORS = \"Linehan WM, Walther MM, Zbar B.\", TITLE = \"The genetic basis of cancer of the kidney.\", JOURNAL = c(\"J Urol 170:2163-72 (2003)\", \"DOI:10.1097/01.ju.0000096060.92397.ed\")), list(REFERENCE = \"PMID:15611513\", AUTHORS = \"Kim WY, Kaelin WG.\", TITLE = \"Role of VHL gene mutation in human cancer.\", JOURNAL = c(\"J Clin Oncol 22:4991-5004 (2004)\", \"DOI:10.1200/JCO.2004.05.061\")), list(REFERENCE = \"PMID:17211469\", AUTHORS = \"Sudarshan S, Linehan WM, Neckers L.\", TITLE = \"HIF and fumarate hydratase in renal cancer.\", JOURNAL = c(\"Br J Cancer 96:403-7 (2007)\", \"DOI:10.1038/sj.bjc.6603547\")), list(REFERENCE = \"PMID:17287871\", AUTHORS = \"Sudarshan S, Pinto PA, Neckers L, Linehan WM.\", TITLE = \"Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.\", JOURNAL = c(\"Nat Clin Pract Urol 4:104-10 (2007)\", \"DOI:10.1038/ncpuro0711\")), list(REFERENCE = \"PMID:14685170\", AUTHORS = \"Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.\", TITLE = \"Met, metastasis, motility and more.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 4:915-25 (2003)\", \"DOI:10.1038/nrm1261\")), list(REFERENCE = \"PMID:18358634\", AUTHORS = \"Muller-Hocker J, Babaryka G, Schmid I, Jung A\", TITLE = \"Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.\", JOURNAL = c(\"Pathol Res Pract 204:589-97 (2008)\", \"DOI:10.1016/j.prp.2008.01.010\")), list(REFERENCE = \"PMID:12351585\", AUTHORS = \"Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.\", TITLE = \"Understanding familial and non-familial renal cell cancer.\", JOURNAL = c(\"Hum Mol Genet 11:2489-98 (2002)\", \"DOI:10.1093/hmg/11.20.2489\")), list(REFERENCE = \"PMID:25048860\", AUTHORS = \"Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM\", TITLE = \"Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.\", JOURNAL = c(\"Nat Rev Urol 11:465-75 (2014)\", \"DOI:10.1038/nrurol.2014.162\")), list(REFERENCE = \"PMID:11313942\", AUTHORS = \"Skalsky YM, Ajuh PM, Parker C, Lamond AI, Goodwin G, Cooper CS\", TITLE = \"PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors.\", JOURNAL = c(\"Oncogene 20:178-87 (2001)\", \"DOI:10.1038/sj.onc.1204056\")), list(REFERENCE = \"PMID:19422821\", AUTHORS = \"Medendorp K, van Groningen JJ, Vreede L, Hetterschijt L, Brugmans L, van den Hurk WH, van Kessel AG\", TITLE = \"The renal cell carcinoma-associated oncogenic fusion protein PRCCTFE3 provokes p21 WAF1/CIP1-mediated cell cycle delay.\", JOURNAL = c(\"Exp Cell Res 315:2399-409 (2009)\", \"DOI:10.1016/j.yexcr.2009.04.022\"))', 'map05211', 'Renal cell carcinoma', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (432, '05212', 'Pancreatic cancer', 'Infiltrating ductal adenocarcinoma is the most common malignancy of the pancreas. When most investigators use the term \'pancreatic cancer\' they are referring to pancreatic ductal adenocarcinoma (PDA). Normal duct epithelium progresses to infiltrating cancer through a series of histologically defined precursors (PanINs). The overexpression of HER-2/neu and activating point mutations in the K-ras gene occur early, inactivation of the p16 gene at an intermediate stage, and the inactivation of p53, SMAD4, and BRCA2 occur relatively late. Activated K-ras engages multiple effector pathways. Although EGF receptors are conventionally regarded as upstream activators of RAS proteins, they can also act as RAS signal transducers via RAS-induced autocrine activation of the EGFR family ligands. Moreover, PDA shows extensive genomic instability and aneuploidy. Telomere attrition and mutations in p53 and BRCA2 are likely to contribute to these phenotypes. Inactivation of the SMAD4 tumour suppressor gene leads to loss of the inhibitory influence of the transforming growth factor-beta signalling pathway.', 'Human Diseases; Cancer: specific types', 'Pancreatic cancer', 'Pancreatic cancer', 'ko05212', 'list(REFERENCE = \"\", AUTHORS = \"Von Hoff D, Evans D, Hruban R (ed).\", TITLE = \"Pancreatic cancer\", JOURNAL = \"Jones and Bartlett publishers (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Niitsu Y, Yokota J (ed).\", TITLE = \"[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)\", JOURNAL = \"Nankodo (1999)\"), list(REFERENCE = \"PMID:12459728\", AUTHORS = \"Bardeesy N, DePinho RA.\", TITLE = \"Pancreatic cancer biology and genetics.\", JOURNAL = c(\"Nat Rev Cancer 2:897-909 (2002)\", \"DOI:10.1038/nrc949\")), list(REFERENCE = \"PMID:11407945\", AUTHORS = \"Bardeesy N, Sharpless NE, DePinho RA, Merlino G.\", TITLE = \"The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.\", JOURNAL = c(\"Semin Cancer Biol 11:201-18 (2001)\", \"DOI:10.1006/scbi.2000.0371\")), list(REFERENCE = \"PMID:12946833\", AUTHORS = \"Cowgill SM, Muscarella P.\", TITLE = \"The genetics of pancreatic cancer.\", JOURNAL = c(\"Am J Surg 186:279-86 (2003)\", \"DOI:10.1016/S0002-9610(03)00226-5\")), list(REFERENCE = \"PMID:16702400\", AUTHORS = \"Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.\", TITLE = \"Genetics and biology of pancreatic ductal adenocarcinoma.\", JOURNAL = c(\"Genes Dev 20:1218-49 (2006)\", \"DOI:10.1101/gad.1415606\")), list(REFERENCE = \"PMID:10740269\", AUTHORS = \"Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.\", TITLE = \"Understanding Ras: \'it ain\'t over \'til it\'s over\'.\", JOURNAL = c(\"Trends Cell Biol 10:147-54 (2000)\", \"DOI:10.1016/S0962-8924(00)01740-2\")), list(REFERENCE = \"PMID:12648469\", AUTHORS = \"Holbro T, Civenni G, Hynes NE.\", TITLE = \"The ErbB receptors and their role in cancer progression.\", JOURNAL = c(\"Exp Cell Res 284:99-110 (2003)\", \"DOI:10.1016/S0014-4827(02)00099-X\")), list(REFERENCE = \"PMID:14967450\", AUTHORS = \"Marmor MD, Skaria KB, Yarden Y.\", TITLE = \"Signal transduction and oncogenesis by ErbB/HER receptors.\", JOURNAL = c(\"Int J Radiat Oncol Biol Phys 58:903-13 (2004)\", \"DOI:10.1016/j.ijrobp.2003.06.002\")), list(REFERENCE = \"PMID:14586404\", AUTHORS = \"DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.\", TITLE = \"Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.\", JOURNAL = c(\"Oncogene 22:7781-95 (2003)\", \"DOI:10.1038/sj.onc.1206966\")), list(REFERENCE = \"PMID:12545153\", AUTHORS = \"Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.\", TITLE = \"Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.\", JOURNAL = c(\"Oncogene 22:319-29 (2003)\", \"DOI:10.1038/sj.onc.1206122\")), list(REFERENCE = \"PMID:14580692\", AUTHORS = \"Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.\", TITLE = \"Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.\", JOURNAL = c(\"Cancer Lett 201:107-16 (2003)\", \"DOI:10.1016/S0304-3835(03)00482-8\")), list(REFERENCE = \"PMID:12079267\", AUTHORS = \"Schmid RM.\", TITLE = \"Genetic basis of pancreatic cancer.\", JOURNAL = c(\"Best Pract Res Clin Gastroenterol 16:421-33 (2002)\", \"DOI:10.1053/bega.2002.0316\")), list(REFERENCE = \"PMID:15774796\", AUTHORS = \"Elliott RL, Blobe GC.\", TITLE = \"Role of transforming growth factor Beta in human cancer.\", JOURNAL = c(\"J Clin Oncol 23:2078-93 (2005)\", \"DOI:10.1200/JCO.2005.02.047\")), list(REFERENCE = \"PMID:15823750\", AUTHORS = \"Rudkin TM, Foulkes WD.\", TITLE = \"BRCA2: breaks, mistakes and failed separations.\", JOURNAL = c(\"Trends Mol Med 11:145-8 (2005)\", \"DOI:10.1016/j.molmed.2005.02.003\")), list(REFERENCE = \"PMID:11707511\", AUTHORS = \"Venkitaraman AR.\", TITLE = \"Functions of BRCA1 and BRCA2 in the biological response to DNA damage.\", JOURNAL = \"J Cell Sci 114:3591-8 (2001)\"), list(REFERENCE = \"PMID:23340292\", AUTHORS = \"Chang Z, Li Z, Wang X, Kang Y, Yuan Y, Niu J, Wang H, Chatterjee D, Fleming JB, Li M, Abbruzzese JL, Chiao PJ\", TITLE = \"Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells.\", JOURNAL = c(\"Clin Cancer Res 19:549-59 (2013)\", \"DOI:10.1158/1078-0432.CCR-12-0032\"))', 'map05212', 'Pancreatic cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (433, '05213', 'Endometrial cancer', 'Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.', 'Human Diseases; Cancer: specific types', 'Endometrial cancer', 'Endometrial cancer, Mismatch repair deficiency', 'ko05213', 'list(REFERENCE = \"PMID:15947972\", AUTHORS = \"Ryan AJ, Susil B, Jobling TW, Oehler MK.\", TITLE = \"Endometrial cancer.\", JOURNAL = c(\"Cell Tissue Res 322:53-61 (2005)\", \"DOI:10.1007/s00441-005-1109-5\")), list(REFERENCE = \"PMID:14747944\", AUTHORS = \"Lax SF.\", TITLE = \"Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.\", JOURNAL = c(\"Virchows Arch 444:213-23 (2004)\", \"DOI:10.1007/s00428-003-0947-3\")), list(REFERENCE = \"PMID:16508724\", AUTHORS = \"Shiozawa T, Konishi I.\", TITLE = \"Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.\", JOURNAL = c(\"Int J Clin Oncol 11:13-21 (2006)\", \"DOI:10.1007/s10147-005-0546-1\")), list(REFERENCE = \"PMID:17028294\", AUTHORS = \"Hecht JL, Mutter GL.\", TITLE = \"Molecular and pathologic aspects of endometrial carcinogenesis.\", JOURNAL = c(\"J Clin Oncol 24:4783-91 (2006)\", \"DOI:10.1200/JCO.2006.06.7173\")), list(REFERENCE = \"PMID:11431710\", AUTHORS = \"Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.\", TITLE = \"Molecular pathology of endometrial hyperplasia and carcinoma.\", JOURNAL = c(\"Hum Pathol 32:569-77 (2001)\", \"DOI:10.1053/hupa.2001.25929\")), list(REFERENCE = \"PMID:15284264\", AUTHORS = \"Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.\", TITLE = \"Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.\", JOURNAL = c(\"J Clin Oncol 22:3126-32 (2004)\", \"DOI:10.1200/JCO.2004.11.154\")), list(REFERENCE = \"PMID:7585656\", AUTHORS = \"Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.\", TITLE = \"Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.\", JOURNAL = \"Cancer Res 55:5693-8 (1995)\"), list(REFERENCE = \"PMID:16248975\", AUTHORS = \"Kim D, Chung J.\", TITLE = \"Akt: versatile mediator of cell survival and beyond.\", JOURNAL = \"J Biochem Mol Biol 35:106-15 (2002)\")', 'map05213', 'Endometrial cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (434, '05214', 'Glioma', 'Gliomas are the most common of the primary brain tumors and account for more than 40% of all central nervous system neoplasms. Gliomas include tumours that are composed predominantly of astrocytes (astrocytomas), oligodendrocytes (oligodendrogliomas), mixtures of various glial cells (for example,oligoastrocytomas) and ependymal cells (ependymomas). The most malignant form of infiltrating astrocytoma - glioblastoma multiforme (GBM) - is one of the most aggressive human cancers. GBM may develop de novo (primary glioblastoma) or by progression from low-grade or anaplastic astrocytoma (secondary glioblastoma). Primary glioblastomas develop in older patients and typically show genetic alterations (EGFR amplification, p16/INK4a deletion, and PTEN mutations) at frequencies of 24-34%. Secondary glioblastomas develop in younger patients and frequently show overexpression of PDGF and CDK4 as well as p53 mutations (65%) and loss of Rb playing major roles in such transformations. Loss of PTEN has been implicated in both pathways, although it is much more common in the pathogenesis of primary GBM.', 'Human Diseases; Cancer: specific types', 'Glioma', 'Glioma', 'ko05214', 'list(REFERENCE = \"PMID:15639402\", AUTHORS = \"Soni D, King JA, Kaye AH, Hovens CM.\", TITLE = \"Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.\", JOURNAL = c(\"J Clin Neurosci 12:1-5 (2005)\", \"DOI:10.1016/j.jocn.2004.04.001\")), list(REFERENCE = \"PMID:12154354\", AUTHORS = \"Zhu Y, Parada LF.\", TITLE = \"The molecular and genetic basis of neurological tumours.\", JOURNAL = c(\"Nat Rev Cancer 2:616-26 (2002)\", \"DOI:10.1038/nrc866\")), list(REFERENCE = \"PMID:11253051\", AUTHORS = \"Holland EC.\", TITLE = \"Gliomagenesis: genetic alterations and mouse models.\", JOURNAL = c(\"Nat Rev Genet 2:120-9 (2001)\", \"DOI:10.1038/35052535\")), list(REFERENCE = \"PMID:16700615\", AUTHORS = \"Bansal K, Liang ML, Rutka JT.\", TITLE = \"Molecular biology of human gliomas.\", JOURNAL = c(\"Technol Cancer Res Treat 5:185-94 (2006)\", \"DOI:10.1177/153303460600500302\")), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Tabuchi K (ed).\", TITLE = \"[Gliomas: Research and therapy] (In Japanese)\", JOURNAL = \"Springer-Verlag Tokyo (2006)\"), list(REFERENCE = \"PMID:12762887\", AUTHORS = \"Kapoor GS, O\'Rourke DM.\", TITLE = \"Mitogenic signaling cascades in glial tumors.\", JOURNAL = c(\"Neurosurgery 52:1425-34; discussion 1434-5 (2003)\", \"DOI:10.1227/01.NEU.0000065135.28143.39\")), list(REFERENCE = \"PMID:16095998\", AUTHORS = \"Hulleman E, Helin K.\", TITLE = \"Molecular mechanisms in gliomagenesis.\", JOURNAL = c(\"Adv Cancer Res 94:1-27 (2005)\", \"DOI:10.1016/S0065-230X(05)94001-3\")), list(REFERENCE = \"PMID:11057895\", AUTHORS = \"Schlessinger J.\", TITLE = \"Cell signaling by receptor tyrosine kinases.\", JOURNAL = c(\"Cell 103:211-25 (2000)\", \"DOI:10.1016/S0092-8674(00)00114-8\")), list(REFERENCE = \"PMID:9643506\", AUTHORS = \"Ng HK, Lam PY.\", TITLE = \"The molecular genetics of central nervous system tumors.\", JOURNAL = \"Pathology 30:196-202 (1998)\"), list(REFERENCE = \"PMID:12084351\", AUTHORS = \"Knobbe CB, Merlo A, Reifenberger G.\", TITLE = \"Pten signaling in gliomas.\", JOURNAL = c(\"Neuro-oncol 4:196-211 (2002)\", \"DOI:10.1093/neuonc/4.3.196\"))', 'map05214', 'Glioma', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (435, '05215', 'Prostate cancer', 'Prostate cancer constitutes a major health problem in Western countries. It is the most frequently diagnosed cancer among men and the second leading cause of male cancer deaths. The identification of key molecular alterations in prostate-cancer cells implicates carcinogen defenses (GSTP1), growth-factor-signaling pathways (NKX3.1, PTEN, and p27), and androgens (AR) as critical determinants of the phenotype of prostate-cancer cells. Glutathione S-transferases (GSTP1) are detoxifying enzymes. Cells of prostatic intraepithelial neoplasia, devoid of GSTP1, undergo genomic damage mediated by carcinogens. NKX3.1, PTEN, and p27 regulate the growth and survival of prostate cells in the normal prostate. Inadequate levels of PTEN and NKX3.1 lead to a reduction in p27 levels and to increased proliferation and decreased apoptosis. Androgen receptor (AR) is a transcription factor that is normally activated by its androgen ligand. During androgen withdrawal therapy, the AR signal transduction pathway also could be activated by amplification of the AR gene, by AR gene mutations, or by altered activity of AR coactivators. Through these mechanisms, tumor cells lead to the emergence of androgen-independent prostate cancer.', 'Human Diseases; Cancer: specific types', 'Prostate cancer', 'Prostate cancer', 'ko05215', 'list(REFERENCE = \"PMID:12878745\", AUTHORS = \"Nelson WG, De Marzo AM, Isaacs WB.\", TITLE = \"Prostate cancer.\", JOURNAL = c(\"N Engl J Med 349:366-81 (2003)\", \"DOI:10.1056/NEJMra021562\")), list(REFERENCE = \"PMID:15724144\", AUTHORS = \"Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.\", TITLE = \"The emerging role of the PI3-K-Akt pathway in prostate cancer progression.\", JOURNAL = c(\"Prostate Cancer Prostatic Dis 8:108-18 (2005)\", \"DOI:10.1038/sj.pcan.4500776\")), list(REFERENCE = \"PMID:16551847\", AUTHORS = \"Pienta KJ, Bradley D.\", TITLE = \"Mechanisms underlying the development of androgen-independent prostate cancer.\", JOURNAL = c(\"Clin Cancer Res 12:1665-71 (2006)\", \"DOI:10.1158/1078-0432.CCR-06-0067\")), list(REFERENCE = \"PMID:11900250\", AUTHORS = \"Feldman BJ, Feldman D.\", TITLE = \"The development of androgen-independent prostate cancer.\", JOURNAL = c(\"Nat Rev Cancer 1:34-45 (2001)\", \"DOI:10.1038/35094009\")), list(REFERENCE = \"PMID:15082523\", AUTHORS = \"Heinlein CA, Chang C.\", TITLE = \"Androgen receptor in prostate cancer.\", JOURNAL = c(\"Endocr Rev 25:276-308 (2004)\", \"DOI:10.1210/er.2002-0032\")), list(REFERENCE = \"PMID:9422516\", AUTHORS = \"Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.\", TITLE = \"Androgen receptor gene and hormonal therapy failure of prostate cancer.\", JOURNAL = \"Am J Pathol 152:1-9 (1998)\"), list(REFERENCE = \"PMID:10835690\", AUTHORS = \"Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.\", TITLE = \"Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.\", JOURNAL = c(\"Nat Med 6:703-6 (2000)\", \"DOI:10.1038/76287\")), list(REFERENCE = \"PMID:10453277\", AUTHORS = \"Macri E, Loda M.\", TITLE = \"Role of p27 in prostate carcinogenesis.\", JOURNAL = c(\"Cancer Metastasis Rev 17:337-44 (1998)\", \"DOI:10.1023/A:1006133620914\")), list(REFERENCE = \"PMID:11750244\", AUTHORS = \"Steers WD.\", TITLE = \"5alpha-reductase activity in the prostate.\", JOURNAL = c(\"Urology 58:17-24; discussion 24 (2001)\", \"DOI:10.1016/S0090-4295(01)01299-7\")), list(REFERENCE = \"PMID:8069858\", AUTHORS = \"Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.\", TITLE = \"Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.\", JOURNAL = \"Cancer Res 54:4920-6 (1994)\"), list(REFERENCE = \"PMID:11527574\", AUTHORS = \"Grimes CA, Jope RS.\", TITLE = \"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.\", JOURNAL = c(\"Prog Neurobiol 65:391-426 (2001)\", \"DOI:10.1016/S0301-0082(01)00011-9\")), list(REFERENCE = \"PMID:21747944\", AUTHORS = \"Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V, Berger R\", TITLE = \"TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.\", JOURNAL = c(\"PLoS One 6:e21650 (2011)\", \"DOI:10.1371/journal.pone.0021650\")), list(REFERENCE = \"PMID:20478527\", AUTHORS = \"Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM\", TITLE = \"An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.\", JOURNAL = c(\"Cancer Cell 17:443-54 (2010)\", \"DOI:10.1016/j.ccr.2010.03.018\")), list(REFERENCE = \"PMID:19399032\", AUTHORS = \"Squire JA\", TITLE = \"TMPRSS2-ERG and PTEN loss in prostate cancer.\", JOURNAL = c(\"Nat Genet 41:509-10 (2009)\", \"DOI:10.1038/ng0509-509\")), list(REFERENCE = \"PMID:25915839\", AUTHORS = \"Adamo P, Ladomery MR\", TITLE = \"The oncogene ERG: a key factor in prostate cancer.\", JOURNAL = c(\"Oncogene 35:403-14 (2016)\", \"DOI:10.1038/onc.2015.109\")), list(REFERENCE = \"PMID:25485532\", AUTHORS = \"Burdova A, Bouchal J, Tavandzis S, Kolar Z\", TITLE = \"TMPRSS2-ERG gene fusion in prostate cancer.\", JOURNAL = c(\"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 158:502-10 (2014)\", \"DOI:10.5507/bp.2014.065\")), list(REFERENCE = \"PMID:18172298\", AUTHORS = \"Helgeson BE, Tomlins SA, Shah N, Laxman B, Cao Q, Prensner JR, Cao X, Singla N, Montie JE, Varambally S, Mehra R, Chinnaiyan AM\", TITLE = \"Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.\", JOURNAL = c(\"Cancer Res 68:73-80 (2008)\", \"DOI:10.1158/0008-5472.CAN-07-5352\")), list(REFERENCE = \"PMID:28968951\", AUTHORS = \"Kim H, Datta A, Talwar S, Saleem SN, Mondal D, Abdel-Mageed AB\", TITLE = \"Estradiol-ERbeta2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion.\", JOURNAL = c(\"Oncotarget 8:62820-62833 (2017)\", \"DOI:10.18632/oncotarget.11355\"))', 'map05215', 'Prostate cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (436, '05216', 'Thyroid cancer', 'Thyroid cancer is the most common endocrine malignancy and accounts for the majority of endocrine cancer- related deaths each year. More than 95% of thyroid carcinomas are derived from follicular cells. Their behavior varies from the indolent growing, well-differentiated papillary and follicular carcinomas (PTC and FTC, respectively) to the extremely aggressive undifferentiated carcinoma (UC). Somatic rearrangements of RET and TRK are almost exclusively found in PTC and may be found in early stages. The most distinctive molecular features of FTC are the prominence of aneuploidy and the high prevalence of RAS mutations and PAX8-PPAR{gamma} rearrangements. p53 seems to play a crucial role in the dedifferentiation process of thyroid carcinoma.', 'Human Diseases; Cancer: specific types', 'Thyroid cancer', 'Thyroid cancer', 'ko05216', 'list(REFERENCE = \"PMID:16557281\", AUTHORS = \"Kondo T, Ezzat S, Asa SL.\", TITLE = \"Pathogenetic mechanisms in thyroid follicular-cell neoplasia.\", JOURNAL = c(\"Nat Rev Cancer 6:292-306 (2006)\", \"DOI:10.1038/nrc1836\")), list(REFERENCE = \"PMID:16551846\", AUTHORS = \"Chiloeches A, Marais R.\", TITLE = \"Is BRAF the Achilles\' Heel of thyroid cancer?\", JOURNAL = c(\"Clin Cancer Res 12:1661-4 (2006)\", \"DOI:10.1158/1078-0432.CCR-06-0051\")), list(REFERENCE = \"PMID:16946003\", AUTHORS = \"Reddi HV, McIver B, Grebe SK, Eberhardt NL\", TITLE = \"The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.\", JOURNAL = c(\"Endocrinology 148:932-5 (2007)\", \"DOI:10.1210/en.2006-0926\")), list(REFERENCE = \"PMID:17062879\", AUTHORS = \"Santoro M, Melillo RM, Fusco A.\", TITLE = \"RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.\", JOURNAL = c(\"Eur J Endocrinol 155:645-653 (2006)\", \"DOI:10.1530/eje.1.02289\")), list(REFERENCE = \"PMID:16242838\", AUTHORS = \"Pierotti MA, Greco A.\", TITLE = \"Oncogenic rearrangements of the NTRK1/NGF receptor.\", JOURNAL = c(\"Cancer Lett 232:90-8 (2006)\", \"DOI:10.1016/j.canlet.2005.07.043\")), list(REFERENCE = \"PMID:16189702\", AUTHORS = \"Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.\", TITLE = \"Molecular pathology of well-differentiated thyroid carcinomas.\", JOURNAL = c(\"Virchows Arch 447:787-93 (2005)\", \"DOI:10.1007/s00428-005-0065-5\")), list(REFERENCE = \"PMID:11165748\", AUTHORS = \"Gimm O.\", TITLE = \"Thyroid cancer.\", JOURNAL = c(\"Cancer Lett 163:143-56 (2001)\", \"DOI:10.1016/S0304-3835(00)00697-2\")), list(REFERENCE = \"PMID:12094241\", AUTHORS = \"Williams D.\", TITLE = \"Cancer after nuclear fallout: lessons from the Chernobyl accident.\", JOURNAL = c(\"Nat Rev Cancer 2:543-9 (2002)\", \"DOI:10.1038/nrc845\"))', 'map05216', 'Thyroid cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (437, '05217', 'Basal cell carcinoma', 'Cancer of the skin is the most common cancer in Caucasians and basal cell carcinomas (BCC) account for 90% of all skin cancers. The vast majority of BCC cases are sporadic, though there is a rare familial syndrome basal cell nevus syndrome (BCNS, or Gorlin syndrome) that predisposes to development of BCC. In addition, there is strong epidemiological and genetic evidence that demonstrates UV exposure as a risk factor of prime importance. The development of basal cell carcinoma is associated with constitutive activation of sonic hedgehog signaling. The mutations in SMOH, PTCH1, and SHH in BCCs result in continuous activation of target genes. At a cellular level, sonic hedgehog signaling promotes cell proliferation. Mutations in TP53 are also found with high frequency (>50%) in sporadic BCC.', 'Human Diseases; Cancer: specific types', 'Basal cell carcinoma', 'Basal cell carcinoma, Basal cell nevus syndrome', 'ko05217', 'list(REFERENCE = \"PMID:15948971\", AUTHORS = \"Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.\", TITLE = \"Molecular aetiology and pathogenesis of basal cell carcinoma.\", JOURNAL = c(\"Br J Dermatol 152:1108-24 (2005)\", \"DOI:10.1111/j.1365-2133.2005.06587.x\")), list(REFERENCE = \"PMID:12588368\", AUTHORS = \"Saldanha G, Fletcher A, Slater DN.\", TITLE = \"Basal cell carcinoma: a dermatopathological and molecular biological update.\", JOURNAL = c(\"Br J Dermatol 148:195-202 (2003)\", \"DOI:10.1046/j.1365-2133.2003.05151.x\")), list(REFERENCE = \"PMID:15978322\", AUTHORS = \"Daya-Grosjean L, Couve-Privat S.\", TITLE = \"Sonic hedgehog signaling in basal cell carcinomas.\", JOURNAL = c(\"Cancer Lett 225:181-92 (2005)\", \"DOI:10.1016/j.canlet.2004.10.003\")), list(REFERENCE = \"PMID:15468170\", AUTHORS = \"Tsai KY, Tsao H.\", TITLE = \"The genetics of skin cancer.\", JOURNAL = c(\"Am J Med Genet C Semin Med Genet 131C:82-92 (2004)\", \"DOI:10.1002/ajmg.c.30037\")), list(REFERENCE = \"PMID:16881963\", AUTHORS = \"Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.\", TITLE = \"Hedgehog signalling in skin development and cancer.\", JOURNAL = c(\"Exp Dermatol 15:667-77 (2006)\", \"DOI:10.1111/j.1600-0625.2006.00473.x\")), list(REFERENCE = \"PMID:16306523\", AUTHORS = \"Rubin AI, Chen EH, Ratner D.\", TITLE = \"Basal-cell carcinoma.\", JOURNAL = c(\"N Engl J Med 353:2262-9 (2005)\", \"DOI:10.1056/NEJMra044151\")), list(REFERENCE = \"PMID:11276000\", AUTHORS = \"Saldanha G.\", TITLE = \"The Hedgehog signalling pathway and cancer.\", JOURNAL = c(\"J Pathol 193:427-32 (2001)\", \"DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N\")), list(REFERENCE = \"PMID:15270885\", AUTHORS = \"Saldanha G, Ghura V, Potter L, Fletcher A.\", TITLE = \"Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.\", JOURNAL = c(\"Br J Dermatol 151:157-64 (2004)\", \"DOI:10.1111/j.1365-2133.2004.06048.x\")), list(REFERENCE = \"PMID:14737121\", AUTHORS = \"Pasca di Magliano M, Hebrok M.\", TITLE = \"Hedgehog signalling in cancer formation and maintenance.\", JOURNAL = c(\"Nat Rev Cancer 3:903-11 (2003)\", \"DOI:10.1038/nrc1229\")), list(REFERENCE = \"PMID:15656799\", AUTHORS = \"Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.\", TITLE = \"Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.\", JOURNAL = c(\"Br J Dermatol 152:43-51 (2005)\", \"DOI:10.1111/j.1365-2133.2005.06353.x\")), list(REFERENCE = \"PMID:14556242\", AUTHORS = \"Cohen MM Jr.\", TITLE = \"The hedgehog signaling network.\", JOURNAL = c(\"Am J Med Genet A 123:5-28 (2003)\", \"DOI:10.1002/ajmg.a.20495\")), list(REFERENCE = \"PMID:11736900\", AUTHORS = \"Yamazaki F, Aragane Y, Kawada A, Tezuka T.\", TITLE = \"Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.\", JOURNAL = c(\"Br J Dermatol 145:771-7 (2001)\", \"DOI:10.1046/j.1365-2133.2001.04468.x\")), list(REFERENCE = \"PMID:16054233\", AUTHORS = \"Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.\", TITLE = \"Role of apoptosis in basal cell and squamous cell carcinoma formation.\", JOURNAL = c(\"Immunol Lett 100:68-72 (2005)\", \"DOI:10.1016/j.imlet.2005.06.008\")), list(REFERENCE = \"PMID:11130178\", AUTHORS = \"Toftgard R.\", TITLE = \"Hedgehog signalling in cancer.\", JOURNAL = c(\"Cell Mol Life Sci 57:1720-31 (2000)\", \"DOI:10.1007/PL00000654\")), list(REFERENCE = \"PMID:28286127\", AUTHORS = \"Wu F, Zhang Y, Sun B, McMahon AP, Wang Y\", TITLE = \"Hedgehog Signaling: From Basic Biology to Cancer Therapy.\", JOURNAL = c(\"Cell Chem Biol 24:252-280 (2017)\", \"DOI:10.1016/j.chembiol.2017.02.010\")), list(REFERENCE = \"PMID:25766766\", AUTHORS = \"Otsuka A, Levesque MP, Dummer R, Kabashima K\", TITLE = \"Hedgehog signaling in basal cell carcinoma.\", JOURNAL = c(\"J Dermatol Sci 78:95-100 (2015)\", \"DOI:10.1016/j.jdermsci.2015.02.007\"))', 'map05217', 'Basal cell carcinoma', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (438, '05218', 'Melanoma', 'Melanoma is a form of skin cancer that has a poor prognosis and which is on the rise in Western populations. Melanoma arises from the malignant transformation of pigment-producing cells, melanocytes. The only known environmental risk factor is exposure to ultraviolet (UV) light and in people with fair skin the risk is greatly increased. Melanoma pathogenesis is also driven by genetic factors. Oncogenic NRAS mutations activate both effector pathways Raf-MEK-ERK and PI3K-Akt. The Raf-MEK-ERK pathway may also be activated via mutations in the BRAF gene. The PI3K-Akt pathway may be activated through loss or mutation of the inhibitory tumor suppressor gene PTEN. These mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Melanoma development has been shown to be strongly associated with inactivation of the p16INK4a/cyclin dependent kinases 4 and 6/retinoblastoma protein (p16INK4a/CDK4,6/pRb) and p14ARF/human double minute 2/p53 (p14ARF/HMD2/p53) tumor suppressor pathways. MITF and TP53 are implicated in further melanoma progression.', 'Human Diseases; Cancer: specific types', 'Melanoma', 'Melanoma', 'ko05218', 'list(REFERENCE = \"PMID:16822996\", AUTHORS = \"Miller AJ, Mihm MC Jr.\", TITLE = \"Melanoma.\", JOURNAL = c(\"N Engl J Med 355:51-65 (2006)\", \"DOI:10.1056/NEJMra052166\")), list(REFERENCE = \"PMID:12894244\", AUTHORS = \"Chin L.\", TITLE = \"The genetics of malignant melanoma: lessons from mouse and man.\", JOURNAL = c(\"Nat Rev Cancer 3:559-70 (2003)\", \"DOI:10.1038/nrc1145\")), list(REFERENCE = \"PMID:16750612\", AUTHORS = \"Takata M, Saida T.\", TITLE = \"Genetic alterations in melanocytic tumors.\", JOURNAL = c(\"J Dermatol Sci 43:1-10 (2006)\", \"DOI:10.1016/j.jdermsci.2006.05.002\")), list(REFERENCE = \"PMID:15841168\", AUTHORS = \"Chudnovsky Y, Khavari PA, Adams AE.\", TITLE = \"Melanoma genetics and the development of rational therapeutics.\", JOURNAL = c(\"J Clin Invest 115:813-24 (2005)\", \"DOI:10.1172/JCI24808\")), list(REFERENCE = \"PMID:16001050\", AUTHORS = \"Merlino G.\", TITLE = \"Cancer biology: the weakest link?\", JOURNAL = c(\"Nature 436:33-5 (2005)\", \"DOI:10.1038/436033a\")), list(REFERENCE = \"PMID:16001072\", AUTHORS = \"Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.\", TITLE = \"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.\", JOURNAL = c(\"Nature 436:117-22 (2005)\", \"DOI:10.1038/nature03664\")), list(REFERENCE = \"PMID:16899407\", AUTHORS = \"Levy C, Khaled M, Fisher DE.\", TITLE = \"MITF: master regulator of melanocyte development and melanoma oncogene.\", JOURNAL = c(\"Trends Mol Med 12:406-14 (2006)\", \"DOI:10.1016/j.molmed.2006.07.008\")), list(REFERENCE = \"PMID:15009714\", AUTHORS = \"Tsao H, Goel V, Wu H, Yang G, Haluska FG.\", TITLE = \"Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.\", JOURNAL = c(\"J Invest Dermatol 122:337-41 (2004)\", \"DOI:10.1046/j.0022-202X.2004.22243.x\")), list(REFERENCE = \"PMID:11224709\", AUTHORS = \"Gruss C, Herlyn M.\", TITLE = \"Role of cadherins and matrixins in melanoma.\", JOURNAL = \"Curr Opin Oncol 13:117-23 (2001)\"), list(REFERENCE = \"PMID:15721476\", AUTHORS = \"Thompson JF, Scolyer RA, Kefford RF.\", TITLE = \"Cutaneous melanoma.\", JOURNAL = c(\"Lancet 365:687-701 (2005)\", \"DOI:10.1016/S0140-6736(05)17951-3\")), list(REFERENCE = \"PMID:14695152\", AUTHORS = \"Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.\", TITLE = \"NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.\", JOURNAL = \"Clin Cancer Res 9:6483-8 (2003)\"), list(REFERENCE = \"PMID:15557758\", AUTHORS = \"Hussein MR.\", TITLE = \"The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?\", JOURNAL = c(\"Tumour Biol 25:200-7 (2004)\", \"DOI:10.1159/000081103\")), list(REFERENCE = \"PMID:10843728\", AUTHORS = \"Lazar-Molnar E, Hegyesi H, Toth S, Falus A.\", TITLE = \"Autocrine and paracrine regulation by cytokines and growth factors in melanoma.\", JOURNAL = c(\"Cytokine 12:547-54 (2000)\", \"DOI:10.1006/cyto.1999.0614\"))', 'map05218', 'Melanoma', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (439, '05219', 'Bladder cancer', 'The urothelium covers the luminal surface of almost the entire urinary tract, extending from the renal pelvis, through the ureter and bladder, to the proximal urethra. The majority of urothelial carcinoma are bladder carcinomas, and urothelial carcinomas of the renal pelvis and ureter account for only approximately 7% of the total. Urothelial tumours arise and evolve through divergent phenotypic pathways. Some tumours progress from urothelial hyperplasia to low-grade non-invasive superficial papillary tumours. More aggressive variants arise either from flat, high-grade carcinoma in situ (CIS) and progress to invasive tumours, or they arise de novo as invasive tumours. Low-grade papillary tumors frequently show a constitutive activation of the receptor tyrosine kinase-Ras pathway, exhibiting activating mutations in the HRAS and fibroblast growth factor receptor 3 (FGFR3) genes. In contrast, CIS and invasive tumors frequently show alterations in the TP53 and RB genes and pathways. Invasion and metastases are promoted by several factors that alter the tumour microenvironment, including the aberrant expression of E-cadherins (E-cad), matrix metalloproteinases (MMPs), angiogenic factors such as vascular endothelial growth factor (VEGF).', 'Human Diseases; Cancer: specific types', 'Bladder cancer', 'Bladder cancer', 'ko05219', 'list(REFERENCE = \"PMID:17158541\", AUTHORS = \"Mitra AP, Datar RH, Cote RJ.\", TITLE = \"Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.\", JOURNAL = c(\"J Clin Oncol 24:5552-64 (2006)\", \"DOI:10.1200/JCO.2006.08.2073\")), list(REFERENCE = \"PMID:16474624\", AUTHORS = \"Wolff EM, Liang G, Jones PA.\", TITLE = \"Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.\", JOURNAL = c(\"Nat Clin Pract Urol 2:502-10 (2005)\", \"DOI:10.1038/ncpuro0318\")), list(REFERENCE = \"PMID:16110317\", AUTHORS = \"Wu XR.\", TITLE = \"Urothelial tumorigenesis: a tale of divergent pathways.\", JOURNAL = c(\"Nat Rev Cancer 5:713-25 (2005)\", \"DOI:10.1038/nrc1697\")), list(REFERENCE = \"PMID:11103787\", AUTHORS = \"Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.\", TITLE = \"Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.\", JOURNAL = \"Cancer Res 60:6298-302 (2000)\"), list(REFERENCE = \"PMID:12850530\", AUTHORS = \"Bellmunt J, Hussain M, Dinney CP.\", TITLE = \"Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.\", JOURNAL = c(\"Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)\", \"DOI:10.1016/S1040-8428(03)00067-2\")), list(REFERENCE = \"PMID:17149381\", AUTHORS = \"Sugano K, Kakizoe T.\", TITLE = \"Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.\", JOURNAL = c(\"Nat Clin Pract Urol 3:642-52 (2006)\", \"DOI:10.1038/ncpuro0649\")), list(REFERENCE = \"PMID:15746962\", AUTHORS = \"Dunn KL, Espino PS, Drobic B, He S, Davie JR.\", TITLE = \"The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.\", JOURNAL = c(\"Biochem Cell Biol 83:1-14 (2005)\", \"DOI:10.1139/o04-121\")), list(REFERENCE = \"PMID:15551095\", AUTHORS = \"Williams SG, Stein JP.\", TITLE = \"Molecular pathways in bladder cancer.\", JOURNAL = c(\"Urol Res 32:373-85 (2004)\", \"DOI:10.1007/s00240-003-0345-y\"))', 'map05219', 'Bladder cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (440, '05220', 'Chronic myeloid leukemia', 'Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder of a pluripotent stem cell. The natural history of CML has a triphasic clinical course comprising of an initial chronic phase (CP), which is characterized by expansion of functionally normal myeloid cells, followed by an accelerated phase (AP) and finally a more aggressive blast phase (BP), with loss of terminal differentiation capacity. On the cellular level, CML is associated with a specific chromosome abnormality, the t(9; 22) reciprocal translocation that forms the Philadelphia (Ph) chromosome. The Ph chromosome is the result of a molecular rearrangement between the c-ABL proto-oncogene on chromosome 9 and the BCR (breakpoint cluster region) gene on chromosome 22. The BCR/ABL fusion gene encodes p210 BCR/ABL, an oncoprotein, which, unlike the normal p145 c-Abl, has constitutive tyrosine kinase activity and is predominantly localized in the cytoplasm. While fusion of c-ABL and BCR is believed to be the primary cause of the chronic phase of CML, progression to blast crisis requires other molecular changes. Common secondary abnormalities include mutations in TP53, RB, and p16/INK4A, or overexpression of genes such as EVI1. Additional chromosome translocations are also observed,such as t(3;21)(q26;q22), which generates AML1-EVI1.', 'Human Diseases; Cancer: specific types', 'Chronic myeloid leukemia', 'Chronic myeloid leukemia', 'ko05220', 'list(REFERENCE = \"PMID:15719031\", AUTHORS = \"Ren R.\", TITLE = \"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.\", JOURNAL = c(\"Nat Rev Cancer 5:172-83 (2005)\", \"DOI:10.1038/nrc1567\")), list(REFERENCE = \"PMID:11071626\", AUTHORS = \"Deininger MW, Goldman JM, Melo JV.\", TITLE = \"The molecular biology of chronic myeloid leukemia.\", JOURNAL = \"Blood 96:3343-56 (2000)\"), list(REFERENCE = \"PMID:14982876\", AUTHORS = \"Calabretta B, Perrotti D.\", TITLE = \"The biology of CML blast crisis.\", JOURNAL = c(\"Blood 103:4010-22 (2004)\", \"DOI:10.1182/blood-2003-12-4111\")), list(REFERENCE = \"PMID:10403855\", AUTHORS = \"Faderl S, Talpaz M, Estrov Z, O\'Brien S, Kurzrock R, Kantarjian HM.\", TITLE = \"The biology of chronic myeloid leukemia.\", JOURNAL = c(\"N Engl J Med 341:164-72 (1999)\", \"DOI:10.1056/NEJM199907153410306\")), list(REFERENCE = \"PMID:15156182\", AUTHORS = \"Mitani K.\", TITLE = \"Molecular mechanisms of leukemogenesis by AML1/EVI-1.\", JOURNAL = c(\"Oncogene 23:4263-9 (2004)\", \"DOI:10.1038/sj.onc.1207777\")), list(REFERENCE = \"PMID:16484590\", AUTHORS = \"Dong M, Blobe GC.\", TITLE = \"Role of transforming growth factor-beta in hematologic malignancies.\", JOURNAL = c(\"Blood 107:4589-96 (2006)\", \"DOI:10.1182/blood-2005-10-4169\")), list(REFERENCE = \"PMID:9834202\", AUTHORS = \"Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.\", TITLE = \"The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.\", JOURNAL = \"Blood 92:4003-12 (1998)\"), list(REFERENCE = \"PMID:12801837\", AUTHORS = \"Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.\", TITLE = \"p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.\", JOURNAL = \"Haematologica 88:622-30 (2003)\"), list(REFERENCE = \"PMID:11160144\", AUTHORS = \"Baldwin AS.\", TITLE = \"Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.\", JOURNAL = c(\"J Clin Invest 107:241-6 (2001)\", \"DOI:10.1172/JCI11991\")), list(REFERENCE = \"PMID:12244301\", AUTHORS = \"Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.\", TITLE = \"PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.\", JOURNAL = c(\"Nat Med 8:1145-52 (2002)\", \"DOI:10.1038/nm759\")), list(REFERENCE = \"PMID:22286129\", AUTHORS = \"Hantschel O, Warsch W, Eckelhart E, Kaupe I, Grebien F, Wagner KU, Superti-Furga G, Sexl V\", TITLE = \"BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia.\", JOURNAL = c(\"Nat Chem Biol 8:285-93 (2012)\", \"DOI:10.1038/nchembio.775\"))', 'map05220', 'Chronic myeloid leukemia', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (441, '05221', 'Acute myeloid leukemia', 'Acute myeloid leukemia (AML) is a disease that is characterized by uncontrolled proliferation of clonal neoplastic cells and accumulation in the bone marrow of blasts with an impaired differentiation program. AML accounts for approximately 80% of all adult leukemias and remains the most common cause of leukemia death. Two major types of genetic events have been described that are crucial for leukemic transformation. A proposed necessary first event is disordered cell growth and upregulation of cell survival genes. The most common of these activating events were observed in the RTK Flt3, in N-Ras and K-Ras, in Kit, and sporadically in other RTKs. Alterations in myeloid transcription factors governing hematopoietic differentiation provide second necessary event for leukemogenesis. Transcription factor fusion proteins such as AML-ETO, PML-RARalpha or PLZF-RARalpha block myeloid cell differentiation by repressing target genes. In other cases, the transcription factors themselves are mutated.', 'Human Diseases; Cancer: specific types', 'Acute myeloid leukemia', 'Acute myeloid leukemia', 'ko05221', 'list(REFERENCE = \"PMID:16236521\", AUTHORS = \"Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.\", TITLE = \"The molecular pathogenesis of acute myeloid leukemia.\", JOURNAL = c(\"Crit Rev Oncol Hematol 56:195-221 (2005)\", \"DOI:10.1016/j.critrevonc.2004.10.012\")), list(REFERENCE = \"PMID:12563308\", AUTHORS = \"Tenen DG.\", TITLE = \"Disruption of differentiation in human cancer: AML shows the way.\", JOURNAL = c(\"Nat Rev Cancer 3:89-101 (2003)\", \"DOI:10.1038/nrc989\")), list(REFERENCE = \"PMID:16146838\", AUTHORS = \"Choudhary C, Muller-Tidow C, Berdel WE, Serve H.\", TITLE = \"Signal transduction of oncogenic Flt3.\", JOURNAL = c(\"Int J Hematol 82:93-9 (2005)\", \"DOI:10.1532/IJH97.05090\")), list(REFERENCE = \"PMID:12951584\", AUTHORS = \"Stirewalt DL, Radich JP.\", TITLE = \"The role of FLT3 in haematopoietic malignancies.\", JOURNAL = c(\"Nat Rev Cancer 3:650-65 (2003)\", \"DOI:10.1038/nrc1169\")), list(REFERENCE = \"PMID:16642045\", AUTHORS = \"Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.\", TITLE = \"Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.\", JOURNAL = c(\"Leukemia 20:911-28 (2006)\", \"DOI:10.1038/sj.leu.2404245\")), list(REFERENCE = \"PMID:15625120\", AUTHORS = \"Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.\", TITLE = \"Normal and oncogenic forms of the receptor tyrosine kinase kit.\", JOURNAL = c(\"Stem Cells 23:16-43 (2005)\", \"DOI:10.1634/stemcells.2004-0117\")), list(REFERENCE = \"PMID:11721960\", AUTHORS = \"Lorsbach RB, Downing JR.\", TITLE = \"The role of the AML1 transcription factor in leukemogenesis.\", JOURNAL = c(\"Int J Hematol 74:258-65 (2001)\", \"DOI:10.1007/BF02982058\")), list(REFERENCE = \"PMID:12468433\", AUTHORS = \"Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.\", TITLE = \"Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.\", JOURNAL = c(\"Blood 101:3164-73 (2003)\", \"DOI:10.1182/blood-2002-06-1677\")), list(REFERENCE = \"PMID:16352814\", AUTHORS = \"Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.\", TITLE = \"ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.\", JOURNAL = c(\"Blood 107:3330-8 (2006)\", \"DOI:10.1182/blood-2005-07-3068\")), list(REFERENCE = \"PMID:12529654\", AUTHORS = \"Roumier C, Fenaux P, Lafage M, Imbert M, Eclache V, Preudhomme C\", TITLE = \"New mechanisms of AML1 gene alteration in hematological malignancies.\", JOURNAL = c(\"Leukemia 17:9-16 (2003)\", \"DOI:10.1038/sj.leu.2402766\")), list(REFERENCE = \"PMID:12032780\", AUTHORS = \"Scandura JM, Boccuni P, Cammenga J, Nimer SD\", TITLE = \"Transcription factor fusions in acute leukemia: variations on a theme.\", JOURNAL = c(\"Oncogene 21:3422-44 (2002)\", \"DOI:10.1038/sj.onc.1205315\")), list(REFERENCE = \"PMID:10717473\", AUTHORS = \"Lutterbach B, Hiebert SW\", TITLE = \"Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation.\", JOURNAL = c(\"Gene 245:223-35 (2000)\", \"DOI:10.1016/S0378-1119(00)00014-7\")), list(REFERENCE = \"PMID:19075268\", AUTHORS = \"Koschmieder S, Halmos B, Levantini E, Tenen DG\", TITLE = \"Dysregulation of the C/EBPalpha differentiation pathway in human cancer.\", JOURNAL = c(\"J Clin Oncol 27:619-28 (2009)\", \"DOI:10.1200/JCO.2008.17.9812\")), list(REFERENCE = \"PMID:15985538\", AUTHORS = \"Gery S, Gombart AF, Yi WS, Koeffler C, Hofmann WK, Koeffler HP\", TITLE = \"Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia.\", JOURNAL = c(\"Blood 106:2827-36 (2005)\", \"DOI:10.1182/blood-2005-01-0358\")), list(REFERENCE = \"PMID:12130514\", AUTHORS = \"Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD, Behre G, Hiddemann W, Ito Y, Tenen DG\", TITLE = \"Heterozygous PU.1 mutations are associated with acute myeloid leukemia.\", JOURNAL = c(\"Blood 100:998-1007 (2002)\", \"DOI:10.1182/blood.V100.3.998\")), list(REFERENCE = \"PMID:12393465\", AUTHORS = \"Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G\", TITLE = \"The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.\", JOURNAL = c(\"Blood 101:270-7 (2003)\", \"DOI:10.1182/blood-2002-04-1288\")), list(REFERENCE = \"PMID:15024077\", AUTHORS = \"Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Kohler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H\", TITLE = \"Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.\", JOURNAL = c(\"Mol Cell Biol 24:2890-904 (2004)\", \"DOI:10.1128/MCB.24.7.2890-2904.2004\")), list(REFERENCE = \"PMID:11090075\", AUTHORS = \"Muller C, Yang R, Park DJ, Serve H, Berdel WE, Koeffler HP\", TITLE = \"The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia.\", JOURNAL = \"Blood 96:3894-9 (2000)\"), list(REFERENCE = \"PMID:15160934\", AUTHORS = \"Jing Y\", TITLE = \"The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.\", JOURNAL = c(\"Leuk Lymphoma 45:639-48 (2004)\", \"DOI:10.1080/10428190310001609933\")), list(REFERENCE = \"PMID:11607818\", AUTHORS = \"Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, Fagioli M, Pelicci PG\", TITLE = \"Common themes in the pathogenesis of acute myeloid leukemia.\", JOURNAL = c(\"Oncogene 20:5680-94 (2001)\", \"DOI:10.1038/sj.onc.1204642\")), list(REFERENCE = \"PMID:19855079\", AUTHORS = \"Rice KL, Hormaeche I, Doulatov S, Flatow JM, Grimwade D, Mills KI, Leiva M, Ablain J, Ambardekar C, McConnell MJ, Dick JE, Licht JD\", TITLE = \"Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.\", JOURNAL = c(\"Blood 114:5499-511 (2009)\", \"DOI:10.1182/blood-2009-03-206524\")), list(REFERENCE = \"PMID:17554387\", AUTHORS = \"Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.\", TITLE = \"The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.\", JOURNAL = c(\"Leukemia 21:1638-47 (2007)\", \"DOI:10.1038/sj.leu.2404732\"))', 'map05221', 'Acute myeloid leukemia', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (442, '05222', 'Small cell lung cancer', 'Lung cancer is a leading cause of cancer death among men and women in industrialized countries. Small cell lung carcinoma (SCLC) is a highly aggressive neoplasm, which accounts for approximately 25% of all lung cancer cases. Molecular mechanisms altered in SCLC include induced expression of oncogene, MYC, and loss of tumorsuppressor genes, such as p53, PTEN, RB, and FHIT. The overexpression of MYC proteins in SCLC is largely a result of gene amplification. Such overexpression leads to more rapid proliferation and loss of terminal differentiation. Mutation or deletion of p53 or PTEN can lead to more rapid proliferation and reduced apoptosis. The retinoblastoma gene RB1 encodes a nuclear phosphoprotein that helps to regulate cell-cycle progression. The fragile histidine triad gene FHIT encodes the enzyme diadenosine triphosphate hydrolase, which is thought to have an indirect role in proapoptosis and cell-cycle control.', 'Human Diseases; Cancer: specific types', 'Small cell lung cancer', 'Small cell lung cancer', 'ko05222', 'list(REFERENCE = \"PMID:12379883\", AUTHORS = \"Osada H, Takahashi T.\", TITLE = \"Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.\", JOURNAL = c(\"Oncogene 21:7421-34 (2002)\", \"DOI:10.1038/sj.onc.1205802\")), list(REFERENCE = \"PMID:12741677\", AUTHORS = \"Yokota J, Nishioka M, Tani M, Kohno T.\", TITLE = \"Genetic alterations responsible for metastatic phenotypes of lung cancer cells.\", JOURNAL = \"Clin Exp Metastasis 20:189-93 (2003)\"), list(REFERENCE = \"PMID:12711111\", AUTHORS = \"Sanchez-Cespedes M.\", TITLE = \"Dissecting the genetic alterations involved in lung carcinogenesis.\", JOURNAL = c(\"Lung Cancer 40:111-21 (2003)\", \"DOI:10.1016/S0169-5002(03)00033-3\")), list(REFERENCE = \"PMID:12407699\", AUTHORS = \"Mitsuuchi Y, Testa JR.\", TITLE = \"Cytogenetics and molecular genetics of lung cancer.\", JOURNAL = c(\"Am J Med Genet 115:183-8 (2002)\", \"DOI:10.1002/ajmg.10692\")), list(REFERENCE = \"PMID:11720739\", AUTHORS = \"Kaye FJ.\", TITLE = \"Molecular biology of lung cancer.\", JOURNAL = c(\"Lung Cancer 34 Suppl 2:S35-41 (2001)\", \"DOI:10.1016/S0169-5002(01)00342-7\")), list(REFERENCE = \"PMID:16112428\", AUTHORS = \"Panani AD, Roussos C.\", TITLE = \"Cytogenetic and molecular aspects of lung cancer.\", JOURNAL = c(\"Cancer Lett 239:1-9 (2006)\", \"DOI:10.1016/j.canlet.2005.06.030\")), list(REFERENCE = \"PMID:11902573\", AUTHORS = \"Altucci L, Gronemeyer H.\", TITLE = \"The promise of retinoids to fight against cancer.\", JOURNAL = c(\"Nat Rev Cancer 1:181-93 (2001)\", \"DOI:10.1038/35106036\")), list(REFERENCE = \"PMID:10944551\", AUTHORS = \"Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.\", TITLE = \"Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.\", JOURNAL = c(\"J Natl Cancer Inst 92:1303-7 (2000)\", \"DOI:10.1093/jnci/92.16.1303\")), list(REFERENCE = \"PMID:11807782\", AUTHORS = \"Sartorius UA, Krammer PH.\", TITLE = \"Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.\", JOURNAL = c(\"Int J Cancer 97:584-92 (2002)\", \"DOI:10.1002/ijc.10096\")), list(REFERENCE = \"PMID:16064138\", AUTHORS = \"Adhikary S, Eilers M.\", TITLE = \"Transcriptional regulation and transformation by Myc proteins.\", JOURNAL = c(\"Nat Rev Mol Cell Biol 6:635-45 (2005)\", \"DOI:10.1038/nrm1703\")), list(REFERENCE = \"PMID:11463388\", AUTHORS = \"Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.\", TITLE = \"A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.\", JOURNAL = c(\"Mol Cell 7:639-50 (2001)\", \"DOI:10.1016/S1097-2765(01)00210-6\")), list(REFERENCE = \"PMID:15109562\", AUTHORS = \"Buttery RC, Rintoul RC, Sethi T.\", TITLE = \"Small cell lung cancer: the importance of the extracellular matrix.\", JOURNAL = c(\"Int J Biochem Cell Biol 36:1154-60 (2004)\", \"DOI:10.1016/S1357-2725(03)00261-9\")), list(REFERENCE = \"PMID:11559746\", AUTHORS = \"Yamada KM, Araki M.\", TITLE = \"Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.\", JOURNAL = \"J Cell Sci 114:2375-82 (2001)\"), list(REFERENCE = \"PMID:11905738\", AUTHORS = \"Rintoul RC, Sethi T.\", TITLE = \"The role of extracellular matrix in small-cell lung cancer.\", JOURNAL = c(\"Lancet Oncol 2:437-42 (2001)\", \"DOI:10.1016/S1470-2045(00)00421-6\")), list(REFERENCE = \"PMID:12243753\", AUTHORS = \"Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.\", TITLE = \"Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.\", JOURNAL = c(\"Exp Cell Res 279:277-90 (2002)\", \"DOI:10.1006/excr.2002.5608\")), list(REFERENCE = \"PMID:12616528\", AUTHORS = \"Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.\", TITLE = \"Apoptosis and lung cancer: a review.\", JOURNAL = c(\"J Cell Biochem 88:885-98 (2003)\", \"DOI:10.1002/jcb.10440\")), list(REFERENCE = \"PMID:23070004\", AUTHORS = \"Weyhenmeyer B, Murphy AC, Prehn JH, Murphy BM\", TITLE = \"Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer.\", JOURNAL = \"Exp Oncol 34:192-9 (2012)\")', 'map05222', 'Small cell lung cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (443, '05223', 'Non-small cell lung cancer', 'Lung cancer is a leading cause of cancer death among men and women in industrialized countries. Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer and represents a heterogeneous group of cancers, consisting mainly of squamous cell (SCC), adeno (AC) and large-cell carcinoma. Molecular mechanisms altered in NSCLC include activation of oncogenes, such as K-RAS, EGFR and EML4-ALK, and inactivation of tumorsuppressor genes, such as p53, p16INK4a, RAR-beta, and RASSF1. Point mutations within the K-RAS gene inactivate GTPase activity and the p21-RAS protein continuously transmits growth signals to the nucleus. Mutations or overexpression of EGFR leads to a proliferative advantage. EML4-ALK fusion leads to constitutive ALK activation, which causes cell proliferation, invasion, and inhibition of apoptosis. Inactivating mutation of p53 can lead to more rapid proliferation and reduced apoptosis. The protein encoded by the p16INK4a inhibits formation of CDK-cyclin-D complexes by competitive binding of CDK4 and CDK6. Loss of p16INK4a expression is a common feature of NSCLC. RAR-beta is a nuclear receptor that bears vitamin-A-dependent transcriptional activity. RASSF1A is able to form heterodimers with Nore-1, an RAS effector.Therefore loss of RASSF1A might shift the balance of RAS activity towards a growth-promoting effect.', 'Human Diseases; Cancer: specific types', 'Non-small cell lung cancer', 'Non-small cell lung cancer', 'ko05223', 'list(REFERENCE = \"PMID:12379883\", AUTHORS = \"Osada H, Takahashi T.\", TITLE = \"Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.\", JOURNAL = c(\"Oncogene 21:7421-34 (2002)\", \"DOI:10.1038/sj.onc.1205802\")), list(REFERENCE = \"PMID:12741677\", AUTHORS = \"Yokota J, Nishioka M, Tani M, Kohno T.\", TITLE = \"Genetic alterations responsible for metastatic phenotypes of lung cancer cells.\", JOURNAL = \"Clin Exp Metastasis 20:189-93 (2003)\"), list(REFERENCE = \"PMID:16870043\", AUTHORS = \"Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.\", TITLE = \"K-ras mutations in non-small-cell lung carcinoma: a review.\", JOURNAL = c(\"Clin Lung Cancer 8:30-8 (2006)\", \"DOI:10.3816/CLC.2006.n.030\")), list(REFERENCE = \"PMID:15948711\", AUTHORS = \"Pfeifer GP, Dammann R.\", TITLE = \"Methylation of the tumor suppressor gene RASSF1A in human tumors.\", JOURNAL = \"Biochemistry (Mosc) 70:576-83 (2005)\"), list(REFERENCE = \"PMID:11902573\", AUTHORS = \"Altucci L, Gronemeyer H.\", TITLE = \"The promise of retinoids to fight against cancer.\", JOURNAL = c(\"Nat Rev Cancer 1:181-93 (2001)\", \"DOI:10.1038/35106036\")), list(REFERENCE = \"PMID:10944551\", AUTHORS = \"Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.\", TITLE = \"Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.\", JOURNAL = c(\"J Natl Cancer Inst 92:1303-7 (2000)\", \"DOI:10.1093/jnci/92.16.1303\")), list(REFERENCE = \"PMID:12867060\", AUTHORS = \"Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.\", TITLE = \"Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.\", JOURNAL = c(\"Lung Cancer 41 Suppl 1:S29-42 (2003)\", \"DOI:10.1016/S0169-5002(03)00137-5\")), list(REFERENCE = \"PMID:16112428\", AUTHORS = \"Panani AD, Roussos C.\", TITLE = \"Cytogenetic and molecular aspects of lung cancer.\", JOURNAL = c(\"Cancer Lett 239:1-9 (2006)\", \"DOI:10.1016/j.canlet.2005.06.030\")), list(REFERENCE = \"PMID:12407699\", AUTHORS = \"Mitsuuchi Y, Testa JR.\", TITLE = \"Cytogenetics and molecular genetics of lung cancer.\", JOURNAL = c(\"Am J Med Genet 115:183-8 (2002)\", \"DOI:10.1002/ajmg.10692\")), list(REFERENCE = \"PMID:15942304\", AUTHORS = \"Breuer RH, Postmus PE, Smit EF.\", TITLE = \"Molecular pathology of non-small-cell lung cancer.\", JOURNAL = c(\"Respiration 72:313-30 (2005)\", \"DOI:10.1159/000085376\")), list(REFERENCE = \"PMID:11895903\", AUTHORS = \"Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.\", TITLE = \"Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.\", JOURNAL = \"Clin Cancer Res 8:734-44 (2002)\"), list(REFERENCE = \"PMID:16189154\", AUTHORS = \"Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.\", TITLE = \"Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.\", JOURNAL = c(\"J Clin Pathol 58:1076-80 (2005)\", \"DOI:10.1136/jcp.2004.025585\")), list(REFERENCE = \"PMID:17625570\", AUTHORS = \"Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H\", TITLE = \"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.\", JOURNAL = c(\"Nature 448:561-6 (2007)\", \"DOI:10.1038/nature05945\")), list(REFERENCE = \"PMID:18593892\", AUTHORS = \"Choi YL, Takeuchi K, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Hamada T, Haruta H, Watanabe H, Kurashina K, Hatanaka H, Ueno T, Takada S, Yamashita Y, Sugiyama Y, Ishikawa Y, Mano H\", TITLE = \"Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.\", JOURNAL = c(\"Cancer Res 68:4971-6 (2008)\", \"DOI:10.1158/0008-5472.CAN-07-6158\")), list(REFERENCE = \"PMID:19629074\", AUTHORS = \"Janne PA, Gray N, Settleman J\", TITLE = \"Factors underlying sensitivity of cancers to small-molecule kinase inhibitors.\", JOURNAL = c(\"Nat Rev Drug Discov 8:709-23 (2009)\", \"DOI:10.1038/nrd2871\")), list(REFERENCE = \"PMID:23201355\", AUTHORS = \"Roskoski R Jr\", TITLE = \"Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition.\", JOURNAL = c(\"Pharmacol Res 68:68-94 (2013)\", \"DOI:10.1016/j.phrs.2012.11.007\")), list(REFERENCE = \"PMID:22154278\", AUTHORS = \"Reungwetwattana T, Weroha SJ, Molina JR\", TITLE = \"Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC).\", JOURNAL = c(\"Clin Lung Cancer 13:252-66 (2012)\", \"DOI:10.1016/j.cllc.2011.09.004\")), list(REFERENCE = \"PMID:21855164\", AUTHORS = \"Popat S, Gonzalez D, Min T, Swansbury J, Dainton M, Croud JG, Rice AJ, Nicholson AG\", TITLE = \"ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma.\", JOURNAL = c(\"Lung Cancer 75:300-5 (2012)\", \"DOI:10.1016/j.lungcan.2011.07.017\")), list(REFERENCE = \"PMID:21753699\", AUTHORS = \"Yoshida A, Tsuta K, Nakamura H, Kohno T, Takahashi F, Asamura H, Sekine I, Fukayama M, Shibata T, Furuta K, Tsuda H\", TITLE = \"Comprehensive histologic analysis of ALK-rearranged lung carcinomas.\", JOURNAL = c(\"Am J Surg Pathol 35:1226-34 (2011)\", \"DOI:10.1097/PAS.0b013e3182233e06\")), list(REFERENCE = \"PMID:22736493\", AUTHORS = \"Shaozhang Z, Xiaomei L, Aiping Z, Jianbo H, Xiangqun S, Qitao Y\", TITLE = \"Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.\", JOURNAL = c(\"Genes Chromosomes Cancer 51:925-32 (2012)\", \"DOI:10.1002/gcc.21976\")), list(REFERENCE = \"PMID:21850578\", AUTHORS = \"Toyooka S, Mitsudomi T, Soh J, Aokage K, Yamane M, Oto T, Kiura K, Miyoshi S\", TITLE = \"Molecular oncology of lung cancer.\", JOURNAL = c(\"Gen Thorac Cardiovasc Surg 59:527-37 (2011)\", \"DOI:10.1007/s11748-010-0743-3\")), list(REFERENCE = \"PMID:23733083\", AUTHORS = \"Koudelakova V, Kneblova M, Trojanec R, Drabek J, Hajduch M\", TITLE = \"Non-small cell lung cancer--genetic predictors.\", JOURNAL = c(\"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 157:125-36 (2013)\", \"DOI:10.5507/bp.2013.034\"))', 'map05223', 'Non-small cell lung cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (444, '05224', 'Breast cancer', 'Breast cancer is the leading cause of cancer death among women worldwide. The vast majority of breast cancers are carcinomas that originate from cells lining the milk-forming ducts of the mammary gland. The molecular subtypes of breast cancer, which are based on the presence or absence of hormone receptors (estrogen and progesterone subtypes) and human epidermal growth factor receptor-2 (HER2), include: hormone receptor positive and HER2 negative (luminal A subtype), hormone receptor positive and HER2 positive (luminal B subtype), hormone receptor negative and HER2 positive (HER2 positive), and hormone receptor negative and HER2 negative (basal-like or triple-negative breast cancers (TNBCs)). Hormone receptor positive breast cancers are largely driven by the estrogen/ER pathway. In HER2 positive breast tumours, HER2 activates the PI3K/AKT and the RAS/RAF/MAPK pathways, and stimulate cell growth, survival and differentiation. In patients suffering from TNBC, the deregulation of various signalling pathways (Notch and Wnt/beta-catenin), EGFR protein have been confirmed. In the case of breast cancer only 8% of all cancers are hereditary, a phenomenon linked to genetic changes in BRCA1 or BRCA2. Somatic mutations in only three genes (TP53, PIK3CA and GATA3) occurred at >10% incidence across all breast cancers.', 'Human Diseases; Cancer: specific types', 'Breast cancer', 'Breast cancer', 'ko05224', 'list(REFERENCE = \"PMID:24649067\", AUTHORS = \"Zhang MH, Man HT, Zhao XD, Dong N, Ma SL\", TITLE = \"Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials (Review).\", JOURNAL = c(\"Biomed Rep 2:41-52 (2014)\", \"DOI:10.3892/br.2013.187\")), list(REFERENCE = \"PMID:27390604\", AUTHORS = \"Dai X, Xiang L, Li T, Bai Z\", TITLE = \"Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes.\", JOURNAL = c(\"J Cancer 7:1281-94 (2016)\", \"DOI:10.7150/jca.13141\")), list(REFERENCE = \"PMID:20436504\", AUTHORS = \"Schnitt SJ\", TITLE = \"Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy.\", JOURNAL = c(\"Mod Pathol 23 Suppl 2:S60-4 (2010)\", \"DOI:10.1038/modpathol.2010.33\")), list(REFERENCE = \"PMID:23000897\", AUTHORS = \"\", TITLE = \"Comprehensive molecular portraits of human breast tumours.\", JOURNAL = c(\"Nature 490:61-70 (2012)\", \"DOI:10.1038/nature11412\")), list(REFERENCE = \"PMID:22178455\", AUTHORS = \"Eroles P, Bosch A, Perez-Fidalgo JA, Lluch A\", TITLE = \"Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.\", JOURNAL = c(\"Cancer Treat Rev 38:698-707 (2012)\", \"DOI:10.1016/j.ctrv.2011.11.005\")), list(REFERENCE = \"\", AUTHORS = \"Karamouzis MV, Papavassiliou KA, Adamopoulos C, Papavassiliou AG.\", TITLE = \"Targeting androgen/estrogen receptors crosstalk in cancer\", JOURNAL = c(\"Trends in Cancer 2(1):35-48 (2016)\", \"DOI:10.1016/j.trecan.2015.12.001\")), list(REFERENCE = \"\", AUTHORS = \"Sharp A, Harper-Wynne C.\", TITLE = \"Treatment of advanced breast cancer (ABC): the expanding landscape of targeted therapies\", JOURNAL = \"J Cancer Biol Res 2(1):1036 (2014)\"), list(REFERENCE = \"PMID:24596345\", AUTHORS = \"Byler S, Goldgar S, Heerboth S, Leary M, Housman G, Moulton K, Sarkar S\", TITLE = \"Genetic and epigenetic aspects of breast cancer progression and therapy.\", JOURNAL = \"Anticancer Res 34:1071-7 (2014)\"), list(REFERENCE = \"PMID:23988612\", AUTHORS = \"Mohamed A, Krajewski K, Cakar B, Ma CX\", TITLE = \"Targeted therapy for breast cancer.\", JOURNAL = c(\"Am J Pathol 183:1096-112 (2013)\", \"DOI:10.1016/j.ajpath.2013.07.005\")), list(REFERENCE = \"PMID:22722193\", AUTHORS = \"Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan MD, Wendl MC, DeSchryver K, Allred DC, Esserman L, Unzeitig G, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Leitch M, Hunt K, Olson J, Tao Y, Maher CA, Fulton LL, Fulton RS, Harrison M, Oberkfell B, Du F, Demeter R, Vickery TL, Elhammali A, Piwnica-Worms H, McDonald S, Watson M, Dooling DJ, Ota D, Chang LW, Bose R, Ley TJ, Piwnica-Worms D, Stuart JM, Wilson RK, Mardis ER\", \n    TITLE = \"Whole-genome analysis informs breast cancer response to aromatase inhibition.\", JOURNAL = c(\"Nature 486:353-60 (2012)\", \"DOI:10.1038/nature11143\")), list(REFERENCE = \"PMID:25907219\", AUTHORS = \"Ma CX, Reinert T, Chmielewska I, Ellis MJ\", TITLE = \"Mechanisms of aromatase inhibitor resistance.\", JOURNAL = c(\"Nat Rev Cancer 15:261-75 (2015)\", \"DOI:10.1038/nrc3920\")), list(REFERENCE = \"PMID:16113099\", AUTHORS = \"Butt AJ, McNeil CM, Musgrove EA, Sutherland RL\", TITLE = \"Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.\", JOURNAL = c(\"Endocr Relat Cancer 12 Suppl 1:S47-59 (2005)\", \"DOI:10.1677/erc.1.00993\")), list(REFERENCE = \"PMID:24111892\", AUTHORS = \"Dasgupta S, Lonard DM, O\'Malley BW\", TITLE = \"Nuclear receptor coactivators: master regulators of human health and disease.\", JOURNAL = c(\"Annu Rev Med 65:279-92 (2014)\", \"DOI:10.1146/annurev-med-051812-145316\")), list(REFERENCE = \"PMID:23702927\", AUTHORS = \"Brisken C\", TITLE = \"Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.\", JOURNAL = c(\"Nat Rev Cancer 13:385-96 (2013)\", \"DOI:10.1038/nrc3518\")), list(REFERENCE = \"PMID:20087430\", AUTHORS = \"Scarpin KM, Graham JD, Mote PA, Clarke CL\", TITLE = \"Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression.\", JOURNAL = c(\"Nucl Recept Signal 7:e009 (2009)\", \"DOI:10.1621/nrs.07009\")), list(REFERENCE = \"PMID:24291072\", AUTHORS = \"Knutson TP, Lange CA\", TITLE = \"Tracking progesterone receptor-mediated actions in breast cancer.\", JOURNAL = c(\"Pharmacol Ther 142:114-25 (2014)\", \"DOI:10.1016/j.pharmthera.2013.11.010\")), list(REFERENCE = \"PMID:25544707\", AUTHORS = \"Dittrich A, Gautrey H, Browell D, Tyson-Capper A\", TITLE = \"The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.\", JOURNAL = c(\"J Mammary Gland Biol Neoplasia 19:253-70 (2014)\", \"DOI:10.1007/s10911-014-9329-5\")), list(REFERENCE = \"PMID:21965336\", AUTHORS = \"Higgins MJ, Baselga J\", TITLE = \"Targeted therapies for breast cancer.\", JOURNAL = c(\"J Clin Invest 121:3797-803 (2011)\", \"DOI:10.1172/JCI57152\")), list(REFERENCE = \"PMID:26028978\", AUTHORS = \"Mukohara T\", TITLE = \"PI3K mutations in breast cancer: prognostic and therapeutic implications.\", JOURNAL = c(\"Breast Cancer (Dove Med Press) 7:111-23 (2015)\", \"DOI:10.2147/BCTT.S60696\")), list(REFERENCE = \"PMID:19088017\", AUTHORS = \"Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM, Richardson A, Sledge GW, Carey LA\", TITLE = \"Triple-negative breast cancer: risk factors to potential targets.\", JOURNAL = c(\"Clin Cancer Res 14:8010-8 (2008)\", \"DOI:10.1158/1078-0432.CCR-08-1208\")), list(REFERENCE = \"PMID:21898546\", AUTHORS = \"King TD, Suto MJ, Li Y\", TITLE = \"The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.\", JOURNAL = c(\"J Cell Biochem 113:13-8 (2012)\", \"DOI:10.1002/jcb.23350\")), list(REFERENCE = \"PMID:11737884\", AUTHORS = \"Brown AM\", TITLE = \"Wnt signaling in breast cancer: have we come full circle?\", JOURNAL = c(\"Breast Cancer Res 3:351-5 (2001)\", \"DOI:10.1186/bcr321\")), list(REFERENCE = \"PMID:21076461\", AUTHORS = \"Geyer FC, Lacroix-Triki M, Savage K, Arnedos M, Lambros MB, MacKay A, Natrajan R, Reis-Filho JS\", TITLE = \"beta-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.\", JOURNAL = c(\"Mod Pathol 24:209-31 (2011)\", \"DOI:10.1038/modpathol.2010.205\")), list(REFERENCE = \"PMID:20971825\", AUTHORS = \"Al-Hussaini H, Subramanyam D, Reedijk M, Sridhar SS\", TITLE = \"Notch signaling pathway as a therapeutic target in breast cancer.\", JOURNAL = c(\"Mol Cancer Ther 10:9-15 (2011)\", \"DOI:10.1158/1535-7163.MCT-10-0677\")), list(REFERENCE = \"PMID:26968398\", AUTHORS = \"Rangel MC, Bertolette D, Castro NP, Klauzinska M, Cuttitta F, Salomon DS\", TITLE = \"Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer.\", JOURNAL = c(\"Breast Cancer Res Treat 156:211-26 (2016)\", \"DOI:10.1007/s10549-016-3746-7\")), list(REFERENCE = \"PMID:26040571\", AUTHORS = \"Jamdade VS, Sethi N, Mundhe NA, Kumar P, Lahkar M, Sinha N\", TITLE = \"Therapeutic targets of triple-negative breast cancer: a review.\", JOURNAL = c(\"Br J Pharmacol 172:4228-37 (2015)\", \"DOI:10.1111/bph.13211\")), list(REFERENCE = \"PMID:23196196\", AUTHORS = \"Karamboulas C, Ailles L\", TITLE = \"Developmental signaling pathways in cancer stem cells of solid tumors.\", JOURNAL = c(\"Biochim Biophys Acta 1830:2481-95 (2013)\", \"DOI:10.1016/j.bbagen.2012.11.008\")), list(REFERENCE = \"PMID:23881035\", AUTHORS = \"Ignatiadis M, Sotiriou C\", TITLE = \"Luminal breast cancer: from biology to treatment.\", JOURNAL = c(\"Nat Rev Clin Oncol 10:494-506 (2013)\", \"DOI:10.1038/nrclinonc.2013.124\")), list(REFERENCE = \"PMID:25013431\", AUTHORS = \"Shin SJ, Gong G, Lee HJ, Kang J, Bae YK, Lee A, Cho EY, Lee JS, Suh KS, Lee DW, Jung WH\", TITLE = \"Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status and a favorable prognosis in breast cancer.\", JOURNAL = c(\"J Breast Cancer 17:113-20 (2014)\", \"DOI:10.4048/jbc.2014.17.2.113\")), list(REFERENCE = \"PMID:11879567\", AUTHORS = \"Gasco M, Shami S, Crook T\", TITLE = \"The p53 pathway in breast cancer.\", JOURNAL = c(\"Breast Cancer Res 4:70-6 (2002)\", \"DOI:10.1186/bcr426\")), list(REFERENCE = \"PMID:15343273\", AUTHORS = \"Narod SA, Foulkes WD\", TITLE = \"BRCA1 and BRCA2: 1994 and beyond.\", JOURNAL = c(\"Nat Rev Cancer 4:665-76 (2004)\", \"DOI:10.1038/nrc1431\"))', 'map05224', 'Breast cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (445, '05225', 'Hepatocellular carcinoma', 'Hepatocellular carcinoma (HCC) is a major type of primary liver cancer and one of the rare human neoplasms etiologically linked to viral factors. It has been shown that, after HBV/HCV infection and alcohol or aflatoxin B1 exposure, genetic and epigenetic changes occur. The recurrent mutated genes were found to be highly enriched in multiple key driver signaling processes, including telomere maintenance, TP53, cell cycle regulation, the Wnt/beta-catenin pathway (CTNNB1 and AXIN1), the phosphatidylinositol-3 kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway. Recent studies using whole-exome sequencing have revealed recurrent mutations in new driver genes involved in the chromatin remodelling (ARID1A and ARID2) and the oxidative stress (NFE2L2) pathways.', 'Human Diseases; Cancer: specific types', 'Hepatocellular carcinoma', 'Hepatocellular carcinoma', 'ko05225', 'list(REFERENCE = \"PMID:20639898\", AUTHORS = \"Whittaker S, Marais R, Zhu AX\", TITLE = \"The role of signaling pathways in the development and treatment of hepatocellular carcinoma.\", JOURNAL = c(\"Oncogene 29:4989-5005 (2010)\", \"DOI:10.1038/onc.2010.236\")), list(REFERENCE = \"PMID:26099527\", AUTHORS = \"Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM\", TITLE = \"Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.\", JOURNAL = c(\"Gastroenterology 149:1226-1239.e4 (2015)\", \"DOI:10.1053/j.gastro.2015.05.061\")), list(REFERENCE = \"PMID:17295177\", AUTHORS = \"Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM.\", TITLE = \"Genomics and signaling pathways in hepatocellular carcinoma.\", JOURNAL = c(\"Semin Liver Dis 27:55-76 (2007)\", \"DOI:10.1055/s-2006-960171\")), list(REFERENCE = \"PMID:16799620\", AUTHORS = \"Breuhahn K, Longerich T, Schirmacher P\", TITLE = \"Dysregulation of growth factor signaling in human hepatocellular carcinoma.\", JOURNAL = c(\"Oncogene 25:3787-800 (2006)\", \"DOI:10.1038/sj.onc.1209556\")), list(REFERENCE = \"PMID:19387255\", AUTHORS = \"Minguez B, Tovar V, Chiang D, Villanueva A, Llovet JM\", TITLE = \"Pathogenesis of hepatocellular carcinoma and molecular therapies.\", JOURNAL = c(\"Curr Opin Gastroenterol 25:186-94 (2009)\", \"DOI:10.1097/MOG.0b013e32832962a1\")), list(REFERENCE = \"PMID:21829020\", AUTHORS = \"Kudo M\", TITLE = \"Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.\", JOURNAL = c(\"Dig Dis 29:289-302 (2011)\", \"DOI:10.1159/000327562\")), list(REFERENCE = \"PMID:23994386\", AUTHORS = \"Nault JC, Zucman-Rossi J\", TITLE = \"Genetics of hepatocellular carcinoma: the next generation.\", JOURNAL = c(\"J Hepatol 60:224-6 (2014)\", \"DOI:10.1016/j.jhep.2013.08.019\")), list(REFERENCE = \"PMID:11935086\", AUTHORS = \"Rocken C, Carl-McGrath S.\", TITLE = \"Pathology and pathogenesis of hepatocellular carcinoma.\", JOURNAL = c(\"Dig Dis 19:269-78 (2001)\", \"DOI:10.1159/000050693\")), list(REFERENCE = \"PMID:21303380\", AUTHORS = \"Cornella H, Alsinet C, Villanueva A\", TITLE = \"Molecular pathogenesis of hepatocellular carcinoma.\", JOURNAL = c(\"Alcohol Clin Exp Res 35:821-5 (2011)\", \"DOI:10.1111/j.1530-0277.2010.01406.x\")), list(REFERENCE = \"PMID:27895396\", AUTHORS = \"Niu ZS, Niu XJ, Wang WH\", TITLE = \"Genetic alterations in hepatocellular carcinoma: An update.\", JOURNAL = c(\"World J Gastroenterol 22:9069-9095 (2016)\", \"DOI:10.3748/wjg.v22.i41.9069\")), list(REFERENCE = \"PMID:11956813\", AUTHORS = \"Tannapfel A, Wittekind C\", TITLE = \"Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis.\", JOURNAL = c(\"Virchows Arch 440:345-52 (2002)\", \"DOI:10.1007/s00428-002-0617-x\")), list(REFERENCE = \"PMID:23426905\", AUTHORS = \"Shiraha H, Yamamoto K, Namba M\", TITLE = \"Human hepatocyte carcinogenesis (review).\", JOURNAL = c(\"Int J Oncol 42:1133-8 (2013)\", \"DOI:10.3892/ijo.2013.1829\")), list(REFERENCE = \"PMID:23887712\", AUTHORS = \"Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J\", TITLE = \"High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.\", JOURNAL = c(\"Nat Commun 4:2218 (2013)\", \"DOI:10.1038/ncomms3218\")), list(REFERENCE = \"PMID:22561517\", AUTHORS = \"Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clement B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouze E, Calvo F, Zucman-Rossi J\", TITLE = \"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.\", JOURNAL = c(\"Nat Genet 44:694-8 (2012)\", \"DOI:10.1038/ng.2256\")), list(REFERENCE = \"\", AUTHORS = \"Praslicka BJ, Kerins MJ, Ooi A\", TITLE = \"The complex role of NRF2 in cancer: a genomic view\", JOURNAL = c(\"Current Opinion in Toxicology 1:37-45 (2016)\", \"DOI:10.1016/j.cotox.2016.09.003\")), list(REFERENCE = \"PMID:24024136\", AUTHORS = \"Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL\", TITLE = \"The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer.\", JOURNAL = c(\"Redox Biol 1:45-9 (2013)\", \"DOI:10.1016/j.redox.2012.10.001\")), list(REFERENCE = \"PMID:21251164\", AUTHORS = \"Taguchi K, Motohashi H, Yamamoto M\", TITLE = \"Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution.\", JOURNAL = c(\"Genes Cells 16:123-40 (2011)\", \"DOI:10.1111/j.1365-2443.2010.01473.x\")), list(REFERENCE = \"PMID:20019356\", AUTHORS = \"Klaunig JE, Kamendulis LM, Hocevar BA\", TITLE = \"Oxidative stress and oxidative damage in carcinogenesis.\", JOURNAL = c(\"Toxicol Pathol 38:96-109 (2010)\", \"DOI:10.1177/0192623309356453\")), list(REFERENCE = \"PMID:11193292\", AUTHORS = \"Krupp G, Bonatz G, Parwaresch R\", TITLE = \"Telomerase, immortality and cancer.\", JOURNAL = c(\"Biotechnol Annu Rev 6:103-40 (2000)\", \"DOI:10.1016/S1387-2656(00)06020-8\")), list(REFERENCE = \"PMID:27323951\", AUTHORS = \"Jafri MA, Ansari SA, Alqahtani MH, Shay JW\", TITLE = \"Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.\", JOURNAL = c(\"Genome Med 8:69 (2016)\", \"DOI:10.1186/s13073-016-0324-x\")), list(REFERENCE = \"PMID:27029895\", AUTHORS = \"Shay JW\", TITLE = \"Role of Telomeres and Telomerase in Aging and Cancer.\", JOURNAL = c(\"Cancer Discov 6:584-93 (2016)\", \"DOI:10.1158/2159-8290.CD-16-0062\")), list(REFERENCE = \"PMID:27508192\", AUTHORS = \"Granito A, Guidetti E, Gramantieri L\", TITLE = \"c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.\", JOURNAL = c(\"J Hepatocell Carcinoma 2:29-38 (2015)\", \"DOI:10.2147/JHC.S77038\")), list(REFERENCE = \"PMID:16934487\", AUTHORS = \"Vita M, Henriksson M\", TITLE = \"The Myc oncoprotein as a therapeutic target for human cancer.\", JOURNAL = c(\"Semin Cancer Biol 16:318-30 (2006)\", \"DOI:10.1016/j.semcancer.2006.07.015\")), list(REFERENCE = \"PMID:24096051\", AUTHORS = \"Qu A, Jiang C, Cai Y, Kim JH, Tanaka N, Ward JM, Shah YM, Gonzalez FJ\", TITLE = \"Role of Myc in hepatocellular proliferation and hepatocarcinogenesis.\", JOURNAL = c(\"J Hepatol 60:331-8 (2014)\", \"DOI:10.1016/j.jhep.2013.09.024\"))', 'map05225', 'Hepatocellular carcinoma', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (446, '05226', 'Gastric cancer', 'Gastric cancer (GC) is one of the world\'s most common cancers. According to Lauren\'s histological classification gastric cancer is divided into two distinct histological groups - the intestinal and diffuse types. Several genetic changes have been identified in intestinal-type GC. The intestinal metaplasia is characterized by mutations in p53 gene, reduced expression of retinoic acid receptor beta (RAR-beta) and hTERT expression. Gastric adenomas furthermore display mutations in the APC gene, reduced p27 expression and cyclin E amplification. In addition, amplification and overexpression of c-ErbB2, reduced TGF-beta receptor type I (TGFBRI) expression and complete loss of p27 expression are commonly observed in more advanced GC. The main molecular changes observed in diffuse-type GCs include loss of E-cadherin function by mutations in CDH1 and amplification of MET and FGFR2F.', 'Human Diseases; Cancer: specific types', 'Gastric cancer', 'Gastric cancer', 'ko05226', 'list(REFERENCE = \"PMID:26073375\", AUTHORS = \"Tan P, Yeoh KG\", TITLE = \"Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.\", JOURNAL = c(\"Gastroenterology 149:1153-1162.e3 (2015)\", \"DOI:10.1053/j.gastro.2015.05.059\")), list(REFERENCE = \"PMID:26267324\", AUTHORS = \"Riquelme I, Saavedra K, Espinoza JA, Weber H, Garcia P, Nervi B, Garrido M, Corvalan AH, Roa JC, Bizama C\", TITLE = \"Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy.\", JOURNAL = c(\"Oncotarget 6:24750-79 (2015)\", \"DOI:10.18632/oncotarget.4990\")), list(REFERENCE = \"PMID:16154715\", AUTHORS = \"Stock M, Otto F\", TITLE = \"Gene deregulation in gastric cancer.\", JOURNAL = c(\"Gene 360:1-19 (2005)\", \"DOI:10.1016/j.gene.2005.06.026\")), list(REFERENCE = \"PMID:18381231\", AUTHORS = \"Panani AD\", TITLE = \"Cytogenetic and molecular aspects of gastric cancer: clinical implications.\", JOURNAL = c(\"Cancer Lett 266:99-115 (2008)\", \"DOI:10.1016/j.canlet.2008.02.053\")), list(REFERENCE = \"PMID:16997151\", AUTHORS = \"Vauhkonen M, Vauhkonen H, Sipponen P\", TITLE = \"Pathology and molecular biology of gastric cancer.\", JOURNAL = c(\"Best Pract Res Clin Gastroenterol 20:651-74 (2006)\", \"DOI:10.1016/j.bpg.2006.03.016\")), list(REFERENCE = \"PMID:16718776\", AUTHORS = \"Smith MG, Hold GL, Tahara E, El-Omar EM.\", TITLE = \"Cellular and molecular aspects of gastric cancer.\", JOURNAL = c(\"World J Gastroenterol 12:2979-90 (2006)\", \"DOI:10.3748/wjg.v12.i19.2979\")), list(REFERENCE = \"PMID:15224192\", AUTHORS = \"Zheng L, Wang L, Ajani J, Xie K.\", TITLE = \"Molecular basis of gastric cancer development and progression.\", JOURNAL = c(\"Gastric Cancer 7:61-77 (2004)\", \"DOI:10.1007/s10120-004-0277-4\")), list(REFERENCE = \"PMID:12894247\", AUTHORS = \"Yuasa Y\", TITLE = \"Control of gut differentiation and intestinal-type gastric carcinogenesis.\", JOURNAL = c(\"Nat Rev Cancer 3:592-600 (2003)\", \"DOI:10.1038/nrc1141\")), list(REFERENCE = \"PMID:28427431\", AUTHORS = \"Wessler S, Krisch LM, Elmer DP, Aberger F\", TITLE = \"From inflammation to gastric cancer - the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases.\", JOURNAL = c(\"Cell Commun Signal 15:15 (2017)\", \"DOI:10.1186/s12964-017-0171-4\")), list(REFERENCE = \"PMID:24744585\", AUTHORS = \"Yan LH, Wei WY, Xie YB, Xiao Q\", TITLE = \"New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.\", JOURNAL = c(\"World J Gastroenterol 20:3960-6 (2014)\", \"DOI:10.3748/wjg.v20.i14.3960\")), list(REFERENCE = \"PMID:11683489\", AUTHORS = \"Hayashi K, Yokozaki H, Goodison S, Oue N, Suzuki T, Lotan R, Yasui W, Tahara E\", TITLE = \"Inactivation of retinoic acid receptor beta by promoter CpG hypermethylation in gastric cancer.\", JOURNAL = c(\"Differentiation 68:13-21 (2001)\", \"DOI:10.1046/j.1432-0436.2001.068001013.x\")), list(REFERENCE = \"PMID:26857262\", AUTHORS = \"Li X, Wu WK, Xing R, Wong SH, Liu Y, Fang X, Zhang Y, Wang M, Wang J, Li L, Zhou Y, Tang S, Peng S, Qiu K, Chen L, Chen K, Yang H, Zhang W, Chan MT, Lu Y, Sung JJ, Yu J\", TITLE = \"Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability.\", JOURNAL = c(\"Cancer Res 76:1724-32 (2016)\", \"DOI:10.1158/0008-5472.CAN-15-2443\")), list(REFERENCE = \"PMID:24061039\", AUTHORS = \"Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA\", TITLE = \"Gastric cancer-molecular and clinical dimensions.\", JOURNAL = c(\"Nat Rev Clin Oncol 10:643-55 (2013)\", \"DOI:10.1038/nrclinonc.2013.170\")), list(REFERENCE = \"PMID:26071484\", AUTHORS = \"Bertotti A, Sassi F\", TITLE = \"Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies.\", JOURNAL = c(\"Clin Cancer Res 21:3377-83 (2015)\", \"DOI:10.1158/1078-0432.CCR-14-0848\")), list(REFERENCE = \"PMID:22042966\", AUTHORS = \"Appleman LJ\", TITLE = \"MET signaling pathway: a rational target for cancer therapy.\", JOURNAL = c(\"J Clin Oncol 29:4837-8 (2011)\", \"DOI:10.1200/JCO.2011.37.7929\")), list(REFERENCE = \"PMID:19318488\", AUTHORS = \"Eder JP, Vande Woude GF, Boerner SA, LoRusso PM\", TITLE = \"Novel therapeutic inhibitors of the c-Met signaling pathway in cancer.\", JOURNAL = c(\"Clin Cancer Res 15:2207-14 (2009)\", \"DOI:10.1158/1078-0432.CCR-08-1306\")), list(REFERENCE = \"PMID:22586678\", AUTHORS = \"Feng Y, Ma PC\", TITLE = \"Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancer.\", JOURNAL = c(\"Cancer Discov 1:550-4 (2011)\", \"DOI:10.1158/2159-8290.CD-11-0289\")), list(REFERENCE = \"PMID:23696246\", AUTHORS = \"Katoh M, Nakagama H\", TITLE = \"FGF receptors: cancer biology and therapeutics.\", JOURNAL = c(\"Med Res Rev 34:280-300 (2014)\", \"DOI:10.1002/med.21288\")), list(REFERENCE = \"PMID:19387476\", AUTHORS = \"Katoh M\", TITLE = \"FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies.\", JOURNAL = c(\"J Invest Dermatol 129:1861-7 (2009)\", \"DOI:10.1038/jid.2009.97\")), list(REFERENCE = \"PMID:20836672\", AUTHORS = \"Katoh M\", TITLE = \"Genetic alterations of FGF receptors: an emerging field in clinical cancer diagnostics and therapeutics.\", JOURNAL = c(\"Expert Rev Anticancer Ther 10:1375-9 (2010)\", \"DOI:10.1586/era.10.128\"))', 'map05226', 'Gastric cancer', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (447, '05230', 'Central carbon metabolism in cancer', 'Malignant transformation of cells requires specific adaptations of cellular metabolism to support growth and survival. In the early twentieth century, Otto Warburg established that there are fundamental differences in the central metabolic pathways operating in malignant tissue. He showed that cancer cells consume a large amount of glucose, maintain high rate of glycolysis and convert a majority of glucose into lactic acid even under normal oxygen concentrations (Warburg\'s Effects). More recently, it has been recognized that the \'Warburg effect\' encompasses a similarly increased utilization of glutamine. From the intermediate molecules provided by enhanced glycolysis and glutaminolysis, cancer cells synthesize most of the macromolecules required for the duplication of their biomass and genome. These cancer-specific alterations represent a major consequence of genetic mutations and the ensuing changes of signalling pathways in cancer cells. Three transcription factors, c-MYC, HIF-1 and p53, are key regulators and coordinate regulation of cancer metabolism in different ways, and many other oncogenes and tumor suppressor genes cluster along the signaling pathways that regulate c-MYC, HIF-1 and p53.', 'Human Diseases; Cancer: overview', 'Central carbon metabolism in cancer', 'ko05230', 'list(REFERENCE = \"PMID:23279446\", AUTHORS = \"Soga T\", TITLE = \"Cancer metabolism: key players in metabolic reprogramming.\", JOURNAL = c(\"Cancer Sci 104:275-81 (2013)\", \"DOI:10.1111/cas.12085\")), list(REFERENCE = \"PMID:19460998\", AUTHORS = \"Vander Heiden MG, Cantley LC, Thompson CB\", TITLE = \"Understanding the Warburg effect: the metabolic requirements of cell proliferation.\", JOURNAL = c(\"Science 324:1029-33 (2009)\", \"DOI:10.1126/science.1160809\")), list(REFERENCE = \"PMID:23071355\", AUTHORS = \"Teicher BA, Linehan WM, Helman LJ\", TITLE = \"Targeting cancer metabolism.\", JOURNAL = c(\"Clin Cancer Res 18:5537-45 (2012)\", \"DOI:10.1158/1078-0432.CCR-12-2587\")), list(REFERENCE = \"PMID:21127244\", AUTHORS = \"Levine AJ, Puzio-Kuter AM\", TITLE = \"The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.\", JOURNAL = c(\"Science 330:1340-4 (2010)\", \"DOI:10.1126/science.1193494\")), list(REFERENCE = \"PMID:24079832\", AUTHORS = \"Amoedo ND, Valencia JP, Rodrigues MF, Galina A, Rumjanek FD\", TITLE = \"How does the metabolism of tumour cells differ from that of normal cells.\", JOURNAL = c(\"Biosci Rep 33:e00080 (2013)\", \"DOI:10.1042/BSR20130066\")), list(REFERENCE = \"PMID:21258394\", AUTHORS = \"Cairns RA, Harris IS, Mak TW\", TITLE = \"Regulation of cancer cell metabolism.\", JOURNAL = c(\"Nat Rev Cancer 11:85-95 (2011)\", \"DOI:10.1038/nrc2981\")), list(REFERENCE = \"PMID:22237205\", AUTHORS = \"Munoz-Pinedo C, El Mjiyad N, Ricci JE\", TITLE = \"Cancer metabolism: current perspectives and future directions.\", JOURNAL = c(\"Cell Death Dis 3:e248 (2012)\", \"DOI:10.1038/cddis.2011.123\")), list(REFERENCE = \"PMID:22156302\", AUTHORS = \"Cairns RA, Harris I, McCracken S, Mak TW\", TITLE = \"Cancer cell metabolism.\", JOURNAL = c(\"Cold Spring Harb Symp Quant Biol 76:299-311 (2011)\", \"DOI:10.1101/sqb.2011.76.012856\")), list(REFERENCE = \"PMID:18538731\", AUTHORS = \"Kroemer G, Pouyssegur J\", TITLE = \"Tumor cell metabolism: cancer\'s Achilles\' heel.\", JOURNAL = c(\"Cancer Cell 13:472-82 (2008)\", \"DOI:10.1016/j.ccr.2008.05.005\")), list(REFERENCE = \"PMID:18177721\", AUTHORS = \"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB\", TITLE = \"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.\", JOURNAL = c(\"Cell Metab 7:11-20 (2008)\", \"DOI:10.1016/j.cmet.2007.10.002\")), list(REFERENCE = \"PMID:21508971\", AUTHORS = \"Koppenol WH, Bounds PL, Dang CV\", TITLE = \"Otto Warburg\'s contributions to current concepts of cancer metabolism.\", JOURNAL = c(\"Nat Rev Cancer 11:325-37 (2011)\", \"DOI:10.1038/nrc3038\")), list(REFERENCE = \"PMID:21801601\", AUTHORS = \"Fogg VC, Lanning NJ, Mackeigan JP\", TITLE = \"Mitochondria in cancer: at the crossroads of life and death.\", JOURNAL = c(\"Chin J Cancer 30:526-39 (2011)\", \"DOI:10.5732/cjc.011.10018\")), list(REFERENCE = \"PMID:16982728\", AUTHORS = \"Kim JW, Dang CV\", TITLE = \"Cancer\'s molecular sweet tooth and the Warburg effect.\", JOURNAL = c(\"Cancer Res 66:8927-30 (2006)\", \"DOI:10.1158/0008-5472.CAN-06-1501\")), list(REFERENCE = \"PMID:18766298\", AUTHORS = \"Yeung SJ, Pan J, Lee MH\", TITLE = \"Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer.\", JOURNAL = c(\"Cell Mol Life Sci 65:3981-99 (2008)\", \"DOI:10.1007/s00018-008-8224-x\")), list(REFERENCE = \"PMID:23897900\", AUTHORS = \"Li B, Simon MC\", TITLE = \"Molecular Pathways: Targeting MYC-induced metabolic reprogramming and oncogenic stress in cancer.\", JOURNAL = c(\"Clin Cancer Res 19:5835-41 (2013)\", \"DOI:10.1158/1078-0432.CCR-12-3629\")), list(REFERENCE = \"PMID:22307140\", AUTHORS = \"Shen L, Sun X, Fu Z, Yang G, Li J, Yao L\", TITLE = \"The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy.\", JOURNAL = c(\"Clin Cancer Res 18:1561-7 (2012)\", \"DOI:10.1158/1078-0432.CCR-11-3040\")), list(REFERENCE = \"PMID:19270154\", AUTHORS = \"Jones RG, Thompson CB\", TITLE = \"Tumor suppressors and cell metabolism: a recipe for cancer growth.\", JOURNAL = c(\"Genes Dev 23:537-48 (2009)\", \"DOI:10.1101/gad.1756509\")), list(REFERENCE = \"PMID:21340684\", AUTHORS = \"Maddocks OD, Vousden KH\", TITLE = \"Metabolic regulation by p53.\", JOURNAL = c(\"J Mol Med (Berl) 89:237-45 (2011)\", \"DOI:10.1007/s00109-011-0735-5\")), list(REFERENCE = \"PMID:22750268\", AUTHORS = \"Chen JQ, Russo J\", TITLE = \"Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.\", JOURNAL = c(\"Biochim Biophys Acta 1826:370-84 (2012)\", \"DOI:10.1016/j.bbcan.2012.06.004\")), list(REFERENCE = \"PMID:20520704\", AUTHORS = \"Kaelin WG Jr, Thompson CB\", TITLE = \"Q&amp;A: Cancer: clues from cell metabolism.\", JOURNAL = c(\"Nature 465:562-4 (2010)\", \"DOI:10.1038/465562a\")), list(REFERENCE = \"PMID:24113830\", AUTHORS = \"Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G\", TITLE = \"Metabolic targets for cancer therapy.\", JOURNAL = c(\"Nat Rev Drug Discov 12:829-46 (2013)\", \"DOI:10.1038/nrd4145\")), list(REFERENCE = \"PMID:24738035\", AUTHORS = \"Phan LM, Yeung SC, Lee MH\", TITLE = \"Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies.\", JOURNAL = c(\"Cancer Biol Med 11:1-19 (2014)\", \"DOI:10.7497/j.issn.2095-3941.2014.01.001\")), list(REFERENCE = \"PMID:22101401\", AUTHORS = \"Icard P, Poulain L, Lincet H\", TITLE = \"Understanding the central role of citrate in the metabolism of cancer cells.\", JOURNAL = c(\"Biochim Biophys Acta 1825:111-6 (2012)\", \"DOI:10.1016/j.bbcan.2011.10.007\")), list(REFERENCE = \"PMID:22349059\", AUTHORS = \"Daye D, Wellen KE\", TITLE = \"Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.\", JOURNAL = c(\"Semin Cell Dev Biol 23:362-9 (2012)\", \"DOI:10.1016/j.semcdb.2012.02.002\")), list(REFERENCE = \"PMID:23018234\", AUTHORS = \"Chiarugi A, Dolle C, Felici R, Ziegler M\", TITLE = \"The NAD metabolome--a key determinant of cancer cell biology.\", JOURNAL = c(\"Nat Rev Cancer 12:741-52 (2012)\", \"DOI:10.1038/nrc3340\")), list(REFERENCE = \"PMID:24398961\", AUTHORS = \"Guarente L\", TITLE = \"The many faces of sirtuins: Sirtuins and the Warburg effect.\", JOURNAL = c(\"Nat Med 20:24-5 (2014)\", \"DOI:10.1038/nm.3438\")), list(REFERENCE = \"PMID:15916903\", AUTHORS = \"Fuchs BC, Bode BP\", TITLE = \"Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?\", JOURNAL = c(\"Semin Cancer Biol 15:254-66 (2005)\", \"DOI:10.1016/j.semcancer.2005.04.005\"))', 'map05230', 'Central carbon metabolism in cancer', 'Malignant transformation of cells requires specific adaptations of cellular metabolism to support growth and survival. In the early twentieth century, Otto Warburg established that there are fundamental differences in the central metabolic pathways operating in malignant tissue. He showed that cancer cells consume a large amount of glucose, maintain high rate of glycolysis and convert a majority of glucose into lactic acid even under normal oxygen concentrations (Warburg\'s Effects). More recently, it has been recognized that the \'Warburg effect\' encompasses a similarly increased utilization of glutamine. From the intermediate molecules provided by enhanced glycolysis and glutaminolysis, cancer cells synthesize most of the macromolecules required for the duplication of their biomass and genome. These cancer-specific alterations represent a major consequence of genetic mutations and the ensuing changes of signalling pathways in cancer cells. Three transcription factors, c-MYC, HIF-1 and p53, are key regulators and coordinate regulation of cancer metabolism in different ways, and many other oncogenes and tumor suppressor genes cluster along the signaling pathways that regulate c-MYC, HIF-1 and p53.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (448, '05231', 'Choline metabolism in cancer', 'Abnormal choline metabolism is emerging as a metabolic hallmark that is associated with oncogenesis and tumour progression. Following transformation, oncogenic signalling via pathways such as the RAS and PI3K-AKT pathways, and transcription factors associated with oncogenesis such as hypoxia-inducible factor 1 (HIF1) mediate overexpression and activation of choline cycle enzymes, which causes increased levels of choline-containing precursors and breakdown products of membrane phospholipids. These products of choline phospholipid metabolism, such as phosphocholine (PCho), diacylglycerol (DAG) and phosphatidic acid, may function as second messengers that are essential for the mitogenic activity of growth factors, particularly in the activation of the ras-raf-1-MAPK cascade and protein kinase C pathway.', 'Human Diseases; Cancer: overview', 'Choline metabolism in cancer', 'ko05231', 'list(REFERENCE = \"PMID:22089420\", AUTHORS = \"Glunde K, Bhujwalla ZM, Ronen SM\", TITLE = \"Choline metabolism in malignant transformation.\", JOURNAL = c(\"Nat Rev Cancer 11:835-48 (2011)\", \"DOI:10.1038/nrc3162\")), list(REFERENCE = \"PMID:19935796\", AUTHORS = \"Beloueche-Babari M, Chung YL, Al-Saffar NM, Falck-Miniotis M, Leach MO\", TITLE = \"Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy.\", JOURNAL = c(\"Br J Cancer 102:1-7 (2010)\", \"DOI:10.1038/sj.bjc.6605457\")), list(REFERENCE = \"PMID:22429397\", AUTHORS = \"Abalsamo L, Spadaro F, Bozzuto G, Paris L, Cecchetti S, Lugini L, Iorio E, Molinari A, Ramoni C, Podo F\", TITLE = \"Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.\", JOURNAL = c(\"Breast Cancer Res 14:R50 (2012)\", \"DOI:10.1186/bcr3151\")), list(REFERENCE = \"PMID:19264150\", AUTHORS = \"Foster DA\", TITLE = \"Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.\", JOURNAL = c(\"Biochim Biophys Acta 1791:949-55 (2009)\", \"DOI:10.1016/j.bbalip.2009.02.009\")), list(REFERENCE = \"PMID:16432178\", AUTHORS = \"Beloueche-Babari M, Jackson LE, Al-Saffar NM, Eccles SA, Raynaud FI, Workman P, Leach MO, Ronen SM\", TITLE = \"Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells.\", JOURNAL = c(\"Mol Cancer Ther 5:187-96 (2006)\", \"DOI:10.1158/1535-7163.MCT-03-0220\")), list(REFERENCE = \"PMID:23350810\", AUTHORS = \"Ridgway ND\", TITLE = \"The role of phosphatidylcholine and choline metabolites to cell proliferation and survival.\", JOURNAL = c(\"Crit Rev Biochem Mol Biol 48:20-38 (2013)\", \"DOI:10.3109/10409238.2012.735643\")), list(REFERENCE = \"PMID:22921309\", AUTHORS = \"Awwad HM, Geisel J, Obeid R\", TITLE = \"The role of choline in prostate cancer.\", JOURNAL = c(\"Clin Biochem 45:1548-53 (2012)\", \"DOI:10.1016/j.clinbiochem.2012.08.012\")), list(REFERENCE = \"PMID:16230400\", AUTHORS = \"Iorio E, Mezzanzanica D, Alberti P, Spadaro F, Ramoni C, D\'Ascenzo S, Millimaggi D, Pavan A, Dolo V, Canevari S, Podo F\", TITLE = \"Alterations of choline phospholipid metabolism in ovarian tumor progression.\", JOURNAL = c(\"Cancer Res 65:9369-76 (2005)\", \"DOI:10.1158/0008-5472.CAN-05-1146\")), list(REFERENCE = \"PMID:14523987\", AUTHORS = \"Ackerstaff E, Glunde K, Bhujwalla ZM\", TITLE = \"Choline phospholipid metabolism: a target in cancer cells?\", JOURNAL = c(\"J Cell Biochem 90:525-33 (2003)\", \"DOI:10.1002/jcb.10659\")), list(REFERENCE = \"PMID:23076158\", AUTHORS = \"Park JB, Lee CS, Jang JH, Ghim J, Kim YJ, You S, Hwang D, Suh PG, Ryu SH\", TITLE = \"Phospholipase signalling networks in cancer.\", JOURNAL = c(\"Nat Rev Cancer 12:782-92 (2012)\", \"DOI:10.1038/nrc3379\")), list(REFERENCE = \"PMID:19855431\", AUTHORS = \"Yalcin A, Clem B, Makoni S, Clem A, Nelson K, Thornburg J, Siow D, Lane AN, Brock SE, Goswami U, Eaton JW, Telang S, Chesney J\", TITLE = \"Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.\", JOURNAL = c(\"Oncogene 29:139-49 (2010)\", \"DOI:10.1038/onc.2009.317\")), list(REFERENCE = \"PMID:21793073\", AUTHORS = \"Glunde K, Jiang L, Moestue SA, Gribbestad IS\", TITLE = \"MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.\", JOURNAL = c(\"NMR Biomed 24:673-90 (2011)\", \"DOI:10.1002/nbm.1751\")), list(REFERENCE = \"PMID:19136975\", AUTHORS = \"Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, Armstrong MD, Arteaga CL, Lindsley CW, Brown HA\", TITLE = \"Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.\", JOURNAL = c(\"Nat Chem Biol 5:108-17 (2009)\", \"DOI:10.1038/nchembio.140\")), list(REFERENCE = \"PMID:14517341\", AUTHORS = \"Foster DA, Xu L\", TITLE = \"Phospholipase D in cell proliferation and cancer.\", JOURNAL = \"Mol Cancer Res 1:789-800 (2003)\"), list(REFERENCE = \"PMID:20528734\", AUTHORS = \"Zhou H, Huang S\", TITLE = \"mTOR signaling in cancer cell motility and tumor metastasis.\", JOURNAL = \"Crit Rev Eukaryot Gene Expr 20:1-16 (2010)\")', 'map05231', 'Choline metabolism in cancer', 'Abnormal choline metabolism is emerging as a metabolic hallmark that is associated with oncogenesis and tumour progression. Following transformation, oncogenic signalling via pathways such as the RAS and PI3K-AKT pathways, and transcription factors associated with oncogenesis such as hypoxia-inducible factor 1 (HIF1) mediate overexpression and activation of choline cycle enzymes, which causes increased levels of choline-containing precursors and breakdown products of membrane phospholipids. These products of choline phospholipid metabolism, such as phosphocholine (PCho), diacylglycerol (DAG) and phosphatidic acid, may function as second messengers that are essential for the mitogenic activity of growth factors, particularly in the activation of the ras-raf-1-MAPK cascade and protein kinase C pathway.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (449, '05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer', 'Programmed cell death 1 (PD1) and its ligand (PDL1) are key regulatory physiological immune checkpoints that maintain self-tolerance in the organism by regulating the degree of activation of T and B  cells amongst other immune cell types. In solid tumors, the PD-1/PD-L1 inhibitory pathway can be (mis-)used to silence the immune system by increasing the expression of PD-L1 on the tumor cell surface. Up-regulation of PD-L1 is caused by activation of pro-survival pathways MAPK and PI3K/Akt as well as transcriptional factors HIF-1, STAT3 and NF-kappa B. The MAPK and PI3K signalling pathways are activated by gene mutations and growth factors. PD-L1 on tumor cells may then engage the PD-1 receptors resulting in suppression of T-cell mediated immune response. Therapeutic antibodies blocking the PD-1/PD-L1 pathway by targeting PD-L1 or PD-1 are highly effective in rescuing T cell anti-tumor effector functions.', 'Human Diseases; Cancer: overview', 'PD-L1 expression and PD-1 checkpoint pathway in cancer', 'ko05235', 'list(REFERENCE = \"PMID:29097600\", AUTHORS = \"Kythreotou A, Siddique A, Mauri FA, Bower M, Pinato DJ\", TITLE = \"PD-L1.\", JOURNAL = c(\"J Clin Pathol 71:189-194 (2018)\", \"DOI:10.1136/jclinpath-2017-204853\")), list(REFERENCE = \"PMID:27816403\", AUTHORS = \"Zhou TC, Sankin AI, Porcelli SA, Perlin DS, Schoenberg MP, Zang X\", TITLE = \"A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment.\", JOURNAL = c(\"Urol Oncol 35:14-20 (2017)\", \"DOI:10.1016/j.urolonc.2016.10.004\")), list(REFERENCE = \"PMID:29910728\", AUTHORS = \"Wang Y, Wang H, Yao H, Li C, Fang JY, Xu J\", TITLE = \"Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion.\", JOURNAL = c(\"Front Pharmacol 9:536 (2018)\", \"DOI:10.3389/fphar.2018.00536\")), list(REFERENCE = \"PMID:30646912\", AUTHORS = \"Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X, Li Y, Li G, Xiong W, Guo C, Zeng Z\", TITLE = \"Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.\", JOURNAL = c(\"Mol Cancer 18:10 (2019)\", \"DOI:10.1186/s12943-018-0928-4\")), list(REFERENCE = \"PMID:28018338\", AUTHORS = \"Bardhan K, Anagnostou T, Boussiotis VA\", TITLE = \"The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation.\", JOURNAL = c(\"Front Immunol 7:550 (2016)\", \"DOI:10.3389/fimmu.2016.00550\")), list(REFERENCE = \"PMID:30120503\", AUTHORS = \"Shi Y\", TITLE = \"Regulatory mechanisms of PD-L1 expression in cancer cells.\", JOURNAL = c(\"Cancer Immunol Immunother 67:1481-1489 (2018)\", \"DOI:10.1007/s00262-018-2226-9\")), list(REFERENCE = \"PMID:29765155\", AUTHORS = \"Zerdes I, Matikas A, Bergh J, Rassidakis GZ, Foukakis T\", TITLE = \"Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations.\", JOURNAL = c(\"Oncogene 37:4639-4661 (2018)\", \"DOI:10.1038/s41388-018-0303-3\")), list(REFERENCE = \"PMID:26681673\", AUTHORS = \"Chen J, Jiang CC, Jin L, Zhang XD\", TITLE = \"Regulation of PD-L1: a novel role of pro-survival signalling in cancer.\", JOURNAL = c(\"Ann Oncol 27:409-16 (2016)\", \"DOI:10.1093/annonc/mdv615\")), list(REFERENCE = \"PMID:29262340\", AUTHORS = \"Glodde N, Holzel M\", TITLE = \"RAS and PD-L1: A Masters\' Liaison in Cancer Immune Evasion.\", JOURNAL = c(\"Immunity 47:1007-1009 (2017)\", \"DOI:10.1016/j.immuni.2017.12.001\")), list(REFERENCE = \"PMID:25500094\", AUTHORS = \"Ritprajak P, Azuma M\", TITLE = \"Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma.\", JOURNAL = c(\"Oral Oncol 51:221-8 (2015)\", \"DOI:10.1016/j.oraloncology.2014.11.014\")), list(REFERENCE = \"PMID:23868869\", AUTHORS = \"Nirschl CJ, Drake CG\", TITLE = \"Molecular pathways: coexpression of immune checkpoint molecules: signaling pathways and implications for cancer immunotherapy.\", JOURNAL = c(\"Clin Cancer Res 19:4917-24 (2013)\", \"DOI:10.1158/1078-0432.CCR-12-1972\")), list(REFERENCE = \"PMID:30473697\", AUTHORS = \"Saeidi A, Zandi K, Cheok YY, Saeidi H, Wong WF, Lee CYQ, Cheong HC, Yong YK, Larsson M, Shankar EM\", TITLE = \"T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses.\", JOURNAL = c(\"Front Immunol 9:2569 (2018)\", \"DOI:10.3389/fimmu.2018.02569\")), list(REFERENCE = \"PMID:28990585\", AUTHORS = \"Sharpe AH, Pauken KE\", TITLE = \"The diverse functions of the PD1 inhibitory pathway.\", JOURNAL = c(\"Nat Rev Immunol 18:153-167 (2018)\", \"DOI:10.1038/nri.2017.108\")), list(REFERENCE = \"PMID:27806234\", AUTHORS = \"Boussiotis VA\", TITLE = \"Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway.\", JOURNAL = c(\"N Engl J Med 375:1767-1778 (2016)\", \"DOI:10.1056/NEJMra1514296\")), list(REFERENCE = \"PMID:28881701\", AUTHORS = \"Arasanz H, Gato-Canas M, Zuazo M, Ibanez-Vea M, Breckpot K, Kochan G, Escors D\", TITLE = \"PD1 signal transduction pathways in T cells.\", JOURNAL = c(\"Oncotarget 8:51936-51945 (2017)\", \"DOI:10.18632/oncotarget.17232\")), list(REFERENCE = \"PMID:29114543\", AUTHORS = \"Zuazo M, Gato-Canas M, Llorente N, Ibanez-Vea M, Arasanz H, Kochan G, Escors D\", TITLE = \"Molecular mechanisms of programmed cell death-1 dependent T cell suppression: relevance for immunotherapy.\", JOURNAL = c(\"Ann Transl Med 5:385 (2017)\", \"DOI:10.21037/atm.2017.06.11\")), list(REFERENCE = \"PMID:23732914\", AUTHORS = \"Patsoukis N, Li L, Sari D, Petkova V, Boussiotis VA\", TITLE = \"PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2.\", JOURNAL = c(\"Mol Cell Biol 33:3091-8 (2013)\", \"DOI:10.1128/MCB.00319-13\")), list(REFERENCE = \"PMID:26162965\", AUTHORS = \"Chinai JM, Janakiram M, Chen F, Chen W, Kaplan M, Zang X\", TITLE = \"New immunotherapies targeting the PD-1 pathway.\", JOURNAL = c(\"Trends Pharmacol Sci 36:587-95 (2015)\", \"DOI:10.1016/j.tips.2015.06.005\")), list(REFERENCE = \"PMID:28242522\", AUTHORS = \"Ok CY, Young KH\", TITLE = \"Targeting the programmed death-1 pathway in lymphoid neoplasms.\", JOURNAL = c(\"Cancer Treat Rev 54:99-109 (2017)\", \"DOI:10.1016/j.ctrv.2017.01.009\"))', 'map05235', 'PD-L1 expression and PD-1 checkpoint pathway in cancer', 'Programmed cell death 1 (PD1) and its ligand (PDL1) are key regulatory physiological immune checkpoints that maintain self-tolerance in the organism by regulating the degree of activation of T and B  cells amongst other immune cell types. In solid tumors, the PD-1/PD-L1 inhibitory pathway can be (mis-)used to silence the immune system by increasing the expression of PD-L1 on the tumor cell surface. Up-regulation of PD-L1 is caused by activation of pro-survival pathways MAPK and PI3K/Akt as well as transcriptional factors HIF-1, STAT3 and NF-kappa B. The MAPK and PI3K signalling pathways are activated by gene mutations and growth factors. PD-L1 on tumor cells may then engage the PD-1 receptors resulting in suppression of T-cell mediated immune response. Therapeutic antibodies blocking the PD-1/PD-L1 pathway by targeting PD-L1 or PD-1 are highly effective in rescuing T cell anti-tumor effector functions.', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (450, '05310', 'Asthma', 'Asthma is a complex syndrome with many clinical phenotypes in both adults and children. Its major characteristics include a variable degree of airflow obstruction, bronchial hyperresponsiveness, and airway inflammation. Inhaled allergens encounter antigen presenting cells (APC) that line the airway. Upon recognition of the antigen and activation by APC, naive T cells differentiate into TH2 cells. Activated TH2 stimulate the formation of IgE by B cells. IgE molecules bind to IgE receptors located on mast cells. The crosslinking of mast-cell-bound IgE by allergens leads to the release of biologically active mediators (histamine, leukotrienes) by means of degranulation and, so, to the immediate symptoms of allergy. Mast cells also release chemotactic factors that contribute to the recruitment of inflammatory cells, particularly eosinophils, whose proliferation and differentiation from bone marrow progenitors is promoted by IL-5. The activation of eosinophils leads to release of toxic granules and oxygen free radicals that lead to tissue damage and promote the development of chronic inflammation.', 'Human Diseases; Immune disease', 'Asthma', 'Asthma, Eosinophil peroxidase deficiency', 'ko05310', 'list(REFERENCE = \"PMID:11172168\", AUTHORS = \"Busse WW, Lemanske RF Jr.\", TITLE = \"Asthma.\", JOURNAL = c(\"N Engl J Med 344:350-62 (2001)\", \"DOI:10.1056/NEJM200102013440507\")), list(REFERENCE = \"PMID:11477111\", AUTHORS = \"Renauld JC.\", TITLE = \"New insights into the role of cytokines in asthma.\", JOURNAL = c(\"J Clin Pathol 54:577-89 (2001)\", \"DOI:10.1136/jcp.54.8.577\")), list(REFERENCE = \"PMID:10719286\", AUTHORS = \"Romagnani S.\", TITLE = \"The role of lymphocytes in allergic disease.\", JOURNAL = c(\"J Allergy Clin Immunol 105:399-408 (2000)\", \"DOI:10.1067/mai.2000.104575\")), list(REFERENCE = \"PMID:17976144\", AUTHORS = \"Averbeck M, Gebhardt C, Emmrich F, Treudler R, Simon JC.\", TITLE = \"Immunologic principles of allergic disease.\", JOURNAL = c(\"J Dtsch Dermatol Ges 5:1015-28 (2007)\", \"DOI:10.1111/j.1610-0387.2007.06538.x\")), list(REFERENCE = \"PMID:11686879\", AUTHORS = \"Conroy DM, Williams TJ.\", TITLE = \"Eotaxin and the attraction of eosinophils to the asthmatic lung.\", JOURNAL = c(\"Respir Res 2:150-6 (2001)\", \"DOI:10.1186/rr52\")), list(REFERENCE = \"PMID:17133123\", AUTHORS = \"Effros RM, Nagaraj H.\", TITLE = \"Asthma: new developments concerning immune mechanisms, diagnosis and treatment.\", JOURNAL = c(\"Curr Opin Pulm Med 13:37-43 (2007)\", \"DOI:10.1097/MCP.0b013e3280108757\")), list(REFERENCE = \"PMID:18274560\", AUTHORS = \"Barnes PJ.\", TITLE = \"Immunology of asthma and chronic obstructive pulmonary disease.\", JOURNAL = c(\"Nat Rev Immunol 8:183-92 (2008)\", \"DOI:10.1038/nri2254\")), list(REFERENCE = \"PMID:18274559\", AUTHORS = \"Holgate ST, Polosa R.\", TITLE = \"Treatment strategies for allergy and asthma.\", JOURNAL = c(\"Nat Rev Immunol 8:218-30 (2008)\", \"DOI:10.1038/nri2262\")), list(REFERENCE = \"PMID:12093011\", AUTHORS = \"Valenta R.\", TITLE = \"The future of antigen-specific immunotherapy of allergy.\", JOURNAL = c(\"Nat Rev Immunol 2:446-53 (2002)\", \"DOI:10.1038/nri824\")), list(REFERENCE = \"PMID:17364144\", AUTHORS = \"Trivedi SG, Lloyd CM.\", TITLE = \"Eosinophils in the pathogenesis of allergic airways disease.\", JOURNAL = c(\"Cell Mol Life Sci 64:1269-89 (2007)\", \"DOI:10.1007/s00018-007-6527-y\")), list(REFERENCE = \"PMID:10811837\", AUTHORS = \"Heinecke JW.\", TITLE = \"Eosinophil-dependent bromination in the pathogenesis of asthma.\", JOURNAL = c(\"J Clin Invest 105:1331-2 (2000)\", \"DOI:10.1172/JCI10072\"))', 'map05310', 'Asthma', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (451, '05320', 'Autoimmune thyroid disease', 'The classification of autoimmune throid disease (AITD) includes Hashimoto\'s thyroiditis (HT) or chronic autoimmune thyroiditis and its variants, Graves\' disease (GD) and autoimmune atrophic thyroiditis or primary myxedema. HT is characterized by the presence of goitre, thyroid autoantibodies against thyroid peroxidase (TPO) and thyroglobulin (Tg) in serum and varying degrees of thyroid dysfunction. During HT, self-reactive CD4+ T lymphocytes (Th) recruit B cells and CD8+ T cells (CTL) into the thyroid. Disease progression leads to the death of thyroid cells and hypothyroidism. Both autoantibodies and thyroid-specific cytotoxic T lymphocytes (CTLs) have been proposed to be responsible for autoimmune thyrocyte depletion. In GD, the TSH-R is the most important autoantigen. Antibodies directed against it mimic the effects of the hormone on thyroid cells, TSH, stimulating autonomous production of thyroxine and triiodothyronine and causing hyperthyroidism. The presence of TSH-R-blocking antibodies that bind the TSH receptor in a similar fashion to the antibodies in patients with Grave\'s disease but that block rather than activate the receptor explains some cases of atrophic hypothyroidism.', 'Human Diseases; Immune disease', 'Autoimmune thyroid disease', 'Hashimoto thyroiditis, Graves disease', 'ko05320', 'list(REFERENCE = \"PMID:15049952\", AUTHORS = \"Fountoulakis S, Tsatsoulis A.\", TITLE = \"On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis.\", JOURNAL = c(\"Clin Endocrinol (Oxf) 60:397-409 (2004)\", \"DOI:10.1046/j.1365-2265.2004.01978.x\")), list(REFERENCE = \"PMID:15762980\", AUTHORS = \"Chistiakov DA.\", TITLE = \"Immunogenetics of Hashimoto\'s thyroiditis.\", JOURNAL = c(\"J Autoimmune Dis 2:1 (2005)\", \"DOI:10.1186/1740-2557-2-1\")), list(REFERENCE = \"PMID:9534029\", AUTHORS = \"McIver B, Morris JC.\", TITLE = \"The pathogenesis of Graves\' disease.\", JOURNAL = c(\"Endocrinol Metab Clin North Am 27:73-89 (1998)\", \"DOI:10.1016/S0889-8529(05)70299-1\")), list(REFERENCE = \"PMID:11913070\", AUTHORS = \"Stassi G, De Maria R.\", TITLE = \"Autoimmune thyroid disease: new models of cell death in autoimmunity.\", JOURNAL = c(\"Nat Rev Immunol 2:195-204 (2002)\", \"DOI:10.1038/nri750\")), list(REFERENCE = \"PMID:12192541\", AUTHORS = \"Collins J, Gough S.\", TITLE = \"Autoimmunity in thyroid disease.\", JOURNAL = c(\"Eur J Nucl Med Mol Imaging 29 Suppl 2:S417-24 (2002)\", \"DOI:10.1007/s00259-002-0848-8\")), list(REFERENCE = \"PMID:11396701\", AUTHORS = \"Ruwhof C, Drexhage HA.\", TITLE = \"Iodine and thyroid autoimmune disease in animal models.\", JOURNAL = c(\"Thyroid 11:427-36 (2001)\", \"DOI:10.1089/105072501300176381\")), list(REFERENCE = \"PMID:17192582\", AUTHORS = \"Tsatsoulis A.\", TITLE = \"The role of stress in the clinical expression of thyroid autoimmunity.\", JOURNAL = c(\"Ann N Y Acad Sci 1088:382-95 (2006)\", \"DOI:10.1196/annals.1366.015\")), list(REFERENCE = \"PMID:15132715\", AUTHORS = \"Prummel MF, Strieder T, Wiersinga WM.\", TITLE = \"The environment and autoimmune thyroid diseases.\", JOURNAL = c(\"Eur J Endocrinol 150:605-18 (2004)\", \"DOI:10.1530/eje.0.1500605\")), list(REFERENCE = \"PMID:11577986\", AUTHORS = \"Kopp P.\", TITLE = \"The TSH receptor and its role in thyroid disease.\", JOURNAL = c(\"Cell Mol Life Sci 58:1301-22 (2001)\", \"DOI:10.1007/PL00000941\"))', 'map05320', 'Autoimmune thyroid disease', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (452, '05321', 'Inflammatory bowel disease (IBD)', 'Inflammatory bowel disease (IBD), which includes Crohn disease (CD) and ulcerative colitis (UC), is characterized by chronic inflammation of the gastrointestinal tract due to environmental and genetic factors, infectious microbes, and the dysregulated immune system. Although many environmental factors (for example, geographic locations, smoking, etc.) affect the development of IBD, the most crucial might be the luminal (external) environment of the epithelial cells. There are pathogens that are found in increasing frequency in IBD. The microbial components such as flagellin, peptidoglycan, and lipopolysaccharide are recognized by receptors such as toll-like receptors (TLRs) and nucleotide-binding oligomerization domain (NOD) proteins, and also by antigen-presenting cells (APCs) in genetically susceptible host. The TLR recognition triggers the activation of NF-kappaB, leading to an inflammatory response. APC-expressed gene NOD2 has been associated with Crohn disease. In case of mutations of NOD2, negative regulation of IL-12 production is reduced with the stimulation of muramyl dipeptide (MDP), leading to CD. In addition, the APC mediates the differentiation of naive T cells into effector T cells (Th1, Th17, Th2) and natural killer T (NKT) cells. Th1 and Th17 cells produce high levels of IFN-gamma and IL-17, -22, respectively, both of which promote CD. In contrast, Th2 cells produce IL-4, -5, -10, which together with IL-13 from NKT induce UC.', 'Human Diseases; Immune disease', 'Inflammatory bowel disease (IBD)', 'Crohn disease, Inflammatory bowel disease (IBD), Ulcerative colitis, IPEX syndrome', 'ko05321', 'list(REFERENCE = \"PMID:20134493\", AUTHORS = \"Melmed GY, Targan SR\", TITLE = \"Future biologic targets for IBD: potentials and pitfalls.\", JOURNAL = c(\"Nat Rev Gastroenterol Hepatol 7:110-7 (2010)\", \"DOI:10.1038/nrgastro.2009.218\")), list(REFERENCE = \"PMID:18200661\", AUTHORS = \"Shih DQ, Targan SR\", TITLE = \"Immunopathogenesis of inflammatory bowel disease.\", JOURNAL = c(\"World J Gastroenterol 14:390-400 (2008)\", \"DOI:10.3748/wjg.14.390\")), list(REFERENCE = \"PMID:17499605\", AUTHORS = \"Baumgart DC, Carding SR\", TITLE = \"Inflammatory bowel disease: cause and immunobiology.\", JOURNAL = c(\"Lancet 369:1627-40 (2007)\", \"DOI:10.1016/S0140-6736(07)60750-8\")), list(REFERENCE = \"PMID:16493424\", AUTHORS = \"Strober W, Murray PJ, Kitani A, Watanabe T\", TITLE = \"Signalling pathways and molecular interactions of NOD1 and NOD2.\", JOURNAL = c(\"Nat Rev Immunol 6:9-20 (2006)\", \"DOI:10.1038/nri1747\")), list(REFERENCE = \"PMID:21487504\", AUTHORS = \"Matricon J, Barnich N, Ardid D\", TITLE = \"Immunopathogenesis of inflammatory bowel disease.\", JOURNAL = c(\"Self Nonself 1:299-309 (2010)\", \"DOI:10.4161/self.1.4.13560\")), list(REFERENCE = \"PMID:12797537\", AUTHORS = \"Agnello D, Lankford CS, Bream J, Morinobu A, Gadina M, O\'Shea JJ, Frucht DM\", TITLE = \"Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights.\", JOURNAL = c(\"J Clin Immunol 23:147-61 (2003)\", \"DOI:10.1023/A:1023381027062\")), list(REFERENCE = \"PMID:10898785\", AUTHORS = \"Glimcher LH, Murphy KM\", TITLE = \"Lineage commitment in the immune system: the T helper lymphocyte grows up.\", JOURNAL = c(\"Genes Dev 14:1693-711 (2000)\", \"DOI:10.1101/gad.14.14.1693\")), list(REFERENCE = \"PMID:12042806\", AUTHORS = \"Neurath MF, Finotto S, Glimcher LH\", TITLE = \"The role of Th1/Th2 polarization in mucosal immunity.\", JOURNAL = c(\"Nat Med 8:567-73 (2002)\", \"DOI:10.1038/nm0602-567\")), list(REFERENCE = \"PMID:12006974\", AUTHORS = \"Afkarian M, Sedy JR, Yang J, Jacobson NG, Cereb N, Yang SY, Murphy TL, Murphy KM\", TITLE = \"T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells.\", JOURNAL = c(\"Nat Immunol 3:549-57 (2002)\", \"DOI:10.1038/ni794\")), list(REFERENCE = \"PMID:18242222\", AUTHORS = \"Sartor RB\", TITLE = \"Microbial influences in inflammatory bowel diseases.\", JOURNAL = c(\"Gastroenterology 134:577-94 (2008)\", \"DOI:10.1053/j.gastro.2007.11.059\")), list(REFERENCE = \"PMID:9759857\", AUTHORS = \"Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K\", TITLE = \"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.\", JOURNAL = \"J Immunol 161:3400-7 (1998)\"), list(REFERENCE = \"PMID:23176791\", AUTHORS = \"Hur SJ, Kang SH, Jung HS, Kim SC, Jeon HS, Kim IH, Lee JD\", TITLE = \"Review of natural products actions on cytokines in inflammatory bowel disease.\", JOURNAL = c(\"Nutr Res 32:801-16 (2012)\", \"DOI:10.1016/j.nutres.2012.09.013\")), list(REFERENCE = \"PMID:18563156\", AUTHORS = \"Bettelli E, Korn T, Oukka M, Kuchroo VK\", TITLE = \"Induction and effector functions of T(H)17 cells.\", JOURNAL = c(\"Nature 453:1051-7 (2008)\", \"DOI:10.1038/nature07036\")), list(REFERENCE = \"PMID:18053739\", AUTHORS = \"Ivanov II, Zhou L, Littman DR\", TITLE = \"Transcriptional regulation of Th17 cell differentiation.\", JOURNAL = c(\"Semin Immunol 19:409-17 (2007)\", \"DOI:10.1016/j.smim.2007.10.011\")), list(REFERENCE = \"PMID:19322214\", AUTHORS = \"Di Cesare A, Di Meglio P, Nestle FO\", TITLE = \"The IL-23/Th17 axis in the immunopathogenesis of psoriasis.\", JOURNAL = c(\"J Invest Dermatol 129:1339-50 (2009)\", \"DOI:10.1038/jid.2009.59\")), list(REFERENCE = \"PMID:19381306\", AUTHORS = \"Jetten AM\", TITLE = \"Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism.\", JOURNAL = c(\"Nucl Recept Signal 7:e003 (2009)\", \"DOI:10.1621/nrs.07003\")), list(REFERENCE = \"PMID:21681604\", AUTHORS = \"Bene L, Falus A, Baffy N, Fulop AK\", TITLE = \"Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.\", JOURNAL = c(\"Pathol Oncol Res 17:463-72 (2011)\", \"DOI:10.1007/s12253-011-9397-4\"))', 'map05321', 'Inflammatory bowel disease (IBD)', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (453, '05322', 'Systemic lupus erythematosus', 'Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterised by the production of IgG autoantibodies that are specific for self-antigens, such as DNA, nuclear proteins and certain cytoplasmic components, in association with a diverse array of clinical manifestations. The primary pathological findings in patients with SLE are those of inflammation, vasculitis, immune complex deposition, and vasculopathy. Immune complexes comprising autoantibody and self-antigen is deposited particulary in the renal glomeruli and mediate a systemic inflammatory response by activating complement or via Fc{gamma}R-mediated neutrophil and macrophage activation. Activation of complement (C5) leads to injury both through formation of the membrane attack complex (C5b-9) or by generation of the anaphylatoxin and cell activator C5a. Neutrophils and macrophages cause tissue injury by the release of oxidants and proteases.', 'Human Diseases; Immune disease', 'Systemic lupus erythematosus', 'Systemic lupus erythematosus', 'ko05322', 'list(REFERENCE = \"PMID:18305268\", AUTHORS = \"Rahman A, Isenberg DA.\", TITLE = \"Systemic lupus erythematosus.\", JOURNAL = c(\"N Engl J Med 358:929-39 (2008)\", \"DOI:10.1056/NEJMra071297\")), list(REFERENCE = \"PMID:12835292\", AUTHORS = \"Mok CC, Lau CS.\", TITLE = \"Pathogenesis of systemic lupus erythematosus.\", JOURNAL = c(\"J Clin Pathol 56:481-90 (2003)\", \"DOI:10.1136/jcp.56.7.481\")), list(REFERENCE = \"PMID:17943287\", AUTHORS = \"Clatworthy MR, Smith KG.\", TITLE = \"B cells in glomerulonephritis: focus on lupus nephritis.\", JOURNAL = c(\"Semin Immunopathol 29:337-53 (2007)\", \"DOI:10.1007/s00281-007-0092-1\")), list(REFERENCE = \"PMID:8048228\", AUTHORS = \"Couser WG.\", TITLE = \"New insights into mechanisms of immune glomerular injury.\", JOURNAL = \"West J Med 160:440-6 (1994)\"), list(REFERENCE = \"PMID:16932712\", AUTHORS = \"Cook HT, Botto M.\", TITLE = \"Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.\", JOURNAL = c(\"Nat Clin Pract Rheumatol 2:330-7 (2006)\", \"DOI:10.1038/ncprheum0191\")), list(REFERENCE = \"PMID:15459673\", AUTHORS = \"Carroll MC.\", TITLE = \"A protective role for innate immunity in systemic lupus erythematosus.\", JOURNAL = c(\"Nat Rev Immunol 4:825-31 (2004)\", \"DOI:10.1038/nri1456\")), list(REFERENCE = \"PMID:15972354\", AUTHORS = \"Sturfelt G, Truedsson L.\", TITLE = \"Complement and its breakdown products in SLE.\", JOURNAL = c(\"Rheumatology (Oxford) 44:1227-32 (2005)\", \"DOI:10.1093/rheumatology/keh719\")), list(REFERENCE = \"PMID:10430616\", AUTHORS = \"Lu L, Kaliyaperumal A, Boumpas DT, Datta SK.\", TITLE = \"Major peptide autoepitopes for nucleosome-specific T cells of human lupus.\", JOURNAL = c(\"J Clin Invest 104:345-55 (1999)\", \"DOI:10.1172/JCI6801\")), list(REFERENCE = \"PMID:12965173\", AUTHORS = \"Zieve GW, Khusial PR.\", TITLE = \"The anti-Sm immune response in autoimmunity and cell biology.\", JOURNAL = c(\"Autoimmun Rev 2:235-40 (2003)\", \"DOI:10.1016/S1568-9972(03)00018-1\")), list(REFERENCE = \"PMID:10025913\", AUTHORS = \"Scofield RH, Farris AD, Horsfall AC, Harley JB.\", TITLE = \"Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins.\", JOURNAL = c(\"Arthritis Rheum 42:199-209 (1999)\", \"DOI:10.1002/1529-0131(199902)42:2<199::AID-ANR1>3.0.CO;2-1\")), list(REFERENCE = \"PMID:15380523\", AUTHORS = \"Hoffman RW.\", TITLE = \"T cells in the pathogenesis of systemic lupus erythematosus.\", JOURNAL = c(\"Clin Immunol 113:4-13 (2004)\", \"DOI:10.1016/j.clim.2004.05.001\"))', 'map05322', 'Systemic lupus erythematosus', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (454, '05323', 'Rheumatoid arthritis', 'Rheumatoid arthritis (RA) is a chronic autoimmune joint disease where persistent inflammation affects bone remodeling leading to progressive bone destruction. In RA, abnormal activation of the immune system elevates pro-inflammatory cytokines and chemokines levels, which can promote synovial angiogenesis and leukocyte infiltration. The synovium forms a hyperplastic pannus with infiltrated macrophage-like and fibroblast-like synoviocytes and invades joints by secreting proteinases and inducing osteoclast differentiation.', 'Human Diseases; Immune disease', 'Rheumatoid arthritis', 'Osteopetrosis, Rheumatoid arthritis', 'ko05323', 'list(REFERENCE = \"PMID:16127012\", AUTHORS = \"Zwerina J, Redlich K, Schett G, Smolen JS\", TITLE = \"Pathogenesis of rheumatoid arthritis: targeting cytokines.\", JOURNAL = c(\"Ann N Y Acad Sci 1051:716-29 (2005)\", \"DOI:10.1196/annals.1361.116\")), list(REFERENCE = \"PMID:20036936\", AUTHORS = \"Szekanecz Z, Vegvari A, Szabo Z, Koch AE\", TITLE = \"Chemokines and chemokine receptors in arthritis.\", JOURNAL = c(\"Front Biosci (Schol Ed) 2:153-67 (2010)\", \"DOI:10.2741/53\")), list(REFERENCE = \"PMID:20651747\", AUTHORS = \"Isaacs JD\", TITLE = \"The changing face of rheumatoid arthritis: sustained remission for all?\", JOURNAL = c(\"Nat Rev Immunol 10:605-11 (2010)\", \"DOI:10.1038/nri2804\")), list(REFERENCE = \"PMID:17195034\", AUTHORS = \"Strand V, Kimberly R, Isaacs JD\", TITLE = \"Biologic therapies in rheumatology: lessons learned, future directions.\", JOURNAL = c(\"Nat Rev Drug Discov 6:75-92 (2007)\", \"DOI:10.1038/nrd2196\")), list(REFERENCE = \"PMID:20193003\", AUTHORS = \"Bartok B, Firestein GS\", TITLE = \"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.\", JOURNAL = c(\"Immunol Rev 233:233-55 (2010)\", \"DOI:10.1111/j.0105-2896.2009.00859.x\")), list(REFERENCE = \"PMID:17502360\", AUTHORS = \"Dai SM, Shan ZZ, Xu H, Nishioka K\", TITLE = \"Cellular targets of interleukin-18 in rheumatoid arthritis.\", JOURNAL = c(\"Ann Rheum Dis 66:1411-8 (2007)\", \"DOI:10.1136/ard.2006.067793\")), list(REFERENCE = \"PMID:9627005\", AUTHORS = \"Koch AE\", TITLE = \"Review: angiogenesis: implications for rheumatoid arthritis.\", JOURNAL = c(\"Arthritis Rheum 41:951-62 (1998)\", \"DOI:10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D\")), list(REFERENCE = \"PMID:20305562\", AUTHORS = \"Szekanecz Z, Besenyei T, Szentpetery A, Koch AE\", TITLE = \"Angiogenesis and vasculogenesis in rheumatoid arthritis.\", JOURNAL = c(\"Curr Opin Rheumatol 22:299-306 (2010)\", \"DOI:10.1097/BOR.0b013e328337c95a\")), list(REFERENCE = \"PMID:15059264\", AUTHORS = \"Brunner-Weinzierl MC, Hoff H, Burmester GR\", TITLE = \"Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases.\", JOURNAL = c(\"Arthritis Res Ther 6:45-54 (2004)\", \"DOI:10.1186/ar1158\")), list(REFERENCE = \"PMID:11861618\", AUTHORS = \"Theill LE, Boyle WJ, Penninger JM\", TITLE = \"RANK-L and RANK: T cells, bone loss, and mammalian evolution.\", JOURNAL = c(\"Annu Rev Immunol 20:795-823 (2002)\", \"DOI:10.1146/annurev.immunol.20.100301.064753\")), list(REFERENCE = \"PMID:19184540\", AUTHORS = \"Mensah KA, Li J, Schwarz EM\", TITLE = \"The emerging field of osteoimmunology.\", JOURNAL = c(\"Immunol Res 45:100-13 (2009)\", \"DOI:10.1007/s12026-009-8093-x\")), list(REFERENCE = \"PMID:16313349\", AUTHORS = \"Takayanagi H, Sato K, Takaoka A, Taniguchi T\", TITLE = \"Interplay between interferon and other cytokine systems in bone metabolism.\", JOURNAL = c(\"Immunol Rev 208:181-93 (2005)\", \"DOI:10.1111/j.0105-2896.2005.00337.x\")), list(REFERENCE = \"PMID:20392226\", AUTHORS = \"Takayanagi H\", TITLE = \"New immune connections in osteoclast formation.\", JOURNAL = c(\"Ann N Y Acad Sci 1192:117-23 (2010)\", \"DOI:10.1111/j.1749-6632.2009.05303.x\")), list(REFERENCE = \"PMID:19585227\", AUTHORS = \"Nakashima T, Takayanagi H\", TITLE = \"Osteoimmunology: crosstalk between the immune and bone systems.\", JOURNAL = c(\"J Clin Immunol 29:555-67 (2009)\", \"DOI:10.1007/s10875-009-9316-6\")), list(REFERENCE = \"PMID:19455385\", AUTHORS = \"Nakashima T, Takayanagi H\", TITLE = \"Osteoclasts and the immune system.\", JOURNAL = c(\"J Bone Miner Metab 27:519-29 (2009)\", \"DOI:10.1007/s00774-009-0089-z\")), list(REFERENCE = \"PMID:17380158\", AUTHORS = \"Takayanagi H\", TITLE = \"Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.\", JOURNAL = c(\"Nat Rev Immunol 7:292-304 (2007)\", \"DOI:10.1038/nri2062\")), list(REFERENCE = \"PMID:20510236\", AUTHORS = \"Fox DA, Gizinski A, Morgan R, Lundy SK\", TITLE = \"Cell-cell interactions in rheumatoid arthritis synovium.\", JOURNAL = c(\"Rheum Dis Clin North Am 36:311-23 (2010)\", \"DOI:10.1016/j.rdc.2010.02.004\")), list(REFERENCE = \"PMID:15055519\", AUTHORS = \"Rho J, Takami M, Choi Y\", TITLE = \"Osteoimmunology: interactions of the immune and skeletal systems.\", JOURNAL = \"Mol Cells 17:1-9 (2004)\")', 'map05323', 'Rheumatoid arthritis', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (455, '05330', 'Allograft rejection', 'Allograft rejection is the consequence of the recipient\'s alloimmune response to nonself antigens expressed by donor tissues. After transplantation of organ allografts, there are two pathways of antigen presentation. In the direct pathway, recipient T cells react to intact allogeneic MHC molecules expressed on the surface of donor cells. This pathway would activate host CD4 or CD8 T cells. In contrast, donor MHC molecules (and all other proteins) shed from the graft can be taken up by host APCs and presented to recipient T cells in the context of self-MHC molecules - the indirect pathway. Such presentation activates predominantly CD4 T cells. A direct cytotoxic T-cell attack on graft cells can be made only by T cells that recognize the graft MHC molecules directly. Nontheless, T cells with indirect allospecificity can contribute to graft rejection by activating macrophages, which cause tissue injury and fibrosis, and are also likely to be important in the development of an alloantibody response to graft.', 'Human Diseases; Immune disease', 'Allograft rejection', 'Allograft rejection', 'ko05330', 'list(REFERENCE = \"PMID:10746853\", AUTHORS = \"Arakelov A, Lakkis FG.\", TITLE = \"The alloimmune response and effector mechanisms of allograft rejection.\", JOURNAL = \"Semin Nephrol 20:95-102 (2000)\"), list(REFERENCE = \"PMID:12023610\", AUTHORS = \"Le Moine A, Goldman M, Abramowicz D.\", TITLE = \"Multiple pathways to allograft rejection.\", JOURNAL = \"Transplantation 73:1373-81 (2002)\"), list(REFERENCE = \"PMID:17445565\", AUTHORS = \"Trivedi HL.\", TITLE = \"Immunobiology of rejection and adaptation.\", JOURNAL = c(\"Transplant Proc 39:647-52 (2007)\", \"DOI:10.1016/j.transproceed.2007.01.047\")), list(REFERENCE = \"PMID:14710779\", AUTHORS = \"Pietra BA.\", TITLE = \"Transplantation immunology 2003: simplified approach.\", JOURNAL = c(\"Pediatr Clin North Am 50:1233-59 (2003)\", \"DOI:10.1016/S0031-3955(03)00119-6\")), list(REFERENCE = \"PMID:8835634\", AUTHORS = \"Oka T, Yoshimura N.\", TITLE = \"Immunosuppression in organ transplantation.\", JOURNAL = c(\"Jpn J Pharmacol 71:89-100 (1996)\", \"DOI:10.1254/jjp.71.89\")), list(REFERENCE = \"PMID:10571983\", AUTHORS = \"Sayegh MH.\", TITLE = \"Why do we reject a graft? Role of indirect allorecognition in graft rejection.\", JOURNAL = c(\"Kidney Int 56:1967-79 (1999)\", \"DOI:10.1046/j.1523-1755.1999.00751.x\")), list(REFERENCE = \"PMID:10331992\", AUTHORS = \"Benichou G.\", TITLE = \"Direct and indirect antigen recognition: the pathways to allograft immune rejection.\", JOURNAL = \"Front Biosci 4:D476-80 (1999)\"), list(REFERENCE = \"PMID:10667806\", AUTHORS = \"Turvey SE, Wood KJ.\", TITLE = \"Immunobiology of solid organ transplantation.\", JOURNAL = \"Int Surg 84:279-90 (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Janeway CA, Travers P, Walport M, Shlomchik MJ.\", TITLE = \"Immunobiology 6th edition\", JOURNAL = \"Garland Science Publishing (2005)\"), list(REFERENCE = \"PMID:12216939\", AUTHORS = \"Game DS, Lechler RI.\", TITLE = \"Pathways of allorecognition: implications for transplantation tolerance.\", JOURNAL = c(\"Transpl Immunol 10:101-8 (2002)\", \"DOI:10.1016/S0966-3274(02)00055-2\")), list(REFERENCE = \"PMID:12563298\", AUTHORS = \"Lechler RI, Garden OA, Turka LA.\", TITLE = \"The complementary roles of deletion and regulation in transplantation tolerance.\", JOURNAL = c(\"Nat Rev Immunol 3:147-58 (2003)\", \"DOI:10.1038/nri1002\"))', 'map05330', 'Allograft rejection', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (456, '05332', 'Graft-versus-host disease', 'Graft-versus-host disease (GVHD) is a lethal complication of allogeneic hematopoietic stem cell transplantation (HSCT) where immunocompetent donor T cells attack the genetically disparate host cells. GVHD pathophysiology can be summerized in a three-step process. Step 1 involves the development of an inflammatory milieu resulting from damage in the host tissues induced by the preparative chemotherapy or radiotherapy regimen. Damaged tissues secrete inflammatory cytokines, including interleukin 1 (IL-1), and tumor necrosis factor (TNF-alpha ). During step 2, antigen-presenting cells (APCs) trigger the activation of donor-derived T cells, which induce further T-cell expansion, induce cytotoxic T lymphocytes (CTL) and natural killer (NK) cells responses and prime additional mononuclear phagocytes to produce TNF-alpha and IL-1. Also, nitric oxide (NO) is produced by activated macrophages, and it may contribute to the tissue damage seen during step 3. During step 3, the effector phase, activated CTL and NK cells mediate cytotoxicity against target host cells through Fas-Fas ligand interactions and perforin-granzyme B.', 'Human Diseases; Immune disease', 'Graft-versus-host disease', 'Graft-versus-host disease', 'ko05332', 'list(REFERENCE = \"PMID:16412784\", AUTHORS = \"Ferrara JL, Reddy P.\", TITLE = \"Pathophysiology of graft-versus-host disease.\", JOURNAL = c(\"Semin Hematol 43:3-10 (2006)\", \"DOI:10.1053/j.seminhematol.2005.09.001\")), list(REFERENCE = \"PMID:14735553\", AUTHORS = \"Reddy P.\", TITLE = \"Pathophysiology of acute graft-versus-host disease.\", JOURNAL = c(\"Hematol Oncol 21:149-61 (2003)\", \"DOI:10.1002/hon.716\")), list(REFERENCE = \"PMID:17900507\", AUTHORS = \"Sun Y, Tawara I, Toubai T, Reddy P.\", TITLE = \"Pathophysiology of acute graft-versus-host disease: recent advances.\", JOURNAL = c(\"Transl Res 150:197-214 (2007)\", \"DOI:10.1016/j.trsl.2007.06.003\")), list(REFERENCE = \"PMID:15882431\", AUTHORS = \"Jaksch M, Mattsson J.\", TITLE = \"The pathophysiology of acute graft-versus-host disease.\", JOURNAL = c(\"Scand J Immunol 61:398-409 (2005)\", \"DOI:10.1111/j.1365-3083.2005.01595.x\")), list(REFERENCE = \"PMID:12359826\", AUTHORS = \"Vogelsang GB, Lee L, Bensen-Kennedy DM.\", TITLE = \"Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant.\", JOURNAL = c(\"Annu Rev Med 54:29-52 (2003)\", \"DOI:10.1146/annurev.med.54.101601.152339\")), list(REFERENCE = \"PMID:14556773\", AUTHORS = \"Reddy P, Ferrara JL.\", TITLE = \"Immunobiology of acute graft-versus-host disease.\", JOURNAL = c(\"Blood Rev 17:187-94 (2003)\", \"DOI:10.1016/S0268-960X(03)00009-2\")), list(REFERENCE = \"PMID:16147539\", AUTHORS = \"Blazar BR, Murphy WJ.\", TITLE = \"Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).\", JOURNAL = c(\"Philos Trans R Soc Lond B Biol Sci 360:1747-67 (2005)\", \"DOI:10.1098/rstb.2005.1701\")), list(REFERENCE = \"PMID:15372473\", AUTHORS = \"Couriel D, Caldera H, Champlin R, Komanduri K.\", TITLE = \"Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.\", JOURNAL = c(\"Cancer 101:1936-46 (2004)\", \"DOI:10.1002/cncr.20613\")), list(REFERENCE = \"PMID:17784964\", AUTHORS = \"Jacobsohn DA, Vogelsang GB.\", TITLE = \"Acute graft versus host disease.\", JOURNAL = c(\"Orphanet J Rare Dis 2:35 (2007)\", \"DOI:10.1186/1750-1172-2-35\"))', 'map05332', 'Graft-versus-host disease', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (457, '05340', 'Primary immunodeficiency', 'Primary immunodeficiencies (PIs) are a heterogeneous group of disorders, which affect cellular and humoral immunity or non-specific host defense mechanisms mediated by complement proteins, and cells such as phagocytes and natural killer (NK) cells. These disorders of the immune system cause increased susceptibility to infection, autoimmune disease, and malignancy. Most of PIs are due to genetic defects that affect cell maturation or function at different levels during hematopoiesis. Disruption of the cellular immunity is observed in patients with defects in T cells or both T and B cells. These cellular immunodeficiencies comprise 20% of all PIs. Disorders of humoral immunity affect B-cell differentiation and antibody production. They account for 70% of all PIs.', 'Human Diseases; Immune disease', 'Primary immunodeficiency', 'Agammaglobulinemias, Hyper IgM syndromes, autosomal recessive type, Common variable immunodeficiency, T-B+Severe combined immunodeficiency, T-B-Severe combined immunodeficiency, Combined immunodeficiency, Ectodermal dysplasia associated immunodeficiency, Other well-defined immunodeficiency syndromes, Bare lymphocyte syndrome type1, Bare lymphocyte syndrome type2, Autoimmune polyendocrinopathy syndrome type 1, Adenosine deaminase deficiency', 'ko05340', 'list(REFERENCE = \"PMID:16261175\", AUTHORS = \"Cunningham-Rundles C, Ponda PP.\", TITLE = \"Molecular defects in T- and B-cell primary immunodeficiency diseases.\", JOURNAL = c(\"Nat Rev Immunol 5:880-92 (2005)\", \"DOI:10.1038/nri1713\")), list(REFERENCE = \"PMID:11941303\", AUTHORS = \"Ballow M.\", TITLE = \"Primary immunodeficiency disorders: antibody deficiency.\", JOURNAL = c(\"J Allergy Clin Immunol 109:581-91 (2002)\", \"DOI:10.1067/mai.2002.122466\")), list(REFERENCE = \"PMID:17960151\", AUTHORS = \"Marodi L, Notarangelo LD.\", TITLE = \"Immunological and genetic bases of new primary immunodeficiencies.\", JOURNAL = c(\"Nat Rev Immunol 7:851-61 (2007)\", \"DOI:10.1038/nri2195\")), list(REFERENCE = \"PMID:17952897\", AUTHORS = \"Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarstrom L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J.\", TITLE = \"Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee.\", JOURNAL = c(\"J Allergy Clin Immunol 120:776-94 (2007)\", \"DOI:10.1016/j.jaci.2007.08.053\")), list(REFERENCE = \"PMID:18093537\", AUTHORS = \"Fischer A.\", TITLE = \"Human primary immunodeficiency diseases.\", JOURNAL = c(\"Immunity 27:835-45 (2007)\", \"DOI:10.1016/j.immuni.2007.11.012\")), list(REFERENCE = \"PMID:14699405\", AUTHORS = \"Fischer A.\", TITLE = \"Human primary immunodeficiency diseases: a perspective.\", JOURNAL = c(\"Nat Immunol 5:23-30 (2004)\", \"DOI:10.1038/ni1023\")), list(REFERENCE = \"PMID:11058677\", AUTHORS = \"Buckley RH.\", TITLE = \"Primary immunodeficiency diseases due to defects in lymphocytes.\", JOURNAL = c(\"N Engl J Med 343:1313-24 (2000)\", \"DOI:10.1056/NEJM200011023431806\")), list(REFERENCE = \"PMID:15661024\", AUTHORS = \"Fischer A, Le Deist F, Hacein-Bey-Abina S, Andre-Schmutz I, Basile Gde S, de Villartay JP, Cavazzana-Calvo M.\", TITLE = \"Severe combined immunodeficiency. A model disease for molecular immunology and therapy.\", JOURNAL = c(\"Immunol Rev 203:98-109 (2005)\", \"DOI:10.1111/j.0105-2896.2005.00223.x\")), list(REFERENCE = \"PMID:14647478\", AUTHORS = \"de Villartay JP, Fischer A, Durandy A.\", TITLE = \"The mechanisms of immune diversification and their disorders.\", JOURNAL = c(\"Nat Rev Immunol 3:962-72 (2003)\", \"DOI:10.1038/nri1247\"))', 'map05340', 'Primary immunodeficiency', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (458, '05410', 'Hypertrophic cardiomyopathy (HCM)', 'Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder with an autosomal dominant pattern of inheritance that is characterized by hypertrophy of the left ventricles with histological features of myocyte hypertrophy, myfibrillar disarray, and interstitial fibrosis. HCM is one of the most common inherited cardiac disorders, with a prevalence in young adults of 1 in 500. Hundreds of mutations in the genes that encode protein constituents of the sarcomere have been identified in HCM. These mutations increase the Ca2+ sensitivity of cardiac myofilaments. Increased myofilament Ca2+ sensitivity is expected to increase the ATP utilization by actomyosin at submaximal Ca2+ concentrations, which might cause an imbalance in energy supply and demand in the heart under severe stress. The inefficient use of ATP suggests that an inability to maintain normal ATP levels could be the central abnormality. This theory might be supported by the discovery of the role of a mutant PRKAG2 gene in HCM, which in active form acts as a central sensing mechanism protecting cells from depletion of ATP supplies. The increase in the myfilament Ca2+ sensitivity well account for the diastolic dysfunction of model animals as well as human patients of HCM. It has been widely proposed that left ventricular hypertrophy is not a primary manifestation but develops as compensatory response to sarcomere dysfunction.', 'Human Diseases; Cardiovascular disease', 'Hypertrophic cardiomyopathy (HCM)', 'Hypertrophic cardiomyopathy, Brugada syndrome, Wolff-Parkinson-White (WPW) syndrome', 'ko05410', 'list(REFERENCE = \"PMID:12270949\", AUTHORS = \"Fatkin D, Graham RM\", TITLE = \"Molecular mechanisms of inherited cardiomyopathies.\", JOURNAL = c(\"Physiol Rev 82:945-80 (2002)\", \"DOI:10.1152/physrev.00012.2002\")), list(REFERENCE = \"PMID:12844200\", AUTHORS = \"Moolman-Smook JC, Mayosi BM, Brink PA, Corfield VA\", TITLE = \"Molecular genetics of cardiomyopathy: changing times, shifting paradigms.\", JOURNAL = \"Cardiovasc J S Afr 14:145-55 (2003)\"), list(REFERENCE = \"PMID:14711353\", AUTHORS = \"Taylor MR, Carniel E, Mestroni L\", TITLE = \"Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.\", JOURNAL = c(\"Expert Rev Mol Diagn 4:99-113 (2004)\", \"DOI:10.1586/14737159.4.1.99\")), list(REFERENCE = \"PMID:10615904\", AUTHORS = \"Marian AJ\", TITLE = \"Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy.\", JOURNAL = c(\"Lancet 355:58-60 (2000)\", \"DOI:10.1016/S0140-6736(99)06187-5\")), list(REFERENCE = \"PMID:11371514\", AUTHORS = \"Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H\", TITLE = \"Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.\", JOURNAL = c(\"Hum Mol Genet 10:1215-20 (2001)\", \"DOI:10.1093/hmg/10.11.1215\")), list(REFERENCE = \"PMID:11716909\", AUTHORS = \"Franz WM, Muller OJ, Katus HA\", TITLE = \"Cardiomyopathies: from genetics to the prospect of treatment.\", JOURNAL = c(\"Lancet 358:1627-37 (2001)\", \"DOI:10.1016/S0140-6736(01)06657-0\")), list(REFERENCE = \"PMID:18056765\", AUTHORS = \"Morimoto S\", TITLE = \"Sarcomeric proteins and inherited cardiomyopathies.\", JOURNAL = c(\"Cardiovasc Res 77:659-66 (2008)\", \"DOI:10.1093/cvr/cvm084\")), list(REFERENCE = \"PMID:19136482\", AUTHORS = \"Cambronero F, Marin F, Roldan V, Hernandez-Romero D, Valdes M, Lip GY\", TITLE = \"Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.\", JOURNAL = c(\"Eur Heart J 30:139-51 (2009)\", \"DOI:10.1093/eurheartj/ehn538\")), list(REFERENCE = \"PMID:11805847\", AUTHORS = \"Towbin JA, Bowles NE\", TITLE = \"The failing heart.\", JOURNAL = c(\"Nature 415:227-33 (2002)\", \"DOI:10.1038/415227a\")), list(REFERENCE = \"PMID:11225594\", AUTHORS = \"Sorajja P, Elliott PM, McKenna WJ\", TITLE = \"The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.\", JOURNAL = c(\"Europace 2:4-14 (2000)\", \"DOI:10.1053/eupc.1999.0067\")), list(REFERENCE = \"PMID:18572189\", AUTHORS = \"Landstrom AP, Parvatiyar MS, Pinto JR, Marquardt ML, Bos JM, Tester DJ, Ommen SR, Potter JD, Ackerman MJ\", TITLE = \"Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.\", JOURNAL = c(\"J Mol Cell Cardiol 45:281-8 (2008)\", \"DOI:10.1016/j.yjmcc.2008.05.003\"))', 'map05410', 'Hypertrophic cardiomyopathy (HCM)', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (459, '05412', 'Arrhythmogenic right ventricular cardiomyopathy (ARVC)', 'Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease that may result in arrhythmia, heart failure, and sudden death. The hallmark pathological findings are progressive myocyte loss and fibrofatty replacement, with a predilection for the right ventricle. A number of genetic studies have identified mutations in various components of the cardiac desmosome that have important roles in the pathogenesis of ARVC. Disruption of desmosomal function by defective proteins might lead to death of myocytes under mechanical stress. The myocardial injury may be accompanied by inflammation. Since regeneration of cardiac myocytes is limited, repair by fibrofatty replacement occurs. Several studies have implicated that desmosome dysfunction results in the delocalization and nuclear translocation of plakoglobin. As a result, competition between plakoglobin and beta-catenin will lead to the inhibition of Wnt/beta-catenin signaling, resulting in a shift from a myocyte fate towards an adipocyte fate of cells. The ryanodine receptor plays a crucial part in electromechanical coupling by control of release of calcium from the sarcoplasmic reticulum into the cytosol. Therefore, defects in this receptor could result in an imbalance of calcium homeostasis that might trigger cell death.', 'Human Diseases; Cardiovascular disease', 'Arrhythmogenic right ventricular cardiomyopathy (ARVC)', 'Arrhythmogenic right ventricular cardiomyopathy, Naxos disease, Brugada syndrome', 'ko05412', 'list(REFERENCE = \"PMID:19205777\", AUTHORS = \"Herren T, Gerber PA, Duru F\", TITLE = \"Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare \\\"disease of the desmosome\\\" with multiple clinical presentations.\", JOURNAL = c(\"Clin Res Cardiol 98:141-58 (2009)\", \"DOI:10.1007/s00392-009-0751-4\")), list(REFERENCE = \"PMID:17413274\", AUTHORS = \"van Tintelen JP, Hofstra RM, Wiesfeld AC, van den Berg MP, Hauer RN, Jongbloed JD\", TITLE = \"Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon?\", JOURNAL = c(\"Curr Opin Cardiol 22:185-92 (2007)\", \"DOI:10.1097/HCO.0b013e3280d942c4\")), list(REFERENCE = \"PMID:12270949\", AUTHORS = \"Fatkin D, Graham RM\", TITLE = \"Molecular mechanisms of inherited cardiomyopathies.\", JOURNAL = c(\"Physiol Rev 82:945-80 (2002)\", \"DOI:10.1152/physrev.00012.2002\")), list(REFERENCE = \"PMID:11716909\", AUTHORS = \"Franz WM, Muller OJ, Katus HA\", TITLE = \"Cardiomyopathies: from genetics to the prospect of treatment.\", JOURNAL = c(\"Lancet 358:1627-37 (2001)\", \"DOI:10.1016/S0140-6736(01)06657-0\")), list(REFERENCE = \"PMID:16823481\", AUTHORS = \"MacRae CA, Birchmeier W, Thierfelder L\", TITLE = \"Arrhythmogenic right ventricular cardiomyopathy: moving toward mechanism.\", JOURNAL = c(\"J Clin Invest 116:1825-8 (2006)\", \"DOI:10.1172/JCI29174\")), list(REFERENCE = \"PMID:18382419\", AUTHORS = \"Awad MM, Calkins H, Judge DP\", TITLE = \"Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy.\", JOURNAL = c(\"Nat Clin Pract Cardiovasc Med 5:258-67 (2008)\", \"DOI:10.1038/ncpcardio1182\")), list(REFERENCE = \"PMID:16101641\", AUTHORS = \"Sen-Chowdhry S, Syrris P, McKenna WJ\", TITLE = \"Genetics of right ventricular cardiomyopathy.\", JOURNAL = c(\"J Cardiovasc Electrophysiol 16:927-35 (2005)\", \"DOI:10.1111/j.1540-8167.2005.40842.x\")), list(REFERENCE = \"PMID:16124859\", AUTHORS = \"Ahmad F, Seidman JG, Seidman CE\", TITLE = \"The genetic basis for cardiac remodeling.\", JOURNAL = c(\"Annu Rev Genomics Hum Genet 6:185-216 (2005)\", \"DOI:10.1146/annurev.genom.6.080604.162132\"))', 'map05412', 'Arrhythmogenic right ventricular cardiomyopathy (ARVC)', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (460, '05414', 'Dilated cardiomyopathy (DCM)', 'Dilated cardiomyopathy (DCM) is a heart muscle disease characterised by dilation and impaired contraction of the left or both ventricles that results in progressive heart failure and sudden cardiac death from ventricular arrhythmia. Genetically inherited forms of DCM (\"familial\" DCM) have been identified in 25-35% of patients presenting with this disease, and the inherited gene defects are an important cause of \"familial\" DCM. The pathophysiology may be separated into two categories: defects in force generation and defects in force transmission. In cases where an underlying pathology cannot be identified, the patient is diagnosed with an \"idiopathic\" DCM. Current hypotheses regarding causes of \"idiopathic\" DCM focus on myocarditis induced by enterovirus and subsequent autoimmune myocardium impairments. Antibodies to the beta1-adrenergic receptor (beta1AR), which are detected in a substantial number of patients with \"idiopathic\" DCM, may increase the concentration of intracellular cAMP and intracellular Ca2+, a condition often leading to a transient hyper-performance of the heart followed by depressed heart function and heart failure.', 'Human Diseases; Cardiovascular disease', 'Dilated cardiomyopathy (DCM)', 'Dilated cardiomyopathy, Brugada syndrome', 'ko05414', 'list(REFERENCE = \"PMID:12270949\", AUTHORS = \"Fatkin D, Graham RM\", TITLE = \"Molecular mechanisms of inherited cardiomyopathies.\", JOURNAL = c(\"Physiol Rev 82:945-80 (2002)\", \"DOI:10.1152/physrev.00012.2002\")), list(REFERENCE = \"PMID:18672201\", AUTHORS = \"Lappe JM, Pelfrey CM, Tang WH\", TITLE = \"Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.\", JOURNAL = c(\"J Card Fail 14:521-30 (2008)\", \"DOI:10.1016/j.cardfail.2008.02.016\")), list(REFERENCE = \"PMID:19273156\", AUTHORS = \"Zhao P, Sharma AC, Ren J\", TITLE = \"Pathogenesis and therapy of autoimmunity-induced dilated cardiomyopathy.\", JOURNAL = c(\"Front Biosci 14:1708-15 (2009)\", \"DOI:10.2741/3334\")), list(REFERENCE = \"PMID:11716909\", AUTHORS = \"Franz WM, Muller OJ, Katus HA\", TITLE = \"Cardiomyopathies: from genetics to the prospect of treatment.\", JOURNAL = c(\"Lancet 358:1627-37 (2001)\", \"DOI:10.1016/S0140-6736(01)06657-0\")), list(REFERENCE = \"PMID:11805847\", AUTHORS = \"Towbin JA, Bowles NE\", TITLE = \"The failing heart.\", JOURNAL = c(\"Nature 415:227-33 (2002)\", \"DOI:10.1038/415227a\")), list(REFERENCE = \"PMID:19017683\", AUTHORS = \"Luk A, Ahn E, Soor GS, Butany J\", TITLE = \"Dilated cardiomyopathy: a review.\", JOURNAL = c(\"J Clin Pathol 62:219-25 (2009)\", \"DOI:10.1136/jcp.2008.060731\")), list(REFERENCE = \"PMID:19246813\", AUTHORS = \"Yoshikawa T, Baba A, Nagatomo Y\", TITLE = \"Autoimmune mechanisms underlying dilated cardiomyopathy.\", JOURNAL = c(\"Circ J 73:602-7 (2009)\", \"DOI:10.1253/circj.CJ-08-1151\")), list(REFERENCE = \"PMID:14522402\", AUTHORS = \"Mason JW\", TITLE = \"Myocarditis and dilated cardiomyopathy: an inflammatory link.\", JOURNAL = c(\"Cardiovasc Res 60:5-10 (2003)\", \"DOI:10.1016/S0008-6363(03)00437-1\")), list(REFERENCE = \"PMID:15146239\", AUTHORS = \"Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ\", TITLE = \"Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.\", JOURNAL = c(\"J Clin Invest 113:1419-29 (2004)\", \"DOI:10.1172/JCI20149\")), list(REFERENCE = \"PMID:11524405\", AUTHORS = \"Liu PP, Mason JW\", TITLE = \"Advances in the understanding of myocarditis.\", JOURNAL = c(\"Circulation 104:1076-82 (2001)\", \"DOI:10.1161/hc3401.095198\")), list(REFERENCE = \"PMID:16817756\", AUTHORS = \"Tam PE\", TITLE = \"Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.\", JOURNAL = c(\"Viral Immunol 19:133-46 (2006)\", \"DOI:10.1089/vim.2006.19.133\"))', 'map05414', 'Dilated cardiomyopathy (DCM)', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (461, '05416', 'Viral myocarditis', 'Myocarditis is a cardiac disease associated with inflammation and injury of the myocardium. It results from various etiologies, both noninfectious and infectious, but coxsackievirus B3 (CVB3) is still considered the dominant etiological agent. Myocarditis may be caused by direct cytopathic effects of virus, a pathologic immune response to persistent virus, or autoimmunity triggered by the viral infection. The virus enters the myocyte through internalization of the coxsackie-adenoviral receptor (CAR) and its coreceptor, decay-accelerating factor (DAF). Viral proteases cleave various proteins in the host cell. One example is viral protease 2A, which cleaves eukaryote initiation factor 4G (eIF4G) and the dystrophin protein, resulting in a complete shutdown of cap-dependent RNA translation and cytoskeletal destruction in infected cardiomyocytes, respectively. CVB3 also cleaves the member of the Bcl-2 family Bid, leading to apoptosis. CVB3 infection also induces the cleavage of cyclin D protein through a proteasome-dependent pathway, leading to the host cell-growth arrest. Viral infection and necrosis of myocytes may lead to the release of intracellular antigens, resulting in activation of self-reactive T cells. CVB infection is a significant cause of dilated cardiomyopathy (DCM) as well as myocarditis. Epidemiologically, myocarditis underlies a significant portion of patients with DCM.', 'Human Diseases; Cardiovascular disease', 'Viral myocarditis', 'Viral myocarditis', 'ko05416', 'list(REFERENCE = \"PMID:18039131\", AUTHORS = \"Esfandiarei M, McManus BM\", TITLE = \"Molecular biology and pathogenesis of viral myocarditis.\", JOURNAL = c(\"Annu Rev Pathol 3:127-55 (2008)\", \"DOI:10.1146/annurev.pathmechdis.3.121806.151534\")), list(REFERENCE = \"PMID:12920582\", AUTHORS = \"Badorff C, Knowlton KU\", TITLE = \"Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside.\", JOURNAL = c(\"Med Microbiol Immunol 193:121-6 (2004)\", \"DOI:10.1007/s00430-003-0189-7\")), list(REFERENCE = \"PMID:17200452\", AUTHORS = \"Maekawa Y, Ouzounian M, Opavsky MA, Liu PP\", TITLE = \"Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity.\", JOURNAL = c(\"Circulation 115:5-8 (2007)\", \"DOI:10.1161/CIRCULATIONAHA.106.670554\")), list(REFERENCE = \"PMID:12439638\", AUTHORS = \"Pankuweit S, Portig I, Maisch B\", TITLE = \"Pathophysiology of cardiac inflammation: molecular mechanisms.\", JOURNAL = c(\"Herz 27:669-76 (2002)\", \"DOI:10.1007/s00059-002-2421-4\")), list(REFERENCE = \"PMID:16845885\", AUTHORS = \"Gao G, Luo H\", TITLE = \"The ubiquitin-proteasome pathway in viral infections.\", JOURNAL = c(\"Can J Physiol Pharmacol 84:5-14 (2006)\", \"DOI:10.1139/y05-144\")), list(REFERENCE = \"PMID:16413486\", AUTHORS = \"Coyne CB, Bergelson JM\", TITLE = \"Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.\", JOURNAL = c(\"Cell 124:119-31 (2006)\", \"DOI:10.1016/j.cell.2005.10.035\")), list(REFERENCE = \"PMID:10904843\", AUTHORS = \"Badorff C, Lee GH, Knowlton KU\", TITLE = \"Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex.\", JOURNAL = c(\"Herz 25:227-32 (2000)\", \"DOI:10.1007/s000590050011\")), list(REFERENCE = \"PMID:18357777\", AUTHORS = \"Knowlton KU\", TITLE = \"CVB infection and mechanisms of viral cardiomyopathy.\", JOURNAL = c(\"Curr Top Microbiol Immunol 323:315-35 (2008)\", \"DOI:10.1007/978-3-540-75546-3_15\")), list(REFERENCE = \"PMID:18545064\", AUTHORS = \"Castellano G, Affuso F, Di Conza P, Fazio S\", TITLE = \"Myocarditis and dilated cardiomyopathy: possible connections and treatments.\", JOURNAL = c(\"J Cardiovasc Med (Hagerstown) 9:666-71 (2008)\", \"DOI:10.2459/JCM.0b013e3282f3e9c2\")), list(REFERENCE = \"PMID:19357408\", AUTHORS = \"Cooper LT Jr\", TITLE = \"Myocarditis.\", JOURNAL = c(\"N Engl J Med 360:1526-38 (2009)\", \"DOI:10.1056/NEJMra0800028\")), list(REFERENCE = \"PMID:10051305\", AUTHORS = \"Kawai C\", TITLE = \"From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.\", JOURNAL = c(\"Circulation 99:1091-100 (1999)\", \"DOI:10.1161/01.CIR.99.8.1091\")), list(REFERENCE = \"PMID:11524405\", AUTHORS = \"Liu PP, Mason JW\", TITLE = \"Advances in the understanding of myocarditis.\", JOURNAL = c(\"Circulation 104:1076-82 (2001)\", \"DOI:10.1161/hc3401.095198\")), list(REFERENCE = \"PMID:14522402\", AUTHORS = \"Mason JW\", TITLE = \"Myocarditis and dilated cardiomyopathy: an inflammatory link.\", JOURNAL = c(\"Cardiovasc Res 60:5-10 (2003)\", \"DOI:10.1016/S0008-6363(03)00437-1\")), list(REFERENCE = \"PMID:16817756\", AUTHORS = \"Tam PE\", TITLE = \"Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.\", JOURNAL = c(\"Viral Immunol 19:133-46 (2006)\", \"DOI:10.1089/vim.2006.19.133\"))', 'map05416', 'Viral myocarditis', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (462, '05418', 'Fluid shear stress and atherosclerosis', 'Shear stress represents the frictional force that the flow of blood exerts at the endothelial surface of the vessel wall and plays a central role in vascular biology and contributes to the progress of atherosclerosis. Sustained laminar flow with high shear stress upregulates expressions of endothelial cell (EC) genes and proteins that are protective against atherosclerosis. The key shear stress-induced transcription factors that govern the expression of these genes are Kruppel-like factor 2 (KLF2) and nuclear factor erythroid 2-like 2 (Nrf2). On the other hand, disturbed flow with associated reciprocating, low shear stress generally upregulates the EC genes and proteins that promote oxidative and inflammatory states in the artery wall, resulting in atherogenesis. Important transcriptional events that reflect this condition of ECs in disturbed flow include the activation of activator protein 1 (AP-1) and nuclear factor kappaB (NF-kappaB).', 'Human Diseases; Cardiovascular disease', 'Fluid shear stress and atherosclerosis', 'ko05418', 'list(REFERENCE = \"PMID:21050140\", AUTHORS = \"Nigro P, Abe J, Berk BC\", TITLE = \"Flow shear stress and atherosclerosis: a matter of site specificity.\", JOURNAL = c(\"Antioxid Redox Signal 15:1405-14 (2011)\", \"DOI:10.1089/ars.2010.3679\")), list(REFERENCE = \"PMID:26597822\", AUTHORS = \"McSweeney SR, Warabi E, Siow RC\", TITLE = \"Nrf2 as an Endothelial Mechanosensitive Transcription Factor: Going With the Flow.\", JOURNAL = c(\"Hypertension 67:20-9 (2016)\", \"DOI:10.1161/HYPERTENSIONAHA.115.06146\")), list(REFERENCE = \"PMID:22076424\", AUTHORS = \"Heo KS, Fujiwara K, Abe J\", TITLE = \"Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction.\", JOURNAL = c(\"Circ J 75:2722-30 (2011)\", \"DOI:10.1253/circj.CJ-11-1124\")), list(REFERENCE = \"PMID:24573382\", AUTHORS = \"Wild J, Soehnlein O, Dietel B, Urschel K, Garlichs CD, Cicha I\", TITLE = \"Rubbing salt into wounded endothelium: sodium potentiates proatherogenic effects of TNF-alpha under non-uniform shear stress.\", JOURNAL = c(\"Thromb Haemost 112:183-95 (2014)\", \"DOI:10.1160/TH13-11-0908\")), list(REFERENCE = \"PMID:21457103\", AUTHORS = \"Noguchi N, Jo H\", TITLE = \"Redox going with vascular shear stress.\", JOURNAL = c(\"Antioxid Redox Signal 15:1367-8 (2011)\", \"DOI:10.1089/ars.2011.4011\")), list(REFERENCE = \"PMID:25165867\", AUTHORS = \"Li X, Yang Q, Wang Z, Wei D\", TITLE = \"Shear stress in atherosclerotic plaque determination.\", JOURNAL = c(\"DNA Cell Biol 33:830-8 (2014)\", \"DOI:10.1089/dna.2014.2480\")), list(REFERENCE = \"PMID:17599600\", AUTHORS = \"Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH\", TITLE = \"Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior.\", JOURNAL = c(\"J Am Coll Cardiol 49:2379-93 (2007)\", \"DOI:10.1016/j.jacc.2007.02.059\")), list(REFERENCE = \"PMID:21733876\", AUTHORS = \"Lu D, Kassab GS\", TITLE = \"Role of shear stress and stretch in vascular mechanobiology.\", JOURNAL = c(\"J R Soc Interface 8:1379-85 (2011)\", \"DOI:10.1098/rsif.2011.0177\")), list(REFERENCE = \"PMID:27027326\", AUTHORS = \"Givens C, Tzima E\", TITLE = \"Endothelial Mechanosignaling: Does One Sensor Fit All?\", JOURNAL = c(\"Antioxid Redox Signal 25:373-88 (2016)\", \"DOI:10.1089/ars.2015.6493\")), list(REFERENCE = \"PMID:16765337\", AUTHORS = \"Paravicini TM, Touyz RM\", TITLE = \"Redox signaling in hypertension.\", JOURNAL = c(\"Cardiovasc Res 71:247-58 (2006)\", \"DOI:10.1016/j.cardiores.2006.05.001\")), list(REFERENCE = \"PMID:19151844\", AUTHORS = \"Boon RA, Horrevoets AJ\", TITLE = \"Key transcriptional regulators of the vasoprotective effects of shear stress.\", JOURNAL = \"Hamostaseologie 29:39-40, 41-3 (2009)\"), list(REFERENCE = \"PMID:24947523\", AUTHORS = \"Bryan MT, Duckles H, Feng S, Hsiao ST, Kim HR, Serbanovic-Canic J, Evans PC\", TITLE = \"Mechanoresponsive networks controlling vascular inflammation.\", JOURNAL = c(\"Arterioscler Thromb Vasc Biol 34:2199-205 (2014)\", \"DOI:10.1161/ATVBAHA.114.303424\")), list(REFERENCE = \"PMID:26822720\", AUTHORS = \"Brown AJ, Teng Z, Evans PC, Gillard JH, Samady H, Bennett MR\", TITLE = \"Role of biomechanical forces in the natural history of coronary atherosclerosis.\", JOURNAL = c(\"Nat Rev Cardiol 13:210-20 (2016)\", \"DOI:10.1038/nrcardio.2015.203\")), list(REFERENCE = \"PMID:24876354\", AUTHORS = \"Zhou J, Li YS, Chien S\", TITLE = \"Shear stress-initiated signaling and its regulation of endothelial function.\", JOURNAL = c(\"Arterioscler Thromb Vasc Biol 34:2191-8 (2014)\", \"DOI:10.1161/ATVBAHA.114.303422\")), list(REFERENCE = \"PMID:23429585\", AUTHORS = \"Liu HB, Zhang J, Xin SY, Liu C, Wang CY, Zhao D, Zhang ZR\", TITLE = \"Mechanosensitive properties in the endothelium and their roles in the regulation of endothelial function.\", JOURNAL = c(\"J Cardiovasc Pharmacol 61:461-70 (2013)\", \"DOI:10.1097/FJC.0b013e31828c0933\")), list(REFERENCE = \"PMID:20032497\", AUTHORS = \"Boon RA, Leyen TA, Fontijn RD, Fledderus JO, Baggen JM, Volger OL, van Nieuw Amerongen GP, Horrevoets AJ\", TITLE = \"KLF2-induced actin shear fibers control both alignment to flow and JNK signaling in vascular endothelium.\", JOURNAL = c(\"Blood 115:2533-42 (2010)\", \"DOI:10.1182/blood-2009-06-228726\")), list(REFERENCE = \"PMID:20353494\", AUTHORS = \"Whyte JJ, Laughlin MH\", TITLE = \"The effects of acute and chronic exercise on the vasculature.\", JOURNAL = c(\"Acta Physiol (Oxf) 199:441-50 (2010)\", \"DOI:10.1111/j.1748-1716.2010.02127.x\")), list(REFERENCE = \"PMID:25638487\", AUTHORS = \"Quillon A, Fromy B, Debret R\", TITLE = \"Endothelium microenvironment sensing leading to nitric oxide mediated vasodilation: a review of nervous and biomechanical signals.\", JOURNAL = c(\"Nitric Oxide 45:20-6 (2015)\", \"DOI:10.1016/j.niox.2015.01.006\")), list(REFERENCE = \"PMID:15388638\", AUTHORS = \"Sorescu GP, Song H, Tressel SL, Hwang J, Dikalov S, Smith DA, Boyd NL, Platt MO, Lassegue B, Griendling KK, Jo H\", TITLE = \"Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase.\", JOURNAL = c(\"Circ Res 95:773-9 (2004)\", \"DOI:10.1161/01.RES.0000145728.22878.45\")), list(REFERENCE = \"PMID:23899566\", AUTHORS = \"Hopkins PN\", TITLE = \"Molecular biology of atherosclerosis.\", JOURNAL = c(\"Physiol Rev 93:1317-542 (2013)\", \"DOI:10.1152/physrev.00004.2012\")), list(REFERENCE = \"PMID:22003002\", AUTHORS = \"Johnson BD, Mather KJ, Wallace JP\", TITLE = \"Mechanotransduction of shear in the endothelium: basic studies and clinical implications.\", JOURNAL = c(\"Vasc Med 16:365-77 (2011)\", \"DOI:10.1177/1358863X11422109\")), list(REFERENCE = \"PMID:23555159\", AUTHORS = \"Hu LS, George J, Wang JH\", TITLE = \"Current concepts on the role of nitric oxide in portal hypertension.\", JOURNAL = c(\"World J Gastroenterol 19:1707-17 (2013)\", \"DOI:10.3748/wjg.v19.i11.1707\")), list(REFERENCE = \"PMID:23084990\", AUTHORS = \"Collins C, Guilluy C, Welch C, O\'Brien ET, Hahn K, Superfine R, Burridge K, Tzima E\", TITLE = \"Localized tensional forces on PECAM-1 elicit a global mechanotransduction response via the integrin-RhoA pathway.\", JOURNAL = c(\"Curr Biol 22:2087-94 (2012)\", \"DOI:10.1016/j.cub.2012.08.051\")), list(REFERENCE = \"PMID:24190880\", AUTHORS = \"Conway DE, Schwartz MA\", TITLE = \"Flow-dependent cellular mechanotransduction in atherosclerosis.\", JOURNAL = c(\"J Cell Sci 126:5101-9 (2013)\", \"DOI:10.1242/jcs.138313\")), list(REFERENCE = \"PMID:26212910\", AUTHORS = \"Chen J, Green J, Yurdagul A Jr, Albert P, McInnis MC, Orr AW\", TITLE = \"alphavbeta3 Integrins Mediate Flow-Induced NF-kappaB Activation, Proinflammatory Gene Expression, and Early Atherogenic Inflammation.\", JOURNAL = c(\"Am J Pathol 185:2575-89 (2015)\", \"DOI:10.1016/j.ajpath.2015.05.013\")), list(REFERENCE = \"PMID:20538799\", AUTHORS = \"Nigro P, Abe J, Woo CH, Satoh K, McClain C, O\'Dell MR, Lee H, Lim JH, Li JD, Heo KS, Fujiwara K, Berk BC\", TITLE = \"PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5.\", JOURNAL = c(\"Blood 116:1971-9 (2010)\", \"DOI:10.1182/blood-2010-02-269134\"))', 'map05418', 'Fluid shear stress and atherosclerosis', 'Shear stress represents the frictional force that the flow of blood exerts at the endothelial surface of the vessel wall and plays a central role in vascular biology and contributes to the progress of atherosclerosis. Sustained laminar flow with high shear stress upregulates expressions of endothelial cell (EC) genes and proteins that are protective against atherosclerosis. The key shear stress-induced transcription factors that govern the expression of these genes are Kruppel-like factor 2 (KLF2) and nuclear factor erythroid 2-like 2 (Nrf2). On the other hand, disturbed flow with associated reciprocating, low shear stress generally upregulates the EC genes and proteins that promote oxidative and inflammatory states in the artery wall, resulting in atherogenesis. Important transcriptional events that reflect this condition of ECs in disturbed flow include the activation of activator protein 1 (AP-1) and nuclear factor kappaB (NF-kappaB).', 65, 0, 65, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (463, '07011', 'Penicillins', 'Penicillins', '6-Aminopenicillanate, Clavulanic acid, Ampicillin (USP/INN), Amoxicillin (USP), Amoxicillin and potassium clavulanate combination, Piperacillin sodium (JP17/USP), Penicillin V potassium (USP), Tazobactam (JP17/USAN/INN), Bacampicillin hydrochloride (JP17/USP), Oxacillin sodium (JAN/USP), Penicillin G potassium (USP), Hetacillin (USAN/INN), Phenethicillin potassium (JP17), Flucloxacillin sodium (JAN), Ampicillin hydrate (JP17), Carbenicillin indanyl sodium (USP), Cyclacillin (USAN), Sulbenicillin sodium (JP17), Pivmecillinam hydrochloride (JP17), Propicillin potassium (JAN), Sultamicillin tosilate hydrate (JP17), Lenampicillin hydrochloride (JP17), Ampicillin sodium (JP17/USP), Dicloxacillin sodium (USP), Carbenicillin disodium (USP), Methicillin sodium (USAN), Carbenicillin phenyl sodium (USAN), Talampicillin hydrochloride (JP17/USAN), Hetacillin potassium (JAN/USAN), Mezlocillin sodium (JAN), Sulbactam sodium (JP17/USP), Cloxacillin sodium (USP), Ticarcillin disodium (USP), Piperacillin (USP), Benzylpenicillin (INN), Azlocillin (USAN/INN), Dicloxacillin (USAN/INN), Clavulanate potassium (JP17/USP), Aspoxicillin hydrate (JP17), Tazobactam and piperacillin (JP17), Pivampicillin hydrochloride (USAN), Amdinocillin pivoxil (USAN), Amoxicillin sodium (USAN), Carbenicillin potassium (USAN), Tazobactam sodium (JAN/USAN), Floxacillin (USAN), Mezlocillin (USAN/INN), Mezlocillin sodium (USP), Octanoic acid (USAN/INN), Octazamide (USAN/INN), Penicillin G sodium (USP), Penicillin V (USP), Sultamicillin (USAN/INN), Ticarcillin cresyl sodium (USAN), Ticarcillin monosodium (USP), Amoxicillin (INN), Aspoxicillin (JAN/INN), Bacampicillin (INN), Carbenicillin (INN), Carindacillin (INN), Clavulanic acid (INN), Cloxacillin (INN), Flucloxacillin sodium salt, Lenampicillin (INN), Oxacillin (INN), Pheneticillin (INN), Phenoxymethylpenicillin calcium, Piperacillin (INN), Pivampicillin (INN), Propicillin (BAN), Sulbactam (INN), Sulbenicillin (INN), Talampicillin (INN), Ticarcillin (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"PMID:3547627\", AUTHORS = \"Sjovall J, Huitfeldt B, Magni L, Nord CE.\", TITLE = \"Effect of beta-lactam prodrugs on human intestinal microflora.\", JOURNAL = \"Scand J Infect Dis Suppl 49:73-84 (1986)\")', 'map07011', 'Penicillins', 'Penicillins', '6-Aminopenicillanate, Clavulanic acid, Ampicillin (USP/INN), Amoxicillin (USP), Amoxicillin and potassium clavulanate combination, Piperacillin sodium (JP17/USP), Penicillin V potassium (USP), Tazobactam (JP17/USAN/INN), Bacampicillin hydrochloride (JP17/USP), Oxacillin sodium (JAN/USP), Penicillin G potassium (USP), Hetacillin (USAN/INN), Phenethicillin potassium (JP17), Flucloxacillin sodium (JAN), Ampicillin hydrate (JP17), Carbenicillin indanyl sodium (USP), Cyclacillin (USAN), Sulbenicillin sodium (JP17), Pivmecillinam hydrochloride (JP17), Propicillin potassium (JAN), Sultamicillin tosilate hydrate (JP17), Lenampicillin hydrochloride (JP17), Ampicillin sodium (JP17/USP), Dicloxacillin sodium (USP), Carbenicillin disodium (USP), Methicillin sodium (USAN), Carbenicillin phenyl sodium (USAN), Talampicillin hydrochloride (JP17/USAN), Hetacillin potassium (JAN/USAN), Mezlocillin sodium (JAN), Sulbactam sodium (JP17/USP), Cloxacillin sodium (USP), Ticarcillin disodium (USP), Piperacillin (USP), Benzylpenicillin (INN), Azlocillin (USAN/INN), Dicloxacillin (USAN/INN), Clavulanate potassium (JP17/USP), Aspoxicillin hydrate (JP17), Tazobactam and piperacillin (JP17), Pivampicillin hydrochloride (USAN), Amdinocillin pivoxil (USAN), Amoxicillin sodium (USAN), Carbenicillin potassium (USAN), Tazobactam sodium (JAN/USAN), Floxacillin (USAN), Mezlocillin (USAN/INN), Mezlocillin sodium (USP), Octanoic acid (USAN/INN), Octazamide (USAN/INN), Penicillin G sodium (USP), Penicillin V (USP), Sultamicillin (USAN/INN), Ticarcillin cresyl sodium (USAN), Ticarcillin monosodium (USP), Amoxicillin (INN), Aspoxicillin (JAN/INN), Bacampicillin (INN), Carbenicillin (INN), Carindacillin (INN), Clavulanic acid (INN), Cloxacillin (INN), Flucloxacillin sodium salt, Lenampicillin (INN), Oxacillin (INN), Pheneticillin (INN), Phenoxymethylpenicillin calcium, Piperacillin (INN), Pivampicillin (INN), Propicillin (BAN), Sulbactam (INN), Sulbenicillin (INN), Talampicillin (INN), Ticarcillin (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"PMID:3547627\", AUTHORS = \"Sjovall J, Huitfeldt B, Magni L, Nord CE.\", TITLE = \"Effect of beta-lactam prodrugs on human intestinal microflora.\", JOURNAL = \"Scand J Infect Dis Suppl 49:73-84 (1986)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (464, '07012', 'Cephalosporins - parenteral agents', 'Cephalosporins - parenteral agents', 'Cephalosporin C, Nocardicin A, 6-Aminopenicillanate, Cephamycin C, Aztreonam (JP17/USP/INN), Cefotetan (JP17/USP/INN), Cefuroxime (USAN/INN), Piperacillin sodium (JP17/USP), Cefazolin sodium (JP17/USP), Cephalothin sodium (USP), Cephapirin sodium (USP), Cefmetazole (USP/INN), Cefmetazole sodium (JP17/USP), Cefoxitin sodium (JAN/USP), Cefuroxime axetil (JP17/USP/INN), Cefuroxime sodium (JAN/USP), Cefoperazone sodium (JP17/USP), Cefotaxime sodium (JP17/USP), Ceftazidime (USP), Ceftizoxime sodium (JP17/USP), Ceftriaxone sodium (USP), Cephaloridine (USAN), Cefotiam hexetil hydrochloride (JP17), Sulbenicillin sodium (JP17), Carumonam sodium (JP17/USAN), Cefpimizole sodium (JAN/USAN), Cefbuperazone sodium (JP17), Cefmenoxime hydrochloride (JP17/USP), Cefotiam hydrochloride (JP17/USP), Cefodizime sodium (JP17), Cefpiramide sodium (JP17/USAN), Cefminox sodium hydrate (JP17), Cefsulodin sodium (JP17/USAN), Cefamandole sodium (JAN), Cefazolin sodium hydrate (JP17), Cefotetan disodium (USP), Piperacillin (USP), Cefazolin (USP), Cefamandole (USAN/INN), Cefoxitin (USAN/INN), Cefbuperazone (USAN/INN), Cefpimizole (USAN/INN), Cefpiramide (USP/INN), Aztreonam lysine (USAN), Carumonam (INN), Cefalotin (BAN), Cefapirin (BAN), Cephapirin benzathine (USP), Cefmenoxime (INN), Cefminox (INN), Cefodizime (INN), Cefoperazone (INN), Cefotaxime (INN), Cefotiam (INN), Cefsulodin (INN), Ceftazidime (INN), Ceftizoxime (INN), Ceftriaxone (INN), Piperacillin (INN), Sulbenicillin (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"PMID:3072926\", AUTHORS = \"Curtis NA, Eisenstadt RL, East SJ, Cornford RJ, Walker LA, White AJ\", TITLE = \"Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporins.\", JOURNAL = c(\"Antimicrob Agents Chemother 32:1879-86 (1988)\", \"DOI:10.1128/AAC.32.12.1879\"))', 'map07012', 'Cephalosporins - parenteral agents', 'Cephalosporins - parenteral agents', 'Cephalosporin C, Nocardicin A, 6-Aminopenicillanate, Cephamycin C, Aztreonam (JP17/USP/INN), Cefotetan (JP17/USP/INN), Cefuroxime (USAN/INN), Piperacillin sodium (JP17/USP), Cefazolin sodium (JP17/USP), Cephalothin sodium (USP), Cephapirin sodium (USP), Cefmetazole (USP/INN), Cefmetazole sodium (JP17/USP), Cefoxitin sodium (JAN/USP), Cefuroxime axetil (JP17/USP/INN), Cefuroxime sodium (JAN/USP), Cefoperazone sodium (JP17/USP), Cefotaxime sodium (JP17/USP), Ceftazidime (USP), Ceftizoxime sodium (JP17/USP), Ceftriaxone sodium (USP), Cephaloridine (USAN), Cefotiam hexetil hydrochloride (JP17), Sulbenicillin sodium (JP17), Carumonam sodium (JP17/USAN), Cefpimizole sodium (JAN/USAN), Cefbuperazone sodium (JP17), Cefmenoxime hydrochloride (JP17/USP), Cefotiam hydrochloride (JP17/USP), Cefodizime sodium (JP17), Cefpiramide sodium (JP17/USAN), Cefminox sodium hydrate (JP17), Cefsulodin sodium (JP17/USAN), Cefamandole sodium (JAN), Cefazolin sodium hydrate (JP17), Cefotetan disodium (USP), Piperacillin (USP), Cefazolin (USP), Cefamandole (USAN/INN), Cefoxitin (USAN/INN), Cefbuperazone (USAN/INN), Cefpimizole (USAN/INN), Cefpiramide (USP/INN), Aztreonam lysine (USAN), Carumonam (INN), Cefalotin (BAN), Cefapirin (BAN), Cephapirin benzathine (USP), Cefmenoxime (INN), Cefminox (INN), Cefodizime (INN), Cefoperazone (INN), Cefotaxime (INN), Cefotiam (INN), Cefsulodin (INN), Ceftazidime (INN), Ceftizoxime (INN), Ceftriaxone (INN), Piperacillin (INN), Sulbenicillin (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"PMID:3072926\", AUTHORS = \"Curtis NA, Eisenstadt RL, East SJ, Cornford RJ, Walker LA, White AJ\", TITLE = \"Iron-regulated outer membrane proteins of Escherichia coli K-12 and mechanism of action of catechol-substituted cephalosporins.\", JOURNAL = c(\"Antimicrob Agents Chemother 32:1879-86 (1988)\", \"DOI:10.1128/AAC.32.12.1879\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (465, '07013', 'Cephalosporins - oral agents', 'Cephalosporins - oral agents', 'Cephalosporin C, Cefaclor (JP17), Cefadroxil (JP17), Cefixime (INN), Cefprozil (USP), Cefalexin (JP17), Cephradine (USP), Cephalexin (USP), Cefuroxime axetil (JP17/USP/INN), Loracarbef (USP), Cefdinir (JP17/USP/INN), Cefpodoxime proxetil (JP17/USP), Ceftibuten (USAN/INN), Ceftizoxime sodium (JP17/USP), Cefotiam hexetil hydrochloride (JP17), Cefditoren pivoxil (JP17), Cefetamet pivoxil hydrochloride (JAN), Cefcapene pivoxil hydrochloride hydrate (JP17), Cefteram pivoxil (JP17), Cefaloglycin (JAN), Ceftibuten hydrate (JP17), Cefaclor (USP), Cefadroxil (USP), Cephalexin hydrochloride (USP), Cefixime (USP), Cefprozil (INN), Ceftizoxime (INN), Loracarbef (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"(ISBN:4753212955)\", AUTHORS = \"Matsumoto K.\", TITLE = \"[Cephem Antibiotics] (In Japanese)\", JOURNAL = \"Iyaku journal (1991)\"), list(REFERENCE = \"PMID:3501757\", AUTHORS = \"Jones RN, Barry AL.\", TITLE = \"Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.\", JOURNAL = c(\"Eur J Clin Microbiol 6:570-1 (1987)\", \"DOI:10.1007/BF02014248\"))', 'map07013', 'Cephalosporins - oral agents', 'Cephalosporins - oral agents', 'Cephalosporin C, Cefaclor (JP17), Cefadroxil (JP17), Cefixime (INN), Cefprozil (USP), Cefalexin (JP17), Cephradine (USP), Cephalexin (USP), Cefuroxime axetil (JP17/USP/INN), Loracarbef (USP), Cefdinir (JP17/USP/INN), Cefpodoxime proxetil (JP17/USP), Ceftibuten (USAN/INN), Ceftizoxime sodium (JP17/USP), Cefotiam hexetil hydrochloride (JP17), Cefditoren pivoxil (JP17), Cefetamet pivoxil hydrochloride (JAN), Cefcapene pivoxil hydrochloride hydrate (JP17), Cefteram pivoxil (JP17), Cefaloglycin (JAN), Ceftibuten hydrate (JP17), Cefaclor (USP), Cefadroxil (USP), Cephalexin hydrochloride (USP), Cefixime (USP), Cefprozil (INN), Ceftizoxime (INN), Loracarbef (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"(ISBN:4753212955)\", AUTHORS = \"Matsumoto K.\", TITLE = \"[Cephem Antibiotics] (In Japanese)\", JOURNAL = \"Iyaku journal (1991)\"), list(REFERENCE = \"PMID:3501757\", AUTHORS = \"Jones RN, Barry AL.\", TITLE = \"Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.\", JOURNAL = c(\"Eur J Clin Microbiol 6:570-1 (1987)\", \"DOI:10.1007/BF02014248\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (466, '07014', 'Quinolones', 'Quinolones', 'Ulifloxacin, Nalidixic acid (JP17/USP/INN), Ciprofloxacin (JP17/USP/INN), Norfloxacin (JP17/USP/INN), Enoxacin (USAN/INN), Ofloxacin (JP17/USP/INN), Gatifloxacin (USAN), Sparfloxacin (JAN/USAN/INN), Cinoxacin (JP17/USP/INN), Moxifloxacin hydrochloride (JAN/USAN), Prulifloxacin (JAN/INN), Piromidic acid (JAN/INN), Pipemidic acid hydrate (JP17), Tosufloxacin tosylate hydrate (JP17), Trovafloxacin mesylate (USAN), Grepafloxacin hydrochloride (JAN/USAN), Ciprofloxacin hydrochloride (USP), Oxolinic acid (USAN/INN), Flumequine (USAN/INN), Miloxacin (INN), Rosoxacin (USAN/INN), Tosufloxacin (USAN), Droxacin sodium (USAN), Gemifloxacin mesylate (USAN), Sitafloxacin (USAN), Clinafloxacin hydrochloride (USAN), Garenoxacin mesylate (USAN), Enoxacin hydrate (JP17), Ciprofloxacin lactate, Gatifloxacin (INN), Gemifloxacin (INN), Moxifloxacin (INN), Norfloxacin nicotinate, Ofloxacin hydrochloride, Pipemidic acid (INN), Trovafloxacin (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sakurai J.\", TITLE = \"[Illustrated Microbiology (2nd ed)] (In Japanese)\", JOURNAL = \"Nanzando\"), list(REFERENCE = \"PMID:2546585\", AUTHORS = \"Shen LL, Mitscher LA, Sharma PN, O\'Donnell TJ, Chu DW, Cooper CS, Rosen T, Pernet AG.\", TITLE = \"Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.\", JOURNAL = c(\"Biochemistry 28:3886-94 (1989)\", \"DOI:10.1021/bi00435a039\")), list(REFERENCE = \"PMID:10997595\", AUTHORS = \"Ball P.\", TITLE = \"Quinolone generations: natural history or natural selection?\", JOURNAL = c(\"J Antimicrob Chemother 46 Suppl T1:17-24 (2000)\", \"DOI:10.1093/oxfordjournals.jac.a020889\")), list(REFERENCE = \"PMID:12702699\", AUTHORS = \"Emmerson AM, Jones AM.\", TITLE = \"The quinolones: decades of development and use.\", JOURNAL = c(\"J Antimicrob Chemother 51 Suppl 1:13-20 (2003)\", \"DOI:10.1093/jac/dkg208\")), list(REFERENCE = \"PMID:15760423\", AUTHORS = \"Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM\", TITLE = \"Quinolones in 2005: an update.\", JOURNAL = c(\"Clin Microbiol Infect 11:256-80 (2005)\", \"DOI:10.1111/j.1469-0691.2005.01131.x\"))', 'map07014', 'Quinolones', 'Quinolones', 'Ulifloxacin, Nalidixic acid (JP17/USP/INN), Ciprofloxacin (JP17/USP/INN), Norfloxacin (JP17/USP/INN), Enoxacin (USAN/INN), Ofloxacin (JP17/USP/INN), Gatifloxacin (USAN), Sparfloxacin (JAN/USAN/INN), Cinoxacin (JP17/USP/INN), Moxifloxacin hydrochloride (JAN/USAN), Prulifloxacin (JAN/INN), Piromidic acid (JAN/INN), Pipemidic acid hydrate (JP17), Tosufloxacin tosylate hydrate (JP17), Trovafloxacin mesylate (USAN), Grepafloxacin hydrochloride (JAN/USAN), Ciprofloxacin hydrochloride (USP), Oxolinic acid (USAN/INN), Flumequine (USAN/INN), Miloxacin (INN), Rosoxacin (USAN/INN), Tosufloxacin (USAN), Droxacin sodium (USAN), Gemifloxacin mesylate (USAN), Sitafloxacin (USAN), Clinafloxacin hydrochloride (USAN), Garenoxacin mesylate (USAN), Enoxacin hydrate (JP17), Ciprofloxacin lactate, Gatifloxacin (INN), Gemifloxacin (INN), Moxifloxacin (INN), Norfloxacin nicotinate, Ofloxacin hydrochloride, Pipemidic acid (INN), Trovafloxacin (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sakurai J.\", TITLE = \"[Illustrated Microbiology (2nd ed)] (In Japanese)\", JOURNAL = \"Nanzando\"), list(REFERENCE = \"PMID:2546585\", AUTHORS = \"Shen LL, Mitscher LA, Sharma PN, O\'Donnell TJ, Chu DW, Cooper CS, Rosen T, Pernet AG.\", TITLE = \"Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.\", JOURNAL = c(\"Biochemistry 28:3886-94 (1989)\", \"DOI:10.1021/bi00435a039\")), list(REFERENCE = \"PMID:10997595\", AUTHORS = \"Ball P.\", TITLE = \"Quinolone generations: natural history or natural selection?\", JOURNAL = c(\"J Antimicrob Chemother 46 Suppl T1:17-24 (2000)\", \"DOI:10.1093/oxfordjournals.jac.a020889\")), list(REFERENCE = \"PMID:12702699\", AUTHORS = \"Emmerson AM, Jones AM.\", TITLE = \"The quinolones: decades of development and use.\", JOURNAL = c(\"J Antimicrob Chemother 51 Suppl 1:13-20 (2003)\", \"DOI:10.1093/jac/dkg208\")), list(REFERENCE = \"PMID:15760423\", AUTHORS = \"Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM\", TITLE = \"Quinolones in 2005: an update.\", JOURNAL = c(\"Clin Microbiol Infect 11:256-80 (2005)\", \"DOI:10.1111/j.1469-0691.2005.01131.x\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (467, '07015', 'Local analgesics', 'Local analgesics', 'alpha-Eucaine, beta-Eucaine, 3-(Dimethylamino)propyl benzoate, p-Aminosalicylic acid methyl ester, Orthoform, Hexylcaine, Piperocaine, Cocaine (USP), Tetracaine (USP/INN), Benzocaine (USP/INN), Procaine hydrochloride (JP17/USP), Tetracaine hydrochloride (JP17/USP), Benoxinate hydrochloride (USP), Cocaine hydrochloride (JP17/USP), Hexylcaine hydrochloride, Piperocaine hydrochloride, Amylocaine (BAN), Amylocaine hydrochloride, Oxybuprocaine (INN), Procaine (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:11895133\", AUTHORS = \"Ruetsch YA, Boni T, Borgeat A.\", TITLE = \"From cocaine to ropivacaine: the history of local anesthetic drugs.\", JOURNAL = c(\"Curr Top Med Chem 1:175-82 (2001)\", \"DOI:10.2174/1568026013395335\"))', 'map07015', 'Local analgesics', 'Local analgesics', 'alpha-Eucaine, beta-Eucaine, 3-(Dimethylamino)propyl benzoate, p-Aminosalicylic acid methyl ester, Orthoform, Hexylcaine, Piperocaine, Cocaine (USP), Tetracaine (USP/INN), Benzocaine (USP/INN), Procaine hydrochloride (JP17/USP), Tetracaine hydrochloride (JP17/USP), Benoxinate hydrochloride (USP), Cocaine hydrochloride (JP17/USP), Hexylcaine hydrochloride, Piperocaine hydrochloride, Amylocaine (BAN), Amylocaine hydrochloride, Oxybuprocaine (INN), Procaine (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:11895133\", AUTHORS = \"Ruetsch YA, Boni T, Borgeat A.\", TITLE = \"From cocaine to ropivacaine: the history of local anesthetic drugs.\", JOURNAL = c(\"Curr Top Med Chem 1:175-82 (2001)\", \"DOI:10.2174/1568026013395335\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (468, '07016', 'Sulfonamide derivatives - sulfa drugs', 'Sulfonamide derivatives - sulfa drugs', 'Cupreine, Chrysoidine free base, Co-Trimoxazole (BAN), Sulfadiazine, silver (USP), Sulfamethoxazole (JP17/USP/INN), Sulfasalazine (USP/INN), Sulfisoxazole (JP17/USP), Sulfadoxine (JAN/USP/INN), Sulfadiazine (JAN/USP/INN), Sulfamethizole (JP17/USP/INN), Sulfacetamide sodium (USP), Sulfathiazole (USP/INN), Sulfamonomethoxine (JAN/USAN/INN), Sulfadimethoxine (JAN/USP), Sulfalene (USAN), Sulfisomidine (JAN), Sulfaphenazole (JAN/INN), Sulfamonomethoxine sodium (JAN), Quinine hydrochloride hydrate (JP17), Quinine sulfate (USP), Optochin hydrochloride, Sulfapyridine (USP/INN), Sulfamerazine (INN), Sulfamethazine (USP), Sulfaguanidine (INN), Sulfamethoxypyridazine (INN), Phthalylsulfathiazole (INN), Succinylsulfathiazole, Sulfamonomethoxine hydrate (JP17), Quinine ascorbate (USAN), Sulfacetamide (USP/INN), Sulfadiazine sodium (USP), Sulfisoxazole diolamine (USAN), Succinylsulfathiazole (INN), Quinine (BAN), Quinine dihydrochloride, Sulfadimethoxine sodium (USP), Sulfadimidine sodium, Sulfamethoxypyridazine sodium salt, Sulfamidochrysoidine, Sulfanilamide (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\")', 'map07016', 'Sulfonamide derivatives - sulfa drugs', 'Sulfonamide derivatives - sulfa drugs', 'Cupreine, Chrysoidine free base, Co-Trimoxazole (BAN), Sulfadiazine, silver (USP), Sulfamethoxazole (JP17/USP/INN), Sulfasalazine (USP/INN), Sulfisoxazole (JP17/USP), Sulfadoxine (JAN/USP/INN), Sulfadiazine (JAN/USP/INN), Sulfamethizole (JP17/USP/INN), Sulfacetamide sodium (USP), Sulfathiazole (USP/INN), Sulfamonomethoxine (JAN/USAN/INN), Sulfadimethoxine (JAN/USP), Sulfalene (USAN), Sulfisomidine (JAN), Sulfaphenazole (JAN/INN), Sulfamonomethoxine sodium (JAN), Quinine hydrochloride hydrate (JP17), Quinine sulfate (USP), Optochin hydrochloride, Sulfapyridine (USP/INN), Sulfamerazine (INN), Sulfamethazine (USP), Sulfaguanidine (INN), Sulfamethoxypyridazine (INN), Phthalylsulfathiazole (INN), Succinylsulfathiazole, Sulfamonomethoxine hydrate (JP17), Quinine ascorbate (USAN), Sulfacetamide (USP/INN), Sulfadiazine sodium (USP), Sulfisoxazole diolamine (USAN), Succinylsulfathiazole (INN), Quinine (BAN), Quinine dihydrochloride, Sulfadimethoxine sodium (USP), Sulfadimidine sodium, Sulfamethoxypyridazine sodium salt, Sulfamidochrysoidine, Sulfanilamide (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (469, '07017', 'Sulfonamide derivatives - diuretics', 'Sulfonamide derivatives - diuretics', 'Acetazolamide (JP17/USP/INN), Bumetanide (JP17/USP/INN), Chlorthalidone (USP), Furosemide (JP17/USP/INN), Hydrochlorothiazide (JP17/USP/INN), Indapamide (JP17/USP), Torsemide (USP), Metolazone (JAN/USP/INN), Quinethazone (JAN/INN), Dichlorphenamide (USP), Chlorothiazide (JAN/USP/INN), Bendroflumethiazide (JAN/USP/INN), Benzthiazide (JAN/INN), Hydroflumethiazide (JAN/USP/INN), Methazolamide (JAN/USP/INN), Polythiazide (JAN/USAN/INN), Trichlormethiazide (JP17/USP/INN), Acetazolamide sodium (JAN), Penflutizide (JAN/INN), Benzylhydrochlorothiazide (JAN), Azosemide (JP17/USAN/INN), Meticrane (JP17/INN), Piretanide (JAN/USAN/INN), Clofenamide (JAN/INN), Mefruside (JP17/USAN/INN), Tripamide (JAN/USAN/INN), Ethoxzolamide, Flumethiazide (INN), Chlorothiazide sodium (USP), Indapamide hydrate, Sodium furosemide, Furosemide diolamine, Sulfanilamide (INN), Torasemide sodium, Carzenide (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\")', 'map07017', 'Sulfonamide derivatives - diuretics', 'Sulfonamide derivatives - diuretics', 'Acetazolamide (JP17/USP/INN), Bumetanide (JP17/USP/INN), Chlorthalidone (USP), Furosemide (JP17/USP/INN), Hydrochlorothiazide (JP17/USP/INN), Indapamide (JP17/USP), Torsemide (USP), Metolazone (JAN/USP/INN), Quinethazone (JAN/INN), Dichlorphenamide (USP), Chlorothiazide (JAN/USP/INN), Bendroflumethiazide (JAN/USP/INN), Benzthiazide (JAN/INN), Hydroflumethiazide (JAN/USP/INN), Methazolamide (JAN/USP/INN), Polythiazide (JAN/USAN/INN), Trichlormethiazide (JP17/USP/INN), Acetazolamide sodium (JAN), Penflutizide (JAN/INN), Benzylhydrochlorothiazide (JAN), Azosemide (JP17/USAN/INN), Meticrane (JP17/INN), Piretanide (JAN/USAN/INN), Clofenamide (JAN/INN), Mefruside (JP17/USAN/INN), Tripamide (JAN/USAN/INN), Ethoxzolamide, Flumethiazide (INN), Chlorothiazide sodium (USP), Indapamide hydrate, Sodium furosemide, Furosemide diolamine, Sulfanilamide (INN), Torasemide sodium, Carzenide (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (470, '07018', 'Sulfonamide derivatives - hypoglycemic agents', 'Sulfonamide derivatives - hypoglycemic agents', 'Acetohexamide (JP17/USP/INN), Chlorpropamide (JP17/USP/INN), Glipizide (USP/INN), Glyburide (USP), Tolazamide (JAN/USP/INN), Tolbutamide (JP17/USP/INN), Glimepiride (JP17/USP/INN), Glybuzole (JAN/INN), Glymidine sodium (JAN/USAN/INN), Gliclazide (JP17/INN), Glyclopyramide (JAN/INN), Glyprothiazol (INN), Carbutamide (INN), Glycyclamide (INN), Glibornuride (USAN/INN), Gliflumide (USAN), Glicetanile sodium (USAN), Glybuthiazol (INN), Sulfanilamide (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\")', 'map07018', 'Sulfonamide derivatives - hypoglycemic agents', 'Sulfonamide derivatives - hypoglycemic agents', 'Acetohexamide (JP17/USP/INN), Chlorpropamide (JP17/USP/INN), Glipizide (USP/INN), Glyburide (USP), Tolazamide (JAN/USP/INN), Tolbutamide (JP17/USP/INN), Glimepiride (JP17/USP/INN), Glybuzole (JAN/INN), Glymidine sodium (JAN/USAN/INN), Gliclazide (JP17/INN), Glyclopyramide (JAN/INN), Glyprothiazol (INN), Carbutamide (INN), Glycyclamide (INN), Glibornuride (USAN/INN), Gliflumide (USAN), Glicetanile sodium (USAN), Glybuthiazol (INN), Sulfanilamide (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (471, '07019', 'Tetracyclines', 'Tetracyclines', 'Tetracycline (JAN/USP/INN), Oxytetracycline (JAN/USP/INN), Demeclocycline hydrochloride (USP), Doxycycline (USP), Methacycline hydrochloride (JAN/USP), Minocycline hydrochloride (JP17/USP), Tigecycline (JAN/USAN), Oxytetracycline hydrochloride (JP17/USP), Tetracycline hydrochloride (JP17/USP), Doxycycline hyclate (USP), Chlortetracycline hydrochloride (JAN/USP), Chlortetracycline bisulfate (USP), Demeclocycline (USP), Doxycycline calcium (USP), Methacycline (USAN), Minocycline (USAN/INN), Oxytetracycline calcium (USP), Chlortetracycline (INN), Doxycycline (INN), Doxycycline hydrochloride', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Zimmerman TJ, Kooner K, Sharir M, Fechtner RD (eds).\", TITLE = \"Textbook of Ocular Pharmacology (1997)\", JOURNAL = \"Lippincott Williams & Wilkins (1997)\"), list(REFERENCE = \"\", AUTHORS = \"Hunter IS, Hill RA.\", TITLE = \"Tetracyclines.\", JOURNAL = \"Drugs and the Pharmaceutical Sciences 82:659-682 (1997)\"), list(REFERENCE = \"\", AUTHORS = \"Nelson ML.\", TITLE = \"The chemistry and biology of the tetracyclines.\", JOURNAL = \"Annual Reports in Medicinal Chemistry 37:105-114 (2002)\"), list(REFERENCE = \"PMID:2280462 (Japanese)\", AUTHORS = \"Kobayashi Y.\", TITLE = \"[Tetracyclines]\", JOURNAL = \"Nippon Rinsho 48:2184-8 (1990)\"), list(REFERENCE = \"PMID:7628979\", AUTHORS = \"Tally FT, Ellestad GA, Testa RT.\", TITLE = \"Glycylcyclines: a new generation of tetracyclines.\", JOURNAL = c(\"J Antimicrob Chemother 35:449-52 (1995)\", \"DOI:10.1093/jac/35.4.449\")), list(REFERENCE = \"PMID:12237079\", AUTHORS = \"Chopra I.\", TITLE = \"New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors.\", JOURNAL = c(\"Drug Resist Updat 5:119-25 (2002)\", \"DOI:10.1016/S1368-7646(02)00051-1\")), list(REFERENCE = \"PMID:16249141\", AUTHORS = \"Scheinfeld N.\", TITLE = \"Tigecycline: a review of a new glycylcycline antibiotic.\", JOURNAL = c(\"J Dermatolog Treat 16:207-12 (2005)\", \"DOI:10.1080/09546630510011810\"))', 'map07019', 'Tetracyclines', 'Tetracyclines', 'Tetracycline (JAN/USP/INN), Oxytetracycline (JAN/USP/INN), Demeclocycline hydrochloride (USP), Doxycycline (USP), Methacycline hydrochloride (JAN/USP), Minocycline hydrochloride (JP17/USP), Tigecycline (JAN/USAN), Oxytetracycline hydrochloride (JP17/USP), Tetracycline hydrochloride (JP17/USP), Doxycycline hyclate (USP), Chlortetracycline hydrochloride (JAN/USP), Chlortetracycline bisulfate (USP), Demeclocycline (USP), Doxycycline calcium (USP), Methacycline (USAN), Minocycline (USAN/INN), Oxytetracycline calcium (USP), Chlortetracycline (INN), Doxycycline (INN), Doxycycline hydrochloride', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Zimmerman TJ, Kooner K, Sharir M, Fechtner RD (eds).\", TITLE = \"Textbook of Ocular Pharmacology (1997)\", JOURNAL = \"Lippincott Williams & Wilkins (1997)\"), list(REFERENCE = \"\", AUTHORS = \"Hunter IS, Hill RA.\", TITLE = \"Tetracyclines.\", JOURNAL = \"Drugs and the Pharmaceutical Sciences 82:659-682 (1997)\"), list(REFERENCE = \"\", AUTHORS = \"Nelson ML.\", TITLE = \"The chemistry and biology of the tetracyclines.\", JOURNAL = \"Annual Reports in Medicinal Chemistry 37:105-114 (2002)\"), list(REFERENCE = \"PMID:2280462 (Japanese)\", AUTHORS = \"Kobayashi Y.\", TITLE = \"[Tetracyclines]\", JOURNAL = \"Nippon Rinsho 48:2184-8 (1990)\"), list(REFERENCE = \"PMID:7628979\", AUTHORS = \"Tally FT, Ellestad GA, Testa RT.\", TITLE = \"Glycylcyclines: a new generation of tetracyclines.\", JOURNAL = c(\"J Antimicrob Chemother 35:449-52 (1995)\", \"DOI:10.1093/jac/35.4.449\")), list(REFERENCE = \"PMID:12237079\", AUTHORS = \"Chopra I.\", TITLE = \"New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors.\", JOURNAL = c(\"Drug Resist Updat 5:119-25 (2002)\", \"DOI:10.1016/S1368-7646(02)00051-1\")), list(REFERENCE = \"PMID:16249141\", AUTHORS = \"Scheinfeld N.\", TITLE = \"Tigecycline: a review of a new glycylcycline antibiotic.\", JOURNAL = c(\"J Dermatolog Treat 16:207-12 (2005)\", \"DOI:10.1080/09546630510011810\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (472, '07020', 'Macrolides and ketolides', 'Macrolides and ketolides', 'Erythromycin (JP17/USP/INN), Clarithromycin (JP17/USP/INN), Erythromycin estolate (USP), Telithromycin (JAN/USAN/INN), Josamycin (JP17/USAN/INN), Troleandomycin (USP/INN), Midecamycin (JP17/INN), Erythromycin ethylsuccinate (JP17/USP), Acetylkitasamycin (JP17), Midecamycin acetate (JP17), Roxithromycin (JP17/USAN/INN), Rokitamycin (JAN/INN), Kitasamycin tartrate (JP17), Erythromycin lactobionate (JP17/USP), Azithromycin hydrate (JP17), Erythromycin stearate (JP17/USP), Oleandomycin phosphate (JAN), Kitasamycin (JP17/USAN), Cethromycin (USAN/INN), Acetylspiramycin (JP17), Tylosin (USP/INN), Tilmicosin (USP/INN), Tilmicosin phosphate (USAN), Erythromycin acistrate (USAN), Erythromycin gluceptate (USP), Erythromycin propionate (USAN), Erythromycin salnacedin (USAN), Josamycin propionate (JP17), Spiramycin (JAN/USAN/INN), Azithromycin (USP), Azithromycin (INN), Clarithromycin lactobionate, Erythromycin thiocyanate, Erythromycin stinoprate (INN), Spiramycin adipate, Spiramycin embonate', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Suzuki I, Maeda K.\", TITLE = \"[Medicine Development (vol.5)] (In Japanese)\", JOURNAL = \"Hirokawa\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Nasu M.\", TITLE = \"[New macrolides.] (In Japanese)\", JOURNAL = \"Sogo Rinsho 42(2):297-302 (1993)\"), list(REFERENCE = \"\", AUTHORS = \"Hunter PA.\", TITLE = \"Ketolides - a novel form of macrolide: the way forward?\", JOURNAL = c(\"Drug Discovery Today 3(6):257-260 (1998)\", \"DOI:10.1016/S1359-6446(98)01194-5\"))', 'map07020', 'Macrolides and ketolides', 'Macrolides and ketolides', 'Erythromycin (JP17/USP/INN), Clarithromycin (JP17/USP/INN), Erythromycin estolate (USP), Telithromycin (JAN/USAN/INN), Josamycin (JP17/USAN/INN), Troleandomycin (USP/INN), Midecamycin (JP17/INN), Erythromycin ethylsuccinate (JP17/USP), Acetylkitasamycin (JP17), Midecamycin acetate (JP17), Roxithromycin (JP17/USAN/INN), Rokitamycin (JAN/INN), Kitasamycin tartrate (JP17), Erythromycin lactobionate (JP17/USP), Azithromycin hydrate (JP17), Erythromycin stearate (JP17/USP), Oleandomycin phosphate (JAN), Kitasamycin (JP17/USAN), Cethromycin (USAN/INN), Acetylspiramycin (JP17), Tylosin (USP/INN), Tilmicosin (USP/INN), Tilmicosin phosphate (USAN), Erythromycin acistrate (USAN), Erythromycin gluceptate (USP), Erythromycin propionate (USAN), Erythromycin salnacedin (USAN), Josamycin propionate (JP17), Spiramycin (JAN/USAN/INN), Azithromycin (USP), Azithromycin (INN), Clarithromycin lactobionate, Erythromycin thiocyanate, Erythromycin stinoprate (INN), Spiramycin adipate, Spiramycin embonate', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Suzuki I, Maeda K.\", TITLE = \"[Medicine Development (vol.5)] (In Japanese)\", JOURNAL = \"Hirokawa\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Nasu M.\", TITLE = \"[New macrolides.] (In Japanese)\", JOURNAL = \"Sogo Rinsho 42(2):297-302 (1993)\"), list(REFERENCE = \"\", AUTHORS = \"Hunter PA.\", TITLE = \"Ketolides - a novel form of macrolide: the way forward?\", JOURNAL = c(\"Drug Discovery Today 3(6):257-260 (1998)\", \"DOI:10.1016/S1359-6446(98)01194-5\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (473, '07021', 'Aminoglycosides', 'Aminoglycosides', 'Tobramycin (JP17/USP), Amikacin sulfate (JP17/USP), Kanamycin sulfate (USP), Netilmicin sulfate (JAN/USP), Paromomycin sulfate (JAN/USP), Spectinomycin hydrochloride (USP), Gentamicin sulfate (JP17/USP), Streptomycin sulfate (JP17/USP), Arbekacin sulfate (JP17), Neomycin sulfate (USP), Dibekacin sulfate (JP17), Micronomicin sulfate (JP17), Isepamicin sulfate (JP17), Bekanamycin sulfate (JP17), Astromicin sulfate (JAN/USAN), Sisomicin sulfate (JAN/USP), Ribostamycin sulfate (JP17), Tobramycin sulfate (USP), Amikacin (USP/INN), Sisomicin (USAN/INN), Isepamicin (USAN/INN), Kanamycin sulfate (JP17), Framycetin (INN), Arbekacin (INN), Paromomycin (INN), Astromicin (INN), Bekanamycin (INN), Dibekacin (INN), Micronomicin (DCF), Netilmicin (INN), Ribostamycin (INN), Spectinomycin (INN), Streptomycin (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sakurai J.\", TITLE = \"[Illustrated Microbiology (2nd ed)] (In Japanese)\", JOURNAL = \"Nanzando\"), list(REFERENCE = \"PMID:12827054\", AUTHORS = \"Scuderi AC, Paladino GM, Marino C, Trombetta F.\", TITLE = \"In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells.\", JOURNAL = \"Cornea 22:468-72 (2003)\")', 'map07021', 'Aminoglycosides', 'Aminoglycosides', 'Tobramycin (JP17/USP), Amikacin sulfate (JP17/USP), Kanamycin sulfate (USP), Netilmicin sulfate (JAN/USP), Paromomycin sulfate (JAN/USP), Spectinomycin hydrochloride (USP), Gentamicin sulfate (JP17/USP), Streptomycin sulfate (JP17/USP), Arbekacin sulfate (JP17), Neomycin sulfate (USP), Dibekacin sulfate (JP17), Micronomicin sulfate (JP17), Isepamicin sulfate (JP17), Bekanamycin sulfate (JP17), Astromicin sulfate (JAN/USAN), Sisomicin sulfate (JAN/USP), Ribostamycin sulfate (JP17), Tobramycin sulfate (USP), Amikacin (USP/INN), Sisomicin (USAN/INN), Isepamicin (USAN/INN), Kanamycin sulfate (JP17), Framycetin (INN), Arbekacin (INN), Paromomycin (INN), Astromicin (INN), Bekanamycin (INN), Dibekacin (INN), Micronomicin (DCF), Netilmicin (INN), Ribostamycin (INN), Spectinomycin (INN), Streptomycin (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sakurai J.\", TITLE = \"[Illustrated Microbiology (2nd ed)] (In Japanese)\", JOURNAL = \"Nanzando\"), list(REFERENCE = \"PMID:12827054\", AUTHORS = \"Scuderi AC, Paladino GM, Marino C, Trombetta F.\", TITLE = \"In vitro toxicity of netilmicin and ofloxacin on corneal epithelial cells.\", JOURNAL = \"Cornea 22:468-72 (2003)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (474, '07023', 'Rifamycins', 'Rifamycins', 'Krm 1657, Rifamycin S, Rifampin (USP), Rifabutin (JAN/USP/INN), Rifapentine (USAN/INN), Rifamycin (USAN/INN), Rifalazil (USAN/INN), Rifamide (USAN), Rifaximin (JAN/USAN/INN), Rifampicin sodium, Rifamycin sodium (USAN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"PMID:2039206\", AUTHORS = \"Saito H, Tomioka H, Sato K, Emori M, Yamane T, Yamashita K, Hosoe K, Hidaka T\", TITLE = \"In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins.\", JOURNAL = c(\"Antimicrob Agents Chemother 35:542-7 (1991)\", \"DOI:10.1128/AAC.35.3.542\")), list(REFERENCE = \"PMID:9869560\", AUTHORS = \"Heifets L, Sanchez T, Vanderkolk J, Pham V\", TITLE = \"Development of rifapentine susceptibility tests for Mycobacterium tuberculosis.\", JOURNAL = \"Antimicrob Agents Chemother 43:25-8 (1999)\"), list(REFERENCE = \"PMID:15700959\", AUTHORS = \"Floss HG, Yu TW.\", TITLE = \"Rifamycin-mode of action, resistance, and biosynthesis.\", JOURNAL = c(\"Chem Rev 105:621-32 (2005)\", \"DOI:10.1021/cr030112j\"))', 'map07023', 'Rifamycins', 'Rifamycins', 'Krm 1657, Rifamycin S, Rifampin (USP), Rifabutin (JAN/USP/INN), Rifapentine (USAN/INN), Rifamycin (USAN/INN), Rifalazil (USAN/INN), Rifamide (USAN), Rifaximin (JAN/USAN/INN), Rifampicin sodium, Rifamycin sodium (USAN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"PMID:2039206\", AUTHORS = \"Saito H, Tomioka H, Sato K, Emori M, Yamane T, Yamashita K, Hosoe K, Hidaka T\", TITLE = \"In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins.\", JOURNAL = c(\"Antimicrob Agents Chemother 35:542-7 (1991)\", \"DOI:10.1128/AAC.35.3.542\")), list(REFERENCE = \"PMID:9869560\", AUTHORS = \"Heifets L, Sanchez T, Vanderkolk J, Pham V\", TITLE = \"Development of rifapentine susceptibility tests for Mycobacterium tuberculosis.\", JOURNAL = \"Antimicrob Agents Chemother 43:25-8 (1999)\"), list(REFERENCE = \"PMID:15700959\", AUTHORS = \"Floss HG, Yu TW.\", TITLE = \"Rifamycin-mode of action, resistance, and biosynthesis.\", JOURNAL = c(\"Chem Rev 105:621-32 (2005)\", \"DOI:10.1021/cr030112j\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (475, '07024', 'HMG-CoA reductase inhibitors', 'HMG-CoA reductase inhibitors, also known as statins, are a class of cholesterol lowering drugs that target HMG-CoA reductase in the mevalonate pathway. In 1971 Akira Endo and his team working for the Japanese pharmaceutical company Sankyo started a project to search for microbial metabolites that would inhibit HMG-CoA reductase, the rate-limiting enzyme in the cholesterol biosynthesis, hoping that certain microorganisms would produce such inhibitors as a weapon against other microbes. After screening 6,000 microbial strains mevastatin was discovered from Penicillium citrinum, but the clinical trial of mevastatin was not completed because of its toxicity. The first successful statin was lovastatin isolated from Aspergillus terreus by Merck, which had repeated Sankyo\'s approach to microbial screening. Following the first generation statins that are based on natural products, the second and the third generation statins were developed using chemical synthesis.', 'HMG-CoA reductase inhibitors', '(S)-3-Hydroxy-3-methylglutaryl-CoA, Pitavastatin, Mevastatin, Lovastatin (USP/INN), Simvastatin (JP17/USP/INN), Atorvastatin calcium anhydorous, Cerivastatin sodium (JAN/USAN), Fluvastatin sodium (JAN/USAN), Pravastatin sodium (JP17/USAN), Pitavastatin calcium (JAN), Rosuvastatin calcium (JAN/USAN), Atorvastatin calcium (USP), Atorvastatin (INN), Cerivastatin (INN), Fluvastatin (INN), Pravastatin (INN), Rosuvastatin (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Teramoto T (ed).\", TITLE = \"[Statins Q & A] (In Japanese)\", JOURNAL = \"Iyaku journal (2001)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Takamisawa I, Shiba M.\", TITLE = \"[Structure, activity and metabolism of statins.] (In Japanese)\", JOURNAL = \"Chiryogaku 36(5):35-40 (2002)\"), list(REFERENCE = \"PMID:9892578\", AUTHORS = \"Furberg CD\", TITLE = \"Natural statins and stroke risk.\", JOURNAL = c(\"Circulation 99:185-8 (1999)\", \"DOI:10.1161/01.CIR.99.2.185\")), list(REFERENCE = \"PMID:12530513\", AUTHORS = \"Veillard NR, Mach F.\", TITLE = \"Statins: the new aspirin?\", JOURNAL = c(\"Cell Mol Life Sci 59:1771-86 (2002)\", \"DOI:10.1007/PL00012505\")), list(REFERENCE = \"PMID:15531278\", AUTHORS = \"Endo A.\", TITLE = \"The discovery and development of HMG-CoA reductase inhibitors. 1992.\", JOURNAL = c(\"Atheroscler Suppl 5:67-80 (2004)\", \"DOI:10.1016/j.atherosclerosissup.2004.08.026\"))', 'map07024', 'HMG-CoA reductase inhibitors', 'HMG-CoA reductase inhibitors, also known as statins, are a class of cholesterol lowering drugs that target HMG-CoA reductase in the mevalonate pathway. In 1971 Akira Endo and his team working for the Japanese pharmaceutical company Sankyo started a project to search for microbial metabolites that would inhibit HMG-CoA reductase, the rate-limiting enzyme in the cholesterol biosynthesis, hoping that certain microorganisms would produce such inhibitors as a weapon against other microbes. After screening 6,000 microbial strains mevastatin was discovered from Penicillium citrinum, but the clinical trial of mevastatin was not completed because of its toxicity. The first successful statin was lovastatin isolated from Aspergillus terreus by Merck, which had repeated Sankyo\'s approach to microbial screening. Following the first generation statins that are based on natural products, the second and the third generation statins were developed using chemical synthesis.', 'HMG-CoA reductase inhibitors', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (476, '07025', 'Quinolines', 'Quinolines', 'Quinidine gluconate (USP), Quinidine polygalacturonate, Mefloquine hydrochloride (JP17/USP), Quinine ethylcarbonate (JP17), Chloroquine phosphate (USP), Primaquine phosphate (JAN/USP), Quinine hydrochloride hydrate (JP17), Quinine sulfate (USP), Quinidine sulfate (USP), Chloroquine (USP/INN), Halofantrine hydrochloride (USAN), Pamaquine, Mepacrine dihydrochloride, Chloroquine hydrochloride (USP), Mefloquine (USAN/INN), Quinine ascorbate (USAN), Chloroquine sulfate, Halofantrine (INN), Mepacrine (INN), Primaquine (INN), Quinidine (BAN), Quinidine phenylethylbarbiturate, Quinine (BAN), Quinine dihydrochloride', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Wataya Y, Hye-Sook K.\", TITLE = \"[Development of anti-mararial drugs: past, present, and future.] (In Japanese)\", JOURNAL = \"Experimental Medicine 23(17):2741-2747 (2005)\")', 'map07025', 'Quinolines', 'Quinolines', 'Quinidine gluconate (USP), Quinidine polygalacturonate, Mefloquine hydrochloride (JP17/USP), Quinine ethylcarbonate (JP17), Chloroquine phosphate (USP), Primaquine phosphate (JAN/USP), Quinine hydrochloride hydrate (JP17), Quinine sulfate (USP), Quinidine sulfate (USP), Chloroquine (USP/INN), Halofantrine hydrochloride (USAN), Pamaquine, Mepacrine dihydrochloride, Chloroquine hydrochloride (USP), Mefloquine (USAN/INN), Quinine ascorbate (USAN), Chloroquine sulfate, Halofantrine (INN), Mepacrine (INN), Primaquine (INN), Quinidine (BAN), Quinidine phenylethylbarbiturate, Quinine (BAN), Quinine dihydrochloride', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Wataya Y, Hye-Sook K.\", TITLE = \"[Development of anti-mararial drugs: past, present, and future.] (In Japanese)\", JOURNAL = \"Experimental Medicine 23(17):2741-2747 (2005)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (477, '07026', 'Antifungal agents', 'Antifungal agents', 'Azomycin, Sch 59884, BMS 379224, Nystatin (JP17/USP/INN), Amphotericin B (JP17/USP/INN), Griseofulvin (JAN/USP/INN), Clotrimazole (JP17/USP/INN), Fluconazole (JP17/USAN/INN), Flucytosine (JP17/USP/INN), Itraconazole (JP17/USAN), Ketoconazole (JP17/USP), Tolnaftate (JP17/USP/INN), Metronidazole (JP17/USP/INN), Miconazole (JP17/USP/INN), Etomidate (USAN/INN), Voriconazole (JP17/USAN/INN), Butoconazole nitrate (USP), Econazole nitrate (JAN/USP), Miconazole nitrate (JP17/USP), Naftifine hydrochloride (USP), Natamycin (USP/INN), Oxiconazole nitrate (JAN/USAN), Sulconazole nitrate (JAN/USP), Terconazole (USAN/INN), Lanoconazole (JAN/INN), Butenafine hydrochloride (JP17/USAN), Fosfluconazole (JAN/INN), Isoconazole nitrate (JAN), Liranaftate (JAN/INN), Neticonazole hydrochloride (JAN), Amorolfine hydrochloride (JAN), Bifonazole (JP17/USAN/INN), Luliconazole (JAN/USAN/INN), Trichomycin (JP17), Croconazole hydrochloride (JP17), Terbinafine hydrochloride (JP17/USP), Terbinafine (USAN/INN), Micafungin sodium (JAN/USAN), Caspofungin acetate (JAN/USAN), Posaconazole (JAN/USAN/INN), Ravuconazole (prop.INN), Chlormidazole (INN), Amorolfine (USAN/INN), Anidulafungin (USAN), Econazole (USAN/INN), Isoconazole (USAN/INN), Pramiconazole (USAN/INN), Butenafine (INN), Butoconazole (INN), Caspofungin (INN), Chlormidazole hydrochloride, Croconazole (INN), Micafungin (INN), Naftifine (INN), Oxiconazole (INN), Sulconazole (INN)', 'list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"PMID:15047519\", AUTHORS = \"Petraitiene R, Petraitis V, Lyman CA, Groll AH, Mickiene D, Peter J, Bacher J, Roussillon K, Hemmings M, Armstrong D, Avila NA, Walsh TJ\", TITLE = \"Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.\", JOURNAL = c(\"Antimicrob Agents Chemother 48:1188-96 (2004)\", \"DOI:10.1128/AAC.48.4.1188-1196.2004\"\n)), list(REFERENCE = \"PMID:11682237\", AUTHORS = \"Kim H, Kumari P, Lin CC, Nomeir AA.\", TITLE = \"Simultaneous high-performance liquid chromatographic determination of SCH 59884 (phosphate ester prodrug of SCH 56592), SCH 207962 and SCH 56592 in dog plasma.\", JOURNAL = c(\"J Pharm Biomed Anal 27:295-303 (2002)\", \"DOI:10.1016/S0731-7085(01)00543-X\")), list(REFERENCE = \"PMID:3069196\", AUTHORS = \"Fromtling RA\", TITLE = \"Overview of medically important antifungal azole derivatives.\", JOURNAL = \"Clin Microbiol Rev 1:187-217 (1988)\")', 'map07026', 'Antifungal agents', 'Antifungal agents', 'Azomycin, Sch 59884, BMS 379224, Nystatin (JP17/USP/INN), Amphotericin B (JP17/USP/INN), Griseofulvin (JAN/USP/INN), Clotrimazole (JP17/USP/INN), Fluconazole (JP17/USAN/INN), Flucytosine (JP17/USP/INN), Itraconazole (JP17/USAN), Ketoconazole (JP17/USP), Tolnaftate (JP17/USP/INN), Metronidazole (JP17/USP/INN), Miconazole (JP17/USP/INN), Etomidate (USAN/INN), Voriconazole (JP17/USAN/INN), Butoconazole nitrate (USP), Econazole nitrate (JAN/USP), Miconazole nitrate (JP17/USP), Naftifine hydrochloride (USP), Natamycin (USP/INN), Oxiconazole nitrate (JAN/USAN), Sulconazole nitrate (JAN/USP), Terconazole (USAN/INN), Lanoconazole (JAN/INN), Butenafine hydrochloride (JP17/USAN), Fosfluconazole (JAN/INN), Isoconazole nitrate (JAN), Liranaftate (JAN/INN), Neticonazole hydrochloride (JAN), Amorolfine hydrochloride (JAN), Bifonazole (JP17/USAN/INN), Luliconazole (JAN/USAN/INN), Trichomycin (JP17), Croconazole hydrochloride (JP17), Terbinafine hydrochloride (JP17/USP), Terbinafine (USAN/INN), Micafungin sodium (JAN/USAN), Caspofungin acetate (JAN/USAN), Posaconazole (JAN/USAN/INN), Ravuconazole (prop.INN), Chlormidazole (INN), Amorolfine (USAN/INN), Anidulafungin (USAN), Econazole (USAN/INN), Isoconazole (USAN/INN), Pramiconazole (USAN/INN), Butenafine (INN), Butoconazole (INN), Caspofungin (INN), Chlormidazole hydrochloride, Croconazole (INN), Micafungin (INN), Naftifine (INN), Oxiconazole (INN), Sulconazole (INN)', 'list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"PMID:15047519\", AUTHORS = \"Petraitiene R, Petraitis V, Lyman CA, Groll AH, Mickiene D, Peter J, Bacher J, Roussillon K, Hemmings M, Armstrong D, Avila NA, Walsh TJ\", TITLE = \"Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.\", JOURNAL = c(\"Antimicrob Agents Chemother 48:1188-96 (2004)\", \"DOI:10.1128/AAC.48.4.1188-1196.2004\"\n)), list(REFERENCE = \"PMID:11682237\", AUTHORS = \"Kim H, Kumari P, Lin CC, Nomeir AA.\", TITLE = \"Simultaneous high-performance liquid chromatographic determination of SCH 59884 (phosphate ester prodrug of SCH 56592), SCH 207962 and SCH 56592 in dog plasma.\", JOURNAL = c(\"J Pharm Biomed Anal 27:295-303 (2002)\", \"DOI:10.1016/S0731-7085(01)00543-X\")), list(REFERENCE = \"PMID:3069196\", AUTHORS = \"Fromtling RA\", TITLE = \"Overview of medically important antifungal azole derivatives.\", JOURNAL = \"Clin Microbiol Rev 1:187-217 (1988)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (478, '07027', 'Antidepressants', 'Antidepressants', 'Amoxapine (JP17/USP/INN), Fluoxetine (USAN/INN), Trimipramine (USAN/INN), Phenelzine sulfate (USP), Mirtazapine (JAN/USAN/INN), Selegiline hydrochloride (JAN/USP), Amitriptyline hydrochloride (JP17/USP), Clomipramine hydrochloride (JP17/USP), Desipramine hydrochloride (JAN/USP), Imipramine hydrochloride (JP17/USP), Nortriptyline hydrochloride (JP17/USP/INN), Maprotiline hydrochloride (JP17/USP), Nefazodone hydrochloride (USAN), Trazodone hydrochloride (JAN/USP), Venlafaxine hydrochloride (JAN/USAN), Citalopram hydrobromide (USAN), Fluoxetine hydrochloride (JAN/USP), Fluvoxamine maleate (JP17/USAN), Sertraline hydrochloride (JAN/USAN), Tranylcypromine sulfate (USP XXI), Milnacipran hydrochloride (JAN/USAN), Melitracen hydrochloride (JAN/USAN), Duloxetine hydrochloride (JAN/USP), Lofepramine hydrochloride (JAN/USAN), Mianserin hydrochloride (JAN/USAN), Dothiepin hydrochloride (USAN), Setiptiline maleate (JAN), Paroxetine hydrochloride hydrate (JP17), Sertraline (INN), Paroxetine (USP/INN), Trimipramine maleate (JAN/USAN), Toloxatone (INN), Brofaromine (INN), Moclobemide (USAN/INN), Rasagiline mesylate (USAN), Dimetacrine (INN), Maprotiline (USAN), Desvenlafaxine succinate (USAN), Sibutramine hydrochloride (USAN), Viloxazine hydrochloride (USAN), Reboxetine mesylate (USAN), Iproniazid (INN), Isocarboxazid (INN), Selegiline (USAN/INN), Paroxetine hydrochloride (USP), Paroxetine mesylate (USAN), Amitriptyline (INN), Citalopram (USP/INN), Citalopram hydrochloride, Clomipramine (INN), Desipramine (INN), Desvenlafaxine (INN), Dosulepin (INN), Duloxetine (INN), Fluvoxamine (INN), Imipramine (INN), Iproniazid phosphate, Lofepramine (INN), Melitracen (INN), Mianserin (INN), Milnacipran (INN), Nefazodone (INN), Nortriptyline (INN), Phenelzine (BAN), Rasagiline (USAN/INN), Reboxetine (INN), Setiptiline (INN), Sibutramine (INN), Tranylcypromine (INN), Trazodone (INN), Venlafaxine (INN), Viloxazine (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Shishikura K, Kamijima K.\", TITLE = \"[History and prospects of antidepressants.] (In Japanese)\", JOURNAL = \"Journal of Japanese Society of Hospital Pharmacists 37(11):25-28 (2001)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Kusumi I, Koyama T.\", TITLE = \"[Pharmacology of novel antidepressants.] (In Japanese)\", JOURNAL = \"Igaku no Ayumi 195(8):519-522 (2000)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Koyama T.\", TITLE = \"[The history of antidepressant development.] (In Japanese)\", JOURNAL = \"Iyaku journal 35(2):137-140 (2000)\"), list(REFERENCE = \"\", AUTHORS = \"Leonard BE.\", TITLE = \"Pharmacological properties of some \\\"second generation\\\" antidepressant drugs.\", JOURNAL = c(\"Neuropharmacology 19(12):1175-1183 (1980)\", \"DOI:10.1016/0028-3908(80)90198-7\")), list(REFERENCE = \"PMID:8471919\", AUTHORS = \"Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J\", TITLE = \"Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.\", JOURNAL = c(\"BMJ 306:683-7 (1993)\", \"DOI:10.1136/bmj.306.6879.683\")), list(REFERENCE = \"PMID:10511010\", AUTHORS = \"Domino EF.\", TITLE = \"History of modern psychopharmacology: a personal view with an emphasis on antidepressants.\", JOURNAL = \"Psychosom Med 61:591-8 (1999)\"), list(REFERENCE = \"PMID:11478422\", AUTHORS = \"Ban TA.\", TITLE = \"Pharmacotherapy of depression: a historical analysis.\", JOURNAL = c(\"J Neural Transm 108:707-16 (2001)\", \"DOI:10.1007/s007020170047\")), list(REFERENCE = \"PMID:14748749\", AUTHORS = \"Slattery DA, Hudson AL, Nutt DJ.\", TITLE = \"Invited review: the evolution of antidepressant mechanisms.\", JOURNAL = c(\"Fundam Clin Pharmacol 18:1-21 (2004)\", \"DOI:10.1111/j.1472-8206.2004.00195.x\")), list(REFERENCE = \"PMID:15618947\", AUTHORS = \"Nutt DJ.\", TITLE = \"Overview of diagnosis and drug treatments of anxiety disorders.\", JOURNAL = \"CNS Spectr 10:49-56 (2005)\")', 'map07027', 'Antidepressants', 'Antidepressants', 'Amoxapine (JP17/USP/INN), Fluoxetine (USAN/INN), Trimipramine (USAN/INN), Phenelzine sulfate (USP), Mirtazapine (JAN/USAN/INN), Selegiline hydrochloride (JAN/USP), Amitriptyline hydrochloride (JP17/USP), Clomipramine hydrochloride (JP17/USP), Desipramine hydrochloride (JAN/USP), Imipramine hydrochloride (JP17/USP), Nortriptyline hydrochloride (JP17/USP/INN), Maprotiline hydrochloride (JP17/USP), Nefazodone hydrochloride (USAN), Trazodone hydrochloride (JAN/USP), Venlafaxine hydrochloride (JAN/USAN), Citalopram hydrobromide (USAN), Fluoxetine hydrochloride (JAN/USP), Fluvoxamine maleate (JP17/USAN), Sertraline hydrochloride (JAN/USAN), Tranylcypromine sulfate (USP XXI), Milnacipran hydrochloride (JAN/USAN), Melitracen hydrochloride (JAN/USAN), Duloxetine hydrochloride (JAN/USP), Lofepramine hydrochloride (JAN/USAN), Mianserin hydrochloride (JAN/USAN), Dothiepin hydrochloride (USAN), Setiptiline maleate (JAN), Paroxetine hydrochloride hydrate (JP17), Sertraline (INN), Paroxetine (USP/INN), Trimipramine maleate (JAN/USAN), Toloxatone (INN), Brofaromine (INN), Moclobemide (USAN/INN), Rasagiline mesylate (USAN), Dimetacrine (INN), Maprotiline (USAN), Desvenlafaxine succinate (USAN), Sibutramine hydrochloride (USAN), Viloxazine hydrochloride (USAN), Reboxetine mesylate (USAN), Iproniazid (INN), Isocarboxazid (INN), Selegiline (USAN/INN), Paroxetine hydrochloride (USP), Paroxetine mesylate (USAN), Amitriptyline (INN), Citalopram (USP/INN), Citalopram hydrochloride, Clomipramine (INN), Desipramine (INN), Desvenlafaxine (INN), Dosulepin (INN), Duloxetine (INN), Fluvoxamine (INN), Imipramine (INN), Iproniazid phosphate, Lofepramine (INN), Melitracen (INN), Mianserin (INN), Milnacipran (INN), Nefazodone (INN), Nortriptyline (INN), Phenelzine (BAN), Rasagiline (USAN/INN), Reboxetine (INN), Setiptiline (INN), Sibutramine (INN), Tranylcypromine (INN), Trazodone (INN), Venlafaxine (INN), Viloxazine (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Shishikura K, Kamijima K.\", TITLE = \"[History and prospects of antidepressants.] (In Japanese)\", JOURNAL = \"Journal of Japanese Society of Hospital Pharmacists 37(11):25-28 (2001)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Kusumi I, Koyama T.\", TITLE = \"[Pharmacology of novel antidepressants.] (In Japanese)\", JOURNAL = \"Igaku no Ayumi 195(8):519-522 (2000)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Koyama T.\", TITLE = \"[The history of antidepressant development.] (In Japanese)\", JOURNAL = \"Iyaku journal 35(2):137-140 (2000)\"), list(REFERENCE = \"\", AUTHORS = \"Leonard BE.\", TITLE = \"Pharmacological properties of some \\\"second generation\\\" antidepressant drugs.\", JOURNAL = c(\"Neuropharmacology 19(12):1175-1183 (1980)\", \"DOI:10.1016/0028-3908(80)90198-7\")), list(REFERENCE = \"PMID:8471919\", AUTHORS = \"Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J\", TITLE = \"Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.\", JOURNAL = c(\"BMJ 306:683-7 (1993)\", \"DOI:10.1136/bmj.306.6879.683\")), list(REFERENCE = \"PMID:10511010\", AUTHORS = \"Domino EF.\", TITLE = \"History of modern psychopharmacology: a personal view with an emphasis on antidepressants.\", JOURNAL = \"Psychosom Med 61:591-8 (1999)\"), list(REFERENCE = \"PMID:11478422\", AUTHORS = \"Ban TA.\", TITLE = \"Pharmacotherapy of depression: a historical analysis.\", JOURNAL = c(\"J Neural Transm 108:707-16 (2001)\", \"DOI:10.1007/s007020170047\")), list(REFERENCE = \"PMID:14748749\", AUTHORS = \"Slattery DA, Hudson AL, Nutt DJ.\", TITLE = \"Invited review: the evolution of antidepressant mechanisms.\", JOURNAL = c(\"Fundam Clin Pharmacol 18:1-21 (2004)\", \"DOI:10.1111/j.1472-8206.2004.00195.x\")), list(REFERENCE = \"PMID:15618947\", AUTHORS = \"Nutt DJ.\", TITLE = \"Overview of diagnosis and drug treatments of anxiety disorders.\", JOURNAL = \"CNS Spectr 10:49-56 (2005)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (479, '07028', 'Antipsychotics', 'Antipsychotics', 'Haloperidol (JP17/USP/INN), Amoxapine (JP17/USP/INN), Chlorpromazine (USP/INN), Diphenhydramine (JP17/INN), Thiothixene (USP), Risperidone (JP17/USAN/INN), Procainamide hydrochloride (JP17/USP), Promethazine hydrochloride (JP17/USP), Promethazine (JAN/INN), Sertindole (USAN/INN), Diphenhydramine hydrochloride (JP17/USP), Metoclopramide (JP17/INN), Chlorpromazine hydrochloride (JP17/USP), Chlorprothixene (JAN/USAN/INN), Molindone hydrochloride (USP), Flupentixol (INN), Sulpiride (JP17/USAN/INN), Promethazine teoclate (JAN/INN), Zotepine (JAN/INN), Meperidine hydrochloride (USP), Perlapine (JAN/USAN/INN), Tripelennamine hydrochloride (USP), Chlorprothixene hydrochloride (JAN), Metoclopramide hydrochloride (JAN), Flupentixol dihydrochloride (JAN), Diphenhydramine salicylate (JAN), Diethazine hydrochloride, Phenoperidine (INN), Thiothixene hydrochloride (USP), Clopenthixol (USAN), Chlorpromazine hibenzate (JAN), Promethazine methylenedisalicylate (JAN), Diphenhydramine laurylsulfate (JAN), Zuclopenthixol (INN), Diphenhydramine citrate (USP), Chlorpromazine phenolphthalinate (JAN), Metoclopramide hydrochloride (USAN), Tripelennamine citrate, Chlorprothixene acetate, Chlorprothixene citrate, Pethidine (INN), Promethazine maleate, Promethazine hibenzate', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\")', 'map07028', 'Antipsychotics', 'Antipsychotics', 'Haloperidol (JP17/USP/INN), Amoxapine (JP17/USP/INN), Chlorpromazine (USP/INN), Diphenhydramine (JP17/INN), Thiothixene (USP), Risperidone (JP17/USAN/INN), Procainamide hydrochloride (JP17/USP), Promethazine hydrochloride (JP17/USP), Promethazine (JAN/INN), Sertindole (USAN/INN), Diphenhydramine hydrochloride (JP17/USP), Metoclopramide (JP17/INN), Chlorpromazine hydrochloride (JP17/USP), Chlorprothixene (JAN/USAN/INN), Molindone hydrochloride (USP), Flupentixol (INN), Sulpiride (JP17/USAN/INN), Promethazine teoclate (JAN/INN), Zotepine (JAN/INN), Meperidine hydrochloride (USP), Perlapine (JAN/USAN/INN), Tripelennamine hydrochloride (USP), Chlorprothixene hydrochloride (JAN), Metoclopramide hydrochloride (JAN), Flupentixol dihydrochloride (JAN), Diphenhydramine salicylate (JAN), Diethazine hydrochloride, Phenoperidine (INN), Thiothixene hydrochloride (USP), Clopenthixol (USAN), Chlorpromazine hibenzate (JAN), Promethazine methylenedisalicylate (JAN), Diphenhydramine laurylsulfate (JAN), Zuclopenthixol (INN), Diphenhydramine citrate (USP), Chlorpromazine phenolphthalinate (JAN), Metoclopramide hydrochloride (USAN), Tripelennamine citrate, Chlorprothixene acetate, Chlorprothixene citrate, Pethidine (INN), Promethazine maleate, Promethazine hibenzate', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (480, '07029', 'Antipsychotics - phenothiazines', 'Antipsychotics - phenothiazines', 'Chlorpromazine (USP/INN), Thioridazine (USP/INN), Triflupromazine (USP/INN), Methotrimeprazine (USP), Prochlorperazine maleate (JP17/USP), Promethazine hydrochloride (JP17/USP), Prochlorperazine (JAN/USP/INN), Promethazine (JAN/INN), Perphenazine (JP17/USP/INN), Chlorpromazine hydrochloride (JP17/USP), Fluphenazine hydrochloride (JAN/USP), Promazine hydrochloride (USP), Thioridazine hydrochloride (JP17/USP), Trifluoperazine hydrochloride (JAN/USP), Triflupromazine hydrochloride (JAN/USP), Profenamine hydrochloride (JAN), Thiethylperazine maleate (JAN/USP), Isothipendyl hydrochloride (JAN), Promethazine teoclate (JAN/INN), Perazine maleate (JAN), Thioproperazine mesilate (JAN), Trifluoperazine maleate (JAN), Levomepromazine hydrochloride (JAN/USAN), Perazine dimalonate (JAN), Prochlorperazine mesilate (JAN), Perphenazine maleate (JP17), Fluphenazine maleate (JAN), Trimeprazine tartrate (USP), Levomepromazine maleate (JP17/USAN), Methylene blue (USP), Thiethylperazine (USAN/INN), Phenothiazine (INN), Fenethazine (INN), Diethazine hydrochloride, Acepromazine maleate (USP), Methoxypromazine maleate, Pipamazine (INN), Mepazine acetate, Perazine fendizoate (JAN), Prochlorperazine edisylate (USP), Thiethylperazine malate (JAN), Chlorpromazine hibenzate (JAN), Profenamine hibenzate (JAN), Promethazine methylenedisalicylate (JAN), Chlorpromazine phenolphthalinate (JAN), Perphenazine fendizoate (JAN), Perphenazine hydrochloride, Acepromazine (INN), Alimemazine (INN), Fluphenazine (INN), Isothipendyl (INN), Profenamine (INN), Promethazine maleate, Thioproperazine (INN), Trifluoperazine (INN), Promethazine hibenzate', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"PMID:5068965\", AUTHORS = \"Nightingale CH, Tse M, Stupak EI.\", TITLE = \"Structure-toxicity relationships of substituted phenothiazines.\", JOURNAL = c(\"J Pharm Sci 61:1498-9 (1972)\", \"DOI:10.1002/jps.2600610939\")), list(REFERENCE = \"PMID:10579370\", AUTHORS = \"Shen WW.\", TITLE = \"A history of antipsychotic drug development.\", JOURNAL = c(\"Compr Psychiatry 40:407-14 (1999)\", \"DOI:10.1016/S0010-440X(99)90082-2\")), list(REFERENCE = \"PMID:11383974\", AUTHORS = \"Ban TA.\", TITLE = \"Pharmacotherapy of mental illness--a historical analysis.\", JOURNAL = c(\"Prog Neuropsychopharmacol Biol Psychiatry 25:709-27 (2001)\", \"DOI:10.1016/S0278-5846(01)00160-9\")), list(REFERENCE = \"PMID:12935655\", AUTHORS = \"Mizuno Y, Sato K, Sano T, Kurihara R, Kojima T, Yamakawa Y, Ishii A, Katsumata Y.\", TITLE = \"Identification and characterization of 17 phenothiazine compounds by capillary high-performance liquid chromatography/fast atom bombardment mass spectrometry.\", JOURNAL = c(\"Leg Med (Tokyo) 4:207-16 (2002)\", \"DOI:10.1016/S1344-6223(02)00051-2\"))', 'map07029', 'Antipsychotics - phenothiazines', 'Antipsychotics - phenothiazines', 'Chlorpromazine (USP/INN), Thioridazine (USP/INN), Triflupromazine (USP/INN), Methotrimeprazine (USP), Prochlorperazine maleate (JP17/USP), Promethazine hydrochloride (JP17/USP), Prochlorperazine (JAN/USP/INN), Promethazine (JAN/INN), Perphenazine (JP17/USP/INN), Chlorpromazine hydrochloride (JP17/USP), Fluphenazine hydrochloride (JAN/USP), Promazine hydrochloride (USP), Thioridazine hydrochloride (JP17/USP), Trifluoperazine hydrochloride (JAN/USP), Triflupromazine hydrochloride (JAN/USP), Profenamine hydrochloride (JAN), Thiethylperazine maleate (JAN/USP), Isothipendyl hydrochloride (JAN), Promethazine teoclate (JAN/INN), Perazine maleate (JAN), Thioproperazine mesilate (JAN), Trifluoperazine maleate (JAN), Levomepromazine hydrochloride (JAN/USAN), Perazine dimalonate (JAN), Prochlorperazine mesilate (JAN), Perphenazine maleate (JP17), Fluphenazine maleate (JAN), Trimeprazine tartrate (USP), Levomepromazine maleate (JP17/USAN), Methylene blue (USP), Thiethylperazine (USAN/INN), Phenothiazine (INN), Fenethazine (INN), Diethazine hydrochloride, Acepromazine maleate (USP), Methoxypromazine maleate, Pipamazine (INN), Mepazine acetate, Perazine fendizoate (JAN), Prochlorperazine edisylate (USP), Thiethylperazine malate (JAN), Chlorpromazine hibenzate (JAN), Profenamine hibenzate (JAN), Promethazine methylenedisalicylate (JAN), Chlorpromazine phenolphthalinate (JAN), Perphenazine fendizoate (JAN), Perphenazine hydrochloride, Acepromazine (INN), Alimemazine (INN), Fluphenazine (INN), Isothipendyl (INN), Profenamine (INN), Promethazine maleate, Thioproperazine (INN), Trifluoperazine (INN), Promethazine hibenzate', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"PMID:5068965\", AUTHORS = \"Nightingale CH, Tse M, Stupak EI.\", TITLE = \"Structure-toxicity relationships of substituted phenothiazines.\", JOURNAL = c(\"J Pharm Sci 61:1498-9 (1972)\", \"DOI:10.1002/jps.2600610939\")), list(REFERENCE = \"PMID:10579370\", AUTHORS = \"Shen WW.\", TITLE = \"A history of antipsychotic drug development.\", JOURNAL = c(\"Compr Psychiatry 40:407-14 (1999)\", \"DOI:10.1016/S0010-440X(99)90082-2\")), list(REFERENCE = \"PMID:11383974\", AUTHORS = \"Ban TA.\", TITLE = \"Pharmacotherapy of mental illness--a historical analysis.\", JOURNAL = c(\"Prog Neuropsychopharmacol Biol Psychiatry 25:709-27 (2001)\", \"DOI:10.1016/S0278-5846(01)00160-9\")), list(REFERENCE = \"PMID:12935655\", AUTHORS = \"Mizuno Y, Sato K, Sano T, Kurihara R, Kojima T, Yamakawa Y, Ishii A, Katsumata Y.\", TITLE = \"Identification and characterization of 17 phenothiazine compounds by capillary high-performance liquid chromatography/fast atom bombardment mass spectrometry.\", JOURNAL = c(\"Leg Med (Tokyo) 4:207-16 (2002)\", \"DOI:10.1016/S1344-6223(02)00051-2\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (481, '07030', 'Anxiolytics', 'Anxiolytics', 'Y 23684, Alprazolam (JP17/USP/INN), Chlordiazepoxide (JP17/USP/INN), Diazepam (JP17/USP/INN), Lorazepam (JP17/USP/INN), Temazepam (USP/INN), Meprobamate (JAN/USP/INN), Oxazepam (JAN/USP/INN), Hydroxyzine hydrochloride (JP17/USP), Chlordiazepoxide hydrochloride (JAN/USP), Clorazepate dipotassium (JP17/USP), Buspirone hydrochloride (USP), Carisoprodol (JAN/USP/INN), Hydroxyzine pamoate (JP17/USP), Tofisopam (JP17/INN), Cloxazolam (JP17/INN), Flutazolam (JAN/INN), Ethyl loflazepate (JAN/INN), Mexazolam (JAN/INN), Clotiazepam (JP17/INN), Etizolam (JP17/INN), Lormetazepam (JAN/USAN/INN), Tandospirone citrate (JAN/USAN), Abecarnil (INN), Mephenesin (INN), Pagoclone (USAN/INN), Ocinaplon (USAN/INN), Clorazepate monopotassium (USAN), Buspirone (INN), Hydroxyzine (INN), Nordazepam (INN), Tandospirone (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"PMID:10653203\", AUTHORS = \"Rickels K, DeMartinis N, Aufdembrinke B.\", TITLE = \"A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder.\", JOURNAL = \"J Clin Psychopharmacol 20:12-8 (2000)\"), list(REFERENCE = \"PMID:34039\", AUTHORS = \"Sternbach LH.\", TITLE = \"The benzodiazepine story.\", JOURNAL = c(\"J Med Chem 22:1-7 (1979)\", \"DOI:10.1021/jm00187a001\")), list(REFERENCE = \"PMID:8783370\", AUTHORS = \"Johnston GA.\", TITLE = \"GABAA receptor pharmacology.\", JOURNAL = c(\"Pharmacol Ther 69:173-98 (1996)\", \"DOI:10.1016/0163-7258(95)02043-8\")), list(REFERENCE = \"PMID:15969894\", AUTHORS = \"Michael Kaplan E, DuPont RL.\", TITLE = \"Benzodiazepines and anxiety disorders: a review for the practicing physician.\", JOURNAL = c(\"Curr Med Res Opin 21:941-50 (2005)\", \"DOI:10.1185/030079905X48401\")), list(REFERENCE = \"PMID:12625036\", AUTHORS = \"Bateson A.\", TITLE = \"Pagoclone Indevus.\", JOURNAL = \"Curr Opin Investig Drugs 4:91-5 (2003)\")', 'map07030', 'Anxiolytics', 'Anxiolytics', 'Y 23684, Alprazolam (JP17/USP/INN), Chlordiazepoxide (JP17/USP/INN), Diazepam (JP17/USP/INN), Lorazepam (JP17/USP/INN), Temazepam (USP/INN), Meprobamate (JAN/USP/INN), Oxazepam (JAN/USP/INN), Hydroxyzine hydrochloride (JP17/USP), Chlordiazepoxide hydrochloride (JAN/USP), Clorazepate dipotassium (JP17/USP), Buspirone hydrochloride (USP), Carisoprodol (JAN/USP/INN), Hydroxyzine pamoate (JP17/USP), Tofisopam (JP17/INN), Cloxazolam (JP17/INN), Flutazolam (JAN/INN), Ethyl loflazepate (JAN/INN), Mexazolam (JAN/INN), Clotiazepam (JP17/INN), Etizolam (JP17/INN), Lormetazepam (JAN/USAN/INN), Tandospirone citrate (JAN/USAN), Abecarnil (INN), Mephenesin (INN), Pagoclone (USAN/INN), Ocinaplon (USAN/INN), Clorazepate monopotassium (USAN), Buspirone (INN), Hydroxyzine (INN), Nordazepam (INN), Tandospirone (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"PMID:10653203\", AUTHORS = \"Rickels K, DeMartinis N, Aufdembrinke B.\", TITLE = \"A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder.\", JOURNAL = \"J Clin Psychopharmacol 20:12-8 (2000)\"), list(REFERENCE = \"PMID:34039\", AUTHORS = \"Sternbach LH.\", TITLE = \"The benzodiazepine story.\", JOURNAL = c(\"J Med Chem 22:1-7 (1979)\", \"DOI:10.1021/jm00187a001\")), list(REFERENCE = \"PMID:8783370\", AUTHORS = \"Johnston GA.\", TITLE = \"GABAA receptor pharmacology.\", JOURNAL = c(\"Pharmacol Ther 69:173-98 (1996)\", \"DOI:10.1016/0163-7258(95)02043-8\")), list(REFERENCE = \"PMID:15969894\", AUTHORS = \"Michael Kaplan E, DuPont RL.\", TITLE = \"Benzodiazepines and anxiety disorders: a review for the practicing physician.\", JOURNAL = c(\"Curr Med Res Opin 21:941-50 (2005)\", \"DOI:10.1185/030079905X48401\")), list(REFERENCE = \"PMID:12625036\", AUTHORS = \"Bateson A.\", TITLE = \"Pagoclone Indevus.\", JOURNAL = \"Curr Opin Investig Drugs 4:91-5 (2003)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (482, '07031', 'Antipsychotics - butyrophenones', 'Antipsychotics - butyrophenones', 'Haloperidol (JP17/USP/INN), Droperidol (JP17/USP/INN), Pimozide (JP17/USP/INN), Spiperone (JAN/USAN), Bromperidol (JAN/USAN/INN), Moperone hydrochloride (JAN), Pipamperone hydrochloride (JAN), Haloperidol decanoate (JAN/USAN), Timiperone (JAN), Azaperone (USP/INN), Fluanisone (INN), Pipamperone (USAN/INN), Moperone (INN), Trifluperidol (USAN/INN), Bromperidol decanoate (USAN), Benperidol (USAN/INN), Milenperone (USAN/INN), Fluspirilene (USAN/INN), Penfluridol (USAN/INN), Haloperidol lactate, Trifluperidol hydrochloride', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Gestel SV, Schuermans V.\", TITLE = \"Thirty-three years of drug discovery and research with Dr. Paul Janssen.\", JOURNAL = c(\"Drug Development Research 8(1-4):1-13 (1986)\", \"DOI:10.1002/ddr.430080103\"))', 'map07031', 'Antipsychotics - butyrophenones', 'Antipsychotics - butyrophenones', 'Haloperidol (JP17/USP/INN), Droperidol (JP17/USP/INN), Pimozide (JP17/USP/INN), Spiperone (JAN/USAN), Bromperidol (JAN/USAN/INN), Moperone hydrochloride (JAN), Pipamperone hydrochloride (JAN), Haloperidol decanoate (JAN/USAN), Timiperone (JAN), Azaperone (USP/INN), Fluanisone (INN), Pipamperone (USAN/INN), Moperone (INN), Trifluperidol (USAN/INN), Bromperidol decanoate (USAN), Benperidol (USAN/INN), Milenperone (USAN/INN), Fluspirilene (USAN/INN), Penfluridol (USAN/INN), Haloperidol lactate, Trifluperidol hydrochloride', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Gestel SV, Schuermans V.\", TITLE = \"Thirty-three years of drug discovery and research with Dr. Paul Janssen.\", JOURNAL = c(\"Drug Development Research 8(1-4):1-13 (1986)\", \"DOI:10.1002/ddr.430080103\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (483, '07032', 'Hypnotics', 'Hypnotics', 'Trichloroethanol, Urea (JP17/USP), Chloral hydrate (JP17/USP), Diazepam (JP17/USP/INN), Diphenhydramine (JP17/INN), Estazolam (JP17/USAN/INN), Flurazepam (JAN/INN), Temazepam (USP/INN), Triazolam (JAN/USP/INN), Triclofos sodium (JP17/USAN), Secobarbital (USP/INN), Quazepam (JAN/USP/INN), Promethazine hydrochloride (JP17/USP), Promethazine (JAN/INN), Pentobarbital (USP/INN), Pentobarbital sodium (JAN/USP), Phenobarbital (JP17/USP/INN), Zaleplon (JAN/USAN/INN), Nitrazepam (JP17/USAN/INN), Glutethimide (JAN/INN), Midazolam (JAN/USP/INN), Amobarbital (JP17/INN), Aminoglutethimide (USP/INN), Diphenhydramine hydrochloride (JP17/USP), Hydroxyzine hydrochloride (JP17/USP), Flurazepam hydrochloride (USP), Midazolam hydrochloride (USAN), Phenobarbital sodium (JAN/USP/INN), Zolpidem tartrate (JP17/USAN), Thalidomide (JAN/USP/INN), Hydroxyzine pamoate (JP17/USP), Methyprylon (JAN/INN), Flunitrazepam (JP17/USAN/INN), Promethazine teoclate (JAN/INN), Secobarbital sodium (JAN/USP), Zopiclone (JAN/INN), Bromovalerylurea (JP17), Flurazepam hydrochloride (JP17), Perlapine (JAN/USAN/INN), Butoctamide semisuccinate (JAN), Etizolam (JP17/INN), Rilmazafone hydrochloride hydrate (JAN), Nimetazepam (JAN/INN), Lormetazepam (JAN/USAN/INN), Barbital (JP17/INN), Brotizolam (JP17/USAN/INN), Haloxazolam (JP17/INN), Amobarbital sodium (JAN/USP), Pentobarbital calcium (JP17), Diphenhydramine salicylate (JAN), Butobarbital (BAN), Carbromal (INN), Eszopiclone (JAN/USAN/INN), Indiplon (USAN/INN), Ramelteon (JAN/USAN/INN), Diphenhydramine tannate (JP17), Promethazine methylenedisalicylate (JAN), Diphenhydramine laurylsulfate (JAN), Diphenhydramine citrate (USP), Midazolam maleate (USAN), Hydroxyzine (INN), Phenobarbital diethylamine, Promethazine maleate, Rilmazafone (INN), Triclofos (INN), Zolpidem (INN), Promethazine hibenzate', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"PMID:16185169\", AUTHORS = \"Neubauer DN.\", TITLE = \"Indiplon: the development of a new hypnotic.\", JOURNAL = c(\"Expert Opin Investig Drugs 14:1269-76 (2005)\", \"DOI:10.1517/13543784.14.10.1269\")), list(REFERENCE = \"PMID:34039\", AUTHORS = \"Sternbach LH.\", TITLE = \"The benzodiazepine story.\", JOURNAL = c(\"J Med Chem 22:1-7 (1979)\", \"DOI:10.1021/jm00187a001\")), list(REFERENCE = \"PMID:16373464\", AUTHORS = \"Halas CJ\", TITLE = \"Eszopiclone.\", JOURNAL = c(\"Am J Health Syst Pharm 63:41-8 (2006)\", \"DOI:10.2146/ajhp050357\"))', 'map07032', 'Hypnotics', 'Hypnotics', 'Trichloroethanol, Urea (JP17/USP), Chloral hydrate (JP17/USP), Diazepam (JP17/USP/INN), Diphenhydramine (JP17/INN), Estazolam (JP17/USAN/INN), Flurazepam (JAN/INN), Temazepam (USP/INN), Triazolam (JAN/USP/INN), Triclofos sodium (JP17/USAN), Secobarbital (USP/INN), Quazepam (JAN/USP/INN), Promethazine hydrochloride (JP17/USP), Promethazine (JAN/INN), Pentobarbital (USP/INN), Pentobarbital sodium (JAN/USP), Phenobarbital (JP17/USP/INN), Zaleplon (JAN/USAN/INN), Nitrazepam (JP17/USAN/INN), Glutethimide (JAN/INN), Midazolam (JAN/USP/INN), Amobarbital (JP17/INN), Aminoglutethimide (USP/INN), Diphenhydramine hydrochloride (JP17/USP), Hydroxyzine hydrochloride (JP17/USP), Flurazepam hydrochloride (USP), Midazolam hydrochloride (USAN), Phenobarbital sodium (JAN/USP/INN), Zolpidem tartrate (JP17/USAN), Thalidomide (JAN/USP/INN), Hydroxyzine pamoate (JP17/USP), Methyprylon (JAN/INN), Flunitrazepam (JP17/USAN/INN), Promethazine teoclate (JAN/INN), Secobarbital sodium (JAN/USP), Zopiclone (JAN/INN), Bromovalerylurea (JP17), Flurazepam hydrochloride (JP17), Perlapine (JAN/USAN/INN), Butoctamide semisuccinate (JAN), Etizolam (JP17/INN), Rilmazafone hydrochloride hydrate (JAN), Nimetazepam (JAN/INN), Lormetazepam (JAN/USAN/INN), Barbital (JP17/INN), Brotizolam (JP17/USAN/INN), Haloxazolam (JP17/INN), Amobarbital sodium (JAN/USP), Pentobarbital calcium (JP17), Diphenhydramine salicylate (JAN), Butobarbital (BAN), Carbromal (INN), Eszopiclone (JAN/USAN/INN), Indiplon (USAN/INN), Ramelteon (JAN/USAN/INN), Diphenhydramine tannate (JP17), Promethazine methylenedisalicylate (JAN), Diphenhydramine laurylsulfate (JAN), Diphenhydramine citrate (USP), Midazolam maleate (USAN), Hydroxyzine (INN), Phenobarbital diethylamine, Promethazine maleate, Rilmazafone (INN), Triclofos (INN), Zolpidem (INN), Promethazine hibenzate', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"PMID:16185169\", AUTHORS = \"Neubauer DN.\", TITLE = \"Indiplon: the development of a new hypnotic.\", JOURNAL = c(\"Expert Opin Investig Drugs 14:1269-76 (2005)\", \"DOI:10.1517/13543784.14.10.1269\")), list(REFERENCE = \"PMID:34039\", AUTHORS = \"Sternbach LH.\", TITLE = \"The benzodiazepine story.\", JOURNAL = c(\"J Med Chem 22:1-7 (1979)\", \"DOI:10.1021/jm00187a001\")), list(REFERENCE = \"PMID:16373464\", AUTHORS = \"Halas CJ\", TITLE = \"Eszopiclone.\", JOURNAL = c(\"Am J Health Syst Pharm 63:41-8 (2006)\", \"DOI:10.2146/ajhp050357\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (484, '07033', 'Anticonvulsants', 'Anticonvulsants', '10-Hydroxycarbazepine, Phenylethylmalonamide, Nirvanol, Fluorofelbamate, Acetazolamide (JP17/USP/INN), Carbamazepine (JP17/USP/INN), Clonazepam (JP17/USP/INN), Diazepam (JP17/USP/INN), Divalproex sodium (USP), Gabapentin (JAN/USAN/INN), Lamotrigine (JAN/USAN/INN), Mephenytoin (USP/INN), Trimethadione (JP17/INN), Valproic acid (USP), Primidone (JP17/USP/INN), Phenacemide (JAN/INN), Phenobarbital (JP17/USP/INN), Phenytoin (JP17/USP/INN), Nitrazepam (JP17/USAN/INN), Oxcarbazepine (JAN/USAN/INN), Vigabatrin (JAN/USAN/INN), Felbamate (USAN/INN), Topiramate (JAN/USAN/INN), Zonisamide (JP17/USAN/INN), Ethosuximide (JP17/USP/INN), Phenobarbital sodium (JAN/USP/INN), Ethotoin (JAN/USP/INN), Levetiracetam (JAN/USAN/INN), Valproate sodium (USAN), Acetazolamide sodium (JAN), Clobazam (JAN/USAN/INN), Metharbital (JAN/INN), Acetylpheneturide (JAN), Barbital (JP17/INN), Sulthiame (USAN), Piracetam (JAN/USAN/INN), Fosphenytoin sodium (USP), Tiagabine hydrochloride (USP), Phenytoin sodium (USP), Pregabalin (JAN/USAN/INN), Valnoctamide (USAN/INN), Valrocemide (USAN/INN), Valpromide (INN), Fosphenytoin sodium hydrate (JAN), Fosphenytoin (INN), Tiagabine (INN), Calcium valproate, Gabapentin enacarbil (JAN/USAN/INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:16382190\", AUTHORS = \"Stepien K, Tomaszewski M, Czuczwar SJ.\", TITLE = \"Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs--an update.\", JOURNAL = \"Pharmacol Rep 57:719-33 (2005)\"), list(REFERENCE = \"PMID:11805728\", AUTHORS = \"Bialer M.\", TITLE = \"New antiepileptic drugs currently in clinical trials: is there a strategy in their development?\", JOURNAL = \"Ther Drug Monit 24:85-90 (2002)\"), list(REFERENCE = \"PMID:11056076\", AUTHORS = \"Aiken SP, Brown WM.\", TITLE = \"Treatment of epilepsy: existing therapies and future developments.\", JOURNAL = \"Front Biosci 5:E124-52 (2000)\"), list(REFERENCE = \"PMID:16922870\", AUTHORS = \"Loscher W, Schmidt D.\", TITLE = \"Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs.\", JOURNAL = c(\"Epilepsia 47:1253-84 (2006)\", \"DOI:10.1111/j.1528-1167.2006.00607.x\"))', 'map07033', 'Anticonvulsants', 'Anticonvulsants', '10-Hydroxycarbazepine, Phenylethylmalonamide, Nirvanol, Fluorofelbamate, Acetazolamide (JP17/USP/INN), Carbamazepine (JP17/USP/INN), Clonazepam (JP17/USP/INN), Diazepam (JP17/USP/INN), Divalproex sodium (USP), Gabapentin (JAN/USAN/INN), Lamotrigine (JAN/USAN/INN), Mephenytoin (USP/INN), Trimethadione (JP17/INN), Valproic acid (USP), Primidone (JP17/USP/INN), Phenacemide (JAN/INN), Phenobarbital (JP17/USP/INN), Phenytoin (JP17/USP/INN), Nitrazepam (JP17/USAN/INN), Oxcarbazepine (JAN/USAN/INN), Vigabatrin (JAN/USAN/INN), Felbamate (USAN/INN), Topiramate (JAN/USAN/INN), Zonisamide (JP17/USAN/INN), Ethosuximide (JP17/USP/INN), Phenobarbital sodium (JAN/USP/INN), Ethotoin (JAN/USP/INN), Levetiracetam (JAN/USAN/INN), Valproate sodium (USAN), Acetazolamide sodium (JAN), Clobazam (JAN/USAN/INN), Metharbital (JAN/INN), Acetylpheneturide (JAN), Barbital (JP17/INN), Sulthiame (USAN), Piracetam (JAN/USAN/INN), Fosphenytoin sodium (USP), Tiagabine hydrochloride (USP), Phenytoin sodium (USP), Pregabalin (JAN/USAN/INN), Valnoctamide (USAN/INN), Valrocemide (USAN/INN), Valpromide (INN), Fosphenytoin sodium hydrate (JAN), Fosphenytoin (INN), Tiagabine (INN), Calcium valproate, Gabapentin enacarbil (JAN/USAN/INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:16382190\", AUTHORS = \"Stepien K, Tomaszewski M, Czuczwar SJ.\", TITLE = \"Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs--an update.\", JOURNAL = \"Pharmacol Rep 57:719-33 (2005)\"), list(REFERENCE = \"PMID:11805728\", AUTHORS = \"Bialer M.\", TITLE = \"New antiepileptic drugs currently in clinical trials: is there a strategy in their development?\", JOURNAL = \"Ther Drug Monit 24:85-90 (2002)\"), list(REFERENCE = \"PMID:11056076\", AUTHORS = \"Aiken SP, Brown WM.\", TITLE = \"Treatment of epilepsy: existing therapies and future developments.\", JOURNAL = \"Front Biosci 5:E124-52 (2000)\"), list(REFERENCE = \"PMID:16922870\", AUTHORS = \"Loscher W, Schmidt D.\", TITLE = \"Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs.\", JOURNAL = c(\"Epilepsia 47:1253-84 (2006)\", \"DOI:10.1111/j.1528-1167.2006.00607.x\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (485, '07034', 'Eicosanoids', 'Eicosanoids', 'Arachidonate, Prostaglandin H2, Leukotriene A4, Leukotriene B4, Thromboxane A2, 5(S)-HPETE, Prostaglandin G2, Epoprostenol (USAN/INN), Zafirlukast (JAN/USAN/INN), Montelukast sodium (JP17/USAN), Seratrodast (JAN/USAN/INN), Ramatroban (JAN/INN), Epoprostenol sodium (JAN/USAN), Beraprost sodium (JP17/USAN), Ozagrel hydrochloride hydrate (JAN), Ozagrel sodium (JP17), Beraprost (USAN), Iloprost (USAN/INN), Pranlukast hydrate (JP17), Iloprost tromethamine, Montelukast (INN), Ozagrel (INN), Pranlukast (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Collins PW, Djuric SW.\", TITLE = \"Synthesis of therapeutically useful prostaglandin and prostacyclin analogs.\", JOURNAL = c(\"Chemical Reviews 93(4):1533-1564 (1993)\", \"DOI:10.1021/cr00020a007\")), list(REFERENCE = \"PMID:11829716\", AUTHORS = \"Dogne JM, de Leval X, Benoit P, Rolin S, Pirotte B, Masereel B.\", TITLE = \"Therapeutic potential of thromboxane inhibitors in asthma.\", JOURNAL = c(\"Expert Opin Investig Drugs 11:275-81 (2002)\", \"DOI:10.1517/13543784.11.2.275\")), list(REFERENCE = \"PMID:12052325\", AUTHORS = \"McMillan RM.\", TITLE = \"Leukotrienes in respiratory disease.\", JOURNAL = c(\"Paediatr Respir Rev 2:238-44 (2001)\", \"DOI:10.1053/prrv.2001.0146\"))', 'map07034', 'Eicosanoids', 'Eicosanoids', 'Arachidonate, Prostaglandin H2, Leukotriene A4, Leukotriene B4, Thromboxane A2, 5(S)-HPETE, Prostaglandin G2, Epoprostenol (USAN/INN), Zafirlukast (JAN/USAN/INN), Montelukast sodium (JP17/USAN), Seratrodast (JAN/USAN/INN), Ramatroban (JAN/INN), Epoprostenol sodium (JAN/USAN), Beraprost sodium (JP17/USAN), Ozagrel hydrochloride hydrate (JAN), Ozagrel sodium (JP17), Beraprost (USAN), Iloprost (USAN/INN), Pranlukast hydrate (JP17), Iloprost tromethamine, Montelukast (INN), Ozagrel (INN), Pranlukast (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Collins PW, Djuric SW.\", TITLE = \"Synthesis of therapeutically useful prostaglandin and prostacyclin analogs.\", JOURNAL = c(\"Chemical Reviews 93(4):1533-1564 (1993)\", \"DOI:10.1021/cr00020a007\")), list(REFERENCE = \"PMID:11829716\", AUTHORS = \"Dogne JM, de Leval X, Benoit P, Rolin S, Pirotte B, Masereel B.\", TITLE = \"Therapeutic potential of thromboxane inhibitors in asthma.\", JOURNAL = c(\"Expert Opin Investig Drugs 11:275-81 (2002)\", \"DOI:10.1517/13543784.11.2.275\")), list(REFERENCE = \"PMID:12052325\", AUTHORS = \"McMillan RM.\", TITLE = \"Leukotrienes in respiratory disease.\", JOURNAL = c(\"Paediatr Respir Rev 2:238-44 (2001)\", \"DOI:10.1053/prrv.2001.0146\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (486, '07035', 'Prostaglandins', 'Prostaglandins', 'Prostaglandin H2, S 1033, Dinoprostone (JAN/USP/INN), Dinoprost (JP17/USAN/INN), Alprostadil (JP17/USP/INN), Latanoprost (JAN/USAN/INN), Misoprostol (JAN/USAN/INN), Carboprost tromethamine (USP), Dinoprost tromethamine (JAN/USP), Isopropyl unoprostone (JAN), Ornoprostil (JAN/INN), Enprostil (JAN/USAN/INN), Travoprost (JAN/USAN/INN), Gemeprost (JAN/USAN/INN), Carboprost (USAN/INN), Alprostadil alfadex (JP17), Rosaprostol (INN), Limaprost (INN), Ecraprost (USAN/INN), Bimatoprost (JAN/USAN/INN), Sulprostone (USAN/INN), Meteneprost (USAN/INN), Limaprost alfadex (JP17), Dinoprostone betadex (JAN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Collins PW, Djuric SW.\", TITLE = \"Synthesis of therapeutically useful prostaglandin and prostacyclin analogs.\", JOURNAL = c(\"Chemical Reviews 93(4):1533-1564 (1993)\", \"DOI:10.1021/cr00020a007\")), list(REFERENCE = \"\", AUTHORS = \"Igarashi R, Mizushima Y.\", TITLE = \"New lipo-PGE1 using a stable prodrug of prostaglandin E1 (PGE1).\", JOURNAL = c(\"Advanced Drug Delivery Reviews 20(2-3):189-194 (1996)\", \"DOI:10.1016/0169-409X(95)00117-P\")), list(REFERENCE = \"PMID:12556403\", AUTHORS = \"Sharif NA, Kelly CR, Crider JY.\", TITLE = \"Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.\", JOURNAL = c(\"Invest Ophthalmol Vis Sci 44:715-21 (2003)\", \"DOI:10.1167/iovs.02-0323\")), list(REFERENCE = \"PMID:15087728\", AUTHORS = \"Nguyen QH.\", TITLE = \"The role of prostaglandin analogues in the treatment of glaucoma in the 21st century.\", JOURNAL = \"Int Ophthalmol Clin 44:15-27 (2004)\")', 'map07035', 'Prostaglandins', 'Prostaglandins', 'Prostaglandin H2, S 1033, Dinoprostone (JAN/USP/INN), Dinoprost (JP17/USAN/INN), Alprostadil (JP17/USP/INN), Latanoprost (JAN/USAN/INN), Misoprostol (JAN/USAN/INN), Carboprost tromethamine (USP), Dinoprost tromethamine (JAN/USP), Isopropyl unoprostone (JAN), Ornoprostil (JAN/INN), Enprostil (JAN/USAN/INN), Travoprost (JAN/USAN/INN), Gemeprost (JAN/USAN/INN), Carboprost (USAN/INN), Alprostadil alfadex (JP17), Rosaprostol (INN), Limaprost (INN), Ecraprost (USAN/INN), Bimatoprost (JAN/USAN/INN), Sulprostone (USAN/INN), Meteneprost (USAN/INN), Limaprost alfadex (JP17), Dinoprostone betadex (JAN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Collins PW, Djuric SW.\", TITLE = \"Synthesis of therapeutically useful prostaglandin and prostacyclin analogs.\", JOURNAL = c(\"Chemical Reviews 93(4):1533-1564 (1993)\", \"DOI:10.1021/cr00020a007\")), list(REFERENCE = \"\", AUTHORS = \"Igarashi R, Mizushima Y.\", TITLE = \"New lipo-PGE1 using a stable prodrug of prostaglandin E1 (PGE1).\", JOURNAL = c(\"Advanced Drug Delivery Reviews 20(2-3):189-194 (1996)\", \"DOI:10.1016/0169-409X(95)00117-P\")), list(REFERENCE = \"PMID:12556403\", AUTHORS = \"Sharif NA, Kelly CR, Crider JY.\", TITLE = \"Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues.\", JOURNAL = c(\"Invest Ophthalmol Vis Sci 44:715-21 (2003)\", \"DOI:10.1167/iovs.02-0323\")), list(REFERENCE = \"PMID:15087728\", AUTHORS = \"Nguyen QH.\", TITLE = \"The role of prostaglandin analogues in the treatment of glaucoma in the 21st century.\", JOURNAL = \"Int Ophthalmol Clin 44:15-27 (2004)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (487, '07036', 'Calcium channel blocking drugs', 'Calcium channel blocking drugs', 'Divalproex sodium (USP), Felodipine (JAN/USP/INN), Isradipine (USP/INN), Valproic acid (USP), Nifedipine (JP17/USP/INN), Nimodipine (USAN/INN), Ethosuximide (JP17/USP/INN), Amlodipine besylate (USAN), Diltiazem hydrochloride (JP17/USP), Nicardipine hydrochloride (JP17/USAN), Nisoldipine (JAN/USAN/INN), Verapamil hydrochloride (JP17/USP), Nitrendipine (JP17/USAN/INN), Bepridil hydrochloride (USAN), Valproate sodium (USAN), Barnidipine hydrochloride (JAN), Azelnidipine (JP17/INN), Cilnidipine (JP17/INN), Cinnarizine (JAN/USAN/INN), Flunarizine hydrochloride (JAN/USAN), Manidipine hydrochloride (JP17), Aranidipine (JAN/INN), Efonidipine hydrochloride ethanolate (JAN), Nilvadipine (JP17/USAN/INN), Gallopamil hydrochloride (JAN), Benidipine hydrochloride (JP17), Verapamil (USAN/INN), Lomerizine hydrochloride (JAN), Amlodipine maleate (USAN), Diltiazem malate (USAN), Lacidipine (USAN/INN), Mibefradil dihydrochloride (USAN), Amlodipine (USAN/INN), Barnidipine (INN), Benidipine (INN), Bepridil (INN), Cinnarizine dihydrochloride, Diltiazem (INN), Efonidipine (INN), Flunarizine (INN), Gallopamil (INN), Manidipine (INN), Mibefradil (INN), Nicardipine (INN), Calcium valproate', 'list(REFERENCE = \"PMID:16150216\", AUTHORS = \"Palamaras I, Kyriakis K.\", TITLE = \"Calcium antagonists in dermatology: a review of the evidence and research-based studies.\", JOURNAL = \"Dermatol Online J 11:8 (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"PMID:11005649\", AUTHORS = \"Arh M, Budihna MV.\", TITLE = \"Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts.\", JOURNAL = \"Pflugers Arch 440:R149-50 (2000)\"), list(REFERENCE = \"PMID:16399866\", AUTHORS = \"Li M, Hu J, Chen Z, Meng J, Wang H, Ma X, Luo X\", TITLE = \"Evidence for histamine as a neurotransmitter in the cardiac sympathetic nervous system.\", JOURNAL = c(\"Am J Physiol Heart Circ Physiol 291:H45-51 (2006)\", \"DOI:10.1152/ajpheart.00939.2005\")), list(REFERENCE = \"PMID:10373231\", AUTHORS = \"Sakata K, Shirotani M, Yoshida H, Nawada R, Obayashi K, Togi K, Miho N.\", TITLE = \"Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.\", JOURNAL = c(\"Hypertension 33:1447-52 (1999)\", \"DOI:10.1161/01.HYP.33.6.1447\")), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\")', 'map07036', 'Calcium channel blocking drugs', 'Calcium channel blocking drugs', 'Divalproex sodium (USP), Felodipine (JAN/USP/INN), Isradipine (USP/INN), Valproic acid (USP), Nifedipine (JP17/USP/INN), Nimodipine (USAN/INN), Ethosuximide (JP17/USP/INN), Amlodipine besylate (USAN), Diltiazem hydrochloride (JP17/USP), Nicardipine hydrochloride (JP17/USAN), Nisoldipine (JAN/USAN/INN), Verapamil hydrochloride (JP17/USP), Nitrendipine (JP17/USAN/INN), Bepridil hydrochloride (USAN), Valproate sodium (USAN), Barnidipine hydrochloride (JAN), Azelnidipine (JP17/INN), Cilnidipine (JP17/INN), Cinnarizine (JAN/USAN/INN), Flunarizine hydrochloride (JAN/USAN), Manidipine hydrochloride (JP17), Aranidipine (JAN/INN), Efonidipine hydrochloride ethanolate (JAN), Nilvadipine (JP17/USAN/INN), Gallopamil hydrochloride (JAN), Benidipine hydrochloride (JP17), Verapamil (USAN/INN), Lomerizine hydrochloride (JAN), Amlodipine maleate (USAN), Diltiazem malate (USAN), Lacidipine (USAN/INN), Mibefradil dihydrochloride (USAN), Amlodipine (USAN/INN), Barnidipine (INN), Benidipine (INN), Bepridil (INN), Cinnarizine dihydrochloride, Diltiazem (INN), Efonidipine (INN), Flunarizine (INN), Gallopamil (INN), Manidipine (INN), Mibefradil (INN), Nicardipine (INN), Calcium valproate', 'list(REFERENCE = \"PMID:16150216\", AUTHORS = \"Palamaras I, Kyriakis K.\", TITLE = \"Calcium antagonists in dermatology: a review of the evidence and research-based studies.\", JOURNAL = \"Dermatol Online J 11:8 (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"PMID:11005649\", AUTHORS = \"Arh M, Budihna MV.\", TITLE = \"Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts.\", JOURNAL = \"Pflugers Arch 440:R149-50 (2000)\"), list(REFERENCE = \"PMID:16399866\", AUTHORS = \"Li M, Hu J, Chen Z, Meng J, Wang H, Ma X, Luo X\", TITLE = \"Evidence for histamine as a neurotransmitter in the cardiac sympathetic nervous system.\", JOURNAL = c(\"Am J Physiol Heart Circ Physiol 291:H45-51 (2006)\", \"DOI:10.1152/ajpheart.00939.2005\")), list(REFERENCE = \"PMID:10373231\", AUTHORS = \"Sakata K, Shirotani M, Yoshida H, Nawada R, Obayashi K, Togi K, Miho N.\", TITLE = \"Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.\", JOURNAL = c(\"Hypertension 33:1447-52 (1999)\", \"DOI:10.1161/01.HYP.33.6.1447\")), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (488, '07037', 'Antiarrhythmic drugs', 'Antiarrhythmic drugs', 'Bretylium, Clofilium, Azimilide, Atenolol (JP17/USP/INN), Disopyramide (JP17/USAN/INN), Lidocaine (JP17/USP/INN), Procainamide hydrochloride (JP17/USP), Propranolol hydrochloride (JP17/USP), Pindolol (JP17/USP/INN), Metoprolol tartrate (JP17/USP), Diltiazem hydrochloride (JP17/USP), Verapamil hydrochloride (JP17/USP), Bepridil hydrochloride (USAN), Metoprolol succinate (USP), Amiodarone hydrochloride (JP17/USAN), Disopyramide phosphate (JAN/USP), Flecainide acetate (JP17/USP), Mexiletine hydrochloride (JP17/USP), Propafenone hydrochloride (JP17/USP), Quinidine gluconate (USP), Quinidine polygalacturonate, Bretylium tosylate (USP), Dofetilide (JAN/USAN/INN), Ibutilide fumarate (USAN), Procaine hydrochloride (JP17/USP), Sotalol hydrochloride (JAN/USP), Alprenolol hydrochloride (JP17/USAN), Aprindine hydrochloride (JP17/USAN), Pilsicainide hydrochloride hydrate (JP17), Pirmenol hydrochloride hydrate (JAN), Benziodarone (JAN/INN), Nifekalant hydrochloride (JAN), Lidocaine hydrochloride (JAN/USP), Tocainide hydrochloride (USP), Quinidine sulfate (USP), Verapamil (USAN/INN), Metoprolol (USAN/INN), Dronedarone (INN), Acecainide hydrochloride (USAN), Amiodarone (USAN/INN), Aprindine (USAN/INN), Azimilide dihydrochloride (USAN), Clofilium phosphate (USAN/INN), Dexsotalol hydrochloride (USAN), Diltiazem malate (USAN), Dronedarone hydrochloride (USAN), Encainide hydrochloride (USAN), Sematilide hydrochloride (USAN), Metoprolol fumarate (USP), Practolol (USAN), Tocainide (USAN/INN), Pirmenol hydrochloride (USAN), Alprenolol (INN), Bepridil (INN), Diltiazem (INN), Encainide (INN), Flecainide (INN), Ibutilide (INN), Lidocaine hydrochloride monohydrate, Mexiletine (INN), Pilsicainide (INN), Pirmenol (INN), Procainamide (INN), Procaine (INN), Propafenone (INN), Propranolol (INN), Quinidine (BAN), Quinidine phenylethylbarbiturate, Sotalol (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:11916001\", AUTHORS = \"Castro A, Bianconi L, Santini M.\", TITLE = \"New antiarrhythmic drugs for the treatment of atrial fibrillation.\", JOURNAL = c(\"Pacing Clin Electrophysiol 25:249-59 (2002)\", \"DOI:10.1046/j.1460-9592.2002.00249.x\")), list(REFERENCE = \"PMID:2447771\", AUTHORS = \"Woosley RL, Funck-Brentano C\", TITLE = \"Overview of the clinical pharmacology of antiarrhythmic drugs.\", JOURNAL = c(\"Am J Cardiol 61:61A-69A (1988)\", \"DOI:10.1016/0002-9149(88)90741-2\"))', 'map07037', 'Antiarrhythmic drugs', 'Antiarrhythmic drugs', 'Bretylium, Clofilium, Azimilide, Atenolol (JP17/USP/INN), Disopyramide (JP17/USAN/INN), Lidocaine (JP17/USP/INN), Procainamide hydrochloride (JP17/USP), Propranolol hydrochloride (JP17/USP), Pindolol (JP17/USP/INN), Metoprolol tartrate (JP17/USP), Diltiazem hydrochloride (JP17/USP), Verapamil hydrochloride (JP17/USP), Bepridil hydrochloride (USAN), Metoprolol succinate (USP), Amiodarone hydrochloride (JP17/USAN), Disopyramide phosphate (JAN/USP), Flecainide acetate (JP17/USP), Mexiletine hydrochloride (JP17/USP), Propafenone hydrochloride (JP17/USP), Quinidine gluconate (USP), Quinidine polygalacturonate, Bretylium tosylate (USP), Dofetilide (JAN/USAN/INN), Ibutilide fumarate (USAN), Procaine hydrochloride (JP17/USP), Sotalol hydrochloride (JAN/USP), Alprenolol hydrochloride (JP17/USAN), Aprindine hydrochloride (JP17/USAN), Pilsicainide hydrochloride hydrate (JP17), Pirmenol hydrochloride hydrate (JAN), Benziodarone (JAN/INN), Nifekalant hydrochloride (JAN), Lidocaine hydrochloride (JAN/USP), Tocainide hydrochloride (USP), Quinidine sulfate (USP), Verapamil (USAN/INN), Metoprolol (USAN/INN), Dronedarone (INN), Acecainide hydrochloride (USAN), Amiodarone (USAN/INN), Aprindine (USAN/INN), Azimilide dihydrochloride (USAN), Clofilium phosphate (USAN/INN), Dexsotalol hydrochloride (USAN), Diltiazem malate (USAN), Dronedarone hydrochloride (USAN), Encainide hydrochloride (USAN), Sematilide hydrochloride (USAN), Metoprolol fumarate (USP), Practolol (USAN), Tocainide (USAN/INN), Pirmenol hydrochloride (USAN), Alprenolol (INN), Bepridil (INN), Diltiazem (INN), Encainide (INN), Flecainide (INN), Ibutilide (INN), Lidocaine hydrochloride monohydrate, Mexiletine (INN), Pilsicainide (INN), Pirmenol (INN), Procainamide (INN), Procaine (INN), Propafenone (INN), Propranolol (INN), Quinidine (BAN), Quinidine phenylethylbarbiturate, Sotalol (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:11916001\", AUTHORS = \"Castro A, Bianconi L, Santini M.\", TITLE = \"New antiarrhythmic drugs for the treatment of atrial fibrillation.\", JOURNAL = c(\"Pacing Clin Electrophysiol 25:249-59 (2002)\", \"DOI:10.1046/j.1460-9592.2002.00249.x\")), list(REFERENCE = \"PMID:2447771\", AUTHORS = \"Woosley RL, Funck-Brentano C\", TITLE = \"Overview of the clinical pharmacology of antiarrhythmic drugs.\", JOURNAL = c(\"Am J Cardiol 61:61A-69A (1988)\", \"DOI:10.1016/0002-9149(88)90741-2\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (489, '07038', 'Antiulcer drugs', 'Antiulcer drugs', 'Cimetidine (JP17/USP/INN), Famotidine (JP17/USP/INN), Lansoprazole (JP17/USP/INN), Misoprostol (JAN/USAN/INN), Ranitidine (USAN/INN), Nizatidine (JP17/USP/INN), Sucralfate (USP/INN), Omeprazole (JP17/USP/INN), Propantheline bromide (JP17/USP/INN), Ranitidine hydrochloride (JP17/USP), Rabeprazole sodium (JP17/USAN), Magnesium hydroxide (JAN/USP), Calcium carbonate (USP), Rebamipide (JP17/INN), Lafutidine (JP17/INN), Oxethazaine (JP17/USAN), Piperidolate hydrochloride (JAN), Magnesium oxide (JP17/USP), Sodium bicarbonate (JP17/USP), Omeprazole sodium (USAN), Pirenzepine hydrochloride (USAN), Prifinium bromide (JAN/INN), Scopolamine butylbromide (JP17), Roxatidine acetate hydrochloride (JP17/USAN), Butropium bromide (JP17/INN), Polaprezinc (JAN/INN), Irsogladine maleate (JP17), Plaunotol (JAN/INN), Oxapium iodide (JP17/INN), Proglumide (JP17/USAN/INN), Teprenone (JP17/INN), Ornoprostil (JAN/INN), Tiquizium bromide (JAN/INN), Enprostil (JAN/USAN/INN), Tenatoprazole (JAN/INN), Sofalcone (JAN), Esomeprazole magnesium (USP), Ecabet sodium hydrate (JP17), Sodium gualenate (INN), Cetraxate hydrochloride (JP17/USAN), Aluminum hydroxide (USP), Timepidium bromide hydrate (JP17), Pantoprazole sodium (USAN), Sodium gualenate hydrate (JAN), Synthetic aluminum silicate (JP17), Natural aluminum silicate (JP17), Hydrotalcite (JAN/INN), Magnesium trisilicate (USP), Cimetidine hydrochloride (USP), Esomeprazole sodium (USAN), Magnesium silicate (JP17/NF), Omeprazole magnesium (USAN), Omeprazole sodium injection (JAN), Pirenzepine hydrochloride hydrate (JP17), Pantoprazole (USAN/INN), Ranitidine bismuth citrate (USAN), Timoprazole (INN), Picoprazole (INN), Leminoprazole (INN), Cetraxate (INN), Ecabet (INN), Esomeprazole (INN), Irsogladine (INN), Piperidolate (INN), Pirenzepine (INN), Rabeprazole (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:16700898\", AUTHORS = \"Sachs G, Shin JM, Howden CW\", TITLE = \"Review article: the clinical pharmacology of proton pump inhibitors.\", JOURNAL = c(\"Aliment Pharmacol Ther 23 Suppl 2:2-8 (2006)\", \"DOI:10.1111/j.1365-2036.2006.02943.x\")), list(REFERENCE = \"PMID:16700900\", AUTHORS = \"Scarpignato C, Pelosini I\", TITLE = \"Review article: the opportunities and benefits of extended acid suppression.\", JOURNAL = c(\"Aliment Pharmacol Ther 23 Suppl 2:23-34 (2006)\", \"DOI:10.1111/j.1365-2036.2006.02945.x\")), list(REFERENCE = \"PMID:14603076\", AUTHORS = \"Der G.\", TITLE = \"An overview of proton pump inhibitors.\", JOURNAL = \"Gastroenterol Nurs 26:182-90 (2003)\")', 'map07038', 'Antiulcer drugs', 'Antiulcer drugs', 'Cimetidine (JP17/USP/INN), Famotidine (JP17/USP/INN), Lansoprazole (JP17/USP/INN), Misoprostol (JAN/USAN/INN), Ranitidine (USAN/INN), Nizatidine (JP17/USP/INN), Sucralfate (USP/INN), Omeprazole (JP17/USP/INN), Propantheline bromide (JP17/USP/INN), Ranitidine hydrochloride (JP17/USP), Rabeprazole sodium (JP17/USAN), Magnesium hydroxide (JAN/USP), Calcium carbonate (USP), Rebamipide (JP17/INN), Lafutidine (JP17/INN), Oxethazaine (JP17/USAN), Piperidolate hydrochloride (JAN), Magnesium oxide (JP17/USP), Sodium bicarbonate (JP17/USP), Omeprazole sodium (USAN), Pirenzepine hydrochloride (USAN), Prifinium bromide (JAN/INN), Scopolamine butylbromide (JP17), Roxatidine acetate hydrochloride (JP17/USAN), Butropium bromide (JP17/INN), Polaprezinc (JAN/INN), Irsogladine maleate (JP17), Plaunotol (JAN/INN), Oxapium iodide (JP17/INN), Proglumide (JP17/USAN/INN), Teprenone (JP17/INN), Ornoprostil (JAN/INN), Tiquizium bromide (JAN/INN), Enprostil (JAN/USAN/INN), Tenatoprazole (JAN/INN), Sofalcone (JAN), Esomeprazole magnesium (USP), Ecabet sodium hydrate (JP17), Sodium gualenate (INN), Cetraxate hydrochloride (JP17/USAN), Aluminum hydroxide (USP), Timepidium bromide hydrate (JP17), Pantoprazole sodium (USAN), Sodium gualenate hydrate (JAN), Synthetic aluminum silicate (JP17), Natural aluminum silicate (JP17), Hydrotalcite (JAN/INN), Magnesium trisilicate (USP), Cimetidine hydrochloride (USP), Esomeprazole sodium (USAN), Magnesium silicate (JP17/NF), Omeprazole magnesium (USAN), Omeprazole sodium injection (JAN), Pirenzepine hydrochloride hydrate (JP17), Pantoprazole (USAN/INN), Ranitidine bismuth citrate (USAN), Timoprazole (INN), Picoprazole (INN), Leminoprazole (INN), Cetraxate (INN), Ecabet (INN), Esomeprazole (INN), Irsogladine (INN), Piperidolate (INN), Pirenzepine (INN), Rabeprazole (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:16700898\", AUTHORS = \"Sachs G, Shin JM, Howden CW\", TITLE = \"Review article: the clinical pharmacology of proton pump inhibitors.\", JOURNAL = c(\"Aliment Pharmacol Ther 23 Suppl 2:2-8 (2006)\", \"DOI:10.1111/j.1365-2036.2006.02943.x\")), list(REFERENCE = \"PMID:16700900\", AUTHORS = \"Scarpignato C, Pelosini I\", TITLE = \"Review article: the opportunities and benefits of extended acid suppression.\", JOURNAL = c(\"Aliment Pharmacol Ther 23 Suppl 2:23-34 (2006)\", \"DOI:10.1111/j.1365-2036.2006.02945.x\")), list(REFERENCE = \"PMID:14603076\", AUTHORS = \"Der G.\", TITLE = \"An overview of proton pump inhibitors.\", JOURNAL = \"Gastroenterol Nurs 26:182-90 (2003)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (490, '07039', 'Opioid analgesics', 'Opioid analgesics', 'Thebaine, Phenazocine, Bremazocine, Codeine (USP), Fentanyl (JAN/USAN/INN), Propoxyphene hydrochloride (USP), Pentazocine (JP17/USP/INN), Alfentanil hydrochloride (USP), Buprenorphine hydrochloride (JP17/USP), Butorphanol tartrate (JAN/USP), Hydromorphone hydrochloride (JAN/USP), Levomethadyl acetate hydrochloride (USAN), Levorphanol tartrate (USP), Morphine sulfate (USP), Nalbuphine hydrochloride (USAN), Oxymorphone hydrochloride (USP), Sufentanil citrate (USP), Oxycodone hydrochloride (USP), Naloxone hydrochloride (JP17/USP), Meperidine hydrochloride (USP), Fentanyl citrate (JP17/USP), Naltrexone hydrochloride (USP), Codeine phosphate (USP), Methadone hydrochloride (JAN/USP), Pentazocine lactate (USP), Pentazocine hydrochloride (JAN/USP), Levallorphan tartrate (JP17), Morphine hydrochloride hydrate (JP17), Butorphanol (USAN/INN), Codeine sulfate (USP), Hydrocodone bitartrate (USP), Oxycodone terephthalate (USP), Levomethadyl acetate (USAN), Naltrexone (USAN/INN), Oxycodone (USAN/INN), Oxycodone hydrochloride hydrate (JP17), Propoxyphene napsylate (USAN), Sufentanil (USAN/INN), Trimeperidine (INN), Alfentanil (INN), Buprenorphine (JAN/INN), Diamorphine (BAN), Codeine hydrochloride, Dextropropoxyphene (INN), Diacetylmorphine hydrochloride, Diprenorphine (INN), Diprenorphine hydrochloride, Hydrocodone (INN), Hydrocodone hydrochloride, Hydromorphone (INN), Levorphanol (INN), Methadone (BAN), Morphine (BAN), Nalbuphine (INN), Nalorphine (INN), Nalorphine hydrochloride (USP), Naloxone (INN), Oxymorphone (INN), Pethidine (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"PMID:8390660\", AUTHORS = \"Brownstein MJ.\", TITLE = \"A brief history of opiates, opioid peptides, and opioid receptors.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 90:5391-3 (1993)\", \"DOI:10.1073/pnas.90.12.5391\"))', 'map07039', 'Opioid analgesics', 'Opioid analgesics', 'Thebaine, Phenazocine, Bremazocine, Codeine (USP), Fentanyl (JAN/USAN/INN), Propoxyphene hydrochloride (USP), Pentazocine (JP17/USP/INN), Alfentanil hydrochloride (USP), Buprenorphine hydrochloride (JP17/USP), Butorphanol tartrate (JAN/USP), Hydromorphone hydrochloride (JAN/USP), Levomethadyl acetate hydrochloride (USAN), Levorphanol tartrate (USP), Morphine sulfate (USP), Nalbuphine hydrochloride (USAN), Oxymorphone hydrochloride (USP), Sufentanil citrate (USP), Oxycodone hydrochloride (USP), Naloxone hydrochloride (JP17/USP), Meperidine hydrochloride (USP), Fentanyl citrate (JP17/USP), Naltrexone hydrochloride (USP), Codeine phosphate (USP), Methadone hydrochloride (JAN/USP), Pentazocine lactate (USP), Pentazocine hydrochloride (JAN/USP), Levallorphan tartrate (JP17), Morphine hydrochloride hydrate (JP17), Butorphanol (USAN/INN), Codeine sulfate (USP), Hydrocodone bitartrate (USP), Oxycodone terephthalate (USP), Levomethadyl acetate (USAN), Naltrexone (USAN/INN), Oxycodone (USAN/INN), Oxycodone hydrochloride hydrate (JP17), Propoxyphene napsylate (USAN), Sufentanil (USAN/INN), Trimeperidine (INN), Alfentanil (INN), Buprenorphine (JAN/INN), Diamorphine (BAN), Codeine hydrochloride, Dextropropoxyphene (INN), Diacetylmorphine hydrochloride, Diprenorphine (INN), Diprenorphine hydrochloride, Hydrocodone (INN), Hydrocodone hydrochloride, Hydromorphone (INN), Levorphanol (INN), Methadone (BAN), Morphine (BAN), Nalbuphine (INN), Nalorphine (INN), Nalorphine hydrochloride (USP), Naloxone (INN), Oxymorphone (INN), Pethidine (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"PMID:8390660\", AUTHORS = \"Brownstein MJ.\", TITLE = \"A brief history of opiates, opioid peptides, and opioid receptors.\", JOURNAL = c(\"Proc Natl Acad Sci U S A 90:5391-3 (1993)\", \"DOI:10.1073/pnas.90.12.5391\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (491, '07040', 'Antineoplastics - alkylating agents', 'Antineoplastics - alkylating agents', 'Triethylenemelamine, Methylnitrosourea, MTIC, Mitomycin (USP/INN), Busulfan (JP17/USP/INN), Carmustine (JAN/USAN/INN), Chlorambucil (JAN/USP/INN), Cisplatin (JP17/USP/INN), Cyclophosphamide (USP), Dacarbazine (JAN/USP/INN), Ifosfamide (JAN/USP/INN), Lomustine (USAN/INN), Melphalan (JP17/USP/INN), Thiotepa (JAN/USP/INN), Nimustine hydrochloride (JAN), Carboquone (JAN/INN), Carboplatin (JP17/USP/INN), Nedaplatin (JAN/INN), Nitrogen mustard N-oxide hydrochloride (JAN), Ranimustine (JAN/INN), Oxaliplatin (JAN/USAN/INN), Estramustine phosphate sodium (USAN), Estramustine (USAN/INN), Mechlorethamine hydrochloride (USP), Semustine (USAN/INN), Streptozocin (JAN/USAN/INN), Temozolomide (JAN/USAN/INN), Miriplatin hydrate (JAN), Estramustine phosphate sodium hydrate (JAN), Chlormethine (INN), Cyclophosphamide (INN), Dacarbazine citrate, Melphalan hydrochloride, Nimustine (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Skeel RT (ed).\", TITLE = \"[Handbook of Cancer Chemotherapy (6th ed)] (In Japanese)\", JOURNAL = \"Medical science international (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\")', 'map07040', 'Antineoplastics - alkylating agents', 'Antineoplastics - alkylating agents', 'Triethylenemelamine, Methylnitrosourea, MTIC, Mitomycin (USP/INN), Busulfan (JP17/USP/INN), Carmustine (JAN/USAN/INN), Chlorambucil (JAN/USP/INN), Cisplatin (JP17/USP/INN), Cyclophosphamide (USP), Dacarbazine (JAN/USP/INN), Ifosfamide (JAN/USP/INN), Lomustine (USAN/INN), Melphalan (JP17/USP/INN), Thiotepa (JAN/USP/INN), Nimustine hydrochloride (JAN), Carboquone (JAN/INN), Carboplatin (JP17/USP/INN), Nedaplatin (JAN/INN), Nitrogen mustard N-oxide hydrochloride (JAN), Ranimustine (JAN/INN), Oxaliplatin (JAN/USAN/INN), Estramustine phosphate sodium (USAN), Estramustine (USAN/INN), Mechlorethamine hydrochloride (USP), Semustine (USAN/INN), Streptozocin (JAN/USAN/INN), Temozolomide (JAN/USAN/INN), Miriplatin hydrate (JAN), Estramustine phosphate sodium hydrate (JAN), Chlormethine (INN), Cyclophosphamide (INN), Dacarbazine citrate, Melphalan hydrochloride, Nimustine (INN)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Skeel RT (ed).\", TITLE = \"[Handbook of Cancer Chemotherapy (6th ed)] (In Japanese)\", JOURNAL = \"Medical science international (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (492, '07041', 'Antineoplastics - antimetabolic agents', 'Antineoplastics - antimetabolic agents', 'Methotrexate (JP17/USP/INN), Pentostatin (JAN/USAN/INN), Mercaptopurine (USP), Cytarabine (JP17/USP/INN), Hydroxyurea (USP), Vidarabine (USP), Fluorouracil (JP17/USP/INN), Raltitrexed (JAN/USAN/INN), Gemcitabine hydrochloride (JAN/USAN), Capecitabine (JAN/USAN/INN), Tegafur (JP17/USAN/INN), Doxifluridine (JP17/INN), Cladribine (JAN/USAN/INN), Ancitabine hydrochloride (JAN), Thioinosine (JAN), Fludarabine phosphate (JAN/USP), Methotrexate sodium, Gemcitabine (USAN/INN), Aminopterin sodium (INN), Azacitidine (JAN/USAN/INN), Cytarabine hydrochloride (USAN), Pemetrexed disodium (USAN), Floxuridine (USP/INN), Mercaptopurine (INN), Thioguanine (USP), Trimetrexate (USAN/INN), Trimetrexate glucuronate (USAN), Vidarabine (JAN), Vidarabine sodium phosphate (USAN), Pemetrexed sodium hydrate (JAN), Pemetrexed (INN), Fludarabine (INN), Fluorouracil sodium salt', 'list(REFERENCE = \"\", AUTHORS = \"Skeel RT (ed).\", TITLE = \"[Handbook of Cancer Chemotherapy (6th ed)] (In Japanese)\", JOURNAL = \"Medical science international (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"\", AUTHORS = \"Kijjoa A, Sawangwong P.\", TITLE = \"Drugs and cosmetics from the sea.\", JOURNAL = c(\"Marine Drugs 2:73-82 (2004)\", \"DOI:10.3390/md202073\")), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Wermuth CG (ed).\", TITLE = \"[The Practice of Medicinal Chemistry vol.1 (2nd ed)] (In Japanese)\", JOURNAL = \"Technomics (2006)\")', 'map07041', 'Antineoplastics - antimetabolic agents', 'Antineoplastics - antimetabolic agents', 'Methotrexate (JP17/USP/INN), Pentostatin (JAN/USAN/INN), Mercaptopurine (USP), Cytarabine (JP17/USP/INN), Hydroxyurea (USP), Vidarabine (USP), Fluorouracil (JP17/USP/INN), Raltitrexed (JAN/USAN/INN), Gemcitabine hydrochloride (JAN/USAN), Capecitabine (JAN/USAN/INN), Tegafur (JP17/USAN/INN), Doxifluridine (JP17/INN), Cladribine (JAN/USAN/INN), Ancitabine hydrochloride (JAN), Thioinosine (JAN), Fludarabine phosphate (JAN/USP), Methotrexate sodium, Gemcitabine (USAN/INN), Aminopterin sodium (INN), Azacitidine (JAN/USAN/INN), Cytarabine hydrochloride (USAN), Pemetrexed disodium (USAN), Floxuridine (USP/INN), Mercaptopurine (INN), Thioguanine (USP), Trimetrexate (USAN/INN), Trimetrexate glucuronate (USAN), Vidarabine (JAN), Vidarabine sodium phosphate (USAN), Pemetrexed sodium hydrate (JAN), Pemetrexed (INN), Fludarabine (INN), Fluorouracil sodium salt', 'list(REFERENCE = \"\", AUTHORS = \"Skeel RT (ed).\", TITLE = \"[Handbook of Cancer Chemotherapy (6th ed)] (In Japanese)\", JOURNAL = \"Medical science international (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"\", AUTHORS = \"Kijjoa A, Sawangwong P.\", TITLE = \"Drugs and cosmetics from the sea.\", JOURNAL = c(\"Marine Drugs 2:73-82 (2004)\", \"DOI:10.3390/md202073\")), list(REFERENCE = \"(Japanese)\", AUTHORS = \"Wermuth CG (ed).\", TITLE = \"[The Practice of Medicinal Chemistry vol.1 (2nd ed)] (In Japanese)\", JOURNAL = \"Technomics (2006)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (493, '07042', 'Antineoplastics - agents from natural products', 'Antineoplastics - agents from natural products', 'Camptothecin, Etoposide (JP17/USP/INN), Mitomycin (USP/INN), Dactinomycin (USP), Paclitaxel (JAN/USP/INN), Sirolimus (JAN/USAN/INN), Irinotecan hydrochloride (USAN), Vinblastine sulfate (JP17/USP), Daunorubicin hydrochloride (JP17/USP), Doxorubicin hydrochloride (JP17/USP), Idarubicin hydrochloride (JP17/USP), Vindesine sulfate (JAN/USAN), Pirarubicin (JP17/INN), Aclarubicin hydrochloride (JP17), Vinorelbine tartrate (USP), Peplomycin sulfate (JP17/USAN), Docetaxel (USAN), Mitoxantrone hydrochloride (JAN/USP), Topotecan hydrochloride (USAN), Bleomycin sulfate (JP17/USP), Vincristine sulfate (JP17/USP), Epirubicin hydrochloride (JP17/USAN), Teniposide (USAN/INN), Everolimus (JAN/USAN/INN), Aclarubicin (USAN/INN), Bleomycin hydrochloride (JP17), Doxorubicin (USAN/INN), Etoposide phosphate (USAN), Paclitaxel poliglumex (USAN/INN), Podofilox (USAN), Temsirolimus (JAN/USAN/INN), Vindesine (USAN/INN), Amrubicin hydrochloride (JAN/USAN), Bleomycin (INN), Daunorubicin (INN), Docetaxel (JAN/INN), Epirubicin (INN), Idarubicin (INN), Irinotecan (INN), Mitoxantrone (INN), Peplomycin (INN), Pirarubicin hydrochloride, Topotecan (BAN), Vinblastine (INN), Vincristine (INN), Vinorelbine (INN), Amrubicin (USAN/INN)', 'list(REFERENCE = \"\", AUTHORS = \"Skeel RT (ed).\", TITLE = \"[Handbook of Cancer Chemotherapy (6th ed)] (In Japanese)\", JOURNAL = \"Medical science international (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\")', 'map07042', 'Antineoplastics - agents from natural products', 'Antineoplastics - agents from natural products', 'Camptothecin, Etoposide (JP17/USP/INN), Mitomycin (USP/INN), Dactinomycin (USP), Paclitaxel (JAN/USP/INN), Sirolimus (JAN/USAN/INN), Irinotecan hydrochloride (USAN), Vinblastine sulfate (JP17/USP), Daunorubicin hydrochloride (JP17/USP), Doxorubicin hydrochloride (JP17/USP), Idarubicin hydrochloride (JP17/USP), Vindesine sulfate (JAN/USAN), Pirarubicin (JP17/INN), Aclarubicin hydrochloride (JP17), Vinorelbine tartrate (USP), Peplomycin sulfate (JP17/USAN), Docetaxel (USAN), Mitoxantrone hydrochloride (JAN/USP), Topotecan hydrochloride (USAN), Bleomycin sulfate (JP17/USP), Vincristine sulfate (JP17/USP), Epirubicin hydrochloride (JP17/USAN), Teniposide (USAN/INN), Everolimus (JAN/USAN/INN), Aclarubicin (USAN/INN), Bleomycin hydrochloride (JP17), Doxorubicin (USAN/INN), Etoposide phosphate (USAN), Paclitaxel poliglumex (USAN/INN), Podofilox (USAN), Temsirolimus (JAN/USAN/INN), Vindesine (USAN/INN), Amrubicin hydrochloride (JAN/USAN), Bleomycin (INN), Daunorubicin (INN), Docetaxel (JAN/INN), Epirubicin (INN), Idarubicin (INN), Irinotecan (INN), Mitoxantrone (INN), Peplomycin (INN), Pirarubicin hydrochloride, Topotecan (BAN), Vinblastine (INN), Vincristine (INN), Vinorelbine (INN), Amrubicin (USAN/INN)', 'list(REFERENCE = \"\", AUTHORS = \"Skeel RT (ed).\", TITLE = \"[Handbook of Cancer Chemotherapy (6th ed)] (In Japanese)\", JOURNAL = \"Medical science international (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (494, '07043', 'Antineoplastics - hormones', 'Antineoplastics - hormones', 'Dexamethasone (JP17/USP/INN), Fluoxymesterone (JAN/USP/INN), Prednisolone (JP17/USP/INN), Prednisone (USP), Goserelin acetate (JAN/USP), Aminoglutethimide (USP/INN), Flutamide (JP17/USP/INN), Diethylstilbestrol diphosphate (USP), Medroxyprogesterone acetate (JP17/USP), Megestrol acetate (USAN), Anastrozole (JAN/USAN/INN), Bicalutamide (JAN/USP/INN), Exemestane (JAN/USP/INN), Letrozole (JAN/USP/INN), Nilutamide (USAN/INN), Tamoxifen citrate (JP17/USP), Toremifene citrate (JAN/USAN), Leuprolide acetate (USAN), Levothyroxine sodium (USP), Liothyronine sodium (JP17/USAN), Fulvestrant (JAN/USAN/INN), Epitiostanol (JAN/INN), Chlormadinone acetate (JP17/USAN), Mepitiostane (JP17/INN), Raloxifene hydrochloride (JAN/USP), Estramustine phosphate sodium (USAN), Fadrozole hydrochloride (USAN), Fadrozole hydrochloride hydrate (JAN), Estramustine (USAN/INN), Goserelin (USAN/INN), Estramustine phosphate sodium hydrate (JAN), Fadrozole (INN), Leuprorelin (INN), Levothyroxine (BAN), Liothyronine (INN), Liothyronine hydrochloride, Raloxifene (INN), Tamoxifen (INN), Toremifene (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Katori S.\", TITLE = \"[Standard Pharmacology (6th ed)] (In Japanese)\", JOURNAL = \"Igaku shoin\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"PMID:17504144\", AUTHORS = \"Musa MA, Khan MO, Cooperwood JS.\", TITLE = \"Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).\", JOURNAL = c(\"Curr Med Chem 14:1249-61 (2007)\", \"DOI:10.2174/092986707780598023\")), list(REFERENCE = \"PMID:12404296\", AUTHORS = \"Buzdar AU, Robertson JF, Eiermann W, Nabholtz JM.\", TITLE = \"An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.\", JOURNAL = c(\"Cancer 95:2006-16 (2002)\", \"DOI:10.1002/cncr.10908\"))', 'map07043', 'Antineoplastics - hormones', 'Antineoplastics - hormones', 'Dexamethasone (JP17/USP/INN), Fluoxymesterone (JAN/USP/INN), Prednisolone (JP17/USP/INN), Prednisone (USP), Goserelin acetate (JAN/USP), Aminoglutethimide (USP/INN), Flutamide (JP17/USP/INN), Diethylstilbestrol diphosphate (USP), Medroxyprogesterone acetate (JP17/USP), Megestrol acetate (USAN), Anastrozole (JAN/USAN/INN), Bicalutamide (JAN/USP/INN), Exemestane (JAN/USP/INN), Letrozole (JAN/USP/INN), Nilutamide (USAN/INN), Tamoxifen citrate (JP17/USP), Toremifene citrate (JAN/USAN), Leuprolide acetate (USAN), Levothyroxine sodium (USP), Liothyronine sodium (JP17/USAN), Fulvestrant (JAN/USAN/INN), Epitiostanol (JAN/INN), Chlormadinone acetate (JP17/USAN), Mepitiostane (JP17/INN), Raloxifene hydrochloride (JAN/USP), Estramustine phosphate sodium (USAN), Fadrozole hydrochloride (USAN), Fadrozole hydrochloride hydrate (JAN), Estramustine (USAN/INN), Goserelin (USAN/INN), Estramustine phosphate sodium hydrate (JAN), Fadrozole (INN), Leuprorelin (INN), Levothyroxine (BAN), Liothyronine (INN), Liothyronine hydrochloride, Raloxifene (INN), Tamoxifen (INN), Toremifene (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Katori S.\", TITLE = \"[Standard Pharmacology (6th ed)] (In Japanese)\", JOURNAL = \"Igaku shoin\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"PMID:17504144\", AUTHORS = \"Musa MA, Khan MO, Cooperwood JS.\", TITLE = \"Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).\", JOURNAL = c(\"Curr Med Chem 14:1249-61 (2007)\", \"DOI:10.2174/092986707780598023\")), list(REFERENCE = \"PMID:12404296\", AUTHORS = \"Buzdar AU, Robertson JF, Eiermann W, Nabholtz JM.\", TITLE = \"An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.\", JOURNAL = c(\"Cancer 95:2006-16 (2002)\", \"DOI:10.1002/cncr.10908\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (495, '07044', 'Antiviral agents', 'Antiviral agents', 'Acyclovir (USP), Cidofovir (USAN/INN), Didanosine (JAN/USAN/INN), Famciclovir (JAN/USAN/INN), Ganciclovir (JAN/USP/INN), Idoxuridine (JP17/USP/INN), Lamivudine (JAN/USP/INN), Trifluridine (JAN/USP/INN), Valacyclovir hydrochloride (USAN), Vidarabine (USP), Zalcitabine (JAN/USP/INN), Zidovudine (JP17/USP/INN), Ribavirin (JP17/USP/INN), Stavudine (USAN/INN), Foscarnet sodium (USAN/INN), Amantadine hydrochloride (JP17/USP), Abacavir sulfate (JAN/USAN), Oseltamivir phosphate (JAN/USAN), Rimantadine hydrochloride (USAN), Zanamivir (USAN/INN), Adefovir dipivoxil (USAN), Sorivudine (JAN/USAN/INN), Fludarabine phosphate (JAN/USP), Zanamivir hydrate (JAN), Tenofovir disoproxil fumarate (JAN/USAN), Penciclovir sodium (USAN), Foscarnet sodium hydrate (JAN), Valganciclovir (INN), Abacavir succinate (USAN), Fomivirsen sodium (USAN), Palivizumab (INN), Interferon alfacon-1 (USAN/INN), Interferon alfa-2b (USAN), Peginterferon alfa-2a (USAN/INN), Peginterferon alfa-2b (INN), Acyclovir sodium (USAN), Acemannan (USAN/INN), Valganciclovir hydrochloride (JAN/USAN), Interferon beta (JAN), Interferon alfa (NAMALWA) (JP17), Celgosivir hydrochloride (USAN), Clevudine (USAN), Peramivir (USAN/INN), Docosanol (USAN), Edoxudine (USAN/INN), Entecavir (USAN), Ganciclovir sodium (USAN), Hepatitis B virus vaccine inactivated (USP XXX), Influenza virus vaccine (USP), Lobucavir (USAN/INN), Maribavir (USAN/INN), Freeze-dried live attenuated measles vaccine (JP17), Freeze-dried live attenuated mumps vaccine (JP17), Influenza HA vaccine (JP17), Freeze-dried inactivated tissue culture ravies vaccine (JP17), Smallpox vaccine (USP), Japanese encephalitis vaccine (JP17), Adsorbed hepatitis B vaccine (huGK-14 cell origin) (JAN), Rubella virus vaccine live (USP), Penciclovir (USAN/INN), Poliovirus vaccine inactivated (USP), Live oral polimyelitis vaccine (JP17), Vidarabine (JAN), Vidarabine phosphate (USAN), Vidarabine sodium phosphate (USAN), Yellow fever vaccine (USP), Adsorbed hepatitis B vaccine (JP17), Mumps virus vaccine live, Freeze-dried smallpox vaccine (JP17), Freeze-dried smallpox vaccine prepared in cell culture (JP17), Freeze-dried live attenuated rubella vaccine (JP17), Taribavirin hydrochloride (USAN), Telbivudine (USAN/INN), Measles virus vaccine live (USP), Abacavir (INN), Brivudine (INN), Amantadine (INN), Entecavir (INN), Fomivirsen (INN), Oseltamivir (INN), Rimantadine (INN), Valaciclovir (INN), Freeze-dried live attenuated varicella vaccine, Freeze-dried, inactivated hepatitis A vaccine (JAN), Laninamivir (INN), Laninamivir octanoate hydrate (JAN), Emulsified influenza HA vaccine (A/H1N1), Danoprevir (USAN/INN), Danoprevir sodium (USAN), Vaniprevir (JAN/USAN/INN), Asunaprevir (JAN/USAN), Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin), Live attenuated human rota virus vaccine, oral, Rotavirus vaccine, live, oral, pentavalent', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"PMID:16308532\", AUTHORS = \"Baba M.\", TITLE = \"[Advances in antiviral chemotherapy]\", JOURNAL = c(\"Uirusu 55:69-75 (2005)\", \"DOI:10.2222/jsv.55.69\")), list(REFERENCE = \"PMID:12187768\", AUTHORS = \"Watabe T, Ogura K, Nishiyama T.\", TITLE = \"[Molecular toxicological mechanism of the lethal interactions of the new antiviral drug, sorivudine, with 5-fluorouracil prodrugs and genetic deficiency of dihydropyrimidine dehydrogenase]\", JOURNAL = c(\"Yakugaku Zasshi 122:527-35 (2002)\", \"DOI:10.1248/yakushi.122.527\")), list(REFERENCE = \"PMID:16421366\", AUTHORS = \"Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, Lu B, McColl D, Chuck S, Enejosa J, Toole JJ, Cheng AK.\", TITLE = \"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.\", JOURNAL = c(\"N Engl J Med 354:251-60 (2006)\", \"DOI:10.1056/NEJMoa051871\")), list(REFERENCE = \"PMID:16641430\", AUTHORS = \"Lim SG, Krastev Z, Ng TM, Mechkov G, Kotzev IA, Chan S, Mondou E, Snow A, Sorbel J, Rousseau F\", TITLE = \"Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B.\", JOURNAL = c(\"Antimicrob Agents Chemother 50:1642-8 (2006)\", \"DOI:10.1128/AAC.50.5.1642-1648.2006\"))', 'map07044', 'Antiviral agents', 'Antiviral agents', 'Acyclovir (USP), Cidofovir (USAN/INN), Didanosine (JAN/USAN/INN), Famciclovir (JAN/USAN/INN), Ganciclovir (JAN/USP/INN), Idoxuridine (JP17/USP/INN), Lamivudine (JAN/USP/INN), Trifluridine (JAN/USP/INN), Valacyclovir hydrochloride (USAN), Vidarabine (USP), Zalcitabine (JAN/USP/INN), Zidovudine (JP17/USP/INN), Ribavirin (JP17/USP/INN), Stavudine (USAN/INN), Foscarnet sodium (USAN/INN), Amantadine hydrochloride (JP17/USP), Abacavir sulfate (JAN/USAN), Oseltamivir phosphate (JAN/USAN), Rimantadine hydrochloride (USAN), Zanamivir (USAN/INN), Adefovir dipivoxil (USAN), Sorivudine (JAN/USAN/INN), Fludarabine phosphate (JAN/USP), Zanamivir hydrate (JAN), Tenofovir disoproxil fumarate (JAN/USAN), Penciclovir sodium (USAN), Foscarnet sodium hydrate (JAN), Valganciclovir (INN), Abacavir succinate (USAN), Fomivirsen sodium (USAN), Palivizumab (INN), Interferon alfacon-1 (USAN/INN), Interferon alfa-2b (USAN), Peginterferon alfa-2a (USAN/INN), Peginterferon alfa-2b (INN), Acyclovir sodium (USAN), Acemannan (USAN/INN), Valganciclovir hydrochloride (JAN/USAN), Interferon beta (JAN), Interferon alfa (NAMALWA) (JP17), Celgosivir hydrochloride (USAN), Clevudine (USAN), Peramivir (USAN/INN), Docosanol (USAN), Edoxudine (USAN/INN), Entecavir (USAN), Ganciclovir sodium (USAN), Hepatitis B virus vaccine inactivated (USP XXX), Influenza virus vaccine (USP), Lobucavir (USAN/INN), Maribavir (USAN/INN), Freeze-dried live attenuated measles vaccine (JP17), Freeze-dried live attenuated mumps vaccine (JP17), Influenza HA vaccine (JP17), Freeze-dried inactivated tissue culture ravies vaccine (JP17), Smallpox vaccine (USP), Japanese encephalitis vaccine (JP17), Adsorbed hepatitis B vaccine (huGK-14 cell origin) (JAN), Rubella virus vaccine live (USP), Penciclovir (USAN/INN), Poliovirus vaccine inactivated (USP), Live oral polimyelitis vaccine (JP17), Vidarabine (JAN), Vidarabine phosphate (USAN), Vidarabine sodium phosphate (USAN), Yellow fever vaccine (USP), Adsorbed hepatitis B vaccine (JP17), Mumps virus vaccine live, Freeze-dried smallpox vaccine (JP17), Freeze-dried smallpox vaccine prepared in cell culture (JP17), Freeze-dried live attenuated rubella vaccine (JP17), Taribavirin hydrochloride (USAN), Telbivudine (USAN/INN), Measles virus vaccine live (USP), Abacavir (INN), Brivudine (INN), Amantadine (INN), Entecavir (INN), Fomivirsen (INN), Oseltamivir (INN), Rimantadine (INN), Valaciclovir (INN), Freeze-dried live attenuated varicella vaccine, Freeze-dried, inactivated hepatitis A vaccine (JAN), Laninamivir (INN), Laninamivir octanoate hydrate (JAN), Emulsified influenza HA vaccine (A/H1N1), Danoprevir (USAN/INN), Danoprevir sodium (USAN), Vaniprevir (JAN/USAN/INN), Asunaprevir (JAN/USAN), Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin), Live attenuated human rota virus vaccine, oral, Rotavirus vaccine, live, oral, pentavalent', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"PMID:16308532\", AUTHORS = \"Baba M.\", TITLE = \"[Advances in antiviral chemotherapy]\", JOURNAL = c(\"Uirusu 55:69-75 (2005)\", \"DOI:10.2222/jsv.55.69\")), list(REFERENCE = \"PMID:12187768\", AUTHORS = \"Watabe T, Ogura K, Nishiyama T.\", TITLE = \"[Molecular toxicological mechanism of the lethal interactions of the new antiviral drug, sorivudine, with 5-fluorouracil prodrugs and genetic deficiency of dihydropyrimidine dehydrogenase]\", JOURNAL = c(\"Yakugaku Zasshi 122:527-35 (2002)\", \"DOI:10.1248/yakushi.122.527\")), list(REFERENCE = \"PMID:16421366\", AUTHORS = \"Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, Lu B, McColl D, Chuck S, Enejosa J, Toole JJ, Cheng AK.\", TITLE = \"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.\", JOURNAL = c(\"N Engl J Med 354:251-60 (2006)\", \"DOI:10.1056/NEJMoa051871\")), list(REFERENCE = \"PMID:16641430\", AUTHORS = \"Lim SG, Krastev Z, Ng TM, Mechkov G, Kotzev IA, Chan S, Mondou E, Snow A, Sorbel J, Rousseau F\", TITLE = \"Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B.\", JOURNAL = c(\"Antimicrob Agents Chemother 50:1642-8 (2006)\", \"DOI:10.1128/AAC.50.5.1642-1648.2006\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (496, '07045', 'Antineoplastics - protein kinases inhibitors', 'Antineoplastics - protein kinases inhibitors', 'Imatinib mesylate (USAN), Gefitinib (JAN/USAN/INN), Everolimus (JAN/USAN/INN), Axitinib (JAN/USAN), Bosutinib (USAN), Trastuzumab (USAN/INN), Canertinib dihydrochloride (USAN), Cetuximab (USAN/INN), Dasatinib (JAN/INN), Enzastaurin hydrochloride (JAN/USAN), Erlotinib hydrochloride (JAN/USAN), Lapatinib ditosylate (USAN), Lestaurtinib (USAN/INN), Midostaurin (JAN/USAN/INN), Panitumumab (USAN/INN), Pazopanib hydrochloride (JAN/USAN), Pertuzumab (USAN/INN), Semaxanib (USAN/INN), Tandutinib (USAN/INN), Temsirolimus (JAN/USAN/INN), Sorafenib tosylate (USAN), Vatalanib (USAN/INN), Sunitinib malate (JAN/USAN), Vandetanib (JAN/USAN/INN), Nilotinib hydrochloride hydrate (JAN), Dasatinib (USAN), Motesanib, Erlotinib (INN), Imatinib (INN), Lapatinib (INN), Sorafenib (USAN/INN), Sunitinib (INN), Motesanib diphosphate (USAN), Nilotinib (USAN/INN), Afatinib (USAN/INN), Bosutinib hydrate (JAN), Crizotinib (JAN/USAN/INN), Afatinib dimaleate (USAN), Quizartinib (USAN/INN), Quizartinib dihydrochloride (USAN), Ruxolitinib (USAN/INN), Ruxolitinib phosphate (JAN/USAN), Trastuzumab emtansine (USAN/INN), Bafetinib (USAN)', 'list(REFERENCE = \"PMID:15710326\", AUTHORS = \"Weisberg E, Manley PW, Breitenstein W, Bruggen J, Cowan-Jacob SW, Ray A, Huntly B, Fabbro D, Fendrich G, Hall-Meyers E, Kung AL, Mestan J, Daley GQ, Callahan L, Catley L, Cavazza C, Azam M, Neuberg D, Wright RD, Gilliland DG, Griffin JD.\", TITLE = \"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.\", JOURNAL = c(\"Cancer Cell 7:129-41 (2005)\", \"DOI:10.1016/j.ccr.2005.01.007\")), list(REFERENCE = \"PMID:17327610\", AUTHORS = \"Chow LQ, Eckhardt SG.\", TITLE = \"Sunitinib: from rational design to clinical efficacy.\", JOURNAL = c(\"J Clin Oncol 25:884-96 (2007)\", \"DOI:10.1200/JCO.2006.06.3602\")), list(REFERENCE = \"PMID:17956080\", AUTHORS = \"Veach DR, Namavari M, Pillarsetty N, Santos EB, Beresten-Kochetkov T, Lambek C, Punzalan BJ, Antczak C, Smith-Jones PM, Djaballah H, Clarkson B, Larson SM.\", TITLE = \"Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib.\", JOURNAL = c(\"J Med Chem 50:5853-7 (2007)\", \"DOI:10.1021/jm070342g\")), list(REFERENCE = \"PMID:15685537\", AUTHORS = \"Debiec-Rychter M, Cools J, Dumez H, Sciot R, Stul M, Mentens N, Vranckx H, Wasag B, Prenen H, Roesel J, Hagemeijer A, Van Oosterom A, Marynen P.\", TITLE = \"Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.\", JOURNAL = c(\"Gastroenterology 128:270-9 (2005)\", \"DOI:10.1053/j.gastro.2004.11.020\")), list(REFERENCE = \"PMID:17419150\", AUTHORS = \"von Mehren M.\", TITLE = \"Beyond imatinib: second generation c-KIT inhibitors for the management of gastrointestinal stromal tumors.\", JOURNAL = c(\"Clin Colorectal Cancer 6 Suppl 1:S30-4 (2006)\", \"DOI:10.3816/CCC.2006.s.005\")), list(REFERENCE = \"PMID:17699867\", AUTHORS = \"Guo T, Agaram NP, Wong GC, Hom G, D\'Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR\", TITLE = \"Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.\", JOURNAL = c(\"Clin Cancer Res 13:4874-81 (2007)\", \"DOI:10.1158/1078-0432.CCR-07-0484\"))', 'map07045', 'Antineoplastics - protein kinases inhibitors', 'Antineoplastics - protein kinases inhibitors', 'Imatinib mesylate (USAN), Gefitinib (JAN/USAN/INN), Everolimus (JAN/USAN/INN), Axitinib (JAN/USAN), Bosutinib (USAN), Trastuzumab (USAN/INN), Canertinib dihydrochloride (USAN), Cetuximab (USAN/INN), Dasatinib (JAN/INN), Enzastaurin hydrochloride (JAN/USAN), Erlotinib hydrochloride (JAN/USAN), Lapatinib ditosylate (USAN), Lestaurtinib (USAN/INN), Midostaurin (JAN/USAN/INN), Panitumumab (USAN/INN), Pazopanib hydrochloride (JAN/USAN), Pertuzumab (USAN/INN), Semaxanib (USAN/INN), Tandutinib (USAN/INN), Temsirolimus (JAN/USAN/INN), Sorafenib tosylate (USAN), Vatalanib (USAN/INN), Sunitinib malate (JAN/USAN), Vandetanib (JAN/USAN/INN), Nilotinib hydrochloride hydrate (JAN), Dasatinib (USAN), Motesanib, Erlotinib (INN), Imatinib (INN), Lapatinib (INN), Sorafenib (USAN/INN), Sunitinib (INN), Motesanib diphosphate (USAN), Nilotinib (USAN/INN), Afatinib (USAN/INN), Bosutinib hydrate (JAN), Crizotinib (JAN/USAN/INN), Afatinib dimaleate (USAN), Quizartinib (USAN/INN), Quizartinib dihydrochloride (USAN), Ruxolitinib (USAN/INN), Ruxolitinib phosphate (JAN/USAN), Trastuzumab emtansine (USAN/INN), Bafetinib (USAN)', 'list(REFERENCE = \"PMID:15710326\", AUTHORS = \"Weisberg E, Manley PW, Breitenstein W, Bruggen J, Cowan-Jacob SW, Ray A, Huntly B, Fabbro D, Fendrich G, Hall-Meyers E, Kung AL, Mestan J, Daley GQ, Callahan L, Catley L, Cavazza C, Azam M, Neuberg D, Wright RD, Gilliland DG, Griffin JD.\", TITLE = \"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.\", JOURNAL = c(\"Cancer Cell 7:129-41 (2005)\", \"DOI:10.1016/j.ccr.2005.01.007\")), list(REFERENCE = \"PMID:17327610\", AUTHORS = \"Chow LQ, Eckhardt SG.\", TITLE = \"Sunitinib: from rational design to clinical efficacy.\", JOURNAL = c(\"J Clin Oncol 25:884-96 (2007)\", \"DOI:10.1200/JCO.2006.06.3602\")), list(REFERENCE = \"PMID:17956080\", AUTHORS = \"Veach DR, Namavari M, Pillarsetty N, Santos EB, Beresten-Kochetkov T, Lambek C, Punzalan BJ, Antczak C, Smith-Jones PM, Djaballah H, Clarkson B, Larson SM.\", TITLE = \"Synthesis and biological evaluation of a fluorine-18 derivative of dasatinib.\", JOURNAL = c(\"J Med Chem 50:5853-7 (2007)\", \"DOI:10.1021/jm070342g\")), list(REFERENCE = \"PMID:15685537\", AUTHORS = \"Debiec-Rychter M, Cools J, Dumez H, Sciot R, Stul M, Mentens N, Vranckx H, Wasag B, Prenen H, Roesel J, Hagemeijer A, Van Oosterom A, Marynen P.\", TITLE = \"Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.\", JOURNAL = c(\"Gastroenterology 128:270-9 (2005)\", \"DOI:10.1053/j.gastro.2004.11.020\")), list(REFERENCE = \"PMID:17419150\", AUTHORS = \"von Mehren M.\", TITLE = \"Beyond imatinib: second generation c-KIT inhibitors for the management of gastrointestinal stromal tumors.\", JOURNAL = c(\"Clin Colorectal Cancer 6 Suppl 1:S30-4 (2006)\", \"DOI:10.3816/CCC.2006.s.005\")), list(REFERENCE = \"PMID:17699867\", AUTHORS = \"Guo T, Agaram NP, Wong GC, Hom G, D\'Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR\", TITLE = \"Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.\", JOURNAL = c(\"Clin Cancer Res 13:4874-81 (2007)\", \"DOI:10.1158/1078-0432.CCR-07-0484\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (497, '07046', 'Immunosuppressive agents', 'Immunosuppressive agents', 'Tacrolimus (USAN/INN), Methotrexate (JP17/USP/INN), Mercaptopurine (USP), Cytarabine (JP17/USP/INN), Cyclosporine (USP), Dactinomycin (USP), Azathioprine (JP17/USP/INN), Cyclophosphamide (USP), Dexamethasone (JP17/USP/INN), Melphalan (JP17/USP/INN), Prednisolone (JP17/USP/INN), Prednisone (USP), Leflunomide (JAN/USAN/INN), Mycophenolate mofetil (JAN/USAN), Sirolimus (JAN/USAN/INN), Thalidomide (JAN/USP/INN), Vinblastine sulfate (JP17/USP), Mizoribine (JP17/INN), Gusperimus trihydrochloride (USAN), Methotrexate sodium, Vincristine sulfate (JP17/USP), Everolimus (JAN/USAN/INN), Azathioprine sodium (USP), Cytarabine hydrochloride (USAN), Lenalidomide (USAN/INN), Mercaptopurine (INN), Mycophenolate mofetil hydrochloride (USAN), Mycophenolate sodium (USP), Mycophenolic acid (USAN/INN), Meprednisone (USP/INN), Cyclophosphamide (INN), Gusperimus (INN), Melphalan hydrochloride, Tacrolimus (INN), Vinblastine (INN), Vincristine (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Katori S.\", TITLE = \"[Standard Pharmacology (6th ed)] (In Japanese)\", JOURNAL = \"Igaku shoin\"), list(REFERENCE = \"\", AUTHORS = \"Wermuth CG (ed).\", TITLE = \"[The Practice of Medicinal Chemistry vol.1 (2nd ed)] (In Japanese)\", JOURNAL = \"Technomics (2006)\"), list(REFERENCE = \"PMID:11896891\", AUTHORS = \"Tsuzuki K.\", TITLE = \"Role of mizoribine in renal transplantation.\", JOURNAL = c(\"Pediatr Int 44:224-31 (2002)\", \"DOI:10.1046/j.1328-8067.2001.01531.x\")), list(REFERENCE = \"PMID:2195722\", AUTHORS = \"Crandall BG, Gilbert EM, Renlund DG, Menlove RL, Herrick CM, Holland CS, Hagan ME, Rasmussen LG, Karwande SV, O\'Connell JB, et al.\", TITLE = \"A randomized trial of the immunosuppressive efficacy of vincristine in cardiac transplantation.\", JOURNAL = \"Transplantation 50:34-8 (1990)\"), list(REFERENCE = \"PMID:17287604\", AUTHORS = \"Nakanishi C, Kawagishi N, Sekiguchi S, Akamatsu Y, Sato K, Miyagi S, Takeda I, Hukushima K, Aiso T, Sato A, Fujimori K, Satomi S.\", TITLE = \"Steroid-resistant late acute rejection after a living donor liver transplantation: case report and review of the literature.\", JOURNAL = c(\"Tohoku J Exp Med 211:195-200 (2007)\", \"DOI:10.1620/tjem.211.195\")), list(REFERENCE = \"PMID:9233698\", AUTHORS = \"Schuler W, Sedrani R, Cottens S, Haberlin B, Schulz M, Schuurman HJ, Zenke G, Zerwes HG, Schreier MH.\", TITLE = \"SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.\", JOURNAL = \"Transplantation 64:36-42 (1997)\")', 'map07046', 'Immunosuppressive agents', 'Immunosuppressive agents', 'Tacrolimus (USAN/INN), Methotrexate (JP17/USP/INN), Mercaptopurine (USP), Cytarabine (JP17/USP/INN), Cyclosporine (USP), Dactinomycin (USP), Azathioprine (JP17/USP/INN), Cyclophosphamide (USP), Dexamethasone (JP17/USP/INN), Melphalan (JP17/USP/INN), Prednisolone (JP17/USP/INN), Prednisone (USP), Leflunomide (JAN/USAN/INN), Mycophenolate mofetil (JAN/USAN), Sirolimus (JAN/USAN/INN), Thalidomide (JAN/USP/INN), Vinblastine sulfate (JP17/USP), Mizoribine (JP17/INN), Gusperimus trihydrochloride (USAN), Methotrexate sodium, Vincristine sulfate (JP17/USP), Everolimus (JAN/USAN/INN), Azathioprine sodium (USP), Cytarabine hydrochloride (USAN), Lenalidomide (USAN/INN), Mercaptopurine (INN), Mycophenolate mofetil hydrochloride (USAN), Mycophenolate sodium (USP), Mycophenolic acid (USAN/INN), Meprednisone (USP/INN), Cyclophosphamide (INN), Gusperimus (INN), Melphalan hydrochloride, Tacrolimus (INN), Vinblastine (INN), Vincristine (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Katori S.\", TITLE = \"[Standard Pharmacology (6th ed)] (In Japanese)\", JOURNAL = \"Igaku shoin\"), list(REFERENCE = \"\", AUTHORS = \"Wermuth CG (ed).\", TITLE = \"[The Practice of Medicinal Chemistry vol.1 (2nd ed)] (In Japanese)\", JOURNAL = \"Technomics (2006)\"), list(REFERENCE = \"PMID:11896891\", AUTHORS = \"Tsuzuki K.\", TITLE = \"Role of mizoribine in renal transplantation.\", JOURNAL = c(\"Pediatr Int 44:224-31 (2002)\", \"DOI:10.1046/j.1328-8067.2001.01531.x\")), list(REFERENCE = \"PMID:2195722\", AUTHORS = \"Crandall BG, Gilbert EM, Renlund DG, Menlove RL, Herrick CM, Holland CS, Hagan ME, Rasmussen LG, Karwande SV, O\'Connell JB, et al.\", TITLE = \"A randomized trial of the immunosuppressive efficacy of vincristine in cardiac transplantation.\", JOURNAL = \"Transplantation 50:34-8 (1990)\"), list(REFERENCE = \"PMID:17287604\", AUTHORS = \"Nakanishi C, Kawagishi N, Sekiguchi S, Akamatsu Y, Sato K, Miyagi S, Takeda I, Hukushima K, Aiso T, Sato A, Fujimori K, Satomi S.\", TITLE = \"Steroid-resistant late acute rejection after a living donor liver transplantation: case report and review of the literature.\", JOURNAL = c(\"Tohoku J Exp Med 211:195-200 (2007)\", \"DOI:10.1620/tjem.211.195\")), list(REFERENCE = \"PMID:9233698\", AUTHORS = \"Schuler W, Sedrani R, Cottens S, Haberlin B, Schulz M, Schuurman HJ, Zenke G, Zerwes HG, Schreier MH.\", TITLE = \"SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.\", JOURNAL = \"Transplantation 64:36-42 (1997)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (498, '07047', 'Osteoporosis drugs', 'Osteoporosis drugs', 'Menatetrenone (JP17/INN), Estradiol (JAN/USP/INN), Calcitriol (JAN/USP/INN), Estriol (JP17/USP), Calcitonin salmon (JP17/USAN/INN), Etidronate disodium (JP17/USP), Calcium phosphate, dihydrate, dibasic (USP), Alendronate sodium (USAN), Pamidronate disodium (USAN), Risedronate sodium (USP), Nandrolone decanoate (JAN/USP), Nandrolone phenpropionate (USP), Methenolone enanthate (USAN), Ipriflavone (JP17/INN), Methenolone acetate (USAN), Alfacalcidol (JAN/INN), Mestanolone (JAN/INN), Calcium L-aspartate hydrate (JAN), Zoledronic acid (USAN), Raloxifene hydrochloride (JAN/USP), Tiludronate disodium (USAN), Etidronic acid (USAN/INN), Bazedoxifene acetate (JAN/USAN), Sodium risedronate hydrate (JP17), Elcatonin (JP17/INN), Dibasic calcium phosphate, anhydrous (JAN), Teriparatide acetate (JAN), Clodronate disodium (USAN), Clodronic acid (USAN/INN), Ibandronate sodium (USAN), Lasofoxifene tartrate (JAN/USAN), Teriparatide (USAN/INN), Zoledronate disodium (USAN), Zoledronate trisodium (USAN), Anhydrous dibasic calcium phosphate (JP17), Alendronic acid (INN), Pamidronic acid (INN), Eldecalcitol (JAN/INN), Clodronic acid disodium salt, Ibandronic acid (INN), Metenolone (INN), Raloxifene (INN), Ranelic acid (INN), Strontium ranelate, Risedronic acid (INN), Tiludronic acid (INN), Zoledronic acid (INN), Minodronic acid hydrate (JAN)', 'map07047', 'Osteoporosis drugs', 'Osteoporosis drugs', 'Menatetrenone (JP17/INN), Estradiol (JAN/USP/INN), Calcitriol (JAN/USP/INN), Estriol (JP17/USP), Calcitonin salmon (JP17/USAN/INN), Etidronate disodium (JP17/USP), Calcium phosphate, dihydrate, dibasic (USP), Alendronate sodium (USAN), Pamidronate disodium (USAN), Risedronate sodium (USP), Nandrolone decanoate (JAN/USP), Nandrolone phenpropionate (USP), Methenolone enanthate (USAN), Ipriflavone (JP17/INN), Methenolone acetate (USAN), Alfacalcidol (JAN/INN), Mestanolone (JAN/INN), Calcium L-aspartate hydrate (JAN), Zoledronic acid (USAN), Raloxifene hydrochloride (JAN/USP), Tiludronate disodium (USAN), Etidronic acid (USAN/INN), Bazedoxifene acetate (JAN/USAN), Sodium risedronate hydrate (JP17), Elcatonin (JP17/INN), Dibasic calcium phosphate, anhydrous (JAN), Teriparatide acetate (JAN), Clodronate disodium (USAN), Clodronic acid (USAN/INN), Ibandronate sodium (USAN), Lasofoxifene tartrate (JAN/USAN), Teriparatide (USAN/INN), Zoledronate disodium (USAN), Zoledronate trisodium (USAN), Anhydrous dibasic calcium phosphate (JP17), Alendronic acid (INN), Pamidronic acid (INN), Eldecalcitol (JAN/INN), Clodronic acid disodium salt, Ibandronic acid (INN), Metenolone (INN), Raloxifene (INN), Ranelic acid (INN), Strontium ranelate, Risedronic acid (INN), Tiludronic acid (INN), Zoledronic acid (INN), Minodronic acid hydrate (JAN)', 'map07047', 'Osteoporosis drugs', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (499, '07048', 'Antimigraines', 'Antimigraines', 'Aspirin (JP17/USP), Naproxen (JP17/USP/INN), Ibuprofen (JP17/USP/INN), Acetaminophen (JP17/USP), Atenolol (JP17/USP/INN), Chlorpromazine (USP/INN), Divalproex sodium (USP), Valproic acid (USP), Zolmitriptan (JAN/USAN/INN), Nadolol (JP17/USP/INN), Sumatriptan (JAN/USP/INN), Prochlorperazine maleate (JP17/USP), Propranolol hydrochloride (JP17/USP), Prochlorperazine (JAN/USP/INN), Metoprolol tartrate (JP17/USP), Verapamil hydrochloride (JP17/USP), Metoprolol succinate (USP), Naratriptan hydrochloride (JAN/USAN), Rizatriptan benzoate (JAN/USAN), Sumatriptan succinate (JAN/USAN), Ergotamine tartrate (JP17/USP), Methysergide maleate (USP), Valproate sodium (USAN), Metoclopramide (JP17/INN), Chlorpromazine hydrochloride (JP17/USP), Amitriptyline hydrochloride (JP17/USP), Nortriptyline hydrochloride (JP17/USP/INN), Naproxen sodium (USP), Ibuprofen piconol (JP17/USAN), Flunarizine hydrochloride (JAN/USAN), Lisuride maleate (JAN), Fonazine mesylate (USAN), Eletriptan hydrobromide (JAN/USAN), Prochlorperazine mesilate (JAN), Dihydroergotamine mesylate (USP), Metoclopramide hydrochloride (JAN), Verapamil (USAN/INN), Methysergide (USAN/INN), Metoprolol (USAN/INN), Prochlorperazine edisylate (USP), Lomerizine hydrochloride (JAN), Almotriptan (USAN), Almotriptan malate (USAN), Avitriptan fumarate (USAN), Frovatriptan succinate (USAN), Ibuprofen aluminum (USAN), Metoclopramide hydrochloride (USAN), Metoprolol fumarate (USP), Aspirin aluminum (JP17), Rizatriptan sulfate (USAN), Ibuprofen lysine (USAN), Flumedroxone (INN), Amitriptyline (INN), Aspirin calcium salt, Aspirin magnesium salt, Aspirin sodium, Dihydroergotamine (INN), Dihydroergotamine tartrate, Dimetotiazine (INN), Eletriptan (INN), Ergotamine (INN), Flunarizine (INN), Frovatriptan (INN), Ibuprofen arginine salt, Ibuprofen sodium, Lisuride (INN), Naratriptan (INN), Nortriptyline (INN), Propranolol (INN), Rizatriptan (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Societas Neurologica Japonica (ed).\", TITLE = \"[Treatment of chronic headache guideline 2002, II Migraine.] (In Japanese)\", JOURNAL = \"\")', 'map07048', 'Antimigraines', 'Antimigraines', 'Aspirin (JP17/USP), Naproxen (JP17/USP/INN), Ibuprofen (JP17/USP/INN), Acetaminophen (JP17/USP), Atenolol (JP17/USP/INN), Chlorpromazine (USP/INN), Divalproex sodium (USP), Valproic acid (USP), Zolmitriptan (JAN/USAN/INN), Nadolol (JP17/USP/INN), Sumatriptan (JAN/USP/INN), Prochlorperazine maleate (JP17/USP), Propranolol hydrochloride (JP17/USP), Prochlorperazine (JAN/USP/INN), Metoprolol tartrate (JP17/USP), Verapamil hydrochloride (JP17/USP), Metoprolol succinate (USP), Naratriptan hydrochloride (JAN/USAN), Rizatriptan benzoate (JAN/USAN), Sumatriptan succinate (JAN/USAN), Ergotamine tartrate (JP17/USP), Methysergide maleate (USP), Valproate sodium (USAN), Metoclopramide (JP17/INN), Chlorpromazine hydrochloride (JP17/USP), Amitriptyline hydrochloride (JP17/USP), Nortriptyline hydrochloride (JP17/USP/INN), Naproxen sodium (USP), Ibuprofen piconol (JP17/USAN), Flunarizine hydrochloride (JAN/USAN), Lisuride maleate (JAN), Fonazine mesylate (USAN), Eletriptan hydrobromide (JAN/USAN), Prochlorperazine mesilate (JAN), Dihydroergotamine mesylate (USP), Metoclopramide hydrochloride (JAN), Verapamil (USAN/INN), Methysergide (USAN/INN), Metoprolol (USAN/INN), Prochlorperazine edisylate (USP), Lomerizine hydrochloride (JAN), Almotriptan (USAN), Almotriptan malate (USAN), Avitriptan fumarate (USAN), Frovatriptan succinate (USAN), Ibuprofen aluminum (USAN), Metoclopramide hydrochloride (USAN), Metoprolol fumarate (USP), Aspirin aluminum (JP17), Rizatriptan sulfate (USAN), Ibuprofen lysine (USAN), Flumedroxone (INN), Amitriptyline (INN), Aspirin calcium salt, Aspirin magnesium salt, Aspirin sodium, Dihydroergotamine (INN), Dihydroergotamine tartrate, Dimetotiazine (INN), Eletriptan (INN), Ergotamine (INN), Flunarizine (INN), Frovatriptan (INN), Ibuprofen arginine salt, Ibuprofen sodium, Lisuride (INN), Naratriptan (INN), Nortriptyline (INN), Propranolol (INN), Rizatriptan (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Societas Neurologica Japonica (ed).\", TITLE = \"[Treatment of chronic headache guideline 2002, II Migraine.] (In Japanese)\", JOURNAL = \"\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (500, '07049', 'Antithrombosis agents', 'Antithrombosis agents', 'Epoprostenol (USAN/INN), Aspirin (JP17/USP), Argatroban (USAN), Warfarin sodium (USP), Clopidogrel bisulfate (USAN), Ticlopidine hydrochloride (JP17/USAN), Tirofiban hydrochloride (USAN), Warfarin potassium (JP17), Epoprostenol sodium (JAN/USAN), Beraprost sodium (JP17/USAN), Sarpogrelate hydrochloride (JP17), Nafamostat mesylate (USAN), Gabexate mesilate (JP17), Ozagrel sodium (JP17), Fondaparinux sodium (JAN/USAN/INN), Cilostazol (JP17/USAN/INN), Ximelagatran (JAN/USAN/INN), Heparin sodium (JP17/USP/INN), Beraprost (USAN), Abciximab (USAN/INN), Anticoagulant heparin (USP), Adomiparin sodium (USAN), Bivalirudin (USAN/INN), Apixaban (JAN/USAN/INN), Nasaruplase (cell culture) (JAN), Urokinase (JP17/USAN/INN), Dalteparin sodium (JAN/USAN/INN), Desirudin (USAN/INN), Aspirin and dialuminate, Heparin calcium (JP17), Nasaruplase beta (USAN/INN), Urokinase alfa (USAN/INN), Antithrombin III human (USP), Lepirudin (INN), Eptifibatide (INN), Dabigatran etexilate mesylate (USAN), Rivaroxaban (JAN/USAN/INN), Dabigatran etexilate (USAN/INN), Adomiparin (USAN), Clopidogrel (USP/INN), Gabexate (INN), Ozagrel (INN), Sarpogrelate (INN), Ticlopidine (INN), Tirofiban (INN), Warfarin (INN), Human anti-thrombin III, freeze-dried concentrated, Edoxaban tosilate hydrate (JAN), Edoxaban (USAN/INN), Darexaban maleate (JAN)', 'list(REFERENCE = \"PMID:20702966\", AUTHORS = \"Morishima Y, Shibano T\", TITLE = \"[Research and development strategy of antithrombotic agents: pharmacology of the oral factor Xa-inhibitor edoxaban].\", JOURNAL = c(\"Nihon Yakurigaku Zasshi 136:83-7 (2010)\", \"DOI:10.1254/fpj.136.83\")), list(REFERENCE = \"PMID:21828942\", AUTHORS = \"Ohmura T, Takahashi I, Ikegami K, Encinas J\", TITLE = \"[Pharmacological and clinical profiles of the direct thrombin inhibitor dabigatran etexilate methane sulfate (Prazaxa((R))) ].\", JOURNAL = c(\"Nihon Yakurigaku Zasshi 138:79-88 (2011)\", \"DOI:10.1254/fpj.138.79\")), list(REFERENCE = \"\", AUTHORS = \"Tomiyama Y.\", TITLE = \"[Types and their mechanism of action of antiplatelet drugs] (in Japanese)\", JOURNAL = \"CLINICIAN\")', 'map07049', 'Antithrombosis agents', 'Antithrombosis agents', 'Epoprostenol (USAN/INN), Aspirin (JP17/USP), Argatroban (USAN), Warfarin sodium (USP), Clopidogrel bisulfate (USAN), Ticlopidine hydrochloride (JP17/USAN), Tirofiban hydrochloride (USAN), Warfarin potassium (JP17), Epoprostenol sodium (JAN/USAN), Beraprost sodium (JP17/USAN), Sarpogrelate hydrochloride (JP17), Nafamostat mesylate (USAN), Gabexate mesilate (JP17), Ozagrel sodium (JP17), Fondaparinux sodium (JAN/USAN/INN), Cilostazol (JP17/USAN/INN), Ximelagatran (JAN/USAN/INN), Heparin sodium (JP17/USP/INN), Beraprost (USAN), Abciximab (USAN/INN), Anticoagulant heparin (USP), Adomiparin sodium (USAN), Bivalirudin (USAN/INN), Apixaban (JAN/USAN/INN), Nasaruplase (cell culture) (JAN), Urokinase (JP17/USAN/INN), Dalteparin sodium (JAN/USAN/INN), Desirudin (USAN/INN), Aspirin and dialuminate, Heparin calcium (JP17), Nasaruplase beta (USAN/INN), Urokinase alfa (USAN/INN), Antithrombin III human (USP), Lepirudin (INN), Eptifibatide (INN), Dabigatran etexilate mesylate (USAN), Rivaroxaban (JAN/USAN/INN), Dabigatran etexilate (USAN/INN), Adomiparin (USAN), Clopidogrel (USP/INN), Gabexate (INN), Ozagrel (INN), Sarpogrelate (INN), Ticlopidine (INN), Tirofiban (INN), Warfarin (INN), Human anti-thrombin III, freeze-dried concentrated, Edoxaban tosilate hydrate (JAN), Edoxaban (USAN/INN), Darexaban maleate (JAN)', 'list(REFERENCE = \"PMID:20702966\", AUTHORS = \"Morishima Y, Shibano T\", TITLE = \"[Research and development strategy of antithrombotic agents: pharmacology of the oral factor Xa-inhibitor edoxaban].\", JOURNAL = c(\"Nihon Yakurigaku Zasshi 136:83-7 (2010)\", \"DOI:10.1254/fpj.136.83\")), list(REFERENCE = \"PMID:21828942\", AUTHORS = \"Ohmura T, Takahashi I, Ikegami K, Encinas J\", TITLE = \"[Pharmacological and clinical profiles of the direct thrombin inhibitor dabigatran etexilate methane sulfate (Prazaxa((R))) ].\", JOURNAL = c(\"Nihon Yakurigaku Zasshi 138:79-88 (2011)\", \"DOI:10.1254/fpj.138.79\")), list(REFERENCE = \"\", AUTHORS = \"Tomiyama Y.\", TITLE = \"[Types and their mechanism of action of antiplatelet drugs] (in Japanese)\", JOURNAL = \"CLINICIAN\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (501, '07050', 'Antirheumatics - DMARDs and biological agents', 'Antirheumatics - DMARDs and biological agents', 'Tacrolimus (USAN/INN), Methotrexate (JP17/USP/INN), Auranofin (JP17/USAN/INN), Azathioprine (JP17/USP/INN), Cyclophosphamide (USP), Sulfasalazine (USP/INN), Penicillamine (JAN/USP/INN), Etanercept (USAN/INN), Leflunomide (JAN/USAN/INN), Gold sodium thiomalate (USP), Iguratimod (JAN/INN), Mizoribine (JP17/INN), Actarit (JAN/INN), Lobenzarit sodium (JP17/USAN), Bucillamine (JP17/INN), Methotrexate sodium, Tocilizumab (USAN/INN), Adalimumab (USAN/INN), Infliximab (USAN/INN), Azathioprine sodium (USP), Abatacept (USAN/INN), Certolizumab pegol (USAN/INN), Golimumab (USAN/INN), Cyclophosphamide (INN), Penicillamine hydrochloride, Tacrolimus (INN), Ofatumumab (USAN/INN), Tofacitinib citrate (JAN/USAN), Secukinumab (USAN/INN)', 'map07050', 'Antirheumatics - DMARDs and biological agents', 'Antirheumatics - DMARDs and biological agents', 'Tacrolimus (USAN/INN), Methotrexate (JP17/USP/INN), Auranofin (JP17/USAN/INN), Azathioprine (JP17/USP/INN), Cyclophosphamide (USP), Sulfasalazine (USP/INN), Penicillamine (JAN/USP/INN), Etanercept (USAN/INN), Leflunomide (JAN/USAN/INN), Gold sodium thiomalate (USP), Iguratimod (JAN/INN), Mizoribine (JP17/INN), Actarit (JAN/INN), Lobenzarit sodium (JP17/USAN), Bucillamine (JP17/INN), Methotrexate sodium, Tocilizumab (USAN/INN), Adalimumab (USAN/INN), Infliximab (USAN/INN), Azathioprine sodium (USP), Abatacept (USAN/INN), Certolizumab pegol (USAN/INN), Golimumab (USAN/INN), Cyclophosphamide (INN), Penicillamine hydrochloride, Tacrolimus (INN), Ofatumumab (USAN/INN), Tofacitinib citrate (JAN/USAN), Secukinumab (USAN/INN)', 'map07050', 'Antirheumatics - DMARDs and biological agents', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (502, '07051', 'Antidiabetics', 'Antidiabetics', 'Insulin (JAN/USP), Acarbose (JAN/USAN/INN), Glyburide (USP), Tolbutamide (JP17/USP/INN), Troglitazone (JAN/USAN/INN), Repaglinide (JAN/USP/INN), Buformin (USAN/INN), Miglitol (JP17/USAN/INN), Metformin hydrochloride (JP17/USP), Pioglitazone hydrochloride (JP17/USP), Nateglinide (JP17/USAN/INN), Voglibose (JP17/USAN/INN), Mitiglinide calcium hydrate (JP17), Buformin hydrochloride (JP17), Insulin human (USP/INN), Insulin glargine (USAN/INN), Exenatide (JAN/USAN/INN), Insulin aspart (USAN/INN), Insulin lispro (USP/INN), Insulin detemir (USAN/INN), Insulin glulisine (USAN/INN), Insulin human, isophane (USP), Insulin, isophane (USP), Metformin (USAN/INN), Liraglutide (USAN/INN), Alogliptin benzoate (JAN/USAN), Sitagliptin phosphate (USAN), Vildagliptin (JAN/USAN/INN), Pioglitazone (INN), Sitagliptin (prop.INN), Dapagliflozin (USAN/INN), Saxagliptin (INN), Linagliptin (JAN/USAN/INN), Canagliflozin (USAN/INN), Insulin degludec (USAN/INN), Lixisenatide (JAN/INN), Saxagliptin hydrate (JAN/USAN), Dapagliflozin propanediol (USAN), Tofogliflozin (USAN), Luseogliflozin hydrate (JAN), Ipragliflozin (INN), Ipragliflozin L-proline (JAN), Fasiglifam (INN)', 'map07051', 'Antidiabetics', 'Antidiabetics', 'Insulin (JAN/USP), Acarbose (JAN/USAN/INN), Glyburide (USP), Tolbutamide (JP17/USP/INN), Troglitazone (JAN/USAN/INN), Repaglinide (JAN/USP/INN), Buformin (USAN/INN), Miglitol (JP17/USAN/INN), Metformin hydrochloride (JP17/USP), Pioglitazone hydrochloride (JP17/USP), Nateglinide (JP17/USAN/INN), Voglibose (JP17/USAN/INN), Mitiglinide calcium hydrate (JP17), Buformin hydrochloride (JP17), Insulin human (USP/INN), Insulin glargine (USAN/INN), Exenatide (JAN/USAN/INN), Insulin aspart (USAN/INN), Insulin lispro (USP/INN), Insulin detemir (USAN/INN), Insulin glulisine (USAN/INN), Insulin human, isophane (USP), Insulin, isophane (USP), Metformin (USAN/INN), Liraglutide (USAN/INN), Alogliptin benzoate (JAN/USAN), Sitagliptin phosphate (USAN), Vildagliptin (JAN/USAN/INN), Pioglitazone (INN), Sitagliptin (prop.INN), Dapagliflozin (USAN/INN), Saxagliptin (INN), Linagliptin (JAN/USAN/INN), Canagliflozin (USAN/INN), Insulin degludec (USAN/INN), Lixisenatide (JAN/INN), Saxagliptin hydrate (JAN/USAN), Dapagliflozin propanediol (USAN), Tofogliflozin (USAN), Luseogliflozin hydrate (JAN), Ipragliflozin (INN), Ipragliflozin L-proline (JAN), Fasiglifam (INN)', 'map07051', 'Antidiabetics', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (503, '07052', 'Antidyslipidemic agents', 'Antidyslipidemic agents', 'Probucol (JP17/USP/INN), gamma Oryzanol (JAN), Nicomol (JP17/INN), Niceritrol (JP17/INN), Icosapent ethyl (USAN), Riboflavin butyrate (JP17), Colestilan chloride (USAN), Ezetimibe (JAN/USAN/INN), Dextran sulfate sodium (JAN), Cholestyramine resin (USP), Dextran sulfate sodium sulfur 5 (JP17), Polyenephosphatidyl choline (JAN), Elastase ES, Soysterol (JAN), Pantothenic acid (BAN), Icosapent (INN)', 'map07052', 'Antidyslipidemic agents', 'Antidyslipidemic agents', 'Probucol (JP17/USP/INN), gamma Oryzanol (JAN), Nicomol (JP17/INN), Niceritrol (JP17/INN), Icosapent ethyl (USAN), Riboflavin butyrate (JP17), Colestilan chloride (USAN), Ezetimibe (JAN/USAN/INN), Dextran sulfate sodium (JAN), Cholestyramine resin (USP), Dextran sulfate sodium sulfur 5 (JP17), Polyenephosphatidyl choline (JAN), Elastase ES, Soysterol (JAN), Pantothenic acid (BAN), Icosapent (INN)', 'map07052', 'Antidyslipidemic agents', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (504, '07053', 'Anti-HIV agents', 'Anti-HIV agents', 'AMD 070, Didanosine (JAN/USAN/INN), Lamivudine (JAN/USP/INN), Zalcitabine (JAN/USP/INN), Zidovudine (JP17/USP/INN), Ritonavir (JAN/USAN/INN), Saquinavir (JAN/USP/INN), Nevirapine (JAN/USP/INN), Stavudine (USAN/INN), Abacavir sulfate (JAN/USAN), Amprenavir (JAN/USAN/INN), Delavirdine mesylate (USAN), Efavirenz (JAN/INN), Indinavir sulfate (USAN), Nelfinavir mesylate (USAN/INN), Emivirine (USAN/INN), Saquinavir mesylate (USP), Emtricitabine (JAN/USAN/INN), Atazanavir sulfate (JAN/USAN), Lopinavir (JAN/USAN/INN), Tenofovir disoproxil fumarate (JAN/USAN), Fosamprenavir (INN), Enfuvirtide (USAN/INN), Indinavir sulfate ethanolate (JAN), Fosamprenavir calcium hydrate (JAN), Amdoxovir (USAN/INN), Darunavir (USAN/INN), Indinavir (USAN), Fosamprenavir calcium (USAN), Fosamprenavir sodium (USAN), Tipranavir disodium (USAN), Elvucitabine (USAN/INN), Etravirine (JAN/USAN/INN), Vicriviroc maleate (USAN), Darunavir ethanolate (JAN), Bevirimat dimeglumine (USAN), Maraviroc (JAN/INN), Raltegravir (USAN/INN), Elvitegravir (JAN/USAN), Raltegravir potassium (JAN/USAN), Atazanavir (INN), Nelfinavir (INN), Tipranavir (INN), Ibalizumab (USAN/INN), Rilpivirine (JAN/USAN/INN), Cobicistat (JAN/USAN/INN), Rilpivirine hydrochloride (JAN/USAN), Dolutegravir (USAN), Dolutegravir sodium (JAN/USAN)', 'map07053', 'Anti-HIV agents', 'Anti-HIV agents', 'AMD 070, Didanosine (JAN/USAN/INN), Lamivudine (JAN/USP/INN), Zalcitabine (JAN/USP/INN), Zidovudine (JP17/USP/INN), Ritonavir (JAN/USAN/INN), Saquinavir (JAN/USP/INN), Nevirapine (JAN/USP/INN), Stavudine (USAN/INN), Abacavir sulfate (JAN/USAN), Amprenavir (JAN/USAN/INN), Delavirdine mesylate (USAN), Efavirenz (JAN/INN), Indinavir sulfate (USAN), Nelfinavir mesylate (USAN/INN), Emivirine (USAN/INN), Saquinavir mesylate (USP), Emtricitabine (JAN/USAN/INN), Atazanavir sulfate (JAN/USAN), Lopinavir (JAN/USAN/INN), Tenofovir disoproxil fumarate (JAN/USAN), Fosamprenavir (INN), Enfuvirtide (USAN/INN), Indinavir sulfate ethanolate (JAN), Fosamprenavir calcium hydrate (JAN), Amdoxovir (USAN/INN), Darunavir (USAN/INN), Indinavir (USAN), Fosamprenavir calcium (USAN), Fosamprenavir sodium (USAN), Tipranavir disodium (USAN), Elvucitabine (USAN/INN), Etravirine (JAN/USAN/INN), Vicriviroc maleate (USAN), Darunavir ethanolate (JAN), Bevirimat dimeglumine (USAN), Maraviroc (JAN/INN), Raltegravir (USAN/INN), Elvitegravir (JAN/USAN), Raltegravir potassium (JAN/USAN), Atazanavir (INN), Nelfinavir (INN), Tipranavir (INN), Ibalizumab (USAN/INN), Rilpivirine (JAN/USAN/INN), Cobicistat (JAN/USAN/INN), Rilpivirine hydrochloride (JAN/USAN), Dolutegravir (USAN), Dolutegravir sodium (JAN/USAN)', 'map07053', 'Anti-HIV agents', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (505, '07054', 'Antiglaucoma agents', 'Antiglaucoma agents', 'Glycerin (JP17/USP), Mannitol (USP), Acetazolamide (JP17/USP/INN), Isosorbide (JP17/USP/INN), Latanoprost (JAN/USAN/INN), Timolol (USAN), Carbachol (JAN/USP/INN), Pilocarpine (JAN/USP), Betaxolol hydrochloride (JP17/USP), Carteolol hydrochloride (JP17/USP), Timolol maleate (JP17/USP), Brinzolamide (JAN/USP/INN), Dorzolamide hydrochloride (JP17/USP), Methazolamide (JAN/USP/INN), Apraclonidine hydrochloride (JAN/USP), Dipivefrin hydrochloride (JAN/USP), Levobunolol hydrochloride (JAN/USP), Acetazolamide sodium (JAN), Distigmine bromide (JP17/INN), Isopropyl unoprostone (JAN), Nipradilol (JAN/INN), Bunazosin hydrochloride (JP17), Travoprost (JAN/USAN/INN), Brimonidine tartrate (JAN/USAN), Metipranolol hydrochloride, Echothiophate iodide (USP), Pilocarpine hydrochloride (JP17/USP), Dipivefrin (USAN), Metipranolol (USAN/INN), Bimatoprost (JAN/USAN/INN), Sezolamide hydrochloride (USAN), Pilocarpine nitrate (USP), Tafluprost (JAN/USAN/INN), Apraclonidine (INN), Latanoprost and timolol maleate, Betaxolol (INN), Brimonidine (INN), Bunazosin (INN), Carteolol (INN), Dorzolamide (INN), Levobunolol (INN), Pilocarpine borate, Dorzolamide hydrochloride and timolol maleate, Timolol (INN), Unoprostone (INN), Travoprost and timolol maleate, Simenepag (USAN/INN), Simenepag isopropyl (USAN), Taprenepag (USAN/INN), Taprenepag isopropyl (USAN), Brimonidine tartrate and timolol maleate', 'map07054', 'Antiglaucoma agents', 'Antiglaucoma agents', 'Glycerin (JP17/USP), Mannitol (USP), Acetazolamide (JP17/USP/INN), Isosorbide (JP17/USP/INN), Latanoprost (JAN/USAN/INN), Timolol (USAN), Carbachol (JAN/USP/INN), Pilocarpine (JAN/USP), Betaxolol hydrochloride (JP17/USP), Carteolol hydrochloride (JP17/USP), Timolol maleate (JP17/USP), Brinzolamide (JAN/USP/INN), Dorzolamide hydrochloride (JP17/USP), Methazolamide (JAN/USP/INN), Apraclonidine hydrochloride (JAN/USP), Dipivefrin hydrochloride (JAN/USP), Levobunolol hydrochloride (JAN/USP), Acetazolamide sodium (JAN), Distigmine bromide (JP17/INN), Isopropyl unoprostone (JAN), Nipradilol (JAN/INN), Bunazosin hydrochloride (JP17), Travoprost (JAN/USAN/INN), Brimonidine tartrate (JAN/USAN), Metipranolol hydrochloride, Echothiophate iodide (USP), Pilocarpine hydrochloride (JP17/USP), Dipivefrin (USAN), Metipranolol (USAN/INN), Bimatoprost (JAN/USAN/INN), Sezolamide hydrochloride (USAN), Pilocarpine nitrate (USP), Tafluprost (JAN/USAN/INN), Apraclonidine (INN), Latanoprost and timolol maleate, Betaxolol (INN), Brimonidine (INN), Bunazosin (INN), Carteolol (INN), Dorzolamide (INN), Levobunolol (INN), Pilocarpine borate, Dorzolamide hydrochloride and timolol maleate, Timolol (INN), Unoprostone (INN), Travoprost and timolol maleate, Simenepag (USAN/INN), Simenepag isopropyl (USAN), Taprenepag (USAN/INN), Taprenepag isopropyl (USAN), Brimonidine tartrate and timolol maleate', 'map07054', 'Antiglaucoma agents', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (506, '07055', 'Sulfonamide derivatives - overview', 'Sulfonamide derivatives - overview', 'Prontosil, Acetazolamide (JP17/USP/INN), Furosemide (JP17/USP/INN), Indapamide (JP17/USP), Tolbutamide (JP17/USP/INN), Dichlorphenamide (USP), Chlorothiazide (JAN/USP/INN), Dorzolamide hydrochloride (JP17/USP), Sulfamethizole (JP17/USP/INN), Sulfadimethoxine (JAN/USP), Acetazolamide sodium (JAN), Carbutamide (INN), Sulfapyridine (USP/INN), Chlorothiazide sodium (USP), Tolbutamide sodium, sterile, Indapamide hydrate, Dorzolamide (INN), Sodium furosemide, Furosemide diolamine, Sulfadimethoxine sodium (USP), Sulfamidochrysoidine, Sulfanilamide (INN)', 'map07055', 'Sulfonamide derivatives - overview', 'Sulfonamide derivatives - overview', 'Prontosil, Acetazolamide (JP17/USP/INN), Furosemide (JP17/USP/INN), Indapamide (JP17/USP), Tolbutamide (JP17/USP/INN), Dichlorphenamide (USP), Chlorothiazide (JAN/USP/INN), Dorzolamide hydrochloride (JP17/USP), Sulfamethizole (JP17/USP/INN), Sulfadimethoxine (JAN/USP), Acetazolamide sodium (JAN), Carbutamide (INN), Sulfapyridine (USP/INN), Chlorothiazide sodium (USP), Tolbutamide sodium, sterile, Indapamide hydrate, Dorzolamide (INN), Sodium furosemide, Furosemide diolamine, Sulfadimethoxine sodium (USP), Sulfamidochrysoidine, Sulfanilamide (INN)', 'map07055', 'Sulfonamide derivatives - overview', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (507, '07056', 'Agents for Alzheimer-type dementia', 'Agents for Alzheimer-type dementia', 'Physostigmine (USP), Donepezil hydrochloride (JP17/USAN), Tacrine hydrochloride (USP), Galantamine hydrobromide (JAN/USAN), Physostigmine salicylate (JAN/USP), Rivastigmine tartrate, Rivastigmine (JAN/USAN/INN), Physostigmine sulfate (USP), Galantamine (USAN/INN), Memantine hydrochloride (JAN/USAN), Tramiprosate (USAN), Donepezil (INN), Memantine (INN), Tacrine (INN), Bapineuzumab (USAN/INN), Begacestat (USAN/INN), Tarenflurbil (USAN/INN), Semagacestat (USAN/INN), Gantenerumab (USAN/INN), Avagacestat (USAN), Latrepirdine (USAN/INN), Latrepirdine dihydrochloride (USAN), Solanezumab (USAN/INN)', 'map07056', 'Agents for Alzheimer-type dementia', 'Agents for Alzheimer-type dementia', 'Physostigmine (USP), Donepezil hydrochloride (JP17/USAN), Tacrine hydrochloride (USP), Galantamine hydrobromide (JAN/USAN), Physostigmine salicylate (JAN/USP), Rivastigmine tartrate, Rivastigmine (JAN/USAN/INN), Physostigmine sulfate (USP), Galantamine (USAN/INN), Memantine hydrochloride (JAN/USAN), Tramiprosate (USAN), Donepezil (INN), Memantine (INN), Tacrine (INN), Bapineuzumab (USAN/INN), Begacestat (USAN/INN), Tarenflurbil (USAN/INN), Semagacestat (USAN/INN), Gantenerumab (USAN/INN), Avagacestat (USAN), Latrepirdine (USAN/INN), Latrepirdine dihydrochloride (USAN), Solanezumab (USAN/INN)', 'map07056', 'Agents for Alzheimer-type dementia', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (508, '07057', 'Antiparkinsonian agents', 'Antiparkinsonian agents', 'Levodopa (JP17/USP/INN), Pergolide mesylate (USP), Zonisamide (JP17/USAN/INN), Carbidopa (USP), Pramipexole hydrochloride (USAN), Amantadine hydrochloride (JP17/USP), Benztropine mesylate (USP), Biperiden (JAN/USP/INN), Bromocriptine mesylate (USP), Entacapone (JP17/USAN/INN), Ropinirole hydrochloride (JAN/USAN), Selegiline hydrochloride (JAN/USP), Tolcapone (JAN/USAN/INN), Trihexyphenidyl hydrochloride (JP17/USP), Cabergoline (JAN/USAN/INN), Profenamine hydrochloride (JAN), Piroheptine hydrochloride (JAN), Droxidopa (JP17/INN), Talipexole hydrochloride (JAN), Benserazide hydrochloride (JP17), Methixene hydrochloride (USAN), Apomorphine hydrochloride (USP), Biperiden hydrochloride (JP17/USP), Biperiden lactate (JAN/USP), Rasagiline mesylate (USAN), Benserazide (USAN/INN), Besonprodil (USAN), Bromocriptine (USAN/INN), Mazaticol hydrochloride hydrate (JAN), Profenamine hibenzate (JAN), Selegiline (USAN/INN), Ethybenztropine (USAN), Istradefylline (JAN/USAN/INN), Pramipexole (USAN/INN), Rotigotine (JAN/USAN/INN), Piribedil (INN), Amantadine (INN), Apomorphine (BAN), Benzatropine (INN), Dihydroergocryptine, Dihydroergocryptine mesilate, Mazaticol (INN), Metixene (INN), Pergolide (INN), Piroheptine (INN), Profenamine (INN), Rasagiline (USAN/INN), Ropinirole (USAN/INN), Talipexole (INN), Trihexyphenidyl (INN), Vipadenant (USAN/INN), Safinamide mesylate (USAN)', 'map07057', 'Antiparkinsonian agents', 'Antiparkinsonian agents', 'Levodopa (JP17/USP/INN), Pergolide mesylate (USP), Zonisamide (JP17/USAN/INN), Carbidopa (USP), Pramipexole hydrochloride (USAN), Amantadine hydrochloride (JP17/USP), Benztropine mesylate (USP), Biperiden (JAN/USP/INN), Bromocriptine mesylate (USP), Entacapone (JP17/USAN/INN), Ropinirole hydrochloride (JAN/USAN), Selegiline hydrochloride (JAN/USP), Tolcapone (JAN/USAN/INN), Trihexyphenidyl hydrochloride (JP17/USP), Cabergoline (JAN/USAN/INN), Profenamine hydrochloride (JAN), Piroheptine hydrochloride (JAN), Droxidopa (JP17/INN), Talipexole hydrochloride (JAN), Benserazide hydrochloride (JP17), Methixene hydrochloride (USAN), Apomorphine hydrochloride (USP), Biperiden hydrochloride (JP17/USP), Biperiden lactate (JAN/USP), Rasagiline mesylate (USAN), Benserazide (USAN/INN), Besonprodil (USAN), Bromocriptine (USAN/INN), Mazaticol hydrochloride hydrate (JAN), Profenamine hibenzate (JAN), Selegiline (USAN/INN), Ethybenztropine (USAN), Istradefylline (JAN/USAN/INN), Pramipexole (USAN/INN), Rotigotine (JAN/USAN/INN), Piribedil (INN), Amantadine (INN), Apomorphine (BAN), Benzatropine (INN), Dihydroergocryptine, Dihydroergocryptine mesilate, Mazaticol (INN), Metixene (INN), Pergolide (INN), Piroheptine (INN), Profenamine (INN), Rasagiline (USAN/INN), Ropinirole (USAN/INN), Talipexole (INN), Trihexyphenidyl (INN), Vipadenant (USAN/INN), Safinamide mesylate (USAN)', 'map07057', 'Antiparkinsonian agents', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (509, '07110', 'Benzoic acid family', 'Benzoic acid family', 'Anthranilate, 4-Hydroxybenzoate, Benzoic acid (JP17/USP), Salicylic acid (JP17/USP), Aspirin (JP17/USP), Cocaine (USP), Diflunisal (JAN/USP/INN), Mefenamic acid (JP17/USP/INN), Benzocaine (USP/INN), Procaine hydrochloride (JP17/USP), Methyl salicylate (JP17/NF), Tolfenamic acid (JAN/INN), Iothalamic acid (USP), Iodamide (JAN/USAN/INN), Methyl parahydroxybenzoate (JP17), Butyl parahydroxybenzoate (JP17), Propyl parahydroxybenzoate (JP17), Flufenamic acid (JAN/USAN/INN), Ethyl parahydroxybenzoate (JP17), Iodipamide (USP), Metrizoate sodium (USAN), Iodipamide meglumine (USP), Iodamide meglumine (USAN), Meglumine sodium iodamide, Cocaine hydrochloride (JP17/USP), Diatrizoic acid (USP), Aminobenzoic acid (USP), Acetrizoic acid, Methylparaben sodium (NF), Propylparaben sodium (NF), Penicillin G procaine (USP)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\")', 'map07110', 'Benzoic acid family', 'Benzoic acid family', 'Anthranilate, 4-Hydroxybenzoate, Benzoic acid (JP17/USP), Salicylic acid (JP17/USP), Aspirin (JP17/USP), Cocaine (USP), Diflunisal (JAN/USP/INN), Mefenamic acid (JP17/USP/INN), Benzocaine (USP/INN), Procaine hydrochloride (JP17/USP), Methyl salicylate (JP17/NF), Tolfenamic acid (JAN/INN), Iothalamic acid (USP), Iodamide (JAN/USAN/INN), Methyl parahydroxybenzoate (JP17), Butyl parahydroxybenzoate (JP17), Propyl parahydroxybenzoate (JP17), Flufenamic acid (JAN/USAN/INN), Ethyl parahydroxybenzoate (JP17), Iodipamide (USP), Metrizoate sodium (USAN), Iodipamide meglumine (USP), Iodamide meglumine (USAN), Meglumine sodium iodamide, Cocaine hydrochloride (JP17/USP), Diatrizoic acid (USP), Aminobenzoic acid (USP), Acetrizoic acid, Methylparaben sodium (NF), Propylparaben sodium (NF), Penicillin G procaine (USP)', 'list(REFERENCE = \"(Japanese)\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (510, '07112', '1,2-Diphenyl substitution family', '1,2-Diphenyl substitution family', 'SB 218655, SR 141716, Oxaprozin (JP17/USAN/INN), Phenylbutazone (JP17/USP/INN), Celecoxib (JAN/USAN/INN), Rofecoxib (JAN/USAN/INN), Pamicogrel (JAN/INN), Mofezolac (JAN/INN)', 'list(REFERENCE = \"PMID:12927511\", AUTHORS = \"Muller G.\", TITLE = \"Medicinal chemistry of target family-directed masterkeys.\", JOURNAL = c(\"Drug Discov Today 8:681-91 (2003)\", \"DOI:10.1016/S1359-6446(03)02781-8\"))', 'map07112', '1,2-Diphenyl substitution family', '1,2-Diphenyl substitution family', 'SB 218655, SR 141716, Oxaprozin (JP17/USAN/INN), Phenylbutazone (JP17/USP/INN), Celecoxib (JAN/USAN/INN), Rofecoxib (JAN/USAN/INN), Pamicogrel (JAN/INN), Mofezolac (JAN/INN)', 'list(REFERENCE = \"PMID:12927511\", AUTHORS = \"Muller G.\", TITLE = \"Medicinal chemistry of target family-directed masterkeys.\", JOURNAL = c(\"Drug Discov Today 8:681-91 (2003)\", \"DOI:10.1016/S1359-6446(03)02781-8\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (511, '07114', 'Naphthalene family', 'Naphthalene family', 'Naphthalene, 2-Naphthol, 1-Naphthol, 1-Methylnaphthalene, 2-Methylnaphthalene, Naproxen (JP17/USP/INN), Tolnaftate (JP17/USP/INN), Nabumetone (JP17/USP/INN), Propranolol hydrochloride (JP17/USP), Naphazoline hydrochloride (JP17/USP), Naproxen sodium (USP), Nafarelin acetate (USAN), Naphazoline nitrate (JP17), Butenafine hydrochloride (JP17/USAN), Indocyanine green (JAN/USP), 1-Naphthylacetic acid (JAN), Nafamostat mesylate (USAN), Naftopidil (JP17/INN), Chromomycin A3 (JAN), Terbinafine hydrochloride (JP17/USP), Terbinafine (USAN/INN), Rifamycin (USAN/INN), Dexpropranolol hydrochloride (USAN), Butenafine (INN), Nafamostat (INN), Nafarelin (INN), Naphazoline (INN), Propranolol (INN), Rifamycin sodium (USAN)', 'map07114', 'Naphthalene family', 'Naphthalene family', 'Naphthalene, 2-Naphthol, 1-Naphthol, 1-Methylnaphthalene, 2-Methylnaphthalene, Naproxen (JP17/USP/INN), Tolnaftate (JP17/USP/INN), Nabumetone (JP17/USP/INN), Propranolol hydrochloride (JP17/USP), Naphazoline hydrochloride (JP17/USP), Naproxen sodium (USP), Nafarelin acetate (USAN), Naphazoline nitrate (JP17), Butenafine hydrochloride (JP17/USAN), Indocyanine green (JAN/USP), 1-Naphthylacetic acid (JAN), Nafamostat mesylate (USAN), Naftopidil (JP17/INN), Chromomycin A3 (JAN), Terbinafine hydrochloride (JP17/USP), Terbinafine (USAN/INN), Rifamycin (USAN/INN), Dexpropranolol hydrochloride (USAN), Butenafine (INN), Nafamostat (INN), Nafarelin (INN), Naphazoline (INN), Propranolol (INN), Rifamycin sodium (USAN)', 'map07114', 'Naphthalene family', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (512, '07117', 'Benzodiazepine family', 'Benzodiazepine family', 'Asperlicin, L-365260, GYKI 52466, GYKI 52895, GV 150013X, LY-202769, Clozapine (JAN/USP/INN), Diazepam (JP17/USP/INN), Olanzapine (JAN/USAN/INN), Tofisopam (JP17/INN), Panazepide (JAN), Devazepide (USAN/INN), Tifluadom (INN), Talampanel (INN), Tarazepide (INN), Tibezonium iodide (INN)', 'list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"PMID:12789687\", AUTHORS = \"Herranz R.\", TITLE = \"Cholecystokinin antagonists: pharmacological and therapeutic potential.\", JOURNAL = c(\"Med Res Rev 23:559-605 (2003)\", \"DOI:10.1002/med.10042\")), list(REFERENCE = \"PMID:12369971\", AUTHORS = \"Zappala M, Grasso S, Micale N, Polimeni S, De Micheli C.\", TITLE = \"Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists.\", JOURNAL = c(\"Mini Rev Med Chem 1:243-53 (2001)\", \"DOI:10.2174/1389557013406783\")), list(REFERENCE = \"PMID:11945139\", AUTHORS = \"Solyom S, Tarnawa I.\", TITLE = \"Non-competitive AMPA antagonists of 2,3-benzodiazepine type.\", JOURNAL = c(\"Curr Pharm Des 8:913-39 (2002)\", \"DOI:10.2174/1381612024607081\")), list(REFERENCE = \"PMID:12477342\", AUTHORS = \"Patchett AA.\", TITLE = \"2002 Alfred Burger Award Address in Medicinal Chemistry. Natural products and design: interrelated approaches in drug discovery.\", JOURNAL = c(\"J Med Chem 45:5609-16 (2002)\", \"DOI:10.1021/jm020424z\"))', 'map07117', 'Benzodiazepine family', 'Benzodiazepine family', 'Asperlicin, L-365260, GYKI 52466, GYKI 52895, GV 150013X, LY-202769, Clozapine (JAN/USP/INN), Diazepam (JP17/USP/INN), Olanzapine (JAN/USAN/INN), Tofisopam (JP17/INN), Panazepide (JAN), Devazepide (USAN/INN), Tifluadom (INN), Talampanel (INN), Tarazepide (INN), Tibezonium iodide (INN)', 'list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"PMID:12789687\", AUTHORS = \"Herranz R.\", TITLE = \"Cholecystokinin antagonists: pharmacological and therapeutic potential.\", JOURNAL = c(\"Med Res Rev 23:559-605 (2003)\", \"DOI:10.1002/med.10042\")), list(REFERENCE = \"PMID:12369971\", AUTHORS = \"Zappala M, Grasso S, Micale N, Polimeni S, De Micheli C.\", TITLE = \"Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists.\", JOURNAL = c(\"Mini Rev Med Chem 1:243-53 (2001)\", \"DOI:10.2174/1389557013406783\")), list(REFERENCE = \"PMID:11945139\", AUTHORS = \"Solyom S, Tarnawa I.\", TITLE = \"Non-competitive AMPA antagonists of 2,3-benzodiazepine type.\", JOURNAL = c(\"Curr Pharm Des 8:913-39 (2002)\", \"DOI:10.2174/1381612024607081\")), list(REFERENCE = \"PMID:12477342\", AUTHORS = \"Patchett AA.\", TITLE = \"2002 Alfred Burger Award Address in Medicinal Chemistry. Natural products and design: interrelated approaches in drug discovery.\", JOURNAL = c(\"J Med Chem 45:5609-16 (2002)\", \"DOI:10.1021/jm020424z\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (513, '07211', 'Serotonin receptor agonists/antagonists', 'Serotonin receptor agonists/antagonists', 'Serotonin, Cisapride (USAN/INN), Clozapine (JAN/USP/INN), Zolmitriptan (JAN/USAN/INN), Risperidone (JP17/USAN/INN), Sumatriptan (JAN/USP/INN), Olanzapine (JAN/USAN/INN), Ondansetron (JAN/USP/INN), Sumatriptan succinate (JAN/USAN), Granisetron hydrochloride (JAN/USAN), Ondansetron hydrochloride hydrate (JAN/USP), Methysergide maleate (USP), Buspirone hydrochloride (USP), Metoclopramide (JP17/INN), Lisuride maleate (JAN), Azasetron hydrochloride (JAN), Sarpogrelate hydrochloride (JP17), Tandospirone citrate (JAN/USAN), Mosapride citrate hydrate (JP17), Ramosetron hydrochloride (JAN), Tropisetron hydrochloride (JAN), Cisapride (JAN), Tropisetron (INN), Metoclopramide hydrochloride (JAN), Methysergide (USAN/INN), Ketanserin (USAN/INN), Perospirone hydrochloride hydrate (JAN), Granisetron (JAN/USAN/INN), Metoclopramide hydrochloride (USAN), Zacopride hydrochloride (USAN), Renzapride (INN), Olanzapine pamoate (USAN), Azasetron (INN), Buspirone (INN), Ketanserin tartrate, Lisuride (INN), Mosapride (INN), Ramosetron (INN), Sarpogrelate (INN), Tandospirone (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"(ISBN4-260-10535-3)\", AUTHORS = \"Katori S.\", TITLE = \"[Standard Pharmacology (6th ed)] (In Japanese)\", JOURNAL = \"Igaku shoin\"), list(REFERENCE = \"PMID:11555327\", AUTHORS = \"Kii Y, Nakatsuji K, Nose I, Yabuuchi M, Mizuki Y, Ito T.\", TITLE = \"Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats.\", JOURNAL = \"Pharmacol Toxicol 89:96-103 (2001)\")', 'map07211', 'Serotonin receptor agonists/antagonists', 'Serotonin receptor agonists/antagonists', 'Serotonin, Cisapride (USAN/INN), Clozapine (JAN/USP/INN), Zolmitriptan (JAN/USAN/INN), Risperidone (JP17/USAN/INN), Sumatriptan (JAN/USP/INN), Olanzapine (JAN/USAN/INN), Ondansetron (JAN/USP/INN), Sumatriptan succinate (JAN/USAN), Granisetron hydrochloride (JAN/USAN), Ondansetron hydrochloride hydrate (JAN/USP), Methysergide maleate (USP), Buspirone hydrochloride (USP), Metoclopramide (JP17/INN), Lisuride maleate (JAN), Azasetron hydrochloride (JAN), Sarpogrelate hydrochloride (JP17), Tandospirone citrate (JAN/USAN), Mosapride citrate hydrate (JP17), Ramosetron hydrochloride (JAN), Tropisetron hydrochloride (JAN), Cisapride (JAN), Tropisetron (INN), Metoclopramide hydrochloride (JAN), Methysergide (USAN/INN), Ketanserin (USAN/INN), Perospirone hydrochloride hydrate (JAN), Granisetron (JAN/USAN/INN), Metoclopramide hydrochloride (USAN), Zacopride hydrochloride (USAN), Renzapride (INN), Olanzapine pamoate (USAN), Azasetron (INN), Buspirone (INN), Ketanserin tartrate, Lisuride (INN), Mosapride (INN), Ramosetron (INN), Sarpogrelate (INN), Tandospirone (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"(ISBN4-260-10535-3)\", AUTHORS = \"Katori S.\", TITLE = \"[Standard Pharmacology (6th ed)] (In Japanese)\", JOURNAL = \"Igaku shoin\"), list(REFERENCE = \"PMID:11555327\", AUTHORS = \"Kii Y, Nakatsuji K, Nose I, Yabuuchi M, Mizuki Y, Ito T.\", TITLE = \"Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats.\", JOURNAL = \"Pharmacol Toxicol 89:96-103 (2001)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (514, '07212', 'Histamine H1 receptor antagonists', 'Histamine H1 receptor antagonists', 'Phenbenzamine hydrochloride, Astemizole (JAN/USP/INN), Chlorpromazine (USP/INN), Diphenhydramine (JP17/INN), Loratadine (JAN/USAN/INN), Promethazine hydrochloride (JP17/USP), Promethazine (JAN/INN), Terfenadine (JAN/USAN/INN), Azelastine hydrochloride (JP17/USAN), Azatadine maleate (USP), Brompheniramine maleate (USAN), Cetirizine hydrochloride (JP17/USAN), Chlorpheniramine maleate (JP17/USP), Clemastine fumarate (JP17/USP), Dexchlorpheniramine maleate (USP), Diphenhydramine hydrochloride (JP17/USP), Fexofenadine hydrochloride (JP17/USAN), Hydroxyzine hydrochloride (JP17/USP), Chlorpromazine hydrochloride (JP17/USP), Hydroxyzine pamoate (JP17/USP), Isothipendyl hydrochloride (JAN), Diphenylpyraline hydrochloride (JAN), Pheniramine maleate (JAN/USP), Olopatadine hydrochloride (JP17/USAN), Promethazine teoclate (JAN/INN), Meclizine hydrochloride (JAN/USP), Mequitazine (JP17/INN), Ketotifen fumarate (JP17/USAN), Carbinoxamine maleate (JAN/USP), Homochlorcyclizine hydrochloride (JP17), Ebastine (JP17/USAN/INN), Diphenylpyraline teoclate (JAN), Bepotastine besylate (USAN), Epinastine hydrochloride (JAN), Levocabastine hydrochloride (JAN/USAN), Oxatomide (JAN/USAN/INN), Triprolidine hydrochloride (USP), Thonzylamine hydrochloride (JAN/USAN), Buclizine hydrochloride (USAN), Cyclizine lactate (BAN), Tripelennamine hydrochloride (USP), Phenindamine tartrate (USAN), Cyproheptadine hydrochloride (JP17/USP), Trimeprazine tartrate (USP), Emedastine difumarate (JP17/USP), Doxylamine succinate (USP), Diphenhydramine salicylate (JAN), Acrivastine (USAN/INN), Bromodiphenhydramine hydrochloride (USP), Chlorpromazine hibenzate (JAN), Diphenhydramine tannate (JP17), Promethazine methylenedisalicylate (JAN), Diphenhydramine laurylsulfate (JAN), Clemastine (USAN), Cyclizine (INN), Cyclizine hydrochloride (USP), Diphenhydramine citrate (USP), Chlorpromazine phenolphthalinate (JAN), Methdilazine (INN), Methdilazine hydrochloride (USP), Pyrilamine maleate (USP), Temelastine (USAN/INN), Tripelennamine citrate, Alimemazine (INN), Chlorphenoxamine (INN), Chlorphenamine (INN), Levocetirizine (USAN/INN), Azatadine (INN), Azelastine (INN), Brompheniramine (INN), Buclizine (INN), Carbinoxamine (INN), Cetirizine (INN), Chlorphenoxamine hydrochloride, Cyproheptadine (INN), Dexchlorpheniramine (INN), Diphenylpyraline (INN), Doxylamine (INN), Emedastine (INN), Epinastine (INN), Fexofenadine (INN), Homochlorcyclizine (INN), Hydroxyzine (INN), Isothipendyl (INN), Ketotifen (INN), Levocabastine (INN), Levocetirizine dihydrochloride (USAN), Meclozine (BAN), Mepyramine (INN), Mepyramine theophyllineacetate, Olopatadine (INN), Phenindamine (INN), Pheniramine (INN), Promethazine maleate, Thonzylamine (INN), Tripelennamine (INN), Triprolidine (INN), Promethazine hibenzate', 'list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\"), list(REFERENCE = \"\", AUTHORS = \"Watanabe T., Kamisaki Y.\", TITLE = \"[Molecular Targeting Pharmacology 2nd Ed)] (In Japanase)\", JOURNAL = \"Ishiyaku Publishers\")', 'map07212', 'Histamine H1 receptor antagonists', 'Histamine H1 receptor antagonists', 'Phenbenzamine hydrochloride, Astemizole (JAN/USP/INN), Chlorpromazine (USP/INN), Diphenhydramine (JP17/INN), Loratadine (JAN/USAN/INN), Promethazine hydrochloride (JP17/USP), Promethazine (JAN/INN), Terfenadine (JAN/USAN/INN), Azelastine hydrochloride (JP17/USAN), Azatadine maleate (USP), Brompheniramine maleate (USAN), Cetirizine hydrochloride (JP17/USAN), Chlorpheniramine maleate (JP17/USP), Clemastine fumarate (JP17/USP), Dexchlorpheniramine maleate (USP), Diphenhydramine hydrochloride (JP17/USP), Fexofenadine hydrochloride (JP17/USAN), Hydroxyzine hydrochloride (JP17/USP), Chlorpromazine hydrochloride (JP17/USP), Hydroxyzine pamoate (JP17/USP), Isothipendyl hydrochloride (JAN), Diphenylpyraline hydrochloride (JAN), Pheniramine maleate (JAN/USP), Olopatadine hydrochloride (JP17/USAN), Promethazine teoclate (JAN/INN), Meclizine hydrochloride (JAN/USP), Mequitazine (JP17/INN), Ketotifen fumarate (JP17/USAN), Carbinoxamine maleate (JAN/USP), Homochlorcyclizine hydrochloride (JP17), Ebastine (JP17/USAN/INN), Diphenylpyraline teoclate (JAN), Bepotastine besylate (USAN), Epinastine hydrochloride (JAN), Levocabastine hydrochloride (JAN/USAN), Oxatomide (JAN/USAN/INN), Triprolidine hydrochloride (USP), Thonzylamine hydrochloride (JAN/USAN), Buclizine hydrochloride (USAN), Cyclizine lactate (BAN), Tripelennamine hydrochloride (USP), Phenindamine tartrate (USAN), Cyproheptadine hydrochloride (JP17/USP), Trimeprazine tartrate (USP), Emedastine difumarate (JP17/USP), Doxylamine succinate (USP), Diphenhydramine salicylate (JAN), Acrivastine (USAN/INN), Bromodiphenhydramine hydrochloride (USP), Chlorpromazine hibenzate (JAN), Diphenhydramine tannate (JP17), Promethazine methylenedisalicylate (JAN), Diphenhydramine laurylsulfate (JAN), Clemastine (USAN), Cyclizine (INN), Cyclizine hydrochloride (USP), Diphenhydramine citrate (USP), Chlorpromazine phenolphthalinate (JAN), Methdilazine (INN), Methdilazine hydrochloride (USP), Pyrilamine maleate (USP), Temelastine (USAN/INN), Tripelennamine citrate, Alimemazine (INN), Chlorphenoxamine (INN), Chlorphenamine (INN), Levocetirizine (USAN/INN), Azatadine (INN), Azelastine (INN), Brompheniramine (INN), Buclizine (INN), Carbinoxamine (INN), Cetirizine (INN), Chlorphenoxamine hydrochloride, Cyproheptadine (INN), Dexchlorpheniramine (INN), Diphenylpyraline (INN), Doxylamine (INN), Emedastine (INN), Epinastine (INN), Fexofenadine (INN), Homochlorcyclizine (INN), Hydroxyzine (INN), Isothipendyl (INN), Ketotifen (INN), Levocabastine (INN), Levocetirizine dihydrochloride (USAN), Meclozine (BAN), Mepyramine (INN), Mepyramine theophyllineacetate, Olopatadine (INN), Phenindamine (INN), Pheniramine (INN), Promethazine maleate, Thonzylamine (INN), Tripelennamine (INN), Triprolidine (INN), Promethazine hibenzate', 'list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\"), list(REFERENCE = \"\", AUTHORS = \"Watanabe T., Kamisaki Y.\", TITLE = \"[Molecular Targeting Pharmacology 2nd Ed)] (In Japanase)\", JOURNAL = \"Ishiyaku Publishers\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (515, '07213', 'Dopamine receptor agonists/antagonists', 'Dopamine receptor agonists/antagonists', 'Haloperidol (JP17/USP/INN), Chlorpromazine (USP/INN), Cisapride (USAN/INN), Clozapine (JAN/USP/INN), Droperidol (JP17/USP/INN), Risperidone (JP17/USAN/INN), Olanzapine (JAN/USAN/INN), Quetiapine fumarate (JP17/USAN), Procainamide hydrochloride (JP17/USP), Promethazine hydrochloride (JP17/USP), Promethazine (JAN/INN), Pramipexole hydrochloride (USAN), Dopamine hydrochloride (JP17/USP), Metoclopramide (JP17/INN), Bromocriptine mesylate (USP), Chlorpromazine hydrochloride (JP17/USP), Imipramine hydrochloride (JP17/USP), Spiperone (JAN/USAN), Aripiprazole (JAN/USAN/INN), Sulpiride (JP17/USAN/INN), Promethazine teoclate (JAN/INN), Lisuride maleate (JAN), Nemonapride (JAN/INN), Talipexole hydrochloride (JAN), Mosapramine hydrochloride (JAN), Clebopride malate (JP17), Domperidone (JP17/USAN/INN), Haloperidol decanoate (JAN/USAN), Apomorphine hydrochloride (USP), Cisapride (JAN), Sultopride hydrochloride (JAN), Metoclopramide hydrochloride (JAN), Clocapramine hydrochloride hydrate (JP17), Perospirone hydrochloride hydrate (JAN), Bromocriptine (USAN/INN), Chlorpromazine hibenzate (JAN), Promethazine methylenedisalicylate (JAN), Clebopride (USAN), Chlorpromazine phenolphthalinate (JAN), Pramipexole (USAN/INN), Olanzapine pamoate (USAN), Levosulpiride (INN), Apomorphine (BAN), Clocapramine (INN), Domperidone maleate, Dopamine (INN), Haloperidol lactate, Lisuride (INN), Mosapramine (INN), Procainamide (INN), Promethazine maleate, Quetiapine (INN), Sultopride (INN), Talipexole (INN), Promethazine hibenzate', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Katori S.\", TITLE = \"[Standard Pharmacology (6th ed)] (In Japanese)\", JOURNAL = \"Igaku shoin\")', 'map07213', 'Dopamine receptor agonists/antagonists', 'Dopamine receptor agonists/antagonists', 'Haloperidol (JP17/USP/INN), Chlorpromazine (USP/INN), Cisapride (USAN/INN), Clozapine (JAN/USP/INN), Droperidol (JP17/USP/INN), Risperidone (JP17/USAN/INN), Olanzapine (JAN/USAN/INN), Quetiapine fumarate (JP17/USAN), Procainamide hydrochloride (JP17/USP), Promethazine hydrochloride (JP17/USP), Promethazine (JAN/INN), Pramipexole hydrochloride (USAN), Dopamine hydrochloride (JP17/USP), Metoclopramide (JP17/INN), Bromocriptine mesylate (USP), Chlorpromazine hydrochloride (JP17/USP), Imipramine hydrochloride (JP17/USP), Spiperone (JAN/USAN), Aripiprazole (JAN/USAN/INN), Sulpiride (JP17/USAN/INN), Promethazine teoclate (JAN/INN), Lisuride maleate (JAN), Nemonapride (JAN/INN), Talipexole hydrochloride (JAN), Mosapramine hydrochloride (JAN), Clebopride malate (JP17), Domperidone (JP17/USAN/INN), Haloperidol decanoate (JAN/USAN), Apomorphine hydrochloride (USP), Cisapride (JAN), Sultopride hydrochloride (JAN), Metoclopramide hydrochloride (JAN), Clocapramine hydrochloride hydrate (JP17), Perospirone hydrochloride hydrate (JAN), Bromocriptine (USAN/INN), Chlorpromazine hibenzate (JAN), Promethazine methylenedisalicylate (JAN), Clebopride (USAN), Chlorpromazine phenolphthalinate (JAN), Pramipexole (USAN/INN), Olanzapine pamoate (USAN), Levosulpiride (INN), Apomorphine (BAN), Clocapramine (INN), Domperidone maleate, Dopamine (INN), Haloperidol lactate, Lisuride (INN), Mosapramine (INN), Procainamide (INN), Promethazine maleate, Quetiapine (INN), Sultopride (INN), Talipexole (INN), Promethazine hibenzate', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Katori S.\", TITLE = \"[Standard Pharmacology (6th ed)] (In Japanese)\", JOURNAL = \"Igaku shoin\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (516, '07214', 'beta-Adrenergic receptor agonists/antagonists', 'beta-Adrenergic receptor agonists/antagonists', 'DCI, Epinephrine (USP/INN), Atenolol (JP17/USP/INN), Propranolol hydrochloride (JP17/USP), Pindolol (JP17/USP/INN), Labetalol hydrochloride (JP17/USP), Metoprolol tartrate (JP17/USP), Dobutamine hydrochloride (JP17/USP), Bisoprolol fumarate (JP17/USP), Metoprolol succinate (USP), Esmolol hydrochloride (JAN/USAN), Metaproterenol sulfate (USP), Epinephrine hydrochloride (JAN), Alprenolol hydrochloride (JP17/USAN), Bevantolol hydrochloride (JAN/USAN), Isoproterenol hydrochloride (USP), Amosulalol hydrochloride (JP17), Arotinolol hydrochloride (JP17), Isoproterenol sulfate (USP), Epinephrine bitartrate (JAN/USP), l-Isoprenaline hydrochloride (JP17), Bisoprolol (JAN/USAN/INN), Metoprolol (USAN/INN), Procaterol hydrochloride (USAN), Denopamine (JAN/INN), Dobutamine (USP/INN), Dobutamine lactobionate (USAN), Dobutamine tartrate (USP), Metoprolol fumarate (USP), Procaterol hydrochloride hydrate (JP17), Alprenolol (INN), Amosulalol (INN), Arotinolol (INN), Esmolol (INN), Isoprenaline (INN), Labetalol (INN), Orciprenaline (INN), Procaterol (INN), Propranolol (INN)', 'map07214', 'beta-Adrenergic receptor agonists/antagonists', 'beta-Adrenergic receptor agonists/antagonists', 'DCI, Epinephrine (USP/INN), Atenolol (JP17/USP/INN), Propranolol hydrochloride (JP17/USP), Pindolol (JP17/USP/INN), Labetalol hydrochloride (JP17/USP), Metoprolol tartrate (JP17/USP), Dobutamine hydrochloride (JP17/USP), Bisoprolol fumarate (JP17/USP), Metoprolol succinate (USP), Esmolol hydrochloride (JAN/USAN), Metaproterenol sulfate (USP), Epinephrine hydrochloride (JAN), Alprenolol hydrochloride (JP17/USAN), Bevantolol hydrochloride (JAN/USAN), Isoproterenol hydrochloride (USP), Amosulalol hydrochloride (JP17), Arotinolol hydrochloride (JP17), Isoproterenol sulfate (USP), Epinephrine bitartrate (JAN/USP), l-Isoprenaline hydrochloride (JP17), Bisoprolol (JAN/USAN/INN), Metoprolol (USAN/INN), Procaterol hydrochloride (USAN), Denopamine (JAN/INN), Dobutamine (USP/INN), Dobutamine lactobionate (USAN), Dobutamine tartrate (USP), Metoprolol fumarate (USP), Procaterol hydrochloride hydrate (JP17), Alprenolol (INN), Amosulalol (INN), Arotinolol (INN), Esmolol (INN), Isoprenaline (INN), Labetalol (INN), Orciprenaline (INN), Procaterol (INN), Propranolol (INN)', 'map07214', 'beta-Adrenergic receptor agonists/antagonists', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (517, '07215', 'alpha-Adrenergic receptor agonists/antagonists', 'alpha-Adrenergic receptor agonists/antagonists', 'Noradrenaline (JP17), Carvedilol (JP17/USAN/INN), Clonidine (JAN/USP/INN), Phentolamine mesylate (USP), Phenylephrine hydrochloride (JP17/USP), Dexmedetomidine (USAN/INN), Clonidine hydrochloride (JP17/USP), Guanabenz acetate (JP17/USP), Guanfacine hydrochloride (JAN/USP), Doxazosin mesylate (USAN), Prazosin hydrochloride (JP17/USP), Terazosin hydrochloride (USAN), Ergotamine tartrate (JP17/USP), Naphazoline hydrochloride (JP17/USP), Tolazoline hydrochloride (JAN/USP), Methoxamine hydrochloride (JAN), Naphazoline nitrate (JP17), Tamsulosin hydrochloride (JP17/USAN), Ergonovine maleate (USP), Dexmedetomidine hydrochloride (JAN/USAN), Urapidil (JP17/INN), Amosulalol hydrochloride (JP17), Naftopidil (JP17/INN), Bunazosin hydrochloride (JP17), Carvedilol phosphate (USAN), Guanabenz (USAN/INN), Amosulalol (INN), Bunazosin (INN), Doxazosin (INN), Ergometrine (INN), Ergotamine (INN), Guanfacine (INN), Methoxamine (BAN), Phentolamine (INN), Phenylephrine (INN), Prazosin (INN), Tamsulosin (INN), Terazosin (INN), Tolazoline (INN), Urapidil hydrochloride, Phenylephrine bitartrate (USP)', 'map07215', 'alpha-Adrenergic receptor agonists/antagonists', 'alpha-Adrenergic receptor agonists/antagonists', 'Noradrenaline (JP17), Carvedilol (JP17/USAN/INN), Clonidine (JAN/USP/INN), Phentolamine mesylate (USP), Phenylephrine hydrochloride (JP17/USP), Dexmedetomidine (USAN/INN), Clonidine hydrochloride (JP17/USP), Guanabenz acetate (JP17/USP), Guanfacine hydrochloride (JAN/USP), Doxazosin mesylate (USAN), Prazosin hydrochloride (JP17/USP), Terazosin hydrochloride (USAN), Ergotamine tartrate (JP17/USP), Naphazoline hydrochloride (JP17/USP), Tolazoline hydrochloride (JAN/USP), Methoxamine hydrochloride (JAN), Naphazoline nitrate (JP17), Tamsulosin hydrochloride (JP17/USAN), Ergonovine maleate (USP), Dexmedetomidine hydrochloride (JAN/USAN), Urapidil (JP17/INN), Amosulalol hydrochloride (JP17), Naftopidil (JP17/INN), Bunazosin hydrochloride (JP17), Carvedilol phosphate (USAN), Guanabenz (USAN/INN), Amosulalol (INN), Bunazosin (INN), Doxazosin (INN), Ergometrine (INN), Ergotamine (INN), Guanfacine (INN), Methoxamine (BAN), Phentolamine (INN), Phenylephrine (INN), Prazosin (INN), Tamsulosin (INN), Terazosin (INN), Tolazoline (INN), Urapidil hydrochloride, Phenylephrine bitartrate (USP)', 'map07215', 'alpha-Adrenergic receptor agonists/antagonists', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (518, '07216', 'Catecholamine transferase inhibitors', 'Catecholamine transferase inhibitors', '1,2,3-Trihydroxybenzene, Tropolone, U 0521, Norselegiline, CGP 28014, Phloroglucinol (JAN), Isoniazid (JP17/USP/INN), Phenelzine sulfate (USP), Entacapone (JP17/USAN/INN), Selegiline hydrochloride (JAN/USP), Tolcapone (JAN/USAN/INN), Tranylcypromine sulfate (USP XXI), Lazabemide hydrochloride (JAN/USAN), Flopropione (JP17/INN), Trepibutone (JP17/INN), Safrazine hydrochloride (JAN), Toloxatone (INN), Brofaromine (INN), Moclobemide (USAN/INN), Rasagiline mesylate (USAN), Befloxatone (INN), Pargyline hydrochloride (USAN), Iproniazid (INN), Isocarboxazid (INN), Ladostigil tartrate (USAN), Nitecapone (INN), Clorgiline (INN), Selegiline (USAN/INN), Lazabemide (USAN/INN), Iproniazid phosphate, Phenelzine (BAN), Pargyline (INN), Rasagiline (USAN/INN), Tranylcypromine (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:1103160\", AUTHORS = \"Guldberg HC, Marsden CA.\", TITLE = \"Catechol-O-methyl transferase: pharmacological aspects and physiological role.\", JOURNAL = \"Pharmacol Rev 27:135-206 (1975)\"), list(REFERENCE = \"PMID:10565698\", AUTHORS = \"Micek ST, Ernst ME.\", TITLE = \"Tolcapone: a novel approach to Parkinson\'s disease.\", JOURNAL = \"Am J Health Syst Pharm 56:2195-205 (1999)\"), list(REFERENCE = \"PMID:16604736\", AUTHORS = \".\", TITLE = \"Tolcapone: new drug. In Parkinson\'s disease: unacceptable risk of severe hepatitis.\", JOURNAL = \"Prescrire Int 15:54-7 (2006)\"), list(REFERENCE = \"PMID:7835624\", AUTHORS = \"Kaakkola S, Gordin A, Mannisto PT.\", TITLE = \"General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase.\", JOURNAL = c(\"Gen Pharmacol 25:813-24 (1994)\", \"DOI:10.1016/0306-3623(94)90082-5\")), list(REFERENCE = \"PMID:8119326\", AUTHORS = \"Tornwall M, Mannisto PT.\", TITLE = \"Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats.\", JOURNAL = c(\"Eur J Pharmacol 250:77-84 (1993)\", \"DOI:10.1016/0014-2999(93)90623-P\")), list(REFERENCE = \"PMID:11159700\", AUTHORS = \"Youdim MB, Gross A, Finberg JP.\", TITLE = \"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.\", JOURNAL = c(\"Br J Pharmacol 132:500-6 (2001)\", \"DOI:10.1038/sj.bjp.0703826\")), list(REFERENCE = \"PMID:16402116\", AUTHORS = \"Youdim MB, Bakhle YS.\", TITLE = \"Monoamine oxidase: isoforms and inhibitors in Parkinson\'s disease and depressive illness.\", JOURNAL = c(\"Br J Pharmacol 147 Suppl 1:S287-96 (2006)\", \"DOI:10.1038/sj.bjp.0706464\")), list(REFERENCE = \"PMID:10581325\", AUTHORS = \"Mannisto PT, Kaakkola S.\", TITLE = \"Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.\", JOURNAL = \"Pharmacol Rev 51:593-628 (1999)\")', 'map07216', 'Catecholamine transferase inhibitors', 'Catecholamine transferase inhibitors', '1,2,3-Trihydroxybenzene, Tropolone, U 0521, Norselegiline, CGP 28014, Phloroglucinol (JAN), Isoniazid (JP17/USP/INN), Phenelzine sulfate (USP), Entacapone (JP17/USAN/INN), Selegiline hydrochloride (JAN/USP), Tolcapone (JAN/USAN/INN), Tranylcypromine sulfate (USP XXI), Lazabemide hydrochloride (JAN/USAN), Flopropione (JP17/INN), Trepibutone (JP17/INN), Safrazine hydrochloride (JAN), Toloxatone (INN), Brofaromine (INN), Moclobemide (USAN/INN), Rasagiline mesylate (USAN), Befloxatone (INN), Pargyline hydrochloride (USAN), Iproniazid (INN), Isocarboxazid (INN), Ladostigil tartrate (USAN), Nitecapone (INN), Clorgiline (INN), Selegiline (USAN/INN), Lazabemide (USAN/INN), Iproniazid phosphate, Phenelzine (BAN), Pargyline (INN), Rasagiline (USAN/INN), Tranylcypromine (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:1103160\", AUTHORS = \"Guldberg HC, Marsden CA.\", TITLE = \"Catechol-O-methyl transferase: pharmacological aspects and physiological role.\", JOURNAL = \"Pharmacol Rev 27:135-206 (1975)\"), list(REFERENCE = \"PMID:10565698\", AUTHORS = \"Micek ST, Ernst ME.\", TITLE = \"Tolcapone: a novel approach to Parkinson\'s disease.\", JOURNAL = \"Am J Health Syst Pharm 56:2195-205 (1999)\"), list(REFERENCE = \"PMID:16604736\", AUTHORS = \".\", TITLE = \"Tolcapone: new drug. In Parkinson\'s disease: unacceptable risk of severe hepatitis.\", JOURNAL = \"Prescrire Int 15:54-7 (2006)\"), list(REFERENCE = \"PMID:7835624\", AUTHORS = \"Kaakkola S, Gordin A, Mannisto PT.\", TITLE = \"General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase.\", JOURNAL = c(\"Gen Pharmacol 25:813-24 (1994)\", \"DOI:10.1016/0306-3623(94)90082-5\")), list(REFERENCE = \"PMID:8119326\", AUTHORS = \"Tornwall M, Mannisto PT.\", TITLE = \"Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats.\", JOURNAL = c(\"Eur J Pharmacol 250:77-84 (1993)\", \"DOI:10.1016/0014-2999(93)90623-P\")), list(REFERENCE = \"PMID:11159700\", AUTHORS = \"Youdim MB, Gross A, Finberg JP.\", TITLE = \"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.\", JOURNAL = c(\"Br J Pharmacol 132:500-6 (2001)\", \"DOI:10.1038/sj.bjp.0703826\")), list(REFERENCE = \"PMID:16402116\", AUTHORS = \"Youdim MB, Bakhle YS.\", TITLE = \"Monoamine oxidase: isoforms and inhibitors in Parkinson\'s disease and depressive illness.\", JOURNAL = c(\"Br J Pharmacol 147 Suppl 1:S287-96 (2006)\", \"DOI:10.1038/sj.bjp.0706464\")), list(REFERENCE = \"PMID:10581325\", AUTHORS = \"Mannisto PT, Kaakkola S.\", TITLE = \"Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.\", JOURNAL = \"Pharmacol Rev 51:593-628 (1999)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (519, '07217', 'Renin-angiotensin system inhibitors', 'Renin-angiotensin system inhibitors', 'Succinylproline, Teprotide, Captopril (JP17/USP/INN), Lisinopril (USP), Ramipril (USP/INN), Quinapril hydrochloride (JP17/USP), Benazepril hydrochloride (JAN/USAN), Enalapril maleate (JP17/USP), Fosinopril sodium (USAN), Cilazapril (USAN), Temocapril hydrochloride (JP17/USAN), Imidapril hydrochloride (JP17), Delapril hydrochloride (JAN/USAN), Alacepril (JP17/INN), Aliskiren (USAN/INN), Ceronapril (USAN/INN), Enalkiren (USAN/INN), Quinapril (USP/INN), Indolapril hydrochloride (USAN), Enalaprilat (USP), Teprotide (USAN/INN), Aliskiren fumarate (JAN/USAN), Benazepril (INN), Cilazapril (INN), Delapril (INN), Enalapril (INN), Fosinopril (INN), Imidapril (INN), Lisinopril (INN), Temocapril (INN), Remikiren (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"PMID:14526382\", AUTHORS = \"Lewis RJ, Garcia ML.\", TITLE = \"Therapeutic potential of venom peptides.\", JOURNAL = c(\"Nat Rev Drug Discov 2:790-802 (2003)\", \"DOI:10.1038/nrd1197\")), list(REFERENCE = \"PMID:10579749\", AUTHORS = \"Timmermans PB.\", TITLE = \"Pharmacological properties of angiotensin II receptor antagonists.\", JOURNAL = \"Can J Cardiol 15 Suppl F:26F-8F (1999)\")', 'map07217', 'Renin-angiotensin system inhibitors', 'Renin-angiotensin system inhibitors', 'Succinylproline, Teprotide, Captopril (JP17/USP/INN), Lisinopril (USP), Ramipril (USP/INN), Quinapril hydrochloride (JP17/USP), Benazepril hydrochloride (JAN/USAN), Enalapril maleate (JP17/USP), Fosinopril sodium (USAN), Cilazapril (USAN), Temocapril hydrochloride (JP17/USAN), Imidapril hydrochloride (JP17), Delapril hydrochloride (JAN/USAN), Alacepril (JP17/INN), Aliskiren (USAN/INN), Ceronapril (USAN/INN), Enalkiren (USAN/INN), Quinapril (USP/INN), Indolapril hydrochloride (USAN), Enalaprilat (USP), Teprotide (USAN/INN), Aliskiren fumarate (JAN/USAN), Benazepril (INN), Cilazapril (INN), Delapril (INN), Enalapril (INN), Fosinopril (INN), Imidapril (INN), Lisinopril (INN), Temocapril (INN), Remikiren (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"PMID:14526382\", AUTHORS = \"Lewis RJ, Garcia ML.\", TITLE = \"Therapeutic potential of venom peptides.\", JOURNAL = c(\"Nat Rev Drug Discov 2:790-802 (2003)\", \"DOI:10.1038/nrd1197\")), list(REFERENCE = \"PMID:10579749\", AUTHORS = \"Timmermans PB.\", TITLE = \"Pharmacological properties of angiotensin II receptor antagonists.\", JOURNAL = \"Can J Cardiol 15 Suppl F:26F-8F (1999)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (520, '07218', 'HIV protease inhibitors', 'HIV protease inhibitors', 'Indinavir, TMC 126, A 77003, A 80987, Dmp 323, Ritonavir (JAN/USAN/INN), Saquinavir (JAN/USP/INN), Amprenavir (JAN/USAN/INN), Indinavir sulfate (USAN), Nelfinavir mesylate (USAN/INN), Saquinavir mesylate (USP), Atazanavir sulfate (JAN/USAN), Lopinavir (JAN/USAN/INN), Fosamprenavir (INN), Indinavir sulfate ethanolate (JAN), Fosamprenavir calcium hydrate (JAN), Brecanavir (USAN), Darunavir (USAN/INN), Indinavir (USAN), Fosamprenavir calcium (USAN), Fosamprenavir sodium (USAN), Droxinavir hydrochloride (USAN), Tipranavir disodium (USAN), Mozenavir (INN), Darunavir ethanolate (JAN), Atazanavir (INN), Nelfinavir (INN), Tipranavir (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:9646869\", AUTHORS = \"Wlodawer A, Vondrasek J.\", TITLE = \"Inhibitors of HIV-1 protease: a major success of structure-assisted drug design.\", JOURNAL = c(\"Annu Rev Biophys Biomol Struct 27:249-84 (1998)\", \"DOI:10.1146/annurev.biophys.27.1.249\")), list(REFERENCE = \"PMID:12929379\", AUTHORS = \"Brik A, Wong CH.\", TITLE = \"HIV-1 protease: mechanism and drug discovery.\", JOURNAL = \"Org Biomol Chem 1:5-14 (2003)\"), list(REFERENCE = \"PMID:15123854\", AUTHORS = \"Wynn GH, Zapor MJ, Smith BH, Wortmann G, Oesterheld JR, Armstrong SC, Cozza KL.\", TITLE = \"Antiretrovirals, part 1: overview, history, and focus on protease inhibitors.\", JOURNAL = c(\"Psychosomatics 45:262-70 (2004)\", \"DOI:10.1176/appi.psy.45.3.262\")), list(REFERENCE = \"PMID:16308534\", AUTHORS = \"Sugiura W.\", TITLE = \"[Progress in antiretroviral drugs]\", JOURNAL = c(\"Uirusu 55:85-94 (2005)\", \"DOI:10.2222/jsv.55.85\")), list(REFERENCE = \"PMID:1799953\", AUTHORS = \"Mimoto T, Imai J, Tanaka S, Hattori N, Kisanuki S, Akaji K, Kiso Y.\", TITLE = \"KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.\", JOURNAL = \"Chem Pharm Bull (Tokyo) 39:3088-90 (1991)\")', 'map07218', 'HIV protease inhibitors', 'HIV protease inhibitors', 'Indinavir, TMC 126, A 77003, A 80987, Dmp 323, Ritonavir (JAN/USAN/INN), Saquinavir (JAN/USP/INN), Amprenavir (JAN/USAN/INN), Indinavir sulfate (USAN), Nelfinavir mesylate (USAN/INN), Saquinavir mesylate (USP), Atazanavir sulfate (JAN/USAN), Lopinavir (JAN/USAN/INN), Fosamprenavir (INN), Indinavir sulfate ethanolate (JAN), Fosamprenavir calcium hydrate (JAN), Brecanavir (USAN), Darunavir (USAN/INN), Indinavir (USAN), Fosamprenavir calcium (USAN), Fosamprenavir sodium (USAN), Droxinavir hydrochloride (USAN), Tipranavir disodium (USAN), Mozenavir (INN), Darunavir ethanolate (JAN), Atazanavir (INN), Nelfinavir (INN), Tipranavir (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:9646869\", AUTHORS = \"Wlodawer A, Vondrasek J.\", TITLE = \"Inhibitors of HIV-1 protease: a major success of structure-assisted drug design.\", JOURNAL = c(\"Annu Rev Biophys Biomol Struct 27:249-84 (1998)\", \"DOI:10.1146/annurev.biophys.27.1.249\")), list(REFERENCE = \"PMID:12929379\", AUTHORS = \"Brik A, Wong CH.\", TITLE = \"HIV-1 protease: mechanism and drug discovery.\", JOURNAL = \"Org Biomol Chem 1:5-14 (2003)\"), list(REFERENCE = \"PMID:15123854\", AUTHORS = \"Wynn GH, Zapor MJ, Smith BH, Wortmann G, Oesterheld JR, Armstrong SC, Cozza KL.\", TITLE = \"Antiretrovirals, part 1: overview, history, and focus on protease inhibitors.\", JOURNAL = c(\"Psychosomatics 45:262-70 (2004)\", \"DOI:10.1176/appi.psy.45.3.262\")), list(REFERENCE = \"PMID:16308534\", AUTHORS = \"Sugiura W.\", TITLE = \"[Progress in antiretroviral drugs]\", JOURNAL = c(\"Uirusu 55:85-94 (2005)\", \"DOI:10.2222/jsv.55.85\")), list(REFERENCE = \"PMID:1799953\", AUTHORS = \"Mimoto T, Imai J, Tanaka S, Hattori N, Kisanuki S, Akaji K, Kiso Y.\", TITLE = \"KNI-102, a novel tripeptide HIV protease inhibitor containing allophenylnorstatine as a transition-state mimic.\", JOURNAL = \"Chem Pharm Bull (Tokyo) 39:3088-90 (1991)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (521, '07219', 'Cyclooxygenase inhibitors', 'Cyclooxygenase inhibitors', 'Aspirin (JP17/USP), Naproxen (JP17/USP/INN), Sulindac (JP17/USP/INN), Ibuprofen (JP17/USP/INN), Piroxicam (JP17/USP/INN), Diflunisal (JAN/USP/INN), Ketoprofen (JP17/USP/INN), Indomethacin (USP), Mefenamic acid (JP17/USP/INN), Tolmetin sodium (JAN/USP), Meclofenamate sodium (USP), Etodolac (JP17/USP/INN), Flurbiprofen (JP17/USP/INN), Nabumetone (JP17/USP/INN), Oxaprozin (JP17/USAN/INN), Sodium salicylate (JP17/USP), Celecoxib (JAN/USAN/INN), Rofecoxib (JAN/USAN/INN), Diclofenac potassium (USAN), Diclofenac sodium (JP17/USP), Fenoprofen calcium (JAN/USP), Meloxicam (JAN/USAN/INN), Naproxen sodium (USP), Ibuprofen piconol (JP17/USAN), Tolfenamic acid (JAN/INN), Tiaprofenic acid (JAN/INN), Ampiroxicam (JP17/INN), Flurbiprofen axetil (JAN), Zaltoprofen (JP17/INN), Indometacin farnesil (JAN), Pranoprofen (JP17/INN), Flufenamic acid (JAN/USAN/INN), Acemetacin (JP17/INN), Loxoprofen sodium hydrate (JP17), Mofezolac (JAN/INN), Proglumetacin maleate (JAN), Tenoxicam (JAN/USAN/INN), Amfenac sodium (USAN), Salicylamide (JAN/USP/INN), Lornoxicam (JAN/USAN/INN), Indomethacin sodium (USP), Flurbiprofen sodium (USP), Meclofenamic acid (USAN/INN), Fenoprofen (USAN/INN), Tolmetin (USAN/INN), Valdecoxib (USAN/INN), Flufenamate aluminum (JAN), Etoricoxib (USAN/INN), Dexibuprofen (USAN/INN), Dexibuprofen lysine (USAN), Piroxicam betadex (USAN), Piroxicam olamine (USAN), Ibuprofen lysine (USAN), Amfenac (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\")', 'map07219', 'Cyclooxygenase inhibitors', 'Cyclooxygenase inhibitors', 'Aspirin (JP17/USP), Naproxen (JP17/USP/INN), Sulindac (JP17/USP/INN), Ibuprofen (JP17/USP/INN), Piroxicam (JP17/USP/INN), Diflunisal (JAN/USP/INN), Ketoprofen (JP17/USP/INN), Indomethacin (USP), Mefenamic acid (JP17/USP/INN), Tolmetin sodium (JAN/USP), Meclofenamate sodium (USP), Etodolac (JP17/USP/INN), Flurbiprofen (JP17/USP/INN), Nabumetone (JP17/USP/INN), Oxaprozin (JP17/USAN/INN), Sodium salicylate (JP17/USP), Celecoxib (JAN/USAN/INN), Rofecoxib (JAN/USAN/INN), Diclofenac potassium (USAN), Diclofenac sodium (JP17/USP), Fenoprofen calcium (JAN/USP), Meloxicam (JAN/USAN/INN), Naproxen sodium (USP), Ibuprofen piconol (JP17/USAN), Tolfenamic acid (JAN/INN), Tiaprofenic acid (JAN/INN), Ampiroxicam (JP17/INN), Flurbiprofen axetil (JAN), Zaltoprofen (JP17/INN), Indometacin farnesil (JAN), Pranoprofen (JP17/INN), Flufenamic acid (JAN/USAN/INN), Acemetacin (JP17/INN), Loxoprofen sodium hydrate (JP17), Mofezolac (JAN/INN), Proglumetacin maleate (JAN), Tenoxicam (JAN/USAN/INN), Amfenac sodium (USAN), Salicylamide (JAN/USP/INN), Lornoxicam (JAN/USAN/INN), Indomethacin sodium (USP), Flurbiprofen sodium (USP), Meclofenamic acid (USAN/INN), Fenoprofen (USAN/INN), Tolmetin (USAN/INN), Valdecoxib (USAN/INN), Flufenamate aluminum (JAN), Etoricoxib (USAN/INN), Dexibuprofen (USAN/INN), Dexibuprofen lysine (USAN), Piroxicam betadex (USAN), Piroxicam olamine (USAN), Ibuprofen lysine (USAN), Amfenac (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Japan Pharmaceutical Association (ed).\", TITLE = \"[Face of Medecine: Structure Activity Relationship] (In Japanese)\", JOURNAL = \"Yakuji Nippo (1999)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Hardman JG, Limbird LE, Gilman AG (eds).\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics (10th ed)\", JOURNAL = \"McGraw-Hill (2001)\"), list(REFERENCE = \"\", AUTHORS = \"Walter S.\", TITLE = \"Drug Discovery: A History\", JOURNAL = \"Wiley (2005)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (522, '07220', 'Cholinergic and anticholinergic drugs', 'Cholinergic and anticholinergic drugs', 'Muscarine, Amprotropine, Isoflurophate, Atropine (USP), Scopolamine (INN), Physostigmine (USP), Tropicamide (JP17/USP/INN), Propantheline bromide (JP17/USP/INN), Pyridostigmine bromide (JP17/USP/INN), Carbachol (JAN/USP/INN), Pilocarpine (JAN/USP), Donepezil hydrochloride (JP17/USAN), Methscopolamine bromide (USP), Dicyclomine hydrochloride (JAN/USP), Mepenzolate bromide (JP17/INN), Methanthelinium bromide (INN), Orphenadrine citrate (USP), Benztropine mesylate (USP), Biperiden (JAN/USP/INN), Trihexyphenidyl hydrochloride (JP17/USP), Edrophonium chloride (JP17/USP/INN), Neostigmine bromide (JAN/USP/INN), Neostigmine methylsulfate (JP17/USP), Acetylcholine chloride (JP17/USP/INN), Bethanechol chloride (JP17/USP), Ambenonium chloride (JP17/INN), Cyclopentolate hydrochloride (JP17/USP), Homatropine hydrobromide (JP17/USP), Propiverine hydrochloride (JP17), Trospium chloride (JAN/USAN/INN), Piperidolate hydrochloride (JAN), Tiemonium iodide (JAN/INN), Pirenzepine hydrochloride (USAN), Methylbenactyzium bromide (JP17/INN), Scopolamine butylbromide (JP17), Butropium bromide (JP17/INN), Diphenylpiperidinomethyldioxolan iodide (JAN), Oxapium iodide (JP17/INN), Tiotropium bromide hydrate (JAN), Oxitropium bromide (JAN/INN), N-Methylscopolamine methylsulfate (JAN), Tacrine hydrochloride (USP), Atropine sulfate (JP17/USP), Scopolamine hydrobromide (USP), Galantamine hydrobromide (JAN/USAN), Echothiophate iodide (USP), Pilocarpine hydrochloride (JP17/USP), Ipratropium bromide (USAN), Biperiden hydrochloride (JP17/USP), Biperiden lactate (JAN/USP), Physostigmine salicylate (JAN/USP), Timepidium bromide hydrate (JP17), Rivastigmine tartrate, Orphenadrine hydrochloride, Adiphenine hydrochloride (USAN), Rivastigmine (JAN/USAN/INN), Physostigmine sulfate (USP), Eucatropine hydrochloride (USP XXXII), Galantamine (USAN/INN), Methacholine chloride (JAN/USAN/INN), Pirenzepine hydrochloride hydrate (JP17), Pilocarpine nitrate (USP), Talsaclidine fumarate (USAN), Xanomeline (USAN), Xanomeline tartrate (USAN), Benzatropine (INN), Cyclopentolate (INN), Dicycloverine (INN), Donepezil (INN), Neostigmine (BAN), Orphenadrine (INN), Pilocarpine borate, Piperidolate (INN), Pirenzepine (INN), Propiverine (INN), Tacrine (INN), Tiemonium methylsulfate, Trihexyphenidyl (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\")', 'map07220', 'Cholinergic and anticholinergic drugs', 'Cholinergic and anticholinergic drugs', 'Muscarine, Amprotropine, Isoflurophate, Atropine (USP), Scopolamine (INN), Physostigmine (USP), Tropicamide (JP17/USP/INN), Propantheline bromide (JP17/USP/INN), Pyridostigmine bromide (JP17/USP/INN), Carbachol (JAN/USP/INN), Pilocarpine (JAN/USP), Donepezil hydrochloride (JP17/USAN), Methscopolamine bromide (USP), Dicyclomine hydrochloride (JAN/USP), Mepenzolate bromide (JP17/INN), Methanthelinium bromide (INN), Orphenadrine citrate (USP), Benztropine mesylate (USP), Biperiden (JAN/USP/INN), Trihexyphenidyl hydrochloride (JP17/USP), Edrophonium chloride (JP17/USP/INN), Neostigmine bromide (JAN/USP/INN), Neostigmine methylsulfate (JP17/USP), Acetylcholine chloride (JP17/USP/INN), Bethanechol chloride (JP17/USP), Ambenonium chloride (JP17/INN), Cyclopentolate hydrochloride (JP17/USP), Homatropine hydrobromide (JP17/USP), Propiverine hydrochloride (JP17), Trospium chloride (JAN/USAN/INN), Piperidolate hydrochloride (JAN), Tiemonium iodide (JAN/INN), Pirenzepine hydrochloride (USAN), Methylbenactyzium bromide (JP17/INN), Scopolamine butylbromide (JP17), Butropium bromide (JP17/INN), Diphenylpiperidinomethyldioxolan iodide (JAN), Oxapium iodide (JP17/INN), Tiotropium bromide hydrate (JAN), Oxitropium bromide (JAN/INN), N-Methylscopolamine methylsulfate (JAN), Tacrine hydrochloride (USP), Atropine sulfate (JP17/USP), Scopolamine hydrobromide (USP), Galantamine hydrobromide (JAN/USAN), Echothiophate iodide (USP), Pilocarpine hydrochloride (JP17/USP), Ipratropium bromide (USAN), Biperiden hydrochloride (JP17/USP), Biperiden lactate (JAN/USP), Physostigmine salicylate (JAN/USP), Timepidium bromide hydrate (JP17), Rivastigmine tartrate, Orphenadrine hydrochloride, Adiphenine hydrochloride (USAN), Rivastigmine (JAN/USAN/INN), Physostigmine sulfate (USP), Eucatropine hydrochloride (USP XXXII), Galantamine (USAN/INN), Methacholine chloride (JAN/USAN/INN), Pirenzepine hydrochloride hydrate (JP17), Pilocarpine nitrate (USP), Talsaclidine fumarate (USAN), Xanomeline (USAN), Xanomeline tartrate (USAN), Benzatropine (INN), Cyclopentolate (INN), Dicycloverine (INN), Donepezil (INN), Neostigmine (BAN), Orphenadrine (INN), Pilocarpine borate, Piperidolate (INN), Pirenzepine (INN), Propiverine (INN), Tacrine (INN), Tiemonium methylsulfate, Trihexyphenidyl (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Bertram GK (ed).\", TITLE = \"Basic & Clinical Pharmacology (9th ed)\", JOURNAL = \"Lange (2004)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Fukai S.\", TITLE = \"[New Drugs Today (6th ed)] (In Japanese)\", JOURNAL = \"Jiho (1995)\"), list(REFERENCE = \"\", AUTHORS = \"Noguchi S, Hibino S (eds).\", TITLE = \"[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)\", JOURNAL = \"Hirokawa (2002)\"), list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (523, '07221', 'Nicotinic cholinergic receptor antagonists', 'Nicotinic cholinergic receptor antagonists', 'Tubocurarine, Atracurium, Mivacurium, Metocurine, Decamethonium, Pancuronium bromide (JP17/USAN/INN), Atracurium besylate (USP), Metocurine iodide (USAN), Mivacurium chloride (USAN/INN), Pipecuronium bromide (JAN/USAN/INN), Rocuronium bromide (JAN/USAN/INN), Succinylcholine chloride (USP), Vecuronium bromide (JAN/USAN/INN), Hexamethonium bromide (JAN/INN), Tubocurarine chloride (USP), Suxamethonium chloride hydrate (JP17), Gallamine triethiodide (USP), Dimethyltubocurarine (BAN), Tubocurarine chloride (INN)', 'list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:16402115\", AUTHORS = \"Bowman WC.\", TITLE = \"Neuromuscular block.\", JOURNAL = c(\"Br J Pharmacol 147 Suppl 1:S277-86 (2006)\", \"DOI:10.1038/sj.bjp.0706404\"))', 'map07221', 'Nicotinic cholinergic receptor antagonists', 'Nicotinic cholinergic receptor antagonists', 'Tubocurarine, Atracurium, Mivacurium, Metocurine, Decamethonium, Pancuronium bromide (JP17/USAN/INN), Atracurium besylate (USP), Metocurine iodide (USAN), Mivacurium chloride (USAN/INN), Pipecuronium bromide (JAN/USAN/INN), Rocuronium bromide (JAN/USAN/INN), Succinylcholine chloride (USP), Vecuronium bromide (JAN/USAN/INN), Hexamethonium bromide (JAN/INN), Tubocurarine chloride (USP), Suxamethonium chloride hydrate (JP17), Gallamine triethiodide (USP), Dimethyltubocurarine (BAN), Tubocurarine chloride (INN)', 'list(REFERENCE = \"\", AUTHORS = \"David AW, Thomas LL, William OF.\", TITLE = \"Foye\'s Principles of Medicinal Chemistry (5th ed)\", JOURNAL = \"Lippincott Williams & Wilkins (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Sano T, Naito T, Kubo T (eds).\", TITLE = \"[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C, Kato R (eds).\", TITLE = \"[New Pharmacology (4th ed)] (In Japanese)\", JOURNAL = \"Nankodo (2002)\"), list(REFERENCE = \"PMID:16402115\", AUTHORS = \"Bowman WC.\", TITLE = \"Neuromuscular block.\", JOURNAL = c(\"Br J Pharmacol 147 Suppl 1:S277-86 (2006)\", \"DOI:10.1038/sj.bjp.0706404\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (524, '07222', 'Peroxisome proliferator-activated receptor (PPAR) agonists', 'Peroxisome proliferator-activated receptor (PPAR) agonists', 'AL-294, AL-321, Clofibrate (JP17/USP/INN), Gemfibrozil (JAN/USP/INN), Troglitazone (JAN/USAN/INN), Fenofibrate (JAN/INN), Rosiglitazone maleate (JAN/USAN), Pioglitazone hydrochloride (JP17/USP), Aluminum clofibrate (JAN/INN), Simfibrate (JAN/INN), Clinofibrate (JP17/INN), Bezafibrate (JP17/USAN/INN), Ciglitazone (USAN/INN), Ciprofibrate (USAN/INN), Darglitazone sodium (USAN), Muraglitazar (USAN/INN), Netoglitazone (USAN/INN), Rivoglitazone (USAN/INN), Ronifibrate (INN), Etofibrate (INN), Clofibride (INN), Binifibrate (INN), Clofibric acid (INN), Magnesium clofibrate (INN), Pioglitazone (INN), Rosiglitazone (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\")', 'map07222', 'Peroxisome proliferator-activated receptor (PPAR) agonists', 'Peroxisome proliferator-activated receptor (PPAR) agonists', 'AL-294, AL-321, Clofibrate (JP17/USP/INN), Gemfibrozil (JAN/USP/INN), Troglitazone (JAN/USAN/INN), Fenofibrate (JAN/INN), Rosiglitazone maleate (JAN/USAN), Pioglitazone hydrochloride (JP17/USP), Aluminum clofibrate (JAN/INN), Simfibrate (JAN/INN), Clinofibrate (JP17/INN), Bezafibrate (JP17/USAN/INN), Ciglitazone (USAN/INN), Ciprofibrate (USAN/INN), Darglitazone sodium (USAN), Muraglitazar (USAN/INN), Netoglitazone (USAN/INN), Rivoglitazone (USAN/INN), Ronifibrate (INN), Etofibrate (INN), Clofibride (INN), Binifibrate (INN), Clofibric acid (INN), Magnesium clofibrate (INN), Pioglitazone (INN), Rosiglitazone (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (525, '07223', 'Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists', 'Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists', 'Tretinoin (JAN/USP/INN), Retinol palmitate (JP17), Etretinate (JAN/USAN/INN), Isotretinoin (USP), Adapalene (JAN/USAN/INN), Tazarotene (JAN/USAN/INN), Tamibarotene (JAN/INN), Retinol acetate (JP17), Acitretin (USP/INN), Alitretinoin (USAN), Bexarotene (JAN/USAN/INN), Isotretinoin anisatil (USAN), Motretinide (USAN/INN), Vitamin A (USP), Retinol propionate', 'list(REFERENCE = \"PMID:18622097\", AUTHORS = \"Kagechika H\", TITLE = \"[Chemical biology research on nuclear receptors]\", JOURNAL = c(\"Nippon Yakurigaku Zasshi 132:11-7 (2008)\", \"DOI:10.1254/fpj.132.11\"))', 'map07223', 'Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists', 'Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists', 'Tretinoin (JAN/USP/INN), Retinol palmitate (JP17), Etretinate (JAN/USAN/INN), Isotretinoin (USP), Adapalene (JAN/USAN/INN), Tazarotene (JAN/USAN/INN), Tamibarotene (JAN/INN), Retinol acetate (JP17), Acitretin (USP/INN), Alitretinoin (USAN), Bexarotene (JAN/USAN/INN), Isotretinoin anisatil (USAN), Motretinide (USAN/INN), Vitamin A (USP), Retinol propionate', 'list(REFERENCE = \"PMID:18622097\", AUTHORS = \"Kagechika H\", TITLE = \"[Chemical biology research on nuclear receptors]\", JOURNAL = c(\"Nippon Yakurigaku Zasshi 132:11-7 (2008)\", \"DOI:10.1254/fpj.132.11\"))', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (526, '07224', 'Opioid receptor agonists/antagonists', 'Opioid receptor agonists/antagonists', 'Nociceptin, Deltorphin A, Deltorphin B, Deltorphin C, Naltrindole, Codeine (USP), Fentanyl (JAN/USAN/INN), Propoxyphene hydrochloride (USP), Pentazocine (JP17/USP/INN), Alfentanil hydrochloride (USP), Buprenorphine hydrochloride (JP17/USP), Butorphanol tartrate (JAN/USP), Hydromorphone hydrochloride (JAN/USP), Levomethadyl acetate hydrochloride (USAN), Levorphanol tartrate (USP), Morphine sulfate (USP), Nalbuphine hydrochloride (USAN), Oxymorphone hydrochloride (USP), Sufentanil citrate (USP), Oxycodone hydrochloride (USP), Remifentanil hydrochloride (JAN/USAN), Naloxone hydrochloride (JP17/USP), Tramadol hydrochloride (JP17/USAN), Meperidine hydrochloride (USP), Fentanyl citrate (JP17/USP), Dihydrocodeine phosphate (JP17), Eptazocine hydrobromide (JAN), Naltrexone hydrochloride (USP), Codeine phosphate (USP), Methadone hydrochloride (JAN/USP), Nalmefene hydrochloride, Pentazocine lactate (USP), Pentazocine hydrochloride (JAN/USP), Levallorphan tartrate (JP17), Morphine hydrochloride hydrate (JP17), Alvimopan (USAN), Brifentanil hydrochloride (USAN), Butorphanol (USAN/INN), Carfentanil citrate (USAN), Codeine sulfate (USP), Cyclazocine (USAN/INN), Hydrocodone bitartrate (USP), Oxycodone terephthalate (USP), Dihydrocodeine bitartrate (USP), Hydrocodone polistirex (USAN), Ketazocine (USAN/INN), Levomethadyl acetate (USAN), Lofentanil oxalate (USAN), Methadyl acetate (USAN), Mirfentanil hydrochloride (USAN), Nalmefene (USAN/INN), Naltrexone (USAN/INN), Ocfentanil hydrochloride (USAN), Oxycodone (USAN/INN), Oxycodone hydrochloride hydrate (JP17), Propoxyphene napsylate (USAN), Spiradoline mesylate (USAN), Sufentanil (USAN/INN), Trefentanil hydrochloride (USAN), Trimeperidine (INN), Nalfurafine hydrochloride (JAN/USAN), Methylnaltrexone bromide (JAN/USAN), Alfentanil (INN), Buprenorphine (JAN/INN), Diamorphine (BAN), Carfentanil (INN), Codeine hydrochloride, Dextropropoxyphene (INN), Diacetylmorphine hydrochloride, Dihydrocodeine (INN), Dihydrocodeine thiocyanate, Diprenorphine (INN), Diprenorphine hydrochloride, Eptazocine (INN), Hydrocodone (INN), Hydrocodone hydrochloride, Hydromorphone (INN), Levomethadone (INN), Levomethadone hydrochloride, Levorphanol (INN), Methadone (BAN), Morphine (BAN), Morphine tartrate, Nalbuphine (INN), Nalorphine (INN), Nalorphine hydrochloride (USP), Naloxone (INN), Oxymorphone (INN), Pethidine (INN), Remifentanil (INN), Tramadol (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Brunton LL, Lazo JS, Parker KL.\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics, eleventh edition\", JOURNAL = \"McGraw-Hill (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\")', 'map07224', 'Opioid receptor agonists/antagonists', 'Opioid receptor agonists/antagonists', 'Nociceptin, Deltorphin A, Deltorphin B, Deltorphin C, Naltrindole, Codeine (USP), Fentanyl (JAN/USAN/INN), Propoxyphene hydrochloride (USP), Pentazocine (JP17/USP/INN), Alfentanil hydrochloride (USP), Buprenorphine hydrochloride (JP17/USP), Butorphanol tartrate (JAN/USP), Hydromorphone hydrochloride (JAN/USP), Levomethadyl acetate hydrochloride (USAN), Levorphanol tartrate (USP), Morphine sulfate (USP), Nalbuphine hydrochloride (USAN), Oxymorphone hydrochloride (USP), Sufentanil citrate (USP), Oxycodone hydrochloride (USP), Remifentanil hydrochloride (JAN/USAN), Naloxone hydrochloride (JP17/USP), Tramadol hydrochloride (JP17/USAN), Meperidine hydrochloride (USP), Fentanyl citrate (JP17/USP), Dihydrocodeine phosphate (JP17), Eptazocine hydrobromide (JAN), Naltrexone hydrochloride (USP), Codeine phosphate (USP), Methadone hydrochloride (JAN/USP), Nalmefene hydrochloride, Pentazocine lactate (USP), Pentazocine hydrochloride (JAN/USP), Levallorphan tartrate (JP17), Morphine hydrochloride hydrate (JP17), Alvimopan (USAN), Brifentanil hydrochloride (USAN), Butorphanol (USAN/INN), Carfentanil citrate (USAN), Codeine sulfate (USP), Cyclazocine (USAN/INN), Hydrocodone bitartrate (USP), Oxycodone terephthalate (USP), Dihydrocodeine bitartrate (USP), Hydrocodone polistirex (USAN), Ketazocine (USAN/INN), Levomethadyl acetate (USAN), Lofentanil oxalate (USAN), Methadyl acetate (USAN), Mirfentanil hydrochloride (USAN), Nalmefene (USAN/INN), Naltrexone (USAN/INN), Ocfentanil hydrochloride (USAN), Oxycodone (USAN/INN), Oxycodone hydrochloride hydrate (JP17), Propoxyphene napsylate (USAN), Spiradoline mesylate (USAN), Sufentanil (USAN/INN), Trefentanil hydrochloride (USAN), Trimeperidine (INN), Nalfurafine hydrochloride (JAN/USAN), Methylnaltrexone bromide (JAN/USAN), Alfentanil (INN), Buprenorphine (JAN/INN), Diamorphine (BAN), Carfentanil (INN), Codeine hydrochloride, Dextropropoxyphene (INN), Diacetylmorphine hydrochloride, Dihydrocodeine (INN), Dihydrocodeine thiocyanate, Diprenorphine (INN), Diprenorphine hydrochloride, Eptazocine (INN), Hydrocodone (INN), Hydrocodone hydrochloride, Hydromorphone (INN), Levomethadone (INN), Levomethadone hydrochloride, Levorphanol (INN), Methadone (BAN), Morphine (BAN), Morphine tartrate, Nalbuphine (INN), Nalorphine (INN), Nalorphine hydrochloride (USP), Naloxone (INN), Oxymorphone (INN), Pethidine (INN), Remifentanil (INN), Tramadol (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Brunton LL, Lazo JS, Parker KL.\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics, eleventh edition\", JOURNAL = \"McGraw-Hill (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (527, '07225', 'Glucocorticoid and mineralocorticoid receptor agonists/antagonists', 'Glucocorticoid and mineralocorticoid receptor agonists/antagonists', 'Progesterone, Cortisol, Cortisone, Aldosterone, Progesterone (JP17/USP/INN), Hydrocortisone (JP17/USP/INN), Hydrocortisone acetate (JP17/USP), Betamethasone (JP17/USP/INN), Dexamethasone (JP17/USP/INN), Fluocinonide (JP17/USP/INN), Triamcinolone (JP17/USP/INN), Methylprednisolone (JP17/USP/INN), Spironolactone (JP17/USP/INN), Prednisolone (JP17/USP/INN), Beclomethasone dipropionate (USP), Methylprednisolone sodium succinate (JAN/USP), Betamethasone sodium phosphate (JP17/USP), Cortisone acetate (JP17/USP), Dexamethasone sodium phosphate (JAN/USP), Hydrocortisone cypionate, Hydrocortisone sodium phosphate (JP17/USP), Hydrocortisone sodium succinate (JP17/USP), Methylprednisolone acetate (JAN/USP), Prednisolone acetate (JP17/USP/INN), Prednisolone sodium phosphate (JP17/USP), Prednisolone tebutate (JAN/USP), Triamcinolone acetonide (JP17/USP), Triamcinolone diacetate (JAN/USP), Triamcinolone hexacetonide (USP/INN), Fludrocortisone acetate (JP17/USP), Eplerenone (JP17/USAN/INN), Paramethasone acetate (JAN/USP), Prednisolone sodium succinate (JP17/USP), Chlormadinone acetate (JP17/USAN), Betamethasone valerate (JP17/USP), Amcinonide (JAN/USP/INN), Betamethasone acetate (JAN/USP), Hydrocortisone succinate (JP17), Dexamethasone metasulfobenzoate sodium (JAN), Dexamethasone palmitate (JAN), Hydrocortisone butyrate (JP17/USP), Dexamethasone dipropionate (USAN), Betamethasone dipropionate (JP17/USP), Fluticasone propionate (JAN/USAN), Fluocinolone acetonide (JP17/USP/INN), Hydrocortisone probutate (USAN), Canrenoate potassium (USAN), Dexamethasone valerate (JAN), Prednisolone farnesylate (JAN), Betamethasone butyrate propionate (JAN), Prednisolone hemisuccinate (USP), Dexamethasone acetate (JAN/USP), Betamethasone benzoate (USP), Hydrocortisone valerate (USP), Dexamethasone acefurate (USAN/INN), Dexamethasone beloxil (USAN), Prednisolone valerate acetate (JAN), Canrenone (USAN), Desoxycorticosterone acetate (USP), Desoxycorticosterone pivalate (USP), Dicirenone (USAN), Drospirenone (JAN/USP/INN), Hydrocortisone hemisuccinate (USP), Methylprednisolone hemisuccinate (USP), Methylprednisolone sodium phosphate (USAN), Methylprednisolone suleptanate (USAN/INN), Mexrenoate potassium (USAN), Prorenoate potassium (USAN/INN), Triamcinolone acetonide sodium phosphate (USAN), Fluticasone furoate (JAN/USAN/INN), Hydrocortisone aceponate (INN), Dexamethasone cipecilate (JAN/INN), Methylprednisolone aceponate (INN), Paramethasone (INN), Beclometasone (INN), Chlormadinone (INN), Cortisone (INN), Desoxycortone (INN), Dexamethasone 21-acetate, Dexamethasone isonicotinate, Dexamethasone sodium hemisulfate, Dexamethasone 21-tebutate, Dexamethasone 21-valerate, Dexamethasone phenylpropionate, Dexamethasone phosphate, Fludrocortisone (INN), Fluticasone (INN), Prednisolone pivalate, Prednisolone sodium metazoate (USAN), Prednisolone 21-(sodium tetrahydrophthalate), Prednisolone steaglate (BAN)', 'list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\")', 'map07225', 'Glucocorticoid and mineralocorticoid receptor agonists/antagonists', 'Glucocorticoid and mineralocorticoid receptor agonists/antagonists', 'Progesterone, Cortisol, Cortisone, Aldosterone, Progesterone (JP17/USP/INN), Hydrocortisone (JP17/USP/INN), Hydrocortisone acetate (JP17/USP), Betamethasone (JP17/USP/INN), Dexamethasone (JP17/USP/INN), Fluocinonide (JP17/USP/INN), Triamcinolone (JP17/USP/INN), Methylprednisolone (JP17/USP/INN), Spironolactone (JP17/USP/INN), Prednisolone (JP17/USP/INN), Beclomethasone dipropionate (USP), Methylprednisolone sodium succinate (JAN/USP), Betamethasone sodium phosphate (JP17/USP), Cortisone acetate (JP17/USP), Dexamethasone sodium phosphate (JAN/USP), Hydrocortisone cypionate, Hydrocortisone sodium phosphate (JP17/USP), Hydrocortisone sodium succinate (JP17/USP), Methylprednisolone acetate (JAN/USP), Prednisolone acetate (JP17/USP/INN), Prednisolone sodium phosphate (JP17/USP), Prednisolone tebutate (JAN/USP), Triamcinolone acetonide (JP17/USP), Triamcinolone diacetate (JAN/USP), Triamcinolone hexacetonide (USP/INN), Fludrocortisone acetate (JP17/USP), Eplerenone (JP17/USAN/INN), Paramethasone acetate (JAN/USP), Prednisolone sodium succinate (JP17/USP), Chlormadinone acetate (JP17/USAN), Betamethasone valerate (JP17/USP), Amcinonide (JAN/USP/INN), Betamethasone acetate (JAN/USP), Hydrocortisone succinate (JP17), Dexamethasone metasulfobenzoate sodium (JAN), Dexamethasone palmitate (JAN), Hydrocortisone butyrate (JP17/USP), Dexamethasone dipropionate (USAN), Betamethasone dipropionate (JP17/USP), Fluticasone propionate (JAN/USAN), Fluocinolone acetonide (JP17/USP/INN), Hydrocortisone probutate (USAN), Canrenoate potassium (USAN), Dexamethasone valerate (JAN), Prednisolone farnesylate (JAN), Betamethasone butyrate propionate (JAN), Prednisolone hemisuccinate (USP), Dexamethasone acetate (JAN/USP), Betamethasone benzoate (USP), Hydrocortisone valerate (USP), Dexamethasone acefurate (USAN/INN), Dexamethasone beloxil (USAN), Prednisolone valerate acetate (JAN), Canrenone (USAN), Desoxycorticosterone acetate (USP), Desoxycorticosterone pivalate (USP), Dicirenone (USAN), Drospirenone (JAN/USP/INN), Hydrocortisone hemisuccinate (USP), Methylprednisolone hemisuccinate (USP), Methylprednisolone sodium phosphate (USAN), Methylprednisolone suleptanate (USAN/INN), Mexrenoate potassium (USAN), Prorenoate potassium (USAN/INN), Triamcinolone acetonide sodium phosphate (USAN), Fluticasone furoate (JAN/USAN/INN), Hydrocortisone aceponate (INN), Dexamethasone cipecilate (JAN/INN), Methylprednisolone aceponate (INN), Paramethasone (INN), Beclometasone (INN), Chlormadinone (INN), Cortisone (INN), Desoxycortone (INN), Dexamethasone 21-acetate, Dexamethasone isonicotinate, Dexamethasone sodium hemisulfate, Dexamethasone 21-tebutate, Dexamethasone 21-valerate, Dexamethasone phenylpropionate, Dexamethasone phosphate, Fludrocortisone (INN), Fluticasone (INN), Prednisolone pivalate, Prednisolone sodium metazoate (USAN), Prednisolone 21-(sodium tetrahydrophthalate), Prednisolone steaglate (BAN)', 'list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (528, '07226', 'Progesterone, androgen and estrogen receptor agonists/antagonists', 'Progesterone, androgen and estrogen receptor agonists/antagonists', 'Progesterone, Estrone, Testosterone, Estradiol-17beta, Estriol, Progesterone (JP17/USP/INN), Estrone (JAN/USP/INN), Testosterone (JAN/USP), Estradiol (JAN/USP/INN), Norethindrone (USP), Estriol (JP17/USP), Danazol (JP17/USP/INN), Estrone sodium sulfate, Fluoxymesterone (JAN/USP/INN), Methyltestosterone (JP17/USP/INN), Stanozolol (JAN/USP/INN), Oxandrolone (JAN/USP/INN), Ethinyl estradiol (USP), Mestranol (JP17/USP/INN), Diethylstilbestrol (USP/INN), Mifepristone (JAN/USAN/INN), Flutamide (JP17/USP/INN), Diethylstilbestrol diphosphate (USP), Hydroxyprogesterone caproate (JAN/USP/INN), Medroxyprogesterone acetate (JP17/USP), Norethindrone acetate (USP), Testosterone cypionate (USP), Testosterone enanthate (JP17/USP), Testosterone propionate (JP17/USP), Bicalutamide (JAN/USP/INN), Clomiphene citrate (USP), Nilutamide (USAN/INN), Tamoxifen citrate (JP17/USP), Toremifene citrate (JAN/USAN), Gestonorone caproate (JAN/USAN), Fulvestrant (JAN/USAN/INN), Dydrogesterone (JP17/USP/INN), Epitiostanol (JAN/INN), Cyclofenil (JAN/INN), Chlormadinone acetate (JP17/USAN), Oxendolone (JAN/USAN/INN), Cyproterone acetate (JAN/USAN), Estradiol valerate (JAN/USP/INN), Mepitiostane (JP17/INN), Estradiol dipropionate (JAN), Estradiol benzoate (JP17), Estriol tripropionate (JAN), Estriol diacetate benzoate (JAN), Desogestrel (USAN/INN), Asoprisnil (USAN/INN), Delmadinone acetate (USAN), Estradiol acetate (USAN), Estradiol cypionate (USP), Estradiol enanthate (USAN), Estradiol undecylate (USAN/INN), Gestodene (USAN/INN), Norgestimate (USP/INN), Testosterone ketolaurate (USAN/INN), Testosterone phenylacetate (USAN), Testosterone undecanoate (USAN), Polyestradiol phosphate (INN), Chlormadinone (INN), Clomifene (INN), Cyproterone (INN), Delmadinone (INN), Hexestrol diphosphate sodium, Estradiol hemihydrate, Estradiol 17 beta-hemisuccinate, Estriol succinate, Estriol sodium succinate (BAN), Ethinylestradiol propanesulfonate, Hydroxyprogesterone (INN), Hydroxyprogesterone 17alfa-acetate, Medroxyprogesterone (INN), Norethisterone enantate, Raloxifene (INN), Tamoxifen (INN), Testosterone decanoate, Testosterone phenylpropionate, Toremifene (INN), Onapristone (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\")', 'map07226', 'Progesterone, androgen and estrogen receptor agonists/antagonists', 'Progesterone, androgen and estrogen receptor agonists/antagonists', 'Progesterone, Estrone, Testosterone, Estradiol-17beta, Estriol, Progesterone (JP17/USP/INN), Estrone (JAN/USP/INN), Testosterone (JAN/USP), Estradiol (JAN/USP/INN), Norethindrone (USP), Estriol (JP17/USP), Danazol (JP17/USP/INN), Estrone sodium sulfate, Fluoxymesterone (JAN/USP/INN), Methyltestosterone (JP17/USP/INN), Stanozolol (JAN/USP/INN), Oxandrolone (JAN/USP/INN), Ethinyl estradiol (USP), Mestranol (JP17/USP/INN), Diethylstilbestrol (USP/INN), Mifepristone (JAN/USAN/INN), Flutamide (JP17/USP/INN), Diethylstilbestrol diphosphate (USP), Hydroxyprogesterone caproate (JAN/USP/INN), Medroxyprogesterone acetate (JP17/USP), Norethindrone acetate (USP), Testosterone cypionate (USP), Testosterone enanthate (JP17/USP), Testosterone propionate (JP17/USP), Bicalutamide (JAN/USP/INN), Clomiphene citrate (USP), Nilutamide (USAN/INN), Tamoxifen citrate (JP17/USP), Toremifene citrate (JAN/USAN), Gestonorone caproate (JAN/USAN), Fulvestrant (JAN/USAN/INN), Dydrogesterone (JP17/USP/INN), Epitiostanol (JAN/INN), Cyclofenil (JAN/INN), Chlormadinone acetate (JP17/USAN), Oxendolone (JAN/USAN/INN), Cyproterone acetate (JAN/USAN), Estradiol valerate (JAN/USP/INN), Mepitiostane (JP17/INN), Estradiol dipropionate (JAN), Estradiol benzoate (JP17), Estriol tripropionate (JAN), Estriol diacetate benzoate (JAN), Desogestrel (USAN/INN), Asoprisnil (USAN/INN), Delmadinone acetate (USAN), Estradiol acetate (USAN), Estradiol cypionate (USP), Estradiol enanthate (USAN), Estradiol undecylate (USAN/INN), Gestodene (USAN/INN), Norgestimate (USP/INN), Testosterone ketolaurate (USAN/INN), Testosterone phenylacetate (USAN), Testosterone undecanoate (USAN), Polyestradiol phosphate (INN), Chlormadinone (INN), Clomifene (INN), Cyproterone (INN), Delmadinone (INN), Hexestrol diphosphate sodium, Estradiol hemihydrate, Estradiol 17 beta-hemisuccinate, Estriol succinate, Estriol sodium succinate (BAN), Ethinylestradiol propanesulfonate, Hydroxyprogesterone (INN), Hydroxyprogesterone 17alfa-acetate, Medroxyprogesterone (INN), Norethisterone enantate, Raloxifene (INN), Tamoxifen (INN), Testosterone decanoate, Testosterone phenylpropionate, Toremifene (INN), Onapristone (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\"), list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (529, '07227', 'Histamine H2/H3 receptor agonists/antagonists', 'Histamine H2/H3 receptor agonists/antagonists', 'Histamine, Burimamide, N-Guanylhistamine, Thiaburimamide, 4-Methylhistamine, Dimaprit, Imetit, Immepip, Thioperamide, Clobenpropit, Cimetidine (JP17/USP/INN), Famotidine (JP17/USP/INN), Ranitidine (USAN/INN), Nizatidine (JP17/USP/INN), Ranitidine hydrochloride (JP17/USP), Lafutidine (JP17/INN), Roxatidine acetate hydrochloride (JP17/USAN), Cimetidine hydrochloride (USP), Impromidine hydrochloride (USAN), Metiamide (USAN/INN), Ranitidine bismuth citrate (USAN), Tiotidine (USAN/INN), Niperotidine (INN), Roxatidine (INN), Roxatidine acetate (BAN)', 'list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\")', 'map07227', 'Histamine H2/H3 receptor agonists/antagonists', 'Histamine H2/H3 receptor agonists/antagonists', 'Histamine, Burimamide, N-Guanylhistamine, Thiaburimamide, 4-Methylhistamine, Dimaprit, Imetit, Immepip, Thioperamide, Clobenpropit, Cimetidine (JP17/USP/INN), Famotidine (JP17/USP/INN), Ranitidine (USAN/INN), Nizatidine (JP17/USP/INN), Ranitidine hydrochloride (JP17/USP), Lafutidine (JP17/INN), Roxatidine acetate hydrochloride (JP17/USAN), Cimetidine hydrochloride (USP), Impromidine hydrochloride (USAN), Metiamide (USAN/INN), Ranitidine bismuth citrate (USAN), Tiotidine (USAN/INN), Niperotidine (INN), Roxatidine (INN), Roxatidine acetate (BAN)', 'list(REFERENCE = \"\", AUTHORS = \"Yamakawa K., Kanaoka Y., Iwasawa Y.\", TITLE = \"[Medicinal Chemistry (5th ed)] (In Japanase)\", JOURNAL = \"Kodansha Scientific\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (530, '07228', 'Eicosanoid receptor agonists/antagonists', 'Eicosanoid receptor agonists/antagonists', 'Dinoprostone (JAN/USP/INN), Dinoprost (JP17/USAN/INN), Epoprostenol (USAN/INN), Alprostadil (JP17/USP/INN), Latanoprost (JAN/USAN/INN), Zafirlukast (JAN/USAN/INN), Misoprostol (JAN/USAN/INN), Montelukast sodium (JP17/USAN), Carboprost tromethamine (USP), Seratrodast (JAN/USAN/INN), Ramatroban (JAN/INN), Pimilprost (JAN/INN), Epoprostenol sodium (JAN/USAN), Dinoprost tromethamine (JAN/USP), Ibudilast (JP17/INN), Isopropyl unoprostone (JAN), Beraprost sodium (JP17/USAN), Ornoprostil (JAN/INN), Enprostil (JAN/USAN/INN), Travoprost (JAN/USAN/INN), Clinprost (JAN/INN), Gemeprost (JAN/USAN/INN), Carboprost (USAN/INN), Alprostadil alfadex (JP17), Rosaprostol (INN), Beraprost (USAN), Iloprost (USAN/INN), Limaprost (INN), Bimatoprost (JAN/USAN/INN), Sulprostone (USAN/INN), Pranlukast hydrate (JP17), Limaprost alfadex (JP17), Butaprost (USAN/INN), Dinoprostone betadex (JAN), Carboprost methyl (USAN), Rioprostil (USAN/INN), Treprostinil (JAN/USAN/INN), Tafluprost (JAN/USAN/INN), Iloprost tromethamine, Montelukast (INN), Pranlukast (INN), Treprostinil monosodium salt, Unoprostone (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\"), list(REFERENCE = \"\", AUTHORS = \"Brunton LL, Lazo JS, Parker KL.\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics, eleventh edition\", JOURNAL = \"McGraw-Hill (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Watanabe T., Kamisaki Y.\", TITLE = \"[Molecular Targeting Pharmacology 2nd Ed)] (In Japanase)\", JOURNAL = \"Ishiyaku Publishers\")', 'map07228', 'Eicosanoid receptor agonists/antagonists', 'Eicosanoid receptor agonists/antagonists', 'Dinoprostone (JAN/USP/INN), Dinoprost (JP17/USAN/INN), Epoprostenol (USAN/INN), Alprostadil (JP17/USP/INN), Latanoprost (JAN/USAN/INN), Zafirlukast (JAN/USAN/INN), Misoprostol (JAN/USAN/INN), Montelukast sodium (JP17/USAN), Carboprost tromethamine (USP), Seratrodast (JAN/USAN/INN), Ramatroban (JAN/INN), Pimilprost (JAN/INN), Epoprostenol sodium (JAN/USAN), Dinoprost tromethamine (JAN/USP), Ibudilast (JP17/INN), Isopropyl unoprostone (JAN), Beraprost sodium (JP17/USAN), Ornoprostil (JAN/INN), Enprostil (JAN/USAN/INN), Travoprost (JAN/USAN/INN), Clinprost (JAN/INN), Gemeprost (JAN/USAN/INN), Carboprost (USAN/INN), Alprostadil alfadex (JP17), Rosaprostol (INN), Beraprost (USAN), Iloprost (USAN/INN), Limaprost (INN), Bimatoprost (JAN/USAN/INN), Sulprostone (USAN/INN), Pranlukast hydrate (JP17), Limaprost alfadex (JP17), Butaprost (USAN/INN), Dinoprostone betadex (JAN), Carboprost methyl (USAN), Rioprostil (USAN/INN), Treprostinil (JAN/USAN/INN), Tafluprost (JAN/USAN/INN), Iloprost tromethamine, Montelukast (INN), Pranlukast (INN), Treprostinil monosodium salt, Unoprostone (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\"), list(REFERENCE = \"\", AUTHORS = \"Brunton LL, Lazo JS, Parker KL.\", TITLE = \"Goodman & Gilman\'s The Pharmacological Basis of Therapeutics, eleventh edition\", JOURNAL = \"McGraw-Hill (2005)\"), list(REFERENCE = \"\", AUTHORS = \"Watanabe T., Kamisaki Y.\", TITLE = \"[Molecular Targeting Pharmacology 2nd Ed)] (In Japanase)\", JOURNAL = \"Ishiyaku Publishers\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (531, '07229', 'Angiotensin receptor and endothelin receptor antagonists', 'Angiotensin receptor and endothelin receptor antagonists', 'Angiotensin II, CV 2961, PD 123177, PD 123319, Losartan potassium (JP17/USAN), Valsartan (JP17/USAN/INN), Candesartan (USAN/INN), Irbesartan (JP17/USAN/INN), Candesartan cilexetil (JP17/USAN), Telmisartan (JP17/USAN/INN), Olmesartan medoxomil (JP17/USAN), Bosentan (USAN), Eprosartan mesylate (USAN), Eprosartan (USAN/INN), Saralasin acetate (USAN), Olmesartan (USAN/INN), Ambrisentan (JAN/INN), Bosentan (INN), Losartan (INN)', 'map07229', 'Angiotensin receptor and endothelin receptor antagonists', 'Angiotensin receptor and endothelin receptor antagonists', 'Angiotensin II, CV 2961, PD 123177, PD 123319, Losartan potassium (JP17/USAN), Valsartan (JP17/USAN/INN), Candesartan (USAN/INN), Irbesartan (JP17/USAN/INN), Candesartan cilexetil (JP17/USAN), Telmisartan (JP17/USAN/INN), Olmesartan medoxomil (JP17/USAN), Bosentan (USAN), Eprosartan mesylate (USAN), Eprosartan (USAN/INN), Saralasin acetate (USAN), Olmesartan (USAN/INN), Ambrisentan (JAN/INN), Bosentan (INN), Losartan (INN)', 'map07229', 'Angiotensin receptor and endothelin receptor antagonists', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (532, '07230', 'GABA-A receptor agonists/antagonists', 'GABA-A receptor agonists/antagonists', 'Thiopental, Bicuculline, Picrotoxinin, Alprazolam (JP17/USP/INN), Chlordiazepoxide (JP17/USP/INN), Clonazepam (JP17/USP/INN), Diazepam (JP17/USP/INN), Estazolam (JP17/USAN/INN), Flurazepam (JAN/INN), Lorazepam (JP17/USP/INN), Temazepam (USP/INN), Triazolam (JAN/USP/INN), Secobarbital (USP/INN), Quazepam (JAN/USP/INN), Oxazepam (JAN/USP/INN), Prazepam (JP17/USAN/INN), Primidone (JP17/USP/INN), Pentobarbital (USP/INN), Pentobarbital sodium (JAN/USP), Phenobarbital (JP17/USP/INN), Nitrazepam (JP17/USAN/INN), Propofol (JAN/USAN/INN), Midazolam (JAN/USP/INN), Amobarbital (JP17/INN), Chlordiazepoxide hydrochloride (JAN/USP), Clorazepate dipotassium (JP17/USP), Flurazepam hydrochloride (USP), Midazolam hydrochloride (USAN), Flumazenil (JAN/USP/INN), Mephobarbital (JAN/USP), Phenobarbital sodium (JAN/USP/INN), Zolpidem tartrate (JP17/USAN), Thiamylal sodium (JP17), Thiopental sodium (JP17/USP/INN), Hexobarbital (JAN/INN), Flunitrazepam (JP17/USAN/INN), Bromazepam (JP17/USAN/INN), Tofisopam (JP17/INN), Cloxazolam (JP17/INN), Oxazolam (JP17/INN), Flutoprazepam (JP17/INN), Flutazolam (JAN/INN), Medazepam (JP17/INN), Ethyl loflazepate (JAN/INN), Secobarbital sodium (JAN/USP), Mexazolam (JAN/INN), Clotiazepam (JP17/INN), Fludiazepam (JP17/INN), Zopiclone (JAN/INN), Flurazepam hydrochloride (JP17), Etizolam (JP17/INN), Rilmazafone hydrochloride hydrate (JAN), Nimetazepam (JAN/INN), Lormetazepam (JAN/USAN/INN), Barbital (JP17/INN), Brotizolam (JP17/USAN/INN), Haloxazolam (JP17/INN), Amobarbital sodium (JAN/USP), Pentobarbital calcium (JP17), Butobarbital (BAN), Eszopiclone (JAN/USAN/INN), Clorazepate monopotassium (USAN), Fospropofol disodium (USAN), Medazepam hydrochloride (USAN), Midazolam maleate (USAN), Thiamylal, Pentetrazol (INN), Phenobarbital diethylamine, Rilmazafone (INN), Zolpidem (INN)', 'map07230', 'GABA-A receptor agonists/antagonists', 'GABA-A receptor agonists/antagonists', 'Thiopental, Bicuculline, Picrotoxinin, Alprazolam (JP17/USP/INN), Chlordiazepoxide (JP17/USP/INN), Clonazepam (JP17/USP/INN), Diazepam (JP17/USP/INN), Estazolam (JP17/USAN/INN), Flurazepam (JAN/INN), Lorazepam (JP17/USP/INN), Temazepam (USP/INN), Triazolam (JAN/USP/INN), Secobarbital (USP/INN), Quazepam (JAN/USP/INN), Oxazepam (JAN/USP/INN), Prazepam (JP17/USAN/INN), Primidone (JP17/USP/INN), Pentobarbital (USP/INN), Pentobarbital sodium (JAN/USP), Phenobarbital (JP17/USP/INN), Nitrazepam (JP17/USAN/INN), Propofol (JAN/USAN/INN), Midazolam (JAN/USP/INN), Amobarbital (JP17/INN), Chlordiazepoxide hydrochloride (JAN/USP), Clorazepate dipotassium (JP17/USP), Flurazepam hydrochloride (USP), Midazolam hydrochloride (USAN), Flumazenil (JAN/USP/INN), Mephobarbital (JAN/USP), Phenobarbital sodium (JAN/USP/INN), Zolpidem tartrate (JP17/USAN), Thiamylal sodium (JP17), Thiopental sodium (JP17/USP/INN), Hexobarbital (JAN/INN), Flunitrazepam (JP17/USAN/INN), Bromazepam (JP17/USAN/INN), Tofisopam (JP17/INN), Cloxazolam (JP17/INN), Oxazolam (JP17/INN), Flutoprazepam (JP17/INN), Flutazolam (JAN/INN), Medazepam (JP17/INN), Ethyl loflazepate (JAN/INN), Secobarbital sodium (JAN/USP), Mexazolam (JAN/INN), Clotiazepam (JP17/INN), Fludiazepam (JP17/INN), Zopiclone (JAN/INN), Flurazepam hydrochloride (JP17), Etizolam (JP17/INN), Rilmazafone hydrochloride hydrate (JAN), Nimetazepam (JAN/INN), Lormetazepam (JAN/USAN/INN), Barbital (JP17/INN), Brotizolam (JP17/USAN/INN), Haloxazolam (JP17/INN), Amobarbital sodium (JAN/USP), Pentobarbital calcium (JP17), Butobarbital (BAN), Eszopiclone (JAN/USAN/INN), Clorazepate monopotassium (USAN), Fospropofol disodium (USAN), Medazepam hydrochloride (USAN), Midazolam maleate (USAN), Thiamylal, Pentetrazol (INN), Phenobarbital diethylamine, Rilmazafone (INN), Zolpidem (INN)', 'map07230', 'GABA-A receptor agonists/antagonists', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (533, '07231', 'Sodium channel blocking drugs', 'Sodium channel blocking drugs', 'Cocaine (USP), Ajmaline (JP17), Carbamazepine (JP17/USP/INN), Disopyramide (JP17/USAN/INN), Lamotrigine (JAN/USAN/INN), Lidocaine (JP17/USP/INN), Procainamide hydrochloride (JP17/USP), Phenytoin (JP17/USP/INN), Topiramate (JAN/USAN/INN), Zonisamide (JP17/USAN/INN), Tetracaine (USP/INN), Benzocaine (USP/INN), Prilocaine (USP/INN), Bepridil hydrochloride (USAN), Amiodarone hydrochloride (JP17/USAN), Disopyramide phosphate (JAN/USP), Flecainide acetate (JP17/USP), Mexiletine hydrochloride (JP17/USP), Propafenone hydrochloride (JP17/USP), Quinidine gluconate (USP), Quinidine polygalacturonate, Dibucaine (USP), Mepivacaine hydrochloride (JP17/USP), Procaine hydrochloride (JP17/USP), Tetracaine hydrochloride (JP17/USP), Levobupivacaine hydrochloride (JAN/USAN), Aprindine hydrochloride (JP17/USAN), Bupivacaine hydrochloride (USP), Cifenline succinate (USAN), Ambroxol hydrochloride (JAN), Pilsicainide hydrochloride hydrate (JP17), Pirmenol hydrochloride hydrate (JAN), Lidocaine hydrochloride (JAN/USP), Tocainide hydrochloride (USP), Proparacaine hydrochloride (USP), Phenytoin sodium (USP), Cocaine hydrochloride (JP17/USP), Dibucaine hydrochloride (JP17/USP), Quinidine sulfate (USP), Dronedarone (INN), Amiodarone (USAN/INN), Aprindine (USAN/INN), Cifenline (USAN), Dronedarone hydrochloride (USAN), Ropivacaine hydrochloride (USP), Tocainide (USAN/INN), Pirmenol hydrochloride (USAN), Ambroxol (INN), Bepridil (INN), Bupivacaine (USAN/INN), Fosphenytoin sodium hydrate (JAN), Flecainide (INN), Fosphenytoin (INN), Levobupivacaine (INN), Lidocaine hydrochloride monohydrate, Mepivacaine (INN), Mexiletine (INN), Pilsicainide (INN), Pirmenol (INN), Procainamide (INN), Procaine (INN), Propafenone (INN), Proxymetacaine (INN), Quinidine (BAN), Quinidine phenylethylbarbiturate, Ropivacaine (INN)', 'map07231', 'Sodium channel blocking drugs', 'Sodium channel blocking drugs', 'Cocaine (USP), Ajmaline (JP17), Carbamazepine (JP17/USP/INN), Disopyramide (JP17/USAN/INN), Lamotrigine (JAN/USAN/INN), Lidocaine (JP17/USP/INN), Procainamide hydrochloride (JP17/USP), Phenytoin (JP17/USP/INN), Topiramate (JAN/USAN/INN), Zonisamide (JP17/USAN/INN), Tetracaine (USP/INN), Benzocaine (USP/INN), Prilocaine (USP/INN), Bepridil hydrochloride (USAN), Amiodarone hydrochloride (JP17/USAN), Disopyramide phosphate (JAN/USP), Flecainide acetate (JP17/USP), Mexiletine hydrochloride (JP17/USP), Propafenone hydrochloride (JP17/USP), Quinidine gluconate (USP), Quinidine polygalacturonate, Dibucaine (USP), Mepivacaine hydrochloride (JP17/USP), Procaine hydrochloride (JP17/USP), Tetracaine hydrochloride (JP17/USP), Levobupivacaine hydrochloride (JAN/USAN), Aprindine hydrochloride (JP17/USAN), Bupivacaine hydrochloride (USP), Cifenline succinate (USAN), Ambroxol hydrochloride (JAN), Pilsicainide hydrochloride hydrate (JP17), Pirmenol hydrochloride hydrate (JAN), Lidocaine hydrochloride (JAN/USP), Tocainide hydrochloride (USP), Proparacaine hydrochloride (USP), Phenytoin sodium (USP), Cocaine hydrochloride (JP17/USP), Dibucaine hydrochloride (JP17/USP), Quinidine sulfate (USP), Dronedarone (INN), Amiodarone (USAN/INN), Aprindine (USAN/INN), Cifenline (USAN), Dronedarone hydrochloride (USAN), Ropivacaine hydrochloride (USP), Tocainide (USAN/INN), Pirmenol hydrochloride (USAN), Ambroxol (INN), Bepridil (INN), Bupivacaine (USAN/INN), Fosphenytoin sodium hydrate (JAN), Flecainide (INN), Fosphenytoin (INN), Levobupivacaine (INN), Lidocaine hydrochloride monohydrate, Mepivacaine (INN), Mexiletine (INN), Pilsicainide (INN), Pirmenol (INN), Procainamide (INN), Procaine (INN), Propafenone (INN), Proxymetacaine (INN), Quinidine (BAN), Quinidine phenylethylbarbiturate, Ropivacaine (INN)', 'map07231', 'Sodium channel blocking drugs', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (534, '07232', 'Potassium channel blocking and opening drugs', 'Potassium channel blocking and opening drugs', 'Bretylium, Pinacidil, Clofilium, E-4031, Azimilide, Chromanol 293B, Diazoxide (JAN/USP/INN), Glyburide (USP), Tolbutamide (JP17/USP/INN), Minoxidil (JAN/USP/INN), Terfenadine (JAN/USAN/INN), Amiodarone hydrochloride (JP17/USAN), Bretylium tosylate (USP), Dofetilide (JAN/USAN/INN), Ibutilide fumarate (USAN), Sotalol hydrochloride (JAN/USP), Nicorandil (JP17/USAN/INN), Nifekalant hydrochloride (JAN), Levcromakalim (USAN/INN), Dronedarone (INN), Amiodarone (USAN/INN), Azimilide dihydrochloride (USAN), Clofilium phosphate (USAN/INN), Dexsotalol hydrochloride (USAN), Dronedarone hydrochloride (USAN), Sematilide hydrochloride (USAN), Pinacidil (USAN), Tolbutamide sodium, sterile, Tedisamil (USAN), Tedisamil sesquifumarate (USAN), Bunaftine (INN), Ibutilide (INN), Sotalol (INN), Ezogabine (USAN), Terikalant (INN)', 'list(REFERENCE = \"PMID:16394574\", AUTHORS = \"Kurachi Y, Yamada M\", TITLE = \"[Relationship between function and structure of ATP-sensitive K+ (KATP) channels].\", JOURNAL = c(\"Nippon Yakurigaku Zasshi 126:311-6 (2005)\", \"DOI:10.1254/fpj.126.311\")), list(REFERENCE = \"PMID:19491413\", AUTHORS = \"Sandhiya S, Dkhar SA\", TITLE = \"Potassium channels in health, disease &amp; development of channel modulators.\", JOURNAL = \"Indian J Med Res 129:223-32 (2009)\"), list(REFERENCE = \"PMID:18651412\", AUTHORS = \"Riera AR, Uchida AH, Ferreira C, Ferreira Filho C, Schapachnik E, Dubner S, Zhang L, Moffa PJ\", TITLE = \"Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.\", JOURNAL = \"Cardiol J 15:209-19 (2008)\"), list(REFERENCE = \"\", AUTHORS = \"Kodama I, et. al\", TITLE = \"[Guidelines for Drug Treatment of Arrhythmias (JCS 2009)] (in Japanese)\", JOURNAL = \"\")', 'map07232', 'Potassium channel blocking and opening drugs', 'Potassium channel blocking and opening drugs', 'Bretylium, Pinacidil, Clofilium, E-4031, Azimilide, Chromanol 293B, Diazoxide (JAN/USP/INN), Glyburide (USP), Tolbutamide (JP17/USP/INN), Minoxidil (JAN/USP/INN), Terfenadine (JAN/USAN/INN), Amiodarone hydrochloride (JP17/USAN), Bretylium tosylate (USP), Dofetilide (JAN/USAN/INN), Ibutilide fumarate (USAN), Sotalol hydrochloride (JAN/USP), Nicorandil (JP17/USAN/INN), Nifekalant hydrochloride (JAN), Levcromakalim (USAN/INN), Dronedarone (INN), Amiodarone (USAN/INN), Azimilide dihydrochloride (USAN), Clofilium phosphate (USAN/INN), Dexsotalol hydrochloride (USAN), Dronedarone hydrochloride (USAN), Sematilide hydrochloride (USAN), Pinacidil (USAN), Tolbutamide sodium, sterile, Tedisamil (USAN), Tedisamil sesquifumarate (USAN), Bunaftine (INN), Ibutilide (INN), Sotalol (INN), Ezogabine (USAN), Terikalant (INN)', 'list(REFERENCE = \"PMID:16394574\", AUTHORS = \"Kurachi Y, Yamada M\", TITLE = \"[Relationship between function and structure of ATP-sensitive K+ (KATP) channels].\", JOURNAL = c(\"Nippon Yakurigaku Zasshi 126:311-6 (2005)\", \"DOI:10.1254/fpj.126.311\")), list(REFERENCE = \"PMID:19491413\", AUTHORS = \"Sandhiya S, Dkhar SA\", TITLE = \"Potassium channels in health, disease &amp; development of channel modulators.\", JOURNAL = \"Indian J Med Res 129:223-32 (2009)\"), list(REFERENCE = \"PMID:18651412\", AUTHORS = \"Riera AR, Uchida AH, Ferreira C, Ferreira Filho C, Schapachnik E, Dubner S, Zhang L, Moffa PJ\", TITLE = \"Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.\", JOURNAL = \"Cardiol J 15:209-19 (2008)\"), list(REFERENCE = \"\", AUTHORS = \"Kodama I, et. al\", TITLE = \"[Guidelines for Drug Treatment of Arrhythmias (JCS 2009)] (in Japanese)\", JOURNAL = \"\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (535, '07233', 'Ion transporter inhibitors', 'Ion transporter inhibitors', 'G-Strophanthin (JAN), Bumetanide (JP17/USP/INN), Chlorthalidone (USP), Digitoxin (JAN/USP/INN), Digoxin (JP17/USP), Ethacrynic acid (USP), Furosemide (JP17/USP/INN), Hydrochlorothiazide (JP17/USP/INN), Indapamide (JP17/USP), Lansoprazole (JP17/USP/INN), Torsemide (USP), Metolazone (JAN/USP/INN), Omeprazole (JP17/USP/INN), Quinethazone (JAN/INN), Chlorothiazide (JAN/USP/INN), Trichlormethiazide (JP17/USP/INN), Rabeprazole sodium (JP17/USAN), Omeprazole sodium (USAN), Deslanoside (JP17/USP/INN), Benzylhydrochlorothiazide (JAN), Azosemide (JP17/USAN/INN), Proscillaridin (JAN/USAN/INN), Meticrane (JP17/INN), Piretanide (JAN/USAN/INN), Mefruside (JP17/USAN/INN), Tripamide (JAN/USAN/INN), Tenatoprazole (JAN/INN), Lanatoside C (JAN/INN), Esomeprazole magnesium (USP), Metildigoxin (JP17), Pantoprazole sodium (USAN), Esomeprazole sodium (USAN), Ethacrynate sodium (USP), Muzolimine (USAN/INN), Omeprazole magnesium (USAN), Omeprazole sodium injection (JAN), Pantoprazole (USAN/INN), Indapamide hydrate, Acetyldigitoxin (INN), Gitoformate (INN), Acetyldigoxin, beta-Acetyldigoxin, Esomeprazole (INN), Sodium furosemide, Furosemide diolamine, Rabeprazole (INN), Torasemide sodium, Esomeprazole potassium (USAN), Metildigoxin (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\")', 'map07233', 'Ion transporter inhibitors', 'Ion transporter inhibitors', 'G-Strophanthin (JAN), Bumetanide (JP17/USP/INN), Chlorthalidone (USP), Digitoxin (JAN/USP/INN), Digoxin (JP17/USP), Ethacrynic acid (USP), Furosemide (JP17/USP/INN), Hydrochlorothiazide (JP17/USP/INN), Indapamide (JP17/USP), Lansoprazole (JP17/USP/INN), Torsemide (USP), Metolazone (JAN/USP/INN), Omeprazole (JP17/USP/INN), Quinethazone (JAN/INN), Chlorothiazide (JAN/USP/INN), Trichlormethiazide (JP17/USP/INN), Rabeprazole sodium (JP17/USAN), Omeprazole sodium (USAN), Deslanoside (JP17/USP/INN), Benzylhydrochlorothiazide (JAN), Azosemide (JP17/USAN/INN), Proscillaridin (JAN/USAN/INN), Meticrane (JP17/INN), Piretanide (JAN/USAN/INN), Mefruside (JP17/USAN/INN), Tripamide (JAN/USAN/INN), Tenatoprazole (JAN/INN), Lanatoside C (JAN/INN), Esomeprazole magnesium (USP), Metildigoxin (JP17), Pantoprazole sodium (USAN), Esomeprazole sodium (USAN), Ethacrynate sodium (USP), Muzolimine (USAN/INN), Omeprazole magnesium (USAN), Omeprazole sodium injection (JAN), Pantoprazole (USAN/INN), Indapamide hydrate, Acetyldigitoxin (INN), Gitoformate (INN), Acetyldigoxin, beta-Acetyldigoxin, Esomeprazole (INN), Sodium furosemide, Furosemide diolamine, Rabeprazole (INN), Torasemide sodium, Esomeprazole potassium (USAN), Metildigoxin (INN)', 'list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (536, '07234', 'Neurotransmitter transporter inhibitors', 'Neurotransmitter transporter inhibitors', 'Cocaine (USP), Amoxapine (JP17/USP/INN), Fluoxetine (USAN/INN), Mazindol (JAN/USP/INN), Trimipramine (USAN/INN), Amitriptyline hydrochloride (JP17/USP), Clomipramine hydrochloride (JP17/USP), Desipramine hydrochloride (JAN/USP), Imipramine hydrochloride (JP17/USP), Nortriptyline hydrochloride (JP17/USP/INN), Maprotiline hydrochloride (JP17/USP), Trazodone hydrochloride (JAN/USP), Venlafaxine hydrochloride (JAN/USAN), Citalopram hydrobromide (USAN), Fluoxetine hydrochloride (JAN/USP), Fluvoxamine maleate (JP17/USAN), Sertraline hydrochloride (JAN/USAN), Milnacipran hydrochloride (JAN/USAN), Duloxetine hydrochloride (JAN/USP), Lofepramine hydrochloride (JAN/USAN), Dothiepin hydrochloride (USAN), Amphetamine sulfate (USP), Dextroamphetamine sulfate (USP), Cocaine hydrochloride (JP17/USP), Methamphetamine hydrochloride (JP17/USP), Paroxetine hydrochloride hydrate (JP17), Sertraline (INN), Paroxetine (USP/INN), Trimipramine maleate (JAN/USAN), Maprotiline (USAN), Escitalopram oxalate (JAN/USAN), Desvenlafaxine succinate (USAN), Reboxetine mesylate (USAN), Atomoxetine hydrochloride (JAN/USP), Amfonelic acid (USAN), Dextroamphetamine (USAN), Nisoxetine (USAN/INN), Nomifensine maleate (USAN), Paroxetine hydrochloride (USP), Paroxetine mesylate (USAN), Imipraminoxide (INN), Amfetamine (INN), Amitriptyline (INN), Amitriptylinoxide (INN), Atomoxetine (USP/INN), Citalopram (USP/INN), Citalopram hydrochloride, Clomipramine (INN), Desipramine (INN), Desvenlafaxine (INN), Dosulepin (INN), Duloxetine (INN), Escitalopram (INN), Fluvoxamine (INN), Imipramine (INN), Imipramine pamoate (USP), Lofepramine (INN), Metamfetamine (INN), Milnacipran (INN), Nortriptyline (INN), Reboxetine (INN), Trazodone (INN), Venlafaxine (INN), Esreboxetine (USAN/INN), Esreboxetine succinate (USAN)', 'list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\")', 'map07234', 'Neurotransmitter transporter inhibitors', 'Neurotransmitter transporter inhibitors', 'Cocaine (USP), Amoxapine (JP17/USP/INN), Fluoxetine (USAN/INN), Mazindol (JAN/USP/INN), Trimipramine (USAN/INN), Amitriptyline hydrochloride (JP17/USP), Clomipramine hydrochloride (JP17/USP), Desipramine hydrochloride (JAN/USP), Imipramine hydrochloride (JP17/USP), Nortriptyline hydrochloride (JP17/USP/INN), Maprotiline hydrochloride (JP17/USP), Trazodone hydrochloride (JAN/USP), Venlafaxine hydrochloride (JAN/USAN), Citalopram hydrobromide (USAN), Fluoxetine hydrochloride (JAN/USP), Fluvoxamine maleate (JP17/USAN), Sertraline hydrochloride (JAN/USAN), Milnacipran hydrochloride (JAN/USAN), Duloxetine hydrochloride (JAN/USP), Lofepramine hydrochloride (JAN/USAN), Dothiepin hydrochloride (USAN), Amphetamine sulfate (USP), Dextroamphetamine sulfate (USP), Cocaine hydrochloride (JP17/USP), Methamphetamine hydrochloride (JP17/USP), Paroxetine hydrochloride hydrate (JP17), Sertraline (INN), Paroxetine (USP/INN), Trimipramine maleate (JAN/USAN), Maprotiline (USAN), Escitalopram oxalate (JAN/USAN), Desvenlafaxine succinate (USAN), Reboxetine mesylate (USAN), Atomoxetine hydrochloride (JAN/USP), Amfonelic acid (USAN), Dextroamphetamine (USAN), Nisoxetine (USAN/INN), Nomifensine maleate (USAN), Paroxetine hydrochloride (USP), Paroxetine mesylate (USAN), Imipraminoxide (INN), Amfetamine (INN), Amitriptyline (INN), Amitriptylinoxide (INN), Atomoxetine (USP/INN), Citalopram (USP/INN), Citalopram hydrochloride, Clomipramine (INN), Desipramine (INN), Desvenlafaxine (INN), Dosulepin (INN), Duloxetine (INN), Escitalopram (INN), Fluvoxamine (INN), Imipramine (INN), Imipramine pamoate (USP), Lofepramine (INN), Metamfetamine (INN), Milnacipran (INN), Nortriptyline (INN), Reboxetine (INN), Trazodone (INN), Venlafaxine (INN), Esreboxetine (USAN/INN), Esreboxetine succinate (USAN)', 'list(REFERENCE = \"\", AUTHORS = \"Tanaka C., Kato R. (eds)\", TITLE = \"[New pharmacology (revision 5th ed)] (In Japanese)\", JOURNAL = \"Nankodo\")', 0, 0, 0, 0, 0, 0, 0, 0);
INSERT INTO `kegg-pathway-bottleneck`.`pathway_data` (`id`, `code`, `name`, `description`, `class`, `pathway_map`, `module`, `disease`, `dblinks`, `ko_pathway`, `reference`, `eukaryotes_count`, `prokaryotes_count`, `animals_count`, `plants_count`, `fungi_count`, `protists_count`, `bacteria_count`, `archaea_count`) VALUES (537, '07235', 'N-Metyl-D-aspartic acid receptor antagonists', 'N-Metyl-D-aspartic acid receptor antagonists', 'Phencyclidine, Dizocilpine, Ketamine hydrochloride (JP17/USP), Amantadine hydrochloride (JP17/USP), Dextromethorphan hydrobromide (USP), Ifenprodil tartrate (JP17), Methadone hydrochloride (JAN/USP), Besonprodil (USAN), Dextromethorphan (USP), Dextromethorphan polistirex (USAN), Dextrorphan hydrochloride (USAN), Dizocilpine maleate (USAN), Memantine hydrochloride (JAN/USAN), Phencyclidine hydrochloride (USAN), Traxoprodil mesylate (USAN), Esketamine (USAN/INN), Amantadine (INN), Ifenprodil (INN), Ketamine (INN), Levomethadone (INN), Levomethadone hydrochloride, Memantine (INN), Methadone (BAN)', 'map07235', 'N-Metyl-D-aspartic acid receptor antagonists', 'N-Metyl-D-aspartic acid receptor antagonists', 'Phencyclidine, Dizocilpine, Ketamine hydrochloride (JP17/USP), Amantadine hydrochloride (JP17/USP), Dextromethorphan hydrobromide (USP), Ifenprodil tartrate (JP17), Methadone hydrochloride (JAN/USP), Besonprodil (USAN), Dextromethorphan (USP), Dextromethorphan polistirex (USAN), Dextrorphan hydrochloride (USAN), Dizocilpine maleate (USAN), Memantine hydrochloride (JAN/USAN), Phencyclidine hydrochloride (USAN), Traxoprodil mesylate (USAN), Esketamine (USAN/INN), Amantadine (INN), Ifenprodil (INN), Ketamine (INN), Levomethadone (INN), Levomethadone hydrochloride, Memantine (INN), Methadone (BAN)', 'map07235', 'N-Metyl-D-aspartic acid receptor antagonists', 0, 0, 0, 0, 0, 0, 0, 0);

COMMIT;

